Citrus Sinensis ID: 001752
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1018 | 2.2.26 [Sep-21-2011] | |||||||
| Q9M0G7 | 1013 | Leucine-rich repeat recep | yes | no | 0.990 | 0.995 | 0.706 | 0.0 | |
| Q9FRS6 | 1029 | Leucine-rich repeat recep | no | no | 0.988 | 0.977 | 0.604 | 0.0 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.923 | 0.902 | 0.461 | 0.0 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.922 | 0.937 | 0.420 | 0.0 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.906 | 0.920 | 0.428 | 0.0 | |
| Q9SYQ8 | 980 | Receptor protein kinase C | no | no | 0.906 | 0.941 | 0.398 | 0.0 | |
| O65440 | 992 | Leucine-rich repeat recep | no | no | 0.917 | 0.941 | 0.415 | 0.0 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.913 | 0.933 | 0.404 | 0.0 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.945 | 0.848 | 0.386 | 0.0 | |
| C0LGX3 | 993 | LRR receptor-like serine/ | no | no | 0.878 | 0.900 | 0.387 | 1e-174 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1427 bits (3694), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 723/1023 (70%), Positives = 842/1023 (82%), Gaps = 15/1023 (1%)
Query: 1 MQLKILLLVLCFYCYIGCTCFGSAKVVAKTALNDELLALLSIKAGLVDPLNSLHDWKL-- 58
M++KI++L L +YCYIG T + V+A +EL LLS+K+ LVDPLN L DWKL
Sbjct: 1 MKMKIIVLFL-YYCYIGST----SSVLASIDNVNELSVLLSVKSTLVDPLNFLKDWKLSD 55
Query: 59 PSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSL 118
S HCNWTGV CNSNG VEKLDL+ MNL+G +SD +L SL S N+ CNG S LP S+
Sbjct: 56 TSDHCNWTGVRCNSNGNVEKLDLAGMNLTGKISDSISQLSSLVSFNISCNGFESLLPKSI 115
Query: 119 ANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLR 178
LK D+SQN +GS + GL LNASGNN SG L EDLGN SLE LDLR
Sbjct: 116 P---PLKSIDISQNSFSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLR 172
Query: 179 GSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEF 238
G+FFQGS+P SFKNLQKL+FLGLSGNNLTG++P LGQL S+ET IL YNEF G IP EF
Sbjct: 173 GNFFQGSLPSSFKNLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGYNEFKGPIPPEF 232
Query: 239 GNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLS 298
GN+ +LKYLDLA+G L G+IP+ELG+L+ LE + LY+NNF G +P EIG+IT+L++LD S
Sbjct: 233 GNINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFS 292
Query: 299 YNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDL 358
N L+ EIP EIT+LKNLQLLNLM N+LSG +P + L QL+VLELWNN+LSG LP DL
Sbjct: 293 DNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDL 352
Query: 359 GKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQ 418
GKNSPLQWLD+SSNSFSGEIP++LCN GNLTKLILFNN F+G IP +LSTC SLVRVRMQ
Sbjct: 353 GKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQ 412
Query: 419 NNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTI 478
NN L+G+IP+GFG+LEKLQRLELA N L+GGI DI+ S SLSFID SRN +RSSLPSTI
Sbjct: 413 NNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTI 472
Query: 479 LSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLR 538
LSI NLQ F+V++N + GE+PDQFQDCPSLS LDLSSN +G+IPSSIASCEKLV+LNLR
Sbjct: 473 LSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLR 532
Query: 539 NNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANG 598
NN LTG+IP+ I+ M LA+LDLSNNSLTG +PE+ G SPALE+LNVSYN+L GPVP NG
Sbjct: 533 NNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPING 592
Query: 599 VLRTINRGDLAGNAGLCGGVLHPCSRYSPIASSHRSLHAKHIIPGWMIAISSLFAVGIAV 658
L+TIN DL GN+GLCGGVL PCS++ SSH SLH K I+ GW+I I+S+ A+GI
Sbjct: 593 FLKTINPDDLRGNSGLCGGVLPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILT 652
Query: 659 FGARSLYKRWNANGSCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRESNVIGMGAT 718
R+LYK+W +NG C +E KGEWPWRLMAF RLGFT++DILACI+ESN+IGMGAT
Sbjct: 653 IVTRTLYKKWYSNGFCGDET--ASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMGAT 710
Query: 719 GIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND 778
GIVYKAEM R +T++AVKKLWRS AD+E ++GDFVGEVN+LGKLRHRNIVRLLGFL+ND
Sbjct: 711 GIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYND 770
Query: 779 TNMMIVYEYMNNGSLGEALHGKQ-AGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHR 837
NMMIVYE+M NG+LG+A+HGK AGRLLVDWVSRYNIALGVA GLAYLHHDC+PP+IHR
Sbjct: 771 KNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHR 830
Query: 838 DIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIY 897
DIKSNNILLD+NL+ RIADFGLARMM RK ETVSMVAGSYGYIAPEYGYTLKVDEKIDIY
Sbjct: 831 DIKSNNILLDANLDARIADFGLARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIY 890
Query: 898 SFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLL 957
S+GVVLLELLTGRRPL+PEFGESVDIVEW+R KIRDN +LEEALDPNVGNC++VQEEMLL
Sbjct: 891 SYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLL 950
Query: 958 VLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDN--RYENNKEKLVFSTSPVS 1015
VL+IA LCT KLPKDRPSMRDVI+MLGEAKPRRKS+SN +N R K VFSTSPV+
Sbjct: 951 VLQIALLCTTKLPKDRPSMRDVISMLGEAKPRRKSNSNEENTSRSLAEKHSSVFSTSPVN 1010
Query: 1016 GLV 1018
GL+
Sbjct: 1011 GLL 1013
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 1182 bits (3057), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 628/1039 (60%), Positives = 766/1039 (73%), Gaps = 33/1039 (3%)
Query: 3 LKILLLVLCFYCYIGCTCFGSAKVVAKTALNDELLALLSIKAGLVDPLNSLHDWKLPS-- 60
+ I L FY YIG F V ++T N E LL+ K+ L DP N+L DWK P
Sbjct: 1 MAIPRLFFLFY-YIGFALF--PFVSSETFQNSEQEILLAFKSDLFDPSNNLQDWKRPENA 57
Query: 61 ------AHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSL 114
HC+WTGV C++NG V KL LS+MNLSG VSD Q SL +L+L N SSL
Sbjct: 58 TTFSELVHCHWTGVHCDANGYVAKLLLSNMNLSGNVSDQIQSFPSLQALDLSNNAFESSL 117
Query: 115 PNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLET 174
P SL+NLTSLK DVS N G+FP GLG A GLT +NAS NNFSGFL EDLGNAT+LE
Sbjct: 118 PKSLSNLTSLKVIDVSVNSFFGTFPYGLGMATGLTHVNASSNNFSGFLPEDLGNATTLEV 177
Query: 175 LDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEI 234
LD RG +F+GS+P SFKNL+ LKFLGLSGNN GK+P+ +G+LSS+ET+IL YN F GEI
Sbjct: 178 LDFRGGYFEGSVPSSFKNLKNLKFLGLSGNNFGGKVPKVIGELSSLETIILGYNGFMGEI 237
Query: 235 PVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQL 294
P EFG LT L+YLDLAVGNL G+IP+ LG+L+ L ++LYQN G+LP E+G +TSL
Sbjct: 238 PEEFGKLTRLQYLDLAVGNLTGQIPSSLGQLKQLTTVYLYQNRLTGKLPRELGGMTSLVF 297
Query: 295 LDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPL 354
LDLS N ++ EIP E+ +LKNLQLLNLM NQL+G +P+ + L LEVLELW NSL G L
Sbjct: 298 LDLSDNQITGEIPMEVGELKNLQLLNLMRNQLTGIIPSKIAELPNLEVLELWQNSLMGSL 357
Query: 355 PVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVR 414
PV LGKNSPL+WLD+SSN SG+IP+ LC NLTKLILFNN+FSG IP + +C +LVR
Sbjct: 358 PVHLGKNSPLKWLDVSSNKLSGDIPSGLCYSRNLTKLILFNNSFSGQIPEEIFSCPTLVR 417
Query: 415 VRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSL 474
VR+Q N +SG+IP G G L LQ LELA N+LTG I DDIA STSLSFIDIS NHL S
Sbjct: 418 VRIQKNHISGSIPAGSGDLPMLQHLELAKNNLTGKIPDDIALSTSLSFIDISFNHLSSLS 477
Query: 475 PSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVN 534
S+I S PNLQTFI S+NN G+IP+Q QD PSLSVLDLS N+FSG IP IAS EKLV+
Sbjct: 478 -SSIFSSPNLQTFIASHNNFAGKIPNQIQDRPSLSVLDLSFNHFSGGIPERIASFEKLVS 536
Query: 535 LNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPV 594
LNL++NQL G+IPKA++ M LA+LDLSNNSLTG IP + GASP LE+LNVS+N+L+GP+
Sbjct: 537 LNLKSNQLVGEIPKALAGMHMLAVLDLSNNSLTGNIPADLGASPTLEMLNVSFNKLDGPI 596
Query: 595 PANGVLRTINRGDLAGNAGLCGGVLHPCSRYSPIASSHRS---LHAKHIIPGWMIAISSL 651
P+N + I+ DL GN GLCGGVL PCS+ +++ R+ +H H + G+++ S +
Sbjct: 597 PSNMLFAAIDPKDLVGNNGLCGGVLPPCSKSLALSAKGRNPGRIHVNHAVFGFIVGTSVI 656
Query: 652 FAVGIAVFGARSLYKRWNANGSCFEEKL--EMGKGEWPWRLMAFQRLGFTSADILACIRE 709
A+G+ R +Y RW+ + E + + + EWPWRL+AFQRL FT+ DIL+ I+E
Sbjct: 657 VAMGMMFLAGRWIYTRWDLYSNFAREYIFCKKPREEWPWRLVAFQRLCFTAGDILSHIKE 716
Query: 710 SNVIGMGATGIVYKAE-MPRLNTIVAVKKLWRSRA--------DLETESSGDFVGEVNVL 760
SN+IGMGA GIVYKAE M R VAVKKLWRS + E + D + EVN+L
Sbjct: 717 SNIIGMGAIGIVYKAEVMRRPLLTVAVKKLWRSPSPQNDIEDHHQEEDEEDDILREVNLL 776
Query: 761 GKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVA 820
G LRHRNIV++LG++HN+ +M+VYEYM NG+LG ALH K LL DW+SRYN+A+GV
Sbjct: 777 GGLRHRNIVKILGYVHNEREVMMVYEYMPNGNLGTALHSKDEKFLLRDWLSRYNVAVGVV 836
Query: 821 QGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI 880
QGL YLH+DCYPPIIHRDIKSNNILLDSNLE RIADFGLA+MM+ KNETVSMVAGSYGYI
Sbjct: 837 QGLNYLHNDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMMLHKNETVSMVAGSYGYI 896
Query: 881 APEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940
APEYGYTLK+DEK DIYS GVVLLEL+TG+ P+DP F +S+D+VEWIR K++ N +LEE
Sbjct: 897 APEYGYTLKIDEKSDIYSLGVVLLELVTGKMPIDPSFEDSIDVVEWIRRKVKKNESLEEV 956
Query: 941 LDPNV-GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNR 999
+D ++ G+CKHV EEMLL LRIA LCTAKLPKDRPS+RDVITML EAKPRRKS
Sbjct: 957 IDASIAGDCKHVIEEMLLALRIALLCTAKLPKDRPSIRDVITMLAEAKPRRKSVC----- 1011
Query: 1000 YENNKEKLVFSTSPVSGLV 1018
+ + +F SPV GL+
Sbjct: 1012 -QVAGDLPIFRNSPVVGLI 1029
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 822 bits (2123), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/970 (46%), Positives = 617/970 (63%), Gaps = 30/970 (3%)
Query: 49 PLNSLHDWKLP------SAHCNWTGVWC-NSNGAVEKLDLSHMNLSGCVSDHFQRLKSLT 101
P ++ DWK+P + C+W+GV C N V LDLSH NLSG + + L SL
Sbjct: 49 PPSAFQDWKVPVNGQNDAVWCSWSGVVCDNVTAQVISLDLSHRNLSGRIPIQIRYLSSLL 108
Query: 102 SLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGF 161
LNL N L S P S+ +LT L D+S+N + SFP G+ L NA NNF G
Sbjct: 109 YLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISKLKFLKVFNAFSNNFEGL 168
Query: 162 LLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSME 221
L D+ LE L+ GS+F+G IP ++ LQ+LKF+ L+GN L GK+P LG L+ ++
Sbjct: 169 LPSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNVLGGKLPPRLGLLTELQ 228
Query: 222 TMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGR 281
M + YN F+G IP EF L+NLKY D++ +L G +P ELG L LE +FL+QN F G
Sbjct: 229 HMEIGYNHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQNGFTGE 288
Query: 282 LPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLE 341
+P N+ SL+LLD S N LS IP+ + LKNL L+L+ N LSG VP G+G L +L
Sbjct: 289 IPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELPELT 348
Query: 342 VLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGP 401
L LWNN+ +G LP LG N L+ +D+S+NSF+G IP+SLC+G L KLILF+N F G
Sbjct: 349 TLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMFEGE 408
Query: 402 IPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLS 461
+P SL+ C SL R R QNN+L+GTIP+GFG L L ++L+NN T I D A++ L
Sbjct: 409 LPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAPVLQ 468
Query: 462 FIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGS 521
++++S N LP I PNLQ F S +NL+GEIP+ + C S ++L N +G+
Sbjct: 469 YLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIPN-YVGCKSFYRIELQGNSLNGT 527
Query: 522 IPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALE 581
IP I CEKL+ LNL N L G IP IS +P++A +DLS+N LTG IP +FG+S +
Sbjct: 528 IPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSSKTIT 587
Query: 582 VLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVL-HPCS--RY----SPIASSHRS 634
NVSYN+L GP+P+ G +N + N GLCG ++ PC+ R+ + I H+
Sbjct: 588 TFNVSYNQLIGPIPS-GSFAHLNPSFFSSNEGLCGDLVGKPCNSDRFNAGNADIDGHHKE 646
Query: 635 LHAKHIIPG--WMIAISSLFAVGIAVFGARSLYKRWNANGSCFEEKLEMGKGEWPWRLMA 692
K W++A + + V R K + G+ + G PW+L A
Sbjct: 647 ERPKKTAGAIVWILAAAIGVGFFVLVAATRCFQKSY---GNRVDGGGRNGGDIGPWKLTA 703
Query: 693 FQRLGFTSADILACI-RESNVIGMGATGIVYKAEMPRLNTIVAVKKLW---RSRADLETE 748
FQRL FT+ D++ C+ + N++GMG+TG VYKAEMP I+AVKKLW + +
Sbjct: 704 FQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPN-GEIIAVKKLWGKNKENGKIRRR 762
Query: 749 SSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALH-GKQAGRLLV 807
SG + EV+VLG +RHRNIVRLLG N M++YEYM NGSL + LH G +
Sbjct: 763 KSG-VLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAA 821
Query: 808 DWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKN 867
+W + Y IA+GVAQG+ YLHHDC P I+HRD+K +NILLD++ E R+ADFG+A+ +I+ +
Sbjct: 822 EWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAK-LIQTD 880
Query: 868 ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWI 927
E++S+VAGSYGYIAPEY YTL+VD+K DIYS+GV+LLE++TG+R ++PEFGE IV+W+
Sbjct: 881 ESMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGNSIVDWV 940
Query: 928 RMKIRDNRNLEEALDPNVG-NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986
R K++ ++EE LD ++G +C ++EEM +LRIA LCT++ P DRP MRDV+ +L EA
Sbjct: 941 RSKLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQEA 1000
Query: 987 KPRRKSSSNN 996
KP+RK+ +N
Sbjct: 1001 KPKRKTVGDN 1010
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 703 bits (1815), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/1011 (42%), Positives = 579/1011 (57%), Gaps = 72/1011 (7%)
Query: 35 ELLALLSIKAGLVDPLNS--LHDWKLPSAHCNWTGVWCN-SNGAVEKLDLSHMNLSGCVS 91
EL ALLS+K+ +S L W L + C+WTGV C+ S V LDLS +NLSG +S
Sbjct: 27 ELHALLSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTLS 86
Query: 92 DHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLG-GAAGLTF 150
L L +L+L N + +P ++NL L+ ++S N NGSFP L G L
Sbjct: 87 SDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLRV 146
Query: 151 LNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKI 210
L+ NN +G L L N T L L L G++F G IP ++ L++L +SGN LTGKI
Sbjct: 147 LDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTGKI 206
Query: 211 PRELGQLSSM-ETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLE 269
P E+G L+++ E I YN F+ +P E GNL+ L D A L G+IP E+G+L+ L+
Sbjct: 207 PPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKLD 266
Query: 270 IMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGH 329
+FL N F G + E+G I+SL+ +DLS NM + EIP +QLKNL LLNL N+L G
Sbjct: 267 TLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGA 326
Query: 330 VPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLT 389
+P +G + +LEVL+LW N+ +G +P LG+N L LDLSSN +G +P ++C+G L
Sbjct: 327 IPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLM 386
Query: 390 KLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLT-- 447
LI N G IP SL C SL R+RM N L+G+IP L KL ++EL +N LT
Sbjct: 387 TLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGE 446
Query: 448 -----GGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQF 502
GG++ D+ I +S N L SLP+ I ++ +Q ++ N G IP +
Sbjct: 447 LPISGGGVSGDLGQ------ISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEI 500
Query: 503 QDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLS 562
LS LD S N FSG I I+ C+ L ++L N+L+GDIP ++ M L L+LS
Sbjct: 501 GRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLS 560
Query: 563 NNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVLHPC 622
N L G IP + +L ++ SYN L G VP+ G N GN+ LCG L PC
Sbjct: 561 RNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPC 620
Query: 623 SRYSPIASSHRSLHAKHIIP----------GWMIAISSLFAVGIAVFGARSLYKRWNANG 672
+ + H H+ P ++ S +FA+ +A+ ARSL A
Sbjct: 621 GKGT---------HQSHVKPLSATTKLLLVLGLLFCSMVFAI-VAIIKARSLRNASEAKA 670
Query: 673 SCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTI 732
WRL AFQRL FT D+L ++E N+IG G GIVYK MP+ +
Sbjct: 671 ---------------WRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPK-GDL 714
Query: 733 VAVKKLWRSRADLETESSGD--FVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNN 790
VAVK+L A + SS D F E+ LG++RHR+IVRLLGF N ++VYEYM N
Sbjct: 715 VAVKRL----ATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPN 770
Query: 791 GSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL 850
GSLGE LHGK+ G L W +RY IAL A+GL YLHHDC P I+HRD+KSNNILLDSN
Sbjct: 771 GSLGEVLHGKKGGHL--HWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNF 828
Query: 851 EPRIADFGLARMMIRK--NETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT 908
E +ADFGLA+ + +E +S +AGSYGYIAPEY YTLKVDEK D+YSFGVVLLEL+T
Sbjct: 829 EAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 888
Query: 909 GRRPLDPEFGESVDIVEWIRMKIRDNRN-LEEALDPNVGNCKHVQEEMLLVLRIAFLCTA 967
G++P+ EFG+ VDIV+W+R N++ + + +D + + E+ V +A LC
Sbjct: 889 GKKPVG-EFGDGVDIVQWVRSMTDSNKDCVLKVIDLRLSSVP--VHEVTHVFYVALLCVE 945
Query: 968 KLPKDRPSMRDVITMLGEAK--PRRKSSSNNDNRYENNKEKLVFSTSPVSG 1016
+ +RP+MR+V+ +L E P K + + E K + +SP SG
Sbjct: 946 EQAVERPTMREVVQILTEIPKIPLSKQQAAESDVTE--KAPAINESSPDSG 994
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 702 bits (1812), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/971 (42%), Positives = 564/971 (58%), Gaps = 48/971 (4%)
Query: 35 ELLALLSIKAGLV----DPLNSLHDWKLPSAHCNWTGVWCN-SNGAVEKLDLSHMNLSGC 89
E ALLS+K L D + L WK+ ++ C W GV C+ S V LDLS +NLSG
Sbjct: 25 EFRALLSLKTSLTGAGDDKNSPLSSWKVSTSFCTWIGVTCDVSRRHVTSLDLSGLNLSGT 84
Query: 90 VSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLG-GAAGL 148
+S L+ L +L+L N + +P +++L+ L+ ++S N NGSFP + G L
Sbjct: 85 LSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSGLVNL 144
Query: 149 TFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTG 208
L+ NN +G L + N T L L L G++F G IP S+ + +++L +SGN L G
Sbjct: 145 RVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVG 204
Query: 209 KIPRELGQLSSM-ETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLEL 267
KIP E+G L+++ E I YN F+ +P E GNL+ L D A L G+IP E+G+L+
Sbjct: 205 KIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIGKLQK 264
Query: 268 LEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLS 327
L+ +FL N F G L E+G ++SL+ +DLS NM + EIPA +LKNL LLNL N+L
Sbjct: 265 LDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKLH 324
Query: 328 GHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGN 387
G +P +G L +LEVL+LW N+ +G +P LG+N L +DLSSN +G +P ++C+G
Sbjct: 325 GEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSGNK 384
Query: 388 LTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLT 447
L LI N G IP SL C SL R+RM N L+G+IP G L KL ++EL +N L+
Sbjct: 385 LETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYLS 444
Query: 448 GGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPS 507
G + S +L I +S N L LP I + +Q ++ N G IP +
Sbjct: 445 GELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQQ 504
Query: 508 LSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLT 567
LS +D S N FSG I I+ C+ L ++L N+L+G+IP I+ M L L+LS N L
Sbjct: 505 LSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLV 564
Query: 568 GGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVLHPCSRYSP 627
G IP + + +L L+ SYN L G VP G N GN LCG L PC
Sbjct: 565 GSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPCK--DG 622
Query: 628 IASSHRSLHAKHIIPGWM--------IAISSLFAVGIAVFGARSLYKRWNANGSCFEEKL 679
+A H+K + M + S FAV +A+ ARSL K +
Sbjct: 623 VAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAV-VAIIKARSLKKASESRA------- 674
Query: 680 EMGKGEWPWRLMAFQRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLW 739
WRL AFQRL FT D+L ++E N+IG G GIVYK MP +VAVK+L
Sbjct: 675 --------WRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPN-GDLVAVKRL- 724
Query: 740 RSRADLETESSGD--FVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL 797
A + SS D F E+ LG++RHR+IVRLLGF N ++VYEYM NGSLGE L
Sbjct: 725 ---AAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL 781
Query: 798 HGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADF 857
HGK+ G L W +RY IAL A+GL YLHHDC P I+HRD+KSNNILLDSN E +ADF
Sbjct: 782 HGKKGGHL--HWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADF 839
Query: 858 GLARMMIRK--NETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
GLA+ + +E +S +AGSYGYIAPEY YTLKVDEK D+YSFGVVLLEL+TGR+P+
Sbjct: 840 GLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVG- 898
Query: 916 EFGESVDIVEWIRMKIRDNRN-LEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRP 974
EFG+ VDIV+W+R N++ + + LDP + + E+ V +A LC + +RP
Sbjct: 899 EFGDGVDIVQWVRKMTDSNKDSVLKVLDPRLSSIP--IHEVTHVFYVAMLCVEEQAVERP 956
Query: 975 SMRDVITMLGE 985
+MR+V+ +L E
Sbjct: 957 TMREVVQILTE 967
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 670 bits (1729), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/967 (39%), Positives = 548/967 (56%), Gaps = 44/967 (4%)
Query: 35 ELLALLSIKAGLVDPL-NSLHDW---KLPSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCV 90
++ LL++K+ ++ P + LHDW P AHC+++GV C+ + V L++S L G +
Sbjct: 27 DMEVLLNLKSSMIGPKGHGLHDWIHSSSPDAHCSFSGVSCDDDARVISLNVSFTPLFGTI 86
Query: 91 SDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNF-LNGSFPAG-LGGAAGL 148
S L L +L L N LP + +LTSLK ++S N L G+FP L L
Sbjct: 87 SPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEILKAMVDL 146
Query: 149 TFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTG 208
L+ NNF+G L ++ L+ L G+FF G IP S+ ++Q L++LGL+G L+G
Sbjct: 147 EVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIPESYGDIQSLEYLGLNGAGLSG 206
Query: 209 KIPRELGQLSSMETMILAY-NEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLEL 267
K P L +L ++ M + Y N + G +P EFG LT L+ LD+A L G+IP L L+
Sbjct: 207 KSPAFLSRLKNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLSNLKH 266
Query: 268 LEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLS 327
L +FL+ NN G +P E+ + SL+ LDLS N L+ EIP L N+ L+NL N L
Sbjct: 267 LHTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFRNNLY 326
Query: 328 GHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGN 387
G +P +G L +LEV E+W N+ + LP +LG+N L LD+S N +G IP LC G
Sbjct: 327 GQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCRGEK 386
Query: 388 LTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLT 447
L LIL NN F GPIP L C SL ++R+ N L+GT+P G L + +EL +N +
Sbjct: 387 LEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDNFFS 446
Query: 448 GGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPS 507
G + + S L I +S N +P I + PNLQT + N G IP + +
Sbjct: 447 GELPVTM-SGDVLDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREIFELKH 505
Query: 508 LSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLT 567
LS ++ S+N +G IP SI+ C L++++L N++ G+IPK I+ + L L++S N LT
Sbjct: 506 LSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQLT 565
Query: 568 GGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVLHPCSRYSP 627
G IP G +L L++S+N L G VP G N AGN LC C
Sbjct: 566 GSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLPHRVSCPTRPG 625
Query: 628 IASSHRS---LHAKHIIPGWMIAISSLFAVGIAVFGARSLYKRWNANGSCFEEKLEMGKG 684
S H I+ + AI+ L + +A+ R + K+ N +
Sbjct: 626 QTSDHNHTALFSPSRIVITVIAAITGLILISVAI---RQMNKKKN-------------QK 669
Query: 685 EWPWRLMAFQRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRAD 744
W+L AFQ+L F S D+L C++E N+IG G GIVY+ MP N VA+K+L
Sbjct: 670 SLAWKLTAFQKLDFKSEDVLECLKEENIIGKGGAGIVYRGSMPN-NVDVAIKRLVGRGTG 728
Query: 745 LETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGR 804
S F E+ LG++RHR+IVRLLG++ N +++YEYM NGSLGE LHG + G
Sbjct: 729 ---RSDHGFTAEIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGH 785
Query: 805 LLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864
L W +R+ +A+ A+GL YLHHDC P I+HRD+KSNNILLDS+ E +ADFGLA+ ++
Sbjct: 786 L--QWETRHRVAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLV 843
Query: 865 --RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVD 922
+E +S +AGSYGYIAPEY YTLKVDEK D+YSFGVVLLEL+ G++P+ EFGE VD
Sbjct: 844 DGAASECMSSIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVG-EFGEGVD 902
Query: 923 IVEWIRMKIRDNRNLEEA------LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSM 976
IV W+R + +A +DP + + ++ V +IA +C + RP+M
Sbjct: 903 IVRWVRNTEEEITQPSDAAIVVAIVDPRL--TGYPLTSVIHVFKIAMMCVEEEAAARPTM 960
Query: 977 RDVITML 983
R+V+ ML
Sbjct: 961 REVVHML 967
|
Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65440|BAME3_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 OS=Arabidopsis thaliana GN=BAM3 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 663 bits (1710), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/967 (41%), Positives = 554/967 (57%), Gaps = 33/967 (3%)
Query: 38 ALLSIKAGLVDPLNSLHDWKLPSAH--CNWTGVWC-NSNGAVEKLDLSHMNLSGCVSDHF 94
L+S+K SL W +P+ + C+WTGV C N N ++ +LDLS++N+SG +S
Sbjct: 37 VLISLKQSFDSYDPSLDSWNIPNFNSLCSWTGVSCDNLNQSITRLDLSNLNISGTISPEI 96
Query: 95 QRLK-SLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPA-GLGGAAGLTFLN 152
RL SL L++ N LP + L+ L+ ++S N G G L L+
Sbjct: 97 SRLSPSLVFLDISSNSFSGELPKEIYELSGLEVLNISSNVFEGELETRGFSQMTQLVTLD 156
Query: 153 ASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPR 212
A N+F+G L L T LE LDL G++F G IP S+ + LKFL LSGN+L G+IP
Sbjct: 157 AYDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLSGNDLRGRIPN 216
Query: 213 ELGQLSSMETMILAY-NEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIM 271
EL ++++ + L Y N++ G IP +FG L NL +LDLA +L G IPAELG L+ LE++
Sbjct: 217 ELANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDLANCSLKGSIPAELGNLKNLEVL 276
Query: 272 FLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVP 331
FL N G +P E+GN+TSL+ LDLS N L EIP E++ L+ LQL NL N+L G +P
Sbjct: 277 FLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNLFFNRLHGEIP 336
Query: 332 AGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKL 391
+ L L++L+LW+N+ +G +P LG N L +DLS+N +G IP SLC G L L
Sbjct: 337 EFVSELPDLQILKLWHNNFTGKIPSKLGSNGNLIEIDLSTNKLTGLIPESLCFGRRLKIL 396
Query: 392 ILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGIT 451
ILFNN GP+P L C L R R+ N L+ +P G L L LEL NN LTG I
Sbjct: 397 ILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLELQNNFLTGEIP 456
Query: 452 DDIASS---TSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSL 508
++ A + +SL+ I++S N L +P +I ++ +LQ ++ N L G+IP + SL
Sbjct: 457 EEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQIPGEIGSLKSL 516
Query: 509 SVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTG 568
+D+S N FSG P C L L+L +NQ++G IP IS + L L++S NS
Sbjct: 517 LKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVSWNSFNQ 576
Query: 569 GIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVLHPCSRYSPI 628
+P G +L + S+N G VP +G N GN LCG +PC+
Sbjct: 577 SLPNELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPCN----- 631
Query: 629 ASSHRSLHAKHIIPGWMIAISSLFAVGIAVFGARSLYKRWNANGSCFEEKLEMGKGEWP- 687
S ++ + + + A FG L + M K P
Sbjct: 632 -GSQNQSQSQLLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRKNN-PN 689
Query: 688 -WRLMAFQRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLE 746
W+L+ FQ+LGF S IL C++E++VIG G GIVYK MP VAVKKL +
Sbjct: 690 LWKLIGFQKLGFRSEHILECVKENHVIGKGGRGIVYKGVMPN-GEEVAVKKLL----TIT 744
Query: 747 TESSGD--FVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGR 804
SS D E+ LG++RHRNIVRLL F N ++VYEYM NGSLGE LHGK
Sbjct: 745 KGSSHDNGLAAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAG-- 802
Query: 805 LLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864
+ + W +R IAL A+GL YLHHDC P IIHRD+KSNNILL E +ADFGLA+ M+
Sbjct: 803 VFLKWETRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMM 862
Query: 865 RKN---ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESV 921
+ N E +S +AGSYGYIAPEY YTL++DEK D+YSFGVVLLEL+TGR+P+D E +
Sbjct: 863 QDNGASECMSSIAGSYGYIAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVDNFGEEGI 922
Query: 922 DIVEWIRMKIRDNRN-LEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
DIV+W +++ NR + + +D + N + E M L +A LC + +RP+MR+V+
Sbjct: 923 DIVQWSKIQTNCNRQGVVKIIDQRLSNIP-LAEAMELFF-VAMLCVQEHSVERPTMREVV 980
Query: 981 TMLGEAK 987
M+ +AK
Sbjct: 981 QMISQAK 987
|
Necessary for male gametophyte development, as well as ovule specification and function. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 659 bits (1700), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/972 (40%), Positives = 559/972 (57%), Gaps = 42/972 (4%)
Query: 31 ALNDELLALLSIKAGLVDPLNSLHDWKLPSAH-CNWTGVWCNSN-GAVEKLDLSHMNLSG 88
+LN + L +K L DP + L W A C W+GV C + +V +DLS NL+G
Sbjct: 15 SLNQDGFILQQVKLSLDDPDSYLSSWNSNDASPCRWSGVSCAGDFSSVTSVDLSSANLAG 74
Query: 89 CVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGL 148
RL +L L+L N + S+LP ++A SL+ D+SQN L G P L L
Sbjct: 75 PFPSVICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLADIPTL 134
Query: 149 TFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLT- 207
L+ +GNNFSG + G +LE L L + G+IP N+ LK L LS N +
Sbjct: 135 VHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNPFSP 194
Query: 208 GKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLEL 267
+IP E G L+++E M L G+IP G L+ L LDLA+ +L G IP LG L
Sbjct: 195 SRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTN 254
Query: 268 LEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLS 327
+ + LY N+ G +P E+GN+ SL+LLD S N L+ +IP E+ ++ L+ LNL N L
Sbjct: 255 VVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVP-LESLNLYENNLE 313
Query: 328 GHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGN 387
G +PA + L + ++ N L+G LP DLG NSPL+WLD+S N FSG++PA LC G
Sbjct: 314 GELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGE 373
Query: 388 LTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLT 447
L +L++ +N+FSG IP SL+ C SL R+R+ N+ SG++P GF L + LEL NNS +
Sbjct: 374 LEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFS 433
Query: 448 GGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPS 507
G I+ I +++LS + +S N SLP I S+ NL S N G +PD
Sbjct: 434 GEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGE 493
Query: 508 LSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLT 567
L LDL N FSG + S I S +KL LNL +N+ TG IP I + L LDLS N +
Sbjct: 494 LGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFS 553
Query: 568 GGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVLHPCSRYSP 627
G IP + S L LN+SYNRL G +P + + + + + GN GLCG + C
Sbjct: 554 GKIPVSL-QSLKLNQLNLSYNRLSGDLPPS-LAKDMYKNSFIGNPGLCGDIKGLC----- 606
Query: 628 IASSHRSLHAKHIIPGWMIAISSLFAVGIAVFGARSLYKRWNANGSCFEEKLEMGKGEWP 687
S + + ++ W++ + A + + G Y ++ F++ M + +
Sbjct: 607 -GSENEAKKRGYV---WLLRSIFVLAAMVLLAGVAWFYFKYRT----FKKARAMERSK-- 656
Query: 688 WRLMAFQRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLW----RSRA 743
W LM+F +LGF+ +IL + E NVIG GA+G VYK + T VAVK+LW +
Sbjct: 657 WTLMSFHKLGFSEHEILESLDEDNVIGAGASGKVYKVVLTNGET-VAVKRLWTGSVKETG 715
Query: 744 DLETE-------SSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEA 796
D + E F EV LGK+RH+NIV+L ++VYEYM NGSLG+
Sbjct: 716 DCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDL 775
Query: 797 LHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856
LH + G ++ W +R+ I L A+GL+YLHHD PPI+HRDIKSNNIL+D + R+AD
Sbjct: 776 LHSSKGG--MLGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVAD 833
Query: 857 FGLAR---MMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
FG+A+ + + +++S++AGS GYIAPEY YTL+V+EK DIYSFGVV+LE++T +RP+
Sbjct: 834 FGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPV 893
Query: 914 DPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDR 973
DPE GE D+V+W+ + D + +E +DP + +C +EE+ +L + LCT+ LP +R
Sbjct: 894 DPELGEK-DLVKWVCSTL-DQKGIEHVIDPKLDSC--FKEEISKILNVGLLCTSPLPINR 949
Query: 974 PSMRDVITMLGE 985
PSMR V+ ML E
Sbjct: 950 PSMRRVVKMLQE 961
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 640 bits (1651), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/1033 (38%), Positives = 587/1033 (56%), Gaps = 70/1033 (6%)
Query: 11 CFYCYIGCTCFGSAKVVAKTALNDELLALLSIKAGLVDPLN-----SLHDWKLPSAHCNW 65
C + YI C+ + V T +N ++S++ L P N SL KL ++ N
Sbjct: 69 CQWPYITCSSSDNKLV---TEIN-----VVSVQLALPFPPNISSFTSLQ--KLVISNTNL 118
Query: 66 TGVWCNSNGAVEKL---DLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLT 122
TG + G +L DLS +L G + +LK+L L L NGL +P L +
Sbjct: 119 TGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCV 178
Query: 123 SLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNN-FSGFLLEDLGNATSLETLDLRGSF 181
SLK ++ N+L+ + P LG + L + A GN+ SG + E++GN +L+ L L +
Sbjct: 179 SLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATK 238
Query: 182 FQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNL 241
GS+PVS L KL+ L + L+G+IP+ELG S + + L N+ G +P E G L
Sbjct: 239 ISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKL 298
Query: 242 TNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNM 301
NL+ + L NL G IP E+G ++ L + L N F G +P GN+++LQ L LS N
Sbjct: 299 QNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNN 358
Query: 302 LSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKN 361
++ IP+ ++ L + NQ+SG +P +G L +L + W N L G +P +L
Sbjct: 359 ITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGC 418
Query: 362 SPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQ 421
LQ LDLS N +G +PA L NLTKL+L +NA SG IP+ + C SLVR+R+ NN+
Sbjct: 419 QNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNR 478
Query: 422 LSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSI 481
++G IP G G L+ L L+L+ N+L+G + +I++ L +++S N L+ LP ++ S+
Sbjct: 479 ITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSL 538
Query: 482 PNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQ 541
LQ VS+N+L G+IPD SL+ L LS N F+G IPSS+ C L L+L +N
Sbjct: 539 TKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNN 598
Query: 542 LTGDIPKAISMMPTLAI-LDLSNNSLTGGIPENFGASPALEV------------------ 582
++G IP+ + + L I L+LS NSL G IPE A L V
Sbjct: 599 ISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSALSGL 658
Query: 583 -----LNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVLHPC-SRYSPIASSHRSLH 636
LN+S+NR G +P + V R + ++ GN GLC C S ++ R +H
Sbjct: 659 ENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRSCFVSNSSQLTTQRGVH 718
Query: 637 AK--HIIPGWMIAISSLFAV--GIAVFGARSLYKRWNANGSCFEEKLEMGKGEWPWRLMA 692
+ I G +I+++++ AV +AV A+ + + N + E G+ W W+
Sbjct: 719 SHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDS--------ETGENLWTWQFTP 770
Query: 693 FQRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRA---DLETES 749
FQ+L FT +L C+ E NVIG G +GIVYKAEMP ++AVKKLW + +T+S
Sbjct: 771 FQKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAEMPN-REVIAVKKLWPVTVPNLNEKTKS 829
Query: 750 SG---DFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLL 806
SG F EV LG +RH+NIVR LG N +++Y+YM+NGSLG LH +++G
Sbjct: 830 SGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLH-ERSGVCS 888
Query: 807 VDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866
+ W RY I LG AQGLAYLHHDC PPI+HRDIK+NNIL+ + EP I DFGLA+++
Sbjct: 889 LGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDG 948
Query: 867 N--ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIV 924
+ + + +AGSYGYIAPEYGY++K+ EK D+YS+GVV+LE+LTG++P+DP + + IV
Sbjct: 949 DFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIV 1008
Query: 925 EWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984
+W++ KIRD + +++ L + EEM+ L +A LC +P+DRP+M+DV ML
Sbjct: 1009 DWVK-KIRDIQVIDQGLQ---ARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAMLS 1064
Query: 985 EAKPRRKSSSNND 997
E R+ S D
Sbjct: 1065 EICQEREESMKVD 1077
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 611 bits (1576), Expect = e-174, Method: Compositional matrix adjust.
Identities = 390/1006 (38%), Positives = 549/1006 (54%), Gaps = 112/1006 (11%)
Query: 43 KAGLVDPLNSLHDWKLP---SAHCNWTGVWCN----SNGAVEKLDLSHMNLSGCVSDHFQ 95
K L DP +L DW + + CNWTG+ C+ S+ AV +DLS N+SG F
Sbjct: 36 KTRLFDPDGNLQDWVITGDNRSPCNWTGITCHIRKGSSLAVTTIDLSGYNISGGFPYGFC 95
Query: 96 RLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSF-PAGLGGAAGLTFLNAS 154
R+++L ++ L SQN LNG+ A L + L L +
Sbjct: 96 RIRTLINITL------------------------SQNNLNGTIDSAPLSLCSKLQNLILN 131
Query: 155 GNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPREL 214
NNFSG L E L L+L + F G IP S+ L L+ L L+GN L+G +P L
Sbjct: 132 QNNFSGKLPEFSPEFRKLRVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFL 191
Query: 215 GQLSSMETMILAYNEFD-------------------------GEIPVEFGNLTNLKYLDL 249
G L+ + + LAY FD GEIP NL L+ LDL
Sbjct: 192 GYLTELTRLDLAYISFDPSPIPSTLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDL 251
Query: 250 AVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAE 309
A+ +L G+IP +GRLE + + LY N G+LP IGN+T L+ D+S N L+ E+P +
Sbjct: 252 AMNSLTGEIPESIGRLESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEK 311
Query: 310 ITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDL 369
I L+ L NL N +G +P + L +++NNS +G LP +LGK S + D+
Sbjct: 312 IAALQ-LISFNLNDNFFTGGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDV 370
Query: 370 SSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG 429
S+N FSGE+P LC L K+I F+N SG IP S CHSL +RM +N+LSG +P
Sbjct: 371 STNRFSGELPPYLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPAR 430
Query: 430 FGRLEKLQRLELANNS-LTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFI 488
F L L RLELANN+ L G I I+ + LS ++IS N+ +P + + +L+
Sbjct: 431 FWEL-PLTRLELANNNQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVID 489
Query: 489 VSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPK 548
+S N+ +G IP +L +++ N G IPSS++SC +L LNL NN+L G IP
Sbjct: 490 LSRNSFLGSIPSCINKLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPP 549
Query: 549 AISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDL 608
+ +P L LDLSNN LTG IP L NVS N+L G +P+ G + I R
Sbjct: 550 ELGDLPVLNYLDLSNNQLTGEIPAEL-LRLKLNQFNVSDNKLYGKIPS-GFQQDIFRPSF 607
Query: 609 AGNAGLCGGVLHPCSRYSPIASSHRSLHAKHIIPGWMIAISSLFAVGIAVF-GARSLYKR 667
GN LC L PI ++I+P ++ I +L + +F + L+KR
Sbjct: 608 LGNPNLCAPNL------DPIRPCRSKRETRYILPISILCIVALTGALVWLFIKTKPLFKR 661
Query: 668 WNANGSCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRESNVIGMGATGIVYKAEMP 727
K + ++ FQR+GFT DI + E N+IG G +G+VY+ ++
Sbjct: 662 ---------------KPKRTNKITIFQRVGFTEEDIYPQLTEDNIIGSGGSGLVYRVKLK 706
Query: 728 RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEY 787
T+ AVKKLW +TES F EV LG++RH NIV+LL + + +VYE+
Sbjct: 707 SGQTL-AVKKLWGETGQ-KTESESVFRSEVETLGRVRHGNIVKLLMCCNGEEFRFLVYEF 764
Query: 788 MNNGSLGEALHGKQAGRLL--VDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNIL 845
M NGSLG+ LH ++ R + +DW +R++IA+G AQGL+YLHHD PPI+HRD+KSNNIL
Sbjct: 765 MENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRDVKSNNIL 824
Query: 846 LDSNLEPRIADFGLARMMIRKNE------TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSF 899
LD ++PR+ADFGLA+ + R++ ++S VAGSYGYIAPEYGYT KV+EK D+YSF
Sbjct: 825 LDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIAPEYGYTSKVNEKSDVYSF 884
Query: 900 GVVLLELLTGRRPLDPEFGESVDIVEWI------------------RMKIRDNRNLEEAL 941
GVVLLEL+TG+RP D FGE+ DIV++ + + + R+L + +
Sbjct: 885 GVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYPSPSAEDGAMNQDSLGNYRDLSKLV 944
Query: 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987
DP + EE+ VL +A LCT+ P +RP+MR V+ +L E K
Sbjct: 945 DPKMKLSTREYEEIEKVLDVALLCTSSFPINRPTMRKVVELLKEKK 990
|
Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1018 | ||||||
| 255590183 | 1017 | Receptor protein kinase CLAVATA1 precurs | 0.991 | 0.992 | 0.792 | 0.0 | |
| 224065541 | 1019 | predicted protein [Populus trichocarpa] | 0.994 | 0.993 | 0.802 | 0.0 | |
| 359480057 | 1022 | PREDICTED: leucine-rich repeat receptor- | 0.991 | 0.987 | 0.791 | 0.0 | |
| 356570674 | 1018 | PREDICTED: leucine-rich repeat receptor- | 0.987 | 0.987 | 0.746 | 0.0 | |
| 356503642 | 1026 | PREDICTED: leucine-rich repeat receptor- | 0.968 | 0.961 | 0.756 | 0.0 | |
| 449468712 | 1024 | PREDICTED: leucine-rich repeat receptor- | 0.992 | 0.986 | 0.742 | 0.0 | |
| 356536856 | 1015 | PREDICTED: leucine-rich repeat receptor- | 0.959 | 0.962 | 0.752 | 0.0 | |
| 357510199 | 1024 | Receptor-like protein kinase [Medicago t | 0.995 | 0.989 | 0.728 | 0.0 | |
| 15235387 | 1013 | putative leucine-rich repeat transmembra | 0.990 | 0.995 | 0.706 | 0.0 | |
| 224145839 | 1018 | predicted protein [Populus trichocarpa] | 0.985 | 0.985 | 0.696 | 0.0 |
| >gi|255590183|ref|XP_002535195.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223523778|gb|EEF27188.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1633 bits (4228), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 808/1020 (79%), Positives = 899/1020 (88%), Gaps = 11/1020 (1%)
Query: 1 MQLKILLLVLCFYCYIGCTCFGSAKVVAKTALNDELLALLSIKAGLVDPLNSLHDWKL-- 58
MQLKIL+ C C + C SA ALN+E+ LLSIKA L+DPLN L DWKL
Sbjct: 7 MQLKILIFFFC-SCSVFCAFSSSA------ALNEEVSVLLSIKASLLDPLNKLQDWKLSN 59
Query: 59 PSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSL 118
SAHCNWTGV CNS+GAVEKLDLSHMNLSG V D L+SLTSLNLCCNG SSL ++
Sbjct: 60 TSAHCNWTGVRCNSHGAVEKLDLSHMNLSGSVPDDIHELQSLTSLNLCCNGFSSSLTKAI 119
Query: 119 ANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLR 178
+NLTSLK FDVSQNF G FP G G AAGLT LNAS NNFSGF+ ED+G+A LETLDLR
Sbjct: 120 SNLTSLKSFDVSQNFFIGKFPIGFGRAAGLTLLNASSNNFSGFIPEDIGDAILLETLDLR 179
Query: 179 GSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEF 238
GSFF+GSIP SFKNL KLKFLGLSGNNLTG+IP ELGQLSS+E +I+ YNEF+G IP EF
Sbjct: 180 GSFFEGSIPKSFKNLHKLKFLGLSGNNLTGQIPAELGQLSSLERIIIGYNEFEGGIPAEF 239
Query: 239 GNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLS 298
GNL+NLKYLDLAVGNLGG+IPAELGRL+LLE +FLYQNNF+G++PA IGN+TSL+LLDLS
Sbjct: 240 GNLSNLKYLDLAVGNLGGEIPAELGRLKLLETVFLYQNNFEGKIPAAIGNMTSLKLLDLS 299
Query: 299 YNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDL 358
N+LS EIPAE +LKNLQLLNLMCNQLSG VPAG+GGLTQL+VLELWNNSLSGPLP DL
Sbjct: 300 DNVLSGEIPAEFAELKNLQLLNLMCNQLSGSVPAGVGGLTQLQVLELWNNSLSGPLPSDL 359
Query: 359 GKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQ 418
GKNS LQWLDLSSNSFSGEIPA LC GGNLTKLILFNNAFSGPIP+SLSTCHSLVRVRMQ
Sbjct: 360 GKNSALQWLDLSSNSFSGEIPAFLCTGGNLTKLILFNNAFSGPIPLSLSTCHSLVRVRMQ 419
Query: 419 NNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTI 478
NN L GTIP+G G+L KL+RLE+ANNSLTG I +D+A+S+SLSFID+S+NHL SSLPSTI
Sbjct: 420 NNFLDGTIPLGLGKLPKLERLEVANNSLTGQIPNDLATSSSLSFIDLSKNHLTSSLPSTI 479
Query: 479 LSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLR 538
L+IPNLQ F+ S+NNL GEIPDQFQDCPSLSVLDLSSN+FS +IP+SIASCEKLV LNL+
Sbjct: 480 LAIPNLQNFMASSNNLEGEIPDQFQDCPSLSVLDLSSNHFSSTIPTSIASCEKLVYLNLK 539
Query: 539 NNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANG 598
NNQL+G+IPKAI+ MPTLAILDLSNNSLTGGIPENFG+SPALEVLNVS+NRLEGPVPANG
Sbjct: 540 NNQLSGEIPKAIAKMPTLAILDLSNNSLTGGIPENFGSSPALEVLNVSHNRLEGPVPANG 599
Query: 599 VLRTINRGDLAGNAGLCGGVLHPCSRYSPIASSHRSLHAKHIIPGWMIAISSLFAVGIAV 658
VLRTIN DL GNAGLCGGVL PCS + AS + LH KHII W+I++S + A+ I +
Sbjct: 600 VLRTINPDDLIGNAGLCGGVLPPCSHEALTASEQKGLHRKHIIAEWIISVSLVLALVIGL 659
Query: 659 FGARSLYKRWNANGSCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRESNVIGMGAT 718
G RSLYKRW +NGSCFEE E GKGEWPWRLMAFQRLGFTSADILAC++ES VIGMGAT
Sbjct: 660 IGVRSLYKRWYSNGSCFEESFETGKGEWPWRLMAFQRLGFTSADILACVKESTVIGMGAT 719
Query: 719 GIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND 778
G VY+AE+PRLNT+VAVKKLWRS D+ET S+ DFVGEVN+LGKLRHRNIVRLLGFLHND
Sbjct: 720 GTVYRAEIPRLNTVVAVKKLWRSGTDIETGSNNDFVGEVNLLGKLRHRNIVRLLGFLHND 779
Query: 779 TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRD 838
T+MMI+YEYM+NG+LGEALHG QAGRLLVDWVSRYNIA+GVAQGLAY+HHDC+PP+IHRD
Sbjct: 780 TDMMILYEYMHNGNLGEALHGNQAGRLLVDWVSRYNIAVGVAQGLAYMHHDCHPPVIHRD 839
Query: 839 IKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYS 898
+KSNNILLD+NLE RIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKID YS
Sbjct: 840 VKSNNILLDANLEARIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDTYS 899
Query: 899 FGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLV 958
+GVVLLELLTG+RPLDPEFGESVDIVEWIR KIRDNR LEEALD NVGNCKHVQEEMLLV
Sbjct: 900 YGVVLLELLTGKRPLDPEFGESVDIVEWIRRKIRDNRPLEEALDNNVGNCKHVQEEMLLV 959
Query: 959 LRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNRYENNKEKLVFSTSPVSGLV 1018
LRIA LCTAKLPKDRPSMRDVITMLGEAKPRRKS +++ +++NKEK VFSTSPV+GLV
Sbjct: 960 LRIALLCTAKLPKDRPSMRDVITMLGEAKPRRKSITSSG--FDSNKEKPVFSTSPVNGLV 1017
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065541|ref|XP_002301848.1| predicted protein [Populus trichocarpa] gi|222843574|gb|EEE81121.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1617 bits (4188), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 817/1018 (80%), Positives = 902/1018 (88%), Gaps = 6/1018 (0%)
Query: 3 LKILLLVLCFYCYIGCTCFGSAKVVAKTALNDELLALLSIKAGLVDPLNSLHDWKLP--S 60
L++ +LVL FYC C GSA VV K DE+ ALLS+KAGL+DP NSL DWKL S
Sbjct: 6 LRLQVLVLLFYC---CVGIGSAVVVEKNVFGDEVSALLSLKAGLLDPSNSLRDWKLSNSS 62
Query: 61 AHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLAN 120
AHCNW GVWCNSNGAVEKLDLSHMNL+G VSD QRL+SLTSLNLCCNG SSL +++N
Sbjct: 63 AHCNWAGVWCNSNGAVEKLDLSHMNLTGHVSDDIQRLESLTSLNLCCNGFSSSLTKAISN 122
Query: 121 LTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGS 180
LTSLK DVSQN GSFP GLG AAGLT LNAS NNFSG + EDLGNATSLETLDLRGS
Sbjct: 123 LTSLKDIDVSQNLFIGSFPVGLGRAAGLTLLNASSNNFSGIIPEDLGNATSLETLDLRGS 182
Query: 181 FFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGN 240
FF+GSIP SF+NL+KLKFLGLSGN+LTG++P ELG LSS+E +I+ YNEF+G IP EFGN
Sbjct: 183 FFEGSIPKSFRNLRKLKFLGLSGNSLTGQLPAELGLLSSLEKIIIGYNEFEGGIPAEFGN 242
Query: 241 LTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYN 300
LTNLKYLDLA+GNL G+IPAELGRL+ LE +FLYQNN +G+LPA IGNITSLQLLDLS N
Sbjct: 243 LTNLKYLDLAIGNLSGEIPAELGRLKALETVFLYQNNLEGKLPAAIGNITSLQLLDLSDN 302
Query: 301 MLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGK 360
LS EIPAEI LKNLQLLNLM NQLSG +PAG+GGLTQL VLELW+NSLSGPLP DLGK
Sbjct: 303 NLSGEIPAEIVNLKNLQLLNLMSNQLSGSIPAGVGGLTQLSVLELWSNSLSGPLPRDLGK 362
Query: 361 NSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNN 420
NSPLQWLD+SSNS SGEIPASLCNGGNLTKLILFNN+FSGPIP SLSTC SLVRVRMQNN
Sbjct: 363 NSPLQWLDVSSNSLSGEIPASLCNGGNLTKLILFNNSFSGPIPDSLSTCFSLVRVRMQNN 422
Query: 421 QLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILS 480
LSG IPVG G+L KLQRLELANNSLTG I D+A S+SLSFIDISRN LRSSLPST+LS
Sbjct: 423 FLSGAIPVGLGKLGKLQRLELANNSLTGQIPIDLAFSSSLSFIDISRNRLRSSLPSTVLS 482
Query: 481 IPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNN 540
I NLQTF+ SNNNL GEIPDQFQD PSLS LDLSSN+FSGSIP+SIASCEKLVNLNL+NN
Sbjct: 483 IQNLQTFMASNNNLEGEIPDQFQDRPSLSALDLSSNHFSGSIPASIASCEKLVNLNLKNN 542
Query: 541 QLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVL 600
+LTG+IPKA++MMP LA+LDLSNNSLTGG+PENFG+SPALE+LNVSYN+L+GPVPANGVL
Sbjct: 543 RLTGEIPKAVAMMPALAVLDLSNNSLTGGLPENFGSSPALEMLNVSYNKLQGPVPANGVL 602
Query: 601 RTINRGDLAGNAGLCGGVLHPCSRYSPIASSHRSLHAKHIIPGWMIAISSLFAVGIAVFG 660
R IN DL GN GLCGGVL PCS AS R++H K I+ GW+I ISS+FAVGIA+ G
Sbjct: 603 RAINPDDLVGNVGLCGGVLPPCSHSLLNASGQRNVHTKRIVAGWLIGISSVFAVGIALVG 662
Query: 661 ARSLYKRWNANGSCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRESNVIGMGATGI 720
A+ LYKRW +NGSCFE+ EMG GEWPWRLMA+QRLGFTS+DILAC++ESNVIGMGATG
Sbjct: 663 AQLLYKRWYSNGSCFEKSYEMGSGEWPWRLMAYQRLGFTSSDILACLKESNVIGMGATGT 722
Query: 721 VYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN 780
VYKAE+PR NT+VAVKKLWRS AD+ET SS DFVGEVN+LGKLRHRNIVRLLGFLHND++
Sbjct: 723 VYKAEVPRSNTVVAVKKLWRSGADIETGSSSDFVGEVNLLGKLRHRNIVRLLGFLHNDSD 782
Query: 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIK 840
MMI+YEYM+NGSLGE LHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC PP+IHRDIK
Sbjct: 783 MMILYEYMHNGSLGEVLHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCRPPVIHRDIK 842
Query: 841 SNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFG 900
SNNILLD++LE RIADFGLAR+MIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYS+G
Sbjct: 843 SNNILLDTDLEARIADFGLARVMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYG 902
Query: 901 VVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLR 960
VVLLELLTG+RPLDPEFGESVDIVEWIR KIRDNR+LEEALD NVGNCKHVQEEMLLVLR
Sbjct: 903 VVLLELLTGKRPLDPEFGESVDIVEWIRRKIRDNRSLEEALDQNVGNCKHVQEEMLLVLR 962
Query: 961 IAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNRYENNKEKLVFSTSPVSGLV 1018
IA LCTAKLPKDRPSMRDVITMLGEAKPRRKSSSN+ Y++NK+K VF+TSPV+GLV
Sbjct: 963 IALLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNSSG-YDSNKDKPVFNTSPVNGLV 1019
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359480057|ref|XP_003632392.1| PREDICTED: leucine-rich repeat receptor-like protein kinase PXL2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1596 bits (4132), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 811/1025 (79%), Positives = 891/1025 (86%), Gaps = 16/1025 (1%)
Query: 1 MQLKILLLVLCFYCYIGCTCFGSAKVVAKTALNDELLALLSIKAGLVDPLNSLHDWKLP- 59
MQ++ L++ FYC IGC G K DE+ LLSIK GLVDPLN L DWK+
Sbjct: 7 MQVQAFLVLFFFYCCIGCYGRGVEK--------DEVSVLLSIKRGLVDPLNQLGDWKVEE 58
Query: 60 ------SAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSS 113
S HCNWTGVWCNS G VE+LDLSHMNLSG V D +RL+SL LNLCCNG SS
Sbjct: 59 NGVGNGSVHCNWTGVWCNSKGGVERLDLSHMNLSGRVLDEIERLRSLAHLNLCCNGFSSS 118
Query: 114 LPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLE 173
LP +++NL +L+ FDVSQNF G FP G G A GLT LNAS NNFSGFL EDLGN T+LE
Sbjct: 119 LPKTMSNLLALRSFDVSQNFFEGGFPVGFGRAPGLTILNASSNNFSGFLPEDLGNLTALE 178
Query: 174 TLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGE 233
LDLRGSFFQGSIP SFKNLQKLKFLGLSGNNLTG+IPRE+GQLSS+ET+IL YNEF+GE
Sbjct: 179 ILDLRGSFFQGSIPKSFKNLQKLKFLGLSGNNLTGQIPREIGQLSSLETIILGYNEFEGE 238
Query: 234 IPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQ 293
IPVE GNLTNLKYLDLAVGN GGKIPA LGRL+LL +FLY+NNF+G +P EIGNITSLQ
Sbjct: 239 IPVELGNLTNLKYLDLAVGNHGGKIPAALGRLKLLNTVFLYKNNFEGEIPPEIGNITSLQ 298
Query: 294 LLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGP 353
LLDLS N+LS EIPAEI +LKNLQLLNLMCNQLSG VP+GL L +LEVLELWNNSL+GP
Sbjct: 299 LLDLSDNLLSGEIPAEIAKLKNLQLLNLMCNQLSGSVPSGLEWLPELEVLELWNNSLTGP 358
Query: 354 LPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLV 413
LP DLGKNSPLQWLD+SSNSF+G IP SLCNGGNLTKLILFNN FSGPIP+ LSTC SLV
Sbjct: 359 LPNDLGKNSPLQWLDVSSNSFTGGIPPSLCNGGNLTKLILFNNGFSGPIPIGLSTCASLV 418
Query: 414 RVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSS 473
RVRM NN +SGT+PVGFG+LEKLQRLELANNSLTG I DIASSTSLSFID+SRN L+SS
Sbjct: 419 RVRMHNNLISGTVPVGFGKLEKLQRLELANNSLTGQIPGDIASSTSLSFIDLSRNRLQSS 478
Query: 474 LPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLV 533
LPSTILSIP LQ F+ S+NNL GEIPDQFQD PSLSVLDLSSN +GSIP+SIASCEK+V
Sbjct: 479 LPSTILSIPQLQNFMASHNNLEGEIPDQFQDSPSLSVLDLSSNQLTGSIPASIASCEKMV 538
Query: 534 NLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGP 593
NLNL+NN+LTG IPK ++ MPTLAILDLSNNSLTG IPENFG SPALE LNVSYNRLEGP
Sbjct: 539 NLNLQNNRLTGQIPKTVATMPTLAILDLSNNSLTGTIPENFGTSPALESLNVSYNRLEGP 598
Query: 594 VPANGVLRTINRGDLAGNAGLCGGVLHPCSRYSPIASSHRSLHAKHIIPGWMIAISSLFA 653
VP NGVLRTIN DL GNAGLCGGVL PCS + AS HR +HAKHI+ GW+I IS++ A
Sbjct: 599 VPTNGVLRTINPDDLVGNAGLCGGVLPPCSWGAETASRHRGVHAKHIVAGWVIGISTVLA 658
Query: 654 VGIAVFGARSLYKRWNANGSCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRESNVI 713
VG+AVFGARSLYKRW +NGSCF E+ E+G GEWPWRLMAFQRLGFTSADILACI+ESNVI
Sbjct: 659 VGVAVFGARSLYKRWYSNGSCFTERFEVGNGEWPWRLMAFQRLGFTSADILACIKESNVI 718
Query: 714 GMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLG 773
GMGATGIVYKAEMPRLNT+VAVKKLWRS D+ET SS D VGEVN+LG+LRHRNIVRLLG
Sbjct: 719 GMGATGIVYKAEMPRLNTVVAVKKLWRSETDIETGSSEDLVGEVNLLGRLRHRNIVRLLG 778
Query: 774 FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPP 833
FLHND+++MIVYE+M+NGSLGEALHGKQ GRLLVDWVSRYNIA+GVAQGLAYLHHDC+PP
Sbjct: 779 FLHNDSDVMIVYEFMHNGSLGEALHGKQGGRLLVDWVSRYNIAIGVAQGLAYLHHDCHPP 838
Query: 834 IIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEK 893
+IHRD+KSNNILLD+NLE RIADFGLARMM+RKNETVSMVAGSYGYIAPEYGYTLKVDEK
Sbjct: 839 VIHRDVKSNNILLDANLEARIADFGLARMMVRKNETVSMVAGSYGYIAPEYGYTLKVDEK 898
Query: 894 IDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQE 953
IDIYSFGVVLLELLTG+RPLD EFGE VDIVEW+R KIRDNR LEEALDPNVGNCK+VQE
Sbjct: 899 IDIYSFGVVLLELLTGKRPLDAEFGELVDIVEWVRWKIRDNRALEEALDPNVGNCKYVQE 958
Query: 954 EMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNRYENNKEKLVFSTSP 1013
EMLLVLRIA LCTAKLPKDRPSMRDVITMLGEAKPRRKSSS N N Y+ NK + VFSTSP
Sbjct: 959 EMLLVLRIALLCTAKLPKDRPSMRDVITMLGEAKPRRKSSS-NINGYDINKARPVFSTSP 1017
Query: 1014 VSGLV 1018
V+GL+
Sbjct: 1018 VNGLM 1022
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356570674|ref|XP_003553510.1| PREDICTED: leucine-rich repeat receptor-like protein kinase PXL2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1531 bits (3965), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 762/1021 (74%), Positives = 863/1021 (84%), Gaps = 16/1021 (1%)
Query: 1 MQLKILLLVLCFYCYIGCTCFGSAKVVAKTALNDELLALLSIKAGLVDPLNSLHDWKL-- 58
MQ+KI + + + YIGC +G A A+ +E+ ALLSIKAGLVDPLN+L DWKL
Sbjct: 1 MQMKIQIFI---FWYIGCFSYGFA-----AAVTNEVSALLSIKAGLVDPLNALQDWKLHG 52
Query: 59 -----PSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSS 113
++HCNWTG+ CNS GAVEKLDLSH NLSG VS+ QRL+SLTSLNLCCN +
Sbjct: 53 KEPGQDASHCNWTGIKCNSAGAVEKLDLSHKNLSGRVSNDIQRLESLTSLNLCCNAFSTP 112
Query: 114 LPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLE 173
LP S+ANLT+L DVSQN G FP GLG A L LNAS N FSG L EDL NA+ LE
Sbjct: 113 LPKSIANLTTLNSLDVSQNLFIGDFPLGLGRALRLVALNASSNEFSGSLPEDLANASCLE 172
Query: 174 TLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGE 233
LDLRGSFF GS+P SF NL KLKFLGLSGNNLTGKIP ELGQLSS+E MIL YNEF+G
Sbjct: 173 MLDLRGSFFVGSVPKSFSNLHKLKFLGLSGNNLTGKIPGELGQLSSLEHMILGYNEFEGG 232
Query: 234 IPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQ 293
IP EFGNLTNLKYLDLAV NLGG+IP LG L+LL +FLY NNF GR+P IGN+TSLQ
Sbjct: 233 IPDEFGNLTNLKYLDLAVANLGGEIPGGLGELKLLNTVFLYNNNFDGRIPPAIGNMTSLQ 292
Query: 294 LLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGP 353
LLDLS NMLS +IP+EI+QLKNL+LLN M N+LSG VP+G G L QLEVLELWNNSLSGP
Sbjct: 293 LLDLSDNMLSGKIPSEISQLKNLKLLNFMGNKLSGPVPSGFGDLQQLEVLELWNNSLSGP 352
Query: 354 LPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLV 413
LP +LGKNSPLQWLD+SSNS SGEIP +LC+ GNLTKLILFNNAF+GPIP SLS C SLV
Sbjct: 353 LPSNLGKNSPLQWLDVSSNSLSGEIPETLCSQGNLTKLILFNNAFTGPIPSSLSMCPSLV 412
Query: 414 RVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSS 473
RVR+QNN LSGT+PVG G+L KLQRLELANNSL+GGI DDI+SSTSLSFID+SRN L SS
Sbjct: 413 RVRIQNNFLSGTVPVGLGKLGKLQRLELANNSLSGGIPDDISSSTSLSFIDLSRNKLHSS 472
Query: 474 LPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLV 533
LPST+LSIP+LQ F+VSNNNL GEIPDQFQDCPSL+VLDLSSN+ SGSIP+SIASC+KLV
Sbjct: 473 LPSTVLSIPDLQAFMVSNNNLEGEIPDQFQDCPSLAVLDLSSNHLSGSIPASIASCQKLV 532
Query: 534 NLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGP 593
NLNL+NNQLT +IPKA++ MPTLA+LDLSNNSLTG IPE+FG SPALE LNVSYN+LEGP
Sbjct: 533 NLNLQNNQLTSEIPKALAKMPTLAMLDLSNNSLTGQIPESFGVSPALEALNVSYNKLEGP 592
Query: 594 VPANGVLRTINRGDLAGNAGLCGGVLHPCSRYSPIASSHRSLHAKHIIPGWMIAISSLFA 653
VPANG+LRTIN DL GNAGLCGG+L PC + S +S H SL AKHII W+ ISS+
Sbjct: 593 VPANGILRTINPNDLLGNAGLCGGILPPCDQNSAYSSRHGSLRAKHIITAWITGISSILV 652
Query: 654 VGIAVFGARSLYKRWNANGSCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRESNVI 713
+GIA+ ARSLY RW +G CF+E+ G WPWRLMAFQRLGFTS DILAC++E+NVI
Sbjct: 653 IGIAILVARSLYIRWYTDGFCFQERFYKGSKGWPWRLMAFQRLGFTSTDILACVKETNVI 712
Query: 714 GMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLG 773
GMGATG+VYKAE+P+ NT+VAVKKLWR+ D+E SS D VGEVNVLG+LRHRNIVRLLG
Sbjct: 713 GMGATGVVYKAEVPQSNTVVAVKKLWRTGTDIEVGSSDDLVGEVNVLGRLRHRNIVRLLG 772
Query: 774 FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPP 833
FLHND ++MIVYE+M+NG+LGEALHG+QA RLLVDWVSRYNIALGVAQGLAYLHHDC+PP
Sbjct: 773 FLHNDIDVMIVYEFMHNGNLGEALHGRQATRLLVDWVSRYNIALGVAQGLAYLHHDCHPP 832
Query: 834 IIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEK 893
+IHRDIK+NNILLD+NLE RIADFGLA+MMIRKNETVSMVAGSYGYIAPEYGY LKVDEK
Sbjct: 833 VIHRDIKTNNILLDANLEARIADFGLAKMMIRKNETVSMVAGSYGYIAPEYGYALKVDEK 892
Query: 894 IDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQE 953
ID+YS+GVVLLELLTG+RPLD +FGES+DIVEWIRMKIRDN++LEEALDP+VGN +HV E
Sbjct: 893 IDVYSYGVVLLELLTGKRPLDSDFGESIDIVEWIRMKIRDNKSLEEALDPSVGNNRHVLE 952
Query: 954 EMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNRYENNKEKLVFSTSP 1013
EMLLVLRIA LCTAKLPKDRP+MRDV+ MLGEAKPRRKSS N+ N NNKE VFSTSP
Sbjct: 953 EMLLVLRIAILCTAKLPKDRPTMRDVVMMLGEAKPRRKSSGNS-NDVANNKETPVFSTSP 1011
Query: 1014 V 1014
V
Sbjct: 1012 V 1012
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503642|ref|XP_003520615.1| PREDICTED: leucine-rich repeat receptor-like protein kinase PXL2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1515 bits (3923), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 752/994 (75%), Positives = 846/994 (85%), Gaps = 8/994 (0%)
Query: 28 AKTALNDELLALLSIKAGLVDPLNSLHDWKL-------PSAHCNWTGVWCNSNGAVEKLD 80
A + NDE+ ALLSIK GLVDPLN+L DWKL +AHCNWTG+ CNS+GAVE LD
Sbjct: 27 AAASTNDEVSALLSIKEGLVDPLNALQDWKLHGKAPGTDAAHCNWTGIKCNSDGAVEILD 86
Query: 81 LSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPA 140
LSH NLSG VS+ QRLKSLTSLNLCCN + LP S+ANLT+L DVSQNF G+FP
Sbjct: 87 LSHKNLSGRVSNDIQRLKSLTSLNLCCNAFSTPLPKSIANLTTLNSLDVSQNFFIGNFPL 146
Query: 141 GLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLG 200
LG A L LNAS N FSG L EDL NA+SLE LDLRGSFF GS+P SF NL KLKFLG
Sbjct: 147 ALGRAWRLVALNASSNEFSGSLPEDLANASSLEVLDLRGSFFVGSVPKSFSNLHKLKFLG 206
Query: 201 LSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPA 260
LSGNNLTGKIP ELGQLSS+E MIL YNEF+G IP EFGNLTNLKYLDLAV NLGG+IP
Sbjct: 207 LSGNNLTGKIPGELGQLSSLEYMILGYNEFEGGIPEEFGNLTNLKYLDLAVANLGGEIPG 266
Query: 261 ELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLN 320
LG L+LL +FLY NNF+GR+P I N+TSLQLLDLS NMLS +IPAEI+QLKNL+LLN
Sbjct: 267 GLGELKLLNTVFLYNNNFEGRIPPAISNMTSLQLLDLSDNMLSGKIPAEISQLKNLKLLN 326
Query: 321 LMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPA 380
M N+LSG VP G G L QLEVLELWNNSLSGPLP +LGKNS LQWLD+SSNS SGEIP
Sbjct: 327 FMGNKLSGPVPPGFGDLPQLEVLELWNNSLSGPLPSNLGKNSHLQWLDVSSNSLSGEIPE 386
Query: 381 SLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLE 440
+LC+ GNLTKLILFNNAF+G IP SLS C SLVRVR+QNN LSGT+PVG G+L KLQRLE
Sbjct: 387 TLCSQGNLTKLILFNNAFTGSIPSSLSMCPSLVRVRIQNNFLSGTVPVGLGKLGKLQRLE 446
Query: 441 LANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPD 500
LANNSL+GGI DDI+SSTSLSFID+SRN L SSLPST+LSIPNLQ F+VSNNNL GEIPD
Sbjct: 447 LANNSLSGGIPDDISSSTSLSFIDLSRNKLHSSLPSTVLSIPNLQAFMVSNNNLEGEIPD 506
Query: 501 QFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILD 560
QFQDCPSL+VLDLSSN+ SGSIP+SIASC+KLVNLNL+NNQLTG+IPKA+ MPTLA+LD
Sbjct: 507 QFQDCPSLAVLDLSSNHLSGSIPASIASCQKLVNLNLQNNQLTGEIPKALGKMPTLAMLD 566
Query: 561 LSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVLH 620
LSNNSLTG IPE+FG SPALE LNVS+N+LEGPVPANG+LRTIN DL GN GLCGG+L
Sbjct: 567 LSNNSLTGQIPESFGISPALEALNVSFNKLEGPVPANGILRTINPNDLLGNTGLCGGILP 626
Query: 621 PCSRYSPIASSHRSLHAKHIIPGWMIAISSLFAVGIAVFGARSLYKRWNANGSCFEEKLE 680
PC + SP +S H SLHAKHII W+ IS++ +GIA+ ARSLY RW +G CF E+
Sbjct: 627 PCDQNSPYSSRHGSLHAKHIITAWIAGISTILVIGIAIVVARSLYIRWYTDGFCFRERFY 686
Query: 681 MGKGEWPWRLMAFQRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWR 740
G WPWRL+AFQRLGFTS DILACI+E+NVIGMGATG+VYKAE+P+ NT VAVKKLWR
Sbjct: 687 KGSKGWPWRLVAFQRLGFTSTDILACIKETNVIGMGATGVVYKAEIPQSNTTVAVKKLWR 746
Query: 741 SRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGK 800
+ D+E SS D VGEVNVLG+LRHRNIVRLLGF+HND ++MIVYE+M+NG+LGEALHG+
Sbjct: 747 TGTDIEVGSSDDLVGEVNVLGRLRHRNIVRLLGFIHNDIDVMIVYEFMHNGNLGEALHGR 806
Query: 801 QAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860
QA RLLVDWVSRYNIALGVAQGLAYLHHDC+PP+IHRDIKSNNILLD+NLE RIADFGLA
Sbjct: 807 QATRLLVDWVSRYNIALGVAQGLAYLHHDCHPPVIHRDIKSNNILLDANLEARIADFGLA 866
Query: 861 RMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
+MMIRKNETVSMVAGSYGYIAPEYGY LKVDEKID+YS+GVVLLELLTG+RPLD +FGES
Sbjct: 867 KMMIRKNETVSMVAGSYGYIAPEYGYALKVDEKIDVYSYGVVLLELLTGKRPLDSDFGES 926
Query: 921 VDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
+DIVEW+RMKIRDN++LEE LDP+VGN +HV EEMLLVLRIA LCTAKLPK+RP+MRDVI
Sbjct: 927 IDIVEWLRMKIRDNKSLEEVLDPSVGNSRHVVEEMLLVLRIAILCTAKLPKERPTMRDVI 986
Query: 981 TMLGEAKPRRKSSSNNDNRYENNKEKLVFSTSPV 1014
MLGEAKPRRKSSSN+ + NNKE VFSTSPV
Sbjct: 987 MMLGEAKPRRKSSSNSKDA-ANNKEIPVFSTSPV 1019
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449468712|ref|XP_004152065.1| PREDICTED: leucine-rich repeat receptor-like protein kinase PXL2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1514 bits (3921), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 757/1020 (74%), Positives = 857/1020 (84%), Gaps = 10/1020 (0%)
Query: 5 ILLLVLCFYCYIGCTCFGSAKVVAKTALNDELLALLSIKAGLVDPLNSLHDWKLP----- 59
I ++ C + Y C G + + ++E LAL+SIK+GLVDPL L DWKL
Sbjct: 9 ITQILFCVFLY---CCIGFYTHCSASGFSEEALALVSIKSGLVDPLKWLRDWKLDDGNDM 65
Query: 60 -SAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSL 118
+ HCNWTGV+CNS GAVEKL L MNLSG +SD Q+L LTSL+L CNG SSLP S+
Sbjct: 66 FAKHCNWTGVFCNSEGAVEKLSLPRMNLSGILSDDLQKLTKLTSLDLSCNGFSSSLPKSI 125
Query: 119 ANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLR 178
NLTSLK FDVSQN+ G P G GG GLT NAS NNFSG + EDLGNATS+E LDLR
Sbjct: 126 GNLTSLKSFDVSQNYFVGEIPVGFGGVVGLTNFNASSNNFSGLIPEDLGNATSMEILDLR 185
Query: 179 GSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEF 238
GSF +GSIP+SFKNLQKLKFLGLSGNNLTG+IP E+GQ+SS+ET+I+ YNEF+G IP EF
Sbjct: 186 GSFLEGSIPISFKNLQKLKFLGLSGNNLTGRIPAEIGQMSSLETVIIGYNEFEGGIPSEF 245
Query: 239 GNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLS 298
GNLTNLKYLDLAVGNLGG IP ELGRL+ LE +FLY+N + ++P+ IGN TSL LDLS
Sbjct: 246 GNLTNLKYLDLAVGNLGGGIPTELGRLKELETLFLYKNGLEDQIPSSIGNATSLVFLDLS 305
Query: 299 YNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDL 358
N L+ E+PAE+ +LKNLQLLNLMCN+LSG VP G+GGLT+L+VLELWNNS SG LP DL
Sbjct: 306 DNKLTGEVPAEVAELKNLQLLNLMCNKLSGEVPPGIGGLTKLQVLELWNNSFSGQLPADL 365
Query: 359 GKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQ 418
GKNS L WLD+SSNSFSG IPASLCN GNLTKLILFNNAFSG IP+ LS+C+SLVRVRMQ
Sbjct: 366 GKNSELVWLDVSSNSFSGPIPASLCNRGNLTKLILFNNAFSGSIPIGLSSCYSLVRVRMQ 425
Query: 419 NNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTI 478
NN LSGTIPVGFG+L KLQRLELANNSL G I DI+SS SLSFID+S N L SSLP +I
Sbjct: 426 NNLLSGTIPVGFGKLGKLQRLELANNSLFGSIPSDISSSKSLSFIDLSENDLHSSLPPSI 485
Query: 479 LSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLR 538
LSIPNLQTFIVS+NNL GEIPDQFQ+CP+LS+LDLSSN F+GSIP SIASCE+LVNLNLR
Sbjct: 486 LSIPNLQTFIVSDNNLDGEIPDQFQECPALSLLDLSSNNFTGSIPESIASCERLVNLNLR 545
Query: 539 NNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANG 598
NN+LTG+IPK I+ MP+L++LDLSNNSLTG IP+NFG SPALE LNVSYN+LEGPVP NG
Sbjct: 546 NNKLTGEIPKQIANMPSLSVLDLSNNSLTGRIPDNFGISPALESLNVSYNKLEGPVPLNG 605
Query: 599 VLRTINRGDLAGNAGLCGGVLHPCSRYSPIASSHRSLHAKHIIPGWMIAISSLFAVGIAV 658
VLRTIN DL GNAGLCG VL PCS S +S H + H HII GW+I IS L A+ I +
Sbjct: 606 VLRTINPSDLQGNAGLCGAVLPPCSPNSAYSSGHGNSHTSHIIAGWVIGISGLLAICITL 665
Query: 659 FGARSLYKRWNANGSCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRESNVIGMGAT 718
FG RSLYKRW ++GSCFE + EMG G+WPWRLMAFQRLGF S+DIL CI+ESNVIGMGAT
Sbjct: 666 FGVRSLYKRWYSSGSCFEGRYEMGGGDWPWRLMAFQRLGFASSDILTCIKESNVIGMGAT 725
Query: 719 GIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND 778
GIVYKAEMP+L T+VAVKKLWRS+ DLE S VGEVN+LGKLRHRNIVRLLGF+HND
Sbjct: 726 GIVYKAEMPQLKTVVAVKKLWRSQPDLEIGSCEGLVGEVNLLGKLRHRNIVRLLGFMHND 785
Query: 779 TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRD 838
++MI+YE+M NGSLGEALHGKQAGRLLVDWVSRYNIA+GVAQGLAYLHHDC PPIIHRD
Sbjct: 786 VDVMIIYEFMQNGSLGEALHGKQAGRLLVDWVSRYNIAIGVAQGLAYLHHDCNPPIIHRD 845
Query: 839 IKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYS 898
+K NNILLDSNLE R+ADFGLARMM RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYS
Sbjct: 846 VKPNNILLDSNLEARLADFGLARMMARKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYS 905
Query: 899 FGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLV 958
+GVVLLELLTG++PLDPEFGESVDIVEWI+ K++DNR LEEALDPN+GN KHVQEEML V
Sbjct: 906 YGVVLLELLTGKKPLDPEFGESVDIVEWIKRKVKDNRPLEEALDPNLGNFKHVQEEMLFV 965
Query: 959 LRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNRYENNKEKLVFSTSPVSGLV 1018
LRIA LCTAK PKDRPSMRD+ITMLGEAKPRRKS+S N+ + NKEK VFSTSPV+GL+
Sbjct: 966 LRIALLCTAKHPKDRPSMRDIITMLGEAKPRRKSNSGNEG-FGTNKEKPVFSTSPVNGLL 1024
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356536856|ref|XP_003536949.1| PREDICTED: leucine-rich repeat receptor-like protein kinase PXL2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1482 bits (3837), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 743/987 (75%), Positives = 840/987 (85%), Gaps = 10/987 (1%)
Query: 39 LLSIKAGLVDPLNSLHDWKLP-------SAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVS 91
LLSIK GL DPLNSLHDWKL +AHCNWTGV CNS GAVEKLDLS MNLSG VS
Sbjct: 32 LLSIKEGLTDPLNSLHDWKLVDKAEGKNAAHCNWTGVRCNSIGAVEKLDLSRMNLSGIVS 91
Query: 92 DHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFL 151
+ QRLKSLTSLNLCCN SSL +S+ANLT+LK DVSQNF G FP GLG A+GL L
Sbjct: 92 NEIQRLKSLTSLNLCCNEFASSL-SSIANLTTLKSLDVSQNFFTGDFPLGLGKASGLITL 150
Query: 152 NASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIP 211
NAS NNFSGFL ED GN +SLETLDLRGSFF+GSIP SF NL KLKFLGLSGNNLTG+IP
Sbjct: 151 NASSNNFSGFLPEDFGNVSSLETLDLRGSFFEGSIPKSFSNLHKLKFLGLSGNNLTGEIP 210
Query: 212 RELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIM 271
LGQLSS+E MI+ YNEF+G IP EFGNLT LKYLDLA GNLGG+IPAELGRL+LL +
Sbjct: 211 GGLGQLSSLECMIIGYNEFEGGIPPEFGNLTKLKYLDLAEGNLGGEIPAELGRLKLLNTV 270
Query: 272 FLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVP 331
FLY+N F+G++P IGN+TSL LDLS NMLS IP EI++LKNLQLLN M N LSG VP
Sbjct: 271 FLYKNKFEGKIPPAIGNMTSLVQLDLSDNMLSGNIPGEISKLKNLQLLNFMRNWLSGPVP 330
Query: 332 AGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKL 391
+GLG L QLEVLELWNNSLSG LP +LGKNSPLQWLD+SSNS SGEIP +LC G LTKL
Sbjct: 331 SGLGDLPQLEVLELWNNSLSGTLPRNLGKNSPLQWLDVSSNSLSGEIPETLCTKGYLTKL 390
Query: 392 ILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGIT 451
ILFNNAF GPIP SLSTC SLVRVR+QNN L+GTIPVG G+L KLQRLE ANNSLTGGI
Sbjct: 391 ILFNNAFLGPIPASLSTCPSLVRVRIQNNFLNGTIPVGLGKLGKLQRLEWANNSLTGGIP 450
Query: 452 DDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVL 511
DDI SSTSLSFID SRN+L SSLPSTI+SIPNLQT IVSNNNL GEIPDQFQDCPSL VL
Sbjct: 451 DDIGSSTSLSFIDFSRNNLHSSLPSTIISIPNLQTLIVSNNNLGGEIPDQFQDCPSLGVL 510
Query: 512 DLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIP 571
DLSSN FSGSIPSSIASC+KLVNLNL+NNQLTG IPK+++ MPTLAILDL+NN+L+G IP
Sbjct: 511 DLSSNRFSGSIPSSIASCQKLVNLNLQNNQLTGGIPKSLASMPTLAILDLANNTLSGHIP 570
Query: 572 ENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVLHPCSRYSPIASS 631
E+FG SPALE NVS+N+LEGPVP NGVLRTIN DL GNAGLCGGVL PC + S S
Sbjct: 571 ESFGMSPALETFNVSHNKLEGPVPENGVLRTINPNDLVGNAGLCGGVLPPCGQTSAYPLS 630
Query: 632 HRSLHAKHIIPGWMIAISSLFAVGIAVFGARSLYKRWNANGSCFEEKLEMGKGEWPWRLM 691
H S AKHI+ GW+I +SS+ A+G+A ARSLY +W +G CF E+ G+ WPWRLM
Sbjct: 631 HGSSRAKHILVGWIIGVSSILAIGVATLVARSLYMKWYTDGLCFRERFYKGRKGWPWRLM 690
Query: 692 AFQRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG 751
AFQRL FTS+DIL+CI+++N+IGMGATG+VYKAE+P+ +TIVAVKKLWRS +D+E SS
Sbjct: 691 AFQRLDFTSSDILSCIKDTNMIGMGATGVVYKAEIPQSSTIVAVKKLWRSGSDIEVGSSD 750
Query: 752 DFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVS 811
D VGEVN+LG+LRHRNIVRLLGFL+ND ++MIVYE+M+NG+LGEALHGKQAGRLLVDWVS
Sbjct: 751 DLVGEVNLLGRLRHRNIVRLLGFLYNDADVMIVYEFMHNGNLGEALHGKQAGRLLVDWVS 810
Query: 812 RYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVS 871
RYNIALG+AQGLAYLHHDC+PP+IHRDIKSNNILLD+NLE RIADFGLA+MM +KNETVS
Sbjct: 811 RYNIALGIAQGLAYLHHDCHPPVIHRDIKSNNILLDANLEARIADFGLAKMMFQKNETVS 870
Query: 872 MVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKI 931
M+AGSYGYIAPEYGY+LKVDEKIDIYS+GVVLLELLTG+RPL+ EFGES+D+V WIR KI
Sbjct: 871 MIAGSYGYIAPEYGYSLKVDEKIDIYSYGVVLLELLTGKRPLNSEFGESIDLVGWIRRKI 930
Query: 932 RDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRK 991
DN++ EEALDP+VGNCKHVQEEMLLVLRIA LCTAK PKDRPSMRDV+ MLGEAKPRRK
Sbjct: 931 -DNKSPEEALDPSVGNCKHVQEEMLLVLRIALLCTAKFPKDRPSMRDVMMMLGEAKPRRK 989
Query: 992 SSSNNDNRYENNKEKLVFSTSPVSGLV 1018
S +++ + NKE S+SPV+GL+
Sbjct: 990 SGRSSET-FSANKEMPAISSSPVNGLL 1015
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357510199|ref|XP_003625388.1| Receptor-like protein kinase [Medicago truncatula] gi|355500403|gb|AES81606.1| Receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1458 bits (3775), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 745/1022 (72%), Positives = 848/1022 (82%), Gaps = 9/1022 (0%)
Query: 1 MQLKILLLVLCFYCYIGCTCFGSAKVVAKTALNDELLALLSIKAGLVDPLNSLHDWKLPS 60
MQ+K + + F+CYI CF ++ A NDE+ ALLS+K GLVDPLN+L DWKL +
Sbjct: 8 MQMKTQIFI--FFCYIVIFCFSNSFSAAS---NDEVSALLSLKEGLVDPLNTLQDWKLDA 62
Query: 61 AHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLAN 120
AHCNWTG+ CNS G VE LDLSH NLSG VS QRL++LTSLNLCCN S P ++N
Sbjct: 63 AHCNWTGIECNSAGTVENLDLSHKNLSGIVSGDIQRLQNLTSLNLCCNAFSSPFPKFISN 122
Query: 121 LTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGS 180
LT+LK DVSQNF G FP GLG A+GLT LNAS N F+G + D+GNATSLE LDLRGS
Sbjct: 123 LTTLKSLDVSQNFFIGEFPLGLGKASGLTTLNASSNEFTGSIPLDIGNATSLEMLDLRGS 182
Query: 181 FFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGN 240
FF+GSIP SF NL KLKFLGLSGNNLTGKIP ELG LSS+E MIL YNEF+GEIP EFGN
Sbjct: 183 FFEGSIPKSFSNLHKLKFLGLSGNNLTGKIPGELGNLSSLEYMILGYNEFEGEIPAEFGN 242
Query: 241 LTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYN 300
LT+LKYLDLAV NLGG+IP ELG L+LL+ +FLY NN +GR+P++IGNITSLQ LDLS N
Sbjct: 243 LTSLKYLDLAVANLGGEIPEELGNLKLLDTLFLYNNNLEGRIPSQIGNITSLQFLDLSDN 302
Query: 301 MLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGK 360
LS +IP E++ LKNL+LLN M NQLSG VP+GLG L QLEV ELWNNSLSGPLP +LG+
Sbjct: 303 NLSGKIPDEMSLLKNLKLLNFMGNQLSGFVPSGLGNLPQLEVFELWNNSLSGPLPSNLGE 362
Query: 361 NSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNN 420
NSPLQWLD+SSNS SGEIP +LC+ GNLTKLILFNNAFSGPIP SLS C SLVRVR+ NN
Sbjct: 363 NSPLQWLDVSSNSLSGEIPETLCSKGNLTKLILFNNAFSGPIPSSLSMCSSLVRVRIHNN 422
Query: 421 QLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILS 480
LSG +PVG G+LEKLQRLELANNSLTG I DDI SS SLSFID+SRN L S LPSTILS
Sbjct: 423 FLSGKVPVGLGKLEKLQRLELANNSLTGEIPDDIPSSMSLSFIDLSRNKLHSFLPSTILS 482
Query: 481 IPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNN 540
IPNLQ F VSNNNL G+IP QFQD PSL+VLDLSSN+ SG+IP SI SC+KLVNLNL+NN
Sbjct: 483 IPNLQVFKVSNNNLEGKIPGQFQDSPSLTVLDLSSNHLSGTIPDSIGSCQKLVNLNLQNN 542
Query: 541 QLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVL 600
L G+IPKA++ MPT+A+LDLSNNSLTG IPENFG SPALE +VSYN+LEG VP NG+L
Sbjct: 543 LLIGEIPKALANMPTMAMLDLSNNSLTGHIPENFGVSPALEAFDVSYNKLEGSVPENGML 602
Query: 601 RTINRGDLAGNAGLCGGVLHPCSRYSPIASSHRSLHAKHIIPGWMIAISSLFAVGIAVFG 660
RTIN +L GNAGLCGG L C++ S +S H S H KHII GW+I ISS+ A+GI +
Sbjct: 603 RTINPNNLVGNAGLCGGTLLSCNQNSAYSSMHGSSHEKHIITGWIIGISSILAIGITILV 662
Query: 661 ARSLYKRWNANGSCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRESNVIGMGATGI 720
ARSLY RW G CF E+ G WPWRLMAFQRLGFTS DILACI+E+NVIGMG TGI
Sbjct: 663 ARSLYVRWYTGGFCFRERFYKGSKGWPWRLMAFQRLGFTSTDILACIKETNVIGMGGTGI 722
Query: 721 VYKAEMPRLNTIVAVKKLWRSRADLET-ESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779
VYKAE+P NT+VAVKKLWRS D+E S + VGEVN+LG+LRHRNIVRLLGFLHNDT
Sbjct: 723 VYKAEVPHSNTVVAVKKLWRSGNDVEVGRGSDELVGEVNLLGRLRHRNIVRLLGFLHNDT 782
Query: 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDI 839
++MIVYE+MNNG+LG+ALHG+Q+ R LVDWVSRYNIALGVAQGLAYLHHDC+PP+IHRDI
Sbjct: 783 DLMIVYEFMNNGNLGDALHGRQSVRHLVDWVSRYNIALGVAQGLAYLHHDCHPPVIHRDI 842
Query: 840 KSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSF 899
KSNNILLD+NLE RIADFGLA+MMI+KNETVSMVAGSYGYIAPEYGY LKVDEKID+YS+
Sbjct: 843 KSNNILLDANLEARIADFGLAKMMIQKNETVSMVAGSYGYIAPEYGYALKVDEKIDVYSY 902
Query: 900 GVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVL 959
GVVLLEL+TG+RPLD EFGESVDIVEWIR KIR+N++LEEALDP+VGNC+HV EEMLLVL
Sbjct: 903 GVVLLELVTGKRPLDSEFGESVDIVEWIRRKIRENKSLEEALDPSVGNCRHVIEEMLLVL 962
Query: 960 RIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNRY---ENNKEKLVFSTSPVSG 1016
RIA +CTAKLPK+RPSMRDVI MLGEAKPRRK + NN+ NNKE VFSTSPVSG
Sbjct: 963 RIAVVCTAKLPKERPSMRDVIMMLGEAKPRRKINGNNETSLAANNNNKEMSVFSTSPVSG 1022
Query: 1017 LV 1018
L+
Sbjct: 1023 LL 1024
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15235387|ref|NP_194594.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|75335753|sp|Q9M0G7.1|PXL2_ARATH RecName: Full=Leucine-rich repeat receptor-like protein kinase PXL2; AltName: Full=Protein PHLOEM INTERCALATED WITH XYLEM-LIKE 2; Flags: Precursor gi|7269720|emb|CAB81453.1| receptor protein kinase-like protein [Arabidopsis thaliana] gi|224589634|gb|ACN59350.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332660118|gb|AEE85518.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1427 bits (3694), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 723/1023 (70%), Positives = 842/1023 (82%), Gaps = 15/1023 (1%)
Query: 1 MQLKILLLVLCFYCYIGCTCFGSAKVVAKTALNDELLALLSIKAGLVDPLNSLHDWKL-- 58
M++KI++L L +YCYIG T + V+A +EL LLS+K+ LVDPLN L DWKL
Sbjct: 1 MKMKIIVLFL-YYCYIGST----SSVLASIDNVNELSVLLSVKSTLVDPLNFLKDWKLSD 55
Query: 59 PSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSL 118
S HCNWTGV CNSNG VEKLDL+ MNL+G +SD +L SL S N+ CNG S LP S+
Sbjct: 56 TSDHCNWTGVRCNSNGNVEKLDLAGMNLTGKISDSISQLSSLVSFNISCNGFESLLPKSI 115
Query: 119 ANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLR 178
LK D+SQN +GS + GL LNASGNN SG L EDLGN SLE LDLR
Sbjct: 116 P---PLKSIDISQNSFSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLR 172
Query: 179 GSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEF 238
G+FFQGS+P SFKNLQKL+FLGLSGNNLTG++P LGQL S+ET IL YNEF G IP EF
Sbjct: 173 GNFFQGSLPSSFKNLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGYNEFKGPIPPEF 232
Query: 239 GNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLS 298
GN+ +LKYLDLA+G L G+IP+ELG+L+ LE + LY+NNF G +P EIG+IT+L++LD S
Sbjct: 233 GNINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFS 292
Query: 299 YNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDL 358
N L+ EIP EIT+LKNLQLLNLM N+LSG +P + L QL+VLELWNN+LSG LP DL
Sbjct: 293 DNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDL 352
Query: 359 GKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQ 418
GKNSPLQWLD+SSNSFSGEIP++LCN GNLTKLILFNN F+G IP +LSTC SLVRVRMQ
Sbjct: 353 GKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQ 412
Query: 419 NNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTI 478
NN L+G+IP+GFG+LEKLQRLELA N L+GGI DI+ S SLSFID SRN +RSSLPSTI
Sbjct: 413 NNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTI 472
Query: 479 LSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLR 538
LSI NLQ F+V++N + GE+PDQFQDCPSLS LDLSSN +G+IPSSIASCEKLV+LNLR
Sbjct: 473 LSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLR 532
Query: 539 NNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANG 598
NN LTG+IP+ I+ M LA+LDLSNNSLTG +PE+ G SPALE+LNVSYN+L GPVP NG
Sbjct: 533 NNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPING 592
Query: 599 VLRTINRGDLAGNAGLCGGVLHPCSRYSPIASSHRSLHAKHIIPGWMIAISSLFAVGIAV 658
L+TIN DL GN+GLCGGVL PCS++ SSH SLH K I+ GW+I I+S+ A+GI
Sbjct: 593 FLKTINPDDLRGNSGLCGGVLPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILT 652
Query: 659 FGARSLYKRWNANGSCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRESNVIGMGAT 718
R+LYK+W +NG C +E KGEWPWRLMAF RLGFT++DILACI+ESN+IGMGAT
Sbjct: 653 IVTRTLYKKWYSNGFCGDET--ASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMGAT 710
Query: 719 GIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND 778
GIVYKAEM R +T++AVKKLWRS AD+E ++GDFVGEVN+LGKLRHRNIVRLLGFL+ND
Sbjct: 711 GIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYND 770
Query: 779 TNMMIVYEYMNNGSLGEALHGKQ-AGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHR 837
NMMIVYE+M NG+LG+A+HGK AGRLLVDWVSRYNIALGVA GLAYLHHDC+PP+IHR
Sbjct: 771 KNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHR 830
Query: 838 DIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIY 897
DIKSNNILLD+NL+ RIADFGLARMM RK ETVSMVAGSYGYIAPEYGYTLKVDEKIDIY
Sbjct: 831 DIKSNNILLDANLDARIADFGLARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIY 890
Query: 898 SFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLL 957
S+GVVLLELLTGRRPL+PEFGESVDIVEW+R KIRDN +LEEALDPNVGNC++VQEEMLL
Sbjct: 891 SYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLL 950
Query: 958 VLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDN--RYENNKEKLVFSTSPVS 1015
VL+IA LCT KLPKDRPSMRDVI+MLGEAKPRRKS+SN +N R K VFSTSPV+
Sbjct: 951 VLQIALLCTTKLPKDRPSMRDVISMLGEAKPRRKSNSNEENTSRSLAEKHSSVFSTSPVN 1010
Query: 1016 GLV 1018
GL+
Sbjct: 1011 GLL 1013
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224145839|ref|XP_002325782.1| predicted protein [Populus trichocarpa] gi|222862657|gb|EEF00164.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1415 bits (3663), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 713/1023 (69%), Positives = 829/1023 (81%), Gaps = 20/1023 (1%)
Query: 8 LVLCFYCYIGCTCFGSAKV----VAKTALNDELLALLSIKAGLVDPLNSLHDWKLP---- 59
L+L F+C CFG + V V ++EL LL I++ LVDP N L W++P
Sbjct: 4 LLLFFFC-----CFGLSLVFVEGVQSVQQHEELSTLLLIRSSLVDPSNQLEGWRMPRNSS 58
Query: 60 ---SAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPN 116
S HCNWTG+WCNS G VE+LDLS+MNL+G VSDH Q L SL+ LN CNG SSLP
Sbjct: 59 ENQSPHCNWTGIWCNSKGFVERLDLSNMNLTGNVSDHIQDLHSLSFLNFSCNGFDSSLPR 118
Query: 117 SLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLD 176
L LTSLK DVSQN GSFP GLG A+GLT +NAS NNFSG+L EDLGNATSLE+LD
Sbjct: 119 ELGTLTSLKTIDVSQNNFVGSFPTGLGMASGLTSVNASSNNFSGYLPEDLGNATSLESLD 178
Query: 177 LRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPV 236
RGSFF+GSIP SFKNLQKLKFLGLSGNNLTG+IPRE+GQL+S+ET+IL YNEF+GEIP
Sbjct: 179 FRGSFFEGSIPGSFKNLQKLKFLGLSGNNLTGRIPREIGQLASLETIILGYNEFEGEIPE 238
Query: 237 EFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLD 296
E GNLTNL+YLDLAVG+L G+IPAELGRL+ L ++LY+NNF G++P E+G+ TSL LD
Sbjct: 239 EIGNLTNLRYLDLAVGSLSGQIPAELGRLKQLTTVYLYKNNFTGQIPPELGDATSLVFLD 298
Query: 297 LSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPV 356
LS N +S EIP E+ +LKNLQLLNLM NQL G +P LG LT+LEVLELW N L+GPLP
Sbjct: 299 LSDNQISGEIPVELAELKNLQLLNLMRNQLKGTIPTKLGELTKLEVLELWKNFLTGPLPE 358
Query: 357 DLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVR 416
+LG+NSPLQWLD+SSNS SGEIP LC+ GNLTKLILFNN+FSGPIP+SLSTC SLVRVR
Sbjct: 359 NLGQNSPLQWLDVSSNSLSGEIPPGLCHSGNLTKLILFNNSFSGPIPMSLSTCESLVRVR 418
Query: 417 MQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPS 476
MQNN +SGTIPVG G L LQRLELANN+LTG I DDI STSLSFID+S NHL+SSLP
Sbjct: 419 MQNNLISGTIPVGLGSLPMLQRLELANNNLTGQIPDDIGLSTSLSFIDVSGNHLQSSLPY 478
Query: 477 TILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLN 536
+ILSIP+LQ F+ SNNNL G+IPDQFQDCPSL++LDLSSN+ SG IP SIASCEKLVNLN
Sbjct: 479 SILSIPSLQIFMASNNNLEGQIPDQFQDCPSLTLLDLSSNHLSGKIPESIASCEKLVNLN 538
Query: 537 LRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPA 596
L+NNQ TG+IPKAIS MPTLAILDLSNNSL G IPENFG SPALE LN+S+N+LEGPVP+
Sbjct: 539 LKNNQFTGEIPKAISTMPTLAILDLSNNSLVGRIPENFGNSPALETLNLSFNKLEGPVPS 598
Query: 597 NGVLRTINRGDLAGNAGLCGGVLHPCSRYSPIASSHRSLHAKHIIPGWMIAISSLFAVGI 656
NG+L TIN DL GNAGLCGG+L PCS S ++ ++L KH+I G+++ IS + ++GI
Sbjct: 599 NGMLTTINPNDLVGNAGLCGGILPPCSPASSVSKQQQNLRVKHVIIGFIVGISIVLSLGI 658
Query: 657 AVFGARSLYKRWNANGSCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRESNVIGMG 716
A F R +YKRW S F + WPW L+AFQR+ FTS+DI+ACI ESN+IGMG
Sbjct: 659 AFFTGRLIYKRWYLYNSFFYDWFNNSNKAWPWTLVAFQRISFTSSDIIACIMESNIIGMG 718
Query: 717 ATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLH 776
TGIVYKAE R + VAVKKLWR+ D+ E+ D EVN+LG+LRHRNIVRLLG++H
Sbjct: 719 GTGIVYKAEAYRPHATVAVKKLWRTERDI--ENGDDLFREVNLLGRLRHRNIVRLLGYIH 776
Query: 777 NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIH 836
N+T++++VYEYM NG+LG ALHGK+AG LLVDWVSRYN+A+GVAQGL YLHHDC+PP+IH
Sbjct: 777 NETDVLMVYEYMPNGNLGTALHGKEAGNLLVDWVSRYNVAVGVAQGLNYLHHDCHPPVIH 836
Query: 837 RDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDI 896
RDIKSNNILLDSNLE RIADFGLARMM KNETVSMVAGSYGYIAPEYGYTLKV EK DI
Sbjct: 837 RDIKSNNILLDSNLEARIADFGLARMMSYKNETVSMVAGSYGYIAPEYGYTLKVGEKSDI 896
Query: 897 YSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV-GNCKHVQEEM 955
YSFGVVLLELLTG+ PLDP FGESVDIVEW+R KIR+NR LEEALD ++ G+CK VQEEM
Sbjct: 897 YSFGVVLLELLTGKMPLDPAFGESVDIVEWVRRKIRNNRALEEALDHSIAGHCKDVQEEM 956
Query: 956 LLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNRYENNKEKLVFSTSPVS 1015
LLVLRIA LCTAKLPKDRPSMRDVITMLGEAKPRRKS +N + +KE+ +FS SPV
Sbjct: 957 LLVLRIAILCTAKLPKDRPSMRDVITMLGEAKPRRKSICHNGVQ-NPSKERPIFSNSPVI 1015
Query: 1016 GLV 1018
GL+
Sbjct: 1016 GLL 1018
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1018 | ||||||
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.990 | 0.995 | 0.693 | 0.0 | |
| TAIR|locus:2025545 | 1029 | AT1G08590 [Arabidopsis thalian | 0.983 | 0.972 | 0.589 | 5.8e-311 | |
| TAIR|locus:2161158 | 1041 | PXY "PHLOEM INTERCALATED WITH | 0.937 | 0.916 | 0.452 | 3.3e-221 | |
| TAIR|locus:2204350 | 980 | CLV1 "AT1G75820" [Arabidopsis | 0.673 | 0.7 | 0.358 | 4.5e-189 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.936 | 0.950 | 0.409 | 4.7e-183 | |
| TAIR|locus:2120412 | 992 | BAM3 "BARELY ANY MERISTEM 3" [ | 0.913 | 0.937 | 0.414 | 1.7e-178 | |
| TAIR|locus:2032553 | 996 | HSL1 "HAESA-like 1" [Arabidops | 0.913 | 0.933 | 0.399 | 5.3e-175 | |
| UNIPROTKB|Q5Z9N5 | 994 | P0481E08.42 "Os06g0717200 prot | 0.921 | 0.943 | 0.387 | 3.4e-171 | |
| TAIR|locus:2005540 | 999 | HAE "HAESA" [Arabidopsis thali | 0.953 | 0.971 | 0.400 | 1.5e-168 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.889 | 0.798 | 0.374 | 1e-155 |
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3622 (1280.1 bits), Expect = 0., P = 0.
Identities = 709/1023 (69%), Positives = 827/1023 (80%)
Query: 1 MQLKILLLVLCFYCYIGCTCFGSAKVVAKTALNDELLALLSIKAGLVDPLNSLHDWKLP- 59
M++KI++L L +YCYIG T + V+A +EL LLS+K+ LVDPLN L DWKL
Sbjct: 1 MKMKIIVLFL-YYCYIGST----SSVLASIDNVNELSVLLSVKSTLVDPLNFLKDWKLSD 55
Query: 60 -SAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSL 118
S HCNWTGV CNSNG VEKLDL+ MNL+G +SD +L SL S N+ CNG S LP S+
Sbjct: 56 TSDHCNWTGVRCNSNGNVEKLDLAGMNLTGKISDSISQLSSLVSFNISCNGFESLLPKSI 115
Query: 119 ANLTSLKRFDVSQNFLNGSFPXXXXXXXXXTFLNASGNNFSGFLLEDLGNATSLETLDLR 178
L S+ D+SQN +GS LNASGNN SG L EDLGN SLE LDLR
Sbjct: 116 PPLKSI---DISQNSFSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLR 172
Query: 179 GSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEF 238
G+FFQGS+P SFKNLQKL+FLGLSGNNLTG++P LGQL S+ET IL YNEF G IP EF
Sbjct: 173 GNFFQGSLPSSFKNLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGYNEFKGPIPPEF 232
Query: 239 GNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLS 298
GN+ +LKYLDLA+G L G+IP+ELG+L+ LE + LY+NNF G +P EIG+IT+L++LD S
Sbjct: 233 GNINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFS 292
Query: 299 YNMLSHEIPAEITXXXXXXXXXXXXXXXSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDL 358
N L+ EIP EIT SG +P + L QL+VLELWNN+LSG LP DL
Sbjct: 293 DNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDL 352
Query: 359 GKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQ 418
GKNSPLQWLD+SSNSFSGEIP++LCN GNLTKLILFNN F+G IP +LSTC SLVRVRMQ
Sbjct: 353 GKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQ 412
Query: 419 NNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTI 478
NN L+G+IP+GFG+LEKLQRLELA N L+GGI DI+ S SLSFID SRN +RSSLPSTI
Sbjct: 413 NNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTI 472
Query: 479 LSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLR 538
LSI NLQ F+V++N + GE+PDQFQDCPSLS LDLSSN +G+IPSSIASCEKLV+LNLR
Sbjct: 473 LSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLR 532
Query: 539 NNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANG 598
NN LTG+IP+ I+ M LA+LDLSNNSLTG +PE+ G SPALE+LNVSYN+L GPVP NG
Sbjct: 533 NNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPING 592
Query: 599 VLRTINRGDLAGNAGLCGGVLHPCSRYSPIASSHRSLHAKHIIPGWMIAISSLFAVGIAV 658
L+TIN DL GN+GLCGGVL PCS++ SSH SLH K I+ GW+I I+S+ A+GI
Sbjct: 593 FLKTINPDDLRGNSGLCGGVLPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILT 652
Query: 659 FGARSLYKRWNANGSCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRESNVIGMGAT 718
R+LYK+W +NG C +E KGEWPWRLMAF RLGFT++DILACI+ESN+IGMGAT
Sbjct: 653 IVTRTLYKKWYSNGFCGDETAS--KGEWPWRLMAFHRLGFTASDILACIKESNMIGMGAT 710
Query: 719 GIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND 778
GIVYKAEM R +T++AVKKLWRS AD+E ++GDFVGEVN+LGKLRHRNIVRLLGFL+ND
Sbjct: 711 GIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYND 770
Query: 779 TNMMIVYEYMNNGSLGEALHGKQA-GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHR 837
NMMIVYE+M NG+LG+A+HGK A GRLLVDWVSRYNIALGVA GLAYLHHDC+PP+IHR
Sbjct: 771 KNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHR 830
Query: 838 DIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIY 897
DIKSNNILLD+NL+ RIADFGLARMM RK ETVSMVAGSYGYIAPEYGYTLKVDEKIDIY
Sbjct: 831 DIKSNNILLDANLDARIADFGLARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIY 890
Query: 898 SFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLL 957
S+GVVLLELLTGRRPL+PEFGESVDIVEW+R KIRDN +LEEALDPNVGNC++VQEEMLL
Sbjct: 891 SYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLL 950
Query: 958 VLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNRYENNKEK--LVFSTSPVS 1015
VL+IA LCT KLPKDRPSMRDVI+MLGEAKPRRKS+SN +N + EK VFSTSPV+
Sbjct: 951 VLQIALLCTTKLPKDRPSMRDVISMLGEAKPRRKSNSNEENTSRSLAEKHSSVFSTSPVN 1010
Query: 1016 GLV 1018
GL+
Sbjct: 1011 GLL 1013
|
|
| TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2983 (1055.1 bits), Expect = 5.8e-311, P = 5.8e-311
Identities = 610/1034 (58%), Positives = 748/1034 (72%)
Query: 8 LVLCFYCYIGCTCFGSAKVVAKTALNDELLALLSIKAGLVDPLNSLHDWKLPS------- 60
L FY YIG F V ++T N E LL+ K+ L DP N+L DWK P
Sbjct: 6 LFFLFY-YIGFALFPF--VSSETFQNSEQEILLAFKSDLFDPSNNLQDWKRPENATTFSE 62
Query: 61 -AHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLA 119
HC+WTGV C++NG V KL LS+MNLSG VSD Q SL +L+L N SSLP SL+
Sbjct: 63 LVHCHWTGVHCDANGYVAKLLLSNMNLSGNVSDQIQSFPSLQALDLSNNAFESSLPKSLS 122
Query: 120 NLTSLKRFDVSQNFLNGSFPXXXXXXXXXTFLNASGNNFSGFLLEDLGNATSLETLDLRG 179
NLTSLK DVS N G+FP T +NAS NNFSGFL EDLGNAT+LE LD RG
Sbjct: 123 NLTSLKVIDVSVNSFFGTFPYGLGMATGLTHVNASSNNFSGFLPEDLGNATTLEVLDFRG 182
Query: 180 SFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFG 239
+F+GS+P SFKNL+ LKFLGLSGNN GK+P+ +G+LSS+ET+IL YN F GEIP EFG
Sbjct: 183 GYFEGSVPSSFKNLKNLKFLGLSGNNFGGKVPKVIGELSSLETIILGYNGFMGEIPEEFG 242
Query: 240 NLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSY 299
LT L+YLDLAVGNL G+IP+ LG+L+ L ++LYQN G+LP E+G +TSL LDLS
Sbjct: 243 KLTRLQYLDLAVGNLTGQIPSSLGQLKQLTTVYLYQNRLTGKLPRELGGMTSLVFLDLSD 302
Query: 300 NMLSHEIPAEITXXXXXXXXXXXXXXXSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLG 359
N ++ EIP E+ +G +P+ + L LEVLELW NSL G LPV LG
Sbjct: 303 NQITGEIPMEVGELKNLQLLNLMRNQLTGIIPSKIAELPNLEVLELWQNSLMGSLPVHLG 362
Query: 360 KNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQN 419
KNSPL+WLD+SSN SG+IP+ LC NLTKLILFNN+FSG IP + +C +LVRVR+Q
Sbjct: 363 KNSPLKWLDVSSNKLSGDIPSGLCYSRNLTKLILFNNSFSGQIPEEIFSCPTLVRVRIQK 422
Query: 420 NQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTIL 479
N +SG+IP G G L LQ LELA N+LTG I DDIA STSLSFIDIS NHL SSL S+I
Sbjct: 423 NHISGSIPAGSGDLPMLQHLELAKNNLTGKIPDDIALSTSLSFIDISFNHL-SSLSSSIF 481
Query: 480 SIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRN 539
S PNLQTFI S+NN G+IP+Q QD PSLSVLDLS N+FSG IP IAS EKLV+LNL++
Sbjct: 482 SSPNLQTFIASHNNFAGKIPNQIQDRPSLSVLDLSFNHFSGGIPERIASFEKLVSLNLKS 541
Query: 540 NQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGV 599
NQL G+IPKA++ M LA+LDLSNNSLTG IP + GASP LE+LNVS+N+L+GP+P+N +
Sbjct: 542 NQLVGEIPKALAGMHMLAVLDLSNNSLTGNIPADLGASPTLEMLNVSFNKLDGPIPSNML 601
Query: 600 LRTINRGDLAGNAGLCGGVLHPCSRYSPIASSHRS---LHAKHIIPGWMIAISSLFAVGI 656
I+ DL GN GLCGGVL PCS+ +++ R+ +H H + G+++ S + A+G+
Sbjct: 602 FAAIDPKDLVGNNGLCGGVLPPCSKSLALSAKGRNPGRIHVNHAVFGFIVGTSVIVAMGM 661
Query: 657 AVFGARSLYKRWNANGSCFEEKL--EMGKGEWPWRLMAFQRLGFTSADILACIRESNVIG 714
R +Y RW+ + E + + + EWPWRL+AFQRL FT+ DIL+ I+ESN+IG
Sbjct: 662 MFLAGRWIYTRWDLYSNFAREYIFCKKPREEWPWRLVAFQRLCFTAGDILSHIKESNIIG 721
Query: 715 MGATGIVYKAEMPRLNTI-VAVKKLWRSRA---DLET-----ESSGDFVGEVNVLGKLRH 765
MGA GIVYKAE+ R + VAVKKLWRS + D+E + D + EVN+LG LRH
Sbjct: 722 MGAIGIVYKAEVMRRPLLTVAVKKLWRSPSPQNDIEDHHQEEDEEDDILREVNLLGGLRH 781
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAY 825
RNIV++LG++HN+ +M+VYEYM NG+LG ALH K LL DW+SRYN+A+GV QGL Y
Sbjct: 782 RNIVKILGYVHNEREVMMVYEYMPNGNLGTALHSKDEKFLLRDWLSRYNVAVGVVQGLNY 841
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYG 885
LH+DCYPPIIHRDIKSNNILLDSNLE RIADFGLA+MM+ KNETVSMVAGSYGYIAPEYG
Sbjct: 842 LHNDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMMLHKNETVSMVAGSYGYIAPEYG 901
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945
YTLK+DEK DIYS GVVLLEL+TG+ P+DP F +S+D+VEWIR K++ N +LEE +D ++
Sbjct: 902 YTLKIDEKSDIYSLGVVLLELVTGKMPIDPSFEDSIDVVEWIRRKVKKNESLEEVIDASI 961
Query: 946 -GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNRYENNK 1004
G+CKHV EEMLL LRIA LCTAKLPKDRPS+RDVITML EAKPRRKS
Sbjct: 962 AGDCKHVIEEMLLALRIALLCTAKLPKDRPSIRDVITMLAEAKPRRKSVCQVAG------ 1015
Query: 1005 EKLVFSTSPVSGLV 1018
+ +F SPV GL+
Sbjct: 1016 DLPIFRNSPVVGLI 1029
|
|
| TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2136 (757.0 bits), Expect = 3.3e-221, P = 3.3e-221
Identities = 445/984 (45%), Positives = 616/984 (62%)
Query: 35 ELLALLSIKAGLVDPLNSLHDWKLP------SAHCNWTGVWC-NSNGAVEKLDLSHMNLS 87
+LL+LLS+K L P ++ DWK+P + C+W+GV C N V LDLSH NLS
Sbjct: 35 QLLSLLSLKTSLSGPPSAFQDWKVPVNGQNDAVWCSWSGVVCDNVTAQVISLDLSHRNLS 94
Query: 88 GCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPXXXXXXXX 147
G + + L SL LNL N L S P S+ +LT L D+S+N + SFP
Sbjct: 95 GRIPIQIRYLSSLLYLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISKLKF 154
Query: 148 XTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLT 207
NA NNF G L D+ LE L+ GS+F+G IP ++ LQ+LKF+ L+GN L
Sbjct: 155 LKVFNAFSNNFEGLLPSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNVLG 214
Query: 208 GKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLEL 267
GK+P LG L+ ++ M + YN F+G IP EF L+NLKY D++ +L G +P ELG L
Sbjct: 215 GKLPPRLGLLTELQHMEIGYNHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSN 274
Query: 268 LEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITXXXXXXXXXXXXXXXS 327
LE +FL+QN F G +P N+ SL+LLD S N LS IP+ + S
Sbjct: 275 LETLFLFQNGFTGEIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLS 334
Query: 328 GHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGN 387
G VP G+G L +L L LWNN+ +G LP LG N L+ +D+S+NSF+G IP+SLC+G
Sbjct: 335 GEVPEGIGELPELTTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNK 394
Query: 388 LTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLT 447
L KLILF+N F G +P SL+ C SL R R QNN+L+GTIP+GFG L L ++L+NN T
Sbjct: 395 LYKLILFSNMFEGELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFT 454
Query: 448 GGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPS 507
I D A++ L ++++S N LP I PNLQ F S +NL+GEIP+ + C S
Sbjct: 455 DQIPADFATAPVLQYLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIPN-YVGCKS 513
Query: 508 LSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLT 567
++L N +G+IP I CEKL+ LNL N L G IP IS +P++A +DLS+N LT
Sbjct: 514 FYRIELQGNSLNGTIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLT 573
Query: 568 GGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVL-HPCS--R 624
G IP +FG+S + NVSYN+L GP+P+ G +N + N GLCG ++ PC+ R
Sbjct: 574 GTIPSDFGSSKTITTFNVSYNQLIGPIPS-GSFAHLNPSFFSSNEGLCGDLVGKPCNSDR 632
Query: 625 YSP----IASSHRSLHAKHIIPGWMIAISSLFAVG--IAVFGARSLYKRWNANGSCFEEK 678
++ I H+ K + +++ VG + V R K + G+ +
Sbjct: 633 FNAGNADIDGHHKEERPKKTAGAIVWILAAAIGVGFFVLVAATRCFQKSY---GNRVDGG 689
Query: 679 LEMGKGEWPWRLMAFQRLGFTSADILACIRES-NVIGMGATGIVYKAEMPRLNTIVAVKK 737
G PW+L AFQRL FT+ D++ C+ ++ N++GMG+TG VYKAEMP I+AVKK
Sbjct: 690 GRNGGDIGPWKLTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPN-GEIIAVKK 748
Query: 738 LW---RSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLG 794
LW + + SG + EV+VLG +RHRNIVRLLG N M++YEYM NGSL
Sbjct: 749 LWGKNKENGKIRRRKSG-VLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLD 807
Query: 795 EALHG-KQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPR 853
+ LHG + +W + Y IA+GVAQG+ YLHHDC P I+HRD+K +NILLD++ E R
Sbjct: 808 DLLHGGDKTMTAAAEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEAR 867
Query: 854 IADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
+ADFG+A++ I+ +E++S+VAGSYGYIAPEY YTL+VD+K DIYS+GV+LLE++TG+R +
Sbjct: 868 VADFGVAKL-IQTDESMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSV 926
Query: 914 DPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG-NCKHVQEEMLLVLRIAFLCTAKLPKD 972
+PEFGE IV+W+R K++ ++EE LD ++G +C ++EEM +LRIA LCT++ P D
Sbjct: 927 EPEFGEGNSIVDWVRSKLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTD 986
Query: 973 RPSMRDVITMLGEAKPRRKSSSNN 996
RP MRDV+ +L EAKP+RK+ +N
Sbjct: 987 RPPMRDVLLILQEAKPKRKTVGDN 1010
|
|
| TAIR|locus:2204350 CLV1 "AT1G75820" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1114 (397.2 bits), Expect = 4.5e-189, Sum P(2) = 4.5e-189
Identities = 256/714 (35%), Positives = 380/714 (53%)
Query: 35 ELLALLSIKAGLVDPL-NSLHDW---KLPSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCV 90
++ LL++K+ ++ P + LHDW P AHC+++GV C+ + V L++S L G +
Sbjct: 27 DMEVLLNLKSSMIGPKGHGLHDWIHSSSPDAHCSFSGVSCDDDARVISLNVSFTPLFGTI 86
Query: 91 SDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNF-LNGSFPXXXXXXXXXT 149
S L L +L L N LP + +LTSLK ++S N L G+FP
Sbjct: 87 SPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEILKAMVDL 146
Query: 150 -FLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTG 208
L+ NNF+G L ++ L+ L G+FF G IP S+ ++Q L++LGL+G L+G
Sbjct: 147 EVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIPESYGDIQSLEYLGLNGAGLSG 206
Query: 209 KIPRELGQLSSMETMILAY-NEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLEL 267
K P L +L ++ M + Y N + G +P EFG LT L+ LD+A L G+IP L L+
Sbjct: 207 KSPAFLSRLKNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLSNLKH 266
Query: 268 LEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITXXXXXXXXXXXXXXXS 327
L +FL+ NN G +P E+ + SL+ LDLS N L+ EIP
Sbjct: 267 LHTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFRNNLY 326
Query: 328 GHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGN 387
G +P +G L +LEV E+W N+ + LP +LG+N L LD+S N +G IP LC G
Sbjct: 327 GQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCRGEK 386
Query: 388 LTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLT 447
L LIL NN F GPIP L C SL ++R+ N L+GT+P G L + +EL +N +
Sbjct: 387 LEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDNFFS 446
Query: 448 GGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPS 507
G + ++ L I +S N +P I + PNLQT + N G IP + +
Sbjct: 447 GELPVTMSGDV-LDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREIFELKH 505
Query: 508 LSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLT 567
LS ++ S+N +G IP SI+ C L++++L N++ G+IPK I+ + L L++S N LT
Sbjct: 506 LSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQLT 565
Query: 568 GGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVLHPC-SRYS 626
G IP G +L L++S+N L G VP G N AGN LC C +R
Sbjct: 566 GSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLPHRVSCPTRPG 625
Query: 627 PIAS-SHRSLHA-KHIIPGWMIAISSLFAVGIAVFGARSLYKRWNANGSCFEEKLEMGKG 684
+ +H +L + I+ + AI+ L + +A+ R + K+ N ++ L
Sbjct: 626 QTSDHNHTALFSPSRIVITVIAAITGLILISVAI---RQMNKKKN------QKSLA---- 672
Query: 685 EWPWRLMAFQRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKL 738
W+L AFQ+L F S D+L C++E N+IG G GIVY+ MP N VA+K+L
Sbjct: 673 ---WKLTAFQKLDFKSEDVLECLKEENIIGKGGAGIVYRGSMPN-NVDVAIKRL 722
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1776 (630.2 bits), Expect = 4.7e-183, P = 4.7e-183
Identities = 408/997 (40%), Positives = 564/997 (56%)
Query: 3 LKILLLVLCFYCYIGCTCFGSAKVVAKTALNDELLALLSIKAGLV---DPLNS-LHDWKL 58
+K+ LL+L F +I T F +++ ++ E ALLS+K L D NS L WK+
Sbjct: 1 MKLFLLLL-FLLHISHT-FTASRPIS------EFRALLSLKTSLTGAGDDKNSPLSSWKV 52
Query: 59 PSAHCNWTGVWCN-SNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNS 117
++ C W GV C+ S V LDLS +NLSG +S L+ L +L+L N + +P
Sbjct: 53 STSFCTWIGVTCDVSRRHVTSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPE 112
Query: 118 LANLTSLKRFDVSQNFLNGSFPXXXXXXXXXT-FLNASGNNFSGFLLEDLGNATSLETLD 176
+++L+ L+ ++S N NGSFP L+ NN +G L + N T L L
Sbjct: 113 ISSLSGLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLH 172
Query: 177 LRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAY-NEFDGEIP 235
L G++F G IP S+ + +++L +SGN L GKIP E+G L+++ + + Y N F+ +P
Sbjct: 173 LGGNYFAGKIPPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLP 232
Query: 236 VEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLL 295
E GNL+ L D A L G+IP E+G+L+ L+ +FL N F G L E+G ++SL+ +
Sbjct: 233 PEIGNLSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSM 292
Query: 296 DLSYNMLSHEIPAEITXXXXXXXXXXXXXXXSGHVPAGLGGLTQLEVLELWNNSLSGPLP 355
DLS NM + EIPA G +P +G L +LEVL+LW N+ +G +P
Sbjct: 293 DLSNNMFTGEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIP 352
Query: 356 VDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRV 415
LG+N L +DLSSN +G +P ++C+G L LI N G IP SL C SL R+
Sbjct: 353 QKLGENGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRI 412
Query: 416 RMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLP 475
RM N L+G+IP G L KL ++EL +N L+G + S +L I +S N L LP
Sbjct: 413 RMGENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLP 472
Query: 476 STILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNL 535
I + +Q ++ N G IP + LS +D S N FSG I I+ C+ L +
Sbjct: 473 PAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFV 532
Query: 536 NLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVP 595
+L N+L+G+IP I+ M L L+LS N L G IP + + +L L+ SYN L G VP
Sbjct: 533 DLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVP 592
Query: 596 ANGVLRTINRGDLAGNAGLCGGVLHPCSRYSPIASSHRSLHAKHIIPGWM--IAISSLFA 653
G N GN LCG L PC +A H+K + M + + L
Sbjct: 593 GTGQFSYFNYTSFLGNPDLCGPYLGPCK--DGVAKGGHQSHSKGPLSASMKLLLVLGLLV 650
Query: 654 VGIAVFGARSLYKRWNANGSCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRESNVI 713
IA F ++ K L+ WRL AFQRL FT D+L ++E N+I
Sbjct: 651 CSIA-FAVVAIIKA---------RSLKKASESRAWRLTAFQRLDFTCDDVLDSLKEDNII 700
Query: 714 GMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGD--FVGEVNVLGKLRHRNIVRL 771
G G GIVYK MP +VAVK+L A + SS D F E+ LG++RHR+IVRL
Sbjct: 701 GKGGAGIVYKGVMPN-GDLVAVKRL----AAMSRGSSHDHGFNAEIQTLGRIRHRHIVRL 755
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
LGF N ++VYEYM NGSLGE LHGK+ G L W +RY IAL A+GL YLHHDC
Sbjct: 756 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHL--HWDTRYKIALEAAKGLCYLHHDCS 813
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK--NETVSMVAGSYGYIAPEYGYTLK 889
P I+HRD+KSNNILLDSN E +ADFGLA+ + +E +S +AGSYGYIAPEY YTLK
Sbjct: 814 PLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLK 873
Query: 890 VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRN-LEEALDPNVGNC 948
VDEK D+YSFGVVLLEL+TGR+P+ EFG+ VDIV+W+R N++ + + LDP + +
Sbjct: 874 VDEKSDVYSFGVVLLELVTGRKPVG-EFGDGVDIVQWVRKMTDSNKDSVLKVLDPRLSSI 932
Query: 949 KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985
E+ V +A LC + +RP+MR+V+ +L E
Sbjct: 933 PI--HEVTHVFYVAMLCVEEQAVERPTMREVVQILTE 967
|
|
| TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1733 (615.1 bits), Expect = 1.7e-178, P = 1.7e-178
Identities = 402/969 (41%), Positives = 556/969 (57%)
Query: 39 LLSIKAGL--VDPLNSLHDWKLPSAH--CNWTGVWC-NSNGAVEKLDLSHMNLSGCVSDH 93
L+S+K DP SL W +P+ + C+WTGV C N N ++ +LDLS++N+SG +S
Sbjct: 38 LISLKQSFDSYDP--SLDSWNIPNFNSLCSWTGVSCDNLNQSITRLDLSNLNISGTISPE 95
Query: 94 FQRLK-SLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPXXXXXXXXXTF-L 151
RL SL L++ N LP + L+ L+ ++S N G L
Sbjct: 96 ISRLSPSLVFLDISSNSFSGELPKEIYELSGLEVLNISSNVFEGELETRGFSQMTQLVTL 155
Query: 152 NASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIP 211
+A N+F+G L L T LE LDL G++F G IP S+ + LKFL LSGN+L G+IP
Sbjct: 156 DAYDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLSGNDLRGRIP 215
Query: 212 RELGQLSSMETMILAY-NEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEI 270
EL ++++ + L Y N++ G IP +FG L NL +LDLA +L G IPAELG L+ LE+
Sbjct: 216 NELANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDLANCSLKGSIPAELGNLKNLEV 275
Query: 271 MFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITXXXXXXXXXXXXXXXSGHV 330
+FL N G +P E+GN+TSL+ LDLS N L EIP E++ G +
Sbjct: 276 LFLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNLFFNRLHGEI 335
Query: 331 PAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTK 390
P + L L++L+LW+N+ +G +P LG N L +DLS+N +G IP SLC G L
Sbjct: 336 PEFVSELPDLQILKLWHNNFTGKIPSKLGSNGNLIEIDLSTNKLTGLIPESLCFGRRLKI 395
Query: 391 LILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGI 450
LILFNN GP+P L C L R R+ N L+ +P G L L LEL NN LTG I
Sbjct: 396 LILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLELQNNFLTGEI 455
Query: 451 TDDIASS---TSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPS 507
++ A + +SL+ I++S N L +P +I ++ +LQ ++ N L G+IP + S
Sbjct: 456 PEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQIPGEIGSLKS 515
Query: 508 LSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLT 567
L +D+S N FSG P C L L+L +NQ++G IP IS + L L++S NS
Sbjct: 516 LLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVSWNSFN 575
Query: 568 GGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVLHPCSRYSP 627
+P G +L + S+N G VP +G N GN LCG +PC+ S
Sbjct: 576 QSLPNELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPCNG-SQ 634
Query: 628 IASSHRSLHAKHIIP-GWMIAISSLFAVGIAVFGARSLYKRWNANGSCFEEKLEMGKGEW 686
S + L+ + G + A LF G+ + G ++ + M K
Sbjct: 635 NQSQSQLLNQNNARSRGEISAKFKLF-FGLGLLGFFLVFVVL-----AVVKNRRMRKNN- 687
Query: 687 P--WRLMAFQRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRAD 744
P W+L+ FQ+LGF S IL C++E++VIG G GIVYK MP VAVKKL
Sbjct: 688 PNLWKLIGFQKLGFRSEHILECVKENHVIGKGGRGIVYKGVMPN-GEEVAVKKLLTITKG 746
Query: 745 LETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN-DTNMMIVYEYMNNGSLGEALHGKQAG 803
+ +G E+ LG++RHRNIVRLL F N D N++ VYEYM NGSLGE LHGK AG
Sbjct: 747 -SSHDNG-LAAEIQTLGRIRHRNIVRLLAFCSNKDVNLL-VYEYMPNGSLGEVLHGK-AG 802
Query: 804 RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863
+ + W +R IAL A+GL YLHHDC P IIHRD+KSNNILL E +ADFGLA+ M
Sbjct: 803 -VFLKWETRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFM 861
Query: 864 IRKN---ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
++ N E +S +AGSYGYIAPEY YTL++DEK D+YSFGVVLLEL+TGR+P+D FGE
Sbjct: 862 MQDNGASECMSSIAGSYGYIAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVD-NFGEE 920
Query: 921 -VDIVEWIRMKIRDNRN-LEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRD 978
+DIV+W +++ NR + + +D + N + E M L +A LC + +RP+MR+
Sbjct: 921 GIDIVQWSKIQTNCNRQGVVKIIDQRLSNIP-LAEAMELFF-VAMLCVQEHSVERPTMRE 978
Query: 979 VITMLGEAK 987
V+ M+ +AK
Sbjct: 979 VVQMISQAK 987
|
|
| TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1700 (603.5 bits), Expect = 5.3e-175, P = 5.3e-175
Identities = 388/972 (39%), Positives = 549/972 (56%)
Query: 31 ALNDELLALLSIKAGLVDPLNSLHDWKLPSAH-CNWTGVWCNSN-GAVEKLDLSHMNLSG 88
+LN + L +K L DP + L W A C W+GV C + +V +DLS NL+G
Sbjct: 15 SLNQDGFILQQVKLSLDDPDSYLSSWNSNDASPCRWSGVSCAGDFSSVTSVDLSSANLAG 74
Query: 89 CVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPXXXXXXXXX 148
RL +L L+L N + S+LP ++A SL+ D+SQN L G P
Sbjct: 75 PFPSVICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLADIPTL 134
Query: 149 TFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLT- 207
L+ +GNNFSG + G +LE L L + G+IP N+ LK L LS N +
Sbjct: 135 VHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNPFSP 194
Query: 208 GKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLEL 267
+IP E G L+++E M L G+IP G L+ L LDLA+ +L G IP LG L
Sbjct: 195 SRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTN 254
Query: 268 LEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITXXXXXXXXXXXXXXXS 327
+ + LY N+ G +P E+GN+ SL+LLD S N L+ +IP E+
Sbjct: 255 VVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVPLESLNLYENNL-E 313
Query: 328 GHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGN 387
G +PA + L + ++ N L+G LP DLG NSPL+WLD+S N FSG++PA LC G
Sbjct: 314 GELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGE 373
Query: 388 LTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLT 447
L +L++ +N+FSG IP SL+ C SL R+R+ N+ SG++P GF L + LEL NNS +
Sbjct: 374 LEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFS 433
Query: 448 GGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPS 507
G I+ I +++LS + +S N SLP I S+ NL S N G +PD
Sbjct: 434 GEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGE 493
Query: 508 LSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLT 567
L LDL N FSG + S I S +KL LNL +N+ TG IP I + L LDLS N +
Sbjct: 494 LGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFS 553
Query: 568 GGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVLHPCSRYSP 627
G IP + S L LN+SYNRL G +P + + + + + GN GLCG + C
Sbjct: 554 GKIPVSL-QSLKLNQLNLSYNRLSGDLPPS-LAKDMYKNSFIGNPGLCGDIKGLCG---- 607
Query: 628 IASSHRSLHAKHIIPGWMIAISSLFAVGIAVFGARSLYKRWNANGSCFEEKLEMGKGEWP 687
S + + ++ W++ + A + + G Y ++ F++ M + +W
Sbjct: 608 --SENEAKKRGYV---WLLRSIFVLAAMVLLAGVAWFYFKYRT----FKKARAMERSKWT 658
Query: 688 WRLMAFQRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLW----RSRA 743
LM+F +LGF+ +IL + E NVIG GA+G VYK + T VAVK+LW +
Sbjct: 659 --LMSFHKLGFSEHEILESLDEDNVIGAGASGKVYKVVLTNGET-VAVKRLWTGSVKETG 715
Query: 744 DLETESS---G--D--FVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEA 796
D + E G D F EV LGK+RH+NIV+L ++VYEYM NGSLG+
Sbjct: 716 DCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDL 775
Query: 797 LHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856
LH + G L W +R+ I L A+GL+YLHHD PPI+HRDIKSNNIL+D + R+AD
Sbjct: 776 LHSSKGGML--GWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVAD 833
Query: 857 FGLARMMI---RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
FG+A+ + + +++S++AGS GYIAPEY YTL+V+EK DIYSFGVV+LE++T +RP+
Sbjct: 834 FGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPV 893
Query: 914 DPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDR 973
DPE GE D+V+W+ + D + +E +DP + +C +EE+ +L + LCT+ LP +R
Sbjct: 894 DPELGEK-DLVKWVCSTL-DQKGIEHVIDPKLDSC--FKEEISKILNVGLLCTSPLPINR 949
Query: 974 PSMRDVITMLGE 985
PSMR V+ ML E
Sbjct: 950 PSMRRVVKMLQE 961
|
|
| UNIPROTKB|Q5Z9N5 P0481E08.42 "Os06g0717200 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1664 (590.8 bits), Expect = 3.4e-171, P = 3.4e-171
Identities = 384/991 (38%), Positives = 556/991 (56%)
Query: 35 ELLALLSIKAGLVDPLNS-----LHDWKLPS---AHCNWTGVWCNSNGAVEKLDLSHMNL 86
++ AL +KA LV ++ L DW + AHC ++GV C+ V ++L+ + L
Sbjct: 22 DIYALAKLKAALVPSPSATAPPPLADWDPAATSPAHCTFSGVTCDGRSRVVAINLTALPL 81
Query: 87 -SGCVSDHFQRLKSLTSLNL--CCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPXXXX 143
SG + L SL +L + CC L +P L L SL+ ++S N L+G FP
Sbjct: 82 HSGYLPPEIALLDSLANLTIAACC--LPGHVPLELPTLPSLRHLNLSNNNLSGHFPVPDS 139
Query: 144 XXXXXTF------LNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLK 197
+ ++A NN SG L + L L L G++F G+IP S+ +L L+
Sbjct: 140 GGGASPYFPSLELIDAYNNNLSGLLPPFSASHARLRYLHLGGNYFTGAIPDSYGDLAALE 199
Query: 198 FLGLSGNNLTGKIPRELGQLSSMETMILAY-NEFDGEIPVEFGNLTNLKYLDLAVGNLGG 256
+LGL+GN L+G +P L +L+ + M + Y N++DG +P EFG+L L LD++ NL G
Sbjct: 200 YLGLNGNTLSGHVPVSLSRLTRLREMYIGYYNQYDGGVPPEFGDLGALLRLDMSSCNLTG 259
Query: 257 KIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITXXXXX 316
+P ELGRL+ L+ +FL N G +P ++G+++SL LDLS N L+ EIP +
Sbjct: 260 PVPPELGRLQRLDTLFLQWNRLSGEIPPQLGDLSSLASLDLSVNDLAGEIPPSLANLSNL 319
Query: 317 XXXXXXXXXXSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSG 376
G +P + G QLEVL+LW+N+L+G +P LGKN L+ LDL++N +G
Sbjct: 320 KLLNLFRNHLRGSIPDFVAGFAQLEVLQLWDNNLTGNIPAGLGKNGRLKTLDLATNHLTG 379
Query: 377 EIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKL 436
IPA LC G L L+L N GPIP SL C +L RVR+ N L+G +P G L +
Sbjct: 380 PIPADLCAGRRLEMLVLMENGLFGPIPDSLGDCKTLTRVRLAKNFLTGPVPAGLFNLPQA 439
Query: 437 QRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVG 496
+EL +N LTG + D I + + + N + +P I ++P LQT + +NN G
Sbjct: 440 NMVELTDNLLTGELPDVIGGD-KIGMLLLGNNGIGGRIPPAIGNLPALQTLSLESNNFSG 498
Query: 497 EIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTL 556
+P + + +LS L++S N +G+IP + C L ++L N +G+IP++I+ + L
Sbjct: 499 ALPPEIGNLKNLSRLNVSGNALTGAIPDELIRCASLAAVDLSRNGFSGEIPESITSLKIL 558
Query: 557 AILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCG 616
L++S N LTG +P +L L+VSYN L GPVP G N GN GLCG
Sbjct: 559 CTLNVSRNRLTGELPPEMSNMTSLTTLDVSYNSLSGPVPMQGQFLVFNESSFVGNPGLCG 618
Query: 617 G-VLHPC--SRYSPIASSHRSLHAKHIIPGWMIAISSLFA-VGIAVFGARSLYKRWNANG 672
G V C S + L + ++A+ + FA V +A GAR W +
Sbjct: 619 GPVADACPPSMAGGGGGAGSQLRLRWDSKKMLVALVAAFAAVAVAFLGARKGCSAWRSAA 678
Query: 673 SCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTI 732
+ G W++ AFQ+L F++ D++ C++E N+IG G GIVY + R
Sbjct: 679 -----RRRSGA----WKMTAFQKLEFSAEDVVECVKEDNIIGKGGAGIVYHG-VTR-GAE 727
Query: 733 VAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN-DTNMMIVYEYMNNG 791
+A+K+L R E + F EV LG++RHRNIVRLLGF+ N +TN+++ YEYM NG
Sbjct: 728 LAIKRLV-GRGGGEHDRG--FSAEVTTLGRIRHRNIVRLLGFVSNRETNLLL-YEYMPNG 783
Query: 792 SLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLE 851
SLGE LHG + G L W +R +A A GL YLHHDC P IIHRD+KSNNILLDS E
Sbjct: 784 SLGEMLHGGKGGHL--GWEARARVAAEAACGLCYLHHDCAPRIIHRDVKSNNILLDSAFE 841
Query: 852 PRIADFGLARMMI-RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGR 910
+ADFGLA+ + +E +S +AGSYGYIAPEY YTL+VDEK D+YSFGVVLLEL+TGR
Sbjct: 842 AHVADFGLAKFLGGATSECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELITGR 901
Query: 911 RPLDPEFGESVDIVEWIRM---KIRDNRNLEEALDPNVGNCKHVQEEMLLVL---RIAFL 964
RP+ FG+ VDIV W+R ++ DN + L V + + E + L++ ++A
Sbjct: 902 RPVGG-FGDGVDIVHWVRKVTAELPDNSDTAAVLA--VADRRLTPEPVALMVNLYKVAMA 958
Query: 965 CTAKLPKDRPSMRDVITMLGEAKPRRKSSSN 995
C + RP+MR+V+ ML + +S +
Sbjct: 959 CVEEASTARPTMREVVHMLSNPNSAQPNSGD 989
|
|
| TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1639 (582.0 bits), Expect = 1.5e-168, P = 1.5e-168
Identities = 405/1010 (40%), Positives = 556/1010 (55%)
Query: 13 YCYIGCTCFGSAKVVAKTALNDELLALLSIKAGLVDPLNSLHDWKLPS--AHCNWTGVWC 70
YC I C S + +LN + L K GL DP SL W + C W GV C
Sbjct: 3 YCLILLLCLSST-YLPSLSLNQDATILRQAKLGLSDPAQSLSSWSDNNDVTPCKWLGVSC 61
Query: 71 NSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLP-NSLANLTSLKRFDV 129
++ V +DLS L G L SL SL+L N + SL + +L D+
Sbjct: 62 DATSNVVSVDLSSFMLVGPFPSILCHLPSLHSLSLYNNSINGSLSADDFDTCHNLISLDL 121
Query: 130 SQNFLNGSFPXXXXXXX-XXTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPV 188
S+N L GS P FL SGNN S + G LE+L+L G+F G+IP
Sbjct: 122 SENLLVGSIPKSLPFNLPNLKFLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLSGTIPA 181
Query: 189 SFKNLQKLKFLGLSGNNLT-GKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYL 247
S N+ LK L L+ N + +IP +LG L+ ++ + LA G IP LT+L L
Sbjct: 182 SLGNVTTLKELKLAYNLFSPSQIPSQLGNLTELQVLWLAGCNLVGPIPPSLSRLTSLVNL 241
Query: 248 DLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIP 307
DL L G IP+ + +L+ +E + L+ N+F G LP +GN+T+L+ D S N L+ +IP
Sbjct: 242 DLTFNQLTGSIPSWITQLKTVEQIELFNNSFSGELPESMGNMTTLKRFDASMNKLTGKIP 301
Query: 308 AEITXXXXXXXXXXXXXXXSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWL 367
+ G +P + L L+L+NN L+G LP LG NSPLQ++
Sbjct: 302 DNLNLLNLESLNLFENML-EGPLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYV 360
Query: 368 DLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIP 427
DLS N FSGEIPA++C G L LIL +N+FSG I +L C SL RVR+ NN+LSG IP
Sbjct: 361 DLSYNRFSGEIPANVCGEGKLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIP 420
Query: 428 VGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTF 487
GF L +L LEL++NS TG I I + +LS + IS+N S+P+ I S+ +
Sbjct: 421 HGFWGLPRLSLLELSDNSFTGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEI 480
Query: 488 IVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIP 547
+ N+ GEIP+ LS LDLS N SG IP + + L LNL NN L+G+IP
Sbjct: 481 SGAENDFSGEIPESLVKLKQLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIP 540
Query: 548 KAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGD 607
K + ++P L LDLS+N +G IP + L VLN+SYN L G +P I D
Sbjct: 541 KEVGILPVLNYLDLSSNQFSGEIPLEL-QNLKLNVLNLSYNHLSGKIPPL-YANKIYAHD 598
Query: 608 LAGNAGLCGGVLHPCSRYSPIASSHRSLHAKHIIPGWMIAISSLFAVGIAVFGARSLYKR 667
GN GLC + C + I S + ++ +++A +F VGI +F A+ ++
Sbjct: 599 FIGNPGLCVDLDGLCRK---ITRSKNIGYVWILLTIFLLA-GLVFVVGIVMFIAKC--RK 652
Query: 668 WNANGSCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRESNVIGMGATGIVYKAEMP 727
A S L K WR +F +L F+ +I C+ E NVIG G++G VYK E+
Sbjct: 653 LRALKS---STLAASK----WR--SFHKLHFSEHEIADCLDEKNVIGFGSSGKVYKVEL- 702
Query: 728 RLNTIVAVKKLWRSRADLETESSGD------FVGEVNVLGKLRHRNIVRLLGFLHNDTNM 781
R +VAVKKL +S + E S D F EV LG +RH++IVRL +
Sbjct: 703 RGGEVVAVKKLNKSVKGGDDEYSSDSLNRDVFAAEVETLGTIRHKSIVRLWCCCSSGDCK 762
Query: 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKS 841
++VYEYM NGSL + LHG + G +++ W R IAL A+GL+YLHHDC PPI+HRD+KS
Sbjct: 763 LLVYEYMPNGSLADVLHGDRKGGVVLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKS 822
Query: 842 NNILLDSNLEPRIADFGLAR---MMIRKN-ETVSMVAGSYGYIAPEYGYTLKVDEKIDIY 897
+NILLDS+ ++ADFG+A+ M K E +S +AGS GYIAPEY YTL+V+EK DIY
Sbjct: 823 SNILLDSDYGAKVADFGIAKVGQMSGSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIY 882
Query: 898 SFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLL 957
SFGVVLLEL+TG++P D E G+ D+ +W+ + D LE +DP + + K +EE+
Sbjct: 883 SFGVVLLELVTGKQPTDSELGDK-DMAKWVCTAL-DKCGLEPVIDPKL-DLKF-KEEISK 938
Query: 958 VLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNRYENNKEKL 1007
V+ I LCT+ LP +RPSMR V+ ML E SS N ++ KL
Sbjct: 939 VIHIGLLCTSPLPLNRPSMRKVVIMLQEVSGAVPCSSPNTSKRSKTGGKL 988
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1518 (539.4 bits), Expect = 1.0e-155, P = 1.0e-155
Identities = 351/938 (37%), Positives = 522/938 (55%)
Query: 76 VEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNF-L 134
+++L L+ L+G + SL +L + N L +LP L +++L+ N L
Sbjct: 156 LQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSEL 215
Query: 135 NGSFPXXXXXXXXXTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQ 194
+G P L + SG L LG + L++L + + G IP N
Sbjct: 216 SGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCS 275
Query: 195 KLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNL 254
+L L L N+L+G +P+ELG+L ++E M+L N G IP E G + +L +DL++
Sbjct: 276 ELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYF 335
Query: 255 GGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITXXX 314
G IP G L L+ + L NN G +P+ + N T L + N +S IP EI
Sbjct: 336 SGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLK 395
Query: 315 XXXXXXXXXXXXSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSF 374
G++P L G L+ L+L N L+G LP L + L L L SN+
Sbjct: 396 ELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAI 455
Query: 375 SGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLE 434
SG IP + N +L +L L NN +G IP + +L + + N LSG +P+
Sbjct: 456 SGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCR 515
Query: 435 KLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNL 494
+LQ L L+NN+L G + ++S T L +D+S N L +P ++ + +L I+S N+
Sbjct: 516 QLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSF 575
Query: 495 VGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKL-VNLNLRNNQLTGDIPKAISMM 553
GEIP C +L +LDLSSN SG+IP + + L + LNL N L G IP+ IS +
Sbjct: 576 NGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISAL 635
Query: 554 PTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAG 613
L++LD+S+N L+G + G + LN+S+NR G +P + V R + ++ GN G
Sbjct: 636 NRLSVLDISHNMLSGDLSALSGLENLVS-LNISHNRFSGYLPDSKVFRQLIGAEMEGNNG 694
Query: 614 LCGGVLHPC--SRYSPIASSHRSLHAKH--IIPGWMIAISSLFAV-GI-AVFGARSLYKR 667
LC C S S + ++ R +H+ I G +I+++++ AV G+ AV A+ + +
Sbjct: 695 LCSKGFRSCFVSNSSQL-TTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIR- 752
Query: 668 WNANGSCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRESNVIGMGATGIVYKAEMP 727
+ N S E G+ W W+ FQ+L FT +L C+ E NVIG G +GIVYKAEMP
Sbjct: 753 -DDNDS------ETGENLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAEMP 805
Query: 728 RLNTIVAVKKLWR---SRADLETESSG---DFVGEVNVLGKLRHRNIVRLLGFLHNDTNM 781
++AVKKLW + +T+SSG F EV LG +RH+NIVR LG N
Sbjct: 806 N-REVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTR 864
Query: 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKS 841
+++Y+YM+NGSLG LH +++G + W RY I LG AQGLAYLHHDC PPI+HRDIK+
Sbjct: 865 LLMYDYMSNGSLGSLLH-ERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKA 923
Query: 842 NNILLDSNLEPRIADFGLARMMIRKN--ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSF 899
NNIL+ + EP I DFGLA+++ + + + +AGSYGYIAPEYGY++K+ EK D+YS+
Sbjct: 924 NNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSY 983
Query: 900 GVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVL 959
GVV+LE+LTG++P+DP + + IV+W++ KIRD + +++ L + V EEM+ L
Sbjct: 984 GVVVLEVLTGKQPIDPTIPDGLHIVDWVK-KIRDIQVIDQGLQARPES--EV-EEMMQTL 1039
Query: 960 RIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNND 997
+A LC +P+DRP+M+DV ML E R+ S D
Sbjct: 1040 GVALLCINPIPEDRPTMKDVAAMLSEICQEREESMKVD 1077
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9M0G7 | PXL2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7067 | 0.9901 | 0.9950 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1018 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.0 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-28 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-28 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-27 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-25 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-25 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-24 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-24 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-19 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-18 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-17 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-17 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-17 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-08 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 5e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-07 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-05 | |
| COG5238 | 388 | COG5238, RNA1, Ran GTPase-activating protein (RanG | 9e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 621 bits (1604), Expect = 0.0
Identities = 362/971 (37%), Positives = 525/971 (54%), Gaps = 53/971 (5%)
Query: 34 DELLALLSIKAGLVDPLNSLHDWKLPSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDH 93
+EL LLS K+ + DPL L +W + C W G+ CN++ V +DLS N+SG +S
Sbjct: 29 EELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSA 88
Query: 94 FQRLKSLTSLNLCCNGLFSSLPNSLANLT-SLKRFDVSQNFLNGSFPAGLGGAAGLTFLN 152
RL + ++NL N L +P+ + + SL+ ++S N GS P G L L+
Sbjct: 89 IFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG--SIPNLETLD 146
Query: 153 ASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPR 212
S N SG + D+G+ +SL+ LDL G+ G IP S NL L+FL L+ N L G+IPR
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR 206
Query: 213 ELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMF 272
ELGQ+ S++ + L YN GEIP E G LT+L +LDL NL G IP+ LG L+ L+ +F
Sbjct: 207 ELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLF 266
Query: 273 LYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPA 332
LYQN G +P I ++ L LDLS N LS EIP + QL+NL++L+L N +G +P
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326
Query: 333 GLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLI 392
L L +L+VL+LW+N SG +P +LGK++ L LDLS+N+ +GEIP LC+ GNL KLI
Sbjct: 327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI 386
Query: 393 LFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITD 452
LF+N+ G IP SL C SL RVR+Q+N SG +P F +L + L+++NN+L G I
Sbjct: 387 LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446
Query: 453 DIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLD 512
SL + ++RN LP + S L+ +S N G +P + L L
Sbjct: 447 RKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLK 505
Query: 513 LSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPE 572
LS N SG IP ++SC+KLV+L+L +NQL+G IP + S MP L+ LDLS N L+G IP+
Sbjct: 506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK 565
Query: 573 NFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGV----LHPCSRYSPI 628
N G +L +N+S+N L G +P+ G IN +AGN LCGG L PC R
Sbjct: 566 NLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK- 624
Query: 629 ASSHRSLHAKHIIPGWMIAISSLFA--VGIAVFGARSLYKRWNANGSCFEEKLEMGKGEW 686
P W I+ + +A+ ++ R N +++E G
Sbjct: 625 ------------TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLEL--KRVENEDGT- 669
Query: 687 PWRLMAFQR---LGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRA 743
W L F T DIL+ ++E NVI G G YK + + VK++ +
Sbjct: 670 -WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS 728
Query: 744 DLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAG 803
+E + +GKL+H NIV+L+G ++ +++EY+ +L E L
Sbjct: 729 IPSSEIAD--------MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---- 776
Query: 804 RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863
+ W R IA+G+A+ L +LH C P ++ ++ I++D EP + L ++
Sbjct: 777 ---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832
Query: 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDI 923
+ A Y+APE T + EK DIY FG++L+ELLTG+ P D EFG I
Sbjct: 833 CTDTKCFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI 888
Query: 924 VEWIRMKIRDNRNLEEALDPNV-GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982
VEW R D +L+ +DP++ G+ Q E++ V+ +A CTA P RP DV+
Sbjct: 889 VEWARYCYSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947
Query: 983 LGEAKPRRKSS 993
L E+ R SS
Sbjct: 948 L-ESASRSSSS 957
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 1e-51
Identities = 88/274 (32%), Positives = 136/274 (49%), Gaps = 31/274 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G G+ G VYKA+ IVAVK L + + + + E+ +L +L H NIVRL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQT--ARREIRILRRLSHPNIVRL 63
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
+ + ++ +V EY G L + L + G L IAL + +GL YLH +
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYLS--RGGPL--SEDEAKKIALQILRGLEYLHSN-- 117
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE-----YGY 886
IIHRD+K NILLD N +IADFGLA+ +++ + +++ G+ Y+APE GY
Sbjct: 118 -GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 887 TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG 946
KV D++S GV+L ELLTG+ P E +D ++ IR + +E +
Sbjct: 177 GPKV----DVWSLGVILYELLTGKPPFSGE--NILDQLQLIRRILGPPLEFDEPKWSSGS 230
Query: 947 -NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDV 979
K + ++ L K P RP+ ++
Sbjct: 231 EEAKDLIKKCL----------NKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 3e-49
Identities = 78/272 (28%), Positives = 123/272 (45%), Gaps = 25/272 (9%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G G+ G VY A + +VA+K + + + + E + E+ +L KL+H NIVR
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRE---RILREIKILKKLKHPNIVR 61
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L ++ + +V EY G L + L K+ GRL D Y + L YLH
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFY--LRQILSALEYLHSKG 117
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
I+HRD+K NILLD + ++ADFGLAR + + + V G+ Y+APE
Sbjct: 118 ---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV-GTPEYMAPEVLLGKGY 173
Query: 891 DEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKH 950
+ +DI+S GV+L ELLTG+ P F ++E + + K
Sbjct: 174 GKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD 229
Query: 951 VQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982
L+ + K P+ R + + +
Sbjct: 230 ------LIRK----LLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 4e-46
Identities = 66/196 (33%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G G VY A + VA+K + + + + + + E+ +L KL H NIV+L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII---KKEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
G ++ ++ +V EY GSL + L + + I L + +GL YLH +
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSN--- 111
Query: 833 PIIHRDIKSNNILLDS-NLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE-YGYTLKV 890
IIHRD+K NILLDS N + ++ADFGL++++ + + G+ Y+APE
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 891 DEKIDIYSFGVVLLEL 906
EK DI+S GV+L EL
Sbjct: 172 SEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 85/292 (29%), Positives = 131/292 (44%), Gaps = 49/292 (16%)
Query: 707 IRESNVIGMGATGIVYKA----EMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
+ +G GA G VYK + T VAVK L + E +F+ E +++ K
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL---KEGASEEEREEFLEEASIMKK 57
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQG 822
L H NIVRLLG + IV EYM G L + L K +L + +AL +A+G
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKD--LLQMALQIAKG 114
Query: 823 LAYLH-HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG--SYGY 879
+ YL + +HRD+ + N L+ NL +I+DFGL+R + + G +
Sbjct: 115 MEYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKW 170
Query: 880 IAPE----YGYTLKVDEKIDIYSFGVVLLELLT-GRRP---LDPEFGESVDIVEWIRMKI 931
+APE +T K D++SFGV+L E+ T G +P + E +++E +
Sbjct: 171 MAPESLKDGKFTSKS----DVWSFGVLLWEIFTLGEQPYPGMSNE-----EVLELLE--- 218
Query: 932 RDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
R L + E ML C A P+DRP+ +++ L
Sbjct: 219 DGYR-----LPRPENCPDELYELML-------QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 81/287 (28%), Positives = 132/287 (45%), Gaps = 40/287 (13%)
Query: 711 NVIGMGATGIVYKAEMPRLN---TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
+G GA G VYK ++ + T VAVK L + A E DF+ E V+ KL H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERK--DFLKEARVMKKLGHPN 57
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLL-----VDWVSRYNIALGVAQG 822
+VRLLG + + +V EYM G L + L + + + A+ +A+G
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG--SYGYI 880
+ YL +HRD+ + N L+ +L +I+DFGL+R + + G ++
Sbjct: 118 MEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174
Query: 881 APEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP---LDPEFGESVDIVEWIRMKIRDNRN 936
APE K D++SFGV+L E+ T G P L E +++E++R + R
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-----EVLEYLR---KGYR- 225
Query: 937 LEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
L P ++ +E+ + C P+DRP+ +++ L
Sbjct: 226 LP---KP-----EYCPDEL---YELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 86/293 (29%), Positives = 136/293 (46%), Gaps = 51/293 (17%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLN----TIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
+ +G GA G VYK + VAVK L + D + +F+ E ++ K
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL---KEDASEQQIEEFLREARIMRK 57
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQG 822
L H NIV+LLG + +MIV EYM G L + L ++ + + AL +A+G
Sbjct: 58 LDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARG 115
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI-- 880
+ YL IHRD+ + N L+ NL +I+DFGL+R + ++ V G I
Sbjct: 116 MEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL--YDDDYYKVKGGKLPIRW 170
Query: 881 -APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP---LDPEFGESVDIVEWIRMKI 931
APE G +T K D++SFGV+L E+ T G P + +++E+++
Sbjct: 171 MAPESLKEGKFT----SKSDVWSFGVLLWEIFTLGEEPYPGMSNA-----EVLEYLKKGY 221
Query: 932 RDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
R P NC + + ML C A+ P+DRP+ +++ +L
Sbjct: 222 R---------LPKPPNCPPELYKLML-------QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 4e-42
Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 52/293 (17%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTI----VAVKKLWRSRADLETESSGDFVGEVNVLGK 762
+ +G GA G VYK ++ VAVK L + D + +F+ E ++ K
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL---KEDASEQQIEEFLREARIMRK 57
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQG 822
L H N+V+LLG + + IV EYM G L L R + + AL +A+G
Sbjct: 58 LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARG 114
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS---YGY 879
+ YL IHRD+ + N L+ NL +I+DFGL+R + ++ G +
Sbjct: 115 MEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL--YDDDYYRKRGGKLPIRW 169
Query: 880 IAPE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP---LDPEFGESVDIVEWIRMKI 931
+APE G +T K D++SFGV+L E+ T G +P + E +++E+++
Sbjct: 170 MAPESLKEGKFT----SKSDVWSFGVLLWEIFTLGEQPYPGMSNE-----EVLEYLK--- 217
Query: 932 RDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
R P NC + + ML C A+ P+DRP+ +++ +L
Sbjct: 218 NGYRL------PQPPNCPPELYDLML-------QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 72/212 (33%), Positives = 106/212 (50%), Gaps = 31/212 (14%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG-EVNVLGKLRHRNIVR 770
IG G G VYKA R VA+K + LE++ + + E+ +L K +H NIV+
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVI-----KLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 771 LLG-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-- 827
G +L D + IV E+ + GSL + L L ++ Y + + +GL YLH
Sbjct: 62 YYGSYLKKD-ELWIVMEFCSGGSLKDLLKSTN-QTLTESQIA-Y-VCKELLKGLEYLHSN 117
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE---- 883
IIHRDIK+ NILL S+ E ++ DFGL+ + +MV G+ ++APE
Sbjct: 118 G-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV-GTPYWMAPEVING 171
Query: 884 --YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
Y Y K DI+S G+ +EL G+ P
Sbjct: 172 KPYDY------KADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 71/232 (30%), Positives = 110/232 (47%), Gaps = 34/232 (14%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766
++G G+ G VY A ++AVK + S E + E+ +L L+H
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA--LEREIRILSSLQHP 59
Query: 767 NIVRLLGFLHNDTNMM--IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLA 824
NIVR G ++ I EY++ GSL L K+ G+L + +Y + +GLA
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKY--TRQILEGLA 115
Query: 825 YLH-HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM-----VAGSYG 878
YLH + I+HRDIK NIL+DS+ ++ADFG A+ R + + V G+
Sbjct: 116 YLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAK---RLGDIETGEGTGSVRGTPY 168
Query: 879 YIAPE------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIV 924
++APE YG DI+S G ++E+ TG+ P E G + +
Sbjct: 169 WMAPEVIRGEEYGR------AADIWSLGCTVIEMATGKPPW-SELGNPMAAL 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 71/209 (33%), Positives = 113/209 (54%), Gaps = 12/209 (5%)
Query: 710 SNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIV 769
++IG GA G+VYK VA+K++ S ++ E+ + E+++L L+H NIV
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQI--SLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
+ +G + ++ I+ EY NGSL + + K+ G V+ Y + V QGLAYLH
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVY-VY-QVLQGLAYLHEQ 118
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLK 889
+IHRDIK+ NIL + ++ADFG+A + ++ + V G+ ++APE
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 890 VDEKIDIYSFGVVLLELLTGRRP---LDP 915
DI+S G ++ELLTG P L+P
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNP 204
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 39/219 (17%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKL-WRSRADLETESSGDFVGEVNVLGKLRHRNIV 769
IG G+ G VY + +K++ + ++ E E + + EV +L KL H NI+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA---LNEVKILKKLNHPNII 62
Query: 770 RLLG-FLHNDTNMMIVYEYMNNGSLGEALH-GKQAGRLL-----VDWVSRYNIALGVAQG 822
+ F + IV EY + G L + + K+ G+ +DW + L
Sbjct: 63 KYYESFEEKG-KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCLA---- 115
Query: 823 LAYLH--HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM---VAGSY 877
L YLH I+HRDIK NI L SN ++ DFG+++++ + TV + V G+
Sbjct: 116 LKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAKTVVGTP 167
Query: 878 GYIAPE----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y++PE Y + K DI+S G VL EL T + P
Sbjct: 168 YYLSPELCQNKPY----NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (315), Expect = 5e-31
Identities = 90/315 (28%), Positives = 140/315 (44%), Gaps = 24/315 (7%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH-RNIVR 770
+G G+ G VY A R +VA+K L + + +++ F+ E+ +L L H NIV+
Sbjct: 7 KLGEGSFGEVYLA---RDRKLVALKVL-AKKLESKSKEVERFLREIQILASLNHPPNIVK 62
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L F ++ ++ +V EY++ GSL + L L + + + I + L YLH
Sbjct: 63 LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF-ILAQILSALEYLHSKG 121
Query: 831 YPPIIHRDIKSNNILLDSNL-EPRIADFGLARMMIRKNETVSMVA------GSYGYIAPE 883
IIHRDIK NILLD + ++ DFGLA+++ T S+ A G+ GY+APE
Sbjct: 122 ---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 884 Y---GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940
DI+S G+ L ELLTG P + E S + +L
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNRY 1000
L P+ + L+ + AK PK+R S ++ A + K S +D
Sbjct: 239 LSPSN-PELISKAASDLLKK----LLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLK 293
Query: 1001 ENNKEKLVFSTSPVS 1015
++ L S P
Sbjct: 294 PDDSAPLRLSLPPSL 308
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
IG GA+G VYKA VA+KK+ L ++ + E+ ++ +H NIV
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKM-----RLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 772 LG-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRY-------NIALGVAQGL 823
+L D + +V EYM+ GSL + ++ + V QGL
Sbjct: 81 YDSYLVGDE-LWVVMEYMDGGSLTD----------IITQNFVRMNEPQIAYVCREVLQGL 129
Query: 824 AYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGL-ARMMIRKNETVSMVAGSYGYIAP 882
YLH +IHRDIKS+NILL + ++ADFG A++ K++ S+V Y ++AP
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPY-WMAP 185
Query: 883 EYGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
E K+DI+S G++ +E+ G P
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 81/277 (29%), Positives = 123/277 (44%), Gaps = 48/277 (17%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
V+G G++G+VYK I A+KK+ D + E + E+ L +V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKI---HVDGDEEFRKQLLRELKTLRSCESPYVVKC 64
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
G + + + IV EYM+ GSL + L K+ G++ ++ IA + +GL YLH +
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLL--KKVGKIPEPVLAY--IARQILKGLDYLHTKRH 120
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFG----LARMMIRKNETVSMVAGSYGYIAPE---- 883
IIHRDIK +N+L++S E +IADFG L + + N V G+ Y++PE
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV----GTVTYMSPERIQG 174
Query: 884 --YGYTLKVDEKIDIYSFGVVLLELLTGRRP-LDPEFGESVDIVEWIRMKIRDNRNLEEA 940
Y Y DI+S G+ LLE G+ P L P ++++ I
Sbjct: 175 ESYSY------AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI--------CDGPP 220
Query: 941 LDPNVGNCKHVQEEMLLVLRIAFL--CTAKLPKDRPS 975
E F+ C K PK RPS
Sbjct: 221 PSLPAEEF---SPEF-----RDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G+ G V + A+K L + + ++ + + E N+L ++ H IV+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVL-KKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-HDCY 831
+ + +V EY G L H + GR + Y A + L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGEL--FSHLSKEGRFSEERARFY--AAEIVLALEYLHSLG-- 113
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY----GYT 887
II+RD+K NILLD++ ++ DFGLA+ + + + G+ Y+APE GY
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRP 912
V D +S GV+L E+LTG+ P
Sbjct: 172 KAV----DWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 69/214 (32%), Positives = 111/214 (51%), Gaps = 15/214 (7%)
Query: 705 ACIRESNVIGMGATGIVYKA--EMPRLNTI-VAVKKLWRSRADLETESSGDFVGEVNVLG 761
+ + VIG G G V + ++P I VA+K L +A + DF+ E +++G
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL---KAGSSDKQRLDFLTEASIMG 60
Query: 762 KLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ 821
+ H NI+RL G + +MI+ EYM NGSL + L + G+ + G+A
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKF--TVGQLVGMLRGIAS 117
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG--SYGY 879
G+ YL Y +HRD+ + NIL++SNL +++DFGL+R + T + G +
Sbjct: 118 GMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW 174
Query: 880 IAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP 912
APE K D++SFG+V+ E+++ G RP
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 10/206 (4%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G G +G+V K I+AVK R ++ + E+++L K IV
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVK---TIRLEINEAIQKQILRELDILHKCNSPYIVG 63
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
G +N+ ++ I EYM+ GSL + + + GR+ + + IA+ V +GL YLH
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKH 120
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
IIHRD+K +NIL++S + ++ DFG++ ++ N G+ Y+APE
Sbjct: 121 K--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV--NSLAKTFVGTSSYMAPERIQGNDY 176
Query: 891 DEKIDIYSFGVVLLELLTGRRPLDPE 916
K DI+S G+ L+EL TGR P PE
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPE 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 73/209 (34%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESS--GDFVGEVNVLGKLRHRNIV 769
IG G+ G VYKA R N +VA+K + DLE D E+ L + R I
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVI-----DLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 770 RLLG-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
+ G FL + + I+ EY GS + L + G+L +++ I V GL YLH
Sbjct: 63 KYYGSFLK-GSKLWIIMEYCGGGSCLDLL---KPGKLDETYIA--FILREVLLGLEYLHE 116
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFG----LARMMIRKNETVSMVAGSYGYIAPEY 884
+ IHRDIK+ NILL + ++ADFG L M ++N V G+ ++APE
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV----GTPFWMAPEV 169
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
DEK DI+S G+ +EL G PL
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPPL 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 70/215 (32%), Positives = 110/215 (51%), Gaps = 16/215 (7%)
Query: 705 ACIRESNVIGMGATGIVYKA--EMP-RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLG 761
+ I + VIG G G V++ +MP R VA+K L + + DF+ E +++G
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL---KPGYTEKQRQDFLSEASIMG 61
Query: 762 KLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ 821
+ H NI+RL G + MI+ EYM NG+L + L V G+A
Sbjct: 62 QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAA 118
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS---YG 878
G+ YL Y +HRD+ + NIL++SNLE +++DFGL+R++ E +G
Sbjct: 119 GMKYLSDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175
Query: 879 YIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP 912
+ APE K D++SFG+V+ E+++ G RP
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G G+ G VYKA +VA+K + DL+ + + E+++L + IV+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQ-----EIIKEISILKQCDSPYIVKY 63
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIAL---GVAQGLAYLHH 828
G +T++ IV EY GS+ + + ++ ++ IA +GL YLH
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIM------KITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTL 888
+ IHRDIK+ NILL+ + ++ADFG++ + + V G+ ++APE +
Sbjct: 118 N---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI 174
Query: 889 KVDEKIDIYSFGVVLLELLTGRRPL 913
+ K DI+S G+ +E+ G+ P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 90/278 (32%), Positives = 132/278 (47%), Gaps = 56/278 (20%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G G V+ T VAVK L T S F+ E ++ KLRH +V+L
Sbjct: 14 LGAGQFGEVWMG-TWNGTTKVAVKTLKPG-----TMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALGVAQGLAYLHH 828
+ + IV EYM+ GSL + L + +L LVD +A +A+G+AYL
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD------MAAQIAEGMAYLES 121
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY--GYIAPE--- 883
Y IHRD+ + NIL+ NL +IADFGLAR +I +E + + + APE
Sbjct: 122 RNY---IHRDLAARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAPEAAN 177
Query: 884 YG-YTLKVDEKIDIYSFGVVLLELLT-GRRPL----DPEFGESVDIVEWIRMKIRDNRNL 937
YG +T+K D++SFG++L E++T GR P + E E V+ RM
Sbjct: 178 YGRFTIKS----DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE--RGYRM-------- 223
Query: 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPS 975
P NC +++L C K P++RP+
Sbjct: 224 -----PRPPNCPEELYDLML------QCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 71/233 (30%), Positives = 103/233 (44%), Gaps = 12/233 (5%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
VIG GA G V + + A+K + + + +E S + + E +L +L H +V
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVN 64
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L ++ NM +V + + G L H Q + + V + + +A L YLH
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDL--RYHLSQKVKFSEEQVKFWICEIVLA--LEYLHSK- 119
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
IIHRDIK +NILLD I DF +A + T S +G+ GY+APE
Sbjct: 120 --GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST-SGTPGYMAPEVLCRQGY 176
Query: 891 DEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943
+D +S GV E L G+RP G S I + IR K L A
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYR---GHSRTIRDQIRAKQETADVLYPATWS 226
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 74/224 (33%), Positives = 119/224 (53%), Gaps = 43/224 (19%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETE----SSGDFVGEVNVLGKLRHRNI 768
+G G G+VYKA + IVA+KK+ R D E E ++ + E+++L +L+H NI
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKI---RLDNEEEGIPSTA---LREISLLKELKHPNI 60
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
V+LL +H + + +V+EY + L + L K+ G L + + + +GLAY H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLD-KRPGPLSPNLIKSI--MYQLLRGLAYCHS 116
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR---MMIRK--NETVSMVAGSYGYIAPE 883
I+HRD+K NIL++ + ++ADFGLAR + +R +E V++ Y APE
Sbjct: 117 HR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTL-----WYRAPE 168
Query: 884 -------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
Y +DI+S G + E++TG +PL P G+S
Sbjct: 169 ILLGSKHYSTA------VDIWSVGCIFAEMITG-KPLFP--GDS 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 71/214 (33%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLET--ESSGDFVGEVNVLGKLRHRNI 768
VIG+GAT +VY A N VA+K++ DLE S + EV + + H N+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRI-----DLEKCQTSVDELRKEVQAMSQCNHPNV 61
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
V+ + +V Y++ GSL + + L D + V +GL YLH
Sbjct: 62 VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGL-DEAIIATVLKEVLKGLEYLHS 120
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFG----LARMMIRKNETVSMVAGSYGYIAPE- 883
+ IHRDIK+ NILL + +IADFG LA R + G+ ++APE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 884 ----YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
+GY D K DI+SFG+ +EL TG P
Sbjct: 178 MEQVHGY----DFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 77/219 (35%), Positives = 105/219 (47%), Gaps = 21/219 (9%)
Query: 710 SNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIV 769
N IG G G VY A ++AVK++ D +T E+ VL L+H N+V
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE--IADEMKVLELLKHPNLV 62
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
+ G + + I EY + G+L E L + V + Y + L +GLAYLH
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV--IRVYTLQL--LEGLAYLHSH 118
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV--SMVAGSYG---YIAPEY 884
I+HRDIK NI LD N ++ DFG A ++ N T V G Y+APE
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAV-KLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 885 --GYTLKVDEK-IDIYSFGVVLLELLTGRRP---LDPEF 917
G K + DI+S G V+LE+ TG+RP LD EF
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766
I + +G G G VY+ + + VAVK L ++E +F+ E V+ +++H
Sbjct: 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-----EFLKEAAVMKEIKHP 62
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
N+V+LLG + I+ E+M G+L + L ++ R V+ V +A ++ + YL
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS---YGYIAPE 883
+ IHRD+ + N L+ N ++ADFGL+R+M +T + AG+ + APE
Sbjct: 121 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE 175
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLT 908
K K D+++FGV+L E+ T
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 9/207 (4%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRAD-LETESSGDFVGEVNVLGKLRHRNIV 769
N IG G+ G+V+K + A+K++ S+ + E E + + E VL KL I+
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEA---IDEARVLAKLDSSYII 62
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
R + + IV EY NG L + L ++ L D V R+ I + + GLA+LH
Sbjct: 63 RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL--GLAHLHSK 120
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLK 889
I+HRDIKS N+ LD+ +I D G+A+++ + + G+ Y++PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 890 VDEKIDIYSFGVVLLELLTGRRPLDPE 916
+EK D+++ GVVL E TG+ P D
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDAN 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 67/216 (31%), Positives = 108/216 (50%), Gaps = 35/216 (16%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG---DFVGEVNVLGKLRHRNIV 769
IG G G VYKA + +VA+KK+ +E E G + E+ +L KLRH NIV
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI-----RMENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 770 RLLGFLHND--TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
RL + + ++ +V+EYM++ G + + + Y + +GL YLH
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV--KFTESQIKCY--MKQLLEGLQYLH 117
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE---TVSMVAGSYGYIAPE- 883
+ I+HRDIK +NIL++++ ++ADFGLAR ++N T ++ + Y PE
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPEL 172
Query: 884 ------YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
YG ++D++S G +L EL G+
Sbjct: 173 LLGATRYGP------EVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 78/274 (28%), Positives = 121/274 (44%), Gaps = 37/274 (13%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G G V + VAVK L + D + F+ E +V+ LRH N+V+LL
Sbjct: 14 IGKGEFGDVMLGDY--RGQKVAVKCL---KDDSTAAQA--FLAEASVMTTLRHPNLVQLL 66
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
G + + IV EYM GSL + L + GR ++ + AL V +G+ YL
Sbjct: 67 GVVLQGNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK--- 121
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY--GYIAPEYGYTLKV 890
+HRD+ + N+L+ +L +++DFGLA K + +G + APE K
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLA-----KEASQGQDSGKLPVKWTAPEALREKKF 176
Query: 891 DEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949
K D++SFG++L E+ + GR P P D+V + R ++ G
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPY-PRIPLK-DVVPHVEKGYR--------MEAPEGCPP 226
Query: 950 HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
V + M C P RP+ + + L
Sbjct: 227 EVYKVMK-------DCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 70/215 (32%), Positives = 110/215 (51%), Gaps = 16/215 (7%)
Query: 705 ACIRESNVIGMGATGIVYKAEMP---RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLG 761
+CI+ VIG G G V + + VA+K L +A + DF+ E +++G
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL---KAGYTEKQRRDFLSEASIMG 60
Query: 762 KLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ 821
+ H NI+ L G + +MIV EYM NGSL L K G+ V + + G+A
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR-KHDGQFTV--IQLVGMLRGIAS 117
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS---YG 878
G+ YL Y +HRD+ + NIL++SNL +++DFGL+R++ E G
Sbjct: 118 GMKYLSDMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174
Query: 879 YIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP 912
+ APE K D++S+G+V+ E+++ G RP
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 65/190 (34%), Positives = 97/190 (51%), Gaps = 22/190 (11%)
Query: 730 NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMN 789
T VAVK L D + DF+ E ++ KLRH +++L + + IV E M
Sbjct: 30 TTPVAVKTLKPGTMDPK-----DFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84
Query: 790 NGSLGEALHGKQAGRL----LVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNIL 845
GSL E L G L L+D +A VA G+AYL Y IHRD+ + N+L
Sbjct: 85 YGSLLEYLQGGAGRALKLPQLID------MAAQVASGMAYLEAQNY---IHRDLAARNVL 135
Query: 846 LDSNLEPRIADFGLARMMIRKNETVSMVAGSY--GYIAPEYGYTLKVDEKIDIYSFGVVL 903
+ N ++ADFGLAR +I+++ + + + APE + K D++SFG++L
Sbjct: 136 VGENNICKVADFGLAR-VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILL 194
Query: 904 LELLT-GRRP 912
E++T GR P
Sbjct: 195 TEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLET-ESSGDFVGEVNVLGKLRHR 766
R+ ++G G+ G VY+ AVK++ + E+ E+ +L KL+H
Sbjct: 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
NIV+ LG + N+ I E + GSL + L K+ G + Y + GL YL
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTRQI--LLGLEYL 118
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY-- 884
H +HRDIK NIL+D+N ++ADFG+A+ ++ + S Y ++APE
Sbjct: 119 HDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY-WMAPEVIA 174
Query: 885 ---GYTLKVDEKIDIYSFGVVLLELLTGRRP 912
GY L DI+S G +LE+ TG+ P
Sbjct: 175 QQGGYGLAA----DIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG---EVNVLGKLRHRNIV 769
IG G G+VYKA IVA+KK+ ES G E+ +L +L H NI+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRF-----ESEGIPKTALREIKLLKELNHPNII 61
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-H 828
+LL + ++ +V+E+M+ L + + +Q R L + + + + QGLA+ H H
Sbjct: 62 KLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQ--RGLPESLIKS-YLYQLLQGLAFCHSH 117
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTL 888
I+HRD+K N+L+++ ++ADFGLAR + + Y APE
Sbjct: 118 G----ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGD 173
Query: 889 KV-DEKIDIYSFGVVLLELLTGRRPLDP 915
K +DI+S G + ELL+ RRPL P
Sbjct: 174 KGYSTPVDIWSVGCIFAELLS-RRPLFP 200
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 70/216 (32%), Positives = 113/216 (52%), Gaps = 26/216 (12%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETES-SGDFVGEVNVLGKLRHRNIVRL 771
IG G G+VYKA +VA+KK+ R D ETE + E+++L +L H NIV+L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI---RLDTETEGVPSTAIREISLLKELNHPNIVKL 64
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-HDC 830
L +H + + +V+E+++ L + + + + + Y L QGLA+ H H
Sbjct: 65 LDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCHSHR- 120
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLAR-----MMIRKNETVSMVAGSYGYIAPEYG 885
++HRD+K N+L+++ ++ADFGLAR + +E V++ Y APE
Sbjct: 121 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL-----WYRAPEIL 172
Query: 886 YTLKV-DEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
K +DI+S G + E++T RR L P G+S
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT-RRALFP--GDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 713 IGMGATGIVYKAE--MPRLNTI-VAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIV 769
+G G+ G+V + E I VAVK L ++D ++ DF+ E ++ L H N++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCL---KSDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
RL G + +M+V E GSL + L G L+ + Y A+ +A G+ YL
Sbjct: 60 RLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY--AVQIANGMRYLESK 116
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG---SYGYIAPEYGY 886
IHRD+ + NILL S+ + +I DFGL R + + + M + + APE
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 887 TLKVDEKIDIYSFGVVLLELLT-GRRP 912
T D++ FGV L E+ T G P
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 76/214 (35%), Positives = 107/214 (50%), Gaps = 20/214 (9%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
V+G GA G+V K IVA+KK S D + + + + EV VL +LRH NIV L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA--LREVKVLRQLRHENIVNL 65
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-HDC 830
+ +V+EY+ +L E L G L D V Y L Q +AY H H+
Sbjct: 66 KEAFRRKGRLYLVFEYVER-TLLELLEASPGG-LPPDAVRSYIWQL--LQAIAYCHSHN- 120
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV--SMVAGSYGYIAPEY--GY 886
IIHRDIK NIL+ + ++ DFG AR + + + VA + Y APE G
Sbjct: 121 ---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW-YRAPELLVGD 176
Query: 887 TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
T + +D+++ G ++ ELL G PL P G+S
Sbjct: 177 T-NYGKPVDVWAIGCIMAELLDG-EPLFP--GDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 64/219 (29%), Positives = 112/219 (51%), Gaps = 20/219 (9%)
Query: 704 LACIRESNVIGMGATGIVYKAEMP---RLNTIVAVKKLWRSRADLETESSGDFVGEVNVL 760
++C++ VIG G G V + + + VA+K L ++ + DF+ E +++
Sbjct: 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL---KSGYTEKQRRDFLSEASIM 59
Query: 761 GKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVA 820
G+ H NI+ L G + +MI+ E+M NG+L L G+ V + + G+A
Sbjct: 60 GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTV--IQLVGMLRGIA 116
Query: 821 QGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG-- 878
G+ YL Y +HRD+ + NIL++SNL +++DFGL+R + + + S G
Sbjct: 117 AGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFL-EDDTSDPTYTSSLGGK 172
Query: 879 ----YIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP 912
+ APE K D++S+G+V+ E+++ G RP
Sbjct: 173 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 76/218 (34%), Positives = 112/218 (51%), Gaps = 31/218 (14%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKK--LWRSRADLETESSGDFV----GEVNVLGKLRH 765
+IG G G VY A ++AVK+ L + A D V E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL---LVDWVSRYNIALGVAQG 822
NIV+ LGF + + I EY+ GS+G L + GR LV + + V +G
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTEQ-----VLEG 120
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM--IRKNETVSMVAGSYGYI 880
LAYLH I+HRD+K++N+L+D++ +I+DFG+++ I N+ + GS ++
Sbjct: 121 LAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 881 APE------YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
APE GY+ KV DI+S G V+LE+ GRRP
Sbjct: 178 APEVIHSYSQGYSAKV----DIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 67/219 (30%), Positives = 98/219 (44%), Gaps = 39/219 (17%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVK--KLWRSRADLETESSGDFVGEVNVLGKLRHRNI 768
IG G G VYKA +VA+K KL + E+++L + RH NI
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKL------EPGDDFEIIQQEISMLKECRHPNI 62
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL---LVDWVSRYNIALGVAQGLAY 825
V G + IV EY GSL + G L + +V R + +GLAY
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ-VTRGPLSELQIAYVCRETL-----KGLAY 116
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA----RMMIRKNETVSMVAGSYGYIA 881
LH IHRDIK NILL + + ++ADFG++ + ++ S + Y ++A
Sbjct: 117 LHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK---SFIGTPY-WMA 169
Query: 882 PE-------YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
PE GY D K DI++ G+ +EL + P+
Sbjct: 170 PEVAAVERKGGY----DGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
IG G+ G V K I+ K++ E E V EVN+L +L+H NIVR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQ-QLVSEVNILRELKHPNIVR 63
Query: 771 LLGFLHNDTN--MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
+ + +N + IV EY G L + + + R ++ + I + L H+
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 829 DCYPP--IIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY-G---YIAP 882
P ++HRD+K NI LD+N ++ DFGLA+++ S A +Y G Y++P
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL----GHDSSFAKTYVGTPYYMSP 179
Query: 883 EYGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
E + DEK DI+S G ++ EL P
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 83/322 (25%), Positives = 137/322 (42%), Gaps = 59/322 (18%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH 765
I E + +G GA G V K + I A+K + + + E+ + +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP---DLQKQILRELEINKSCKS 58
Query: 766 RNIVRLLG-FLHN-DTNMMIVYEYMNNGSLGEALHG---KQAGRLLVDWVSRY---NIAL 817
IV+ G FL +++ I EY GSL ++++ K+ GR + IA
Sbjct: 59 PYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGR-----IGEKVLGKIAE 112
Query: 818 GVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY 877
V +GL+YLH IIHRDIK +NILL + ++ DFG++ E V+ +AG++
Sbjct: 113 SVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS------GELVNSLAGTF 163
Query: 878 G----YIAPEY----GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRM 929
Y+APE Y++ D++S G+ LLE+ R P PE + +E +
Sbjct: 164 TGTSFYMAPERIQGKPYSITS----DVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY 219
Query: 930 KIR-DNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTA--KLPKDRPSMRDVITMLGEA 986
+ N L++ + + ++ F+ K P RP+ D ML
Sbjct: 220 IVNMPNPELKDEPGNGIKWSEEFKD---------FIKQCLEKDPTRRPTPWD---ML--E 265
Query: 987 KPRRKSSSNNDNRYENNKEKLV 1008
P K+ + + N K V
Sbjct: 266 HPWIKAQM----KKKVNMAKFV 283
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 89/308 (28%), Positives = 141/308 (45%), Gaps = 55/308 (17%)
Query: 703 ILACIRESNVIGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVGEV 757
L+ +R +G GA G VYK E+ N T VA+K L + + E + +F E
Sbjct: 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL---KENAEPKVQQEFRQEA 59
Query: 758 NVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL------------HGKQAGRL 805
++ L+H NIV LLG + +++EY+ +G L E L G + +
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 806 LVDWVSRYNIALGVAQGLAYL--HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863
+D +IA+ +A G+ YL HH +HRD+ + N L+ L +I+DFGL+R
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR-D 173
Query: 864 IRKNETVSMVAGS---YGYIAPE---YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEF 917
I + + + S ++ PE YG K + DI+SFGVVL E+ + L P +
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPEAILYG---KFTTESDIWSFGVVLWEIFS--YGLQPYY 228
Query: 918 GES-VDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSM 976
G S +++E IR + L P +C V + C ++P RP
Sbjct: 229 GFSNQEVIEMIRSRQ---------LLPCPEDCPAR------VYALMIECWNEIPARRPRF 273
Query: 977 RDVITMLG 984
+D+ T L
Sbjct: 274 KDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 85/300 (28%), Positives = 126/300 (42%), Gaps = 54/300 (18%)
Query: 707 IRESNVIGMGATGIVYKA--EMPRLNT--IVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
++ +G G G V + NT VAVK L E + DF E+ +L
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL---NHSGEEQHRSDFEREIEILRT 62
Query: 763 LRHRNIVRLLGFLHND--TNMMIVYEYMNNGSLGEALHGKQA----GRLLVDWVSRYNIA 816
L H NIV+ G ++ ++ EY+ +GSL + L + RLL + +
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL-----LF--S 115
Query: 817 LGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS 876
+ +G+ YL Y IHRD+ + NIL++S +I+DFGLA+++ +
Sbjct: 116 SQICKGMDYLGSQRY---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKD-------- 164
Query: 877 YGYI-----------APEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDP--EFGESVD 922
Y Y+ APE T K D++SFGV L EL T G P EF +
Sbjct: 165 YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIG 224
Query: 923 IVEWIRMKIRDNRNLEEALDPNVG-NC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
I + + R L E L +E V + LC P+DRPS D+I
Sbjct: 225 IAQGQMIVTR----LLELLKEGERLPRPPSCPDE---VYDLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 69/216 (31%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVR 770
VIG G G VYKA + +VA+K + D E E E N+L K H NI
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKE----EYNILRKYSNHPNIAT 67
Query: 771 LLG--FLHNDTNM----MIVYEYMNNGSLGEALHG--KQAGRLLVDWVSRYNIALGVAQG 822
G N +V E GS+ + + G K+ RL +W++ Y I +G
Sbjct: 68 FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-Y-ILRETLRG 125
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAP 882
LAYLH + +IHRDIK NILL N E ++ DFG++ + + G+ ++AP
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182
Query: 883 E-----YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
E D + D++S G+ +EL G+ PL
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 6e-23
Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 27/220 (12%)
Query: 707 IRESNVIGMGATGIVYKA----EMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
+ + V+G GA G VYK E ++ VA+K L R + +++ + + E V+
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL---REETSPKANKEILDEAYVMAS 65
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQA---GRLLVDWVSRYNIALGV 819
+ H ++VRLLG + + ++ + M G L + + + + L++W + +
Sbjct: 66 VDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQI 118
Query: 820 AQGLAYL--HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY 877
A+G++YL ++HRD+ + N+L+ + +I DFGLA+++ + G
Sbjct: 119 AKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173
Query: 878 --GYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLD 914
++A E K D++S+GV + EL+T G +P +
Sbjct: 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 72/236 (30%), Positives = 104/236 (44%), Gaps = 59/236 (25%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG-------EVNVLGKLRH 765
+G G +VYKA IVA+KK+ L G E+ +L +L+H
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKI-----KLGERKEAK-DGINFTALREIKLLQELKH 61
Query: 766 RNIVRLLG-FLHNDTNMMIVYEYM----------NNGSLGEALHGKQAGRLLVDWVSRYN 814
NI+ LL F H +N+ +V+E+M + L A K
Sbjct: 62 PNIIGLLDVFGH-KSNINLVFEFMETDLEKVIKDKSIVLTPA-DIKS------------- 106
Query: 815 IALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA 874
L +GL YLH + I+HRD+K NN+L+ S+ ++ADFGLAR N ++
Sbjct: 107 YMLMTLRGLEYLH-SNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQV 163
Query: 875 GSYGYIAPE-------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDI 923
+ Y APE YG +D++S G + ELL R P P G+S DI
Sbjct: 164 VTRWYRAPELLFGARHYGVG------VDMWSVGCIFAELLL-RVPFLP--GDS-DI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 87/280 (31%), Positives = 121/280 (43%), Gaps = 47/280 (16%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G+ G VY A R N +VA+KK+ S E D + EV L +LRH N +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
G + +V EY LG A + + + V I G QGLAYLH
Sbjct: 82 GCYLREHTAWLVMEY----CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE-- 135
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDE 892
IHRDIK+ NILL ++ADFG A ++ N S V Y ++APE L +DE
Sbjct: 136 -RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---SFVGTPY-WMAPE--VILAMDE 188
Query: 893 -----KIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL------ 941
K+D++S G+ +E L R+P P F N N AL
Sbjct: 189 GQYDGKVDVWSLGITCIE-LAERKP--PLF----------------NMNAMSALYHIAQN 229
Query: 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981
D + + + C K+P+DRPS +++
Sbjct: 230 DSPTLSSNDWSDYFRNFVD---SCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 69/203 (33%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+IG G G V + E VAVK + + D+ ++ F+ E V+ KL H+N+VRL
Sbjct: 13 IIGEGEFGAVLQGEY--TGQKVAVKNI---KCDVTAQA---FLEETAVMTKLHHKNLVRL 64
Query: 772 LG-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
LG LHN + IV E M+ G+L L + GR LV + +L VA+G+ YL
Sbjct: 65 LGVILHN--GLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK- 119
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
++HRD+ + NIL+ + +++DFGLAR+ + + + APE K
Sbjct: 120 --KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL---PVKWTAPEALKHKKF 174
Query: 891 DEKIDIYSFGVVLLELLT-GRRP 912
K D++S+GV+L E+ + GR P
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 2e-22
Identities = 77/228 (33%), Positives = 106/228 (46%), Gaps = 48/228 (21%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG-----EVNVLGKLRH 765
IG GA G+V A R VA+KK+ DL E+ +L LRH
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLID-------AKRILREIKLLRHLRH 58
Query: 766 RNIVRLLGFL-----HNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSR--YNIALG 818
NI+ LL L + ++ IV E M L + + Q L D + Y I
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ--PLTDDHIQYFLYQILR- 114
Query: 819 VAQGLAYLH--HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR-MMIRKNETVSM--- 872
GL YLH + +IHRD+K +NIL++SN + +I DFGLAR + ++E +
Sbjct: 115 ---GLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 873 VAGSYGYIAPE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
V + Y APE YT + IDI+S G + ELLT R+PL P
Sbjct: 167 VVTRW-YRAPELLLSSSRYT----KAIDIWSVGCIFAELLT-RKPLFP 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 75/221 (33%), Positives = 107/221 (48%), Gaps = 39/221 (17%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETE----SSGDFVGEVNVLGKLRHR 766
N IG G GIVY+A IVA+KK+ R D E + SS + E+ +L LRH
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKV---RMDNERDGIPISS---LREITLLLNLRHP 66
Query: 767 NIVRLLGFLHND--TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN------IALG 818
NIV L + ++ +V EY + LL + + ++ + L
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCE----------QDLASLLDNMPTPFSESQVKCLMLQ 116
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM--MIRKNETVSMVAGS 876
+ +GL YLH + IIHRD+K +N+LL +IADFGLAR + K T +V +
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--T 171
Query: 877 YGYIAPE--YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
Y APE G T ID+++ G +L ELL +PL P
Sbjct: 172 LWYRAPELLLGCT-TYTTAIDMWAVGCILAELLAH-KPLLP 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESS--GDFVGEVNVLGKLRH 765
+ +IG GA G VY+ + +VA+K + +L+T D EV +L +LR
Sbjct: 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKII-----NLDTPDDDVSDIQREVALLSQLRQ 58
Query: 766 ---RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQG 822
NI + G + I+ EY GS+ + +AG + ++S I V
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISV--IIREVLVA 113
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAP 882
L Y+H +IHRDIK+ NIL+ + ++ DFG+A ++ + + S G+ ++AP
Sbjct: 114 LKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170
Query: 883 EYGYTLKV-DEKIDIYSFGVVLLELLTGRRPL 913
E K D K DI+S G+ + E+ TG P
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 5e-22
Identities = 82/299 (27%), Positives = 138/299 (46%), Gaps = 61/299 (20%)
Query: 713 IGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
IG GA G V++A P L T+VAVK L + + + DF E ++ + H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDHPN 69
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQA------------------GRLLVDW 809
IV+LLG M +++EYM G L E L + L +
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 810 VSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM------ 863
+ IA VA G+AYL + +HRD+ + N L+ N+ +IADFGL+R +
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 864 -IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES-V 921
+N+ + + ++ PE + + + D++++GVVL E+ + + P +G +
Sbjct: 187 KASENDAIPI-----RWMPPESIFYNRYTTESDVWAYGVVLWEIFS--YGMQPYYGMAHE 239
Query: 922 DIVEWIRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDV 979
+++ ++R D NV +C + E+ ++R LC +KLP DRPS +
Sbjct: 240 EVIYYVR-------------DGNVLSCPDNCPLELYNLMR---LCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 7e-22
Identities = 83/266 (31%), Positives = 136/266 (51%), Gaps = 53/266 (19%)
Query: 730 NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMN 789
+T VA+K L + E F+ E N++ +L+H +VRL + + + I+ EYM
Sbjct: 30 HTKVAIKSLKQGSMSPEA-----FLAEANLMKQLQHPRLVRLYAVVTQEP-IYIITEYME 83
Query: 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN 849
NGSL + L + +L ++ ++A +A+G+A++ Y IHRD+++ NIL+
Sbjct: 84 NGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGMAFIERKNY---IHRDLRAANILVSET 138
Query: 850 LEPRIADFGLARMMIRKNETVSMVAGSY--GYIAPE---YG-YTLKVDEKIDIYSFGVVL 903
L +IADFGLAR +I NE + + + APE YG +T+K D++SFG++L
Sbjct: 139 LCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS----DVWSFGILL 193
Query: 904 LELLT-GRRPL----DPEFGESVDIVEWIRMKIRDNRNLEEALD-PNVGNCKHVQEEMLL 957
E++T GR P +PE +NLE P NC EE+
Sbjct: 194 TEIVTYGRIPYPGMTNPEV----------------IQNLERGYRMPRPDNCP---EELYE 234
Query: 958 VLRIAFLCTAKLPKDRPS---MRDVI 980
++R LC + P++RP+ +R V+
Sbjct: 235 LMR---LCWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 83/312 (26%), Positives = 135/312 (43%), Gaps = 62/312 (19%)
Query: 701 ADILACIRESNVIGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVG 755
D + RE +G GA G V+ E L +VAVK L + ++ ++ DF
Sbjct: 4 RDTIVLKRE---LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN---DARKDFER 57
Query: 756 EVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL--HGKQAGRLL------- 806
E +L +H NIV+ G ++V+EYM +G L + L HG A L
Sbjct: 58 EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117
Query: 807 -VDWVSRYNIALGVAQGLAYL--HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863
+ IA+ +A G+ YL H +HRD+ + N L+ +L +I DFG++R +
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDV 172
Query: 864 IRKNETVSMVAGS----YGYIAPE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRPLD 914
+ V G ++ PE Y +T + D++SFGVVL E+ T G++P
Sbjct: 173 YTTD--YYRVGGHTMLPIRWMPPESIMYRKFTTES----DVWSFGVVLWEIFTYGKQPW- 225
Query: 915 PEFGES-VDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDR 973
+G S +++E I L V + ML C + P+ R
Sbjct: 226 --YGLSNEEVIECITQGR--------LLQRPRTCPSEVYDIML-------GCWKRDPQQR 268
Query: 974 PSMRDVITMLGE 985
+++D+ L +
Sbjct: 269 INIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 69/215 (32%), Positives = 109/215 (50%), Gaps = 20/215 (9%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G G V+KA+ + IVA+K++ D SS + E+ +L +L+H+NIVRL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHKNIVRLY 65
Query: 773 GFLHNDTNMMIVYEYMNNG--SLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-HD 829
LH+D + +V+EY + ++ +G +D + + +GLA+ H H+
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSCNGD------IDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE--YGYT 887
++HRD+K N+L++ N E ++ADFGLAR S + Y P+ +G
Sbjct: 120 ----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVD 922
L ID++S G + EL RPL P G VD
Sbjct: 176 L-YSTSIDMWSAGCIFAELANAGRPLFP--GNDVD 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 68/227 (29%), Positives = 109/227 (48%), Gaps = 33/227 (14%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV-GEVNVLGKLRHRNIVRL 771
I GA G V+ A+ I A+K + +AD+ ++ D V E ++L + + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVI--KKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
N+ +V EY+ G L L G L D Y IA + L YLH +
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIY-IA-EIVLALEYLHSN-- 112
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARM-MIRKNETVSM-------VAGSYGYIAPE 883
IIHRD+K +NIL+DSN ++ DFGL+++ ++R+ ++ + G+ YIAPE
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 884 ------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIV 924
+ T +D +S G +L E L G P GE+ + +
Sbjct: 172 VILGQGHSKT------VDWWSLGCILYEFLVGIPPF---HGETPEEI 209
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 72/207 (34%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G G V+ T VA+K L T S F+ E V+ KLRH +V+L
Sbjct: 14 LGQGCFGEVWMGTW-NGTTRVAIKTLKPG-----TMSPEAFLQEAQVMKKLRHEKLVQLY 67
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALGVAQGLAYLHH 828
+ + + IV EYM+ GSL + L G+ L LVD ++ +A G+AY+
Sbjct: 68 AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ------IASGMAYVER 120
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY--GYIAPEYGY 886
Y +HRD+++ NIL+ NL ++ADFGLAR +I NE + + + APE
Sbjct: 121 MNY---VHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAAL 176
Query: 887 TLKVDEKIDIYSFGVVLLELLT-GRRP 912
+ K D++SFG++L EL T GR P
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G+G G V ++ N A+K + + R +ET E +L + H IV+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV-KKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
+ + ++ EY G L L G L ++ +R+ IA V YLH+
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILR--DRG-LFDEYTARFYIA-CVVLAFEYLHNR--- 112
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY----GYTL 888
II+RD+K N+LLDSN ++ DFG A+ + +T + G+ Y+APE GY
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC-GTPEYVAPEIILNKGYDF 171
Query: 889 KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVD 922
V D +S G++L ELLTGR P FGE +
Sbjct: 172 SV----DYWSLGILLYELLTGRPP----FGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESS-GDFVGEVNVLGKLRHR 766
R ++G GA G VY +AVK++ ET+ E+ +L L+H
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
IV+ G L +D + I EYM GS+ + L K G L +Y + +G+ YL
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQ--ILEGVEYL 120
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM--IRKNET-VSMVAGSYGYIAPE 883
H + I+HRDIK NIL DS ++ DFG ++ + I + T + V G+ +++PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 884 ------YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
YG K D++S G ++E+LT + P
Sbjct: 178 VISGEGYG------RKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVK--KLWRSRADLETESSGDFVGEVNVLGKLRHRNIV 769
+G GA Y+A + T++AVK R+ + + E E+ ++ +L H +I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
R+LG D++ + E+M GS+ L + G + Y + +GL+YLH +
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLS--KYGAFKEAVIINY--TEQLLRGLSYLHEN 122
Query: 830 CYPPIIHRDIKSNNILLDSNLEP-RIADFG----LARMMIRKNETVSMVAGSYGYIAPEY 884
IIHRD+K N+L+DS + RIADFG LA E + G+ ++APE
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRP 912
+ D++S G V++E+ T + P
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 5e-21
Identities = 74/279 (26%), Positives = 130/279 (46%), Gaps = 34/279 (12%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G G V K + T++A K + ++ + E+ ++ + R IV
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVH---IGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL---HHD 829
G N+ N+ + E+M+ GSL K+ G + V+ + + IA+ V +GL YL H
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIY--KKGGPIPVEILGK--IAVAVVEGLTYLYNVHR- 124
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----YG 885
I+HRDIK +NIL++S + ++ DFG++ +I N G+ Y++PE
Sbjct: 125 ----IMHRDIKPSNILVNSRGQIKLCDFGVSGELI--NSIADTFVGTSTYMSPERIQGGK 178
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD--NRNLEEALDP 943
YT+K D++S G+ ++EL G+ P F D + M I D + ++E P
Sbjct: 179 YTVKS----DVWSLGISIIELALGKFPFA--FSNIDDDGQDDPMGILDLLQQIVQEP-PP 231
Query: 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982
+ + ++ V C K P +RP+ + + M
Sbjct: 232 RLPSSDFPEDLRDFVDA----CLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 28/205 (13%)
Query: 717 ATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLH 776
A ++ K++M N + VK RA + + +V +L
Sbjct: 25 AIKVLKKSDMIAKNQVTNVKA---ERAIMMIQGESPYV--------------AKLYYSFQ 67
Query: 777 NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIH 836
+ + +V EY+N G + K G L DW +Y V G+ LH IIH
Sbjct: 68 SKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLHQR---GIIH 120
Query: 837 RDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDI 896
RDIK N+L+D ++ DFGL+R + + V G+ Y+APE + D+ D
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV----GTPDYLAPETILGVGDDKMSDW 176
Query: 897 YSFGVVLLELLTGRRPLDPEFGESV 921
+S G V+ E L G P E ++V
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAV 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 75/233 (32%), Positives = 111/233 (47%), Gaps = 60/233 (25%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG---DFVGEVNVLGKLRHRNIV 769
IG G G+VYKA IVA+KK+ LETE G + E+++L +L H NIV
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-----RLETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 770 RLLGFLHNDTNMMIVYEYMN-----------NGSLGEALHGKQAGRLLVDWVSRYNIALG 818
RLL +H++ + +V+E+++ L L +LL
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL------------ 109
Query: 819 VAQGLAYLH-HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR-----MMIRKNETVSM 872
QG+AY H H ++HRD+K N+L+D ++ADFGLAR + +E V++
Sbjct: 110 --QGIAYCHSHR----VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTL 163
Query: 873 VAGSYGYIAPEY-----GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
Y APE Y+ V DI+S G + E++ RRPL P G+S
Sbjct: 164 -----WYRAPEILLGSRQYSTPV----DIWSIGCIFAEMVN-RRPLFP--GDS 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 7e-21
Identities = 64/197 (32%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 713 IGMGATGIVYKAEMPRLNTI-VAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G G G V++ N + VA+K L D DF EV L +LRH++++ L
Sbjct: 14 LGSGYFGEVWEGLW--KNRVRVAIKIL--KSDD--LLKQQDFQKEVQALKRLRHKHLISL 67
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
+ I+ E M GSL L G++L S ++A VA+G+AYL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVL-PVASLIDMACQVAEGMAYLEEQ-- 123
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVD 891
IHRD+ + NIL+ +L ++ADFGLAR++ S Y + APE
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 892 EKIDIYSFGVVLLELLT 908
K D++SFG++L E+ T
Sbjct: 183 TKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 8e-21
Identities = 72/220 (32%), Positives = 102/220 (46%), Gaps = 43/220 (19%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLE--TESSGDFVGEVNVLGKL-RHRNIV 769
+G G G VY A +VA+KK+ + E + EV L KL H NIV
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-----LREVKSLRKLNEHPNIV 61
Query: 770 RLLG-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
+L F ND + V+EYM G+L + L + G+ + V R +I + QGLA++H
Sbjct: 62 KLKEVFREND-ELYFVFEYME-GNLYQ-LMKDRKGKPFSESVIR-SIIYQILQGLAHIHK 117
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM------VAGSYGYIAP 882
+ HRD+K N+L+ +IADFGLAR E S V+ + Y AP
Sbjct: 118 HGF---FHRDLKPENLLVSGPEVVKIADFGLAR------EIRSRPPYTDYVSTRW-YRAP 167
Query: 883 E-------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
E Y +DI++ G ++ EL T RPL P
Sbjct: 168 EILLRSTSY------SSPVDIWALGCIMAELYTL-RPLFP 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 72/190 (37%), Positives = 100/190 (52%), Gaps = 23/190 (12%)
Query: 730 NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMN 789
NT VAVK L T S F+ E ++ KLRH +V+L + + + IV EYM+
Sbjct: 30 NTKVAVKTLKPG-----TMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEP-IYIVTEYMS 83
Query: 790 NGSLGEALHGKQAGRL----LVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNIL 845
GSL + L + L LVD +A VA G+AY+ Y IHRD++S NIL
Sbjct: 84 KGSLLDFLKDGEGRALKLPNLVD------MAAQVAAGMAYIERMNY---IHRDLRSANIL 134
Query: 846 LDSNLEPRIADFGLARMMIRKNETVSMVAGSY--GYIAPEYGYTLKVDEKIDIYSFGVVL 903
+ L +IADFGLAR +I NE + + + APE + K D++SFG++L
Sbjct: 135 VGDGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 193
Query: 904 LELLT-GRRP 912
EL+T GR P
Sbjct: 194 TELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 43/229 (18%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG-EVNVLGKL-RHRNIV 769
+IG G+ V A+ N A+K L + L E +V E VL +L H I+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKIL--DKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ---GLAYL 826
+L ++ N+ V EY NG L + + ++ G L Y A+ L YL
Sbjct: 66 KLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFY-----AAEILLALEYL 118
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM----------IRKNETVSMVAGS 876
H IIHRD+K NILLD ++ +I DFG A+++ S + +
Sbjct: 119 HSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 877 YG----------YIAPEYGYTL---KVDEKIDIYSFGVVLLELLTGRRP 912
Y++PE L + D+++ G ++ ++LTG+ P
Sbjct: 176 RRRFASFVGTAEYVSPE---LLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-20
Identities = 69/204 (33%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G+ G VY A N +VAVKK+ S E D + EV L +L+H N +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN-EKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
G + +V EY LG A + + + V I G QGLAYLH
Sbjct: 88 GCYLKEHTAWLVMEY----CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTL---K 889
+IHRDIK+ NILL + ++ADFG A N V G+ ++APE + +
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV----GTPYWMAPEVILAMDEGQ 196
Query: 890 VDEKIDIYSFGVVLLELLTGRRPL 913
D K+D++S G+ +EL + PL
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 62/190 (32%), Positives = 106/190 (55%), Gaps = 22/190 (11%)
Query: 730 NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMN 789
+T VAVK L ++ F+ E N++ L+H +VRL + + + I+ EYM
Sbjct: 30 STKVAVKTLKPGTMSVQA-----FLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84
Query: 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN 849
GSL + L + G++L+ + + +A+G+AY+ Y IHRD+++ N+L+ +
Sbjct: 85 KGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKNY---IHRDLRAANVLVSES 139
Query: 850 LEPRIADFGLARMMIRKNETVSMVAGSY--GYIAPE---YG-YTLKVDEKIDIYSFGVVL 903
L +IADFGLAR +I NE + + + APE +G +T+K D++SFG++L
Sbjct: 140 LMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS----DVWSFGILL 194
Query: 904 LELLT-GRRP 912
E++T G+ P
Sbjct: 195 YEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 16/211 (7%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKK--LWRSRADLETESSGDFVGEVNVLGKLRHRNI 768
V+G GA G VY + ++AVK+ L S + EV++L L+H NI
Sbjct: 6 EVLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
V+ LG +D + I E++ GS+ L + G L +Y + G+AYLH+
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQ--ILDGVAYLHN 120
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM------IRKNETVSMVAGSYGYIAP 882
+C ++HRDIK NN++L N ++ DFG AR + + + + G+ ++AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 883 EYGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
E K DI+S G + E+ TG+ PL
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 73/267 (27%), Positives = 123/267 (46%), Gaps = 35/267 (13%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G G+V+ VA+K + R +E DF+ E V+ KL H +V+L
Sbjct: 12 IGSGQFGLVWLGYW-LEKRKVAIKTI---REGAMSEE--DFIEEAQVMMKLSHPKLVQLY 65
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
G + + +V+E+M +G L + L + R + + L V +G+AYL
Sbjct: 66 GVCTERSPICLVFEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN-- 120
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS---YGYIAPEYGYTLK 889
+IHRD+ + N L+ N +++DFG+ R ++ T S G+ + +PE K
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS--TGTKFPVKWSSPEVFSFSK 177
Query: 890 VDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNC 948
K D++SFGV++ E+ + G+ P + + ++VE I R P + +
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENR--SNSEVVETINAGFR-------LYKPRLAS- 227
Query: 949 KHVQEEMLLVLRIAFLCTAKLPKDRPS 975
+ V E M C + P+DRPS
Sbjct: 228 QSVYELMQ-------HCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESS-GDFVGEVNVLGKLRHRNIVRL 771
+G GA G VYKA+ A K +E+E DF+ E+++L + +H NIV L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAK-----IIQIESEEELEDFMVEIDILSECKHPNIVGL 67
Query: 772 LGFLHNDTNMMIVYEYMNNGSLG----EALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
+ + I+ E+ + G+L E G ++ V R + + L +LH
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY--VCRQ-----MLEALNFLH 120
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY--G 885
+IHRD+K+ NILL + + ++ADFG++ + G+ ++APE
Sbjct: 121 SH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVAC 177
Query: 886 YTLK---VDEKIDIYSFGVVLLELLTGRRP 912
T K D K DI+S G+ L+EL P
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 27/217 (12%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESS--GDFVGEVNVLGKLRH 765
+ +G G G+V K I+A R LE + + + E+ VL +
Sbjct: 4 EKLGELGAGNGGVVTKVLHRPSGLIMA-----RKLIHLEIKPAIRNQIIRELKVLHECNS 58
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAY 825
IV G ++D + I E+M+ GSL + L K+AGR+ + + + I++ V +GL Y
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPENILGK--ISIAVLRGLTY 114
Query: 826 LH--HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE 883
L H I+HRD+K +NIL++S E ++ DFG++ +I + + G+ Y++PE
Sbjct: 115 LREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPE 168
Query: 884 ----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPE 916
YT++ DI+S G+ L+E+ GR P+ P
Sbjct: 169 RLQGTHYTVQS----DIWSLGLSLVEMAIGRYPIPPP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 6e-20
Identities = 75/274 (27%), Positives = 135/274 (49%), Gaps = 39/274 (14%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV-GEVNVLGKLRHRNIVRL 771
IG G+TGIV A VAVKK+ DL + + + EV ++ +H NIV +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 772 LG-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
+L D + +V E++ G+L + + R+ + ++ + L V + L++LH
Sbjct: 82 YSSYLVGD-ELWVVMEFLEGGALTDIV---THTRMNEEQIA--TVCLAVLKALSFLHAQ- 134
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFG----LARMMIRKNETVSMVAGSYGYIAPEYGY 886
+IHRDIKS++ILL S+ +++DFG +++ + R+ S+V Y ++APE
Sbjct: 135 --GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK---SLVGTPY-WMAPEVIS 188
Query: 887 TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG 946
L ++DI+S G++++E++ G P F E ++ ++ IRDN L P +
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPY---FNEPP--LQAMKR-IRDN------LPPKLK 236
Query: 947 NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
N V + L + P R + +++
Sbjct: 237 NLHKVSPRLRSFLD---RMLVRDPAQRATAAELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 72/214 (33%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG GA GIV+KA+ VA+KK+ R + + + E+ L +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ--ALREIKALQACQHPYVVKLL 65
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
+ + ++V EYM L E L ++ L V Y L +G+AY+H +
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVLRDEERP-LPEAQVKSYMRML--LKGVAYMHAN--- 118
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV-SMVAGSYGYIAPE--YGYTLK 889
I+HRD+K N+L+ ++ +IADFGLAR+ + + S + Y APE YG K
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG-ARK 177
Query: 890 VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDI 923
D +D+++ G + ELL G PL P GE+ DI
Sbjct: 178 YDPGVDLWAVGCIFAELLNG-SPLFP--GEN-DI 207
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 8e-20
Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+GMGA G+V A VA+KK+ + + + E+ +L LRH NI+ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 773 G-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
F+ ++ V E + G LH R L +Y + +GL Y+H
Sbjct: 76 DIFISPLEDIYFVTELL-----GTDLHRLLTSRPLEKQFIQY-FLYQILRGLKYVHS--- 126
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTL-KV 890
++HRD+K +NIL++ N + +I DFGLAR I+ + V+ Y Y APE T K
Sbjct: 127 AGVVHRDLKPSNILINENCDLKICDFGLAR--IQDPQMTGYVSTRY-YRAPEIMLTWQKY 183
Query: 891 DEKIDIYSFGVVLLELLTGRRPLDP 915
D ++DI+S G + E+L G +PL P
Sbjct: 184 DVEVDIWSAGCIFAEMLEG-KPLFP 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-19
Identities = 68/204 (33%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G+ G VY A R N +VA+KK+ S E D + EV L +++H N +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYS-GKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
G + +V EY LG A + + + V I G QGLAYLH
Sbjct: 92 GCYLREHTAWLVMEY----CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH--- 144
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTL---K 889
+IHRDIK+ NILL + ++ADFG A + N V G+ ++APE + +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV----GTPYWMAPEVILAMDEGQ 200
Query: 890 VDEKIDIYSFGVVLLELLTGRRPL 913
D K+D++S G+ +EL + PL
Sbjct: 201 YDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 74/289 (25%), Positives = 128/289 (44%), Gaps = 46/289 (15%)
Query: 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLE-------TESSGDFVGE 756
L ++E +G G G+V+ + WR + D+ S DF+ E
Sbjct: 6 LTFLKE---LGSGQFGVVHLGK-------------WRGKIDVAIKMIREGAMSEDDFIEE 49
Query: 757 VNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIA 816
V+ KL H N+V+L G + IV EYM NG L L ++ G+L +W+ ++
Sbjct: 50 AKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWL--LDMC 106
Query: 817 LGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG- 875
V + + YL + + IHRD+ + N L+ + +++DFGLAR ++ T S
Sbjct: 107 SDVCEAMEYLESNGF---IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF 163
Query: 876 SYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR 935
+ PE + K D++SFGV++ E+ + + F S ++VE + R R
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-EVVESVSAGYRLYR 222
Query: 936 NLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984
P + V M + C + P+DRP+ + +++ L
Sbjct: 223 -------PKLAP-TEVYTIM-------YSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-19
Identities = 88/303 (29%), Positives = 128/303 (42%), Gaps = 66/303 (21%)
Query: 710 SNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV---GEVNVLGKLRHR 766
S V+G GATG V A+ AVK + D+E S D EV L
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVV-----DMEGMSEADKNRAQAEVCCLLNCDFF 91
Query: 767 NIVRLL-GFLHNDTN-------MMIVYEYMNNGSLGEALHGK-QAGRLLVDWVSRYNIAL 817
+IV+ F D + +V +Y N G L + + + + R + + L
Sbjct: 92 SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFRE----HEAGL 147
Query: 818 GVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVS-----M 872
Q L +HH +IHRDIKS NILL SN ++ DFG ++M TVS
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY---AATVSDDVGRT 204
Query: 873 VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIR 932
G+ Y+APE +K D++S GV+L ELLT +RP D GE+++ V
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---GENMEEVM------- 254
Query: 933 DNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKD-RPSMRDVITMLGEAKPRRK 991
++ L DP LP P M++++T L + P+R+
Sbjct: 255 -HKTLAGRYDP-------------------------LPPSISPEMQEIVTALLSSDPKRR 288
Query: 992 SSS 994
SS
Sbjct: 289 PSS 291
|
Length = 496 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-19
Identities = 71/215 (33%), Positives = 106/215 (49%), Gaps = 20/215 (9%)
Query: 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
+ + +RE IG G+ G VY A R + +VA+KK+ S E D + EV L K
Sbjct: 16 LFSDLRE---IGHGSFGAVYFARDVRNSEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQK 71
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQG 822
LRH N ++ G + +V EY LG A + + + V + G QG
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEY----CLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 823 LAYLH-HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIA 881
LAYLH H+ +IHRD+K+ NILL ++ DFG A +M N V G+ ++A
Sbjct: 128 LAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV----GTPYWMA 179
Query: 882 PEYGYTL---KVDEKIDIYSFGVVLLELLTGRRPL 913
PE + + D K+D++S G+ +EL + PL
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 36/284 (12%)
Query: 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL 763
L ++E +G G G+V+ + R VA+K + A S DF+ E V+ KL
Sbjct: 6 LTFMKE---LGSGQFGVVHLGKW-RAQIKVAIKAI-NEGA----MSEEDFIEEAKVMMKL 56
Query: 764 RHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGL 823
H +V+L G + IV E+M NG L L +Q G+L D + ++ V +G+
Sbjct: 57 SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDML--LSMCQDVCEGM 113
Query: 824 AYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY--GYIA 881
YL + + IHRD+ + N L+ S +++DFG+ R ++ +E S + +
Sbjct: 114 EYLERNSF---IHRDLAARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSP 169
Query: 882 PEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940
PE K K D++SFGV++ E+ T G+ P E E + M R R
Sbjct: 170 PEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF-----EKKSNYEVVEMISRGFRLYRPK 224
Query: 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984
L V + + C + P+ RP+ +++ +
Sbjct: 225 LASMT------------VYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 72/229 (31%), Positives = 111/229 (48%), Gaps = 50/229 (21%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG---DFVGEVNVLGKLRHRN 767
IG G G VYKA +VA+KK+ L+ E G + E+ +L +L HRN
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKV-----RLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 768 IVRL----------LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIAL 817
IV L L F + +V+EYM++ +G G LV + S +I
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG------LVHF-SEDHIKS 120
Query: 818 GVAQ---GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK------NE 868
+ Q GL Y H + +HRDIK +NILL++ + ++ADFGLAR+ + N+
Sbjct: 121 FMKQLLEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 869 TVSMVAGSYGYIAPEYGYTLKVDEK----IDIYSFGVVLLELLTGRRPL 913
+++ Y PE L +E+ ID++S G +L EL T ++P+
Sbjct: 178 VITL-----WYRPPEL---LLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
IG GA G+V A R VA+KK+ + + E+ +L +H NI+ +
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT--LRELKILRHFKHDNIIAI 69
Query: 772 LGFLHNDTNMMI-VYEYMN--NGSLGEALHGKQAGRLLVDWVSR--YNIALGVAQGLAYL 826
L VY M+ L +H Q L + + Y + +GL Y+
Sbjct: 70 RDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP--LTEEHIRYFLYQLL----RGLKYI 123
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY----GYIAP 882
H +IHRD+K +N+L++ + E RI DFG+AR + Y Y AP
Sbjct: 124 HSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 883 EYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDP 915
E +L + ID++S G + E+L GRR L P
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFP 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 78/287 (27%), Positives = 130/287 (45%), Gaps = 39/287 (13%)
Query: 713 IGMGATGIVYKAEMPRL-NTIVAVKKL------WRSRADLETESSGDFVGEVNVLGK-LR 764
+G GA G VYK ++A+K++ + +S GD V EV ++ + LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 765 HRNIVRLL-GFLHNDTNMMIVYEYMNNGSLGEALHG--KQAGRLLVDWVSRYNIALGVAQ 821
H NIVR FL ND + IV + + LGE + ++ R + + +NI + +
Sbjct: 68 HPNIVRYYKTFLEND-RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI--WNIFVQMVL 124
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIA 881
L YLH + I+HRD+ NNI+L + + I DFGLA+ + ++ V G+ Y
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQK-QPESKLTSVVGTILYSC 181
Query: 882 PEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941
PE EK D+++FG +L ++ T L P F S +++ + KI +E
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT----LQPPF-YSTNMLS-LATKI-----VEAVY 230
Query: 942 DPNVGNCKHVQEEMLLVLRIAFL---CTAKLPKDRPSMRDVITMLGE 985
+P E + + + C + RP + V M+ +
Sbjct: 231 EP--------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 7/203 (3%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
V+G GA G +++V K++ + L + D + E+ +L L+H NI+
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVVWKEV--NLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
+D ++I EY N G+L + + ++ + V Y + ++Y+H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ--IVSAVSYIHKA-- 120
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVD 891
I+HRDIK+ NI L ++ DFG+++++ + V G+ Y++PE +K +
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYN 179
Query: 892 EKIDIYSFGVVLLELLTGRRPLD 914
K DI++ G VL ELLT +R D
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 67/211 (31%), Positives = 116/211 (54%), Gaps = 32/211 (15%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G G V+ A + +T VAVK + +E F+ E NV+ L+H +V+L
Sbjct: 14 LGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEA-----FLAEANVMKTLQHDKLVKLH 67
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALGVAQGLAYLHH 828
+ + + I+ E+M GSL + L + + L+D+ ++ +A+G+A++
Sbjct: 68 AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQ 120
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY--GYIAPE--- 883
Y IHRD+++ NIL+ ++L +IADFGLAR +I NE + + + APE
Sbjct: 121 RNY---IHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAIN 176
Query: 884 YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
+G +T+K D++SFG++L+E++T GR P
Sbjct: 177 FGSFTIKS----DVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 3e-19
Identities = 78/218 (35%), Positives = 114/218 (52%), Gaps = 33/218 (15%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRL 771
+G GA GIV+KA R +VA+KK++ + + T++ F E+ L +L H NIV+L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQRTF-REIMFLQELGDHPNIVKL 72
Query: 772 LGFLH--NDTNMMIVYEYMNNGSLGEA-LHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
L + ND ++ +V+EYM E LH +L D RY I + + L Y+H
Sbjct: 73 LNVIKAENDKDIYLVFEYM------ETDLHAVIRANILEDVHKRY-IMYQLLKALKYIHS 125
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM------VAGSYGYIAP 882
+IHRD+K +NILL+S+ ++ADFGLAR + E VA + Y AP
Sbjct: 126 G---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW-YRAP 181
Query: 883 E-----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
E YT V D++S G +L E+L G +PL P
Sbjct: 182 EILLGSTRYTKGV----DMWSVGCILGEMLLG-KPLFP 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
V+G GA GIV+ +V +K++ + + + E VL L H NI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ--NECQVLKLLSHPNIIEY 64
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
D +MIV EY G+L E + + L D + + Q L LHH
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHF-----FVQILLALHHVHT 119
Query: 832 PPIIHRDIKSNNILLDSN-LEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
I+HRD+K+ NILLD + + +I DFG+++++ K++ V G+ YI+PE
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA-YTVVGTPCYISPELCEGKPY 178
Query: 891 DEKIDIYSFGVVLLELLTGRRPLDPE 916
++K DI++ G VL EL + +R +
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 13/205 (6%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKL-WRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G G+ G VYK + N A+K++ S + E E + V E+ +L + H NI+
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDA---VNEIRILASVNHPNIISY 64
Query: 772 L-GFLHNDTNMM-IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
FL D N + IV EY G L +A+ ++ R L+ + I + + +GL LH
Sbjct: 65 KEAFL--DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLK 889
I+HRD+KS NILL +N +I D G+++++ K G+ Y+APE
Sbjct: 123 ---KILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQIGTPHYMAPEVWKGRP 177
Query: 890 VDEKIDIYSFGVVLLELLTGRRPLD 914
K DI+S G +L E+ T P +
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 33/214 (15%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG---DFVGEVNVLGKLRHRNIV 769
IG G G+VYK + IVA+KK+ LE+E G + E+++L +L+H NIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-----RLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 770 RLLGFLHNDTNMMIVYEYMN---NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
L L ++ + +++E+++ L G+ LV Y I QG+ +
Sbjct: 63 CLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYL-YQIL----QGILFC 117
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR-----MMIRKNETVSMVAGSYGYIA 881
H ++HRD+K N+L+D+ ++ADFGLAR + + +E V++ Y A
Sbjct: 118 HSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTL-----WYRA 169
Query: 882 PE--YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
PE G + +DI+S G + E+ T ++PL
Sbjct: 170 PEVLLGSP-RYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 20/210 (9%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADL-ETESSGDFVGEVNVLGKLRHRNIVR 770
IG G+ G +Y A+ + +K++ ++ + E E+S EV +L K++H NIV
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIVT 63
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL-----LVDWVSRYNIALGVAQGLAY 825
+ + IV EY + G L + ++ +Q G L ++ W + ++ GL +
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRIN-RQRGVLFSEDQILSWFVQ------ISLGLKH 116
Query: 826 LHHDCYPPIIHRDIKSNNILLDSN-LEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY 884
+H I+HRDIKS NI L N + ++ DFG+AR + E G+ Y++PE
Sbjct: 117 IHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI 173
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRPLD 914
+ K DI+S G VL EL T + P +
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 30/208 (14%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G G VYK + + NT VAVK R+ L + F+ E +L + H NIV+L+
Sbjct: 3 IGKGNFGDVYKGVL-KGNTEVAVKT---CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
G + IV E + GSL L K RL V ++L A G+ YL
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKK-KNRLTVK--KLLQMSLDAAAGMEYLESKN-- 113
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG-------YIAPE-- 883
IHRD+ + N L+ N +I+DFG++R E + S G + APE
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEAL 167
Query: 884 -YG-YTLKVDEKIDIYSFGVVLLELLTG 909
YG YT + D++S+G++L E +
Sbjct: 168 NYGRYTSES----DVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 71/231 (30%), Positives = 106/231 (45%), Gaps = 40/231 (17%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV------GEVNVLGKLRHR 766
IG G+ G+V+K IVA+KK ES D V E+ +L +L+H
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF--------VESEDDPVIKKIALREIRMLKQLKHP 60
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
N+V L+ + +V+EY ++ L E L G V I Q + +
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRG---VPEHLIKKIIWQTLQAVNFC 116
Query: 827 H-HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE-- 883
H H+C IHRD+K NIL+ + ++ DFG AR++ + + + Y APE
Sbjct: 117 HKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL 172
Query: 884 -----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES-VDIVEWIR 928
YG +D+++ G V ELLTG +PL P G+S VD + IR
Sbjct: 173 VGDTQYG------PPVDVWAIGCVFAELLTG-QPLWP--GKSDVDQLYLIR 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 7e-19
Identities = 66/202 (32%), Positives = 97/202 (48%), Gaps = 9/202 (4%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLG-KLRHRNIVR 770
V+G G+ G V AE+ N A+K L + LE + + E VL H +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKAL-KKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L ++ V EY+N G L H + +GR Y A + GL +LH
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFY--AAEIICGLQFLHKK- 115
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
II+RD+K +N+LLD + +IADFG+ + + S G+ YIAPE K
Sbjct: 116 --GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 891 DEKIDIYSFGVVLLELLTGRRP 912
+E +D +SFGV+L E+L G+ P
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 8e-19
Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 14/206 (6%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G VYK IVA+K++ D E + + E++++ +L+H NIVRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKHENIVRLH 64
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEAL--HGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
+H + +M+V+EYM+ L + + HG + +D + + + +G+A+ H +
Sbjct: 65 DVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGA---LDPNTVKSFTYQLLKGIAFCHEN- 119
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
++HRD+K N+L++ E ++ADFGLAR T S + Y AP+ +
Sbjct: 120 --RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 891 -DEKIDIYSFGVVLLELLTGRRPLDP 915
IDI+S G ++ E++TG RPL P
Sbjct: 178 YSTSIDIWSVGCIMAEMITG-RPLFP 202
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 9e-19
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
N IG GA G VYK + A+K ++ + D E+ +L + H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ---ICREIEILRDVNHPNVVK 136
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
++ + ++ E+M+ GSL E H L ++A + G+AYLH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSL-EGTHIADEQFLA-------DVARQILSGIAYLHRR- 187
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
I+HRDIK +N+L++S +IADFG++R++ + + + G+ Y++PE T
Sbjct: 188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLN 245
Query: 891 DEKI-----DIYSFGVVLLELLTGRRPL 913
DI+S GV +LE GR P
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 1e-18
Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G+ G V+K R +VA+K + A+ E E D E+ VL + + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE---DIQQEITVLSQCDSPYVTKYY 68
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
G DT + I+ EY+ GS AL + G L D I + +GL YLH +
Sbjct: 69 GSYLKDTKLWIIMEYLGGGS---ALDLLEPGPL--DETQIATILREILKGLDYLHSE--- 120
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDE 892
IHRDIK+ N+LL + E ++ADFG+A + + G+ ++APE D
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 893 KIDIYSFGVVLLELLTGRRP 912
K DI+S G+ +EL G P
Sbjct: 181 KADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 56/190 (29%), Positives = 92/190 (48%), Gaps = 25/190 (13%)
Query: 739 WRSRADLETE-------SSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNG 791
WR + D+ + S +F+ E V+ KL H +V+L G + IV EYM+NG
Sbjct: 25 WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84
Query: 792 S----LGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLD 847
L E Q +LL + V +G+AYL + IHRD+ + N L+D
Sbjct: 85 CLLNYLREHGKRFQPSQLL-------EMCKDVCEGMAYLESKQF---IHRDLAARNCLVD 134
Query: 848 SNLEPRIADFGLARMMIRKNETVSMVAGSY--GYIAPEYGYTLKVDEKIDIYSFGVVLLE 905
+++DFGL+R ++ +E S V + + PE K K D+++FGV++ E
Sbjct: 135 DQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWE 193
Query: 906 LLT-GRRPLD 914
+ + G+ P +
Sbjct: 194 VYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 81/264 (30%), Positives = 120/264 (45%), Gaps = 48/264 (18%)
Query: 731 TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNN 790
T VA+K L T F+ E ++ KLRH +V L + + + IV E+M
Sbjct: 31 TKVAIKTLKPG-----TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEP-IYIVTEFMGK 84
Query: 791 GSLGEALHGKQAGRL----LVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILL 846
GSL + L L LVD ++ +A G+AY+ Y IHRD+++ NIL+
Sbjct: 85 GSLLDFLKEGDGKYLKLPQLVDMAAQ------IADGMAYIERMNY---IHRDLRAANILV 135
Query: 847 DSNLEPRIADFGLARMMIRKNETVSMVAGSY--GYIAPEYGYTLKVDEKIDIYSFGVVLL 904
NL +IADFGLAR +I NE + + + APE + K D++SFG++L
Sbjct: 136 GDNLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 194
Query: 905 ELLT-GRRP----LDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVL 959
EL+T GR P ++ E E V+ RM P C E++
Sbjct: 195 ELVTKGRVPYPGMVNREVLEQVE--RGYRM-------------PCPQGCPESLHELMK-- 237
Query: 960 RIAFLCTAKLPKDRPSMRDVITML 983
LC K P +RP+ + + L
Sbjct: 238 ----LCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 4e-18
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+ +G GA G V A + VA+KKL R + + E+ +L + H N++
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI-HAKRTY-RELRLLKHMDHENVIG 78
Query: 771 LLGFLHNDTNMMIVYE-YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
LL +++ + Y+ +G L+ + L D ++ + + +GL Y+H
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQILRGLKYIHS- 136
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE------ 883
IIHRD+K +NI ++ + E +I DFGLAR +E VA + Y APE
Sbjct: 137 --AGIIHRDLKPSNIAVNEDCELKILDFGLARHT--DDEMTGYVATRW-YRAPEIMLNWM 191
Query: 884 -YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
Y T +DI+S G ++ ELLTG + L P
Sbjct: 192 HYNQT------VDIWSVGCIMAELLTG-KTLFP 217
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 50/162 (30%), Positives = 87/162 (53%), Gaps = 10/162 (6%)
Query: 753 FVGEVNVLGKLRHRNIVRLLGFLHND-TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVS 811
F+ E +V+ +LRH N+V+LLG + + + IV EYM GSL + L + GR ++
Sbjct: 46 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDC 103
Query: 812 RYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVS 871
+L V + + YL + + +HRD+ + N+L+ + +++DFGL + +T
Sbjct: 104 LLKFSLDVCEAMEYLEANNF---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 160
Query: 872 MVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP 912
+ + APE K K D++SFG++L E+ + GR P
Sbjct: 161 L---PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-18
Identities = 61/203 (30%), Positives = 108/203 (53%), Gaps = 11/203 (5%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G G+V K + + + ++ +KL +++ + E+ VL + IV
Sbjct: 13 LGAGNGGVVTKVQH-KPSGLIMARKL--IHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
G ++D + I E+M+ GSL + L K+A R+ + + + +IA V +GLAYL
Sbjct: 70 GAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIA--VLRGLAYLREK--H 123
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDE 892
I+HRD+K +NIL++S E ++ DFG++ +I + + G+ Y++PE
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV 181
Query: 893 KIDIYSFGVVLLELLTGRRPLDP 915
+ DI+S G+ L+EL GR P+ P
Sbjct: 182 QSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 6e-18
Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRS--RADLETESSGDFVGEVNVLGKL-RHRNI 768
V+G G+ G V AE+ + + AVK L + D + E + + E VL +H +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECT---MTEKRVLALAGKHPFL 58
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH- 827
+L + V EY+N G L H +++GR Y A + GL +LH
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFY--AAEIVLGLQFLHE 114
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYT 887
II+RD+K +N+LLDS +IADFG+ + I T S G+ YIAPE
Sbjct: 115 RG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRPLDPE 916
+D ++ GV+L E+L G+ P + +
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 6e-18
Identities = 55/160 (34%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 511 LDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGI 570
L L + G IP+ I+ L ++NL N + G+IP ++ + +L +LDLS NS G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 571 PENFGASPALEVLNVSYNRLEGPVPANGVLRTINRG--DLAGNAGLCG-GVLHPCSRYSP 627
PE+ G +L +LN++ N L G VPA R ++R + NAGLCG L C
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC----- 537
Query: 628 IASSHRSLHAKHIIPGWMIAISSLFAVGIAVFGARSLYKR 667
H S+ AK IA A V A +KR
Sbjct: 538 --GPHLSVGAK-----IGIAFGVSVAFLFLVICAMCWWKR 570
|
Length = 623 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 6e-18
Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG---DFVGEVNVLGKLRHRNIV 769
IG G G+VYKA N +A+KK+ LE E G + E+++L +++H NIV
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-----RLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
RL +H++ + +V+EY++ L H + + + +G+AY H
Sbjct: 65 RLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 830 CYPPIIHRDIKSNNILLD-SNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----- 883
++HRD+K N+L+D ++ADFGLAR T + + Y APE
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS 178
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
Y+ V DI+S G + E++ ++PL P G+S
Sbjct: 179 RHYSTPV----DIWSVGCIFAEMVN-QKPLFP--GDS 208
|
Length = 294 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 8e-18
Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESS-----GDFVGEVNVLGKLRHR 766
+IG G+ G VY ++AVK++ ++ E+ +L +L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL--HGKQAGRLLVDWVSRYNIALGVAQGLA 824
NIV+ LG + ++ I EY+ GS+ L +G L+ ++V + + +GL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------ILKGLN 120
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR------MMIRKNETVSMVAGSYG 878
YLH+ IIHRDIK NIL+D+ +I+DFG+++ + + N + GS
Sbjct: 121 YLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 879 YIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
++APE K DI+S G +++E+LTG+ P
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVR 770
V+G G G VYK + + A+K + D+ + + E+N+L K HRNI
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVM-----DVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 771 LLG-FLH-----NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLA 824
G F+ +D + +V E+ GS+ + + + L DW++ I + +GLA
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLA 135
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY 884
+LH +IHRDIK N+LL N E ++ DFG++ + R + G+ ++APE
Sbjct: 136 HLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE- 191
Query: 885 GYTLKVDE--------KIDIYSFGVVLLELLTGRRPL 913
+ DE + DI+S G+ +E+ G PL
Sbjct: 192 --VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 9e-18
Identities = 66/231 (28%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 702 DILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLG 761
D L I E +G GA G+V K TI+AVK++ RA + ++ + ++++
Sbjct: 1 DDLEVIEE---LGRGAYGVVDKMRHVPTGTIMAVKRI---RATVNSQEQKRLLMDLDISM 54
Query: 762 KLRH-RNIVRLLGFLHNDTNMMIVYEYMNNGSLGE-----ALHGKQAGRLLVDWVSRYNI 815
+ V G L + ++ I E M+ SL + G D + + I
Sbjct: 55 RSVDCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPE---DILGK--I 108
Query: 816 ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMV-- 873
A+ + + L YLH +IHRD+K +N+L++ N + ++ DFG I S+
Sbjct: 109 AVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFG-----ISGYLVDSVAKT 161
Query: 874 --AGSYGYIAPE--------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLD 914
AG Y+APE GY D K D++S G+ ++EL TGR P D
Sbjct: 162 IDAGCKPYMAPERINPELNQKGY----DVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G+ G VYK R +VA+K + A+ E E D E+ VL + I R
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE---DIQQEITVLSQCDSPYITRYY 68
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
G T + I+ EY+ GS AL + G L +++ I + +GL YLH +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGS---ALDLLKPGPLEETYIA--TILREILKGLDYLHSE--- 120
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDE 892
IHRDIK+ N+LL + ++ADFG+A + + G+ ++APE D
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 893 KIDIYSFGVVLLELLTGRRP 912
K DI+S G+ +EL G P
Sbjct: 181 KADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 24/218 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
++G G+ G+V K + IVA+KK S D + + E+ +L +LRH N+V L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIA--MREIRMLKQLRHENLVNL 65
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGE---ALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH- 827
+ + +V+E++++ L + +G R V +Y + +G+ + H
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESR-----VRKY--LFQILRGIEFCHS 118
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY--G 885
H+ IIHRDIK NIL+ + ++ DFG AR + E + + Y APE G
Sbjct: 119 HN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG 174
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDI 923
T K +DI++ G ++ E+LTG +P F DI
Sbjct: 175 DT-KYGRAVDIWAVGCLVTEMLTG----EPLFPGDSDI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 68/203 (33%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK-LRHRNIVR 770
VIG G+ G V A+ + AVK L + + L+ + + E NVL K L+H +V
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVL-QKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L + V +Y+N G L L Q R ++ +R+ A VA + YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHL---QRERCFLEPRARF-YAAEVASAIGYLHS-- 114
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
II+RD+K NILLDS + DFGL + + ET S G+ Y+APE
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 891 DEKIDIYSFGVVLLELLTGRRPL 913
D +D + G VL E+L G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 75/276 (27%), Positives = 122/276 (44%), Gaps = 34/276 (12%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
V+G G GIVY A +A+K++ + ++ E+ + L+HRNIV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEI----PERDSRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
LG + I E + GSL L K G L + + + +GL YLH +
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN-- 127
Query: 832 PPIIHRDIKSNNILLDS-NLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY------ 884
I+HRDIK +N+L+++ + +I+DFG ++ + N G+ Y+APE
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944
GY DI+S G ++E+ TG+ P E GE + + M + + + E+L
Sbjct: 187 GY----GAPADIWSLGCTIVEMATGKPPFI-ELGEPQAAMFKVGM-FKIHPEIPESLSAE 240
Query: 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
N +LR C P R S D++
Sbjct: 241 AKN---------FILR----CFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-17
Identities = 61/212 (28%), Positives = 110/212 (51%), Gaps = 11/212 (5%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G G+V+K I+A K + +++ + E+ VL + IV
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLI---HLEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
G ++D + I E+M+ GSL + L K+AGR+ + + +IA V +GL YL
Sbjct: 70 GAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIA--VIKGLTYLREK--H 123
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDE 892
I+HRD+K +NIL++S E ++ DFG++ +I + + G+ Y++PE
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV 181
Query: 893 KIDIYSFGVVLLELLTGRRPLDPEFGESVDIV 924
+ DI+S G+ L+E+ GR P+ P + ++++
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELELM 213
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 53/161 (32%), Positives = 80/161 (49%), Gaps = 18/161 (11%)
Query: 756 EVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNI 815
E +L +RH +V L G +D+N+ +V EY+ G L L +++GR Y
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVARFY-- 106
Query: 816 ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG 875
A V L YLH I++RD+K N+LLDS+ +I DFG A+ R + G
Sbjct: 107 AAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAK---RVKGRTYTLCG 160
Query: 876 SYGYIAPEY----GYTLKVDEKIDIYSFGVVLLELLTGRRP 912
+ Y+APE GY V D ++ G+++ E+L G P
Sbjct: 161 TPEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-17
Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLG-KLRHRNIVR 770
++G G+ G V+ AE+ N A+K L + ++ + V E VL H +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMV-EKRVLSLAWEHPFLTH 60
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L N+ V EY+N G L H + + + + Y A + GL +LH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFY--AAEIICGLQFLHSK- 115
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
I++RD+K +NILLD++ +IADFG+ + + + G+ YIAPE K
Sbjct: 116 --GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY 173
Query: 891 DEKIDIYSFGVVLLELLTGRRPL 913
+ +D +SFGV+L E+L G+ P
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G+ G V+K R +VA+K + A+ E E D E+ VL + + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE---DIQQEITVLSQCDSPYVTKYY 68
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIAL---GVAQGLAYLHHD 829
G T + I+ EY+ GS AL +AG + IA + +GL YLH +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGS---ALDLLRAGPF-----DEFQIATMLKEILKGLDYLHSE 120
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLK 889
IHRDIK+ N+LL + ++ADFG+A + + G+ ++APE
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 890 VDEKIDIYSFGVVLLELLTGRRP 912
D K DI+S G+ +EL G P
Sbjct: 178 YDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 67/239 (28%), Positives = 105/239 (43%), Gaps = 58/239 (24%)
Query: 709 ESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG---DFVGEVNVLGKLR- 764
E IG GA G VYKA VA+KK+ + G + E+ +L +L
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKV-----RVPLSEEGIPLSTLREIALLKQLES 57
Query: 765 --HRNIVRLLGFLH-----NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRY---- 813
H NIVRLL H + + +V+E+++ + L ++S+
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD--------------QDLATYLSKCPKPG 103
Query: 814 -------NIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866
++ + +G+ +LH I+HRD+K NIL+ S+ + +IADFGLAR+ +
Sbjct: 104 LPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160
Query: 867 NETVSMVAGSYGYIAPE------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGE 919
S+V + Y APE Y +D++S G + EL RRPL E
Sbjct: 161 MALTSVVVTLW-YRAPEVLLQSSYATP------VDMWSVGCIFAELFR-RRPLFRGTSE 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 77/254 (30%), Positives = 120/254 (47%), Gaps = 25/254 (9%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN--IV 769
V+G G+ G V AE+ AVK L + ++ + V E VL L N +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMV-EKRVLA-LAWENPFLT 59
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
L ++ V E++N G L H + GR + + Y A + GL +LH
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFY--AAEIVCGLQFLHSK 115
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLK 889
II+RD+K +N++LD + +IADFG+ + + + S G+ YIAPE LK
Sbjct: 116 ---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 890 VDEKIDIYSFGVVLLELLTGRRPL----DPEFGES--VDIVEWIRMKIRDNRNLEEAL-- 941
+D +SFGV+L E+L G+ P + E ES VD + R ++++++ E L
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFE 232
Query: 942 -DPN-----VGNCK 949
DP VGN +
Sbjct: 233 RDPTRRLGVVGNIR 246
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 80/265 (30%), Positives = 117/265 (44%), Gaps = 30/265 (11%)
Query: 732 IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN--DTNMMIVYEYMN 789
+VAVK L R T + E+N+L L H NIV+ G + ++ EY+
Sbjct: 35 MVAVKTLKRECGQQNTSG---WKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP 91
Query: 790 NGSLGEAL--HGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLD 847
GSL + L H +LL+ A + +G+AYLH Y IHRD+ + N+LLD
Sbjct: 92 LGSLRDYLPKHKLNLAQLLL-------FAQQICEGMAYLHSQHY---IHRDLAARNVLLD 141
Query: 848 SNLEPRIADFGLARMMIRKNETVSMVAGSYG---YIAPEYGYTLKVDEKIDIYSFGVVLL 904
++ +I DFGLA+ + +E + + A E K D++SFGV L
Sbjct: 142 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLY 201
Query: 905 ELLTGRRP-LDP--EFGESVDIVEWIRMKIRDNRNLEEALD-PNVGNCKHVQEEMLLVLR 960
ELLT P +F E + + +R LE + P NC QE V
Sbjct: 202 ELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCP--QE----VYI 255
Query: 961 IAFLCTAKLPKDRPSMRDVITMLGE 985
+ C K RP+ R +I +L E
Sbjct: 256 LMKNCWETEAKFRPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 20/208 (9%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G V+K +VA+K++ R + E + + EV++L L+H NIV L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ---GLAYLHHD 829
+H + + +V+EY+++ L + L G L+ S +N+ + + Q GL+Y H
Sbjct: 70 DIIHTERCLTLVFEYLDS-DLKQYL--DNCGNLM----SMHNVKIFMFQLLRGLSYCHKR 122
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE--YGYT 887
I+HRD+K N+L++ E ++ADFGLAR +T S + Y P+ G T
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRPLDP 915
+ ID++ G +L E+ TG RP+ P
Sbjct: 180 -EYSTPIDMWGVGCILYEMATG-RPMFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 65/183 (35%), Positives = 93/183 (50%), Gaps = 17/183 (9%)
Query: 732 IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN--DTNMMIVYEYMN 789
+VAVKKL S A E DF E+ +L L+H NIV+ G ++ N+ +V EY+
Sbjct: 35 VVAVKKLQHSTA----EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90
Query: 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN 849
GSL + L Q R +D A + +G+ YL Y +HRD+ + NIL++S
Sbjct: 91 YGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGSKRY---VHRDLATRNILVESE 144
Query: 850 LEPRIADFGLARMMIRKNE--TVSMVAGS--YGYIAPEYGYTLKVDEKIDIYSFGVVLLE 905
+I DFGL +++ + E V S + Y APE K D++SFGVVL E
Sbjct: 145 NRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYE 203
Query: 906 LLT 908
L T
Sbjct: 204 LFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 70/223 (31%), Positives = 110/223 (49%), Gaps = 33/223 (14%)
Query: 713 IGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
+G GA G V+ AE L+ +VAVK L D + DF E +L L+H +
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL----KDPTLAARKDFQREAELLTNLQHEH 68
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEAL--HGKQAGRLLVDWVSR-----------YN 814
IV+ G + +++V+EYM +G L + L HG A +LVD R +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDA-MILVDGQPRQAKGELGLSQMLH 127
Query: 815 IALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA 874
IA +A G+ YL + +HRD+ + N L+ +NL +I DFG++R + + V
Sbjct: 128 IASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD--YYRVG 182
Query: 875 G----SYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP 912
G ++ PE K + D++SFGV+L E+ T G++P
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-17
Identities = 67/203 (33%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK-LRHRNIVR 770
VIG G+ G V A AVK L + +A L+ + + E NVL K ++H +V
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVL-QKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L + V +Y+N G L + Q R ++ +R+ A +A L YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARF-YAAEIASALGYLHS-- 114
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
I++RD+K NILLDS + DFGL + I N T S G+ Y+APE +
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 891 DEKIDIYSFGVVLLELLTGRRPL 913
D +D + G VL E+L G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 69/236 (29%), Positives = 106/236 (44%), Gaps = 39/236 (16%)
Query: 711 NVIGMGATGIVYKAEM---PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
VIG G G VY + AVK L R + E F+ E ++ H N
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT---DLEEVEQFLKEGIIMKDFSHPN 57
Query: 768 IVRLLGF-LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
++ LLG L ++ + ++V YM +G L + + + D + L VA+G+ YL
Sbjct: 58 VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG---FGLQVAKGMEYL 114
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG-----YIA 881
+ +HRD+ + N +LD + ++ADFGLAR + K E S+ + ++A
Sbjct: 115 ASKKF---VHRDLAARNCMLDESFTVKVADFGLARDIYDK-EYYSVHNHTGAKLPVKWMA 170
Query: 882 PEYGYTLKVDEKIDIYSFGVVLLELLT--------------------GRRPLDPEF 917
E T K K D++SFGV+L EL+T GRR L PE+
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEY 226
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 81/307 (26%), Positives = 124/307 (40%), Gaps = 61/307 (19%)
Query: 713 IGMGATGIVYKAEMPRLN----------------TIVAVKKLWRSRADLETESSGDFVGE 756
+G G G V+ E L +VAVK L R D + DF+ E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL---RPDASDNAREDFLKE 69
Query: 757 VNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQA-------GRLLVDW 809
V +L +L NI RLLG D + ++ EYM NG L + L A + +
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 810 VSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869
+ +A +A G+ YL + +HRD+ + N L+ N +IADFG++R
Sbjct: 130 STLLYMATQIASGMRYLESLNF---VHRDLATRNCLVGKNYTIKIADFGMSR-------- 178
Query: 870 VSMVAGSYGYI-----------APEYGYTLKVDEKIDIYSFGVVLLELLT--GRRPLDPE 916
++ + Y + A E K K D+++FGV L E+LT +P +
Sbjct: 179 -NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237
Query: 917 FGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSM 976
+ V I D R + PN K + E ML C + +DRP+
Sbjct: 238 TDQQV-IENAGHFFRDDGRQIYLPRPPNCP--KDIYELML-------ECWRRDEEDRPTF 287
Query: 977 RDVITML 983
R++ L
Sbjct: 288 REIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 76/223 (34%), Positives = 113/223 (50%), Gaps = 35/223 (15%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDF----VGEVNVLGKLRHR 766
N I G G+VY+A + IVA+KKL +E E G F + E+N+L KL+H
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKL-----KMEKEKEG-FPITSLREINILLKLQHP 64
Query: 767 NIVRL----LGFLHNDTNMMIVYEYMNNG--SLGEALHGKQAGRLLVDWVSRYNIALGVA 820
NIV + +G N + +V EY+ + SL E + L V + L +
Sbjct: 65 NIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQ----PFLQSEVK--CLMLQLL 116
Query: 821 QGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM--IRKNETVSMVAGSYG 878
G+A+LH + I+HRD+K++N+LL++ +I DFGLAR K T +V +
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLW 171
Query: 879 YIAPE--YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGE 919
Y APE G + ID++S G + ELLT ++PL P E
Sbjct: 172 YRAPELLLG-AKEYSTAIDMWSVGCIFAELLT-KKPLFPGKSE 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-17
Identities = 76/273 (27%), Positives = 110/273 (40%), Gaps = 32/273 (11%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G G V +M + A KKL + R G V E +L K+ R IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-EKRILAKVHSRFIVSLA 59
Query: 773 GFLHNDTNMMIVYEYMNNGSL-------GEALHGKQAGRLLVDWVSRYNIALGVAQGLAY 825
T++ +V MN G L E G R + GL +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF-------YTAQIISGLEH 112
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYG 885
LH II+RD+K N+LLD++ RI+D GLA + AG+ G++APE
Sbjct: 113 LHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL 169
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945
+ D +D ++ GV L E++ R P GE V+ E + + D+ + P
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGPFRAR-GEKVENKELKQRILNDSVTYPDKFSP-- 226
Query: 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRD 978
K E +L AK P+ R RD
Sbjct: 227 -ASKSFCEALL----------AKDPEKRLGFRD 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 7e-17
Identities = 41/91 (45%), Positives = 58/91 (63%)
Query: 247 LDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEI 306
L L L G IP ++ +L L+ + L N+ +G +P +G+ITSL++LDLSYN + I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 307 PAEITQLKNLQLLNLMCNQLSGHVPAGLGGL 337
P + QL +L++LNL N LSG VPA LGG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 69/223 (30%), Positives = 105/223 (47%), Gaps = 34/223 (15%)
Query: 713 IGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
+G GA G V+ AE L +VAVK L + + DF E +L L+H++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL----KEASESARQDFQREAELLTVLQHQH 68
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEAL--HGKQA-----------GRLLVDWVSRYN 814
IVR G +++V+EYM +G L L HG A G+L + +
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM--LA 126
Query: 815 IALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA 874
IA +A G+ YL + +HRD+ + N L+ L +I DFG++R + + V
Sbjct: 127 IASQIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD--YYRVG 181
Query: 875 GS----YGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP 912
G ++ PE K + DI+SFGVVL E+ T G++P
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 8e-17
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 28/217 (12%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVR 770
++G G G VYK + + A+K + D+ + + E+N+L K HRNI
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVM-----DVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 771 LLG-FLHN-----DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLA 824
G F+ D + +V E+ GS+ + + + L +W++ I + +GL+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLS 125
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY 884
+LH +IHRDIK N+LL N E ++ DFG++ + R + G+ ++APE
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE- 181
Query: 885 GYTLKVDE--------KIDIYSFGVVLLELLTGRRPL 913
+ DE K D++S G+ +E+ G PL
Sbjct: 182 --VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 60/301 (19%)
Query: 707 IRESNVIGMGATGIVYKA-----EMPRLNTIVAVKKLWRSRADLETESSGD---FVGEVN 758
IRE +G G+ G+VY+ T VA+K + E S + F+ E +
Sbjct: 11 IRE---LGQGSFGMVYEGLAKGVVKGEPETRVAIKTV------NENASMRERIEFLNEAS 61
Query: 759 VLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQ------AGRLLVDWVSR 812
V+ + ++VRLLG + ++V E M G L L ++ G
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 813 YNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM 872
+A +A G+AYL + +HRD+ + N ++ +L +I DFG+ R + ET
Sbjct: 122 IQMAAEIADGMAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRDI---YETDYY 175
Query: 873 VAGSYG-----YIAPEYGYTLK---VDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDI 923
G G ++APE +LK K D++SFGVVL E+ T +P E V
Sbjct: 176 RKGGKGLLPVRWMAPE---SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-- 230
Query: 924 VEWIRMK-IRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982
+K + D +L+ P NC +++L ++R +C PK RP+ ++++
Sbjct: 231 -----LKFVIDGGHLDL---PE--NC---PDKLLELMR---MCWQYNPKMRPTFLEIVSS 274
Query: 983 L 983
L
Sbjct: 275 L 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 69/228 (30%), Positives = 96/228 (42%), Gaps = 32/228 (14%)
Query: 705 ACIRESNVIGMGATGIVYKAE---MPRLNT--IVAVKKLWRSRADLETESSGDFVGEVNV 759
I +G GA G VY+ VAVK L + ES DF+ E +
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDES--DFLMEALI 62
Query: 760 LGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL-----HGKQAGRL-LVDWVSRY 813
+ K H+NIVRL+G I+ E M G L L ++ L + D +
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL--- 119
Query: 814 NIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPR---IADFGLARMM-----IR 865
A VA+G YL + + IHRDI + N LL R IADFG+AR + R
Sbjct: 120 FCARDVAKGCKYLEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176
Query: 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP 912
K + ++ PE K D++SFGV+L E+ + G P
Sbjct: 177 KGGRAML---PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 43/219 (19%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR--NIVR 770
IG G G VYK + ++AVK++ R+ E + + +++V+ K H IV+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLK-SHDCPYIVK 78
Query: 771 LLGFLHNDTNMMIVYEYMN----------NGSLGEALHGKQAGRLLVDWVSRYNIALGVA 820
G+ D+++ I E M+ G + E + GK + + +
Sbjct: 79 CYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGK--------------MTVAIV 124
Query: 821 QGLAYL--HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA-RMMIRKNETVSMVAGSY 877
+ L YL H +IHRD+K +NILLD++ ++ DFG++ R++ K +T S AG
Sbjct: 125 KALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS--AGCA 178
Query: 878 GYIAPEY----GYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y+APE K D + D++S G+ L+EL TG+ P
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV-GEVNVLGKLRHRNIVRL 771
IG GA+G VY A VA+K++ +L+ + + + E+ V+ + +H NIV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM-----NLQQQPKKELIINEILVMRENKHPNIVNY 81
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
L + +V EY+ GSL + + + V R Q L +LH +
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLHSN-- 134
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGL-ARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
+IHRDIKS+NILL + ++ DFG A++ +++ +MV Y ++APE
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEVVTRKAY 192
Query: 891 DEKIDIYSFGVVLLELLTGRRP 912
K+DI+S G++ +E++ G P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 62/231 (26%), Positives = 94/231 (40%), Gaps = 8/231 (3%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G G V ++ + A KKL + R E +L K+ R IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN-EKKILEKVSSRFIVSLA 59
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
++ +V MN G L H G A + GL +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDL--KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--- 114
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDE 892
I++RD+K N+LLD + RI+D GLA + + + AG+ GY+APE D
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 893 KIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943
+D ++ G L E++ GR P + E V+ E R + + P
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFR-QRKEKVEKEELKRRTLEMAVEYPDKFSP 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 74/266 (27%), Positives = 122/266 (45%), Gaps = 39/266 (14%)
Query: 723 KAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782
K E+P VA+ L RA + F+ E LG+ H NIVRL G + MM
Sbjct: 31 KRELP-----VAIHTL---RAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82
Query: 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSN 842
IV EYM+NG+L L K G+L+ + + G+A G+ YL Y +H+ + ++
Sbjct: 83 IVTEYMSNGALDSFLR-KHEGQLVAGQL--MGMLPGLASGMKYLSEMGY---VHKGLAAH 136
Query: 843 NILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG---YIAPEYGYTLKVDEKIDIYSF 899
+L++S+L +I+ F R+ K+E + + APE D++SF
Sbjct: 137 KVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSF 194
Query: 900 GVVLLELLT-GRRPLDPEFGESVDIVEWIRMK-IRDNRNLEEALDPNVGNCKHVQEEMLL 957
G+V+ E+++ G RP G+ V +K + D L P NC ++ +++L
Sbjct: 195 GIVMWEVMSYGERPYWDMSGQDV-------IKAVEDGFRL-----PAPRNCPNLLHQLML 242
Query: 958 VLRIAFLCTAKLPKDRPSMRDVITML 983
C K +RP + ++L
Sbjct: 243 D------CWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
V+G G+ G + + A+K++ ++ E S E +L K++H NIV
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAF 63
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL-----LVDWVSRYNIALGVAQGLAYL 826
D ++ IV EY + G L + + Q G+L ++ W + + LGV
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIK-LQRGKLFPEDTILQWFVQ--MCLGV------- 113
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGY 886
H ++HRDIKS NI L N + ++ DFG AR++ G+ Y+ PE
Sbjct: 114 QHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWE 173
Query: 887 TLKVDEKIDIYSFGVVLLELLTGRRPL 913
+ + K DI+S G +L EL T + P
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 62/227 (27%), Positives = 110/227 (48%), Gaps = 30/227 (13%)
Query: 698 FTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEV 757
FT+ D+ ++ IG GA G V K TI+AVK R R+ ++ + + ++
Sbjct: 1 FTAEDL----KDLGEIGRGAFGTVNKMLHKPSGTIMAVK---RIRSTVDEKEQKRLLMDL 53
Query: 758 NVLGKLRH-RNIVRLLGFLHNDTNMMIVYEYMNNG--SLGEALHGKQAGRLLVDWVSRYN 814
+V+ + IV+ G L + + I E M+ + ++ + + + +
Sbjct: 54 DVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK-- 111
Query: 815 IALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV--SM 872
IA+ + L YL + IIHRD+K +NILLD N ++ DFG++ ++ +++ +
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTR 166
Query: 873 VAGSYGYIAPEY-------GYTLKVDEKIDIYSFGVVLLELLTGRRP 912
AG Y+APE GY D + D++S G+ L E+ TG+ P
Sbjct: 167 DAGCRPYMAPERIDPSARDGY----DVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 22/215 (10%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G VYK + +VA+K++ R + E + + EV++L L+H NIV L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ---GLAYLHHD 829
+H + ++ +V+EY++ L + L G ++ +N+ L + Q GL Y H
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNS----INMHNVKLFLFQLLRGLNYCHRR 123
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE--YGYT 887
++HRD+K N+L++ E ++ADFGLAR +T S + Y P+ G T
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVD 922
+ID++ G + E+ TG RPL P G +V+
Sbjct: 181 -DYSTQIDMWGVGCIFYEMSTG-RPLFP--GSTVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 68/202 (33%), Positives = 95/202 (47%), Gaps = 9/202 (4%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK-LRHRNIVR 770
VIG G+ G V A+ AVK L + A L+ + + E NVL K ++H +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKK-AILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L + V +Y+N G L L Q R + +R+ A +A L YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHL---QRERSFPEPRARF-YAAEIASALGYLHS-- 114
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
II+RD+K NILLDS + DFGL + I ++T S G+ Y+APE
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 891 DEKIDIYSFGVVLLELLTGRRP 912
D +D + G VL E+L G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 16/202 (7%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV-GEVNVLGKLRHRNIVRL 771
IG G+TGIV A VAVKK+ DL + + + EV ++ H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM-----DLRKQQRRELLFNEVVIMRDYHHENVVDM 84
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEAL-HGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
+ +V E++ G+L + + H + + + L V + L+YLH+
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA------TVCLSVLRALSYLHNQ- 137
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
+IHRDIKS++ILL S+ +++DFG + ++ + G+ ++APE L
Sbjct: 138 --GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY 195
Query: 891 DEKIDIYSFGVVLLELLTGRRP 912
++DI+S G++++E++ G P
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 59/290 (20%)
Query: 713 IGMGATGIVYKA--EMPRLNTI-VAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIV 769
+G G G V K M + VAVK L + + +F+ E +V+ +L H IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTL---KQEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
RL+G + +M+V E G L + L ++ + +A VA G+AYL
Sbjct: 60 RLIGVCKGEP-LMLVMELAPLGPLLKYLKKRRE----IPVSDLKELAHQVAMGMAYLESK 114
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGY---------- 879
+ +HRD+ + N+LL + + +I+DFG++R ++ AGS Y
Sbjct: 115 HF---VHRDLAARNVLLVNRHQAKISDFGMSR---------ALGAGSDYYRATTAGRWPL 162
Query: 880 --IAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGE--SVDIVEWIRMKIRDN 934
APE K K D++S+GV L E + G +P +GE +++ + R
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP----YGEMKGAEVIAMLESGERLP 218
Query: 935 RNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
R P C + + ML C P+DRP+ ++ +
Sbjct: 219 R-------PE--ECPQEIYSIML-------SCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-16
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV-GEVNVLGKLRHRNIVRL 771
IG GA+G V+ A VA+K++ +L+ + + + E+ V+ +L++ NIV
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI-----NLQKQPKKELIINEILVMKELKNPNIVNF 81
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
L + +V EY+ GSL + + + V R + Q L +LH +
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN-- 134
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVD 891
+IHRDIKS+N+LL + ++ DFG + + S + G+ ++APE
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 892 EKIDIYSFGVVLLELLTGRRP 912
K+DI+S G++ +E++ G P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766
I+ ++G G G VYKA I+AVK + D+ E + E+ +L K
Sbjct: 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVI---PLDITVELQKQIMSELEILYKCDSP 59
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
I+ G + + I E+M+ GSL ++ K +L IA+ V +GL YL
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLD--VYRKIPEHVL------GRIAVAVVKGLTYL 111
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGY 886
I+HRD+K +N+L+++ + ++ DFG++ ++ N G+ Y+APE
Sbjct: 112 WS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERIS 166
Query: 887 TLKVDEKIDIYSFGVVLLELLTGRRP 912
+ D++S G+ +EL GR P
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-16
Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 34/196 (17%)
Query: 732 IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNG 791
+VAVK L RAD+ + DF+ E+ ++ +L++ NI+RLLG +D + ++ EYM NG
Sbjct: 46 LVAVKML---RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENG 102
Query: 792 SLGEALHGKQAGRLL-----VDWVSRYNI---ALGVAQGLAYLHHDCYPPIIHRDIKSNN 843
L + L ++ + VS N+ A+ +A G+ YL + +HRD+ + N
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF---VHRDLATRN 159
Query: 844 ILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY-----------GYIAPEYGYTLKVDE 892
L+ ++ +IADFG++R ++ +G Y ++A E K
Sbjct: 160 CLVGNHYTIKIADFGMSR---------NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTT 210
Query: 893 KIDIYSFGVVLLELLT 908
D+++FGV L E+ T
Sbjct: 211 ASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 66/240 (27%), Positives = 120/240 (50%), Gaps = 26/240 (10%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV-GEVNVLGKLRHRNIVRL 771
IG G+TGIV A + +VAVKK+ DL + + + EV ++ +H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEM 82
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
+ +V E++ G+L + + R+ + ++ + L V + L+ LH
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIA--AVCLAVLKALSVLHAQ-- 135
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVD 891
+IHRDIKS++ILL + +++DFG + ++ + G+ ++APE L
Sbjct: 136 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 892 EKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHV 951
++DI+S G++++E++ G P F E ++ ++M IRDN L P + N V
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPY---FNEPP--LKAMKM-IRDN------LPPKLKNLHKV 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 48/133 (36%), Positives = 71/133 (53%), Gaps = 7/133 (5%)
Query: 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNN 843
V EY+N G L H +Q G+ Y A +A GL +LH II+RD+K +N
Sbjct: 79 VMEYVNGGDL--MYHIQQVGKFKEPHAVFY--AAEIAIGLFFLHSK---GIIYRDLKLDN 131
Query: 844 ILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVL 903
++LD+ +IADFG+ + I +T G+ YIAPE + +D ++FGV+L
Sbjct: 132 VMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191
Query: 904 LELLTGRRPLDPE 916
E+L G+ P D E
Sbjct: 192 YEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-16
Identities = 65/223 (29%), Positives = 109/223 (48%), Gaps = 19/223 (8%)
Query: 694 QRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRS-RADLETESSGD 752
Q + T ++ R+ +G GA G V A R VA+KKL+R +++L + +
Sbjct: 4 QEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRA-- 61
Query: 753 FVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLL-VDWVS 811
E+ +L ++H N++ LL D ++ + ++ L G G+L+ + +S
Sbjct: 62 -YRELRLLKHMKHENVIGLLDVFTPDLSL----DRFHDFYLVMPFMGTDLGKLMKHEKLS 116
Query: 812 RYNIALGVAQ---GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE 868
I V Q GL Y+H IIHRD+K N+ ++ + E +I DFGLAR +E
Sbjct: 117 EDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQT--DSE 171
Query: 869 TVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGR 910
V + Y APE + + +DI+S G ++ E+LTG+
Sbjct: 172 MTGYVVTRW-YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-16
Identities = 62/218 (28%), Positives = 115/218 (52%), Gaps = 23/218 (10%)
Query: 707 IRESNVIGMGATGIVYKA-EMPRLNTI---VAVKKLWRSRADLETESSGDFVGEVNVLGK 762
++ V+G GA G VYK +P T+ VA+K L + +++ +F+ E ++
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG---PKANVEFMDEALIMAS 65
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQ---AGRLLVDWVSRYNIALGV 819
+ H ++VRLLG + T + +V + M +G L + +H + +LL++W + +
Sbjct: 66 MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQI 118
Query: 820 AQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY-- 877
A+G+ YL ++HRD+ + N+L+ S +I DFGLAR++ + + G
Sbjct: 119 AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 175
Query: 878 GYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLD 914
++A E + K + D++S+GV + EL+T G +P D
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 5e-16
Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 20/214 (9%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G V+K +VA+K++ R + E + + EV++L L+H NIV L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ---GLAYLHHD 829
+H D ++ +V+EY++ KQ + +S +N+ + + Q GLAY H
Sbjct: 71 DIVHTDKSLTLVFEYLDKDL-------KQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGY-TL 888
++HRD+K N+L++ E ++ADFGLAR +T S + Y P+ +
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS 180
Query: 889 KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVD 922
+ +ID++ G + E+ +G RPL P G +V+
Sbjct: 181 EYSTQIDMWGVGCIFFEMASG-RPLFP--GSTVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 32/219 (14%)
Query: 713 IGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHR 766
+G GA G V KAE L+ + VAVK L + + D V E+ ++ + +H+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS---DLVSEMEMMKMIGKHK 76
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQ---------AGRLLVDWVSRYNI-- 815
NI+ LLG + + +V EY +G+L + L ++ R + +++ ++
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 816 -ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM-----IRKNET 869
A VA+G+ +L IHRD+ + N+L+ + +IADFGLAR + RK
Sbjct: 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT 908
+ ++APE + + D++SFGV+L E+ T
Sbjct: 194 GRL---PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G G VYK +A+K++ R +L+ + E+++L K IV
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI---RLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
G + + + EYM+ GSL + G A + + V R I V +GL +L +
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR-ITYAVVKGLKFLKEE--H 122
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY-------- 884
IIHRD+K N+L++ N + ++ DFG++ ++ ++ G Y+APE
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI--GCQSYMAPERIKSGGPNQ 180
Query: 885 --GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESV 921
YT++ D++S G+ +LE+ GR P PE ++
Sbjct: 181 NPTYTVQS----DVWSLGLSILEMALGRYPYPPETYANI 215
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-16
Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRL 771
IG G G VYK + ++ AVK L D ++ + E N+L L H N+V+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKIL-----DPISDVDEEIEAEYNILQSLPNHPNVVKF 84
Query: 772 LGFLHNDTN-----MMIVYEYMNNGSLGEALHGK-QAGRLLVDWVSRYNIALGVAQGLAY 825
G + + +V E N GS+ E + G G+ L + + Y I G GL +
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY-ILYGALLGLQH 143
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM----IRKNETVSMVAGSYGYIA 881
LH++ IIHRD+K NNILL + ++ DFG++ + +R+N +V G+ ++A
Sbjct: 144 LHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV----GTPFWMA 196
Query: 882 PEY-----GYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
PE Y D + D++S G+ +EL G PL
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-16
Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 23/203 (11%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G GA G VYKA+ + +A K+ ++++ E E D++ E+ +L H IV+LL
Sbjct: 20 LGDGAFGKVYKAK-NKETGALAAAKVIETKSEEELE---DYMVEIEILATCNHPYIVKLL 75
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEAL----HGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
G + D + I+ E+ G++ + G ++ V I + + L YLH
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------ICRQMLEALQYLHS 128
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGY-- 886
IIHRD+K+ N+LL + + ++ADFG++ ++ + G+ ++APE
Sbjct: 129 M---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 887 TLK---VDEKIDIYSFGVVLLEL 906
T+K D K DI+S G+ L+E+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 7e-16
Identities = 78/282 (27%), Positives = 124/282 (43%), Gaps = 53/282 (18%)
Query: 732 IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNG 791
+VAVK L R D + DF+ EV +L +L+ NI+RLLG ++ + ++ EYM NG
Sbjct: 48 LVAVKIL---RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENG 104
Query: 792 SLGEALHGK--------------QAGRLLV-DWVSRYNIALGVAQGLAYLHHDCYPPIIH 836
L + L A L + S ++AL +A G+ YL + +H
Sbjct: 105 DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF---VH 161
Query: 837 RDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY-----------GYIAPEYG 885
RD+ + N L+ NL +IADFG++R ++ AG Y ++A E
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMSR---------NLYAGDYYRIQGRAVLPIRWMAWECI 212
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVD--IVEWIRMKIRDNRNLEEALDP 943
K D+++FGV L E+L + + +GE D ++E RD P
Sbjct: 213 LMGKFTTASDVWAFGVTLWEILMLCK--EQPYGELTDEQVIENAGEFFRDQGRQVYLFRP 270
Query: 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985
C E++L C ++ ++RPS D+ L E
Sbjct: 271 PP--CPQGLYELMLQ------CWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 9e-16
Identities = 40/121 (33%), Positives = 60/121 (49%), Gaps = 1/121 (0%)
Query: 452 DDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVL 511
D + + + LR +P+ I + +LQ+ +S N++ G IP SL VL
Sbjct: 412 DSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL 471
Query: 512 DLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTL-AILDLSNNSLTGGI 570
DLS N F+GSIP S+ L LNL N L+G +P A+ A + ++N+ GI
Sbjct: 472 DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGI 531
Query: 571 P 571
P
Sbjct: 532 P 532
|
Length = 623 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 71/282 (25%), Positives = 129/282 (45%), Gaps = 24/282 (8%)
Query: 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADL-ETESSGDFVGEVNVLGK 762
LA R IG G VY+A VA+KK+ DL + ++ D + E+++L +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKV--QIFDLMDAKARADCIKEIDLLKQ 58
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL-HGKQAGRLLVD-WVSRYNIALGVA 820
L H N+++ D + IV E + G L + H K+ RL+ + V +Y + L A
Sbjct: 59 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 821 QGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI 880
L ++H ++HRDIK N+ + + ++ D GL R K + G+ Y+
Sbjct: 119 --LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 881 APEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940
+PE + + K DI+S G +L E+ + P +G+ +++ + +E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLYSLC-------KKIEQC 223
Query: 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982
P + + H EE+ ++ +C P+ RP + V +
Sbjct: 224 DYPPLPS-DHYSEEL---RQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G +VYKA +VA+KK+ + ++ ++ D + E+++L +L H N+++ L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEAL-HGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
+ + IV E + G L + H K+ RL+ + + + + L ++H
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLI-PERTIWKYFVQLCSALEHMHSK-- 125
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKN-ETVSMVAGSYGYIAPEY----GY 886
I+HRDIK N+ + + ++ D GL R K S+V Y Y++PE GY
Sbjct: 126 -RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSPERIHENGY 183
Query: 887 TLKVDEKIDIYSFGVVLLELLTGRRP 912
+ K DI+S G +L E+ + P
Sbjct: 184 ----NFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-15
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN---IV 769
IG G G VY+ I A+K L + + E + +GE N+L + IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHT-IGERNILVRTLLDESPFIV 59
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-H 828
L D+++ +V +YM+ G L H ++ GR D Y L +A L +LH +
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLA--LEHLHKY 115
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY---- 884
D I++RD+K NILLD+ + DFGL++ + N+T + G+ Y+APE
Sbjct: 116 D----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 885 -GYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
GYT + +D +S GV++ E+ G P
Sbjct: 172 KGYT----KHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV-GEVNVLGKL-RHRNIV 769
VIG G+ V + + I A+K + + + + D+V E +V + H +V
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVV--KKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
L ++ + V EY+N G L H ++ +L + Y+ + +A L YLH
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--LNYLHER 115
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE------ 883
II+RD+K +N+LLDS ++ D+G+ + +R +T S G+ YIAPE
Sbjct: 116 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLTGRRPLD 914
YG++ +D ++ GV++ E++ GR P D
Sbjct: 173 YGFS------VDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-15
Identities = 43/101 (42%), Positives = 63/101 (62%), Gaps = 2/101 (1%)
Query: 295 LDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPL 354
L L L IP +I++L++LQ +NL N + G++P LG +T LEVL+L NS +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 355 PVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFN 395
P LG+ + L+ L+L+ NS SG +PA+L GG L FN
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL--GGRLLHRASFN 521
|
Length = 623 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG-EVNVLGKLRHR 766
R ++G GA G VY +AVK++ ET + + E+ +L LRH
Sbjct: 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 767 NIVRLLGFL--HNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLA 824
IV+ G L + + I EYM GS+ + L K G L + RY + QG++
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQ--ILQGVS 120
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM-------VAGSY 877
YLH + I+HRDIK NIL DS ++ DFG ++ + +T+ M V G+
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI----QTICMSGTGIKSVTGTP 173
Query: 878 GYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
+++PE K D++S ++E+LT + P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G GA G VYKA+ + ++A K+ ++++ E E D++ E+++L H NIV+LL
Sbjct: 13 LGDGAFGKVYKAQ-NKETGVLAAAKVIDTKSEEELE---DYMVEIDILASCDHPNIVKLL 68
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
+ + N+ I+ E+ G++ + + R L + R + + L YLH +
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVM--LELERPLTEPQIRV-VCKQTLEALNYLHEN--- 122
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY-----GYT 887
IIHRD+K+ NIL + + ++ADFG++ R + G+ ++APE
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 888 LKVDEKIDIYSFGVVLLEL 906
D K D++S G+ L+E+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 69/276 (25%), Positives = 121/276 (43%), Gaps = 49/276 (17%)
Query: 732 IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNG 791
+VAVK L R D + DF+ E+ ++ +L+ NI+RLL + ++ EYM NG
Sbjct: 48 LVAVKML---REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENG 104
Query: 792 SLGEAL-------HGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNI 844
L + L ++A + + + + +A +A G+ YL + +HRD+ + N
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF---VHRDLATRNC 161
Query: 845 LLDSNLEPRIADFGLARMMIRKNETVSMVAGSY-----------GYIAPEYGYTLKVDEK 893
L+ N +IADFG++R + G Y +++ E K
Sbjct: 162 LVGKNYTIKIADFGMSRNLYS---------GDYYRIQGRAVLPIRWMSWESILLGKFTTA 212
Query: 894 IDIYSFGVVLLELLT--GRRPLDPEFGESV--DIVEWIRMKIRDNRNLEEALDPNVGNCK 949
D+++FGV L E+LT +P E V + E+ R + R + AL P+
Sbjct: 213 SDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPD----- 267
Query: 950 HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985
+ ++ C + K+RPS +++ L E
Sbjct: 268 -------SLYKLMLSCWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 68/221 (30%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 713 IGMGATGIVYKAEMPRLN-TIVAVKKLWRSRADLETESSGDF--VGEVNVLGKLRHRNIV 769
+G G+ VYK + R+N +VA+K + ++TE F + E ++L L+H NIV
Sbjct: 13 LGEGSYATVYKG-ISRINGQLVALKVI-----SMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ---GLAYL 826
L +H + V+EYM+ L + + G + YN+ L + Q GLAY+
Sbjct: 67 LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGG------LHPYNVRLFMFQLLRGLAYI 119
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE--Y 884
H I+HRD+K N+L+ E ++ADFGLAR ++T S + Y P+
Sbjct: 120 HGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL 176
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVE 925
G T +DI+ G + +E+L G+ P F D+ E
Sbjct: 177 GAT-DYSSALDIWGAGCIFIEMLQGQ----PAFPGVSDVFE 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 713 IGMGATGIVYKAEM--PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
IG G G VYKA+ + A+KK + + T S E+ +L +L+H N+V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 771 LLGFLHNDTNMMI--VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
L+ + + +++Y + +QA R+ + ++ + G+ YLH
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPR----IADFGLARM---MIRKNETVSMVAGSYGYIA 881
+ ++HRD+K NIL+ R I D GLAR+ ++ + V + Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRA 183
Query: 882 PE--YG---YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEF-GESVDI 923
PE G YT + IDI++ G + ELLT L+P F G I
Sbjct: 184 PELLLGARHYT----KAIDIWAIGCIFAELLT----LEPIFKGREAKI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 65/228 (28%), Positives = 96/228 (42%), Gaps = 49/228 (21%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG---EVNVLGKLRHRNIV 769
+G G G VYKA + +VA+KK+ + E G + E+ +L KL+H N+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKIL-----MHNEKDGFPITALREIKILKKLKHPNVV 70
Query: 770 RLL----------GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGV 819
L+ M V YM++ G L + +L + L +
Sbjct: 71 PLIDMAVERPDKSKRKRGSVYM--VTPYMDHDLSG--LLENPSVKLTESQIK--CYMLQL 124
Query: 820 AQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG- 878
+G+ YLH + I+HRDIK+ NIL+D+ +IADFGLAR G G
Sbjct: 125 LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR-PYDGPPPNPKGGGGGGT 180
Query: 879 -----------YIAPEYGYTLKVDEK-----IDIYSFGVVLLELLTGR 910
Y PE L + E+ +DI+ G V E+ T R
Sbjct: 181 RKYTNLVVTRWYRPPE----LLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 11/207 (5%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLG-KLRHRNIVR 770
V+G G+ G V AE+ + + A+K L + L+ + + E +L +H +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVL-KKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-HD 829
L + V EY+N G L + Q R + SR+ A V L +LH H
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRHG 116
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLK 889
+I+RD+K +NILLD+ ++ADFG+ + I T + G+ YIAPE L+
Sbjct: 117 ----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 890 VDEKIDIYSFGVVLLELLTGRRPLDPE 916
+D ++ GV++ E++ G+ P + +
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFEAD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 4e-15
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG----EVNVLGKL 763
R ++G GA G VY +A K++ + D E+ + V E+ +L L
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQV---QFDPESPETSKEVSALECEIQLLKNL 61
Query: 764 RHRNIVRLLGFL--HNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ 821
+H IV+ G L + + I EYM GS+ + L A L + V+R + +
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA---LTESVTR-KYTRQILE 117
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM-------VA 874
G++YLH + I+HRDIK NIL DS ++ DFG ++ + +T+ M V
Sbjct: 118 GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL----QTICMSGTGIRSVT 170
Query: 875 GSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
G+ +++PE K D++S G ++E+LT + P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 47/231 (20%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDF--VGEVNVLGKLRHRNIV 769
+G G+ VYK +VA+K++ LE E F + E ++L L+H NIV
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI-----RLEHEEGAPFTAIREASLLKDLKHANIV 66
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ---GLAYL 826
L +H + +V+EY++ L + + G L S +N+ L + Q GLAY
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDT-DLKQYM--DDCGGGL----SMHNVRLFLFQLLRGLAYC 119
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR-----MMIRKNETVSM-------VA 874
H ++HRD+K N+L+ E ++ADFGLAR NE V++ +
Sbjct: 120 HQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLL 176
Query: 875 GSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVE 925
GS Y +D++ G + E+ TGR P F S D+ +
Sbjct: 177 GSTEYSTS-----------LDMWGVGCIFYEMATGR----PLFPGSTDVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 5e-15
Identities = 70/217 (32%), Positives = 110/217 (50%), Gaps = 33/217 (15%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKL---WRSRAD-LETESSGDFVGEVNVLGKLRHRNI 768
IG GA GIV A+ N VA+KK+ + +R D T + E+ +L L H N+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT------LREIKLLRHLDHENV 66
Query: 769 VRLLGFL---HNDT--NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGL 823
+ + + H + ++ IVYE M+ L + + Q L D +Y + + +GL
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQT---LSDDHCQYFL-YQLLRGL 121
Query: 824 AYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE 883
Y+H ++HRD+K +N+LL++N + +I DFGLAR K + ++ + Y APE
Sbjct: 122 KYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 884 Y-----GYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
YT ID++S G + ELL GR+PL P
Sbjct: 179 LLLNCSEYT----TAIDVWSVGCIFAELL-GRKPLFP 210
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 6e-15
Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 713 IGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
+G GA G V+ AE L +VAVK L D + DF E +L L+H +
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTL----KDASDNARKDFHREAELLTNLQHEH 68
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEAL--HGKQAGRLL-------VDWVSRYNIALG 818
IV+ G +++V+EYM +G L + L HG A + + +IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG--- 875
+A G+ YL + +HRD+ + N L+ NL +I DFG++R + + V G
Sbjct: 129 IAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD--YYRVGGHTM 183
Query: 876 -SYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP 912
++ PE K + D++S GVVL E+ T G++P
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 78/301 (25%), Positives = 136/301 (45%), Gaps = 45/301 (14%)
Query: 704 LACIRESNVIGMGATGIVYKAEM--PRLN--TIVAVKKLWRSRADLET-ESSGDFVGEVN 758
L+ +R +G A G +YK + P ++ +VA+K L D+ + G+F E +
Sbjct: 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL----KDINNPQQWGEFQQEAS 59
Query: 759 VLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL-----------HGKQAG--RL 805
++ +L H NIV LLG + + + +++EY+N G L E L + G +
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 806 LVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865
+D +IA+ +A G+ YL + +H+D+ + NIL+ L +I+D GL+R +
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 866 KN--ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES-VD 922
+ ++ PE K DI+SFGVVL E+ + L P +G S +
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS--FGLQPYYGFSNQE 234
Query: 923 IVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982
++E +R + L P +C ++ C + P RP +D+ T
Sbjct: 235 VIEMVRKR---------QLLPCSEDCPPRMYSLMTE------CWQEGPSRRPRFKDIHTR 279
Query: 983 L 983
L
Sbjct: 280 L 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-15
Identities = 40/103 (38%), Positives = 60/103 (58%)
Query: 175 LDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEI 234
L L +G IP L+ L+ + LSGN++ G IP LG ++S+E + L+YN F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 235 PVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNN 277
P G LT+L+ L+L +L G++PA LG L F + +N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 9e-15
Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 36/221 (16%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLW---RSRADLETESSGDFVGEVNVLGKLRHRN 767
+ IG GA G+V A VA+KK+ T + E+ +L + +H N
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT------LREIKILRRFKHEN 64
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLL-VDWVSRYNIALGVAQ---GL 823
I+ +L + + +E N+ + + L +L+ +S +I + Q GL
Sbjct: 65 IIGILDIIRPPS-----FESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGL 119
Query: 824 AYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM----VAGSYGY 879
Y+H ++HRD+K +N+LL++N + +I DFGLAR+ +++ VA + Y
Sbjct: 120 KYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW-Y 175
Query: 880 IAPEY-----GYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
APE GYT + IDI+S G +L E+L+ RPL P
Sbjct: 176 RAPEIMLNSKGYT----KAIDIWSVGCILAEMLSN-RPLFP 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 67/233 (28%), Positives = 98/233 (42%), Gaps = 40/233 (17%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG----------EVNVL 760
+G G G V KA IVA+KK+ + VG E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 761 GKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVA 820
+++H NI+ L+ + +V + M L + + K RL V I L +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVK--CILLQIL 129
Query: 821 QGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR----------------MMI 864
GL LH Y +HRD+ NI ++S +IADFGLAR M
Sbjct: 130 NGLNVLH-KWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 865 RKNETVSMVAGSYGYIAPE--YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
R+ T +V + Y APE G K +D++S G + ELLTG +PL P
Sbjct: 187 REEMTSKVV--TLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTG-KPLFP 235
|
Length = 335 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 21/215 (9%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG-EVNVLGKLRHR 766
R ++G GA G VY +AVK++ ET + + E+ +L L H
Sbjct: 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 767 NIVRLLGFLHN--DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLA 824
IV+ G L + + + I E+M GS+ + L K G L + +Y + +G++
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKY--TRQILEGVS 120
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM-------VAGSY 877
YLH + I+HRDIK NIL DS ++ DFG ++ + +T+ + V G+
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL----QTICLSGTGMKSVTGTP 173
Query: 878 GYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
+++PE K DI+S G ++E+LT + P
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 9/203 (4%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK-LRHRNIVR 770
VIG G+ G V A+ AVK L + + L + + E NVL K ++H +V
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVL-QKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L + V +++N G L L Q R + +R+ A +A L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHL---QRERSFPEPRARFYAA-EIASALGYLHS-- 114
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
I++RD+K NILLDS + DFGL + I +++T + G+ Y+APE
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 891 DEKIDIYSFGVVLLELLTGRRPL 913
D +D + G VL E+L G P
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 9/206 (4%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVR 770
V+G G+ G V AE + + A+K L + + + V E VL + + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMV-EKRVLALQDKPPFLTQ 65
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L + V EY+N G L H +Q G+ Y A ++ GL +LH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFY--AAEISVGLFFLHRR- 120
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
II+RD+K +N++LDS +IADFG+ + + T G+ YIAPE
Sbjct: 121 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY 178
Query: 891 DEKIDIYSFGVVLLELLTGRRPLDPE 916
+ +D +++GV+L E+L G+ P D E
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 74/285 (25%), Positives = 131/285 (45%), Gaps = 41/285 (14%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVR 770
V+ A GI + P VAVK L + D + D V E+ ++ + +H+NI+
Sbjct: 28 VVMAEAIGI--DKDKPNKPVTVAVKML---KDDATDKDLSDLVSEMEMMKMIGKHKNIIN 82
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQ---------AGRLLVDWVSRYNI---ALG 818
LLG D + ++ EY + G+L E L ++ +L + ++ ++ A
Sbjct: 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQ 142
Query: 819 VAQGLAYL-HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY 877
VA+G+ YL C IHRD+ + N+L+ + +IADFGLAR + + G
Sbjct: 143 VARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198
Query: 878 --GYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR 935
++APE + + D++SFGV+L E+ T L + + E ++ +R
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT----LGGSPYPGIPVEELFKLLKEGHR 254
Query: 936 NLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
+ A NC H E+ +++R C +P RP+ + ++
Sbjct: 255 MDKPA------NCTH---ELYMIMR---ECWHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 53/159 (33%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 756 EVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL-----LVDWV 810
EV VL ++H NIV+ + N+ IV +Y G L + ++ Q G L ++DW
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINA-QRGVLFPEDQILDWF 107
Query: 811 SRYNIALGVAQGLAYLH-HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869
V LA H HD I+HRDIKS NI L + ++ DFG+AR++ E
Sbjct: 108 --------VQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157
Query: 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT 908
G+ Y++PE + K DI++ G VL E+ T
Sbjct: 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 58/211 (27%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV-GEVNVLGKL-RHRNIV 769
VIG G+ V E+ + I A+K + + + + D+V E +V H +V
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVI--KKELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
L ++ + V E+++ G L H ++ +L + Y+ + +A L +LH
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLA--LNFLHER 115
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE------ 883
II+RD+K +N+LLD+ ++ D+G+ + IR +T S G+ YIAPE
Sbjct: 116 ---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLTGRRPLD 914
YG++ +D ++ GV++ E++ GR P D
Sbjct: 173 YGFS------VDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 63/235 (26%), Positives = 94/235 (40%), Gaps = 45/235 (19%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
VIG GA G V+ + A+K L R ++ E ++L IV+L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
++ ++ +V EYM G L L K + R+ IA V L +H +
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETA-RFYIAELVL-ALDSVHKLGF 122
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM------------------- 872
IHRDIK +NIL+D++ ++ADFGL + M + +
Sbjct: 123 ---IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 873 ----------VAGSYGYIAPE----YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
G+ YIAPE Y L+ D +S GV+L E+L G P
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC----DWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 47/136 (34%), Positives = 70/136 (51%), Gaps = 7/136 (5%)
Query: 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIK 840
+ V EY+N G L +Q GR Y A +A GL +LH II+RD+K
Sbjct: 76 LYFVMEYVNGGDL--MYQIQQVGRFKEPHAVFY--AAEIAIGLFFLHSK---GIIYRDLK 128
Query: 841 SNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFG 900
+N++LDS +IADFG+ + + T G+ YIAPE + +D ++FG
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFG 188
Query: 901 VVLLELLTGRRPLDPE 916
V+L E+L G+ P + E
Sbjct: 189 VLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G VY+A VA+KK+ + ++ ++ D V E+++L +L H N+++ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKV-QIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEAL-HGKQAGRLLVD-WVSRYNIALGVAQGLAYLHHDC 830
D + IV E + G L + + + K+ RL+ + V +Y + L A + ++H
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VEHMHSR- 125
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
++HRDIK N+ + + ++ D GL R K + G+ Y++PE +
Sbjct: 126 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 891 DEKIDIYSFGVVLLELLTGRRPL 913
+ K DI+S G +L E+ + P
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 74/292 (25%), Positives = 134/292 (45%), Gaps = 48/292 (16%)
Query: 713 IGMGATGIVYKAEM-------PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-R 764
+G G G V AE P T VAVK L ++D + D + E+ ++ + +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML---KSDATEKDLSDLISEMEMMKMIGK 82
Query: 765 HRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL------------LVDWVSR 812
H+NI+ LLG D + ++ EY + G+L E L ++ + + +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 813 YNIALGVAQGLAYL-HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVS 871
+ A VA+G+ YL C IHRD+ + N+L+ + +IADFGLAR + +
Sbjct: 143 VSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 872 MVAGSY--GYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIR 928
G ++APE + + D++SFGV+L E+ T G P V + E +
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-----PGVPVEELFK 253
Query: 929 MKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
+ +++ +++ NC + E+ +++R C +P RP+ + ++
Sbjct: 254 L-LKEGHRMDKP-----SNCTN---ELYMMMRD---CWHAVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV-GEVNVLGKLRHRNIVRL 771
IG GA+G VY A VA+K++ +L+ + + + E+ V+ + ++ NIV
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM-----NLQQQPKKELIINEILVMRENKNPNIVNY 81
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
L + +V EY+ GSL + + + V R + Q L +LH +
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN-- 134
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVD 891
+IHRDIKS+NILL + ++ DFG + + S + G+ ++APE
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 892 EKIDIYSFGVVLLELLTGRRP 912
K+DI+S G++ +E++ G P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-14
Identities = 48/148 (32%), Positives = 73/148 (49%), Gaps = 12/148 (8%)
Query: 29 KTALNDELLALLSIKAGLVDPLNSLHDWK----LPSAHCNWTGVWC-----NSNGAVEKL 79
L +E+ AL ++K+ L PL W +P H W+G C ++ L
Sbjct: 367 SKTLLEEVSALQTLKSSLGLPLR--FGWNGDPCVPQQH-PWSGADCQFDSTKGKWFIDGL 423
Query: 80 DLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFP 139
L + L G + + +L+ L S+NL N + ++P SL ++TSL+ D+S N NGS P
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 140 AGLGGAAGLTFLNASGNNFSGFLLEDLG 167
LG L LN +GN+ SG + LG
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 3e-14
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV-GEVNVLGKLRHRNIVRL 771
IG GA+G VY A VA++++ +L+ + + + E+ V+ + ++ NIV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-----NLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
L + +V EY+ GSL + + + V R + Q L +LH +
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN-- 135
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVD 891
+IHRDIKS+NILL + ++ DFG + + S + G+ ++APE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 892 EKIDIYSFGVVLLELLTGRRP 912
K+DI+S G++ +E++ G P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-14
Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
+V L + + +V EY+N G L H ++ +L + Y + +A L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIA--LNFLH 113
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE---- 883
II+RD+K +N+LLD++ ++ D+G+ + + +T S G+ YIAPE
Sbjct: 114 ER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170
Query: 884 --YGYTLKVDEKIDIYSFGVVLLELLTGRRPLD 914
YG++ +D ++ GV++ E++ GR P D
Sbjct: 171 EEYGFS------VDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV-GEVNVLGKLRHRNIVRL 771
IG G+TGIV A VAVK + DL + + + EV ++ +H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM-----DLRKQQRRELLFNEVVIMRDYQHQNVVEM 83
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
+ ++ E++ G+L + + RL + ++ + V Q L YLH
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTDIV---SQTRLNEEQIA--TVCESVLQALCYLHSQ-- 136
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVD 891
+IHRDIKS++ILL + +++DFG + + + G+ ++APE
Sbjct: 137 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 892 EKIDIYSFGVVLLELLTGRRP 912
++DI+S G++++E++ G P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG---DFVGEVNVLGKLR---HR 766
IG+GA G VYKA P VA+K + ++T G V EV +L +L H
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV-----RVQTNEDGLPLSTVREVALLKRLEAFDHP 62
Query: 767 NIVRLLGF-----LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ 821
NIVRL+ +T + +V+E+++ L L L + + ++ +
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIK--DLMRQFLR 119
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIA 881
GL +LH +C I+HRD+K NIL+ S + ++ADFGLAR+ ++ V + Y A
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY-SCQMALTPVVVTLWYRA 175
Query: 882 PEYGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
PE +D++S G + E+ R+PL
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 5e-14
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVR 770
V+G G+ G V A + + AVK L + L+ + + E +L R H + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVL-KKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L + V E++N G L H +++ R Y A + L +LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFY--AAEITSALMFLHDK- 115
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
II+RD+K +N+LLD ++ADFG+ + I +T S G+ YIAPE +
Sbjct: 116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 891 DEKIDIYSFGVVLLELLTGRRPLDPE 916
+D ++ GV+L E+L G P + E
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 6e-14
Identities = 70/213 (32%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG GA G+V+ PR VA+KK+ +L S E+ +L +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV--SCKRVFRELKMLCFFKHDNVLSAL 65
Query: 773 GFLHND-----TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVS--RYNIALGVAQGLAY 825
L + +V E M + L + + Q L D V Y I +GL Y
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQ--PLSSDHVKVFLYQIL----RGLKY 118
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM---VAGSYGYIAP 882
LH I+HRDIK N+L++SN +I DFGLAR+ +E+ M V Y Y AP
Sbjct: 119 LHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVE-EPDESKHMTQEVVTQY-YRAP 173
Query: 883 EY-----GYTLKVDEKIDIYSFGVVLLELLTGR 910
E YT +DI+S G + ELL R
Sbjct: 174 EILMGSRHYT----SAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-14
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 19/221 (8%)
Query: 695 RLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV 754
++ ++ +L ++ IG GA GIV A L VAVKKL R + +T + +
Sbjct: 11 QVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAY- 68
Query: 755 GEVNVLGKLRHRNIVRLLGF------LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVD 808
E+ +L + H+NI+ LL L ++ +V E M+ +L + +H + +D
Sbjct: 69 RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIH------MELD 121
Query: 809 WVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE 868
+ + G+ +LH IIHRD+K +NI++ S+ +I DFGLAR
Sbjct: 122 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM 178
Query: 869 TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTG 909
V Y Y APE + E +DI+S G ++ EL+ G
Sbjct: 179 MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 20/232 (8%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G G+ G V A+ A+K L + R L+ + E ++L +L H IV
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCL-KKREILKMKQVQHVAQEKSILMELSHPFIVN 82
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
++ ++ + + E++ G L H ++AGR D Y+ L +A YLH
Sbjct: 83 MMCSFQDENRVYFLLEFVVGGELFT--HLRKAGRFPNDVAKFYHAELVLA--FEYLHSK- 137
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
II+RD+K N+LLD+ ++ DFG A+ + + + G+ Y+APE +
Sbjct: 138 --DIIYRDLKPENLLLDNKGHVKVTDFGFAK---KVPDRTFTLCGTPEYLAPEVIQSKGH 192
Query: 891 DEKIDIYSFGVVLLELLTGRRPL--DPEFGESVDIVE-------WIRMKIRD 933
+ +D ++ GV+L E + G P D F I+ W + RD
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARD 244
|
Length = 329 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 55/193 (28%), Positives = 88/193 (45%), Gaps = 16/193 (8%)
Query: 722 YKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND--T 779
Y E VAVK L + + D E+ +L L H NIV+ G D
Sbjct: 25 YDPEGDNTGEQVAVKSL---KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81
Query: 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDI 839
+ ++ E++ +GSL E L + ++ + A+ + +G+ YL Y +HRD+
Sbjct: 82 GIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLGSRQY---VHRDL 135
Query: 840 KSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG----YIAPEYGYTLKVDEKID 895
+ N+L++S + +I DFGL + I ++ V + APE K D
Sbjct: 136 AARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASD 194
Query: 896 IYSFGVVLLELLT 908
++SFGV L ELLT
Sbjct: 195 VWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 12/230 (5%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG--EVNVLGKLRHRNIVR 770
+G G G V ++ + A KKL + R + SG+ + E +L K+ IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL---KKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L + T++ +V MN G L H G ++ + + + G+ +LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDL--KYHIYNVGERGLEMERVIHYSAQITCGILHLHS-- 113
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
I++RD+K N+LLD R++D GLA + ++ +T++ AG+ GY+APE
Sbjct: 114 -MDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 891 DEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940
+D ++ G + E++ GR P + E V E R + D E
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFK-DHKEKVAKEELKRRTLEDEVKFEHQ 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 75/292 (25%), Positives = 132/292 (45%), Gaps = 48/292 (16%)
Query: 713 IGMGATGIVYKAEM-------PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-R 764
+G G G V AE P+ VAVK L + D + D V E+ ++ + +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGK 79
Query: 765 HRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDW-VSRY---------- 813
H+NI+ LLG D + ++ EY + G+L E L ++ + + ++R
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 814 -NIALGVAQGLAYL-HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVS 871
+ VA+G+ YL C IHRD+ + N+L+ N +IADFGLAR + +
Sbjct: 140 VSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 872 MVAGSY--GYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIR 928
G ++APE + + D++SFGV++ E+ T G P + + E +
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-----PGIPVEELFK 250
Query: 929 MKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
+ +R + A NC + E+ +++R C +P RP+ + ++
Sbjct: 251 LLKEGHRMDKPA------NCTN---ELYMMMRD---CWHAIPSHRPTFKQLV 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 69/221 (31%), Positives = 105/221 (47%), Gaps = 27/221 (12%)
Query: 711 NVIGMGATGIVYKAEMPRLNTI------VAVKKLWRSRADLETESSGDFVGEVNVLGKLR 764
N +G GA G VY+ + VAVK L + D E + +F+ E +++
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK---EFLKEAHLMSNFN 57
Query: 765 HRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL---LVDWVSRYNIALGVAQ 821
H NIV+LLG + I+ E M G L L + R L+ +I L VA+
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILL-----DSNLEPRIADFGLARMMIRKNETVSMVAGS 876
G YL + IHRD+ + N L+ D++ +I DFGLAR I K++ G
Sbjct: 118 GCVYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYR-KEGE 172
Query: 877 ----YGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP 912
++APE K + D++SFGV++ E+LT G++P
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 712 VIGMGATGIVYKAEM---PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNI 768
V+G G G V++ I A+K L ++ + + E N+L ++H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
V L+ + ++ EY++ G L +H ++ G + D Y + +A L +LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLA--LEHLHQ 118
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTL 888
II+RD+K NILLD+ ++ DFGL + I + G+ Y+APE
Sbjct: 119 Q---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS 175
Query: 889 KVDEKIDIYSFGVVLLELLTGRRPLDPE 916
+ +D +S G ++ ++LTG P E
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-13
Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G GA G V A RL VAVKKL R L + E+ +L ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLI--HARRTYRELRLLKHMKHENVIGLL 80
Query: 773 GFLHNDTNMMIVYE-YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
T++ E Y+ +G L+ + L D ++ I + +GL Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLI-YQLLRGLKYIHS--- 136
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYT-LKV 890
IIHRD+K +N+ ++ + E RI DFGLAR +E VA + Y APE +
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLARQA--DDEMTGYVATRW-YRAPEIMLNWMHY 193
Query: 891 DEKIDIYSFGVVLLELLTGR 910
++ +DI+S G ++ ELL G+
Sbjct: 194 NQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 16/225 (7%)
Query: 712 VIGMGATGIVY---KAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNI 768
V+G GA G V+ K + A+K L ++ + +++ E VL +R
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 769 VRLLGF-LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
+ L + DT + ++ +Y+N G L H Q R V Y+ + +A L +LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGEIVLA--LEHLH 122
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR-KNETVSMVAGSYGYIAPEY-- 884
II+RDIK NILLDSN + DFGL++ + E G+ Y+AP+
Sbjct: 123 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRP--LDPEFGESVDIVEWI 927
G D+ +D +S GV++ ELLTG P +D E +I I
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI 224
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 71/295 (24%), Positives = 128/295 (43%), Gaps = 42/295 (14%)
Query: 707 IRESNVIGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVLG 761
++E +G G G V+ A+ + T+V VK L + D +S +F E+++
Sbjct: 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL-QKTKDENLQS--EFRRELDMFR 63
Query: 762 KLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDW-----VSRYNIA 816
KL H+N+VRLLG ++ EY + G L + L ++ + + +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 817 LGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK-----NETVS 871
+A G+ +L + + +HRD+ + N L+ S E +++ L++ + +
Sbjct: 124 TQIALGMDHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180
Query: 872 MVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMK 930
+ ++APE K D++SFGV++ E+ T G P E V + ++
Sbjct: 181 PLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV--LNRLQAG 234
Query: 931 IRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985
LE L G + + M C A PKDRPS ++++ LGE
Sbjct: 235 -----KLE--LPVPEGCPSRLYKLMT-------RCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 7/206 (3%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
R+ V+G G G V ++ + A KKL + R + + + E +L K+ R
Sbjct: 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRF 61
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
+V L + +V MN G L H G + A + GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDL--KFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYT 887
+ I++RD+K NILLD + RI+D GLA + + + +T+ G+ GY+APE
Sbjct: 120 QE---RIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVKN 175
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRPL 913
+ D ++ G +L E++ G+ P
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV---GEVNVLGKLRHRNIV 769
+G G G VYKA + AVK + + E DF E+ ++ + +H NIV
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKII-------KLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALH-GKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
G + + I EY GSL + H L + +V R + QGLAYLH
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHS 124
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTL 888
+HRDIK NILL N + ++ADFG+A + G+ ++APE
Sbjct: 125 KGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 889 K---VDEKIDIYSFGVVLLELLTGRRPL 913
K ++ DI++ G+ +EL + P+
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 38/225 (16%)
Query: 707 IRESNVIGMGATGIVYKAEMPR----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
I+ +VIG G G V +A + + +N + + K + S D DF GE+ VL K
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR-----DFAGELEVLCK 58
Query: 763 L-RHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL---------------HGKQAGRLL 806
L H NI+ LLG N + I EY G+L + L HG A L
Sbjct: 59 LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGT-ASTLT 117
Query: 807 VDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR---MM 863
+ ++ A VA G+ YL + IHRD+ + N+L+ NL +IADFGL+R +
Sbjct: 118 SQQLLQF--ASDVATGMQYLSEKQF---IHRDLAARNVLVGENLASKIADFGLSRGEEVY 172
Query: 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT 908
++K +M ++A E K D++SFGV+L E+++
Sbjct: 173 VKK----TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 57/299 (19%)
Query: 712 VIGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766
+G G G V KA RL T VAVK L + + E D + E N+L ++ H
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR---DLLSEFNLLKQVNHP 63
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALH--------------GKQAGRLLVDWVSR 812
++++L G D ++++ EY GSL L + + L
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 813 YNI------ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866
+ A +++G+ YL ++HRD+ + N+L+ + +I+DFGL+R + +
Sbjct: 124 LTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 867 NETVSMVAGS--YGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP---LDPEFGES 920
+ V G ++A E + + D++SFGV+L E++T G P + PE
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---- 236
Query: 921 VDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDV 979
+ ++ R R P NC EEM + C + P RP+ D+
Sbjct: 237 -RLFNLLKTGYRMER-------PE--NC---SEEM---YNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 4e-13
Identities = 77/298 (25%), Positives = 135/298 (45%), Gaps = 54/298 (18%)
Query: 713 IGMGATGIVYKAEM-------PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-R 764
+G G G V +AE P VAVK L + D + D + E+ ++ + +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD---KDLADLISEMELMKLIGK 76
Query: 765 HRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQA--------------GRL-LVDW 809
H+NI+ LLG + + ++ EY G+L E L ++ +L D
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 810 VSRYNIALGVAQGLAYLH-HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM--IRK 866
VS A VA+G+ YL C IHRD+ + N+L+ + +IADFGLAR + I
Sbjct: 137 VS---CAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY 189
Query: 867 NETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVE 925
+ S ++APE + + D++SFG+++ E+ T G P + + E
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY-----PGIPVEE 244
Query: 926 WIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
++ +R+ +++ NC H E+ +++R C +P RP+ + ++ L
Sbjct: 245 LFKL-LREGHRMDKP-----SNCTH---ELYMLMR---ECWHAVPTQRPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRA-DLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G G G V+ A+K + L+ E E VL ++ H I+RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH--VHNEKRVLKEVSHPFIIRL 66
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
H+ + ++ EY+ G L L + +GR + + A + L YLH
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRF-SNSTGLF-YASEIVCALEYLHSK-- 120
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVD 891
I++RD+K NILLD ++ DFG A+ + + T + G+ Y+APE + +
Sbjct: 121 -EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT---LCGTPEYLAPEVIQSKGHN 176
Query: 892 EKIDIYSFGVVLLELLTGRRP 912
+ +D ++ G+++ E+L G P
Sbjct: 177 KAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
V+G GA G+V K IVA+KK S + E + + + E+ +L L+ NIV L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETT--LRELKMLRTLKQENIVEL 65
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
+ +V+EY+ L E L G + + V Y L + + + H +
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNML-ELLEEMPNG-VPPEKVRSYIYQL--IKAIHWCHKN-- 119
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLK 889
I+HRDIK N+L+ N ++ DFG AR + + VA + Y +PE
Sbjct: 120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRSPELLLGAP 177
Query: 890 VDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
+ +D++S G +L EL G +PL P GES
Sbjct: 178 YGKAVDMWSVGCILGELSDG-QPLFP--GES 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-13
Identities = 34/89 (38%), Positives = 53/89 (59%)
Query: 199 LGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKI 258
LGL L G IP ++ +L ++++ L+ N G IP G++T+L+ LDL+ + G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 259 PAELGRLELLEIMFLYQNNFQGRLPAEIG 287
P LG+L L I+ L N+ GR+PA +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 42/229 (18%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG---DFVGEVNVLGKLRHRN-I 768
IG G G VYKA +VA+KK LE + G + E+++L L I
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK-----TRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 769 VRLLGFLHNDTN-----MMIVYEYMNNGSLGEAL--HGKQAGRLLVDWVSRYNIALGVAQ 821
VRLL H + + +V+EY+++ L + + +G+ GR L + + + +
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPL-PAKTIKSFMYQLLK 121
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEP-RIADFGLARMMIRKNETVSMVAGSYG-- 878
G+A+ H ++HRD+K N+L+D +IAD GL R S+ SY
Sbjct: 122 GVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR-------AFSIPVKSYTHE 171
Query: 879 -----YIAPE--YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
Y APE G T +DI+S G + E+ ++PL P G+S
Sbjct: 172 IVTLWYRAPEVLLGST-HYSTPVDIWSVGCIFAEMSR-KQPLFP--GDS 216
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWR----SRADLETESSGDFVGEVNVLGKLRHRN 767
V+G G G V AE + + A+K L + +R ++E+ + E RH
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFET--ANSERHPF 63
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSR---YNIALGVAQGLA 824
+V L + ++ V EY G L +H R Y A V GL
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSE------PRAVFY--AACVVLGLQ 115
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY 884
YLH + I++RD+K +N+LLD+ +IADFGL + + + S G+ ++APE
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRP 912
+D + GV++ E+L G P
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-13
Identities = 87/312 (27%), Positives = 144/312 (46%), Gaps = 54/312 (17%)
Query: 707 IRESNVIGMGATGIVYKAEMPR--LNTIVAVKKL--WRSRADLETESSGDFVGEVNVLGK 762
I+ +VIG G G V KA + + L A+K++ + S+ D DF GE+ VL K
Sbjct: 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-----DFAGELEVLCK 63
Query: 763 L-RHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQ----------AGRLLVDWVS 811
L H NI+ LLG + + + EY +G+L + L + A S
Sbjct: 64 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 812 RYNIALG--VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR---MMIRK 866
+ + VA+G+ YL + IHRD+ + NIL+ N +IADFGL+R + ++K
Sbjct: 124 QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 180
Query: 867 NETVSMVAGSYGYIAPE-YGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGES-VDI 923
+M ++A E Y++ D++S+GV+L E+++ G P G + ++
Sbjct: 181 ----TMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTPY---CGMTCAEL 232
Query: 924 VEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
E + R LE+ L NC +E+ ++R C + P +RPS ++ L
Sbjct: 233 YEKLPQGYR----LEKPL-----NC---DDEVYDLMR---QCWREKPYERPSFAQILVSL 277
Query: 984 GEAKPRRKSSSN 995
RK+ N
Sbjct: 278 NRMLEERKTYVN 289
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 706 CIRESNVIGMGATGIVYKA-EMPRLNTIVAVKKLWRSRADLETESSG---DFVGEVNVLG 761
C+ E IG GA G V+KA ++ VA+K R ++T G + EV VL
Sbjct: 5 CVAE---IGEGAYGKVFKARDLKNGGRFVALK-----RVRVQTGEEGMPLSTIREVAVLR 56
Query: 762 KLR---HRNIVRLLGF-----LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRY 813
L H N+VRL +T + +V+E+++ + G V +
Sbjct: 57 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIK 113
Query: 814 NIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMV 873
++ + +GL +LH ++HRD+K NIL+ S+ + ++ADFGLAR+ + S+V
Sbjct: 114 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 170
Query: 874 AGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
+ Y APE +D++S G + E+ R+PL
Sbjct: 171 VTLW-YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-12
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G GA G V A + VAVKKL SR + E+ +L ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 773 GFLHNDTNMMIVYE-YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
++ + Y+ +G L+ + L D ++ I + +GL Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS--- 138
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYT-LKV 890
IIHRD+K +N+ ++ + E +I DFGLAR +E VA + Y APE +
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW-YRAPEIMLNWMHY 195
Query: 891 DEKIDIYSFGVVLLELLTGR 910
++ +DI+S G ++ ELLTGR
Sbjct: 196 NQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 27/203 (13%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G G V+ + NT VAVK R L + F+ E +L + H NIVRL+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKS---CRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
G + IV E + G L + RL V + + + A G+ YL
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLR-TEGPRLKVKELIQ--MVENAAAGMEYLESKH-- 114
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG-------YIAPE-- 883
IHRD+ + N L+ +I+DFG++R E + A + G + APE
Sbjct: 115 -CIHRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 884 -YGYTLKVDEKIDIYSFGVVLLE 905
YG + + D++SFG++L E
Sbjct: 169 NYG---RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
IG GA GIV A VA+KKL SR + E+ ++ + H+NI+ L
Sbjct: 23 PIGSGAQGIVCAAYDTVTGQNVAIKKL--SRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80
Query: 772 LGFLHNDTNM------MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAY 825
L ++ +V E M+ +L + + + +D + + G+ +
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ------MDLDHERMSYLLYQMLCGIKH 133
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM---VAGSYGYIAP 882
LH IIHRD+K +NI++ S+ +I DFGLAR + M V Y Y AP
Sbjct: 134 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRY-YRAP 186
Query: 883 EYGYTLKVDEKIDIYSFGVVLLELLTGR 910
E + E +DI+S G ++ E++ G
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
++G G G V+K + T VAVK + DL E F+ E +L + H NIV+L
Sbjct: 2 LLGKGNFGEVFKGTLKD-KTPVAVKT---CKEDLPQELKIKFLSEARILKQYDHPNIVKL 57
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-HDC 830
+G + IV E + G L K+ L + ++ AL A G+AYL +C
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKF--ALDAAAGMAYLESKNC 114
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG----SYGYIAPE--- 883
IHRD+ + N L+ N +I+DFG++R ++++ + +G + APE
Sbjct: 115 ----IHRDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALN 167
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLT 908
YG + + D++S+G++L E +
Sbjct: 168 YG---RYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 712 VIGMGATGIVY---KAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN- 767
V+G GA G V+ K + A+K L ++ + +++ E VL +R
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
+V L DT + ++ +Y+N G L L+ Q V Y + +A L +LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLY--QREHFTESEVRVYIAEIVLA--LDHLH 122
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKN-ETVSMVAGSYGYIAPEY-- 884
II+RDIK NILLDS + DFGL++ + + E G+ Y+APE
Sbjct: 123 Q---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRP 912
G + D+ +D +S GV+ ELLTG P
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 55/218 (25%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 707 IRESNVIGMGATGIVYKA-EMPRLNTI---VAVKKL--WRSRADLETESSGDFVGEVNVL 760
+R+ ++G G G V+K +P ++I VA+K + R ++ + + +
Sbjct: 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR-----QTFQEITDHMLAM 63
Query: 761 GKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALH---GKQAGRLLVDWVSRYNIAL 817
G L H IVRLLG + ++ +V + GSL + + + L++W +
Sbjct: 64 GSLDHAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CV 116
Query: 818 GVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI--RKNETVSMVAG 875
+A+G+ YL ++HR++ + NILL S+ +IADFG+A ++ K S
Sbjct: 117 QIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 876 SYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP 912
++A E + + D++S+GV + E+++ G P
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-12
Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 22/222 (9%)
Query: 717 ATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLH 776
ATG Y ++ R I+A ++ A TES VL RH + L
Sbjct: 18 ATGRYYAMKILRKEVIIAKDEV----AHTVTES--------RVLQNTRHPFLTALKYAFQ 65
Query: 777 NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIH 836
+ V EY N G L L + R+ + +R+ A + L YLH +++
Sbjct: 66 THDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGA-EIVSALEYLHSR---DVVY 118
Query: 837 RDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDI 896
RDIK N++LD + +I DFGL + I T+ G+ Y+APE +D
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 897 YSFGVVLLELLTGRRPLDPEFGESVDIVEWIRM-KIRDNRNL 937
+ GVV+ E++ GR P + E + E I M +IR R L
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHER--LFELILMEEIRFPRTL 218
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-12
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G+ VYK + +VA+K + R E + + E ++L L+H NIV L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLKHANIVLLH 69
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
+H + +V+EY++ L + + K G L + V + L +GL+Y+H
Sbjct: 70 DIIHTKETLTLVFEYVHT-DLCQYMD-KHPGGLHPENVKLFLFQL--LRGLSYIHQRY-- 123
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE--YGYTLKV 890
I+HRD+K N+L+ E ++ADFGLAR + T S + Y P+ G T +
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST-EY 181
Query: 891 DEKIDIYSFGVVLLELLTG 909
+D++ G + +E++ G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 38/221 (17%)
Query: 711 NVIGMGATGIVYKAEMPR----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RH 765
+VIG G G V KA + + ++ + K + S+ D DF GE+ VL KL H
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-----DFAGELEVLCKLGHH 55
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL---------------HGKQAGRLLVDWV 810
NI+ LLG + + + EY +G+L + L + A L +
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST-ASTLSSQQL 114
Query: 811 SRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR---MMIRKN 867
+ A VA+G+ YL + IHRD+ + NIL+ N +IADFGL+R + ++K
Sbjct: 115 LHF--AADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK- 168
Query: 868 ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT 908
+M ++A E D++S+GV+L E+++
Sbjct: 169 ---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 71/213 (33%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKL--WRSRADLETESSGDFVGEVNVLGKLRHRNIV 769
VIG GA G V +M I A+K L W ET F E NVL + I
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETAC---FREERNVLVNGDCQWIT 64
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
L ++ + +V +Y G L L K RL D ++R+ IA V + +H
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGGDL-LTLLSKFEDRLPED-MARFYIAEMVL-AIHSIHQL 121
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA-GSYGYIAPEYGYTL 888
Y +HRDIK +N+LLD N R+ADFG M + S VA G+ YI+PE +
Sbjct: 122 HY---VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 889 -----KVDEKIDIYSFGVVLLELLTGRRPLDPE 916
K + D +S GV + E+L G P E
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 5e-12
Identities = 66/214 (30%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKL--WRSRADLETESSGDFVGEVNVLGKLRHRNIV 769
VIG GA G V ++ + + A+K L W ET F E +VL ++ I
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC---FREERDVLVNGDNQWIT 64
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVA-QGLAYLHH 828
L ++ N+ +V +Y G L L K RL D Y + +A + LH+
Sbjct: 65 TLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY 123
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA-GSYGYIAPEYGYT 887
+HRDIK +NIL+D N R+ADFG ++ S VA G+ YI+PE
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 888 L-----KVDEKIDIYSFGVVLLELLTGRRPLDPE 916
+ K + D +S GV + E+L G P E
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-12
Identities = 62/219 (28%), Positives = 91/219 (41%), Gaps = 32/219 (14%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETES-SGDFVGEVNVLGKLRHR 766
VIG GA G V + A+K L S+ ++ S S F E +++
Sbjct: 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLL--SKFEMIKRSDSAFFWEERDIMAHANSE 103
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNI--------ALG 818
IV+L +D + +V EYM G L V+ +S Y+I
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDL-------------VNLMSNYDIPEKWARFYTAE 150
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA-GSY 877
V L +H + IHRD+K +N+LLD + ++ADFG M A G+
Sbjct: 151 VVLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTP 207
Query: 878 GYIAPEYGYTLKVD----EKIDIYSFGVVLLELLTGRRP 912
YI+PE + D + D +S GV L E+L G P
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 68/278 (24%), Positives = 117/278 (42%), Gaps = 41/278 (14%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG---EVNVLGKLRHRNI 768
V+G G+ G V +KKL +L S + E +L +L+H NI
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKL-----NLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 769 VRLL-GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLL-----VDWVSRYNIALGVAQG 822
V + D + IV + G L L +Q G+LL V+W + +A
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLK-EQKGKLLPENQVVEWF------VQIAMA 114
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAP 882
L YLH I+HRD+K+ N+ L ++ D G+AR++ + + S + G+ Y++P
Sbjct: 115 LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSP 171
Query: 883 EYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942
E + K D+++ G + E+ T + + + M R +E L
Sbjct: 172 ELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----------DMNSLVYRIIEGKLP 220
Query: 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
P K E+ ++ L K P+ RPS++ ++
Sbjct: 221 PMP---KDYSPELGELIA-TMLS--KRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 38/216 (17%)
Query: 716 GATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV---GEVNVLGKLRHRNIVRLL 772
+ K + NT+VAVKK+ +L++ S D E+ +L+H NI+ +
Sbjct: 13 LMIVHLAKHK--PTNTLVAVKKI-----NLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIAL---GVAQGLAYLHHD 829
D+ + +V M GS + L + + IA V L Y+H
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLK-----THFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI-------AP 882
+ IHR +K+++ILL + + ++ + MI+ + +V +P
Sbjct: 121 GF---IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 883 E------YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
E GY +EK DIYS G+ EL G P
Sbjct: 178 EVLQQNLQGY----NEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 712 VIGMGATGIVYKA-----EMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766
IG G G VY+ E ++ VAVK + F+ E ++ + H
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIA--VAVKT---CKNCTSPSVREKFLQEAYIMRQFDHP 67
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
+IV+L+G + + + IV E G L L Q + +D S + ++ LAYL
Sbjct: 68 HIVKLIGVI-TENPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYL 123
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG-----YIA 881
+ +HRDI + N+L+ S ++ DFGL+R + E S S G ++A
Sbjct: 124 ESKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYL----EDESYYKASKGKLPIKWMA 176
Query: 882 PEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP 912
PE + D++ FGV + E+L G +P
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 28/207 (13%)
Query: 709 ESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADL-ETESSGDFVGEVNVLGKL-RHR 766
E+ G+ + V K VAVK L + A E E+ + E+ ++ L H
Sbjct: 53 EATAYGLSKSDAVMK---------VAVKML-KPTAHSSEREA---LMSELKIMSHLGNHE 99
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
NIV LLG ++++ EY G L L K+ + + + VA+G+A+L
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFL 157
Query: 827 -HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS----YGYIA 881
+C IHRD+ + N+LL +I DFGLAR + N++ +V G+ ++A
Sbjct: 158 ASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDI--MNDSNYVVKGNARLPVKWMA 211
Query: 882 PEYGYTLKVDEKIDIYSFGVVLLELLT 908
PE + + D++S+G++L E+ +
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 15/218 (6%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G G V+ A+ IVA+K++ +S E + E ++L + +V+LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVR-HVLTERDILTTTKSEWLVKLL 67
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
+D + + EY+ G L+ +L + +R+ +A + LH Y
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFE-AVDALHELGY- 122
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDE 892
IHRD+K N L+D++ ++ DFGL++ ++ + V GS Y+APE D
Sbjct: 123 --IHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANSVVGSPDYMAPEVLRGKGYDF 177
Query: 893 KIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMK 930
+D +S G +L E L G P G + + W +K
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFS---GSTPNET-WENLK 211
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 18/206 (8%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG-EVNVLGKLRHRNIVRL 771
IG G G VYKA + A+K + LE V E+ ++ +H NIV
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI-----KLEPGEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALH-GKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
G + I E+ GSL + H + +VSR + QGL YLH
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKG 126
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLK- 889
+HRDIK NILL N ++ADFG++ + G+ ++APE +
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 890 --VDEKIDIYSFGVVLLELLTGRRPL 913
++ DI++ G+ +EL + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 51/158 (32%), Positives = 77/158 (48%), Gaps = 18/158 (11%)
Query: 756 EVNVLGKLRHRNIVRLLG-FLHNDTNMMIVYEYMNNGSLGEALHG-KQAGRLL-----VD 808
E +L KL H IV+ FL D I+ EY L L K G+ L +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERD-AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCE 110
Query: 809 WVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE 868
W + + LGV Y+H I+HRD+K+ NI L +NL +I DFG++R+++ +
Sbjct: 111 WFIQ--LLLGVH----YMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD 160
Query: 869 TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLEL 906
+ G+ Y++PE D K DI+S G +L E+
Sbjct: 161 LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 71/266 (26%), Positives = 110/266 (41%), Gaps = 21/266 (7%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
R V+G G G V ++ + A KKL + R + + + E +L K+ R
Sbjct: 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRF 61
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
+V L + +V MN G L H G D A + GL L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDL--KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYT 887
+ I++RD+K NILLD RI+D GLA + I + ETV G+ GY+APE
Sbjct: 120 RE---RIVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETVRGRVGTVGYMAPEVINN 175
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGN 947
K D + G ++ E++ G+ P F + + V+ + R + EE + +
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSP----FRKRKERVKREEVDRRVKEDQEEYSEKFSED 231
Query: 948 CKHVQEEMLLVLRIAFLCTAKLPKDR 973
K + +L K PK+R
Sbjct: 232 AKSICRMLL----------TKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 7/205 (3%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
R V+G G G V ++ + A KKL + R + + + E +L K+ R
Sbjct: 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRF 61
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
+V L + +V MN G L ++ + Y A + GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY--AAEITCGLEDLH 119
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYT 887
+ I++RD+K NILLD RI+D GLA + I + ET+ G+ GY+APE
Sbjct: 120 RE---RIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKN 175
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRP 912
+ D + G ++ E++ G+ P
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGD-FVGEVNVLGKLRHRNIVR 770
VIG G+ G+V A VA+KK+ E S + E+ +L LRH +IV
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLRHPDIVE 63
Query: 771 LLGFL-----HNDTNMMIVYEYMNNGSLGEALHGK-QAGRLLVDWVSRYNIAL-GVAQGL 823
+ + ++ +V+E M LH +A L + L + + L
Sbjct: 64 IKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTP--EHHQFFLYQLLRAL 116
Query: 824 AYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET----VSMVAGSYGY 879
Y+H + HRD+K NIL +++ + +I DFGLAR+ T VA + Y
Sbjct: 117 KYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW-Y 172
Query: 880 IAPEY--GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESV 921
APE + K IDI+S G + E+LTG +PL P G++V
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFP--GKNV 213
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 24/166 (14%)
Query: 765 HRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLA 824
+ N ++L + +++ +Y+ +G L + L K+ G+L V I + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAEVK--KIIRQLVEALN 123
Query: 825 YLH-HDCYPPIIHRDIKSNNILLDSNLEP-RIADFGLARMMIRKNETVSMVAGSYGYIAP 882
LH H+ IIH DIK N+L D + + D+GL +++ T S G+ Y +P
Sbjct: 124 DLHKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKII----GTPSCYDGTLDYFSP 175
Query: 883 EYGYTLKV-----DEKIDIYSFGVVLLELLTGRRPLDPEFGESVDI 923
E K+ D D ++ GV+ ELLTG+ P + E +D+
Sbjct: 176 E-----KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216
|
Length = 267 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 70/219 (31%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKL--WRSRADLETESSGDFVGEVNVLGKLRHRNIV 769
VIG GA G V +M + A+K L W ET F E +VL R I
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC---FREERDVLVNGDRRWIT 64
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
L ++ N+ +V +Y G L L K RL D ++R+ +A V + +H
Sbjct: 65 NLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPED-MARFYLAEMVL-AIDSVHQL 121
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA-GSYGYIAPE----- 883
Y +HRDIK +N+LLD N R+ADFG ++ S VA G+ YI+PE
Sbjct: 122 GY---VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 884 ------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPE 916
YG + D +S GV + E+L G P E
Sbjct: 179 EDGKGRYG------PECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 60/213 (28%), Positives = 89/213 (41%), Gaps = 19/213 (8%)
Query: 713 IGMGATGIVYKAEMPRL--NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
IG G G V E R V VK+L RA + F+ EV +L H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKEL---RASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQ-AGRLLVDWVSRYNIALGVAQGLAYLHHD 829
LG ++V E+ G L L + + +A VA GL +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKN--ETVSMVAGSYGYIAPE---- 883
+ IH D+ N L ++L +I D+GLA ++ T A ++APE
Sbjct: 120 DF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 884 YGYTLKV---DEKIDIYSFGVVLLELLT-GRRP 912
G L +K +I+S GV + EL T +P
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 7/206 (3%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
R+ V+G G G V ++ + A K+L + R + + + E +L K+ +
Sbjct: 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQF 61
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
+V L + +V MN G L H G + A + GL LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDL--KFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYT 887
+ ++RD+K NILLD RI+D GLA + I + E++ G+ GY+APE
Sbjct: 120 RE---NTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVGYMAPEVLNN 175
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRPL 913
+ D + G ++ E++ G+ P
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 3e-11
Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 7/158 (4%)
Query: 756 EVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNI 815
E VL RH + L + V EY+N G L L + R+ + +R+
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE---RVFSEDRTRFYG 101
Query: 816 ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG 875
A + L YLH I++RD+K N++LD + +I DFGL + I T+ G
Sbjct: 102 A-EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157
Query: 876 SYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
+ Y+APE +D + GVV+ E++ GR P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 25/219 (11%)
Query: 707 IRESNVIGMGATGIVYKA----EMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
+++ V+G GA G VYK + + VA+K L R + +++ + + E V+
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVL---RENTSPKANKEILDEAYVMAG 65
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALH---GKQAGRLLVDWVSRYNIALGV 819
+ + RLLG T + +V + M G L + + + + L++W + +
Sbjct: 66 VGSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQI 118
Query: 820 AQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS--- 876
A+G++YL ++HRD+ + N+L+ S +I DFGLAR++ +ET G
Sbjct: 119 AKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL-DIDETEYHADGGKVP 174
Query: 877 YGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLD 914
++A E + + D++S+GV + EL+T G +P D
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRL 771
IG G G V+K + + N A K+ D++ E ++ N+L L H N+V+
Sbjct: 26 IGKGTYGKVFKV-LNKKNGSKAAVKILDPIHDIDEEIEAEY----NILKALSDHPNVVKF 80
Query: 772 LGFLH-----NDTNMMIVYEYMNNGSLGEALHG--KQAGRLLVDWVSRYNIALGVAQGLA 824
G + N + +V E N GS+ + + G K+ R+ IA + + L
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM-----EEPIIAYILHEALM 135
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM----IRKNETVSMVAGSYGYI 880
L H IHRD+K NNILL + ++ DFG++ + +R+N +V G+ ++
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV----GTPFWM 191
Query: 881 APEY-----GYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
APE D + D++S G+ +EL G PL
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-11
Identities = 42/109 (38%), Positives = 55/109 (50%), Gaps = 1/109 (0%)
Query: 343 LELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPI 402
L L N L G +P D+ K LQ ++LS NS G IP SL + +L L L N+F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 403 PVSLSTCHSLVRVRMQNNQLSGTIPVGFG-RLEKLQRLELANNSLTGGI 450
P SL SL + + N LSG +P G RL +N+ GI
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGI 531
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-11
Identities = 72/279 (25%), Positives = 120/279 (43%), Gaps = 37/279 (13%)
Query: 267 LLEIMFLYQNNFQ-GRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLK-NLQLLNLMCN 324
LL + L N + +E+ +T+L LDL N ++ +IP I LK NL+ L+L N
Sbjct: 92 LLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDN 150
Query: 325 QLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCN 384
++ +P+ L L L+ L+L N LS ++P L N
Sbjct: 151 KIE-SLPSPLRNLPNLKNLDLSFNDLS-------------------------DLPKLLSN 184
Query: 385 GGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANN 444
NL L L N S +P + +L + + NN + + L+ L LEL+NN
Sbjct: 185 LSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNN 242
Query: 445 SLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQD 504
L + + I + ++L +D+S N + S S++ S+ NL+ +S N+L +P
Sbjct: 243 KLED-LPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNALPLIALL 299
Query: 505 CPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLT 543
L +L + L+N N+ +N T
Sbjct: 300 LLLLELLLNLLLT---LKALELKLNSILLNNNILSNGET 335
|
Length = 394 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 76/303 (25%), Positives = 133/303 (43%), Gaps = 49/303 (16%)
Query: 704 LACIRESNVIGMGATGIVYKAEM----PRLNT-IVAVKKLWRSRADLETESSGDFVGEVN 758
L+ +R +G G VYK + P T VA+K L + +A+ +F E
Sbjct: 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLRE--EFKHEAM 60
Query: 759 VLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL-----HGK-------QAGRLL 806
+ +L+H NIV LLG + + + +++ Y ++ L E L H + +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 807 VDWVSRYNIALGVAQGLAYL--HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864
++ +I +A G+ +L HH ++H+D+ + N+L+ L +I+D GL R +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFR-EV 174
Query: 865 RKNETVSMVAGSY---GYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES- 920
+ ++ S +++PE K DI+S+GVVL E+ + L P G S
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS--YGLQPYCGYSN 232
Query: 921 VDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
D++E IR NR + D +C V + C + P RP +D+
Sbjct: 233 QDVIEMIR-----NRQVLPCPD----DCP------AWVYTLMLECWNEFPSRRPRFKDIH 277
Query: 981 TML 983
+ L
Sbjct: 278 SRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 54/217 (24%), Positives = 106/217 (48%), Gaps = 23/217 (10%)
Query: 708 RESNVIGMGATGIVYKA----EMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL 763
++ V+G GA G VYK E ++ VA+K+L R +++ + + E V+ +
Sbjct: 10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEILDEAYVMASV 66
Query: 764 RHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQ---AGRLLVDWVSRYNIALGVA 820
+ ++ RLLG T + ++ + M G L + + + + L++W + +A
Sbjct: 67 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 119
Query: 821 QGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY--G 878
+G+ YL ++HRD+ + N+L+ + +I DFGLA+++ + G
Sbjct: 120 KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176
Query: 879 YIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLD 914
++A E + D++S+GV + EL+T G +P D
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G+ G V + I A+K + ++ +E + + E VL ++ IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHT-LAERTVLAQVNCPFIVPLK 59
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
+ + +V ++N G L H ++ GR A+ L L +
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFH--HLQREGRF-----DLSRARFYTAELLCALENLHKF 112
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----YGYTL 888
+I+RD+K NILLD + DFGL ++ ++ ++ + G+ Y+APE +GYT
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT- 171
Query: 889 KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVD 922
+ +D ++ GV+L E+LTG L P + E+V+
Sbjct: 172 ---KAVDWWTLGVLLYEMLTG---LPPFYDENVN 199
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 6e-11
Identities = 66/232 (28%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G G V+ + R K + S L+ V EVNV+ +L+H+NIVR +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIEVNVMRELKHKNIVRYI 78
Query: 773 GFLHNDTN--MMIVYEYMNNGSLGEALH------GKQAGRLLVDWVSRYNIALGVAQGLA 824
N N + I+ E+ + G L + GK +VD I + LA
Sbjct: 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD------ITRQLLHALA 132
Query: 825 YLHHDCYPP----IIHRDIKSNNILLDS-------------NLEPR----IADFGLARMM 863
Y H+ P ++HRD+K NI L + NL R I DFGL++ +
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 864 IRKNETVSMVAGSYGYIAPE--YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
++ S V Y Y +PE T D+K D+++ G ++ EL +G+ P
Sbjct: 193 GIESMAHSCVGTPY-YWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 67/241 (27%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDF----VGEVNVLGKL 763
+ IG G G V+KA + IVA+KK+ +E E G F + E+ +L L
Sbjct: 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVL-----MENEKEG-FPITALREIKILQLL 68
Query: 764 RHRNIVRLLGFLHNDTNM--------MIVYEY--------MNNG----SLGEALHGKQAG 803
+H N+V L+ +V+E+ ++N +L E K+
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEI---KKVM 125
Query: 804 RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR-M 862
++L++ GL Y+H + I+HRD+K+ NIL+ + ++ADFGLAR
Sbjct: 126 KMLLN-------------GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAF 169
Query: 863 MIRKNETVSMVAG---SYGYIAPE-------YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
+ KN + + Y PE YG ID++ G ++ E+ T R P
Sbjct: 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYG------PPIDMWGAGCIMAEMWT-RSP 222
Query: 913 L 913
+
Sbjct: 223 I 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-11
Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 717 ATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLH 776
ATG Y ++ + IVA ++ + + E VL RH + L
Sbjct: 18 ATGRYYAMKILKKEVIVAKDEVAHT------------LTENRVLQNSRHPFLTALKYSFQ 65
Query: 777 NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIH 836
+ V EY N G L L + R+ + +R+ A + L YLH + +++
Sbjct: 66 THDRLCFVMEYANGGELFFHLSRE---RVFSEDRARFYGA-EIVSALDYLHSE--KNVVY 119
Query: 837 RDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDI 896
RD+K N++LD + +I DFGL + I+ T+ G+ Y+APE +D
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 179
Query: 897 YSFGVVLLELLTGRRPL 913
+ GVV+ E++ GR P
Sbjct: 180 WGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-11
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+++G G G V I A+K + +S L E+ F E ++L I +
Sbjct: 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKS-VLLAQETVSFFEEERDILSISNSPWIPQ 65
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L + N+ +V EY G L +L + + D Y L +A + +H
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYEDQFDEDMAQFYLAELVLA--IHSVHQMG 122
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFG-LARMMIRKNETVSMVAGSYGYIAPEYGYTLK 889
Y +HRDIK N+L+D ++ADFG AR+ K + G+ YIAPE T+
Sbjct: 123 Y---VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 890 VDEK------IDIYSFGVVLLELLTGRRP 912
D K D +S GV+ E++ GR P
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 45/291 (15%)
Query: 713 IGMGATGIVYKAEMP-----RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
+G G+ G+VY+ T VAVK + S A L +F+ E +V+ +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-ASLRERI--EFLNEASVMKGFTCHH 70
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHG------KQAGRLLVDWVSRYNIALGVAQ 821
+VRLLG + ++V E M +G L L GR +A +A
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG--- 878
G+AYL+ + +HRD+ + N ++ + +I DFG+ R + ET G G
Sbjct: 131 GMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY---ETDYYRKGGKGLLP 184
Query: 879 --YIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMK-IRDN 934
++APE D++SFGVVL E+ + +P E V +K + D
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV-------LKFVMDG 237
Query: 935 RNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985
L++ P+ NC E + ++R +C PK RP+ +++ +L +
Sbjct: 238 GYLDQ---PD--NC---PERVTDLMR---MCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 712 VIGMGATGIVY---KAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNI 768
V+G G+ G V+ K P + A+K L +A L+ E ++L ++ H I
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVL--KKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
V+L + + ++ +++ G L L K+ + + ++ +A +A L +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEV--MFTEEDVKFYLA-ELALALDHLHS 116
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTL 888
II+RD+K NILLD ++ DFGL++ I + G+ Y+APE
Sbjct: 117 ---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 889 KVDEKIDIYSFGVVLLELLTGRRP 912
+ D +SFGV++ E+LTG P
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 713 IGMGATGIVYKA--EMPRLNTIVAVKKLWRSRADLETESSGD-FVGEVNVLGKLRHRNIV 769
+G G G V K +M + VAVK L + D + D + E NV+ +L + IV
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL---KNDNNDPALKDELLREANVMQQLDNPYIV 59
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ---GLAYL 826
R++G + + M+V E G L + L + V+ NI V Q G+ YL
Sbjct: 60 RMIGICEAE-SWMLVMELAELGPLNKFLQKNKH-------VTEKNITELVHQVSMGMKYL 111
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG-----YIA 881
+ +HRD+ + N+LL + +I+DFGL++ + +E A ++G + A
Sbjct: 112 EETNF---VHRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYK-AKTHGKWPVKWYA 166
Query: 882 PEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP 912
PE K K D++SFGV++ E + G++P
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 40/221 (18%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G+ G+V+ A + VAVKK+ + +S + E+ ++ +L H NIV++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVY 68
Query: 773 GFL----HNDTNMM----------IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALG 818
L + T + IV EYM L L + G L + + L
Sbjct: 69 EVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLSEEHARLFMYQL- 123
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDS-NLEPRIADFGLARMMIRKNE---TVSMVA 874
+GL Y+H ++HRD+K N+ +++ +L +I DFGLAR++ +S
Sbjct: 124 -LRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179
Query: 875 GSYGYIAPEY-----GYTLKVDEKIDIYSFGVVLLELLTGR 910
+ Y +P YT + ID+++ G + E+LTG+
Sbjct: 180 VTKWYRSPRLLLSPNNYT----KAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 69/290 (23%), Positives = 122/290 (42%), Gaps = 43/290 (14%)
Query: 713 IGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
+G G+ G+VY+ + T VA+K + + + E +F+ E +V+ + +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVMKEFNCHH 70
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHG------KQAGRLLVDWVSRYNIALGVAQ 821
+VRLLG + +++ E M G L L + +A +A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG--- 878
G+AYL+ + + +HRD+ + N ++ + +I DFG+ R + ET G G
Sbjct: 131 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY---ETDYYRKGGKGLLP 184
Query: 879 --YIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNR 935
+++PE D++SFGVVL E+ T +P E V +R
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV-----LRFV----- 234
Query: 936 NLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985
+E L NC ++ + +C PK RPS ++I+ + E
Sbjct: 235 -MEGGLLDKPDNCPD------MLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 44/160 (27%), Positives = 70/160 (43%), Gaps = 24/160 (15%)
Query: 756 EVNVLGKLRHRNIVRLLGFLHNDTNMMIV--------YEYMNNGSLGEALHGKQAGRLLV 807
E +L + H +++R+ L + +V Y Y+ S L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS----------RPLPI 156
Query: 808 DWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKN 867
D I + +GL YLH IIHRD+K+ NI ++ + I D G A+ +
Sbjct: 157 D--QALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211
Query: 868 ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELL 907
+ +AG+ APE K + K DI+S G+VL E+L
Sbjct: 212 AFLG-LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-10
Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 17/166 (10%)
Query: 756 EVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNI 815
E++ L H IV+ +D ++++ EY + G L + + + L Y +
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF---QEYEV 171
Query: 816 ALGVAQ---GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM 872
L Q L +H ++HRD+KS NI L ++ DFG ++ + +++VS+
Sbjct: 172 GLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSK---QYSDSVSL 225
Query: 873 -VAGSYG----YIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
VA S+ Y+APE + +K D++S GV+L ELLT RP
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 48/163 (29%), Positives = 69/163 (42%), Gaps = 19/163 (11%)
Query: 756 EVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNI 815
E VL RH + L + V EY N G L H + D Y
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 102
Query: 816 ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG 875
+ A L YLH +++RD+K N++LD + +I DFGL + I T+ G
Sbjct: 103 EIVSA--LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157
Query: 876 SYGYIAPE------YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
+ Y+APE YG +D + GVV+ E++ GR P
Sbjct: 158 TPEYLAPEVLEDNDYG------RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRS-RADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G GA G V A R VA+KKL R ++++ + + E+ +L ++H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRA---YRELTLLKHMQHENVIGL 79
Query: 772 LGF------LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAY 825
L + +V YM K G L + +Y + + GL Y
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQTDL------QKIMGHPLSEDKVQY-LVYQMLCGLKY 132
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYG 885
+H IIHRD+K N+ ++ + E +I DFGLAR E V + Y APE
Sbjct: 133 IHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVVTRW-YRAPEVI 186
Query: 886 YT-LKVDEKIDIYSFGVVLLELLTGR 910
+ ++ +DI+S G ++ E+LTG+
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 48/199 (24%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 721 VYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN 780
VYK +++ + V K ++ + + + E ++ +L + IVR++G +
Sbjct: 15 VYKMRKKQIDVAIKVLKNENEKSVRD-----EMMREAEIMHQLDNPYIVRMIGVCEAE-A 68
Query: 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIAL---GVAQGLAYLHHDCYPPIIHR 837
+M+V E + G L + L GK+ D ++ N+ V+ G+ YL + +HR
Sbjct: 69 LMLVMEMASGGPLNKFLSGKK------DEITVSNVVELMHQVSMGMKYLEGKNF---VHR 119
Query: 838 DIKSNNILLDSNLEPRIADFGLARMM-IRKNETVSMVAGSY--GYIAPEYGYTLKVDEKI 894
D+ + N+LL + +I+DFGL++ + + + AG + + APE K +
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179
Query: 895 DIYSFGVVLLELLT-GRRP 912
D++S+G+ + E + G++P
Sbjct: 180 DVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 70/294 (23%), Positives = 129/294 (43%), Gaps = 68/294 (23%)
Query: 712 VIGMGATGIVYKAEMPRLNTI---VAVKKLWRSRADLETESS-GDFVGEVNVLGKLRHRN 767
++G G G V + ++ + + VAVK + + D+ T S +F+ E + H N
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTM---KLDIHTYSEIEEFLSEAACMKDFDHPN 62
Query: 768 IVRLLG--FLHNDTNM----MIVYEYMNNGSLGEALH----GKQAGRLLVDWVSRYNIAL 817
+++L+G F + M++ +M +G L L G +L + + ++ +
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF--MV 120
Query: 818 GVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY 877
+A G+ YL + + IHRD+ + N +L ++ +ADFGL++ + +G Y
Sbjct: 121 DIALGMEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSK---------KIYSGDY 168
Query: 878 ---GYIA------------PEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFG-ESV 921
G IA + YT K D+++FGV + E+ T R P G E+
Sbjct: 169 YRQGRIAKMPVKWIAIESLADRVYTSKS----DVWAFGVTMWEIAT--RGQTPYPGVENH 222
Query: 922 DIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPS 975
+I +++R R + E+ LD + + + C PKDRP+
Sbjct: 223 EIYDYLRHGNRLKQP-EDCLDE--------------LYDLMYSCWRADPKDRPT 261
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG GA GIV A L VA+KKL R + +T + + E+ ++ + H+NI+ LL
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAY-RELVLMKCVNHKNIIGLL 89
Query: 773 GF------LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
L ++ IV E M+ Q ++ +D + + G+ +L
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDANLC-------QVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGY 886
H IIHRD+K +NI++ S+ +I DFGLAR V Y Y APE
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVIL 198
Query: 887 TLKVDEKIDIYSFGVVLLELLTGR 910
+ E +DI+S G ++ E++ G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-10
Identities = 65/223 (29%), Positives = 111/223 (49%), Gaps = 8/223 (3%)
Query: 362 SPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQ 421
PL LDL+ N I L NLT L L NN + P+ +L + + +N+
Sbjct: 93 LPLPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNK 151
Query: 422 LSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSI 481
+ ++P L L+ L+L+ N L+ + +++ ++L+ +D+S N + LP I +
Sbjct: 152 IE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKISD-LPPEIELL 208
Query: 482 PNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQ 541
L+ +SNN+++ E+ + +LS L+LS+N +P SI + L L+L NNQ
Sbjct: 209 SALEELDLSNNSII-ELLSSLSNLKNLSGLELSNN-KLEDLPESIGNLSNLETLDLSNNQ 266
Query: 542 LTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLN 584
++ I + + L LDLS NSL+ +P LE+L
Sbjct: 267 IS-SISS-LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL 307
|
Length = 394 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 16/238 (6%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN---I 768
+IG G G VY + A+K L + R ++ + + E +L + + I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFI 59
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
V + H + + + MN G L H Q G + Y A + GL ++H+
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDL--HYHLSQHGVFSEKEMRFY--ATEIILGLEHMHN 115
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE-YGYT 887
+++RD+K NILLD + RI+D GLA +K S+ G++GY+APE
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPEVLQKG 170
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945
D D +S G +L +LL G P ++ D E RM + N L ++ P +
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFRQH--KTKDKHEIDRMTLTVNVELPDSFSPEL 226
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 31/237 (13%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+I GA G VY A+KK+ + L + FV E ++L + +V +
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVSM 66
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
++ +V EY+ G L K G L VD Y +A L YLH+ Y
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVLA--LEYLHN--Y 120
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM----------------VAG 875
I+HRD+K +N+L+ S ++ DFGL+++ + + T ++ V G
Sbjct: 121 G-IVHRDLKPDNLLITSMGHIKLTDFGLSKIGL-MSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 876 SYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPL---DPE--FGESV-DIVEW 926
+ YIAPE + +D ++ G++L E L G P PE FG+ + D +EW
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 712 VIGMGATGIVY---KAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNI 768
V+G GA G V+ K + A+K L ++ + ++ E NVL +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 769 VRLLGF-LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
+ L + + + ++ +Y++ G + L+ + D S + + + L
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR-------DNFSEDEVRFYSGEIILALE 119
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI--RKNETVSMVAGSYGYIAPEYG 885
H I++RDIK NILLDS + DFGL++ + K T S G+ Y+APE
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF-CGTIEYMAPEII 178
Query: 886 YTLKVDEK-IDIYSFGVVLLELLTGRRPLDPEFGE 919
K +D +S G+++ ELLTG P E GE
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLE-GE 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-10
Identities = 90/297 (30%), Positives = 128/297 (43%), Gaps = 38/297 (12%)
Query: 96 RLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASG 155
L L SL+L N L S + L LT+L D+ N + P + L L+ S
Sbjct: 91 NLLPLPSLDLNLNRL-RSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSD 149
Query: 156 NNFSGFLLEDLGNATSLETLDLRGSFFQ-GSIPVSFKNLQKLKFLGLSGNNLTGKIPREL 214
N L L N +L+ LDL SF +P NL L L LSGN ++ +P E+
Sbjct: 150 NKIE-SLPSPLRNLPNLKNLDL--SFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEI 205
Query: 215 GQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLY 274
LS++E + L+ N E+ NL NL L+L+
Sbjct: 206 ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELS------------------------ 240
Query: 275 QNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGL 334
NN LP IGN+++L+ LDLS N +S + + L NL+ L+L N LS +P
Sbjct: 241 -NNKLEDLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNALPLIA 297
Query: 335 GGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKL 391
L +LEL N L ++L NS L ++ SN P +L +L L
Sbjct: 298 LLLL---LLELLLNLLLTLKALELKLNSILLNNNILSNGE-TSSPEALSILESLNNL 350
|
Length = 394 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG GA GIV A L+ VA+KKL R + +T + + E+ ++ + H+NI+ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAY-RELVLMKCVNHKNIISLL 82
Query: 773 GF------LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
L ++ +V E M+ Q ++ +D + + G+ +L
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLC-------QVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGY 886
H IIHRD+K +NI++ S+ +I DFGLAR V Y Y APE
Sbjct: 136 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVIL 191
Query: 887 TLKVDEKIDIYSFGVVLLELL 907
+ E +DI+S G ++ E++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 72/288 (25%), Positives = 131/288 (45%), Gaps = 59/288 (20%)
Query: 713 IGMGATGIVYKAEMPRLNTI--VAVKKLWR---SRADLETESSGDFVGEVNVLGKLRHRN 767
+G G G V + ++ + ++I VAVK + +R+++E DF+ E + + H N
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME-----DFLSEAVCMKEFDHPN 61
Query: 768 IVRLLGFLHNDTNM------MIVYEYMNNGSLGEALHGKQAG--------RLLVDWVSRY 813
++RL+G +++ +M +G L L + G ++LV +++
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT-- 119
Query: 814 NIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM-----IRKNE 868
+A G+ YL + IHRD+ + N +L+ N+ +ADFGL++ + R+
Sbjct: 120 ----DIASGMEYLSSKSF---IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGR 172
Query: 869 TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFG-ESVDIVEWI 927
M +IA E K D++SFGV + E+ T R P G E+ +I +++
Sbjct: 173 IAKM---PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT--RGQTPYPGVENSEIYDYL 227
Query: 928 RMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPS 975
R + NR L++ P+ + + + C PKDRPS
Sbjct: 228 R---QGNR-LKQP--PDCLDG---------LYSLMSSCWLLNPKDRPS 260
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-10
Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 48/213 (22%)
Query: 733 VAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL-------GFLHNDTNMMIVY 785
VA+K L R+ A E F E + +L H NIV LL G L V+
Sbjct: 6 VAIK-LLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLL------FAVF 58
Query: 786 EYMNNGSLGE------ALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDI 839
EY+ +L E AL + GRL+ L V LA H+ I+HRD+
Sbjct: 59 EYVPGRTLREVLAADGALPAGETGRLM----------LQVLDALACAHNQ---GIVHRDL 105
Query: 840 KSNNILLD-SNLEP--RIADFGLARMM--------IRKNETVSMVAGSYGYIAPEYGYTL 888
K NI++ + + P ++ DFG+ ++ T ++ G+ Y APE
Sbjct: 106 KPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL-GTPTYCAPEQLRGE 164
Query: 889 KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESV 921
V D+Y++G++ LE LTG+R + G SV
Sbjct: 165 PVTPNSDLYAWGLIFLECLTGQRVVQ---GASV 194
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 9e-10
Identities = 56/235 (23%), Positives = 94/235 (40%), Gaps = 45/235 (19%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV-GEVNVLGKLRHRNIVR 770
++G G G V+ + + A+K L + ++ + V E +L L H +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVL--DKKEMIKRNKVKRVLTEQEILATLDHPFLPT 65
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L +T + +V +Y G L L +Q G+ L + V+R+ A + L YLH
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQ-RQPGKCLSEEVARFYAAEVLL-ALEYLHLL- 122
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLA------------------RMMIRKNETVSM 872
I++RD+K NILL + ++DF L+ R +
Sbjct: 123 --GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 873 VA-----------GSYGYIAPE----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
+ G+ YIAPE G+ V D ++ G++L E+L G P
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 9e-10
Identities = 66/246 (26%), Positives = 103/246 (41%), Gaps = 60/246 (24%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
VIG GA G V + I A+KKL +S LE E E ++L + + +V+L
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM-LEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLA--YLHHD 829
++ + ++ EY+ G + L K + +R+ IA + LA +H
Sbjct: 67 YYSFQDENYLYLIMEYLPGGDMMTLLMKKD---TFTEEETRFYIAETI---LAIDSIHKL 120
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGL------------ARMMI------------- 864
Y IHRDIK +N+LLD+ +++DFGL R++
Sbjct: 121 GY---IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177
Query: 865 --------------RKNETVSMVAGSYGYIAPE----YGYTLKVDEKIDIYSFGVVLLEL 906
R+ S V G+ YIAPE GY ++ D +S GV++ E+
Sbjct: 178 PMSSKRKAETWKRNRRALAYSTV-GTPDYIAPEVFLQTGYN----KECDWWSLGVIMYEM 232
Query: 907 LTGRRP 912
L G P
Sbjct: 233 LVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 69/251 (27%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 347 NNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSL 406
+SLS L +DL S + LD S N + SL L L + + L
Sbjct: 63 PSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSL-------DLNLNRLRSNISELLEL 115
Query: 407 STCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDIS 466
+ SL + NN ++ P+ L+ L+L++N + + + + +L +D+S
Sbjct: 116 TNLTSL---DLDNNNITDIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLS 171
Query: 467 RNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSI 526
N L S LP + ++ NL +S N + ++P + + +L LDLS+N + SS+
Sbjct: 172 FNDL-SDLPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNN-SIIELLSSL 228
Query: 527 ASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVS 586
++ + L L L NN+L D+P++I + L LDLSNN ++ + G+ L L++S
Sbjct: 229 SNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLS 285
Query: 587 YNRLEGPVPAN 597
N L +P
Sbjct: 286 GNSLSNALPLI 296
|
Length = 394 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 41/219 (18%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLE--TESSGDFVGEVNVLGKLR-HRNIV 769
IG G V KA+ + A+K + + LE E+ L +L H NI+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-----EIQALRRLSPHPNIL 61
Query: 770 RLLGFLHNDTN--MMIVYEYMNNGSLGEALHGKQAGRLLVDW-VSRYNIALGVAQGLAYL 826
RL+ L + + +V+E M+ +L E + G++ R L + V Y L + L ++
Sbjct: 62 RLIEVLFDRKTGRLALVFELMD-MNLYELIKGRK--RPLPEKRVKSYMYQL--LKSLDHM 116
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK---NETVSMVAGSYGYIAPE 883
H + I HRDIK NIL+ ++ ++ADFG R + K E +S + Y APE
Sbjct: 117 HRN---GIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYIS----TRWYRAPE 168
Query: 884 -------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
YG K+DI++ G V E+L+ PL P
Sbjct: 169 CLLTDGYYGP------KMDIWAVGCVFFEILS-LFPLFP 200
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 29/89 (32%), Positives = 46/89 (51%)
Query: 151 LNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKI 210
L GF+ D+ L++++L G+ +G+IP S ++ L+ L LS N+ G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 211 PRELGQLSSMETMILAYNEFDGEIPVEFG 239
P LGQL+S+ + L N G +P G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 713 IGMGATGIVYKAEM-PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
IG G G V E+ V K R A ++ + F+ E L+H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK--FLEEAQPYRSLQHSNLLQC 60
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLV-DWVSRYNIALGVAQGLAYLHHDC 830
LG T ++V E+ G L L + L+ D + +A +A GL +LH +
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE--TVSMVAGSYGYIAPE----- 883
+ IH D+ N LL ++L +I D+GL+ +++ T + +IAPE
Sbjct: 121 F---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 884 YGYTLKVDE--KIDIYSFGVVLLELLT-GRRP 912
+G L VD+ + +++S GV + EL G +P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 44/139 (31%), Positives = 67/139 (48%), Gaps = 10/139 (7%)
Query: 775 LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPI 834
H + + + MN G L H Q G + Y A + GL ++H+ +
Sbjct: 66 FHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEAEMRFY--AAEIILGLEHMHNRF---V 118
Query: 835 IHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE-YGYTLKVDEK 893
++RD+K NILLD + RI+D GLA +K S+ G++GY+APE + D
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPEVLQKGVAYDSS 176
Query: 894 IDIYSFGVVLLELLTGRRP 912
D +S G +L +LL G P
Sbjct: 177 ADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 30/88 (34%), Positives = 51/88 (57%)
Query: 439 LELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEI 498
L L N L G I +DI+ L I++S N +R ++P ++ SI +L+ +S N+ G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 499 PDQFQDCPSLSVLDLSSNYFSGSIPSSI 526
P+ SL +L+L+ N SG +P+++
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 66/249 (26%), Positives = 112/249 (44%), Gaps = 44/249 (17%)
Query: 753 FVGEVNVLGKLRHRNIVRLLGFLHNDTNM-MIVYEYMNNGSLGEALHGKQAGRLLVDWVS 811
+ E +L L H+NI+ +L D ++Y YMN G+L L Q RL
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL---QQCRLGEANNP 111
Query: 812 R-------YNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM- 863
+ ++A+ +A G++YLH +IH+DI + N ++D L+ +I D L+R +
Sbjct: 112 QALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLF 168
Query: 864 ------IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPE 916
+ NE + ++A E + D++SFGV+L EL+T G+ P
Sbjct: 169 PMDYHCLGDNENRPV-----KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY--- 220
Query: 917 FGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSM 976
+D E ++D L + P NC +E+ V+ C A P++RPS
Sbjct: 221 --VEIDPFEMAAY-LKDGYRLAQ---PI--NCP---DELFAVMA---CCWALDPEERPSF 266
Query: 977 RDVITMLGE 985
++ L +
Sbjct: 267 SQLVQCLTD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 63/241 (26%), Positives = 100/241 (41%), Gaps = 45/241 (18%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRAD-LETESSGDFVGEVNVLGKLRHRNIVR 770
VIG GA G V + + A+K L +AD LE E G E ++L + +V+
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKIL--RKADMLEKEQVGHIRAERDILVEADSLWVVK 65
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
+ + N+ ++ E++ G + L K L + +++ IA V + +H
Sbjct: 66 MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT---LTEEETQFYIAETVL-AIDSIHQLG 121
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMM--------------------------- 863
+ IHRDIK +N+LLDS +++DFGL +
Sbjct: 122 F---IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 864 IRKNET--------VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
RK ET G+ YIAPE ++ D +S GV++ E+L G P
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 916 E 916
E
Sbjct: 239 E 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-09
Identities = 64/264 (24%), Positives = 107/264 (40%), Gaps = 63/264 (23%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG+GA G V N + A+K L R L + E ++L + + +V+L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTL-RKADVLMRNQAAHVKAERDILAEADNEWVVKLY 67
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
+ N+ V +Y+ G + L + + ++R+ IA + + +H +
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLG---IFEEDLARFYIA-ELTCAIESVHKMGF- 122
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLA-------------------------------- 860
IHRDIK +NIL+D + ++ DFGL
Sbjct: 123 --IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180
Query: 861 ---------RMMIRKNETV---SMVAGSYGYIAPEY----GYTLKVDEKIDIYSFGVVLL 904
R R+++ S+V G+ YIAPE GYT + D +S GV+L
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLV-GTPNYIAPEVLLRTGYT----QLCDWWSVGVILY 235
Query: 905 ELLTGRRP-LDPEFGES-VDIVEW 926
E+L G+ P L E+ + ++ W
Sbjct: 236 EMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-09
Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 38/178 (21%)
Query: 819 VAQGLAYL-HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS- 876
VA+G+ +L C IHRD+ + NILL N +I DFGLAR + + + V GS
Sbjct: 183 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--KGSA 236
Query: 877 ---YGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP-----LDPEFGESVDIVEWI 927
++APE + + D++SFGV+L E+ + G P ++ EF + + +
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK--DGT 294
Query: 928 RMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985
RM+ +N E + RI C PK+RP+ ++ +LG+
Sbjct: 295 RMRAPENATPE-------------------IYRIMLACWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 751 GDFVGEVNVLGKLRHRNIVRLLG-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDW 809
G E ++L + H +I++L G F +N +I+ Y + L+ A + +
Sbjct: 128 GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD------LYCYLAAKRNIAI 181
Query: 810 VSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA--RMMIRKN 867
I V + + YLH + IIHRDIK+ NI ++ + + DFG A + I N
Sbjct: 182 CDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238
Query: 868 ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
+ AG+ APE +DI+S G+VL E+ T L
Sbjct: 239 KYYGW-AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 37/220 (16%)
Query: 713 IGMGATGIVYKAEM--PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIV 769
+G GA GIV A VA+KK+ + + + + E+ +L R H+NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKI--TNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 770 RLLGFLHNDTNMMIVYEYMNNG-----SLGEA-LHGK-QAGRLLVDWVSRYNIALGVAQG 822
L +M IV+ N L EA LH ++G+ L D + I + G
Sbjct: 66 CLY-------DMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-YQILCG 117
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY----G 878
L Y+H ++HRD+K N+L++++ E +I DFGLAR + Y
Sbjct: 118 LKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 879 YIAPEY-----GYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
Y APE YT + ID++S G +L ELL GR+P+
Sbjct: 175 YRAPEIMLSFQSYT----KAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 54/235 (22%), Positives = 105/235 (44%), Gaps = 33/235 (14%)
Query: 753 FVGEVNVLGKLRHRNIVRLLGFLHNDTN----MMIVYEYMNNGSLGEALHGKQAGRLLVD 808
E+ L ++ NI+++ GF+ + + + ++ EY G L E L ++ +
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD----LS 120
Query: 809 WVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK-- 866
+ ++ ++A+ +GL L+ P ++++ S + L+ N + +I GL +++
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPF 178
Query: 867 NETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEW 926
MV SY + + + K DIYS GVVL E+ TG+ P E++ E
Sbjct: 179 KNVNFMVYFSYKMLNDIFS---EYTIKDDIYSLGVVLWEIFTGKIPF-----ENLTTKEI 230
Query: 927 IRMKIRDNRNLEEALD-PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
+ I N +L+ LD P C I CT+ RP++++++
Sbjct: 231 YDLIINKNNSLKLPLDCPLEIKC------------IVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-08
Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 41/218 (18%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
N+IG G+ G+VY+A + VA+KK+ + D + ++ E+ ++ L H NI+
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQ---DPQYKNR-----ELLIMKNLNHINIIF 123
Query: 771 LLGFLH------NDTNMMI----------VYEYMNNGSLGEALHGKQAGRLLVDWVSRYN 814
L + + N+ N+ + V++YM + + A L + V Y+
Sbjct: 124 LKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA-----RNNHALPLFL--VKLYS 176
Query: 815 IALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP-RIADFGLARMMIRKNETVSMV 873
L + LAY+H I HRD+K N+L+D N ++ DFG A+ ++ +VS +
Sbjct: 177 YQL--CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYI 231
Query: 874 AGSYGYIAPE--YGYTLKVDEKIDIYSFGVVLLELLTG 909
+ Y APE G T ID++S G ++ E++ G
Sbjct: 232 CSRF-YRAPELMLGAT-NYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 22/211 (10%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
VIG GA G V + A+K L + ++ S F E +++ +V+L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
+D + +V EYM G L + W Y + +A L +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE---KWAKFYTAEVVLA--LDAIHS--- 160
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMV-----AGSYGYIAPEYGY 886
+IHRD+K +N+LLD + ++ADFG M + MV G+ YI+PE
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM----DETGMVRCDTAVGTPDYISPEVLK 216
Query: 887 TLKVD----EKIDIYSFGVVLLELLTGRRPL 913
+ D + D +S GV L E+L G P
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 16/208 (7%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
VIG GA G V + A+K L + ++ S F E +++ +V+L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
+D + +V EYM G L + W Y + +A L +H +
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFYTAEVVLA--LDAIHSMGF 163
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV--SMVAGSYGYIAPEYGYTLK 889
IHRD+K +N+LLD + ++ADFG M + K V G+ YI+PE +
Sbjct: 164 ---IHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 890 VD----EKIDIYSFGVVLLELLTGRRPL 913
D + D +S GV L E+L G P
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-08
Identities = 84/331 (25%), Positives = 125/331 (37%), Gaps = 113/331 (34%)
Query: 288 NITSLQLLDLSYNMLSHEIPAEITQL--KNLQLLNLMCNQLSGHVPAGL-GGLTQLEVLE 344
N T L+L L + IP +IT L N +L +L P L G + L
Sbjct: 179 NKTELRLKILGLTTIPACIPEQITTLILDNNELKSL---------PENLQGNIKTLYANS 229
Query: 345 LWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPV 404
S+ LP +Q ++LS N + E+P L + L L LF+N S
Sbjct: 230 NQLTSIPATLP------DTIQEMELSINRIT-ELPERLPSA--LQSLDLFHNKISC---- 276
Query: 405 SLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLT-------GGITDDIASS 457
L +P E+L+ L + +NS+ GIT S
Sbjct: 277 -----------------LPENLP------EELRYLSVYDNSIRTLPAHLPSGITHLNVQS 313
Query: 458 TSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNY 517
SL+ LP T+ P L+T N L
Sbjct: 314 NSLTA-----------LPETL--PPGLKTLEAGENALT---------------------- 338
Query: 518 FSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGAS 577
S+P+S+ +L L++ NQ+T +P+ ++ PT+ LD+S N+LT +PEN A
Sbjct: 339 ---SLPASLPP--ELQVLDVSKNQITV-LPE--TLPPTITTLDVSRNALT-NLPENLPA- 388
Query: 578 PALEVLNVSYNRL------------EGPVPA 596
AL+++ S N L EGP P
Sbjct: 389 -ALQIMQASRNNLVRLPESLPHFRGEGPQPT 418
|
Length = 754 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-08
Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 43/240 (17%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
VIG GA G V + I A+K L R LE E E ++L + +V++
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKIL-RKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
+ N+ ++ E++ G + L K L + +++ IA V + +H +
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT---LSEEATQFYIAETVL-AIDAIHQLGF 122
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMM---------------------------I 864
IHRDIK +N+LLD+ +++DFGL +
Sbjct: 123 ---IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179
Query: 865 RKNET--------VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPE 916
RK ET G+ YIAPE ++ D +S GV++ E+L G P E
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 74/298 (24%), Positives = 132/298 (44%), Gaps = 60/298 (20%)
Query: 712 VIGMGATGIVYKAEMPRLNTI---VAVKKLWRSRADLETESS-GDFVGEVNVLGKLRHRN 767
++G G G V +A++ + VAVK L +AD+ + S +F+ E + + H N
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKML---KADIFSSSDIEEFLREAACMKEFDHPN 62
Query: 768 IVRLLGF-LHNDTNM-----MIVYEYMNNGSLGEALHGKQAGR----LLVDWVSRYNIAL 817
+++L+G L + M++ +M +G L L + G L + + R+ I
Sbjct: 63 VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI-- 120
Query: 818 GVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY 877
+A G+ YL IHRD+ + N +L+ N+ +ADFGL++ + +G Y
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSK---------KIYSGDY 168
Query: 878 -----------GYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFG-ESVDIVE 925
++A E D+++FGV + E++T R P G E+ +I
Sbjct: 169 YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--RGQTPYAGVENSEIYN 226
Query: 926 WIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
++ I+ NR L++ D C + V + C + PK RPS + + L
Sbjct: 227 YL---IKGNR-LKQPPD-----C------LEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 50/181 (27%), Positives = 82/181 (45%), Gaps = 38/181 (20%)
Query: 816 ALGVAQGLAYL-HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA 874
+ VA+G+ +L C IHRD+ + NILL N +I DFGLAR + + + V
Sbjct: 179 SFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--K 232
Query: 875 GS----YGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP-----LDPEFGESVDIV 924
G ++APE + + D++SFGV+L E+ + G P +D EF +
Sbjct: 233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK-- 290
Query: 925 EWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984
E RM+ + + E+ I C P+DRP+ +++ +LG
Sbjct: 291 EGTRMRAPE----------------YATPEI---YSIMLDCWHNNPEDRPTFSELVEILG 331
Query: 985 E 985
+
Sbjct: 332 D 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-07
Identities = 32/112 (28%), Positives = 49/112 (43%), Gaps = 21/112 (18%)
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM---------IRKNET 869
+ + Y+H ++HRD+K +NILL E I D+G A I +E
Sbjct: 122 ICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 870 VSM---------VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
+ G+ Y+APE + E DIY+ GV+L ++LT P
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-07
Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 20/160 (12%)
Query: 713 IGMGATGIVY---KAEMPRLNTIVAVKKLWRSRADLETESSGDFV-GEVNVLGKLRHRNI 768
I GA G VY K +L + VKK AD+ ++ V E + L + I
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKK-----ADMINKNMVHQVQAERDALALSKSPFI 66
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALH--GKQAGRLLVDWVSRYNIALGVAQGLAYL 826
V L L + N+ +V EY+ G + LH G + V ++S VA L YL
Sbjct: 67 VHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE------VALALDYL 120
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866
H IIHRD+K +N+L+ + ++ DFGL+++ + +
Sbjct: 121 HRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 5e-07
Identities = 21/60 (35%), Positives = 31/60 (51%)
Query: 483 NLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQL 542
NL++ +SNN L F+ P+L VLDLS N + P + + L +L+L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 51/185 (27%), Positives = 77/185 (41%), Gaps = 47/185 (25%)
Query: 756 EVNVLGKLRHRNIVRLL-GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSR-- 812
E+++L + HR I+ L+ + T M++ +Y + L +V R
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD---------------LFTYVDRSG 180
Query: 813 -------YNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865
I + + LAYLH IIHRD+K+ NI LD + DFG A +
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237
Query: 866 KNETVSMVAGSYGYI------APEYGYTLKVD---EKIDIYSFGVVLLELLTGRRPLDPE 916
+T YG+ +PE L +D K DI+S G+VL E+ L
Sbjct: 238 HPDT----PQCYGWSGTLETNSPEL---LALDPYCAKTDIWSAGLVLFEMSVKNVTL--- 287
Query: 917 FGESV 921
FG+ V
Sbjct: 288 FGKQV 292
|
Length = 392 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 7e-07
Identities = 34/121 (28%), Positives = 56/121 (46%), Gaps = 1/121 (0%)
Query: 391 LILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGI 450
L L N G IP +S L + + N + G IP G + L+ L+L+ NS G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 451 TDDIASSTSLSFIDISRNHLRSSLPSTILSIP-NLQTFIVSNNNLVGEIPDQFQDCPSLS 509
+ + TSL ++++ N L +P+ + + +F ++N + IP P LS
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLS 542
Query: 510 V 510
V
Sbjct: 543 V 543
|
Length = 623 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 1e-06
Identities = 19/42 (45%), Positives = 25/42 (59%), Gaps = 2/42 (4%)
Query: 32 LNDELLALLSIKAGLV-DPLNSLHDWKLP-SAHCNWTGVWCN 71
LND+ ALL+ K+ L DP +L W S C+WTGV C+
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 33/100 (33%), Positives = 58/100 (58%), Gaps = 12/100 (12%)
Query: 819 VAQGLAYL-HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS- 876
VAQG+ +L +C IHRD+ + N+LL +I DFGLAR ++ N++ +V G+
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIM--NDSNYVVKGNA 274
Query: 877 ---YGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP 912
++APE + + D++S+G++L E+ + G+ P
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 713 IGMGATGIVYKAEMPRLN-TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G G+ G V A + VA+K+ +S+ + + F E +L + H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNL 96
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
G +++ + +V E++ G L ++ R D Y AQ + +
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFL--RRNKRFPNDVGCFY-----AAQIVLIFEYLQS 149
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVD 891
I++RD+K N+LLD + ++ DFG A+++ + T + G+ YIAPE +
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT---LCGTPEYIAPEILLNVGHG 206
Query: 892 EKIDIYSFGVVLLELLTGRRPL 913
+ D ++ G+ + E+L G P
Sbjct: 207 KAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 46/189 (24%), Positives = 82/189 (43%), Gaps = 7/189 (3%)
Query: 425 TIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSL--PSTILSIP 482
P + RL L +S T + +S + L +D+ SSL +L++
Sbjct: 36 NFPDSNLESVAVNRLALNLSSNT--LLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLL 93
Query: 483 NLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQL 542
L + ++ N L I + + +L+ LDL +N + P L L+L +N++
Sbjct: 94 PLPSLDLNLNRLRSNISELLEL-TNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI 152
Query: 543 TGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRT 602
+P + +P L LDLS N L+ +P+ L L++S N++ P +L
Sbjct: 153 E-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSA 210
Query: 603 INRGDLAGN 611
+ DL+ N
Sbjct: 211 LEELDLSNN 219
|
Length = 394 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 38/176 (21%)
Query: 819 VAQGLAYL-HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS- 876
VA+G+++L +C IHRD+ + NILL +I DFGLAR + +N++ +V G+
Sbjct: 223 VAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI--RNDSNYVVKGNA 276
Query: 877 ---YGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT------GRRPLDPEFGESVDIVEWI 927
++APE + + D++S+G++L E+ + P+D +F + I E
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM--IKEGY 334
Query: 928 RMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
RM L P + EM +++ C P RP+ + ++ ++
Sbjct: 335 RM-----------LSP-----ECAPSEMYDIMKS---CWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 50/176 (28%), Positives = 77/176 (43%), Gaps = 34/176 (19%)
Query: 819 VAQGLAYL-HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS- 876
VA+G+ +L C IHRD+ + NILL N +I DFGLAR + + + V
Sbjct: 188 VAKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 877 -YGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP-----LDPEFGESVDIVEWIRM 929
++APE + + D++SFGV+L E+ + G P +D EF + E RM
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--EGTRM 301
Query: 930 KIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985
+ D E + + ML C P RP+ +++ LG
Sbjct: 302 RAPDYTTPE------------MYQTML-------DCWHGEPSQRPTFSELVEHLGN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 20/163 (12%)
Query: 753 FVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSR 812
F +++ +L H+++V+L G D N+M V EY+ G L LH ++ + + W +
Sbjct: 48 FFETASLMSQLSHKHLVKLYGVCVRDENIM-VEEYVKFGPLDVFLH-REKNNVSLHW--K 103
Query: 813 YNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILL---DSNLEP----RIADFGLARMMIR 865
++A +A L YL ++H ++ NIL+ N +++D G+ ++
Sbjct: 104 LDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS 160
Query: 866 KNETVSMVAGSYGYIAPEY--GYTLKVDEKIDIYSFGVVLLEL 906
+ E V + +IAPE + D +SFG LLE+
Sbjct: 161 REERVERIP----WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 52/193 (26%), Positives = 88/193 (45%), Gaps = 30/193 (15%)
Query: 727 PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV-- 784
P+ ++A + SRA ++ E+ E+ LG+L H NI+++ L ++ N ++
Sbjct: 190 PKCERLIAKRVKAGSRAAIQLEN------EILALGRLNHENILKIEEILRSEANTYMITQ 243
Query: 785 ------YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRD 838
Y +M + A K L +R I + + Y+H +IHRD
Sbjct: 244 KYDFDLYSFMYDE----AFDWKDRPLL---KQTR-AIMKQLLCAVEYIHDK---KLIHRD 292
Query: 839 IKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVD---EKID 895
IK NI L+ + + + DFG A M + E + G G +A L D E D
Sbjct: 293 IKLENIFLNCDGKIVLGDFGTA--MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITD 350
Query: 896 IYSFGVVLLELLT 908
I+S G++LL++L+
Sbjct: 351 IWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 41/146 (28%), Positives = 67/146 (45%), Gaps = 14/146 (9%)
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
N+V L ++ ++ ++ +V ++ G L + K + + V R+ + VA L L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-SKFL-NIPEECVKRWAAEMVVA--LDAL 101
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK--NETVSMVAGSYGYIAPEY 884
H + I+ RD+ NNILLD ++ F + E V + Y APE
Sbjct: 102 HRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPEV 153
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGR 910
G + E D +S G +L ELLTG+
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 55/183 (30%), Positives = 94/183 (51%), Gaps = 7/183 (3%)
Query: 430 FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTI-LSIPNLQTFI 488
L L L+L N L I++ + T+L+ +D+ N++ + +P I L NL+
Sbjct: 89 LLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNI-TDIPPLIGLLKSNLKELD 146
Query: 489 VSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPK 548
+S+N + +P ++ P+L LDLS N S +P +++ L NL+L N+++ D+P
Sbjct: 147 LSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPP 203
Query: 549 AISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDL 608
I ++ L LDLSNNS+ + + L L +S N+LE + G L + DL
Sbjct: 204 EIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDL 262
Query: 609 AGN 611
+ N
Sbjct: 263 SNN 265
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 1e-05
Identities = 22/60 (36%), Positives = 29/60 (48%)
Query: 459 SLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYF 518
+L +D+S N L +PNL+ +S NNL P+ F PSL LDLS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-05
Identities = 71/304 (23%), Positives = 115/304 (37%), Gaps = 65/304 (21%)
Query: 292 LQLLDLSYNMLSHE----IPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWN 347
LQ+L L N L E + + + +L+ L L N+ G +P GL L Q
Sbjct: 25 LQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNET-GRIPRGLQSLLQG------- 76
Query: 348 NSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPA---SLCNGGNLTKLILFNNAFSGPIPV 404
L K LQ LDLS N+ + SL +L +L L NN G +
Sbjct: 77 ----------LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGL-GDRGL 125
Query: 405 SLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIA----SSTSL 460
L L + LEKL L N L G + +A ++ L
Sbjct: 126 RLL-AKGLKDLPP--------------ALEKLV---LGRNRLEGASCEALAKALRANRDL 167
Query: 461 SFIDISRNHLRSSLPSTILSI----PNLQTFIVSNNNL----VGEIPDQFQDCPSLSVLD 512
++++ N + + + NL+ ++NN L + + SL VL+
Sbjct: 168 KELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLN 227
Query: 513 LSSNYFSGSIPSSIAS-----CEKLVNLNLRNNQLT----GDIPKAISMMPTLAILDLSN 563
L N + + +++AS L+ L+L N +T D+ + ++ +L LDL
Sbjct: 228 LGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRG 287
Query: 564 NSLT 567
N
Sbjct: 288 NKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 51/194 (26%), Positives = 82/194 (42%), Gaps = 37/194 (19%)
Query: 742 RADLETESSGDFV----GEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL 797
R +LE + + V GE++V H NIV D + +V +M GS + +
Sbjct: 32 RINLEA-CTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI 90
Query: 798 --HGKQAGRLLVDWVSRYNIA---LGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP 852
H +D +S IA GV + L Y+HH Y +HR +K+++IL+ + +
Sbjct: 91 CTH-------FMDGMSELAIAYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKV 140
Query: 853 RIADFGLARMMIRKNETVSMV-------AGSYGYIAPEY------GYTLKVDEKIDIYSF 899
++ MI + + +V +++PE GY D K DIYS
Sbjct: 141 YLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGY----DAKSDIYSV 196
Query: 900 GVVLLELLTGRRPL 913
G+ EL G P
Sbjct: 197 GITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 57/230 (24%), Positives = 83/230 (36%), Gaps = 38/230 (16%)
Query: 433 LEKLQRLELANNSLTGGITDDIASS----TSLSFIDISRNHLRS------SLPSTILSIP 482
L LQ L L N+L +AS+ SL + +S N SL +
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81
Query: 483 NLQTFIVSNNNLVGEIPDQFQDC---PSLSVLDLSSNYFSGSI--------PSSIASCEK 531
LQ +S+N L + + SL L L++N + EK
Sbjct: 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141
Query: 532 LV-NLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTG-GIP---ENFGASPALEVLNVS 586
LV N + KA+ L L+L+NN + GI E A+ LEVL+++
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN 201
Query: 587 YN--------RLEGPVPANGVLRTINRGD----LAGNAGLCGGVLHPCSR 624
N L + + L +N GD AG A L +L P
Sbjct: 202 NNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNIS 251
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 59/269 (21%), Positives = 101/269 (37%), Gaps = 69/269 (25%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G+GA G V A + + A+K L R + L E ++L + + +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTL-RKKDVLNRNQVAHVKAERDILAEADNEWVVKLY 67
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEAL--HGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
+ N+ V +Y+ G + L L +++ +A+ + +
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF----- 122
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLA------------------------------ 860
IHRDIK +NIL+D + ++ DFGL
Sbjct: 123 ----IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 861 ---------RMMIRKNETVSM--------VAGSYGYIAPEY----GYTLKVDEKIDIYSF 899
R+ + + G+ YIAPE GYT + D +S
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT----QLCDWWSV 234
Query: 900 GVVLLELLTGRRP-LDPEFGES-VDIVEW 926
GV+L E+L G+ P L P E+ + ++ W
Sbjct: 235 GVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG---EVNVLGKLRHRNIV 769
+G G G VYKA+ K + A + E +G + E+ +L +L+H N++
Sbjct: 9 VGRGTYGHVYKAKRKD-------GKDEKEYALKQIEGTGISMSACREIALLRELKHPNVI 61
Query: 770 RLLG-FL-HNDTNMMIVYEYMNNGSLGEALHGKQAGR-----LLVDWVSRYNIALGVAQG 822
L FL H+D + ++++Y + L + +A + + + ++ + G
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDSNLEPR----IADFGLARMM---IRKNETVSMVAG 875
+ YLH + ++HRD+K NIL+ R IAD G AR+ ++ + V
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 876 SYGYIAPEYGYTLK-VDEKIDIYSFGVVLLELLT 908
++ Y APE + + IDI++ G + ELLT
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-05
Identities = 61/252 (24%), Positives = 95/252 (37%), Gaps = 63/252 (25%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G+GA G V A + A+K L R + L E ++L + + +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTL-RKKDVLLRNQVAHVKAERDILAEADNEWVVRLY 67
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
+ N+ V +Y+ G + L + G D Y L A + +H +
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLL--IRMGIFPEDLARFYIAELTCA--VESVHKMGF- 122
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLA-------------------------------- 860
IHRDIK +NIL+D + ++ DFGL
Sbjct: 123 --IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 861 -------------RMMIRKNET--VSMVAGSYGYIAPEY----GYTLKVDEKIDIYSFGV 901
R R+++ + G+ YIAPE GYT + D +S GV
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT----QLCDWWSVGV 236
Query: 902 VLLELLTGRRPL 913
+L E+L G+ P
Sbjct: 237 ILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 819 VAQGLAYL-HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS- 876
VA G+ +L +C +HRD+ + N+L+ +I DFGLAR ++R + +S GS
Sbjct: 248 VANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS--KGST 301
Query: 877 ---YGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT 908
++APE + D++SFG++L E+ T
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 9e-05
Identities = 69/282 (24%), Positives = 101/282 (35%), Gaps = 57/282 (20%)
Query: 367 LDLSSNSFSGEIPASLCNG-GNLTKLIL--FNNAFSG----PIPVSL-------STCHSL 412
+DLS N+ E LCN N+ L + F++AF+G + +L C L
Sbjct: 35 VDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRL 94
Query: 413 VRVRMQNNQLSGTIPVGFGRL----EKLQRLELANNSL-------------TGGITDDIA 455
+V + +N P G L L L+L NN L A
Sbjct: 95 QKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAA 154
Query: 456 SSTSLSFIDISRNHLRSS----LPSTILSIPNLQTFIVSNNNLVGE-----IPDQFQDCP 506
L + RN L + + + S NL+ + N + E
Sbjct: 155 DKPKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSH 214
Query: 507 SLSVLDLSSNYFS--GSIPSSIASCE--KLVNLNLRNNQLTGDIPKAI------SMMPTL 556
SL VLDL N F+ GS + A CE L L L + L+ + K++ +P L
Sbjct: 215 SLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNL 274
Query: 557 AILDLSNNSLTGGIPENF-------GASPALEVLNVSYNRLE 591
L N GGI + A P L L + NR++
Sbjct: 275 MPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIK 316
|
Length = 388 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 713 IGMGATGIVYKAEMP--RLNTIVAVKKLWRSRADLETESSGDFVG---EVNVLGKLRHRN 767
+G G G VYKA+ + + A+K++ E +G + E+ +L +L+H N
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI---------EGTGISMSACREIALLRELKHPN 59
Query: 768 IVRLLG-FL-HNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSR-----YNIALGVA 820
++ L FL H D + ++++Y + L + +A + V ++ +
Sbjct: 60 VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118
Query: 821 QGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPR----IADFGLARMM---IRKNETVSMV 873
G+ YLH + ++HRD+K NIL+ R IAD G AR+ ++ + V
Sbjct: 119 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 874 AGSYGYIAPEYGYTLK-VDEKIDIYSFGVVLLELLT 908
++ Y APE + + IDI++ G + ELLT
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 819 VAQGLAYL-HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS- 876
VA+G+ +L +C +HRD+ + N+LL +I DFGLAR ++ + VS GS
Sbjct: 246 VARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS--KGST 299
Query: 877 ---YGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT 908
++APE + D++S+G++L E+ +
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 26/60 (43%), Positives = 35/60 (58%)
Query: 531 KLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRL 590
L +L+L NN+LT A +P L +LDLS N+LT PE F P+L L++S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 24/115 (20%)
Query: 814 NIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM--MIRKNETVS 871
NI G +GL YLH + Y IHR+IK+++IL+ + ++ GL+ + ++R +
Sbjct: 105 NILFGALRGLNYLHQNGY---IHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAK 159
Query: 872 MV-------AGSYGYIAPE------YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
+V +++PE YGY +K D IYS G+ EL TGR P
Sbjct: 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSD----IYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 43/170 (25%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 753 FVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSR 812
F +++ ++ H++IV L G D ++V E++ G L +H +++ L W +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPW--K 107
Query: 813 YNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILL-----DSNLEP--RIADFGLARMMIR 865
+ +A +A L+YL ++H ++ + NILL D P +++D G+ ++
Sbjct: 108 FKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS 164
Query: 866 KNETVSMVAGSYGYIAPE-YGYTLKVDEKIDIYSFGVVLLEL-LTGRRPL 913
+ E V + +IAPE + + D +SFG L E+ G PL
Sbjct: 165 RQECVERIP----WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 43/184 (23%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 733 VAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGS 792
V VK+L +A+ ++ +F+ + + L+H NI++ LG ++V+EY G
Sbjct: 25 VVVKEL---KANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81
Query: 793 LGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP 852
L L +Q R + +A +A G+ ++H + +H D+ N L S+L
Sbjct: 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF---LHSDLALRNCFLTSDLTV 138
Query: 853 RIADFGLARMMIRKN--ETVSMVAGSYGYIAPE-----YGYTLKVDEK--IDIYSFGVVL 903
++ D+G+ +++ ET ++APE +G + ++ ++++ GV L
Sbjct: 139 KVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTL 198
Query: 904 LELL 907
EL
Sbjct: 199 WELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 7e-04
Identities = 24/61 (39%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 291 SLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNS 349
+L+ LDLS N L+ IP L NL++L+L N L+ P GL L L+L N+
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 350 L 350
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 7e-04
Identities = 22/60 (36%), Positives = 31/60 (51%)
Query: 171 SLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEF 230
+L++LDL + +FK L LK L LSGNNLT P L S+ ++ L+ N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 23/60 (38%), Positives = 32/60 (53%)
Query: 507 SLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSL 566
+L LDLS+N + + L L+L N LT P+A S +P+L LDLS N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 76/318 (23%), Positives = 115/318 (36%), Gaps = 69/318 (21%)
Query: 90 VSDHFQRLKSLTSLNLCCNGL----FSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGA 145
++ +L L L L N L +L ++L SLK +S N G P GL
Sbjct: 15 ATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNET-GRIPRGLQ-- 71
Query: 146 AGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLG---LS 202
LL+ L L+ LDL + ++L + L L+
Sbjct: 72 ---------------SLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLN 116
Query: 203 GNNLTGKIPRELGQ-----LSSMETMILAYNEFDGE----IPVEFGNLTNLKYLDLAVGN 253
N L + R L + ++E ++L N +G + +LK L+LA
Sbjct: 117 NNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNG 176
Query: 254 LGGK-IPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHE----IPA 308
+G I A L E + N L++LDL+ N L+ E +
Sbjct: 177 IGDAGIRA------LAEGLKANCN---------------LEVLDLNNNGLTDEGASALAE 215
Query: 309 EITQLKNLQLLNLMCNQLSGH-----VPAGLGGLTQLEVLELWNNSLSGPLPVDLGK--- 360
+ LK+L++LNL N L+ A L L L L N ++ DL +
Sbjct: 216 TLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLA 275
Query: 361 -NSPLQWLDLSSNSFSGE 377
L LDL N F E
Sbjct: 276 EKESLLELDLRGNKFGEE 293
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 21/60 (35%), Positives = 27/60 (45%)
Query: 99 SLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNF 158
+L SL+L N L + L +LK D+S N L P G L L+ SGNN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 20/57 (35%), Positives = 31/57 (54%)
Query: 76 VEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQN 132
++ LDLS+ L+ F+ L +L L+L N L S P + + L SL+ D+S N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.003
Identities = 82/321 (25%), Positives = 124/321 (38%), Gaps = 46/321 (14%)
Query: 165 DLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSG-NNL----TGKIPRELGQLSS 219
DL AT+LETL L +P S + L KL+ L +S NL TG + L +L+
Sbjct: 652 DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNL 711
Query: 220 METMILAYNEFDGEIPVEFGNL-TNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNF 278
L F ++ TN+ +LDL + P+ L RLE L+ + L +
Sbjct: 712 SGCSRLK----------SFPDISTNISWLDLD-ETAIEEFPSNL-RLENLDELILCEMKS 759
Query: 279 QGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLT 338
+ Q L MLS +L L L +P+ + L
Sbjct: 760 EKLWERV-------QPLTPLMTMLSP----------SLTRLFLSDIPSLVELPSSIQNLH 802
Query: 339 QLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAF 398
+LE LE+ N LP + S L+ LDLS S P N++ L L
Sbjct: 803 KLEHLEIENCINLETLPTGINLES-LESLDLSGCSRLRTFPDI---STNISDLNLSRTGI 858
Query: 399 SGPIPVSLSTCHSLVRVRMQN-NQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASS 457
+P + +L + M N L + KL+ LE + S G +T+ +
Sbjct: 859 E-EVPWWIEKFSNLSFLDMNGCNNLQRVSL----NISKLKHLETVDFSDCGALTEASWNG 913
Query: 458 TSLSFIDISRNHLRSSLPSTI 478
+ + N + S LPST+
Sbjct: 914 SPSEVAMATDN-IHSKLPSTV 933
|
syringae 6; Provisional. Length = 1153 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1018 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.61 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.46 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.37 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.23 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.18 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.13 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.12 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.1 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.09 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.06 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.04 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.02 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.99 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.98 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.94 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.93 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.77 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.76 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.73 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.72 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.61 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.52 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.5 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.41 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.41 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-118 Score=1144.21 Aligned_cols=921 Identities=39% Similarity=0.653 Sum_probs=798.5
Q ss_pred cHHHHHHHHHHHhccCCCCCCcCCCCCCCCCceeeeEEeCCCCCEEEEEcCCCCCCcccccccccCCCCCEEEcCCCCcC
Q 001752 32 LNDELLALLSIKAGLVDPLNSLHDWKLPSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLF 111 (1018)
Q Consensus 32 ~~~~~~~Ll~~k~~~~d~~~~~~~w~~~~~~c~w~gv~c~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~i~ 111 (1018)
.++|+.||++||+++.||...+.+|...++||.|.||+|+..++|+.|+|++++++|.+++.|..+++|+.|+|++|++.
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~ 106 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLS 106 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccC
Confidence 35789999999999998888889998888999999999998889999999999999999999999999999999999999
Q ss_pred CCCChhhh-CCCCCcEEEeeecccCCCCcccccCCCCCceeccCCCCCCcccccccccccccceEeccCcccCccccccc
Q 001752 112 SSLPNSLA-NLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSF 190 (1018)
Q Consensus 112 ~~~~~~l~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~ 190 (1018)
+.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|++|.+.+.+|..++++++|++|+|++|.+.+.+|..+
T Consensus 107 ~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~ 184 (968)
T PLN00113 107 GPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184 (968)
T ss_pred CcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhh
Confidence 88887765 999999999999999998886 568999999999999999999999999999999999999999999999
Q ss_pred ccccccceeeecccccCCCCCcccccccchhhhhccccccCCCCCccccCccccccccccccccCccCcccccCCCccce
Q 001752 191 KNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEI 270 (1018)
Q Consensus 191 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 270 (1018)
+++++|++|+|++|.+++.+|..++++++|++|+|++|++++.+|..++++++|++|++++|++.+.+|..++++++|+.
T Consensus 185 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 264 (968)
T PLN00113 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQY 264 (968)
T ss_pred hhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEccCCcCCccCChhhcCCCCCCeeeccCCCCccccCCccccccCCceeecccCccccccCCCCCCCCccceEEeccCcc
Q 001752 271 MFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSL 350 (1018)
Q Consensus 271 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 350 (1018)
|++++|++.+.+|..+.++++|++|++++|.+++.+|..+.++++|++|++++|.+++..|..+..+++|+.|++++|.+
T Consensus 265 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l 344 (968)
T PLN00113 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344 (968)
T ss_pred EECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcCCCCCCCCceeecccccccccccccccCCCCCceeccccccCCCCCcccccccccccEEeccCCcccCCCcccC
Q 001752 351 SGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGF 430 (1018)
Q Consensus 351 ~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~ 430 (1018)
.+.+|..++.+++|+.|++++|++++.+|..++.+++|+.|++++|++.+.+|..+..+++|+.|++++|++++.+|..|
T Consensus 345 ~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~ 424 (968)
T PLN00113 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424 (968)
T ss_pred cCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccccceeecccccccCCCccccCCCCccceEeccCCcccCCCCccccCCCCcccccccCCcccCCCCcccCCCCccce
Q 001752 431 GRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSV 510 (1018)
Q Consensus 431 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 510 (1018)
..++.|+.|++++|.+++.++..+..+++|+.|+|++|++.+.+|..+ ..++|+.|++++|++++.+|..|..+++|+.
T Consensus 425 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~ 503 (968)
T PLN00113 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQ 503 (968)
T ss_pred hcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCE
Confidence 999999999999999999999999999999999999999998888765 4689999999999999999999999999999
Q ss_pred eecccccccCCCCCccccccccceeecccccccCCcccccccCCccceeecccccccCCCCCCCCCCCCCceEEecCCcc
Q 001752 511 LDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRL 590 (1018)
Q Consensus 511 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 590 (1018)
|+|++|++++.+|..+.++++|+.|+|++|++++.+|..|..+++|+.|||++|++++.+|..+..+++|+.|++++|++
T Consensus 504 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l 583 (968)
T PLN00113 504 LKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583 (968)
T ss_pred EECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCccccccCCCCCCCCcCCCCCCC----CCCCCCCCCCCcccccccccchhHHHHHHHHHHHHHhheeeEEEecc
Q 001752 591 EGPVPANGVLRTINRGDLAGNAGLCGGVL----HPCSRYSPIASSHRSLHAKHIIPGWMIAISSLFAVGIAVFGARSLYK 666 (1018)
Q Consensus 591 ~~~~p~~~~~~~~~~~~~~~n~~~c~~~~----~~~~~~~~~~~~~~~~~~~~i~~~~~~~i~~~~~~~~~~~~~~~~~~ 666 (1018)
+|.+|..+.+.++...++.||+.+||.+. ++|... .+......++.+++++++++++++++++.+ ++
T Consensus 584 ~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 654 (968)
T PLN00113 584 HGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV------RKTPSWWFYITCTLGAFLVLALVAFGFVFI---RG 654 (968)
T ss_pred eeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc------cccceeeeehhHHHHHHHHHHHHHHHHHHH---Hh
Confidence 99999999999999999999999999653 355321 111111222222222222222222222211 11
Q ss_pred ccccCCCchhhhhccCCCCCcccchhhh---hcccChHHHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeecccc
Q 001752 667 RWNANGSCFEEKLEMGKGEWPWRLMAFQ---RLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRA 743 (1018)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~ 743 (1018)
+++......+ ...+. |....+. ...++.+++...|...+.||+|+||.||+|++..+++.||||++....
T Consensus 655 ~~~~~~~~~~----~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~- 727 (968)
T PLN00113 655 RNNLELKRVE----NEDGT--WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN- 727 (968)
T ss_pred hhcccccccc----ccccc--ccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc-
Confidence 1111111101 11111 1111111 112344556677888899999999999999998889999999983211
Q ss_pred ccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHH
Q 001752 744 DLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGL 823 (1018)
Q Consensus 744 ~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L 823 (1018)
....+|++.+++++|||||+++|+|.+++..++||||+++|+|.++++. ++|.++.+++.|||+|+
T Consensus 728 -------~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L 793 (968)
T PLN00113 728 -------SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKAL 793 (968)
T ss_pred -------cccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHH
Confidence 1123468889999999999999999999999999999999999999952 78999999999999999
Q ss_pred HHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHH
Q 001752 824 AYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVL 903 (1018)
Q Consensus 824 ~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il 903 (1018)
+|||+.+.++|+||||||+||+++.++.+++. ||.+...... ....+|++|+|||++.+..++.++|||||||++
T Consensus 794 ~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl 868 (968)
T PLN00113 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPETRETKDITEKSDIYGFGLIL 868 (968)
T ss_pred HHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccCcccccCCCCCcccchhhHHHHH
Confidence 99997766799999999999999999888875 6655432111 223678999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCC-chhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 904 LELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 904 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
|||++|+.||+........+..|.+...... ......|+..... ....++..++.+++.+||+.||++||||+||+++
T Consensus 869 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 869 IELLTGKSPADAEFGVHGSIVEWARYCYSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHhCCCCCCcccCCCCcHHHHHHHhcCcc-chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 9999999999776666667777776544332 2445555554322 2234566678899999999999999999999999
Q ss_pred hhccCCCCC
Q 001752 983 LGEAKPRRK 991 (1018)
Q Consensus 983 L~~~~~~~~ 991 (1018)
|+++.+...
T Consensus 948 L~~~~~~~~ 956 (968)
T PLN00113 948 LESASRSSS 956 (968)
T ss_pred HHHhhcccc
Confidence 998765443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-63 Score=632.45 Aligned_cols=517 Identities=37% Similarity=0.600 Sum_probs=494.2
Q ss_pred CCCCEEEcCCCCcCCCCChhhhCCCCCcEEEeeecccCCCCccccc-CCCCCceeccCCCCCCcccccccccccccceEe
Q 001752 98 KSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLG-GAAGLTFLNASGNNFSGFLLEDLGNATSLETLD 176 (1018)
Q Consensus 98 ~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ 176 (1018)
.+++.|+|++|++.+.+|..|..+++|++|+|++|+++|.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 4789999999999999999999999999999999999999998765 899999999999999987774 5789999999
Q ss_pred ccCcccCcccccccccccccceeeecccccCCCCCcccccccchhhhhccccccCCCCCccccCccccccccccccccCc
Q 001752 177 LRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGG 256 (1018)
Q Consensus 177 L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 256 (1018)
|++|.+.+.+|..++++++|++|+|++|.+++.+|..++++++|++|+|++|++.+.+|..++++++|++|+|++|++.+
T Consensus 147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 226 (968)
T PLN00113 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG 226 (968)
T ss_pred CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCccceEEccCCcCCccCChhhcCCCCCCeeeccCCCCccccCCccccccCCceeecccCccccccCCCCCC
Q 001752 257 KIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGG 336 (1018)
Q Consensus 257 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 336 (1018)
.+|..++++++|+.|++++|++.+.+|..+.++++|+.|+|++|.+++.+|..+..+++|++|+|++|.+++.+|..+.+
T Consensus 227 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~ 306 (968)
T PLN00113 227 EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306 (968)
T ss_pred cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccceEEeccCccccCCCcCCCCCCCCceeecccccccccccccccCCCCCceeccccccCCCCCcccccccccccEEe
Q 001752 337 LTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVR 416 (1018)
Q Consensus 337 l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 416 (1018)
+++|+.|++++|.+.+..|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|++++.+|..+..+.+|+.|+
T Consensus 307 l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~ 386 (968)
T PLN00113 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI 386 (968)
T ss_pred CCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCcccCCCcccCCCccccceeecccccccCCCccccCCCCccceEeccCCcccCCCCccccCCCCcccccccCCcccC
Q 001752 417 MQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVG 496 (1018)
Q Consensus 417 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 496 (1018)
+++|.+.+.+|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++.+|..+..+++|+.|++++|++.+
T Consensus 387 l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~ 466 (968)
T PLN00113 387 LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFG 466 (968)
T ss_pred CcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcccCCCCccceeecccccccCCCCCccccccccceeecccccccCCcccccccCCccceeecccccccCCCCCCCCC
Q 001752 497 EIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGA 576 (1018)
Q Consensus 497 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 576 (1018)
.+|..+. .++|+.|||++|++++.+|..+.++++|+.|+|++|++.+.+|..+..+++|++|+|++|.+++.+|..|..
T Consensus 467 ~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 545 (968)
T PLN00113 467 GLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSE 545 (968)
T ss_pred ecCcccc-cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhC
Confidence 8888764 589999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCceEEecCCcccCCCCCC-ccccccCCCCCCCCcCCCCC
Q 001752 577 SPALEVLNVSYNRLEGPVPAN-GVLRTINRGDLAGNAGLCGG 617 (1018)
Q Consensus 577 l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~ 617 (1018)
+++|+.|++++|+++|.+|.. ..+..+..+++.+|+..+..
T Consensus 546 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~ 587 (968)
T PLN00113 546 MPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSL 587 (968)
T ss_pred cccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeC
Confidence 999999999999999988863 34566788889999876543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=435.62 Aligned_cols=291 Identities=43% Similarity=0.747 Sum_probs=249.1
Q ss_pred cccchhhhhcccChHHHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCC
Q 001752 687 PWRLMAFQRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766 (1018)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 766 (1018)
+.+.|.+.++.. +++.|...+.||+|+||.||+|... +++.||||++...... . .++|.+|+.++.+++||
T Consensus 61 ~~~~fs~~el~~----AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~---~-~~eF~~Ei~~ls~l~H~ 131 (361)
T KOG1187|consen 61 PLRSFSYDELRK----ATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQ---G-EREFLNEVEILSRLRHP 131 (361)
T ss_pred CcceeeHHHHHH----HHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCc---c-hhHHHHHHHHHhcCCCc
Confidence 567778887754 8999999999999999999999998 4589999988322111 1 56699999999999999
Q ss_pred CcceeeeeEecCC-ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEE
Q 001752 767 NIVRLLGFLHNDT-NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNIL 845 (1018)
Q Consensus 767 niv~~~~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl 845 (1018)
|+|+++|||.+.+ +.++|||||++|+|+++++..... +++|.+|++||.++|+||+|||+.+.++|+||||||+|||
T Consensus 132 Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNIL 209 (361)
T KOG1187|consen 132 NLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNIL 209 (361)
T ss_pred CcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHee
Confidence 9999999999988 599999999999999999986654 6899999999999999999999999889999999999999
Q ss_pred EcCCCCeEEcccccceeeccCCcceEee-ccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCC-CCcccH
Q 001752 846 LDSNLEPRIADFGLARMMIRKNETVSMV-AGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEF-GESVDI 923 (1018)
Q Consensus 846 l~~~~~~kl~DfG~a~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~-~~~~~~ 923 (1018)
+|+++.+||+|||+|+............ .||.+|+||||...+..+.|+|||||||+++|+++|+.|.+... .....+
T Consensus 210 LD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l 289 (361)
T KOG1187|consen 210 LDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL 289 (361)
T ss_pred ECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence 9999999999999996543213333333 89999999999999999999999999999999999999988654 345568
Q ss_pred HHHHHHHhhcccccccccCCCCCCCchh-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCC
Q 001752 924 VEWIRMKIRDNRNLEEALDPNVGNCKHV-QEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPR 989 (1018)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 989 (1018)
..|........ .+.+++|+.+...... .++..++..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 290 ~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 290 VEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99987777666 5899999998632222 26788899999999999999999999999999665544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=376.10 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=214.8
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC-ceEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT-NMMIV 784 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lV 784 (1018)
..+..+.||+|..|+|||+.++.+++.+|+|++. ...++...+++.+|++++++.+||+||+++|.|.... ...++
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~---~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL---LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec---ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 4456788999999999999999999999999992 3445577889999999999999999999999999888 59999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
||||++|||++++...+. +++...-+|+.+|++||.|||+.. +||||||||+|||++..|.|||+|||.++.+.
T Consensus 157 mEYMDgGSLd~~~k~~g~----i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGR----IPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred hhhcCCCCHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 999999999999986643 889999999999999999999631 99999999999999999999999999998764
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
.. .....+||..|||||.+.+..|+.++||||||++++|+++|+.||.+......+..+.+.....+.. |.
T Consensus 231 nS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp-------P~ 301 (364)
T KOG0581|consen 231 NS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP-------PR 301 (364)
T ss_pred hh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC-------CC
Confidence 43 4466889999999999999999999999999999999999999998763434444454444333221 22
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
+... ....++..++..|+++||.+||+++|++++
T Consensus 302 lP~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 302 LPEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCcc----cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2111 234457788999999999999999999875
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=379.76 Aligned_cols=259 Identities=27% Similarity=0.381 Sum_probs=210.3
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeecccccccc---chhhhHHHHHHHHhccCCCCcceeeeeEecCC
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLET---ESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
..+.|...+.||+|+||.|-+|..+.+|+.||||++......... .......+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456678889999999999999999999999999999554333211 12334579999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC---CCeEEcc
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN---LEPRIAD 856 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~D 856 (1018)
..||||||++||+|.+++-..+. +.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999977665 55666677999999999999999 99999999999999766 6799999
Q ss_pred cccceeeccCCcceEeeccCCCccCcCCCCCCCC---CccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV---DEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD 933 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 933 (1018)
||+|+..+ .+..+.+.+|||.|.|||++.++.+ ..++|+||+||++|-+++|.+||.....+.. +.+.+ .+.
T Consensus 323 FGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-l~eQI---~~G 397 (475)
T KOG0615|consen 323 FGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-LKEQI---LKG 397 (475)
T ss_pred cchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-HHHHH---hcC
Confidence 99999865 5566778999999999999886553 3478999999999999999999987543321 11111 111
Q ss_pred ccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 934 NRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
...+ ....+.+...+..+++.+||..||++|||++|++++
T Consensus 398 ~y~f---------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 398 RYAF---------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cccc---------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1111 112345566677889999999999999999999874
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=388.40 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=218.4
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
.+|...+.||+|||+.||++++..+|+.||+|++.+. .-......+...+|+++.++++|||||+++++|++..++|+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~-~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKK-LLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehH-HhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 6788999999999999999999889999999999443 233455677788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
.|+|+.++|.++++.++. +++.++..+..||+.|+.|||+. +|+|||||..|++++++.+|||+|||+|..+.
T Consensus 97 LELC~~~sL~el~Krrk~----ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKP----LTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEecCCccHHHHHHhcCC----CCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeec
Confidence 999999999999985544 89999999999999999999999 99999999999999999999999999999998
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
.++....+.+|||-|+|||++.....+..+||||+||+||.|+.|++||+.. ++.+.+.........+..
T Consensus 170 ~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~vkety~~Ik~~~Y~~P~----- 239 (592)
T KOG0575|consen 170 YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----TVKETYNKIKLNEYSMPS----- 239 (592)
T ss_pred CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----hHHHHHHHHHhcCccccc-----
Confidence 7888888999999999999999999999999999999999999999999753 333333332222221111
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.......+||..+|+++|.+|||+++|+.+
T Consensus 240 --------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 240 --------HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --------ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122346678999999999999999999874
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=388.51 Aligned_cols=255 Identities=36% Similarity=0.522 Sum_probs=207.2
Q ss_pred ccceeecCCCeeEEEEEcCCCCeE-EEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC-ceEEEEE
Q 001752 709 ESNVIGMGATGIVYKAEMPRLNTI-VAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT-NMMIVYE 786 (1018)
Q Consensus 709 ~~~~lG~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lV~e 786 (1018)
..+.||+|+||+||+|.+. |+. ||||++........ ..++|.+|+.++.+++|||||+++|+|.+.. ..++|||
T Consensus 45 ~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~--~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDE--SRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChH--HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 3445999999999999998 555 99999954332222 2779999999999999999999999999887 7999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCC-eEeecCCCCcEEEcCCC-CeEEcccccceeec
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPP-IIHRDIKSNNILLDSNL-EPRIADFGLARMMI 864 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~~NIll~~~~-~~kl~DfG~a~~~~ 864 (1018)
||++|+|.++++.. ....+++..+++++.|||+|++|||++ + ||||||||+|||++.++ ++||+|||+++...
T Consensus 121 y~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred eCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 99999999999874 223489999999999999999999999 7 99999999999999998 99999999998765
Q ss_pred cCCcceEeeccCCCccCcCCCC--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGY--TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
......+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ..+...+.. ... .
T Consensus 196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~---~~~------R 264 (362)
T KOG0192|consen 196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVV---GGL------R 264 (362)
T ss_pred cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHh---cCC------C
Confidence 4334445578999999999999 66999999999999999999999999986432 222222211 111 1
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCC
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKP 988 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 988 (1018)
+..... ....+..++.+||+.||+.||++.+++..|+.+..
T Consensus 265 p~~p~~-----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 265 PPIPKE-----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCcc-----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 111110 22346678889999999999999999999987644
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=355.09 Aligned_cols=264 Identities=25% Similarity=0.355 Sum_probs=217.8
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeee-eEecCCc-e
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLG-FLHNDTN-M 781 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~-~~~~~~~-~ 781 (1018)
...|++.++||+|.||+|||+....+|..||.|.++ -...+....++...|+.++++++|||||++++ .+.++.. +
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~--f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ--FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc--hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 456778899999999999999999999999999994 33345556778899999999999999999998 4544444 8
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeecCCCCcEEEcCCCCeEEcccccc
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP-PIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~kl~DfG~a 860 (1018)
++||||+++|+|...++..+..+..+++..+|++..|+++||.++|+..+. -|+||||||.||+++.+|.||++|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999999988777777799999999999999999999995432 2899999999999999999999999999
Q ss_pred eeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccc
Q 001752 861 RMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 861 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
+++..........+|||.||+||.+.+.+|++++||||+||++|||+.-++||.+. .+.+..+. +....
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~K-I~qgd----- 244 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKK-IEQGD----- 244 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHH-HHcCC-----
Confidence 99866666666689999999999999999999999999999999999999999863 33332222 22221
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
+.|. ....+...+..++..|+.+||+.||+...+++.+..
T Consensus 245 ~~~~-----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 245 YPPL-----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCC-----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1111 123456678889999999999999996666655544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=352.91 Aligned_cols=265 Identities=24% Similarity=0.346 Sum_probs=215.8
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+...++|+|+||+|||++++.+|+.||||++.. +..++...+-..+|+.++++++|||+|.++++|......++|+
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~E--sedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVE--SEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeecc--CCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 46777889999999999999999999999999933 2334566778889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||++. ++-+.+.....+ ++.....+++.|++.|+.|+|++ +++||||||+||+++.+|.+|++|||+|+.+..
T Consensus 81 E~~dh-TvL~eLe~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNG---VPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred eecch-HHHHHHHhccCC---CCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99976 777777665543 78889999999999999999999 999999999999999999999999999999987
Q ss_pred CCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH-----------hhc
Q 001752 866 KNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMK-----------IRD 933 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----------~~~ 933 (1018)
++...+.++.|..|+|||.+.+ .+|+.++||||+||++.||++|.+-|.+.. +.|....++.. +..
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S--DiDQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS--DIDQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc--hHHHHHHHHHHHcccCHHHHHHhcc
Confidence 8888888999999999998876 789999999999999999999999987642 22222222221 222
Q ss_pred ccccccccCCCCCCCch----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 934 NRNLEEALDPNVGNCKH----VQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 934 ~~~~~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
...+..+.-|.+..... .+.....+++++..|++.||++|++-++++.
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 22223333333332222 1222335678999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=364.57 Aligned_cols=204 Identities=33% Similarity=0.549 Sum_probs=183.8
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
....|...+.||+|+||+||+|+++.++..||||.+.... ......+-...|+.+++.++|||||++++++..++++|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~--l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK--LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc--cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 3466778888999999999999999999999999994332 23445667789999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC------CCeEEcc
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN------LEPRIAD 856 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~------~~~kl~D 856 (1018)
+|||||.||+|.+|++.++. +++..+..++.|+|.||++||++ +||||||||+|||++.. -.+||+|
T Consensus 86 lVMEyC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecc
Confidence 99999999999999998764 89999999999999999999999 99999999999999875 4589999
Q ss_pred cccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPE 916 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 916 (1018)
||+|+.+. .+....+.+|+|-|||||++...+|+.|+|+||+|+++|||++|+.||+..
T Consensus 159 FGfAR~L~-~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 159 FGFARFLQ-PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred cchhhhCC-chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99999874 445566789999999999999999999999999999999999999999864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=392.13 Aligned_cols=478 Identities=28% Similarity=0.376 Sum_probs=348.3
Q ss_pred cCCCCCEEEcCCCCcCCCCChhhhCCCCCcEEEeeecccCCCCcccccCCCCCceeccCCCCCCcccccccccccccceE
Q 001752 96 RLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETL 175 (1018)
Q Consensus 96 ~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L 175 (1018)
.-..|+.|.+++|.+. .+.+.+.+|..|++|++++|+++ ..|++++.+.+++.|+.++|+++. +|++++.+.+|..|
T Consensus 43 ~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~-lp~~i~s~~~l~~l 119 (565)
T KOG0472|consen 43 EQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSE-LPEQIGSLISLVKL 119 (565)
T ss_pred hhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhh-ccHHHhhhhhhhhh
Confidence 3344555666666653 23344666667777777777766 666677777777777777777664 55667777777777
Q ss_pred eccCcccCcccccccccccccceeeecccccCCCCCcccccccchhhhhccccccCCCCCccccCccccccccccccccC
Q 001752 176 DLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLG 255 (1018)
Q Consensus 176 ~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 255 (1018)
+.++|.+. .+|+.++.+..|..|+..+|+++ ..|..++++.+|..|++.+|++....|..+. |+.|++||...|.+.
T Consensus 120 ~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~ 196 (565)
T KOG0472|consen 120 DCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE 196 (565)
T ss_pred hcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh
Confidence 77777777 56677777777777777777777 5677777777777777777777744444444 777777777766554
Q ss_pred ccCcccccCCCccceEEccCCcCCccCChhhcCCCCCCeeeccCCCCccccCCccc-cccCCceeecccCccccccCCCC
Q 001752 256 GKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEIT-QLKNLQLLNLMCNQLSGHVPAGL 334 (1018)
Q Consensus 256 ~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~~~~~ 334 (1018)
.+|..++.+++|+-|+|++|++. .+| +|..++.|++|+++.|+|. .+|.+.. .+++|..|||.+|+++ ..|+.+
T Consensus 197 -tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~ 271 (565)
T KOG0472|consen 197 -TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEI 271 (565)
T ss_pred -cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHH
Confidence 67777777778888888888877 455 6777888888888888886 5666544 7888888888888887 677777
Q ss_pred CCCCccceEEeccCccccCCCcCCCCCCCCceeecccccccccccccccCCCC--Cceecc-------ccc---cCC-CC
Q 001752 335 GGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGN--LTKLIL-------FNN---AFS-GP 401 (1018)
Q Consensus 335 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~L-------~~N---~l~-~~ 401 (1018)
+-+++|+.||+++|.|+ .+|..++++ +|+.|-+.+|.+..+-...+...+. |++|.= +.- .-+ +.
T Consensus 272 clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t 349 (565)
T KOG0472|consen 272 CLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMT 349 (565)
T ss_pred HHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCC
Confidence 77888888888888887 567778887 7888888888776322221211110 222211 100 000 00
Q ss_pred -Cc---ccccccccccEEeccCCcccCCCcccCCCc--cccceeecccccccCCCccccCCCCccc-eEeccCCcccCCC
Q 001752 402 -IP---VSLSTCHSLVRVRMQNNQLSGTIPVGFGRL--EKLQRLELANNSLTGGITDDIASSTSLS-FIDISRNHLRSSL 474 (1018)
Q Consensus 402 -~~---~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~ 474 (1018)
.+ .......+.+.|+++.-+++....+.|..- .-.+..+++.|++. .+|..+..+..+. .+.+++|.+ +.+
T Consensus 350 ~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv 427 (565)
T KOG0472|consen 350 LPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFV 427 (565)
T ss_pred CCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccc
Confidence 11 122334567888899999984444444332 23788999999998 5677777776654 455666665 588
Q ss_pred CccccCCCCcccccccCCcccCCCCcccCCCCccceeecccccccCCCCCccccccccceeecccccccCCcccccccCC
Q 001752 475 PSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMP 554 (1018)
Q Consensus 475 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 554 (1018)
|..++.+++|..|+|++|-+. .+|..++.+..|+.||+|.|+|. ..|..+-.+..|+.+-.++|++....|..+.+|.
T Consensus 428 ~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~ 505 (565)
T KOG0472|consen 428 PLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMR 505 (565)
T ss_pred hHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhh
Confidence 889999999999999999888 78999999999999999999998 7899888888899999999999988888899999
Q ss_pred ccceeecccccccCCCCCCCCCCCCCceEEecCCccc
Q 001752 555 TLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591 (1018)
Q Consensus 555 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 591 (1018)
+|.+|||.+|.|. .+|+.++++++|++|+++||+|.
T Consensus 506 nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 506 NLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 9999999999998 88999999999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=358.87 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=208.8
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|+..++||+|+||.||.++.+.+++.+|+|++++.. -......+...+|..++.+++||+||+++-.|++.+..|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~-iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKK-IVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhH-hhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 466889999999999999999999999999999995433 2333457788899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
|+||+.||.|..+|..... +++..+.-++..|+.||.|||+. |||||||||+|||+|.+|+++++|||+++.-
T Consensus 103 Vld~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999986654 78888888999999999999999 9999999999999999999999999999976
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
...+....+.+||+.|||||++.+..|+.++|+||+|+++|||++|.+||... +...++........... +
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~~~~I~~~k~~~~----p 246 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKMYDKILKGKLPLP----P 246 (357)
T ss_pred ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHHHHHHhcCcCCCC----C
Confidence 66666677789999999999999999999999999999999999999999763 34444444333331100 1
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCC
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRP 974 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 974 (1018)
. -......+++.+.++.||++|-
T Consensus 247 ~--------~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 247 G--------YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred c--------cCCHHHHHHHHHHhccCHHHhc
Confidence 0 0123356788899999999994
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=377.13 Aligned_cols=475 Identities=30% Similarity=0.415 Sum_probs=392.9
Q ss_pred CEEEEEcCCCCCCcccccccccCCCCCEEEcCCCCcCCCCChhhhCCCCCcEEEeeecccCCCCcccccCCCCCceeccC
Q 001752 75 AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNAS 154 (1018)
Q Consensus 75 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls 154 (1018)
....+++++|.+.. +.+.+.+|..|++|++++|++ ...|++++.+..++.|+.|+|+++ .+|..++.+.+|+.|+.+
T Consensus 46 ~l~~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l-~~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLEV-LREDLKNLACLTVLNVHDNKL-SQLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchhh-ccHhhhcccceeEEEeccchh-hhCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 35789999999875 556789999999999999999 467889999999999999999999 899999999999999999
Q ss_pred CCCCCcccccccccccccceEeccCcccCcccccccccccccceeeecccccCCCCCcccccccchhhhhccccccCCCC
Q 001752 155 GNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEI 234 (1018)
Q Consensus 155 ~n~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~ 234 (1018)
+|.+.. .++.++.+-.|+.|+..+|+++ ..|.++.++.+|..|++.+|+++.. |+..-+++.|++|+...|-++ .+
T Consensus 123 ~n~~~e-l~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~~N~L~-tl 198 (565)
T KOG0472|consen 123 SNELKE-LPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCNSNLLE-TL 198 (565)
T ss_pred ccceee-cCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhC-CHHHHHHHHHHhcccchhhhh-cC
Confidence 999987 5678999999999999999999 7889999999999999999999954 444445999999999999998 78
Q ss_pred CccccCccccccccccccccCccCcccccCCCccceEEccCCcCCccCChhhc-CCCCCCeeeccCCCCccccCCccccc
Q 001752 235 PVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIG-NITSLQLLDLSYNMLSHEIPAEITQL 313 (1018)
Q Consensus 235 ~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l 313 (1018)
|+.++.|.+|..|+|..|++. .+| +|.++..|.+|+++.|+|. .+|++.. ++++|..|||.+|+++ ..|..+.-+
T Consensus 199 P~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clL 274 (565)
T KOG0472|consen 199 PPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLL 274 (565)
T ss_pred ChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHh
Confidence 999999999999999999998 566 8999999999999999998 6666555 8999999999999997 789999999
Q ss_pred cCCceeecccCccccccCCCCCCCCccceEEeccCccccCCCcCCCCCC--CCceee-------ccccccc----cc---
Q 001752 314 KNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNS--PLQWLD-------LSSNSFS----GE--- 377 (1018)
Q Consensus 314 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~--~L~~L~-------Ls~N~l~----~~--- 377 (1018)
++|.+||+++|.|+ ..|..++++ .|+.|-+.+|.+...-.+.+.+-+ -|++|. +|...=. +.
T Consensus 275 rsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~ 352 (565)
T KOG0472|consen 275 RSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPS 352 (565)
T ss_pred hhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCC
Confidence 99999999999999 578889999 899999999988631111111111 022221 1111100 01
Q ss_pred -ccccccCCCCCceeccccccCCCCCccccccc--ccccEEeccCCcccCCCcccCCCccccce-eecccccccCCCccc
Q 001752 378 -IPASLCNGGNLTKLILFNNAFSGPIPVSLSTC--HSLVRVRMQNNQLSGTIPVGFGRLEKLQR-LELANNSLTGGITDD 453 (1018)
Q Consensus 378 -~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~-L~L~~N~l~~~~~~~ 453 (1018)
.........+.+.|+++.-+++..+...|..- .-.+.++++.|++. .+|..+..+..+.+ +.+++|.+. .+|..
T Consensus 353 ~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~ 430 (565)
T KOG0472|consen 353 ESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLE 430 (565)
T ss_pred CcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHH
Confidence 11122345578889999999984433333322 23788999999998 78887777776654 556666554 78888
Q ss_pred cCCCCccceEeccCCcccCCCCccccCCCCcccccccCCcccCCCCcccCCCCccceeecccccccCCCCCccccccccc
Q 001752 454 IASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLV 533 (1018)
Q Consensus 454 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 533 (1018)
+..+++|+.|+|++|-+. .+|..++.+..|+.|++++|++. .+|.....+..|+.+-.+.|++....|..+.++.+|.
T Consensus 431 l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~ 508 (565)
T KOG0472|consen 431 LSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLT 508 (565)
T ss_pred HHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcc
Confidence 999999999999999997 67889999999999999999998 7898888888888888888999866666699999999
Q ss_pred eeecccccccCCcccccccCCccceeeccccccc
Q 001752 534 NLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLT 567 (1018)
Q Consensus 534 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 567 (1018)
+|||.+|.|. .+|..+++|.+|+.|+|++|+++
T Consensus 509 tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 509 TLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred eeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 9999999999 78889999999999999999998
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=370.27 Aligned_cols=388 Identities=24% Similarity=0.243 Sum_probs=277.4
Q ss_pred EEEEcCCCCCCcccccccccC--CCCCEEEcCCCCcCCCCChhhhCCCCCcEEEeeecccCCCCcccccCCCCCceeccC
Q 001752 77 EKLDLSHMNLSGCVSDHFQRL--KSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNAS 154 (1018)
Q Consensus 77 ~~L~L~~~~l~~~~~~~~~~l--~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls 154 (1018)
..||.+++.|..+-...+.++ +.-+.|++++|++..+.+..|.++++|++++|.+|.++ .||...+...+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 455555555544333333222 34567999999999999999999999999999999998 899888888899999999
Q ss_pred CCCCCcccccccccccccceEeccCcccCcccccccccccccceeeecccccCCCCCcccccccchhhhhccccccCCCC
Q 001752 155 GNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEI 234 (1018)
Q Consensus 155 ~n~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~ 234 (1018)
+|.|+.+-.++++.++.|+.||||.|.|+.+.-.+|..-.++++|+|++|+|+..--..|.++.+|.+|.|+.|+++...
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp 213 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP 213 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence 99999988999999999999999999999666667877788999999999999877788888888888888888888666
Q ss_pred CccccCccccccccccccccCccCcccccCCCccceEEccCCcCCccCChhhcCCCCCCeeeccCCCCccccCCcccccc
Q 001752 235 PVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLK 314 (1018)
Q Consensus 235 ~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 314 (1018)
+..|.+|++|+.|+|..|++.-.-.- .|..+++|+.|.|..|.|+..-...|..+.
T Consensus 214 ~r~Fk~L~~L~~LdLnrN~irive~l------------------------tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~ 269 (873)
T KOG4194|consen 214 QRSFKRLPKLESLDLNRNRIRIVEGL------------------------TFQGLPSLQNLKLQRNDISKLDDGAFYGLE 269 (873)
T ss_pred HHHhhhcchhhhhhccccceeeehhh------------------------hhcCchhhhhhhhhhcCcccccCcceeeec
Confidence 66777788888888877766532222 345555556666666666555555566666
Q ss_pred CCceeecccCccccccCCCCCCCCccceEEeccCccccCCCcCCCCCCCCceeecccccccccccccccCCCCCceeccc
Q 001752 315 NLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILF 394 (1018)
Q Consensus 315 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 394 (1018)
++++|+|+.|+++..-..++.+++.|+.|+|++|.|...-++.+.-.++|++|+|++|+|+...+.+|..+..|+.|+|+
T Consensus 270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs 349 (873)
T KOG4194|consen 270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLS 349 (873)
T ss_pred ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccc
Confidence 66666666666665555566666666666666666665556666666666666666666666666666666777777777
Q ss_pred cccCCCCCcccccccccccEEeccCCcccCCCcc---cCCCccccceeecccccccCCCccccCCCCccceEeccCCccc
Q 001752 395 NNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPV---GFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLR 471 (1018)
Q Consensus 395 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 471 (1018)
+|+++..-...|..+++|+.|||.+|.|+..+.. .|..+++|+.|+|.+|+|..+...+|.++..|++|||.+|.|.
T Consensus 350 ~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Naia 429 (873)
T KOG4194|consen 350 HNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIA 429 (873)
T ss_pred ccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcce
Confidence 7777665556666666666666666666644432 4666777777777777777666666666666666666666666
Q ss_pred CCCCccccCCCCccccccc
Q 001752 472 SSLPSTILSIPNLQTFIVS 490 (1018)
Q Consensus 472 ~~~~~~~~~l~~L~~L~L~ 490 (1018)
++-|.+|..+ .|++|.+.
T Consensus 430 SIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 430 SIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred eecccccccc-hhhhhhhc
Confidence 6666666666 66666554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=363.67 Aligned_cols=253 Identities=32% Similarity=0.473 Sum_probs=204.3
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
++..+.||+|.||+||.|.+.. ...||+|.++.. .....+|.+|+++|++++|++||+++++|..++.+|||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~-----~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG-----SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEecc-----ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 4456789999999999999983 458999999332 3456789999999999999999999999999889999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
||+.|+|.++|+... +..+...+.+.++.|||+|++||+++ ++|||||.+.||||+++..+||+|||+|+... +
T Consensus 282 ~m~~GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d 355 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG-D 355 (468)
T ss_pred ecccCcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC-C
Confidence 999999999998733 23378889999999999999999999 99999999999999999999999999999432 2
Q ss_pred CcceEe--eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 867 NETVSM--VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 867 ~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
+..... ..-...|+|||.+...+++.|||||||||+||||+| |+.||.... ..++...+....+- |
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--n~ev~~~le~GyRl---------p 424 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--NEEVLELLERGYRL---------P 424 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--HHHHHHHHhccCcC---------C
Confidence 222222 223457999999999999999999999999999999 899987642 22233333221111 2
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCC
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKP 988 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 988 (1018)
.+..|+ ..+.+++..||+.+|++|||++.+...++....
T Consensus 425 ~P~~CP------~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 425 RPEGCP------DEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCC------HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 222332 347789999999999999999999888877543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=356.18 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=208.1
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 783 (1018)
+.|.+++.||+|+|++||+|+...+++.||||++.+.. -..+...+.+.+|-.+|.++ .||.|++++-.|+++..+|+
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~-Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRY-IIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHH-HHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 55778899999999999999999999999999994432 33445566778899999999 89999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
|+||+++|+|.+++++.+. +++.-...++.+|+.|++|||++ |||||||||+|||+|+||+++|+|||.|+.+
T Consensus 152 vLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999988765 78888888999999999999999 9999999999999999999999999999987
Q ss_pred ccCCcc-------------eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 001752 864 IRKNET-------------VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMK 930 (1018)
Q Consensus 864 ~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 930 (1018)
.+.... ....+||..|.+||++.....++.+|+|+||||+|+|+.|++||.+..+ +.. .+..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----yli-FqkI 299 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----YLI-FQKI 299 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----HHH-HHHH
Confidence 432111 1347899999999999999999999999999999999999999975311 111 1111
Q ss_pred hhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 931 IRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
+.-...+.+. .+ ..+.+|+.+.|..||.+|+|.++|.++-
T Consensus 300 ~~l~y~fp~~----------fp---~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 300 QALDYEFPEG----------FP---EDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHhcccCCCC----------CC---HHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1111111111 11 3356788899999999999999988753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=322.06 Aligned_cols=267 Identities=24% Similarity=0.341 Sum_probs=210.7
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
.+|...+++|+|.||.||+|++..+|+.||||+++... ..........+|+..++.++||||+.++++|...+.+.+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~--~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGN--AKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccc--cccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence 45777889999999999999999999999999995542 2334456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
+|||+. +|+..+++... .+...++..++.++++|++|+|++ .|+||||||.|++++.+|.+|++|||+|+.+.
T Consensus 80 fEfm~t-dLe~vIkd~~i---~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNI---ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred EEeccc-cHHHHhccccc---ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccC
Confidence 999975 99999976543 488899999999999999999999 99999999999999999999999999999998
Q ss_pred cCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHH-HHHHhhcc-------c
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEW-IRMKIRDN-------R 935 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~-~~~~~~~~-------~ 935 (1018)
.++......+-|..|+|||.+.| +.|+..+||||.|||+.||+.|.+-|.+.. +.+.... .+..-.+. .
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s--DidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS--DIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc--hHHHHHHHHHHcCCCCcccCcccc
Confidence 88877777789999999998776 569999999999999999999887776532 1111111 11110000 0
Q ss_pred ccccccC----CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 936 NLEEALD----PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 936 ~~~~~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.+.+..+ |......-.+......++++..|+..||.+|++++|++++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0111100 0000000111223345789999999999999999999875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=353.79 Aligned_cols=266 Identities=25% Similarity=0.317 Sum_probs=207.5
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC--Cce
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND--TNM 781 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 781 (1018)
.+.|+..++||+|.||.||+|++..+|+.||+|++.... .++.......+||.++++++||||+++.+...+. ..+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~--~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN--EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc--CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 355677789999999999999999999999999994332 2345567778999999999999999999998776 689
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
|||+|||+. +|.-++..... .+++.++..++.|++.||+|+|++ ||+|||||.+|||+|.+|.+||+|||+|+
T Consensus 194 YlVFeYMdh-DL~GLl~~p~v---kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGV---KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEEecccc-hhhhhhcCCCc---ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccccee
Confidence 999999987 99999876433 389999999999999999999999 99999999999999999999999999999
Q ss_pred eeccCCcc-eEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHh-hcc---c
Q 001752 862 MMIRKNET-VSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKI-RDN---R 935 (1018)
Q Consensus 862 ~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~---~ 935 (1018)
++...... .+..+.|..|+|||.+.| ..|+.++|+||.|||+.||++|++.|.+..+-++ ..-+.... ... +
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ--l~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ--LHKIFKLCGSPTEDYW 344 (560)
T ss_pred eccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH--HHHHHHHhCCCChhcc
Confidence 88655443 566788999999998776 5699999999999999999999999987533211 11111111 000 0
Q ss_pred c---cc--cccCCCCCCCchh-H----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 936 N---LE--EALDPNVGNCKHV-Q----EEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 936 ~---~~--~~~~~~~~~~~~~-~----~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
. +. ..+.+... .... . ......++|+..+|..||++|.|+.++++
T Consensus 345 ~~~kLP~~~~~kp~~~-y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQP-YKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCcccccCCCCc-ccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 00 11111110 0011 1 11234667899999999999999999986
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=366.72 Aligned_cols=363 Identities=23% Similarity=0.226 Sum_probs=262.2
Q ss_pred hhccccccCCCCCccccCccccccccccccccCccCcccccCCCccceEEccCCcCCccCChhhcCCCCCCeeeccCCCC
Q 001752 223 MILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNML 302 (1018)
Q Consensus 223 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 302 (1018)
|++++|+++..-+..|.++++|++++|..|.++ .+|.......+|+.|+|.+|.|+..-.+++..++.|+.||||.|.|
T Consensus 83 LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~i 161 (873)
T KOG4194|consen 83 LDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLI 161 (873)
T ss_pred eeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchh
Confidence 444444444344444444444444444444443 3444444444455555566666655556677777777777777777
Q ss_pred ccccCCccccccCCceeecccCccccccCCCCCCCCccceEEeccCccccCCCcCCCCCCCCceeecccccccccccccc
Q 001752 303 SHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASL 382 (1018)
Q Consensus 303 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~ 382 (1018)
+.+.-..|..-.++++|+|++|.|+..-.+.|.++.+|..|.|++|+++...+..|..+++|+.|+|..|+|.-.--..|
T Consensus 162 s~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltF 241 (873)
T KOG4194|consen 162 SEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTF 241 (873)
T ss_pred hcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhh
Confidence 75444556666777777777777777777777777777777888887776666667777778888888887764335567
Q ss_pred cCCCCCceeccccccCCCCCcccccccccccEEeccCCcccCCCcccCCCccccceeecccccccCCCccccCCCCccce
Q 001752 383 CNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSF 462 (1018)
Q Consensus 383 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 462 (1018)
.++++|+.|.|..|.+.......|..+.++++|+|..|++...-..++-+++.|+.|+||+|.|..+.++.+...++|++
T Consensus 242 qgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~ 321 (873)
T KOG4194|consen 242 QGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKE 321 (873)
T ss_pred cCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhccccee
Confidence 77888888888888887777777888888888888888888777777778888888888888888777778888888888
Q ss_pred EeccCCcccCCCCccccCCCCcccccccCCcccCCCCcccCCCCccceeecccccccCCCC---Cccccccccceeeccc
Q 001752 463 IDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIP---SSIASCEKLVNLNLRN 539 (1018)
Q Consensus 463 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~Ls~ 539 (1018)
|+||+|+|+...+..|..+..|++|.|++|.++..-...|..+.+|++|||++|.|+..+. ..|.+|++|+.|+|.+
T Consensus 322 LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~g 401 (873)
T KOG4194|consen 322 LDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTG 401 (873)
T ss_pred EeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecC
Confidence 8888888887777888888888888888888876556677778888888888888776543 3466788888888888
Q ss_pred ccccCCcccccccCCccceeecccccccCCCCCCCCCCCCCceEEecC
Q 001752 540 NQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSY 587 (1018)
Q Consensus 540 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 587 (1018)
|+|..+...+|.+++.|+.|||.+|.|..+.|+.|..+ .|++|-+..
T Consensus 402 Nqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 402 NQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred ceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence 88886666788888888888888888887888888777 676665544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.39 Aligned_cols=268 Identities=25% Similarity=0.322 Sum_probs=209.7
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeeeEecCC-c
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHNDT-N 780 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~-~ 780 (1018)
+-++|...+.||.|.||.||+|+...++..||||+++++-..++ .-.=.||+..+++++ ||||+++.+.+.+.+ .
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e---e~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE---ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH---HHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 56789999999999999999999999999999999955433322 223368999999998 999999999998877 8
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 860 (1018)
.|+|||||+ .+|+++++.+. ..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|
T Consensus 85 L~fVfE~Md-~NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 85 LYFVFEFMD-CNLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLA 157 (538)
T ss_pred EeeeHHhhh-hhHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccc
Confidence 999999995 59999998773 3589999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceEeeccCCCccCcCCCC-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc-c----
Q 001752 861 RMMIRKNETVSMVAGSYGYIAPEYGY-TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD-N---- 934 (1018)
Q Consensus 861 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~---- 934 (1018)
+.. ......+.++-|..|+|||++. ..-|+.+.||||+|||++|+.+-++-|.+..+ .|...-+...+.. .
T Consensus 158 Rev-~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE--~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 158 REV-RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE--IDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred ccc-ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH--HHHHHHHHHHhCCCccccc
Confidence 975 3455667789999999999754 67799999999999999999999998976322 2211111111110 0
Q ss_pred ---cccccccCCCCCCC------chhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 935 ---RNLEEALDPNVGNC------KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 935 ---~~~~~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
..+.....-....+ .-.+....+..+++.+|+..||.+|||+++++++-
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 00001111000000 00112345677899999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=335.83 Aligned_cols=262 Identities=25% Similarity=0.353 Sum_probs=210.9
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|+....||.|..++||+|+....++.||||++.-+... ...+.+.+|+..++.++||||++++..|..++..|+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~---~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN---NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh---hhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 46688889999999999999999989999999999544333 346789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||.||.+||+.+.++..-..+ +++..+..|.+++++||.|||.+ |.||||||+.|||++.+|.|||+|||.+..+
T Consensus 102 VmpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred eehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeee
Confidence 999999999999998765544 88999999999999999999999 9999999999999999999999999998776
Q ss_pred ccCCcceE----eeccCCCccCcCCCC--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 001752 864 IRKNETVS----MVAGSYGYIAPEYGY--TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 864 ~~~~~~~~----~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
...+.... ..+||++|+|||++. ...|+.|+||||||++..|+.+|..||.....- ....+.+....+.
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-----kvLl~tLqn~pp~ 251 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-----KVLLLTLQNDPPT 251 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-----HHHHHHhcCCCCC
Confidence 55544333 358999999999954 346999999999999999999999999753221 1122222222211
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.+ ...............+.+++..|+++||++|||++++++
T Consensus 252 ~~---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 LL---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cc---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11 000011111222335778999999999999999999987
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=354.39 Aligned_cols=254 Identities=27% Similarity=0.362 Sum_probs=213.3
Q ss_pred HHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCce
Q 001752 702 DILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 702 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 781 (1018)
+....|+....||+|+.|.||.|....+++.||||++... .....+-+.+|+.+|+..+|+|||++++.|-.++..
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~----~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR----KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEec----cCCchhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 3556677778999999999999999999999999999322 223445678999999999999999999999988999
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
++|||||+||+|.+.+.... +++.++..|+.++++||+|||.+ ||+|||||.+||+++.+|.+||+|||++.
T Consensus 346 WVVMEym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred EEEEeecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeee
Confidence 99999999999999997655 89999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 862 MMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 862 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
.+..........+|||+|||||+.....|++++||||||++++||+-|.+||-.+. -+...+. +....
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~----PlrAlyL--------Ia~ng 485 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN----PLRALYL--------IATNG 485 (550)
T ss_pred ccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC----hHHHHHH--------HhhcC
Confidence 88766666777899999999999999999999999999999999999999995421 1111111 11112
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.|.+... ......+.+++.+||+.||++||+++|++++
T Consensus 486 ~P~lk~~---~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 486 TPKLKNP---EKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCCcCCc---cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2333222 2234456678889999999999999999974
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=350.05 Aligned_cols=250 Identities=27% Similarity=0.395 Sum_probs=214.7
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
++|.+.+.||+|.||.||||+.+.+.+.||+|.+.+. ...+...+.+.+|++++++++||||+.++++|+...++++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~--gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKS--GRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhc--CCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 4567778899999999999999999999999999433 22344567789999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
.||+.| +|..++...+. ++++.+..|+.+++.||.|||+. +|.|||+||.||+++..|.+|++|||+|+.+.
T Consensus 80 te~a~g-~L~~il~~d~~----lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGK----LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred ehhhhh-hHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcc
Confidence 999977 99999987766 89999999999999999999999 99999999999999999999999999999987
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
......+.+.|||.|||||...++.|+..+|+||+||++||+++|++||... .+.+.++....+... +
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~v~------~- 219 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDPVK------P- 219 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCCCC------C-
Confidence 7766777789999999999999999999999999999999999999999642 344444444433321 1
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
..........++...+.+||..|.+..+++.+
T Consensus 220 ------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 220 ------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ------cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 11223445678889999999999999998763
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=321.03 Aligned_cols=241 Identities=23% Similarity=0.298 Sum_probs=201.4
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
...|+..+.||.|+||.|..++.+.+|..+|+|++.... -......++..+|..+++.+.||+++++++.+.+.+..||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~-vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK-VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH-HHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 456777889999999999999999999999999994332 2233445667889999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||++||.|.+++++.+. +++.++.-+|.||+.|++|||+. +|++||+||+|||+|++|.+||+|||+|+..
T Consensus 122 vmeyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 9999999999999987665 88889999999999999999999 9999999999999999999999999999875
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
. ....+.+|||.|+|||.+..+.+..++|.|||||++|||+.|.+||..... ...+.........+...+
T Consensus 195 ~---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~iY~KI~~~~v~fP~~f-- 264 (355)
T KOG0616|consen 195 S---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQIYEKILEGKVKFPSYF-- 264 (355)
T ss_pred c---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HHHHHHHHhCcccCCccc--
Confidence 2 236678999999999999999999999999999999999999999976422 222222232222222221
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCC
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDR 973 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 973 (1018)
...+.+|+...++.|-.+|
T Consensus 265 -----------s~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 265 -----------SSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -----------CHHHHHHHHHHHhhhhHhh
Confidence 2235567788888888888
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.51 Aligned_cols=254 Identities=26% Similarity=0.354 Sum_probs=211.9
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccc-cchhhhHHHHHHHHhccC-CCCcceeeeeEecCCc
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLE-TESSGDFVGEVNVLGKLR-HRNIVRLLGFLHNDTN 780 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 780 (1018)
..+.|...+.||+|+||.||.|.+..++..||+|++.+...... ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 45788999999999999999999999999999997744322111 134556778999999998 9999999999999999
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC-CCeEEccccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN-LEPRIADFGL 859 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG~ 859 (1018)
.|+||||+.||+|.+++..... +.+..+..++.|++.|++|+|+. ||+||||||+||++|.+ +.+||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~----l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGR----LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCC----CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999987443 77889999999999999999999 99999999999999999 9999999999
Q ss_pred ceeeccCCcceEeeccCCCccCcCCCCCCC-CC-ccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 001752 860 ARMMIRKNETVSMVAGSYGYIAPEYGYTLK-VD-EKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 860 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
+......+......+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+.. +.....+........+
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-----~~~~l~~ki~~~~~~~ 242 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-----NVPNLYRKIRKGEFKI 242 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcCCccC
Confidence 987644456667789999999999999877 76 7999999999999999999999862 3333333323333322
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 980 (1018)
...+. ...+..++.+|+.++|.+|+|+.+++
T Consensus 243 p~~~~------------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 243 PSYLL------------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCCcC------------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 22221 34467799999999999999999999
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=324.13 Aligned_cols=270 Identities=23% Similarity=0.244 Sum_probs=211.9
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec--CCc
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN--DTN 780 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 780 (1018)
..+.|+..++|++|.||.||+|+++.+++.||+|+++.+. ......-...+|+.++.+++|||||.+-++... -+.
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek--ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK--EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc--ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 4567888999999999999999999999999999995543 223334567899999999999999999988754 467
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 860 (1018)
+|+|||||+. +|..+++..+. ++...++..+..|+++|++|||.+ .|+|||||++|+++...|.+||+|||+|
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q---~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQ---PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchh
Confidence 9999999987 99999987763 478888889999999999999999 8999999999999999999999999999
Q ss_pred eeeccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 861 RMMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 861 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
+.+..+.+..+..+.|..|+|||.+.+ ..|+++.||||+|||+.||+++++.|.+...- ..+...++..-.+...+..
T Consensus 225 R~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 225 REYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred hhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HHHHHHHHHhCCCccccCC
Confidence 999888888888999999999998776 45999999999999999999999999774321 1122222222111111111
Q ss_pred ccCC-C----CC---CCch-----hHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 940 ALDP-N----VG---NCKH-----VQE--EMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 940 ~~~~-~----~~---~~~~-----~~~--~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
-++. . .. .... ... ....-++++..++..||.+|.|++|.+++
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1100 0 00 0000 000 12345678899999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=340.98 Aligned_cols=261 Identities=27% Similarity=0.392 Sum_probs=203.8
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC--ceE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT--NMM 782 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~ 782 (1018)
..+...+.||+|+||+||.+...++|+..|||.+..... ...+.+.+|+.++++++|||||+++|...... .++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~----~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS----PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc----hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 345667899999999999999998899999999843311 11667899999999999999999999855444 689
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcC-CCCeEEcccccce
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS-NLEPRIADFGLAR 861 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~a~ 861 (1018)
+.|||+++|+|.+++...+. .+++..+..++.||++||+|||++ |||||||||+|||++. ++.+||+|||.++
T Consensus 93 i~mEy~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~ 166 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAK 166 (313)
T ss_pred eeeeccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccc
Confidence 99999999999999987653 389999999999999999999999 9999999999999999 7999999999998
Q ss_pred eeccC---CcceEeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 001752 862 MMIRK---NETVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 862 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
..... ........||+.|||||++..+ ...+++||||+||++.||+||++||... .+...++........ .
T Consensus 167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~~-~ 241 (313)
T KOG0198|consen 167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGREDS-L 241 (313)
T ss_pred ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccCC-C
Confidence 76431 1223347899999999999853 3445999999999999999999999752 111222211111110 1
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
|.+.. .......+++.+|+..+|++|||+++++++---.+...
T Consensus 242 -----P~ip~-----~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 242 -----PEIPD-----SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred -----CCCCc-----ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 11111 11234567888999999999999999999875544433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=366.89 Aligned_cols=263 Identities=30% Similarity=0.452 Sum_probs=213.0
Q ss_pred hcccccceeecCCCeeEEEEEcC-----CCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC
Q 001752 705 ACIRESNVIGMGATGIVYKAEMP-----RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
......+.||+|+||.||+|+.. ++...||||.++. ..+....++|++|++.++.++|||||+++|.|.+++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd---~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD---KAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc---cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 33456678999999999999864 3457899999943 233457889999999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHhhhcCCC------C----ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQA------G----RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN 849 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~------~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 849 (1018)
..+||+|||..|+|.+||..+.. . +.+++..+.+.||.|||.|++||-++ .+|||||..+|++|.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 99999999999999999975432 1 23488999999999999999999999 89999999999999999
Q ss_pred CCeEEcccccceeeccCCcceE--eeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 001752 850 LEPRIADFGLARMMIRKNETVS--MVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEW 926 (1018)
Q Consensus 850 ~~~kl~DfG~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~ 926 (1018)
..|||+|||+++..-..+.... ...-..+|||||.+..+++|+++|||||||+|||+++ |+.||.+... .++++.
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--~EVIe~ 717 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--QEVIEC 717 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--HHHHHH
Confidence 9999999999986533222211 2334679999999999999999999999999999999 9999976422 233343
Q ss_pred HHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 927 IRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
++ .+.. -+....|+ .+++.|+..||+..|.+||+++||-..|+.+....
T Consensus 718 i~----~g~l-----L~~Pe~CP------~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 718 IR----AGQL-----LSCPENCP------TEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HH----cCCc-----ccCCCCCC------HHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 32 2221 12223332 45788999999999999999999999998876544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=360.34 Aligned_cols=260 Identities=28% Similarity=0.502 Sum_probs=217.0
Q ss_pred hcccccceeecCCCeeEEEEEcCCCC---eEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCce
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLN---TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 781 (1018)
.+..+.++||.|.||+||+|+++..+ ..||||.++. ...+....+|..|+.+|.+++||||+++.|+......+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~---GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA---GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeecc---CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 44567889999999999999997554 6799999943 44556788999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
++|.|||++|+|+.||+.+... +.+.+...+.++||.|+.||-+. ++|||||.+.|||++.+-.+||+|||+++
T Consensus 706 MIiTEyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccccee
Confidence 9999999999999999877643 88999999999999999999999 99999999999999999999999999999
Q ss_pred eeccCCcceEe-ecc--CCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccc
Q 001752 862 MMIRKNETVSM-VAG--SYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 862 ~~~~~~~~~~~-~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
.+.++...... ..| ..+|+|||.+..+++|.++||||||++|||.++ |.+||... ..+++...+...++-
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm--SNQdVIkaIe~gyRL---- 853 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--SNQDVIKAIEQGYRL---- 853 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc--chHHHHHHHHhccCC----
Confidence 87554422222 222 368999999999999999999999999999998 99998653 334444444332221
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
|.+.+| ...+.+|+..||++|-.+||.+.+|+.+|.++....
T Consensus 854 -----PpPmDC------P~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 854 -----PPPMDC------PAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred -----CCCCCC------cHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 122233 345789999999999999999999999999876544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=347.26 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=213.2
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
+-|+.++-||+|+-|.|-.|++..+|+.+|||++... ..........+.+|+.+|+-+.||||+++++.|.+..++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~-~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKR-SELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccc-cccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 3456677899999999999999999999999999433 234445566788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
.||++||.|.+++-.++. +++.++.+++.||+.|+.|+|+. +|+|||+||+|+++|..+.+||+|||+|.. .
T Consensus 91 lEyv~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsL-e 162 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASL-E 162 (786)
T ss_pred EEecCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeec-c
Confidence 999999999999977665 78888999999999999999999 999999999999999999999999999975 4
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVD-EKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
.+++-..+.+|+|.|.|||++++.+|. .++||||.|||+|.+++|+.||++ +++........+.......
T Consensus 163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLlKV~~G~f~MPs---- 233 (786)
T KOG0588|consen 163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLLKVQRGVFEMPS---- 233 (786)
T ss_pred cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHHHHHcCcccCCC----
Confidence 567777889999999999999999985 699999999999999999999984 2343333332222221111
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
....+..+|+.+|+.+||++|.|++||.++-
T Consensus 234 ---------~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 234 ---------NISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ---------cCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 1223466789999999999999999999864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.38 Aligned_cols=261 Identities=32% Similarity=0.429 Sum_probs=208.1
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
+.+.....||+|.||+||+|.+- ..||||++... .-..+..+.|+.|+.++++-+|.||+=+.|||..+.. .+|
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~--~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVD--DPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred HHhhccceeccccccceeecccc---cceEEEEEecC--CCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 44556789999999999999996 35999999433 3344578899999999999999999999999998877 999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
..+|+|.+|+.++|..+.. ++..+...||+|||+|+.|||.+ +|||||||..||++.+++.|||+|||++....
T Consensus 466 TqwCeGsSLY~hlHv~etk---fdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETK---FDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ehhccCchhhhhccchhhh---hhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeee
Confidence 9999999999999977643 88899999999999999999999 99999999999999999999999999996532
Q ss_pred --cCCcceEeeccCCCccCcCCCCC---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 865 --RKNETVSMVAGSYGYIAPEYGYT---LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 865 --~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
..........|...|||||+++. .+|++.+||||||+++|||++|..||.....+. +..++..+.
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq------IifmVGrG~---- 609 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ------IIFMVGRGY---- 609 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh------eEEEecccc----
Confidence 22333444668889999998764 569999999999999999999999997422211 111111111
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
.-+++ .........++.+|+..||..++++||.+.+|+..|+++.+..
T Consensus 610 -l~pd~--s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 610 -LMPDL--SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred -cCccc--hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 01111 0111222345778899999999999999999999999987743
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=339.10 Aligned_cols=252 Identities=28% Similarity=0.370 Sum_probs=212.1
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
...|+....||+|.||.||+|.+..+++.||+|++..+. ......++++|+.++.+++++||.++++.|..+..+++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence 345666789999999999999999999999999994433 34556788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
+||||.||++.+.+..... +++..+.-|..++..|+.|+|++ +.+|||||+.||++..+|.||++|||.+..+
T Consensus 89 iMey~~gGsv~~lL~~~~~----~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql 161 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNI----LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQL 161 (467)
T ss_pred HHHHhcCcchhhhhccCCC----CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeee
Confidence 9999999999999976553 46666777899999999999999 9999999999999999999999999999888
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
........+.+|||.|||||++....|+.|+||||||++.+||++|.+|+...... +--..+.+-..|
T Consensus 162 ~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm------------rvlflIpk~~PP 229 (467)
T KOG0201|consen 162 TNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM------------RVLFLIPKSAPP 229 (467)
T ss_pred echhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc------------eEEEeccCCCCC
Confidence 66666667789999999999999989999999999999999999999999753221 111112233334
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.+.. .....+.+++..|+++||+.||++++++++
T Consensus 230 ~L~~-----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDG-----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccc-----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 4432 233447789999999999999999999874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=336.61 Aligned_cols=253 Identities=23% Similarity=0.280 Sum_probs=205.6
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|+..++||+|+||.||.|+.+.+|..+|+|++++. .-......+....|-.+|....+|.||+++-.|++.+++|+
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS-~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKS-EMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHH-HHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 46688999999999999999999999999999999543 33445567788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||++||++..+|..... +++..+..++.+++-|++.+|.. |+|||||||+|+|+|..|++||+|||++.-+
T Consensus 219 iMEylPGGD~mTLL~~~~~----L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT----LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHHhcCc----CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999987665 88888888999999999999999 9999999999999999999999999998643
Q ss_pred cc----------------------CCcc-----e--------------------EeeccCCCccCcCCCCCCCCCccccc
Q 001752 864 IR----------------------KNET-----V--------------------SMVAGSYGYIAPEYGYTLKVDEKIDI 896 (1018)
Q Consensus 864 ~~----------------------~~~~-----~--------------------~~~~gt~~y~aPE~~~~~~~~~~~Dv 896 (1018)
.. .... . ...+|||.|+|||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 21 0000 0 01469999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCC--cccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCC
Q 001752 897 YSFGVVLLELLTGRRPLDPEFGE--SVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRP 974 (1018)
Q Consensus 897 ~slG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 974 (1018)
||+|||+|||+.|-+||.++... ...+..|......+.. .+...+..++|.+|+. ||+.|-
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~----------------~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE----------------VDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc----------------CcccHHHHHHHHHHhc-CHHHhc
Confidence 99999999999999999875432 2233333322111111 1112456778899998 999997
Q ss_pred C---HHHHHH
Q 001752 975 S---MRDVIT 981 (1018)
Q Consensus 975 t---~~evl~ 981 (1018)
- ++||.+
T Consensus 435 G~~G~~EIK~ 444 (550)
T KOG0605|consen 435 GSKGAEEIKK 444 (550)
T ss_pred CcccHHHHhc
Confidence 5 555554
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=352.16 Aligned_cols=264 Identities=26% Similarity=0.413 Sum_probs=203.7
Q ss_pred hhcccccceeecCCCeeEEEEEc-----CCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEec
Q 001752 704 LACIRESNVIGMGATGIVYKAEM-----PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHN 777 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 777 (1018)
.++|+..+.||+|+||.||+|.+ ..+++.||||++... ......+.+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG---ATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc---cchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 46788889999999999999974 234578999998432 1223456788999999999 89999999998875
Q ss_pred C-CceEEEEEecCCCCHHHhhhcCCCC-----------------------------------------------------
Q 001752 778 D-TNMMIVYEYMNNGSLGEALHGKQAG----------------------------------------------------- 803 (1018)
Q Consensus 778 ~-~~~~lV~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 803 (1018)
. ..+++||||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 4689999999999999999753210
Q ss_pred -----ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc--eEeeccC
Q 001752 804 -----RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET--VSMVAGS 876 (1018)
Q Consensus 804 -----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt 876 (1018)
..++++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++........ .....++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 12477888999999999999999999 9999999999999999999999999999765322211 1223456
Q ss_pred CCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHH
Q 001752 877 YGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEM 955 (1018)
Q Consensus 877 ~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 955 (1018)
+.|+|||++.+..++.++|||||||++|||++ |..||....... ... ........ +... ....
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~----~~~~~~~~------~~~~-----~~~~ 303 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFC----QRLKDGTR------MRAP-----ENAT 303 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHH----HHHhcCCC------CCCC-----CCCC
Confidence 78999999999899999999999999999997 999997532211 111 11111110 0000 0112
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCC
Q 001752 956 LLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPR 989 (1018)
Q Consensus 956 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 989 (1018)
..+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 3467899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=329.89 Aligned_cols=287 Identities=25% Similarity=0.303 Sum_probs=217.1
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeecccccc----------ccchhhhHHHHHHHHhccCCCCcceee
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADL----------ETESSGDFVGEVNVLGKLRHRNIVRLL 772 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~~E~~~l~~l~hpniv~~~ 772 (1018)
..++|+..+.||+|.||.|-+|+...+++.||||++.+..... .....+...+|+.++++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 5789999999999999999999999999999999995432111 112234788999999999999999999
Q ss_pred eeEecC--CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC
Q 001752 773 GFLHND--TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL 850 (1018)
Q Consensus 773 ~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 850 (1018)
++..+. +.+|||+|||..|.+...-.... .+++.++++++.+++.||+|||.+ |||||||||+|+|++++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~----els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKP----ELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcc----cccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 998764 67899999999887755433222 288999999999999999999999 999999999999999999
Q ss_pred CeEEcccccceeecc-----CCcceEeeccCCCccCcCCCCCCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCcc
Q 001752 851 EPRIADFGLARMMIR-----KNETVSMVAGSYGYIAPEYGYTLK----VDEKIDIYSFGVVLLELLTGRRPLDPEFGESV 921 (1018)
Q Consensus 851 ~~kl~DfG~a~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 921 (1018)
+|||+|||.+..... .+......+|||.|+|||...++. .+.+.||||+||++|-|+.|+.||-+.+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--- 324 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--- 324 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---
Confidence 999999999976522 222334478999999999876532 45789999999999999999999975321
Q ss_pred cHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCC---CCCCCCCCCc
Q 001752 922 DIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKP---RRKSSSNNDN 998 (1018)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~---~~~~~~~~~~ 998 (1018)
...... ++...+ ..+...+....+.+++.++|.+||+.|.+..+|..+..-... ...+....+.
T Consensus 325 --~~l~~K----------Ivn~pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~~~~c~ 391 (576)
T KOG0585|consen 325 --LELFDK----------IVNDPL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSEPSSCS 391 (576)
T ss_pred --HHHHHH----------HhcCcc-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCCcccce
Confidence 111111 111111 112233456667889999999999999999999887644322 3334444555
Q ss_pred hhhccccceeEeec
Q 001752 999 RYENNKEKLVFSTS 1012 (1018)
Q Consensus 999 ~~~~~~~~~~~~~~ 1012 (1018)
..+-.++..+-+++
T Consensus 392 ~v~v~eeev~~sv~ 405 (576)
T KOG0585|consen 392 RVEVTEEEVNNSVS 405 (576)
T ss_pred eeeeecccccccee
Confidence 55555555554443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=305.52 Aligned_cols=254 Identities=28% Similarity=0.393 Sum_probs=213.0
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
..+.|+..+.||+|.||.||.|+.++++..||+|++.++. -.......++.+|+++.+.++||||.++++||.+....|
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq-i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ-ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH-HHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 3466888999999999999999999999999999996554 234455678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+++||.++|++...|...+..+ +++.....++.|+|.|+.|+|.. .|+||||||+|++++.++..|++|||.+..
T Consensus 99 LilEya~~gel~k~L~~~~~~~--f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKR--FDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EEEEecCCchHHHHHHhccccc--ccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 9999999999999998555433 67888888999999999999999 999999999999999999999999999864
Q ss_pred eccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
.+.....+.+||..|.|||+..+...+..+|+|++|++.||++.|.+||+.... ...+..... . +...
T Consensus 174 --~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI~k----~-----~~~~ 241 (281)
T KOG0580|consen 174 --APSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRIRK----V-----DLKF 241 (281)
T ss_pred --cCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHHHH----c-----cccC
Confidence 346666778999999999999999999999999999999999999999986431 111211111 1 1112
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
|.. ......+++.+|+.++|.+|.+..|++.+
T Consensus 242 p~~--------is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 PST--------ISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred Ccc--------cChhHHHHHHHHhccCccccccHHHHhhh
Confidence 211 12335678999999999999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=306.61 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=212.2
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC-----
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND----- 778 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 778 (1018)
.++|++.+.+|+|||+-||.++.-.+++.+|+|++.... .+..+...+|++..++++|||+++++++...+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 578999999999999999999998899999999994332 35567788999999999999999999987433
Q ss_pred CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccc
Q 001752 779 TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFG 858 (1018)
Q Consensus 779 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 858 (1018)
...|++++|+..|+|.+.+...+.++..+++.+.+.|+.+|++||++||+.. ++++||||||.||++.+++.+++.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence 3589999999999999999988888878999999999999999999999983 359999999999999999999999999
Q ss_pred cceeeccCCcc---------eEeeccCCCccCcCCCC---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 001752 859 LARMMIRKNET---------VSMVAGSYGYIAPEYGY---TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEW 926 (1018)
Q Consensus 859 ~a~~~~~~~~~---------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~ 926 (1018)
.++...-.-.. .....-|..|+|||.+. +...++++|||||||++|+|+.|..||+.......
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg----- 249 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG----- 249 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-----
Confidence 98754211111 11134688999999764 56688999999999999999999999976432211
Q ss_pred HHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 927 IRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
.+.-++-......+........+.+++.+|+++||.+||++.+++..+...
T Consensus 250 ---------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 250 ---------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ---------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 122111111111122223566788999999999999999999999988764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=346.77 Aligned_cols=246 Identities=27% Similarity=0.375 Sum_probs=205.4
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 782 (1018)
...|...++||+|.||.|+.|..+.+++.+|||++++.. ....+.......|.+++... +||++++++.+|+..+++|
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~-Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGD-ILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccc-eeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 466888999999999999999999999999999995543 34556677788888887777 5999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||..||++..+.+... +++..+.-++..|+.||.|||++ ||||||||.+||++|.+|++||+|||+++.
T Consensus 446 fvmey~~Ggdm~~~~~~~~-----F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHTDV-----FSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEecCCCcEEEEEeccc-----ccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999655554333 88999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
-...+...++.+|||.|+|||++.+..|+.++|.|||||++|||+.|..||.++.+ .++-+.+. . .+..-
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE--ee~FdsI~---~-----d~~~y 587 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE--EEVFDSIV---N-----DEVRY 587 (694)
T ss_pred cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHh---c-----CCCCC
Confidence 65566678889999999999999999999999999999999999999999987433 22322221 1 11111
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCH
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSM 976 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 976 (1018)
|. -...+.+.++++++.++|++|--+
T Consensus 588 P~--------~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 588 PR--------FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CC--------cccHHHHHHHHHHhccCcccccCC
Confidence 11 122346678889999999999755
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=314.33 Aligned_cols=256 Identities=24% Similarity=0.297 Sum_probs=209.9
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
..+.|+..+.||+|.|+.||++.+..+|+.+|+|++... .......+.+.+|+.+.+.++|||||++.+.+.+.+..|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~--k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK--KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhh--hhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 456677888999999999999999999999999988332 233446778899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcC---CCCeEEccccc
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS---NLEPRIADFGL 859 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfG~ 859 (1018)
+|+|+|.|++|..-+-.+ ..+++..+...++||+++|.|+|.+ +|||||+||+|+++.. ...+|++|||+
T Consensus 87 lvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGv 159 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGL 159 (355)
T ss_pred EEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccce
Confidence 999999999998776544 3488899999999999999999999 9999999999999954 34699999999
Q ss_pred ceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 860 ARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 860 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
|..+. ++......+|||+|+|||+....+|+..+|||+.||++|-++.|.+||.++.. ..+.+ .....
T Consensus 160 Ai~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--~rlye---~I~~g------ 227 (355)
T KOG0033|consen 160 AIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYE---QIKAG------ 227 (355)
T ss_pred EEEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--HHHHH---HHhcc------
Confidence 99876 56666778999999999999999999999999999999999999999986322 12222 21111
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.+|-....+.+ ......+++++|+..||.+|.|+.|.+++
T Consensus 228 ~yd~~~~~w~~---is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 228 AYDYPSPEWDT---VTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ccCCCCcccCc---CCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 12222212222 33445678889999999999999998863
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=373.25 Aligned_cols=484 Identities=26% Similarity=0.326 Sum_probs=353.6
Q ss_pred EEcCCCCCCcccccccccCCCCCEEEcCCCCcCCCCChhhhCCCCCcEEEeeecccCCCCcccccCCCCCceeccCCCCC
Q 001752 79 LDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNF 158 (1018)
Q Consensus 79 L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l 158 (1018)
+|++..++.- +|..+-.-..++.|++++|-+....-+.+.+..+|+.||||+|++. ..|..+..+.+|+.|+++.|.|
T Consensus 3 vd~s~~~l~~-ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLEL-IPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCcc-cchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 4556666654 3333333344888888888875544455566667999999999887 8889999999999999999988
Q ss_pred CcccccccccccccceEeccCcccCcccccccccccccceeeecccccCCCCCcccccccchhhhhccccccCCCCCccc
Q 001752 159 SGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEF 238 (1018)
Q Consensus 159 ~~~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~ 238 (1018)
.. .|.+.+++.+|++|+|.+|.+. ..|.++..+.+|++|+++.|++. .+|..+..++.++.+..++|... ..+
T Consensus 81 ~~-vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~----~~l 153 (1081)
T KOG0618|consen 81 RS-VPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKI----QRL 153 (1081)
T ss_pred hh-Cchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhh----hhh
Confidence 86 4577888999999999999888 78899999999999999999987 78888888889999999988322 123
Q ss_pred cCccccccccccccccCccCcccccCCCccceEEccCCcCCccCChhhcCCCCCCeeeccCCCCccccCCccccccCCce
Q 001752 239 GNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQL 318 (1018)
Q Consensus 239 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 318 (1018)
+.+. ++.++|..|.+.+.++.++..+.. .|+|++|.+. . ..+.++.+|+.|....|+++.. --..++|+.
T Consensus 154 g~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~ 223 (1081)
T KOG0618|consen 154 GQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSEL----EISGPSLTA 223 (1081)
T ss_pred cccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceE----EecCcchhe
Confidence 3333 888888888888888888777776 7888888886 2 3466777888888888888642 123467888
Q ss_pred eecccCccccccCCCCCCCCccceEEeccCccccCCCcCCCCCCCCceeecccccccccccccccCCCCCceeccccccC
Q 001752 319 LNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAF 398 (1018)
Q Consensus 319 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 398 (1018)
|+.++|.++...+.. --.+|+++++++|+++ .+|.++..+.+|+.++..+|+++ .+|..+....+|+.|.+..|.+
T Consensus 224 L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel 299 (1081)
T KOG0618|consen 224 LYADHNPLTTLDVHP--VPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNEL 299 (1081)
T ss_pred eeeccCcceeecccc--ccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhh
Confidence 888888887333221 2246788888888887 45677888888888888888885 6777777788888888888888
Q ss_pred CCCCcccccccccccEEeccCCcccCCCcccCCCccc-cceeecccccccCCCccccCCCCccceEeccCCcccCCCCcc
Q 001752 399 SGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEK-LQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPST 477 (1018)
Q Consensus 399 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 477 (1018)
. .+|.....++.|+.|+|..|+|....+..|..+.. |..|+.+.|++.....-.=.....|+.|++.+|++++..-..
T Consensus 300 ~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~ 378 (1081)
T KOG0618|consen 300 E-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPV 378 (1081)
T ss_pred h-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhh
Confidence 7 45666777788888888888887443333333333 666677777766444333334566778888888887766667
Q ss_pred ccCCCCcccccccCCcccCCCCcccCCCCccceeecccccccCCCCCccccccccceeecccccccCCcccccccCCccc
Q 001752 478 ILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLA 557 (1018)
Q Consensus 478 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 557 (1018)
+.+++.|+.|+|++|+|.......+.++..|++|+||+|+++ .+|..+.++..|++|...+|+|. ..| .+..++.|+
T Consensus 379 l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~ 455 (1081)
T KOG0618|consen 379 LVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLK 455 (1081)
T ss_pred hccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcce
Confidence 777778888888888877444445677777888888888887 67777777788888888888777 556 677778888
Q ss_pred eeecccccccCCCCCCCCCCCCCceEEecCCc
Q 001752 558 ILDLSNNSLTGGIPENFGASPALEVLNVSYNR 589 (1018)
Q Consensus 558 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 589 (1018)
.+|+|.|+|+...-..-...++|++|||+||.
T Consensus 456 ~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 456 VLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred EEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 88888888775433222233778888888877
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=326.42 Aligned_cols=264 Identities=27% Similarity=0.371 Sum_probs=200.2
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC--C---
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND--T--- 779 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~--- 779 (1018)
-.|...+++|.|+||.||+|+...+++.||||+....... -.+|+++|+.++|||||++.-+|... .
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~--------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY--------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc--------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 3566778999999999999999999999999999543332 23599999999999999999988532 1
Q ss_pred ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC-CCeEEcccc
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN-LEPRIADFG 858 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG 858 (1018)
...+|||||+. +|.++++.....+..++...+.-+..||++||+|||+. +|+||||||+|+++|.+ |.+||+|||
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCC
Confidence 34689999976 99999986433334467777778999999999999998 99999999999999988 899999999
Q ss_pred cceeeccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccc-
Q 001752 859 LARMMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRN- 936 (1018)
Q Consensus 859 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~- 936 (1018)
.|+.+..+... ..+..|..|+|||.+.+ ..|+.+.||||.||++.||+.|++-|.+... ...+...++..-.+...
T Consensus 172 SAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 172 SAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIKVLGTPTRED 249 (364)
T ss_pred cceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHHHhCCCCHHH
Confidence 99987654444 55567899999998776 5699999999999999999999999987432 22233333332211111
Q ss_pred c-------ccccCCCCCCCc----hhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 937 L-------EEALDPNVGNCK----HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 937 ~-------~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
+ .+...|...... .......+.++++.+++..+|.+|.++.|++++
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0 011111111100 112334557789999999999999999999863
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=344.84 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=200.6
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNN 790 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~ 790 (1018)
+.||+|+||.||+|.+..+++.||+|++..... ........+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 469999999999999998999999999954321 2233456678899999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcce
Q 001752 791 GSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV 870 (1018)
Q Consensus 791 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 870 (1018)
|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~----~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 152 (323)
T cd05571 80 GELFFHLSRERV----FSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcc
Confidence 999999976543 78999999999999999999999 99999999999999999999999999997644344444
Q ss_pred EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCch
Q 001752 871 SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKH 950 (1018)
Q Consensus 871 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 950 (1018)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .............+ ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~~~~~~~~~----p~------- 216 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEEIRF----PR------- 216 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCCCCC----CC-------
Confidence 557799999999999999999999999999999999999999965321 11111111111100 00
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 001752 951 VQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVITM 982 (1018)
Q Consensus 951 ~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 982 (1018)
.....+.+++.+|++.||++|| ++.+++++
T Consensus 217 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 --TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred --CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1123466889999999999999 79998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=308.42 Aligned_cols=259 Identities=23% Similarity=0.352 Sum_probs=213.5
Q ss_pred HHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccc----cchhhhHHHHHHHHhcc-CCCCcceeeeeEe
Q 001752 702 DILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLE----TESSGDFVGEVNVLGKL-RHRNIVRLLGFLH 776 (1018)
Q Consensus 702 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 776 (1018)
...+.|+..+.+|.|..++|-++.++.+++.+|+|++........ .+..+.-.+|+.+++++ .||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 356778888999999999999999999999999999954322222 22234556799999998 6999999999999
Q ss_pred cCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcc
Q 001752 777 NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 777 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 856 (1018)
.+..+++|+|.|+.|.|.|++.+... +++....+|+.|+..|++|||.. .||||||||+||++|++.+++|+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~Vt----lSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVT----LSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhee----ecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 99999999999999999999987654 89999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceEeeccCCCccCcCCCC------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGY------TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMK 930 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 930 (1018)
||+|+.+ +++......+|||+|.|||.+. ...|+..+|+||+|||||.++.|.+||... ...-..++.
T Consensus 167 FGFa~~l-~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-----kQmlMLR~I 240 (411)
T KOG0599|consen 167 FGFACQL-EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-----KQMLMLRMI 240 (411)
T ss_pred cceeecc-CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-----HHHHHHHHH
Confidence 9999986 4567778899999999999754 345888999999999999999999999631 111112222
Q ss_pred hhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 931 IRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
......+ ..+.+.+......+++.+|++.||.+|.|++|++++
T Consensus 241 meGkyqF---------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 241 MEGKYQF---------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred Hhccccc---------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 2222211 223345556667889999999999999999999874
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=373.95 Aligned_cols=486 Identities=27% Similarity=0.345 Sum_probs=411.6
Q ss_pred EEEcCCCCcCCCCChhhhCCCCCcEEEeeecccCCCCcccccCCCCCceeccCCCCCCcccccccccccccceEeccCcc
Q 001752 102 SLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSF 181 (1018)
Q Consensus 102 ~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~ 181 (1018)
.+|+++.++ ..+|..+..-..|+.|++++|.+..-.-..+.+..+|+.||+++|++.. .|..+..+.+|+.|+++.|.
T Consensus 2 ~vd~s~~~l-~~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~~-fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 2 HVDASDEQL-ELIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQISS-FPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred CcccccccC-cccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeecccccccc-CCchhhhHHHHhhcccchhh
Confidence 356677666 4677777766679999999998763222344555669999999999987 56789999999999999999
Q ss_pred cCcccccccccccccceeeecccccCCCCCcccccccchhhhhccccccCCCCCccccCccccccccccccccCccCccc
Q 001752 182 FQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAE 261 (1018)
Q Consensus 182 ~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 261 (1018)
|. ..|.+..++.+|++|+|.+|.+. ..|.++..+.+|++|++++|++. .+|.-+..++.+..+..++|.....
T Consensus 80 i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~---- 152 (1081)
T KOG0618|consen 80 IR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR---- 152 (1081)
T ss_pred Hh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----
Confidence 99 77899999999999999999998 78999999999999999999998 7899999999999999999833322
Q ss_pred ccCCCccceEEccCCcCCccCChhhcCCCCCCeeeccCCCCccccCCccccccCCceeecccCccccccCCCCCCCCccc
Q 001752 262 LGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLE 341 (1018)
Q Consensus 262 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 341 (1018)
++... ++.+++..|.+.+.++..+.+++. .|||++|.+. -..+..+.+|+.|....|+++... -.-++|+
T Consensus 153 lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~ 222 (1081)
T KOG0618|consen 153 LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLT 222 (1081)
T ss_pred hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchh
Confidence 23332 788899999999999888888777 7999999996 245778899999999999998432 2347899
Q ss_pred eEEeccCccccCCCcCCCCCCCCceeecccccccccccccccCCCCCceeccccccCCCCCcccccccccccEEeccCCc
Q 001752 342 VLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQ 421 (1018)
Q Consensus 342 ~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 421 (1018)
.|+.++|.+....+ -....+|+++++++|+++ .+|.+++.+.+|+.+...+|+++ .+|..+....+|+.|.+.+|.
T Consensus 223 ~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~ne 298 (1081)
T KOG0618|consen 223 ALYADHNPLTTLDV--HPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNE 298 (1081)
T ss_pred eeeeccCcceeecc--ccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhh
Confidence 99999999983222 234467999999999999 56799999999999999999996 788889999999999999999
Q ss_pred ccCCCcccCCCccccceeecccccccCCCccccCCCCc-cceEeccCCcccCCCCccccCCCCcccccccCCcccCCCCc
Q 001752 422 LSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTS-LSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPD 500 (1018)
Q Consensus 422 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 500 (1018)
+. -+|....+++.|++|+|..|.|...+...+.-+.. |..|+.+.|++....-..=..++.|+.|++.+|.|++..-.
T Consensus 299 l~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p 377 (1081)
T KOG0618|consen 299 LE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFP 377 (1081)
T ss_pred hh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchh
Confidence 99 77888888999999999999999766655655544 89999999999855433334578899999999999988878
Q ss_pred ccCCCCccceeecccccccCCCCCccccccccceeecccccccCCcccccccCCccceeecccccccCCCCCCCCCCCCC
Q 001752 501 QFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPAL 580 (1018)
Q Consensus 501 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 580 (1018)
.+.+.++|++|+|++|+|.......+.++..|++|+||+|+|+ .+|..+..++.|++|...+|+|. ..| .+..+++|
T Consensus 378 ~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL 454 (1081)
T KOG0618|consen 378 VLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQL 454 (1081)
T ss_pred hhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcc
Confidence 8899999999999999998655567889999999999999999 78899999999999999999998 677 89999999
Q ss_pred ceEEecCCcccC-CCCCCccccccCCCCCCCCcCC
Q 001752 581 EVLNVSYNRLEG-PVPANGVLRTINRGDLAGNAGL 614 (1018)
Q Consensus 581 ~~L~ls~N~l~~-~~p~~~~~~~~~~~~~~~n~~~ 614 (1018)
+.+|+|.|+|+. .+|....+.+++.+++.||+++
T Consensus 455 ~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 455 KVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred eEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 999999999975 4555555678999999999974
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=324.06 Aligned_cols=268 Identities=25% Similarity=0.329 Sum_probs=206.8
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec-----
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN----- 777 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 777 (1018)
+...|...+.||+|+||.|++|.++.+|+.||||++. .........++..+|+..++.++|+||+.+.+.+..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~--~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL--NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhh--hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 4556666789999999999999999999999999993 234455667888999999999999999999998854
Q ss_pred CCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccc
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADF 857 (1018)
Q Consensus 778 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 857 (1018)
-..+|+|+|+| +.+|...++..+. ++..++.-++.|+++||.|+|+. +|+|||+||+|++++.+...||+||
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~~----L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQD----LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCcc----ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence 35689999999 5699999987764 78899999999999999999999 9999999999999999999999999
Q ss_pred ccceeecc--CCcceEeeccCCCccCcCCC-CCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcc
Q 001752 858 GLARMMIR--KNETVSMVAGSYGYIAPEYG-YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDN 934 (1018)
Q Consensus 858 G~a~~~~~--~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 934 (1018)
|+|+.... ....++.++.|..|+|||.. ....|+.+.||||.|||+.||++|++-|.+...- +....+.......
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v--~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV--HQLQLILELLGTP 247 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH--HHHHHHHHhcCCC
Confidence 99998753 24455678899999999975 4678999999999999999999999999764211 1111111100000
Q ss_pred c-------------ccccccCCCCCCC--chhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 935 R-------------NLEEALDPNVGNC--KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 935 ~-------------~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
. ....-........ .-.+......++++.+||..||.+|+|++|++++
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0000000000000 0011223446788999999999999999999874
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=339.18 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=217.6
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCc-eEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN-MMI 783 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~l 783 (1018)
++|...+.+|+|+||.++.++++.+++.+++|.+.-.. ......+...+|+.++++++|||||.+.+.|.+++. .++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~--~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEK--LTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccc--cCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 56888899999999999999999999999999994332 223334477899999999999999999999998888 999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||+|++||++.+.+..++ +..+++.+++.++.|++.|+.|||++ .|+|||||+.||+++.++.|+++|||+|+.+
T Consensus 82 vm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred EEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhc
Confidence 999999999999998776 45589999999999999999999988 9999999999999999999999999999998
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
.........+.||+.|+.||...+.+|..|+||||+||++|||++-+++|... +....+....+.. ..|
T Consensus 157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~Li~ki~~~~------~~P 225 (426)
T KOG0589|consen 157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSELILKINRGL------YSP 225 (426)
T ss_pred CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHHHHHHhhcc------CCC
Confidence 87776788899999999999999999999999999999999999999999764 2233332222221 222
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.. ..+...+..++..|+..+|+.||++.+++.+
T Consensus 226 lp------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LP------SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CC------ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 22 2334557788999999999999999999986
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=319.56 Aligned_cols=275 Identities=23% Similarity=0.311 Sum_probs=211.7
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCC-cceeeeeEecCC----
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN-IVRLLGFLHNDT---- 779 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~---- 779 (1018)
..|+..++||+|+||+||+|+...+|+.||+|++...... +.......+|+.++++++|+| |+++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 3455667799999999999999999999999999544332 334566789999999999999 999999998776
Q ss_pred --ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccc
Q 001752 780 --NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADF 857 (1018)
Q Consensus 780 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 857 (1018)
..++|+||++ -+|.+++.........++...+..++.||++|++|+|++ +|+||||||+||+++++|.+|++||
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeecc
Confidence 7899999995 599999987664322356688899999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceEeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcc-c
Q 001752 858 GLARMMIRKNETVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDN-R 935 (1018)
Q Consensus 858 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~ 935 (1018)
|+|+.+.-+....+..++|..|+|||++.+. .|++.+||||+|||++||+++++-|.+... ...+....+..-.+. .
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLGTPNEK 243 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcCCCCcc
Confidence 9999876666667778899999999998876 699999999999999999999999976433 112222222111111 1
Q ss_pred ccccc-----cCCCCCCCc---hhH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhcc
Q 001752 936 NLEEA-----LDPNVGNCK---HVQ----EEMLLVLRIAFLCTAKLPKDRPSMRDVITM--LGEA 986 (1018)
Q Consensus 936 ~~~~~-----~~~~~~~~~---~~~----~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~ 986 (1018)
..... .++....+. ... .......+++.+|++.+|..|.|++.++++ +.+.
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 01100 111111111 111 111357789999999999999999999987 5443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=335.66 Aligned_cols=255 Identities=25% Similarity=0.317 Sum_probs=201.9
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
|+..+.||+|+||+||+|.+..+++.||+|++...... .......+.+|+.++++++|++++++++++.+++..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 56778999999999999999889999999998433221 22334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~- 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE- 154 (285)
T ss_pred ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC-
Confidence 9999999988864332 2378999999999999999999999 999999999999999999999999999976532
Q ss_pred CcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCC
Q 001752 867 NETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG 946 (1018)
Q Consensus 867 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 946 (1018)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+........ ....
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~---~~~~---- 225 (285)
T cd05631 155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--KREEVDRRVKEDQ---EEYS---- 225 (285)
T ss_pred CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--hHHHHHHHhhccc---ccCC----
Confidence 223334578999999999999999999999999999999999999997643211 1111111111110 0000
Q ss_pred CCchhHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 001752 947 NCKHVQEEMLLVLRIAFLCTAKLPKDRPS-----MRDVITM 982 (1018)
Q Consensus 947 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 982 (1018)
......+.+++.+||+.||++||+ +++++++
T Consensus 226 -----~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 226 -----EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -----ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 011234678999999999999997 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=332.30 Aligned_cols=265 Identities=21% Similarity=0.307 Sum_probs=213.4
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
++|+..+.||+|+||.||+|+...+++.||||++.... .........+.+|++++++++|||++++++++.+.+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFE-MMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccc-cCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 46788899999999999999998899999999884322 22334556788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
+||+++|+|.+++.........+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999999999865444344578899999999999999999999 99999999999999999999999999998764
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
..........+++.|+|||+..+..++.++||||+|+++|||++|+.||....... ..+........ ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~------~~~~ 228 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---FSLCQKIEQCD------YPPL 228 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH---HHHHHHHhcCC------CCCC
Confidence 43333334568899999999988889999999999999999999999996532221 22221111101 0011
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
. .......+.+++.+||+.+|++||++.+|++.+++++
T Consensus 229 ~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 P-----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred C-----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1 1122345778999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.59 Aligned_cols=266 Identities=24% Similarity=0.327 Sum_probs=201.3
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
+.|+..+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH---EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc---cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 56888899999999999999999899999999984332 122345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++ +|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 82 ~e~~~~-~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred EeCCCc-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 999975 99998865432 368888999999999999999999 99999999999999999999999999997654
Q ss_pred cCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc----------
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD---------- 933 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---------- 933 (1018)
..........+++.|+|||++.+ ..++.++||||+||++|||++|+.||...... +....+......
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK--EELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhccc
Confidence 33333344568999999998765 56899999999999999999999999754221 111111111000
Q ss_pred -ccccccccCCCCCCCc---hhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 934 -NRNLEEALDPNVGNCK---HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 934 -~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
...+.....+...... ..........+++.+|++.||.+|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000111100000 000112346789999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.83 Aligned_cols=249 Identities=21% Similarity=0.294 Sum_probs=197.6
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec----CCceEEEEE
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN----DTNMMIVYE 786 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lV~e 786 (1018)
..||+|++|.||+|... |+.||||++..... ......+.|.+|+.++++++||||+++++++.+ ....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN--NKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEEC--CEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 57999999999999984 89999999843321 122235678899999999999999999999876 356899999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
|+++|+|.+++..... +++....+++.+++.|++|||+.. +++||||||+||+++.++.+|++|||+++.+...
T Consensus 103 y~~~g~L~~~l~~~~~----~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 103 YCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred eCCCCcHHHHHhhCCC----CChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 9999999999976543 789999999999999999999742 7889999999999999999999999998765322
Q ss_pred CcceEeeccCCCccCcCCCCC--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 867 NETVSMVAGSYGYIAPEYGYT--LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 867 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
.....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+........... +.
T Consensus 177 ---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-----~~~~~~~i~~~~~~------~~ 242 (283)
T PHA02988 177 ---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-----TKEIYDLIINKNNS------LK 242 (283)
T ss_pred ---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhcCCC------CC
Confidence 123467899999999876 679999999999999999999999997532 12222222111111 11
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
.. ......+.+++.+||+.||++|||++|+++.|+..+
T Consensus 243 ~~-----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 LP-----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CC-----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 10 011234678999999999999999999999998764
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=337.33 Aligned_cols=248 Identities=21% Similarity=0.267 Sum_probs=201.8
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||+|+||.||+|.+..+++.||+|++..... ......+.+.+|+.++++++||||+++++++.++...++||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV-IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 57788999999999999999998999999999843221 12234566889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSGR----FSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999976543 78889999999999999999999 999999999999999999999999999976532
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .............+. .
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~~----~-- 219 (291)
T cd05612 154 ---RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEKILAGKLEFP----R-- 219 (291)
T ss_pred ---CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCcCCC----c--
Confidence 22335789999999999988899999999999999999999999975321 111221111111010 0
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPS-----MRDVITM 982 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 982 (1018)
.....+.+++.+|++.||.+||+ +++++++
T Consensus 220 -------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 220 -------HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -------cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11234678999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=341.45 Aligned_cols=250 Identities=21% Similarity=0.274 Sum_probs=202.7
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|+..+.||+|+||.||+|++..+++.||+|++..... ......+.+.+|+.++++++||||+++++++.+++..++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI-LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 3567888999999999999999998999999999943221 122345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 96 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGR----FPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEcCCCCChHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 9999999999999976543 68888888999999999999999 9999999999999999999999999999865
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .............+ +
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i~~~~~~~-----p 235 (329)
T PTZ00263 169 PDR---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRIYEKILAGRLKF-----P 235 (329)
T ss_pred CCC---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHHHHHHhcCCcCC-----C
Confidence 322 2345799999999999999999999999999999999999999965311 11111111111100 0
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPS-----MRDVITM 982 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 982 (1018)
.. ....+.+++.+||+.||.+||+ +++++++
T Consensus 236 ---~~-----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 236 ---NW-----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CC-----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00 1134668999999999999997 6777754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=333.57 Aligned_cols=266 Identities=26% Similarity=0.381 Sum_probs=202.6
Q ss_pred hhcccccceeecCCCeeEEEEEcCC----------------CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCC
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPR----------------LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 767 (1018)
.++|+..+.||+|+||.||+|.+.. ++..||+|++.... ......+|.+|+.++++++|||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCC
Confidence 3568888999999999999998532 34579999984321 2334567899999999999999
Q ss_pred cceeeeeEecCCceEEEEEecCCCCHHHhhhcCCC---------------CccccCHHHHHHHHHHHHHHHHHhhcCCCC
Q 001752 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQA---------------GRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832 (1018)
Q Consensus 768 iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~ 832 (1018)
|+++++++.+.+..++||||+++|+|.+++..... ....+++..+.+++.||+.||+|||+.
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--- 157 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--- 157 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---
Confidence 99999999999999999999999999999865321 112368889999999999999999999
Q ss_pred CeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh--
Q 001752 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-- 908 (1018)
Q Consensus 833 ~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-- 908 (1018)
+|+||||||+||+++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|||++
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999999999999999999999865333221 112345788999999888889999999999999999997
Q ss_pred CCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 909 GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 909 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
+..||.... ..+....+......... ........ .....+.+++.+||+.||++|||+++|.+.|++
T Consensus 238 ~~~p~~~~~--~~~~~~~~~~~~~~~~~--~~~~~~~~------~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 238 KEQPYGELT--DEQVIENAGEFFRDQGR--QVYLFRPP------PCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCCcCC--HHHHHHHHHHHhhhccc--cccccCCC------CCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 556775432 22222222222211110 00000000 112346789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=339.33 Aligned_cols=243 Identities=23% Similarity=0.319 Sum_probs=196.8
Q ss_pred eecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCCCC
Q 001752 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGS 792 (1018)
Q Consensus 713 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gs 792 (1018)
||+|+||.||+|.+..+++.||+|++.... .........+.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAH-IVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 699999999999999889999999984322 1223445678899999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcceEe
Q 001752 793 LGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM 872 (1018)
Q Consensus 793 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 872 (1018)
|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++...........
T Consensus 80 L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 152 (312)
T cd05585 80 LFHHLQREGR----FDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152 (312)
T ss_pred HHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccc
Confidence 9999976433 78899999999999999999999 9999999999999999999999999999764333333445
Q ss_pred eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhH
Q 001752 873 VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQ 952 (1018)
Q Consensus 873 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1018)
..||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..............+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~~~~~~~------------- 214 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQEPLRFPD------------- 214 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcCCCCCCC-------------
Confidence 679999999999999999999999999999999999999997531 22222222221111110
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 001752 953 EEMLLVLRIAFLCTAKLPKDRPS---MRDVIT 981 (1018)
Q Consensus 953 ~~~~~l~~l~~~cl~~dP~~RPt---~~evl~ 981 (1018)
.....+.+++.+||+.||++||+ +.|++.
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 11234667899999999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.39 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=215.5
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
...+|++.+.||+|.||.|-+|.....|+.||||.+++... .++...-.+.+|+++|+.++||||+.++++|++.+...
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI-kdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI-KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc-ccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 34678888899999999999999988999999999955443 34556678899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||..+|.|++|+..++. +++.++..++.||..|+.|+|.+ ++||||||.+||++|.++.+||+|||++..
T Consensus 130 ivMEYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEEecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhh
Confidence 99999999999999988765 89999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcceEeeccCCCccCcCCCCCCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGYTLKVD-EKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
+ .+++...+.+|+|-|.+||...+.+|. +.+|-||+||++|.++.|..||++. |....+++.-.... .+
T Consensus 203 y-~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQIs~GaY--rE-- 272 (668)
T KOG0611|consen 203 Y-ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQISRGAY--RE-- 272 (668)
T ss_pred h-ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHHhhcccc--cC--
Confidence 6 445666778999999999999998875 7899999999999999999999874 33333333222211 11
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 984 (1018)
| +.......+|++|+-.+|++|.|..+|..+..
T Consensus 273 -P---------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 273 -P---------ETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred -C---------CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1 11122446889999999999999999998873
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=338.66 Aligned_cols=246 Identities=23% Similarity=0.306 Sum_probs=199.1
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNN 790 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~ 790 (1018)
+.||+|+||.||+|....+++.||+|++..... ........+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 468999999999999998999999999954322 1233456778899999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcce
Q 001752 791 GSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV 870 (1018)
Q Consensus 791 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 870 (1018)
|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 152 (323)
T cd05595 80 GELFFHLSRERV----FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcc
Confidence 999999875543 78999999999999999999999 99999999999999999999999999987543333334
Q ss_pred EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCch
Q 001752 871 SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKH 950 (1018)
Q Consensus 871 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 950 (1018)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .............+ ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~~~~~~~~~----p~------- 216 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILMEEIRF----PR------- 216 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCCCCC----CC-------
Confidence 456799999999999999999999999999999999999999965321 11111111111100 00
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 001752 951 VQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVITM 982 (1018)
Q Consensus 951 ~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 982 (1018)
.....+.+++.+|++.||++|| ++.+++++
T Consensus 217 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 --TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred --CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1123466789999999999998 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=339.08 Aligned_cols=246 Identities=22% Similarity=0.299 Sum_probs=199.9
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNN 790 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~ 790 (1018)
+.||+|+||.||+|.+..+++.||+|++..... ........+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 468999999999999998999999999954321 2334456788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcce
Q 001752 791 GSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV 870 (1018)
Q Consensus 791 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 870 (1018)
|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 g~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 152 (328)
T cd05593 80 GELFFHLSRERV----FSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM 152 (328)
T ss_pred CCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccc
Confidence 999999875443 78999999999999999999999 99999999999999999999999999987543333334
Q ss_pred EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCch
Q 001752 871 SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKH 950 (1018)
Q Consensus 871 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 950 (1018)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..............+ ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-----~~~~~~~~~~~~~~~----p~------- 216 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILMEDIKF----PR------- 216 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-----HHHHHHHhccCCccC----CC-------
Confidence 45679999999999998899999999999999999999999996531 111111111111100 01
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 001752 951 VQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVITM 982 (1018)
Q Consensus 951 ~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 982 (1018)
.....+.+++.+|+++||++|| ++.+++++
T Consensus 217 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 --TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1123466788999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=342.83 Aligned_cols=261 Identities=28% Similarity=0.415 Sum_probs=206.4
Q ss_pred ccccceeecCCCeeEEEEEcCCCC----eEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLN----TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
....++||+|+||.||+|.....+ ..||||.... ..........+|.+|++++++++|||||+++|++..+..+|
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~-~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG-SSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecc-cccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 344589999999999999986532 2389998832 22345677889999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+|||+|+||+|.++|.+.+. .++..++.+++.++|.||+|||++ +++||||.++|+|++.++.+||+|||+++.
T Consensus 238 ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999999987764 388999999999999999999999 999999999999999999999999999865
Q ss_pred eccCCcceE-eeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccc
Q 001752 863 MIRKNETVS-MVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 863 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
-. ...... ...-...|+|||.+....+++++|||||||++||+++ |..||.+.. ..++..++. ..+...
T Consensus 312 ~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~--~~~v~~kI~---~~~~r~--- 382 (474)
T KOG0194|consen 312 GS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK--NYEVKAKIV---KNGYRM--- 382 (474)
T ss_pred Cc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC--HHHHHHHHH---hcCccC---
Confidence 32 011111 1234578999999999999999999999999999999 898997642 222333321 111100
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCCC
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRK 991 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 991 (1018)
+ ..... ...+..++..|+..+|++||+|.++.+.++.+.....
T Consensus 383 --~---~~~~~---p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 383 --P---IPSKT---PKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --C---CCCCC---HHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 0 00112 2335567779999999999999999999988765543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=342.40 Aligned_cols=256 Identities=21% Similarity=0.285 Sum_probs=204.6
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..+.||+|+||.||+|++..+++.||+|++..... ........+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 57888999999999999999998899999999954321 12234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGV----LSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999975543 78889999999999999999999 999999999999999999999999999976432
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+. ....... .+..
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~i~---~~~~~~~---~~~~ 222 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--ETWENLK---YWKETLQ---RPVY 222 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH--HHHHHHH---hcccccc---CCCC
Confidence 233467999999999999989999999999999999999999999753211 1111111 1010000 0111
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.. ........+.+++.+|+..+|++||++++++++
T Consensus 223 ~~--~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DD--PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred Cc--cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 001223456788899999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=338.50 Aligned_cols=202 Identities=28% Similarity=0.444 Sum_probs=177.7
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.++|+..+.||+|+||.||+|++..++..||+|++... ........+.+|++++++++||||+++++++..++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 36788889999999999999999999999999998432 123445679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++|+|.+++..... +++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.++|+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred EeecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 9999999999999976543 788999999999999999999862 6999999999999999999999999998765
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPE 916 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 916 (1018)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 155 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 155 ID--SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred cc--cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 32 2223457899999999999989999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=335.02 Aligned_cols=266 Identities=23% Similarity=0.288 Sum_probs=202.0
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
++|+..+.||+|+||.||+|++..+++.||+|++.... ......+.+.+|+.++++++||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE--ENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc--ccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence 35788899999999999999999899999999984332 2234456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||++++.+..+..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 79 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 79 FEYVEKNMLELLEEMPN----GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLS 151 (287)
T ss_pred EecCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999877765543322 378889999999999999999999 99999999999999999999999999998653
Q ss_pred cCCc-ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHh-----------h
Q 001752 865 RKNE-TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKI-----------R 932 (1018)
Q Consensus 865 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----------~ 932 (1018)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .... +.... .
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFT-IQKVLGPLPAEQMKLFY 229 (287)
T ss_pred ccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHhhCCCCHHHHHhhh
Confidence 3222 2234578999999999998889999999999999999999999997642211 1111 10000 0
Q ss_pred cccccccccCCCCCCCch-----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 933 DNRNLEEALDPNVGNCKH-----VQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
..........+....... .......+.+++.+|+++||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000011100000 0012345788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=325.95 Aligned_cols=265 Identities=22% Similarity=0.327 Sum_probs=214.6
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
++|+..+.||+|+||.||+|....+++.||+|.++... .......+.+.+|++++++++|++++++++++.+.+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFE-MMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccc-ccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 46888899999999999999999889999999884322 22233466788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++.........+++..+..++.+++.|++|||+. +|+||||+|+||+++.++.++++|||.+....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999999976544444588999999999999999999999 99999999999999999999999999987664
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
..........+++.|+|||+..+..++.++|||||||++|+|++|+.||..... ............ ...+.
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~------~~~~~ 228 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEKC------DYPPL 228 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhhhhcC------CCCCC
Confidence 443334446788999999999888899999999999999999999999965322 222222111111 01111
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
. .......+.+++.+|++.+|++||++.+|+++++++.
T Consensus 229 ~-----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 P-----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred C-----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1 1122345678999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=322.10 Aligned_cols=266 Identities=29% Similarity=0.429 Sum_probs=198.6
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHh--ccCCCCcceeeeeEecCC----c
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLG--KLRHRNIVRLLGFLHNDT----N 780 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~--~l~hpniv~~~~~~~~~~----~ 780 (1018)
....++||+|.||.||||... ++.||||++ .....+.|++|-++.+ .++|+||++++++-.... .
T Consensus 212 l~l~eli~~Grfg~V~KaqL~--~~~VAVKif-------p~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD--NRLVAVKIF-------PEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred hhhHHHhhcCccceeehhhcc--CceeEEEec-------CHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 344578999999999999997 699999999 2244566777777755 458999999999876544 7
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCC------CCeEeecCCCCcEEEcCCCCeEE
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY------PPIIHRDIKSNNILLDSNLEPRI 854 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~------~~ivH~Dlk~~NIll~~~~~~kl 854 (1018)
+++|+||.+.|+|.+||..+. ++|....+|+..+++||+|||+..+ |+|+|||||..|||+..|+++.|
T Consensus 283 ywLVt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred eeEEeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 899999999999999998765 7999999999999999999998643 58999999999999999999999
Q ss_pred cccccceeeccCCcce--EeeccCCCccCcCCCCCCC------CCccccchhHHHHHHHHHhCCCCCCCC--------CC
Q 001752 855 ADFGLARMMIRKNETV--SMVAGSYGYIAPEYGYTLK------VDEKIDIYSFGVVLLELLTGRRPLDPE--------FG 918 (1018)
Q Consensus 855 ~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~elltg~~pf~~~--------~~ 918 (1018)
+|||+|..+....... ...+||.+|||||++.+.- .-.+.||||+|.++|||++....+++. ++
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 9999998875433222 2278999999999976532 224799999999999999965444311 11
Q ss_pred ----CcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCCCC
Q 001752 919 ----ESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKS 992 (1018)
Q Consensus 919 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 992 (1018)
....+.+.-...++ +-..|.+.........+..+.+.+..||+.||+.|.|+.=|-+.+.++......
T Consensus 438 ~evG~hPt~e~mq~~VV~------kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVR------KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HHhcCCCCHHHHHHHHHh------hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 11111111111111 111122221111223455577899999999999999999999998887665543
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.19 Aligned_cols=265 Identities=21% Similarity=0.312 Sum_probs=212.6
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
++|+..+.||+|+||.||+|....+++.||||.+.... ........++.+|+.+++.++|||++++++++.+++..++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD-LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh-hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 45777889999999999999998889999999884322 22333456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++.........+++..++.++.||+.|++|||+. +++|+||||+||+++.++.++++|||.+..+.
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 999999999999875433344589999999999999999999999 99999999999999999999999999987764
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
..........++..|+|||+..+..++.++||||||+++|+|++|..||.....+ ........... ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~-------~~~~ 227 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIEQC-------DYPP 227 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhhhcC-------CCCC
Confidence 4333334457889999999998888999999999999999999999999653222 11211111100 0111
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
.. .......+.+++.+|++.+|++||||.+|+++++++.
T Consensus 228 ~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 LP----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CC----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 10 0122345778999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=331.54 Aligned_cols=247 Identities=33% Similarity=0.474 Sum_probs=200.2
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
+.+.+.||+|+.|.||.|+.. ++.||||+++. .-..+|.-+++++||||+.+.|+|.....+++|||
T Consensus 126 IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e-----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME 192 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE-----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME 192 (904)
T ss_pred hhhhhhhccCcccceeeeecc--CceehhHHHhh-----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence 345678999999999999997 89999999821 11247788999999999999999999999999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
||+.|-|.+.|+.... +.......+..+||.|+.|||.+ +|||||||.-|||++.+..|||+|||.++.+.+.
T Consensus 193 fCa~GqL~~VLka~~~----itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRP----ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred ccccccHHHHHhccCc----cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 9999999999987654 77788888999999999999999 9999999999999999999999999999876433
Q ss_pred CcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCC
Q 001752 867 NETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG 946 (1018)
Q Consensus 867 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 946 (1018)
...-.++||..|||||++...+.++|+|||||||++|||+||..||..-... ..+. .+... ..--|.+.
T Consensus 266 -STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----AIIw-GVGsN----sL~LpvPs 334 (904)
T KOG4721|consen 266 -STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----AIIW-GVGSN----SLHLPVPS 334 (904)
T ss_pred -hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----eeEE-eccCC----cccccCcc
Confidence 3344478999999999999999999999999999999999999999642111 1000 00000 00012222
Q ss_pred CCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 947 NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 947 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
.|+. -+.-|++.||+-.|..||++++++.+|+-+.++.
T Consensus 335 tcP~------GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 335 TCPD------GFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred cCch------HHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 2221 2345788999999999999999999998877765
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=342.99 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=203.8
Q ss_pred hhcccccceeecCCCeeEEEEEc-----CCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEec
Q 001752 704 LACIRESNVIGMGATGIVYKAEM-----PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHN 777 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 777 (1018)
.++|+..+.||+|+||.||+|.+ ..++..||||++.... .....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 45688899999999999999974 3456789999984322 223456788999999999 89999999999999
Q ss_pred CCceEEEEEecCCCCHHHhhhcCCC-------------------------------------------------------
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQA------------------------------------------------------- 802 (1018)
Q Consensus 778 ~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------- 802 (1018)
.+..++||||+++|+|.+++.....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999965321
Q ss_pred ----------------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 803 ----------------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 803 ----------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
....+++..+.+++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 012478899999999999999999999 9999999999999999999999999999865433
Q ss_pred Ccce--EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 867 NETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 867 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
.... ....++..|+|||++.+..++.++|||||||++|||++ |..||...... ......+. ..... ..+
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~----~~~~~---~~~ 339 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIK----EGYRM---LSP 339 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHH----hCccC---CCC
Confidence 2211 12334568999999999999999999999999999998 88898653221 11222211 11100 001
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
. ....++.+++.+|++.||++||+++||+++|++.
T Consensus 340 ~--------~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 E--------CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred C--------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0 0123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=335.33 Aligned_cols=268 Identities=21% Similarity=0.305 Sum_probs=199.8
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.++|+..+.||+|+||.||+|....+++.||+|++.... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE---EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccc---ccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 357888999999999999999999889999999984322 12233467789999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||++ ++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 81 VFEYVH-TDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAK 153 (303)
T ss_pred EEECCC-cCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence 999995 688888865432 267888899999999999999999 9999999999999999999999999999765
Q ss_pred ccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc-ccc---
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR-NLE--- 938 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~--- 938 (1018)
...........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.........+............ ...
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 333333344668999999998765 457889999999999999999999997532211111111110000000 000
Q ss_pred --cccCCC-CC--CCchhHH------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 939 --EALDPN-VG--NCKHVQE------EMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 939 --~~~~~~-~~--~~~~~~~------~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
...++. .. ....... ....+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 00 0000000 1134668999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=335.75 Aligned_cols=247 Identities=24% Similarity=0.338 Sum_probs=198.1
Q ss_pred ceeecCCCeeEEEEEcC---CCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEe
Q 001752 711 NVIGMGATGIVYKAEMP---RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEY 787 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 787 (1018)
+.||+|+||.||++... .+++.||+|++..............+.+|+.++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999863 468899999995433222333455678899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCC
Q 001752 788 MNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKN 867 (1018)
Q Consensus 788 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 867 (1018)
+++|+|.+++..... +.+..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREGI----FMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999976543 67888888999999999999999 99999999999999999999999999997654434
Q ss_pred cceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCC
Q 001752 868 ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGN 947 (1018)
Q Consensus 868 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1018)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .............+ .+.
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~~~~~~~~~~----~~~--- 222 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTIDKILKGKLNL----PPY--- 222 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCCCC----CCC---
Confidence 334446799999999999988899999999999999999999999975321 12222222111111 111
Q ss_pred CchhHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 001752 948 CKHVQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVITM 982 (1018)
Q Consensus 948 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 982 (1018)
....+.+++.+|++++|++|| ++.+++++
T Consensus 223 ------~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 223 ------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ------CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 123466899999999999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=343.21 Aligned_cols=262 Identities=25% Similarity=0.385 Sum_probs=203.2
Q ss_pred hhcccccceeecCCCeeEEEEEcCC-----CCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEec
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPR-----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHN 777 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 777 (1018)
.++|+..+.||+|+||.||+|++.. ++..||+|++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 3568888999999999999998533 34579999994322 223356788999999999 89999999999999
Q ss_pred CCceEEEEEecCCCCHHHhhhcCCC-------------------------------------------------------
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQA------------------------------------------------------- 802 (1018)
Q Consensus 778 ~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------- 802 (1018)
.+..++||||+++|+|.+++.....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999999864321
Q ss_pred -----------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcce-
Q 001752 803 -----------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV- 870 (1018)
Q Consensus 803 -----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~- 870 (1018)
....+++..+.+++.||+.||+|||+. +|+||||||+||+++.++.++|+|||+++.........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 012478889999999999999999999 99999999999999999999999999997653322211
Q ss_pred -EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCC
Q 001752 871 -SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNC 948 (1018)
Q Consensus 871 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1018)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ...... .... .+.....
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~----~~~~------~~~~~~~ 339 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMV----KRGY------QMSRPDF 339 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHH----Hccc------CccCCCC
Confidence 11234568999999988899999999999999999997 999997532211 111111 1110 0000000
Q ss_pred chhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 949 KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 949 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
....+.+++.+||+.||++|||+.+++++|+++.
T Consensus 340 -----~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 -----APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1234678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=329.74 Aligned_cols=252 Identities=25% Similarity=0.299 Sum_probs=199.2
Q ss_pred eecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCCCC
Q 001752 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGS 792 (1018)
Q Consensus 713 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gs 792 (1018)
||+|+||+||+|.+..+++.||+|++...... .....+.+..|+.++++++||||+++.+++..+...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 69999999999999989999999998433221 22234567889999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcceEe
Q 001752 793 LGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM 872 (1018)
Q Consensus 793 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 872 (1018)
|.+++.........+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++++|||.+..+.........
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence 9988865433334589999999999999999999999 9999999999999999999999999999876444433444
Q ss_pred eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhH
Q 001752 873 VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQ 952 (1018)
Q Consensus 873 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1018)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............. ... ..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~----------~~~---~~ 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILNDS----------VTY---PD 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhcccC----------CCC---cc
Confidence 678999999999999999999999999999999999999997532211 1111111111110 000 01
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 001752 953 EEMLLVLRIAFLCTAKLPKDRP-----SMRDVITM 982 (1018)
Q Consensus 953 ~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 982 (1018)
.....+.+++.+|++.||++|| ++++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1234467889999999999999 66777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=336.79 Aligned_cols=250 Identities=19% Similarity=0.247 Sum_probs=201.7
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCC-eEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLN-TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
.+.|+..+.||+|+||.||+|.+..++ ..||+|++..... ........+.+|+.+++.++||||+++++++.+++..+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI-IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 467888999999999999999876544 7899999843321 12334567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKR----FPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999999976543 78899999999999999999999 999999999999999999999999999986
Q ss_pred eccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............. ++
T Consensus 181 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~i~~~~~~----~p 248 (340)
T PTZ00426 181 VDT---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-----LLIYQKILEGIIY----FP 248 (340)
T ss_pred cCC---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-----HHHHHHHhcCCCC----CC
Confidence 532 23456799999999999988899999999999999999999999975321 1111111111110 11
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVITM 982 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 982 (1018)
+. . ...+.+++.+|++.||++|+ ++++++++
T Consensus 249 ~~------~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 KF------L---DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC------C---CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11 1 12356789999999999995 89988775
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=347.25 Aligned_cols=259 Identities=23% Similarity=0.300 Sum_probs=210.3
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeee-Ee-----c
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGF-LH-----N 777 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~-~~-----~ 777 (1018)
.++++.++|.+|||+.||.|.+...|..||+|++.. .++...+...+|+++|++++ |||||.+++. .. .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~----~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV----NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec----CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 456778899999999999999997779999999832 25677888999999999996 9999999993 21 1
Q ss_pred -CCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcc
Q 001752 778 -DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 778 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 856 (1018)
..++++.||||+||+|-+++..+-..+ +++.++++|+.++++|+++||.. .++|||||||-+|||++.+|..||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 246899999999999999998776554 89999999999999999999997 55799999999999999999999999
Q ss_pred cccceeeccCC-cceE--------eeccCCCccCcCCC---CCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHH
Q 001752 857 FGLARMMIRKN-ETVS--------MVAGSYGYIAPEYG---YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIV 924 (1018)
Q Consensus 857 fG~a~~~~~~~-~~~~--------~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~ 924 (1018)
||.|.-....- .... ....|+.|+|||++ .+..+++|+|||||||+||-++....||+....-
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----- 264 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----- 264 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----
Confidence 99997542222 1111 14579999999974 5788999999999999999999999999763111
Q ss_pred HHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 925 EWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
.+++.... .+..+.+...+..||..||+++|++||++-+|+..+.+++...
T Consensus 265 --------------aIlng~Y~-~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 --------------AILNGNYS-FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred --------------eEEecccc-CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 11111111 1122456677889999999999999999999999998876544
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=339.72 Aligned_cols=251 Identities=26% Similarity=0.413 Sum_probs=196.7
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
...|+..+.||+|+||.||+|++..+++.||||++.... .......+.+|++++++++|+||+++++++...+..++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 345667789999999999999999889999999984322 23445678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++|+|.+.. ...+..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 150 v~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 150 LLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred EEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 99999999986532 145677788999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceEeeccCCCccCcCCCCC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYT-----LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
...........||..|+|||++.. ...+.++|||||||++|||++|+.||..... .+.............
T Consensus 219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~--- 293 (353)
T PLN00034 219 AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMCAICMSQP--- 293 (353)
T ss_pred ccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHHHHhccCC---
Confidence 443333345679999999998642 3345689999999999999999999974221 111111111111100
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
+.. .......+.+++.+||+.||++||+++|++++
T Consensus 294 ----~~~-----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 ----PEA-----PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCC-----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 01122347789999999999999999999985
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=334.10 Aligned_cols=245 Identities=25% Similarity=0.354 Sum_probs=197.1
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceEEEEEecC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
+.||+|+||+||+|.+..+++.||+|++..... ........+..|..++... +||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 368999999999999998999999999954321 1233455677888888776 69999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++........
T Consensus 80 ~g~L~~~i~~~~~----l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~ 152 (320)
T cd05590 80 GGDLMFHIQKSRR----FDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT 152 (320)
T ss_pred CchHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc
Confidence 9999999976543 78899999999999999999999 9999999999999999999999999998764333444
Q ss_pred eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCc
Q 001752 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1018)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .............. +.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~~-----~~----- 217 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILNDEVVY-----PT----- 217 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcCCCCC-----CC-----
Confidence 4556799999999999988999999999999999999999999975321 12222211111100 10
Q ss_pred hhHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 001752 950 HVQEEMLLVLRIAFLCTAKLPKDRPSM------RDVIT 981 (1018)
Q Consensus 950 ~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~ 981 (1018)
.....+.+++.+|++.||++||++ +++++
T Consensus 218 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 218 ---WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred ---CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 012346778999999999999998 66655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=324.66 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=201.6
Q ss_pred hhcccccceeecCCCeeEEEEEcC---CCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCc
Q 001752 704 LACIRESNVIGMGATGIVYKAEMP---RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN 780 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 780 (1018)
.+.|+..+.||+|+||.||+|.+. ..+..||+|.++.. ........|.+|+..+++++||||+++++++..++.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG---CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC---CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 356788899999999999999864 34678999998432 122335678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 860 (1018)
.++||||+++|+|.+++..... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccc
Confidence 9999999999999999976432 378999999999999999999999 9999999999999999999999999987
Q ss_pred eeeccCCcce-EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 001752 861 RMMIRKNETV-SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 861 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
.......... ....++..|+|||+..+..++.++|||||||++||+++ |+.||..... .+....+ ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--~~~~~~~----~~~~~~- 227 (266)
T cd05064 155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--QDVIKAV----EDGFRL- 227 (266)
T ss_pred ccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHH----HCCCCC-
Confidence 5432111111 11234578999999998999999999999999999875 9999975321 1111111 111100
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
+... .....+.+++.+||+.+|++||+++++.+.|+++
T Consensus 228 ----~~~~------~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 ----PAPR------NCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCC------CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111 1223467889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=336.66 Aligned_cols=246 Identities=22% Similarity=0.300 Sum_probs=199.1
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNN 790 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~ 790 (1018)
+.||+|+||.||+|.+..+++.||+|++..... ........+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 368999999999999988999999999954322 2233456678899999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 791 GSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH-DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 791 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
|+|.+++..... +++..+..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 80 GELFFHLSRERV----FSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred CcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence 999999875443 7899999999999999999997 6 9999999999999999999999999998764433444
Q ss_pred eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCc
Q 001752 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1018)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .............+. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~i~~~~~~~p----~------ 217 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEEIRFP----R------ 217 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHHHhcCCCCCC----C------
Confidence 4456799999999999988999999999999999999999999965321 111111111111010 0
Q ss_pred hhHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 001752 950 HVQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVITM 982 (1018)
Q Consensus 950 ~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 982 (1018)
.....+.+++.+|++.||++|+ ++++++++
T Consensus 218 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 ---TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ---CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1123466789999999999996 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=334.16 Aligned_cols=246 Identities=25% Similarity=0.356 Sum_probs=197.9
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceEEEEEecC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
+.||+|+||.||+|++..+++.||+|++..... ........+..|.++++.+ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 368999999999999998899999999954321 1233455677888888766 79999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 80 GGDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT 152 (321)
T ss_pred CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence 9999999875543 78889999999999999999999 9999999999999999999999999999765444444
Q ss_pred eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCc
Q 001752 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1018)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-----~~~~~~i~~~~~~-----~p~~---- 218 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-----DDLFESILHDDVL-----YPVW---- 218 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCCC-----CCCC----
Confidence 4456799999999999988999999999999999999999999975321 1112211111110 0100
Q ss_pred hhHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 001752 950 HVQEEMLLVLRIAFLCTAKLPKDRP-------SMRDVITM 982 (1018)
Q Consensus 950 ~~~~~~~~l~~l~~~cl~~dP~~RP-------t~~evl~~ 982 (1018)
....+.+++.+|++.||++|| ++++++++
T Consensus 219 ----~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 ----LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ----CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 123466789999999999999 78888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.56 Aligned_cols=245 Identities=28% Similarity=0.359 Sum_probs=193.4
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhc-cCCCCcceeeeeEecCCceEEEEEecC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK-LRHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
+.||+|+||.||+|.+..+++.||+|++...... .....+.+..|..++.. .+||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 3699999999999999989999999999543221 22334455566666664 489999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 80 gg~L~~~~~~~~~----~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 152 (316)
T cd05592 80 GGDLMFHIQSSGR----FDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK 152 (316)
T ss_pred CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc
Confidence 9999999976543 78888999999999999999999 9999999999999999999999999999865444444
Q ss_pred eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCc
Q 001752 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1018)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............ ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~~--------~~~~-- 217 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILNDRP--------HFPR-- 217 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCC--------CCCC--
Confidence 4556799999999999998999999999999999999999999975321 111111111111 0100
Q ss_pred hhHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 001752 950 HVQEEMLLVLRIAFLCTAKLPKDRPSMR-DVIT 981 (1018)
Q Consensus 950 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~ 981 (1018)
.....+.+++.+||+.||++||++. ++++
T Consensus 218 ---~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 ---WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ---CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 0123356788999999999999876 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=332.60 Aligned_cols=249 Identities=25% Similarity=0.349 Sum_probs=196.6
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHH---hccCCCCcceeeeeEecCCceEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVL---GKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
|+..+.||+|+||.||+|.+..+++.||||++..... ......+.+.+|+.++ ++++||||+++++++.+.+..|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI-IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 5567899999999999999998999999999954321 1222344566666554 56789999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++|+|..+++.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 80 v~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 80 VMEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EEcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 99999999999988643 278999999999999999999999 9999999999999999999999999998754
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
...........|++.|+|||++.+..++.++|||||||++|||++|+.||..... .............. ..
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-----~~~~~~i~~~~~~~----p~ 222 (324)
T cd05589 152 MGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-----EEVFDSIVNDEVRY----PR 222 (324)
T ss_pred CCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCC----CC
Confidence 3333344456799999999999998999999999999999999999999975321 11111111111100 00
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVITM 982 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 982 (1018)
.....+.+++.+|++.||++|| ++.+++++
T Consensus 223 ---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 223 ---------FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---------CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1123456789999999999999 56666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=323.40 Aligned_cols=255 Identities=27% Similarity=0.361 Sum_probs=204.3
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
..|+..+.||+|+||.||+|.+..+++.||+|++.. +.....++.+|++++++++|||++++++++..++..++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecC-----CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 457778899999999999999998899999999832 223356788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++..... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+|++|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 81 TEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred EEeCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 999999999999975432 2378999999999999999999999 99999999999999999999999999997654
Q ss_pred cCCcceE-eeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 865 RKNETVS-MVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 865 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
....... ...+++.|+|||+..+..++.++|||||||++|||++ |..||..... ...... ..... .
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~-~~~~~------~ 223 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYEL-LEKGY------R 223 (263)
T ss_pred cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH-HHCCC------C
Confidence 3221111 1234568999999998899999999999999999998 9999865321 111111 11110 0
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
+... . .....+.+++.+|++.+|++||++.++.++|+++
T Consensus 224 ~~~~--~---~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERP--E---GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCC--C---CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0000 0 1123477899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=335.30 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=198.3
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceEEEEEecC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 4699999999999999989999999999543222 223445677888888776 89999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~~L~~~~~~~~~----l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~ 152 (329)
T cd05618 80 GGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 152 (329)
T ss_pred CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc
Confidence 9999998865543 78899999999999999999999 9999999999999999999999999999764333344
Q ss_pred eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCC---cccHHHHHHHHhhcccccccccCCCCC
Q 001752 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGE---SVDIVEWIRMKIRDNRNLEEALDPNVG 946 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 946 (1018)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+.......... .++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---~~p~--- 226 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---RIPR--- 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC---CCCC---
Confidence 44567999999999999999999999999999999999999999632111 11222222222211110 0111
Q ss_pred CCchhHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 001752 947 NCKHVQEEMLLVLRIAFLCTAKLPKDRPS------MRDVITM 982 (1018)
Q Consensus 947 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~evl~~ 982 (1018)
.....+.+++.+|++.||++||+ +.+++++
T Consensus 227 ------~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 227 ------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ------CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11234668999999999999998 4666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=334.83 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=199.7
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceEEEEEecC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
+.||+|+||.||+|.+..+++.||+|++..... ......+.+.+|..+++++ +||||+++++++.+....++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 468999999999999998999999999954322 1233455678899999888 79999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 80 ~g~L~~~~~~~~~----l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~ 152 (329)
T cd05588 80 GGDLMFHMQRQRK----LPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT 152 (329)
T ss_pred CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCc
Confidence 9999999865433 89999999999999999999999 9999999999999999999999999998754333444
Q ss_pred eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCC---cccHHHHHHHHhhcccccccccCCCCC
Q 001752 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGE---SVDIVEWIRMKIRDNRNLEEALDPNVG 946 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 946 (1018)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+..... ......+......... . ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~------~~p 225 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-I------RIP 225 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-C------CCC
Confidence 45567999999999999999999999999999999999999999642211 1112222222222211 0 000
Q ss_pred CCchhHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 001752 947 NCKHVQEEMLLVLRIAFLCTAKLPKDRPS------MRDVITM 982 (1018)
Q Consensus 947 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~evl~~ 982 (1018)
. .....+.+++.+|++.||.+||+ +++++++
T Consensus 226 ~-----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 226 R-----SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred C-----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 0 11234678999999999999997 6777653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=331.71 Aligned_cols=249 Identities=26% Similarity=0.327 Sum_probs=199.3
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCC-CCcceeeeeEecCCceEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH-RNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lV~ 785 (1018)
|+..+.||+|+||.||+|.+..+++.||+|++..... ......+.+..|..+++.++| ++|+++++++.+.+..|+||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 6778899999999999999998899999999954321 123345677889999999976 56888999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK----FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999976543 78889999999999999999999 999999999999999999999999999875433
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ... ..........+ ..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~---~~~i~~~~~~~----~~-- 222 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DEL---FQSIMEHNVSY----PK-- 222 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHH---HHHHHcCCCCC----CC--
Confidence 34444557799999999999999999999999999999999999999975321 111 11111111100 00
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSM-----RDVIT 981 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 981 (1018)
.....+.+++.+|+++||.+||+. +++.+
T Consensus 223 -------~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 223 -------SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred -------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 112346678999999999999976 56554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=339.34 Aligned_cols=260 Identities=24% Similarity=0.259 Sum_probs=198.8
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.++|+..+.||+|+||.||+|.+..+++.||+|+.. ...+.+|++++++++||||+++++++......++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 357999999999999999999999999999999751 2346789999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
|+|++. ++|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|+..
T Consensus 161 v~e~~~-~~L~~~l~~~~~----l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRN----IAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred EEecCC-CCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 999995 689988865433 78899999999999999999999 9999999999999999999999999999754
Q ss_pred ccCC-cceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCC------cccHHHHHHHHhhc--c
Q 001752 864 IRKN-ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGE------SVDIVEWIRMKIRD--N 934 (1018)
Q Consensus 864 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~------~~~~~~~~~~~~~~--~ 934 (1018)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+...+...... .
T Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred ccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 2221 2233467999999999999989999999999999999999999887432211 00111111100000 0
Q ss_pred c------cccc---------ccCCCC-CCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 935 R------NLEE---------ALDPNV-GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 935 ~------~~~~---------~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
. .+.. ...+.. ..+....+....+.+++.+||+.||++|||++|+++
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0000 000000 001111223345778999999999999999999985
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=334.60 Aligned_cols=241 Identities=27% Similarity=0.323 Sum_probs=191.9
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHH-HHhccCCCCcceeeeeEecCCceEEEEEecC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVN-VLGKLRHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
+.||+|+||+||+|.+..+++.||+|++........ ....++.+|.. +++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK-KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 369999999999999998999999999954322212 22334455544 4678999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 80 ~g~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 80 GGELFFHLQRERS----FPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred CCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCc
Confidence 9999999976443 78889999999999999999999 9999999999999999999999999998754333344
Q ss_pred eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCc
Q 001752 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1018)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............. ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~----~~~------ 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDNILNKPLR----LKP------ 217 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcCCCC----CCC------
Confidence 445679999999999999999999999999999999999999997531 22222222211110 111
Q ss_pred hhHHHHHHHHHHHHHccCCCCCCCCCHH
Q 001752 950 HVQEEMLLVLRIAFLCTAKLPKDRPSMR 977 (1018)
Q Consensus 950 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 977 (1018)
.....+.+++.+|++.||.+||+++
T Consensus 218 ---~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 ---NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1123467889999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.27 Aligned_cols=259 Identities=31% Similarity=0.472 Sum_probs=205.3
Q ss_pred hcccccceeecCCCeeEEEEEcCCCC-----eEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
+.|+..+.||+|+||.||+|.....+ ..||+|.+... .......+|.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN---AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC---CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 46778899999999999999976544 68999988422 22344567899999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHhhhcCCCC------------ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEc
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAG------------RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLD 847 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~ 847 (1018)
..+++|||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVG 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEc
Confidence 999999999999999999754211 13478889999999999999999999 999999999999999
Q ss_pred CCCCeEEcccccceeeccCCc--ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHH
Q 001752 848 SNLEPRIADFGLARMMIRKNE--TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIV 924 (1018)
Q Consensus 848 ~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~ 924 (1018)
.++.++|+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||..... .++.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--~~~~ 236 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--QEVI 236 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHH
Confidence 999999999999976533221 1222456788999999988899999999999999999998 9999975322 1222
Q ss_pred HHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 925 EWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
..+. ... .. +.. ......+.+++.+||+.||++||+++||+++|+++
T Consensus 237 ~~i~----~~~-~~----~~~------~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 237 EMIR----SRQ-LL----PCP------EDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHH----cCC-cC----CCc------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 2211 111 00 101 12234577899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.59 Aligned_cols=245 Identities=28% Similarity=0.390 Sum_probs=194.9
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhc-cCCCCcceeeeeEecCCceEEEEEecC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK-LRHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
+.||+|+||.||+|.+..+++.||+|++...... .......+..|..++.. .+||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 4689999999999999988999999999543211 12334456677778776 489999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 80 ~g~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 80 GGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK 152 (316)
T ss_pred CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence 9999999976433 78888999999999999999999 9999999999999999999999999999764333444
Q ss_pred eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCc
Q 001752 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1018)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..+...+. ... +....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i~---~~~--------~~~~~-- 217 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSIR---MDN--------PCYPR-- 217 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHH---hCC--------CCCCc--
Confidence 4557799999999999998999999999999999999999999975321 11111111 111 10100
Q ss_pred hhHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 001752 950 HVQEEMLLVLRIAFLCTAKLPKDRPSMR-DVIT 981 (1018)
Q Consensus 950 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~ 981 (1018)
.....+.+++.+|++.||++||++. ++.+
T Consensus 218 ---~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 ---WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 0123466789999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=331.23 Aligned_cols=202 Identities=27% Similarity=0.437 Sum_probs=176.4
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.++|+..+.||+|+||.||+|.+..++..+|+|++.... .......+.+|++++++++||||+++++++.++++.++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 367888999999999999999999899999999884321 22345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++|+|.+++..... +++.....++.+++.|++|||+.+ +|+||||||+||+++.++.+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred EEecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 9999999999999976443 788889999999999999999752 7999999999999999999999999998754
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPE 916 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 916 (1018)
... ......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 155 IDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hhh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 322 223356899999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=356.43 Aligned_cols=263 Identities=29% Similarity=0.438 Sum_probs=208.0
Q ss_pred hcccccceeecCCCeeEEEEEcCCCC-----eEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
...+..+.||+|+||.||+|...... ..||||.+.+ ..+.....+|.+|..+|+.++|||||+++|.|-+..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~---~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR---LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc---cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 44566789999999999999986433 3489998843 234566789999999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHhhhcCCC---CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcc
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQA---GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 856 (1018)
..++++|||+||+|..||++.+. ....+.....+.++.|||+|+.||+++ ++|||||.++|+|+++...|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999987632 234588899999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceEe--eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhc
Q 001752 857 FGLARMMIRKNETVSM--VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRD 933 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 933 (1018)
||+|+.+...+..... ..-...|||||.+..+.++.|+|||||||++||++| |..||.... ..++...+ ...
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~--n~~v~~~~---~~g 920 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS--NFEVLLDV---LEG 920 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc--hHHHHHHH---HhC
Confidence 9999954333222221 233468999999999999999999999999999999 999997531 11222211 111
Q ss_pred ccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 934 NRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
++ +++ +..| ...+++++..||+.+|++||++..+++.+..+....
T Consensus 921 gR-----L~~-P~~C------P~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 921 GR-----LDP-PSYC------PEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred Cc-----cCC-CCCC------ChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 11 111 1112 234678999999999999999999999887765443
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=329.29 Aligned_cols=244 Identities=27% Similarity=0.346 Sum_probs=194.2
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhc-cCCCCcceeeeeEecCCceEEEEEecC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK-LRHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
+.||+|+||.||+|++..+++.||+|++...... .......+..|..++.. .+||+|+++++++.+.++.|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 4699999999999999999999999999543221 12334456677777765 489999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++........
T Consensus 80 ~g~L~~~i~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05620 80 GGDLMFHIQDKGR----FDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR 152 (316)
T ss_pred CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc
Confidence 9999999876433 78889999999999999999999 9999999999999999999999999998754333444
Q ss_pred eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCc
Q 001752 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1018)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..+...+ .... +.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~---~~~~--------~~~~~~- 218 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESI---RVDT--------PHYPRW- 218 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHH---HhCC--------CCCCCC-
Confidence 5557799999999999999999999999999999999999999975321 1111111 1111 111110
Q ss_pred hhHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 001752 950 HVQEEMLLVLRIAFLCTAKLPKDRPSMR-DVI 980 (1018)
Q Consensus 950 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl 980 (1018)
....+.+++.+|++.||++||++. ++.
T Consensus 219 ----~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ----ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ----CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 123466789999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=347.62 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=203.4
Q ss_pred hcccccceeecCCCeeEEEEEcCCC-CeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRL-NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
..|...+.||+|+||.||+|....+ ++.||+|++... .......+.+|+.+++.++||||+++++++..++..|+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 4488889999999999999998777 788888876221 22334567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++|+|.+++........++++..+..++.||+.||+|+|+. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 9999999999999875444444588999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCc--ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 864 IRKNE--TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 864 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
..... ......||++|+|||++.+..++.++|||||||++|||++|+.||.... .............
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----~~~~~~~~~~~~~------ 288 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----QREIMQQVLYGKY------ 288 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCC------
Confidence 43222 1234569999999999999999999999999999999999999996531 1122222111111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
++... .....+.+++.+|++.||++||++++++.
T Consensus 289 ~~~~~------~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 DPFPC------PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCc------cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11110 11234678899999999999999999875
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=311.67 Aligned_cols=256 Identities=22% Similarity=0.266 Sum_probs=206.6
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|+..+.||+|.-|+||.++..+++..+|+|++.+... .......+.+.|.++++.++||.++.++..++.++..|+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l-~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL-ASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH-hhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 3557778899999999999999999999999999954332 234556778889999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
|||||+||+|...++++.... +++..+.-++.+|+-||+|||.. |||+|||||+|||+.++|++-++||.++...
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~--fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKR--FSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEecCCCccHHHHHhhCCCCc--cchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 999999999999998877654 67777888999999999999999 9999999999999999999999999986533
Q ss_pred cc---------------------------------CCcc-----------------------eEeeccCCCccCcCCCCC
Q 001752 864 IR---------------------------------KNET-----------------------VSMVAGSYGYIAPEYGYT 887 (1018)
Q Consensus 864 ~~---------------------------------~~~~-----------------------~~~~~gt~~y~aPE~~~~ 887 (1018)
.. ..+. ....+||-.|.|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 10 0000 001469999999999999
Q ss_pred CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccC
Q 001752 888 LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTA 967 (1018)
Q Consensus 888 ~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 967 (1018)
...+.++|+|+|||++|||+.|+.||-+.... ..+... +... + .....++......+||++.|.
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~-~Tl~NI----v~~~----------l-~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK-ETLRNI----VGQP----------L-KFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCch-hhHHHH----hcCC----------C-cCCCCCcchhHHHHHHHHHhc
Confidence 99999999999999999999999999764321 122221 1111 1 111122445667889999999
Q ss_pred CCCCCCCC----HHHHHH
Q 001752 968 KLPKDRPS----MRDVIT 981 (1018)
Q Consensus 968 ~dP~~RPt----~~evl~ 981 (1018)
+||.+|.- +.||-+
T Consensus 374 KdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cChhhhhccccchHHhhc
Confidence 99999998 677655
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=340.05 Aligned_cols=255 Identities=25% Similarity=0.300 Sum_probs=204.5
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
++|+..+.||+|+||+||+|.+..+++.||+|++..... ........+.+|+.+++.++||||+++++++.++++.++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM-IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH-hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 357888999999999999999998999999999943321 1224456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++..... +++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++...
T Consensus 80 ~e~~~~~~L~~~l~~~~~----l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDV----FPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred EcCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999999976532 78899999999999999999998 99999999999999999999999999997654
Q ss_pred cCC-----------------------------cceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 001752 865 RKN-----------------------------ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915 (1018)
Q Consensus 865 ~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 915 (1018)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 333 122335689999999999999999999999999999999999999976
Q ss_pred CCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 001752 916 EFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPS-MRDVITM 982 (1018)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~ 982 (1018)
... .............. .-+... .....+.+++.+|+. ||.+||+ +++++++
T Consensus 233 ~~~-----~~~~~~i~~~~~~~---~~p~~~------~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 233 DTL-----QETYNKIINWKESL---RFPPDP------PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCH-----HHHHHHHhccCCcc---cCCCCC------CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 421 11111111100000 001000 023446678889997 9999999 9999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=317.71 Aligned_cols=250 Identities=27% Similarity=0.455 Sum_probs=199.0
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
+.|+..+.||+|+||.||+|.+. ++..+|+|.+... ......+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG-----AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC-----CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 45777889999999999999886 4668999987322 22346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++|+|.++++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.++...
T Consensus 78 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 78 TEFMENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred EEcCCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 999999999999975432 378999999999999999999999 99999999999999999999999999987653
Q ss_pred cCCcce-EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 865 RKNETV-SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 865 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
...... ....++..|+|||+..+..++.++||||||+++|||++ |+.||..... .+....+ ..... ...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i---~~~~~----~~~ 222 (256)
T cd05114 152 DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMI---SRGFR----LYR 222 (256)
T ss_pred CCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH---HCCCC----CCC
Confidence 222111 11234568999999988889999999999999999999 8999965321 1122211 11111 001
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
+.. ....+.+++.+||+.+|++||+++++++.|
T Consensus 223 ~~~--------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 PKL--------ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCC--------CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111 123577899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=332.44 Aligned_cols=245 Identities=27% Similarity=0.312 Sum_probs=192.2
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHH-HHhccCCCCcceeeeeEecCCceEEEEEecC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVN-VLGKLRHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
+.||+|+||+||+|++..+++.||+|++....... ......+.+|.. +++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh-hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 36899999999999999889999999995432211 122334444444 5678899999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+|+|.+++..... +.+..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 80 GGELFYHLQRERC----FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred CCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC
Confidence 9999999976443 67788888999999999999999 9999999999999999999999999999765443444
Q ss_pred eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCc
Q 001752 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1018)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............ ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~----~~~~------ 217 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNILNKPL----QLKP------ 217 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHHHHhCCc----CCCC------
Confidence 4556799999999999999999999999999999999999999975321 111111111111 0111
Q ss_pred hhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 950 HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 950 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.....+.+++.+|++.||.+||++.+.+.
T Consensus 218 ---~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 218 ---NITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred ---CCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 11234667889999999999998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=329.67 Aligned_cols=246 Identities=28% Similarity=0.351 Sum_probs=198.2
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceEEEEEecC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
+.||+|+||+||+|.+..+++.||+|++..... ........+.+|..+++.+ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 468999999999999998899999999953321 1223455677888888877 79999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++........
T Consensus 80 ~~~L~~~~~~~~~----l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 152 (318)
T cd05570 80 GGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT 152 (318)
T ss_pred CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence 9999999876543 78999999999999999999999 9999999999999999999999999998754333334
Q ss_pred eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCc
Q 001752 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1018)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ............. +..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~i~~~~~~----~~~------ 217 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQSILEDEVR----YPR------ 217 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCCC----CCC------
Confidence 4456799999999999999999999999999999999999999975321 1111111111110 000
Q ss_pred hhHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 001752 950 HVQEEMLLVLRIAFLCTAKLPKDRPSM-----RDVITM 982 (1018)
Q Consensus 950 ~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~ 982 (1018)
.....+.+++.+||+.||.+||++ .+++++
T Consensus 218 ---~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 ---WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ---cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 112346789999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=337.19 Aligned_cols=263 Identities=25% Similarity=0.358 Sum_probs=205.1
Q ss_pred hhcccccceeecCCCeeEEEEEcCC-----CCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeeeEec
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPR-----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHN 777 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 777 (1018)
.++|...+.||+|+||.||+|++.. .+..||||++.... .....+.+.+|+.++++++ ||||+++++++.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 4678888999999999999998643 23579999984322 2234567899999999996 9999999999999
Q ss_pred CCceEEEEEecCCCCHHHhhhcCCC-------------------------------------------------------
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQA------------------------------------------------------- 802 (1018)
Q Consensus 778 ~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------- 802 (1018)
.+..++||||+++|+|.++++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999999865321
Q ss_pred -------------------------------------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEE
Q 001752 803 -------------------------------------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNIL 845 (1018)
Q Consensus 803 -------------------------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl 845 (1018)
....+++..+..++.||++|++|||+. +|+||||||+||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 012367888899999999999999999 9999999999999
Q ss_pred EcCCCCeEEcccccceeeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCccc
Q 001752 846 LDSNLEPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVD 922 (1018)
Q Consensus 846 l~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~ 922 (1018)
++.++.+|++|||+++........ .....+++.|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-~ 348 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-T 348 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-H
Confidence 999999999999999865332221 122456788999999988889999999999999999997 999986532211 1
Q ss_pred HHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCC
Q 001752 923 IVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKP 988 (1018)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 988 (1018)
... ....... +.. . ......+.+++.+||+.||++||++.+|.++|+++.+
T Consensus 349 ~~~----~~~~~~~------~~~--~---~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 FYN----KIKSGYR------MAK--P---DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHH----HHhcCCC------CCC--C---ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111 1111110 000 0 1122457789999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=355.23 Aligned_cols=265 Identities=25% Similarity=0.295 Sum_probs=205.3
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
++|+..+.||+|+||.||+|.+..+++.||+|++.... .......+++.+|++++++++||||+++++++.+.+..++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l-~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc-ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 46888899999999999999999889999999984322 22233456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCC-------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccc
Q 001752 785 YEYMNNGSLGEALHGKQA-------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADF 857 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 857 (1018)
|||++||+|.+++..... .....++..+++++.||++||+|||+. +|+||||||+||+++.++.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEec
Confidence 999999999999864211 112356778899999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCc------------------ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 001752 858 GLARMMIRKNE------------------TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGE 919 (1018)
Q Consensus 858 G~a~~~~~~~~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 919 (1018)
|+++....... .....+||+.|+|||+..+..++.++|||||||++|||++|+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99986521110 011246899999999999999999999999999999999999999753221
Q ss_pred cccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhccCC
Q 001752 920 SVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRP-SMRDVITMLGEAKP 988 (1018)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~~~ 988 (1018)
.. .. ....... .. ..+ ..+....+.+++.+|++.||++|| +++++.+.|+....
T Consensus 238 ki--~~--~~~i~~P---~~-~~p-------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 KI--SY--RDVILSP---IE-VAP-------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh--hh--hhhccCh---hh-ccc-------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11 00 0000000 00 000 111223466789999999999996 67777777776533
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=336.17 Aligned_cols=265 Identities=25% Similarity=0.347 Sum_probs=196.5
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC-----Cc
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND-----TN 780 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 780 (1018)
+|+..+.||+|+||.||+|++..+++.||||++.... ........+.+|+.++++++||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 4777899999999999999999899999999984321 1223345688999999999999999999987543 34
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 860 (1018)
.|+||||++ ++|.+++..... +++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDD----LTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred EEEEEecCC-CCHHHHHHhccc----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence 799999995 699999875443 78999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcc---eEeeccCCCccCcCCCCC--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc--
Q 001752 861 RMMIRKNET---VSMVAGSYGYIAPEYGYT--LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD-- 933 (1018)
Q Consensus 861 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-- 933 (1018)
+........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~ 228 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLGTPS 228 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCC
Confidence 764322211 233578999999998765 67899999999999999999999999653211 111111000000
Q ss_pred ---------c---cccccccCCCCCC-CchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 934 ---------N---RNLEEALDPNVGN-CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 934 ---------~---~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
. ............. ....+.....+.+++.+|++.||++|||++|++++
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 0000000000000 00000112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=324.09 Aligned_cols=256 Identities=24% Similarity=0.301 Sum_probs=202.6
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||+|+||+||+|.+..+++.||+|++...... .......+.+|+.++++++||||+++++++.+++..++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 367788999999999999999888999999998432221 2223456778999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.++++|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 80 TLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred eccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999998865432 2378999999999999999999999 999999999999999999999999999976532
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
........|++.|+|||++.+..++.++||||+||++|||++|+.||...... .....+........ ...
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~-------~~~ 224 (285)
T cd05605 155 -GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK--VKREEVERRVKEDQ-------EEY 224 (285)
T ss_pred -CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh--hHHHHHHHHhhhcc-------ccc
Confidence 22223457899999999998888999999999999999999999999753221 11111111111110 000
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVITM 982 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 982 (1018)
.......+.+++.+|++.||++|| ++++++++
T Consensus 225 -----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 -----SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -----CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 011233467899999999999999 78888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=347.19 Aligned_cols=258 Identities=27% Similarity=0.307 Sum_probs=206.7
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC---
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT--- 779 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 779 (1018)
..++|+..+.||+|+||+||+|.+..+++.||||++.... ........+.+|+..+..++|+|++++.+.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG--MSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc--CCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 3478999999999999999999998899999999984432 23344567889999999999999999988765332
Q ss_pred -----ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEE
Q 001752 780 -----NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRI 854 (1018)
Q Consensus 780 -----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 854 (1018)
..++||||+++|+|.++++.+......+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 36899999999999999976554445688999999999999999999999 9999999999999999999999
Q ss_pred cccccceeeccCC--cceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhh
Q 001752 855 ADFGLARMMIRKN--ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIR 932 (1018)
Q Consensus 855 ~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 932 (1018)
+|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +....+.....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~~~~~~~~~ 259 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NMEEVMHKTLA 259 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHhc
Confidence 9999998764321 1223467999999999999999999999999999999999999999753 22222222221
Q ss_pred cccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 933 DNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
... ++... .....+.+++.+||+.||++||++.+++++
T Consensus 260 ~~~------~~~~~------~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRY------DPLPP------SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC------CCCCC------CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 11111 112346789999999999999999999864
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=329.54 Aligned_cols=249 Identities=26% Similarity=0.328 Sum_probs=198.3
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
|+..+.||+|+||.||+|.+..+++.||+|++..... ........+..|..++..+ +||+|+++++++.+.+..++||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 6678899999999999999998899999999954321 1223345567788887777 5899999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR----FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999976543 78899999999999999999999 999999999999999999999999999976443
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ........ +..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~---~i~~~~~~----~p~-- 222 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQ---SIMEHNVA----YPK-- 222 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--HHHHH---HHHhCCCC----CCC--
Confidence 34444456799999999999999999999999999999999999999975321 11111 11111110 000
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSM-----RDVIT 981 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 981 (1018)
.....+.+++.+|+++||++|++. .++.+
T Consensus 223 -------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 223 -------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred -------cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 112346778999999999999984 56554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=337.65 Aligned_cols=254 Identities=23% Similarity=0.299 Sum_probs=199.7
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..+.||+|+||+||+|++..+++.||||++..... ........+.+|+.+++.++||||+++++++.+++..++||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM-LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 57788999999999999999998999999999943221 12234566788999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKDT----FTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999976543 78999999999999999999999 999999999999999999999999999876432
Q ss_pred CCc--------------------------------------ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHH
Q 001752 866 KNE--------------------------------------TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELL 907 (1018)
Q Consensus 866 ~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 907 (1018)
... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 110 001236899999999999989999999999999999999
Q ss_pred hCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 001752 908 TGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPS---MRDVITM 982 (1018)
Q Consensus 908 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~~ 982 (1018)
+|..||..... .............+. +... . .....+.+++.+|+. +|.+|++ +++++++
T Consensus 234 ~G~~Pf~~~~~-----~~~~~~i~~~~~~~~--~~~~----~---~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNP-----QETYRKIINWKETLQ--FPDE----V---PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCH-----HHHHHHHHcCCCccC--CCCC----C---CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999975321 111111111111000 0000 0 112345577888886 9999998 8888773
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=316.84 Aligned_cols=255 Identities=29% Similarity=0.406 Sum_probs=203.0
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.++|+..+.||+|++|.||+|.+. +++.||+|.++.. ....+++.+|+.++++++|||++++++++...+..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPG-----TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCC-----cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 456888899999999999999976 4678999998322 2235678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||+++.+
T Consensus 79 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 79 VTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred eeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 999999999999997654 22378999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceE-eeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 864 IRKNETVS-MVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 864 ~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
........ ....+..|+|||+..+..++.++||||||+++|||++ |+.||..... ..... ........
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~----~~~~~~~~---- 223 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVLQ----QVDQGYRM---- 223 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHH----HHHcCCCC----
Confidence 42221111 1223457999999998899999999999999999999 9999965321 11111 11111100
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
+.. ......+.+++.+|++.+|++||+++++.+.|+++
T Consensus 224 -~~~------~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 -PCP------PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -CCC------CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 001 01124577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=326.25 Aligned_cols=258 Identities=24% Similarity=0.326 Sum_probs=215.7
Q ss_pred HHHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeeeEecCC
Q 001752 701 ADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHNDT 779 (1018)
Q Consensus 701 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 779 (1018)
..+...|+..+.||+|.||.||+++.+.+|+.+|+|++.+.... .......+.+|+.+++++. |||||.+.+.|++..
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~-~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLR-GKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcc-ccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 33667888899999999999999999999999999999544332 2224568899999999998 999999999999999
Q ss_pred ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC----CCeEEc
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN----LEPRIA 855 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~ 855 (1018)
.+++|||++.||.|.+.+... .+++..+..++.||+.+++|||+. ||+|||+||+|+++... +.++++
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~ 181 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLI 181 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEe
Confidence 999999999999999999776 188999999999999999999999 99999999999999643 479999
Q ss_pred ccccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc
Q 001752 856 DFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR 935 (1018)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 935 (1018)
|||++..... .......+||++|+|||++....|+.++||||+||++|.|++|.+||.+........ .......
T Consensus 182 DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~i~~~~~ 255 (382)
T KOG0032|consen 182 DFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----AILRGDF 255 (382)
T ss_pred eCCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----HHHcCCC
Confidence 9999998755 677888999999999999999999999999999999999999999998753321111 1111111
Q ss_pred ccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 936 NLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.+. ...+......+.+++..|+..||.+|+|+.+++++
T Consensus 256 ~f~---------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 DFT---------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCC---------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111 11233345556789999999999999999999996
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=335.27 Aligned_cols=256 Identities=23% Similarity=0.256 Sum_probs=201.5
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|+..+.||+|+||.||+|++..+++.||+|++.... .......+.+.+|+.+++.++||||+++++++.++...++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFE-MIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 467888999999999999999999899999999994321 1122334567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++|+|.+++.... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~~~-----l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYD-----IPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999996542 67778888999999999999999 9999999999999999999999999999865
Q ss_pred ccCCc-ceEeeccCCCccCcCCCCCC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 001752 864 IRKNE-TVSMVAGSYGYIAPEYGYTL----KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 864 ~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...............
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~~~~~ 267 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMDHKNSLT 267 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCCCcCC
Confidence 43322 22345799999999987643 478999999999999999999999975321 111121111111000
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKD--RPSMRDVITM 982 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 982 (1018)
.+ ........+.+++.+|++.+|.+ ||+++|++++
T Consensus 268 ---~~------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 ---FP------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---CC------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 01 01112345667889999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=328.83 Aligned_cols=259 Identities=23% Similarity=0.365 Sum_probs=203.4
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCe----EEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCc
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNT----IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN 780 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 780 (1018)
..|+..+.||+|+||.||+|++..+++ .||+|++... ......+++.+|+.+++.++||||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 558888999999999999998765554 4899988321 2234456788999999999999999999999764 5
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 860 (1018)
.++|+||+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccc
Confidence 7899999999999999976532 278889999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceEe--eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccc
Q 001752 861 RMMIRKNETVSM--VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 861 ~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
+.+......... ..++..|+|||++.+..++.++|||||||++|||++ |+.||+.... ..+.... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--~~~~~~~----~~~~~~ 230 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSIL----EKGERL 230 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH----hCCCCC
Confidence 876443332222 234568999999999999999999999999999998 9999975321 1111111 111100
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
+.... ....+.+++.+||+.+|++||++.++++.+..+..+.
T Consensus 231 -----~~~~~------~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 -----PQPPI------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -----CCCCC------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 11111 1234678999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=318.95 Aligned_cols=255 Identities=27% Similarity=0.391 Sum_probs=202.8
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|+..++||+|+||.||+|... +++.||+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG-----TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC-----chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 356788899999999999999976 5677999988322 2235678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++++|.+++..... ...++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 79 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred EEecCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceec
Confidence 9999999999999975432 2378889999999999999999999 9999999999999999999999999999875
Q ss_pred ccCCcc-eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 864 IRKNET-VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 864 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
...... .....++..|+|||+..+..++.++|||||||++|+|++ |+.||..... .+....+. ....
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~----~~~~----- 222 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--SDVMSALQ----RGYR----- 222 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--HHHHHHHH----cCCC-----
Confidence 332211 112335678999999988889999999999999999998 9999965321 11222111 1110
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
.+... .....+.+++.+|++.+|++||+++++.+.|+++
T Consensus 223 ~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 MPRME------NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCC------CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 01111 1123467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=317.40 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=206.2
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
|+..+.||+|++|.||+|....+++.|++|.+... .........+.+|++++++++|||++++++++.+++..++|||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS--KMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehh--hCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 56678999999999999999989999999998432 2234456778899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
|+++++|.+++..... ..+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||+++.+...
T Consensus 80 ~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 80 YAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred eCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999976432 2478999999999999999999998 9999999999999999999999999999876554
Q ss_pred CcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCC
Q 001752 867 NETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG 946 (1018)
Q Consensus 867 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 946 (1018)
........+++.|+|||+..+..++.++|+||||+++|||++|+.||.... .... ...... . ...+..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~---~~~~~~-~-----~~~~~~- 222 (256)
T cd08529 155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--QGAL---ILKIIR-G-----VFPPVS- 222 (256)
T ss_pred cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHH---HHHHHc-C-----CCCCCc-
Confidence 444444678899999999998889999999999999999999999997532 1111 111111 1 011100
Q ss_pred CCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 947 NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 947 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
......+.+++.+|++.+|++||++.++++.
T Consensus 223 -----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 -----QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -----cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0223457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=323.78 Aligned_cols=265 Identities=25% Similarity=0.323 Sum_probs=194.7
Q ss_pred cccccceeecCCCeeEEEEEcCC-CCeEEEEEEeeccccccccchhhhHHHHHHHHhcc---CCCCcceeeeeEe-----
Q 001752 706 CIRESNVIGMGATGIVYKAEMPR-LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL---RHRNIVRLLGFLH----- 776 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~----- 776 (1018)
+|+..+.||+|+||.||+|++.. +++.||+|++..... .......+.+|+.+++.+ +||||+++++++.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG--EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC--CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 57888999999999999999853 468899999843322 122234556677776665 6999999999985
Q ss_pred cCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcc
Q 001752 777 NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 777 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 856 (1018)
.....++||||++ ++|.+++...... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcc
Confidence 2456899999996 6999999754332 378899999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcc--
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDN-- 934 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-- 934 (1018)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||..... .+....+.......
T Consensus 154 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~--~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 154 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLPGE 230 (290)
T ss_pred ccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCCh
Confidence 9999865332 233446789999999999888899999999999999999999999976422 11111111111000
Q ss_pred ccc-------ccccCCCCCCCch--hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 935 RNL-------EEALDPNVGNCKH--VQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 935 ~~~-------~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
... ...+.+....... .......+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 0001110000000 0112234568999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=331.24 Aligned_cols=255 Identities=23% Similarity=0.278 Sum_probs=199.2
Q ss_pred ccccceeecCCCeeEEEEEcC---CCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceE
Q 001752 707 IRESNVIGMGATGIVYKAEMP---RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 782 (1018)
|+..+.||+|+||.||+|+.. .+++.||+|++............+.+.+|+.+++.+ +||+|+++++++..++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 677889999999999998863 468999999995433222334456788899999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||+++|+|.+++..+.. +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 82 lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDN----FSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999976543 78899999999999999999999 999999999999999999999999999976
Q ss_pred eccCCc-ceEeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccc
Q 001752 863 MIRKNE-TVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 863 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
+..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .............
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~------ 227 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVSRRILKCD------ 227 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHHHHHhcCC------
Confidence 533322 23346799999999998765 47889999999999999999999996532211 1111111111111
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVITM 982 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 982 (1018)
+.... .....+.+++.+|++.||++|| ++++++++
T Consensus 228 --~~~~~-----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 --PPFPS-----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CCCCC-----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11100 1123466789999999999999 77788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=330.16 Aligned_cols=241 Identities=27% Similarity=0.327 Sum_probs=190.4
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHH-HHhccCCCCcceeeeeEecCCceEEEEEecC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVN-VLGKLRHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
+.||+|+||.||+|++..+++.||+|++...... .......+.+|.. +++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 3699999999999999989999999999543222 1222344555554 5788999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 80 GGELFFHLQRERC----FLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc
Confidence 9999998865432 67888888999999999999999 9999999999999999999999999998754333333
Q ss_pred eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCc
Q 001752 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1018)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............. +.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~----~~~------ 217 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNILHKPLQ----LPG------ 217 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHHhcCCCC----CCC------
Confidence 444679999999999998899999999999999999999999997532 22222221111110 000
Q ss_pred hhHHHHHHHHHHHHHccCCCCCCCCCHH
Q 001752 950 HVQEEMLLVLRIAFLCTAKLPKDRPSMR 977 (1018)
Q Consensus 950 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 977 (1018)
.....+.+++.+|++.||.+||++.
T Consensus 218 ---~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 ---GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1123467889999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=333.89 Aligned_cols=203 Identities=26% Similarity=0.375 Sum_probs=176.2
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..+.||+|+||+||+|.+..+++.||+|++.... .........+.+|+.++.+++||+|+++++++.+....|+||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD-MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH-HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 5778899999999999999999899999999994322 122334567888999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKDT----LTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999976543 78899999999999999999999 999999999999999999999999999875422
Q ss_pred CCc-----------------------------------ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCC
Q 001752 866 KNE-----------------------------------TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGR 910 (1018)
Q Consensus 866 ~~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~ 910 (1018)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 012357999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 001752 911 RPLDPE 916 (1018)
Q Consensus 911 ~pf~~~ 916 (1018)
.||...
T Consensus 234 ~Pf~~~ 239 (363)
T cd05628 234 PPFCSE 239 (363)
T ss_pred CCCCCC
Confidence 999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=335.94 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=196.8
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..+.||+|+||+||+|.+..+++.||+|++..... ........+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV-LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 46778899999999999999999999999999943221 12334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 81 DYIPGGDMMSLLIRMEV----FPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred ecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 99999999999976543 78888888999999999999999 999999999999999999999999999754310
Q ss_pred CCc-----------------------------------------------ceEeeccCCCccCcCCCCCCCCCccccchh
Q 001752 866 KNE-----------------------------------------------TVSMVAGSYGYIAPEYGYTLKVDEKIDIYS 898 (1018)
Q Consensus 866 ~~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 898 (1018)
... .....+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 000 011246999999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHH--ccCCCCCCCCCH
Q 001752 899 FGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFL--CTAKLPKDRPSM 976 (1018)
Q Consensus 899 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPt~ 976 (1018)
|||++|||++|+.||....... . ............ . + .... ....+.+++.+ |+..+|..||++
T Consensus 234 lG~il~elltG~~Pf~~~~~~~--~---~~~i~~~~~~~~--~-~---~~~~---~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTE--T---QLKVINWENTLH--I-P---PQVK---LSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHH--H---HHHHHccccccC--C-C---CCCC---CCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999999997532211 1 111111000000 0 1 0001 12234456666 556677779999
Q ss_pred HHHHHH
Q 001752 977 RDVITM 982 (1018)
Q Consensus 977 ~evl~~ 982 (1018)
++++++
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=318.35 Aligned_cols=256 Identities=28% Similarity=0.437 Sum_probs=204.5
Q ss_pred hcccccceeecCCCeeEEEEEcCCC---CeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCce
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRL---NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 781 (1018)
++|+..+.||+|+||.||+|.+..+ ...||+|++... .......+|.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG---SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC---CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 5688889999999999999998643 468999988432 2234456788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
++||||+++++|.+++..... .+++..+.+++.|++.|++|||+. +|+||||||+||++++++.++++|||+++
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhh
Confidence 999999999999999976432 378999999999999999999998 99999999999999999999999999998
Q ss_pred eeccCCcceEe--eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 001752 862 MMIRKNETVSM--VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 862 ~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
........... ..+++.|+|||...+..++.++||||||+++|||++ |..||..... ......+ .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~----~~~~~-- 226 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDVIKAV----EDGYR-- 226 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--HHHHHHH----HcCCC--
Confidence 76422222222 234578999999998899999999999999999998 9999864321 1111111 11110
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
.+... .....+.+++.+|++.+|++||+++|++++|+++
T Consensus 227 ---~~~~~------~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 ---LPPPM------DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111 1123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=330.42 Aligned_cols=252 Identities=22% Similarity=0.330 Sum_probs=199.2
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceEEEEEecC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
+.||+|+||.||+|....+++.||+|++..... ......+.+.+|+.++.++ +||+|+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 469999999999999998999999999954322 2233456688899998888 69999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~~L~~~~~~~~~----l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 80 GGDLMFHMQRQRK----LPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence 9999998865443 88999999999999999999999 9999999999999999999999999999764333444
Q ss_pred eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCC-cccHHHHHHHHhhcccccccccCCCCCCC
Q 001752 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGE-SVDIVEWIRMKIRDNRNLEEALDPNVGNC 948 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1018)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+......... .. +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~--~p~----- 224 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-IR--IPR----- 224 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-CC--CCC-----
Confidence 45578999999999999999999999999999999999999999643221 1122222222221111 00 000
Q ss_pred chhHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 001752 949 KHVQEEMLLVLRIAFLCTAKLPKDRPSM------RDVITM 982 (1018)
Q Consensus 949 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~ 982 (1018)
.....+.+++.+|++.||++||++ .++.++
T Consensus 225 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 225 ----FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred ----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 012335678999999999999984 566553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=320.71 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=196.4
Q ss_pred eecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCCCC
Q 001752 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGS 792 (1018)
Q Consensus 713 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gs 792 (1018)
||+|+||+||++....+|+.||+|++...... .....+.+..|++++++++||||+++++++.++.+.++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK-KKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhh-cchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 69999999999999989999999998432211 12233455679999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcceEe
Q 001752 793 LGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM 872 (1018)
Q Consensus 793 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 872 (1018)
|.+++..... ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++.++|+|||++..... ......
T Consensus 80 L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~-~~~~~~ 153 (277)
T cd05607 80 LKYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD-GKTITQ 153 (277)
T ss_pred HHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCC-Cceeec
Confidence 9998865432 2378899999999999999999999 999999999999999999999999999976533 223344
Q ss_pred eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhH
Q 001752 873 VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQ 952 (1018)
Q Consensus 873 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1018)
..|++.|+|||++.+..++.++||||+||++|||++|+.||...... .............. ..... .
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~------~~~~~------~ 220 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLEDE------VKFEH------Q 220 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhccc------ccccc------c
Confidence 57899999999998888999999999999999999999999653221 11111111111111 00000 0
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 953 EEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 953 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
.....+.+++.+||++||++||+++|+++..
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 1223467899999999999999997776544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=330.32 Aligned_cols=262 Identities=25% Similarity=0.394 Sum_probs=202.7
Q ss_pred hcccccceeecCCCeeEEEEEcCC-----CCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEec-
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPR-----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHN- 777 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~- 777 (1018)
++|+..+.||+|+||.||+|.... +++.||+|++.... .....+.+.+|+.+++++ +||||++++++|..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 568888999999999999997532 35789999984321 223345678899999999 89999999998864
Q ss_pred CCceEEEEEecCCCCHHHhhhcCCCC------------------------------------------------------
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQAG------------------------------------------------------ 803 (1018)
Q Consensus 778 ~~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 803 (1018)
+...++||||+++++|.+++......
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 46689999999999999998643210
Q ss_pred ---ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc--eEeeccCCC
Q 001752 804 ---RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET--VSMVAGSYG 878 (1018)
Q Consensus 804 ---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~ 878 (1018)
...+++..+.+++.||+.||+|||+. +|+||||||+||+++.++.++|+|||+++.+...... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12578999999999999999999999 9999999999999999999999999999875333222 122445678
Q ss_pred ccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHH
Q 001752 879 YIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLL 957 (1018)
Q Consensus 879 y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 957 (1018)
|+|||++.+..++.++|||||||++|||++ |+.||...... ...... ...... +... ......
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~----~~~~~~------~~~~-----~~~~~~ 304 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRR----LKEGTR------MRAP-----EYATPE 304 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHH----HhccCC------CCCC-----ccCCHH
Confidence 999999999999999999999999999998 99999653221 111111 111110 0000 012245
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhhccCC
Q 001752 958 VLRIAFLCTAKLPKDRPSMRDVITMLGEAKP 988 (1018)
Q Consensus 958 l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 988 (1018)
+.+++.+|++.+|++||++.|++++|+++..
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 7789999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=333.06 Aligned_cols=244 Identities=27% Similarity=0.324 Sum_probs=192.9
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHH-HHhccCCCCcceeeeeEecCCceEEEEEecC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVN-VLGKLRHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
+.||+|+||+||+|.+..+++.||+|++...... .......+..|.. +++.++||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 3689999999999999989999999999443221 2233345555655 4677999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+|+|..++..... +++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 80 GGELFFHLQRERS----FPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC
Confidence 9999998865443 78999999999999999999999 9999999999999999999999999998754333334
Q ss_pred eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCc
Q 001752 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1018)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............. ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~~~~~~~----~~~~------ 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----VAEMYDNILHKPL----VLRP------ 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----HHHHHHHHHcCCc----cCCC------
Confidence 445679999999999999999999999999999999999999997532 1122222111111 0111
Q ss_pred hhHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001752 950 HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980 (1018)
Q Consensus 950 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 980 (1018)
.....+.+++.+|++.+|.+||++++.+
T Consensus 218 ---~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 218 ---GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred ---CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 1123466789999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=324.74 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=204.7
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
...+|+..+.||+|+||.||+|+...+++.||+|.+.... ......+.+|+.+++.++|||++++++++..+.+.+
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC----cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 5578888999999999999999998889999999984322 223467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||+++++|.+++.... +++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||.+..
T Consensus 94 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 94 VVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred EeecccCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchh
Confidence 9999999999999996432 68889999999999999999999 999999999999999999999999999876
Q ss_pred eccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
............+++.|+|||+..+..++.++|||||||++|+|++|+.||...... ..+. .......
T Consensus 166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~----~~~~-~~~~~~~------- 233 (296)
T cd06654 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALY-LIATNGT------- 233 (296)
T ss_pred ccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH----HhHH-HHhcCCC-------
Confidence 543333333457889999999998888999999999999999999999999653221 1111 1111110
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
+.... .......+.+++.+|+.++|++||++.++++.
T Consensus 234 ~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 234 PELQN---PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCC---ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00100 11223446789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=318.65 Aligned_cols=256 Identities=25% Similarity=0.315 Sum_probs=202.0
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|+..+.||+|+||.||+|....+++.||+|++.... ......+.+|+.++++++|||++++++++..++..++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 456888999999999999999998889999999984321 1234567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++++|.++++.... +++..+..++.|++.|++|||+. +|+|||+||+||+++.++.++++|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGP----LSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKI 156 (267)
T ss_pred EEeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceee
Confidence 9999999999999975432 78899999999999999999999 9999999999999999999999999999866
Q ss_pred ccCCcceEeeccCCCccCcCCCC---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccc
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGY---TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
...........+++.|+|||.+. ...++.++||||+||++|||++|+.||........ ... . .. ...
T Consensus 157 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~-----~-~~---~~~ 226 (267)
T cd06646 157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFL-----M-SK---SNF 226 (267)
T ss_pred cccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-hee-----e-ec---CCC
Confidence 43333333456889999999874 44578899999999999999999999854321100 000 0 00 000
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
..+.... .......+.+++.+||+.+|++||+++++++.+
T Consensus 227 ~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKLKD---KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCcc---ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0111111 112234577899999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=332.68 Aligned_cols=255 Identities=22% Similarity=0.237 Sum_probs=201.9
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..+.||+|+||+||+|....+++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 57788999999999999999998999999999954321 22345567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 81 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999976522 378899999999999999999999 999999999999999999999999999987644
Q ss_pred CCcce-EeeccCCCccCcCCCC------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 001752 866 KNETV-SMVAGSYGYIAPEYGY------TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 866 ~~~~~-~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
..... ....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...+........ ..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~~-~~ 228 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----AKTYNNIMNFQR-FL 228 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----HHHHHHHHcCCC-cc
Confidence 33322 2357899999999876 45678999999999999999999999975321 111111111111 00
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.. + . .......+.+++..|++ +|.+||++.+++++
T Consensus 229 ~~--~---~---~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 KF--P---E---DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CC--C---C---CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 0 0 01112346678889997 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=333.18 Aligned_cols=257 Identities=23% Similarity=0.266 Sum_probs=200.2
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
..++|+..+.||+|+||.||+|.+..+++.||+|++.... .......+.+.+|+.+++.++||||+++++++.++...+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFE-MIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 3567899999999999999999999899999999984321 112233456789999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||+++|+|.+++.... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~~~-----~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 9999999999999996542 67888889999999999999999 999999999999999999999999999987
Q ss_pred eccCCc-ceEeeccCCCccCcCCCCCC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 001752 863 MIRKNE-TVSMVAGSYGYIAPEYGYTL----KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 863 ~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... .............+
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~~ 266 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----VGTYSKIMDHKNSL 266 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCccc
Confidence 643322 12346799999999987654 378899999999999999999999975321 11122111111100
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKD--RPSMRDVITM 982 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 982 (1018)
. + + ........+.+++..|+..+|.+ ||++.|++++
T Consensus 267 ~--~-p------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 N--F-P------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred C--C-C------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 0 0 01112233556788888755543 8999999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=321.27 Aligned_cols=258 Identities=27% Similarity=0.409 Sum_probs=204.1
Q ss_pred hcccccceeecCCCeeEEEEEcCC-----CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPR-----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
++|...+.||+|+||.||+|.... +++.||+|++... ......+.+.+|++++++++|||++++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET---ASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc---CCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 457778899999999999998742 3578999998432 12234678999999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHhhhcCCC----------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQA----------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN 849 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 849 (1018)
..++||||+++++|.+++..... ....+++..+..++.|++.|++|||+. +++||||||+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC
Confidence 99999999999999999976432 223478899999999999999999999 99999999999999999
Q ss_pred CCeEEcccccceeeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 001752 850 LEPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEW 926 (1018)
Q Consensus 850 ~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~ 926 (1018)
+.++++|||.++........ .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ......
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--~~~~~~ 236 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--EEVIEC 236 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH
Confidence 99999999999765332211 122345678999999999999999999999999999998 9999865321 122222
Q ss_pred HHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 927 IRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
+. ... ...... .....+.+++.+||+.||++||++.||++.|++
T Consensus 237 ~~----~~~-----~~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 IT----QGR-----LLQRPR------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HH----cCC-----cCCCCC------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11 111 000000 112446789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=314.39 Aligned_cols=249 Identities=27% Similarity=0.337 Sum_probs=196.3
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNN 790 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~ 790 (1018)
+.||+|+||.||+|.+..+++.||+|.+... ........+.+|++++++++||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 3689999999999999888999999987322 2234556789999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcce
Q 001752 791 GSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV 870 (1018)
Q Consensus 791 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 870 (1018)
++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+..........
T Consensus 78 ~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 151 (252)
T cd05084 78 GDFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS 151 (252)
T ss_pred CcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccc
Confidence 99999996543 2378999999999999999999999 99999999999999999999999999987543211111
Q ss_pred --EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCC
Q 001752 871 --SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGN 947 (1018)
Q Consensus 871 --~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1018)
.....+..|+|||.+.+..++.++||||||+++|||++ |..||..... ..... ...... .. +..
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--~~~~~----~~~~~~--~~---~~~-- 218 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--QQTRE----AIEQGV--RL---PCP-- 218 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--HHHHH----HHHcCC--CC---CCc--
Confidence 11123456999999988889999999999999999998 8888864321 11111 111110 00 000
Q ss_pred CchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 948 CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 948 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
......+.+++.+|++.+|++|||++++.++|++
T Consensus 219 ----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 219 ----ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 0112357789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=318.58 Aligned_cols=255 Identities=29% Similarity=0.417 Sum_probs=205.4
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
...|+..+.||.|+||.||+|.+.. ++.+|+|++... .......+.+|+.+++.++|||++++++++.+.+..++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD----DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc----chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 3557788999999999999999986 889999998332 22245578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.+|++|||.+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred EEeecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhc
Confidence 9999999999999976542 2378999999999999999999999 9999999999999999999999999999765
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
...........+++.|+|||+..+..++.++||||||+++|+|++ |+.||..... ......+. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~~----~~~~~----- 223 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQIT----AGYRM----- 223 (261)
T ss_pred CCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHH----hCCcC-----
Confidence 433222233445678999999988889999999999999999998 8999965321 11222111 11000
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
+.. ......+.+++.+|++.||++|||++++++.|+.
T Consensus 224 ~~~------~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCP------AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCC------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 000 1112346789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=318.48 Aligned_cols=260 Identities=23% Similarity=0.368 Sum_probs=202.0
Q ss_pred HhhcccccceeecCCCeeEEEEEcCC-----CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPR-----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN 777 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 777 (1018)
..++|+..+.||+|+||.||+|.+.. ++..||+|++... .......++.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 45778999999999999999998642 3578999988321 122345578899999999999999999999999
Q ss_pred CCceEEEEEecCCCCHHHhhhcCCCC------ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCC
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQAG------RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLE 851 (1018)
Q Consensus 778 ~~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 851 (1018)
....++||||+++|+|.+++...... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCC
Confidence 99999999999999999999753321 22367889999999999999999998 9999999999999999999
Q ss_pred eEEcccccceeeccCCcceE--eeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 001752 852 PRIADFGLARMMIRKNETVS--MVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIR 928 (1018)
Q Consensus 852 ~kl~DfG~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 928 (1018)
++++|||+++.......... ...+++.|+|||++.+..++.++|||||||++|||++ |..||..... .....
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~~~~~ 232 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQVLR 232 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Confidence 99999999875432222111 1245678999999988889999999999999999999 7888865321 11111
Q ss_pred HHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 929 MKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
....... .. .... ....+.+++.+|++.+|++|||+.|++++|++
T Consensus 233 ~~~~~~~--~~----~~~~------~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVMEGGL--LD----KPDN------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCCc--CC----CCCC------CCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111110 00 0011 12346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=335.97 Aligned_cols=254 Identities=22% Similarity=0.270 Sum_probs=197.4
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..+.||+|+||+||+|....+++.||||++.... .......+.+.+|++++++++||||+++++++.+.++.|+||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE-MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH-HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 5778899999999999999999999999999984322 112334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~~----~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYDT----FSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999976443 78888888999999999999999 999999999999999999999999999864321
Q ss_pred CCcc-----------------------------------------------eEeeccCCCccCcCCCCCCCCCccccchh
Q 001752 866 KNET-----------------------------------------------VSMVAGSYGYIAPEYGYTLKVDEKIDIYS 898 (1018)
Q Consensus 866 ~~~~-----------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 898 (1018)
.... .....||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1000 00146899999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCC---CC
Q 001752 899 FGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDR---PS 975 (1018)
Q Consensus 899 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt 975 (1018)
|||++|||++|+.||..... .............+ .-+.. ......+.+++.+|+. +|.+| ++
T Consensus 234 lGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~~~~---~~p~~------~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENS-----HETYRKIINWRETL---YFPDD------IHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred cchhhhhhhcCCCCCCCCCH-----HHHHHHHHccCCcc---CCCCC------CCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 99999999999999975322 11111111111000 00100 0112346678889997 66665 59
Q ss_pred HHHHHHH
Q 001752 976 MRDVITM 982 (1018)
Q Consensus 976 ~~evl~~ 982 (1018)
+.|++++
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=326.11 Aligned_cols=244 Identities=25% Similarity=0.320 Sum_probs=195.1
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeeeEecCCceEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~ 785 (1018)
|+..+.||+|+||+||+|.+..+++.||+|++..... ........+..|..+++.+. |++|+++++++.+.+..|+||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5677899999999999999998999999999853321 12234456778888888885 578889999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~~----l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK----FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999976543 78999999999999999999999 999999999999999999999999999875433
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ... ........... ..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~---~~~i~~~~~~~----p~-- 222 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DEL---FQSIMEHNVSY----PK-- 222 (323)
T ss_pred CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHH---HHHHHhCCCCC----Cc--
Confidence 33334446799999999999988999999999999999999999999975321 111 11111111100 00
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCCCH
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSM 976 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 976 (1018)
.....+.+++.+|++++|.+|++.
T Consensus 223 -------~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 223 -------SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -------cCCHHHHHHHHHHcccCHhhCCCC
Confidence 112346678999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=327.36 Aligned_cols=265 Identities=22% Similarity=0.327 Sum_probs=200.4
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
++|...+.||+|+||.||+|++..+++.||+|++..... ......+.+|+.++++++||||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 568888999999999999999998899999999843322 22344677899999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++ +|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++...
T Consensus 83 ~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred EeCCCC-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 999975 88888865432 368888999999999999999999 99999999999999999999999999997654
Q ss_pred cCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc--------
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR-------- 935 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 935 (1018)
..........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...... +....+........
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE--DELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhhc
Confidence 43333344568899999998764 56889999999999999999999999754221 11111111100000
Q ss_pred ---ccccccCCCCCC---CchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 936 ---NLEEALDPNVGN---CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 936 ---~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.......+.... ..........+.+++.+|++.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000 0000112334678999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=321.56 Aligned_cols=250 Identities=36% Similarity=0.528 Sum_probs=191.8
Q ss_pred ccceeecCCCeeEEEEEcC----CCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 709 ESNVIGMGATGIVYKAEMP----RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 709 ~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
..+.||.|.||.||+|.+. ..+..|+||++.. .......+.|.+|++.+++++||||++++|++...+..++|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~---~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP---SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST---TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc---ccccccceeeeeccccccccccccccccccccccccccccc
Confidence 3568999999999999987 3468899999932 22334478899999999999999999999999988889999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++|+|.+++..... ..+++..+++++.||++||+|||+. +++|+||+++||+++.++.+||+|||++....
T Consensus 80 ~e~~~~g~L~~~L~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNK--EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EE--TTEBHHHHHHHTCT--TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 999999999999987722 2389999999999999999999999 99999999999999999999999999998752
Q ss_pred cCCcce--EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 865 RKNETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 865 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
...... ........|+|||.+.+..++.++||||||+++|||++ |+.||... +........ ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~~~~~~~~-~~~~~~---- 224 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DNEEIIEKL-KQGQRL---- 224 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CHHHHHHHH-HTTEET----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccc-cccccc----
Confidence 222221 11346678999999988889999999999999999999 78888653 222222222 222110
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
+.... ....+.+++..||+.+|++||+++++++.|
T Consensus 225 -~~~~~------~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 -PIPDN------CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TSBTT------SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -eeccc------hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00111 123467899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=318.04 Aligned_cols=259 Identities=22% Similarity=0.357 Sum_probs=201.2
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCe----EEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCc
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNT----IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN 780 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 780 (1018)
+.|+..+.||+|+||+||+|.+..+++ .|++|.+.. ........++..|+..+++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD---RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc---ccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 457778899999999999999876665 466776621 1122334677888889999999999999999864 45
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 860 (1018)
.++++||+++|+|.+++..... .+++..+..++.||+.||+|||+. +++||||||+||+++.++.+|++|||.+
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccc
Confidence 7899999999999999975432 378999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccc
Q 001752 861 RMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 861 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
+........ .....++..|+|||+..+..++.++|||||||++||+++ |+.||.+... ......+ ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~----~~~~~~ 230 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLL----EKGERL 230 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH----HCCCcC
Confidence 875433222 123456778999999988899999999999999999998 9999975321 1122221 111100
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
. .+. .+ ...+.+++.+|+..+|++|||+.|+++.|..+..+.
T Consensus 231 ~---~~~--~~------~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 231 A---QPQ--IC------TIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred C---CCC--CC------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 0 111 11 134567889999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.76 Aligned_cols=263 Identities=27% Similarity=0.401 Sum_probs=211.1
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
....+.++||+|.||+|..++... +..||||+++.. .......+|.+|+++|.+++||||++++|+|..++.+++|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~---a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPD---ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcc---cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 344567899999999999999873 799999999443 3345578999999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
+|||++|+|.+++....... .......+|+.|||.|++||.+. .+||||+.+.|+++|+++++||+|||+++.+-
T Consensus 614 ~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999998775432 45566777999999999999999 99999999999999999999999999998654
Q ss_pred cCCcce--EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCcccHHHHHHHHhhcccccccc
Q 001752 865 RKNETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT--GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 865 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
.++... ...+-..+|||||.+.-+++++++|||+||+++||+++ ...||+.... .++++-.......+. ...
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--e~vven~~~~~~~~~--~~~ 764 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--EQVVENAGEFFRDQG--RQV 764 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--HHHHHhhhhhcCCCC--cce
Confidence 444332 22556789999999999999999999999999999987 7889875322 233333333333222 222
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
+-+.+..|. ..+++++.+||..|.++||+++++...|.+.
T Consensus 765 ~l~~P~~cp------~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 VLSRPPACP------QGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eccCCCcCc------HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 233333332 3467899999999999999999999988763
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.41 Aligned_cols=255 Identities=34% Similarity=0.494 Sum_probs=203.0
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
|+..+.||+|+||+||+|....+++.||+|++..... .........+|+.++++++||||+++++++.+....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhcccccccccccccccccccccccccccc
Confidence 5677899999999999999999999999999944322 22223344569999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
|+++++|.+++.... .+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.++|+|||.+......
T Consensus 79 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp EETTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred ccccccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999998332 279999999999999999999999 9999999999999999999999999999765334
Q ss_pred CcceEeeccCCCccCcCCCC-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 867 NETVSMVAGSYGYIAPEYGY-TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 867 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
........+++.|+|||+.. +..++.++||||+|+++|+|++|..||... ...+............. .....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~--~~~~~~~~~~~~~~~~~--~~~~~--- 224 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES--NSDDQLEIIEKILKRPL--PSSSQ--- 224 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS--SHHHHHHHHHHHHHTHH--HHHTT---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc--cchhhhhhhhhcccccc--ccccc---
Confidence 44445577899999999988 888999999999999999999999999764 11111122211111110 00000
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
........+.+++.+|++.||++||++.++++
T Consensus 225 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 ----QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ----SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ----ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011256788999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=329.48 Aligned_cols=241 Identities=23% Similarity=0.310 Sum_probs=193.7
Q ss_pred ceeecCCCeeEEEEEc---CCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEe
Q 001752 711 NVIGMGATGIVYKAEM---PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEY 787 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 787 (1018)
+.||+|+||.||++.. ..+++.||+|++..... .......+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 5799999999999876 34689999999954321 222345677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCC
Q 001752 788 MNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKN 867 (1018)
Q Consensus 788 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 867 (1018)
+++|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 80 LRGGDLFTRLSKEVM----FTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999999965432 78999999999999999999999 99999999999999999999999999997654443
Q ss_pred cceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCC
Q 001752 868 ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGN 947 (1018)
Q Consensus 868 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1018)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..............+. .
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-----~~~~~~~i~~~~~~~p----~---- 219 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-----RKETMTMILKAKLGMP----Q---- 219 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC-----HHHHHHHHHcCCCCCC----C----
Confidence 34445679999999999988889999999999999999999999997531 1111221111111100 0
Q ss_pred CchhHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 001752 948 CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRD 978 (1018)
Q Consensus 948 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 978 (1018)
.....+.+++.+||++||++||++.+
T Consensus 220 -----~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 -----FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -----CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11234667899999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=335.82 Aligned_cols=203 Identities=25% Similarity=0.337 Sum_probs=174.1
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..+.||+|+||+||+|+...+++.||+|++.... .........+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD-VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH-hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 4778899999999999999999899999999984321 112334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 81 DYIPGGDMMSLLIRMGI----FPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred eCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 99999999999976432 67888888999999999999999 999999999999999999999999999753210
Q ss_pred CC-----------------------------------------------cceEeeccCCCccCcCCCCCCCCCccccchh
Q 001752 866 KN-----------------------------------------------ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYS 898 (1018)
Q Consensus 866 ~~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 898 (1018)
.. .......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 00 0001246899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCC
Q 001752 899 FGVVLLELLTGRRPLDPE 916 (1018)
Q Consensus 899 lG~il~elltg~~pf~~~ 916 (1018)
+||++|||++|+.||...
T Consensus 234 lGvil~elltG~~Pf~~~ 251 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred chHHHHHHHhCCCCCCCC
Confidence 999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=336.50 Aligned_cols=367 Identities=29% Similarity=0.441 Sum_probs=245.1
Q ss_pred ccccceEeccCcccC-cccccccccccccceeeecccccCCCCCcccccccchhhhhccccccCCCCCccccCccccccc
Q 001752 169 ATSLETLDLRGSFFQ-GSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYL 247 (1018)
Q Consensus 169 l~~L~~L~L~~n~~~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 247 (1018)
|+..+-.|+++|.|+ +..|.....+++++.|-|...++. .+|++++.+.+|++|.+++|++. .+-..++.++.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 334445556666655 345666666666666666666665 56666666666666666666665 344456666666666
Q ss_pred cccccccCccCcccccCCCccceEEccCCcCCccCChhhcCCCCCCeeeccCCCCccccCCccccccCCceeecccCccc
Q 001752 248 DLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLS 327 (1018)
Q Consensus 248 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 327 (1018)
++..|++... -+|..+..+..|+.||||+|++. ..|..+..-+++-.|+|++|+|.
T Consensus 84 ~~R~N~LKns-----------------------GiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie 139 (1255)
T KOG0444|consen 84 IVRDNNLKNS-----------------------GIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE 139 (1255)
T ss_pred hhhccccccC-----------------------CCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc
Confidence 6666655421 23344444444555555555553 44555555555555555555554
Q ss_pred cccCCCCCCCCccceEEeccCccccCCCcCCCCCCCCceeecccccccccccccccCCCCCceeccccccCC-CCCcccc
Q 001752 328 GHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFS-GPIPVSL 406 (1018)
Q Consensus 328 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~l 406 (1018)
.+....|-+++.|-.||||+|++. .+|..+..+..|++|+|++|.+.-.--..+-.+++|+.|++++.+=+ .-+|.++
T Consensus 140 tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsl 218 (1255)
T KOG0444|consen 140 TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSL 218 (1255)
T ss_pred cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCch
Confidence 322223445555555555555554 44445555555555555555554222233334555666666654422 2567778
Q ss_pred cccccccEEeccCCcccCCCcccCCCccccceeecccccccCCCccccCCCCccceEeccCCcccCCCCccccCCCCccc
Q 001752 407 STCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQT 486 (1018)
Q Consensus 407 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 486 (1018)
..+++|..+|++.|.+. ..|..+-++++|+.|+||+|+|+. .....+...+|+.|+||+|+++ .+|.+++.+++|+.
T Consensus 219 d~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k 295 (1255)
T KOG0444|consen 219 DDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK 295 (1255)
T ss_pred hhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH
Confidence 88888888888888887 778888888888888888888873 4445556678889999999997 68889999999999
Q ss_pred ccccCCcccC-CCCcccCCCCccceeecccccccCCCCCccccccccceeecccccccCCcccccccCCccceeeccccc
Q 001752 487 FIVSNNNLVG-EIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNS 565 (1018)
Q Consensus 487 L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 565 (1018)
|++.+|+++- -+|..++.+.+|+++..++|.+. .+|+.++.+.+|+.|.|++|+|- .+|.++--++.|+.|||..|.
T Consensus 296 Ly~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 296 LYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred HHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 9999998863 37888888888999999888887 78888888888888999998887 678888888888888888886
Q ss_pred cc
Q 001752 566 LT 567 (1018)
Q Consensus 566 l~ 567 (1018)
=-
T Consensus 374 nL 375 (1255)
T KOG0444|consen 374 NL 375 (1255)
T ss_pred Cc
Confidence 44
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=320.54 Aligned_cols=262 Identities=27% Similarity=0.415 Sum_probs=205.5
Q ss_pred hcccccceeecCCCeeEEEEEcC-----CCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC
Q 001752 705 ACIRESNVIGMGATGIVYKAEMP-----RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
+.|...+.||+|+||.||+|... .++..+++|.+.. ......+.+.+|++++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD----PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 45677789999999999999853 3456789998832 22234467889999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHhhhcCCC------------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEc
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQA------------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLD 847 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~ 847 (1018)
..++||||+++++|.+++..... ....+++..+++++.||+.|++|||++ +|+||||||+||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence 99999999999999999975432 122378999999999999999999999 999999999999999
Q ss_pred CCCCeEEcccccceeeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHH
Q 001752 848 SNLEPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIV 924 (1018)
Q Consensus 848 ~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~ 924 (1018)
.++.++|+|||+++........ .....+++.|+|||+..+..++.++|||||||++|||++ |+.||...... ...
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~ 235 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EVI 235 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 9999999999999765332211 122446788999999998899999999999999999999 99998653221 111
Q ss_pred HHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 925 EWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
.. ..... ... .. ......+.+++.+|++.+|++||++++|+++|+++.+..
T Consensus 236 ~~----~~~~~-~~~----~~------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 236 EC----ITQGR-VLE----RP------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred HH----HhCCC-CCC----CC------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 11 11111 000 00 011234778999999999999999999999999886643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=320.18 Aligned_cols=261 Identities=26% Similarity=0.400 Sum_probs=204.8
Q ss_pred hcccccceeecCCCeeEEEEEc-----CCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC
Q 001752 705 ACIRESNVIGMGATGIVYKAEM-----PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
..|...+.||+|+||.||++.. ..++..+|+|.+.. ......+.+.+|++++++++|||++++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD----ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC----cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 4567788999999999999985 33456799998832 22344567899999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHhhhcCCC---------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQA---------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL 850 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~---------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 850 (1018)
..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999999975431 223489999999999999999999999 999999999999999999
Q ss_pred CeEEcccccceeeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHH
Q 001752 851 EPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWI 927 (1018)
Q Consensus 851 ~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~ 927 (1018)
.++|+|||.++........ .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .+....
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--~~~~~~- 234 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIEC- 234 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH-
Confidence 9999999999765332211 112335678999999998899999999999999999998 8999865321 111111
Q ss_pred HHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCC
Q 001752 928 RMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPR 989 (1018)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 989 (1018)
..... .. +.... ....+.+++.+|++.+|.+|||++++.+.|+.+.+.
T Consensus 235 ---i~~~~-~~----~~~~~------~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ---ITQGR-VL----QRPRT------CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ---HHcCC-cC----CCCCC------CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11111 00 00001 123478899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=324.04 Aligned_cols=269 Identities=27% Similarity=0.356 Sum_probs=207.9
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeE--EEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCce
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTI--VAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 781 (1018)
+.|+..+.||+|+||.||+|.+..++.. +|+|.+.. .......+.+.+|+.++.++ +||||+++++++..++..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~---~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc---cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 5677889999999999999998766654 57776622 12234456788999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHhhhcCCC------------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC
Q 001752 782 MIVYEYMNNGSLGEALHGKQA------------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN 849 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 849 (1018)
++||||+++++|.++++.... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence 999999999999999975432 122478999999999999999999999 99999999999999999
Q ss_pred CCeEEcccccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 001752 850 LEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIR 928 (1018)
Q Consensus 850 ~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 928 (1018)
+.+||+|||+++..... .......++..|+|||+..+..++.++|||||||++|||++ |..||...... +...
T Consensus 161 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~ 234 (303)
T cd05088 161 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYE 234 (303)
T ss_pred CcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----HHHH
Confidence 99999999998642111 11111234568999999888889999999999999999998 99999653221 1111
Q ss_pred HHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCCCCCCCCC
Q 001752 929 MKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNND 997 (1018)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~ 997 (1018)
. ..... ... ... .....+.+++.+|++.+|++||++++++++++++.....+..+..
T Consensus 235 ~-~~~~~------~~~--~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~~~ 291 (303)
T cd05088 235 K-LPQGY------RLE--KPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT 291 (303)
T ss_pred H-HhcCC------cCC--CCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhhhh
Confidence 1 11110 000 000 112346789999999999999999999999999877776665544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=327.60 Aligned_cols=199 Identities=30% Similarity=0.369 Sum_probs=175.2
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-C-----CCcceeeeeEec
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-H-----RNIVRLLGFLHN 777 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~~~~~~~~ 777 (1018)
..+|++.+.||+|+||.|.+|.+.++++.||||+++.. .....+...|+.++..++ | -|+|++++||.-
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 34889999999999999999999999999999999433 344566778999999996 4 589999999999
Q ss_pred CCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC--CeEEc
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL--EPRIA 855 (1018)
Q Consensus 778 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~--~~kl~ 855 (1018)
.++.|+|+|.+. -+|+++++.+...+ ++...+..++.||+.||.+||+. +|||+||||+|||+...+ .+||+
T Consensus 260 r~HlciVfELL~-~NLYellK~n~f~G--lsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVI 333 (586)
T KOG0667|consen 260 RNHLCIVFELLS-TNLYELLKNNKFRG--LSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVI 333 (586)
T ss_pred ccceeeeehhhh-hhHHHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEE
Confidence 999999999994 59999999887655 77888888999999999999999 999999999999997654 69999
Q ss_pred ccccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 001752 856 DFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPE 916 (1018)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 916 (1018)
|||.++.. ......+..+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+.
T Consensus 334 DFGSSc~~---~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 334 DFGSSCFE---SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred eccccccc---CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 99999874 33334678899999999999999999999999999999999998888764
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=321.77 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=205.2
Q ss_pred HHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCce
Q 001752 702 DILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 702 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 781 (1018)
+..++|+..+.||+|+||.||+|....+++.||+|.+.... ....+.+.+|+.+++.++|||++++++++..++..
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc----cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 35688999999999999999999998889999999984322 22345678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
++||||+++++|.+++.... +++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+.
T Consensus 92 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred EEeecccCCCCHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccce
Confidence 99999999999999996532 68889999999999999999999 99999999999999999999999999997
Q ss_pred eeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 862 MMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 862 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
.............+++.|+|||+..+..++.++|||||||++|+|++|+.||.......... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-----~~~~~~------- 231 (297)
T cd06656 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNG------- 231 (297)
T ss_pred EccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-----eeccCC-------
Confidence 65444333344578899999999988889999999999999999999999996532211100 000000
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.+.... .......+.+++.+|++.+|++||+++++++
T Consensus 232 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 232 TPELQN---PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011100 1112234667899999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=335.84 Aligned_cols=254 Identities=22% Similarity=0.269 Sum_probs=196.4
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..+.||+|+||.||+|+...+++.||||++..... ........+.+|++++++++||||+++++.+.+++..++||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV-LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH-HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 57888999999999999999998999999999843221 12234566889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|..+..
T Consensus 81 E~~~~g~L~~~i~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRLGI----FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999976543 67888888999999999999999 999999999999999999999999999753210
Q ss_pred CC-------------------------------------------cceEeeccCCCccCcCCCCCCCCCccccchhHHHH
Q 001752 866 KN-------------------------------------------ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVV 902 (1018)
Q Consensus 866 ~~-------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~i 902 (1018)
.. .......||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 00112469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCC---CHHHH
Q 001752 903 LLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRP---SMRDV 979 (1018)
Q Consensus 903 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---t~~ev 979 (1018)
+|||++|+.||...... ............. ..+.. . .....+.+++.+|+ .+|.+|+ ++.++
T Consensus 234 lyell~G~~Pf~~~~~~-----~~~~~i~~~~~~~---~~~~~---~---~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 234 LYEMLVGQPPFLADTPA-----ETQLKVINWETTL---HIPSQ---A---KLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eeehhhCCCCCCCCCHH-----HHHHHHhccCccc---cCCCC---C---CCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 99999999999753211 1111111110000 00100 0 11223455666765 5999999 88999
Q ss_pred HHH
Q 001752 980 ITM 982 (1018)
Q Consensus 980 l~~ 982 (1018)
+++
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.42 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=204.2
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
|+..+.||+|+||.||++.+..+++.||+|.+.... .....+.+.+|+.++++++|||++++++++.+++..++|||
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 667789999999999999999899999999984322 22345678889999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
|+++++|.+++..... ..+++.....++.|++.|++|||+. +|+|+||||+||+++.++.++++|||.+......
T Consensus 79 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 79 YCDGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred eCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 9999999999865432 2368889999999999999999999 9999999999999999999999999999876544
Q ss_pred CcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCC
Q 001752 867 NETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG 946 (1018)
Q Consensus 867 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 946 (1018)
........+++.|+|||+..+..++.++||||||+++|+|++|+.||.... ............. .+...
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~------~~~~~ 222 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKVCQGSY------KPLPS 222 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHHhcCCC------CCCCc
Confidence 444445678999999999988889999999999999999999999997531 1111111111111 11110
Q ss_pred CCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 947 NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 947 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.....+.+++.+||+.||++||++.++++.
T Consensus 223 ------~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 ------HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112346788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.62 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=201.9
Q ss_pred hcccccceeecCCCeeEEEEEc----CCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCc
Q 001752 705 ACIRESNVIGMGATGIVYKAEM----PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN 780 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 780 (1018)
..|+..+.||+|+||.||+|.. ..++..||+|.+... .......++.+|+.++++++||||+++++++..++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI---NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 4567778999999999999985 235688999998422 122345678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHhhhcCCC-------------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQA-------------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLD 847 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~ 847 (1018)
.++||||+++++|.+++..... ....+++.+...++.|++.||+|||+. +|+||||||+||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIG 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEc
Confidence 9999999999999999853321 123478899999999999999999999 999999999999999
Q ss_pred CCCCeEEcccccceeeccCCc--ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHH
Q 001752 848 SNLEPRIADFGLARMMIRKNE--TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIV 924 (1018)
Q Consensus 848 ~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~ 924 (1018)
.++.+|++|||+++....... ......++..|+|||+..+..++.++|||||||++|||++ |..||.... ...+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--~~~~~ 236 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--NQEVI 236 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHH
Confidence 999999999999976533221 1122345678999999988889999999999999999998 999986531 11222
Q ss_pred HHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 925 EWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
..+. ..... +.... ....+.+++.+|+++||++||++.++.++|+.+
T Consensus 237 ~~~~----~~~~~-----~~~~~------~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 237 EMVR----KRQLL-----PCSED------CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHH----cCCcC-----CCCCC------CCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 2221 11100 00111 123467789999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=303.91 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=208.3
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
+-|++..+||+|+||.||+|.++.+|+.+|+|.+ .. +...+++..|+.++++++.|++|+++|.|-....+++|
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~V-----PV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKV-----PV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEec-----Cc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 4466778999999999999999999999999998 22 24577889999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
||||..|++.+.++-+.+ ++.+.++..|...-+.||+|||.. .-+|||||+.||++.-+|.+|++|||.|..+.
T Consensus 107 MEYCGAGSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred hhhcCCCcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhh
Confidence 999999999999976543 489999999999999999999998 88999999999999999999999999998775
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
.......++.|||-|||||++..-.|..++||||+|++..||.-|++||.....-. .-.-+.---.|.
T Consensus 181 DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR------------AIFMIPT~PPPT 248 (502)
T KOG0574|consen 181 DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR------------AIFMIPTKPPPT 248 (502)
T ss_pred hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc------------eeEeccCCCCCC
Confidence 55555566889999999999999999999999999999999999999997531100 000001111122
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
..+ ..+...++.++++.|+-+.|++|-|+-+++++
T Consensus 249 F~K---PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKK---PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCC---hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 222 22334456688999999999999999988774
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.00 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=198.5
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
+.|+..+.||+|+||+||.|.... +..||+|.+... .....++.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEG-----SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCC-----cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 456778899999999999998763 556999988322 12345789999999999999999999999998999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++|+|.+++..... .+++..++.++.||+.|++|||+. +++|+||||+||+++.++.+|++|||.++...
T Consensus 78 ~e~~~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 78 TEYMSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL 151 (256)
T ss_pred EEcCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecC
Confidence 999999999999976432 378999999999999999999999 99999999999999999999999999987653
Q ss_pred cCCcce-EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 865 RKNETV-SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 865 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
...... ....++..|+|||+..+..++.++||||||+++|||++ |+.||..... .+....+ ..... .
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~---~~~~~------~ 220 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--SETVEKV---SQGLR------L 220 (256)
T ss_pred CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHH---hcCCC------C
Confidence 322111 11234567999999988889999999999999999999 9999864321 1111111 11111 0
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 984 (1018)
+... .....+.+++.+||+.+|++||++.++++.++
T Consensus 221 ~~~~------~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPH------LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCC------CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0000 11245778999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=316.53 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=199.9
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecC---
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHND--- 778 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--- 778 (1018)
+.+.|+..+.||+|+||.||+|....+++.||+|++... ......+.+|+.+++++ +|||++++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-----CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 567788889999999999999999988999999998322 23345788899999998 799999999998642
Q ss_pred ---CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEc
Q 001752 779 ---TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIA 855 (1018)
Q Consensus 779 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 855 (1018)
...++||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +|+|+||||+||++++++.++++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence 458999999999999999976432 2378999999999999999999999 99999999999999999999999
Q ss_pred ccccceeeccCCcceEeeccCCCccCcCCCC-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 001752 856 DFGLARMMIRKNETVSMVAGSYGYIAPEYGY-----TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMK 930 (1018)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 930 (1018)
|||++..............|++.|+|||++. +..++.++||||+||++|||++|+.||..... ......
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----~~~~~~-- 227 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRALFL-- 227 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----HHHHHH--
Confidence 9999986543333344567899999999875 34578899999999999999999999964321 111110
Q ss_pred hhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 931 IRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
..... .....+. .....+.+++.+||+.+|.+|||+++++++
T Consensus 228 ~~~~~-~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 228 IPRNP-APRLKSK---------KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HhcCC-CCCCCCC---------CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00000 0000000 112346789999999999999999999763
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=329.77 Aligned_cols=267 Identities=25% Similarity=0.311 Sum_probs=199.5
Q ss_pred HHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC--
Q 001752 702 DILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT-- 779 (1018)
Q Consensus 702 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-- 779 (1018)
.+.++|+..+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 36788999999999999999999999899999999984332 22344567889999999999999999999986443
Q ss_pred ----ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEc
Q 001752 780 ----NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIA 855 (1018)
Q Consensus 780 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 855 (1018)
..|+||||+++ ++.+.+... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~ 165 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIHME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 165 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHhcc------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEe
Confidence 47999999965 677766432 67888889999999999999999 99999999999999999999999
Q ss_pred ccccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHH---------
Q 001752 856 DFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEW--------- 926 (1018)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~--------- 926 (1018)
|||+++.... ........+|+.|+|||++.+..++.++||||+||++|+|++|+.||....... .....
T Consensus 166 Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~ 243 (359)
T cd07876 166 DFGLARTACT-NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSA 243 (359)
T ss_pred cCCCcccccc-CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcH
Confidence 9999975422 222334578999999999999999999999999999999999999997542110 00000
Q ss_pred ---------HHHHhhcccc-----cccccCCCC-C-CCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 927 ---------IRMKIRDNRN-----LEEALDPNV-G-NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 927 ---------~~~~~~~~~~-----~~~~~~~~~-~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
+......... +.+...... . ...........+.+++.+|++.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 000000000 0 000000112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=312.20 Aligned_cols=255 Identities=25% Similarity=0.333 Sum_probs=202.7
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeecccccc-ccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADL-ETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
+.|+..+.||+|++|.||+|....+++.||+|.+....... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 45788899999999999999998889999999985432211 12234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++++|.+++..... +++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++|+|||.++..
T Consensus 82 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGA----LTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999976543 78888899999999999999999 9999999999999999999999999999765
Q ss_pred ccCCcce---EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccc
Q 001752 864 IRKNETV---SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 864 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
....... ....++..|+|||+..+..++.++||||+|+++|||++|+.||..... . ..+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~-~~~~~~~~~~~----- 224 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----M-AAIFKIATQPT----- 224 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----H-HHHHHHhccCC-----
Confidence 3322211 234578899999999998899999999999999999999999964311 1 11111111110
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.+... ......+.+++.+|++.+|++|||+.+++++
T Consensus 225 -~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 -NPQLP-----SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCC-----ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00010 0122346788999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.63 Aligned_cols=260 Identities=26% Similarity=0.403 Sum_probs=203.8
Q ss_pred hhcccccceeecCCCeeEEEEEcCCC-----CeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEec
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHN 777 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 777 (1018)
.++|+..+.||+|+||.||+|..... ...+|+|.+... .......++.+|+++++++ +||||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC---CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 45678889999999999999987533 378999988432 1223446788999999999 89999999999999
Q ss_pred CCceEEEEEecCCCCHHHhhhcCC------------CCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEE
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQ------------AGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNIL 845 (1018)
Q Consensus 778 ~~~~~lV~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl 845 (1018)
++..++||||+++|+|.++++.+. .....+++..+++++.|++.|++|||+. +|+||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence 999999999999999999997532 1233488999999999999999999999 9999999999999
Q ss_pred EcCCCCeEEcccccceeeccCCcce--EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCccc
Q 001752 846 LDSNLEPRIADFGLARMMIRKNETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVD 922 (1018)
Q Consensus 846 l~~~~~~kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~ 922 (1018)
++.++.+|++|||.++.+....... ....++..|+|||+..+..++.++|||||||++|||++ |..||..... ..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~ 242 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--EE 242 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--HH
Confidence 9999999999999998654332211 11234578999999988899999999999999999998 9999865321 11
Q ss_pred HHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 923 IVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
.... ....... +.. ......+.+++.+|++.+|++|||++|+++.|+++
T Consensus 243 ~~~~----~~~~~~~-----~~~------~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 LFKL----LKEGYRM-----EKP------QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHH----HHcCCcC-----CCC------CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1111 1111100 000 11123577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.29 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=203.4
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCe----EEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCc
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNT----IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN 780 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 780 (1018)
+.|+..+.||+|+||+||+|.+..+++ .||+|++... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN---TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC---CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 567788999999999999999765655 4899988322 2234456788999999999999999999999754 5
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 860 (1018)
.+++|||+++|+|.+++..... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCce
Confidence 7899999999999999976432 378899999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceEe--eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccc
Q 001752 861 RMMIRKNETVSM--VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 861 ~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
+.+......... ..+++.|+|||...+..++.++|||||||++|||++ |..||+.... ..+..++. .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~----~~~~~ 230 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLE----KGERL 230 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH----CCCcC
Confidence 876432222111 234678999999988899999999999999999998 8999865321 22222222 11100
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
+.. ......+.+++.+|++.||++||++.++++.++++..+.
T Consensus 231 -----~~~------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 -----PQP------PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -----CCC------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 000 011234678999999999999999999999998876655
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.60 Aligned_cols=258 Identities=22% Similarity=0.366 Sum_probs=199.8
Q ss_pred ccccceeecCCCeeEEEEEcCCC---CeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCc---
Q 001752 707 IRESNVIGMGATGIVYKAEMPRL---NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN--- 780 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--- 780 (1018)
|...+.||+|+||.||+|....+ +..||+|++.... ........+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI--HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 45678899999999999997643 4789999984321 122345678999999999999999999998865543
Q ss_pred ---eEEEEEecCCCCHHHhhhcCCC--CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEc
Q 001752 781 ---MMIVYEYMNNGSLGEALHGKQA--GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIA 855 (1018)
Q Consensus 781 ---~~lV~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 855 (1018)
.++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence 7999999999999999865432 223478999999999999999999999 99999999999999999999999
Q ss_pred ccccceeeccCCcce--EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhh
Q 001752 856 DFGLARMMIRKNETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIR 932 (1018)
Q Consensus 856 DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 932 (1018)
|||.++......... ....++..|+|||+..+..++.++|||||||++|||++ |..||..... ......+ ..
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~---~~ 230 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYL---RH 230 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---Hc
Confidence 999998764332221 11335678999999988889999999999999999999 8899865321 1122211 11
Q ss_pred cccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 933 DNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
... .+.. ......+.+++.+|++.||++||++.|+++.|+++
T Consensus 231 ~~~------~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNR------LKQP------EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC------CCCC------cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 0000 11234577899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=328.87 Aligned_cols=258 Identities=23% Similarity=0.275 Sum_probs=200.0
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
..++|+..+.||+|+||.||+|.+..+++.||+|++.... .......+.+.+|+.+++.++||||+++++++.++...+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE-MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHH-hhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 3578999999999999999999999999999999984321 112233456788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||+++|+|.+++.... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 120 lv~Ey~~gg~L~~~~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 9999999999999996543 67788888999999999999999 999999999999999999999999999987
Q ss_pred eccCCc-ceEeeccCCCccCcCCCCCC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 001752 863 MIRKNE-TVSMVAGSYGYIAPEYGYTL----KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 863 ~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...............
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~~~~ 266 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----LVGTYSKIMNHKNSL 266 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCCCcc
Confidence 643322 22346799999999987653 37899999999999999999999997532 112222211111100
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHh
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKD--RPSMRDVITML 983 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~L 983 (1018)
. . +. .......+.+++.+|+..++.+ ||++.|++++.
T Consensus 267 ~-~--~~------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 267 T-F--PD------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred c-C--CC------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0 0 00 1112334567888999844433 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=314.95 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=198.8
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||+|+||.||+|.+..+++.||+|++... ......+.+.+|++++++++||||+++++++..++..++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD---ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC---CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 466778999999999999999889999999998432 12334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 79 EFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred ecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999999997653 157788889999999999999999 999999999999999999999999999976532
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCccc--HHHHHHHHhhcccccccccCC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVD--IVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
. ......+|..|+|||++.+..++.++||||||+++|+|++|+.||......... ............ .+
T Consensus 148 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~ 218 (279)
T cd06619 148 S--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-------PP 218 (279)
T ss_pred c--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-------CC
Confidence 2 233457899999999999889999999999999999999999999653322111 111111111110 11
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.... ......+.+++.+|++.+|++||+++|++++
T Consensus 219 ~~~~----~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 VLPV----GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCC----CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1100 1122346788999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=314.01 Aligned_cols=257 Identities=24% Similarity=0.374 Sum_probs=197.3
Q ss_pred cccceeecCCCeeEEEEEcCCCCe--EEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC------C
Q 001752 708 RESNVIGMGATGIVYKAEMPRLNT--IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND------T 779 (1018)
Q Consensus 708 ~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~ 779 (1018)
...+.||+|+||.||+|++..++. .||+|.++... ......+.+.+|+.++++++||||+++++++... .
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 356789999999999999876654 68999884321 2234467788999999999999999999987432 3
Q ss_pred ceEEEEEecCCCCHHHhhhcCC--CCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccc
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQ--AGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADF 857 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 857 (1018)
..++||||+++|+|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+||++++++.++|+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence 4689999999999999885332 1223478999999999999999999998 9999999999999999999999999
Q ss_pred ccceeeccCCcce--EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcc
Q 001752 858 GLARMMIRKNETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDN 934 (1018)
Q Consensus 858 G~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 934 (1018)
|+++.+....... ....+++.|+|||+..+..++.++||||||+++|||++ |+.||.... ....... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~----~~~~ 230 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--NSEIYDY----LRQG 230 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH----HHcC
Confidence 9998754332211 12345678999999998899999999999999999999 888986521 1111111 1111
Q ss_pred cccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 935 RNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
.... ..+ .....+.+++.+||+.+|++|||+.++++.|+++
T Consensus 231 ~~~~--~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLK--QPP---------DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC--CCC---------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1100 000 1123467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.72 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=197.7
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
..|+..+.||+|+||.||+|.+. ++..+|+|++... ......+.+|++++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREG-----AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccC-----CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 34677889999999999999986 4678999988322 12345688899999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++...
T Consensus 78 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 78 TEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151 (256)
T ss_pred EecCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecc
Confidence 999999999999975432 378999999999999999999999 99999999999999999999999999997653
Q ss_pred cCCcce-EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 865 RKNETV-SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 865 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
...... ....++..|+|||+..+..++.++||||||+++|||++ |+.||..... .+....+ .... .
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~----~~~~------~ 219 (256)
T cd05059 152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--SEVVESV----SAGY------R 219 (256)
T ss_pred cccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--HHHHHHH----HcCC------c
Confidence 221111 11223457999999998899999999999999999999 8999965321 1111111 1111 0
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
..... .....+.+++.+|++.+|++|||+.|+++.|
T Consensus 220 ~~~~~-----~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPK-----LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCC-----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00000 1234577899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=338.43 Aligned_cols=264 Identities=21% Similarity=0.276 Sum_probs=193.8
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC-----
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND----- 778 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 778 (1018)
.++|+..+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~--------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC--------cchHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 35788999999999999999999888999999988321 12345799999999999999999886432
Q ss_pred ---CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC-CeEE
Q 001752 779 ---TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL-EPRI 854 (1018)
Q Consensus 779 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl 854 (1018)
...++||||+++ ++.+++.........+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceee
Confidence 246799999974 88887764433334588999999999999999999999 999999999999999765 6999
Q ss_pred cccccceeeccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc
Q 001752 855 ADFGLARMMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD 933 (1018)
Q Consensus 855 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 933 (1018)
+|||+|+.+.... ......||+.|+|||++.+ ..++.++||||+||++|||++|.+||.+.... ..+...+......
T Consensus 213 ~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p 290 (440)
T PTZ00036 213 CDFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTP 290 (440)
T ss_pred eccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCC
Confidence 9999998654322 2334578999999998765 46899999999999999999999999764221 1111111110000
Q ss_pred c--------cccccccCCCCCCCchhH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 934 N--------RNLEEALDPNVGNCKHVQ-----EEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 934 ~--------~~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
. ..+.+..-+... ..... ....++.+++.+||++||.+|||+.|++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVK-PKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccC-chhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 000000000000 00000 112357789999999999999999999864
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.21 Aligned_cols=260 Identities=23% Similarity=0.362 Sum_probs=202.5
Q ss_pred ccccceeecCCCeeEEEEEcCC-----CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCce
Q 001752 707 IRESNVIGMGATGIVYKAEMPR-----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 781 (1018)
|+..+.||+|+||.||+|.... ....+|+|.+.... .....+++.+|+.++++++||||+++++++..++..
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 5667899999999999998743 23578888873322 223356788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhcCCC--------------------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCC
Q 001752 782 MIVYEYMNNGSLGEALHGKQA--------------------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKS 841 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 841 (1018)
++||||+++|+|.+++..... ....+++..++.++.|++.|++|||+. +|+||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence 999999999999999864321 123478999999999999999999999 999999999
Q ss_pred CcEEEcCCCCeEEcccccceeeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCC
Q 001752 842 NNILLDSNLEPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFG 918 (1018)
Q Consensus 842 ~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~ 918 (1018)
+||++++++.++|+|||.++........ .....++..|+|||+..+..++.++||||||+++|||++ |+.||.+...
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999999765332221 122345678999999888889999999999999999999 9999965321
Q ss_pred CcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCC
Q 001752 919 ESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPR 989 (1018)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 989 (1018)
..+..... ... ..... ......+.+++.+|++.+|++||+++++++.|+++..+
T Consensus 236 --~~~~~~~~----~~~------~~~~~-----~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 --ERLFNLLK----TGY------RMERP-----ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred --HHHHHHHh----CCC------CCCCC-----CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 11222111 111 00000 01123577899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.77 Aligned_cols=253 Identities=27% Similarity=0.430 Sum_probs=200.4
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|+..++||+|+||.||+|... +++.||+|.+... .....++.+|+.++++++|||++++++++. .+..++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQG-----SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCC-----CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 356788899999999999999976 5788999998322 223467889999999999999999999874 456899
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++++|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 78 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred EEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeec
Confidence 9999999999999865432 3478999999999999999999998 9999999999999999999999999999765
Q ss_pred ccCCc-ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 864 IRKNE-TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 864 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
..... ......++..|+|||+..+..++.++||||||+++|||++ |+.||..... .+..... ......
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~----~~~~~~---- 222 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQNL----ERGYRM---- 222 (260)
T ss_pred CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHH----HcCCCC----
Confidence 42221 1122345678999999988889999999999999999999 9999975321 1121111 111100
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
+... .....+.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 -~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 -PRPD------NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCC------CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0000 112347789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=320.15 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=203.8
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
...+|+..+.||.|+||.||+|.+..+++.||+|.+... .....+.+.+|+.+++.++|||++++++++...+..+
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ----KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc----cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence 346688899999999999999999888999999998432 2233567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+|+||+++++|.+++.... +++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++..
T Consensus 93 lv~e~~~~~~L~~~~~~~~-----l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 93 VVMEYLAGGSLTDVVTETC-----MDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred EEEEecCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchh
Confidence 9999999999999986532 78999999999999999999999 999999999999999999999999999876
Q ss_pred eccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
............+++.|+|||...+..++.++|||||||++|+|++|+.||...... ...........
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-----~~~~~~~~~~~------- 232 (296)
T cd06655 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----RALYLIATNGT------- 232 (296)
T ss_pred cccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcCC-------
Confidence 544333333456889999999999888999999999999999999999999753221 11111111110
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
+..... ......+.+++.+||..||++||++.++++
T Consensus 233 ~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 233 PELQNP---EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cccCCc---ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 001011 111234667899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=318.14 Aligned_cols=258 Identities=25% Similarity=0.310 Sum_probs=200.9
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEe-----
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLH----- 776 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~----- 776 (1018)
..++|+..+.||+|+||.||+|.+..+++.+|+|++... .....++.+|+.+++++ +||||+++++++.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-----HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-----cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 668889999999999999999999988999999987321 12345678899999999 6999999999873
Q ss_pred cCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcc
Q 001752 777 NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 777 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 856 (1018)
.+...++||||+++++|.+++.........+++..+..++.|+++|+.|||+. +|+||||||+||+++.++.++++|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEcc
Confidence 34568999999999999998865433334478899999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceEeeccCCCccCcCCCC-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHh
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGY-----TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKI 931 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 931 (1018)
||.++.............|++.|+|||++. +..++.++||||+||++|||++|+.||...... ..... .
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----~~~~~--~ 241 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----RALFK--I 241 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----HHHhh--c
Confidence 999987643333334457899999999874 345788999999999999999999999653211 11100 0
Q ss_pred hcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 932 RDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
.... ......+.. ....+.+++.+|++.||++|||++|+++..
T Consensus 242 ~~~~-~~~~~~~~~--------~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 PRNP-PPTLHQPEL--------WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cccC-CCcccCCCC--------cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0000 001111110 123467899999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=311.04 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=195.4
Q ss_pred eeecCCCeeEEEEEc--CCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecC
Q 001752 712 VIGMGATGIVYKAEM--PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 712 ~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
.||+|+||.||+|.+ ..+++.||+|++... .......+++.+|+.++++++||||+++++++.. +..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC--CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCC
Confidence 589999999999965 456789999998432 2233456778999999999999999999999864 56789999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+|+|.+++..... +++..+..++.|++.|++|+|+. +|+||||||+||+++.++.++|+|||.++.+......
T Consensus 79 ~~~L~~~l~~~~~----~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 79 LGPLNKFLQKNKH----VTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999999975432 78899999999999999999999 9999999999999999999999999999876443322
Q ss_pred eEe---eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 870 VSM---VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 870 ~~~---~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
... ..+++.|+|||......++.++|||||||++|||++ |+.||..... ......+. .... . +..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~----~~~~-~----~~~ 220 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIE----SGER-M----ECP 220 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH----CCCC-C----CCC
Confidence 211 234578999999888889999999999999999998 9999975322 12222221 1110 0 000
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
. .....+.+++.+|++.||++||++++|++.|++.
T Consensus 221 ~------~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 Q------RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred C------CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 0 1123467899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=319.68 Aligned_cols=256 Identities=29% Similarity=0.415 Sum_probs=206.6
Q ss_pred ChHHHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC
Q 001752 699 TSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND 778 (1018)
Q Consensus 699 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 778 (1018)
..+|....|...+.||.|+||.||-|++..+.+.||||++.. ..+...+...++..|+..+++++|||++.+-|+|-.+
T Consensus 20 ~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsy-SGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre 98 (948)
T KOG0577|consen 20 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY-SGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE 98 (948)
T ss_pred ccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccc-cccccHHHHHHHHHHHHHHHhccCCCcccccceeecc
Confidence 344566778888899999999999999999999999999933 2333455678899999999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccc
Q 001752 779 TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFG 858 (1018)
Q Consensus 779 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 858 (1018)
...++|||||- |+-.|.+.-.++ ++.+..+..|+.+.++||+|||+. +.||||||+.||++++.|.||++|||
T Consensus 99 ~TaWLVMEYCl-GSAsDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFG 171 (948)
T KOG0577|consen 99 HTAWLVMEYCL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFG 171 (948)
T ss_pred chHHHHHHHHh-ccHHHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeecccc
Confidence 99999999995 588888865443 378889999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceEeeccCCCccCcCCCC---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc
Q 001752 859 LARMMIRKNETVSMVAGSYGYIAPEYGY---TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR 935 (1018)
Q Consensus 859 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 935 (1018)
.|....+ ...++|||.|||||++. .+.|+-++||||+|++..|+.-.++|+-.. +..+.........
T Consensus 172 SAsi~~P----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-----NAMSALYHIAQNe- 241 (948)
T KOG0577|consen 172 SASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSALYHIAQNE- 241 (948)
T ss_pred chhhcCc----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-----hHHHHHHHHHhcC-
Confidence 9976533 34468999999999865 578999999999999999999999997432 1122222111111
Q ss_pred ccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 936 NLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.|.+. ..++.+ .+..++..|+++-|.+|||..+++++
T Consensus 242 ------sPtLq-s~eWS~---~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 ------SPTLQ-SNEWSD---YFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ------CCCCC-CchhHH---HHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 12222 122333 34567889999999999999998874
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.02 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=201.3
Q ss_pred hcccccceeecCCCeeEEEEEcCC-----CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPR-----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
..|+..+.||+|+||.||+|.+.. .++.||+|++.... .......+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 346667889999999999998753 35789999984221 2234567889999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHhhhcCC------------CCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEc
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQ------------AGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLD 847 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~ 847 (1018)
..++++||+++++|.+++.... .....+++..+.+++.|++.||+|+|+. +|+||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEec
Confidence 9999999999999999985321 1123478889999999999999999999 999999999999999
Q ss_pred CCCCeEEcccccceeeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHH
Q 001752 848 SNLEPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIV 924 (1018)
Q Consensus 848 ~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~ 924 (1018)
+++.+||+|||+++........ .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+... .
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~ 233 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----Q 233 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----H
Confidence 9999999999998765332221 122445778999999988889999999999999999998 8888865311 1
Q ss_pred HHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 925 EWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
.+......... .+.... ....+.+++.+|++.+|++||++++|++.|+.+
T Consensus 234 ~~~~~i~~~~~------~~~~~~------~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 234 DVIEMIRNRQV------LPCPDD------CPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred HHHHHHHcCCc------CCCCCC------CCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 22222111111 011111 123366899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=310.47 Aligned_cols=254 Identities=30% Similarity=0.445 Sum_probs=200.0
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.++|+..+.||+|+||+||+|.+..+ ..||+|++... ....+.+.+|++++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~-----~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-----TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccC-----ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence 35688899999999999999998754 56999998321 1234578999999999999999999998754 56799
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++|+|.+++..... ..+++..+..++.|++.||+|+|+. +++||||||+||+++.++.++|+|||.++.+
T Consensus 78 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred EEEcCCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeec
Confidence 9999999999999975432 2368999999999999999999999 9999999999999999999999999999766
Q ss_pred ccCCcce-EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 864 IRKNETV-SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 864 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
....... ....++..|+|||+..+..++.++||||||+++|||++ |+.||...... .. ... .......
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~~---~~~-~~~~~~~---- 222 (262)
T cd05071 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EV---LDQ-VERGYRM---- 222 (262)
T ss_pred cccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--HH---HHH-HhcCCCC----
Confidence 4332221 12345678999999988889999999999999999999 88888653211 11 111 1111100
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
+. ..+....+.+++.+|++++|++||+++++.+.|++.
T Consensus 223 -~~------~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 -PC------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CC------ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00 112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.81 Aligned_cols=257 Identities=28% Similarity=0.439 Sum_probs=202.8
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCe---EEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCc
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNT---IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN 780 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 780 (1018)
.+.|+..+.||+|+||.||+|....+++ .+|+|++.... .....+++.+|+.++++++|||++++++++...+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 3567788999999999999999865543 79999883321 22345678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 860 (1018)
.++||||+++++|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||++
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccc
Confidence 9999999999999999975432 278999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceEe---eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccc
Q 001752 861 RMMIRKNETVSM---VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRN 936 (1018)
Q Consensus 861 ~~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 936 (1018)
............ ...++.|+|||++.+..++.++|||||||++|||++ |+.||..... . ....... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~---~~~~~i~-~~~~ 228 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--H---EVMKAIN-DGFR 228 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--H---HHHHHHh-cCCC
Confidence 766433222111 123457999999988889999999999999999998 9999965321 1 1111111 1110
Q ss_pred cccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 937 LEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
.+... +....+.+++.+|++.+|++||++.+|++.|+++
T Consensus 229 -----~~~~~------~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 -----LPAPM------DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111 1123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=315.31 Aligned_cols=265 Identities=26% Similarity=0.377 Sum_probs=201.2
Q ss_pred hcccccceeecCCCeeEEEEEcCCC--------------CeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcce
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRL--------------NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 770 (1018)
++|+..+.||+|+||.||+|..... ...||+|++... ........|.+|++++++++|||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD---VTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 5788889999999999999987532 235899988432 22344567899999999999999999
Q ss_pred eeeeEecCCceEEEEEecCCCCHHHhhhcCCC--------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCC
Q 001752 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQA--------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSN 842 (1018)
Q Consensus 771 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 842 (1018)
+++++......++||||+++++|.+++..... ....+++..++.++.|++.|++|||+. +++||||||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence 99999999999999999999999999965421 112368899999999999999999999 9999999999
Q ss_pred cEEEcCCCCeEEcccccceeeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh--CCCCCCCCCC
Q 001752 843 NILLDSNLEPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT--GRRPLDPEFG 918 (1018)
Q Consensus 843 NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~pf~~~~~ 918 (1018)
||+++.++.+|++|||++......... .....+++.|+|||+..+..++.++|||||||++|+|++ |..||.....
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 999999999999999999765332211 112345678999999988889999999999999999998 6667765322
Q ss_pred CcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 919 ESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
.+....................+. .....+.+++.+|++.+|++||++++|++.|++
T Consensus 239 --~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 --EQVIENTGEFFRNQGRQIYLSQTP--------LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHHHhhhhccccccCCCCC--------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 122222111111110000000000 112357889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.51 Aligned_cols=268 Identities=27% Similarity=0.337 Sum_probs=199.1
Q ss_pred ccccceeecCCCeeEEEEE----cCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC--Cc
Q 001752 707 IRESNVIGMGATGIVYKAE----MPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND--TN 780 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~ 780 (1018)
|+..+.||+|+||+||.+. ...+++.||+|.+.... .......+.+|++++++++||||+++++++... ..
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 3778999999999998765 33467899999984321 123456788999999999999999999998653 45
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 860 (1018)
.++||||+++++|.+++.... +++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++|||++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~-----l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccc
Confidence 799999999999999997543 79999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcce---EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 001752 861 RMMIRKNETV---SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 861 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
+.+....... ....++..|+|||...+..++.++||||||+++|||++|+.||........+.......... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 233 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT-VVRL 233 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccc-hhhh
Confidence 8654322211 11235567999999988889999999999999999999999986432211111100000000 0000
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
.+..+..... .........+.+++.+|++.+|++|||++++++.|+++.
T Consensus 234 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0001100000 000112345778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=308.43 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=207.4
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||.|+||.||.+....+++.+++|++.... ......+++.+|++++++++|+||+++++++.+.+..++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR--LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc--cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 4778899999999999999999899999999984322 23345667889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+|++|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 79 EYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS 153 (256)
T ss_pred EecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence 9999999999997653 23478999999999999999999999 999999999999999999999999999987644
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
.........+++.|+|||+..+..++.++||||||+++|||++|+.||.... ....+........ .+..
T Consensus 154 ~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~~~------~~~~ 222 (256)
T cd08221 154 EYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLVVKIVQGNY------TPVV 222 (256)
T ss_pred ccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCCC------CCCc
Confidence 4433344678999999999988889999999999999999999999996531 1222222211111 1100
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
......+.+++.+|++.+|++||++++++++.
T Consensus 223 ------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 ------SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ------cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11234467889999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=319.80 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=209.9
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
+...++||-|.||.||.|.|++..-.||||.+ +.+.....+|..|+.+|+.++|||+|+++|+|.-+..+|+|.|
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtL-----KEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhh-----hhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 34567899999999999999988899999999 3445667899999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
||..|+|.+||++... ..++....+.++.||+.|++||..+ .+|||||.+.|.++.++..|||+|||+++++..+
T Consensus 344 fM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred cccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 9999999999987653 3367778888999999999999999 9999999999999999999999999999987443
Q ss_pred CcceEeecc---CCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 867 NETVSMVAG---SYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 867 ~~~~~~~~g---t~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
. .+...| .+-|+|||-+....++.|+|||+|||++||+.| |..||.+.. ...+.......++..
T Consensus 419 T--YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--lSqVY~LLEkgyRM~-------- 486 (1157)
T KOG4278|consen 419 T--YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYGLLEKGYRMD-------- 486 (1157)
T ss_pred c--eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--HHHHHHHHhcccccc--------
Confidence 2 233333 467999999999999999999999999999999 888987531 111222222211111
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
..+.| ...+++|++.||+..|.+||++.|+-+.|+.+..+.
T Consensus 487 -~PeGC------PpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 487 -GPEGC------PPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred -CCCCC------CHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 11222 245788999999999999999999999998875443
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=315.33 Aligned_cols=266 Identities=27% Similarity=0.389 Sum_probs=204.0
Q ss_pred hhcccccceeecCCCeeEEEEEcCCC----------------CeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCC
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRL----------------NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~----------------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 767 (1018)
..+|+..+.||+|+||.||+|.+... +..||+|++.... .....+++.+|++++++++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCCCC
Confidence 35688889999999999999987643 3568999984322 2245678899999999999999
Q ss_pred cceeeeeEecCCceEEEEEecCCCCHHHhhhcCCCC-------ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCC
Q 001752 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAG-------RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIK 840 (1018)
Q Consensus 768 iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 840 (1018)
++++++++..++..++||||+++++|.+++...... ...+++..++.++.|++.||+|||+. +|+|||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlk 157 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA 157 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence 999999999999999999999999999999765421 12489999999999999999999999 99999999
Q ss_pred CCcEEEcCCCCeEEcccccceeeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh--CCCCCCCC
Q 001752 841 SNNILLDSNLEPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT--GRRPLDPE 916 (1018)
Q Consensus 841 ~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~pf~~~ 916 (1018)
|+||+++.++.++++|||.++........ .....+++.|+|||+..+..++.++|||||||++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 99999999999999999998765332211 122446778999999888889999999999999999998 67777542
Q ss_pred CCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 917 FGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
. ..+.............. ... .+.. .....++.+++.+|++.||++|||+.|+++.|++
T Consensus 238 ~--~~~~~~~~~~~~~~~~~-~~~-~~~~------~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 238 T--DQQVIENAGHFFRDDGR-QIY-LPRP------PNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred C--hHHHHHHHHhccccccc-ccc-CCCc------cCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 2 11222211111111110 000 0000 1112457889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.49 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=197.3
Q ss_pred ceeecCCCeeEEEEEcCCCC---eEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEe
Q 001752 711 NVIGMGATGIVYKAEMPRLN---TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEY 787 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 787 (1018)
+.||+|+||.||+|.....+ ..||+|.+...... ...+++.+|+.++++++|||++++++++. ....++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence 46899999999999875544 78999998433221 35667899999999999999999999876 4568999999
Q ss_pred cCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCC
Q 001752 788 MNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKN 867 (1018)
Q Consensus 788 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 867 (1018)
+++|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++......
T Consensus 77 ~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 77 APLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred CCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 99999999997655 378999999999999999999999 99999999999999999999999999998764433
Q ss_pred cceEe---eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 868 ETVSM---VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 868 ~~~~~---~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
..... ..++..|+|||...+..++.++||||||+++|||++ |+.||..... .+...++. ..... +
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~----~~~~~-----~ 218 (257)
T cd05060 150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLE----SGERL-----P 218 (257)
T ss_pred cccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHH----cCCcC-----C
Confidence 32221 123467999999998899999999999999999998 9999965321 22222221 11100 0
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
... .....+.+++.+|++.+|++||++.++++.|++..
T Consensus 219 ~~~------~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 RPE------ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCC------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 111 11235678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=315.70 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=203.4
Q ss_pred hhcccccceeecCCCeeEEEEEcCCC-----CeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND 778 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 778 (1018)
.++|+..+.||+|+||.||+|..... +..||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc---cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 35678889999999999999987643 478999998322 1223356788999999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHhhhcCCCC------ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCe
Q 001752 779 TNMMIVYEYMNNGSLGEALHGKQAG------RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP 852 (1018)
Q Consensus 779 ~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 852 (1018)
...++||||+++|+|.+++...... ...+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence 9999999999999999999754321 12368899999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCc--ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHH
Q 001752 853 RIADFGLARMMIRKNE--TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRM 929 (1018)
Q Consensus 853 kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 929 (1018)
+++|||+++....... ......++..|+|||+..+..++.++|||||||++||+++ |..||..... ........
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~- 235 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFVI- 235 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHHHh-
Confidence 9999999876533221 1122346788999999988889999999999999999998 9999864321 11222111
Q ss_pred HhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 930 KIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
... ... .... ....+.+++.+|++.+|++|||+.++++.|++
T Consensus 236 ---~~~-~~~----~~~~------~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 ---DGG-HLD----LPEN------CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---cCC-CCC----CCCC------CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111 000 0001 13457789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=310.70 Aligned_cols=252 Identities=31% Similarity=0.453 Sum_probs=198.8
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
++|+..+.||+|+||.||+|... .+..||+|.+.... ...+.+.+|+.++++++||+++++++++. ....++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGT-----MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCC-----CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 56788899999999999999876 56779999984321 23456899999999999999999999885 4568999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++..... ..+++.++..++.+++.|++|||+. +|+||||||+||++++++.++++|||.+..+.
T Consensus 79 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred EEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 999999999999976432 2378999999999999999999999 99999999999999999999999999997654
Q ss_pred cCCcce-EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 865 RKNETV-SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 865 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
...... ....++..|+|||+..+..++.++||||||+++|||++ |..||..... .+..... . .....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~---~-~~~~~----- 222 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQV---E-RGYRM----- 222 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH---H-cCCCC-----
Confidence 322211 12335568999999988889999999999999999999 8899965321 1111211 1 11100
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
+.. ......+.+++.+|++++|++|||++++.+.|++
T Consensus 223 ~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCP------QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCC------CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000 1122457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=318.49 Aligned_cols=266 Identities=28% Similarity=0.342 Sum_probs=203.9
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCe--EEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCce
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNT--IVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 781 (1018)
++|++.+.||+|+||.||+|....++. .+++|.++.. ......+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 467788899999999999999876654 4688877321 1223456788999999999 799999999999999999
Q ss_pred EEEEEecCCCCHHHhhhcCCCC------------ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC
Q 001752 782 MIVYEYMNNGSLGEALHGKQAG------------RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN 849 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 849 (1018)
++||||+++|+|.+++...... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGEN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCC
Confidence 9999999999999999754311 12478899999999999999999998 99999999999999999
Q ss_pred CCeEEcccccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 001752 850 LEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIR 928 (1018)
Q Consensus 850 ~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 928 (1018)
+.+||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||..... .....
T Consensus 156 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----~~~~~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----AELYE 229 (297)
T ss_pred CeEEECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Confidence 99999999998642111 01111223457999999988889999999999999999998 9999965321 11111
Q ss_pred HHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCCCCCC
Q 001752 929 MKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSS 994 (1018)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 994 (1018)
. ..... .+... . .....+.+++.+|++.+|.+||+++++++.|+.+....+...
T Consensus 230 ~-~~~~~------~~~~~--~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 283 (297)
T cd05089 230 K-LPQGY------RMEKP--R---NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283 (297)
T ss_pred H-HhcCC------CCCCC--C---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence 1 11110 00000 0 112346789999999999999999999999988776554443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=318.38 Aligned_cols=261 Identities=24% Similarity=0.358 Sum_probs=202.3
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..+.||+|+||.||+|.+..++..||+|.+... .......++.+|++++++++||||+++++++.+++..++||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE---IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 577889999999999999999988999999988432 12334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++++|.++++.... +++..+..++.|++.||+|||+.+ +++||||||+||+++.++.++++|||++.....
T Consensus 79 ey~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 79 EHMDGGSLDQVLKKAGR----IPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred eccCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 99999999999976532 788889999999999999999732 899999999999999999999999999875432
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccc--------
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNL-------- 937 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 937 (1018)
. ......+++.|+|||+..+..++.++||||||+++|+|++|+.||..... .....+...........
T Consensus 153 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 153 S--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred c--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccCCcccccC
Confidence 2 22335688999999998888899999999999999999999999964321 11111111000000000
Q ss_pred ---------------ccc---cCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 938 ---------------EEA---LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 938 ---------------~~~---~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
... ..+... .......+.+++.+|++.+|++||++++++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLP----SGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCc----CcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000 000000 001233477899999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.97 Aligned_cols=257 Identities=27% Similarity=0.353 Sum_probs=200.8
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecC---
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHND--- 778 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--- 778 (1018)
+.++|+..+.||+|+||.||+|....+++.+|+|++... ......+.+|+.+++++ +|||++++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-----~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-----SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-----ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 578899999999999999999999889999999998321 22345677899999998 899999999998643
Q ss_pred --CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcc
Q 001752 779 --TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 779 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 856 (1018)
+..++||||+++++|.++++........+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEee
Confidence 358999999999999999875433334478999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceEeeccCCCccCcCCCCCC-----CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHh
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGYTL-----KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKI 931 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 931 (1018)
||.+..............++..|+|||++... .++.++|||||||++|||++|+.||...... ..+.. .
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~-----~ 245 (291)
T cd06639 172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFK-----I 245 (291)
T ss_pred cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHH-----H
Confidence 99987654333333345688999999986543 3688999999999999999999999653211 11111 1
Q ss_pred hcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 932 RDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.... .....++ ......+.+++.+|++.+|++||++.|++++
T Consensus 246 ~~~~-~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 PRNP-PPTLLHP--------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred hcCC-CCCCCcc--------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1110 0001011 1122347789999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=328.26 Aligned_cols=267 Identities=23% Similarity=0.283 Sum_probs=199.9
Q ss_pred HHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC---
Q 001752 702 DILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND--- 778 (1018)
Q Consensus 702 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 778 (1018)
...++|+..+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 36788999999999999999999998889999999984322 2233456778899999999999999999988643
Q ss_pred ---CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEc
Q 001752 779 ---TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIA 855 (1018)
Q Consensus 779 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 855 (1018)
...++||||+++ ++.+.+... +++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~~------l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence 347999999965 777776431 67888999999999999999999 99999999999999999999999
Q ss_pred ccccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHH--------
Q 001752 856 DFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWI-------- 927 (1018)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~-------- 927 (1018)
|||+++.... ........+|+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+
T Consensus 162 Dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 239 (355)
T cd07874 162 DFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCP 239 (355)
T ss_pred eCcccccCCC-ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCH
Confidence 9999976422 222234578999999999999899999999999999999999999997532110 000000
Q ss_pred ----------HHHhhccccccc-----ccCCCCC--CCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 928 ----------RMKIRDNRNLEE-----ALDPNVG--NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 928 ----------~~~~~~~~~~~~-----~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
............ ....... ...........+.+++.+|++.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000000 0000000 000011123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=315.93 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=203.8
Q ss_pred hhcccccceeecCCCeeEEEEEc-----CCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEec
Q 001752 704 LACIRESNVIGMGATGIVYKAEM-----PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHN 777 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 777 (1018)
.++|...+.||+|+||.||+|.. ..++..||||++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 45688899999999999999975 3346689999884321 223456789999999999 79999999999999
Q ss_pred CCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccc
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADF 857 (1018)
Q Consensus 778 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 857 (1018)
.+..++||||+++|+|.++++.... ..+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.++++||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence 9999999999999999999975432 2278999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcce--EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcc
Q 001752 858 GLARMMIRKNETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDN 934 (1018)
Q Consensus 858 G~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 934 (1018)
|.++......... ....+++.|+|||++.+..++.++||||+||++|||++ |+.||....... .... .....
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~----~~~~~ 260 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYK----LIKEG 260 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHH----HHHcC
Confidence 9997654332211 12345678999999998889999999999999999998 999986532211 1111 11111
Q ss_pred cccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 935 RNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
.. +.. .. .....+.+++.+|++++|++|||+.|+++.|+++
T Consensus 261 ~~------~~~--~~---~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 YR------MAQ--PE---HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred Cc------CCC--CC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 10 000 00 1123477899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.10 Aligned_cols=259 Identities=29% Similarity=0.388 Sum_probs=201.8
Q ss_pred hhcccccceeecCCCeeEEEEEcCC-----CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPR-----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND 778 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 778 (1018)
.+.|...+.||+|+||.||+|.+.. .+..||+|.+... ........|.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES---CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4668888999999999999999976 6788999987321 2223456789999999999999999999999998
Q ss_pred CceEEEEEecCCCCHHHhhhcCCC---CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC---Ce
Q 001752 779 TNMMIVYEYMNNGSLGEALHGKQA---GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL---EP 852 (1018)
Q Consensus 779 ~~~~lV~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ 852 (1018)
+..++||||+++++|.+++..... ....+++..+.+++.||+.|++|||+. +++||||||+||+++.++ .+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcce
Confidence 899999999999999999976532 122488999999999999999999999 999999999999998764 59
Q ss_pred EEcccccceeeccCCcce--EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHH
Q 001752 853 RIADFGLARMMIRKNETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRM 929 (1018)
Q Consensus 853 kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 929 (1018)
|++|||+++......... .....+..|+|||+..+..++.++|||||||++|||++ |+.||...... .. ...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~---~~~ 233 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EV---MEF 233 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HH---HHH
Confidence 999999998652221111 11223567999999988899999999999999999997 99999753221 11 111
Q ss_pred HhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 930 KIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
...... . . ..+ .....+.+++.+|++.+|++||++.+|++.|.+
T Consensus 234 ~~~~~~-~-~-~~~---------~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 234 VTGGGR-L-D-PPK---------GCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHcCCc-C-C-CCC---------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 111111 0 0 000 112356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=314.82 Aligned_cols=261 Identities=24% Similarity=0.360 Sum_probs=207.0
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
+.|+..+.||+|+||+||+|.+..+++.||+|++... ......+.+.+|+++++.++||||+++++++......++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG---AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec---CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 5677788999999999999999888999999988432 2234467889999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++...+ .+++..+..++.+++.|+.|||+.+ +++||||||+||+++.++.++++|||++....
T Consensus 82 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 82 MEFMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred EecCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999999987643 2789999999999999999999742 89999999999999999999999999986542
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCC------cccHHHHHHHHhhcccccc
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGE------SVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~ 938 (1018)
.. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ...+..+.........
T Consensus 156 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 230 (284)
T cd06620 156 NS--IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--- 230 (284)
T ss_pred hh--ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC---
Confidence 21 122356899999999988888999999999999999999999999754321 1112222222221110
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
+... ..+....+.+++.+|+++||++|||++|++++..-.+
T Consensus 231 ----~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 231 ----PRLP----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred ----CCCC----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 1110 0112345778999999999999999999998754333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.83 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=199.4
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..+.||+|+||.||+|.+..++..+|+|.+... .......+.+|+++++.++|||++++++++..+...++||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~ 81 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 81 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEE
Confidence 356778899999999999999988999999998322 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 82 EFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred EecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccc
Confidence 9999999999886532 2378999999999999999999999 999999999999999999999999999876533
Q ss_pred CCcceEeeccCCCccCcCCCC-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccc
Q 001752 866 KNETVSMVAGSYGYIAPEYGY-----TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
.........+++.|+|||++. +..++.++|||||||++|||++|++||..... ...+........
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~~----- 225 (282)
T cd06643 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSEP----- 225 (282)
T ss_pred cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-----HHHHHHHhhcCC-----
Confidence 333333456889999999873 45578899999999999999999999965321 111111111111
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
+...... .....+.+++.+||+.+|++||++.+++++-
T Consensus 226 --~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 226 --PTLAQPS---RWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred --CCCCCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 0000000 1123467899999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=311.88 Aligned_cols=256 Identities=29% Similarity=0.477 Sum_probs=202.2
Q ss_pred hcccccceeecCCCeeEEEEEcCCC---CeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCce
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRL---NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 781 (1018)
.+|+..+.||+|+||.||+|.+..+ +..+|+|.+.... .....+.+.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 5677889999999999999987533 3479999884321 223456889999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
++||||+++++|.+++..... .+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccc
Confidence 999999999999999975432 378899999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceEe---eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccc
Q 001752 862 MMIRKNETVSM---VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 862 ~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
.+......... ..++..|+|||++.+..++.++||||||+++||+++ |+.||..... .+....+. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~----~~~~~ 228 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAIE----EGYRL 228 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHHh----CCCcC
Confidence 76433322211 123467999999998889999999999999999887 9999965321 11112111 11100
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
+... .....+.+++.+|++.+|++||++.++++.|+++
T Consensus 229 -----~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -----PAPM------DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----CCCC------CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1111 1123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=312.95 Aligned_cols=256 Identities=27% Similarity=0.477 Sum_probs=202.4
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCe---EEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCce
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNT---IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 781 (1018)
.+|+..+.||+|+||.||+|.+..+++ .||+|++... .......+|..|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 457788999999999999999876554 6999998432 2334567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
++||||+++++|.+++..... .+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccc
Confidence 999999999999999975432 378999999999999999999999 99999999999999999999999999987
Q ss_pred eeccCCcceE--e-ec--cCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccc
Q 001752 862 MMIRKNETVS--M-VA--GSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNR 935 (1018)
Q Consensus 862 ~~~~~~~~~~--~-~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 935 (1018)
.......... . .. .+..|+|||+..+..++.++|||||||++|||++ |..||..... .+...++. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~----~~~ 228 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIE----QDY 228 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHH----cCC
Confidence 6533222111 1 11 2357999999998899999999999999999987 9999965321 12222221 111
Q ss_pred ccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 936 NLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
.. +... +....+.+++.+|++.+|++||+++++++.|+++
T Consensus 229 ~~-----~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 RL-----PPPM------DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cC-----CCcc------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 1111 1123467899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=310.93 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=203.4
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
+.|+..+.||+|+||.||+|....+++.||+|.+... ...+++.+|++++++++|||++++++++.++...+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE------EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 5678888999999999999999888899999998322 1167899999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
+||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+....
T Consensus 77 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 77 MEYCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150 (256)
T ss_pred EecCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcc
Confidence 99999999999996533 2378999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
..........++..|+|||++.+..++.++||||||+++|+|++|+.||........ .... ... ..+.
T Consensus 151 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-----~~~~-~~~------~~~~ 218 (256)
T cd06612 151 DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-----IFMI-PNK------PPPT 218 (256)
T ss_pred cCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-----hhhh-ccC------CCCC
Confidence 443333445688999999999888999999999999999999999999975322110 0000 000 0011
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.. ........+.+++.+|++.+|++|||++|+++
T Consensus 219 ~~---~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 LS---DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CC---chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 10 11122345778999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=320.58 Aligned_cols=266 Identities=23% Similarity=0.341 Sum_probs=200.4
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|+..+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 3568888999999999999999988899999999843221 2234467789999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||++ ++|.+++..... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.++|+|||.+...
T Consensus 82 v~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAK 154 (301)
T ss_pred EEeccc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence 999996 599998865432 378889999999999999999999 9999999999999999999999999999765
Q ss_pred ccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcc--cccccc
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDN--RNLEEA 940 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 940 (1018)
...........+++.|+|||+..+ ..++.++|||||||++|||++|+.||...... +....+....... ......
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhh
Confidence 433333334567899999998765 45788999999999999999999999754221 1111111110000 000000
Q ss_pred c---------CCCC-CCCch--hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 941 L---------DPNV-GNCKH--VQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 941 ~---------~~~~-~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
. .+.. ..+.. .......+.+++.+|++.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 0000 00000 0011234678999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=314.20 Aligned_cols=266 Identities=24% Similarity=0.370 Sum_probs=201.6
Q ss_pred hhcccccceeecCCCeeEEEEEcC----------------CCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCC
Q 001752 704 LACIRESNVIGMGATGIVYKAEMP----------------RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 767 (1018)
.++|+..+.||+|+||.||+|... .++..||+|++... .......++.+|+.++++++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED---ANKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCC
Confidence 356888899999999999998643 23457999988322 12344568899999999999999
Q ss_pred cceeeeeEecCCceEEEEEecCCCCHHHhhhcCCCC-------ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCC
Q 001752 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAG-------RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIK 840 (1018)
Q Consensus 768 iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 840 (1018)
|+++++++..++..++||||+++|+|.+++...... ...+++..+..++.|++.|++|||+. +++|||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlk 157 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLA 157 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCC
Confidence 999999999999999999999999999999764321 12367889999999999999999999 99999999
Q ss_pred CCcEEEcCCCCeEEcccccceeeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh--CCCCCCCC
Q 001752 841 SNNILLDSNLEPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT--GRRPLDPE 916 (1018)
Q Consensus 841 ~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~pf~~~ 916 (1018)
|+||+++.++.++++|||.++.+...... .....+++.|+|||+..+..++.++|||||||++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999999999765332211 112334678999999888889999999999999999998 77888643
Q ss_pred CCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 917 FGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
.. ............... .....+.... ....+.+++.+|++.||++||++.+|++.|++
T Consensus 238 ~~--~~~~~~~~~~~~~~~--~~~~~~~~~~------~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 238 SD--EQVIENTGEFFRDQG--RQVYLPKPAL------CPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred Ch--HHHHHHHHHHHhhcc--ccccCCCCCC------CCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 21 111111111111110 0011111111 12456789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.59 Aligned_cols=254 Identities=25% Similarity=0.321 Sum_probs=200.1
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
|+..+.||+|+||+||+|.+..+++.||+|.+...... .....+.+.+|+.++++++|++++++++.+.+.+..++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 56678899999999999999999999999998433221 22334567789999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
|+++++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999999865432 2378899999999999999999998 9999999999999999999999999998764322
Q ss_pred CcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCC
Q 001752 867 NETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG 946 (1018)
Q Consensus 867 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 946 (1018)
.......|++.|+|||++.+..++.++||||+||++|+|++|+.||........ ........... ......
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~~~~~~~~~---~~~~~~--- 226 (285)
T cd05630 156 -QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKEV---QEEYSE--- 226 (285)
T ss_pred -ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHHHHhhhhhh---hhhcCc---
Confidence 222335789999999999988999999999999999999999999975322110 01111111000 000000
Q ss_pred CCchhHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 001752 947 NCKHVQEEMLLVLRIAFLCTAKLPKDRPS-----MRDVIT 981 (1018)
Q Consensus 947 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 981 (1018)
.....+.+++.+|++.||++||| ++|+++
T Consensus 227 ------~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 227 ------KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ------cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11234678899999999999999 788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.81 Aligned_cols=255 Identities=24% Similarity=0.295 Sum_probs=201.1
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.++|+..+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 356778889999999999999998889999999984321 2234567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++++|.+++..... +++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred EEeccCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 9999999999999875543 78999999999999999999999 9999999999999999999999999998766
Q ss_pred ccCCcceEeeccCCCccCcCCCC---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccc
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGY---TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
...........|++.|+|||++. ...++.++||||+||++|+|++|+.||....... .+.. ......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~----~~~~~~----- 226 (267)
T cd06645 157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFL----MTKSNF----- 226 (267)
T ss_pred cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHh----hhccCC-----
Confidence 43333334467899999999864 4568899999999999999999999985432111 1100 000110
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
..+..... ......+.+++.+|++.+|++||++++++++
T Consensus 227 ~~~~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 227 QPPKLKDK---MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCccccc---CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00111000 0112346688999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=321.81 Aligned_cols=247 Identities=28% Similarity=0.422 Sum_probs=199.2
Q ss_pred eeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCCC
Q 001752 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNG 791 (1018)
Q Consensus 712 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 791 (1018)
+||+|.||+||.|++..+...+|||-+.. ......+-...|+..-++++|+|||+++|.+.++++.-+.||-++||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe----kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE----KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc----ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 79999999999999999999999999822 12234556778999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEc-CCCCeEEcccccceeeccCCcce
Q 001752 792 SLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLD-SNLEPRIADFGLARMMIRKNETV 870 (1018)
Q Consensus 792 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DfG~a~~~~~~~~~~ 870 (1018)
+|.++++..-. ...-.+.++-.+..||++||.|||++ .|||||||-+||+++ -.|.+||+|||.++.+..-..-.
T Consensus 658 SLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 658 SLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred cHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 99999986533 22236777777899999999999999 999999999999995 57899999999999876666666
Q ss_pred EeeccCCCccCcCCCCCC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCC
Q 001752 871 SMVAGSYGYIAPEYGYTL--KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNC 948 (1018)
Q Consensus 871 ~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1018)
.+..||..|||||++..+ .|+.++|||||||++.||.||++||........ ...+ +..- . +.|.+
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---AMFk--VGmy----K-vHP~i--- 800 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---AMFK--VGMY----K-VHPPI--- 800 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---hhhh--hcce----e-cCCCC---
Confidence 778999999999998754 488999999999999999999999964322111 1111 1000 0 01111
Q ss_pred chhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 949 KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 949 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
..+...+...++.+|+.+||.+||+++++++
T Consensus 801 --Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 --PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred --cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1233455667999999999999999999986
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=314.28 Aligned_cols=255 Identities=24% Similarity=0.304 Sum_probs=200.1
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
|+..+.||+|+||+||+|.+..+++.||+|.+...... .......+.+|++++++++|++++++.+++..++..++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 56678899999999999999989999999998433211 22234557789999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
|+++++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999998865432 2389999999999999999999999 9999999999999999999999999998764322
Q ss_pred CcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCC
Q 001752 867 NETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG 946 (1018)
Q Consensus 867 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 946 (1018)
.......|+..|+|||++.+..++.++|+||+||++|||++|+.||...... . ....+........ ....+
T Consensus 156 -~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-~-~~~~~~~~~~~~~---~~~~~--- 226 (285)
T cd05632 156 -ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-V-KREEVDRRVLETE---EVYSA--- 226 (285)
T ss_pred -CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-H-HHHHHHHhhhccc---cccCc---
Confidence 2223457899999999998889999999999999999999999999753211 1 1111111111111 00111
Q ss_pred CCchhHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 001752 947 NCKHVQEEMLLVLRIAFLCTAKLPKDRPS-----MRDVITM 982 (1018)
Q Consensus 947 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 982 (1018)
.....+.+++.+|++.||++||+ +++++++
T Consensus 227 ------~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 227 ------KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ------cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11234567899999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=314.34 Aligned_cols=268 Identities=22% Similarity=0.291 Sum_probs=199.0
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
|+..+.||+|++|.||+|....+++.||+|++.... ........+.+|+.++++++|||++++++++.++...++|||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES--EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEecccc--ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 667789999999999999998889999999984322 122334678889999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
|++ ++|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 80 FLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred cCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 997 689998865433 23478999999999999999999999 9999999999999999999999999999765433
Q ss_pred CcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcc-------cc--
Q 001752 867 NETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDN-------RN-- 936 (1018)
Q Consensus 867 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------~~-- 936 (1018)
........+++.|+|||+..+ ..++.++|||||||++|+|++|+.||...... .............. ..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-DQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhcchhhH
Confidence 333333457889999998765 44788999999999999999999999753221 11111111000000 00
Q ss_pred -cccccCCCCCCC--chhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 937 -LEEALDPNVGNC--KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 937 -~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
....++...... ........++.+++.+|++.||++|||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000 0000123456689999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.09 Aligned_cols=250 Identities=27% Similarity=0.367 Sum_probs=202.3
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
+.|+..+.||+|+||.||+|.+..+++.||+|.+.... .....+.+.+|+.++++++||||+++++++..+...++|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 45667788999999999999998889999999883221 223456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++... .+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.++++|||++..+.
T Consensus 81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 81 MEYLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEccCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccccccccc
Confidence 9999999999998643 278899999999999999999999 99999999999999999999999999997654
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
..........++..|+|||+..+..++.++|||||||++|||++|+.||....... ... ..... ..+.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~----~~~~~------~~~~ 220 (277)
T cd06642 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLF----LIPKN------SPPT 220 (277)
T ss_pred CcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHh----hhhcC------CCCC
Confidence 43333333568889999999998889999999999999999999999986432211 111 01111 0111
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.. ......+.+++.+|++.+|++||++.+++++
T Consensus 221 ~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LE-----GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CC-----cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11 1123446789999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=311.95 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=204.7
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
...|+..+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++|||++++++++.++...++
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 355777789999999999999998889999999984321 12345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++|+|.+++.... +++.....++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||++...
T Consensus 80 v~e~~~~~~L~~~i~~~~-----l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 80 IMEYLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred EEecCCCCcHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceec
Confidence 999999999999996532 68888999999999999999999 9999999999999999999999999999776
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
...........++..|+|||+..+..++.++|||||||++|||++|+.||...... .... ...... .+
T Consensus 152 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~-~~~~~~------~~ 219 (277)
T cd06640 152 TDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----RVLF-LIPKNN------PP 219 (277)
T ss_pred cCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----hHhh-hhhcCC------CC
Confidence 44333334456888999999998888999999999999999999999999753211 1010 000000 11
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.. .......+.+++.+|++.+|++||+++++++.
T Consensus 220 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TL-----TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CC-----chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11 11234557789999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=307.76 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=203.1
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec-CCceEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN-DTNMMIV 784 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lV 784 (1018)
.|+..+.||+|++|.||+|.+..+++.||+|++.... ......+.+.+|++++++++|||++++++.+.. +...++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN--ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh--cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 3778899999999999999998889999999984321 223345678899999999999999999998864 4467999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++..... ..+++.++..++.+++.|++|||+. +++||||||+||+++.++.++++|||++....
T Consensus 79 ~e~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~ 153 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153 (257)
T ss_pred ecccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEec
Confidence 999999999999975432 2378999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
..........+++.|+|||+..+..++.++||||+|+++|+|++|+.||.... .......... .. . +.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~~~-~~-~-----~~ 221 (257)
T cd08223 154 NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRIIE-GK-L-----PP 221 (257)
T ss_pred ccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHh-cC-C-----CC
Confidence 44333444678899999999999899999999999999999999999997532 1122211111 11 0 00
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
. .......+.+++.+|++.+|++||++.+++++
T Consensus 222 ~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 M-----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred C-----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1 01223457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=326.72 Aligned_cols=262 Identities=24% Similarity=0.367 Sum_probs=203.3
Q ss_pred hhcccccceeecCCCeeEEEEEcC-----CCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeeeEec
Q 001752 704 LACIRESNVIGMGATGIVYKAEMP-----RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHN 777 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 777 (1018)
.++|...+.||+|+||.||+|.+. ..++.||+|++.... .....+.+.+|+.++.++. ||||+++++++..
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 356777889999999999999854 345789999994322 2233457889999999997 9999999999999
Q ss_pred CCceEEEEEecCCCCHHHhhhcCCC-------------------------------------------------------
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQA------------------------------------------------------- 802 (1018)
Q Consensus 778 ~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------- 802 (1018)
.+..++||||+++|+|.++++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999975421
Q ss_pred ---------------------------------------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCc
Q 001752 803 ---------------------------------------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNN 843 (1018)
Q Consensus 803 ---------------------------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 843 (1018)
....+++..+.+++.||+.||+|||+. +|+||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 112367788899999999999999998 99999999999
Q ss_pred EEEcCCCCeEEcccccceeeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCc
Q 001752 844 ILLDSNLEPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGES 920 (1018)
Q Consensus 844 Ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~ 920 (1018)
|+++.++.++++|||+++.+...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 99999999999999999865332211 122356788999999988889999999999999999998 899986532111
Q ss_pred ccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 921 VDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
............. .+ . .....+.+++.+||+.+|++||+++++++.|+.+.
T Consensus 350 -----~~~~~~~~~~~~~---~p-----~---~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 -----QFYNAIKRGYRMA---KP-----A---HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -----HHHHHHHcCCCCC---CC-----C---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111111000 01 0 11245778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=315.15 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=201.5
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|+..+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++|||++++++++..+...++
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 35688889999999999999999988999999998322 23446678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++++|..++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+...
T Consensus 87 v~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred EEecCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999988764332 278999999999999999999999 9999999999999999999999999998764
Q ss_pred ccCCcceEeeccCCCccCcCCCC-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGY-----TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
...........+++.|+|||++. ...++.++|||||||++|||++|+.||..... ...+........
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~--- 232 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSEP--- 232 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHHHHhcCCC---
Confidence 33333334566889999999874 34568899999999999999999999964321 111111111111
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
+.... .......+.+++.+|++.+|++||+++++++.
T Consensus 233 ----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 ----PTLSQ---PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ----ccCCC---CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11100 01122346788999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=330.04 Aligned_cols=264 Identities=25% Similarity=0.318 Sum_probs=197.1
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC-----ce
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT-----NM 781 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~ 781 (1018)
|+..+.||+|+||.||+|.+..+++.||+|++... .......+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV--FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEecccc--ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 56778999999999999999888999999998322 122234567889999999999999999999998776 78
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
|+||||+. ++|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~----l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQP----LSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccccee
Confidence 99999996 588888865432 78999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCC-cceEeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc----
Q 001752 862 MMIRKN-ETVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR---- 935 (1018)
Q Consensus 862 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---- 935 (1018)
...... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||...... +....+........
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLDLITDLLGTPSLEAM 229 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCCHHHH
Confidence 653222 122334678999999988764 4789999999999999999999999754221 11111110000000
Q ss_pred -----c-----cccccCC-CCCC-CchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 936 -----N-----LEEALDP-NVGN-CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 936 -----~-----~~~~~~~-~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
. ......+ .... .....+....+.+++.+|++.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 0000000 0000 00000113456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=310.39 Aligned_cols=254 Identities=26% Similarity=0.335 Sum_probs=204.2
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
++|+..+.||+|+||.||+|....+++.+|+|++.... ....+.+.+|++++++++|||++++++++.+.+..+++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 46778899999999999999998889999999984322 22457788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 79 ~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 79 MEYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred EeCCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhh
Confidence 99999999999987642 1278899999999999999999999 99999999999999999999999999987654
Q ss_pred cCCcceEeeccCCCccCcCCCCCC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTL---KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
..........++..|+|||...+. .++.++||||||+++|||++|+.||........ ......... .
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-----~~~~~~~~~-----~ 222 (262)
T cd06613 153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-----LFLISKSNF-----P 222 (262)
T ss_pred hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhccC-----C
Confidence 433333446788899999998776 889999999999999999999999965321111 111111100 0
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.+... ........+.+++.+|++.+|.+|||+++++.
T Consensus 223 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 PPKLK---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred Ccccc---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01111 11233455778999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.32 Aligned_cols=262 Identities=27% Similarity=0.367 Sum_probs=198.0
Q ss_pred hcccccceeecCCCeeEEEEEc----CCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec--C
Q 001752 705 ACIRESNVIGMGATGIVYKAEM----PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN--D 778 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~ 778 (1018)
..|+..+.||+|+||+||+|.. ..+++.||+|++... .....+.+.+|++++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 4577788999999999999974 446889999998322 23345678999999999999999999998743 3
Q ss_pred CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccc
Q 001752 779 TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFG 858 (1018)
Q Consensus 779 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 858 (1018)
...++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg 153 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFG 153 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCc
Confidence 568999999999999999965432 378999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceEe---eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc----------cHHH
Q 001752 859 LARMMIRKNETVSM---VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESV----------DIVE 925 (1018)
Q Consensus 859 ~a~~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~----------~~~~ 925 (1018)
+++........... ..++..|+|||+..+..++.++|||||||++|||++|..|+........ ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY 233 (284)
T ss_pred ccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchH
Confidence 99876433221111 1233469999999888899999999999999999998877643211000 0000
Q ss_pred HHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 926 WIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
.......... .... .......+.+++.+||+.+|++|||++|+++.|+.++
T Consensus 234 ~~~~~~~~~~--------~~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 234 HLIELLKNNG--------RLPA---PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHHHHHhcCC--------cCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 0000010000 0000 0111234778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=309.20 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=193.8
Q ss_pred eeecCCCeeEEEEEcC--CCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecC
Q 001752 712 VIGMGATGIVYKAEMP--RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 712 ~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
.||+|+||.||+|.+. ..+..||+|++... ......+.+.+|+.++++++||||+++++++.. +..++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE---NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc---cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCC
Confidence 3899999999999764 34567999988432 123345678999999999999999999999864 56899999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+++|.+++..... .+++..+.+++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+..+......
T Consensus 78 ~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 78 GGPLNKFLSGKKD---EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151 (257)
T ss_pred CCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence 9999999975432 378999999999999999999999 9999999999999999999999999999765433322
Q ss_pred eEe---eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 870 VSM---VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 870 ~~~---~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
... ..+++.|+|||+..+..++.++|||||||++||+++ |+.||..... .+....+ ..... ...++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~----~~~~~--~~~~~-- 221 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--PEVMSFI----EQGKR--LDCPA-- 221 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHH----HCCCC--CCCCC--
Confidence 221 223568999999888889999999999999999996 9999975322 1121111 11110 00111
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
.....+.+++.+||..+|++||++.+|.+.|+..
T Consensus 222 -------~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 -------ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1124566799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=314.37 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=206.3
Q ss_pred hhcccccceeecCCCeeEEEEEcCC----CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec-C
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPR----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN-D 778 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 778 (1018)
.++|+..+.||+|+||.||+|.+.. .+..|++|++.. .........+.+|+.++++++|||++++++++.. +
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~---~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC---CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 4678888999999999999999875 258899998832 2233456778899999999999999999998765 5
Q ss_pred CceEEEEEecCCCCHHHhhhcCCCC----ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEE
Q 001752 779 TNMMIVYEYMNNGSLGEALHGKQAG----RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRI 854 (1018)
Q Consensus 779 ~~~~lV~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 854 (1018)
...++++||+++++|.+++...... +..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence 6789999999999999999765332 14588999999999999999999999 9999999999999999999999
Q ss_pred cccccceeeccCCcce--EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHh
Q 001752 855 ADFGLARMMIRKNETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKI 931 (1018)
Q Consensus 855 ~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 931 (1018)
+|||+++.+....... ....++..|+|||++.+..++.++|||||||++||+++ |+.||.... ..++..++.
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~--- 233 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYLK--- 233 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHHH---
Confidence 9999998654332221 11345678999999988889999999999999999999 999996531 122222221
Q ss_pred hcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCC
Q 001752 932 RDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKP 988 (1018)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 988 (1018)
...... .... ....+.+++.+|++.||++|||+.++++.|+.+.+
T Consensus 234 -~~~~~~-----~~~~------~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 -DGYRLA-----QPIN------CPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -cCCCCC-----CCCc------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111110 0001 12346789999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=313.40 Aligned_cols=250 Identities=30% Similarity=0.401 Sum_probs=204.3
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||.|++|.||+|.+..+++.||+|++.... .......+.+|+++++.++|||++++++++.++...++|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 5677789999999999999999899999999984321 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.++....
T Consensus 79 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 79 EYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EeeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 999999999999764 378999999999999999999999 999999999999999999999999999987754
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
.........+++.|+|||+..+..++.++||||||+++|+|++|+.||..... ..... ..... ..+..
T Consensus 151 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--~~~~~----~~~~~------~~~~~ 218 (274)
T cd06609 151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--MRVLF----LIPKN------NPPSL 218 (274)
T ss_pred cccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--HHHHH----Hhhhc------CCCCC
Confidence 43334456788899999999988899999999999999999999999965321 11111 11111 11111
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
... .....+.+++.+|++.+|++|||+++++++
T Consensus 219 ~~~----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 EGN----KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ccc----ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111 022346778999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=345.36 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=203.0
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec--CCc
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN--DTN 780 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 780 (1018)
..+.|++.+.||+|+||+||+|.+..++..||+|++... .........|..|+.++++++|||||+++++|.. ...
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~--~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYR--GLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecc--ccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 457899999999999999999999999999999998432 2233445678999999999999999999998854 456
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCC----CCeEeecCCCCcEEEcCC-------
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY----PPIIHRDIKSNNILLDSN------- 849 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlk~~NIll~~~------- 849 (1018)
+|+||||+++|+|.+++.........+++..++.|+.||+.||+|||+... .+||||||||+|||++.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999997643333348999999999999999999998521 259999999999999642
Q ss_pred ----------CCeEEcccccceeeccCCcceEeeccCCCccCcCCCCC--CCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 001752 850 ----------LEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYT--LKVDEKIDIYSFGVVLLELLTGRRPLDPEF 917 (1018)
Q Consensus 850 ----------~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~~~~ 917 (1018)
+.+||+|||++..+... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 35899999999765322 22234579999999998754 458899999999999999999999996421
Q ss_pred CCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--Hhhcc
Q 001752 918 GESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT--MLGEA 986 (1018)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~ 986 (1018)
.....+.. +.... .+.. ......+.+++..||+.+|.+||++.++++ .+...
T Consensus 248 ----~~~qli~~-lk~~p--------~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 248 ----NFSQLISE-LKRGP--------DLPI----KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred ----cHHHHHHH-HhcCC--------CCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 11121111 11111 0000 011244678999999999999999999984 44433
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=308.66 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=205.6
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||+|+||.||++....+++.||+|++..... .....+++.+|+.++++++||||+++++++.+.++.++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 47778999999999999999988899999999843222 2334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+.....
T Consensus 79 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 79 DYCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred ecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 99999999999975432 2368889999999999999999999 999999999999999999999999999987644
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
.........+++.|+|||+..+..++.++|||||||++|+|++|+.||... +....+........ .+..
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~~~~------~~~~ 222 (256)
T cd08218 154 TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NMKNLVLKIIRGSY------PPVS 222 (256)
T ss_pred chhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----CHHHHHHHHhcCCC------CCCc
Confidence 433333456888999999998888999999999999999999999999642 12222222221111 0000
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
......+.+++.+|++.+|++||++++|+++
T Consensus 223 ------~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 223 ------SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ------ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1123447789999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=316.63 Aligned_cols=262 Identities=25% Similarity=0.395 Sum_probs=204.5
Q ss_pred hhcccccceeecCCCeeEEEEEcC-------CCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMP-------RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFL 775 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 775 (1018)
..+|+..+.||+|+||.||+|... .++..||+|++... ......+++.+|+.+++.+ +||||+++++++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc---cchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 456778899999999999999742 23457999988322 2234456789999999999 899999999999
Q ss_pred ecCCceEEEEEecCCCCHHHhhhcCCCC------------ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCc
Q 001752 776 HNDTNMMIVYEYMNNGSLGEALHGKQAG------------RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNN 843 (1018)
Q Consensus 776 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 843 (1018)
......++||||+++|+|.+++...... ...+++..+..++.||+.||+|||+. +|+||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 9999999999999999999999764321 23478889999999999999999999 99999999999
Q ss_pred EEEcCCCCeEEcccccceeeccCCcce--EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCc
Q 001752 844 ILLDSNLEPRIADFGLARMMIRKNETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGES 920 (1018)
Q Consensus 844 Ill~~~~~~kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~ 920 (1018)
|+++.++.+|++|||.++......... ....+++.|+|||+..+..++.++||||||+++|||++ |..||....
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--- 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--- 244 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---
Confidence 999999999999999998764332221 12345678999999988889999999999999999998 788886431
Q ss_pred ccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCC
Q 001752 921 VDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKP 988 (1018)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 988 (1018)
....... ........ ... .....+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 245 --~~~~~~~-~~~~~~~~-----~~~------~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 245 --VEELFKL-LKEGHRMD-----KPA------NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred --HHHHHHH-HHcCCcCC-----CCC------CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1222211 11111000 000 112446778999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=312.70 Aligned_cols=257 Identities=28% Similarity=0.389 Sum_probs=200.4
Q ss_pred hcccccceeecCCCeeEEEEEc-----CCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC
Q 001752 705 ACIRESNVIGMGATGIVYKAEM-----PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
++|...+.||+|+||.||+|.. ..++..+|+|.+.. ........+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc----CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 4567788999999999999964 23567899998732 22344568999999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHhhhcCCCC-----------ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcC
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAG-----------RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS 848 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 848 (1018)
..++||||+++++|.+++...... ...+++..+..++.|++.|++|||+. +++||||||+||++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence 999999999999999999754321 12478999999999999999999999 9999999999999999
Q ss_pred CCCeEEcccccceeeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHH
Q 001752 849 NLEPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVE 925 (1018)
Q Consensus 849 ~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~ 925 (1018)
++.++|+|||+++........ .....+++.|+|||+..+..++.++|||||||++|||++ |+.||..... .+.
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~-- 233 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--TEA-- 233 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--HHH--
Confidence 999999999999765322211 112334678999999998899999999999999999998 8999864321 111
Q ss_pred HHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 926 WIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
......... . ..+ . .....+.+++.+||+.||++||+++||.+.|++
T Consensus 234 -~~~~~~~~~-~---~~~--~------~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 -IECITQGRE-L---ERP--R------TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -HHHHHcCcc-C---CCC--C------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111111110 0 000 0 112346789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=328.09 Aligned_cols=203 Identities=26% Similarity=0.370 Sum_probs=175.8
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..+.||+|+||.||+|....+++.||+|++.... .........+.+|+.++.+++||+|+++++++.+++..++||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD-MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5777899999999999999999899999999994321 122344567888999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT----LSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999976543 78889999999999999999999 999999999999999999999999999875422
Q ss_pred CCc-----------------------------------ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCC
Q 001752 866 KNE-----------------------------------TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGR 910 (1018)
Q Consensus 866 ~~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~ 910 (1018)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 011246999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 001752 911 RPLDPE 916 (1018)
Q Consensus 911 ~pf~~~ 916 (1018)
.||...
T Consensus 234 ~Pf~~~ 239 (360)
T cd05627 234 PPFCSE 239 (360)
T ss_pred CCCCCC
Confidence 999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=332.61 Aligned_cols=382 Identities=24% Similarity=0.317 Sum_probs=293.7
Q ss_pred CEEEEEcCCCCCC-cccccccccCCCCCEEEcCCCCcCCCCChhhhCCCCCcEEEeeecccCCCCcccccCCCCCceecc
Q 001752 75 AVEKLDLSHMNLS-GCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNA 153 (1018)
Q Consensus 75 ~v~~L~L~~~~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 153 (1018)
-|..+|+++|.++ +..|.+...+++++.|.|...++ ..+|+.++.|.+|++|.+++|++. .+-..+..++.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L-~~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKL-EQVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhh-hhChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 3788899999998 56777788889999999988888 567888999999999999999887 56677888889999999
Q ss_pred CCCCCCc-ccccccccccccceEeccCcccCcccccccccccccceeeecccccCCCCCcccccccchhhhhccccccCC
Q 001752 154 SGNNFSG-FLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDG 232 (1018)
Q Consensus 154 s~n~l~~-~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 232 (1018)
..|++.. -+|+.+-.+..|+.||||+|+++ ..|..+..-.++-.|+||+|+|..+....|.+|..|-.|+|++|++.
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe- 163 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE- 163 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-
Confidence 9988863 36777788889999999999988 77888888888889999999988433345678888888999999988
Q ss_pred CCCccccCccccccccccccccCccCcccccCCCccceEEccCCcCC-ccCChhhcCCCCCCeeeccCCCCccccCCccc
Q 001752 233 EIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQ-GRLPAEIGNITSLQLLDLSYNMLSHEIPAEIT 311 (1018)
Q Consensus 233 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 311 (1018)
.+|+.+..+..|+.|+|++|.+.-.--..+..+..|+.|.+++.+-+ ..+|.++..+.+|..+|+|.|++. .+|+.+.
T Consensus 164 ~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly 242 (1255)
T KOG0444|consen 164 MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLY 242 (1255)
T ss_pred hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHh
Confidence 67788888889999999888876544445556667777777765432 356777788888888888888886 6788888
Q ss_pred cccCCceeecccCccccccCCCCCCCCccceEEeccCccccCCCcCCCCCCCCceeeccccccc-ccccccccCCCCCce
Q 001752 312 QLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFS-GEIPASLCNGGNLTK 390 (1018)
Q Consensus 312 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~ 390 (1018)
.+++|+.|+|++|+|+ .+....+...+|++|+||+|+++ .+|..+.+++.|+.|++.+|+++ .-+|..++.+.+|+.
T Consensus 243 ~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Lev 320 (1255)
T KOG0444|consen 243 KLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEV 320 (1255)
T ss_pred hhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHH
Confidence 8888888888888887 44555566777888888888887 67777888888888888888775 346777777888888
Q ss_pred eccccccCCCCCcccccccccccEEeccCCcccCCCcccCCCccccceeecccccccCCCccccCCCCccceEec
Q 001752 391 LILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDI 465 (1018)
Q Consensus 391 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 465 (1018)
+..++|.+. .+|..+..|..|+.|.|+.|++. +.|.++.-++.|+.||+.+|.---.+|..-..-++|++-++
T Consensus 321 f~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYNI 393 (1255)
T KOG0444|consen 321 FHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNI 393 (1255)
T ss_pred HHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcchhhhcceeeec
Confidence 888877776 67777778888888888888777 67777777778888888777644333433333344444433
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=315.66 Aligned_cols=266 Identities=25% Similarity=0.298 Sum_probs=194.6
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc---CCCCcceeeeeEec-----
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL---RHRNIVRLLGFLHN----- 777 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~----- 777 (1018)
+|+..+.||+|+||+||+|.+..+++.||+|.+..... .......+.+|+.+++++ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN--EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC--CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 47778899999999999999999999999999843221 112233456677777665 79999999998864
Q ss_pred CCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccc
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADF 857 (1018)
Q Consensus 778 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 857 (1018)
....++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 79 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 79 ETKVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred CceEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence 345799999997 489998875432 2378999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhh-cccc
Q 001752 858 GLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIR-DNRN 936 (1018)
Q Consensus 858 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~ 936 (1018)
|+++..... .......+|+.|+|||++.+..++.++||||+||++|||++|++||...... ..+......... ....
T Consensus 153 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 153 GLARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDD 230 (288)
T ss_pred CccccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhh
Confidence 999765322 2223356889999999998889999999999999999999999999653221 111111111000 0000
Q ss_pred c-------ccccCCCCCCCch--hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 937 L-------EEALDPNVGNCKH--VQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 937 ~-------~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
. ...+.+....... ..+....+.+++.+|+++||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0001110000000 0112344678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=307.06 Aligned_cols=249 Identities=28% Similarity=0.425 Sum_probs=201.6
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
+.|+..+.||+|+||.||+|... ++.||+|.+... ....+++.+|+.++++++|+|++++++++.+.+..++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDD-----STAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccc-----hhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 56778899999999999999975 789999999322 12467789999999999999999999999989999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||.++...
T Consensus 79 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred EEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccc
Confidence 999999999999976542 2378999999999999999999999 99999999999999999999999999997652
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
.. ......+..|+|||+..+..++.++||||||+++|||++ |+.||..... .++... ...... +
T Consensus 154 ~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~----~~~~~~------~ 218 (256)
T cd05039 154 QG---QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPH----VEKGYR------M 218 (256)
T ss_pred cc---cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH----HhcCCC------C
Confidence 21 112344668999999988889999999999999999998 9999965321 111111 111110 0
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
... ......+.+++.+|++.+|++||+++|++++|+.
T Consensus 219 ~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAP-----EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCc-----cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 000 0112457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=313.55 Aligned_cols=256 Identities=26% Similarity=0.354 Sum_probs=202.2
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCC--
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDT-- 779 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~-- 779 (1018)
..++|+..+.||+|++|.||+|.+..+++.+++|++... ....+++.+|+.+++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-----EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC-----chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 457899999999999999999999888999999998322 23456789999999999 7999999999996544
Q ss_pred ----ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEc
Q 001752 780 ----NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIA 855 (1018)
Q Consensus 780 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 855 (1018)
..++||||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEEC
Confidence 48999999999999999876443334478999999999999999999999 99999999999999999999999
Q ss_pred ccccceeeccCCcceEeeccCCCccCcCCCCC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 001752 856 DFGLARMMIRKNETVSMVAGSYGYIAPEYGYT-----LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMK 930 (1018)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 930 (1018)
|||.+..............+++.|+|||++.. ..++.++|||||||++|+|++|+.||...... ..... .
T Consensus 156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~----~ 230 (275)
T cd06608 156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFK----I 230 (275)
T ss_pred CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHH----h
Confidence 99999765443333444668899999998643 34778999999999999999999999642111 11111 1
Q ss_pred hhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 931 IRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
. .. ..+... ........+.+++.+|+..||++|||+.++++
T Consensus 231 ~-~~------~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 P-RN------PPPTLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred h-cc------CCCCCC---chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 00 011111 11123345778999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=326.56 Aligned_cols=244 Identities=24% Similarity=0.298 Sum_probs=189.3
Q ss_pred eecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc---CCCCcceeeeeEecCCceEEEEEecC
Q 001752 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL---RHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 713 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
||+|+||+||+|++..+++.||||++...... .......+..|..++.+. +||+|+++++++.+....|+||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 69999999999999989999999998433221 122334455666666655 69999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+|+|.+++..... +++..+..++.||++||+|||+. +|+||||||+||+++.++.++|+|||+++........
T Consensus 80 ~g~L~~~l~~~~~----~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 80 GGELFWHLQKEGR----FSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152 (330)
T ss_pred CChHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence 9999999875443 78899999999999999999999 9999999999999999999999999998754333333
Q ss_pred eEeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCC
Q 001752 870 VSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNC 948 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1018)
.....||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..............+ + ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~~~~-----~---~~ 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-----TQQMYRNIAFGKVRF-----P---KN 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-----HHHHHHHHHcCCCCC-----C---Cc
Confidence 4456799999999988754 48999999999999999999999997532 112222111111100 0 00
Q ss_pred chhHHHHHHHHHHHHHccCCCCCCCC----CHHHHHH
Q 001752 949 KHVQEEMLLVLRIAFLCTAKLPKDRP----SMRDVIT 981 (1018)
Q Consensus 949 ~~~~~~~~~l~~l~~~cl~~dP~~RP----t~~evl~ 981 (1018)
.....+.+++.+|++.||.+|| ++.++++
T Consensus 220 ----~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 ----VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ----cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1123456789999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=313.09 Aligned_cols=267 Identities=24% Similarity=0.338 Sum_probs=202.9
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
++|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.++++++|||++++++++......++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecc--cCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence 35778889999999999999999889999999984322 1223345678999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|..+...... +++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 79 ~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 79 FEYCDHTVLNELEKNPRG----VPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILT 151 (286)
T ss_pred EeccCccHHHHHHhCCCC----CCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecC
Confidence 999999888887754332 78999999999999999999998 99999999999999999999999999998765
Q ss_pred cCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc----------
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD---------- 933 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---------- 933 (1018)
..........++..|+|||++.+ ..++.++||||||+++|||++|+.||...... +...........
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV--DQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChHHhhhcc
Confidence 44433334567889999998765 55789999999999999999999999754321 111111110000
Q ss_pred -ccccccccCCCCCCCch----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 934 -NRNLEEALDPNVGNCKH----VQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 934 -~~~~~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.........+....... .......+.+++.+|++.+|++||++.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000111100000 01123457789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=310.55 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=204.4
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec--CCceEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN--DTNMMIV 784 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lV 784 (1018)
|+..+.||.|+||.||+|.+..+++.||+|++... .......+.+.+|++++++++|||++++++++.. +...+++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG--NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecc--cCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 66778999999999999999989999999998432 2233445678899999999999999999998754 4567999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhh-----cCCCCCeEeecCCCCcEEEcCCCCeEEccccc
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-----HDCYPPIIHRDIKSNNILLDSNLEPRIADFGL 859 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 859 (1018)
|||+++++|.+++.........+++..++.++.|++.|++||| +. +++|+||+|+||+++.++.++++|||.
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence 9999999999999765444445899999999999999999999 66 999999999999999999999999999
Q ss_pred ceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 860 ARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 860 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
+..............+++.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+ .... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~----~~~~-~-- 227 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKI----KEGK-F-- 227 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHH----hcCC-C--
Confidence 9876544433445678999999999998889999999999999999999999997532 11111111 1111 0
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
+.. .......+.+++.+|++.+|++||++++|+++
T Consensus 228 ---~~~-----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ---RRI-----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCC-----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 001 01223457789999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=310.24 Aligned_cols=257 Identities=25% Similarity=0.343 Sum_probs=198.9
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
.++.+.....||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.++++++||||+++++++..++..+
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 345555667899999999999999888999999988322 2234567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcC-CCCeEEcccccce
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS-NLEPRIADFGLAR 861 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~a~ 861 (1018)
+|+||+++++|.+++...... ...++..+..++.||+.|++|||+. +|+||||||+||+++. ++.++|+|||.+.
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 999999999999999754221 1127788888999999999999999 9999999999999987 6799999999997
Q ss_pred eeccCCcceEeeccCCCccCcCCCCCC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 862 MMIRKNETVSMVAGSYGYIAPEYGYTL--KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 862 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
.............+++.|+|||+..+. .++.++||||||+++|+|++|+.||........ ..+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~~~~------ 229 (268)
T cd06624 158 RLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGMFKI------ 229 (268)
T ss_pred ecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhhhcc------
Confidence 654433333445688999999987654 378899999999999999999999964321111 1110000000
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.+... ......+.+++.+|++.+|++|||+.|++++
T Consensus 230 --~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 230 --HPEIP-----ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --CCCCC-----cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 01110 0122346788999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.56 Aligned_cols=267 Identities=25% Similarity=0.336 Sum_probs=198.9
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|++++++++|||++++++++.+....++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccc--ccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 4677889999999999999999899999999984332 12233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||++ ++|.+++..... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.++|+|||.++....
T Consensus 79 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 79 EYCD-QDLKKYFDSCNG---DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred ecCC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 9996 588888765322 278999999999999999999999 999999999999999999999999999976544
Q ss_pred CCcceEeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc--------c
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR--------N 936 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------~ 936 (1018)
.........+++.|+|||++.+. .++.++|||||||++|||++|+.||.........+..... ...... .
T Consensus 152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (284)
T cd07839 152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR-LLGTPTEESWPGVSK 230 (284)
T ss_pred CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHH-HhCCCChHHhHHhhh
Confidence 33333445678899999987664 4689999999999999999999987443221111111110 000000 0
Q ss_pred cccc-cCCCCCCCch----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 937 LEEA-LDPNVGNCKH----VQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 937 ~~~~-~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
..+. .-+....... .......+.+++.+|++.||++|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000 0000000000 01123456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=319.68 Aligned_cols=257 Identities=24% Similarity=0.284 Sum_probs=195.9
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..+.||+|+||+||+|....+++.||+|++.... .......+.+.+|+.+++.++||||+++++++.++++.++||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE-MLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 5788899999999999999999899999999994321 122334566889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999965322 278888999999999999999999 999999999999999999999999999876543
Q ss_pred CCcc-eEeeccCCCccCcCCCCC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 866 KNET-VSMVAGSYGYIAPEYGYT-----LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 866 ~~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
.... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||.... ................
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~-----~~~~~~~i~~~~~~~~- 228 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHKEHFQ- 228 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC-----HHHHHHHHHcCCCccc-
Confidence 3322 223569999999998763 457889999999999999999999996531 1121111111111000
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHH
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAK--LPKDRPSMRDVITM 982 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPt~~evl~~ 982 (1018)
+.+.. .. ....+.+++.+|+.. ++..||++++++++
T Consensus 229 -~~~~~---~~---~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 -FPPDV---TD---VSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -CCCcc---CC---CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11111 01 122345566676654 34448899999876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=327.74 Aligned_cols=261 Identities=21% Similarity=0.241 Sum_probs=197.1
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
..|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|++++++++|||||++++++..++..++|
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 46888999999999999999999899999999641 12356899999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
||++. ++|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||+++...
T Consensus 239 ~e~~~-~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EEccC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 99994 699998865432 389999999999999999999999 99999999999999999999999999998653
Q ss_pred cCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCC------cccHHHHHHHHhhcccc
Q 001752 865 RKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGE------SVDIVEWIRMKIRDNRN 936 (1018)
Q Consensus 865 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~------~~~~~~~~~~~~~~~~~ 936 (1018)
..... .....||+.|+|||++.+..++.++|||||||++|||++|..|+-..... ...+...+.........
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 32221 12356999999999999999999999999999999999988765321110 11122222211100000
Q ss_pred ccccc----------------CCCCCC--CchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 937 LEEAL----------------DPNVGN--CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 937 ~~~~~----------------~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
+.... .+.... +.........+.+++.+||+.||.+|||+.|++++
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 000000 00000112346789999999999999999999975
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=308.73 Aligned_cols=251 Identities=30% Similarity=0.481 Sum_probs=201.9
Q ss_pred ceeecCCCeeEEEEEcCCC---CeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEe
Q 001752 711 NVIGMGATGIVYKAEMPRL---NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEY 787 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 787 (1018)
+.||+|+||.||+|..... +..||+|.+...... ...+.+.+|++.++.++|+|++++++++.+....++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE---EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch---hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence 4689999999999999866 889999998433221 2467889999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCC-----ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 788 MNNGSLGEALHGKQAG-----RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 788 ~~~gsL~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+++++|.+++...... ...+++..++.++.|+++|++|||+. +++||||||+||+++.++.++++|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccc
Confidence 9999999999875321 23489999999999999999999999 999999999999999999999999999987
Q ss_pred eccCC--cceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 863 MIRKN--ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 863 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
..... .......+++.|+|||...+..++.++||||+|+++|||++ |..||.... ...+..... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~----~~~~~-- 226 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--NEEVLEYLR----KGYRL-- 226 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHH----cCCCC--
Confidence 64432 12233557889999999888889999999999999999999 699997641 111212111 11100
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 984 (1018)
+.. ......+.+++.+|++.+|++||++.++++.|+
T Consensus 227 ---~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 ---PKP------EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCC------ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 011345778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=325.70 Aligned_cols=257 Identities=25% Similarity=0.379 Sum_probs=208.8
Q ss_pred ccccceeecCCCeeEEEEEcCCCC----eEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLN----TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
.+..++||+|+||+||+|.+--.| -+||+|++.. ........++.+|+.+|.+++|||+++++|+|.... +.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~---~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE---FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeec---cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 455689999999999999985444 4688888832 334456788999999999999999999999998765 89
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+|++||+.|+|.++++..+. .+.....+.+..|||+|+.|||.+ .+|||||.++|||+..-..+|+.|||+|+.
T Consensus 774 lvtq~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHHhcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 99999999999999987654 377788899999999999999999 999999999999999999999999999998
Q ss_pred eccCCcceEeec--cCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 863 MIRKNETVSMVA--GSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 863 ~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
+..+........ -.+-|+|-|.+....++.++|||||||++||++| |..|+++...+ ++.+..+ .+..
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--eI~dlle----~geR--- 918 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--EIPDLLE----KGER--- 918 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--HhhHHHh----cccc---
Confidence 866655554433 3457999999999999999999999999999999 99999874332 2222221 1111
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
+. ..+--..+++.++.+||..|++.||+++++...+.++..+.
T Consensus 919 -----Ls---qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 919 -----LS---QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred -----CC---CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 10 11122456788999999999999999999999998886654
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=313.88 Aligned_cols=259 Identities=32% Similarity=0.468 Sum_probs=202.8
Q ss_pred hhcccccceeecCCCeeEEEEEcCC-----CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPR-----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND 778 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 778 (1018)
.++|+..+.||+|+||.||+|.+.. ++..||+|++... ......+++.+|+.++++++|||++++++++.++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC---cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 4568888999999999999998742 5789999998322 2234456789999999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHhhhcCCC------------------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCC
Q 001752 779 TNMMIVYEYMNNGSLGEALHGKQA------------------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIK 840 (1018)
Q Consensus 779 ~~~~lV~e~~~~gsL~~~l~~~~~------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 840 (1018)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++|||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~ 157 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLA 157 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence 999999999999999999974321 122478889999999999999999999 99999999
Q ss_pred CCcEEEcCCCCeEEcccccceeeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 001752 841 SNNILLDSNLEPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEF 917 (1018)
Q Consensus 841 ~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~ 917 (1018)
|+||+++.++.++++|||.+..+...... ......++.|+|||+..+..++.++|||||||++|||++ |..||.+..
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999998765322211 112334667999999988899999999999999999998 888886431
Q ss_pred CCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 918 GESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
. .+.... ....... +... .....+.+++.+|++.+|++|||+.|+++.|++
T Consensus 238 ~-----~~~~~~-~~~~~~~-----~~~~------~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 H-----EEVIYY-VRDGNVL-----SCPD------NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H-----HHHHHH-HhcCCCC-----CCCC------CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 122221 1111100 0000 112457789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.13 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=202.8
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.++|+..+.||+|+||.||+|.+..++..||+|++... .......+.+|+.++++++|||++++++++..+...++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence 35688888999999999999999888999999998322 23345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++++|.+++..... .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++++|||.+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 80 LIEFCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKN 153 (280)
T ss_pred EeeccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhh
Confidence 9999999999999875432 378999999999999999999999 9999999999999999999999999998765
Q ss_pred ccCCcceEeeccCCCccCcCCCC-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGY-----TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
...........+++.|+|||++. +..++.++||||||+++|||++|+.||..... ............
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~--- 225 (280)
T cd06611 154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-----MRVLLKILKSEP--- 225 (280)
T ss_pred cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----HHHHHHHhcCCC---
Confidence 44444444567899999999864 44577899999999999999999999975321 111111111110
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
+..... ......+.+++.+|++.+|++||++.++++.
T Consensus 226 ----~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 ----PTLDQP---SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----CCcCCc---ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111000 1112346678999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.41 Aligned_cols=252 Identities=30% Similarity=0.446 Sum_probs=198.0
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
++|+....||+|++|.||+|.+.. +..+|+|++... ....+.+.+|+.++++++|||++++++++. .+..++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~lK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPG-----TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC-CceEEEEEcccC-----CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 557888899999999999999874 456999987322 223467889999999999999999999885 4567999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.++++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||.++...
T Consensus 79 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIE 153 (260)
T ss_pred EEcCCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEcc
Confidence 999999999999976432 2378999999999999999999999 99999999999999999999999999997653
Q ss_pred cCCcc-eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 865 RKNET-VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 865 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
..... .....++..|+|||+..+..++.++||||||+++|||++ |+.||..... ....... ......
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~----~~~~~~----- 222 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQV----ERGYRM----- 222 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcCCCC-----
Confidence 32211 112345678999999988889999999999999999999 8999965321 1111111 111100
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
+.. ......+.+++.+|++++|++||+++++++.|++
T Consensus 223 ~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCP------QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCC------cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000 1122446789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=318.34 Aligned_cols=263 Identities=25% Similarity=0.378 Sum_probs=204.3
Q ss_pred hhcccccceeecCCCeeEEEEEcCC-------CCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPR-------LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFL 775 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 775 (1018)
.++|...+.||+|+||.||+|.+.. +...+|+|.+... .......++.+|+.+++++ +||||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC---CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3568889999999999999998642 2357999998432 1223456788899999999 799999999999
Q ss_pred ecCCceEEEEEecCCCCHHHhhhcCCCC------------ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCc
Q 001752 776 HNDTNMMIVYEYMNNGSLGEALHGKQAG------------RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNN 843 (1018)
Q Consensus 776 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 843 (1018)
...+..++||||+++|+|.+++...... ...+++..+.+++.|++.||+|||+. +++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 9999999999999999999999765321 12478999999999999999999998 99999999999
Q ss_pred EEEcCCCCeEEcccccceeeccCCcce--EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCc
Q 001752 844 ILLDSNLEPRIADFGLARMMIRKNETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGES 920 (1018)
Q Consensus 844 Ill~~~~~~kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~ 920 (1018)
|+++.++.++++|||.++......... ....+++.|+|||+..+..++.++|||||||++|||++ |+.||....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~--- 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---
Confidence 999999999999999987653222111 11234568999999988889999999999999999998 888886431
Q ss_pred ccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCC
Q 001752 921 VDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPR 989 (1018)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 989 (1018)
....... ...... . +.. . .....+.+++.+|++.+|++||++.++++.|+++.+.
T Consensus 248 --~~~~~~~-~~~~~~-~----~~~---~---~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 --VEELFKL-LKEGHR-M----DKP---S---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred --HHHHHHH-HHcCCC-C----CCC---C---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111111 111110 0 000 0 1123566789999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=326.37 Aligned_cols=265 Identities=24% Similarity=0.285 Sum_probs=199.4
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC----
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND---- 778 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 778 (1018)
..++|+..+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 5688999999999999999999998889999999984321 2233456788999999999999999999987543
Q ss_pred --CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcc
Q 001752 779 --TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 779 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 856 (1018)
...|+||||+++ +|.+.+... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHhc------CCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence 357999999965 788777431 67888999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH------
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMK------ 930 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~------ 930 (1018)
||+++.... ........+|+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+...
T Consensus 170 fG~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~ 246 (364)
T cd07875 170 FGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTPCP 246 (364)
T ss_pred CCCccccCC-CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCH
Confidence 999976432 22223457899999999999999999999999999999999999999753211 110000000
Q ss_pred -------------hhccccc-----ccccCCCCC--CCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 931 -------------IRDNRNL-----EEALDPNVG--NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 931 -------------~~~~~~~-----~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
....... ......... ...........+.+++.+|++.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 000000000 000001122356789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=324.90 Aligned_cols=266 Identities=22% Similarity=0.289 Sum_probs=197.9
Q ss_pred HHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC---
Q 001752 702 DILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND--- 778 (1018)
Q Consensus 702 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 778 (1018)
++.++|+..+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 35678999999999999999999998899999999984321 1223345677899999999999999999987543
Q ss_pred ---CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEc
Q 001752 779 ---TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIA 855 (1018)
Q Consensus 779 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 855 (1018)
...++++|++ +++|.+++.... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQK-----LSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 3468999988 789998886432 78999999999999999999999 99999999999999999999999
Q ss_pred ccccceeeccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcc
Q 001752 856 DFGLARMMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDN 934 (1018)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 934 (1018)
|||+++.... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ..+..+........
T Consensus 161 Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~ 236 (343)
T cd07878 161 DFGLARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPS 236 (343)
T ss_pred CCccceecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCC
Confidence 9999986532 2334578999999999876 56899999999999999999999999653211 11111110000000
Q ss_pred ccc---------ccccCCCCCCCchh-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 935 RNL---------EEALDPNVGNCKHV-----QEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 935 ~~~---------~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
... .............. ......+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000000000000 0012236689999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=309.26 Aligned_cols=255 Identities=25% Similarity=0.353 Sum_probs=190.0
Q ss_pred ceeecCCCeeEEEEEcCC--CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEec
Q 001752 711 NVIGMGATGIVYKAEMPR--LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYM 788 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 788 (1018)
+.||+|+||.||+|.... ++..+|+|++.... .......+.+|+.++++++||||+++++++.+....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence 358999999999998642 45679999883322 2234457889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCC-CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCC
Q 001752 789 NNGSLGEALHGKQA-GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKN 867 (1018)
Q Consensus 789 ~~gsL~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 867 (1018)
++|+|.+++..... .....++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||.++......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 99999999975432 223467778888999999999999999 99999999999999999999999999987543222
Q ss_pred cce--EeeccCCCccCcCCCCCC-------CCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccc
Q 001752 868 ETV--SMVAGSYGYIAPEYGYTL-------KVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 868 ~~~--~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
... ....+++.|+|||++.+. .++.++||||||+++|||++ |+.||...... +..... .... .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~~~~---~~~~--~ 227 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--QVLTYT---VREQ--Q 227 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--HHHHHH---hhcc--c
Confidence 111 124567889999987532 35789999999999999997 99999653221 111111 1111 0
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 984 (1018)
....++..... ....+.+++..|+ .+|++|||++||++.|+
T Consensus 228 ~~~~~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLPKPRLKLP-----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCccCCC-----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111221110 1123556788998 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.38 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=201.3
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|.....||+|+||.||+|....++..||||++... .....+.+.+|+..++.++|||++++++.+..++..++
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 34444556799999999999999888999999998322 22345668899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++++|.+++.... +++..+..++.||+.|++|||+. +|+||||||+||+++.++.++++|||++...
T Consensus 97 v~e~~~~~~L~~~~~~~~-----l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 97 VMEFLEGGALTDIVTHTR-----MNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred EEeCCCCCcHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 999999999999985432 68899999999999999999999 9999999999999999999999999998765
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
...........+++.|+|||+..+..++.++||||||+++|||++|+.||..... ......+. . ...+
T Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~----~------~~~~ 236 (292)
T cd06658 169 SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQAMRRIR----D------NLPP 236 (292)
T ss_pred ccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH----h------cCCC
Confidence 4333333446789999999999888899999999999999999999999965321 11111111 0 1111
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
..... ......+..++.+|++.||++|||++++++.
T Consensus 237 ~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 237 RVKDS---HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccc---cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11110 1122346678899999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=305.01 Aligned_cols=247 Identities=26% Similarity=0.351 Sum_probs=194.7
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNN 790 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~ 790 (1018)
++||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 36899999999999975 68899999883321 223445788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcce
Q 001752 791 GSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV 870 (1018)
Q Consensus 791 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 870 (1018)
++|.+++..... .+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.++++|||++..........
T Consensus 77 ~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 150 (250)
T cd05085 77 GDFLSFLRKKKD---ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS 150 (250)
T ss_pred CcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccccc
Confidence 999999865432 278999999999999999999999 99999999999999999999999999987542221111
Q ss_pred -EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCC
Q 001752 871 -SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNC 948 (1018)
Q Consensus 871 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1018)
....+++.|+|||+..+..++.++||||||+++||+++ |..||..... ..... ........ . ..
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--~~~~~----~~~~~~~~-~-~~------ 216 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN--QQARE----QVEKGYRM-S-CP------ 216 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--HHHHH----HHHcCCCC-C-CC------
Confidence 11234567999999988889999999999999999998 9999965321 11111 11111100 0 00
Q ss_pred chhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 001752 949 KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984 (1018)
Q Consensus 949 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 984 (1018)
......+.+++.+|++.+|++||++.|++++|.
T Consensus 217 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 ---QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 011245778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=335.16 Aligned_cols=268 Identities=18% Similarity=0.213 Sum_probs=195.2
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCC------CCcceeeeeEe
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH------RNIVRLLGFLH 776 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~~~~~~~ 776 (1018)
..++|+..+.||+|+||+||+|.+..+++.||||++... ....+.+..|+.+++.++| ++++++++++.
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 357899999999999999999999888999999998321 1223345667777776654 45889999887
Q ss_pred cC-CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeecCCCCcEEEcCCC----
Q 001752 777 ND-TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH-DCYPPIIHRDIKSNNILLDSNL---- 850 (1018)
Q Consensus 777 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~---- 850 (1018)
.+ .+.++|||++ +++|.+++..... +++..+..|+.||+.||+|||+ . +||||||||+||+++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~----l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGP----FSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccc
Confidence 64 5789999988 7799998875533 7899999999999999999997 5 999999999999998765
Q ss_pred ------------CeEEcccccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 001752 851 ------------EPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFG 918 (1018)
Q Consensus 851 ------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 918 (1018)
.+||+|||.+... ........||+.|+|||++.+..++.++|||||||++|||++|+.||+....
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~---~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDE---RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cccccccCCCCceEEECCCCccccC---ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 4999999988542 2223456799999999999999999999999999999999999999976422
Q ss_pred CcccHHHHHHHHhhcc-------c---cccccc------CCCCC----------CCchhHHHHHHHHHHHHHccCCCCCC
Q 001752 919 ESVDIVEWIRMKIRDN-------R---NLEEAL------DPNVG----------NCKHVQEEMLLVLRIAFLCTAKLPKD 972 (1018)
Q Consensus 919 ~~~~~~~~~~~~~~~~-------~---~~~~~~------~~~~~----------~~~~~~~~~~~l~~l~~~cl~~dP~~ 972 (1018)
.+....+......- . ...+.+ .+... ...........+.+++.+||+.||++
T Consensus 351 --~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 351 --LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred --HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 11111111110000 0 000000 00000 00000011234668999999999999
Q ss_pred CCCHHHHHH--HhhccCC
Q 001752 973 RPSMRDVIT--MLGEAKP 988 (1018)
Q Consensus 973 RPt~~evl~--~L~~~~~ 988 (1018)
|||++|+++ .|.....
T Consensus 429 R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 429 RLNARQMTTHPYVLKYYP 446 (467)
T ss_pred CCCHHHHhcCccccccCC
Confidence 999999997 3444333
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=313.80 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=201.3
Q ss_pred hcccccceeecCCCeeEEEEEc----CCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC--
Q 001752 705 ACIRESNVIGMGATGIVYKAEM----PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND-- 778 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 778 (1018)
+.|+..+.||+|+||.||.|.. ..++..||+|.+.... .......+.+|+.++++++|||++++.+++.+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3467788999999999999974 3468899999984321 233456789999999999999999999998775
Q ss_pred CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccc
Q 001752 779 TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFG 858 (1018)
Q Consensus 779 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 858 (1018)
...++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg 154 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG 154 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCc
Confidence 568999999999999999965432 378999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcce---EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCC----------CcccHHH
Q 001752 859 LARMMIRKNETV---SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFG----------ESVDIVE 925 (1018)
Q Consensus 859 ~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~----------~~~~~~~ 925 (1018)
.++.+....... ....++..|+|||+..+..++.++|||||||++|||++++.|+..... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05079 155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR 234 (284)
T ss_pred cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence 998764332221 124466789999998888899999999999999999998776532111 0111111
Q ss_pred HHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 926 WIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
.+.. ...... .+.. ......+.+++.+|++.+|++||+++++++.++++
T Consensus 235 ~~~~-~~~~~~-----~~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRV-LEEGKR-----LPRP------PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHH-HHcCcc-----CCCC------CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111 111100 0000 11234577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=325.20 Aligned_cols=192 Identities=26% Similarity=0.310 Sum_probs=166.1
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
...|+..+.||+|+||.||+|.+..+++.||+|+... .....|+.++++++||||+++++++......++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc----------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 4569999999999999999999998899999997521 123468999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+. ++|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.++..
T Consensus 135 v~e~~~-~~l~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRSR---PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEccC-CcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 999995 689988865432 378999999999999999999999 9999999999999999999999999999753
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf 913 (1018)
. .........||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 208 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 208 V-VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c-cCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 2 222333467999999999999999999999999999999999965554
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=321.07 Aligned_cols=263 Identities=24% Similarity=0.401 Sum_probs=200.9
Q ss_pred hhcccccceeecCCCeeEEEEEc-----CCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEec
Q 001752 704 LACIRESNVIGMGATGIVYKAEM-----PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHN 777 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 777 (1018)
.++|+..+.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 35788899999999999999984 2457899999984321 223356788999999999 68999999998865
Q ss_pred C-CceEEEEEecCCCCHHHhhhcCCCC-----------------------------------------------------
Q 001752 778 D-TNMMIVYEYMNNGSLGEALHGKQAG----------------------------------------------------- 803 (1018)
Q Consensus 778 ~-~~~~lV~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 803 (1018)
. ...++||||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 5679999999999999998653210
Q ss_pred ----------ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc--eE
Q 001752 804 ----------RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET--VS 871 (1018)
Q Consensus 804 ----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~ 871 (1018)
...+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+|++|||++......... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 12367888999999999999999999 9999999999999999999999999999765322221 11
Q ss_pred eeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCch
Q 001752 872 MVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKH 950 (1018)
Q Consensus 872 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 950 (1018)
...+++.|+|||+..+..++.++||||||+++|||++ |..||...... .... ......... . .+. .
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~----~~~~~~~~~-~--~~~---~-- 306 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFC----RRLKEGTRM-R--APD---Y-- 306 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHH----HHHhccCCC-C--CCC---C--
Confidence 2345678999999988889999999999999999997 99998653221 1111 111111100 0 010 0
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCC
Q 001752 951 VQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKP 988 (1018)
Q Consensus 951 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 988 (1018)
....+.+++.+||+.+|++|||+.|++++|+.+..
T Consensus 307 ---~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 ---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12346788999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=309.42 Aligned_cols=253 Identities=28% Similarity=0.374 Sum_probs=195.2
Q ss_pred ceeecCCCeeEEEEEcCCCCe--EEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceEEEEEe
Q 001752 711 NVIGMGATGIVYKAEMPRLNT--IVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMMIVYEY 787 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~ 787 (1018)
+.||+|+||.||+|.+.+++. .+|+|.+... ........+.+|+.+++++ +||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc---CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence 368999999999999887665 4688877321 1234456788999999999 899999999999999999999999
Q ss_pred cCCCCHHHhhhcCCC------------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEc
Q 001752 788 MNNGSLGEALHGKQA------------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIA 855 (1018)
Q Consensus 788 ~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 855 (1018)
+++|+|.+++..... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEEC
Confidence 999999999975432 112378999999999999999999998 99999999999999999999999
Q ss_pred ccccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcc
Q 001752 856 DFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDN 934 (1018)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 934 (1018)
|||++...... ........+..|+|||+.....++.++|||||||++|||++ |..||..... ...... ....
T Consensus 155 dfgl~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~-~~~~ 227 (270)
T cd05047 155 DFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEK-LPQG 227 (270)
T ss_pred CCCCccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----HHHHHH-HhCC
Confidence 99998532111 11111234567999999988889999999999999999997 9999965321 111111 1111
Q ss_pred cccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 935 RNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
... + . . ......+.+++.+|++.+|.+|||+.++++.|+++.
T Consensus 228 ~~~----~--~--~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRL----E--K--P---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC----C--C--C---CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 100 0 0 0 011234678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.19 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=212.1
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
+.+-|+..+-||+|.|+.|-.|++-.+|..||||++.+ .+.+.....++.+|+++|+.++|||||++|++......+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDK--TKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDK--TKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecc--cccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 66778888999999999999999999999999999944 3455667788999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEE-cCCCCeEEcccccce
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILL-DSNLEPRIADFGLAR 861 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~DfG~a~ 861 (1018)
+|+|.-++|+|++|+.+...+ +.+....+++.||+.|+.|+|.. .+|||||||+||.+ ..-|-||+.|||++.
T Consensus 94 LiLELGD~GDl~DyImKHe~G---l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEG---LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred EEEEecCCchHHHHHHhhhcc---ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccc
Confidence 999999999999999876654 78899999999999999999999 89999999999976 566899999999997
Q ss_pred eeccCCcceEeeccCCCccCcCCCCCCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccc
Q 001752 862 MMIRKNETVSMVAGSYGYIAPEYGYTLKVD-EKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 862 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
.+ .+++...+.+|+..|-|||.+.+..|+ +++||||+|||+|.+++|++||...... +-..+.+
T Consensus 168 kf-~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-----ETLTmIm--------- 232 (864)
T KOG4717|consen 168 KF-QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-----ETLTMIM--------- 232 (864)
T ss_pred cC-CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----hhhhhhh---------
Confidence 76 456777889999999999999998886 6899999999999999999999653211 1111111
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
|=...- ......+..++|..|+..||.+|.+.+||+..
T Consensus 233 -DCKYtv---PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 233 -DCKYTV---PSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred -cccccC---chhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 111111 12233456678899999999999999999864
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=307.08 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=197.5
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeE-ecCCceEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFL-HNDTNMMI 783 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~l 783 (1018)
+.|+..+.||+|+||.||+|... +..||+|.+... ...+.+.+|+.++++++|++++++++++ .++...++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 46778899999999999999875 788999988321 2345788999999999999999999976 45567899
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++..
T Consensus 78 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred EEECCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceec
Confidence 9999999999999976443 2378899999999999999999999 9999999999999999999999999998754
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
.... ....++..|+|||+..+..++.++|||||||++|||++ |+.||... +........ .... .
T Consensus 153 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~-~~~~------~ 217 (256)
T cd05082 153 SSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRV-EKGY------K 217 (256)
T ss_pred cccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHH-hcCC------C
Confidence 2221 22344568999999988889999999999999999998 99998642 122221111 1111 0
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
+... ......+.+++.+|++.+|++|||+.++++.|+++
T Consensus 218 ~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 MDAP-----DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCC-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0000 01123467889999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.98 Aligned_cols=266 Identities=28% Similarity=0.370 Sum_probs=204.7
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhc--cCCCCcceeeeeEecC--
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK--LRHRNIVRLLGFLHND-- 778 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~-- 778 (1018)
+.++....+.||+|.||+||+|.+. |+.||||++.. ...+.+.+|.++.+. ++|+||..+++.-..+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s-------rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS-------RDERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecc-------cchhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 5667788899999999999999998 89999999921 223456667777665 4999999999886433
Q ss_pred --CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEeecCCCCcEEEcCCCC
Q 001752 779 --TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD-----CYPPIIHRDIKSNNILLDSNLE 851 (1018)
Q Consensus 779 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlk~~NIll~~~~~ 851 (1018)
..+++|.+|.+.|||+|||.... ++....++++..+|.||+|||.. ..|.|.|||||..||++..++.
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~t-----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRNT-----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhcc-----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 24799999999999999998643 78999999999999999999974 4578999999999999999999
Q ss_pred eEEcccccceeeccCCcc----eEeeccCCCccCcCCCCCCC----C--CccccchhHHHHHHHHHhC----------CC
Q 001752 852 PRIADFGLARMMIRKNET----VSMVAGSYGYIAPEYGYTLK----V--DEKIDIYSFGVVLLELLTG----------RR 911 (1018)
Q Consensus 852 ~kl~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~slG~il~elltg----------~~ 911 (1018)
+.|+|+|+|-........ ....+||-+|||||++...- + -..+||||||.++||++.. +.
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 999999999776444222 23478999999999876421 1 1368999999999999873 56
Q ss_pred CCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCC
Q 001752 912 PLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKP 988 (1018)
Q Consensus 912 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 988 (1018)
||.+.-..+....+... .+ -.+-+.|.........+.+..+.++++.||..+|..|-|+-.+-+.|.++..
T Consensus 435 Pyyd~Vp~DPs~eeMrk-VV-----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 435 PYYDVVPSDPSFEEMRK-VV-----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CcccCCCCCCCHHHHhc-ce-----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 77543222222222110 00 1122334444445556778888999999999999999999999999988764
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.60 Aligned_cols=259 Identities=26% Similarity=0.398 Sum_probs=203.8
Q ss_pred ccccceeecCCCeeEEEEEcCC-CCeEEEEEEeeccccc------cccchhhhHHHHHHHHhc-cCCCCcceeeeeEecC
Q 001752 707 IRESNVIGMGATGIVYKAEMPR-LNTIVAVKKLWRSRAD------LETESSGDFVGEVNVLGK-LRHRNIVRLLGFLHND 778 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~ 778 (1018)
|+..+.||+|+||.||+|.+.. .++.+|+|.+...... .......++.+|+.++.+ ++|||++++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 6677889999999999999987 6789999988433221 122344567788888765 7999999999999999
Q ss_pred CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeecCCCCcEEEcCCCCeEEccc
Q 001752 779 TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH-DCYPPIIHRDIKSNNILLDSNLEPRIADF 857 (1018)
Q Consensus 779 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 857 (1018)
+..++||||+++++|.+++.........+++..+++++.|++.|+.|||+ . +++|+||+|+||+++.++.++++||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999986543334458999999999999999999996 5 8999999999999999999999999
Q ss_pred ccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 001752 858 GLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 858 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
|.+....... ......++..|+|||+..+..++.++||||||+++|||++|+.||... +.............
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~~~~~-- 230 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NMLSLATKIVEAVY-- 230 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----CHHHHHHHHhhccC--
Confidence 9998654332 334467889999999999888999999999999999999999999642 11111111111110
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
.+... ......+.+++.+|++.||++||++.|+.+++++
T Consensus 231 ----~~~~~-----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 ----EPLPE-----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ----CcCCc-----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11110 0112446788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.41 Aligned_cols=249 Identities=28% Similarity=0.425 Sum_probs=197.6
Q ss_pred ceeecCCCeeEEEEEcCC-CC--eEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEe
Q 001752 711 NVIGMGATGIVYKAEMPR-LN--TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEY 787 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 787 (1018)
+.||+|++|.||+|.+.. .+ ..||+|.+...... ...+.+.+|+.++++++||||+++++++.+ ...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence 368999999999999854 23 36999998443222 556789999999999999999999999988 889999999
Q ss_pred cCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCC
Q 001752 788 MNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKN 867 (1018)
Q Consensus 788 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 867 (1018)
+++++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+|++|||.++.+....
T Consensus 77 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 77 APLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred cCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccc
Confidence 999999999976542 3479999999999999999999999 99999999999999999999999999998764433
Q ss_pred cceE---eeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 868 ETVS---MVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 868 ~~~~---~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
.... ...++..|+|||+..+..++.++|||||||++|||++ |+.||..... .+..... ....... +
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~---~~~~~~~-----~ 221 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--SQILKKI---DKEGERL-----E 221 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---HhcCCcC-----C
Confidence 2211 2456788999999988899999999999999999999 9999964311 1111111 1111100 0
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 984 (1018)
.. ......+.+++.+|++.+|++||++.++++.|.
T Consensus 222 ~~------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RP------EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CC------ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00 011234778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=311.14 Aligned_cols=262 Identities=24% Similarity=0.366 Sum_probs=202.6
Q ss_pred HhhcccccceeecCCCeeEEEEEcC-----CCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMP-----RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN 777 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 777 (1018)
..++|++.+.||+|+||.||+|... ..+..||+|.+.... .......+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 3577888999999999999999754 235689999873221 22334567889999999999999999999999
Q ss_pred CCceEEEEEecCCCCHHHhhhcCCC------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCC
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQA------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLE 851 (1018)
Q Consensus 778 ~~~~~lV~e~~~~gsL~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 851 (1018)
....++||||+++|+|.+++..... .....++..+.+++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCc
Confidence 9999999999999999999975321 123356778889999999999999999 9999999999999999999
Q ss_pred eEEcccccceeeccCCcce--EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 001752 852 PRIADFGLARMMIRKNETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIR 928 (1018)
Q Consensus 852 ~kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 928 (1018)
++++|||+++......... ....++..|+|||+..+..++.++|||||||++|||++ |..||..... .+...
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----~~~~~ 232 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLK 232 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence 9999999987653322211 11234678999999988889999999999999999999 7888865321 12111
Q ss_pred HHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 929 MKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
....... . +... .....+.+++.+|++.+|++|||+.++++.+++..
T Consensus 233 ~~~~~~~-~-----~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 233 FVMDGGY-L-----DQPD------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHcCCC-C-----CCCC------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111111 0 0000 11245778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=309.30 Aligned_cols=255 Identities=29% Similarity=0.438 Sum_probs=205.5
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..+.||+|+||.||+|.+..+++.||+|.+.... .....+++.+|++.+++++||||+++++++..+...++|+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 4667788999999999999999889999999984332 2245667889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH-DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
||+++++|.+++.... ..+++..+..++.|++.|++|+|+ . +++|+||||+||+++.++.++|+|||.+....
T Consensus 79 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 79 EYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 9999999999997653 237888999999999999999999 7 99999999999999999999999999987653
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
..... ...++..|+|||+..+..++.++||||||+++|+|++|+.||...................... +.
T Consensus 153 ~~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~ 223 (265)
T cd06605 153 NSLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-------PR 223 (265)
T ss_pred HHHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-------CC
Confidence 32221 2678899999999998899999999999999999999999997643322333333322221111 11
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
... ......+.+++.+|+..+|++|||+.+++++
T Consensus 224 ~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 LPS----GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCh----hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 100 0123447789999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=319.13 Aligned_cols=257 Identities=23% Similarity=0.265 Sum_probs=196.8
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..+.||+|+||+||+++...+++.||+|++.... .........+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-MLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH-HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 5778899999999999999999889999999984321 112233456888999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++|+|.+++..... .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999975322 278888889999999999999999 999999999999999999999999999976533
Q ss_pred CCcce-EeeccCCCccCcCCCC-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 866 KNETV-SMVAGSYGYIAPEYGY-----TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 866 ~~~~~-~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
..... ....||+.|+|||++. ...++.++|||||||++|||++|+.||.... ...............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~-- 227 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHKERF-- 227 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-----HHHHHHHHhCCCccc--
Confidence 33222 2357999999999875 3468899999999999999999999997531 222222211111100
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCC--CCCCHHHHHHH
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPK--DRPSMRDVITM 982 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~--~RPt~~evl~~ 982 (1018)
.+.... ......+.+++.+|+..+|. .|++++|++++
T Consensus 228 ~~p~~~------~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 QFPAQV------TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCCcc------ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 011100 11123455677787755444 47899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=308.11 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=200.3
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccc-----cchhhhHHHHHHHHhccCCCCcceeeeeEecCCc
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLE-----TESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN 780 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 780 (1018)
+|...+.||+|++|.||+|.+..+++.||+|.+........ ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 36677899999999999999988899999998854322211 1233578899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 860 (1018)
.++||||+++++|.+++..... +++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGA----FEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccC----ccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999976543 78888999999999999999999 9999999999999999999999999998
Q ss_pred eeeccCCc------ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcc
Q 001752 861 RMMIRKNE------TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDN 934 (1018)
Q Consensus 861 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 934 (1018)
+....... ......++..|+|||+..+..++.++||||+||++|+|++|+.||..... ... +.... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~-~~~~~-~- 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----LQA-IFKIG-E- 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----HHH-HHHHh-c-
Confidence 86642211 11224578899999999888899999999999999999999999975311 111 11100 0
Q ss_pred cccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 935 RNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
...+... ......+.+++.+||+.||.+||++.++++
T Consensus 227 -----~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 -----NASPEIP-----SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----cCCCcCC-----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0111111 012244677889999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=312.34 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=204.0
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.++|+..+.||+|+||.||+|....+++.||+|.+... .....+.+.+|+.++++++|||++++++++...+..++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ----QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc----cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 46788889999999999999998888999999998322 22335678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
|+||+++++|.+++.... +++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.+...
T Consensus 94 v~e~~~~~~L~~~~~~~~-----l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 94 VMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (293)
T ss_pred EEecCCCCcHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence 999999999999997542 67889999999999999999999 9999999999999999999999999998765
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
...........+++.|+|||+..+..++.++||||||+++|++++|+.||........ +........ +
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-----~~~~~~~~~-------~ 233 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYLIATNGT-------P 233 (293)
T ss_pred cccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-----eeehhcCCC-------C
Confidence 4444334445788999999998888899999999999999999999999975322110 000000000 0
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
... ........+.+++.+||+.+|++||++++++.+
T Consensus 234 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 ELQ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 111123346789999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.13 Aligned_cols=260 Identities=23% Similarity=0.382 Sum_probs=204.8
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCe----EEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNT----IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
..+|+..+.||+|+||.||+|....+++ .||+|+..... ......++.+|+..+++++|||++++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 3567788999999999999999765554 68999873322 13445678899999999999999999999987 7
Q ss_pred ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccc
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGL 859 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 859 (1018)
..++||||+++|+|.+++..... .+++..+..++.||+.|++|||+. +++||||||+||+++.++.+||+|||.
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcc
Confidence 88999999999999999976433 278999999999999999999998 999999999999999999999999999
Q ss_pred ceeeccCCcceEe--eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccc
Q 001752 860 ARMMIRKNETVSM--VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRN 936 (1018)
Q Consensus 860 a~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 936 (1018)
++........... ..++..|+|||......++.++|+||||+++||+++ |+.||..... .++...+. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~----~~~~ 229 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLE----KGER 229 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHh----CCCC
Confidence 9876433222221 223568999999888889999999999999999999 9999975321 12222211 1110
Q ss_pred cccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 937 LEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
. +.... ....+.+++.+||..+|.+||++.++++.|+++..+.
T Consensus 230 ~-----~~~~~------~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 230 L-----PQPPI------CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred C-----CCCCC------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 0 10111 1234678899999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=306.95 Aligned_cols=254 Identities=30% Similarity=0.427 Sum_probs=202.4
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.++|+..+.||+|+||.||+|... +++.||||.+.. .....+++.+|+.++++++|||++++++++......++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKP-----GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecC-----CccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 467888899999999999999976 467899999832 22345678999999999999999999999999899999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++++|.+++..... ..+++..+..++.+++.|++|||+. +++|+||||+||+++.++.++++|||.+...
T Consensus 79 v~e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred EEeccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceec
Confidence 9999999999999976532 2378999999999999999999999 9999999999999999999999999998765
Q ss_pred ccCCcc-eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 864 IRKNET-VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 864 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
...... ......+..|+|||+..+..++.++||||+|+++||+++ |+.||..... ......+ . ... .
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~---~-~~~--~--- 222 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQV---E-RGY--R--- 222 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---H-cCC--C---
Confidence 432111 112234568999999998889999999999999999999 9999965321 1111111 1 110 0
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
.+.... ....+.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 ~~~~~~------~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPN------CPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCC------CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 000001 12347789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=319.27 Aligned_cols=258 Identities=24% Similarity=0.260 Sum_probs=197.9
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
++|+..+.||+|+||+||+|++..+++.||+|++.... .........+.+|..++..++|++|+++++++.+++..|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE-MLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 35788899999999999999999899999999984321 11223345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 80 ~Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 80 MDYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred EeCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999976322 278888889999999999999999 99999999999999999999999999997764
Q ss_pred cCCcce-EeeccCCCccCcCCCCC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 001752 865 RKNETV-SMVAGSYGYIAPEYGYT-----LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 865 ~~~~~~-~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
...... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...............
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~- 227 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHEERF- 227 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-----HHHHHHHHHcCCCcc-
Confidence 333222 23579999999998765 467889999999999999999999997532 111111111111100
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKD--RPSMRDVITM 982 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 982 (1018)
.+.+.. .+....+.+++.+|+..++.+ |+++++++++
T Consensus 228 -~~p~~~------~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 -QFPSHI------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -cCCCcc------ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 011111 112234667788888866544 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=314.29 Aligned_cols=267 Identities=25% Similarity=0.381 Sum_probs=201.5
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 57778999999999999999988899999999843221 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++++|.++...... +++..+..++.||++|++|||+. +++||||+|+||++++++.++++|||++.....
T Consensus 80 e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 80 EFVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred ecCCccHHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99999999887754332 78999999999999999999999 999999999999999999999999999987644
Q ss_pred CCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH----------Hhhcc
Q 001752 866 KNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRM----------KIRDN 934 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~----------~~~~~ 934 (1018)
.........++..|+|||+..+ ..++.++||||||+++|||++|++||...... ......... .....
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccc
Confidence 4433344567899999998765 45788999999999999999999999653211 000000000 00000
Q ss_pred cccccccCCCCCCCch----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 935 RNLEEALDPNVGNCKH----VQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 935 ~~~~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
........+....... .......+.+++.+|++.+|++||+++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000111100000 01123457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=308.18 Aligned_cols=263 Identities=26% Similarity=0.349 Sum_probs=203.2
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC--CceEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND--TNMMI 783 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 783 (1018)
+|+..+.||.|++|.||+|.+..+++.+|+|.+.... .......+.+|++++++++||||+++++++.+. ..+++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 5777889999999999999998889999999984321 224457789999999999999999999998653 46899
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++++|.+++.........+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++++|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 9999999999998865433344478899999999999999999999 9999999999999999999999999998654
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
.... .....++..|+|||...+..++.++||||+||++|+|++|+.||...........+.......... .. ...
T Consensus 156 ~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~ 230 (287)
T cd06621 156 VNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN--PE-LKD 230 (287)
T ss_pred cccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc--hh-hcc
Confidence 3221 123457889999999988899999999999999999999999997653211111222211111110 00 010
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
... ........+.+++.+|++.+|++|||+.|+++.
T Consensus 231 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 231 EPG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 010 001123456789999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=312.66 Aligned_cols=268 Identities=22% Similarity=0.315 Sum_probs=198.0
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|+..+.||+|++|.||+|....+++.||+|.+..... ......+.+|++++++++||||+++++++.+++..++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE---EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc---cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 3678888999999999999999988899999999843321 1223456789999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++ +|.+++..... .+++.....++.|++.||+|||+. +|+||||||+||+++.++.++++|||.++..
T Consensus 81 v~e~~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred EEecCCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccccccc
Confidence 9999975 99998875432 378899999999999999999999 9999999999999999999999999998654
Q ss_pred ccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc-ccccc---
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD-NRNLE--- 938 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~--- 938 (1018)
...........++..|+|||+..+ ..++.++||||+|+++|||++|+.||.........+.......... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 322222223356789999998765 4578999999999999999999999965432111111111000000 00000
Q ss_pred ---cccC---CCCCCCc-----hhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 939 ---EALD---PNVGNCK-----HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 939 ---~~~~---~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.... +...... ..........+++.+|++.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 0000000 00011145678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.44 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=200.2
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.++|+..+.||+|+||.||+|.+. .+..+|+|.+.. .......+.+|++++++++|+|++++++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKP-----GSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCC-----ChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 466888899999999999999876 466799998832 22345678899999999999999999999887 77899
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++++|.+++..... ...++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||.+...
T Consensus 78 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred EEEeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeec
Confidence 9999999999999976432 2378889999999999999999998 9999999999999999999999999999765
Q ss_pred ccCCcc-eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 864 IRKNET-VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 864 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
...... .....++..|+|||++.+..++.++|+|||||++|++++ |+.||..... .+...... .....
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~----~~~~~---- 222 (260)
T cd05073 153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALE----RGYRM---- 222 (260)
T ss_pred cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHh----CCCCC----
Confidence 332211 112345677999999988889999999999999999999 8999965321 11222111 11100
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
+.. ......+.+++.+|++++|++||++.++.+.|+.
T Consensus 223 -~~~------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 -PRP------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCc------ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000 1122347788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.81 Aligned_cols=261 Identities=27% Similarity=0.409 Sum_probs=203.1
Q ss_pred hcccccceeecCCCeeEEEEEcCC----CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec--C
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPR----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN--D 778 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~ 778 (1018)
+.|+..+.||+|+||.||+|.... +++.||||++...... ...+.|.+|++++++++|||++++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 456677899999999999998643 4789999998432221 356789999999999999999999999877 5
Q ss_pred CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccc
Q 001752 779 TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFG 858 (1018)
Q Consensus 779 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 858 (1018)
...++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 154 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFG 154 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence 678999999999999999976542 378999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceE---eeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCccc----------HHH
Q 001752 859 LARMMIRKNETVS---MVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVD----------IVE 925 (1018)
Q Consensus 859 ~a~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~----------~~~ 925 (1018)
.+........... ...++..|+|||+..+..++.++||||||+++|||++|+.|+......... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 9987643222111 123456799999998889999999999999999999999998653222110 111
Q ss_pred HHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 926 WIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
+.. ........ +.. ......+.+++.+|++.+|++|||+.||+++|+++
T Consensus 235 ~~~-~~~~~~~~-----~~~------~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLE-LLKEGERL-----PRP------PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHH-HHHcCCcC-----CCC------ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111 11111100 000 11124577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=317.48 Aligned_cols=199 Identities=24% Similarity=0.313 Sum_probs=166.6
Q ss_pred cceeecC--CCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEe
Q 001752 710 SNVIGMG--ATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEY 787 (1018)
Q Consensus 710 ~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 787 (1018)
.++||+| +|++||++....+++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 4678999 789999999999999999999843322 223455677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCC
Q 001752 788 MNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKN 867 (1018)
Q Consensus 788 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 867 (1018)
+++|+|.+++...... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+......+
T Consensus 81 ~~~~~l~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 81 MAYGSAKDLICTHFMD--GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred cCCCcHHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999999654322 278999999999999999999999 99999999999999999999999998754432211
Q ss_pred cc-------eEeeccCCCccCcCCCCC--CCCCccccchhHHHHHHHHHhCCCCCCC
Q 001752 868 ET-------VSMVAGSYGYIAPEYGYT--LKVDEKIDIYSFGVVLLELLTGRRPLDP 915 (1018)
Q Consensus 868 ~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~~ 915 (1018)
.. .....++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 11 112346678999999875 4588999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=316.38 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=200.4
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
..|+....||+|+||.||+|....+++.||+|++... .....+.+.+|+.+++.++|||++++++++..++..++|
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR----KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec----ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence 3444456799999999999999888999999998432 123345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++.... +++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 97 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 97 MEFLQGGALTDIVSQTR-----LNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168 (297)
T ss_pred EecCCCCCHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence 99999999999885432 78999999999999999999999 99999999999999999999999999987554
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
..........+++.|+|||++.+..++.++|||||||++|||++|+.||..... . ..... ..... .+.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~---~~~~~-~~~~~------~~~ 236 (297)
T cd06659 169 KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--V---QAMKR-LRDSP------PPK 236 (297)
T ss_pred cccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H---HHHHH-HhccC------CCC
Confidence 333333446789999999999888899999999999999999999999964321 1 11111 11110 000
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.... ......+.+++.+|++.+|++||++++++++
T Consensus 237 ~~~~---~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 237 LKNA---HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccc---CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 1112346678999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.39 Aligned_cols=262 Identities=24% Similarity=0.391 Sum_probs=202.5
Q ss_pred hhcccccceeecCCCeeEEEEEcC-------CCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMP-------RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFL 775 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 775 (1018)
.++|...+.||+|+||.||+|... .....||+|++... .......++.+|+.+++++ +||||+++++++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN---ATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC---CChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 356778899999999999999753 23567999988422 1223456788999999999 699999999999
Q ss_pred ecCCceEEEEEecCCCCHHHhhhcCCC------------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCc
Q 001752 776 HNDTNMMIVYEYMNNGSLGEALHGKQA------------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNN 843 (1018)
Q Consensus 776 ~~~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 843 (1018)
...+..++||||+++|+|.+++..... ....+++..+.+++.|++.||+|||+. |++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 999999999999999999999976432 123478999999999999999999999 99999999999
Q ss_pred EEEcCCCCeEEcccccceeeccCCcce--EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCc
Q 001752 844 ILLDSNLEPRIADFGLARMMIRKNETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGES 920 (1018)
Q Consensus 844 Ill~~~~~~kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~ 920 (1018)
|+++.++.+|++|||.++......... ....+++.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-- 242 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-- 242 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--
Confidence 999999999999999997653322111 11224467999999988889999999999999999999 8889864311
Q ss_pred ccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCC
Q 001752 921 VDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKP 988 (1018)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 988 (1018)
.+...... .... . + ... .....+.+++.+|++.+|++||++.++++.|+++..
T Consensus 243 ~~~~~~~~----~~~~-~---~-~~~------~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 243 EELFKLLR----EGHR-M---D-KPS------NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHHHH----cCCC-C---C-CCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11222111 1110 0 0 000 112346679999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=302.83 Aligned_cols=251 Identities=26% Similarity=0.449 Sum_probs=198.8
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
..|+..+.||+|+||.||+|.+. .++.+|+|++... ......|.+|++++++++||+++++++++......++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREG-----AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCC-----CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 35677789999999999999886 4778999988322 22345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++..... .+++..+..++.+++.|++|||+. +++|+||||+||+++.++.++++|||.++...
T Consensus 78 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVL 151 (256)
T ss_pred EEcCCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecc
Confidence 999999999999975432 268899999999999999999999 99999999999999999999999999987653
Q ss_pred cCCcc-eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 865 RKNET-VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 865 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
..... .....++.+|+|||+..+..++.++||||||+++|||++ |+.||..... ...... ..... ....
T Consensus 152 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~-~~~~~---~~~~ 222 (256)
T cd05112 152 DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVET-INAGF---RLYK 222 (256)
T ss_pred cCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHH-HhCCC---CCCC
Confidence 22111 112234578999999988889999999999999999998 9999965321 111111 11110 0011
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 984 (1018)
+.. ....+.+++.+|++.+|++||++.+++++|.
T Consensus 223 ~~~--------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 PRL--------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCC--------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 111 1245778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=315.57 Aligned_cols=282 Identities=26% Similarity=0.391 Sum_probs=215.3
Q ss_pred ccccceeecCCCeeEEEEEcCCC---CeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRL---NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
....+.||+|.||.|++|.|+.. --.||||.+..... .....+|.+|+.+|-+++|||+++++|...+ ...+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l---~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL---NAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc---chhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 34456899999999999999643 35799999943322 2367899999999999999999999999987 67899
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
|||.++.|+|.+.|++. .+..+-......++.|||.|+.||.++ +.||||+.+.|+++-....|||+|||+.+.+
T Consensus 188 V~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred HhhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceecc
Confidence 99999999999999873 334477788889999999999999999 9999999999999999999999999999988
Q ss_pred ccCCcceEe---eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 864 IRKNETVSM---VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 864 ~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
........+ ..-...|+|||.+...+++.++|||+|||++|||++ |..||-+-.+ .++.. .+.++
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--~qIL~----~iD~~----- 331 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--IQILK----NIDAG----- 331 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--HHHHH----hcccc-----
Confidence 766555433 224568999999999999999999999999999999 8889965321 11111 11111
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh--hccCCCCCCCCCCC-----chhhccccceeEeec
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML--GEAKPRRKSSSNND-----NRYENNKEKLVFSTS 1012 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L--~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 1012 (1018)
.++.+.+ ...+.+++++..||...|++|||+..+.+.+ .++++......-.. -..+.+-+.+|++-+
T Consensus 332 ---erLpRPk---~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp~~a~~~~d~~ep~aLh~~kgD~IvVIegs 405 (1039)
T KOG0199|consen 332 ---ERLPRPK---YCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAVARETYDSIEPGALHLTKGDEIVVIEGS 405 (1039)
T ss_pred ---ccCCCCC---CChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCceeeeeccccCCCceeeccCCeEEEEecC
Confidence 1122222 2345688999999999999999999998544 44444332222211 133445556777665
Q ss_pred cc
Q 001752 1013 PV 1014 (1018)
Q Consensus 1013 ~~ 1014 (1018)
.+
T Consensus 406 ~a 407 (1039)
T KOG0199|consen 406 GA 407 (1039)
T ss_pred Cc
Confidence 53
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=324.73 Aligned_cols=262 Identities=22% Similarity=0.199 Sum_probs=197.2
Q ss_pred hhcccccceeecCCCeeEEEEEcC--CCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCce
Q 001752 704 LACIRESNVIGMGATGIVYKAEMP--RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 781 (1018)
..+|+..+.||+|+||.||+|... ..++.||+|.+... +.+.+|++++++++||||+++++++......
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 456889999999999999999764 34678999988221 2356799999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
++|||++. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||+++
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSG----PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred EEEehhcC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 99999995 68999884433 389999999999999999999999 99999999999999999999999999997
Q ss_pred eeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc--ccHHHHHHHHhhccccc
Q 001752 862 MMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES--VDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 862 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 937 (1018)
........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ..+...+.........+
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 65433222 223579999999999999999999999999999999999999996543221 11111111100000000
Q ss_pred ---------------ccccCCCCCCCc--hhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 938 ---------------EEALDPNVGNCK--HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 938 ---------------~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.....+...... ........+.+++.+|+..||++|||+.|++++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 000112346678999999999999999999875
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.49 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=203.1
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|+..+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.++++++||||+++++++.++...++
T Consensus 3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence 455778889999999999999998889999999873221 12345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++++|.+++... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++...
T Consensus 80 v~e~~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 80 IMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred EEEeCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceec
Confidence 99999999999998643 278999999999999999999999 9999999999999999999999999998766
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
...........++..|+|||+..+..++.++|||||||++|+|++|..||..... ...... ..... .+
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~-~~~~~------~~ 219 (277)
T cd06641 152 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFL-IPKNN------PP 219 (277)
T ss_pred ccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHH-HhcCC------CC
Confidence 4433333345688899999999888899999999999999999999999964321 111111 11111 01
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
... ......+.+++.+|++.+|++||++.+++++
T Consensus 220 ~~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLE-----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCC-----cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 110 1122446778999999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=304.11 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=195.4
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccc-cccchhhhHHHHHHHHhccCCCCcceeeeeEec--CCceE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRAD-LETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN--DTNMM 782 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 782 (1018)
.|+..+.||+|+||.||+|.+..+++.||+|++...... ........+.+|+.++++++||||+++++++.+ +...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 577889999999999999999888999999988433221 122334578899999999999999999999865 35678
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
++|||+++++|.+++..... +++.....++.|++.|++|||+. +|+||||||+||+++.++.++|+|||+++.
T Consensus 83 l~~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGA----LTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 99999999999999975443 78888999999999999999998 999999999999999999999999999876
Q ss_pred eccCC---cceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 863 MIRKN---ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 863 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
..... .......++..|+|||++.+..++.++||||+||++|||++|+.||..... ...+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----~~~~~~~~~~~----- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----MAAIFKIATQP----- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-----HHHHHHHhcCC-----
Confidence 53211 122235588899999999988899999999999999999999999975311 11111111110
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
..+... ......+..++ .|+..+|++||+++|+++
T Consensus 226 -~~~~~~-----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -TNPQLP-----SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCCCc-----hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 011111 01122344455 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=314.23 Aligned_cols=197 Identities=25% Similarity=0.386 Sum_probs=160.7
Q ss_pred cceeecCCCeeEEEEEcC--CCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec--CCceEEEE
Q 001752 710 SNVIGMGATGIVYKAEMP--RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN--DTNMMIVY 785 (1018)
Q Consensus 710 ~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lV~ 785 (1018)
.++||+|+||+||+|.+. .+++.||+|++... .....+.+|+.++++++||||+++++++.. +...++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT------GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC------CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 458999999999999965 35789999998322 123457789999999999999999999854 45689999
Q ss_pred EecCCCCHHHhhhcCCC-----CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEE----cCCCCeEEcc
Q 001752 786 EYMNNGSLGEALHGKQA-----GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILL----DSNLEPRIAD 856 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~D 856 (1018)
||++ ++|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 9995 589888754321 123478899999999999999999999 99999999999999 4567899999
Q ss_pred cccceeeccCCc---ceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 001752 857 FGLARMMIRKNE---TVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPE 916 (1018)
Q Consensus 857 fG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~ 916 (1018)
||+++....... ......+|+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 999987643222 2233578999999998876 45899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=315.73 Aligned_cols=263 Identities=25% Similarity=0.376 Sum_probs=204.6
Q ss_pred hcccccceeecCCCeeEEEEEcCC-------CCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEe
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPR-------LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLH 776 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 776 (1018)
.+|+..+.||+|+||.||+|.+.. .+..||+|.+... ......+++.+|+.+++++ +||||+++++++.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 467888999999999999998532 2347899987322 2234456889999999999 7999999999999
Q ss_pred cCCceEEEEEecCCCCHHHhhhcCCC------------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcE
Q 001752 777 NDTNMMIVYEYMNNGSLGEALHGKQA------------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNI 844 (1018)
Q Consensus 777 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NI 844 (1018)
.++..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence 99999999999999999999975431 123478899999999999999999999 999999999999
Q ss_pred EEcCCCCeEEcccccceeeccCCcceEe--eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcc
Q 001752 845 LLDSNLEPRIADFGLARMMIRKNETVSM--VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESV 921 (1018)
Q Consensus 845 ll~~~~~~kl~DfG~a~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~ 921 (1018)
+++.++.+||+|||.++........... ..++..|+|||+..+..++.++||||||+++|||++ |..||....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---- 241 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---- 241 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC----
Confidence 9999999999999999765332211111 234567999999999899999999999999999998 888886531
Q ss_pred cHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 922 DIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
......... .... . +... .....+.+++.+|++.+|++||++.|+++.|+++....
T Consensus 242 -~~~~~~~~~-~~~~-~----~~~~------~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 242 -VEELFKLLK-EGHR-M----DKPA------NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -HHHHHHHHH-cCCC-C----CCCC------CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 222222111 1110 0 0000 11234778999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=308.23 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=196.1
Q ss_pred ceeecCCCeeEEEEEcCCCC------eEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 711 NVIGMGATGIVYKAEMPRLN------TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
+.||+|+||.||+|...... +.+|+|.+... ........+.+|+.++++++||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG---ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc---cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 36899999999999976433 68999987322 1224456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCC---ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC-----CeEEcc
Q 001752 785 YEYMNNGSLGEALHGKQAG---RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL-----EPRIAD 856 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~D 856 (1018)
|||+++++|.+++...... ...+++..+..++.|++.|++|||+. +++|+||||+||+++.++ .++++|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECC
Confidence 9999999999999754321 23478899999999999999999998 999999999999999887 899999
Q ss_pred cccceeeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhc
Q 001752 857 FGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRD 933 (1018)
Q Consensus 857 fG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 933 (1018)
||+++........ .....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+....+ ..
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--~~~~~~~~----~~ 228 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--NQEVLQHV----TA 228 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC--HHHHHHHH----hc
Confidence 9998765322211 112345678999999998899999999999999999998 999996431 11121111 11
Q ss_pred ccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 934 NRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
.... ... ......+.+++.+|+..+|++||+++++++.|++
T Consensus 229 ~~~~--------~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 GGRL--------QKP---ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCcc--------CCc---ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1100 000 1122456789999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=306.26 Aligned_cols=258 Identities=24% Similarity=0.352 Sum_probs=200.8
Q ss_pred hcccccceeecCCCeeEEEEEcCCC---CeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCce
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRL---NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 781 (1018)
++|...+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.++++++|||++++++++.+ ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 4577788999999999999987533 3578999873221 13445688999999999999999999999875 457
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
++||||+++|+|.+++..... .+++..+..++.+++.|++|||+. +++||||||+||+++.++.++++|||+++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceee
Confidence 899999999999999975432 378999999999999999999998 99999999999999999999999999997
Q ss_pred eeccCCcceE-eeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 862 MMIRKNETVS-MVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 862 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
.......... ...++..|+|||++....++.++||||||+++||+++ |..||...... +....+ ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~----~~~~~~-- 227 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRI----ENGERL-- 227 (270)
T ss_pred ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHH----HcCCcC--
Confidence 6543322111 1234567999999988889999999999999999997 99999754221 111111 111100
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCC
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPR 989 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 989 (1018)
+... .....+.+++.+|+..+|++|||+.++++.|+++..+
T Consensus 228 ---~~~~------~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 ---PMPP------NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ---CCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0011 1123477789999999999999999999999886554
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.67 Aligned_cols=248 Identities=27% Similarity=0.404 Sum_probs=199.7
Q ss_pred cccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCc--eEEEE
Q 001752 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN--MMIVY 785 (1018)
Q Consensus 708 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~lV~ 785 (1018)
+...+||+|+|-+||||.+..+|..||=--++.......+...++|..|+.+++.++||||++++++|.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3456899999999999999888877764333222333445566899999999999999999999999987655 78999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC-CCeEEcccccceeec
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN-LEPRIADFGLARMMI 864 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG~a~~~~ 864 (1018)
|.|..|+|..|+++.+. .+.....+++.||++||.|||++ .|+|+|||||.+||+++++ |.|||+|+|+|..+.
T Consensus 123 EL~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999988776 77889999999999999999998 4589999999999999876 899999999998763
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccc--cccccC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRN--LEEALD 942 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 942 (1018)
..+...+.|||.|||||+.. ..|.+.+||||||+.++||+|+..||.. -..-.+.++......++ +..+-
T Consensus 198 --~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE----C~n~AQIYKKV~SGiKP~sl~kV~- 269 (632)
T KOG0584|consen 198 --KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE----CTNPAQIYKKVTSGIKPAALSKVK- 269 (632)
T ss_pred --ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh----hCCHHHHHHHHHcCCCHHHhhccC-
Confidence 33444589999999999866 6899999999999999999999999963 22223333332222211 11111
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
..++.++|.+|+.. .++|||+.|+++
T Consensus 270 ------------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 ------------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ------------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 23467899999999 999999999987
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.35 Aligned_cols=240 Identities=22% Similarity=0.317 Sum_probs=186.3
Q ss_pred eeecCCCeeEEEEEcCCC------------CeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC
Q 001752 712 VIGMGATGIVYKAEMPRL------------NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 712 ~lG~G~~g~Vy~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
.||+|+||.||+|..... ...||+|++... .......|.+|+.+++.++||||+++++++..+.
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 689999999999986422 335888887332 2234557888999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCC-------e
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLE-------P 852 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-------~ 852 (1018)
..++||||+++|+|..++..... .+++..+.+++.||++|++|||+. +|+||||||+||+++.++. +
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCcee
Confidence 99999999999999999865432 378889999999999999999999 9999999999999987664 8
Q ss_pred EEcccccceeeccCCcceEeeccCCCccCcCCCC-CCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHH
Q 001752 853 RIADFGLARMMIRKNETVSMVAGSYGYIAPEYGY-TLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMK 930 (1018)
Q Consensus 853 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 930 (1018)
+++|||.+..... .....++..|+|||+.. +..++.++|||||||++|||++ |+.||...... .... .
T Consensus 152 ~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~~~-~ 221 (262)
T cd05077 152 KLSDPGIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-----EKER-F 221 (262)
T ss_pred EeCCCCCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-----HHHH-H
Confidence 9999999865422 22345788999999876 5678999999999999999984 88887643211 1100 0
Q ss_pred hhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 001752 931 IRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984 (1018)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 984 (1018)
..... .... .....+.+++.+||+.||++||++.++++.++
T Consensus 222 ~~~~~---~~~~----------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 YEGQC---MLVT----------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HhcCc---cCCC----------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 11110 0000 11234678999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.30 Aligned_cols=260 Identities=24% Similarity=0.381 Sum_probs=201.7
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCe----EEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNT----IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
.++|+..+.||+|+||.||+|.+..++. .||+|.+... .......++.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET---TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 3557778899999999999999876665 5688877322 1223345688999999999999999999998754
Q ss_pred ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccc
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGL 859 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 859 (1018)
..++++||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred CceeeehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccc
Confidence 46799999999999999975432 378889999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcce--EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccc
Q 001752 860 ARMMIRKNETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRN 936 (1018)
Q Consensus 860 a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 936 (1018)
++.+....... ....++..|+|||+..+..++.++|||||||++|||++ |+.||.... ......++. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~~~----~~~~ 229 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLE----KGER 229 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH----CCCC
Confidence 98654322211 12345678999999998899999999999999999998 999996532 112222221 1110
Q ss_pred cccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 937 LEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
. +... .....+.+++.+|+..+|++||+++++++.++++..+.
T Consensus 230 ~-----~~~~------~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 230 L-----PQPP------ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred C-----CCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0 0011 11234678899999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=310.62 Aligned_cols=268 Identities=23% Similarity=0.267 Sum_probs=197.8
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|...+.||+|+||.||+|....+++.||+|++.... .......+.+|+.+++.++|+||+++.+++.+++..++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT---EEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccC---cCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 467888999999999999999998889999999984322 12233467789999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||++ +++.+++..... .+.+..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||+++..
T Consensus 81 v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPG---GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred EEeccc-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccccccc
Confidence 999995 688777754332 267788888999999999999999 9999999999999999999999999998764
Q ss_pred ccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHh-h---------
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKI-R--------- 932 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~--------- 932 (1018)
...........+++.|+|||++.+ ..++.++|||||||++|||++|+.||+........+........ .
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 333333334557899999998865 35788999999999999999999999754321111111100000 0
Q ss_pred c-ccccccccCCCCC----CCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 933 D-NRNLEEALDPNVG----NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 933 ~-~~~~~~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
. .....+....... ...........+.+++.+|++.||++|||++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 0000000000000 00000011345668899999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.79 Aligned_cols=259 Identities=27% Similarity=0.396 Sum_probs=204.2
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
+.|+..+.||.|+||+||+|....++..+|+|++..... ....+.+.+|+.+++.++|+|++++++.+..+...++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence 357888999999999999999888899999999843222 12567889999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++..... ...+++.....++.|++.|++|||+. +++||||+|+||++++++.++++|||.+..+.
T Consensus 78 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred EeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 999999999999975432 12378999999999999999999999 99999999999999999999999999987664
Q ss_pred cCCcce----EeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 865 RKNETV----SMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 865 ~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
...... ....++..|+|||++... .++.++|||||||++|||++|+.||....... .... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~----~~~~~----- 223 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLML----TLQND----- 223 (267)
T ss_pred cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHH----HhcCC-----
Confidence 433321 334688999999988766 78999999999999999999999996532211 1111 11111
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.+..............+.+++.+|++.||++||++.+++++
T Consensus 224 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 224 --PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred --CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 01111100011223456789999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.69 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=198.4
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccc--cccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRAD--LETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
+|+..+.||+|+||+||+|... +++.+|+|.+...... ........+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 3667889999999999999875 6889999988433211 122334678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+++++|.+++..... +++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.++++|||.+...
T Consensus 80 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999975432 68889999999999999999999 9999999999999999999999999998754
Q ss_pred ccCC------cceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 001752 864 IRKN------ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 864 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
.... .......++..|+|||+..+..++.++||||||+++|||++|+.||...... .... ........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~- 226 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----AAMF-YIGAHRGL- 226 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----HHHH-HhhhccCC-
Confidence 2211 1112356889999999999888999999999999999999999999653211 1111 00000000
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.+.... .....+.+++.+|++.+|++||++.++++
T Consensus 227 ----~~~~~~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 ----MPRLPD-----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----CCCCCC-----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011111 12234678899999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.00 Aligned_cols=252 Identities=27% Similarity=0.371 Sum_probs=201.0
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeecccc-ccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRA-DLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
+|+..+.||+|+||.||+|....+++.|++|.+..... ....+..+.+.+|++++++++|||++++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 46677899999999999999988899999999843221 11233556789999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++..... +++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYGS----FPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999975532 78899999999999999999999 99999999999999999999999999987653
Q ss_pred cCCcceEeeccCCCccCcCCCCCCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLK-VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
... ......+++.|+|||...... ++.++|+||||+++|+|++|+.||..... ......... ...... +.+
T Consensus 154 ~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~-~~~~~~-~~~ 225 (258)
T cd06632 154 EFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-----VAAVFKIGR-SKELPP-IPD 225 (258)
T ss_pred ccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----HHHHHHHHh-cccCCC-cCC
Confidence 322 234466889999999887766 89999999999999999999999965321 111111111 000000 000
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.....+.+++.+|++.+|++||+++++++
T Consensus 226 ---------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 226 ---------HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---------CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11244667899999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=310.24 Aligned_cols=269 Identities=24% Similarity=0.302 Sum_probs=202.3
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeecccccc-ccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADL-ETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
+|+..+.||+|+||.||+|.+..+++.||+|++....... .......+..|++++++++||||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667789999999999999998889999999995433221 122345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+ +|+|.+++.... ..+++..+..++.||++||+|||+. +|+|+||+|+||+++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 899999997654 2388999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc-------ccc
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD-------NRN 936 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------~~~ 936 (1018)
..........+++.|+|||.+.+ ..++.++|||||||++|||++|.+||...... ..+.......... ...
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 154 SPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhccc
Confidence 44444444567888999998754 45789999999999999999998888653221 1111111100000 000
Q ss_pred cccccCCCCCCC----chhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 937 LEEALDPNVGNC----KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 937 ~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
............ .........+.+++.+|++++|++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 0011223457789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=310.32 Aligned_cols=253 Identities=26% Similarity=0.361 Sum_probs=198.3
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEec----
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHN---- 777 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~---- 777 (1018)
..+.|+..+.||+|+||.||+|.+..+++.||+|++.. ......++..|+.+++++ +|||++++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~-----~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-----TEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEec-----ChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 45778888999999999999999988899999999832 223345678899999998 79999999999853
Q ss_pred --CCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEc
Q 001752 778 --DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIA 855 (1018)
Q Consensus 778 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 855 (1018)
....++||||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.++++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEe
Confidence 4578999999999999999976443 2367888889999999999999999 99999999999999999999999
Q ss_pred ccccceeeccCCcceEeeccCCCccCcCCCC-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 001752 856 DFGLARMMIRKNETVSMVAGSYGYIAPEYGY-----TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMK 930 (1018)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 930 (1018)
|||.+..............|++.|+|||.+. +..++.++|||||||++|||++|+.||...... .. ...
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~----~~-~~~- 237 (282)
T cd06636 164 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM----RA-LFL- 237 (282)
T ss_pred eCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH----hh-hhh-
Confidence 9999876533333334466889999999875 356788999999999999999999999643211 00 000
Q ss_pred hhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 931 IRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.... ..+... .......+.+++.+||+.||.+||++.|+++
T Consensus 238 ~~~~------~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 IPRN------PPPKLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HhhC------CCCCCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000 011110 0112345778999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=291.63 Aligned_cols=252 Identities=24% Similarity=0.308 Sum_probs=207.6
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
-+.|+..++||+|.||.|..++.+.+++.+|+|+++++. ....+....-..|-++++..+||.+..+--.|+..++.++
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKev-iiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEV-IIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhh-eeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 356888999999999999999999999999999995443 3445566677889999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||..||.|.-++...+. +++....-+...|+.||.|||++ +||+||+|.+|.++|.||++||+|||+++.-
T Consensus 246 VMeyanGGeLf~HLsrer~----FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERV----FSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehhhhhc----ccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999999976544 77888888899999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
...+......+|||.|.|||++....|+.++|.|.+||++|||++|+.||..... ..+.+.+.+ ....+ ..
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--~kLFeLIl~---ed~kF----Pr 389 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--EKLFELILM---EDLKF----PR 389 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--hHHHHHHHh---hhccC----Cc
Confidence 6667777889999999999999999999999999999999999999999976322 122222211 11100 00
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVIT 981 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 981 (1018)
....+...++...+.+||.+|. .++||.+
T Consensus 390 ---------~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 390 ---------TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ---------cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 1122345677789999999994 4566654
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=302.14 Aligned_cols=252 Identities=25% Similarity=0.286 Sum_probs=202.2
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|+.-++||+||||.||-++...+|+.+|.|++.+++.+ ......-...|-.++.+++.|+||.+--.|+..+..++
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiK-kr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIK-KRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHH-HhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 35677778999999999999999999999999999554433 33445567789999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
|+..|.||+|.-+|...... .+++..+.-++.+|+.||++||+. .||+||+||+|||+|+.|+++|+|.|+|..+
T Consensus 263 VLtlMNGGDLkfHiyn~g~~--gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNP--GFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEeecCCceeEEeeccCCC--CCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999999766543 388999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
.+ +......+||.||||||++.+..|+...|.||+||++|||+.|+.||..... .....+.-++.......+.
T Consensus 338 ~~-g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-Kvk~eEvdrr~~~~~~ey~----- 410 (591)
T KOG0986|consen 338 PE-GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-KVKREEVDRRTLEDPEEYS----- 410 (591)
T ss_pred CC-CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-hhhHHHHHHHHhcchhhcc-----
Confidence 54 4444556999999999999999999999999999999999999999964211 1111111111111111111
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCH
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSM 976 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 976 (1018)
.....+...+....|++||++|--.
T Consensus 411 --------~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 411 --------DKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred --------cccCHHHHHHHHHHHccCHHHhccC
Confidence 1122345567778999999998543
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=302.41 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=190.8
Q ss_pred ceeecCCCeeEEEEEcCC---CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEe-cCCceEEEEE
Q 001752 711 NVIGMGATGIVYKAEMPR---LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLH-NDTNMMIVYE 786 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lV~e 786 (1018)
+.||+|+||.||+|.+.. ....||+|++... ......+.+.+|+.+++.++|||++++++++. .++..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence 368999999999998642 3467999987321 12234567889999999999999999999875 4556899999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
|+++|+|.+++..... ..++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 78 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 78 YMKHGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred cCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 9999999999975432 256777888999999999999999 9999999999999999999999999999754322
Q ss_pred Cc----ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 867 NE----TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTG-RRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 867 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
.. ......++..|+|||+..+..++.++|||||||++|||++| .+||... +.............
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-----~~~~~~~~~~~~~~------ 220 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----DSFDITVYLLQGRR------ 220 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHhcCCC------
Confidence 11 11123456789999998888899999999999999999995 5556432 11122221111111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
+.... .....+.+++.+||+.+|++||++.++++.|+++.
T Consensus 221 -~~~~~-----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 221 -LLQPE-----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -CCCCC-----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00000 01234678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=303.27 Aligned_cols=253 Identities=30% Similarity=0.422 Sum_probs=201.9
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|...+.||+|+||.||+|....+++.||+|++..... .....+.+.+|++++++++|+||+++++++.+.+..++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence 46778899999999999999988899999999854322 2346778999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++++|.+++..... +++..+..++.++++|++|||+. +|+|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~~----~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 79 EYCSGGTLEELLEHGRI----LDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred ecCCCCcHHHHHhhcCC----CChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 99999999999976432 68888999999999999999999 999999999999999999999999999977643
Q ss_pred CCcceE----eeccCCCccCcCCCCCCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 001752 866 KNETVS----MVAGSYGYIAPEYGYTLK---VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 866 ~~~~~~----~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
...... ...+++.|+|||++.+.. ++.++||||||+++||+++|+.||...... ........ ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~----~~---- 222 (264)
T cd06626 152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVG----AG---- 222 (264)
T ss_pred CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHh----cC----
Confidence 333221 256788999999988766 889999999999999999999999653211 11111110 00
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
..+.... .......+.+++.+|++.+|++||++.++++
T Consensus 223 --~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 --HKPPIPD---SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --CCCCCCc---ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0111111 1111344668899999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.67 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=195.2
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHH-HhccCCCCcceeeeeEecCCceEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNV-LGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
.|+..+.||+|+||.||+|.+..+++.||+|++..... ......+..|+.. ++..+|||++++++++..++..++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN---SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC---cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 57778899999999999999998999999999843221 1223455556665 6667999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||++ |+|.+++.........+++..++.++.||+.|++|||+++ +++||||||+||+++.++.+||+|||.++...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99996 6898888654433445899999999999999999999853 89999999999999999999999999997653
Q ss_pred cCCcceEeeccCCCccCcCCCCC----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccc
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYT----LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
.. .......++..|+|||++.+ ..++.++|+|||||++|||++|+.||.........+.. .....
T Consensus 156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~------ 224 (283)
T cd06617 156 DS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ----VVEEP------ 224 (283)
T ss_pred cc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH----HHhcC------
Confidence 22 12233568889999998764 45688999999999999999999999643221111111 11110
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.+.... ......+.+++.+|++.+|++||++++++++
T Consensus 225 -~~~~~~----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 225 -SPQLPA----EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -CCCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011100 0112346789999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.76 Aligned_cols=240 Identities=21% Similarity=0.334 Sum_probs=185.2
Q ss_pred eeecCCCeeEEEEEcCC------------------------CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCC
Q 001752 712 VIGMGATGIVYKAEMPR------------------------LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767 (1018)
Q Consensus 712 ~lG~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 767 (1018)
.||+|+||.||+|.... ....||+|++... .......|.+|+.++++++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS----HRDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH----HHHHHHHHHHHHHHHhcCCCCC
Confidence 58999999999998532 1245888888322 2233467888999999999999
Q ss_pred cceeeeeEecCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEc
Q 001752 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLD 847 (1018)
Q Consensus 768 iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~ 847 (1018)
|+++++++.+....++||||+++|+|..++..... .+++..+..++.||++||+|||+. +|+||||||+||+++
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~ 151 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLA 151 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEe
Confidence 99999999999999999999999999999865322 268888999999999999999999 999999999999998
Q ss_pred CCC-------CeEEcccccceeeccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHH-hCCCCCCCCCC
Q 001752 848 SNL-------EPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELL-TGRRPLDPEFG 918 (1018)
Q Consensus 848 ~~~-------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell-tg~~pf~~~~~ 918 (1018)
..+ .++++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.....
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred ccCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 654 3799999988643221 22357788999998765 56899999999999999995 69999865322
Q ss_pred CcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 001752 919 ESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984 (1018)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 984 (1018)
. ....... ..... +. .....+.+++.+||+.+|++|||+.++++.|.
T Consensus 228 ~--~~~~~~~----~~~~~-----~~--------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 S--EKERFYE----KKHRL-----PE--------PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H--HHHHHHH----hccCC-----CC--------CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 1111111 11100 00 01124678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=302.09 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=207.0
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..+.||+|++|.||+|++..+++.||+|++..... ......+.+|+..+++++|||++++++++......++||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 46778899999999999999998899999999843221 145678999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH-DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
||+++++|.+++.... .+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++++|||.+....
T Consensus 79 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 79 EYMDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999997653 37899999999999999999999 8 99999999999999999999999999998765
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
..........++..|+|||+..+..++.++||||||+++|+|++|+.||..... ............... ...+.
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~---~~~~~- 225 (264)
T cd06623 152 NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDGPP---PSLPA- 225 (264)
T ss_pred cCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcCCC---CCCCc-
Confidence 444444456788999999999988899999999999999999999999976432 111121111111110 00000
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
......+.+++.+|++++|++||++.+++++
T Consensus 226 -------~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 226 -------EEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -------ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0023457789999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=307.45 Aligned_cols=240 Identities=21% Similarity=0.339 Sum_probs=187.0
Q ss_pred eeecCCCeeEEEEEcCCCCe-------EEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 712 VIGMGATGIVYKAEMPRLNT-------IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 712 ~lG~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
.||+|+||.||+|.....+. .||+|.+... .....+.+.+|+.+++.++|||++++++++..++..++|
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 68999999999999865443 4888877221 223456788899999999999999999999998999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCC--------eEEcc
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLE--------PRIAD 856 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~kl~D 856 (1018)
|||+++|+|.+++..... .+++..+..++.||+.|++|||+. +|+||||||+||+++.++. ++++|
T Consensus 78 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EecCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecc
Confidence 999999999999976543 378899999999999999999999 9999999999999988765 59999
Q ss_pred cccceeeccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCC-CCCCCCCCCcccHHHHHHHHhhcc
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGR-RPLDPEFGESVDIVEWIRMKIRDN 934 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~ 934 (1018)
||.+..... .....+++.|+|||++.+ ..++.++|||||||++|||++|. .||..... ..... .....
T Consensus 152 ~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-----~~~~~-~~~~~ 221 (258)
T cd05078 152 PGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-----QKKLQ-FYEDR 221 (258)
T ss_pred cccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-----HHHHH-HHHcc
Confidence 998865422 223567889999999876 45789999999999999999985 55543211 11110 01111
Q ss_pred cccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 001752 935 RNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984 (1018)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 984 (1018)
. .... .....+.+++.+|++.+|++|||+++++++|+
T Consensus 222 ~--------~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 H--------QLPA-----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c--------cCCC-----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1 0000 11234778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=306.48 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=200.8
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC---CCCcceeeeeEecCCceE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR---HRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~ 782 (1018)
.|+..+.||+|+||.||+|.+..+++.||+|.+... .......++.+|+.++++++ |||++++++++.++...+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD---TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCC---CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence 366678899999999999999888999999998432 12334567888999999996 999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||+++++|.+++... .+++.....++.|++.|++|||+. +|+|+||+|+||+++.++.++++|||.+..
T Consensus 79 lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAAL 150 (277)
T ss_pred EEEecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence 999999999999998653 378999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
+...........|+..|+|||+..+ ..++.++|||||||++|+|++|+.||..... ...... .... .
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~-~~~~------~ 218 (277)
T cd06917 151 LNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMML-IPKS------K 218 (277)
T ss_pred cCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhc-cccC------C
Confidence 7554444444678999999998765 4568999999999999999999999975321 111110 0000 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.+..... .....+.+++.+|++.||++||++.+++++
T Consensus 219 ~~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 219 PPRLEDN----GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1111110 123457789999999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.02 Aligned_cols=267 Identities=23% Similarity=0.312 Sum_probs=199.2
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
|+..+.||.|++|.||+|++..+++.||||++.... ........+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc--cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 677889999999999999998889999999884322 122334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
|+. ++|.+++..... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+......
T Consensus 80 ~~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 80 FLH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred ccc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 995 689999875432 2378999999999999999999999 9999999999999999999999999998765433
Q ss_pred CcceEeeccCCCccCcCCCCCCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccc--------
Q 001752 867 NETVSMVAGSYGYIAPEYGYTLK-VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNL-------- 937 (1018)
Q Consensus 867 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 937 (1018)
........+++.|+|||+..+.. ++.++||||||+++|||++|+.||...... ......+..........
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHH
Confidence 33333445788999999876544 688999999999999999999999653211 11111111100000000
Q ss_pred --ccccCCCCCCC-ch-hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 938 --EEALDPNVGNC-KH-VQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 938 --~~~~~~~~~~~-~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
...+....... .. .......+.+++.+|++.||++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 00 00112345689999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=308.00 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=200.3
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
..|+..+.||+|++|.||+|....+++.||+|++... .....+.+.+|+.++++++|||++++++++...++.++|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc----chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence 3455567999999999999999888999999988321 223345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
+||+++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+....
T Consensus 95 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 95 MEFLEGGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred EeccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 9999999999999762 278899999999999999999999 99999999999999999999999999887543
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
..........|++.|+|||+..+..++.++||||||+++|||++|+.||..... ........... .+.
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~~~~~~-------~~~ 234 (285)
T cd06648 167 KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKRIRDNL-------PPK 234 (285)
T ss_pred cCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHHHhcC-------CCC
Confidence 333333345689999999999888899999999999999999999999965311 11111111110 011
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
... .......+.+++.+|++.+|++||++.++++
T Consensus 235 ~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 235 LKN---LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred Ccc---cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 110 0112245778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=300.74 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=202.6
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||+|+||.||+|....+++.+|+|.+... .........+.+|++++++++|||++++++.+..++..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVE--QMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecc--ccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 467788999999999999999889999999998433 223344678899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC-CeEEcccccceeec
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL-EPRIADFGLARMMI 864 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~a~~~~ 864 (1018)
||+++++|.+++.... ...+++..+.+++.+++.|++|||++ +++|+||+|+||+++.++ .++++|||.+....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 79 EYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred ecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 9999999999997643 23378899999999999999999999 999999999999998654 58999999998764
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
... ......+++.|+|||...+..++.++||||||+++|+|++|+.||..... ............ ....+
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~~--~~~~~-- 223 (256)
T cd08220 154 SKS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLKIMSGTF--APISD-- 223 (256)
T ss_pred CCc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHHHHhcCC--CCCCC--
Confidence 332 22335688999999999988899999999999999999999999965321 122221111110 00000
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.....+.+++.+|++.+|++|||++|++++
T Consensus 224 --------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 224 --------RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --------CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 112346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=301.30 Aligned_cols=254 Identities=24% Similarity=0.304 Sum_probs=196.9
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccc-cccchhhhHHHHHHHHhccCCCCcceeeeeEecC--Cce
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRAD-LETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND--TNM 781 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 781 (1018)
+.|+..+.||+|+||.||+|.+..+++.||+|.+...... ......+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 3577889999999999999999988999999988432211 1223356788999999999999999999998763 467
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
++||||+++++|.+++..... +++..+.+++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA----LTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999975432 67888899999999999999999 99999999999999999999999999987
Q ss_pred eeccCC---cceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 001752 862 MMIRKN---ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 862 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
...... .......++..|+|||+..+..++.++|||||||++|||++|+.||..... ... +........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~-~~~~~~~~~--- 226 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAA-IFKIATQPT--- 226 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHH-HHHHhcCCC---
Confidence 543211 112235688899999999888899999999999999999999999964211 111 111111100
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.+.. .......+..++.+|+. +|++||+++|++++
T Consensus 227 ---~~~~-----~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 ---NPVL-----PPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---CCCC-----chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1111 11223446678888884 89999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=301.87 Aligned_cols=239 Identities=23% Similarity=0.353 Sum_probs=189.5
Q ss_pred ceeecCCCeeEEEEEcCCCC----------eEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCc
Q 001752 711 NVIGMGATGIVYKAEMPRLN----------TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN 780 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 780 (1018)
+.||+|+||.||+|.+..++ ..|++|++.... .....+.+|+.++++++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence 36899999999999997665 357788773221 126788999999999999999999999988 77
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC-------CeE
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL-------EPR 853 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-------~~k 853 (1018)
.++||||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .++
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEE
Confidence 8999999999999999976542 378899999999999999999999 999999999999999888 799
Q ss_pred EcccccceeeccCCcceEeeccCCCccCcCCCCCC--CCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHH
Q 001752 854 IADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTL--KVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMK 930 (1018)
Q Consensus 854 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 930 (1018)
++|||.+..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||..... .....+..
T Consensus 149 l~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~~~~~~~~-- 220 (259)
T cd05037 149 LSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQ-- 220 (259)
T ss_pred eCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--hhHHHHHh--
Confidence 999999976532 2234567789999998776 78999999999999999999 5777755321 11111111
Q ss_pred hhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 001752 931 IRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984 (1018)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 984 (1018)
... . .+.. ....+.+++.+|++.+|++|||+.++++.|+
T Consensus 221 --~~~---~--~~~~--------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 --DQH---R--LPMP--------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --cCC---C--CCCC--------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0 0000 0145778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=312.16 Aligned_cols=257 Identities=21% Similarity=0.258 Sum_probs=201.1
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..+.||+|+||.||+|.+..+++.||+|.+..... ........+.+|+.+++.++||||+++++++..+++.++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 57778999999999999999998999999999843321 12234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++++|.+++..... +++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||.++....
T Consensus 81 e~~~g~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIGA----LPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999976542 78899999999999999999999 999999999999999999999999999863210
Q ss_pred CCc---------------ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 001752 866 KNE---------------TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMK 930 (1018)
Q Consensus 866 ~~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 930 (1018)
... ......++..|+|||++.+..++.++|+|||||++|||++|+.||.+.. ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-----~~~~~~~~ 228 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-----PEELFGQV 228 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHH
Confidence 000 0012357889999999988889999999999999999999999996531 11222221
Q ss_pred hhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 931 IRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
..... ..+... ......+.+++.+|++.+|++||++.++.+.++.
T Consensus 229 ~~~~~-----~~~~~~-----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISDDI-----EWPEGD-----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred Hhccc-----CCCCcc-----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11111 001110 0122346789999999999999997767666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=306.30 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=199.6
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||+|+||.||+|.+..+++.||+|.+... ........+.+|+.++++++||||+++++++...+..++||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 567788999999999999999988999999988322 12334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++++|.+++..... ...+++..+..++.+++.|++|||+.+ +|+||||||+||+++.++.++++|||.+..+..
T Consensus 79 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred eecCCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 99999999999876421 224799999999999999999999632 899999999999999999999999999876532
Q ss_pred CCcceEeeccCCCccCcCCCCCC------CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTL------KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
. ......+++.|+|||+..+. .++.++|||||||++|+|++|+.||..... ..............
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~----- 226 (286)
T cd06622 156 S--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFAQLSAIVDGD----- 226 (286)
T ss_pred C--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHHHHHHHhhcC-----
Confidence 2 22334678899999987543 358899999999999999999999965321 11111111111110
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.+.. ..+....+.+++.+|++.+|++||++++++..
T Consensus 227 --~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 --PPTL-----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --CCCC-----CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0111 11133446788999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.81 Aligned_cols=266 Identities=25% Similarity=0.329 Sum_probs=202.2
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|++++++++|+||+++++++..++..++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE--DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc--ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 5788899999999999999999889999999984322 22344577899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||++++.+..+...... +++..+..++.||+.|++|||+. +++|+||+|+||++++++.++++|||.+.....
T Consensus 80 e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 80 EYVERTLLELLEASPGG----LPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred ecCCCCHHHHHHhcCCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99998777666644322 78999999999999999999999 999999999999999999999999999987644
Q ss_pred CCc-ceEeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc----------
Q 001752 866 KNE-TVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD---------- 933 (1018)
Q Consensus 866 ~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---------- 933 (1018)
... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...... +...........
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhcc
Confidence 433 23345678899999998887 8899999999999999999999999753221 111111110000
Q ss_pred -ccccccccCCCCCCCchh-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 934 -NRNLEEALDPNVGNCKHV-----QEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 934 -~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
........-+........ ......+.+++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000000000000000 0114557889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=302.95 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=187.5
Q ss_pred eeecCCCeeEEEEEcCCC--CeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecC
Q 001752 712 VIGMGATGIVYKAEMPRL--NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 712 ~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
.||+|+||.||+|....+ ...+++|.+... ......+.+.+|+..++.++||||+++++++.+....++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC---CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 589999999999975432 234566665222 122346789999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCc-
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE- 868 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~- 868 (1018)
+|+|.++++.........++..+..++.||+.||+|||+. +++||||||+||+++.++.++++|||++........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 9999999976543333467777888999999999999999 999999999999999999999999999864321111
Q ss_pred -ceEeeccCCCccCcCCCCC-------CCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 869 -TVSMVAGSYGYIAPEYGYT-------LKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 869 -~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
......++..|+|||+... ..++.++|||||||++|||++ |..||..... ...+........ ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~~~~~--~~ 228 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHVIKDQQ--VK 228 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhhcc--cc
Confidence 1123567889999998643 345789999999999999997 5667754211 122222221111 12
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 984 (1018)
..++..... ....+.+++..|+ .+|++||++++|++.|.
T Consensus 229 ~~~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELP-----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCC-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222322211 1234566788899 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=301.96 Aligned_cols=254 Identities=25% Similarity=0.334 Sum_probs=186.6
Q ss_pred eeecCCCeeEEEEEcCC--CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecC
Q 001752 712 VIGMGATGIVYKAEMPR--LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 712 ~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
.||+|+||.||+|.... ....+|+|.+... ........+.+|+..++.++||||+++++++......++||||++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS---ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc---CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 58999999999997532 3457888876322 223345678899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCC-ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCc
Q 001752 790 NGSLGEALHGKQAG-RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE 868 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~ 868 (1018)
+|+|.+++...... ....++.....++.||+.|++|||+. +|+||||||+||+++.++.+|++|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 99999999765431 22346778889999999999999999 999999999999999999999999999865432221
Q ss_pred c--eEeeccCCCccCcCCCC-------CCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 001752 869 T--VSMVAGSYGYIAPEYGY-------TLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 869 ~--~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
. .....+++.|+|||+.. ...++.++|||||||++|||++ |..||..... .+. ......... .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~---~~~~~~~~~--~ 228 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQV---LKQVVREQD--I 228 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--HHH---HHHHhhccC--c
Confidence 1 12234567899999853 3457889999999999999999 7888864311 111 111111111 1
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 984 (1018)
...++... ......+.+++..|+ .||++|||+++|++.+.
T Consensus 229 ~~~~~~~~-----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLD-----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCccc-----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111111 112233456777888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=301.76 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=201.6
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeecccccc--ccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADL--ETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
+|+..+.||+|+||.||+|....+++.||+|++....... .....+.+.+|+.++++++|||++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 3667789999999999999998899999999985332211 12245788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC-CeEEccccccee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL-EPRIADFGLARM 862 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~a~~ 862 (1018)
||||+++++|.+++.... ++++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .++++|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999997543 278899999999999999999999 999999999999998876 599999999876
Q ss_pred eccCCcc----eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 001752 863 MIRKNET----VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 863 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
+...... .....++..|+|||+..+..++.++||||+|+++|+|++|..||...... .............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~---- 227 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFKIASAT---- 227 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHHHHHhccC----
Confidence 6433111 12346788999999998888999999999999999999999999643221 1111111111000
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
..+.. .......+.+++.+|++.+|++||++.++++
T Consensus 228 --~~~~~-----~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 --TAPSI-----PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --CCCCC-----chhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00111 1123345778999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=305.39 Aligned_cols=247 Identities=22% Similarity=0.298 Sum_probs=200.4
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||+|+||.||+|.+..+++.||+|++..... ......+.+.+|++++++++||||+++++++.++...++||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 57788999999999999999998899999999843221 12234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++++|.+++..... +++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~----l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSGR----FPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999976543 78899999999999999999998 999999999999999999999999999976533
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
. .....+++.|+|||...+...+.++||||||+++|+|++|+.||..... .............+ .+
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~----~~-- 219 (290)
T cd05580 154 R---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQIYEKILEGKVRF----PS-- 219 (290)
T ss_pred C---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCCccC----Cc--
Confidence 2 3345688999999998888889999999999999999999999965321 11111111111100 00
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVIT 981 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 981 (1018)
.....+.+++.+||+.+|.+|| +++|+++
T Consensus 220 -------~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 220 -------FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -------cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0123466889999999999999 6777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=308.48 Aligned_cols=267 Identities=24% Similarity=0.257 Sum_probs=200.7
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC--CceE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND--TNMM 782 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 782 (1018)
+.|+..+.||+|+||.||+|.+..+++.+|+|.++.... .......+.+|+.++++++||||+++++++... ...+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE--KEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc--cccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 568888999999999999999998899999999954322 223345677899999999999999999998877 8899
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||++ ++|.+++..... .+++..+..++.||+.||+|||+. +++|+||||+||+++.++.++|+|||.+..
T Consensus 83 lv~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred EEehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceee
Confidence 9999997 599999875432 378999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcceEeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcc-------
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDN------- 934 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------- 934 (1018)
............+++.|+|||+..+. .++.++|+||+|+++|+|++|+.||...... +....+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI--DQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchHHHHH
Confidence 65443333445678899999987654 4689999999999999999999999753211 1111111000000
Q ss_pred ---------cccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 935 ---------RNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 935 ---------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.......................+.+++.+|++.+|++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000000000000023446789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=298.84 Aligned_cols=247 Identities=29% Similarity=0.397 Sum_probs=195.4
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNN 790 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~ 790 (1018)
++||+|+||.||+|.+.. ++.||+|++..... ......+.+|++++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 368999999999999986 99999998843222 13456789999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcce
Q 001752 791 GSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV 870 (1018)
Q Consensus 791 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 870 (1018)
++|.+++..... .+++..+..++.+++.|++|||++ +++||||||+||+++.++.++++|||.++.........
T Consensus 77 ~~l~~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 150 (251)
T cd05041 77 GSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV 150 (251)
T ss_pred CcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence 999999965432 368889999999999999999999 99999999999999999999999999997643211111
Q ss_pred E--eeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCC
Q 001752 871 S--MVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGN 947 (1018)
Q Consensus 871 ~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1018)
. ....+..|+|||+..+..++.++|+||||+++|||++ |..||..... ...... ....... ..+
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~----~~~~~~~---~~~---- 217 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRER----IESGYRM---PAP---- 217 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHHH----HhcCCCC---CCC----
Confidence 1 1223567999999988889999999999999999999 8888865321 111111 1111000 000
Q ss_pred CchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 001752 948 CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984 (1018)
Q Consensus 948 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 984 (1018)
......+.+++.+|++.+|++|||+.|+++.|+
T Consensus 218 ----~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 ----QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ----ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 111235778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=310.12 Aligned_cols=197 Identities=25% Similarity=0.381 Sum_probs=160.2
Q ss_pred cceeecCCCeeEEEEEcCC--CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEe--cCCceEEEE
Q 001752 710 SNVIGMGATGIVYKAEMPR--LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLH--NDTNMMIVY 785 (1018)
Q Consensus 710 ~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~lV~ 785 (1018)
..+||+|+||+||+|+... ++..||+|.+... .....+.+|+.++++++||||+++++++. .+...++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT------GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC------CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 3589999999999999653 5688999988321 12345778999999999999999999985 356789999
Q ss_pred EecCCCCHHHhhhcCC-----CCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEE----cCCCCeEEcc
Q 001752 786 EYMNNGSLGEALHGKQ-----AGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILL----DSNLEPRIAD 856 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~D 856 (1018)
||++ ++|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 9986 48888775321 1223478999999999999999999999 99999999999999 5567899999
Q ss_pred cccceeeccCCc---ceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 001752 857 FGLARMMIRKNE---TVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPE 916 (1018)
Q Consensus 857 fG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~ 916 (1018)
||+++....... ......+|+.|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 999987643322 1233568999999998876 45899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=301.67 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=203.6
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||+|+||.||+|..+.++..||+|.+.... ......+.+.+|+.++++++|||++++++++.+....++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK--MPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh--ccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 3677889999999999999999899999999984432 12234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC-CeEEcccccceeec
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL-EPRIADFGLARMMI 864 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~a~~~~ 864 (1018)
||+++++|.+++..... ..+++..+..++.|+++|++|||+. +++|+||||+||++++++ .++++|||.+....
T Consensus 79 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 79 EYCDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred ecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 99999999999975432 2368999999999999999999999 999999999999999886 46999999997764
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
..........|++.|+|||+..+..++.++||||||+++|||++|+.||... +....+....... ..+.
T Consensus 154 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~------~~~~ 222 (257)
T cd08225 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-----NLHQLVLKICQGY------FAPI 222 (257)
T ss_pred CCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHhccc------CCCC
Confidence 4433334456899999999988888999999999999999999999999643 2222222222111 1111
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.. .....+.+++.+|++.+|++|||+.|++++
T Consensus 223 ~~------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 SP------NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CC------CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 10 112346788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.04 Aligned_cols=253 Identities=24% Similarity=0.326 Sum_probs=204.1
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+-|++...||.|+||.||+|..+.++-..|.|++ .....+...+|.-|++++..++||+||++++.|..++.+++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvI----etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi 106 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVI----ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI 106 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhh----cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence 34466677899999999999999988888888988 23345678889999999999999999999999988899999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
+.|||+||-++..+-.-.. .+.+.++.-++.|++.||.|||++ .|+|||||+.||+++-+|.++++|||.+...
T Consensus 107 liEFC~GGAVDaimlEL~r---~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGR---VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred EEeecCCchHhHHHHHhcc---ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccc
Confidence 9999999999988754332 388899999999999999999999 9999999999999999999999999998655
Q ss_pred ccCCcceEeeccCCCccCcCCC-----CCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 001752 864 IRKNETVSMVAGSYGYIAPEYG-----YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
...........|||+|||||+. ...+|+.++||||||+++.||..+.+|...- .....+....
T Consensus 181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-----npMRVllKia------- 248 (1187)
T KOG0579|consen 181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPMRVLLKIA------- 248 (1187)
T ss_pred hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-----chHHHHHHHh-------
Confidence 4444445567899999999974 4778999999999999999999999997532 1111111111
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
..-.|.+....++ ...+.+++.+|+.++|..||++.++++
T Consensus 249 KSePPTLlqPS~W---s~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 249 KSEPPTLLQPSHW---SRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hcCCCcccCcchh---hhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1112333333333 344556788999999999999999987
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=307.01 Aligned_cols=254 Identities=27% Similarity=0.383 Sum_probs=205.1
Q ss_pred HHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCce
Q 001752 702 DILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 702 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 781 (1018)
+..+.|+..+.||+|++|.||+|.+..+++.||+|++..... ....+.+|++.+++++|+|++++++++......
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 356778888999999999999999998899999999832211 456788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
++|+||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhh
Confidence 99999999999999998754 2389999999999999999999998 99999999999999999999999999986
Q ss_pred eeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 862 MMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 862 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
.............+++.|+|||+..+..++.++||||||+++|+|++|+.||...... ........... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-----~~~~~~~~~~~--~~-- 235 (286)
T cd06614 165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----RALFLITTKGI--PP-- 235 (286)
T ss_pred hhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcCC--CC--
Confidence 5543333333456788999999998888999999999999999999999999642111 11111111110 00
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.. ........+.+++.+|++.+|.+||++.++++
T Consensus 236 ---~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 ---LK---NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---Cc---chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00 01112245678999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=307.18 Aligned_cols=270 Identities=22% Similarity=0.265 Sum_probs=198.3
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeeeEecCCc----
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHNDTN---- 780 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~---- 780 (1018)
+|+..+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.++++++ ||||+++++++...+.
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM--DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc--cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 5778899999999999999999899999999984322 12233457888999999995 6999999999877665
Q ss_pred -eEEEEEecCCCCHHHhhhcCCCC-ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcC-CCCeEEccc
Q 001752 781 -MMIVYEYMNNGSLGEALHGKQAG-RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS-NLEPRIADF 857 (1018)
Q Consensus 781 -~~lV~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Df 857 (1018)
.|+||||+++ +|.+++...... ...+++..+..++.||+.||+|||+. +|+||||+|+||+++. ++.++++||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999975 899988654332 34579999999999999999999999 9999999999999999 889999999
Q ss_pred ccceeeccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc-
Q 001752 858 GLARMMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR- 935 (1018)
Q Consensus 858 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 935 (1018)
|.++.+...........+++.|+|||+..+ ..++.++||||||+++|+|++|..||...... ..+............
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-QQLLHIFKLLGTPTEQ 234 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHhCCCChh
Confidence 999865433333333457889999998765 45789999999999999999999999653211 111111110000000
Q ss_pred ccccc------cC-CCCC--CCc-hhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 936 NLEEA------LD-PNVG--NCK-HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 936 ~~~~~------~~-~~~~--~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
..... .. +... ... ........+.+++.+|++++|.+||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 00 0000 000 001223457789999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=299.12 Aligned_cols=247 Identities=30% Similarity=0.429 Sum_probs=195.7
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
+.|+..+.||+|+||.||+|.. +++.||+|++... .....+.+|+.++++++|||++++++++..+ ..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 5678889999999999999975 4788999998321 2345788999999999999999999998764 47999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+....
T Consensus 77 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 77 MELMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred EECCCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecc
Confidence 999999999999976432 2378889999999999999999998 99999999999999999999999999987542
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
.. ......+..|+|||++.+..++.++|||||||++|||++ |+.||..... ...... ...... +
T Consensus 152 ~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~-~~~~~~------~ 216 (254)
T cd05083 152 MG---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEVKEC-VEKGYR------M 216 (254)
T ss_pred cc---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHHHHH-HhCCCC------C
Confidence 21 122334568999999988889999999999999999998 9999965321 111111 111110 0
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
... ......+.+++.+|++.+|++||+++++++.|++
T Consensus 217 ~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPP-----EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCC-----CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 000 0112446789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=301.73 Aligned_cols=251 Identities=26% Similarity=0.329 Sum_probs=202.7
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||.|+||.||+|.+..+++.||+|++..... ......+.+.+|++++++++||||+++++++.++...++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 36778899999999999999998899999999943321 22245678899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++++|.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++++|||.+.....
T Consensus 80 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 80 DLLLGGDLRYHLSQKV----KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred eCCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 9999999999997652 378899999999999999999999 999999999999999999999999999876533
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
.. ......++..|+|||+..+..++.++|+||+|+++|+|++|+.||...... ....+....... .....+
T Consensus 153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~---~~~~~~-- 223 (258)
T cd05578 153 DT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQETA---DVLYPA-- 223 (258)
T ss_pred Cc-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhccc---cccCcc--
Confidence 32 233456888999999998888999999999999999999999999764332 112221111110 000011
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSM--RDVI 980 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~--~evl 980 (1018)
.....+.+++.+|++.||.+||++ +|++
T Consensus 224 -------~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 -------TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -------cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 112456789999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=311.09 Aligned_cols=254 Identities=20% Similarity=0.269 Sum_probs=200.9
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||+|+||+||+|....+++.||+|.+..... ......+.+.+|+++++.++||||+++++.+.+....++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc-chHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 57788899999999999999998899999999954322 12235567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999975432 2378899999999999999999999 999999999999999999999999999875432
Q ss_pred CCcc-----------------------------eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 001752 866 KNET-----------------------------VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPE 916 (1018)
Q Consensus 866 ~~~~-----------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 916 (1018)
.... .....||..|+|||+..+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2111 01235788999999999888999999999999999999999999753
Q ss_pred CCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 001752 917 FGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPS----MRDVIT 981 (1018)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~evl~ 981 (1018)
... ............ . .........+.+++.+|++.||++||+ ++|+++
T Consensus 236 ~~~-----~~~~~~~~~~~~--------~---~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRD-----ETFSNILKKEVT--------F---PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chH-----HHHHHHhcCCcc--------C---CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 221 111111111110 0 001113355778999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=305.31 Aligned_cols=266 Identities=26% Similarity=0.354 Sum_probs=201.7
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.++++++|||++++++++..+...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR--LEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccc--ccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 3677889999999999999998889999999984432 12334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+ +++|.+++.... ..+++..+..++.||++||+|||+. +++|+||||+||+++.++.++++|||.+.....
T Consensus 79 e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 79 EYM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred ccc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 999 999999987543 2388999999999999999999999 999999999999999999999999999976643
Q ss_pred CCc-ceEeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccc-------
Q 001752 866 KNE-TVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRN------- 936 (1018)
Q Consensus 866 ~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------- 936 (1018)
... ......++..|+|||++.+. .++.++||||+|+++|||++|.+||..... ......+.........
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHHhhcc
Confidence 322 23345688999999987654 468999999999999999999888865321 1111111111100000
Q ss_pred ----cccccCCCCCC--Cc-hhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 937 ----LEEALDPNVGN--CK-HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 937 ----~~~~~~~~~~~--~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
......+.... .. ...+....+.+++.+|++.+|++||++++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00 001223567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=301.98 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=200.8
Q ss_pred hcccccceeecCCCeeEEEEEcCC-----CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPR-----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
+.|+..+.||+|+||+||+|+... +.+.||+|.+... ......+.+.+|++++++++|||++++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT---KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc---cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 457778899999999999999643 3567999987321 12234567899999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHhhhcCCCCc-----cccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEE
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAGR-----LLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRI 854 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 854 (1018)
..++||||+++|+|.+++....... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEE
Confidence 9999999999999999997655221 2489999999999999999999999 9999999999999999999999
Q ss_pred cccccceeeccCCc-ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhh
Q 001752 855 ADFGLARMMIRKNE-TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIR 932 (1018)
Q Consensus 855 ~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 932 (1018)
+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..+.... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~~~~----~ 232 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLNRL----Q 232 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHHHHHH----H
Confidence 99999865422111 1122345678999999888888999999999999999999 7888854211 1111111 1
Q ss_pred cccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 933 DNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
... ... +... .....+.+++.+|++.+|++||++.|++++|.+
T Consensus 233 ~~~-~~~---~~~~------~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 233 AGK-LEL---PVPE------GCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cCC-cCC---CCCC------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 111 000 0000 112357789999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=305.81 Aligned_cols=253 Identities=30% Similarity=0.410 Sum_probs=199.6
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
..++|+..+.||+|+||+||+|....+++.||+|++.... .......+++.+|+.+++.++|||++++++++.+++..+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc-cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 4567888899999999999999998889999999984322 222334567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||++ |++.+++..... .+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++++|||++..
T Consensus 92 lv~e~~~-g~l~~~~~~~~~---~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 92 LVMEYCL-GSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred EEHHhhC-CCHHHHHHHccc---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCccee
Confidence 9999996 588777754322 378999999999999999999999 999999999999999999999999999876
Q ss_pred eccCCcceEeeccCCCccCcCCCC---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGY---TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
.... ....+++.|+|||++. ...++.++||||||+++|||++|+.||.... ............
T Consensus 165 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-----~~~~~~~~~~~~----- 230 (307)
T cd06607 165 VSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQND----- 230 (307)
T ss_pred cCCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-----HHHHHHHHhcCC-----
Confidence 4322 2346788999999874 4568899999999999999999999996431 111111111110
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
.+... .......+.+++.+||+.+|++||++.+++++-
T Consensus 231 --~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 231 --SPTLS----SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred --CCCCC----chhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 01110 111234577899999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=300.73 Aligned_cols=258 Identities=28% Similarity=0.411 Sum_probs=198.6
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccc------cchhhhHHHHHHHHhccCCCCcceeeeeEecCC
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLE------TESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
+|...+.||+|+||.||+|....+++.||+|.+........ ....+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 35667899999999999999988899999998843221111 112356788999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccc
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGL 859 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 859 (1018)
..++||||+++++|.+++.... .+++..+..++.||+.|+.|||+. +++||||+|+||+++.++.++++|||.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999997653 278889999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCc--ceEeeccCCCccCcCCCCCCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc
Q 001752 860 ARMMIRKNE--TVSMVAGSYGYIAPEYGYTLK--VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR 935 (1018)
Q Consensus 860 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 935 (1018)
++....... ......++..|+|||+..... ++.++||||||+++||+++|+.||..... ... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~-~~~~~~~~- 228 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAA-MFKLGNKR- 228 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHH-HHHhhccc-
Confidence 875432211 122346888999999877654 88999999999999999999999964211 111 11111110
Q ss_pred ccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 936 NLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
....++... ..+....+.+++.+|++++|++||++++++++
T Consensus 229 -~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 -SAPPIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -cCCcCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000111111 01223456778999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=298.14 Aligned_cols=251 Identities=31% Similarity=0.512 Sum_probs=199.3
Q ss_pred cccceeecCCCeeEEEEEcCCCC----eEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 708 RESNVIGMGATGIVYKAEMPRLN----TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 708 ~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
+..+.||.|+||.||+|.+...+ ..||+|++.... .....+.+.+|+..+++++||||+++++++.+.+..++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 45678999999999999998665 899999983321 12256788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
+|||+++++|.+++....... +++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||.++..
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~--~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEeccCCCCHHHHHHhhhhcc--CCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence 999999999999997644321 78999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceE-eeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 864 IRKNETVS-MVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 864 ~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
........ ...+++.|+|||...+..++.++||||+|+++|+|++ |+.||.... ..+....+ ..... .
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--~~~~~~~~---~~~~~--~--- 223 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--NEEVLEYL---KKGYR--L--- 223 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH---hcCCC--C---
Confidence 43322211 1236789999999988889999999999999999998 788886521 11121111 11110 0
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
+.. ......+.+++.+|++.+|++|||+.++++.|
T Consensus 224 -~~~------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -PKP------ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCC------CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000 01234577899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=303.63 Aligned_cols=267 Identities=24% Similarity=0.324 Sum_probs=199.2
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
|+..+.||.|++|.||+|.+..+|+.||+|++.... ........+.+|++++++++|||++++++++.+++..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET--EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccc--ccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 456788999999999999998899999999984332 122334568889999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
|++ ++|.+++..... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++++|||.+......
T Consensus 79 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 79 FLD-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152 (283)
T ss_pred ccC-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence 995 699999876542 2378999999999999999999999 9999999999999999999999999999765433
Q ss_pred CcceEeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc----------
Q 001752 867 NETVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR---------- 935 (1018)
Q Consensus 867 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---------- 935 (1018)
........+++.|+|||++.+. .++.++||||||+++|+|++|+.||..... ...+....+.......
T Consensus 153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-IDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHHhhhhhhch
Confidence 3333334568899999987654 468899999999999999999999965321 1111111111000000
Q ss_pred ccccccCCCC-CC-CchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 936 NLEEALDPNV-GN-CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 936 ~~~~~~~~~~-~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.....+.... .. ..........+.+++.+|++++|++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 00 00001122456789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=304.30 Aligned_cols=247 Identities=24% Similarity=0.384 Sum_probs=198.4
Q ss_pred ccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEec
Q 001752 709 ESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYM 788 (1018)
Q Consensus 709 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 788 (1018)
....||+|+||.||+|....+++.||+|++... .......+.+|+.+++.++|||++++++++...+..++||||+
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 346799999999999999889999999988321 2234567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCc
Q 001752 789 NNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE 868 (1018)
Q Consensus 789 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~ 868 (1018)
++++|.+++.... +++.....++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+........
T Consensus 100 ~~~~L~~~~~~~~-----~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 100 EGGALTDIVTHTR-----MNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred CCCcHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 9999999885432 68889999999999999999999 999999999999999999999999999876544333
Q ss_pred ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCC
Q 001752 869 TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNC 948 (1018)
Q Consensus 869 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1018)
......+++.|+|||+..+..++.++|+||+|+++|+|++|+.||..... ........... .+....
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~----------~~~~~~- 238 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNL----------PPKLKN- 238 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhC----------CcccCC-
Confidence 33446788999999998888899999999999999999999999965311 11111111111 111101
Q ss_pred chhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 949 KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 949 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.......+.+++.+|++.+|.+||++.+++++
T Consensus 239 --~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 239 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred --cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 01122346678999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=283.22 Aligned_cols=255 Identities=24% Similarity=0.292 Sum_probs=205.2
Q ss_pred Hhhccccc-ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhc-cCCCCcceeeeeEec---
Q 001752 703 ILACIRES-NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK-LRHRNIVRLLGFLHN--- 777 (1018)
Q Consensus 703 ~~~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~--- 777 (1018)
+++.|... ++||-|-.|.|-.+.++.+++.+|+|++.. .....+|++.-=. -.|||||.++++|.+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D---------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD---------SPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc---------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 55666543 689999999999999999999999999922 2235678877333 379999999999854
Q ss_pred -CCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC---CCeE
Q 001752 778 -DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN---LEPR 853 (1018)
Q Consensus 778 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~k 853 (1018)
...+.+|||.|+||.|.+.+.+++. ..+++.++..|+.||+.|+.|||+. +|.||||||+|+|.... ..+|
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lK 204 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLK 204 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceE
Confidence 4567899999999999999987764 3489999999999999999999999 99999999999999654 4699
Q ss_pred EcccccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc
Q 001752 854 IADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD 933 (1018)
Q Consensus 854 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 933 (1018)
++|||+|+.-.+ .....+.+-||.|.|||++...+|+..+|+||+||++|-|++|.+||....+ ..+..-++..+..
T Consensus 205 LtDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~ 281 (400)
T KOG0604|consen 205 LTDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRT 281 (400)
T ss_pred ecccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhc
Confidence 999999986432 3455667889999999999999999999999999999999999999987543 3334444444433
Q ss_pred ccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 934 NRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
+. -++ ...++.+......++++.+|..+|++|.|+.+++.+
T Consensus 282 gq--y~F------P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 282 GQ--YEF------PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cC--ccC------CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 32 011 112455667777899999999999999999999864
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=300.91 Aligned_cols=255 Identities=26% Similarity=0.397 Sum_probs=202.7
Q ss_pred cccccceeecCCCeeEEEEEcCC----CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCce
Q 001752 706 CIRESNVIGMGATGIVYKAEMPR----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 781 (1018)
.....++||.|.||.||+|+... ..-.||||..+. +...+..+.|..|..++++++||||++++|.|.+. ..
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~---d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKT---DCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhcc---CCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence 34556789999999999998742 234588887743 23345577899999999999999999999999864 58
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
++|||.++-|.|.+|++.++.. ++......++.||..||+|||+. .+|||||.+.||++.....||++|||+++
T Consensus 466 WivmEL~~~GELr~yLq~nk~s---L~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDS---LPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eEEEecccchhHHHHHHhcccc---chHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence 9999999999999999877653 78888889999999999999999 99999999999999999999999999999
Q ss_pred eeccCCcceEe-eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 862 MMIRKNETVSM-VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 862 ~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
.+..+...... ..-..-|||||-+.-++++.++|||.|||.+||++. |..||.+-...+. +. .+..+.
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--I~----~iEnGe---- 609 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--IG----HIENGE---- 609 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--EE----EecCCC----
Confidence 87554443332 233567999999999999999999999999999998 9999976322111 10 000110
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
--|.+..|+ ..++.++.+||++||.+||++.++...|.+..
T Consensus 610 -RlP~P~nCP------p~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 610 -RLPCPPNCP------PALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred -CCCCCCCCC------hHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 112223332 45678999999999999999999999886643
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=303.52 Aligned_cols=267 Identities=25% Similarity=0.364 Sum_probs=200.3
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||.|++|.||+|++..+++.||+|++..... ......+.+|+.++++++|||++++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence 36778899999999999999998999999999843321 233456778999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++ +|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||.+.....
T Consensus 78 e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 78 EYMDK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred ecCCc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 99975 89998865442 23479999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc-------cc
Q 001752 866 KNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR-------NL 937 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~ 937 (1018)
.........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .............. ..
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcC
Confidence 3333334567889999998765 456889999999999999999999997643211 11111111000000 00
Q ss_pred ccccCCCCCCCchh-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 938 EEALDPNVGNCKHV-----QEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.............. ......+.+++.+|++.||++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000000 112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=283.40 Aligned_cols=207 Identities=27% Similarity=0.366 Sum_probs=173.0
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCC----eEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec-
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLN----TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN- 777 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 777 (1018)
....|+..+.||+|.||.||+|+.+.++ +.+|+|+++.+.. .........+|+..++.++|||++.+..++-.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd--~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD--GTGISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC--CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 3567888899999999999999765443 3799999943322 23445677899999999999999999999876
Q ss_pred CCceEEEEEecCCCCHHHhhhcCCC-CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC----CCe
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQA-GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN----LEP 852 (1018)
Q Consensus 778 ~~~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~ 852 (1018)
+..+++++||.+. +|.+.++..+. ....++......|..||+.|+.|||++ -|+||||||.||++..+ |.|
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCee
Confidence 7889999999987 99998864332 223578899999999999999999999 79999999999999888 899
Q ss_pred EEcccccceeeccCCcceE---eeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCC
Q 001752 853 RIADFGLARMMIRKNETVS---MVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDP 915 (1018)
Q Consensus 853 kl~DfG~a~~~~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~ 915 (1018)
||+|+|+++.+..+-.... .++.|..|+|||.+.+ ..||.+.||||.|||+.||++-++.|..
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999999998866655442 3678999999998776 5599999999999999999998888854
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=301.77 Aligned_cols=246 Identities=24% Similarity=0.280 Sum_probs=188.4
Q ss_pred eeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHh---ccCCCCcceeeeeEecCCceEEEEEec
Q 001752 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLG---KLRHRNIVRLLGFLHNDTNMMIVYEYM 788 (1018)
Q Consensus 712 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~---~l~hpniv~~~~~~~~~~~~~lV~e~~ 788 (1018)
.||+|+||.||+|....+++.||+|.+....... ......+.+|..+++ ..+||+++.+++++..++..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEcccccc-chHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 4799999999999998889999999985432221 122233444544433 347999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCc
Q 001752 789 NNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE 868 (1018)
Q Consensus 789 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~ 868 (1018)
++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||++......
T Consensus 80 ~~~~L~~~i~~~~~----l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-- 150 (279)
T cd05633 80 NGGDLHYHLSQHGV----FSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 150 (279)
T ss_pred CCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc--
Confidence 99999999875543 89999999999999999999999 9999999999999999999999999998754322
Q ss_pred ceEeeccCCCccCcCCCC-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCC
Q 001752 869 TVSMVAGSYGYIAPEYGY-TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGN 947 (1018)
Q Consensus 869 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1018)
......|++.|+|||... +..++.++||||+||++|||++|+.||........ ........... ..+.
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~--------~~~~- 219 (279)
T cd05633 151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTVN--------VELP- 219 (279)
T ss_pred CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhhcCC--------cCCc-
Confidence 223356899999999876 45688999999999999999999999975432211 11111111100 1110
Q ss_pred CchhHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 001752 948 CKHVQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVITM 982 (1018)
Q Consensus 948 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 982 (1018)
......+.+++.+|++.||++|| +++|++++
T Consensus 220 ----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 ----DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ----cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11223567889999999999999 59998875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.03 Aligned_cols=246 Identities=26% Similarity=0.349 Sum_probs=197.7
Q ss_pred eecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCCCC
Q 001752 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGS 792 (1018)
Q Consensus 713 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gs 792 (1018)
||.|+||.||+|++..+++.||+|++.... .......+.+.+|+.++++++||||+++++++.++...++||||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH-IVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhc-chhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999999889999999984332 2223445778999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcceEe
Q 001752 793 LGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM 872 (1018)
Q Consensus 793 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 872 (1018)
|.+++..... +++..+..++.|++.||+|+|+. +++|+||+|+||+++.++.++++|||.+....... ....
T Consensus 80 L~~~l~~~~~----l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~ 151 (262)
T cd05572 80 LWTILRDRGL----FDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWT 151 (262)
T ss_pred HHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccc
Confidence 9999976543 78899999999999999999998 99999999999999999999999999998664332 2233
Q ss_pred eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhH
Q 001752 873 VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQ 952 (1018)
Q Consensus 873 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1018)
..+++.|+|||+..+..++.++|+||+|+++|+|++|+.||.....+ ............. ......
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~------~~~~~~----- 217 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---PMEIYNDILKGNG------KLEFPN----- 217 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---HHHHHHHHhccCC------CCCCCc-----
Confidence 56889999999988888999999999999999999999999764321 1222222121110 000000
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 001752 953 EEMLLVLRIAFLCTAKLPKDRPS-----MRDVIT 981 (1018)
Q Consensus 953 ~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 981 (1018)
.....+.+++.+|++.+|++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 01345778999999999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=295.70 Aligned_cols=255 Identities=25% Similarity=0.378 Sum_probs=207.8
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|++++++++|||++++++.+...+..++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc--CChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence 3677789999999999999999889999999984322 22345667889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++++|.+++.........+++..+..++.+++.|++|||+. +++|+||+|+||+++.++.++++|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999999999987643344589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
.........+++.|+|||...+..++.++||||+|+++|+|++|+.||.... ............ ..+..
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~------~~~~~ 224 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQ------YPPIP 224 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCC------CCCCC
Confidence 4433344678899999999888889999999999999999999999996532 222222221111 11111
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
. .....+.+++.+|++.+|++|||+.++++.
T Consensus 225 ~------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 S------QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred C------CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 112346788999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=307.43 Aligned_cols=268 Identities=27% Similarity=0.331 Sum_probs=199.3
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC--Cce
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND--TNM 781 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 781 (1018)
.+.|+..+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++|+|++++++++.+. +..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE--RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC--CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 4678889999999999999999998999999999843321 122233566899999999999999999998754 568
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
++||||++ ++|.+++.... ..+++..+..++.||+.|++|||+. +++||||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~ 156 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLAR 156 (309)
T ss_pred EEEEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceee
Confidence 99999996 48988887543 2378999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcc-cccc-
Q 001752 862 MMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDN-RNLE- 938 (1018)
Q Consensus 862 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~- 938 (1018)
.............+++.|+|||.+.+ ..++.++||||+||++|||++|+.||..... .+....+....... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCChhhch
Confidence 76543333333456788999998765 5578999999999999999999999975321 11111111111100 0000
Q ss_pred --------ccc--CCCC-CCCch-hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 939 --------EAL--DPNV-GNCKH-VQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 939 --------~~~--~~~~-~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
..+ .... ..... .......+.+++.+|++.||++|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0000 00000 00123456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=305.85 Aligned_cols=268 Identities=23% Similarity=0.326 Sum_probs=197.2
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
++|+..+.||+|++|+||+|.+..+++.||+|++.... ......+.+.+|++++++++|||++++++++.+....++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcc--ccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 46788899999999999999998889999999884322 1223446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcC-CCCeEEcccccceee
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS-NLEPRIADFGLARMM 863 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~a~~~ 863 (1018)
|||++ ++|.+++..... ...++..+..++.||+.||+|||+. +++||||+|+||+++. ++.+|++|||.+...
T Consensus 80 ~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred Eeccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 99995 588888865432 2257888889999999999999999 9999999999999985 467999999999765
Q ss_pred ccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc-------
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR------- 935 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------- 935 (1018)
...........+++.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ..+............
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhccccc
Confidence 333223333467889999998765 45789999999999999999999999753221 111111100000000
Q ss_pred ccccccC--CCCC-CC--chhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 936 NLEEALD--PNVG-NC--KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 936 ~~~~~~~--~~~~-~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.+.+... +... .. .........+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 0000 00 000112344678999999999999999999986
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=299.86 Aligned_cols=258 Identities=23% Similarity=0.363 Sum_probs=197.1
Q ss_pred ccccceeecCCCeeEEEEEcC---CCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC----
Q 001752 707 IRESNVIGMGATGIVYKAEMP---RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT---- 779 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---- 779 (1018)
|+..+.||+|+||.||+|.+. .+++.||||++.... ......+++.+|+.++++++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 456678999999999999864 357899999984322 12334567889999999999999999999885432
Q ss_pred --ceEEEEEecCCCCHHHhhhcCC--CCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEc
Q 001752 780 --NMMIVYEYMNNGSLGEALHGKQ--AGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIA 855 (1018)
Q Consensus 780 --~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 855 (1018)
..++++||+++|+|.+++.... .....+++....+++.||+.|++|||+. +|+||||||+||+++.++.+|++
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence 2478999999999998875332 1223478889999999999999999999 99999999999999999999999
Q ss_pred ccccceeeccCCcc--eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhh
Q 001752 856 DFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIR 932 (1018)
Q Consensus 856 DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 932 (1018)
|||.++........ .....+++.|++||......++.++|||||||++|||++ |+.||..... .+...++. .
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~---~ 230 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLI---K 230 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHH---c
Confidence 99999865332211 112345678999999988889999999999999999999 8888864321 12222111 1
Q ss_pred cccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 933 DNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
... .. .. ......+.+++.+|++.+|++||++.++++.|+++
T Consensus 231 ~~~-~~--~~---------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNR-LK--QP---------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCc-CC--CC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 00 00 11224577899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=309.96 Aligned_cols=265 Identities=25% Similarity=0.283 Sum_probs=199.8
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC----
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND---- 778 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 778 (1018)
+.++|+..+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc--cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 6788999999999999999999999899999999984321 2233445677899999999999999999988643
Q ss_pred --CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcc
Q 001752 779 --TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 779 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 856 (1018)
.+.|+||||++ ++|.+.+... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 35799999995 5888888542 67888899999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH-------
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRM------- 929 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~------- 929 (1018)
||.++...... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... +....+..
T Consensus 162 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~ 238 (353)
T cd07850 162 FGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI--DQWNKIIEQLGTPSD 238 (353)
T ss_pred CccceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhcCCCCH
Confidence 99998653322 223346788999999999999999999999999999999999999653211 00000000
Q ss_pred ------------Hhhcc-----cccccccCCCCCC---CchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 930 ------------KIRDN-----RNLEEALDPNVGN---CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 930 ------------~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
..... ..+.+........ ..........+.+++.+|++.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0000111100000 00011223456789999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=303.38 Aligned_cols=260 Identities=29% Similarity=0.400 Sum_probs=202.7
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
..+.|+..+.||+|+||.||+|.+..++..||+|++...... ......++.+|++++++++|||++++++++.++...+
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 345577888999999999999999888999999998433222 2344567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||++ |++.+.+.... ..+++..+..++.+++.|+.|||+. +|+||||+|+||+++.++.++++|||++..
T Consensus 102 lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~ 174 (317)
T cd06635 102 LVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI 174 (317)
T ss_pred EEEeCCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccc
Confidence 9999996 48888775432 2378999999999999999999999 999999999999999999999999999865
Q ss_pred eccCCcceEeeccCCCccCcCCCC---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGY---TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
... .....+++.|+|||++. +..++.++|||||||++|||++|+.||.... .............
T Consensus 175 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~~~~~~~~~~~~~---- 241 (317)
T cd06635 175 ASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNES---- 241 (317)
T ss_pred cCC----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHhccC----
Confidence 422 22346888999999863 4568899999999999999999999986531 1111111111111
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
+... .......+.+++.+|++.+|.+||++.+++++........
T Consensus 242 ---~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 242 ---PTLQ----SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ---CCCC----CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 0000 1112234678999999999999999999998765544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=298.94 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=194.1
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 783 (1018)
..|+..+.||+||.+.||++... +.+.||+|++.. ...+.....-|..|+..+.++ .|.+|+++++|-..+++.||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~--~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVL--LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHH--hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 45788899999999999999986 467778877622 234456678899999999999 48999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||= ..+|..+|+.+.. ....| .+..+..||+.++.+.|.+ ||||.||||.|+++-. |.+||+|||.|..+
T Consensus 438 vmE~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred Eeecc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 99986 5699999987654 22345 6667999999999999999 9999999999999865 69999999999877
Q ss_pred ccCCcce--EeeccCCCccCcCCCCCC-----------CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHH-HHHHH
Q 001752 864 IRKNETV--SMVAGSYGYIAPEYGYTL-----------KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIV-EWIRM 929 (1018)
Q Consensus 864 ~~~~~~~--~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~-~~~~~ 929 (1018)
..+.... ...+||+-||+||.+... ++++++||||+|||+|+|+.|+.||.. +. .|.+.
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~-------~~n~~aKl 582 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ-------IINQIAKL 582 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-------HHHHHHHH
Confidence 5443322 337899999999976522 367899999999999999999999963 22 22221
Q ss_pred HhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 930 KIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
. .+.+|...-.........++++++..||+.||.+||+..|++++
T Consensus 583 ~--------aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 583 H--------AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred H--------hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1 12222110000000111127789999999999999999999974
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=310.83 Aligned_cols=271 Identities=23% Similarity=0.335 Sum_probs=202.4
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC------Cc
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND------TN 780 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~ 780 (1018)
|...+.||+||||.||+|+++.+|+.||||.+.... .....+...+|++++++++|||||++++.-++. +.
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 344568999999999999999999999999994432 234456678899999999999999999986543 35
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEc--CCC--CeEEcc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLD--SNL--EPRIAD 856 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~--~~kl~D 856 (1018)
..+|||||.||||...+.+.... ..+++.+.+.+..+++.||.|||++ +||||||||.||++- ++| ..||+|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~-~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENA-YGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccc-cCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeec
Confidence 68999999999999999876543 3489999999999999999999998 999999999999983 334 489999
Q ss_pred cccceeeccCCcceEeeccCCCccCcCCCC-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccH-HHHHHHHhhcc
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGY-TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDI-VEWIRMKIRDN 934 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~ 934 (1018)
||.|+.+. ++......+||..|.+||... .+.|+..+|.|||||++|+++||..||.+........ ..|..- .+..
T Consensus 168 fG~Arel~-d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~-tkkp 245 (732)
T KOG4250|consen 168 FGAARELD-DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHII-TKKP 245 (732)
T ss_pred ccccccCC-CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhh-ccCC
Confidence 99999874 445777799999999999988 4889999999999999999999999998754432111 111111 1111
Q ss_pred cccccccCCCC-----------CCCchhHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHhhcc
Q 001752 935 RNLEEALDPNV-----------GNCKHVQEEMLLVLRIAFLCTAKLPKDRP--SMRDVITMLGEA 986 (1018)
Q Consensus 935 ~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~cl~~dP~~RP--t~~evl~~L~~~ 986 (1018)
..+.-...+.. ..+...+.....+...+..++..+|.+|- .+.+..+.+..+
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 10100000000 11112233444455677788888899987 666665555443
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=307.37 Aligned_cols=272 Identities=20% Similarity=0.255 Sum_probs=198.8
Q ss_pred cccccceeecCCCeeEEEEEcCC--CCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC--Cce
Q 001752 706 CIRESNVIGMGATGIVYKAEMPR--LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND--TNM 781 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 781 (1018)
+|+..+.||+|+||.||+|.... +++.||+|.+..... ........+.+|+.++++++||||+++++++.+. ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 36777899999999999999987 789999999954321 1223345678899999999999999999999887 789
Q ss_pred EEEEEecCCCCHHHhhhcCCCC-ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcC----CCCeEEcc
Q 001752 782 MIVYEYMNNGSLGEALHGKQAG-RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS----NLEPRIAD 856 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~D 856 (1018)
++||||+++ ++.+++...... ...+++..+..++.||+.|++|||+. +|+||||||+||+++. ++.+|++|
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 999999965 777777543322 23578999999999999999999999 9999999999999999 89999999
Q ss_pred cccceeeccCCc---ceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc--------cHH
Q 001752 857 FGLARMMIRKNE---TVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESV--------DIV 924 (1018)
Q Consensus 857 fG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~--------~~~ 924 (1018)
||+++....... ......+++.|+|||+..+ ..++.++|||||||++|+|++|+.||........ .+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999986543322 1123467889999998765 4578999999999999999999999976433220 111
Q ss_pred HHHHHHhhcc----------ccccc---ccC-CCCCCCc-hhH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 925 EWIRMKIRDN----------RNLEE---ALD-PNVGNCK-HVQ-----EEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 925 ~~~~~~~~~~----------~~~~~---~~~-~~~~~~~-~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
..+....... ..... ... ....... ... .....+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111000000 00000 000 0000000 000 123457789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.65 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=205.4
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||+|+||.||+|.+..+++.+|+|++..... .......+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 36677899999999999999988899999999843221 2334567788999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++++|.+++.........+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 99999999999976544444589999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
. ......+++.|+|||+..+..++.++|+||+|+++|||++|+.||..... ........ ... . .+ .
T Consensus 156 ~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~-~~~-~----~~-~ 221 (256)
T cd08530 156 N--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----QDLRYKVQ-RGK-Y----PP-I 221 (256)
T ss_pred C--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHh-cCC-C----CC-C
Confidence 3 23335688999999999998899999999999999999999999975321 11111111 110 0 01 0
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.......+.+++.+|++.+|++||++.++++.
T Consensus 222 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 -----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01233457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=295.62 Aligned_cols=247 Identities=23% Similarity=0.261 Sum_probs=189.5
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHH-HhccCCCCcceeeeeEecCCceEEEEEecC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNV-LGKLRHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
+.||+|+||.||+|....+++.||+|++...... .......+..|..+ ....+|||++++++++..++..++||||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 4689999999999999888999999998432211 11223344455544 445589999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
+++|.+++..... +++..+..++.|++.||.|||+. +++||||+|+||+++.++.++++|||.++....
T Consensus 81 ~~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 81 GGDCASLIKTLGG----LPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 9999999976543 78888999999999999999999 999999999999999999999999999875422
Q ss_pred eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCc
Q 001752 870 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1018)
.....+++.|+|||...+..++.++||||+|+++|||++|..||..... .............. ....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~----~~~~---- 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILSRRINW----PEEV---- 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcccCC----CCcc----
Confidence 2335688999999998888889999999999999999999999965321 11111111111100 0000
Q ss_pred hhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 950 HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 950 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
.......+.+++.+|++.+|++||++.++.+.+
T Consensus 217 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 217 -KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred -cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 001224467899999999999999876665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=299.41 Aligned_cols=263 Identities=18% Similarity=0.193 Sum_probs=187.2
Q ss_pred hhcccccceeecCCCeeEEEEEcCCC---CeEEEEEEeeccccccccc-------hhhhHHHHHHHHhccCCCCcceeee
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRL---NTIVAVKKLWRSRADLETE-------SSGDFVGEVNVLGKLRHRNIVRLLG 773 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~ 773 (1018)
.++|...+.||+|+||+||+|....+ +..+|+|+..........+ .......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46789999999999999999998766 5667777642221111000 0112233445566779999999999
Q ss_pred eEecCC----ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC
Q 001752 774 FLHNDT----NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN 849 (1018)
Q Consensus 774 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 849 (1018)
++.... ..++++|++. .++.+.+..... .++..+..++.|++.|++|||+. +|+||||||+||+++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKC----KNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhcc----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 865443 3478888774 477776654322 46778889999999999999999 99999999999999999
Q ss_pred CCeEEcccccceeeccCCcc-------eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCccc
Q 001752 850 LEPRIADFGLARMMIRKNET-------VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVD 922 (1018)
Q Consensus 850 ~~~kl~DfG~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~ 922 (1018)
+.++|+|||+|+.+...... .....||+.|+|||+..+..++.++|||||||++|||++|+.||....... .
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-~ 241 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-N 241 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-H
Confidence 99999999999876432221 122469999999999999999999999999999999999999997642221 1
Q ss_pred HHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 001752 923 IVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984 (1018)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 984 (1018)
..............-... .... ....+.+++..|++.+|++||++.++++.++
T Consensus 242 ~~~~~~~~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKI---KIKN------ANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHHhhhhhh---ccCC------CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111111111000000000 0011 1234678899999999999999999998763
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=304.65 Aligned_cols=271 Identities=22% Similarity=0.297 Sum_probs=197.4
Q ss_pred HHHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC-
Q 001752 701 ADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT- 779 (1018)
Q Consensus 701 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 779 (1018)
.+..++|+..+.||+|+||.||+|....+++.||||++..... .......+.+|+.++++++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 3456789999999999999999999998999999999843221 2223345678999999999999999999986544
Q ss_pred -------ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCe
Q 001752 780 -------NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP 852 (1018)
Q Consensus 780 -------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 852 (1018)
..++||||++ ++|.+++.... ..+++..+..++.||+.||+|||+. +++|+||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGIL 158 (310)
T ss_pred cccCCCceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcE
Confidence 3599999996 58888886543 2378999999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCcc----eEeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 001752 853 RIADFGLARMMIRKNET----VSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWI 927 (1018)
Q Consensus 853 kl~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~ 927 (1018)
||+|||.+..+...... .....++..|+|||+..+. .++.++||||||+++|||++|+.||...... .....+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~ 236 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLI 236 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence 99999999765332221 1234577889999987654 4788999999999999999999999653221 111111
Q ss_pred HHHhhccc-c-cc-----cccCC-CC-CCCch-hH------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 928 RMKIRDNR-N-LE-----EALDP-NV-GNCKH-VQ------EEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 928 ~~~~~~~~-~-~~-----~~~~~-~~-~~~~~-~~------~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
........ . .. +..+. .. ..... .. .....+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 11110000 0 00 00000 00 00000 00 012345689999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=310.23 Aligned_cols=271 Identities=23% Similarity=0.307 Sum_probs=200.1
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC----
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND---- 778 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 778 (1018)
+.++|+..+.||+|+||.||+|.+..+++.||+|++... ........+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF---EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc---ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 456788999999999999999999989999999998421 1223456678899999999999999999987644
Q ss_pred -CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccc
Q 001752 779 -TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADF 857 (1018)
Q Consensus 779 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 857 (1018)
...++|+||++ +++.+.+.... +++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++||
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~~~~-----l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~df 150 (336)
T cd07849 80 FNDVYIVQELME-TDLYKLIKTQH-----LSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDF 150 (336)
T ss_pred cceEEEEehhcc-cCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcc
Confidence 35799999996 48888886532 78899999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcc---eEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc
Q 001752 858 GLARMMIRKNET---VSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD 933 (1018)
Q Consensus 858 G~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 933 (1018)
|++......... .....+++.|+|||++.+ ..++.++||||+||++|+|++|+.||..... ......+......
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~ 228 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGT 228 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCC
Confidence 999765332221 123568899999998654 5688999999999999999999999965321 1111111100000
Q ss_pred cc--ccccc-----------cCCCCCCC--chhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhccC
Q 001752 934 NR--NLEEA-----------LDPNVGNC--KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM--LGEAK 987 (1018)
Q Consensus 934 ~~--~~~~~-----------~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~ 987 (1018)
.. ..... ........ ...+.....+.+++.+|++.+|++|||+.|++++ ++...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00 00000 00000000 0001223457789999999999999999999987 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=292.96 Aligned_cols=252 Identities=27% Similarity=0.354 Sum_probs=204.6
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC--CceEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND--TNMMIV 784 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lV 784 (1018)
|+..+.||+|++|.||+|....+++.|++|++..... .....+.+.+|+..+++++|||++++++.+.+. ...++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 6677899999999999999998899999999843322 134567889999999999999999999999988 889999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
+||+++++|.+++.... .+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 99999999999997654 389999999999999999999998 99999999999999999999999999998764
Q ss_pred cCCc--ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 865 RKNE--TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 865 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
.... ......++..|+|||...+...+.++||||||+++|+|++|+.||.... +.......... .....
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~-~~~~~---- 223 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYKIGS-SGEPP---- 223 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHhccc-cCCCc----
Confidence 4432 1344678899999999988889999999999999999999999997643 11111111110 00000
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
. .. ......+.+++.+|++.+|++||++.++++.
T Consensus 224 ~-~~-----~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 E-IP-----EHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred C-CC-----cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0 00 0113457788999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=290.80 Aligned_cols=250 Identities=29% Similarity=0.430 Sum_probs=203.7
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
+|+..+.||+|++|.||+|....+++.||+|.+..... .......+.+|++++++++|||++++++++.++...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 36677899999999999999988899999999944322 2245668899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 79 EYAENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred ecCCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 9999999999997653 379999999999999999999999 999999999999999999999999999987655
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1018)
.........++..|+|||+..+..++.++||||+|+++|+|++|+.||.... ........ .... ...+.+
T Consensus 152 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~~-~~~~---~~~~~~-- 221 (254)
T cd06627 152 VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFRI-VQDD---HPPLPE-- 221 (254)
T ss_pred CcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHH-hccC---CCCCCC--
Confidence 4443344678899999999888888999999999999999999999996532 11111111 1110 000111
Q ss_pred CCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 946 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.....+.+++.+|++.+|++||++.+++.
T Consensus 222 -------~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 -------GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -------CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11234668899999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=293.64 Aligned_cols=250 Identities=28% Similarity=0.383 Sum_probs=202.6
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
|+..+.||+|++|.||+|.+..+++.+++|++..... ...+.+.+|++.+++++||+++++++++..+...++++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 5667899999999999999988899999999943222 356788999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
|+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+......
T Consensus 78 ~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 78 FCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred cCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 999999999997653 2379999999999999999999998 9999999999999999999999999999776443
Q ss_pred CcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCC
Q 001752 867 NETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG 946 (1018)
Q Consensus 867 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 946 (1018)
.. .....++..|+|||+..+..++.++||||||+++|+|++|+.||..... ........... ......
T Consensus 152 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~--~~~~~~---- 219 (253)
T cd05122 152 KA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-----MKALFKIATNG--PPGLRN---- 219 (253)
T ss_pred cc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-----HHHHHHHHhcC--CCCcCc----
Confidence 32 3446788999999999888899999999999999999999999975321 11111111110 111100
Q ss_pred CCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 947 NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 947 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.......+.+++.+|++.||++|||+.+++++
T Consensus 220 ----~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 ----PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01112447789999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=302.89 Aligned_cols=258 Identities=25% Similarity=0.361 Sum_probs=194.8
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeeeEecCCceEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV 784 (1018)
.|+..+.||+|+||.||++.+..+++.||+|.+..... ......+.+|+.++.++. ||||+++++++..+...+++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 34556789999999999999998999999999843222 244567889999999996 99999999999998999999
Q ss_pred EEecCCCCHHHhhhcC-CCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 785 YEYMNNGSLGEALHGK-QAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
|||++ +++.++.... ......+++..+..++.+++.||+|||+.. +++||||||+||+++.++.++++|||+++..
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 99985 4666543211 111133789999999999999999999742 8999999999999999999999999998755
Q ss_pred ccCCcceEeeccCCCccCcCCCCCC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccc
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTL---KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
.... ......+++.|+|||++.+. .++.++||||+||++|||++|+.||.... .....+........
T Consensus 159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~~----- 228 (288)
T cd06616 159 VDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGDP----- 228 (288)
T ss_pred ccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCCC-----
Confidence 3322 22334688999999998765 68999999999999999999999996532 11111111111110
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
+..... ........+.+++.+|++.+|++|||+++|++.
T Consensus 229 --~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 --PILSNS-EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CcCCCc-CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111000 011233457789999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=298.67 Aligned_cols=248 Identities=25% Similarity=0.300 Sum_probs=194.2
Q ss_pred eecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCCCC
Q 001752 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGS 792 (1018)
Q Consensus 713 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gs 792 (1018)
||+|+||+||+|....+++.||+|++...... .......+.+|++++++++|||++++++++...+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 68999999999999888999999998433211 22335566789999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcceEe
Q 001752 793 LGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM 872 (1018)
Q Consensus 793 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 872 (1018)
|.+++..... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+..... ......
T Consensus 80 L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~ 153 (277)
T cd05577 80 LKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKG 153 (277)
T ss_pred HHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCcccc
Confidence 9999976543 2378999999999999999999999 999999999999999999999999999876432 222334
Q ss_pred eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhH
Q 001752 873 VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQ 952 (1018)
Q Consensus 873 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1018)
..++..|+|||+..+..++.++||||+|+++|+|++|+.||...... ......... .... .... ..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-~~~~-------~~~~-----~~ 219 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRR-TLEM-------AVEY-----PD 219 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhc-cccc-------cccC-----Cc
Confidence 56788999999988888999999999999999999999999654321 111111111 0000 0000 00
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 001752 953 EEMLLVLRIAFLCTAKLPKDRP-----SMRDVIT 981 (1018)
Q Consensus 953 ~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 981 (1018)
.....+.+++.+||+.+|++|| ++.++++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 1133467889999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=308.98 Aligned_cols=273 Identities=23% Similarity=0.314 Sum_probs=203.1
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC----
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND---- 778 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 778 (1018)
+.++|...+.||+|+||+||+|.+..+++.||||.+.... ........+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 4567888999999999999999999899999999984321 1223345677899999999999999999988644
Q ss_pred -CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccc
Q 001752 779 -TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADF 857 (1018)
Q Consensus 779 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 857 (1018)
...++||||+. ++|.+++..... +++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~~----l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Df 152 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSSQT----LSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDF 152 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcCCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcC
Confidence 35799999995 699998875432 78999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc-
Q 001752 858 GLARMMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR- 935 (1018)
Q Consensus 858 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 935 (1018)
|+++.............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ..............
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~ 230 (337)
T cd07858 153 GLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV--HQLKLITELLGSPSE 230 (337)
T ss_pred ccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCh
Confidence 999866443333344567889999998764 46889999999999999999999999653211 11111110000000
Q ss_pred ---------cccccc---C--CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhccC
Q 001752 936 ---------NLEEAL---D--PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM--LGEAK 987 (1018)
Q Consensus 936 ---------~~~~~~---~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~ 987 (1018)
...... . +..............+.+++.+|++.+|++|||+++++++ ++.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000000 0 0000000011223456789999999999999999999987 65543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=295.94 Aligned_cols=262 Identities=23% Similarity=0.282 Sum_probs=194.2
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeeeEecC--CceEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHND--TNMMI 783 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~l 783 (1018)
|+..+.||+|+||.||+|....+++.||+|++..... ........+|+.+++++. |||++++++++.+. +..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK---SLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC---CchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 4567889999999999999988899999999843221 122234457888888885 99999999999887 88999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||++ +++.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.++..
T Consensus 78 v~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~ 149 (282)
T cd07831 78 VFELMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGI 149 (282)
T ss_pred EEecCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccc
Confidence 999996 58888886543 2379999999999999999999999 9999999999999999 99999999999765
Q ss_pred ccCCcceEeeccCCCccCcCCCC-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc---------
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGY-TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD--------- 933 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------- 933 (1018)
.... ......+++.|+|||+.. +..++.++||||+||++|||++|+.||..... .+...........
T Consensus 150 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 150 YSKP-PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred ccCC-CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhh
Confidence 3322 223346788999999754 45678999999999999999999999965322 1222222111110
Q ss_pred --ccccccccCCCCCCC--chhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 934 --NRNLEEALDPNVGNC--KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 934 --~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
............... .........+.+++.+|++++|++||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000000000 0011234567889999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=293.04 Aligned_cols=244 Identities=20% Similarity=0.266 Sum_probs=190.5
Q ss_pred hhccccccee--ecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCc
Q 001752 704 LACIRESNVI--GMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTN 780 (1018)
Q Consensus 704 ~~~~~~~~~l--G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 780 (1018)
.+.|+..+.+ |+|+||.||++....+++.+|+|.+...... .. |+.....+ +|||++++++++...+.
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-------~~--e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-------AI--EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-------hh--hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 3555665555 9999999999999989999999998432211 11 22222222 79999999999999999
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC-CeEEccccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL-EPRIADFGL 859 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~ 859 (1018)
.++||||+++++|.+++.... .+++..+..++.|+++|++|||+. +++||||||+||+++.++ .++++|||.
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999997654 389999999999999999999999 999999999999999998 999999999
Q ss_pred ceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 860 ARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 860 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
++..... ....++..|+|||++.+..++.++||||+|+++|||++|+.||........+...+.... ....
T Consensus 157 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~---- 227 (267)
T PHA03390 157 CKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKL---- 227 (267)
T ss_pred ceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccC----
Confidence 8765322 234688999999999988899999999999999999999999975433332333322221 1100
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPS-MRDVIT 981 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~ 981 (1018)
+. .......+.+++.+|++.+|++||+ ++++++
T Consensus 228 ---~~------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 ---PF------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---Cc------ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 0123345778899999999999996 688874
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=272.96 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=196.9
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeeeEecCCceEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.+....||.|..|.||+++...+|...|||.+.+ ....+..+++...++++..-+ .|+||+.+|||..+..+++.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~r---t~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRR---TGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecc---cCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3445679999999999999999999999999943 334466677788888866654 899999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
|.|. .-.+.++...+. ++++...-++...++.||.||-+++ +|+|||+||+||++|+.|.+|++|||.+..+.+
T Consensus 171 elMs-~C~ekLlkrik~---piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 171 ELMS-TCAEKLLKRIKG---PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHH-HHHHHHHHHhcC---CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence 9994 356666654332 3788888889999999999999886 999999999999999999999999999987743
Q ss_pred CCcceEeeccCCCccCcCCCCC---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYT---LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
....+..+|-+.|||||.+.- .+|+.++||||||++++|+.||+.||..-..+ .+....+. ... .
T Consensus 245 -SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~ltkvl----n~e------P 312 (391)
T KOG0983|consen 245 -SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEVLTKVL----NEE------P 312 (391)
T ss_pred -ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHHHHHHH----hcC------C
Confidence 344555789999999998764 46889999999999999999999999764222 11211111 111 1
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
|.+..... ....+.+++..|+.+|+.+||...+++++
T Consensus 313 P~L~~~~g---FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 PLLPGHMG---FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCcccC---cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 22221111 33456678889999999999999999874
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=309.07 Aligned_cols=268 Identities=22% Similarity=0.292 Sum_probs=200.1
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec----C
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN----D 778 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~ 778 (1018)
+...|+..+.||+|+||.||+|....+++.||+|++.... ......+.+.+|+.++++++||||+++++++.. .
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF--DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc--ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence 3467888899999999999999999899999999984322 122345677889999999999999999998753 3
Q ss_pred CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccc
Q 001752 779 TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFG 858 (1018)
Q Consensus 779 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 858 (1018)
...++||||+. ++|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg 152 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSDQP----LTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG 152 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccCCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence 56899999995 699999865433 78999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcc----eEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc
Q 001752 859 LARMMIRKNET----VSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD 933 (1018)
Q Consensus 859 ~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 933 (1018)
.++........ .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~g~ 230 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVLGS 230 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHhCC
Confidence 99765432221 123568899999998765 46889999999999999999999999653221 111111111000
Q ss_pred c----------ccccc---ccCCCCCCC-c-hhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 934 N----------RNLEE---ALDPNVGNC-K-HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 934 ~----------~~~~~---~~~~~~~~~-~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
. ..... ......... . ........+.+++.+|++.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 00000 000000000 0 001224567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=324.25 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=193.0
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC----
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND---- 778 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 778 (1018)
....|++..+||+||||.||+++.+-+|+.||||++.... .......+.+|+..+++++|||||+++..|.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 5677888899999999999999999999999999993322 445667788999999999999999998221000
Q ss_pred --------------------------------------------------------------------------------
Q 001752 779 -------------------------------------------------------------------------------- 778 (1018)
Q Consensus 779 -------------------------------------------------------------------------------- 778 (1018)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHH
Q 001752 779 -----------------------------------TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGL 823 (1018)
Q Consensus 779 -----------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L 823 (1018)
...|+-||||+..++.++++.+.... .....|+++.+|+.||
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGL 710 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHH
Confidence 12478899999888888887655321 4677889999999999
Q ss_pred HHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec------------------cCCcceEeeccCCCccCcCCC
Q 001752 824 AYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI------------------RKNETVSMVAGSYGYIAPEYG 885 (1018)
Q Consensus 824 ~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~ 885 (1018)
+|+|++ |||||||||.||++|+++.|||+|||+|+... ......+..+||.-|+|||.+
T Consensus 711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999999 99999999999999999999999999998721 111234457899999999987
Q ss_pred CCC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHH
Q 001752 886 YTL---KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIA 962 (1018)
Q Consensus 886 ~~~---~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 962 (1018)
.+. +|+.|+|+||+|++++||+. ||... .+....+.. ++... +... + ....+.+..-.+++
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts----MERa~iL~~-LR~g~-iP~~--~-----~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS----MERASILTN-LRKGS-IPEP--A-----DFFDPEHPEEASLI 851 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCch----HHHHHHHHh-cccCC-CCCC--c-----ccccccchHHHHHH
Confidence 654 59999999999999999996 66542 222332222 22211 1111 1 11122333445789
Q ss_pred HHccCCCCCCCCCHHHHHH
Q 001752 963 FLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 963 ~~cl~~dP~~RPt~~evl~ 981 (1018)
++|++.||.+|||+.|+++
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcCCCccCCCHHHHhh
Confidence 9999999999999999986
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=294.71 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=201.4
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeecccc-ccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRA-DLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
+|...+.||+|+||.||+|.+...+..+++|+++.... ........++.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778899999999999999987777777777643221 12223345677899999999999999999999998999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++.........+++..+..++.|++.|++|||+. +++|+||+|+||+++. +.++++|||.++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999976444444589999999999999999999999 9999999999999975 579999999998765
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
..........+++.|+|||+..+..++.++|+||||+++|+|++|..||... ............. .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~-------~~~ 224 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----NFLSVVLRIVEGP-------TPS 224 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHHcCC-------CCC
Confidence 4444444466889999999988888899999999999999999999999642 1122221111111 111
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
. .......+.+++.+|++.+|++||++.|+++.
T Consensus 225 ~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 L-----PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred C-----cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1 11223456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=295.61 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=198.1
Q ss_pred eecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCCCC
Q 001752 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGS 792 (1018)
Q Consensus 713 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gs 792 (1018)
||+|+||.||+|++..+++.||+|++.... .........+.+|++++++++|||++++++.+..+...|+||||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD-MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchh-hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 589999999999999889999999984322 2223456778899999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCc----
Q 001752 793 LGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE---- 868 (1018)
Q Consensus 793 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~---- 868 (1018)
|.+++.... .+++..+..++.||++||+|||+. +++||||+|+||+++.++.++++|||++........
T Consensus 80 L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 80 LASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 999997654 378999999999999999999999 999999999999999999999999999875433211
Q ss_pred ----ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 869 ----TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 869 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
......++..|+|||+..+...+.++||||||+++|++++|+.||..... .............. +
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~-----~- 221 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQNILNGKIEW-----P- 221 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCCcCC-----C-
Confidence 22335678899999998888899999999999999999999999975321 11111111111100 0
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
.. ......+.+++.+|++.+|++|||+.++.+.++.
T Consensus 222 -~~----~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 222 -ED----VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred -cc----ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00 0013456789999999999999999666666643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=297.91 Aligned_cols=265 Identities=24% Similarity=0.288 Sum_probs=201.6
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
|+..+.||+|++|.||+|....+++.+|+|++.... ........+.+|+.++++++||+++++++++..+...++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 456678999999999999998889999999984332 122345678889999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
|+++ ++.+++.... ..+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++++|||.+......
T Consensus 79 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 79 FMDT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred ccCC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 9975 8988887643 2378999999999999999999999 9999999999999999999999999999876544
Q ss_pred CcceEeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc-c-ccc----
Q 001752 867 NETVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR-N-LEE---- 939 (1018)
Q Consensus 867 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~-~~~---- 939 (1018)
........++..|+|||...+. .++.++||||+|+++|+|++|+.||..... .+............. . ...
T Consensus 152 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 152 VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCchHhcccchhh
Confidence 3233335678899999988766 789999999999999999999999965321 111111111100000 0 000
Q ss_pred -------ccCCCCCC-CchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 940 -------ALDPNVGN-CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 940 -------~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
..+..... ..........+.+++.+|+++||.+||++++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000000 00112234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=290.57 Aligned_cols=254 Identities=24% Similarity=0.306 Sum_probs=198.0
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccc-cccccchhhhHHHHHHHHhccCCCCcceeeeeEecC--Cce
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSR-ADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND--TNM 781 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 781 (1018)
..|+..+.||+|+||.||+|.+..+++.||+|.+.... ..........+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 35778899999999999999998889999999873321 112234456888999999999999999999998764 457
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
++|+||+++++|.+++..... +++....+++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~----l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA----LTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999975433 67888999999999999999999 99999999999999999999999999997
Q ss_pred eeccC---CcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 001752 862 MMIRK---NETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 862 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
..... ........++..|+|||+..+..++.++|||||||++|+|++|+.||..... ...+........ .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~--~ 227 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-----MAAIFKIATQPT--K 227 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-----HHHHHHHHcCCC--C
Confidence 65321 1122335688999999999888899999999999999999999999964211 111111111110 0
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
..+. ......+.+++.+|++ +|..||++.+++.+
T Consensus 228 ~~~p---------~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 228 PMLP---------DGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCC---------cccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1111 1122446778889998 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-34 Score=331.28 Aligned_cols=254 Identities=30% Similarity=0.392 Sum_probs=201.3
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
++=++.....||.|.||.||.|....+|...|+|-+.-... .....+...+|+.++..++|||+|+++|+-..++.++
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~--~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS--DHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc--ccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 34456677899999999999999999999999998733222 2455677889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+.||||++|+|++.+...+. .++.....+..|++.|++|||+. |||||||||.||+++.+|.+|.+|||.|..
T Consensus 1311 IFMEyC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeE
Confidence 99999999999999976554 55666666888999999999999 999999999999999999999999999987
Q ss_pred eccCCcc----eEeeccCCCccCcCCCCCCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH-Hhhcc
Q 001752 863 MIRKNET----VSMVAGSYGYIAPEYGYTLK---VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRM-KIRDN 934 (1018)
Q Consensus 863 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~ 934 (1018)
....... ....+||+.|||||++.+.+ -..+.||||+||++.||+||++||...+.+ |..+ .+..+
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------WAIMYHVAAG 1457 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------hHHHhHHhcc
Confidence 7544222 22368999999999987643 557999999999999999999999753222 2211 11111
Q ss_pred cccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 935 RNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
. .|.... ....+-.+++..|+..||.+|-++.|++++
T Consensus 1458 h------~Pq~P~-----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 H------KPQIPE-----RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred C------CCCCch-----hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1 111111 133445678899999999999888776654
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=295.28 Aligned_cols=245 Identities=24% Similarity=0.276 Sum_probs=187.4
Q ss_pred eeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHH---HHhccCCCCcceeeeeEecCCceEEEEEec
Q 001752 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVN---VLGKLRHRNIVRLLGFLHNDTNMMIVYEYM 788 (1018)
Q Consensus 712 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~---~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 788 (1018)
.||+|+||.||+|.+..+++.||+|.+....... ......+..|.. .++...||+++++++++.+.+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeecccccc-chhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 4799999999999998889999999985432221 111222334433 344457999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCc
Q 001752 789 NNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE 868 (1018)
Q Consensus 789 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~ 868 (1018)
+||+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++|||++......
T Consensus 80 ~g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-- 150 (278)
T cd05606 80 NGGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 150 (278)
T ss_pred CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--
Confidence 9999999986543 389999999999999999999999 9999999999999999999999999998754322
Q ss_pred ceEeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCC
Q 001752 869 TVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGN 947 (1018)
Q Consensus 869 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1018)
......|+..|+|||+..++ .++.++||||+||++|||++|+.||........ .......... ++....
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~--------~~~~~~ 220 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTM--------AVELPD 220 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHhhcc--------CCCCCC
Confidence 22235689999999998744 689999999999999999999999976422111 1111110000 111100
Q ss_pred CchhHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 001752 948 CKHVQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVIT 981 (1018)
Q Consensus 948 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 981 (1018)
.....+.+++.+|+..+|++|| ++.++++
T Consensus 221 -----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 -----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1134577889999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=294.75 Aligned_cols=265 Identities=27% Similarity=0.358 Sum_probs=198.8
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC--CceEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND--TNMMIV 784 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lV 784 (1018)
|+..+.||+|+||.||+|....+++.+|+|++.... ........+.+|++++++++|||++++++++.+. +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 456788999999999999999889999999995432 2233456788999999999999999999999887 889999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++ +|.+++.... ..+++..+..++.||+.|++|||+. +++|+||+|+||++++++.++++|||.+....
T Consensus 79 ~e~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 79 FEYMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYT 151 (287)
T ss_pred eccccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence 999975 8999886543 2378999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCc-ceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcc--cccc--
Q 001752 865 RKNE-TVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDN--RNLE-- 938 (1018)
Q Consensus 865 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~-- 938 (1018)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+....... ....
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE--LEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchhhcccc
Confidence 4322 1233456788999997654 4578999999999999999999999975432 11111111110000 0000
Q ss_pred -c-----ccCCCCCCCc---hh-HH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 939 -E-----ALDPNVGNCK---HV-QE-EMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 939 -~-----~~~~~~~~~~---~~-~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
. ...+...... .. .. ....+.+++.+|++.+|++||+++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 0000000000 00 01 14567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=304.36 Aligned_cols=267 Identities=27% Similarity=0.370 Sum_probs=198.9
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecC--C
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHND--T 779 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~ 779 (1018)
+.++|+..+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++++ +||||+++++++... .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF--RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc--CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 6778899999999999999999998889999999884321 1223345677899999999 999999999998653 3
Q ss_pred ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccc
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGL 859 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 859 (1018)
..++||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|++|||.
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 6799999997 5999998654 278889999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCc-----ceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc
Q 001752 860 ARMMIRKNE-----TVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD 933 (1018)
Q Consensus 860 a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 933 (1018)
+........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...... +....+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~--~~~~~~~~~~~~ 231 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL--NQLEKIIEVIGP 231 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCC
Confidence 986643322 2233568899999998754 55788999999999999999999999653211 110000000000
Q ss_pred c----------cccccccC----CCCCCC-chhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 934 N----------RNLEEALD----PNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 934 ~----------~~~~~~~~----~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
. ....+..+ ...... .........+.+++.+|++.+|++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 00000000 000000 0001123457789999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=302.54 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=192.1
Q ss_pred eeecC--CCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecC
Q 001752 712 VIGMG--ATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 712 ~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
.||+| +||+||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 45555 999999999988999999999843321 22345678899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 869 (1018)
++++.+++...... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 83 YGSANSLLKTYFPE--GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCCHHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999999765322 378889999999999999999998 9999999999999999999999999865433221111
Q ss_pred eE-------eeccCCCccCcCCCCC--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhh--------
Q 001752 870 VS-------MVAGSYGYIAPEYGYT--LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIR-------- 932 (1018)
Q Consensus 870 ~~-------~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------- 932 (1018)
.. ...++..|+|||++.+ ..++.++||||+||++|||++|+.||....... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-MLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-HHHHHhcCCCCCCcccccc
Confidence 11 1234567999999876 347899999999999999999999997542211 11110000000
Q ss_pred ---------ccccc----c----------cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 933 ---------DNRNL----E----------EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 933 ---------~~~~~----~----------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
..... . ...+... ...........+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000 0 0000000 011122344567899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=296.65 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=201.4
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeeeEecCCceEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV 784 (1018)
+|...+.||+|+||.||+|....+++.||+|++.... .......+.+.+|++++++++ ||||+++++++.+++..++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ-LIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHh-ccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 5777889999999999999999899999999984322 122334567889999999998 99999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999997654 389999999999999999999999 99999999999999999999999999987654
Q ss_pred cCCc--------------------ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHH
Q 001752 865 RKNE--------------------TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIV 924 (1018)
Q Consensus 865 ~~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~ 924 (1018)
.... ......++..|+|||...+..++.++||||||++++++++|+.||..... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~- 228 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----Y- 228 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----H-
Confidence 3321 11224578899999998888899999999999999999999999975321 1
Q ss_pred HHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 001752 925 EWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSM----RDVIT 981 (1018)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~evl~ 981 (1018)
............+. . .....+.+++.+|++.+|++||++ +++++
T Consensus 229 ~~~~~~~~~~~~~~----~---------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LTFQKILKLEYSFP----P---------NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHHhcCCCCC----C---------ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11111111111000 0 113346789999999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=319.75 Aligned_cols=277 Identities=19% Similarity=0.213 Sum_probs=189.5
Q ss_pred HHhhcccccceeecCCCeeEEEEEcCCCC-eEEEEEEee-------------ccccccccchhhhHHHHHHHHhccCCCC
Q 001752 702 DILACIRESNVIGMGATGIVYKAEMPRLN-TIVAVKKLW-------------RSRADLETESSGDFVGEVNVLGKLRHRN 767 (1018)
Q Consensus 702 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~-------------~~~~~~~~~~~~~~~~E~~~l~~l~hpn 767 (1018)
.+.+.|+..+.||+|+||+||+|..+... ..++.|.+. .............+.+|+.++++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 36688999999999999999998764322 222222110 0011112234556889999999999999
Q ss_pred cceeeeeEecCCceEEEEEecCCCCHHHhhhcCCCC-ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEE
Q 001752 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAG-RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILL 846 (1018)
Q Consensus 768 iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll 846 (1018)
|+++++++...+..|+|+|++. +++.+++...... ........+..++.||+.||+|||+. +|+||||||+||++
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999994 5888877543211 11133556778999999999999999 99999999999999
Q ss_pred cCCCCeEEcccccceeeccCCcc-eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCC-CCCCCCCc-ccH
Q 001752 847 DSNLEPRIADFGLARMMIRKNET-VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRP-LDPEFGES-VDI 923 (1018)
Q Consensus 847 ~~~~~~kl~DfG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p-f~~~~~~~-~~~ 923 (1018)
+.++.+||+|||+++.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.+ |....... ..+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 99999999999999876433222 2236799999999999999999999999999999999998764 43221111 111
Q ss_pred HHHHHHHhhccccc-------ccccCC-CCCCC-chhH------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 924 VEWIRMKIRDNRNL-------EEALDP-NVGNC-KHVQ------EEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 924 ~~~~~~~~~~~~~~-------~~~~~~-~~~~~-~~~~------~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
...+.........+ .+.++. ..... .... .....+.+++.+|++.||.+|||+.|++++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111000000000 000000 00000 0000 011234567889999999999999999874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=297.11 Aligned_cols=257 Identities=28% Similarity=0.376 Sum_probs=200.0
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
..+.|+..+.||+|+||.||+|+...+++.||+|.+..... ......+++.+|+++++.++|||++++++++......+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 44567778899999999999999988899999999843211 12234567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||+. |++.+.+.... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||++..
T Consensus 92 lv~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred EEEEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCccccee
Confidence 9999996 58888775433 2378899999999999999999999 999999999999999999999999999876
Q ss_pred eccCCcceEeeccCCCccCcCCCC---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGY---TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
.... ....+++.|+|||++. ...++.++|||||||++|+|++|+.||..... ............
T Consensus 165 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~---- 231 (308)
T cd06634 165 MAPA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNES---- 231 (308)
T ss_pred ecCc----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-----HHHHHHHhhcCC----
Confidence 5322 2346788999999864 35678899999999999999999999864211 111111111110
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
+... .......+.+++.+||+.+|++||++.++++.-.-..
T Consensus 232 ---~~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 232 ---PALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ---CCcC----cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 1100 0122344678999999999999999999998754433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=303.30 Aligned_cols=269 Identities=24% Similarity=0.267 Sum_probs=197.5
Q ss_pred Hhhcccc-cceeecCCCeeEEEEEcCCCCeEEEEEEeecccccccc----------chhhhHHHHHHHHhccCCCCccee
Q 001752 703 ILACIRE-SNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLET----------ESSGDFVGEVNVLGKLRHRNIVRL 771 (1018)
Q Consensus 703 ~~~~~~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~~ 771 (1018)
+.++|.. .+.||+|+||+||+|.+..+++.||||++......... .....+.+|++++++++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4456654 47799999999999999888999999998443221100 012257789999999999999999
Q ss_pred eeeEecCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCC
Q 001752 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLE 851 (1018)
Q Consensus 772 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 851 (1018)
++++..++..++||||++ |+|.+++..... +++.....++.|++.||+|||+. +++||||+|+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIR----LTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGI 157 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCC
Confidence 999999999999999996 699999865433 78899999999999999999999 9999999999999999999
Q ss_pred eEEcccccceeeccC--------------CcceEeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCC
Q 001752 852 PRIADFGLARMMIRK--------------NETVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPE 916 (1018)
Q Consensus 852 ~kl~DfG~a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~ 916 (1018)
++++|||.+...... ........+++.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999765411 1112223467889999998764 4689999999999999999999999754
Q ss_pred CCCcccHHHHHHHHhhcccc--cccc--------cCCCC-CCCc-hhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 917 FGESVDIVEWIRMKIRDNRN--LEEA--------LDPNV-GNCK-HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~--~~~~--------~~~~~-~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.. .+....+......... .... ..... .... ........+.+++.+|++.+|++||+++|++.
T Consensus 238 ~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 238 NE--IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CH--HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 22 1111111111110000 0000 00000 0000 00111345678999999999999999999996
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=300.03 Aligned_cols=253 Identities=25% Similarity=0.310 Sum_probs=206.9
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
....|...+.||+|.|+.|..|++..++..||+|.+++. ..+....+.+.+|+++++.++|||||+++.+......+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt--~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKT--QLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhc--ccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 456788889999999999999999999999999999443 334444455899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||..+|.+++++..... ..+..+..++.|+.+|++|+|++ .|||||||++||+++.+..+||+|||++.+
T Consensus 132 lV~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred EEEEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecccccee
Confidence 99999999999999987665 44577777899999999999999 999999999999999999999999999998
Q ss_pred eccCCcceEeeccCCCccCcCCCCCCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGYTLKV-DEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
+. .+......+|++.|.|||++.+.+| ++++|+||+|+++|-|+.|..||++..- ...-...+...
T Consensus 205 ~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-----k~Lr~rvl~gk------- 271 (596)
T KOG0586|consen 205 FD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-----KELRPRVLRGK------- 271 (596)
T ss_pred ec-ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-----ccccchheeee-------
Confidence 75 4555667899999999999998776 5799999999999999999999986321 11101111111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
.+-..... .+.-+++++++-.+|.+|++++++.+.-
T Consensus 272 ---~rIp~~ms---~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 272 ---YRIPFYMS---CDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred ---ecccceee---chhHHHHHHhhccCccccCCHHHhhhhc
Confidence 10111111 1234578899999999999999998754
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=294.29 Aligned_cols=258 Identities=25% Similarity=0.285 Sum_probs=199.8
Q ss_pred ccccceeecCCCeeEEEEEcC---CCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceE
Q 001752 707 IRESNVIGMGATGIVYKAEMP---RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 782 (1018)
|+..+.||+|+||.||+|+.. .+++.||||++............+.+.+|+.+++++ +||+|+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 566789999999999999863 357889999985433222334456788999999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++++|||+++.
T Consensus 82 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 82 LILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999987543 278888999999999999999998 999999999999999999999999999876
Q ss_pred eccCCcc-eEeeccCCCccCcCCCCCCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 863 MIRKNET-VSMVAGSYGYIAPEYGYTLK--VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 863 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
....... .....++..|+|||...+.. .+.++||||||+++|||++|+.||..... ................
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~---- 229 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKSKP---- 229 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHccCC----
Confidence 5333221 22356889999999877654 78899999999999999999999964211 1111222222111111
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
+... .....+.+++.+|++.+|++|||++++.+.++.
T Consensus 230 ---~~~~------~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 230 ---PFPK------TMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ---CCCc------ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0000 112346678999999999999999988887755
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=305.22 Aligned_cols=269 Identities=22% Similarity=0.281 Sum_probs=197.3
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC----
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND---- 778 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 778 (1018)
+.++|...+.||+|+||.||+|++..+++.||+|++.... ........+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF--QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc--ccccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 4567888899999999999999998889999999984321 1223345688999999999999999999998654
Q ss_pred --CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcc
Q 001752 779 --TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 779 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 856 (1018)
...++|+||+.. +|.++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIMGH------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred CCceEEEEeccccc-CHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEee
Confidence 246999999964 77776531 278889999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhh-cc
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIR-DN 934 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~ 934 (1018)
||+++.... ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+..... ..
T Consensus 161 fg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~ 235 (342)
T cd07879 161 FGLARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPG 235 (342)
T ss_pred CCCCcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCC
Confidence 999875422 2223467889999998766 4688999999999999999999999975321 111111110000 00
Q ss_pred ccc---------ccccC--CCCCCC---chhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhccCC
Q 001752 935 RNL---------EEALD--PNVGNC---KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM--LGEAKP 988 (1018)
Q Consensus 935 ~~~---------~~~~~--~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~ 988 (1018)
..+ ..... +..... ...+.....+.+++.+|++.||++||++++++++ ++...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000 00000 000000 0001122346789999999999999999999965 666544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=291.58 Aligned_cols=265 Identities=25% Similarity=0.290 Sum_probs=196.5
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc---CCCCcceeeeeEecCCc---
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL---RHRNIVRLLGFLHNDTN--- 780 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~--- 780 (1018)
|+..+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 5667899999999999999988899999999943322 222234566787776665 69999999999987776
Q ss_pred --eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccc
Q 001752 781 --MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFG 858 (1018)
Q Consensus 781 --~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 858 (1018)
.+++|||++ ++|.+++...... .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++++|||
T Consensus 79 ~~~~l~~e~~~-~~l~~~l~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg 152 (287)
T cd07838 79 LKLTLVFEHVD-QDLATYLSKCPKP--GLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG 152 (287)
T ss_pred ceeEEEehhcc-cCHHHHHHHccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence 899999996 4899988754332 378999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc---
Q 001752 859 LARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR--- 935 (1018)
Q Consensus 859 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--- 935 (1018)
.+..+.... ......++..|+|||+..+..++.++|||||||++|||++|++||...... ..+..+.........
T Consensus 153 ~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 153 LARIYSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred cceeccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhc
Confidence 997763332 223345788999999999889999999999999999999999999753221 111111111000000
Q ss_pred cc-----ccccCCCCCCCc--hhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 936 NL-----EEALDPNVGNCK--HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 936 ~~-----~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.. ...+........ ...+....+.+++.+||+.||++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 000011000100 01123455678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=296.39 Aligned_cols=269 Identities=24% Similarity=0.307 Sum_probs=198.5
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC---
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT--- 779 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 779 (1018)
..+.|+..+.||+|+||.||+|.+..+++.||+|++..... .......+.+|++++++++|||++++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc--ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 45778889999999999999999998899999999843321 2233456778999999999999999999987654
Q ss_pred -------ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCe
Q 001752 780 -------NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP 852 (1018)
Q Consensus 780 -------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 852 (1018)
..++|+||+++ ++.+.+.... ..+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence 78999999975 7877776542 2378999999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCc-ceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 001752 853 RIADFGLARMMIRKNE-TVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMK 930 (1018)
Q Consensus 853 kl~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 930 (1018)
||+|||.+........ ......++..|+|||...+ ..++.++|||||||++|||++|++||.... ..+....+...
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~--~~~~~~~~~~~ 233 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ--ELAQLELISRL 233 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHH
Confidence 9999999986643332 1222346788999998754 457899999999999999999999997532 11111111111
Q ss_pred hhcccc--cccc--------cCCCCCCCc----hhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 931 IRDNRN--LEEA--------LDPNVGNCK----HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 931 ~~~~~~--~~~~--------~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
...... ..+. .++...... ........+.+++.+|++.+|++||++++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111000 0000 000000000 000113457789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=295.50 Aligned_cols=252 Identities=29% Similarity=0.400 Sum_probs=196.5
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceE
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
..+.|...+.||+|+||+||+|++..+++.||+|++..... ......+.+.+|++++++++|||++++++++.++...+
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 34446667789999999999999988899999999843322 22234457888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||+. |++.+++.... ..+++..+..++.||+.|++|||+. +++|+||+|+||+++.++.++++|||.+..
T Consensus 98 lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred EEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 9999995 58888876433 2378999999999999999999999 999999999999999999999999999864
Q ss_pred eccCCcceEeeccCCCccCcCCCC---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGY---TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
.. ......++..|+|||++. ...++.++|||||||++|||++|..||..... ............
T Consensus 171 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~~---- 237 (313)
T cd06633 171 SS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNDS---- 237 (313)
T ss_pred cC----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcCC----
Confidence 32 223356888999999874 45688899999999999999999999865311 111111111111
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
+.... ......+.+++.+|++.+|.+||++.++++.
T Consensus 238 ---~~~~~----~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 ---PTLQS----NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---CCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0112346778999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=299.84 Aligned_cols=271 Identities=26% Similarity=0.301 Sum_probs=205.0
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC-----c
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT-----N 780 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~ 780 (1018)
+|+..+.||+|++|.||+|+...+++.||+|++... .......+.+.+|+.+++.++||||+++++++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV--FDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccc--cccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 467788999999999999999888999999998432 112345567899999999999999999999987765 7
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 860 (1018)
.|+||||++ ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred eEEEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence 899999997 58999987544 389999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCC---cceEeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc-
Q 001752 861 RMMIRKN---ETVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR- 935 (1018)
Q Consensus 861 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 935 (1018)
....... .......+++.|+|||++.+. .++.++|+||+|+++|+|++|+.||...... .....+........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~ 228 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLGTPSE 228 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcCCCCh
Confidence 8764433 123345678899999998877 7899999999999999999999999764321 11111111100000
Q ss_pred ---------ccccccCCCCCCCc-h----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhccCC
Q 001752 936 ---------NLEEALDPNVGNCK-H----VQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM--LGEAKP 988 (1018)
Q Consensus 936 ---------~~~~~~~~~~~~~~-~----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~ 988 (1018)
...+.+........ . .......+.+++.+||+.+|++||++++++++ ++....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000000000 0 01123457789999999999999999999985 555444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=284.96 Aligned_cols=244 Identities=27% Similarity=0.314 Sum_probs=196.5
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 783 (1018)
..|....+||+|+||.|-.|..+++.+.+|||++++.... ..+..+--..|-+++... +-|.++++..+++.-+.+|+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDVii-QdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVII-QDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceee-ecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 5577889999999999999999999999999999554332 222333334566666655 56899999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||||+.||+|--.++.... +.+..+.-+|..||-||-+||++ ||++||||.+||++|.+|++||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999999976655 66677778999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCC
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
.-++....+.+|||.|+|||.+...+|+.++|.|||||++|||+.|++||++++. .++.+.+.. .... +.
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE--~elF~aI~e---hnvs----yP- 570 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELFQAIME---HNVS----YP- 570 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHH---ccCc----Cc-
Confidence 6677778889999999999999999999999999999999999999999998533 223332221 1110 01
Q ss_pred CCCCCchhHHHHHHHHHHHHHccCCCCCCCC
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRP 974 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 974 (1018)
+ ....+...++...+.+.|.+|.
T Consensus 571 -----K---slSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 571 -----K---SLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -----c---cccHHHHHHHHHHhhcCCcccc
Confidence 1 1123345567788888898884
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=296.97 Aligned_cols=255 Identities=26% Similarity=0.413 Sum_probs=194.0
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 782 (1018)
.+.|+..+.||+|+||.||+|.+..+++.||||.+.... .......+.+|+.++.+. .||||+++++++.++...+
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC---ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 356778899999999999999999889999999984322 123345566777766666 4999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||++ +++.++...... .+++..+..++.|++.|++|||+.+ +|+||||+|+||+++.++.++|+|||.+..
T Consensus 91 ~v~e~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 91 ICMELMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred EEeeccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchh
Confidence 9999985 578777755322 4789999999999999999999732 899999999999999999999999999876
Q ss_pred eccCCcceEeeccCCCccCcCCCCCCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGYTLK----VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
+.... ......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||...... .+..........
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~--- 236 (296)
T cd06618 165 LVDSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----FEVLTKILQEEP--- 236 (296)
T ss_pred ccCCC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----HHHHHHHhcCCC---
Confidence 53222 222345788999999987554 788999999999999999999999642111 111111111111
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
+...... .....+.+++.+|++.||++||++.+++++
T Consensus 237 ----~~~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 ----PSLPPNE---GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----CCCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000 122346789999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=291.93 Aligned_cols=255 Identities=26% Similarity=0.314 Sum_probs=196.2
Q ss_pred ccccceeecCCCeeEEEEEcC---CCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceE
Q 001752 707 IRESNVIGMGATGIVYKAEMP---RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 782 (1018)
|+..+.||+|+||.||+|... .+|+.||+|++............+.+.+|+.+++++ +|++|+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 667789999999999999874 368999999985433222334456788899999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+||||+++++|.+++..... +++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 82 LILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999976432 77888888999999999999999 999999999999999999999999999976
Q ss_pred eccCC-cceEeeccCCCccCcCCCCCC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccc
Q 001752 863 MIRKN-ETVSMVAGSYGYIAPEYGYTL--KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 863 ~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
..... .......|+..|+|||+..+. .++.++||||||+++|+|++|+.||..... ...................
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~- 232 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSEPPYP- 232 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccCCCCC-
Confidence 53322 122235688999999987653 467899999999999999999999964211 1122222222111111100
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVITM 982 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 982 (1018)
......+.+++.+|++.||++|| ++++++.+
T Consensus 233 ------------~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 233 ------------QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ------------ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 01123466889999999999997 66666553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=302.46 Aligned_cols=266 Identities=23% Similarity=0.339 Sum_probs=197.1
Q ss_pred HHHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCC-
Q 001752 701 ADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT- 779 (1018)
Q Consensus 701 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 779 (1018)
.++.++|+..+.||+|+||.||+|....+++.||||++.... ........+.+|+.++++++||||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 346678999999999999999999998899999999984321 12233456789999999999999999999987543
Q ss_pred -----ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEE
Q 001752 780 -----NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRI 854 (1018)
Q Consensus 780 -----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 854 (1018)
..++||||+ +++|.+++... .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+++
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence 358999999 77999888643 278999999999999999999999 9999999999999999999999
Q ss_pred cccccceeeccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc
Q 001752 855 ADFGLARMMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD 933 (1018)
Q Consensus 855 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 933 (1018)
+|||.+..... ......+++.|+|||++.+ ..++.++|+||+|+++|++++|+.||...... .............
T Consensus 160 ~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~ 235 (343)
T cd07880 160 LDFGLARQTDS---EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTP 235 (343)
T ss_pred eeccccccccc---CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCC
Confidence 99999976432 2233467889999998765 45889999999999999999999999753211 0011100000000
Q ss_pred ccccc---------cccC--CCCCCC--ch-hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 934 NRNLE---------EALD--PNVGNC--KH-VQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 934 ~~~~~---------~~~~--~~~~~~--~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
...+. .... +..... .. .......+.+++.+|++.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 0000 000000 00 0111234678999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=286.87 Aligned_cols=240 Identities=26% Similarity=0.333 Sum_probs=195.0
Q ss_pred eecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCCCC
Q 001752 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGS 792 (1018)
Q Consensus 713 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gs 792 (1018)
||+|+||.||++....+++.+|+|++.... .........+..|+.++++++|||++++++.+..+...++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK-IIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhh-hcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 689999999999998889999999984432 2223356678899999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcceEe
Q 001752 793 LGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM 872 (1018)
Q Consensus 793 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 872 (1018)
|.+++..... +++.....++.|+++|+.|+|+. +++|+||+|+||+++.++.++++|||.+............
T Consensus 80 L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (250)
T cd05123 80 LFSHLSKEGR----FSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT 152 (250)
T ss_pred HHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccC
Confidence 9999976542 78999999999999999999998 9999999999999999999999999999876443333445
Q ss_pred eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhH
Q 001752 873 VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQ 952 (1018)
Q Consensus 873 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 952 (1018)
..++..|+|||...+...+.++|+||||+++|++++|+.||..... .............+...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~------------ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKDPLRFPEF------------ 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcCCCCCCCC------------
Confidence 6788999999999888889999999999999999999999965321 11111111111111100
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHH
Q 001752 953 EEMLLVLRIAFLCTAKLPKDRPSMRD 978 (1018)
Q Consensus 953 ~~~~~l~~l~~~cl~~dP~~RPt~~e 978 (1018)
....+.+++.+|+..||++||++.+
T Consensus 216 -~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 -LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 0234677899999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=292.70 Aligned_cols=264 Identities=24% Similarity=0.296 Sum_probs=196.5
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeeeEecCCceEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~ 785 (1018)
|+..+.||+|++|+||+|+...+++.||+|++..... ........+|+..+++++ |||++++++++.+++..++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY---SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc---chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence 4567889999999999999988899999999843221 122334557999999999 999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
||+ +|+|.+++.... ...+++..+..++.|++.+|+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 78 e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 78 EYM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred ecC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 999 789999987654 12379999999999999999999999 999999999999999999999999999976533
Q ss_pred CCcceEeeccCCCccCcCCCC-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc--------cc-
Q 001752 866 KNETVSMVAGSYGYIAPEYGY-TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD--------NR- 935 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------~~- 935 (1018)
.. ......++..|+|||+.. +..++.++|+||||++++||++|+.||....... ........... ..
T Consensus 152 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 152 RP-PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID--QLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred CC-CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH--HHHHHHHhcCCCChhhhhhHhh
Confidence 22 223356788999999764 4557899999999999999999999996542211 11000000000 00
Q ss_pred ---ccccccCCCCCCC--chhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 936 ---NLEEALDPNVGNC--KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 936 ---~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.....+....... .........+.+++.+|++.+|++|||++|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000000 0001113557789999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-33 Score=318.88 Aligned_cols=254 Identities=22% Similarity=0.238 Sum_probs=202.1
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|++.++||+|+||.|..++++.+++.||.|++.+.. -.......-|..|-++|...+.+=|+.++-.|+++.+.|+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~e-MlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWE-MLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHH-HhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 456889999999999999999999999999999994321 1223445678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
|||||+||+|-.++..... +++..+..++..|+-||+-+|+. |+|||||||+|||+|..|++|++|||.+-.+
T Consensus 153 VMdY~pGGDlltLlSk~~~----~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDR----LPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred EEecccCchHHHHHhhcCC----ChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhc
Confidence 9999999999999987662 67777777899999999999999 9999999999999999999999999999887
Q ss_pred ccCCcceE-eeccCCCccCcCCCC----C-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc--cc
Q 001752 864 IRKNETVS-MVAGSYGYIAPEYGY----T-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD--NR 935 (1018)
Q Consensus 864 ~~~~~~~~-~~~gt~~y~aPE~~~----~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~ 935 (1018)
..++...+ ..+|||.|++||++. + +.|++.+|.||+||++|||+.|..||..+ .++.-+...... ..
T Consensus 226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm~hk~~l 300 (1317)
T KOG0612|consen 226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIMNHKESL 300 (1317)
T ss_pred CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHhchhhhc
Confidence 76665544 478999999999854 3 67999999999999999999999999753 333333222221 11
Q ss_pred ccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 001752 936 NLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPS---MRDVITM 982 (1018)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~~ 982 (1018)
.+.+. .+......++|.+.+ -+|+.|-. ++++..+
T Consensus 301 ~FP~~-----------~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 301 SFPDE-----------TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred CCCcc-----------cccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 11111 122334455666665 46888877 7777653
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=296.45 Aligned_cols=258 Identities=23% Similarity=0.274 Sum_probs=188.6
Q ss_pred CCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCCCCHHHh
Q 001752 717 ATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEA 796 (1018)
Q Consensus 717 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~ 796 (1018)
++|.||.++...+++.||||++... .......+.+.+|++++++++||||+++++++.+.+..+++|||+++|+|.++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLD--SCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecc--ccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence 4455566665567999999998432 12334567899999999999999999999999999999999999999999999
Q ss_pred hhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcc-------
Q 001752 797 LHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET------- 869 (1018)
Q Consensus 797 l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~------- 869 (1018)
+...... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+..+......
T Consensus 90 l~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 90 LKTHFPE--GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 9764322 267888899999999999999999 9999999999999999999999999998765432221
Q ss_pred eEeeccCCCccCcCCCCC--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc---ccc-------c
Q 001752 870 VSMVAGSYGYIAPEYGYT--LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD---NRN-------L 937 (1018)
Q Consensus 870 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~-------~ 937 (1018)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...+........ ... .
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCccccccCchhhhcCCc
Confidence 122456778999998765 358899999999999999999999997532111 111111000000 000 0
Q ss_pred cc----ccCCCC---CCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 938 EE----ALDPNV---GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 938 ~~----~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.. ..++.. ............+.+++.+||+.||++|||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00 000000 0011112223457789999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-33 Score=293.68 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=199.1
Q ss_pred cceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecC
Q 001752 710 SNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 710 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
.++||+|.||+||-|+++++|+.||||++.+.+..... ..+..+|+.++++++||.||.+--.|+..+.+++|||.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq--esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ--ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch--HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence 46899999999999999999999999999665554333 4678999999999999999999999999999999999995
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC---CCeEEcccccceeeccC
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN---LEPRIADFGLARMMIRK 866 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfG~a~~~~~~ 866 (1018)
|+..+.+-..+.++ +++.....++.||+.||.|||.+ +|||+||||+||++... -++|++|||+|+..++.
T Consensus 647 -GDMLEMILSsEkgR--L~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 647 -GDMLEMILSSEKGR--LPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred -chHHHHHHHhhccc--chHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 57766665555444 67777777899999999999999 99999999999999754 46999999999987543
Q ss_pred CcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCC
Q 001752 867 NETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG 946 (1018)
Q Consensus 867 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 946 (1018)
.....++|||.|.|||++..+.|...-|+||.|||+|.=++|..||.. +.++-+.++.. .-.+.+
T Consensus 721 -sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE----dEdIndQIQNA-------aFMyPp--- 785 (888)
T KOG4236|consen 721 -SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE----DEDINDQIQNA-------AFMYPP--- 785 (888)
T ss_pred -hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC----ccchhHHhhcc-------ccccCC---
Confidence 344568999999999999999999999999999999999999999964 23333332211 111112
Q ss_pred CCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 947 NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 947 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
..+.+.....+++|...++..=.+|-+.+..+.
T Consensus 786 --~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 786 --NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred --CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 124455556677888888888888888776543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=293.60 Aligned_cols=264 Identities=25% Similarity=0.327 Sum_probs=200.9
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
|+..+.||+|++|.||+|+...+++.||+|++.... ......+.+.+|+.++++++|||++++++++.+.+..++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence 455678999999999999999889999999994332 223445677889999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
|++ ++|.+++.... ..+++..+..++.+++.|++|||+. +|+||||+|+||+++.++.++|+|||.++.....
T Consensus 79 ~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 79 YCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred CcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 997 59999997653 2388999999999999999999999 9999999999999999999999999999876444
Q ss_pred CcceEeeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc--------c-
Q 001752 867 NETVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR--------N- 936 (1018)
Q Consensus 867 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------~- 936 (1018)
........++..|+|||++.+. .++.++|||||||++|||++|+.||...... +....+........ .
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 152 LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--DQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHHHhCCCcHHHHHhhccc
Confidence 4333345567889999998766 7899999999999999999999999653211 11111111000000 0
Q ss_pred --cccccCCCCCCC--chhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 937 --LEEALDPNVGNC--KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 937 --~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
....+....... ...+.....+.+++.+|+..+|++||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000000 001112345788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=296.46 Aligned_cols=267 Identities=25% Similarity=0.304 Sum_probs=194.8
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC-----
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND----- 778 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 778 (1018)
.++|+..+.||+|+||.||+|.+..+++.||+|++..... .......+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC--CCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 5788899999999999999999998899999999843321 122234577899999999999999999987443
Q ss_pred ---CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEc
Q 001752 779 ---TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIA 855 (1018)
Q Consensus 779 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 855 (1018)
...++||||+++ ++.+.+.... ..+++..+..++.|+++||+|||+. +|+|+||||+||++++++.++++
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence 346999999964 7877776432 2389999999999999999999999 99999999999999999999999
Q ss_pred ccccceeeccCCcc-----------eEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccH
Q 001752 856 DFGLARMMIRKNET-----------VSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDI 923 (1018)
Q Consensus 856 DfG~a~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~ 923 (1018)
|||+++........ .....+++.|+|||+..+ ..++.++|||||||++|||++|++||.+.... ..
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~--~~ 235 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI--DQ 235 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH--HH
Confidence 99999765332211 122456888999998764 45889999999999999999999999753221 11
Q ss_pred HHHHHHHhhcc--------cccccccC-CCCCCCchh-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 924 VEWIRMKIRDN--------RNLEEALD-PNVGNCKHV-----QEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 924 ~~~~~~~~~~~--------~~~~~~~~-~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
...+....... ..+....+ ......... ......+.+++.+|++.||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11111100000 00000000 000000000 111245778999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=275.32 Aligned_cols=252 Identities=25% Similarity=0.327 Sum_probs=197.8
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceEEEEEecC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~~ 789 (1018)
+.||+|+|+.|-.++...+|..||||++. +.......+..+|++++... .|+||+.++++|+++...|+|||.|.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiid----Kq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIID----KQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhh----cCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 57999999999999999999999999993 23456778899999999988 59999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC---CeEEcccccceeeccC
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL---EPRIADFGLARMMIRK 866 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfG~a~~~~~~ 866 (1018)
||+|..++++++. +++.++.+++.+|+.||.|||.+ ||.|||+||+||+-.... .+||+||.++.-....
T Consensus 160 GGplLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 160 GGPLLSHIQKRKH----FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred CchHHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 9999999988776 89999999999999999999999 999999999999986654 4899999887543211
Q ss_pred --C-----cceEeeccCCCccCcCCCC-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc-----ccHHHHHHH
Q 001752 867 --N-----ETVSMVAGSYGYIAPEYGY-----TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES-----VDIVEWIRM 929 (1018)
Q Consensus 867 --~-----~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~-----~~~~~~~~~ 929 (1018)
- ....+.+|+..|||||+.. ...|+.++|.||+|||+|-|++|.+||.+.-+.+ ...-...+.
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN 312 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence 1 1223467888999999632 3458899999999999999999999997653321 111111111
Q ss_pred ----HhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 930 ----KIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 930 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.++++. -++-| +.+.....+..+++...+..|+..|-++.+++.
T Consensus 313 ~LFesIQEGk--YeFPd------kdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 313 KLFESIQEGK--YEFPD------KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHhccC--CcCCh------hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 122221 11111 123344445567888889999999999999887
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=302.26 Aligned_cols=266 Identities=23% Similarity=0.281 Sum_probs=196.5
Q ss_pred HHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC---
Q 001752 702 DILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND--- 778 (1018)
Q Consensus 702 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 778 (1018)
.+.++|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 36688999999999999999999998889999999984321 1222345678899999999999999999988543
Q ss_pred ---CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEc
Q 001752 779 ---TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIA 855 (1018)
Q Consensus 779 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 855 (1018)
...+++++++ +++|.+++.... +++..+..++.|+++|++|||+. +|+||||||+||+++.++.++++
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKCQK-----LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEe
Confidence 3468888887 789998886432 78999999999999999999999 99999999999999999999999
Q ss_pred ccccceeeccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcc
Q 001752 856 DFGLARMMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDN 934 (1018)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 934 (1018)
|||+++... .......+++.|+|||+..+ ..++.++|||||||++|||++|+.||...... ..+...........
T Consensus 163 dfg~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~ 238 (345)
T cd07877 163 DFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 238 (345)
T ss_pred ccccccccc---ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCC
Confidence 999987542 22234567899999998765 56888999999999999999999999643211 11111111000000
Q ss_pred ccccc------------ccCCCCCCCc--hhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 935 RNLEE------------ALDPNVGNCK--HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 935 ~~~~~------------~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
..... ..+....... ........+.+++.+|++.||++||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 0000000000 000112346789999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=303.66 Aligned_cols=264 Identities=23% Similarity=0.308 Sum_probs=198.3
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCc--
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN-- 780 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-- 780 (1018)
+.++|+..+.||+|++|.||+|.+..+++.||+|++.... ......+.+.+|+.++++++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 5678899999999999999999999889999999984321 122344567789999999999999999998866554
Q ss_pred ----eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcc
Q 001752 781 ----MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 781 ----~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 856 (1018)
.++|+||+ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++|+|
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence 89999999 67999998753 278999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR 935 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 935 (1018)
||.+...... .....++..|+|||...+ ..++.++||||+||++|||++|+.||..... ......+........
T Consensus 162 fg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~~~~~ 236 (343)
T cd07851 162 FGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMNLVGTPD 236 (343)
T ss_pred cccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCC
Confidence 9999765322 334567889999998754 4678999999999999999999999965321 111111111000000
Q ss_pred -cc---------ccccCCCC-CCCchh----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 936 -NL---------EEALDPNV-GNCKHV----QEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 936 -~~---------~~~~~~~~-~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.+ ........ ...... ......+.+++.+|++.+|++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00 00000000 000000 0124567789999999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=247.38 Aligned_cols=267 Identities=25% Similarity=0.333 Sum_probs=202.8
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.|+..++||+|.||+||+|+...+++.||+|.++.. +.++.......+|+-+++.++|+|||++++....+...-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrld--dddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEecc--CCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 355567899999999999999999999999998443 223344566789999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
|||. .+|..+..+-... ++.+....++.|+++||.+.|++ .+.|||+||.|.++..+|..|++|||+++.++-
T Consensus 81 e~cd-qdlkkyfdslng~---~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 81 EFCD-QDLKKYFDSLNGD---LDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred HHhh-HHHHHHHHhcCCc---CCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 9995 4898888765432 78888889999999999999999 999999999999999999999999999998866
Q ss_pred CCcceEeeccCCCccCcCCCCCCC-CCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhh---cccc-ccc
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLK-VDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIR---DNRN-LEE 939 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~---~~~~-~~~ 939 (1018)
+-.-.+..+.|..|++|.++.+.+ |++..|+||.|||+.|+.. |++.|.+... ...+....+..-. +.++ ...
T Consensus 154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv-ddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH-HHHHHHHHHHhCCCccccCCcccc
Confidence 666666678899999999988765 8999999999999999998 5555654322 2223332222111 1110 011
Q ss_pred ccC----CCCCCCchhHHHHHH----HHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 940 ALD----PNVGNCKHVQEEMLL----VLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 940 ~~~----~~~~~~~~~~~~~~~----l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.-| |.......+.+.... -.+++.+.+.-+|..|.++++.++.
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111 111111122222222 2367778888899999999998764
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=295.70 Aligned_cols=270 Identities=23% Similarity=0.296 Sum_probs=200.6
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec-CCce
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN-DTNM 781 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 781 (1018)
+.++|+..+.||.|+||.||+|....+++.||+|++.... ......+.+.+|++++++++|||++++.+++.. ....
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF--STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 6788999999999999999999999899999999884322 122345678899999999999999999999865 5678
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
++|+||+ +++|.+++.... +++.....++.|++.||+|||+. +|+||||+|+||+++.++.++++|||.+.
T Consensus 86 ~lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSRP-----LEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999999 569998886432 67788888999999999999999 99999999999999999999999999987
Q ss_pred eeccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhh--------
Q 001752 862 MMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIR-------- 932 (1018)
Q Consensus 862 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------- 932 (1018)
.... ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||..... ............
T Consensus 157 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--VNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHHH
Confidence 5422 2233467889999998765 5689999999999999999999999965321 110000000000
Q ss_pred ---cccccccccCC-CCCCCchh----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhccCCC
Q 001752 933 ---DNRNLEEALDP-NVGNCKHV----QEEMLLVLRIAFLCTAKLPKDRPSMRDVITM--LGEAKPR 989 (1018)
Q Consensus 933 ---~~~~~~~~~~~-~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~~ 989 (1018)
.... .+.... ........ ......+.+++.+|++.+|++||++.++++. ++..+..
T Consensus 232 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 232 TICSENT-LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred hccchhh-HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 0000 000000 00000000 0122457789999999999999999999876 4444333
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=296.37 Aligned_cols=264 Identities=23% Similarity=0.280 Sum_probs=191.9
Q ss_pred cccccceeecCCCeeEEEEEcCCC--CeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEec----C
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRL--NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHN----D 778 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~----~ 778 (1018)
+|+..+.||+|+||.||+|....+ +..||+|++.... ......+.+.+|+.+++++ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 367778999999999999999877 8899999984221 1223356778899999999 59999999987532 2
Q ss_pred CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccc
Q 001752 779 TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFG 858 (1018)
Q Consensus 779 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 858 (1018)
..+++++||+. ++|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg 150 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRSGQP----LTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFG 150 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhcCCC----CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCC
Confidence 45788999985 699999865432 78999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCc----ceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHh--
Q 001752 859 LARMMIRKNE----TVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKI-- 931 (1018)
Q Consensus 859 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-- 931 (1018)
.++.+..... ......|++.|+|||+..+ ..++.++||||+||++|+|++|+.||...... .....+....
T Consensus 151 ~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~ 228 (332)
T cd07857 151 LARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--DQLNQILQVLGT 228 (332)
T ss_pred CceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH--HHHHHHHHHhCC
Confidence 9986543221 1223568899999998765 56899999999999999999999999753211 1111000000
Q ss_pred ----------hccc-ccccccC--CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 932 ----------RDNR-NLEEALD--PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 932 ----------~~~~-~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.... ....... +..............+.+++.+|++.||++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 0000000 000000000011345778999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-33 Score=273.80 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=197.6
Q ss_pred ccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhc-cCCCCcceeeeeEecCCceEEEEEe
Q 001752 709 ESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK-LRHRNIVRLLGFLHNDTNMMIVYEY 787 (1018)
Q Consensus 709 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lV~e~ 787 (1018)
....||.|+||+|+|-.++.+|+..|||++..... ....+++..|.+...+ =+.||||+++|.+-.++..++-||.
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 34579999999999999999999999999944322 3556788888887444 4789999999999999999999999
Q ss_pred cCCCCHHHhhh---cCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 788 MNNGSLGEALH---GKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 788 ~~~gsL~~~l~---~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|+ .|++.+-+ ..+ ...+++...-.|....+.||+||-... .|+|||+||+||++|..|.+|++|||.+..+.
T Consensus 145 Md-~SlDklYk~vy~vq--~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQ--KSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred Hh-hhHHHHHHHHHHHH--hccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 94 57766532 222 223777777788888999999998874 89999999999999999999999999997653
Q ss_pred cCCcceEeeccCCCccCcCCCCC--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYT--LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
+....+.-+|-..|+|||.+.. ..|+-++||||+|+++||+.||+.||... ..+.+.+.+......
T Consensus 220 -~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w----~svfeql~~Vv~gdp------- 287 (361)
T KOG1006|consen 220 -DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW----DSVFEQLCQVVIGDP------- 287 (361)
T ss_pred -HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH----HHHHHHHHHHHcCCC-------
Confidence 2334455678899999998763 34889999999999999999999999753 234444444443332
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
|.+....+..+....+..++.-|+.+|-..||..+++.+
T Consensus 288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 222222333455666888999999999999999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=321.53 Aligned_cols=149 Identities=28% Similarity=0.348 Sum_probs=133.1
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
++|.+.+.||+|+||+||+|.+..+++.||||++.... .........+.+|+.+++.++||||+++++++....+.|+|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~-~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKAD-MINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhh-ccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 56888899999999999999999899999999994322 12234456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
|||+++++|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~----l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999975443 78888999999999999999999 99999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-33 Score=272.65 Aligned_cols=270 Identities=21% Similarity=0.302 Sum_probs=201.6
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec-----
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN----- 777 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 777 (1018)
..++|+...+||+|.||+||+|+.+.+++.||+|++..+.. .+.......+|+.++..++|+|++.+++.|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene--KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc--ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 45678888899999999999999999999999998733222 23334567899999999999999999998853
Q ss_pred ---CCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEE
Q 001752 778 ---DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRI 854 (1018)
Q Consensus 778 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 854 (1018)
....|+||++|+. +|+-.+.....+ ++..++.+++.++..||.|+|+. .|+|||+||.|++++.+|.+|+
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr---~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilkl 165 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVR---FSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKL 165 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCcccc---ccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEe
Confidence 2357999999987 999999766432 78889999999999999999999 9999999999999999999999
Q ss_pred cccccceeeccCCc----ceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 001752 855 ADFGLARMMIRKNE----TVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRM 929 (1018)
Q Consensus 855 ~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~ 929 (1018)
+|||+++.+..... ..+..+.|..|++||.+.+ +.|+++.|||+.|||+.||++|.+.|.+..... ....+..
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqq--ql~~Is~ 243 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ--QLHLISQ 243 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHH--HHHHHHH
Confidence 99999987643322 2233566899999998765 569999999999999999999999987754321 1111221
Q ss_pred Hhh----cccc------ccccc--CCCCCCCchh-HHHH------HHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 930 KIR----DNRN------LEEAL--DPNVGNCKHV-QEEM------LLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 930 ~~~----~~~~------~~~~~--~~~~~~~~~~-~~~~------~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
... +.++ +.+.+ .|........ .+.. ....+++..++..||.+|+++++++.+-
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 111 0000 00111 1111111111 1111 1466789999999999999999998754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=282.15 Aligned_cols=261 Identities=26% Similarity=0.347 Sum_probs=200.0
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccc----cchhhhHHHHHHHHhccCCCCcceeeeeEec-
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLE----TESSGDFVGEVNVLGKLRHRNIVRLLGFLHN- 777 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 777 (1018)
..++|-..+.||+|||+.||+|.+-...++||||+-.. ...+. +...+...+|.++-+.+.||.||++++|+.-
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHql-NK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQL-NKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehh-ccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 45678888999999999999999988899999998732 22222 2334567799999999999999999999974
Q ss_pred CCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC---CCeEE
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN---LEPRI 854 (1018)
Q Consensus 778 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl 854 (1018)
.+.++-|+|||+|.+|+-+|+..+. +++..+..|++||+.||.||.+. .++|+|-||||.||++-.. |.+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhkl----mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKL----MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhh----hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 4678999999999999999987765 89999999999999999999987 4589999999999999543 78999
Q ss_pred cccccceeeccCCcc-------eEeeccCCCccCcCCCC----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccH
Q 001752 855 ADFGLARMMIRKNET-------VSMVAGSYGYIAPEYGY----TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDI 923 (1018)
Q Consensus 855 ~DfG~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~ 923 (1018)
.|||+++.+..+... .+...||+.|++||.+. ..+++.++||||.|||+|+++.|+.||..... ..++
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs-QQdI 693 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS-QQDI 693 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh-HHHH
Confidence 999999988544332 23367999999999654 23578899999999999999999999965321 1222
Q ss_pred HHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 924 VEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.+.-. .+.. . .--+.+. +....+...+|++|+++.-++|....++..
T Consensus 694 LqeNT-IlkA-t--EVqFP~K-------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 LQENT-ILKA-T--EVQFPPK-------PVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred Hhhhc-hhcc-e--eccCCCC-------CccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 22110 0000 0 0011121 122334567899999999999988877653
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=297.17 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=192.1
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC-----
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND----- 778 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 778 (1018)
..+|+..+.||.|+||.||+|....+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~----~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC----CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 467888999999999999999999899999999984332 23456788999999999999999999876543
Q ss_pred ---------CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcC-
Q 001752 779 ---------TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS- 848 (1018)
Q Consensus 779 ---------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~- 848 (1018)
...++||||++ ++|.+++.... +++..+..++.||+.|++|||+. +|+||||||+||+++.
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~ 150 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQGP-----LSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTE 150 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCC
Confidence 35789999996 59988886432 78899999999999999999999 9999999999999985
Q ss_pred CCCeEEcccccceeeccCCcc---eEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHH
Q 001752 849 NLEPRIADFGLARMMIRKNET---VSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIV 924 (1018)
Q Consensus 849 ~~~~kl~DfG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~ 924 (1018)
++.++++|||.++........ .....++..|+|||+..+ ..++.++|||||||++|||++|+.||....... ...
T Consensus 151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~ 229 (342)
T cd07854 151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQ 229 (342)
T ss_pred CceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHH
Confidence 457899999999765322111 122457889999997543 568889999999999999999999996532110 000
Q ss_pred HHHHHHhhccc---------ccccccC--CCCCCCc-h--hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 925 EWIRMKIRDNR---------NLEEALD--PNVGNCK-H--VQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 925 ~~~~~~~~~~~---------~~~~~~~--~~~~~~~-~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
..... ..... ....... ....... . .......+.+++.+|++.||++|||++|+++
T Consensus 230 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 230 LILES-VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHh-cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 00000 0000000 0000000 0 0012245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=292.79 Aligned_cols=241 Identities=23% Similarity=0.279 Sum_probs=193.2
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 782 (1018)
+..|+....+|.|+|+.|-.+.+..+++..+||++... ..+-.+|+.++... +|||++++.+.+.++.+.|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc--------ccccccccchhhhhcCCCcceeecceecCCceee
Confidence 45566667799999999999999999999999999333 22334577665555 7999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEE-cCCCCeEEcccccce
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILL-DSNLEPRIADFGLAR 861 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~DfG~a~ 861 (1018)
+|||.+.|+-+.+.+...+. .. ..+..|+.+|+.|+.|||++ ||||||+||+|||+ +..++++|+|||.++
T Consensus 393 ~v~e~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eeehhccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhh
Confidence 99999999988888876553 23 67777999999999999999 99999999999999 588999999999998
Q ss_pred eeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 862 MMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 862 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
..... ....+-|..|.|||+.....|++++|+||||+++|+|++|+.||.....+ .+ +...+.... +.
T Consensus 465 ~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~e-i~~~i~~~~-~s--- 532 (612)
T KOG0603|consen 465 ELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IE-IHTRIQMPK-FS--- 532 (612)
T ss_pred hCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HH-HHHhhcCCc-cc---
Confidence 75433 33456788999999999999999999999999999999999999765443 11 111111111 01
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
........+|+.+||+.||.+||+|+++..+
T Consensus 533 ----------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 ----------ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ----------cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1223345678899999999999999999864
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=280.29 Aligned_cols=264 Identities=20% Similarity=0.255 Sum_probs=202.5
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-C-C----CcceeeeeEe
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-H-R----NIVRLLGFLH 776 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-p----niv~~~~~~~ 776 (1018)
..++|...+.+|+|.||.|-++.+..++..||||+++. .........-|+++++++. + | -+|.+.+||.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-----V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-----VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-----HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 47899999999999999999999998999999999922 2223445567999999993 2 3 3788889999
Q ss_pred cCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcC--------
Q 001752 777 NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS-------- 848 (1018)
Q Consensus 777 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-------- 848 (1018)
-.++.++|+|.+ |-|+.+++..+.. .+++..++..++.|+++++++||+. +++|-||||+||++..
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEec
Confidence 999999999999 6799999987654 3477888899999999999999999 9999999999999841
Q ss_pred ------------CCCeEEcccccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 001752 849 ------------NLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPE 916 (1018)
Q Consensus 849 ------------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 916 (1018)
+..++|+|||.|+.- ....+..+.|..|+|||++.+-.++.++||||+|||++|+.+|..-|...
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~---~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFD---HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred cCCccceeccCCCcceEEEecCCccee---ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 235899999999864 33447788999999999999999999999999999999999999998654
Q ss_pred CCCcccHHHHHHHHhhcc----------------cccc--------------cccCCCCCCCchhHHHHHHHHHHHHHcc
Q 001752 917 FGESVDIVEWIRMKIRDN----------------RNLE--------------EALDPNVGNCKHVQEEMLLVLRIAFLCT 966 (1018)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~----------------~~~~--------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl 966 (1018)
.. .+....++..+.+- ..+. +...|.-.-.....++...+++|+++|+
T Consensus 313 en--~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 313 EN--LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred Cc--HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 21 11111111111100 0000 0000000001123356677999999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 001752 967 AKLPKDRPSMRDVITM 982 (1018)
Q Consensus 967 ~~dP~~RPt~~evl~~ 982 (1018)
..||.+|+|++|++.+
T Consensus 391 ~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 391 EFDPARRITLREALSH 406 (415)
T ss_pred ccCccccccHHHHhcC
Confidence 9999999999999863
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=295.53 Aligned_cols=254 Identities=25% Similarity=0.343 Sum_probs=207.6
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEe-----
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLH----- 776 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~----- 776 (1018)
.+..|++...||.|.+|.||++....+++.+|+|++ ....+...++..|..+++.. .|||++.++|+|.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~-----~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIM-----DPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEee-----cCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 456678888999999999999999999999999998 33444556677899998888 6999999999984
Q ss_pred cCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcc
Q 001752 777 NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 777 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 856 (1018)
.++.+++|||||.+||..|+++... +..+.|..+..|++.++.|+.|||.. .++|||||-.||+++.++.||++|
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence 4578999999999999999998766 44589999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceEeeccCCCccCcCCCC-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHh
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGY-----TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKI 931 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 931 (1018)
||.+..+........+..|||.|||||++. ...|+..+|+||+|++..||.-|.+|+...... +..
T Consensus 167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------raL- 237 (953)
T KOG0587|consen 167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------RAL- 237 (953)
T ss_pred eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------hhh-
Confidence 999988766555566688999999999875 345778999999999999999999998653110 111
Q ss_pred hcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 932 RDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
..+...-.|.+..+. ....++.++|..|+.+|.++||++.++++
T Consensus 238 ---F~IpRNPPPkLkrp~---kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 ---FLIPRNPPPKLKRPK---KWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ---ccCCCCCCccccchh---hHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 111122233333333 33455667888999999999999998876
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=307.90 Aligned_cols=259 Identities=30% Similarity=0.448 Sum_probs=204.1
Q ss_pred cccceeecCCCeeEEEEEcCC-------CCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCC
Q 001752 708 RESNVIGMGATGIVYKAEMPR-------LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 708 ~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 779 (1018)
...+.+|+|+||.|++|.... ....||||.++.... ....+.+..|+.+++.+ +||||+.++|+|..++
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~---~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS---SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccC---cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 445599999999999998531 156799999843322 25678899999999999 6999999999999999
Q ss_pred ceEEEEEecCCCCHHHhhhcCC---C---Cc------cccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEc
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQ---A---GR------LLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLD 847 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~---~---~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~ 847 (1018)
..++|+||++.|+|.++++..+ . .+ ..+.....+.++.|||.|++||++. ++||||+.++||+++
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEec
Confidence 9999999999999999998776 0 00 2378899999999999999999999 999999999999999
Q ss_pred CCCCeEEcccccceeeccCCcceEe-ecc--CCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccH
Q 001752 848 SNLEPRIADFGLARMMIRKNETVSM-VAG--SYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDI 923 (1018)
Q Consensus 848 ~~~~~kl~DfG~a~~~~~~~~~~~~-~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~ 923 (1018)
++..+||+|||+|+........... ..+ ...|||||.+....++.++|||||||++||+++ |..||.+.. ...++
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-~~~~l 531 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-PTEEL 531 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-cHHHH
Confidence 9999999999999865433333211 222 346999999999999999999999999999999 899996521 12223
Q ss_pred HHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCC
Q 001752 924 VEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKP 988 (1018)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 988 (1018)
..+++...+.. .... ...+++++++.||+.+|++||++.++++.++....
T Consensus 532 ~~~l~~G~r~~------------~P~~---c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 532 LEFLKEGNRME------------QPEH---CSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHhcCCCCC------------CCCC---CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 33222211111 1111 13457789999999999999999999999988543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=275.41 Aligned_cols=266 Identities=22% Similarity=0.290 Sum_probs=207.2
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-----C---CCcceeeeeE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-----H---RNIVRLLGFL 775 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~~~~~~ 775 (1018)
.++|.+.++||.|.|++||.|.+....+.||+|+. +..+...+....||.++++++ | ..||++++.|
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVv-----KSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVV-----KSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEE-----ehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 37899999999999999999999999999999999 334455667788999999993 3 4699999998
Q ss_pred e----cCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEc----
Q 001752 776 H----NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLD---- 847 (1018)
Q Consensus 776 ~----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---- 847 (1018)
. .+.+++||+|++ |.+|..++.....++ ++...+.+|++||+.||.|||..| ||+|-||||+|||+.
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrG--lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~ 226 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRG--LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEI 226 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCC--CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecccc
Confidence 5 457899999999 779999998777665 677889999999999999999999 999999999999984
Q ss_pred --------------------------------------------------------------------------------
Q 001752 848 -------------------------------------------------------------------------------- 847 (1018)
Q Consensus 848 -------------------------------------------------------------------------------- 847 (1018)
T Consensus 227 ~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~ 306 (590)
T KOG1290|consen 227 DPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNE 306 (590)
T ss_pred chhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccc
Confidence
Q ss_pred ------------------------------CC------------------------------------------------
Q 001752 848 ------------------------------SN------------------------------------------------ 849 (1018)
Q Consensus 848 ------------------------------~~------------------------------------------------ 849 (1018)
..
T Consensus 307 ~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~ 386 (590)
T KOG1290|consen 307 PRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPL 386 (590)
T ss_pred cCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCC
Confidence 00
Q ss_pred ----CCeEEcccccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCC----cc
Q 001752 850 ----LEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGE----SV 921 (1018)
Q Consensus 850 ----~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~----~~ 921 (1018)
-++||+|||-|++. ..+++.-..|..|+|||++.+..|++.+||||++|+++|++||...|++..++ +.
T Consensus 387 ~~~di~vKIaDlGNACW~---~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE 463 (590)
T KOG1290|consen 387 PECDIRVKIADLGNACWV---HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE 463 (590)
T ss_pred CccceeEEEeeccchhhh---hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence 02677777777764 34555567889999999999999999999999999999999999999876543 22
Q ss_pred cHHHHHHHH--------hhcccccccccCCCC------------------CCCchhHHHHHHHHHHHHHccCCCCCCCCC
Q 001752 922 DIVEWIRMK--------IRDNRNLEEALDPNV------------------GNCKHVQEEMLLVLRIAFLCTAKLPKDRPS 975 (1018)
Q Consensus 922 ~~~~~~~~~--------~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 975 (1018)
+....+... ...++.-.++++..- +...-..++...+.+++.-||+.+|++|||
T Consensus 464 DHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t 543 (590)
T KOG1290|consen 464 DHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT 543 (590)
T ss_pred HHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence 222222221 111221222222110 112223466778889999999999999999
Q ss_pred HHHHHHH
Q 001752 976 MRDVITM 982 (1018)
Q Consensus 976 ~~evl~~ 982 (1018)
+.+.+++
T Consensus 544 A~~cl~h 550 (590)
T KOG1290|consen 544 AAQCLKH 550 (590)
T ss_pred HHHHhcC
Confidence 9999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=277.04 Aligned_cols=221 Identities=21% Similarity=0.191 Sum_probs=176.3
Q ss_pred CCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCCCCHHH
Q 001752 716 GATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGE 795 (1018)
Q Consensus 716 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~ 795 (1018)
|.+|.||++.+..+++.||+|++.... .+.+|...+....|||++++++++.+.+..++||||+++|+|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 899999999999999999999993321 23345555556679999999999999999999999999999999
Q ss_pred hhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcceEeecc
Q 001752 796 ALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG 875 (1018)
Q Consensus 796 ~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 875 (1018)
++..... +++..+..++.|++.||+|+|+. +|+||||||+||+++.++.++++|||.+...... .....+
T Consensus 75 ~l~~~~~----l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~ 144 (237)
T cd05576 75 HISKFLN----IPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAV 144 (237)
T ss_pred HHHHhcC----CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCc
Confidence 9975432 78999999999999999999999 9999999999999999999999999987654322 223456
Q ss_pred CCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHH
Q 001752 876 SYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEM 955 (1018)
Q Consensus 876 t~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 955 (1018)
+..|+|||+..+..++.++||||+|+++|||++|+.|+....... ... ....... ...
T Consensus 145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~------~~~~~~~-----~~~ 202 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTH------TTLNIPE-----WVS 202 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------ccc------cccCCcc-----cCC
Confidence 778999999988889999999999999999999998875321100 000 0000000 112
Q ss_pred HHHHHHHHHccCCCCCCCCCHH
Q 001752 956 LLVLRIAFLCTAKLPKDRPSMR 977 (1018)
Q Consensus 956 ~~l~~l~~~cl~~dP~~RPt~~ 977 (1018)
..+.+++.+|++.||++||++.
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCC
Confidence 3467889999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=262.09 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=202.7
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 782 (1018)
...|+..++||+|+|+.|-.+++.++.+.+|+|+++++....+ +...-.+.|-.+..+. +||.+|.+..+|+.+...+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd-edidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc-ccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 4668889999999999999999999999999999966544333 3334455676676665 7999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
+|.||++||+|--+++.+++ ++++.+..+...|.-||.|||++ ||++||+|.+||++|..|++|+.|+|+++.
T Consensus 328 fvieyv~ggdlmfhmqrqrk----lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehhhhhc----CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999888876655 88888888999999999999999 999999999999999999999999999987
Q ss_pred eccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCC--CCcccHHHHHHHHhhcccccccc
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEF--GESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
-..++...++.+|||-|+|||.+.+..|...+|.|++||+++||+.|+.||+--. ..+.+-.++.-+.+.+.. +.
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq-ir-- 477 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ-IR-- 477 (593)
T ss_pred CCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-cc--
Confidence 7777778888999999999999999999999999999999999999999996422 222333333332222221 00
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCC
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRP 974 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 974 (1018)
-|+. ...+...++..-+++||.+|.
T Consensus 478 -iprs--------lsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 -IPRS--------LSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -ccce--------eehhhHHHHHHhhcCCcHHhc
Confidence 0111 112344577788999999984
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=245.80 Aligned_cols=204 Identities=25% Similarity=0.374 Sum_probs=170.8
Q ss_pred ccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhc-cCCCCcceeeeeEecCCceEEEEEe
Q 001752 709 ESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK-LRHRNIVRLLGFLHNDTNMMIVYEY 787 (1018)
Q Consensus 709 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lV~e~ 787 (1018)
....||+|++|.|-+.++..+|+..|+|.+... ......++..+|+.+..+ ..+|.+|+++|.+.....+++.||.
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~t---vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT---VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhh---cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 345799999999999999999999999999332 234556677888888544 5799999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCC
Q 001752 788 MNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKN 867 (1018)
Q Consensus 788 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 867 (1018)
|+ -||+.+-.+.-..+...++...-+||..|..||.|||++. .++|||+||+|||++.+|+||++|||.+..+. +.
T Consensus 127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~-dS 202 (282)
T KOG0984|consen 127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV-DS 202 (282)
T ss_pred hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh-hh
Confidence 95 5888876654445556899999999999999999999985 89999999999999999999999999998763 23
Q ss_pred cceEeeccCCCccCcCCCC----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 001752 868 ETVSMVAGSYGYIAPEYGY----TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGE 919 (1018)
Q Consensus 868 ~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 919 (1018)
-..+...|-..|+|||.+. ...|+-++||||+|+++.||.+++.||+.....
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 3344467888999999754 447899999999999999999999999875443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=297.59 Aligned_cols=263 Identities=18% Similarity=0.201 Sum_probs=170.7
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCC----CeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeee----
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRL----NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGF---- 774 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~---- 774 (1018)
..+.|+..+.||+|+||.||+|++..+ +..||+|++.... .......| .++...+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 456789999999999999999999888 8999999873211 11111111 1122222233322221
Q ss_pred --EecCCceEEEEEecCCCCHHHhhhcCCCC----------------ccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 001752 775 --LHNDTNMMIVYEYMNNGSLGEALHGKQAG----------------RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIH 836 (1018)
Q Consensus 775 --~~~~~~~~lV~e~~~~gsL~~~l~~~~~~----------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 836 (1018)
...+...++||||+++++|.+++...... ........+..++.||+.||+|||+. +|+|
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiH 278 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVH 278 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 24566789999999999999998754311 00112344567999999999999999 9999
Q ss_pred ecCCCCcEEEcC-CCCeEEcccccceeeccCC-cceEeeccCCCccCcCCCCCC----------------------CCCc
Q 001752 837 RDIKSNNILLDS-NLEPRIADFGLARMMIRKN-ETVSMVAGSYGYIAPEYGYTL----------------------KVDE 892 (1018)
Q Consensus 837 ~Dlk~~NIll~~-~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ 892 (1018)
|||||+||+++. ++.+||+|||+|+.+.... .......++++|+|||.+... .++.
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 999999999986 5799999999998653322 223446789999999954321 2345
Q ss_pred cccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccc---cccCCCC----CCC-chhHHHHHHHHHHHHH
Q 001752 893 KIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE---EALDPNV----GNC-KHVQEEMLLVLRIAFL 964 (1018)
Q Consensus 893 ~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~----~~~-~~~~~~~~~l~~l~~~ 964 (1018)
++||||+||++|||+++..|++. +...+............ ....+.. ... ...........+++.+
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence 67999999999999997766543 11111111111110000 0011110 000 0000011234579999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 001752 965 CTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 965 cl~~dP~~RPt~~evl~~ 982 (1018)
|+++||++|||+++++++
T Consensus 433 mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 433 MMRFKGRQRISAKAALAH 450 (566)
T ss_pred HccCCcccCCCHHHHhCC
Confidence 999999999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-31 Score=295.19 Aligned_cols=245 Identities=26% Similarity=0.397 Sum_probs=189.2
Q ss_pred ccccceeecCCCe-eEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCceEEE
Q 001752 707 IRESNVIGMGATG-IVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 707 ~~~~~~lG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV 784 (1018)
|...+++|.|+.| .||+|... ++.||||++.. +....+.+|+..++.- .|||||++++.-.++.+.|+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~-------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLE-------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhh-------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence 4455678999977 68999997 89999999822 3344567899998888 699999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcC---C--CCeEEccccc
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS---N--LEPRIADFGL 859 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~--~~~kl~DfG~ 859 (1018)
.|.|. .+|.+++...............+.+..|++.||+|||+. +||||||||.|||++. + .+++|+|||+
T Consensus 582 lELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 582 LELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred ehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccc
Confidence 99995 599999987411111112244567899999999999998 9999999999999976 3 4799999999
Q ss_pred ceeeccCCcce---EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhccc
Q 001752 860 ARMMIRKNETV---SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNR 935 (1018)
Q Consensus 860 a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 935 (1018)
++.+..+.... ....||.||+|||.+.....+.++||||+||++|+.++ |.+||......+.++. ....
T Consensus 658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl-------~~~~ 730 (903)
T KOG1027|consen 658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL-------TGNY 730 (903)
T ss_pred ccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh-------cCcc
Confidence 99886554433 34779999999999998888899999999999999999 5999976422222221 1221
Q ss_pred ccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 936 NLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.+.... + ..+. ...+||.+|++++|..||++.+|+.
T Consensus 731 ~L~~L~-~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 731 TLVHLE-P-------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ceeeec-c-------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111110 0 0111 5668999999999999999999986
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=274.84 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=201.7
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
..++...-||-||||.|-.+........+|+|++++.+ ..+.........|-.+|...+.|.||+++..|.+..++||.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~h-IVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKH-IVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhh-ccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 44555667999999999999988656668999885443 33445567788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
||-|-||.|...+++++. ++......++..+++|++|||++ +||+|||||+|.++|.+|-+|+.|||+|+.+.
T Consensus 499 mEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999988765 77777777888999999999999 99999999999999999999999999999875
Q ss_pred cCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCC
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
.+. ..-+.+|||.|.|||.+..+..+.++|.||+|+++||+++|.+||.+... ...+...+..-. ..+ +..
T Consensus 572 ~g~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp-----mktYn~ILkGid-~i~-~Pr- 642 (732)
T KOG0614|consen 572 SGR-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP-----MKTYNLILKGID-KIE-FPR- 642 (732)
T ss_pred cCC-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch-----HHHHHHHHhhhh-hhh-ccc-
Confidence 544 44457999999999999999999999999999999999999999976321 111111111110 000 011
Q ss_pred CCCCchhHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPS-----MRDVITM 982 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 982 (1018)
.......+++++....+|.+|-- +.+|-++
T Consensus 643 --------~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 643 --------RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred --------ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 11223557888888999999975 5666654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=264.37 Aligned_cols=240 Identities=28% Similarity=0.413 Sum_probs=192.8
Q ss_pred CCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCCCCHHHh
Q 001752 717 ATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEA 796 (1018)
Q Consensus 717 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~ 796 (1018)
+||.||+|+...+++.+|+|++...... ...+.+.+|++.+++++|++++++++++......+++|||+++++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 5899999999988999999998433221 1167899999999999999999999999999999999999999999999
Q ss_pred hhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcceEeeccC
Q 001752 797 LHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS 876 (1018)
Q Consensus 797 l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 876 (1018)
+..... +++..++.++.+++++++|||+. +++|+||+|+||+++.++.++++|||.+....... ......++
T Consensus 78 ~~~~~~----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 149 (244)
T smart00220 78 LKKRGR----LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGT 149 (244)
T ss_pred HHhccC----CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCC
Confidence 976543 78899999999999999999999 99999999999999999999999999998764332 33445688
Q ss_pred CCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHH
Q 001752 877 YGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEML 956 (1018)
Q Consensus 877 ~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 956 (1018)
+.|+|||...+..++.++||||+|++++++++|..||.... +.............. ... .......
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~----~~~~~~~~~~~~~~~------~~~----~~~~~~~ 215 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD----QLLELFKKIGKPKPP------FPP----PEWKISP 215 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHhccCCC------Ccc----ccccCCH
Confidence 89999999988889999999999999999999999996521 111111111111110 000 0000224
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 957 LVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 957 ~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.+.+++.+|+..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 5778999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=279.69 Aligned_cols=264 Identities=21% Similarity=0.263 Sum_probs=179.9
Q ss_pred hhcccccceeecCCCeeEEEEEcC----------------CCCeEEEEEEeeccccccc----------cchhhhHHHHH
Q 001752 704 LACIRESNVIGMGATGIVYKAEMP----------------RLNTIVAVKKLWRSRADLE----------TESSGDFVGEV 757 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~----------~~~~~~~~~E~ 757 (1018)
.+.|+..++||+|+||+||+|... ..++.||||++........ ......+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 567899999999999999999742 2356899999843211100 01122344577
Q ss_pred HHHhccCCCCc-----ceeeeeEec--------CCceEEEEEecCCCCHHHhhhcCCCC--------------------c
Q 001752 758 NVLGKLRHRNI-----VRLLGFLHN--------DTNMMIVYEYMNNGSLGEALHGKQAG--------------------R 804 (1018)
Q Consensus 758 ~~l~~l~hpni-----v~~~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~~--------------------~ 804 (1018)
.++.+++|.++ ++++++|.. .+..++||||+++++|.++++..... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77888876554 677787753 35679999999999999999753210 1
Q ss_pred cccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcce-EeeccCCCccCcC
Q 001752 805 LLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV-SMVAGSYGYIAPE 883 (1018)
Q Consensus 805 ~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~gt~~y~aPE 883 (1018)
...++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+++......... ....+|+.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1246778889999999999999999 99999999999999999999999999997653322111 1234578999999
Q ss_pred CCCCCC----------------------CCccccchhHHHHHHHHHhCCC-CCCCCCCC-------cccHHHHHHHHhhc
Q 001752 884 YGYTLK----------------------VDEKIDIYSFGVVLLELLTGRR-PLDPEFGE-------SVDIVEWIRMKIRD 933 (1018)
Q Consensus 884 ~~~~~~----------------------~~~~~Dv~slG~il~elltg~~-pf~~~~~~-------~~~~~~~~~~~~~~ 933 (1018)
.+.... ...+.||||+||++|||++|.. ||.....- ..+...|... ..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~~ 458 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--KG 458 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--cc
Confidence 865322 1134799999999999999875 66432110 1111122110 00
Q ss_pred ccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHH
Q 001752 934 NRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLP---KDRPSMRDVITM 982 (1018)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPt~~evl~~ 982 (1018)
.. .+ . ...........+++.+++.++| .+|+|++|++++
T Consensus 459 ~~-----~~--~---~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QK-----YD--F---SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cC-----CC--c---ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00 00 0 0111223446678889999766 689999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=253.44 Aligned_cols=266 Identities=24% Similarity=0.342 Sum_probs=194.8
Q ss_pred ccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC-----CceEE
Q 001752 709 ESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND-----TNMMI 783 (1018)
Q Consensus 709 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~l 783 (1018)
..+.||.|+||.||.+.+..+|+.||+|++ .+....-...+.+.+|+.++..++|.|+...++..+.. .+.|+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~--pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKM--PNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhc--chHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 457899999999999999999999999998 33344455678899999999999999999998887543 24688
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
|.|.|. .+|.+.+-+.. .++...+.-+..||++||+|||+. +|.||||||.|.+++.+...||+|||+|+..
T Consensus 135 ~TELmQ-SDLHKIIVSPQ----~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSPQ----ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHH-hhhhheeccCC----CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence 999984 48888775543 377778888999999999999999 9999999999999999999999999999875
Q ss_pred ccC-CcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCC-CcccHHH---------HHHHHh
Q 001752 864 IRK-NETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFG-ESVDIVE---------WIRMKI 931 (1018)
Q Consensus 864 ~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~-~~~~~~~---------~~~~~~ 931 (1018)
..+ ..+++..+.|..|+|||.+++ +.|+.++||||.|||+.|++..+.-|..... +..+++. .++...
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 332 334555678899999999886 4599999999999999999998888854211 1111110 000000
Q ss_pred hcccc--ccc-ccCCCCCC---CchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 001752 932 RDNRN--LEE-ALDPNVGN---CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984 (1018)
Q Consensus 932 ~~~~~--~~~-~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 984 (1018)
...+. +.. .-.|.... .......-.+...+...+++.||++|.+..+.+...-
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 00000 000 00111110 0001111123446778899999999999999988764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=252.76 Aligned_cols=259 Identities=22% Similarity=0.283 Sum_probs=200.4
Q ss_pred hcccccceeecCCCeeEEEEEcCCCC-----eEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEec-C
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN-D 778 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 778 (1018)
.+++....+-+|.||.||+|.+.+.+ +.|-||.++. ...+-....+..|.-.+..+.|||+..+.+.+.+ .
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~---~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ---HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh---cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 44666677899999999999876433 3456666622 2233445667788888888899999999999855 4
Q ss_pred CceEEEEEecCCCCHHHhhhcCC----CCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEE
Q 001752 779 TNMMIVYEYMNNGSLGEALHGKQ----AGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRI 854 (1018)
Q Consensus 779 ~~~~lV~e~~~~gsL~~~l~~~~----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 854 (1018)
...+.+|.++.-|+|..++...+ .....+...+...++.|++.|++|||++ +|||.||.++|.++|+.-+||+
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEe
Confidence 66799999999999999998322 2234477788889999999999999999 9999999999999999999999
Q ss_pred cccccceeeccCCcceEe--eccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHh
Q 001752 855 ADFGLARMMIRKNETVSM--VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKI 931 (1018)
Q Consensus 855 ~DfG~a~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 931 (1018)
+|-.+++.+.+.+.+--. ......||+||.+....|+.++|||||||++|||+| |+.|+...+. ..+...+
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP------fEm~~yl 511 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP------FEMEHYL 511 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH------HHHHHHH
Confidence 999999988766554322 234568999999999999999999999999999999 9999965322 1122233
Q ss_pred hcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 932 RDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
.++..+.. ..+.++ +++.++.-||..+|++||++++++.-|.+.
T Consensus 512 kdGyRlaQ--------P~NCPD---eLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 512 KDGYRLAQ--------PFNCPD---ELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred hccceecC--------CCCCcH---HHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 33332221 112222 366788899999999999999999988775
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=266.80 Aligned_cols=206 Identities=24% Similarity=0.344 Sum_probs=175.6
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
.-|.+.+.||-|+||+|..+...++...||.|.+.+.. -.........+.|-+++.....+-||+++-.|++++.+|+|
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaD-Vl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKAD-VLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHH-HHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 44677889999999999999988888899999984332 23344566788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
|||++||++-.+|-..+. +++..+..++..+..|+++.|.. |+|||||||+|||+|.+|++||.|||++.-+.
T Consensus 708 MdYIPGGDmMSLLIrmgI----FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGI----FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHHhcc----CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 999999999999976654 67777777888999999999999 99999999999999999999999999986331
Q ss_pred --c------CCcce----------------------------------EeeccCCCccCcCCCCCCCCCccccchhHHHH
Q 001752 865 --R------KNETV----------------------------------SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVV 902 (1018)
Q Consensus 865 --~------~~~~~----------------------------------~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~i 902 (1018)
. .+.+. -..+||+-|+|||++....++..+|.||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 0 00000 01469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCC
Q 001752 903 LLELLTGRRPLDPEFG 918 (1018)
Q Consensus 903 l~elltg~~pf~~~~~ 918 (1018)
+|||+.|+.||.....
T Consensus 861 l~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTP 876 (1034)
T ss_pred HHHHhhCCCCccCCCC
Confidence 9999999999966543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=249.47 Aligned_cols=266 Identities=24% Similarity=0.275 Sum_probs=202.8
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecC----
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND---- 778 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 778 (1018)
+..+|...+.+|.|+. .|..|.+.-.+++||+|++..+ .......++..+|..++..+.|+|+++++.++.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p--f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP--FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc--cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 4567778889999999 8888998888999999998554 33456678889999999999999999999998644
Q ss_pred --CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcc
Q 001752 779 --TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 779 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 856 (1018)
...|+|||+| .++|...+... ++..+...|..|++.|+.|||+. +|+||||||+||++..+..+||.|
T Consensus 92 ~~~e~y~v~e~m-~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~d 161 (369)
T KOG0665|consen 92 EFQEVYLVMELM-DANLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILD 161 (369)
T ss_pred HHHhHHHHHHhh-hhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeecc
Confidence 3579999999 45999988722 67888999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc---------------
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESV--------------- 921 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~--------------- 921 (1018)
||+|+.-... -..+.++.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+...-++
T Consensus 162 fg~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 162 FGLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred chhhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 9999864322 355668899999999999988899999999999999999999998875311000
Q ss_pred --cHHHHHHHHhhcc-----cccccccC-CCCCC-CchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 922 --DIVEWIRMKIRDN-----RNLEEALD-PNVGN-CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 922 --~~~~~~~~~~~~~-----~~~~~~~~-~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
++...++...... ..+.+.+. ..... .....-..-...+++.+||..+|++|.++++++++
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1111111111110 11111111 10000 00111223345578999999999999999999984
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=263.97 Aligned_cols=201 Identities=28% Similarity=0.376 Sum_probs=174.1
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccc----hhhhHHHHHHHHhccC---CCCcceeeeeEec
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETE----SSGDFVGEVNVLGKLR---HRNIVRLLGFLHN 777 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~~E~~~l~~l~---hpniv~~~~~~~~ 777 (1018)
..|...+.+|.|+||.|+.|+++.+...|+||.+.+++.-.+.. .....-.|+++|.+++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 44788899999999999999999999999999986554332221 2234567999999997 9999999999999
Q ss_pred CCceEEEEEec-CCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcc
Q 001752 778 DTNMMIVYEYM-NNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 778 ~~~~~lV~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 856 (1018)
++++|++||-. +|.+|.+++..++. +++..+.-|+.||+.|+++||++ ||||||||-+||.++.+|-+|++|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~----m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR----MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc----cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999975 45599999987665 88888999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceEeeccCCCccCcCCCCCCCC-CccccchhHHHHHHHHHhCCCCCC
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV-DEKIDIYSFGVVLLELLTGRRPLD 914 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~pf~ 914 (1018)
||.|... ........+||.+|.|||++.+.+| +..-|||++|+++|.++....||.
T Consensus 714 fgsaa~~--ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYT--KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhh--cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999754 3445667899999999999999886 467899999999999999988885
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-30 Score=264.52 Aligned_cols=309 Identities=22% Similarity=0.221 Sum_probs=192.5
Q ss_pred HHHHhhhccccccchhcccccHHHHHHHHHHHhccCCCCCCcCCCCCCCCCceeeeEEeCCCCCEEEEEcCCCCCCcccc
Q 001752 12 FYCYIGCTCFGSAKVVAKTALNDELLALLSIKAGLVDPLNSLHDWKLPSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVS 91 (1018)
Q Consensus 12 ~~~~~~~~c~~~~~~~~~~~~~~~~~~Ll~~k~~~~d~~~~~~~w~~~~~~c~w~gv~c~~~~~v~~L~L~~~~l~~~~~ 91 (1018)
..||..|+|.... ...+.| +...|.++++.+ ....+.++|..|+|+.+.+
T Consensus 35 ~~CP~pC~Cs~~~-g~~VdC---r~~GL~eVP~~L--------------------------P~~tveirLdqN~I~~iP~ 84 (498)
T KOG4237|consen 35 SACPAPCTCSDVE-GGIVDC---RGKGLTEVPANL--------------------------PPETVEIRLDQNQISSIPP 84 (498)
T ss_pred ccCCCCcccCCCC-CceEEc---cCCCcccCcccC--------------------------CCcceEEEeccCCcccCCh
Confidence 4699999998644 233333 113344444433 1234888999999998888
Q ss_pred cccccCCCCCEEEcCCCCcCCCCChhhhCCCCCcEEEeee-cccCCCCcccccCCCCCceeccCCCCCCccccccccccc
Q 001752 92 DHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQ-NFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNAT 170 (1018)
Q Consensus 92 ~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~ 170 (1018)
.+|+.+++||+||||+|+|+.+.|++|..|.+|..|-+-+ |+|+...-..|++|..|+.|.+.-|++.-+..+.|..++
T Consensus 85 ~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~ 164 (498)
T KOG4237|consen 85 GAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLP 164 (498)
T ss_pred hhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhh
Confidence 8899999999999999999888899998888887776655 888844445788888888888888888888888888888
Q ss_pred ccceEeccCcccCcccccccccccccceeeeccccc------------CCCCCcccccccchhhhhccccccCCCCCccc
Q 001752 171 SLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNL------------TGKIPRELGQLSSMETMILAYNEFDGEIPVEF 238 (1018)
Q Consensus 171 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l------------~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~ 238 (1018)
+|..|.+.+|.+..+--.+|..+..++.+.+..|.+ ....|-+++...-.....+.++++..+-+..|
T Consensus 165 ~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf 244 (498)
T KOG4237|consen 165 SLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKF 244 (498)
T ss_pred hcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhh
Confidence 888888888888744444788888888888888872 22334445555555555555555553333333
Q ss_pred cCc-cccccccccccccCccCcc-cccCCCccceEEccCCcCCccCChhhcCCCCCCeeeccCCCCccccCCccccccCC
Q 001752 239 GNL-TNLKYLDLAVGNLGGKIPA-ELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNL 316 (1018)
Q Consensus 239 ~~l-~~L~~L~L~~n~l~~~~~~-~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 316 (1018)
... ..+..=-.+.+...+..|. .|..|++|+.|+|++|+++++-+.+|..+..+++|.|..|+|.......|.++.+|
T Consensus 245 ~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L 324 (498)
T KOG4237|consen 245 LCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGL 324 (498)
T ss_pred hhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccc
Confidence 221 1111111122222222232 24555555555555555555555555555555555555555544444445555555
Q ss_pred ceeecccCccccccCCCCCCCCccceEEeccCcc
Q 001752 317 QLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSL 350 (1018)
Q Consensus 317 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 350 (1018)
+.|+|.+|+|+...|.+|..+.+|..|+|-.|.+
T Consensus 325 ~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 325 KTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred eeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence 5555555555555555555555555555555443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=236.13 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=194.9
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeee-EecCCc
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGF-LHNDTN 780 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~-~~~~~~ 780 (1018)
..+.|++.+.+|+|.||.+-.++++++.+.+++|.+ .......++|.+|...--.+ .|.||+.-++. |+..+.
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKav-----p~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAV-----PRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeecc-----CcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 567889999999999999999999999999999998 33445678899999875555 58999987764 677888
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEE-cCC-CCeEEcccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILL-DSN-LEPRIADFG 858 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll-~~~-~~~kl~DfG 858 (1018)
+++++||++-|+|.+-+...+ +.+....+++.|+++|++|||++ ++||||||.+||++ +.| .++|++|||
T Consensus 97 YvF~qE~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred EEEeeccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecc
Confidence 999999999999999987644 67888889999999999999999 99999999999998 333 479999999
Q ss_pred cceeeccCCcceEeeccCCCccCcCCCCC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhc
Q 001752 859 LARMMIRKNETVSMVAGSYGYIAPEYGYT-----LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD 933 (1018)
Q Consensus 859 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 933 (1018)
..+.. +........+..|.|||.... -...+.+|||.||+++|.++||+.||......+..+..|.....+.
T Consensus 169 ~t~k~---g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 169 LTRKV---GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK 245 (378)
T ss_pred ccccc---CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence 98643 223333445667999997442 2356789999999999999999999986544444444444333222
Q ss_pred ccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 934 NRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
.....+.+. .....+.++.++-+.++|++|=-..++.++.
T Consensus 246 ~~~~P~~F~----------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 246 NPALPKKFN----------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred CccCchhhc----------ccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 222222222 2234466777899999999995555555554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=228.50 Aligned_cols=261 Identities=18% Similarity=0.259 Sum_probs=195.0
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeeeEecC--Cc
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHND--TN 780 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~ 780 (1018)
.+.|+..+++|+|.|++||.|....+.+.++||++++ ...+.+.+|+.+++.++ ||||+++++...+. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 3568888999999999999999888899999999933 33567889999999996 99999999998765 45
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC-CCeEEccccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN-LEPRIADFGL 859 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG~ 859 (1018)
..+|+||+.+.+....-.. ++...+...+.+++.||.|+|+. ||.|||+||.|+++|.. ...+++|+|+
T Consensus 110 paLiFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred chhHhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecch
Confidence 6899999988776655432 45566677899999999999999 99999999999999976 4699999999
Q ss_pred ceeeccCCcceEeeccCCCccCcCCCCC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH--------
Q 001752 860 ARMMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMK-------- 930 (1018)
Q Consensus 860 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~-------- 930 (1018)
|.++.++ ......+.+..|--||.+-. ..|+..-|+|||||++..|+..+.||-........++....-.
T Consensus 180 AEFYHp~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 180 AEFYHPG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred HhhcCCC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence 9988554 44455667788999998654 5588999999999999999999999854333333333322211
Q ss_pred -----hhcccccccccCCCCC-------CCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 931 -----IRDNRNLEEALDPNVG-------NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 931 -----~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
+.-...+.+++..... ...+..-...+.++++.+.+..|-.+|||++|++++
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0001111111111110 011111113457788889999999999999998763
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=239.31 Aligned_cols=213 Identities=34% Similarity=0.549 Sum_probs=184.3
Q ss_pred eecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCCCC
Q 001752 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGS 792 (1018)
Q Consensus 713 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gs 792 (1018)
||+|++|.||++....+++.+++|++...... ...+.+.+|+..++.++|++++++++++......++++||+++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS---SLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccch---hHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 68999999999999878999999999432221 135678999999999999999999999999899999999999999
Q ss_pred HHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcC-CCCeEEcccccceeeccCCcceE
Q 001752 793 LGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS-NLEPRIADFGLARMMIRKNETVS 871 (1018)
Q Consensus 793 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~ 871 (1018)
|.+++.... ...++..+..++.++++++++||+. +++|+||+|.||+++. ++.++++|||.+...........
T Consensus 78 l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (215)
T cd00180 78 LKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151 (215)
T ss_pred HHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhh
Confidence 999997653 2378899999999999999999999 9999999999999999 89999999999987644332234
Q ss_pred eeccCCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCch
Q 001752 872 MVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKH 950 (1018)
Q Consensus 872 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 950 (1018)
...+...|++||..... .++.++|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 45678899999998777 888999999999999998
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 951 VQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 951 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
..+.+++.+|++.+|++||++.++++.+
T Consensus 188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2366788999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-27 Score=259.53 Aligned_cols=254 Identities=25% Similarity=0.320 Sum_probs=201.5
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
...|+...++|+|.||.||||++..+++..|+|+++.... +..+..++|+-+++..+|||||.++|.|-..+..++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~----dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG----DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC----ccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 3557778899999999999999999999999999954322 345567789999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
.||||.||+|++.-+.... +++.++..+++...+|++|||+. |-+|||||-.||+++..|.+|++|||.+..+
T Consensus 90 cMEycgggslQdiy~~Tgp----lselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGP----LSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred EEEecCCCcccceeeeccc----chhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhh
Confidence 9999999999998765443 89999999999999999999999 9999999999999999999999999998777
Q ss_pred ccCCcceEeeccCCCccCcCCC---CCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccc
Q 001752 864 IRKNETVSMVAGSYGYIAPEYG---YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
...-.......||+.|||||+. ..+.|...+|||+.|++..|+---++|.-.. .-.+....+.+...
T Consensus 163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl-----hpmr~l~LmTkS~~----- 232 (829)
T KOG0576|consen 163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL-----HPMRALFLMTKSGF----- 232 (829)
T ss_pred hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc-----chHHHHHHhhccCC-----
Confidence 5555555667899999999974 4667899999999999999998877774321 00111111111111
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
-.|.+.+...+ ...+-++++.|+.++|.+||++..+++
T Consensus 233 qpp~lkDk~kw---s~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 233 QPPTLKDKTKW---SEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCcccCCccc---hHHHHHHHHHHhcCCCccCCChhhhee
Confidence 12222222222 234557888999999999999987765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-27 Score=250.59 Aligned_cols=268 Identities=19% Similarity=0.203 Sum_probs=203.7
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC------CCCcceeeeeEe
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR------HRNIVRLLGFLH 776 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~ 776 (1018)
...+|.+....|+|-|++|.+|.+...|..||||++.. .+...+.=..|+++++++. --+.++++-.|.
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-----NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-----NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-----chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 56789999999999999999999998899999999933 3344555678999999994 257899999999
Q ss_pred cCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC-CeEEc
Q 001752 777 NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL-EPRIA 855 (1018)
Q Consensus 777 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~ 855 (1018)
...++|||+|-+ .-+|.+.|+..+. ...+....+..++.|+.-||.+|-.. +|+|.||||.|||+.+.. .+|||
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeec
Confidence 999999999988 4599999987654 23367778888999999999999998 999999999999999874 68999
Q ss_pred ccccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCccc-------------
Q 001752 856 DFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVD------------- 922 (1018)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~------------- 922 (1018)
|||.|.... ....+.+..+..|.|||.+.|.+|+...|+||.||++||+.||+..|.+.+....-
T Consensus 580 DfGSA~~~~--eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 580 DFGSASFAS--ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred cCccccccc--cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 999997643 33344455667899999999999999999999999999999999999765322110
Q ss_pred ---HHHHHHHHhhccccc----------------ccccCC----------CCCCCchhHHHHHHHHHHHHHccCCCCCCC
Q 001752 923 ---IVEWIRMKIRDNRNL----------------EEALDP----------NVGNCKHVQEEMLLVLRIAFLCTAKLPKDR 973 (1018)
Q Consensus 923 ---~~~~~~~~~~~~~~~----------------~~~~~~----------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 973 (1018)
..++..+.+.....+ ...+.| ...-..........+.+|+..|+..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 000111111111000 001111 001122234455667789999999999999
Q ss_pred CCHHHHHHH
Q 001752 974 PSMRDVITM 982 (1018)
Q Consensus 974 Pt~~evl~~ 982 (1018)
.|..+++++
T Consensus 738 it~nqAL~H 746 (752)
T KOG0670|consen 738 ITVNQALKH 746 (752)
T ss_pred CCHHHHhcC
Confidence 999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=243.23 Aligned_cols=272 Identities=26% Similarity=0.357 Sum_probs=200.8
Q ss_pred hcccChHHHhhcccccceeecCCCeeEEEEEcCC---CCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcce
Q 001752 695 RLGFTSADILACIRESNVIGMGATGIVYKAEMPR---LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVR 770 (1018)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~ 770 (1018)
++......+.+.|...++||+|.|++||+|.+.. ..+.||+|.+... .....+.+|++++..+ .+.||++
T Consensus 26 ~l~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t------s~p~ri~~El~~L~~~gG~~ni~~ 99 (418)
T KOG1167|consen 26 QLRQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT------SSPSRILNELEMLYRLGGSDNIIK 99 (418)
T ss_pred HHHhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc------cCchHHHHHHHHHHHhccchhhhc
Confidence 3333444577889999999999999999999876 6889999999332 2344588999999999 5899999
Q ss_pred eeeeEecCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC-
Q 001752 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN- 849 (1018)
Q Consensus 771 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~- 849 (1018)
+.+++...+.+.+|+||++...-.++... ++...+..++..+..||+++|+. |||||||||+|++++..
T Consensus 100 ~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t 169 (418)
T KOG1167|consen 100 LNGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRT 169 (418)
T ss_pred chhhhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCcccccccccc
Confidence 99999999999999999999998888865 55677778999999999999999 99999999999999865
Q ss_pred CCeEEcccccceeeccCC------------------c---------------ce-----------EeeccCCCccCcCCC
Q 001752 850 LEPRIADFGLARMMIRKN------------------E---------------TV-----------SMVAGSYGYIAPEYG 885 (1018)
Q Consensus 850 ~~~kl~DfG~a~~~~~~~------------------~---------------~~-----------~~~~gt~~y~aPE~~ 885 (1018)
++-.|.|||+|..+.... . .. ....||+||+|||++
T Consensus 170 ~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL 249 (418)
T KOG1167|consen 170 QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVL 249 (418)
T ss_pred CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHH
Confidence 778999999997321000 0 00 014699999999987
Q ss_pred CC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH---------Hhhccc-cccc---------------
Q 001752 886 YT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRM---------KIRDNR-NLEE--------------- 939 (1018)
Q Consensus 886 ~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~---------~~~~~~-~~~~--------------- 939 (1018)
.. ...++++||||.|||++-+++++.||-....+-..+.+.+.- ....+. .+.+
T Consensus 250 ~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~ 329 (418)
T KOG1167|consen 250 FRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFE 329 (418)
T ss_pred hhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchh
Confidence 65 457889999999999999999999996544333333322211 000011 0000
Q ss_pred ccC-CCCCCC-------chhHHH-HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 940 ALD-PNVGNC-------KHVQEE-MLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 940 ~~~-~~~~~~-------~~~~~~-~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
-++ .....+ ....+. ...+++++.+|++.||.+|.|+++++++
T Consensus 330 s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 330 TLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 000 000010 001111 2257799999999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=233.42 Aligned_cols=200 Identities=35% Similarity=0.505 Sum_probs=173.1
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
|+..+.||+|++|.||+|....+++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence 45668899999999999999988899999999433221 256788899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
|+++++|.+++...... +++.....++.+++.++.+||+. +++|+|++|+||+++.++.++++|||.+......
T Consensus 78 ~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 78 YCEGGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred ccCCCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 99999999999765431 68889999999999999999999 9999999999999999999999999999876443
Q ss_pred C-cceEeeccCCCccCcCCC-CCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 001752 867 N-ETVSMVAGSYGYIAPEYG-YTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915 (1018)
Q Consensus 867 ~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg~~pf~~ 915 (1018)
. .......++..|++||.. ....++.++|||+||+++++|++|+.||+.
T Consensus 152 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 152 LAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2 122345678899999998 677788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-27 Score=246.54 Aligned_cols=414 Identities=20% Similarity=0.217 Sum_probs=246.2
Q ss_pred CCceeccCCCCCCcccccccccccccceEeccCcccCcccccccccccccceeeecc-cccCCCCCcccccccchhhhhc
Q 001752 147 GLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSG-NNLTGKIPRELGQLSSMETMIL 225 (1018)
Q Consensus 147 ~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L 225 (1018)
.-+.++|..|+|+.+++.+|+.+++|+.||||+|.|+.+-|.+|.++.+|..|-+-+ |+|+......|++|.+|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 346788888888888888888888888888888888888888888888887766655 8888655567888888888888
Q ss_pred cccccCCCCCccccCccccccccccccccCccCcccccCCCccceEEccCCcCCccCChhhcCCCCCCeeeccCCCCccc
Q 001752 226 AYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHE 305 (1018)
Q Consensus 226 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 305 (1018)
.-|++.......|..|++|..|.+-.|.+...--..|..+..++.+.+..|.+.. .++++.+.. +...
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic-----dCnL~wla~-------~~a~ 215 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC-----DCNLPWLAD-------DLAM 215 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----ccccchhhh-------HHhh
Confidence 8888887777778888888888877777664333466666666666666665321 122222221 1112
Q ss_pred cCCccccccCCceeecccCccccccCCCCCCC-CccceEEeccCccccCCC-cCCCCCCCCceeeccccccccccccccc
Q 001752 306 IPAEITQLKNLQLLNLMCNQLSGHVPAGLGGL-TQLEVLELWNNSLSGPLP-VDLGKNSPLQWLDLSSNSFSGEIPASLC 383 (1018)
Q Consensus 306 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~-~~~~~~~~L~~L~Ls~N~l~~~~~~~~~ 383 (1018)
.|..++...-..-..+.++++..+.+..|... ..+..=..+.+...+..| ..|..+++|+.|+|++|+++++-+.+|.
T Consensus 216 ~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe 295 (498)
T KOG4237|consen 216 NPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFE 295 (498)
T ss_pred chhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhc
Confidence 23334444445555556666654444433321 122111122222222333 2466777777777777777777777777
Q ss_pred CCCCCceeccccccCCCCCcccccccccccEEeccCCcccCCCcccCCCccccceeecccccccCCC-ccccCCCCccce
Q 001752 384 NGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGI-TDDIASSTSLSF 462 (1018)
Q Consensus 384 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~ 462 (1018)
+...+++|+|..|++...-...|.+++.|+.|+|++|+|+..-|.+|..+..|.+|+|-.|.+.-.- -.+++.
T Consensus 296 ~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~------ 369 (498)
T KOG4237|consen 296 GAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE------ 369 (498)
T ss_pred chhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH------
Confidence 7777777777777776666666777777777777777777777777777777777777666553100 000000
Q ss_pred EeccCCcccCCCCccccCCCCcccccccCCcccC---CCCccc---------CCCCccce-eecccccccCCCCCccccc
Q 001752 463 IDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVG---EIPDQF---------QDCPSLSV-LDLSSNYFSGSIPSSIASC 529 (1018)
Q Consensus 463 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~---~~~~~~---------~~l~~L~~-L~Ls~N~l~~~~~~~~~~l 529 (1018)
.|..+.-.|..| . .+-..++.+.++++.+.. ..|++. ..++-+.. ...|++.++ .+|..+.
T Consensus 370 -Wlr~~~~~~~~~-C-q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP-- 443 (498)
T KOG4237|consen 370 -WLRKKSVVGNPR-C-QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP-- 443 (498)
T ss_pred -HHhhCCCCCCCC-C-CCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--
Confidence 011111111110 0 001123333333332221 111111 12223332 334444444 5555444
Q ss_pred cccceeecccccccCCcccccccCCccceeecccccccCCCCCCCCCCCCCceEEecCC
Q 001752 530 EKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYN 588 (1018)
Q Consensus 530 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 588 (1018)
..-.+|++.+|.++ .+|.. .+.+| .+|+|+|+++..--..|.++.+|.+|-+|+|
T Consensus 444 ~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 444 VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 34566778888887 55655 55667 7888888887666677888888888888776
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=268.51 Aligned_cols=312 Identities=22% Similarity=0.240 Sum_probs=142.5
Q ss_pred CceeccCCCCCCcccccccccccccceEeccCcccCcccccccccccccceeeecccccCCCCCcccccccchhhhhccc
Q 001752 148 LTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAY 227 (1018)
Q Consensus 148 L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 227 (1018)
|+.|++.++.+.. +|..| ...+|++|+|++|.+. .+|..+..+++|+.|+|++|.....+|. ++.+++|++|+|++
T Consensus 591 Lr~L~~~~~~l~~-lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 591 LRLLRWDKYPLRC-MPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSD 666 (1153)
T ss_pred cEEEEecCCCCCC-CCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecC
Confidence 4444444444433 22223 2344555555555444 3444444455555555554433223332 44444555555544
Q ss_pred cccCCCCCccccCccccccccccccccCccCcccccCCCccceEEccCCcCCccCChhhcCCCCCCeeeccCCCCccccC
Q 001752 228 NEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIP 307 (1018)
Q Consensus 228 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 307 (1018)
|.....+|..++++++|+.|++++|...+.+|..+ ++++|+.|++++|.....+|.. .++|++|+|++|.+. .+|
T Consensus 667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP 741 (1153)
T PLN03210 667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFP 741 (1153)
T ss_pred CCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-ccc
Confidence 44333445555555555555555544333444433 4445555555554433333322 234555666666554 344
Q ss_pred CccccccCCceeecccCccccccCCCCCCCCccceEEeccCccccCCCcCCCCCCCCceeecccccccccccccccCCCC
Q 001752 308 AEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGN 387 (1018)
Q Consensus 308 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~ 387 (1018)
..+ .+++|++|++.++.... +...+.. ..+..+...++|+.|+|++|...+.+|.++.++++
T Consensus 742 ~~~-~l~~L~~L~l~~~~~~~-l~~~~~~----------------l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~ 803 (1153)
T PLN03210 742 SNL-RLENLDELILCEMKSEK-LWERVQP----------------LTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHK 803 (1153)
T ss_pred ccc-cccccccccccccchhh-ccccccc----------------cchhhhhccccchheeCCCCCCccccChhhhCCCC
Confidence 433 34555555554432210 0000000 00111111233444444444443344444444444
Q ss_pred CceeccccccCCCCCcccccccccccEEeccCCcccCCCcccCCCccccceeecccccccCCCccccCCCCccceEeccC
Q 001752 388 LTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISR 467 (1018)
Q Consensus 388 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 467 (1018)
|+.|++++|..-+.+|... ++++|+.|++++|..-..+|.. .++|+.|+|++|.++ .+|..+..+++|++|+|++
T Consensus 804 L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 804 LEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNG 878 (1153)
T ss_pred CCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCC
Confidence 4444444443222333332 3445555555554333233322 245666666666665 3455566666666666666
Q ss_pred -CcccCCCCccccCCCCcccccccCC
Q 001752 468 -NHLRSSLPSTILSIPNLQTFIVSNN 492 (1018)
Q Consensus 468 -N~l~~~~~~~~~~l~~L~~L~L~~N 492 (1018)
|++. .+|..+..+++|+.+++++|
T Consensus 879 C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 879 CNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CCCcC-ccCcccccccCCCeeecCCC
Confidence 3343 35555666666666666655
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=268.32 Aligned_cols=346 Identities=21% Similarity=0.248 Sum_probs=213.1
Q ss_pred ccccccccccceEeccCcc------cCccccccccccc-ccceeeecccccCCCCCcccccccchhhhhccccccCCCCC
Q 001752 163 LEDLGNATSLETLDLRGSF------FQGSIPVSFKNLQ-KLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIP 235 (1018)
Q Consensus 163 ~~~l~~l~~L~~L~L~~n~------~~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~ 235 (1018)
+.+|.++++|+.|.+..+. +...+|..|..++ +|+.|++.++.++ .+|..| ...+|++|++.+|++. .++
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence 4456667777777775543 2234556666554 5777777777766 566665 3567777777777766 455
Q ss_pred ccccCccccccccccccccCccCcccccCCCccceEEccCCcCCccCChhhcCCCCCCeeeccCCCCccccCCccccccC
Q 001752 236 VEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKN 315 (1018)
Q Consensus 236 ~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 315 (1018)
..+..+++|++|+|+++.....+|. ++.+++|+.|+|++|.....+|..+.++++|+.|++++|.....+|..+ ++++
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s 705 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS 705 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence 6666677777777776654445553 5566666666666665555666666666666666666654333455444 5666
Q ss_pred CceeecccCccccccCCCCCCCCccceEEeccCccccCCCcCCCCCCCCceeecccccccccccccccCCCCCceecccc
Q 001752 316 LQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFN 395 (1018)
Q Consensus 316 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 395 (1018)
|+.|++++|......|.. .++|+.|++++|.+. .+|..+ .+++|++|++.++... .+.
T Consensus 706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~-~l~---------------- 763 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSE-KLW---------------- 763 (1153)
T ss_pred CCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchh-hcc----------------
Confidence 666666665433333322 234555666666554 333332 3444555555443221 000
Q ss_pred ccCCCCCcccccccccccEEeccCCcccCCCcccCCCccccceeecccccccCCCccccCCCCccceEeccCCcccCCCC
Q 001752 396 NAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLP 475 (1018)
Q Consensus 396 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 475 (1018)
+.+....+..+...++|+.|+|++|...+.+|..++++++|+.|++++|..-+.+|..+ ++++|+.|+|++|..-..+|
T Consensus 764 ~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p 842 (1153)
T PLN03210 764 ERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFP 842 (1153)
T ss_pred ccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccc
Confidence 01111112222334567777777777666777777778888888887765444555554 67788888888775544444
Q ss_pred ccccCCCCcccccccCCcccCCCCcccCCCCccceeeccc-ccccCCCCCccccccccceeeccccc
Q 001752 476 STILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSS-NYFSGSIPSSIASCEKLVNLNLRNNQ 541 (1018)
Q Consensus 476 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~ 541 (1018)
.. .++|+.|+|++|.++ .+|..+..+++|+.|+|++ |++. .+|..+..+++|+.|+++++.
T Consensus 843 ~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 843 DI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 32 357888888888887 6788888888888888887 4565 577777888888888888773
|
syringae 6; Provisional |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-24 Score=264.83 Aligned_cols=196 Identities=18% Similarity=0.235 Sum_probs=140.4
Q ss_pred hccCC-CCcceeeeeE-------ecCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCC
Q 001752 761 GKLRH-RNIVRLLGFL-------HNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832 (1018)
Q Consensus 761 ~~l~h-pniv~~~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~ 832 (1018)
+.++| +||+++++++ ...+.++.++||+ +++|.+++.... ..+++.++..++.||++||+|||++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~--- 99 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ--- 99 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---
Confidence 34456 6888888887 2234578889988 569999997532 2388999999999999999999999
Q ss_pred CeEeecCCCCcEEEcC-------------------CCCeEEcccccceeeccCC----------------cceEeeccCC
Q 001752 833 PIIHRDIKSNNILLDS-------------------NLEPRIADFGLARMMIRKN----------------ETVSMVAGSY 877 (1018)
Q Consensus 833 ~ivH~Dlk~~NIll~~-------------------~~~~kl~DfG~a~~~~~~~----------------~~~~~~~gt~ 877 (1018)
||+||||||+|||++. ++.+|++|||+++...... .......||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 9999999999999954 4456677777765321100 0011145788
Q ss_pred CccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHH
Q 001752 878 GYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLL 957 (1018)
Q Consensus 878 ~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 957 (1018)
.|+|||++.+..++.++|||||||++|||++|..|+.... ......... ..++.. ......
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~---------~~~~~~------~~~~~~ 240 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHR---------VLPPQI------LLNWPK 240 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHh---------hcChhh------hhcCHH
Confidence 9999999999999999999999999999999988875311 111111100 011110 111233
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 958 VLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 958 l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
...++.+||+++|.+||+|.|++++
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhhc
Confidence 4577889999999999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-23 Score=207.79 Aligned_cols=169 Identities=21% Similarity=0.215 Sum_probs=126.6
Q ss_pred CCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcce
Q 001752 791 GSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV 870 (1018)
Q Consensus 791 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 870 (1018)
|+|.++++.+.. .+++..++.++.||+.||+|||+. + ||+||+++.++.+++ ||.++......
T Consensus 1 GsL~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRGR---PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 689999975432 389999999999999999999998 5 999999999999999 99998753322
Q ss_pred EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCch
Q 001752 871 SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKH 950 (1018)
Q Consensus 871 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 950 (1018)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.........+..+..... .. ++.......
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~-------~~~~~~~~~ 133 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP-AD-------DPRDRSNLE 133 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc-cC-------CccccccHH
Confidence 26889999999999999999999999999999999999999653322222222211111 00 000000001
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 001752 951 VQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 951 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 986 (1018)
.......+.+++.+|++.+|++||++.|+++++...
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 111112578999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=240.78 Aligned_cols=260 Identities=28% Similarity=0.372 Sum_probs=159.0
Q ss_pred CeeeccCCCCccccCCccccccCCceeecccCccccccCCCCCCCCccceEEeccCccccCCCcCCCCCCCCceeecccc
Q 001752 293 QLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSN 372 (1018)
Q Consensus 293 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N 372 (1018)
..|+|++|.++ .+|..+. ++|+.|++.+|+|+. +|.. +++|++|+|++|+|+. +|.. .++|+.|+|++|
T Consensus 204 ~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N 272 (788)
T PRK15387 204 AVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSN 272 (788)
T ss_pred cEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCc-ccCc---ccccceeeccCC
Confidence 34455555554 3444433 245555555555542 2321 3455555555555552 2321 234555556655
Q ss_pred cccccccccccCCCCCceeccccccCCCCCcccccccccccEEeccCCcccCCCcccCCCccccceeecccccccCCCcc
Q 001752 373 SFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITD 452 (1018)
Q Consensus 373 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 452 (1018)
.++ .+|.. ..+|+.|++++|+++. +|.. .++|+.|+|++|+|++ +|... ..|+.|++++|.|++ +|.
T Consensus 273 ~L~-~Lp~l---p~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~ 339 (788)
T PRK15387 273 PLT-HLPAL---PSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPT 339 (788)
T ss_pred chh-hhhhc---hhhcCEEECcCCcccc-cccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-ccc
Confidence 554 23322 2345566666666653 2321 2456677777777664 33322 346677777777764 332
Q ss_pred ccCCCCccceEeccCCcccCCCCccccCCCCcccccccCCcccCCCCcccCCCCccceeecccccccCCCCCcccccccc
Q 001752 453 DIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKL 532 (1018)
Q Consensus 453 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 532 (1018)
...+|+.|+|++|+|++ +|.. .++|+.|++++|+|++ +|... .+|+.|+|++|+|++ +|... ++|
T Consensus 340 ---lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l~---~~L~~LdLs~N~Lt~-LP~l~---s~L 404 (788)
T PRK15387 340 ---LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPALP---SGLKELIVSGNRLTS-LPVLP---SEL 404 (788)
T ss_pred ---cccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Ccccc---cccceEEecCCcccC-CCCcc---cCC
Confidence 12467888888888874 4432 3467778888888874 55432 468888888888874 55433 578
Q ss_pred ceeecccccccCCcccccccCCccceeecccccccCCCCCCCCCCCCCceEEecCCcccCCCCC
Q 001752 533 VNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPA 596 (1018)
Q Consensus 533 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 596 (1018)
+.|++++|+|++ +|.. ..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|.
T Consensus 405 ~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 405 KELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred CEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 888999998884 5653 346788899999988 6788888888999999999999887663
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.9e-23 Score=241.34 Aligned_cols=245 Identities=27% Similarity=0.342 Sum_probs=143.8
Q ss_pred CCCeeeccCCCCccccCCccccccCCceeecccCccccccCCCCCCCCccceEEeccCccccCCCcCCCCCCCCceeecc
Q 001752 291 SLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLS 370 (1018)
Q Consensus 291 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls 370 (1018)
+|+.|++++|+++. +|.. +++|++|+|++|+|+. +|.. .++|+.|++++|.+.. +|.. ...|+.|+++
T Consensus 223 ~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~~-Lp~l---p~~L~~L~Ls 290 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLTH-LPAL---PSGLCKLWIF 290 (788)
T ss_pred CCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCc-ccCc---ccccceeeccCCchhh-hhhc---hhhcCEEECc
Confidence 44444454444442 3321 2445555555555542 2321 2344555555555442 2221 1334555555
Q ss_pred cccccccccccccCCCCCceeccccccCCCCCcccccccccccEEeccCCcccCCCcccCCCccccceeecccccccCCC
Q 001752 371 SNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGI 450 (1018)
Q Consensus 371 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 450 (1018)
+|+++ .+|.. +++|+.|+|++|++++. |... .+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++.
T Consensus 291 ~N~Lt-~LP~~---p~~L~~LdLS~N~L~~L-p~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~L- 357 (788)
T PRK15387 291 GNQLT-SLPVL---PPGLQELSVSDNQLASL-PALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLASL- 357 (788)
T ss_pred CCccc-ccccc---ccccceeECCCCccccC-CCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCCC-
Confidence 55554 22321 24455555555555532 2211 235556666666653 3321 13577777777777743
Q ss_pred ccccCCCCccceEeccCCcccCCCCccccCCCCcccccccCCcccCCCCcccCCCCccceeecccccccCCCCCcccccc
Q 001752 451 TDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCE 530 (1018)
Q Consensus 451 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 530 (1018)
|.. ..+|+.|++++|+|++ +|.. ..+|+.|++++|+|++ +|... ++|+.|++++|+|++ +|..+ .
T Consensus 358 P~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Lss-IP~l~---~ 422 (788)
T PRK15387 358 PTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLTS-LPMLP---S 422 (788)
T ss_pred CCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCcc---cCCCEEEccCCcCCC-CCcch---h
Confidence 322 2456777777777774 4443 2467888888888874 45432 578889999999884 66543 4
Q ss_pred ccceeecccccccCCcccccccCCccceeecccccccCCCCCCCCC
Q 001752 531 KLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGA 576 (1018)
Q Consensus 531 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 576 (1018)
+|+.|++++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..
T Consensus 423 ~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 423 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 467 (788)
T ss_pred hhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence 6788999999998 67888889999999999999999887776643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.6e-22 Score=200.00 Aligned_cols=272 Identities=19% Similarity=0.214 Sum_probs=205.4
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeeeEecCCceE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 782 (1018)
--.|++.++||+|.||+++.|+.--++++||||.-... ....++..|....+.+. .++|+.++-+..++.+-.
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk------S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK------SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc------CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 34688999999999999999999888999999975221 23446778888888884 699999999988888889
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC-----CeEEccc
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL-----EPRIADF 857 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~Df 857 (1018)
+|+|.+ |.||+|+..-... .++..++..||.|++.-++|+|++ ..|.|||||+|+||...+ .+.++||
T Consensus 101 LVidLL-GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEec
Confidence 999999 7899999865433 388999999999999999999999 999999999999997654 4899999
Q ss_pred ccceeeccCCcce-------EeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 001752 858 GLARMMIRKNETV-------SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMK 930 (1018)
Q Consensus 858 G~a~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 930 (1018)
|+|+.+.++.... ....||.+||+-....++.-+.+.|+-|+|-++.+.+.|..||.+...+.. .+-+ +.
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn--K~kY-eK 250 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN--KEKY-EK 250 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch--HHHH-HH
Confidence 9999886554322 236799999999999999999999999999999999999999987533211 1111 11
Q ss_pred hhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCCCCCCCCCc
Q 001752 931 IRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDN 998 (1018)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~ 998 (1018)
+.+.+... +.-.-|...++++...++.++ ..+-.+-|..+-+...+.....+...-.|..+
T Consensus 251 IGe~Kr~T----~i~~Lc~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~y 311 (449)
T KOG1165|consen 251 IGETKRST----PIEVLCEGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDRLGETDDGEY 311 (449)
T ss_pred hccccccC----CHHHHHhcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHhcCCcccccc
Confidence 21111110 111123345566666655555 45677888888887777666554444444333
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9e-22 Score=216.49 Aligned_cols=168 Identities=19% Similarity=0.132 Sum_probs=129.4
Q ss_pred HhhcccccceeecCCCeeEEEEEcCC-CCeEEEEEEeeccccc-cccchhhhHHHHHHHHhccCCCCcceeeeeEecCCc
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPR-LNTIVAVKKLWRSRAD-LETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN 780 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 780 (1018)
..++|+..+.||+|+||+||+|.+.. +++.||||++...... ........|.+|++++++++|+|+++.+..+ +.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CC
Confidence 45779999999999999999998875 6788899987322110 1223456789999999999999998533222 45
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecC-CCCcEEEcCCCCeEEccccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDI-KSNNILLDSNLEPRIADFGL 859 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~DfG~ 859 (1018)
.|+||||++|++|... . .. . ...++.+++++|+|+|+. ||+|||| ||+||+++.++.+||+|||+
T Consensus 93 ~~LVmE~~~G~~L~~~-~--~~-----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-R--PH-----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred cEEEEEccCCCCHHHh-C--cc-----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 7999999999999732 1 11 1 135678999999999999 9999999 99999999999999999999
Q ss_pred ceeeccCCcc--------eEeeccCCCccCcCCCCC
Q 001752 860 ARMMIRKNET--------VSMVAGSYGYIAPEYGYT 887 (1018)
Q Consensus 860 a~~~~~~~~~--------~~~~~gt~~y~aPE~~~~ 887 (1018)
|+.+...+.. .....+++.|.|||++..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9976443311 123567888999998764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.8e-23 Score=200.94 Aligned_cols=250 Identities=25% Similarity=0.355 Sum_probs=188.8
Q ss_pred cccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEe
Q 001752 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEY 787 (1018)
Q Consensus 708 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 787 (1018)
....+|.+...|+.|+|++. |..+++|++ ..........++|..|.-.++-+.||||.+++|.|.......++..|
T Consensus 193 nl~tkl~e~hsgelwrgrwq--gndivakil--~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ--GNDIVAKIL--NVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhccCCCccccccccc--Ccchhhhhh--hhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 34457888999999999997 566777877 23344556678999999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEc--ccccceeecc
Q 001752 788 MNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIA--DFGLARMMIR 865 (1018)
Q Consensus 788 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~--DfG~a~~~~~ 865 (1018)
|+-|+|+..+++.. ....+..++.+++.+||+|++|||+.. +-|..--+....|++|++.+++|+ |--++. .+
T Consensus 269 mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--qe 343 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--QE 343 (448)
T ss_pred ccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--ec
Confidence 99999999998754 355788899999999999999999973 334455789999999999887775 322211 11
Q ss_pred CCcceEeeccCCCccCcCCCCCCCCC---ccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccC
Q 001752 866 KNETVSMVAGSYGYIAPEYGYTLKVD---EKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 866 ~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
....-.|.|++||.+..++-+ .++|+|||++++||+-|...||.....-+.. +++.-+. +...+.
T Consensus 344 -----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------mkialeg-lrv~ip 411 (448)
T KOG0195|consen 344 -----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------MKIALEG-LRVHIP 411 (448)
T ss_pred -----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------hhhhhcc-ccccCC
Confidence 112345889999998766543 5899999999999999999999753221110 1111010 111122
Q ss_pred CCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
|. ....+.+++.-|++.||.+||.++.|+-.|+++.
T Consensus 412 pg---------is~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 412 PG---------ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CC---------ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 21 2334667888999999999999999999998864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-21 Score=212.83 Aligned_cols=273 Identities=21% Similarity=0.220 Sum_probs=197.3
Q ss_pred cccccceeecCCCeeEEEEEcCCCC-eEEEEEEeeccccccccchhhhHHHHHHHHhccCC----CCcceeeeeE-ecCC
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLN-TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH----RNIVRLLGFL-HNDT 779 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~~~~~~-~~~~ 779 (1018)
+|...+.||+|+||.||.|....++ ..+|+|........ ....+..|..++..+.. +++..+++.. ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~----~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS----KPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC----CCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 7899999999999999999987654 67888877322111 11157778888888863 6899999999 5778
Q ss_pred ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC-----CCeEE
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN-----LEPRI 854 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~kl 854 (1018)
+.++||+.+ |.+|.++...... ..++..+..+|+.|++.+|+++|+. |++||||||+|+.+... ..+++
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~--~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPP--GRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCC--CCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEE
Confidence 899999988 7899998866552 2388899999999999999999999 99999999999999865 46999
Q ss_pred cccccce--eeccCCcc--------eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHH
Q 001752 855 ADFGLAR--MMIRKNET--------VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIV 924 (1018)
Q Consensus 855 ~DfG~a~--~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~ 924 (1018)
.|||+++ .+...... .....||..|+++..+.+...+.+.|+||++.++.|+..|..||........ ..
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~ 247 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KS 247 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HH
Confidence 9999998 43222211 1235599999999999999999999999999999999999999965322111 11
Q ss_pred HHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCCCCCCCCCchhh
Q 001752 925 EWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNRYE 1001 (1018)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~ 1001 (1018)
. +....... .... .+...+.+... +...+-..+..++|....+...++..........+...+++
T Consensus 248 ~-~~~~~~~~-----~~~~---~~~~~~~~~~~---~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~ 312 (322)
T KOG1164|consen 248 K-FEKDPRKL-----LTDR---FGDLKPEEFAK---ILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWE 312 (322)
T ss_pred H-HHHHhhhh-----cccc---ccCCChHHHHH---HHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccc
Confidence 1 11111010 0000 11112233333 33344458899999999999998777655433333334443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=191.83 Aligned_cols=265 Identities=18% Similarity=0.189 Sum_probs=196.7
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCC-CCcceeeeeEecCCce
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH-RNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~ 781 (1018)
+.+.|...++||+|+||.+|.|..-.+|..||||+-... ....+...|..+.+.+++ ..|+.+.-|..+.++-
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~------a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK------AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc------CCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 357789999999999999999999999999999986222 223457779999999975 7888889999999999
Q ss_pred EEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC---CCeEEcccc
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN---LEPRIADFG 858 (1018)
Q Consensus 782 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfG 858 (1018)
.+|||.+ |.||+++..-.... ++..+.+-++-|++.-++|+|.+ +++||||||+|+++.-+ ..+.++|||
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~---ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRR---FTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhh---hhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEecc
Confidence 9999999 78999998754432 78888999999999999999999 99999999999999654 469999999
Q ss_pred cceeeccCCcc-------eEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHh
Q 001752 859 LARMMIRKNET-------VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKI 931 (1018)
Q Consensus 859 ~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 931 (1018)
+|+.+.+.... .....||.+|.+-....+...+.+.|+-|+|.++.++-.|..||.+...... .+-++ .+
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk--~QKyE-kI 236 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK--KQKYE-KI 236 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH--HHHHH-HH
Confidence 99877432221 1236799999999988888889999999999999999999999987533211 11111 11
Q ss_pred hcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 932 RDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
.+.+ .-.+.-.-|+..+.+... .+..|-..--++-|+..-+-+.++-+....
T Consensus 237 ~EkK----~s~~ie~LC~G~P~EF~m---yl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 237 SEKK----MSTPIEVLCKGFPAEFAM---YLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred HHhh----cCCCHHHHhCCCcHHHHH---HHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 1110 000001123333344433 344666666777788777777765544433
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.2e-21 Score=226.57 Aligned_cols=343 Identities=19% Similarity=0.285 Sum_probs=247.4
Q ss_pred cHHHHHHHHHHHhccCCCCCCcC----CCCCCCCCceeee----------------EEeCCCCCEEEEEcCCCCCCccc-
Q 001752 32 LNDELLALLSIKAGLVDPLNSLH----DWKLPSAHCNWTG----------------VWCNSNGAVEKLDLSHMNLSGCV- 90 (1018)
Q Consensus 32 ~~~~~~~Ll~~k~~~~d~~~~~~----~w~~~~~~c~w~g----------------v~c~~~~~v~~L~L~~~~l~~~~- 90 (1018)
..++.++++++.+.+..|. .+. .|...++.|.-.. |.|.. +.|+.+...+.-.....
T Consensus 61 ~~~~~~~~~~~~~~l~~p~-~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~-~~vt~l~~~g~~~~~~~~ 138 (754)
T PRK15370 61 SPEEIKSKFECLRMLAFPA-YADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGG-KSVTYTRVTESEQASSAS 138 (754)
T ss_pred CHHHHHHHHHHHHHhcCCc-hhhccccccCCCCcccccCCcchhhheeeecCCceEEecCC-CcccccccccccccccCC
Confidence 3578889999999997774 333 5988888886544 55632 34555554432111000
Q ss_pred ---------------------------cccc-----ccCCCCCEEEcCCCCcCCCCChhhhCCCCCcEEEeeecccCCCC
Q 001752 91 ---------------------------SDHF-----QRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSF 138 (1018)
Q Consensus 91 ---------------------------~~~~-----~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~ 138 (1018)
...+ .-..+.+.|++++++++. +|..+. ++|+.|+|++|+|+ .+
T Consensus 139 ~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sL 214 (754)
T PRK15370 139 GSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SL 214 (754)
T ss_pred CCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cC
Confidence 0011 112467899999999864 566553 58999999999999 67
Q ss_pred cccccCCCCCceeccCCCCCCcccccccccccccceEeccCcccCcccccccccccccceeeecccccCCCCCccccccc
Q 001752 139 PAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLS 218 (1018)
Q Consensus 139 p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 218 (1018)
|..+. .+|++|++++|+++++ |..+. ++|+.|+|++|.+. .+|..+. .+|+.|+|++|+++ .+|..+. .
T Consensus 215 P~~l~--~nL~~L~Ls~N~LtsL-P~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~ 283 (754)
T PRK15370 215 PENLQ--GNIKTLYANSNQLTSI-PATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--E 283 (754)
T ss_pred Chhhc--cCCCEEECCCCccccC-Chhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--C
Confidence 77664 5899999999999864 54443 47999999999998 6777664 58999999999999 5787665 5
Q ss_pred chhhhhccccccCCCCCccccCccccccccccccccCccCcccccCCCccceEEccCCcCCccCChhhcCCCCCCeeecc
Q 001752 219 SMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLS 298 (1018)
Q Consensus 219 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls 298 (1018)
+|+.|++++|++++ +|..+. ++|+.|++++|++.. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|+++
T Consensus 284 sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls 354 (754)
T PRK15370 284 ELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVS 354 (754)
T ss_pred CCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECC
Confidence 89999999999984 555443 579999999999984 555443 689999999999985 676654 799999999
Q ss_pred CCCCccccCCccccccCCceeecccCccccccCCCCCCCCccceEEeccCccccCCCcC----CCCCCCCceeecccccc
Q 001752 299 YNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVD----LGKNSPLQWLDLSSNSF 374 (1018)
Q Consensus 299 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~----~~~~~~L~~L~Ls~N~l 374 (1018)
+|+++ .+|..+. ++|++|+|++|+|+. +|..+. ..|+.|++++|+|. .+|.. +...+++..|+|.+|.+
T Consensus 355 ~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npl 427 (754)
T PRK15370 355 KNQIT-VLPETLP--PTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPF 427 (754)
T ss_pred CCCCC-cCChhhc--CCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCc
Confidence 99997 5676653 689999999999994 555543 47999999999998 45554 34457899999999998
Q ss_pred cccccccccCCCCCceeccccccCCC-CCcccccccccccE
Q 001752 375 SGEIPASLCNGGNLTKLILFNNAFSG-PIPVSLSTCHSLVR 414 (1018)
Q Consensus 375 ~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~ 414 (1018)
+. ..+.+|+.| ++.+.+.| .++........++.
T Consensus 428 s~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~ 461 (754)
T PRK15370 428 SE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRV 461 (754)
T ss_pred cH------HHHHHHHHh-hhcccccCCcccccccccccccc
Confidence 72 234455555 34454443 33434444444443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-20 Score=195.65 Aligned_cols=239 Identities=18% Similarity=0.238 Sum_probs=158.2
Q ss_pred hcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCC----------CCcceeeee
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH----------RNIVRLLGF 774 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------pniv~~~~~ 774 (1018)
..+...+.||.|+++.||.+++..+++.+|||++.... .......+++.+|.-....+.+ -.++-.++.
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 34556789999999999999999999999999996554 4445567777777766665422 122222222
Q ss_pred Ee---------cC---C-----ceEEEEEecCCCCHHHhhh---cCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 001752 775 LH---------ND---T-----NMMIVYEYMNNGSLGEALH---GKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPI 834 (1018)
Q Consensus 775 ~~---------~~---~-----~~~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i 834 (1018)
.. .. . ..+++|+-+ .++|.+++. .............+..+..|+++.+++||+. |+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---Gl 166 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GL 166 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ce
Confidence 21 11 1 236788887 458988764 2222233456677788889999999999999 99
Q ss_pred EeecCCCCcEEEcCCCCeEEcccccceeeccCCcceEeeccCCCccCcCCCCC--------CCCCccccchhHHHHHHHH
Q 001752 835 IHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYT--------LKVDEKIDIYSFGVVLLEL 906 (1018)
Q Consensus 835 vH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el 906 (1018)
||+||+|+|++++++|.++++||+..... +........+..|.+||.... ..++.+.|.|++|+++|.|
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~---g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRA---GTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEET---TEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeec---CceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999999987643 222222455678999996532 3578899999999999999
Q ss_pred HhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCC
Q 001752 907 LTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDR 973 (1018)
Q Consensus 907 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 973 (1018)
++|+.||+......... .....|. +....+..|+..+|+.+|++|
T Consensus 244 WC~~lPf~~~~~~~~~~-------------------~~f~~C~---~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPE-------------------WDFSRCR---DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSG-------------------GGGTTSS------HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCcccccc-------------------ccchhcC---CcCHHHHHHHHHHccCCcccC
Confidence 99999997642211100 0233454 334456678889999999988
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-19 Score=200.45 Aligned_cols=261 Identities=30% Similarity=0.416 Sum_probs=197.4
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCC-CcceeeeeEecCCceEEEE
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR-NIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~lV~ 785 (1018)
|...+.||.|+||.||++.+. ..+++|.+...... .......+.+|+..++.+.|+ +++++.+.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLES-KSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhcc-chhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 556778999999999999987 78899998443222 112577899999999999988 7999999997777789999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC-CeEEcccccceeec
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL-EPRIADFGLARMMI 864 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~a~~~~ 864 (1018)
+|+.++++.+++...... ..+.......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++...
T Consensus 78 ~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred ecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999999777655321 2378888999999999999999999 999999999999999998 79999999998654
Q ss_pred cCCc------ceEeeccCCCccCcCCCCC---CCCCccccchhHHHHHHHHHhCCCCCCCCCCC--cccHHHHHHHHhhc
Q 001752 865 RKNE------TVSMVAGSYGYIAPEYGYT---LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGE--SVDIVEWIRMKIRD 933 (1018)
Q Consensus 865 ~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~~ 933 (1018)
.... ......||..|+|||...+ ..+....|+||+|++++++++|..||...... .......+......
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 4432 2355789999999999887 57899999999999999999999997654321 11111111111111
Q ss_pred ccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 934 NRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.......+... ......+.+++..|+..+|..|.++.+....
T Consensus 234 --~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNP-----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCcccc-----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000000 1122346678889999999999999987764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=226.05 Aligned_cols=244 Identities=27% Similarity=0.431 Sum_probs=106.4
Q ss_pred ceEEccCCcCCccCChhhcCCCCCCeeeccCCCCccccCCccccccCCceeecccCccccccCCCCCCCCccceEEeccC
Q 001752 269 EIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNN 348 (1018)
Q Consensus 269 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 348 (1018)
..|++++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|++++|+++ .+|..+. .+|+.|+|++|
T Consensus 181 ~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N 251 (754)
T PRK15370 181 TELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSIN 251 (754)
T ss_pred eEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCC
Confidence 34444444444 2333221 34555555555554 2343332 35555555555555 2333322 24555555555
Q ss_pred ccccCCCcCCCCCCCCceeecccccccccccccccCCCCCceeccccccCCCCCcccccccccccEEeccCCcccCCCcc
Q 001752 349 SLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPV 428 (1018)
Q Consensus 349 ~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~ 428 (1018)
++. .+|..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|+|+. +|.
T Consensus 252 ~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-------------------------LP~ 300 (754)
T PRK15370 252 RIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-------------------------LPA 300 (754)
T ss_pred ccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-------------------------Ccc
Confidence 554 3333332 24555555555554 2333222 244444444444442 121
Q ss_pred cCCCccccceeecccccccCCCccccCCCCccceEeccCCcccCCCCccccCCCCcccccccCCcccCCCCcccCCCCcc
Q 001752 429 GFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSL 508 (1018)
Q Consensus 429 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 508 (1018)
.+. ++|+.|++++|+++.. |..+ .++|+.|++++|.+++ +|..+. ++|+.|++++|+|+ .+|..+. ++|
T Consensus 301 ~lp--~sL~~L~Ls~N~Lt~L-P~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L 369 (754)
T PRK15370 301 HLP--SGITHLNVQSNSLTAL-PETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTI 369 (754)
T ss_pred cch--hhHHHHHhcCCccccC-Cccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCc
Confidence 111 2334444444444321 1111 1344444444444442 232221 34555555555554 2343332 355
Q ss_pred ceeecccccccCCCCCccccccccceeecccccccCCccc----ccccCCccceeeccccccc
Q 001752 509 SVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPK----AISMMPTLAILDLSNNSLT 567 (1018)
Q Consensus 509 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~ 567 (1018)
+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|. .+..++.+..|+|.+|+++
T Consensus 370 ~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 370 TTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 55555555555 3343333 24555555555555 2232 2233455566666666655
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-21 Score=225.37 Aligned_cols=256 Identities=21% Similarity=0.253 Sum_probs=187.6
Q ss_pred ccceeecCCCeeEEEEEcCCCCeEEEEEEeecc--ccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 709 ESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRS--RADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 709 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
..+++|.|++|.|+.+......+..+.|.+... ...........+..|+-+-.+++|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 457899999998888887766666666655311 111111222225668888888999999988888776666666699
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccC
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
|+++ +|..++..... +....+..+..|+..|++|+|+. ||.|||+|++|++++.+|.+|++|||.+.....+
T Consensus 402 ~~~~-Dlf~~~~~~~~----~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGK----LTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhcccc----cchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 99999976522 67778888999999999999999 9999999999999999999999999999876554
Q ss_pred Ccc----eEeeccCCCccCcCCCCCCCCCc-cccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccccccccc
Q 001752 867 NET----VSMVAGSYGYIAPEYGYTLKVDE-KIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 867 ~~~----~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
.+. ....+|+..|+|||+..+..|.+ ..||||.|+++..|.+|+.||-.....+... ......... ...
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~~~~--~~~- 547 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYSDQR--NIF- 547 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhcccccc--ccc-
Confidence 443 23478999999999999999876 6899999999999999999996543322211 000000000 000
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 981 (1018)
.+...-..........++.+|+++||.+|.|+++|++
T Consensus 548 ---~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 ---EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ---cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000011222334557899999999999999999986
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-20 Score=215.98 Aligned_cols=252 Identities=20% Similarity=0.236 Sum_probs=180.3
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.+...+.+|++.|=.|.+|++. .|. |+||++-+......-....+-..|++ ...++|||.+++.-+-..+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 5667789999999999999987 354 99999944332322223333333444 55568999999998888888889999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee--e
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM--M 863 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~--~ 863 (1018)
+|..+ +|+|.+..++- +...+...|+.|++.|+..+|.. ||+|||||.+|||++.=.=+.++||..-+- +
T Consensus 101 qyvkh-nLyDRlSTRPF----L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPF----LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHhh-hhhhhhccchH----HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccC
Confidence 99966 99999977654 77788888999999999999999 999999999999999988899999987642 2
Q ss_pred ccCCc-ceEeec----cCCCccCcCCCCC----------CC-CCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 001752 864 IRKNE-TVSMVA----GSYGYIAPEYGYT----------LK-VDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEW 926 (1018)
Q Consensus 864 ~~~~~-~~~~~~----gt~~y~aPE~~~~----------~~-~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~ 926 (1018)
.+++. ...... .-.+|.|||.+.. .. .+++.||||+||++.|+++ |++||.- .+.
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L--------SQL 244 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL--------SQL 244 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--------HHH
Confidence 22222 122222 3347999996432 12 6789999999999999999 7888852 222
Q ss_pred HHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 927 IRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
..............+.. ++ ...+..++..|++.||++|-++++.++.-++
T Consensus 245 ~aYr~~~~~~~e~~Le~-Ie--------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 245 LAYRSGNADDPEQLLEK-IE--------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HhHhccCccCHHHHHHh-Cc--------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 21111111000000000 00 0135678999999999999999999997443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5e-20 Score=187.78 Aligned_cols=175 Identities=14% Similarity=0.139 Sum_probs=134.7
Q ss_pred HhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhh------HHHHHHHHhccCCCCcceeeeeEe
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGD------FVGEVNVLGKLRHRNIVRLLGFLH 776 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~------~~~E~~~l~~l~hpniv~~~~~~~ 776 (1018)
..++|+..+++|.|+||.||.+.. ++..+|+|++.+.... .+..... +.+|+..+.++.||+|+.+.+++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~-~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKR-TERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCc-hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 578899999999999999999766 3668999999544322 2222222 679999999999999999999865
Q ss_pred cC--------CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcC
Q 001752 777 ND--------TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS 848 (1018)
Q Consensus 777 ~~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 848 (1018)
.. ...++||||++|.+|.++.. .+. ....+++.++..+|+. |++|||++|+||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 33 35799999999999988742 222 2456899999999999 9999999999999999
Q ss_pred CCCeEEcccccceeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh
Q 001752 849 NLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT 908 (1018)
Q Consensus 849 ~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt 908 (1018)
+| ++++|||........ ... ..+.....+..++|+|+||+++.....
T Consensus 171 ~g-i~liDfg~~~~~~e~-~a~-----------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQR-KAK-----------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CC-EEEEECCCcccccch-hhH-----------HHHHHHhHhcccccccceeEeehHHHH
Confidence 88 999999988654211 111 113344556789999999999876653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-19 Score=180.74 Aligned_cols=142 Identities=18% Similarity=0.131 Sum_probs=108.4
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccc----------------------hhhhHHHHHHHHhccCCCCc
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETE----------------------SSGDFVGEVNVLGKLRHRNI 768 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~----------------------~~~~~~~E~~~l~~l~hpni 768 (1018)
..||+|+||.||+|.+. +|+.||||+++......... .......|+..+.++.++++
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 57999999999999997 89999999996542211110 01122359999999988887
Q ss_pred ceeeeeEecCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHh-hcCCCCCeEeecCCCCcEEEc
Q 001752 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL-HHDCYPPIIHRDIKSNNILLD 847 (1018)
Q Consensus 769 v~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk~~NIll~ 847 (1018)
.....+... ..++||||++|+++........ .+++.....++.|++.+|+|+ |+. ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~----~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA----PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 544443322 2389999999887765432222 378889999999999999999 687 999999999999998
Q ss_pred CCCCeEEcccccceee
Q 001752 848 SNLEPRIADFGLARMM 863 (1018)
Q Consensus 848 ~~~~~kl~DfG~a~~~ 863 (1018)
++.++++|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999999653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.5e-19 Score=175.69 Aligned_cols=188 Identities=14% Similarity=0.037 Sum_probs=139.1
Q ss_pred ccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeeeEecCCceEEEEEe
Q 001752 709 ESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHNDTNMMIVYEY 787 (1018)
Q Consensus 709 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~e~ 787 (1018)
+...|++|+||+||.+.. .+.+++.+.+.....-........|.+|++++++++ |+++++++++ +..+++|||
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 456899999999997776 478888777722111111112235889999999995 5889999987 346999999
Q ss_pred cCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecC-CCCcEEEcCCCCeEEcccccceeeccC
Q 001752 788 MNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDI-KSNNILLDSNLEPRIADFGLARMMIRK 866 (1018)
Q Consensus 788 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~DfG~a~~~~~~ 866 (1018)
++|.+|.+.... . ...++.|++++++++|+. ||+|||| ||+||+++.++.++|+|||+|....+.
T Consensus 80 I~G~~L~~~~~~--------~---~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR--------G---DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh--------h---hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999998754321 0 124678899999999999 9999999 799999999999999999999865433
Q ss_pred Ccc----e-E--------eeccCCCccCcCCCC--CCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 001752 867 NET----V-S--------MVAGSYGYIAPEYGY--TLKVDEKIDIYSFGVVLLELLTGRRPLDPE 916 (1018)
Q Consensus 867 ~~~----~-~--------~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~elltg~~pf~~~ 916 (1018)
... . . ....++.|++|+... ..+--.+.+.++-|.-+|.++|++.++...
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 321 0 0 123577888888533 222236789999999999999999887543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=176.85 Aligned_cols=142 Identities=19% Similarity=0.172 Sum_probs=110.7
Q ss_pred cceeecCCCeeEEEEEcCCCCeEEEEEEeecccccccc----------------------chhhhHHHHHHHHhccCCCC
Q 001752 710 SNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLET----------------------ESSGDFVGEVNVLGKLRHRN 767 (1018)
Q Consensus 710 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~hpn 767 (1018)
.+.||+|++|.||+|.+. +|+.||||++......... .....+..|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 368999999999999987 8999999999654211100 00122457899999999998
Q ss_pred cceeeeeEecCCceEEEEEecCCCCHHHh-hhcCCCCccccCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeecCCCCcEE
Q 001752 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEA-LHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH-DCYPPIIHRDIKSNNIL 845 (1018)
Q Consensus 768 iv~~~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIl 845 (1018)
+.....+.... .++||||++|+++... +... .++.....+++.|++.++.++|+ . ||+||||||+||+
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIl 150 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDV-----PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNIL 150 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhc-----cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEE
Confidence 86555544332 4899999998865443 3322 25778888999999999999999 8 9999999999999
Q ss_pred EcCCCCeEEcccccceee
Q 001752 846 LDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 846 l~~~~~~kl~DfG~a~~~ 863 (1018)
++ ++.++++|||+++..
T Consensus 151 l~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 151 YH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred EE-CCCEEEEEcccceec
Confidence 99 889999999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-20 Score=170.87 Aligned_cols=162 Identities=30% Similarity=0.535 Sum_probs=109.8
Q ss_pred CCCCceeccCCCCCCcccccccccccccceEeccCcccCcccccccccccccceeeecccccCCCCCcccccccchhhhh
Q 001752 145 AAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMI 224 (1018)
Q Consensus 145 l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 224 (1018)
+++.+.|-||+|+++. +|+.++.+.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. ..|..|+.++.|+.|+
T Consensus 32 ~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 3444455555555553 3456677777777777777777 67788888888888888888887 7788888888888888
Q ss_pred ccccccC-CCCCccccCccccccccccccccCccCcccccCCCccceEEccCCcCCccCChhhcCCCCCCeeeccCCCCc
Q 001752 225 LAYNEFD-GEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLS 303 (1018)
Q Consensus 225 L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 303 (1018)
|.+|++. ...|..|..|+.|+.|.|+.|.+. .+|.+++++++|++|.++.|.+- .+|..++.++.|++|++.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 8888875 455777777777777777777665 55555666666666666666555 45556666666666666666664
Q ss_pred cccCCcccc
Q 001752 304 HEIPAEITQ 312 (1018)
Q Consensus 304 ~~~p~~l~~ 312 (1018)
.+|..+++
T Consensus 187 -vlppel~~ 194 (264)
T KOG0617|consen 187 -VLPPELAN 194 (264)
T ss_pred -ecChhhhh
Confidence 44444443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.7e-20 Score=207.88 Aligned_cols=110 Identities=32% Similarity=0.403 Sum_probs=52.9
Q ss_pred CCCCCeeeccCCCCccc----cCCccccccCCceeecccCccccccCCCCC-----CCCccceEEeccCcccc----CCC
Q 001752 289 ITSLQLLDLSYNMLSHE----IPAEITQLKNLQLLNLMCNQLSGHVPAGLG-----GLTQLEVLELWNNSLSG----PLP 355 (1018)
Q Consensus 289 l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~----~~~ 355 (1018)
+++|++|++++|.+++. ++..+..+++|++|++++|.+++.....+. ..++|+.|++++|.++. .+.
T Consensus 192 ~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~ 271 (319)
T cd00116 192 NCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLA 271 (319)
T ss_pred CCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHH
Confidence 34455555555554322 122233445555555555555432111111 12456666666665541 122
Q ss_pred cCCCCCCCCceeeccccccccc----ccccccCC-CCCceeccccccC
Q 001752 356 VDLGKNSPLQWLDLSSNSFSGE----IPASLCNG-GNLTKLILFNNAF 398 (1018)
Q Consensus 356 ~~~~~~~~L~~L~Ls~N~l~~~----~~~~~~~l-~~L~~L~L~~N~l 398 (1018)
..+..+++|+++++++|.++.. ....+... ..|+.+++.+|.+
T Consensus 272 ~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 272 EVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 2344446666777777766633 33333333 5677777766653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.7e-18 Score=189.79 Aligned_cols=217 Identities=26% Similarity=0.444 Sum_probs=166.4
Q ss_pred HhccCCCCcceeeeeEecCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCe-Eeec
Q 001752 760 LGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPI-IHRD 838 (1018)
Q Consensus 760 l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~D 838 (1018)
++.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.... ..++|.....++.+|+.||+|+|+- +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 357899999999999999999999999999999999997633 3389999999999999999999998 55 9999
Q ss_pred CCCCcEEEcCCCCeEEcccccceeeccC--CcceEeeccCCCccCcCCCCCC-------CCCccccchhHHHHHHHHHhC
Q 001752 839 IKSNNILLDSNLEPRIADFGLARMMIRK--NETVSMVAGSYGYIAPEYGYTL-------KVDEKIDIYSFGVVLLELLTG 909 (1018)
Q Consensus 839 lk~~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~il~elltg 909 (1018)
++++|.++|..+.+|++|||+....... ...........-|.|||.+.+. ..+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998765321 1111112344579999987653 246789999999999999999
Q ss_pred CCCCCCCCCCcc--cHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccC
Q 001752 910 RRPLDPEFGESV--DIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 910 ~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 987 (1018)
+.||+....... ++...+.. . -...+.|...... +....+..++..||..+|++||+++.|-..++.+.
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~----~--~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK----G--GSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cCccccccccCChHHHHHHHHh----c--CCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 999976443322 23333222 1 1122223332111 22225778999999999999999999999999887
Q ss_pred CCCC
Q 001752 988 PRRK 991 (1018)
Q Consensus 988 ~~~~ 991 (1018)
+...
T Consensus 226 ~~~~ 229 (484)
T KOG1023|consen 226 KGGS 229 (484)
T ss_pred cccc
Confidence 7664
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.5e-20 Score=207.01 Aligned_cols=277 Identities=26% Similarity=0.277 Sum_probs=157.0
Q ss_pred EEEcCCCCCCc-ccccccccCCCCCEEEcCCCCcCCC----CChhhhCCCCCcEEEeeecccCC------CCcccccCCC
Q 001752 78 KLDLSHMNLSG-CVSDHFQRLKSLTSLNLCCNGLFSS----LPNSLANLTSLKRFDVSQNFLNG------SFPAGLGGAA 146 (1018)
Q Consensus 78 ~L~L~~~~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~----~~~~l~~l~~L~~L~Ls~n~l~~------~~p~~l~~l~ 146 (1018)
.|+|.++.+++ .....|..+++|++|+++++.++.. ++..+...+.|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 35666666663 2334456666677777777776432 44455666677777777776652 1233455556
Q ss_pred CCceeccCCCCCCcccccccccccc---cceEeccCcccCc----ccccccccc-cccceeeecccccCCCCCccccccc
Q 001752 147 GLTFLNASGNNFSGFLLEDLGNATS---LETLDLRGSFFQG----SIPVSFKNL-QKLKFLGLSGNNLTGKIPRELGQLS 218 (1018)
Q Consensus 147 ~L~~L~Ls~n~l~~~~~~~l~~l~~---L~~L~L~~n~~~~----~~p~~~~~l-~~L~~L~L~~n~l~~~~p~~l~~l~ 218 (1018)
+|+.|++++|.+.+..+..+..+.. |++|++++|.+++ .+...+..+ ++|+.|+|++|.+++..+.
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~------ 155 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE------ 155 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH------
Confidence 6666666666665544444444444 6666666666552 122334444 5566666666665532111
Q ss_pred chhhhhccccccCCCCCccccCccccccccccccccCcc----CcccccCCCccceEEccCCcCCcc----CChhhcCCC
Q 001752 219 SMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGK----IPAELGRLELLEIMFLYQNNFQGR----LPAEIGNIT 290 (1018)
Q Consensus 219 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~ 290 (1018)
.++..+..+++|++|+|++|.+++. ++..+..+++|+.|++++|.+.+. ++..+..++
T Consensus 156 --------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~ 221 (319)
T cd00116 156 --------------ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK 221 (319)
T ss_pred --------------HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC
Confidence 1122334445555666665555532 223344445666666666666532 233455667
Q ss_pred CCCeeeccCCCCccccCCcccc-----ccCCceeecccCcccc----ccCCCCCCCCccceEEeccCccccC----CCcC
Q 001752 291 SLQLLDLSYNMLSHEIPAEITQ-----LKNLQLLNLMCNQLSG----HVPAGLGGLTQLEVLELWNNSLSGP----LPVD 357 (1018)
Q Consensus 291 ~L~~L~Ls~N~l~~~~p~~l~~-----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~ 357 (1018)
+|++|++++|.+++.....+.. .+.|++|++++|.+++ .+...+..+++|+++++++|.+... ....
T Consensus 222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~ 301 (319)
T cd00116 222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAES 301 (319)
T ss_pred CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHH
Confidence 7888888887776533222222 3678888888887752 2233445557788888888887743 3334
Q ss_pred CCCC-CCCceeecccccc
Q 001752 358 LGKN-SPLQWLDLSSNSF 374 (1018)
Q Consensus 358 ~~~~-~~L~~L~Ls~N~l 374 (1018)
+... +.|+.|++.+|.+
T Consensus 302 ~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 302 LLEPGNELESLWVKDDSF 319 (319)
T ss_pred HhhcCCchhhcccCCCCC
Confidence 4444 6788888877753
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.6e-20 Score=169.96 Aligned_cols=178 Identities=29% Similarity=0.465 Sum_probs=115.8
Q ss_pred CccccceeecccccccCCCccccCCCCccceEeccCCcccCCCCccccCCCCcccccccCCcccCCCCcccCCCCcccee
Q 001752 432 RLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVL 511 (1018)
Q Consensus 432 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 511 (1018)
.+..++.|.|++|+++ .+|..++.+.+|+.|++++|+|. .+|..++.+++|+.|+++-|++. ..|..|+.++.|++|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3455566666666666 34555666666666666666665 45666667777777777777766 666777777777777
Q ss_pred ecccccccC-CCCCccccccccceeecccccccCCcccccccCCccceeecccccccCCCCCCCCCCCCCceEEecCCcc
Q 001752 512 DLSSNYFSG-SIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRL 590 (1018)
Q Consensus 512 ~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 590 (1018)
||++|++.. ..|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+..|.+- ..|..++.+..|++|.+.+|+|
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 777776653 35666666777777777777776 56666777777777777777766 5677777777777777777777
Q ss_pred cCCCCCCcccccc---CCCCCCCCcCC
Q 001752 591 EGPVPANGVLRTI---NRGDLAGNAGL 614 (1018)
Q Consensus 591 ~~~~p~~~~~~~~---~~~~~~~n~~~ 614 (1018)
+-.+|+.+.+... .......|||.
T Consensus 186 ~vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 186 TVLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred eecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 7666654433322 12335566654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.2e-19 Score=195.81 Aligned_cols=227 Identities=23% Similarity=0.305 Sum_probs=176.8
Q ss_pred eecCCCeeEEEEEc---CCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeeeEecCCceEEEEEec
Q 001752 713 IGMGATGIVYKAEM---PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHNDTNMMIVYEYM 788 (1018)
Q Consensus 713 lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~e~~ 788 (1018)
+|+|.||.|+.+.- ...+..+|.|+.++......... ....|..++..++ ||.++++...++.+...+++++|.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 68999999987643 33578899998855443332222 5667888888887 999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCc
Q 001752 789 NNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE 868 (1018)
Q Consensus 789 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~ 868 (1018)
.||.+...+..... +...........++-+++++|+. +|+|||+|++||+++.+|++++.|||.++...+...
T Consensus 80 rgg~lft~l~~~~~----f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVM----FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred ccchhhhccccCCc----hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 99999999876654 56666666788899999999999 999999999999999999999999999987644333
Q ss_pred ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCC
Q 001752 869 TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNC 948 (1018)
Q Consensus 869 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1018)
. +||..|||||++. ....++|.||||++++||++|..||.. +. .....+...
T Consensus 153 ~----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~---~~~Il~~~~------------- 204 (612)
T KOG0603|consen 153 A----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DT---MKRILKAEL------------- 204 (612)
T ss_pred c----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HH---HHHHhhhcc-------------
Confidence 2 8999999999987 567899999999999999999999975 11 111111111
Q ss_pred chhHHHHHHHHHHHHHccCCCCCCCCCH
Q 001752 949 KHVQEEMLLVLRIAFLCTAKLPKDRPSM 976 (1018)
Q Consensus 949 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 976 (1018)
....+......+++..++..+|..|--.
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 0112334445567778888888888644
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.2e-18 Score=200.12 Aligned_cols=249 Identities=19% Similarity=0.177 Sum_probs=183.4
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccC---CCCcceeeeeEecCCc
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR---HRNIVRLLGFLHNDTN 780 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~ 780 (1018)
.+.|.+.+.||+|+||+||+|.... |+.||+|+-++.. .+ +|.-=.+++.|++ -+-|.++...+.-.+.
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~-~W------EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN-PW------EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC-ce------eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3557788899999999999999986 9999999873332 22 2333334455555 2445555566666677
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcC-------CCCeE
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS-------NLEPR 853 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-------~~~~k 853 (1018)
-++|+||.+.|+|.+++...+. ++|.-.+.++.|+++.+++||.. +||||||||+|+++.. ...++
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~----m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKV----MDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred ceeeeeccccccHHHhhccCCC----CCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence 7999999999999999985554 89999999999999999999999 9999999999999943 24599
Q ss_pred Ecccccceee--ccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHh
Q 001752 854 IADFGLARMM--IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKI 931 (1018)
Q Consensus 854 l~DfG~a~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 931 (1018)
|+|||.+..+ ..++......++|-++-.+|+..|+.+++.+|-|.++.+++-|+.|+..= .
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------------~ 904 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------------V 904 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------------h
Confidence 9999999766 34455677789999999999999999999999999999999999987521 1
Q ss_pred hcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccCCCC
Q 001752 932 RDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 990 (1018)
..+. ...++..+.+ .-..+.+. ++...+|+.|-..=|...++...|++...+.
T Consensus 905 ~~g~--~~~~~~~~~R-y~~~~~W~---~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 905 KNGS--SWMVKTNFPR-YWKRDMWN---KFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred cCCc--ceeccccchh-hhhHHHHH---HHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 1111 0111111111 11122222 4555677766556688888888887765443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.1e-18 Score=174.92 Aligned_cols=195 Identities=22% Similarity=0.283 Sum_probs=134.7
Q ss_pred CCCCcceeeeeEec---------------------------CCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHH
Q 001752 764 RHRNIVRLLGFLHN---------------------------DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIA 816 (1018)
Q Consensus 764 ~hpniv~~~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~ 816 (1018)
+|||||++.++|.+ ....|+||..++. +|.+++..+. .+...+.-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence 69999999877632 2246899998854 9999997765 3444555588
Q ss_pred HHHHHHHHHhhcCCCCCeEeecCCCCcEEE--cCCC--CeEEcccccceeeccCC------cceEeeccCCCccCcCCCC
Q 001752 817 LGVAQGLAYLHHDCYPPIIHRDIKSNNILL--DSNL--EPRIADFGLARMMIRKN------ETVSMVAGSYGYIAPEYGY 886 (1018)
Q Consensus 817 ~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll--~~~~--~~kl~DfG~a~~~~~~~------~~~~~~~gt~~y~aPE~~~ 886 (1018)
.|+++|+.|||.+ ||.|||+|.+||++ |.|+ ...|+|||.+-.-...+ .......|.-..+|||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 8999999999999 99999999999998 4443 47889999874321111 1122245778899999876
Q ss_pred CCC------CCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHH
Q 001752 887 TLK------VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLR 960 (1018)
Q Consensus 887 ~~~------~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 960 (1018)
..+ --.|+|.|+.|.+.||++....||....+-..+...+-+.++ .+....+ ...+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL----------Palp~~v------pp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL----------PALPSRV------PPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC----------CCCcccC------ChHHHH
Confidence 432 124899999999999999999999763322222222111111 1111111 123557
Q ss_pred HHHHccCCCCCCCCCHHHHHHHh
Q 001752 961 IAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 961 l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
++...++.||++||+..-....+
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHH
Confidence 88899999999999876554444
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.7e-17 Score=164.57 Aligned_cols=136 Identities=18% Similarity=0.232 Sum_probs=105.2
Q ss_pred cccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-----CCCCcceeeeeEecCC---
Q 001752 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-----RHRNIVRLLGFLHNDT--- 779 (1018)
Q Consensus 708 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~--- 779 (1018)
...+.||+|+||.||. ++.++.. +||++.... ....+.+.+|+.+++.+ .||||++++|++.++.
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccc----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 3456899999999995 6656555 699884322 22456789999999999 5799999999998763
Q ss_pred ceE-EEEEe--cCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHH-HHhhcCCCCCeEeecCCCCcEEEcCC----CC
Q 001752 780 NMM-IVYEY--MNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGL-AYLHHDCYPPIIHRDIKSNNILLDSN----LE 851 (1018)
Q Consensus 780 ~~~-lV~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlk~~NIll~~~----~~ 851 (1018)
.++ +|+|| +++|+|.+++.... +++. ..++.+++.++ +|||++ +|+||||||+||+++.. +.
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~ 147 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVI 147 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCc
Confidence 433 78999 55799999996532 4444 24577888777 999999 99999999999999743 47
Q ss_pred eEEcccccc
Q 001752 852 PRIADFGLA 860 (1018)
Q Consensus 852 ~kl~DfG~a 860 (1018)
++|+||+.+
T Consensus 148 ~~LiDg~G~ 156 (210)
T PRK10345 148 PVVCDNIGE 156 (210)
T ss_pred EEEEECCCC
Confidence 999995444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=167.71 Aligned_cols=145 Identities=15% Similarity=0.153 Sum_probs=111.2
Q ss_pred ccccceeecCCCeeEEEEE-cCCCCeEEEEEEeecccccccc--------------------chhhhHHHHHHHHhccCC
Q 001752 707 IRESNVIGMGATGIVYKAE-MPRLNTIVAVKKLWRSRADLET--------------------ESSGDFVGEVNVLGKLRH 765 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~h 765 (1018)
|+..+.||+|+||.||+|. +..+|+.||+|++......... .....+.+|+..++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5667899999999999998 6668999999998543221100 012345689999999976
Q ss_pred C--CcceeeeeEecCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCC-eEeecCCCC
Q 001752 766 R--NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPP-IIHRDIKSN 842 (1018)
Q Consensus 766 p--niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~~ 842 (1018)
. .+++++++ ...++||||++|+++........ .........++.||+.++++||+. + |+||||||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 3 34455543 23489999999988877653222 245556678999999999999999 9 999999999
Q ss_pred cEEEcCCCCeEEcccccceee
Q 001752 843 NILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 843 NIll~~~~~~kl~DfG~a~~~ 863 (1018)
||+++ ++.++++|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999998654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.4e-17 Score=187.70 Aligned_cols=214 Identities=23% Similarity=0.290 Sum_probs=144.3
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEE
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
...|+..+.|..|+||.||.++++.+.+.+|.|+= +.. . +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~-----l----ilRn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQN-----L----ILRN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccc-ccc-----h----hhhc--cccccCCccee--------------
Confidence 45677789999999999999999988999999432 110 0 1110 22333344444
Q ss_pred EEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceee
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
|+=...++..+. ++. +++.+++|+|+. ||+|||+||+|.+++.-|++|+.|||+.+.-
T Consensus 136 -------gDc~tllk~~g~----lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGP----LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred -------chhhhhcccCCC----Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhh
Confidence 344444443322 222 237899999999 9999999999999999999999999998643
Q ss_pred ccCC---------c------ceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 001752 864 IRKN---------E------TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIR 928 (1018)
Q Consensus 864 ~~~~---------~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~ 928 (1018)
.... . ....++|||.|+|||++..+.|+..+|+|++|+|+||.+-|+.||.++..++ + +.
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee--l---fg 268 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--L---FG 268 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH--H---Hh
Confidence 1100 0 0123689999999999999999999999999999999999999998753321 1 11
Q ss_pred HHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001752 929 MKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980 (1018)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 980 (1018)
..+.+.....+- |. ....+..+++.+.++.+|..|--....+
T Consensus 269 ~visd~i~wpE~-de---------a~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 269 QVISDDIEWPEE-DE---------ALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred hhhhhhcccccc-Cc---------CCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 111111111111 11 1123356678899999999995333333
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.8e-16 Score=160.20 Aligned_cols=138 Identities=20% Similarity=0.331 Sum_probs=114.4
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccc----cchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLE----TESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
+.||+|++|.||+|.+ .+..|++|+......... ......+.+|+.++..++|++++....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999987 477899998743222111 1123467889999999999999888888777778899999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
|++|++|.+++.... + .+..++.+++.+++++|+. +++|||++|.||+++ ++.++++|||.++.
T Consensus 80 ~~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999986432 2 7788999999999999999 999999999999999 78999999998854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.7e-15 Score=156.44 Aligned_cols=134 Identities=20% Similarity=0.325 Sum_probs=108.1
Q ss_pred eeecCCCeeEEEEEcCCCCeEEEEEEeeccccccc----cchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEe
Q 001752 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLE----TESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEY 787 (1018)
Q Consensus 712 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 787 (1018)
.||+|+||.||+|.+ ++..|++|+......... .....++.+|+++++.++|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999996 478899998643221111 11235678899999999998776666666666777999999
Q ss_pred cCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 788 MNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 788 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
++|++|.+++.... . .++.+++.+++++|+. +++|||++|.||+++ ++.++++|||.++.
T Consensus 79 ~~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999885432 1 6889999999999999 999999999999999 88999999998854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.2e-15 Score=155.09 Aligned_cols=139 Identities=22% Similarity=0.182 Sum_probs=107.7
Q ss_pred ccccceeecCCCeeEEEEEcCCCCeEEEEEEeecccccccc------------------chhhhHHHHHHHHhccCCC--
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLET------------------ESSGDFVGEVNVLGKLRHR-- 766 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~~~~E~~~l~~l~hp-- 766 (1018)
|...+.||+|+||.||+|... +|+.||||++......... .....+..|+..+..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 666789999999999999986 7999999997443211100 1122367789999999887
Q ss_pred CcceeeeeEecCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEE
Q 001752 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILL 846 (1018)
Q Consensus 767 niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll 846 (1018)
.++..++. ...++||||++|++|.+.... .....++.+++.++.++|+. +|+||||||+||++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill 158 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV 158 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence 44444442 345899999999999776431 22346888999999999998 99999999999999
Q ss_pred cCCCCeEEcccccceee
Q 001752 847 DSNLEPRIADFGLARMM 863 (1018)
Q Consensus 847 ~~~~~~kl~DfG~a~~~ 863 (1018)
++++.++|+|||.+...
T Consensus 159 ~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 159 DDDEKIYIIDWPQMVST 175 (198)
T ss_pred cCCCcEEEEECCccccC
Confidence 99999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.7e-15 Score=181.51 Aligned_cols=150 Identities=31% Similarity=0.531 Sum_probs=102.5
Q ss_pred ccccHHHHHHHHHHHhccCCCCCCcCCCCCCCCCc----eeeeEEeCCC-----CCEEEEEcCCCCCCcccccccccCCC
Q 001752 29 KTALNDELLALLSIKAGLVDPLNSLHDWKLPSAHC----NWTGVWCNSN-----GAVEKLDLSHMNLSGCVSDHFQRLKS 99 (1018)
Q Consensus 29 ~~~~~~~~~~Ll~~k~~~~d~~~~~~~w~~~~~~c----~w~gv~c~~~-----~~v~~L~L~~~~l~~~~~~~~~~l~~ 99 (1018)
..+.++|..||+++|+++.+|.. .+|. +..|| .|.||.|+.. .+|+.|+|++++++|.+++.++.+++
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~-g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~ 443 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR--FGWN-GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH 443 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc--CCCC-CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence 34566789999999999977642 4896 33442 7999999531 24777888887777777777777777
Q ss_pred CCEEEcCCCCcCCCCChhhhCCCCCcEEEeeecccCCCCcccccCCCCCceeccCCCCCCcccccccccc-cccceEecc
Q 001752 100 LTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNA-TSLETLDLR 178 (1018)
Q Consensus 100 L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l-~~L~~L~L~ 178 (1018)
|+.|+|++|++.+.+|..++.+++|+.|||++|+++|.+|..++.+++|++|+|++|++++.+|..++.+ .++..+++.
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~ 523 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT 523 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEec
Confidence 7777777777777777777777777777777777776666666666666666666666666666555442 344455555
Q ss_pred Ccc
Q 001752 179 GSF 181 (1018)
Q Consensus 179 ~n~ 181 (1018)
+|.
T Consensus 524 ~N~ 526 (623)
T PLN03150 524 DNA 526 (623)
T ss_pred CCc
Confidence 553
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.4e-16 Score=172.13 Aligned_cols=173 Identities=24% Similarity=0.388 Sum_probs=129.3
Q ss_pred ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccc
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGL 859 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 859 (1018)
+.|+.|+++...+|.+|+..++.. ...++.....++.|++.|++| + +.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~-e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG-EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc-cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 578999999999999999765543 336888999999999999999 5 899999999999999999999999999
Q ss_pred ceeeccCC------cceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhh
Q 001752 860 ARMMIRKN------ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIR 932 (1018)
Q Consensus 860 a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 932 (1018)
........ ...+...||..||+||.+.+..|+.++||||||++++|++. =..+|+. .. ....++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er--------~~-t~~d~r 473 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER--------IA-TLTDIR 473 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH--------HH-hhhhhh
Confidence 98764433 12344789999999999999999999999999999999997 2222211 00 001111
Q ss_pred cccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 001752 933 DNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDV 979 (1018)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 979 (1018)
.+. ++|. .......-..++.+++++.|.+||++.++
T Consensus 474 ~g~-----ip~~------~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DGI-----IPPE------FLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCC-----CChH------HhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 111 1111 11122223467889999999999955444
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=4e-15 Score=176.73 Aligned_cols=141 Identities=21% Similarity=0.253 Sum_probs=113.0
Q ss_pred hhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccc----cccchhhhHHHHHHHHhccCCCCcceeeeeEecCC
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRAD----LETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
...|...+.||+|+||+||+|.+.. ..+++|+....... ........+.+|++++++++|++++....++.+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3445667899999999999998863 34455543221111 11123456889999999999999998888887777
Q ss_pred ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccc
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGL 859 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 859 (1018)
..++||||++|++|.+++. ....++.+++++++|||+. +++|||+||+||++ .++.++++|||+
T Consensus 410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 7899999999999999885 2456899999999999999 99999999999999 678999999999
Q ss_pred cee
Q 001752 860 ARM 862 (1018)
Q Consensus 860 a~~ 862 (1018)
++.
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.6e-14 Score=144.10 Aligned_cols=138 Identities=20% Similarity=0.202 Sum_probs=97.7
Q ss_pred cceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhh---------------------hHHHHHHHHhccCCCC-
Q 001752 710 SNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG---------------------DFVGEVNVLGKLRHRN- 767 (1018)
Q Consensus 710 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~hpn- 767 (1018)
.+.||+|+||+||+|.+. +++.||||++......... ... ....|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKK-RKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhh-hhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 467999999999999987 7899999998543221111 111 1134666666664433
Q ss_pred -cceeeeeEecCCceEEEEEecCCCCHHH-hhhcCCCCccccCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeecCCCCcE
Q 001752 768 -IVRLLGFLHNDTNMMIVYEYMNNGSLGE-ALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH-DCYPPIIHRDIKSNNI 844 (1018)
Q Consensus 768 -iv~~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NI 844 (1018)
+++.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++|+ . +|+||||||+||
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Ni 146 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNI 146 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhE
Confidence 4444443 23589999999854432 121111 11 4567789999999999999 7 999999999999
Q ss_pred EEcCCCCeEEcccccceee
Q 001752 845 LLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 845 ll~~~~~~kl~DfG~a~~~ 863 (1018)
+++ ++.++++|||.+...
T Consensus 147 li~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EEE-CCcEEEEECcccccc
Confidence 999 899999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.3e-13 Score=145.04 Aligned_cols=139 Identities=18% Similarity=0.213 Sum_probs=107.4
Q ss_pred cceee-cCCCeeEEEEEcCCCCeEEEEEEeecccc---------ccccchhhhHHHHHHHHhccCCCCc--ceeeeeEec
Q 001752 710 SNVIG-MGATGIVYKAEMPRLNTIVAVKKLWRSRA---------DLETESSGDFVGEVNVLGKLRHRNI--VRLLGFLHN 777 (1018)
Q Consensus 710 ~~~lG-~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~~~E~~~l~~l~hpni--v~~~~~~~~ 777 (1018)
...|| .||.|+||.+... +..++||.+..... .........+.+|+.++.+++|+++ ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45788 8999999999886 77899998843211 1112334578899999999998875 677776543
Q ss_pred C-Cc---eEEEEEecCC-CCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCe
Q 001752 778 D-TN---MMIVYEYMNN-GSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP 852 (1018)
Q Consensus 778 ~-~~---~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 852 (1018)
. .. .++||||++| .+|.+++.... ++.. .+.+|+.++++||+. ||+||||||.||+++.++.+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~-----l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAP-----LSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCC-----CCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCE
Confidence 2 22 2599999997 69999886432 3333 356899999999999 99999999999999999999
Q ss_pred EEccccccee
Q 001752 853 RIADFGLARM 862 (1018)
Q Consensus 853 kl~DfG~a~~ 862 (1018)
+++|||.++.
T Consensus 182 ~LIDfg~~~~ 191 (239)
T PRK01723 182 WLIDFDRGEL 191 (239)
T ss_pred EEEECCCccc
Confidence 9999998865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=135.69 Aligned_cols=134 Identities=23% Similarity=0.212 Sum_probs=112.3
Q ss_pred cceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCC--CCcceeeeeEecCCceEEEEEe
Q 001752 710 SNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH--RNIVRLLGFLHNDTNMMIVYEY 787 (1018)
Q Consensus 710 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lV~e~ 787 (1018)
.+.||+|.++.||++... +..+++|....... ...+.+|+..++.++| +.+++++++....+..+++|||
T Consensus 3 ~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred ceecccccccceEEEEec--CCeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 467999999999999986 37899998832211 4578899999999976 5899999998888889999999
Q ss_pred cCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 788 MNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 788 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
++++.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++.
T Consensus 75 ~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998777654 3455667889999999999997545799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.8e-15 Score=164.80 Aligned_cols=179 Identities=32% Similarity=0.544 Sum_probs=151.0
Q ss_pred ccccccEEeccCCcccCCCcccCCCccccceeecccccccCCCccccCCCCccceEeccCCcccCCCCccccCCCCcccc
Q 001752 408 TCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTF 487 (1018)
Q Consensus 408 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 487 (1018)
.+.--...||+.|++. .+|..+..+-.|+.+.|.+|.+. .+|..+.++..|++|||+.|+++ ..|..++.++ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3344556778888887 77887777888888888888887 67888888888999999999987 6777777776 8899
Q ss_pred cccCCcccCCCCcccCCCCccceeecccccccCCCCCccccccccceeecccccccCCcccccccCCccceeeccccccc
Q 001752 488 IVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLT 567 (1018)
Q Consensus 488 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 567 (1018)
.+++|+++ .+|+.++.+..|..||.|.|.+. .+|..++++.+|+.|++..|++. .+|..+..++ |..||+|.|+++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis 224 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS 224 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee
Confidence 99999998 78888888899999999999997 78888999999999999999998 5677777654 889999999998
Q ss_pred CCCCCCCCCCCCCceEEecCCcccCCCC
Q 001752 568 GGIPENFGASPALEVLNVSYNRLEGPVP 595 (1018)
Q Consensus 568 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p 595 (1018)
.+|-.|..+..|++|-|.+|+|++++.
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQSPPA 251 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCCCChH
Confidence 889999999999999999999987554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=5e-15 Score=174.46 Aligned_cols=258 Identities=25% Similarity=0.262 Sum_probs=188.6
Q ss_pred hcccccceeecCCCeeEEEEEcCC-CCeEEEEEEeeccccccccchhhhHHHHHHHHhccC-CCCcceeeeeEecCCceE
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPR-LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 782 (1018)
..|...+.||+|+|+.|-.+.... ....+|+|.+... ........+...|..+-+.+. |+|++++++...+.+..+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~--~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIP--PKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCC--CCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 345666779999999999888743 3455666666222 233444555566888877776 999999999999999999
Q ss_pred EEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhh-cCCCCCeEeecCCCCcEEEcCCC-CeEEcccccc
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-HDCYPPIIHRDIKSNNILLDSNL-EPRIADFGLA 860 (1018)
Q Consensus 783 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~a 860 (1018)
++.+|..|+++.+.+....... .+....-.+..|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~--~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTG--TSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cccCcccccccccccccCCccC--CCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhh
Confidence 9999999999999984222112 333444457899999999999 77 999999999999999999 9999999999
Q ss_pred eeecc-CCcc--eEeecc-CCCccCcCCCCCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhccc
Q 001752 861 RMMIR-KNET--VSMVAG-SYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR 935 (1018)
Q Consensus 861 ~~~~~-~~~~--~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 935 (1018)
..+.. .+.. ....+| ++.|.|||...+. ...+..|+||.|+++.-+++|..||+...........|........
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 251 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT- 251 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc-
Confidence 88765 2222 233678 9999999998874 4568899999999999999999999765444433344333221000
Q ss_pred ccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 936 NLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
... +........++..+++..+|+.|.+.+++...
T Consensus 252 ---------~~~---~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 252 ---------QLP---WNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ---------cCc---cccCChhhhhcccccccCCchhcccccccccc
Confidence 000 11112234567778888999999999888653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.2e-14 Score=148.20 Aligned_cols=204 Identities=24% Similarity=0.300 Sum_probs=144.9
Q ss_pred HHHhccCCCCcceeeeeEecC-----CceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCC
Q 001752 758 NVLGKLRHRNIVRLLGFLHND-----TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832 (1018)
Q Consensus 758 ~~l~~l~hpniv~~~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~ 832 (1018)
.-+-++-|-|+|+++.||.+. .+..++.|||..|++..+|++.+.....+......+++.||..||.|||+. .|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 335566799999999998654 457899999999999999998877777788888889999999999999995 67
Q ss_pred CeEeecCCCCcEEEcCCCCeEEcccccceeeccC----CcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHh
Q 001752 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK----NETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT 908 (1018)
Q Consensus 833 ~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt 908 (1018)
+|+|+++..+-|++..+|-+|+.--.-....... ......-.+-++|.|||+......+.++|||+||....||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 8999999999999999998888632211110000 001112346789999999988888999999999999999988
Q ss_pred CCCC-CCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001752 909 GRRP-LDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983 (1018)
Q Consensus 909 g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 983 (1018)
+..- -..... ......+.... ...-++.. ...+.+|++..|..||+|++++.+.
T Consensus 278 lEiq~tnseS~--~~~ee~ia~~i------~~len~lq-------------r~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 278 LEIQSTNSESK--VEVEENIANVI------IGLENGLQ-------------RGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred heeccCCCcce--eehhhhhhhhe------eeccCccc-------------cCcCcccccCCCCCCcchhhhhcCc
Confidence 6542 222111 11111110000 00001111 1256689999999999999988654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=9.5e-14 Score=166.47 Aligned_cols=117 Identities=37% Similarity=0.604 Sum_probs=89.2
Q ss_pred ccceeecccccccCCCCCccccccccceeecccccccCCcccccccCCccceeecccccccCCCCCCCCCCCCCceEEec
Q 001752 507 SLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVS 586 (1018)
Q Consensus 507 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 586 (1018)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|+.++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36677888888887888888888888888888888887788778888888888888888888888888888888888888
Q ss_pred CCcccCCCCCCc--cccccCCCCCCCCcCCCCCC-CCCCC
Q 001752 587 YNRLEGPVPANG--VLRTINRGDLAGNAGLCGGV-LHPCS 623 (1018)
Q Consensus 587 ~N~l~~~~p~~~--~~~~~~~~~~~~n~~~c~~~-~~~~~ 623 (1018)
+|+|+|.+|... ....+...++.+|+++|+.+ +..|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 888888777532 12234456789999999975 45674
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.3e-12 Score=149.63 Aligned_cols=159 Identities=19% Similarity=0.209 Sum_probs=110.7
Q ss_pred hcccChHHHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccc--------------------------
Q 001752 695 RLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETE-------------------------- 748 (1018)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-------------------------- 748 (1018)
+++...++....|+. +.||+|++|+||+|+.. +|+.||||+.++.....-..
T Consensus 108 elg~~~~~~F~~fd~-~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~ 185 (437)
T TIGR01982 108 ALGGPLEELFAEFEE-KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTE 185 (437)
T ss_pred HhCcCHHHHHhhCCC-cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHH
Confidence 455566667777764 78999999999999986 69999999985432110000
Q ss_pred ----------hhhhHHHHHHHHhccC-----CCCcceeeeeEecCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHH
Q 001752 749 ----------SSGDFVGEVNVLGKLR-----HRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRY 813 (1018)
Q Consensus 749 ----------~~~~~~~E~~~l~~l~-----hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~ 813 (1018)
..-+|.+|+..+.+++ ++++.-..-|.......++||||++|++|.++....... . .+.
T Consensus 186 ~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~ 259 (437)
T TIGR01982 186 VVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRK 259 (437)
T ss_pred HHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHH
Confidence 0113556676666663 343332222222334579999999999999887532211 1 234
Q ss_pred HHHHHHHH-HHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeec
Q 001752 814 NIALGVAQ-GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 814 ~i~~~i~~-~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 864 (1018)
+++..++. .+..+|.. |++|+|++|.||+++.++.++++|||++..+.
T Consensus 260 ~ia~~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 260 ALAENLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 46666666 47888988 99999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.8e-14 Score=154.59 Aligned_cols=195 Identities=29% Similarity=0.418 Sum_probs=130.1
Q ss_pred CCCCCcEEEeeecccCCCCcccccCCCCCceeccCCCCCCcccccccccccccceEeccCcccCccccccccccccccee
Q 001752 120 NLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFL 199 (1018)
Q Consensus 120 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L 199 (1018)
.|.--...||+.|++. ++|..+..+..|+.|.|..|.+.. +|..+.++..|++|||+.|+++ ..|..+..|+ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r~-ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIRT-IPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhcccee-cchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 4445556677777776 677777777777777777777664 5667777777777777777777 6677777777 7888
Q ss_pred eecccccCCCCCcccccccchhhhhccccccCCCCCccccCccccccccccccccCccCcccccCCCccceEEccCCcCC
Q 001752 200 GLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQ 279 (1018)
Q Consensus 200 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 279 (1018)
-+++|+++ .+|..++.+..|..|+.+.|++. .+|..++.+.+|+.|.+..|++.
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~------------------------ 202 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE------------------------ 202 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh------------------------
Confidence 88888887 67777777777788888887776 56777777777777777766665
Q ss_pred ccCChhhcCCCCCCeeeccCCCCccccCCccccccCCceeecccCccccccCCCCCC---CCccceEEeccC
Q 001752 280 GRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGG---LTQLEVLELWNN 348 (1018)
Q Consensus 280 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~---l~~L~~L~L~~N 348 (1018)
.+|+.+..| .|..||+|.|+++ .+|-.|.+|+.|++|-|.+|.++ ..|..++- ..-.++|+..-+
T Consensus 203 -~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 203 -DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred -hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 344444432 3566666666665 56666666666666666666666 34443322 222345555444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.1e-12 Score=150.80 Aligned_cols=199 Identities=36% Similarity=0.519 Sum_probs=118.4
Q ss_pred eEeccCcccCcccccccccccccceeeecccccCCCCCccccccc-chhhhhccccccCCCCCccccCcccccccccccc
Q 001752 174 TLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLS-SMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVG 252 (1018)
Q Consensus 174 ~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 252 (1018)
.|+++.|.+.. .+..+..++.++.|++.+|.++ .+|...+.+. +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 45555555531 2233344455666666666665 4454455443 5666666666665 34445566666666666666
Q ss_pred ccCccCcccccCCCccceEEccCCcCCccCChhhcCCCCCCeeeccCCCCccccCCccccccCCceeecccCccccccCC
Q 001752 253 NLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPA 332 (1018)
Q Consensus 253 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 332 (1018)
++. .+|...+.++.|+.|++++|++. .+|..+..+..|++|++++|.+. ..+..+..+.++..|.+.+|++.. .+.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence 665 34444445566666666666666 45555555556777777777543 455566677777777777777662 355
Q ss_pred CCCCCCccceEEeccCccccCCCcCCCCCCCCceeeccccccccccccc
Q 001752 333 GLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPAS 381 (1018)
Q Consensus 333 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~ 381 (1018)
.++.+++++.|++++|.++.. +. ++...+++.|++++|.+....+..
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hhccccccceecccccccccc-cc-ccccCccCEEeccCccccccchhh
Confidence 666677777777777777633 22 666777777777777776554443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-12 Score=149.74 Aligned_cols=199 Identities=35% Similarity=0.476 Sum_probs=101.6
Q ss_pred EEEcCCCCcCCCCChhhhCCCCCcEEEeeecccCCCCcccccCCC-CCceeccCCCCCCcccccccccccccceEeccCc
Q 001752 102 SLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAA-GLTFLNASGNNFSGFLLEDLGNATSLETLDLRGS 180 (1018)
Q Consensus 102 ~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~-~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n 180 (1018)
.|+++.|.+... +..+..++.++.|++.+|.++ .+|...+.+. +|+.|++++|++... +..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l-~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESL-PSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchhhh-hhhhhccccccccccCCc
Confidence 344444444221 223344455555555555555 4444444443 555555555555542 234455555555555555
Q ss_pred ccCcccccccccccccceeeecccccCCCCCcccccccchhhhhccccccCCCCCccccCccccccccccccccCccCcc
Q 001752 181 FFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPA 260 (1018)
Q Consensus 181 ~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 260 (1018)
+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|.+++|++. ..+..+.+++++..|.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~------------ 238 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLE------------ 238 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccc------------
Confidence 555 33433334555555555555555 44444444444555555555322 2333444444444444
Q ss_pred cccCCCccceEEccCCcCCccCChhhcCCCCCCeeeccCCCCccccCCccccccCCceeecccCccccccCCC
Q 001752 261 ELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAG 333 (1018)
Q Consensus 261 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 333 (1018)
+.+|++. .++..+..+++++.|++++|.++.. +. ++.+.+++.|++++|.+....+..
T Consensus 239 ------------l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 239 ------------LSNNKLE-DLPESIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred ------------cCCceee-eccchhccccccceecccccccccc-cc-ccccCccCEEeccCccccccchhh
Confidence 4444444 2245566666666666666666532 22 666666666666666666544443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.4e-12 Score=150.37 Aligned_cols=161 Identities=17% Similarity=0.158 Sum_probs=104.5
Q ss_pred hhcccChHHHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeecccccc-------------------------c--
Q 001752 694 QRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADL-------------------------E-- 746 (1018)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------------~-- 746 (1018)
++++...++....|+. +.||+|++|+||+|+...+|+.||||+.++..... .
T Consensus 109 ~elG~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~ 187 (537)
T PRK04750 109 KALGGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPR 187 (537)
T ss_pred HHhCCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHH
Confidence 3456666778888887 89999999999999998779999999996442110 0
Q ss_pred ---cchh------hhHHHHHHHHhccC----CCCcceeeeeEe-cCCceEEEEEecCCCCHHHh--hhcCCCCccccCHH
Q 001752 747 ---TESS------GDFVGEVNVLGKLR----HRNIVRLLGFLH-NDTNMMIVYEYMNNGSLGEA--LHGKQAGRLLVDWV 810 (1018)
Q Consensus 747 ---~~~~------~~~~~E~~~l~~l~----hpniv~~~~~~~-~~~~~~lV~e~~~~gsL~~~--l~~~~~~~~~~~~~ 810 (1018)
.+.. -+|.+|+..+.+++ +...+.+-..+. -....++||||++|+.+.+. +.........+...
T Consensus 188 ~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~ 267 (537)
T PRK04750 188 EVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAER 267 (537)
T ss_pred HHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHH
Confidence 0111 13445555555552 333233222222 23456899999999999874 32222111112222
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC----CeEEcccccceeecc
Q 001752 811 SRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL----EPRIADFGLARMMIR 865 (1018)
Q Consensus 811 ~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfG~a~~~~~ 865 (1018)
....++.|+ ... |++|+|++|.||+++.++ +++++|||++..+.+
T Consensus 268 ~v~~~~~Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 268 GVEVFFTQV-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHH-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 222233333 345 999999999999999988 999999999987743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.3e-12 Score=141.45 Aligned_cols=251 Identities=22% Similarity=0.189 Sum_probs=181.9
Q ss_pred hcccccceeec--CCCeeEEEEEc--CCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCC
Q 001752 705 ACIRESNVIGM--GATGIVYKAEM--PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 705 ~~~~~~~~lG~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 779 (1018)
..|...+.+|. |.+|.||.+.. ..++..+|+|+-+.... .......-.+|+..-+++ .|++.++....+...+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s--~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS--PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC--CccccccccchhhcccccCccccccccCcccccCC
Confidence 44556678999 99999999998 88899999998522211 122233345677777777 4999999999999999
Q ss_pred ceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHH----HHHHhhcCCCCCeEeecCCCCcEEEcCC-CCeEE
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ----GLAYLHHDCYPPIIHRDIKSNNILLDSN-LEPRI 854 (1018)
Q Consensus 780 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl 854 (1018)
..++-+|++ +.+|.++.+.... .++....+.+..+..+ |+.++|+. +++|-|+||.||+...+ ...++
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred cceeeeccc-cchhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeec
Confidence 999999998 4688888765443 2566677777888888 99999999 99999999999999999 88999
Q ss_pred cccccceeeccCCcceEee-----ccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 001752 855 ADFGLARMMIRKNETVSMV-----AGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRM 929 (1018)
Q Consensus 855 ~DfG~a~~~~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~ 929 (1018)
+|||....+....-..... .|...|++||...+ .++.+.|+|++|.++.+..++..+..... ...|..
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~-----~~~W~~- 337 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK-----NSSWSQ- 337 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC-----CCCccc-
Confidence 9999998876554333222 57778999998665 57899999999999999999877664321 011111
Q ss_pred HhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001752 930 KIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 982 (1018)
.+....-.+..++. ...+...+..|++.+|-.|++.+.+.+.
T Consensus 338 -~r~~~ip~e~~~~~----------s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 338 -LRQGYIPLEFCEGG----------SSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred -cccccCchhhhcCc----------chhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 00110001111111 1123337788999999999998887653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.4e-10 Score=131.04 Aligned_cols=170 Identities=19% Similarity=0.219 Sum_probs=129.9
Q ss_pred EEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEEecCCCCHHHhhhcCCC
Q 001752 723 KAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQA 802 (1018)
Q Consensus 723 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~ 802 (1018)
.|..+.++.+|.|.+.+.... .......+.+..++.++||+|+++++.++.++..|+|+|-+. .|..+++...
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-
Confidence 466667888999998843322 233456678888999999999999999999999999999884 6887886543
Q ss_pred CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcceEeeccCCCccCc
Q 001752 803 GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAP 882 (1018)
Q Consensus 803 ~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aP 882 (1018)
.....-.+.||+.||.|||+.| +++|+++..+.|++++.|..||++|-++......+.......--..|..|
T Consensus 103 ------~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P 174 (690)
T KOG1243|consen 103 ------KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDP 174 (690)
T ss_pred ------HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccCh
Confidence 3455557889999999999876 89999999999999999999999999886543222211222223356677
Q ss_pred CCCCCCCCCccccchhHHHHHHHHHhC
Q 001752 883 EYGYTLKVDEKIDIYSFGVVLLELLTG 909 (1018)
Q Consensus 883 E~~~~~~~~~~~Dv~slG~il~elltg 909 (1018)
+.+.... -..|.|.|||+++|++.|
T Consensus 175 ~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 175 EEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhcCccc--cchhhhhHHHHHHHHhCc
Confidence 7543322 457999999999999998
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.5e-12 Score=129.51 Aligned_cols=134 Identities=25% Similarity=0.372 Sum_probs=96.1
Q ss_pred CCCccceEeccCCcccCCCCccccCCCCcccccccCCcccCCCCcccCCCCccceeecccccccCCCCCcccccccccee
Q 001752 456 SSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNL 535 (1018)
Q Consensus 456 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 535 (1018)
....|+++|||+|.|+ .+.+...-+|.++.|++|+|.|... +.+..+++|+.||||+|.++ .+..+-.++.+.+.|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 3445666667776665 3445555567777777777777632 23667788888888888887 556666677888888
Q ss_pred ecccccccCCcccccccCCccceeecccccccCCC-CCCCCCCCCCceEEecCCcccCCCC
Q 001752 536 NLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGI-PENFGASPALEVLNVSYNRLEGPVP 595 (1018)
Q Consensus 536 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p 595 (1018)
.|+.|.|.. -..++.+.+|..||+++|+|.... -..++++|-|+.+.|.+|+|.+.+.
T Consensus 358 ~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 358 KLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred ehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 888888763 234677788888888888887543 3568888889999999999887554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=2e-10 Score=115.00 Aligned_cols=140 Identities=14% Similarity=0.162 Sum_probs=99.9
Q ss_pred ceeecCCCeeEEEEEcCC------CCeEEEEEEeeccccccc------------------cchhhhHH----HHHHHHhc
Q 001752 711 NVIGMGATGIVYKAEMPR------LNTIVAVKKLWRSRADLE------------------TESSGDFV----GEVNVLGK 762 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~------------------~~~~~~~~----~E~~~l~~ 762 (1018)
..||.|.-+.||.|.... .+..+|||+.+....... ....+.+. +|+..+++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999998653 357899998843221110 01122333 79999999
Q ss_pred cCC--CCcceeeeeEecCCceEEEEEecCCCCHHH-hhhcCCCCccccCHHHHHHHHHHHHHHHHHh-hcCCCCCeEeec
Q 001752 763 LRH--RNIVRLLGFLHNDTNMMIVYEYMNNGSLGE-ALHGKQAGRLLVDWVSRYNIALGVAQGLAYL-HHDCYPPIIHRD 838 (1018)
Q Consensus 763 l~h--pniv~~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~D 838 (1018)
+.. -+++.++++ ..-++||||+.+..+.. .+... .++......+..+++.++..+ |.. ++||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 954 567777765 34589999997654422 22221 134455667789999999999 777 999999
Q ss_pred CCCCcEEEcCCCCeEEcccccceee
Q 001752 839 IKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 839 lk~~NIll~~~~~~kl~DfG~a~~~ 863 (1018)
++++||+++ ++.++++|||.+...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 468999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.7e-11 Score=118.18 Aligned_cols=129 Identities=20% Similarity=0.129 Sum_probs=95.0
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcc-eeeeeEecCCceEEEEEecC
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIV-RLLGFLHNDTNMMIVYEYMN 789 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lV~e~~~ 789 (1018)
+.++.|.++.||++... ++.|++|+..... .....+.+|+.+++.+.+.+++ +++.+.. ...++||||++
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGT-----ELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCc-----ccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 57899999999999875 7889999873221 1233567899999988665544 4554433 33589999999
Q ss_pred CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCC--CCCeEeecCCCCcEEEcCCCCeEEcccccce
Q 001752 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC--YPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 790 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 861 (1018)
|.++.+.- . ....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCcccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 98876530 0 01235678999999999982 12359999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.7e-12 Score=132.07 Aligned_cols=187 Identities=22% Similarity=0.247 Sum_probs=84.5
Q ss_pred cccccceeeecccccCCCCCccc----ccccchhhhhccccccCCCCCcc-------------ccCcccccccccccccc
Q 001752 192 NLQKLKFLGLSGNNLTGKIPREL----GQLSSMETMILAYNEFDGEIPVE-------------FGNLTNLKYLDLAVGNL 254 (1018)
Q Consensus 192 ~l~~L~~L~L~~n~l~~~~p~~l----~~l~~L~~L~L~~n~l~~~~~~~-------------~~~l~~L~~L~L~~n~l 254 (1018)
..++|++|+||+|-+.-..+..| .++..|++|.|.+|.+.-..... .++-+.|+++...+|++
T Consensus 90 ~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrl 169 (382)
T KOG1909|consen 90 GCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRL 169 (382)
T ss_pred cCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccc
Confidence 34455666666665543333322 23455666666655554111111 12234555555555555
Q ss_pred Ccc----CcccccCCCccceEEccCCcCCcc----CChhhcCCCCCCeeeccCCCCccccCCccccccCCceeecccCcc
Q 001752 255 GGK----IPAELGRLELLEIMFLYQNNFQGR----LPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQL 326 (1018)
Q Consensus 255 ~~~----~~~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 326 (1018)
... +...|...+.|+.+.+++|.|... +...+..+++|+.|||.+|.++.....
T Consensus 170 en~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~------------------ 231 (382)
T KOG1909|consen 170 ENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSV------------------ 231 (382)
T ss_pred ccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHH------------------
Confidence 432 122333444555555555554311 112344455555555555554421110
Q ss_pred ccccCCCCCCCCccceEEeccCccccCCCcCC-----CCCCCCceeeccccccccc----ccccccCCCCCceecccccc
Q 001752 327 SGHVPAGLGGLTQLEVLELWNNSLSGPLPVDL-----GKNSPLQWLDLSSNSFSGE----IPASLCNGGNLTKLILFNNA 397 (1018)
Q Consensus 327 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~~~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~ 397 (1018)
.+...+..+++|+.|++++|.+.......| ...++|+.|.+.+|.++.. +...+...+.|.+|+|++|.
T Consensus 232 --~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~ 309 (382)
T KOG1909|consen 232 --ALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNR 309 (382)
T ss_pred --HHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccc
Confidence 112233344445555555554443222211 1245566666666666421 22233445667777777777
Q ss_pred C
Q 001752 398 F 398 (1018)
Q Consensus 398 l 398 (1018)
+
T Consensus 310 l 310 (382)
T KOG1909|consen 310 L 310 (382)
T ss_pred c
Confidence 6
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.6e-12 Score=143.03 Aligned_cols=247 Identities=28% Similarity=0.301 Sum_probs=136.5
Q ss_pred ccCCCCCEEEcCCCCcCCCCChhhhCCCCCcEEEeeecccCCCCcccccCCCCCceeccCCCCCCcccccccccccccce
Q 001752 95 QRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLET 174 (1018)
Q Consensus 95 ~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~ 174 (1018)
..+..+..+++..|.|.. +-..+..+++|+.|++.+|+|.. +...+..+++|++|++++|.|+.+. .+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhh
Confidence 345566666677777643 23346667777777777777763 3333566677777777777776543 3555666777
Q ss_pred EeccCcccCcccccccccccccceeeecccccCCCCCcc-cccccchhhhhccccccCCCCCccccCccccccccccccc
Q 001752 175 LDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRE-LGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGN 253 (1018)
Q Consensus 175 L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 253 (1018)
|++++|.|+.. ..+..+..|+.+++++|+++..-+ . ...+.+++.+.+..|.+... ..+..+..+..+++..|.
T Consensus 145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchhc--cCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchhcc--cchHHHHHHHHhhccccc
Confidence 77777776632 345556667777777777663322 1 35566666666666666522 233444444444555554
Q ss_pred cCccCcccccCCCccceEEccCCcCCccCChhhcCCC--CCCeeeccCCCCccccCCccccccCCceeecccCccccccC
Q 001752 254 LGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNIT--SLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVP 331 (1018)
Q Consensus 254 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 331 (1018)
+...-+ +..+. .|+.+++++|.+. ..+..+..+.++..|++.+|++...
T Consensus 220 i~~~~~--------------------------l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~-- 270 (414)
T KOG0531|consen 220 ISKLEG--------------------------LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL-- 270 (414)
T ss_pred ceeccC--------------------------cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--
Confidence 442111 11111 2566666666664 2334555566666666666666532
Q ss_pred CCCCCCCccceEEeccCcccc---CCCcC-CCCCCCCceeeccccccccccc
Q 001752 332 AGLGGLTQLEVLELWNNSLSG---PLPVD-LGKNSPLQWLDLSSNSFSGEIP 379 (1018)
Q Consensus 332 ~~~~~l~~L~~L~L~~N~l~~---~~~~~-~~~~~~L~~L~Ls~N~l~~~~~ 379 (1018)
..+.....+..+.+..|.+.. ..... ......++.+.+..|.+....+
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 271 EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 223444555555666665542 11111 4455666777777776654443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=4e-12 Score=131.75 Aligned_cols=247 Identities=29% Similarity=0.393 Sum_probs=154.1
Q ss_pred CCCCCccceEEeccCcccc----CCCcCCCCCCCCceeecccc---ccccccccc-------ccCCCCCceeccccccCC
Q 001752 334 LGGLTQLEVLELWNNSLSG----PLPVDLGKNSPLQWLDLSSN---SFSGEIPAS-------LCNGGNLTKLILFNNAFS 399 (1018)
Q Consensus 334 ~~~l~~L~~L~L~~N~l~~----~~~~~~~~~~~L~~L~Ls~N---~l~~~~~~~-------~~~l~~L~~L~L~~N~l~ 399 (1018)
+..+..++.++|++|.+.. .+...+...++|+..++|+- ++..++|.. +...++|++|+||.|.|.
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 4456677788888887652 22334556667777776642 222233332 233446666666666665
Q ss_pred CCCcc----cccccccccEEeccCCcccCCCcccCCCccccceeecccccccCCCccccCCCCccceEeccCCcccCCC-
Q 001752 400 GPIPV----SLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSL- 474 (1018)
Q Consensus 400 ~~~~~----~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~- 474 (1018)
...+. -+.+++.|++|.|.+|.+...--..++ ..|..|. . ....+.-+.|+++..++|++....
T Consensus 106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~--~al~~l~--~-------~kk~~~~~~Lrv~i~~rNrlen~ga 174 (382)
T KOG1909|consen 106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG--RALFELA--V-------NKKAASKPKLRVFICGRNRLENGGA 174 (382)
T ss_pred ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH--HHHHHHH--H-------HhccCCCcceEEEEeeccccccccH
Confidence 33222 224455555555555555411111111 0111111 1 112345567888888888886432
Q ss_pred ---CccccCCCCcccccccCCcccCC----CCcccCCCCccceeecccccccCC----CCCccccccccceeeccccccc
Q 001752 475 ---PSTILSIPNLQTFIVSNNNLVGE----IPDQFQDCPSLSVLDLSSNYFSGS----IPSSIASCEKLVNLNLRNNQLT 543 (1018)
Q Consensus 475 ---~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~ 543 (1018)
...|...+.|+.+.++.|.|... +...|..+++|++|||..|.|+.. +...++.++.|+.|+++++.+.
T Consensus 175 ~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~ 254 (382)
T KOG1909|consen 175 TALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLE 254 (382)
T ss_pred HHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccc
Confidence 34566778899999999888522 234577889999999999998743 3445667889999999999987
Q ss_pred CCccccc-----ccCCccceeecccccccCC----CCCCCCCCCCCceEEecCCccc
Q 001752 544 GDIPKAI-----SMMPTLAILDLSNNSLTGG----IPENFGASPALEVLNVSYNRLE 591 (1018)
Q Consensus 544 ~~~~~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~ 591 (1018)
.....+| ...|+|++|+|.+|.++.. +...+...|.|..|+|++|++.
T Consensus 255 ~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 255 NEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred cccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 5544333 2468999999999998732 3344566889999999999994
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.6e-11 Score=141.13 Aligned_cols=246 Identities=25% Similarity=0.279 Sum_probs=105.1
Q ss_pred cccCCceeecccCccccccCCCCCCCCccceEEeccCccccCCCcCCCCCCCCceeecccccccccccccccCCCCCcee
Q 001752 312 QLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKL 391 (1018)
Q Consensus 312 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 391 (1018)
.+..++.+++..|.+.. +-..+..+++|+.|++.+|+|.. +...+..+++|++|+|++|.|+...+ +..+..|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhhh
Confidence 34444445555555542 22234445555555555555552 12124445555555555555543221 3333335555
Q ss_pred ccccccCCCCCcccccccccccEEeccCCcccCCCc-ccCCCccccceeecccccccCCCccccCCCCccceEeccCCcc
Q 001752 392 ILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIP-VGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHL 470 (1018)
Q Consensus 392 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 470 (1018)
++++|.|+.. ..+..+..|+.+++++|+++...+ . ...+.+++.+++++|.+.. ..
T Consensus 146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~------------------ 202 (414)
T KOG0531|consen 146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IE------------------ 202 (414)
T ss_pred eeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--cc------------------
Confidence 5555554421 122223444444444444442222 1 2333444444444444432 11
Q ss_pred cCCCCccccCCCCcccccccCCcccCCCCcccCCCC--ccceeecccccccCCCCCccccccccceeecccccccCCccc
Q 001752 471 RSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCP--SLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPK 548 (1018)
Q Consensus 471 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 548 (1018)
.+..+..+..+++..|.++..-+ +..+. .|+.+++++|++. ..+..+..+.++..|++++|++...-
T Consensus 203 ------~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~-- 271 (414)
T KOG0531|consen 203 ------GLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE-- 271 (414)
T ss_pred ------chHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--
Confidence 12222233333444444432111 11111 2455555555554 22234444555555555555554221
Q ss_pred ccccCCccceeecccccccCC---CCCC-CCCCCCCceEEecCCcccCCCC
Q 001752 549 AISMMPTLAILDLSNNSLTGG---IPEN-FGASPALEVLNVSYNRLEGPVP 595 (1018)
Q Consensus 549 ~~~~l~~L~~L~Ls~N~l~~~---~p~~-~~~l~~L~~L~ls~N~l~~~~p 595 (1018)
.+...+.+..+.++.|.+... .... ....+.+..+.+.+|+.....+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 272 GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred cccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 123344455555555554421 1111 3445556666666666655443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-11 Score=130.95 Aligned_cols=187 Identities=19% Similarity=0.239 Sum_probs=116.2
Q ss_pred ccccccccEEeccCCcccCCCcc--cCCCccccceeecccccccCCCccc-cCCCCccceEeccCCcccCC-CCccccCC
Q 001752 406 LSTCHSLVRVRMQNNQLSGTIPV--GFGRLEKLQRLELANNSLTGGITDD-IASSTSLSFIDISRNHLRSS-LPSTILSI 481 (1018)
Q Consensus 406 l~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l 481 (1018)
...|++++.|||+.|-+....+. -...+++|+.|+|+.|++....... -..++.|+.|.|+.|.++.. +-.....+
T Consensus 142 ~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~f 221 (505)
T KOG3207|consen 142 SKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTF 221 (505)
T ss_pred hhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhC
Confidence 34455555666666555532221 2345677777777777765322222 12556788888888887622 22234567
Q ss_pred CCcccccccCCcccCCCCcccCCCCccceeecccccccCCC-CCccccccccceeecccccccCC-cccc-----cccCC
Q 001752 482 PNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSI-PSSIASCEKLVNLNLRNNQLTGD-IPKA-----ISMMP 554 (1018)
Q Consensus 482 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~-~~~~-----~~~l~ 554 (1018)
|+|+.|+|..|...........-+..|+.|||++|++-+.. -...+.++.|+.|+++.+.+... .|+. ....+
T Consensus 222 Psl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~ 301 (505)
T KOG3207|consen 222 PSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFP 301 (505)
T ss_pred CcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccc
Confidence 88888888888643344444555678888888888876432 13466788888888888887743 2333 34567
Q ss_pred ccceeecccccccCC-CCCCCCCCCCCceEEecCCcccC
Q 001752 555 TLAILDLSNNSLTGG-IPENFGASPALEVLNVSYNRLEG 592 (1018)
Q Consensus 555 ~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~ 592 (1018)
+|++|+++.|++... .-..+..+++|+.|....|.|+.
T Consensus 302 kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 302 KLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred cceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 888888888888622 12334456667777777777753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.4e-11 Score=131.58 Aligned_cols=251 Identities=22% Similarity=0.176 Sum_probs=174.4
Q ss_pred HhhcccccceeecCCCeeEEEEEcC-CCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeEecCCc
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMP-RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTN 780 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 780 (1018)
....|..+..||.|.|+.||+.... .++..|++|.......... ....-..|+.+...+ .|.+++++...|...+.
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~--~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA--SDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH--hhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 4566788899999999999998765 6788899998744322211 111223455554444 58899999888888888
Q ss_pred eEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCC-CCeEEccccc
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN-LEPRIADFGL 859 (1018)
Q Consensus 781 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG~ 859 (1018)
.|+--||++++++....... ..++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence 88999999999888776322 2267788889999999999999998 99999999999999886 7889999999
Q ss_pred ceeeccCCcceEeeccCCCc-cCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 001752 860 ARMMIRKNETVSMVAGSYGY-IAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 860 a~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
+..+ .........++..| .+|+......+-.+.|+||||..+.+.++|.. +.........+ ..+
T Consensus 414 ~t~~--~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~-ls~~~~~~~~i--------~~~---- 478 (524)
T KOG0601|consen 414 WTRL--AFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP-LSESGVQSLTI--------RSG---- 478 (524)
T ss_pred cccc--ceecccccccccccccchhhccccccccccccccccccccccccCcc-cCcccccceee--------ecc----
Confidence 8642 11111112233344 35555666778889999999999999998764 22211111100 000
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 985 (1018)
.+............+...+..+++..||.+.+...+.+.
T Consensus 479 --------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 479 --------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred --------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 011111222345567778899999999999988766544
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.2e-11 Score=121.66 Aligned_cols=131 Identities=27% Similarity=0.219 Sum_probs=78.7
Q ss_pred CCccceEEccCCcCCccCChhhcCCCCCCeeeccCCCCccccCCccccccCCceeecccCccccccCCCCCCCCccceEE
Q 001752 265 LELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLE 344 (1018)
Q Consensus 265 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 344 (1018)
.+.|++++|++|.|+ .+.+++.-++.++.|++|+|.|... ..+..+++|+.|||++|.++ .+..+-..+-+++.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 344555555555555 4445555566666666666666522 23666666666666666665 3333334555666666
Q ss_pred eccCccccCCCcCCCCCCCCceeeccccccccc-ccccccCCCCCceeccccccCCCC
Q 001752 345 LWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGE-IPASLCNGGNLTKLILFNNAFSGP 401 (1018)
Q Consensus 345 L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~ 401 (1018)
|+.|.|.. -..++++-+|..||+++|+|... --..+++++.|+.+.|.+|.+.+.
T Consensus 359 La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 359 LAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 66666642 22455666677777777776532 234567778888888888887753
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.4e-11 Score=128.21 Aligned_cols=160 Identities=24% Similarity=0.174 Sum_probs=102.9
Q ss_pred hCCCCCcEEEeeecccCCCCc--ccccCCCCCceeccCCCCCCcc--cccccccccccceEeccCcccCccccccc-ccc
Q 001752 119 ANLTSLKRFDVSQNFLNGSFP--AGLGGAAGLTFLNASGNNFSGF--LLEDLGNATSLETLDLRGSFFQGSIPVSF-KNL 193 (1018)
Q Consensus 119 ~~l~~L~~L~Ls~n~l~~~~p--~~l~~l~~L~~L~Ls~n~l~~~--~~~~l~~l~~L~~L~L~~n~~~~~~p~~~-~~l 193 (1018)
.++.+|+...|.+..+. ..+ .....+++++.||||+|-+... +..-...|++|+.|+|+.|++........ ..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 46778888888887776 333 2456688888888888887754 23345678889999999988763322222 356
Q ss_pred cccceeeecccccCCC-CCcccccccchhhhhccccccCCCCCccccCccccccccccccccCccC-cccccCCCccceE
Q 001752 194 QKLKFLGLSGNNLTGK-IPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKI-PAELGRLELLEIM 271 (1018)
Q Consensus 194 ~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L 271 (1018)
++|+.|.|+.|.++.. +...+..+++|+.|+|..|..-..-......++.|+.|||++|++...- -...+.++.|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 7888999999888732 1122345678888888888633344445566777888888877765321 1223444555555
Q ss_pred EccCCcCC
Q 001752 272 FLYQNNFQ 279 (1018)
Q Consensus 272 ~L~~n~l~ 279 (1018)
.++.+.+.
T Consensus 277 nls~tgi~ 284 (505)
T KOG3207|consen 277 NLSSTGIA 284 (505)
T ss_pred hccccCcc
Confidence 55554443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.8e-10 Score=105.70 Aligned_cols=135 Identities=26% Similarity=0.349 Sum_probs=104.1
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccc----cccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEEE
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRAD----LETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 786 (1018)
..+++|+-+.||.+.+. |.++++|.=.++..- ...-...+-.+|+.++.+++--.|....-+..+.+...++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999775 555666643121111 111223456789999999988787777777778888899999
Q ss_pred ecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEccccccee
Q 001752 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 787 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 862 (1018)
|++|..|.+.+... +..++..+-.-+.-||.. ||+|+|+.++||++..++ +.++|||++.+
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999898654 134677788888999999 999999999999998875 99999999864
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.2e-10 Score=142.53 Aligned_cols=248 Identities=23% Similarity=0.210 Sum_probs=110.6
Q ss_pred ccccccccceEeccCcccCcccccccccccccceeeecccccCCCCCcccccccchhhhhccccccCCCCCccccCcccc
Q 001752 165 DLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNL 244 (1018)
Q Consensus 165 ~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 244 (1018)
.|..++.|++|||++|.=-+.+|..++.|-+||+|+|++..++ .+|..+++|.+|.+|++..+.....+|.....|++|
T Consensus 566 ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~L 644 (889)
T KOG4658|consen 566 FFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSL 644 (889)
T ss_pred HHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccc
Confidence 3444444444444444433344555555555555555555444 444455555555555554444333333444445555
Q ss_pred ccccccccc--cCccCcccccCCCccceEEccCCcCCccCChhhcCCCCCC----eeeccCCCCccccCCccccccCCce
Q 001752 245 KYLDLAVGN--LGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQ----LLDLSYNMLSHEIPAEITQLKNLQL 318 (1018)
Q Consensus 245 ~~L~L~~n~--l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~l~~l~~L~~ 318 (1018)
++|.+..-. .+...-..+..|+.|+.+....... .+-..+..++.|. .+.+..+... ..+..+..+.+|+.
T Consensus 645 r~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~ 721 (889)
T KOG4658|consen 645 RVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEE 721 (889)
T ss_pred cEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcce
Confidence 555543321 1112222233334444433322221 0001112222222 2332222222 34556667777777
Q ss_pred eecccCccccccCCCCCC------CCccceEEeccCccccCCCcCCCCCCCCceeecccccccccccccccCCCCCceec
Q 001752 319 LNLMCNQLSGHVPAGLGG------LTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLI 392 (1018)
Q Consensus 319 L~L~~N~l~~~~~~~~~~------l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 392 (1018)
|.+.++.+.......... ++++..+...++... ..+....-.++|+.|++.++.....+.+....+..+..+.
T Consensus 722 L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i 800 (889)
T KOG4658|consen 722 LSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELI 800 (889)
T ss_pred EEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEE
Confidence 777777775433322221 112222222222111 1222223456777888877776656555555555666555
Q ss_pred cccccCCCC-CcccccccccccEEec
Q 001752 393 LFNNAFSGP-IPVSLSTCHSLVRVRM 417 (1018)
Q Consensus 393 L~~N~l~~~-~~~~l~~l~~L~~L~L 417 (1018)
+..+.+.+. .-.....++++..+.+
T Consensus 801 ~~f~~~~~l~~~~~l~~l~~i~~~~l 826 (889)
T KOG4658|consen 801 LPFNKLEGLRMLCSLGGLPQLYWLPL 826 (889)
T ss_pred ecccccccceeeecCCCCceeEeccc
Confidence 555555544 2334444444444433
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.8e-10 Score=140.87 Aligned_cols=288 Identities=23% Similarity=0.248 Sum_probs=161.4
Q ss_pred CEEEEEcCCCCCCcccccccccCCCCCEEEcCCCC--cCCCCChhhhCCCCCcEEEeeecccCCCCcccccCCCCCceec
Q 001752 75 AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNG--LFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLN 152 (1018)
Q Consensus 75 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~--i~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~ 152 (1018)
.|....+.++.+.-... =...+.|++|-+..|. +....++.|..++.|++||||+|.=-+.+|..++.|.+|++|+
T Consensus 524 ~~rr~s~~~~~~~~~~~--~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 524 SVRRMSLMNNKIEHIAG--SSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred heeEEEEeccchhhccC--CCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 45566666665533221 1234478899888886 5445555688899999999999877678999999999999999
Q ss_pred cCCCCCCcccccccccccccceEeccCcccCcccccccccccccceeeecccccC--CCCCcccccccchhhhhcccccc
Q 001752 153 ASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLT--GKIPRELGQLSSMETMILAYNEF 230 (1018)
Q Consensus 153 Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~--~~~p~~l~~l~~L~~L~L~~n~l 230 (1018)
|++..+.. +|..+++|+.|.+||+..+.....+|.....|++|++|.+..-... ...-.++.+|..|+.+.......
T Consensus 602 L~~t~I~~-LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~ 680 (889)
T KOG4658|consen 602 LSDTGISH-LPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV 680 (889)
T ss_pred ccCCCccc-cchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh
Confidence 99999884 7888999999999999988766666777777999999988765422 12222333344444443322221
Q ss_pred CCCCCccccCccccc----cccccccccCccCcccccCCCccceEEccCCcCCccCChhhcC------CCCCCeeeccCC
Q 001752 231 DGEIPVEFGNLTNLK----YLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGN------ITSLQLLDLSYN 300 (1018)
Q Consensus 231 ~~~~~~~~~~l~~L~----~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~------l~~L~~L~Ls~N 300 (1018)
.+-..+..++.|. .+.+.. ......+..+..+.+|+.|.+.++.+.......... ++++..+...++
T Consensus 681 --~~~e~l~~~~~L~~~~~~l~~~~-~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~ 757 (889)
T KOG4658|consen 681 --LLLEDLLGMTRLRSLLQSLSIEG-CSKRTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNC 757 (889)
T ss_pred --HhHhhhhhhHHHHHHhHhhhhcc-cccceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcc
Confidence 1112233344443 222222 111234455666677777777776665322211111 111111111111
Q ss_pred CCccccCCccccccCCceeecccCccccccCCCCCCCCccceEEeccCccccC-CCcCCCCCCCCceeec
Q 001752 301 MLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGP-LPVDLGKNSPLQWLDL 369 (1018)
Q Consensus 301 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~~~~L~~L~L 369 (1018)
..- ..+....-.++|+.|++..+.....+......+..+..+.+..+.+.+. .-...+.++++.++.+
T Consensus 758 ~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l 826 (889)
T KOG4658|consen 758 HML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPL 826 (889)
T ss_pred ccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEeccc
Confidence 111 1122222345666666666555444444444444455445555555443 2333344444444333
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=9.5e-11 Score=137.63 Aligned_cols=249 Identities=20% Similarity=0.233 Sum_probs=167.9
Q ss_pred cccccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEEE
Q 001752 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVY 785 (1018)
Q Consensus 706 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 785 (1018)
.+...+.+-+|.++.++-+.-..+|...+.|+.... ........+....+-.+.-..++|.++...-.+......++|+
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~a-p~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLA-PKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccc-hhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 345556888999999999988777766666655211 1111112223333333333345677777666666677789999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
+|..+++|...++.... .+.+........+.++++|||+. .+.|+|++|.|.+...+++.+++|||......-
T Consensus 884 ~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred HHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 99999999999987653 33344444566688999999998 799999999999999999999999984332110
Q ss_pred ---------------------CC----------cceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCCCC
Q 001752 866 ---------------------KN----------ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLD 914 (1018)
Q Consensus 866 ---------------------~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~ 914 (1018)
.. .......+|+.|.|||...+......+|+|+.|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 00 00112568999999999999999999999999999999999999997
Q ss_pred CCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCCCCCCCCHH
Q 001752 915 PEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMR 977 (1018)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 977 (1018)
....+.. ++....... +.... ..+......+++...+..+|.+|-.+.
T Consensus 1037 a~tpq~~-----f~ni~~~~~-------~~p~g---~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQI-----FENILNRDI-------PWPEG---PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhhh-----hhccccCCC-------CCCCC---ccccChhhhhhhhhhhccCchhccCcc
Confidence 6433211 111111110 11111 112223345567778888899887766
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.99 E-value=2e-10 Score=112.75 Aligned_cols=104 Identities=28% Similarity=0.422 Sum_probs=20.8
Q ss_pred ccceeecccccccCCCccccC-CCCccceEeccCCcccCCCCccccCCCCcccccccCCcccCCCCccc-CCCCccceee
Q 001752 435 KLQRLELANNSLTGGITDDIA-SSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQF-QDCPSLSVLD 512 (1018)
Q Consensus 435 ~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~ 512 (1018)
++++|+|++|.|+.+ ..++ .+.+|+.|+|++|.|+.. ..+..++.|++|++++|+|+. +++.+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence 445555555555421 1222 344455555555555422 123334444444444444442 22222 2344444444
Q ss_pred cccccccCCC-CCccccccccceeeccccccc
Q 001752 513 LSSNYFSGSI-PSSIASCEKLVNLNLRNNQLT 543 (1018)
Q Consensus 513 Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~ 543 (1018)
|++|+|.... -..+..+++|+.|+|.+|.++
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 4444443211 122333444444444444443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.98 E-value=2e-10 Score=112.72 Aligned_cols=85 Identities=27% Similarity=0.284 Sum_probs=14.4
Q ss_pred ccCCCCCEEEcCCCCcCCCCChhhh-CCCCCcEEEeeecccCCCCcccccCCCCCceeccCCCCCCcccccccccccccc
Q 001752 95 QRLKSLTSLNLCCNGLFSSLPNSLA-NLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLE 173 (1018)
Q Consensus 95 ~~l~~L~~L~L~~n~i~~~~~~~l~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~ 173 (1018)
.+...+++|+|++|+|+.+ +.++ .+.+|+.||||+|.|+. ++ .+..+++|+.|++++|.|+.........+++|+
T Consensus 16 ~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQ 91 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--
T ss_pred ccccccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCccccchHHhCCcCC
Confidence 3344455555555555433 1233 34455555555555542 21 233444444444444444432111112344444
Q ss_pred eEeccCcccC
Q 001752 174 TLDLRGSFFQ 183 (1018)
Q Consensus 174 ~L~L~~n~~~ 183 (1018)
+|+|++|+|.
T Consensus 92 ~L~L~~N~I~ 101 (175)
T PF14580_consen 92 ELYLSNNKIS 101 (175)
T ss_dssp EEE-TTS---
T ss_pred EEECcCCcCC
Confidence 4444444443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.1e-08 Score=105.50 Aligned_cols=270 Identities=13% Similarity=0.139 Sum_probs=166.7
Q ss_pred cccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhcc-CCCCcceeeeeE------ecC-C
Q 001752 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFL------HND-T 779 (1018)
Q Consensus 708 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~------~~~-~ 779 (1018)
...+.||+|+.+.+|..-.- +. .+.|+....... .. .+.+..+... .||-+-.-+.+- .++ .
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa----~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPA----AQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred CCCccccCCccceeeecchh--hc-hhheeecCCCch----HH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 34578999999999976432 22 345666322111 11 1223333443 566554423221 122 2
Q ss_pred ceEEEEEecCCC-CHHHhhhc--CCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcc
Q 001752 780 NMMIVYEYMNNG-SLGEALHG--KQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 780 ~~~lV~e~~~~g-sL~~~l~~--~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 856 (1018)
...+.|..+++. .+..+... ++.......|...++++..+|.+.+.||.. |.+-||+.++|+|+++++.|.+.|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEc
Confidence 367888887664 22222221 122233478999999999999999999999 999999999999999999999998
Q ss_pred cccceeeccCCcceEeeccCCCccCcCCC-----CCCCCCccccchhHHHHHHHHHhC-CCCCCCCCCC-------cccH
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYG-----YTLKVDEKIDIYSFGVVLLELLTG-RRPLDPEFGE-------SVDI 923 (1018)
Q Consensus 857 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slG~il~elltg-~~pf~~~~~~-------~~~~ 923 (1018)
-..-... ..+......+|...|++||.- .+...+...|-|.+|+++++++.| ++||.+.... +.++
T Consensus 161 sDsfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 161 SDSFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred ccceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 7665443 344455567899999999963 355567889999999999999996 9999764321 1112
Q ss_pred HHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHccCCC--CCCCCCHHHHHHHhhccCCCCCCCCC
Q 001752 924 VEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKL--PKDRPSMRDVITMLGEAKPRRKSSSN 995 (1018)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d--P~~RPt~~evl~~L~~~~~~~~~~~~ 995 (1018)
... .+.....-..-..+..... ...--...+..+..+|+... +.-|||++.++..|.++..+.+.++-
T Consensus 240 a~g---~f~ya~~~~~g~~p~P~~~-P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v 309 (637)
T COG4248 240 AHG---RFAYASDQRRGLKPPPRSI-PLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTV 309 (637)
T ss_pred hcc---eeeechhccCCCCCCCCCC-ChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhh
Confidence 111 0000000000111111111 11111223444556777654 56899999999999888776666554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.9e-09 Score=109.60 Aligned_cols=143 Identities=20% Similarity=0.219 Sum_probs=108.3
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCC--CCcceeeeeEecC---CceEEEE
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH--RNIVRLLGFLHND---TNMMIVY 785 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~---~~~~lV~ 785 (1018)
+.|+.|.++.||++... +|+.+++|+....... .....+.+|+++++.+++ ..+++++.+.... +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 57899999999999875 3688999987332211 234578899999999976 4467778877654 3568999
Q ss_pred EecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------
Q 001752 786 EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC----------------------------------- 830 (1018)
Q Consensus 786 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----------------------------------- 830 (1018)
||++|+++.+.+.. . .++...+..++.++++++++||+..
T Consensus 80 e~i~G~~l~~~~~~-~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 80 ERVDGRVLRDRLLR-P----ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred EEeCCEecCCCCCC-C----CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 99999988876632 1 2566777778888888888888531
Q ss_pred ------------------CCCeEeecCCCCcEEEcC--CCCeEEccccccee
Q 001752 831 ------------------YPPIIHRDIKSNNILLDS--NLEPRIADFGLARM 862 (1018)
Q Consensus 831 ------------------~~~ivH~Dlk~~NIll~~--~~~~kl~DfG~a~~ 862 (1018)
...++|+|+.+.||+++. ++.+.++||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=9.6e-09 Score=97.87 Aligned_cols=147 Identities=20% Similarity=0.268 Sum_probs=107.9
Q ss_pred ccceeecCCCeeEEEEEcCCCCeEEEEEEeeccccc----cccchhhhHHHHHHHHhccCCCCcceeeeeEecCCceEEE
Q 001752 709 ESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRAD----LETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 709 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 784 (1018)
....+-+|+-+.|+++.+. |+...||.=..+... ...-..++..+|+..+.+++--.|.-..-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 3567899999999999986 787777743221111 1223356678899999999766666666666666666899
Q ss_pred EEecCC-CCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC---CeEEcccccc
Q 001752 785 YEYMNN-GSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL---EPRIADFGLA 860 (1018)
Q Consensus 785 ~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfG~a 860 (1018)
|||++| .++.+++....... ........++..|-+.+.-||.. +|+||||..+||++..++ .+.++|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecch
Confidence 999976 48888886544322 22233366889999999999999 999999999999997665 3589999998
Q ss_pred ee
Q 001752 861 RM 862 (1018)
Q Consensus 861 ~~ 862 (1018)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 53
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.1e-08 Score=98.20 Aligned_cols=129 Identities=24% Similarity=0.221 Sum_probs=82.0
Q ss_pred eEEEEEcCCCCeEEEEEEeeccccc----------------------cccchhhhHHHHHHHHhccCCC--CcceeeeeE
Q 001752 720 IVYKAEMPRLNTIVAVKKLWRSRAD----------------------LETESSGDFVGEVNVLGKLRHR--NIVRLLGFL 775 (1018)
Q Consensus 720 ~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~~ 775 (1018)
.||.|... +|..+|||+.+..... ..........+|++.|.++... ++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38999876 5889999987432111 1112234567899999999765 567776553
Q ss_pred ecCCceEEEEEecC--CCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHH-hhcCCCCCeEeecCCCCcEEEcCCCCe
Q 001752 776 HNDTNMMIVYEYMN--NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAY-LHHDCYPPIIHRDIKSNNILLDSNLEP 852 (1018)
Q Consensus 776 ~~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlk~~NIll~~~~~~ 852 (1018)
.-++||||++ |..+..+.... ++......++.+++..+.. +|.. ||+|||+.+.||+++++ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eE
Confidence 2379999998 54554433322 1122334467777775555 4677 99999999999999988 99
Q ss_pred EEcccccceee
Q 001752 853 RIADFGLARMM 863 (1018)
Q Consensus 853 kl~DfG~a~~~ 863 (1018)
.++|||.+...
T Consensus 146 ~iIDf~qav~~ 156 (188)
T PF01163_consen 146 YIIDFGQAVDS 156 (188)
T ss_dssp EE--GTTEEET
T ss_pred EEEecCcceec
Confidence 99999998653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4e-09 Score=77.63 Aligned_cols=39 Identities=41% Similarity=0.831 Sum_probs=31.2
Q ss_pred HHHHHHHHHHHhccC-CCCCCcCCCCCC--CCCceeeeEEeC
Q 001752 33 NDELLALLSIKAGLV-DPLNSLHDWKLP--SAHCNWTGVWCN 71 (1018)
Q Consensus 33 ~~~~~~Ll~~k~~~~-d~~~~~~~w~~~--~~~c~w~gv~c~ 71 (1018)
++|++||++||+++. ||...+.+|..+ ++||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 679999999999998 577899999987 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.6e-09 Score=85.33 Aligned_cols=58 Identities=45% Similarity=0.581 Sum_probs=24.9
Q ss_pred cceeecccccccCCCCCccccccccceeecccccccCCcccccccCCccceeeccccc
Q 001752 508 LSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNS 565 (1018)
Q Consensus 508 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 565 (1018)
|++|++++|+|+...+..|.++++|++|++++|+++...|..|.++++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 4444444444443333344444444444444444443333444444444444444443
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.2e-09 Score=84.91 Aligned_cols=61 Identities=44% Similarity=0.612 Sum_probs=57.6
Q ss_pred cccceeecccccccCCcccccccCCccceeecccccccCCCCCCCCCCCCCceEEecCCcc
Q 001752 530 EKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRL 590 (1018)
Q Consensus 530 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 590 (1018)
++|+.|++++|+|+...+..|.++++|++|++++|+++...|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999977778999999999999999999988889999999999999999986
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=3.8e-08 Score=100.37 Aligned_cols=137 Identities=22% Similarity=0.183 Sum_probs=98.7
Q ss_pred ccceeecCCCeeEEEEEcCCCCeEEEEEEeecccc------------------ccccchhhhHHHHHHHHhccCCC--Cc
Q 001752 709 ESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRA------------------DLETESSGDFVGEVNVLGKLRHR--NI 768 (1018)
Q Consensus 709 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~~~~~E~~~l~~l~hp--ni 768 (1018)
..+.||.|.-+.||.|... .|.++|||.-+.... .+-..+.....+|.++|.++... .|
T Consensus 95 iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4578999999999999987 689999996532111 11122334567899999999654 77
Q ss_pred ceeeeeEecCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcC
Q 001752 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS 848 (1018)
Q Consensus 769 v~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 848 (1018)
++.+++ +...+||||++|-.|...-- +....-.|+..|++-+...-.. ||||||+.+-||++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 777775 45589999998866654331 1222233455555555555566 9999999999999999
Q ss_pred CCCeEEccccccee
Q 001752 849 NLEPRIADFGLARM 862 (1018)
Q Consensus 849 ~~~~kl~DfG~a~~ 862 (1018)
||.+.++||-.+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999987754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.2e-07 Score=100.97 Aligned_cols=145 Identities=16% Similarity=0.071 Sum_probs=101.0
Q ss_pred ceeecCCCeeEEEEEcCCCCeEEEEEEeeccccc--cc-----cchhhhHHHHHHHHhccCCCCc--ceeeeeEec----
Q 001752 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRAD--LE-----TESSGDFVGEVNVLGKLRHRNI--VRLLGFLHN---- 777 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~-----~~~~~~~~~E~~~l~~l~hpni--v~~~~~~~~---- 777 (1018)
+.+-......|+++... |+.|.||........ .. ......+.+|...+.++...+| ++++++...
T Consensus 28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34444444557777664 788999977221100 00 0112247899999988854443 344556543
Q ss_pred -CCceEEEEEecCCC-CHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcC-------
Q 001752 778 -DTNMMIVYEYMNNG-SLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS------- 848 (1018)
Q Consensus 778 -~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~------- 848 (1018)
...-++|+|++++. +|.+++..... .+.+...+..++.+++..+..||.. ||+|+|++++||+++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCC
Confidence 23468999999886 89999854321 1245566778999999999999999 9999999999999985
Q ss_pred CCCeEEccccccee
Q 001752 849 NLEPRIADFGLARM 862 (1018)
Q Consensus 849 ~~~~kl~DfG~a~~ 862 (1018)
++.+.++||+.++.
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46799999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.72 E-value=3.1e-07 Score=100.89 Aligned_cols=172 Identities=19% Similarity=0.280 Sum_probs=129.2
Q ss_pred CCeeEEEEEcCCCCeEEEEEEeeccccccccchhhhHHHHHHHHhccCCCCcceeeeeEe----cCCceEEEEEecCCC-
Q 001752 717 ATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLH----NDTNMMIVYEYMNNG- 791 (1018)
Q Consensus 717 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~~~~~lV~e~~~~g- 791 (1018)
--.+.||+....+|..|++|++...+.. . ...-..-+++++++.|+|+|++.+++. .+...++||+|+++.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~-~---~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ-S---TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc-C---cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 4568999999999999999999222111 1 111233567889999999999999886 345679999999864
Q ss_pred CHHHhhhcCCC-----------CccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccc
Q 001752 792 SLGEALHGKQA-----------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 792 sL~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 860 (1018)
+|.++-..... .....++...|.++.|+..||.++|+. |..-+-+.+.+|+++++.+++++..|..
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccce
Confidence 77665432221 123467899999999999999999999 9999999999999999999999988887
Q ss_pred eeeccCCcceEeeccCCCccCcCCCCCCCCCccccchhHHHHHHHHHhCCCC
Q 001752 861 RMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRP 912 (1018)
Q Consensus 861 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p 912 (1018)
..+..+. . |-+ .--.+-|.-.||.+++.+.||..-
T Consensus 441 Dvl~~d~------------~--~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 441 DVLQEDP------------T--EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred eeecCCC------------C--cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 6553332 0 111 113467899999999999998543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=6.1e-10 Score=125.16 Aligned_cols=129 Identities=32% Similarity=0.334 Sum_probs=96.3
Q ss_pred CccceEeccCCcccCCCCccccCCCCcccccccCCcccCCCCcccCCCCccceeecccccccCCCCCccccccccceeec
Q 001752 458 TSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNL 537 (1018)
Q Consensus 458 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 537 (1018)
..|...+.++|++. .....+.-++.|+.|+|++|+++.. +.+..++.|+.|||++|.++ .+|..=..=..|+.|+|
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~l 239 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNL 239 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhhheeeee
Confidence 35778888889887 5666777788899999999999854 37788899999999999987 44432222234889999
Q ss_pred ccccccCCcccccccCCccceeecccccccCCCC-CCCCCCCCCceEEecCCcccC
Q 001752 538 RNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIP-ENFGASPALEVLNVSYNRLEG 592 (1018)
Q Consensus 538 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~ 592 (1018)
++|.++.. ..+.++.+|+.||||+|-|.+--. .-+..+..|..|+|.||++-+
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 99988742 346788889999999998875321 224456778888999998875
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.8e-09 Score=121.55 Aligned_cols=127 Identities=28% Similarity=0.295 Sum_probs=73.1
Q ss_pred cccEEeccCCcccCCCcccCCCccccceeecccccccCCCccccCCCCccceEeccCCcccCCCCccccCCCCccccccc
Q 001752 411 SLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVS 490 (1018)
Q Consensus 411 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 490 (1018)
.|...+.++|.+. ....++.-++.|+.|+|++|+++... .+..++.|++|||++|+++ .+|..-..--.|+.|.++
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhhheeeeec
Confidence 3455566666666 44455555666777777777776432 5666667777777777776 333221112236666677
Q ss_pred CCcccCCCCcccCCCCccceeecccccccCCCC-Cccccccccceeeccccccc
Q 001752 491 NNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIP-SSIASCEKLVNLNLRNNQLT 543 (1018)
Q Consensus 491 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~ 543 (1018)
+|.++.. ..+.++.+|+.||||+|-|.+.-. ..+..|..|+.|+|.+|.+-
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 7766532 234556666677777776654211 12344566666677776664
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=9.7e-07 Score=88.56 Aligned_cols=141 Identities=16% Similarity=0.095 Sum_probs=104.5
Q ss_pred ecCCCeeEEEEEcCCCCeEEEEEEeecc-ccccc-cchhhhHHHHHHHHhccCCC--CcceeeeeEe-c----CCceEEE
Q 001752 714 GMGATGIVYKAEMPRLNTIVAVKKLWRS-RADLE-TESSGDFVGEVNVLGKLRHR--NIVRLLGFLH-N----DTNMMIV 784 (1018)
Q Consensus 714 G~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~-~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~-~----~~~~~lV 784 (1018)
|+||-+-|++.... |+.+-+|.-... ..... +.....|.+|+..+.++..- .+++++ ++. . ...-++|
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 77999999998876 557888977311 11111 44677899999999999542 255555 332 1 1235899
Q ss_pred EEecCC-CCHHHhhhcCCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCC--eEEcccccce
Q 001752 785 YEYMNN-GSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLE--PRIADFGLAR 861 (1018)
Q Consensus 785 ~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DfG~a~ 861 (1018)
+|-++| -+|.+++...... +.+...+..+..+|++.++-||+. |+.|+|+.+.||+++.++. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~--~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVS--PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcC--CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998753 4899998654322 256777788999999999999999 9999999999999987667 9999997665
Q ss_pred e
Q 001752 862 M 862 (1018)
Q Consensus 862 ~ 862 (1018)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=4.8e-07 Score=104.20 Aligned_cols=161 Identities=19% Similarity=0.222 Sum_probs=107.6
Q ss_pred hhcccChHHHhhcccccceeecCCCeeEEEEEcCCCCeEEEEEEeecccccccc--------------------------
Q 001752 694 QRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLET-------------------------- 747 (1018)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-------------------------- 747 (1018)
++++...++....|+. +.|+.++-|+||+|+.. +|+.||||+.++.....-.
T Consensus 115 ~eLG~~iee~F~eF~~-~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~ 192 (517)
T COG0661 115 EELGRPIEELFSEFEP-EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLV 192 (517)
T ss_pred HHhCCCHHHHHHHcCC-CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChH
Confidence 4567777888888864 79999999999999998 5999999998543211100
Q ss_pred ----------chhhhHHHHHHHHhccC-----CCCcceeeeeEecCCceEEEEEecCCCCHHHhhhcCCCCccccCHHHH
Q 001752 748 ----------ESSGDFVGEVNVLGKLR-----HRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSR 812 (1018)
Q Consensus 748 ----------~~~~~~~~E~~~l~~l~-----hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~ 812 (1018)
...-++.+|...+.+++ .|.+.-.--|++-.....++|||++|-.+.+...-...+ .+.
T Consensus 193 ~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g---~d~--- 266 (517)
T COG0661 193 EVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG---IDR--- 266 (517)
T ss_pred HHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC---CCH---
Confidence 00113445555555552 344443333444445669999999999998884322221 332
Q ss_pred HHHHHHHHHH-HHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeecc
Q 001752 813 YNIALGVAQG-LAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865 (1018)
Q Consensus 813 ~~i~~~i~~~-L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 865 (1018)
..++..++++ +..+-.. |++|+|..|.||+++.+|++.+.|||+...+.+
T Consensus 267 k~ia~~~~~~f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 267 KELAELLVRAFLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHHHHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2233333333 3333334 899999999999999999999999999877643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.4e-08 Score=111.60 Aligned_cols=151 Identities=18% Similarity=0.265 Sum_probs=100.3
Q ss_pred HHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCCCeEEcccccceeeccCCcce-E--------eeccCCCccCcCCCC
Q 001752 816 ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV-S--------MVAGSYGYIAPEYGY 886 (1018)
Q Consensus 816 ~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~--------~~~gt~~y~aPE~~~ 886 (1018)
+.+++.|+.|+|.. .++||++|.|++|.++..+.+|++.|+++.....+.... . .......|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34566999999997 489999999999999999999999999876543321110 0 022345799999999
Q ss_pred CCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHhhcccccccccCCCCCCCchhHHHHHHHHHHHHHc
Q 001752 887 TLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLC 965 (1018)
Q Consensus 887 ~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 965 (1018)
+...+.++|+||+||++|.+.. |+.-++..... .... ......+.. . . ........++.+=+.++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~--~~~~-~~~~~~~~~---~-~-------~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL--LSYS-FSRNLLNAG---A-F-------GYSNNLPSELRESLKKL 248 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCc--chhh-hhhcccccc---c-c-------cccccCcHHHHHHHHHH
Confidence 9889999999999999999994 55555442111 1111 100000000 0 0 00011223345556689
Q ss_pred cCCCCCCCCCHHHHHHH
Q 001752 966 TAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 966 l~~dP~~RPt~~evl~~ 982 (1018)
+..++..||++.++...
T Consensus 249 l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLSI 265 (700)
T ss_pred hcCCcccCcchhhhhcc
Confidence 99999999988877653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.41 E-value=2e-06 Score=88.72 Aligned_cols=126 Identities=20% Similarity=0.220 Sum_probs=92.3
Q ss_pred CeEEEEEEeeccccc---cccchhhhHHHHHHHHhccCCC--CcceeeeeEecC----CceEEEEEecCCC-CHHHhhhc
Q 001752 730 NTIVAVKKLWRSRAD---LETESSGDFVGEVNVLGKLRHR--NIVRLLGFLHND----TNMMIVYEYMNNG-SLGEALHG 799 (1018)
Q Consensus 730 ~~~vavK~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~~~----~~~~lV~e~~~~g-sL~~~l~~ 799 (1018)
++.+.+|........ ........+.+|...+.++... .+++.+++.... ...++|+|++++. +|.+++..
T Consensus 32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~ 111 (206)
T PF06293_consen 32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ 111 (206)
T ss_pred ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence 556666654221111 1113445678898888888543 355666666542 2358999999884 89999976
Q ss_pred CCCCccccCHHHHHHHHHHHHHHHHHhhcCCCCCeEeecCCCCcEEEcCCC---CeEEccccccee
Q 001752 800 KQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL---EPRIADFGLARM 862 (1018)
Q Consensus 800 ~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfG~a~~ 862 (1018)
... .+......++.+++..++-||.. ||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 112 ~~~----~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 112 WEQ----LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hcc----cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 433 45566778999999999999999 999999999999999887 899999998865
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.41 E-value=9.1e-08 Score=97.29 Aligned_cols=86 Identities=28% Similarity=0.277 Sum_probs=42.8
Q ss_pred CCCCcEEEeeecccCC--CCcccccCCCCCceeccCCCCCCcccccccccccccceEeccCcccCccc-ccccccccccc
Q 001752 121 LTSLKRFDVSQNFLNG--SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSI-PVSFKNLQKLK 197 (1018)
Q Consensus 121 l~~L~~L~Ls~n~l~~--~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~-p~~~~~l~~L~ 197 (1018)
.++++.|||.+|.|+. ++..-+.+++.|++|+|+.|++...+-..-..+.+|++|-|.+..+.-.- ...+..+|+++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 3445555555555543 12223344455555555555554322111133456677777666554322 23345667777
Q ss_pred eeeeccccc
Q 001752 198 FLGLSGNNL 206 (1018)
Q Consensus 198 ~L~L~~n~l 206 (1018)
+|.+|.|.+
T Consensus 150 elHmS~N~~ 158 (418)
T KOG2982|consen 150 ELHMSDNSL 158 (418)
T ss_pred hhhhccchh
Confidence 777776643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1018 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-49 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-49 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-46 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 8e-46 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-46 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-45 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-37 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-30 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-30 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-21 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-21 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-21 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-19 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-19 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-19 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-19 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 9e-19 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-19 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-18 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-18 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-18 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-18 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-18 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-18 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-18 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-18 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-18 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-18 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-18 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-18 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-18 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-18 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-18 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-18 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-18 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-18 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-18 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-18 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-18 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-18 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-18 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-18 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-18 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-18 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-18 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-18 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-18 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-18 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-18 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-18 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-18 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-18 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-18 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-18 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-18 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-18 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-18 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-18 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-17 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-17 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-17 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-16 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-14 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 3a79_A | 580 | Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len | 1e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 2z81_A | 549 | Crystal Structure Of The Tlr1-tlr2 Heterodimer Indu | 3e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 2e-06 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 4e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-06 | ||
| 3v47_A | 455 | Crystal Structure Of The N-Tetminal Fragment Of Zeb | 5e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 8e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-05 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3t6q_A | 606 | Crystal Structure Of Mouse Rp105MD-1 Complex Length | 3e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-05 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3A79|A Chain A, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 580 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2Z81|A Chain A, Crystal Structure Of The Tlr1-tlr2 Heterodimer Induced By Binding Of A Tri-acylated Lipopeptide Length = 549 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex Length = 606 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 560 bits (1445), Expect = 0.0
Identities = 179/570 (31%), Positives = 269/570 (47%), Gaps = 14/570 (2%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
E LD+S N S + +L L++ N L +++ T LK ++S N G
Sbjct: 203 EFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLEDL-GNATSLETLDLRGSFFQGSIPVSFKNLQK 195
P L +L+ + N F+G + + L G +L LDL G+ F G++P F +
Sbjct: 262 PIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319
Query: 196 LKFLGLSGNNLTGKIPRE-LGQLSSMETMILAYNEFDGEIPVEFGNLT-NLKYLDLAVGN 253
L+ L LS NN +G++P + L ++ ++ + L++NEF GE+P NL+ +L LDL+ N
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 254 LGGKIPAELGRLEL--LEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEIT 311
G I L + L+ ++L N F G++P + N + L L LS+N LS IP+ +
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 312 QLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSS 371
L L+ L L N L G +P L + LE L L N L+G +P L + L W+ LS+
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 372 NSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFG 431
N +GEIP + NL L L NN+FSG IP L C SL+ + + N +GTIP
Sbjct: 500 NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF 559
Query: 432 RLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSS--LPSTILSIPNLQTFIV 489
+ ++A N + G I + + N L + + +
Sbjct: 560 KQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNI 615
Query: 490 SNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKA 549
++ G F + S+ LD+S N SG IP I S L LNL +N ++G IP
Sbjct: 616 TSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE 675
Query: 550 ISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLA 609
+ + L ILDLS+N L G IP+ A L +++S N L GP+P G T
Sbjct: 676 VGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFL 735
Query: 610 GNAGLCGGVLHPCSRYSPIASSHRSLHAKH 639
N GLCG L C + +H H
Sbjct: 736 NNPGLCGYPLPRCDPSNADGYAHHQRSHHH 765
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 506 bits (1305), Expect = e-166
Identities = 195/635 (30%), Positives = 297/635 (46%), Gaps = 47/635 (7%)
Query: 31 ALNDELLALLSIKAGLVDPLNSLHDWKLPSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCV 90
+L E+ L+S K L D N L DW C + GV C + V +DLS L
Sbjct: 9 SLYREIHQLISFKDVLPDK-NLLPDWSSNKNPCTFDGVTCR-DDKVTSIDLSSKPL---- 62
Query: 91 SDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTF 150
N FS++ +SL +LT L+ +S + +NGS G +A LT
Sbjct: 63 -----------------NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTS 104
Query: 151 LNASGNNFSGFL--LEDLGNATSLETLDLRGSFFQGSIPVS-FKNLQKLKFLGLSGNNLT 207
L+ S N+ SG + L LG+ + L+ L++ + VS L L+ L LS N+++
Sbjct: 105 LDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS 164
Query: 208 GKIPREL---GQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGR 264
G ++ + ++ N+ G++ NL++LD++ N IP LG
Sbjct: 165 GANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGD 221
Query: 265 LELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCN 324
L+ + + N G I T L+LL++S N IP LK+LQ L+L N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAEN 279
Query: 325 QLSGHVPAGLGG-LTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPA-SL 382
+ +G +P L G L L+L N G +P G S L+ L LSSN+FSGE+P +L
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339
Query: 383 CNGGNLTKLILFNNAFSGPIPVSLSTCH-SLVRVRMQNNQLSGTIPVGFGR--LEKLQRL 439
L L L N FSG +P SL+ SL+ + + +N SG I + LQ L
Sbjct: 340 LKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 399
Query: 440 ELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIP 499
L NN TG I +++ + L + +S N+L ++PS++ S+ L+ + N L GEIP
Sbjct: 400 YLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459
Query: 500 DQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAIL 559
+ +L L L N +G IPS +++C L ++L NN+LTG+IPK I + LAIL
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL 519
Query: 560 DLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPAN-GVLRTINRGDLAGN--AGLCG 616
LSNNS +G IP G +L L+++ N G +PA G +A N AG
Sbjct: 520 KLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRY 575
Query: 617 GVLHPCSRYSPIASSHRSLHAKHIIPGWMIAISSL 651
+ + L + I + +S+
Sbjct: 576 VYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTR 610
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-19
Identities = 39/182 (21%), Positives = 59/182 (32%), Gaps = 54/182 (29%)
Query: 76 VEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLN 135
+++ G + N S+ D+S N L+
Sbjct: 610 RNPCNITSRVYGG------------------------HTSPTFDNNGSMMFLDMSYNMLS 645
Query: 136 GSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQK 195
G P +G L LN N+ S GSIP +L+
Sbjct: 646 GYIPKEIGSMPYLFILNLGHNDIS------------------------GSIPDEVGDLRG 681
Query: 196 LKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVE--FGNLTNLKYLDLAVGN 253
L L LS N L G+IP+ + L+ + + L+ N G IP F K+ + N
Sbjct: 682 LNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKF----LNN 737
Query: 254 LG 255
G
Sbjct: 738 PG 739
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 385 bits (991), Expect = e-122
Identities = 114/629 (18%), Positives = 212/629 (33%), Gaps = 97/629 (15%)
Query: 29 KTALNDELLALLSIKAGLVDPLNSLHDWK-------------LPSAHCNWT--------- 66
+ + LS A + +L + NW
Sbjct: 11 ALTDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWG 70
Query: 67 ---GVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGL----FSSLPNSLA 119
GV NSNG V L L SG V D +L L L L +G P ++
Sbjct: 71 AQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGIS 130
Query: 120 NLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRG 179
S ++ + +F + + L +
Sbjct: 131 ANMSDEQKQKMRMHYQKTFVDYDP----------------------REDFSDLIKDCINS 168
Query: 180 SFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFG 239
Q SI S + K +G NN+T + + + +L+ + + + F E E
Sbjct: 169 DPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAW 227
Query: 240 NLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSY 299
N +Y + L+ L + +Y +LP + + +QL++++
Sbjct: 228 ENENSEYA-----QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVAC 282
Query: 300 NML--------SHEIPAEITQLKNLQLLNLMCNQL-SGHVPAGLGGLTQLEVLELWNNSL 350
N + A+ + +Q++ + N L + V L + +L +LE N L
Sbjct: 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQL 342
Query: 351 SGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNG-GNLTKLILFNNAFSG-PIPVSLST 408
G LP G L L+L+ N + IPA+ C + L +N P +
Sbjct: 343 EGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKS 400
Query: 409 CHSLVRVRMQNNQLSG-------TIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLS 461
+ + N++ + + + + L+NN ++ + ++ + LS
Sbjct: 401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS 460
Query: 462 FIDISRNHLRS-------SLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDC--PSLSVLD 512
I++ N L + L + + N L + D F+ P L +D
Sbjct: 461 SINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGID 519
Query: 513 LSSNYFSGSIPSSIASCEKLVNLNLRN------NQLTGDIPKAISMMPTLAILDLSNNSL 566
LS N FS P+ + L +RN N+ + P+ I++ P+L L + +N +
Sbjct: 520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578
Query: 567 TGGIPENFGASPALEVLNVSYNRLEGPVP 595
+ E + + VL++ N
Sbjct: 579 RK-VNEKITPN--ISVLDIKDNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 6e-73
Identities = 69/438 (15%), Positives = 132/438 (30%), Gaps = 43/438 (9%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
+ + + ++ + N + + NL L +V
Sbjct: 209 RQFYMGNSPFVA-----ENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263
Query: 137 SFPAGLGGAAGLTFLNASGNNF--------SGFLLEDLGNATSLETLDLRG-SFFQGSIP 187
P L + +N + N L D ++ + + + +
Sbjct: 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE 323
Query: 188 VSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYL 247
S + ++KL L N L GK+P G + ++ LAYN+ G ++ L
Sbjct: 324 TSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENL 382
Query: 248 DLAVGNLGGKIPA--ELGRLELLEIMFLYQNNFQG-------RLPAEIGNITSLQLLDLS 298
A N IP + + ++ + N L ++ ++LS
Sbjct: 383 SFA-HNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLS 441
Query: 299 YNMLSHEIPAEITQLKNLQLLNLMCNQLSG-------HVPAGLGGLTQLEVLELWNNSLS 351
N +S + L +NLM N L+ L ++L N L+
Sbjct: 442 NNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT 501
Query: 352 G-PLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFN------NAFSGPIPV 404
L +DLS NSFS P N L + N N P
Sbjct: 502 KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560
Query: 405 SLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFID 464
++ C SL ++++ +N + + + L++ +N +
Sbjct: 561 GITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYM 617
Query: 465 ISRNHLRSSLPSTILSIP 482
+ + + L I
Sbjct: 618 LFYDKTQDIRGCDALDIK 635
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-08
Identities = 15/125 (12%), Positives = 33/125 (26%), Gaps = 10/125 (8%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLC------CNGLFSSLPNSLANLTSLKRFDVS 130
+DLS+ + S +L + N P + SL + +
Sbjct: 516 VGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574
Query: 131 QNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSF 190
N + + ++ L+ N L + L Q
Sbjct: 575 SNDIR-KVNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDA 631
Query: 191 KNLQK 195
++++
Sbjct: 632 LDIKR 636
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 335 bits (862), Expect = e-107
Identities = 112/295 (37%), Positives = 165/295 (55%), Gaps = 13/295 (4%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWR-SRADLETESSGDFVGEVNVLGKLRHR 766
N++G G G VYK + T+VAVK+L E + F EV ++ HR
Sbjct: 33 SNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQ----FQTEVEMISMAVHR 87
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
N++RL GF T ++VY YM NGS+ L + + +DW R IALG A+GLAYL
Sbjct: 88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 147
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVS-MVAGSYGYIAPEYG 885
H C P IIHRD+K+ NILLD E + DFGLA++M K+ V+ V G+ G+IAPEY
Sbjct: 148 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 207
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRPLD---PEFGESVDIVEWIRMKIRDNRNLEEALD 942
T K EK D++ +GV+LLEL+TG+R D + V +++W++ + + LE +D
Sbjct: 208 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK-GLLKEKKLEALVD 266
Query: 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML-GEAKPRRKSSSNN 996
++ + EE+ ++++A LCT P +RP M +V+ ML G+ R
Sbjct: 267 VDLQG-NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQK 320
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 340 bits (875), Expect = e-104
Identities = 121/561 (21%), Positives = 203/561 (36%), Gaps = 32/561 (5%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
+ L+L H LS F +LT L+L N + N +L D+S N L+
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNA--TSLETLDLRGSFFQGSIPVSFKNLQ 194
+ L L S N E+L +SL+ L+L + + P F +
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195
Query: 195 KLKFLGLSGNNLTGKIPRELG---QLSSMETMILAYNEFDGEIPVEFGNL--TNLKYLDL 249
+L L L+ L + +L +S+ + L+ ++ F L TNL LDL
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 250 AVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNM-------- 301
+ NL L LE FL NN Q + + +++ L+L +
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 302 -LSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLS-GPLPVDLG 359
L LK L+ LN+ N + G GL L+ L L N+ S L +
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375
Query: 360 KN---SPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVS-LSTCHSLVRV 415
+ SPL L+L+ N S + G+L L L N + ++ +
Sbjct: 376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEI 435
Query: 416 RMQNNQLSGTIPVGFGRLEKLQRLELANNSLTG--GITDDIASSTSLSFIDISRNHLRSS 473
+ N+ F + LQRL L +L +L+ +D+S N++ +
Sbjct: 436 YLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI 495
Query: 474 LPSTILSIPNLQTFIVSNNNL--------VGEIPDQFQDCPSLSVLDLSSNYFSGSIPSS 525
+ + L+ + +NNL G + L +L+L SN F
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
Query: 526 IASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGAS-PALEVLN 584
+L ++L N L + +L L+L N +T + FG + L L+
Sbjct: 556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELD 615
Query: 585 VSYNRLEGPVPANGVLRTINR 605
+ +N + +
Sbjct: 616 MRFNPFDCTCESIAWFVNWIN 636
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = 8e-96
Identities = 117/536 (21%), Positives = 200/536 (37%), Gaps = 34/536 (6%)
Query: 70 CNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDV 129
C + E D SH+ L+ V D ++T LNL N L + + L DV
Sbjct: 2 CTVSH--EVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDV 56
Query: 130 SQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVS 189
N ++ P L LN N S + T+L L L + Q
Sbjct: 57 GFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNP 116
Query: 190 FKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFG--NLTNLKYL 247
F + L L LS N L+ QL +++ ++L+ N+ E ++LK L
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176
Query: 248 DLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIG---NITSLQLLDLSYNMLSH 304
+L+ + P + L +FL L ++ TS++ L LS + LS
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236
Query: 305 EIPAEITQLK--NLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNS 362
LK NL +L+L N L+ L QLE L N++ L
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296
Query: 363 PLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQL 422
+++L+L + TK + + S L + M++N +
Sbjct: 297 NVRYLNLK---------------RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDI 341
Query: 423 SGTIPVGFGRLEKLQRLELANNSLTGGITDDIA----SSTSLSFIDISRNHLRSSLPSTI 478
G F L L+ L L+N+ + + + + L +++++N +
Sbjct: 342 PGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF 401
Query: 479 LSIPNLQTFIVSNNNLVGEIPDQ-FQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNL 537
+ +L+ + N + E+ Q ++ ++ + LS N + +S A L L L
Sbjct: 402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLML 461
Query: 538 RNNQLTG--DIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
R L P + L ILDLSNN++ + LE+L++ +N L
Sbjct: 462 RRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 2e-81
Identities = 89/466 (19%), Positives = 165/466 (35%), Gaps = 24/466 (5%)
Query: 148 LTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLT 207
+ S + + +DL T++ L+L + + +F +L L + N ++
Sbjct: 6 HEVADCSHLKLTQ-VPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 208 GKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLEL 267
P +L ++ + L +NE F TNL L L ++ + +
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 268 LEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKN--LQLLNLMCNQ 325
L + L N + +LQ L LS N + E+ N L+ L L NQ
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182
Query: 326 LSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLG---KNSPLQWLDLSSNSFSGEIPASL 382
+ P + +L L L N L L L N+ ++ L LS++ S +
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 383 --CNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLE 440
NLT L L N + S + L ++ N + L ++ L
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302
Query: 441 LANN---------SLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSN 491
L + SL L +++ N + + + NL+ +SN
Sbjct: 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSN 362
Query: 492 N--NLVGEIPDQFQDCP--SLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIP 547
+ +L + F L +L+L+ N S + + L L+L N++ ++
Sbjct: 363 SFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422
Query: 548 -KAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEG 592
+ + + + LS N +F P+L+ L + L+
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 2e-60
Identities = 73/344 (21%), Positives = 129/344 (37%), Gaps = 19/344 (5%)
Query: 268 LEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLS 327
E+ ++P ++ T++ +L+L++N L A T+ L L++ N +S
Sbjct: 6 HEVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 328 GHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGN 387
P L L+VL L +N LS + L L L SNS N
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 388 LTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLE--KLQRLELANNS 445
L L L +N S + +L + + NN++ L++LEL++N
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182
Query: 446 LTGGITDDIASSTSLSFIDISRNHLRSSLPSTI---LSIPNLQTFIVSNNNLVGEIPDQF 502
+ + L + ++ L SL + L+ +++ +SN+ L F
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 503 QDC--PSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILD 560
+L++LDLS N + S A +L L N + ++ + + L+
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302
Query: 561 LSNN---------SLTGGIPENFGASPALEVLNVSYNRLEGPVP 595
L + SL +F LE LN+ N + G
Sbjct: 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-31
Identities = 39/187 (20%), Positives = 72/187 (38%), Gaps = 5/187 (2%)
Query: 411 SLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHL 470
S + +L+ +P + L L +N L + + L+ +D+ N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 471 RSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCE 530
P +P L+ + +N L F C +L+ L L SN + +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 531 KLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGA--SPALEVLNVSYN 588
L+ L+L +N L+ + L L LSNN + E + +L+ L +S N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 589 RLEGPVP 595
+++ P
Sbjct: 182 QIKEFSP 188
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 339 bits (871), Expect = e-102
Identities = 99/595 (16%), Positives = 203/595 (34%), Gaps = 61/595 (10%)
Query: 41 SIKAGLVDPLNSLHDWKLPSAHCNW---TGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRL 97
+G ++ +W W GV ++NG V L L+ G V D +L
Sbjct: 287 RYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQL 346
Query: 98 KSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAG-LGGAAGLTFLNASGN 156
L L+ + S + + ++ + + L L + +
Sbjct: 347 TELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406
Query: 157 NFSGFLLEDLGNATSLETLDLRGSFFQG------SIPVSFKNLQKLKFLGLSGNNLTGKI 210
+ ++ + L+ + I + + L KL+ + + + T
Sbjct: 407 AINRNP--EMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDN 464
Query: 211 PRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEI 270
+ ++ Y + + + NL +L ++L ++P L L L+
Sbjct: 465 IAVDWEDAN-----SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519
Query: 271 MFLYQNNFQG---------RLPAEIGNITSLQLLDLSYNMLSHEIPAE--ITQLKNLQLL 319
+ + N RL + +Q+ + YN L E PA + ++ L LL
Sbjct: 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLL 578
Query: 320 NLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSP-LQWLDLSSNSFSGEI 378
+ + N++ H+ A G +L L+L N + +P D + ++ L S N I
Sbjct: 579 DCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YI 634
Query: 379 P--ASLCNGGNLTKLILFNNAFSG-----PIPVSLSTCHSLVRVRMQNNQLSGTIPVGFG 431
P + + + + N + + V + N++ F
Sbjct: 635 PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFA 694
Query: 432 RLEKLQRLELANNSLT-------GGITDDIASSTSLSFIDISRNHLRSSLPSTIL--SIP 482
+ + L+NN +T + ++ L+ ID+ N L +SL ++P
Sbjct: 695 TGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFRATTLP 753
Query: 483 NLQTFIVSNNNLVGEIPDQFQDCPSLSVLDL------SSNYFSGSIPSSIASCEKLVNLN 536
L VS N P Q + L + N P+ I +C L+ L
Sbjct: 754 YLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812
Query: 537 LRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
+ +N + + + + P L ILD+++N + + + Y++ +
Sbjct: 813 IGSNDIRK-VDE--KLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 1e-58
Identities = 63/439 (14%), Positives = 125/439 (28%), Gaps = 47/439 (10%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
+ + ++ + N + + S +NL L ++
Sbjct: 451 QIIYFANSPFTY-----DNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMT 505
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGF---------LLEDLGNATSLETLDLRGSFFQG-SI 186
P L L LN + N L +D ++ + + +
Sbjct: 506 QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPA 565
Query: 187 PVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVE-FGNLTNLK 245
S + + KL L N + G + + L YN+ + EIP + ++
Sbjct: 566 SASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVE 622
Query: 246 YLDLAVGNLGGKIP--AELGRLELLEIMFLYQNNFQGRLPAEIG------NITSLQLLDL 297
L + N IP + ++ + N I + + L
Sbjct: 623 GLGFS-HNKLKYIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTL 680
Query: 298 SYNMLSHEIPAEITQLKNLQLLNLMCNQLS-------GHVPAGLGGLTQLEVLELWNNSL 350
SYN + + + L N ++ L ++L N L
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740
Query: 351 SG-PLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKL------ILFNNAFSGPIP 403
+ L +D+S N FS P N L N P
Sbjct: 741 TSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWP 799
Query: 404 VSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFI 463
++TC SL+++++ +N + + +L L++A+N +
Sbjct: 800 TGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMY 856
Query: 464 DISRNHLRSSLPSTILSIP 482
+ + + L I
Sbjct: 857 VLLYDKTQDIRGCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-37
Identities = 53/401 (13%), Positives = 122/401 (30%), Gaps = 40/401 (9%)
Query: 215 GQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLY 274
+ ++ M + Y E E N KY+D+ V + G +++ Y
Sbjct: 168 RVTTELKGMKVTYKEDSKEHQNPDN--ANDKYMDIGVATCDSAVWLPAGTYQVVAYT-TY 224
Query: 275 QNNFQGRLPAEIGNITSLQL-LDLSYNMLSHEIPAEITQ----LKNLQLLNLMCNQLSGH 329
+ R E ++ + + +P ++ + +K+ + L + L G
Sbjct: 225 SQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGK 284
Query: 330 VPAGLGGLTQ-LEVLELWN-----NSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLC 383
G WN + VDL N + L L+ G +P ++
Sbjct: 285 NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIG 344
Query: 384 NGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGR-LEKLQRLELA 442
L L ++ + + + + +++ F ++L +L
Sbjct: 345 QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLL 404
Query: 443 NNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQF 502
+++ ++ S I + + + N + I
Sbjct: 405 QDAINRN--PEMKPIKKDSRISLKDTQIGNL------------------TNRITFISKAI 444
Query: 503 QDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLS 562
Q L ++ +++ F+ + N + + + S + L ++L
Sbjct: 445 QRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499
Query: 563 NNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTI 603
N +P+ P L+ LN++ NR +
Sbjct: 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 15/125 (12%), Positives = 32/125 (25%), Gaps = 10/125 (8%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLC------CNGLFSSLPNSLANLTSLKRFDVS 130
+D+S+ S L + + N + P + SL + +
Sbjct: 756 SNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIG 814
Query: 131 QNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSF 190
N + L L L+ + N + + L Q
Sbjct: 815 SNDIR-KVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDA 871
Query: 191 KNLQK 195
+++
Sbjct: 872 LGIER 876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = 7e-99
Identities = 105/295 (35%), Positives = 149/295 (50%), Gaps = 16/295 (5%)
Query: 698 FTSADILAC---IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV 754
D+ +IG G G VYK + VA+K+ + E F
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEE----FE 83
Query: 755 GEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN 814
E+ L RH ++V L+GF M+++Y+YM NG+L L+G + + W R
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 815 IALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET-VS-M 872
I +G A+GL YLH IIHRD+KS NILLD N P+I DFG+++ ++T +S +
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200
Query: 873 VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEF-GESVDIVEWIRMKI 931
V G+ GYI PEY ++ EK D+YSFGVVL E+L R + E V++ EW
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 932 RDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986
N LE+ +DPN+ + K E + A C A +DRPSM DV+ L A
Sbjct: 261 N-NGQLEQIVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = 2e-97
Identities = 94/277 (33%), Positives = 140/277 (50%), Gaps = 12/277 (4%)
Query: 709 ESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNI 768
N +G G G+VYK + NT VAVKKL E F E+ V+ K +H N+
Sbjct: 35 GGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
V LLGF + ++ +VY YM NGSL + L L W R IA G A G+ +LH
Sbjct: 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL-SWHMRCKIAQGAANGINFLHE 151
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET-VS-MVAGSYGYIAPEYGY 886
+ IHRDIKS NILLD +I+DFGLAR + +T ++ + G+ Y+APE
Sbjct: 152 NH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-L 207
Query: 887 TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG 946
++ K DIYSFGVVLLE++TG +D +++ + + +E+ +D +
Sbjct: 208 RGEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIEDYIDKKMN 266
Query: 947 NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
+ + + +A C + RP ++ V +L
Sbjct: 267 DAD--STSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 315 bits (808), Expect = 9e-96
Identities = 103/545 (18%), Positives = 190/545 (34%), Gaps = 31/545 (5%)
Query: 70 CNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDV 129
C +N + D+ S +L+L N L S + L+ D+
Sbjct: 3 CVEVVPNITYQCMELNFYK-IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 130 SQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVS 189
S+ + + L+ L +GN L +SL+ L +
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 190 FKNLQKLKFLGLSGNNLTG-KIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKY-- 246
+L+ LK L ++ N + K+P L+++E + L+ N+ + L +
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179
Query: 247 --LDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAE-IGNITSLQLLDLSYN--- 300
LDL++ + P + L ++ L N + I + L++ L
Sbjct: 180 LSLDLSLNPMNFIQPGAFKEIRLHKL-TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 301 ---MLSHEIPAEITQLKNLQLLNLMCNQLS---GHVPAGLGGLTQLEVLELWNNSLSGPL 354
L + + L NL + L + LT + L + ++
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298
Query: 355 PVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVR 414
N Q L+L + F L +L +L +N S SL
Sbjct: 299 D--FSYNFGWQHLELVNCKFGQFPTLKL---KSLKRLTFTSNKGGNAF--SEVDLPSLEF 351
Query: 415 VRMQNNQLS--GTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRS 472
+ + N LS G L+ L+L+ N + ++ + L +D ++L+
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 473 SLP-STILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSI-PSSIASCE 530
S LS+ NL +S+ + F SL VL ++ N F + P
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 531 KLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRL 590
L L+L QL P A + + +L +L++S+N+ + +L+VL+ S N +
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530
Query: 591 EGPVP 595
Sbjct: 531 MTSKK 535
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 300 bits (769), Expect = 4e-90
Identities = 104/515 (20%), Positives = 174/515 (33%), Gaps = 29/515 (5%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
+ LDLS + +Q L L++L L N + S + + L+SL++ + L
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLL-EDLGNATSLETLDLRGSFFQGSIPVSFKNLQK 195
+G L LN + N F L E N T+LE LDL + Q + L +
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 196 LKF----LGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIP-VEFGNLTNLKYLDLA 250
+ L LS N + I + + + L N + L L+ L
Sbjct: 175 MPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 251 VGNLGGKIPAE---------LGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNM 301
+G + E L L + E Y + + + +T++ L
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 302 LSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKN 361
+ + Q L L+ + L L +L +N
Sbjct: 294 IERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFT---SNKGGNAFS--EVDL 346
Query: 362 SPLQWLDLSSN--SFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQN 419
L++LDLS N SF G S +L L L N + + L + Q+
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQH 405
Query: 420 NQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTI 478
+ L F L L L++++ +SL + ++ N + + I
Sbjct: 406 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
Query: 479 LS-IPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNL 537
+ + NL +S L P F SL VL++S N F L L+
Sbjct: 466 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY 525
Query: 538 RNNQLTGDIPKAISMMPT-LAILDLSNNSLTGGIP 571
N + + + P+ LA L+L+ N
Sbjct: 526 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 2e-74
Identities = 103/527 (19%), Positives = 174/527 (33%), Gaps = 46/527 (8%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
L L+ + F L SL L L S + +L +LK +V+ N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 137 -SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLE----TLDLRGSFFQGSIPVSFK 191
P L L+ S N DL + +LDL + P +FK
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 192 NLQKLKFLGLSGNNLTGKIPRE-LGQLSSMETMILAYNEFDGEIPVE------FGNLTNL 244
+ +L L L N + + + + L+ +E L EF E +E L NL
Sbjct: 199 EI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 245 KYLDLA---VGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNM 301
+ + I L + L + Q L+L
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCK 315
Query: 302 LSH-------------------EIPAEITQLKNLQLLNLMCNQLS--GHVPAGLGGLTQL 340
L +L+ L+L N LS G G T L
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 341 EVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPAS-LCNGGNLTKLILFNNAFS 399
+ L+L N + + + L+ LD ++ S + NL L + +
Sbjct: 376 KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 400 GPIPVSLSTCHSLVRVRMQNNQLSGTI-PVGFGRLEKLQRLELANNSLTGGITDDIASST 458
+ SL ++M N P F L L L+L+ L S +
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
Query: 459 SLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCP-SLSVLDLSSNY 517
SL +++S N+ S + +LQ S N+++ + Q P SL+ L+L+ N
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
Query: 518 FSGSIPSS--IASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLS 562
F+ + + + L + ++ P MP L+ L+++
Sbjct: 555 FACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLS-LNIT 600
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 3e-87
Identities = 101/555 (18%), Positives = 189/555 (34%), Gaps = 18/555 (3%)
Query: 70 CNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDV 129
C + + ++ L+ + S L N L + + + L +L D+
Sbjct: 8 CIEKEVNKTYNCENLGLNE-IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDL 64
Query: 130 SQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVS 189
++ + L L + N L +L+ L + +
Sbjct: 65 TRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIP 124
Query: 190 FKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDL 249
N + L+ L L N+++ + ++ + N + +L L L
Sbjct: 125 LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSL 184
Query: 250 AV-GNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGN--ITSLQLLDLSYNMLSHEI 306
+ GN I + + + + + N I SL L
Sbjct: 185 NLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDIS 244
Query: 307 PAEITQLKNLQL--LNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPL 364
PA L + + +NL + + L+ L+L LS LP L S L
Sbjct: 245 PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTL 303
Query: 365 QWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPI-PVSLSTCHSLVRVRMQNNQL- 422
+ L LS+N F S N +LT L + N + L +L + + ++ +
Sbjct: 304 KKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363
Query: 423 -SGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILS- 480
S + L LQ L L+ N T+ L +D++ L+ +
Sbjct: 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423
Query: 481 IPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSI---PSSIASCEKLVNLNL 537
+ L+ +S++ L F P+L L+L N+F +S+ + +L L L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
Query: 538 RNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPAN 597
L+ A + + + +DLS+N LT E + LN++ N + +P+
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSL 542
Query: 598 -GVLRTINRGDLAGN 611
+L +L N
Sbjct: 543 LPILSQQRTINLRQN 557
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 7e-82
Identities = 103/532 (19%), Positives = 188/532 (35%), Gaps = 22/532 (4%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
LDL+ + D FQ L +L L N L +L+ +LK Q ++
Sbjct: 60 TFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS 119
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKL 196
L L L N+ S L L+ LD + + +LQ+
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179
Query: 197 K--FLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGN-----LTNLKYLDL 249
L L+GN++ G I + +++ + I N L + D+
Sbjct: 180 TNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 250 AVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAE 309
++ + L + + I L ++ F + LQ LDL+ LS +P+
Sbjct: 239 DDEDISPAVFEGLCEMSVESI-NLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSG 296
Query: 310 ITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSP-LQWLD 368
+ L L+ L L N+ L L + N+ L +N L+ LD
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356
Query: 369 LSSN--SFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTI 426
LS + S L N +L L L N + C L + + +L
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416
Query: 427 PVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRS---SLPSTILSIP 482
F L L+ L L+++ L +L +++ NH +++ ++
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476
Query: 483 NLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQL 542
L+ ++S +L F ++ +DLS N + S +++ + + LNL +N +
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHI 535
Query: 543 TGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPV 594
+ +P + ++ ++L N L LE + +LE
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPLDC----TCSNIYFLEWYKENMQKLEDTE 583
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 2e-86
Identities = 83/281 (29%), Positives = 131/281 (46%), Gaps = 6/281 (2%)
Query: 347 NNSLSGPLPVDLGKNSPLQWLDLSSNSFSGE--IPASLCNGGNLTKLILFN-NAFSGPIP 403
N + G L + + LDLS + IP+SL N L L + N GPIP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 404 VSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFI 463
+++ L + + + +SG IP +++ L L+ + N+L+G + I+S +L I
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 464 DISRNHLRSSLPSTILSIPNLQTFI-VSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSI 522
N + ++P + S L T + +S N L G+IP F + +L+ +DLS N G
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDA 213
Query: 523 PSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEV 582
S + ++L N L D+ K + + L LDL NN + G +P+ L
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272
Query: 583 LNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVLHPCS 623
LNVS+N L G +P G L+ + A N LCG L C+
Sbjct: 273 LNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 7e-82
Identities = 99/332 (29%), Positives = 145/332 (43%), Gaps = 35/332 (10%)
Query: 33 NDELLALLSIKAGLVDPLNSLHDWK--LPSAHCNWTGVWCNSNG---AVEKLDLSHMNLS 87
+ ALL IK L +P +L W + W GV C+++ V LDLS +NL
Sbjct: 5 PQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 88 GCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVS-QNFLNGSFPAGLGGAA 146
+P+SLANL L + N L G P +
Sbjct: 64 KPYP----------------------IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLT 101
Query: 147 GLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNL 206
L +L + N SG + + L +L TLD + G++P S +L L + GN +
Sbjct: 102 QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161
Query: 207 TGKIPRELGQLSSMET-MILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRL 265
+G IP G S + T M ++ N G+IP F NL NL ++DL+ L G G
Sbjct: 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSD 220
Query: 266 ELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQ 325
+ + + L +N+ L ++G +L LDL N + +P +TQLK L LN+ N
Sbjct: 221 KNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 326 LSGHVPAGLGGLTQLEVLELWNNSL--SGPLP 355
L G +P G G L + +V NN PLP
Sbjct: 280 LCGEIPQG-GNLQRFDVSAYANNKCLCGSPLP 310
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 7e-73
Identities = 84/322 (26%), Positives = 120/322 (37%), Gaps = 35/322 (10%)
Query: 137 SFPAGLGGAAGL----TFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGS--IPVSF 190
LG L + + G L + + LDL G IP S
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 191 KNLQKLKFLGLSG-NNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDL 249
NL L FL + G NNL G IP + +L+ + + + + G IP + L LD
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 250 AVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSL-QLLDLSYNMLSHEIPA 308
+ L G +P + L L + N G +P G+ + L + +S N L+ +IP
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
Query: 309 EITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLD 368
L NL ++L N L G G + + L NSL+ L +G + L LD
Sbjct: 193 TFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLD 250
Query: 369 LSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPV 428
L +N G +P L L L N +S N L G IP
Sbjct: 251 LRNNRIYGTLPQGL---TQLKFLHSLN----------VS-----------FNNLCGEIPQ 286
Query: 429 GFGRLEKLQRLELANNSLTGGI 450
G G L++ ANN G
Sbjct: 287 G-GNLQRFDVSAYANNKCLCGS 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 3e-70
Identities = 73/300 (24%), Positives = 121/300 (40%), Gaps = 31/300 (10%)
Query: 228 NEFDGEIPVEFGNLTNLKYLDLAVGNLGG--KIPAELGRLELLEIMFLY-QNNFQGRLPA 284
+ G + + LDL+ NL IP+ L L L +++ NN G +P
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 285 EIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLE 344
I +T L L +++ +S IP ++Q+K L L+ N LSG +P + L L +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 345 LWNNSLSGPLPVDLGKNSPL-QWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIP 403
N +SG +P G S L + +S N +G+IP + N NL + L N G
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN-LNLAFVDLSRNMLEGDAS 214
Query: 404 VSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFI 463
V + + ++ + N L+ + + S +L+ +
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLG-------------------------KVGLSKNLNGL 249
Query: 464 DISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIP 523
D+ N + +LP + + L + VS NNL GEIP V ++N P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN-LQRFDVSAYANNKCLCGSP 308
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 5e-78
Identities = 105/510 (20%), Positives = 178/510 (34%), Gaps = 29/510 (5%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
+ LDLS + + L L++L L N + S P S + LTSL+ + L
Sbjct: 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLED-LGNATSLETLDLRGSFFQGSIPVSFKNLQK 195
+G L LN + N L N T+L +DL ++ Q + L++
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178
Query: 196 LKF----LGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVE-FGNLTNLKYLDLA 250
L +S N + I + Q + + L N I NL L L
Sbjct: 179 NPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 251 VGNLGG---------KIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNM 301
+G I L + + E L N + + ++ + L+
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFR-LTYTNDFSDDIVKFHCLANVSAMSLAGVS 296
Query: 302 LSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKN 361
+ + ++ + Q L+++ QL L L+ L L N S
Sbjct: 297 IKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGSISFK--KVAL 349
Query: 362 SPLQWLDLSSNSFSGEIPASLCNGG--NLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQN 419
L +LDLS N+ S S + G +L L L N + + L + Q+
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQH 408
Query: 420 NQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTI 478
+ L F LEKL L+++ + TSL+ + ++ N + + S +
Sbjct: 409 STLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468
Query: 479 LS-IPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNL 537
+ NL +S L F L +L++S N S L L+
Sbjct: 469 FANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDC 528
Query: 538 RNNQLTGDIPKAISMMPTLAILDLSNNSLT 567
N++ +LA +L+NNS+
Sbjct: 529 SFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 2e-76
Identities = 108/545 (19%), Positives = 185/545 (33%), Gaps = 30/545 (5%)
Query: 70 CNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDV 129
C LS D S +++L N L S +N + L+ D+
Sbjct: 7 CIEVVPNITYQCMDQKLSKVPDDIP---SSTKNIDLSFNPLKILKSYSFSNFSELQWLDL 63
Query: 130 SQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVS 189
S+ + G L+ L +GN F TSLE L +
Sbjct: 64 SRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFP 123
Query: 190 FKNLQKLKFLGLSGNNLTG-KIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLK--- 245
L LK L ++ N + K+P L+++ + L+YN + L
Sbjct: 124 IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVN 183
Query: 246 -YLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAE-IGNITSLQLLDLSYNMLS 303
LD++ N I + + L + L N + + N+ L + L
Sbjct: 184 LSLDMS-LNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFK 242
Query: 304 HEIPAEITQ------LKNLQL--LNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLP 355
E EI + L ++ + L L + + L S+
Sbjct: 243 DERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL-- 300
Query: 356 VDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRV 415
D+ K+ Q L + L L L L N S I SL +
Sbjct: 301 EDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGS--ISFKKVALPSLSYL 355
Query: 416 RMQNNQLSGTIPVGFGRLE--KLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSS 473
+ N LS + + L L+ L+L+ N ++ + L +D + L+
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRV 414
Query: 474 LP-STILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSI-ASCEK 531
S LS+ L +S N + F SL+ L ++ N F + S++ A+
Sbjct: 415 TEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN 474
Query: 532 LVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
L L+L QL + L +L++S+N+L ++ +L L+ S+NR+E
Sbjct: 475 LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534
Query: 592 GPVPA 596
Sbjct: 535 TSKGI 539
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 4e-69
Identities = 100/500 (20%), Positives = 176/500 (35%), Gaps = 33/500 (6%)
Query: 112 SSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATS 171
SL + + ++ + L+ P + + ++ S N N +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 172 LETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFD 231
L+ LDL + ++ L L L L+GN + P L+S+E ++ +
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 232 GEIPVEFGNLTNLKYLDLAVGNL--GGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNI 289
G L LK L++A N K+PA L L + L N Q ++ +
Sbjct: 118 SLESFPIGQLITLKKLNVA-HNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176
Query: 290 TSLQL----LDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLE 344
LD+S N + I + Q L L L N S ++ L L L V
Sbjct: 177 RENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235
Query: 345 LWNNSLSGPLPVDLGKNSPLQ--------WLDLSSNSFSGEIPASLCNGGNLTKLILFNN 396
L +++ + S ++ L+ + + N++ + L
Sbjct: 236 LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295
Query: 397 AFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIAS 456
+ + + + QL P L L+ L L N + I+ +
Sbjct: 296 SIKY--LEDVPKHFKWQSLSIIRCQLK-QFP--TLDLPFLKSLTLTMNKGS--ISFKKVA 348
Query: 457 STSLSFIDISRNHLRSSLPST--ILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLS 514
SLS++D+SRN L S + L +L+ +S N + + F L LD
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQ 407
Query: 515 SNYFSGSIP-SSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPEN 573
+ S+ S EKL+ L++ D + +L L ++ NS N
Sbjct: 408 HSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
Query: 574 -FGASPALEVLNVSYNRLEG 592
F + L L++S +LE
Sbjct: 468 VFANTTNLTFLDLSKCQLEQ 487
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-50
Identities = 84/468 (17%), Positives = 156/468 (33%), Gaps = 41/468 (8%)
Query: 51 NSLHDWKLPSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLT----SLNLC 106
N +H KLP+ N T + +DLS+ + + Q L+ SL++
Sbjct: 138 NFIHSCKLPAYFSNLT--------NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189
Query: 107 CNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGA-AGLTFLNASGNNFSGF---- 161
N + + + L + NF + + AGL F
Sbjct: 190 LNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 162 -----LLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQ 216
++E L + +++ L + V F L + + L+G ++ ++ +
Sbjct: 249 IFEPSIMEGLCD-VTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPK 305
Query: 217 LSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQN 276
+++ + + +L LK L L N G ++ L L + L +N
Sbjct: 306 HFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLT-MNKGSISFKKVA-LPSLSYLDLSRN 360
Query: 277 NFQ--GRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAG- 333
G SL+ LDLS+N + A L+ LQ L+ + L
Sbjct: 361 ALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSA 419
Query: 334 LGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPAS-LCNGGNLTKLI 392
L +L L++ + + L L ++ NSF ++ N NLT L
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479
Query: 393 LFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITD 452
L T H L + M +N L + +L L L+ + N +
Sbjct: 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539
Query: 453 DIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPD 500
SL+F +++ N + I ++ + +
Sbjct: 540 LQHFPKSLAFFNLTNNSVAC-----ICEHQKFLQWVKEQKQFLVNVEQ 582
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 4e-75
Identities = 78/303 (25%), Positives = 123/303 (40%), Gaps = 37/303 (12%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKL-WRSRADLETESSGDFVGEVNVLGKLRH 765
++ V G G V+KA++ N VAVK + + + E EV L ++H
Sbjct: 26 LQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEY------EVYSLPGMKH 77
Query: 766 RNIVRLLGF----LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ 821
NI++ +G D ++ ++ + GSL + L V W +IA +A+
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHIAETMAR 132
Query: 822 GLAYLHHDCY-------PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM-- 872
GLAYLH D P I HRDIKS N+LL +NL IADFGLA
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 873 VAGSYGYIAPEY-----GYTLKVDEKIDIYSFGVVLLELLTGRRPLD---PEFGESVDIV 924
G+ Y+APE + +ID+Y+ G+VL EL + D E+ +
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252
Query: 925 EWIRMKIRDNRNL--EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982
+ D + + + P + + M ++ C + R S V
Sbjct: 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312
Query: 983 LGE 985
+ +
Sbjct: 313 ITQ 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 1e-65
Identities = 90/279 (32%), Positives = 140/279 (50%), Gaps = 26/279 (9%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766
+ IG G+ G V++AE + VAVK L D E +F+ EV ++ +LRH
Sbjct: 39 LNIKEKIGAGSFGTVHRAEW--HGSDVAVKIL--MEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
NIV +G + N+ IV EY++ GSL LH A L D R ++A VA+G+ YL
Sbjct: 95 NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQL-DERRRLSMAYDVAKGMNYL 153
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGY 886
H+ PPI+HR++KS N+L+D ++ DFGL+R+ + AG+ ++APE
Sbjct: 154 HN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 887 TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE--EALDPN 944
+EK D+YSFGV+L EL T ++P +G ++ + + + LE L+P
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQP----WGN-LNPAQVVAAVGFKCKRLEIPRNLNPQ 267
Query: 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
V ++ C P RPS ++ +L
Sbjct: 268 VAA---------IIEG----CWTNEPWKRPSFATIMDLL 293
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 1e-63
Identities = 84/289 (29%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG---DFVGEVNVLGKL 763
I IG G G+V+K + + ++VA+K L ++ ETE +F EV ++ L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 764 RHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGL 823
H NIV+L G +HN +V E++ G L L K + W + + L +A G+
Sbjct: 81 NHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGI 135
Query: 824 AYLHHDCYPPIIHRDIKSNNILLDSNLEPR-----IADFGLARMMIRKNETVSMVAGSYG 878
Y+ + PPI+HRD++S NI L S E +ADFGL++ +VS + G++
Sbjct: 136 EYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---SVHSVSGLLGNFQ 191
Query: 879 YIAPE--YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRN 936
++APE EK D YSF ++L +LTG P D S +++I M +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD---EYSYGKIKFINMIREEGLR 248
Query: 937 LE--EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
E P + N ++ C + PK RP ++ L
Sbjct: 249 PTIPEDCPPRLRN---------VIEL----CWSGDPKKRPHFSYIVKEL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-63
Identities = 79/287 (27%), Positives = 122/287 (42%), Gaps = 37/287 (12%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766
+ +IG+G G VY+A + VAVK + +++ + E + L+H
Sbjct: 9 LTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
NI+ L G + N+ +V E+ G L L GK+ + N A+ +A+G+ YL
Sbjct: 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYL 121
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPR--------IADFGLARMMIRKNETVSMVAGSYG 878
H + PIIHRD+KS+NIL+ +E I DFGLAR T AG+Y
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAAGAYA 179
Query: 879 YIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938
++APE + D++S+GV+L ELLTG P +D + + L
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-----RGIDGLAVAYGVAMNKLALP 234
Query: 939 --EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
L+ C P RPS +++ L
Sbjct: 235 IPSTCPEPFAK---------LMED----CWNPDPHSRPSFTNILDQL 268
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 3e-63
Identities = 77/278 (27%), Positives = 125/278 (44%), Gaps = 30/278 (10%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766
I V+G GA G+V KA+ VA+K++ F+ E+ L ++ H
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW--RAKDVAIKQI------ESESERKAFIVELRQLSRVNHP 61
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
NIV+L G N + +V EY GSL LHG + + L +QG+AYL
Sbjct: 62 NIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYY-TAAHAMSWCLQCSQGVAYL 118
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLE-PRIADFGLARMMIRKNETVSMVAGSYGYIAPEYG 885
H +IHRD+K N+LL + +I DFG A ++ GS ++APE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD---IQTHMTNNKGSAAWMAPEVF 175
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945
EK D++S+G++L E++T R+P F E I + +
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAVHNGTRPPLI----- 226
Query: 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
K++ + + ++ C +K P RPSM +++ ++
Sbjct: 227 ---KNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIM 258
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 5e-61
Identities = 99/540 (18%), Positives = 185/540 (34%), Gaps = 31/540 (5%)
Query: 70 CNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDV 129
C +N + S +L+L N L S + L+ D+
Sbjct: 3 CVEVVPNITYQCMELNFYKIPDNLPF---STKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 130 SQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVS 189
S+ + + L+ L +GN L +SL+ L +
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 190 FKNLQKLKFLGLSGNNLT-GKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKY-- 246
+L+ LK L ++ N + K+P L+++E + L+ N+ + L +
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179
Query: 247 --LDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAE-IGNITSLQLLDL------ 297
LDL+ N I + L + L N + I + L++ L
Sbjct: 180 LSLDLS-LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 298 SYNMLSHEIPAEITQLKNLQLLNL---MCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPL 354
+ L + + L NL + + + LT + L + ++
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298
Query: 355 PVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVR 414
D N Q L+L + F L +L +L +N S SL
Sbjct: 299 --DFSYNFGWQHLELVNCKFGQFPTLKL---KSLKRLTFTSNKGGNAF--SEVDLPSLEF 351
Query: 415 VRMQNNQLS--GTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRS 472
+ + N LS G L+ L+L+ N + ++ + L +D ++L+
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 473 SLPSTIL-SIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSI-ASCE 530
++ S+ NL +S+ + F SL VL ++ N F + I
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 531 KLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRL 590
L L+L QL P A + + +L +L++++N L F +L+ + + N
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 2e-59
Identities = 107/529 (20%), Positives = 190/529 (35%), Gaps = 40/529 (7%)
Query: 68 VWCNSNG----------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNS 117
C + + LDLS L S F L L+L + + +
Sbjct: 12 YQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 118 LANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDL 177
+L+ L ++ N + G + L L A N + +G+ +L+ L++
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 178 RGSFFQ-GSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMI----LAYNEFDG 232
+ Q +P F NL L+ L LS N + +L L M + L+ N +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN- 190
Query: 233 EIPVEFGNLTNLKYLDLAVGNLGGKIP-------AELGRLELLEIMFLYQNNFQGRLPAE 285
I L L L + A L L+ F + N + +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 286 IGNITSLQLLDLSYNMLSH---EIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEV 342
+ + +L + + L + +I L N+ +L+ + +
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQH 308
Query: 343 LELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNN--AFSG 400
LEL N + L L+ L +SN S + +L L L N +F G
Sbjct: 309 LELVNCKFGQFPTLKLKS---LKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKG 363
Query: 401 PIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIA--SST 458
S SL + + N + T+ F LE+L+ L+ +++L +++ S
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLR 421
Query: 459 SLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEI-PDQFQDCPSLSVLDLSSNY 517
+L ++DIS H R + + +L+ ++ N+ PD F + +L+ LDLS
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 518 FSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSL 566
P++ S L LN+ +NQL + +L + L N
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 6e-56
Identities = 94/474 (19%), Positives = 163/474 (34%), Gaps = 30/474 (6%)
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKL 196
P L L+ S N + L+ LDL Q ++++L L
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 197 KFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLG- 255
L L+GN + LSS++ ++ G+L LK L++A +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 256 GKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQL----LDLSYNMLSHEIPAEIT 311
K+P L LE + L N Q ++ + + L LDLS N ++ I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAF 197
Query: 312 QLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLELWNNSLSGP---LPVDLGKNSPLQWL 367
+ L L L N S +V + GL LEV L D L L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 368 DLSSNS------FSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQ 421
+ + +I N++ L + + S + + N +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VK-DFSYNFGWQHLELVNCK 315
Query: 422 LSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLR--SSLPSTIL 479
+L+ L+RL +N ++ SL F+D+SRN L +
Sbjct: 316 FGQ---FPTLKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 480 SIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSI-ASCEKLVNLNLR 538
+L+ +S N ++ + F L LD + S+ S L+ L++
Sbjct: 371 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 539 NNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPEN-FGASPALEVLNVSYNRLE 591
+ + + +L +L ++ NS + F L L++S +LE
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-51
Identities = 99/485 (20%), Positives = 172/485 (35%), Gaps = 40/485 (8%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
+ LDLS + +Q L L++L L N + S + + L+SL++ + L
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLED-LGNATSLETLDLRGSFFQGSIPVSFKNLQK 195
+G L LN + N F L + N T+LE LDL + Q + L +
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 196 LKF----LGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIP-VEFGNLTNLKYLDLA 250
+ L LS N + I + + + L N + L L+ L
Sbjct: 175 MPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 251 VGNLGG---------KIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNM 301
+G L L + E Y + + + +T++ L
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 302 LSHEIPAEI--TQLKNLQLLNLMCNQLSGHVPAGL----------------GGLTQLEVL 343
+ + ++L+L+N Q L L LE L
Sbjct: 294 IE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFL 352
Query: 344 ELWNNSLS--GPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGP 401
+L N LS G + L++LDLS N + ++ L L ++
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQM 411
Query: 402 IPVS-LSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASS-TS 459
S + +L+ + + + F L L+ L++A NS DI + +
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471
Query: 460 LSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFS 519
L+F+D+S+ L P+ S+ +LQ +++N L F SL + L +N +
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
Query: 520 GSIPS 524
S P
Sbjct: 532 CSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-43
Identities = 95/443 (21%), Positives = 158/443 (35%), Gaps = 26/443 (5%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFS-SLPNSLANLTSLKRFDVSQNFLN 135
+KL NL+ + LK+L LN+ N + S LP +NLT+L+ D+S N +
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 136 GSFPAGLGGAAGLTFLNAS---GNNFSGFLLEDLGNATSLETLDLRGSFFQGSIP-VSFK 191
+ L + LN S N F+ L L LR +F ++ +
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
Query: 192 NLQKLKFLGL------SGNNLTGKIPRELGQLSSMETMILAYNEFDG---EIPVEFGNLT 242
L L+ L + NL L L ++ D +I F LT
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282
Query: 243 NLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNML 302
N+ L V ++ + + N G+ P + SL+ L + N
Sbjct: 283 NVSSFSL-VSVTIERVKDFSYNFGWQHLELV--NCKFGQFPT--LKLKSLKRLTFTSNKG 337
Query: 303 SHEIPAEITQLKNLQLLNLMCNQLS--GHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGK 360
+ +E+ L +L+ L+L N LS G G T L+ L+L N + + +
Sbjct: 338 GN-AFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLG 394
Query: 361 NSPLQWLDLSSNSFSGEIPAS-LCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQN 419
L+ LD ++ S + NL L + + + SL ++M
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 420 NQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTI 478
N F L L L+L+ L S +SL ++++ N L+S
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIF 514
Query: 479 LSIPNLQTFIVSNNNLVGEIPDQ 501
+ +LQ + N P
Sbjct: 515 DRLTSLQKIWLHTNPWDCSCPRI 537
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 4e-59
Identities = 98/495 (19%), Positives = 175/495 (35%), Gaps = 60/495 (12%)
Query: 99 SLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNF 158
L S + + + + L + + + + + +T L A
Sbjct: 2 PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 159 SGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLS 218
++ + +L ++ + P KNL KL + ++ N + P L L+
Sbjct: 59 KS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLT 112
Query: 219 SMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNF 278
++ + L N+ P NLTNL L+L N
Sbjct: 113 NLTGLTLFNNQITDIDP--LKNLTNLNRLEL------------------------SSNTI 146
Query: 279 QGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLT 338
+ + +TSLQ L + + L L+ L++ N++S + L LT
Sbjct: 147 SD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSD--ISVLAKLT 199
Query: 339 QLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAF 398
LE L NN +S P LG + L L L+ N +L + NLT L L NN
Sbjct: 200 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 255
Query: 399 SGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASST 458
S P LS L +++ NQ+S P L L LEL N L I++
Sbjct: 256 SNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLK 309
Query: 459 SLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYF 518
+L+++ + N++ P + S+ LQ NN + + +++ L N
Sbjct: 310 NLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQI 365
Query: 519 SGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASP 578
S P +A+ ++ L L + T + + + +L P
Sbjct: 366 SDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGG 421
Query: 579 ALEVLNVSYNRLEGP 593
+ ++++N
Sbjct: 422 SYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 9e-58
Identities = 108/502 (21%), Positives = 183/502 (36%), Gaps = 62/502 (12%)
Query: 76 VEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLN 135
K L N++ VS L +T+L G+ S+ + L +L + + S N L
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI-KSIDG-VEYLNNLTQINFSNNQLT 81
Query: 136 GSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQK 195
P L L + + N + + L N T+L L L + P KNL
Sbjct: 82 DITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--LKNLTN 135
Query: 196 LKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLG 255
L L LS N ++ LT+L+ L GN
Sbjct: 136 LNRLELSSNTISD--------------------------ISALSGLTSLQQLSF--GNQV 167
Query: 256 GKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKN 315
+ L L LE + + N + + +T+L+ L + N +S P + L N
Sbjct: 168 TDLKP-LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTN 222
Query: 316 LQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFS 375
L L+L NQL L LT L L+L NN +S P L + L L L +N S
Sbjct: 223 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278
Query: 376 GEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEK 435
P L LT L L N P +S +L + + N +S P L K
Sbjct: 279 NISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTK 332
Query: 436 LQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLV 495
LQRL NN ++ +A+ T+++++ N + P + ++ + +++
Sbjct: 333 LQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388
Query: 496 GEIPDQFQDCPSLSVLDLSSNYFSGSI-PSSIASCEKLVNLNLRNNQLTGDIPKAISMMP 554
+ + +S+ + N I P++I+ ++ N + +
Sbjct: 389 NAPVNYKAN---VSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS-YTNEVSYTFS 444
Query: 555 TLAILDLSNNSLTGGIPENFGA 576
+ + +G + + A
Sbjct: 445 QPVTIGKGTTTFSGTVTQPLKA 466
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-50
Identities = 88/407 (21%), Positives = 145/407 (35%), Gaps = 55/407 (13%)
Query: 189 SFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLD 248
+ L + L N+T + L + T+ + L NL ++
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQIN 74
Query: 249 LAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPA 308
+ L P L L L + + N + N+T+L L L N ++ P
Sbjct: 75 FSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP- 129
Query: 309 EITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLD 368
+ L NL L L N +S + L GLT L+ L N ++ P L + L+ LD
Sbjct: 130 -LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLD 183
Query: 369 LSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPV 428
+SSN S + L NL LI NN S P L +L + + NQL
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IG 237
Query: 429 GFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFI 488
L L L+LANN ++ + + + L
Sbjct: 238 TLASLTNLTDLDLANNQISN--------------------------LAPLSGLTKLTELK 271
Query: 489 VSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPK 548
+ N + P +L+ L+L+ N P I++ + L L L N ++ P
Sbjct: 272 LGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP- 326
Query: 549 AISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVP 595
+S + L L NN ++ + + L+ +N++ P
Sbjct: 327 -VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP 370
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 205 bits (522), Expect = 5e-59
Identities = 74/347 (21%), Positives = 123/347 (35%), Gaps = 75/347 (21%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKL-WRSRADLETESSGDFVGEVNVLGKLRH 765
++ +IG G G VYK + VAVK + +R + E + + + H
Sbjct: 15 LKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEK------NIYRVPLMEH 66
Query: 766 RNIVRLLGF-----LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVA 820
NI R + ++V EY NGSL + L DWVS +A V
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVT 121
Query: 821 QGLAYLHHD------CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR--------K 866
+GLAYLH + P I HRD+ S N+L+ ++ I+DFGL+ + +
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 867 NETVSMVAGSYGYIAPEY-------GYTLKVDEKIDIYSFGVVLLELLTGRR-------- 911
+ G+ Y+APE +++D+Y+ G++ E+
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
Query: 912 -----------PLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVL- 959
P F + +V R K R P + L
Sbjct: 242 PEYQMAFQTEVGNHPTFEDMQVLV--SREKQR----------PKFPEAWKENSLAVRSLK 289
Query: 960 RIAFLCTAKLPKDRPSMRDVITMLGE---AKPRRKSSSNNDNRYENN 1003
C + + R + + + E R KS S + + ++
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHHHH 336
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-58
Identities = 63/286 (22%), Positives = 109/286 (38%), Gaps = 41/286 (14%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766
+ + +G ++K + VK L D T S DF E L H
Sbjct: 12 LNFLTKLNENHSGELWKGRW--QGNDIVVKVL--KVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 767 NIVRLLGFLHN--DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLA 824
N++ +LG + + ++ +M GSL LH +VD AL +A+G+A
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMA 125
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE- 883
+LH P I + S ++++D ++ RI+ + + ++APE
Sbjct: 126 FLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM-----YAPAWVAPEA 179
Query: 884 --YGYTLKVDEKIDIYSFGVVLLELLTGRRP---LDP-EFGESVDIVEWIRMKIRDNRNL 937
D++SF V+L EL+T P L E G V +E +R I
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV-ALEGLRPTI------ 232
Query: 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
P + + +++I C + P RP ++ +L
Sbjct: 233 -----P-----PGISPHVSKLMKI---CMNEDPAKRPKFDMIVPIL 265
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 8e-57
Identities = 75/295 (25%), Positives = 123/295 (41%), Gaps = 55/295 (18%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
V+G G G K ++ +K+L R + E+ F+ EV V+ L H N+++
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
+G L+ D + + EY+ G+L + + W R + A +A G+AYLH
Sbjct: 72 FIGVLYKDKRLNFITEYIKGGTLRGIIK-SMDSQY--PWSQRVSFAKDIASGMAYLHS-- 126
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM--------------VAGS 876
IIHRD+ S+N L+ N +ADFGLAR+M+ + V G+
Sbjct: 127 -MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 877 YGYIAPE---YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES-----VDIVEWIR 928
++APE DEK+D++SFG+VL E++ DP++ +++ ++
Sbjct: 186 PYWMAPEMINGR---SYDEKVDVFSFGIVLCEIIGRVNA-DPDYLPRTMDFGLNVRGFLD 241
Query: 929 MKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
NC I C P+ RPS + L
Sbjct: 242 RYC-------------PPNCPPS------FFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-56
Identities = 64/309 (20%), Positives = 121/309 (39%), Gaps = 48/309 (15%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766
+ +IG G G VY R + VA++ + + F EV + RH
Sbjct: 35 LEIGELIGKGRFGQVYHG---RWHGEVAIRLI--DIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
N+V +G + ++ I+ +L + ++++D IA + +G+ YL
Sbjct: 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYL 146
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM-----IRKNETVSMVAGSYGYIA 881
H I+H+D+KS N+ D N + I DFGL + R+ + + + G ++A
Sbjct: 147 HA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 882 PE---------YGYTLKVDEKIDIYSFGVVLLELLTGRRP---LDPEFGESVDIVEWIRM 929
PE L + D+++ G + EL P E I+ +
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-----AIIWQMGT 257
Query: 930 KIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPR 989
++ PN+ +E ++L C A ++RP+ ++ ML + R
Sbjct: 258 GMK----------PNLSQIGMGKEISDILLF----CWAFEQEERPTFTKLMDMLEKLPKR 303
Query: 990 RKSSSNNDN 998
+ S+ +
Sbjct: 304 NRRLSHPGH 312
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-56
Identities = 82/286 (28%), Positives = 131/286 (45%), Gaps = 37/286 (12%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766
I IG G+ G VYK + + VAVK L + + F EV VL K RH
Sbjct: 26 ITVGQRIGSGSFGTVYKG---KWHGDVAVKML--NVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
NI+ +G+ + IV ++ SL LH + + +IA A+G+ YL
Sbjct: 81 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLH-ASETKF--EMKKLIDIARQTARGMDYL 136
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM--VAGSYGYIAPE- 883
H IIHRD+KSNNI L + +I DFGLA R + + ++GS ++APE
Sbjct: 137 HA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 884 --YGYTLKVDEKIDIYSFGVVLLELLTGRRP---LDPEFGESVDIVEWIRMKIRDNRNLE 938
+ + D+Y+FG+VL EL+TG+ P ++ + +++V R + + +
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIEMVG------RGSLSPD 246
Query: 939 EALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
+ + NC K ++ M C K +RPS ++ +
Sbjct: 247 LSKVRS--NCPKRMKRLMA-------ECLKKKRDERPSFPRILAEI 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-54
Identities = 77/313 (24%), Positives = 114/313 (36%), Gaps = 61/313 (19%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKL-WRSRADLETESSGDFVGEVNVLGKLRH 765
I+ IG G G V+ + VAVK A E+ E+ +RH
Sbjct: 39 IQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRET------EIYQTVLMRH 90
Query: 766 RNIVRLLG----FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ 821
NI+ + + T + ++ +Y NGSL + L +D S +A
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVS 145
Query: 822 GLAYLH-----HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMV--- 873
GL +LH P I HRD+KS NIL+ N IAD GLA I V +
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 874 -AGSYGYIAPE------YGYTLKVDEKIDIYSFGVVLLELLTGRR--------------- 911
G+ Y+ PE + D+YSFG++L E+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 912 -PLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLP 970
P DP + + +IV K+R P+ N E + + ++ C A P
Sbjct: 266 VPSDPSYEDMREIV--CIKKLR----------PSFPNRWSSDECLRQMGKLMTECWAHNP 313
Query: 971 KDRPSMRDVITML 983
R + V L
Sbjct: 314 ASRLTALRVKKTL 326
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-54
Identities = 78/315 (24%), Positives = 122/315 (38%), Gaps = 61/315 (19%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKL-WRSRADLETESSGDFVGEVNVLGKLRH 765
I +G G G V++ VAVK R E+ E+ LRH
Sbjct: 10 ITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRET------ELYNTVMLRH 61
Query: 766 RNIVRLLG----FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ 821
NI+ + H+ T + ++ Y GSL + L +D VS I L +A
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIAS 116
Query: 822 GLAYLHHDCY-----PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMV--- 873
GLA+LH + + P I HRD+KS NIL+ N + IAD GLA M + + +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 874 -AGSYGYIAPE------YGYTLKVDEKIDIYSFGVVLLELLTGRR--------------- 911
G+ Y+APE +++DI++FG+VL E+
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236
Query: 912 -PLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLP 970
P DP F + +V + R PN+ N + + ++ C + P
Sbjct: 237 VPNDPSFEDMRKVV--CVDQQR----------PNIPNRWFSDPTLTSLAKLMKECWYQNP 284
Query: 971 KDRPSMRDVITMLGE 985
R + + L +
Sbjct: 285 SARLTALRIKKTLTK 299
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 2e-54
Identities = 110/558 (19%), Positives = 197/558 (35%), Gaps = 39/558 (6%)
Query: 70 CNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDV 129
C+ +G NL+ Q L + L L N + + +S L L+ ++
Sbjct: 2 CSFDG--RIAFYRFCNLT----QVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLEL 55
Query: 130 SQNFLNGSFPAG-LGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSI-- 186
+ + L L+ + + L L L ++
Sbjct: 56 GSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK 115
Query: 187 PVSFKNLQKLKFLGLSGNNLTG-KIPRELGQLSSMETMILAYNEFDGEIPVEFGNLT--N 243
F+NL+ L L LS N + + G+L+S++++ + N+ E L
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175
Query: 244 LKYLDLAVGNLGGKIPAELGR-LELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNML 302
L + LA +L ++ + G+ + M L + G N ++ + N +
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFSNAI 228
Query: 303 SHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGL--TQLEVLELWNNSLSGPLPVDLGK 360
S + ++ + + GL + + L+L + +
Sbjct: 229 SKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFET 288
Query: 361 NSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNN 420
L+ L+L+ N + + NL L L N + + + +Q N
Sbjct: 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 421 QLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILS 480
++ F LEKLQ L+L +N+LT I S+ I +S N L +LP L+
Sbjct: 349 HIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKL-VTLPKINLT 402
Query: 481 IPNLQTFIVSNNNLVG-EIPDQFQDCPSLSVLDLSSNYFSG-SIPSSIASCEKLVNLNLR 538
+S N L +I P L +L L+ N FS S + + L L L
Sbjct: 403 ---ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLG 459
Query: 539 NNQLTGDI-----PKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGP 593
N L + L +L L++N L P F AL L+++ NRL
Sbjct: 460 ENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV- 518
Query: 594 VPANGVLRTINRGDLAGN 611
+ N + + D++ N
Sbjct: 519 LSHNDLPANLEILDISRN 536
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 6e-53
Identities = 106/531 (19%), Positives = 198/531 (37%), Gaps = 39/531 (7%)
Query: 77 EKLDLSHMNLSGCV-SDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLN 135
+ L+L + + F+ L +L L+L + ++ P++ L L + L+
Sbjct: 51 QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110
Query: 136 GSF--PAGLGGAAGLTFLNASGNNFSGFLLED-LGNATSLETLDLRGSFFQGSIPVSFKN 192
+ LT L+ S N L G SL+++D + +
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170
Query: 193 LQ--KLKFLGLSGNNLTGKIPRELGQ-LSSMETMILAYNEFDGEIPVEFGNLTNLKYLDL 249
LQ L F L+ N+L ++ + G+ ++ M+L + G N +
Sbjct: 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDITGN 223
Query: 250 AVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNI--TSLQLLDLSYNMLSHEIP 307
+ L + +N + + +S++ LDLS+ +
Sbjct: 224 FSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS 283
Query: 308 AEITQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQW 366
LK+L++LNL N+++ + GL L+VL L N L + + +
Sbjct: 284 RVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342
Query: 367 LDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTI 426
+DL N + + L L L +NA + ++ S+ + + N+L
Sbjct: 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLP 397
Query: 427 PVGFGRLEKLQRLELANNSLTG-GITDDIASSTSLSFIDISRNHLRSSLPSTILSI-PNL 484
+ + L+ N L I + L + +++N S S P+L
Sbjct: 398 KINL----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL 453
Query: 485 QTFIVSNNNLVGEI-----PDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRN 539
+ + N L D F+ L VL L+ NY + P + L L+L +
Sbjct: 454 EQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNS 513
Query: 540 NQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRL 590
N+LT + + L ILD+S N L P+ F +L VL++++N+
Sbjct: 514 NRLT-VLSHN-DLPANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKF 559
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 1e-44
Identities = 95/503 (18%), Positives = 173/503 (34%), Gaps = 46/503 (9%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSL--PNSLANLTSLKRFDVSQNFL 134
LDL + D FQ L L L L GL ++ NL +L R D+S+N +
Sbjct: 76 RILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135
Query: 135 NG-SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGN--ATSLETLDLRGSFFQGSIPVSFK 191
G L ++ S N +L +L L + + V +
Sbjct: 136 RSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWG 195
Query: 192 NLQK------LKFLGLSGNNLTGKIPR------------ELGQLSSMETMILAYNEFDGE 233
L+ L +SGN T I L + ++
Sbjct: 196 KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDP 255
Query: 234 IPVEFGNL--TNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITS 291
F L +++++LDL+ G + L+ L+++ L N + +
Sbjct: 256 DQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDN 315
Query: 292 LQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLS 351
LQ+L+LSYN+L + L + ++L N ++ L +L+ L+L +N+L+
Sbjct: 316 LQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
Query: 352 GPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSG-PIPVSLSTCH 410
+ + + LS N +L + L N I L
Sbjct: 376 -----TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFLLRVP 426
Query: 411 SLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASS-----TSLSFID 464
L + + N+ S L++L L N L ++ + L +
Sbjct: 427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLY 486
Query: 465 ISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPS 524
++ N+L S P + L+ +++N L + +L +LD+S N P
Sbjct: 487 LNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPD 544
Query: 525 SIASCEKLVNLNLRNNQLTGDIP 547
L L++ +N+ +
Sbjct: 545 ---VFVSLSVLDITHNKFICECE 564
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-31
Identities = 84/427 (19%), Positives = 146/427 (34%), Gaps = 51/427 (11%)
Query: 76 VEKLDLSHMNLSGCVSDHFQRLK--SLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNF 133
+ N+ + F L S+ L+L +FS L LK +++ N
Sbjct: 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNK 301
Query: 134 LNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNL 193
+N G L LN S N + + +DL+ + +FK L
Sbjct: 302 INKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFL 361
Query: 194 QKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGN 253
+KL+ L L N LT + + S+ + L+ N L L ++L
Sbjct: 362 EKLQTLDLRDNALT-----TIHFIPSIPDIFLSGN-----------KLVTLPKINLT--- 402
Query: 254 LGGKIPAELGRLELLEIMFLYQNNFQG-RLPAEIGNITSLQLLDLSYNMLSH-EIPAEIT 311
++ L +N + + + + LQ+L L+ N S +
Sbjct: 403 --------------ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448
Query: 312 QLKNLQLLNLMCNQLSGHVPAGL-----GGLTQLEVLELWNNSLSGPLPVDLGKNSP-LQ 365
+ +L+ L L N L L GL+ L+VL L +N L+ LP + + L+
Sbjct: 449 ENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS-LPPGVFSHLTALR 507
Query: 366 WLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGT 425
L L+SN + L NL L + N + SL + + +N+
Sbjct: 508 GLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLA---PNPDVFVSLSVLDITHNKFICE 562
Query: 426 IPVG-FGRLEKLQRLELANNSLT-GGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPN 483
+ F + +A + D S SL + L S S+
Sbjct: 563 CELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFI 622
Query: 484 LQTFIVS 490
+ T ++
Sbjct: 623 VCTVTLT 629
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 2e-54
Identities = 103/499 (20%), Positives = 193/499 (38%), Gaps = 42/499 (8%)
Query: 120 NLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRG 179
+ + D S P+GL A + L+ S N + DL +L+ L L+
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 180 SFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRE-LGQLSSMETMILAYNEFDG-EIPVE 237
S +F +L L+ L LS N+L+ + G LSS++ + L N + +
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 238 FGNLTNLKYLDLAVGNLGGKIPAE-LGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLD 296
F NLTNL+ L + +I L L + + + + + +I + L
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 297 LSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGP--- 353
L + + + L +++ L L L+ + L ++ S
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238
Query: 354 -------LPVDLGKNSPLQWLDLSSN---SFSGEIPASLCNGG-----NLTKLILFNNAF 398
L + + S +++ D + N F+ + G + +L +
Sbjct: 239 SFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL 298
Query: 399 SGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDD---I 454
+ S + R+ ++N+++ +P L+ L+ L+L+ N + +
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357
Query: 455 ASSTSLSFIDISRNHLRS--SLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLD 512
+ SL + +S+NHLRS +L++ NL + +S N +PD Q + L+
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLN 416
Query: 513 LSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPE 572
LSS + + I L L++ NN L +P L L +S N L +P+
Sbjct: 417 LSSTGIR-VVKTCIPQ--TLEVLDVSNNNLD-SFS---LFLPRLQELYISRNKLKT-LPD 468
Query: 573 NFGASPALEVLNVSYNRLE 591
P L V+ +S N+L+
Sbjct: 469 ASL-FPVLLVMKISRNQLK 486
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 5e-54
Identities = 89/499 (17%), Positives = 171/499 (34%), Gaps = 25/499 (5%)
Query: 76 VEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLN 135
++ LDLS ++ + +L L L + + + ++ +L SL+ D+S N L+
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 136 GSFPAGLGGAAGLTFLNASGNNFSGFLLEDL-GNATSLETLDLRGSFFQGSIPV-SFKNL 193
+ G + L +LN GN + + L N T+L+TL + I F L
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147
Query: 194 QKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGN 253
L L + +L + L + + + L +E + + L++++YL+L N
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207
Query: 254 LGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQL 313
L + L E+ M + L L + +
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE------FDDC 261
Query: 314 KNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNS 373
L + ++ G + L + L L ++ + + ++
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321
Query: 374 FSGEIPASLCNG-GNLTKLILFNNAFS---GPIPVSLSTCHSLVRVRMQNNQLS--GTIP 427
+P S +L L L N SL + + N L
Sbjct: 322 VF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTG 380
Query: 428 VGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTF 487
L+ L L+++ N+ + D + F+++S + + + I L+
Sbjct: 381 EILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI-RVVKTCIP--QTLEVL 436
Query: 488 IVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIP 547
VSNNNL P L L +S N ++P + + L+ + + NQL
Sbjct: 437 DVSNNNL-DSFSLFL---PRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPD 490
Query: 548 KAISMMPTLAILDLSNNSL 566
+ +L + L N
Sbjct: 491 GIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 3e-51
Identities = 94/539 (17%), Positives = 176/539 (32%), Gaps = 71/539 (13%)
Query: 79 LDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSF 138
D + + S ++ SL+L N + L +
Sbjct: 10 CDGRSRSFTSIPSGLTA---AMKSLDLSFNKITYIGHGDLRACAN--------------- 51
Query: 139 PAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKF 198
L L + + + + SLE LDL + F L LK+
Sbjct: 52 ---------LQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKY 102
Query: 199 LGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKI 258
L L GN + F NLTNL+ L + +I
Sbjct: 103 LNLMGNPYQ-----------------------TLGVTSLFPNLTNLQTLRIGNVETFSEI 139
Query: 259 PAE-LGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQ 317
L L + + + + + +I + L L + + + L +++
Sbjct: 140 RRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVR 199
Query: 318 LLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGE 377
L L L+ + L ++ S + L L +
Sbjct: 200 YLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV--- 256
Query: 378 IPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQ 437
+ + + ++ R+ + L + + LEK++
Sbjct: 257 ---EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVK 313
Query: 438 RLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPST---ILSIPNLQTFIVSNNNL 494
R+ + N+ + SL F+D+S N + + P+LQT ++S N+L
Sbjct: 314 RITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373
Query: 495 --VGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISM 552
+ + + +L+ LD+S N F +P S EK+ LNL + + + I
Sbjct: 374 RSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI-- 429
Query: 553 MPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGN 611
TL +LD+SNN+L P L+ L +S N+L+ +P + + ++ N
Sbjct: 430 PQTLEVLDVSNNNLD-SFSLFL---PRLQELYISRNKLKT-LPDASLFPVLLVMKISRN 483
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 7e-44
Identities = 91/446 (20%), Positives = 158/446 (35%), Gaps = 39/446 (8%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFS-SLPNSLANLTSLKRFDVSQNFLN 135
E LDLS +LS S F L SL LNL N + + + NLT+L+ +
Sbjct: 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136
Query: 136 GSFPAG-LGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQ 194
G L L + + + L + + L L S + + L
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILS 196
Query: 195 KLKFLGLSGNNLTG---KIPRELGQLSSMETMILAYNEFDG-------EIPVEFGNLTNL 244
+++L L NL S M+ + + ++ L+ +
Sbjct: 197 SVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV 256
Query: 245 KYLDLAVGNLGG------KIPAELGRLEL--LEIMFLYQNNFQGRLPAEIGNITSLQLLD 296
++ D + LG + +ELG++E + + + Q L + ++ +
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316
Query: 297 LSYNMLSHEIPAEITQLKNLQLLNLMCNQLS---GHVPAGLGGLTQLEVLELWNNSLS-- 351
+ + + + LK+L+ L+L N + A G L+ L L N L
Sbjct: 317 VENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSM 376
Query: 352 GPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTC-- 409
L L LD+S N+F +P S + L L + + TC
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-----VVKTCIP 430
Query: 410 HSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNH 469
+L + + NN L + + L +LQ L ++ N L D + L + ISRN
Sbjct: 431 QTLEVLDVSNNNLD-SFSLF---LPRLQELYISRNKLK--TLPDASLFPVLLVMKISRNQ 484
Query: 470 LRSSLPSTILSIPNLQTFIVSNNNLV 495
L+S + +LQ + N
Sbjct: 485 LKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-13
Identities = 32/157 (20%), Positives = 56/157 (35%), Gaps = 13/157 (8%)
Query: 459 SLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYF 518
+ D +S+PS + +++ +S N + + C +L VL L S+
Sbjct: 6 ASGVCDGRSRSF-TSIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 519 SGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTG-GIPENFGAS 577
+ + S L +L+L +N L+ + +L L+L N G+ F
Sbjct: 63 NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 578 PALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGL 614
L+ L + I R D AG L
Sbjct: 123 TNLQTLRIGNVET---------FSEIRRIDFAGLTSL 150
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-53
Identities = 97/510 (19%), Positives = 167/510 (32%), Gaps = 83/510 (16%)
Query: 97 LKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGN 156
L + L + +P N+ S + + + + P G G +
Sbjct: 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 157 NFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQ 216
L+L S+P +L+ L S N+LT ++P
Sbjct: 69 LD-----------RQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQS 112
Query: 217 LSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQN 276
L S+ P L+YL ++ N K+P EL L+I+ + N
Sbjct: 113 LKSLLVDNNNLKALSDLPP-------LLEYLGVS-NNQLEKLP-ELQNSSFLKIIDVDNN 163
Query: 277 NFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGG 336
+ + +LP + L+ + N L E+P E+ L L + N L +P
Sbjct: 164 SLK-KLPDLPPS---LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPL- 215
Query: 337 LTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNN 396
LE + NN L +L L + +N +P +L L + +N
Sbjct: 216 --SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLP---PSLEALNVRDN 267
Query: 397 AFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIAS 456
+ +P + L + LS P L L ++N I
Sbjct: 268 YLTD-LPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNE----IRSLCDL 315
Query: 457 STSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSN 516
SL +++S N L LP+ P L+ I S N+L E+P+ Q +L L + N
Sbjct: 316 PPSLEELNVSNNKL-IELPA---LPPRLERLIASFNHLA-EVPELPQ---NLKQLHVEYN 367
Query: 517 YFSGSIPSSIASCE----------------KLVNLNLRNNQLTGDIPKAISMMPTLAILD 560
P S E L L++ N L + P ++ L
Sbjct: 368 PLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPE---SVEDLR 422
Query: 561 LSNNSLTGGIPENFGASPALEVLNVSYNRL 590
+++ + + LE ++
Sbjct: 423 MNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-50
Identities = 109/487 (22%), Positives = 171/487 (35%), Gaps = 71/487 (14%)
Query: 57 KLPSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPN 116
+ +A W NG E+ +++ L C + L L GL SSLP
Sbjct: 38 EYYNAWSEWERNAPPGNG--EQREMAVSRLRDC------LDRQAHELELNNLGL-SSLPE 88
Query: 117 SLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLD 176
+L SL S N L P L N + S LE L
Sbjct: 89 LPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLP-------PLLEYLG 137
Query: 177 LRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPV 236
+ + + +P +N LK + + N+L K+P L E + N+ + E+P
Sbjct: 138 VSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSL---EFIAAGNNQLE-ELP- 189
Query: 237 EFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLD 296
E NL L + N K+P LE + NN LP E+ N+ L +
Sbjct: 190 ELQNLPFLTAIYAD-NNSLKKLPDLPLSLESIVA----GNNILEELP-ELQNLPFLTTIY 243
Query: 297 LSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPV 356
N+L +P L+ L + + N L+ +P LT L+V E + LS P
Sbjct: 244 ADNNLLK-TLPDLPPSLEALNVRD---NYLT-DLPELPQSLTFLDVSENIFSGLSELPPN 298
Query: 357 DLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVR 416
L +L+ SSN + +L +L + NN +P L
Sbjct: 299 -------LYYLNASSNEIR-SLCDLP---PSLEELNVSNNKLIE-LPALPPRLERL---I 343
Query: 417 MQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPS 476
N L+ +P L++L + N L D S L N + +P
Sbjct: 344 ASFNHLA-EVPELPQ---NLKQLHVEYNPLRE-FPDIPESVEDLRM-----NSHLAEVPE 393
Query: 477 TILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLN 536
NL+ V N L E PD + S+ L ++S + + +KL +
Sbjct: 394 ---LPQNLKQLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDV 446
Query: 537 LRNNQLT 543
++
Sbjct: 447 FEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 9e-47
Identities = 101/431 (23%), Positives = 157/431 (36%), Gaps = 62/431 (14%)
Query: 161 FLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSM 220
F+ + T L+ S +PV +N++ + + P G+ M
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 221 ETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQG 280
L L+L L +P LE L N+
Sbjct: 61 AVSRLRDC-----------LDRQAHELELNNLGL-SSLPELPPHLESLV---ASCNSLT- 104
Query: 281 RLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQL 340
LP ++ SL + + + LS P L+ L + NQL +P L + L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSFL 155
Query: 341 EVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSG 400
+++++ NNSL LP L+++ +N E+P L N LT + NN+
Sbjct: 156 KIIDVDNNSLKK-LPDLPPS---LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKK 209
Query: 401 PIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSL 460
+P SL + NN L L L + NN L + D SL
Sbjct: 210 -LPDLPL---SLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLP---PSL 259
Query: 461 SFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSG 520
+++ N+L + LP +L VS N + + P+L L+ SSN
Sbjct: 260 EALNVRDNYL-TDLPE---LPQSLTFLDVSENIF-SGLSELP---PNLYYLNASSNEIR- 310
Query: 521 SIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPAL 580
S+ S L LN+ NN+L ++P P L L S N L +PE L
Sbjct: 311 SLCDLPPS---LEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPELPQ---NL 359
Query: 581 EVLNVSYNRLE 591
+ L+V YN L
Sbjct: 360 KQLHVEYNPLR 370
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 6e-53
Identities = 73/397 (18%), Positives = 147/397 (37%), Gaps = 51/397 (12%)
Query: 147 GLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNL 206
G L + + + L+ + + + L+ + L ++G +
Sbjct: 1 GAATLATLPAPINQ--IFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56
Query: 207 TGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLE 266
I LTNL+YL+L + P L L
Sbjct: 57 A-SIQ-------------------------GIEYLTNLEYLNLNGNQITDISP--LSNLV 88
Query: 267 LLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQL 326
L +++ N + + N+T+L+ L L+ + +S P + L + LNL N
Sbjct: 89 KLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHN 144
Query: 327 SGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGG 386
+ L +T L L + + + P + + L L L+ N P L +
Sbjct: 145 LSD-LSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLT 199
Query: 387 NLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSL 446
+L + N + P ++ L +++ NN+++ P L +L LE+ N +
Sbjct: 200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI 255
Query: 447 TGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCP 506
+ + + T L +++ N + S + ++ L + ++NN L E +
Sbjct: 256 SD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311
Query: 507 SLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLT 543
+L+ L LS N+ + P +AS K+ + + N +
Sbjct: 312 NLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-51
Identities = 83/375 (22%), Positives = 148/375 (39%), Gaps = 30/375 (8%)
Query: 97 LKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGN 156
+L +L N +F A+L R + + + +T L +G
Sbjct: 2 AATLATLPAPINQIFP-----DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGE 54
Query: 157 NFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQ 216
+ ++ + T+LE L+L G+ P NL KL L + N +T L
Sbjct: 55 KVAS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQN 108
Query: 217 LSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQN 276
L+++ + L + P NLT + L+L N + L + L + + ++
Sbjct: 109 LTNLRELYLNEDNISDISP--LANLTKMYSLNLG-ANHNLSDLSPLSNMTGLNYLTVTES 165
Query: 277 NFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGG 336
+ I N+T L L L+YN + P + L +L NQ++ P +
Sbjct: 166 KVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VAN 219
Query: 337 LTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNN 396
+T+L L++ NN ++ P L S L WL++ +N S ++ + L L + +N
Sbjct: 220 MTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSN 275
Query: 397 AFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIAS 456
S L+ L + + NNQL G L L L L+ N +T +AS
Sbjct: 276 QISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLAS 331
Query: 457 STSLSFIDISRNHLR 471
+ + D + ++
Sbjct: 332 LSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 5e-51
Identities = 68/352 (19%), Positives = 136/352 (38%), Gaps = 25/352 (7%)
Query: 240 NLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSY 299
+L L ++ + LE + + + I +T+L+ L+L+
Sbjct: 20 DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNG 75
Query: 300 NMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLG 359
N ++ P ++ L L L + N+++ + L LT L L L +++S P+
Sbjct: 76 NQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISPLANL 131
Query: 360 KNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQN 419
+ L+L +N ++ L N L L + + P ++ L + +
Sbjct: 132 TK--MYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNY 186
Query: 420 NQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTIL 479
NQ+ P L L N +T +A+ T L+ + I N + P +
Sbjct: 187 NQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP--LA 240
Query: 480 SIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRN 539
++ L + N + + +D L +L++ SN S S + + +L +L L N
Sbjct: 241 NLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNN 296
Query: 540 NQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
NQL + + I + L L LS N +T + ++ + + ++
Sbjct: 297 NQLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 9e-47
Identities = 75/352 (21%), Positives = 133/352 (37%), Gaps = 28/352 (7%)
Query: 241 LTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYN 300
L L + + L L + + + + S+ L ++
Sbjct: 2 AATLATLPAPINQI-----FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE 54
Query: 301 MLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGK 360
++ I I L NL+ LNL NQ++ P L L +L L + N ++ L
Sbjct: 55 KVAS-IQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQN 108
Query: 361 NSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNN 420
+ L+ L L+ ++ S P L N + L L N + LS L + + +
Sbjct: 109 LTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTES 165
Query: 421 QLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILS 480
++ P L L L L N + +AS TSL + N + P + +
Sbjct: 166 KVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VAN 219
Query: 481 IPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNN 540
+ L + + NN + P + L+ L++ +N S +++ KL LN+ +N
Sbjct: 220 MTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSN 275
Query: 541 QLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEG 592
Q++ ++ + L L L+NN L E G L L +S N +
Sbjct: 276 QISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-42
Identities = 72/321 (22%), Positives = 135/321 (42%), Gaps = 23/321 (7%)
Query: 76 VEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLN 135
+ KL ++ ++ + L +L LNL N + + + L+NL L + N +
Sbjct: 46 ITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQI-TDISP-LSNLVKLTNLYIGTNKI- 100
Query: 136 GSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQK 195
+ + L L L + +N S + L N T + +L+L + + N+
Sbjct: 101 -TDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS-PLSNMTG 156
Query: 196 LKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLG 255
L +L ++ + + P + L+ + ++ L YN+ + P +LT+L Y V +
Sbjct: 157 LNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQIT 212
Query: 256 GKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKN 315
P + + L + + N + + N++ L L++ N +S +I A + L
Sbjct: 213 DITP--VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQIS-DINA-VKDLTK 266
Query: 316 LQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFS 375
L++LN+ NQ+S + L L+QL L L NN L +G + L L LS N +
Sbjct: 267 LKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
Query: 376 GEIPASLCNGGNLTKLILFNN 396
P L + + N
Sbjct: 325 DIRP--LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 134 bits (341), Expect = 1e-34
Identities = 52/302 (17%), Positives = 115/302 (38%), Gaps = 23/302 (7%)
Query: 292 LQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLS 351
L ++ P L L ++ V L + L + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 352 GPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHS 411
++ N L++L+L+ N + P L N LT L + N + L +
Sbjct: 58 SIQGIEYLTN--LEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQNLTN 111
Query: 412 LVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLR 471
L + + + +S P L K+ L L N ++ +++ T L+++ ++ + ++
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVK 168
Query: 472 SSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEK 531
+ I ++ +L + ++ N + P SL N + P +A+ +
Sbjct: 169 DV--TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222
Query: 532 LVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
L +L + NN++T ++ + L L++ N ++ L++LNV N++
Sbjct: 223 LNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278
Query: 592 GP 593
Sbjct: 279 DI 280
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 1e-15
Identities = 25/176 (14%), Positives = 60/176 (34%), Gaps = 12/176 (6%)
Query: 436 LQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLV 495
L + D A + + + T + ++ +V+ +
Sbjct: 2 AATLATLPAPINQIFPD--ADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV- 56
Query: 496 GEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPT 555
I + +L L+L+ N + P +++ KL NL + N++T A+ +
Sbjct: 57 ASIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 556 LAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGN 611
L L L+ ++++ + LN+ N + + +N + +
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTES 165
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 1e-15
Identities = 34/153 (22%), Positives = 54/153 (35%), Gaps = 10/153 (6%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
++ + L SL + N + + L LANL+ L ++ N ++
Sbjct: 202 HYFTAYVNQITD--ITPVANMTRLNSLKIGNNKI-TDLSP-LANLSQLTWLEIGTNQISD 257
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKL 196
+ L LN N S + L N + L +L L + L L
Sbjct: 258 --INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313
Query: 197 KFLGLSGNNLTGKIPRELGQLSSMETMILAYNE 229
L LS N++T P L LS M++ A
Sbjct: 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 2e-13
Identities = 27/131 (20%), Positives = 51/131 (38%), Gaps = 8/131 (6%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
L + + ++ L LT L + N + S + ++ +LT LK +V N ++
Sbjct: 224 NSLKIGNNKITD--LSPLANLSQLTWLEIGTNQI-SDIN-AVKDLTKLKMLNVGSNQISD 279
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKL 196
+ L + L L + N +E +G T+L TL L + P +L K+
Sbjct: 280 --ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKM 335
Query: 197 KFLGLSGNNLT 207
+ +
Sbjct: 336 DSADFANQVIK 346
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-52
Identities = 80/319 (25%), Positives = 119/319 (37%), Gaps = 61/319 (19%)
Query: 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKL-WRSRADLETESSGDFVGEVNVLG 761
I I IG G G V++ + VAVK R E+ E+
Sbjct: 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREA------EIYQTV 91
Query: 762 KLRHRNIVRLLG----FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIAL 817
LRH NI+ + T + +V +Y +GSL + L+ R V +AL
Sbjct: 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLAL 146
Query: 818 GVAQGLAYLHHD-----CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM 872
A GLA+LH + P I HRD+KS NIL+ N IAD GLA +T+ +
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 206
Query: 873 V----AGSYGYIAPE------YGYTLKVDEKIDIYSFGVVLLELLTGRR----------- 911
G+ Y+APE + ++ DIY+ G+V E+
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
Query: 912 -----PLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCT 966
P DP E +V K+R PN+ N E + ++ +I C
Sbjct: 267 YYDLVPSDPSVEEMRKVV--CEQKLR----------PNIPNRWQSCEALRVMAKIMRECW 314
Query: 967 AKLPKDRPSMRDVITMLGE 985
R + + L +
Sbjct: 315 YANGAARLTALRIKKTLSQ 333
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-52
Identities = 60/317 (18%), Positives = 113/317 (35%), Gaps = 23/317 (7%)
Query: 92 DHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFL 151
H +L + + L+ D ++ +
Sbjct: 6 HHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIE 61
Query: 152 NASGNNFSGFLLEDLGNATS--LETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGK 209
+G + L +AT L+LR P L L+ + + L +
Sbjct: 62 TRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 210 IPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLEL-- 267
+P + Q + +ET+ LA N +P +L L+ L + ++P L +
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 268 -------LEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLN 320
L+ + L + LPA I N+ +L+ L + + L + I L L+ L+
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKLEELD 235
Query: 321 LM-CNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIP 379
L C L + P GG L+ L L + S LP+D+ + + L+ LDL +P
Sbjct: 236 LRGCTALR-NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 380 ASLCNGGNLTKLILFNN 396
+ + +++ +
Sbjct: 295 SLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-48
Identities = 57/372 (15%), Positives = 108/372 (29%), Gaps = 51/372 (13%)
Query: 211 PRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEI 270
S E + + D + +I
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQI 60
Query: 271 MFLYQNNFQGRLPAEIGNITSLQL--LDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSG 328
+ + + T L+L L + P + +L +LQ + + L
Sbjct: 61 ETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM- 117
Query: 329 HVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNL 388
+P + LE L L N L LP + + L+ L + + E+P L +
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLAST--- 173
Query: 389 TKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTG 448
+L +R++ + ++P L+ L+ L++ N+ L+
Sbjct: 174 ------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS- 219
Query: 449 GITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSL 508
+L I +P L+ + + P F L
Sbjct: 220 ------------------------ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255
Query: 509 SVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTG 568
L L ++P I +L L+LR +P I+ +P I+ + +
Sbjct: 256 KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315
Query: 569 GIPENFGASPAL 580
A PA
Sbjct: 316 LDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-47
Identities = 55/324 (16%), Positives = 110/324 (33%), Gaps = 21/324 (6%)
Query: 111 FSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNAT 170
S + + + + + + L + + + N+
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWH----SAWRQANSN 56
Query: 171 SLETLDLRGSFFQGSIPVSFKNLQ--KLKFLGLSGNNLTGKIPRELGQLSSMETMILAYN 228
+ + G + + ++ L L L + P + +LS ++ M +
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114
Query: 229 EFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGN 288
E+P L+ L LA L +PA + L L + + LP + +
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLAS 172
Query: 289 I---------TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQ 339
+LQ L L + + +PA I L+NL+ L + + LS + + L +
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPK 230
Query: 340 LEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFS 399
LE L+L + P G +PL+ L L S +P + L KL L
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290
Query: 400 GPIPVSLSTCHSLVRVRMQNNQLS 423
+P ++ + + + + +
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-43
Identities = 47/287 (16%), Positives = 96/287 (33%), Gaps = 18/287 (6%)
Query: 81 LSHMNLSGCVS-DHFQRLKSLTSLNLCCNGLFSSLPNSLANLTS--LKRFDVSQNFLNGS 137
+ + + S + L + + L + T ++ L
Sbjct: 38 HYNADRNRWHSAWRQANSNNPQIETRTGRAL-KATADLLEDATQPGRVALELRSVPLP-Q 95
Query: 138 FPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLK 197
FP + L + L + + LETL L + + ++P S +L +L+
Sbjct: 96 FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR 153
Query: 198 FLGLSGNNLTGKIPRELGQ---------LSSMETMILAYNEFDGEIPVEFGNLTNLKYLD 248
L + ++P L L +++++ L + +P NL NLK L
Sbjct: 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLK 212
Query: 249 LAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPA 308
+ + + + L LE + L P G L+ L L +P
Sbjct: 213 IR-NSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPL 271
Query: 309 EITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLP 355
+I +L L+ L+L +P+ + L ++ + + +
Sbjct: 272 DIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 58/358 (16%), Positives = 106/358 (29%), Gaps = 53/358 (14%)
Query: 237 EFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLD 296
+ + + L L + + + + N + Q+
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYN----ADRNRWHSAWRQANSNNPQIET 62
Query: 297 LSYNMLSHEIPAEITQLK--NLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPL 354
+ L + L L L P L+ L+ + + L L
Sbjct: 63 RTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-L 119
Query: 355 PVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVR 414
P + + + L+ L L+ N +PAS+ + L +L + +P L++
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST----- 173
Query: 415 VRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSL 474
L LQ L L + SL
Sbjct: 174 ----------DASGEHQGLVNLQSLRLEWTGIR-------------------------SL 198
Query: 475 PSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVN 534
P++I ++ NL++ + N+ L + P L LDL + P L
Sbjct: 199 PASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257
Query: 535 LNLRN-NQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
L L++ + L +P I + L LDL +P PA ++ V +
Sbjct: 258 LILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-42
Identities = 54/246 (21%), Positives = 96/246 (39%), Gaps = 14/246 (5%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
L+L + L D RL L + + GL LP+++ L+ +++N L
Sbjct: 84 VALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNPLR- 140
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNA---------TSLETLDLRGSFFQGSIP 187
+ PA + L L+ L E L + +L++L L + + S+P
Sbjct: 141 ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLP 199
Query: 188 VSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYL 247
S NLQ LK L + + L+ + + L +E + L P FG LK L
Sbjct: 200 ASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258
Query: 248 DLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIP 307
L + +P ++ RL LE + L RLP+ I + + ++ + ++ +
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
Query: 308 AEITQL 313
Sbjct: 319 HRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 8e-05
Identities = 11/119 (9%), Positives = 25/119 (21%), Gaps = 24/119 (20%)
Query: 495 VGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLN------------------ 536
+G L + ++ ++ N +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60
Query: 537 --LRNNQLTGDIPKAISM--MPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
L + P L+L + L P+ L+ + + L
Sbjct: 61 ETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-49
Identities = 70/447 (15%), Positives = 144/447 (32%), Gaps = 41/447 (9%)
Query: 164 EDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETM 223
E N + + S + ++ ++ +K L LSGN L+ +L + +E +
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 224 ILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLP 283
L+ N E + +L+ L+ LDL + EL +E + NN R+
Sbjct: 64 NLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS 115
Query: 284 AEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSG-HVPAGLGGLTQLEV 342
G + + L+ N ++ + +Q L+L N++ + LE
Sbjct: 116 CSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173
Query: 343 LELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPI 402
L L N + + + L+ LDLSSN + + + +T + L NN I
Sbjct: 174 LNLQYNFIYD-VKGQVVFAK-LKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-I 229
Query: 403 PVSLSTCHSLVRVRMQNNQLS-GTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLS 461
+L +L ++ N GT+ F + +++Q +A ++ + T +
Sbjct: 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ--TVAKQTVKKLTGQNEEECTVPT 287
Query: 462 FIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGS 521
+ L+ ++L +
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKR-------------------KEHALLSGQGSETE-R 327
Query: 522 IPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALE 581
+ + + ++ Q I + L+ +L + A L+
Sbjct: 328 LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELD 387
Query: 582 VLN---VSYNRLEGPVPANGVLRTINR 605
V L+ L+ +
Sbjct: 388 GTLQQAVGQIELQHATEEQSPLQLLRA 414
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 4e-47
Identities = 78/502 (15%), Positives = 158/502 (31%), Gaps = 46/502 (9%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
+ ++ +L ++ Q ++ L+L N L LA T L+ ++S N L
Sbjct: 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE 72
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKL 196
+ L + L L+ + N +++L S+ETL + VS Q
Sbjct: 73 TLD--LESLSTLRTLDLNNNY-----VQELLVGPSIETLHAANNNISR---VSCSRGQGK 122
Query: 197 KFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDG-EIPVEFGNLTNLKYLDLAVGNLG 255
K + L+ N +T + G S ++ + L NE D + L++L+L
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL------ 176
Query: 256 GKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKN 315
Q NF + ++ L+ LDLS N L+ + E
Sbjct: 177 -------------------QYNFIYDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAG 215
Query: 316 LQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLS-GPLPVDLGKNSPLQWLDLSSNSF 374
+ ++L N+L + L LE +L N G L KN +Q + +
Sbjct: 216 VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK 274
Query: 375 SGEIPASLCNGGNLTKL-ILFNNAFSGPIPVSLS--TCHSLVRVRMQNNQLSGTIPVGFG 431
C L P L + Q ++ +
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER-LECERE 333
Query: 432 RLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSN 491
+ + ++ I + ++ + L + + + L +
Sbjct: 334 NQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQA 393
Query: 492 NNLVGEIPDQFQDCPSLSVLDLSSNYFS-GSIPSSIASCEKLVNLNLRNNQLTGDIPKAI 550
+ E+ ++ L +L + + + + ++ ++ T +
Sbjct: 394 VGQI-ELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENA 452
Query: 551 SMMPTLAILDLSNNSLTGGIPE 572
+ DL+ S + E
Sbjct: 453 RLKKLNGEADLALASANATLQE 474
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-46
Identities = 79/490 (16%), Positives = 149/490 (30%), Gaps = 24/490 (4%)
Query: 113 SLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSL 172
++ N K V+ + L + + A + L+ SGN S DL T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 173 ETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDG 232
E L+L + ++L L+ L L+ N + EL S+ET+ A N
Sbjct: 61 ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 233 EIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQG-RLPAEIGNITS 291
V K + LA + + G ++ + L N + +
Sbjct: 114 ---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 292 LQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLS 351
L+ L+L YN + ++ ++ L+ L+L N+L+ + + + L NN L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 352 GPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHS 411
+ L + L+ DL N F N + + C
Sbjct: 228 L-IEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 412 LVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTG----GITDDIASSTSLSFIDISR 467
RL L+R E A S G + + + ID +
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345
Query: 468 NHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLS--VLDLSSNYFSGSIPSS 525
R+ + L T L ++ + + L +
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405
Query: 526 IASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNV 585
+ + L + R ++ + + + D+ + T EN ++
Sbjct: 406 QSPLQLLRAIVKRYEEMYVEQQSVQNN--AIRDWDMYQHKETQLAEENARLKKLNGEADL 463
Query: 586 SYNRLEGPVP 595
+ +
Sbjct: 464 ALASANATLQ 473
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-45
Identities = 65/305 (21%), Positives = 119/305 (39%), Gaps = 16/305 (5%)
Query: 282 LPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLE 341
+ N ++ ++ + L + + N++ L+L N LS A L T+LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 342 VLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGP 401
+L L +N L L L S L+ LDL++N L G ++ L NN S
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR- 113
Query: 402 IPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTG-GITDDIASSTSL 460
VS S + + NN+++ + G ++Q L+L N + + ASS +L
Sbjct: 114 --VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 461 SFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSG 520
+++ N + + + L+T +S+N L + +FQ ++ + L +N
Sbjct: 172 EHLNLQYNFI-YDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 521 SIPSSIASCEKLVNLNLRNNQLTGD-IPKAISMMPTLAILDLSNNSLTGGIPENFGASPA 579
I ++ + L + +LR N + S + + G E P
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 580 LEVLN 584
L
Sbjct: 288 LGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-41
Identities = 61/358 (17%), Positives = 123/358 (34%), Gaps = 47/358 (13%)
Query: 164 EDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETM 223
E N + + S + ++ ++ +K L LSGN L+ +L + +E +
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 224 ILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLP 283
L+ N E + +L+ L+ LDL + EL +E + NN R+
Sbjct: 64 NLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS 115
Query: 284 AEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSG-HVPAGLGGLTQLEV 342
G + + L+ N ++ + +Q L+L N++ + LE
Sbjct: 116 CSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173
Query: 343 LELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPI 402
L L N + + + L+ LDLSSN + + + +T + L
Sbjct: 174 LNLQYNFIYD-VKGQVVFAK-LKTLDLSSNKLA-FMGPEFQSAAGVTWISL--------- 221
Query: 403 PVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDD-IASSTSLS 461
+NN+L I + L+ +L N G D + + +
Sbjct: 222 ---------------RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265
Query: 462 FIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFS 519
+ + ++P L + ++P F + ++ L ++
Sbjct: 266 TVAKQTVKKLTGQNEEECTVPTLGHY---GAYCCEDLPAPF----ADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-40
Identities = 64/304 (21%), Positives = 112/304 (36%), Gaps = 18/304 (5%)
Query: 91 SDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTF 150
+ Q + + L +L + + ++K D+S N L+ A L L
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 151 LNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKI 210
LN S N DL + ++L TLDL ++ Q ++ L + NN++ ++
Sbjct: 63 LNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RV 114
Query: 211 PRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIP--AELGRLELL 268
GQ + + LA N+ ++ G + ++YLDL N + + L
Sbjct: 115 SCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLK-LNEIDTVNFAELAASSDTL 171
Query: 269 EIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSG 328
E + L N + ++ L+ LDLS N L+ + E + ++L N+L
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 329 HVPAGLGGLTQLEVLELWNNSLS-GPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGN 387
+ L LE +L N G L KN +Q + + C
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 388 LTKL 391
L
Sbjct: 288 LGHY 291
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 63/327 (19%), Positives = 117/327 (35%), Gaps = 27/327 (8%)
Query: 148 LTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLT 207
+ ++ L +A +++ LDL G+ KL+ L LS N L
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 208 GKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLEL 267
+ +L LS++ T+ L N E +++ L A N ++ G+
Sbjct: 72 -ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAA-NNNISRVSCSRGQ--G 121
Query: 268 LEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSH-EIPAEITQLKNLQLLNLMCNQL 326
+ ++L N + G + +Q LDL N + L+ LNL N +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 327 SGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGG 386
V + +L+ L+L +N L+ + + + + W+ L +N I +L
Sbjct: 182 Y-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 387 NLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSL 446
NL L N F C +L +N ++ +L E +L
Sbjct: 238 NLEHFDLRGNGFH---------CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288
Query: 447 T--GGIT-DDIASSTSLSFIDISRNHL 470
G +D+ + + I + +H
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-33
Identities = 49/249 (19%), Positives = 98/249 (39%), Gaps = 14/249 (5%)
Query: 364 LQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLS 423
+ ++ +S + + + N+ +L L N S L+ L + + +N L
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 424 GTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPN 483
T+ L L+ L+L NN + ++ S+ + + N++ S + +
Sbjct: 72 ETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSRG--QG 121
Query: 484 LQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSG-SIPSSIASCEKLVNLNLRNNQL 542
+ ++NN + + LDL N + AS + L +LNL+ N +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 543 TGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRT 602
D+ + L LDLS+N L + F ++ + +++ N+L A +
Sbjct: 182 Y-DVKGQVVF-AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQN 238
Query: 603 INRGDLAGN 611
+ DL GN
Sbjct: 239 LEHFDLRGN 247
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 30/162 (18%), Positives = 67/162 (41%), Gaps = 10/162 (6%)
Query: 430 FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIV 489
+ + ++ ++SL + S+ ++ +D+S N L + + L+ +
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 490 SNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKA 549
S+N L E D + +L LDL++NY + + L+ NN ++ +
Sbjct: 66 SSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS-- 115
Query: 550 ISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
S + L+NN +T + G ++ L++ N ++
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 36/230 (15%), Positives = 78/230 (33%), Gaps = 16/230 (6%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
E L ++ N+S Q ++ L N + + ++ D+ N ++
Sbjct: 102 ETLHAANNNISRVSCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT 158
Query: 137 -SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQK 195
+F + L LN N ++ L+TLDL + + F++
Sbjct: 159 VNFAELAASSDTLEHLNLQYNFIYD--VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAG 215
Query: 196 LKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFD-GEIPVEFGNLTNLKYLDLAVGNL 254
+ ++ L N L I + L ++E L N F G + F ++ +
Sbjct: 216 VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK----- 269
Query: 255 GGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSH 304
+ +L E ++ ++ + +L+ L ++ H
Sbjct: 270 --QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 28/119 (23%), Positives = 52/119 (43%), Gaps = 7/119 (5%)
Query: 473 SLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKL 532
++ + + V++++L + Q ++ LDLS N S + +A KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 533 VNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
LNL +N L + + + TL LDL+NN + P++E L+ + N +
Sbjct: 61 ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-44
Identities = 70/358 (19%), Positives = 140/358 (39%), Gaps = 25/358 (6%)
Query: 258 IPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEI-TQLKNL 316
I + L + + + E + + +++ + + +PA + + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQV 71
Query: 317 QLLNLMCNQLSGHVPAG-LGGLTQLEVLELWNNSLSGPLPVDLGKNSP-LQWLDLSSNSF 374
+LLNL Q+ + ++ L + N++ LP + +N P L L L N
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDL 129
Query: 375 SGEIPASLCNG-GNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRL 433
S +P + + LT L + NN + SL +++ +N+L+ + +
Sbjct: 130 S-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLI 185
Query: 434 EKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNN 493
L ++ N L+ +A ++ +D S N + + + + L + +NN
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGPVNV--ELTILKLQHNN 237
Query: 494 LVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMM 553
L + + P L +DLS N + ++L L + NN+L + +
Sbjct: 238 LT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 294
Query: 554 PTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGN 611
PTL +LDLS+N L + N LE L + +N + + T+ L+ N
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL-STHHTLKNLTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-40
Identities = 82/382 (21%), Positives = 138/382 (36%), Gaps = 54/382 (14%)
Query: 170 TSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRE-LGQLSSMETMILAYN 228
+ + L K + + + K+P L +E + L
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 79
Query: 229 EFDGEIPVE-FGNLTNLKYLDLAVGNLGGKIPAELGR-LELLEIMFLYQNNFQGRLPAEI 286
+ + EI F ++ L + N +P + + + LL ++ L +N+ LP I
Sbjct: 80 QIE-EIDTYAFAYAHTIQKLYMG-FNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGI 136
Query: 287 -GNITSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLE 344
N L L +S N L I + +LQ L L N+L+ HV L + L
Sbjct: 137 FHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHAN 192
Query: 345 LWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPV 404
+ N LS L ++ LD S NS + + + LT L L +N +
Sbjct: 193 VSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNV--ELTILKLQHNNLT-DTA- 242
Query: 405 SLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFI 463
L LV V + N+L I F ++++L+RL ++NN L
Sbjct: 243 WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV---------------- 285
Query: 464 DISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIP 523
+L IP L+ +S+N+L+ + L L L N ++
Sbjct: 286 ---------ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK 334
Query: 524 SSIASCEKLVNLNLRNNQLTGD 545
S + L NL L +N +
Sbjct: 335 LS--THHTLKNLTLSHNDWDCN 354
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-40
Identities = 78/412 (18%), Positives = 135/412 (32%), Gaps = 72/412 (17%)
Query: 111 FSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNAT 170
+ + ++L + + F + + L +
Sbjct: 10 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 69
Query: 171 SLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEF 230
+E L+L + +F ++ L + N + +P +
Sbjct: 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV---------------- 112
Query: 231 DGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEI-GNI 289
F N+ L L L + N LP I N
Sbjct: 113 -------FQNVPLLTVLVL-------------------------ERNDLSSLPRGIFHNT 140
Query: 290 TSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNN 348
L L +S N L I + +LQ L L N+L+ HV L + L + N
Sbjct: 141 PKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYN 196
Query: 349 SLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLST 408
LS L ++ LD S NS + + + LT L L +N + L
Sbjct: 197 LLS-----TLAIPIAVEELDASHNSIN-VVRGPVNV--ELTILKLQHNNLT-DTA-WLLN 246
Query: 409 CHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISR 467
LV V + N+L I F ++++L+RL ++NN L + +L +D+S
Sbjct: 247 YPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSH 304
Query: 468 NHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFS 519
NHL + L+ + +N++V + +L L LS N +
Sbjct: 305 NHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-36
Identities = 63/348 (18%), Positives = 123/348 (35%), Gaps = 24/348 (6%)
Query: 79 LDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSF 138
+ + L + + + + L + ++ +++ +
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 85
Query: 139 PAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVS-FKNLQKLK 197
A + L N N L L L + S+P F N KL
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLT 144
Query: 198 FLGLSGNNLTGKIPRELGQ-LSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGG 256
L +S NNL +I + Q +S++ + L+ N V+ + +L + +++ L
Sbjct: 145 TLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLL-- 198
Query: 257 KIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNL 316
+ L +E + N+ + + L +L L +N L+ + + L
Sbjct: 199 ---STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGL 250
Query: 317 QLLNLMCNQLSGHVPAG-LGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFS 375
++L N+L + + +LE L + NN L L + L+ LDLS N
Sbjct: 251 VEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL 308
Query: 376 GEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLS 423
+ + L L L +N+ + LST H+L + + +N
Sbjct: 309 -HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 58/300 (19%), Positives = 95/300 (31%), Gaps = 44/300 (14%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
+KL + + FQ + LT L L N L S N L +S N L
Sbjct: 96 QKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER 155
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKL 196
L L S N + DL SL ++ + + +
Sbjct: 156 IEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS-----TLAIPIAV 207
Query: 197 KFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGG 256
+ L S N++ + + + L +N + N L +DL
Sbjct: 208 EELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDL------- 255
Query: 257 KIPAELGRLELLEIMFLYQNNFQGRLPAEI-GNITSLQLLDLSYNMLSHEIPAEITQLKN 315
N ++ + L+ L +S N L + +
Sbjct: 256 ------------------SYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 296
Query: 316 LQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFS 375
L++L+L N L HV +LE L L +NS+ + L + L+ L LS N +
Sbjct: 297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 39/176 (22%), Positives = 59/176 (33%), Gaps = 34/176 (19%)
Query: 75 AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFL 134
AVE+LD SH +++ LT L L N L + L N L D+S N L
Sbjct: 206 AVEELDASHNSIN---VVRGPVNVELTILKLQHNNL-TDTA-WLLNYPGLVEVDLSYNEL 260
Query: 135 NGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQ 194
LE L + + ++ + + +
Sbjct: 261 E-KIMYHP-----------------------FVKMQRLERLYISNNRLV-ALNLYGQPIP 295
Query: 195 KLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLA 250
LK L LS N+L + R Q +E + L +N + LK L L+
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLK--LSTHHTLKNLTLS 347
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 18/120 (15%), Positives = 39/120 (32%)
Query: 472 SSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEK 531
+ S + + + + ++ ++ + + S +
Sbjct: 11 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 532 LVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
+ LNL + Q+ A + T+ L + N++ P F P L VL + N L
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 70/279 (25%), Positives = 120/279 (43%), Gaps = 34/279 (12%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766
++ IG G+ VYK VA +L L F E +L L+H
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL--QDRKLTKSERQRFKEEAEMLKGLQHP 85
Query: 767 NIVRLLG----FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQG 822
NIVR + +++V E M +G+L L K+ + + + + + +G
Sbjct: 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSW--CRQILKG 141
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDSNL-EPRIADFGLARMMIRKNETVSMVAGSYGYIA 881
L +LH PPIIHRD+K +NI + +I D GLA + R + +++ G+ ++A
Sbjct: 142 LQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVI-GTPEFMA 198
Query: 882 PEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941
PE Y K DE +D+Y+FG+ +LE+ T P E + I + ++ + ++
Sbjct: 199 PEM-YEEKYDESVDVYAFGMCMLEMATSEYPY-SECQNAAQIYRRVTSGVK-PASFDKVA 255
Query: 942 DPNVGNCKHVQEEMLLVLRIAFL--CTAKLPKDRPSMRD 978
P V + C + +R S++D
Sbjct: 256 IPEVKE---------------IIEGCIRQNKDERYSIKD 279
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 162 bits (410), Expect = 7e-42
Identities = 71/351 (20%), Positives = 140/351 (39%), Gaps = 28/351 (7%)
Query: 265 LELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMC 323
+ I Q+ + G E + + +++ + + +PA + + ++LLNL
Sbjct: 29 FYDVHIDMQTQDVYFGF---EDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLND 84
Query: 324 NQLSGHVPAG-LGGLTQLEVLELWNNSLSGPLPVDLGKNSP-LQWLDLSSNSFSGEIPAS 381
Q+ + ++ L + N++ LP + +N P L L L N S +P
Sbjct: 85 LQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS-SLPRG 141
Query: 382 LCNG-GNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLE 440
+ + LT L + NN + SL +++ +N+L+ + + L
Sbjct: 142 IFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHAN 198
Query: 441 LANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPD 500
++ N L+ +A ++ +D S N + + + + L + +NNL +
Sbjct: 199 VSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGPVN--VELTILKLQHNNLT-DTA- 248
Query: 501 QFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILD 560
+ P L +DLS N + ++L L + NN+L + +PTL +LD
Sbjct: 249 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLD 307
Query: 561 LSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGN 611
LS+N L + N LE L + +N + + T+ L+ N
Sbjct: 308 LSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL-STHHTLKNLTLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-38
Identities = 78/412 (18%), Positives = 135/412 (32%), Gaps = 72/412 (17%)
Query: 111 FSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNAT 170
+ + ++L + + F + + L +
Sbjct: 16 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75
Query: 171 SLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEF 230
+E L+L + +F ++ L + N + +P +
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV---------------- 118
Query: 231 DGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEI-GNI 289
F N+ L L L + N LP I N
Sbjct: 119 -------FQNVPLLTVLVL-------------------------ERNDLSSLPRGIFHNT 146
Query: 290 TSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNN 348
L L +S N L I + +LQ L L N+L+ HV L + L + N
Sbjct: 147 PKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYN 202
Query: 349 SLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLST 408
LS L ++ LD S NS + + + LT L L +N + L
Sbjct: 203 LLS-----TLAIPIAVEELDASHNSIN-VVRGPVNV--ELTILKLQHNNLT-DTA-WLLN 252
Query: 409 CHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISR 467
LV V + N+L I F ++++L+RL ++NN L + +L +D+S
Sbjct: 253 YPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSH 310
Query: 468 NHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFS 519
NHL + L+ + +N++V + +L L LS N +
Sbjct: 311 NHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-36
Identities = 76/493 (15%), Positives = 163/493 (33%), Gaps = 38/493 (7%)
Query: 89 CVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAG-LGGAAG 147
C+ + Q +++ L + K + + PA L
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76
Query: 148 LTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVS-FKNLQKLKFLGLSGNNL 206
+ LN + A +++ L + + + +P F+N+ L L L N+L
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
Query: 207 TGKIPREL-GQLSSMETMILAYNEFDGEIPVE-FGNLTNLKYLDLAVGNLGGKIPAELGR 264
+ +PR + + T+ ++ N + I + F T+L+ L L+ N + L
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS-SNRLTHVD--LSL 190
Query: 265 LELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCN 324
+ L + N + +++ LD S+N ++ + + L +L L N
Sbjct: 191 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHN 242
Query: 325 QLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCN 384
L+ L L ++L N L + K L+ L +S+N +
Sbjct: 243 NLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 299
Query: 385 GGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANN 444
L L L +N + + L + + +N + T+ L+ L L++N
Sbjct: 300 IPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHN 355
Query: 445 SLTGG-ITDDIASSTSLSFIDISRN-----HLRSSLPSTILSIPNLQTFI--VSNNNLVG 496
+ + + D ++ L L P L + ++ ++V
Sbjct: 356 DWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVE 415
Query: 497 EIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDI----PKAISM 552
++ C + ++ + + L N+L ++ + I
Sbjct: 416 KVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQ 475
Query: 553 MPTLAILDLSNNS 565
L L ++
Sbjct: 476 EQLLQGLHAEIDT 488
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-34
Identities = 64/325 (19%), Positives = 118/325 (36%), Gaps = 22/325 (6%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
+ + + + + + + LNL + + A ++++ + N +
Sbjct: 54 KIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR- 112
Query: 137 SFPAG-LGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQK 195
P LT L N+ S N L TL + + + +F+
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS 172
Query: 196 LKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLG 255
L+ L LS N LT + L + S+ ++YN ++ LD + N
Sbjct: 173 LQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDAS-HNSI 223
Query: 256 GKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEI-TQLK 314
+ + L I+ L NN + N L +DLSYN L I +++
Sbjct: 224 NVVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEK-IMYHPFVKMQ 278
Query: 315 NLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSF 374
L+ L + N+L + + L+VL+L +N L + + + L+ L L NS
Sbjct: 279 RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSI 336
Query: 375 SGEIPASLCNGGNLTKLILFNNAFS 399
+ S + L L L +N +
Sbjct: 337 V-TLKLSTHH--TLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-29
Identities = 75/520 (14%), Positives = 148/520 (28%), Gaps = 49/520 (9%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
+KL + + FQ + LT L L N L S N L +S N L
Sbjct: 102 QKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER 161
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKL 196
L L S N + DL SL ++ + + +
Sbjct: 162 IEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS-----TLAIPIAV 213
Query: 197 KFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGG 256
+ L S N++ + + + + L +N + N L +DL+
Sbjct: 214 EELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLS------ 262
Query: 257 KIPAELGRLELLEIMFLYQNNFQGRLPAEI-GNITSLQLLDLSYNMLSHEIPAEITQLKN 315
N ++ + L+ L +S N L + +
Sbjct: 263 -------------------YNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 302
Query: 316 LQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFS 375
L++L+L N L HV +LE L L +NS+ + L + L+ L LS N +
Sbjct: 303 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWD 358
Query: 376 GEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEK 435
+L + + + C + L +
Sbjct: 359 CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQ 418
Query: 436 LQRLELANNSLTGGITDDIASSTSLSFIDISRN-HLRSSLPSTILSIPNLQTFIVSNNNL 494
+ + + T + + N L + + + L + L
Sbjct: 419 RAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQL 478
Query: 495 VGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLT-GDIPKAISMM 553
+ + + +L L + + S + L + T +A +
Sbjct: 479 LQGLHA--EIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQ 536
Query: 554 PTLAILDLSNNSLTGGIPENFGAS-PALEVLNVSYNRLEG 592
L+ N +L + + ++ +++
Sbjct: 537 KETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQ 576
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 56/300 (18%), Positives = 110/300 (36%), Gaps = 30/300 (10%)
Query: 313 LKNLQLLNLMCNQLS-GHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSS 371
+ Q N+ Q + + L + + + + + + + +
Sbjct: 1 VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60
Query: 372 NSFSGEIPASLCNG-GNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG- 429
++ ++PA+L + + L L + + + H++ ++ M N + +P
Sbjct: 61 STMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV 118
Query: 430 FGRLEKLQRLELANNSLTGGITDDI-ASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFI 488
F + L L L N L+ + I ++ L+ + +S N+L T + +LQ
Sbjct: 119 FQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 177
Query: 489 VSNNNLVGEIPD-----------------QFQDCPSLSVLDLSSNYFSGSIPSSIASCEK 531
+S+N L + ++ LD S N + + + +
Sbjct: 178 LSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVE 233
Query: 532 LVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
L L L++N LT D + P L +DLS N L + F LE L +S NRL
Sbjct: 234 LTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 8e-12
Identities = 46/250 (18%), Positives = 80/250 (32%), Gaps = 45/250 (18%)
Query: 75 AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFL 134
AVE+LD SH +++ LT L L N L + L N L D+S N L
Sbjct: 212 AVEELDASHNSIN---VVRGPVNVELTILKLQHNNL-TDTA-WLLNYPGLVEVDLSYNEL 266
Query: 135 NGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQ 194
LE L + + ++ + + +
Sbjct: 267 E-KIMYHP-----------------------FVKMQRLERLYISNNRLV-ALNLYGQPIP 301
Query: 195 KLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNL 254
LK L LS N+L + R Q +E + L +N + LK L L+ N
Sbjct: 302 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLK--LSTHHTLKNLTLS-HN- 355
Query: 255 GGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLK 314
+ + L++N + + + L+ + P L+
Sbjct: 356 ---------DWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQ 406
Query: 315 NLQLLNLMCN 324
+ L +++
Sbjct: 407 YIALTSVVEK 416
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-41
Identities = 84/467 (17%), Positives = 157/467 (33%), Gaps = 33/467 (7%)
Query: 76 VEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLN 135
L++S +S + L L L + N + + L+ D+S N L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 136 GSFPAGLGGAAGLTFLNASGNNFSGF-LLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQ 194
L L+ S N F + ++ GN + L+ L L + + S + +L
Sbjct: 83 KISCHPT---VNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139
Query: 195 KLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNL 254
K L + G K + L T L + +++ +L + N+
Sbjct: 140 ISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 255 GGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNIT-------------------SLQLL 295
+ L + L N L T S+ +
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNV 257
Query: 296 DLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLP 355
L + + T LK L + ++ + + + + +
Sbjct: 258 KLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHM 317
Query: 356 VDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCH--SLV 413
+ K SP LD S+N + + + + L LIL N ++ T SL
Sbjct: 318 LCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQ 377
Query: 414 RVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRS 472
++ + N +S G + L L +++N LT I + + +D+ N +
Sbjct: 378 QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI-K 434
Query: 473 SLPSTILSIPNLQTFIVSNNNLVGEIPDQ-FQDCPSLSVLDLSSNYF 518
S+P ++ + LQ V++N L +PD F SL + L +N +
Sbjct: 435 SIPKQVVKLEALQELNVASNQL-KSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-39
Identities = 101/481 (20%), Positives = 172/481 (35%), Gaps = 33/481 (6%)
Query: 98 KSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNN 157
+ T LN+ N + + + +L+ L+ +S N + + L +L+ S N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 158 FSGFLLEDLGNATSLETLDLRGSFFQGSIPVS--FKNLQKLKFLGLSGNNLTGKIPRELG 215
+L+ LDL + F ++P+ F N+ +LKFLGLS +L +
Sbjct: 81 LVKI---SCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 216 QLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQ 275
L+ + +++ + + + L + L + K + + + + L
Sbjct: 137 HLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194
Query: 276 NNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLG 335
+N + L + L L N +L NL L N+ S L
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNP----------KLSNLTLNNIETTWNSFIRILQLV 244
Query: 336 GLTQLEVLELWNNSLSGPLPVDLGKNSP-----LQWLDLSSNSFSGEIPASLCNGGNLTK 390
T + + N L G L S L + S+ F N+
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 391 LIL-FNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLT-- 447
+ + S + + NN L+ T+ G L +L+ L L N L
Sbjct: 305 KNFTVSGTRMVHMLCP-SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKEL 363
Query: 448 GGITDDIASSTSLSFIDISRNHLRSSLPSTILS-IPNLQTFIVSNNNLVGEIPDQFQDCP 506
I + SL +DIS+N + S +L + +S+N L I P
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--P 421
Query: 507 SLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPK-AISMMPTLAILDLSNNS 565
+ VLDL SN SIP + E L LN+ +NQL +P + +L + L N
Sbjct: 422 RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNP 479
Query: 566 L 566
Sbjct: 480 W 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-38
Identities = 95/488 (19%), Positives = 197/488 (40%), Gaps = 39/488 (7%)
Query: 130 SQNFLNGSF------PAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQ 183
S+ ++ S P L T LN S N S D+ + + L L + + Q
Sbjct: 1 SEFLVDRSKNGLIHVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ 58
Query: 184 GSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPV--EFGNL 241
FK Q+L++L LS N L KI +++ + L++N FD +P+ EFGN+
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNM 114
Query: 242 TNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAE---IGNITSLQLLDLS 298
+ LK+L L+ +L + L + +++ + + + E N SL ++ +
Sbjct: 115 SQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174
Query: 299 YNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEV------LELWNNSLSG 352
+ + + NL+L N+ C L L +L+ L L N +
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW 234
Query: 353 PLPVDLGK---NSPLQWLDLSSNSFSGEIPASLCNGGN-----LTKLILFNNAFSGPIPV 404
+ + + ++ + + +S+ G++ + L+ + ++ F P
Sbjct: 235 NSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSY 294
Query: 405 SLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFID 464
++ + + ++ L+ +NN LT + ++ T L +
Sbjct: 295 IYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLI 354
Query: 465 ISRNHLRS--SLPSTILSIPNLQTFIVSNNNL-VGEIPDQFQDCPSLSVLDLSSNYFSGS 521
+ N L+ + + +LQ +S N++ E SL L++SSN + +
Sbjct: 355 LQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT 414
Query: 522 IPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPEN-FGASPAL 580
I + ++ L+L +N++ IPK + + L L++++N L +P+ F +L
Sbjct: 415 IFRCLPP--RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSL 470
Query: 581 EVLNVSYN 588
+ + + N
Sbjct: 471 QKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-35
Identities = 77/443 (17%), Positives = 161/443 (36%), Gaps = 29/443 (6%)
Query: 170 TSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNE 229
L++ ++ +L KL+ L +S N + +E + L++N+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 230 FDGEIPVEFGNLTNLKYLDLAVGNLGGKIP--AELGRLELLEIMFLYQNNFQGRLPAEIG 287
+I NLK+LDL+ N +P E G + L+ + L + + I
Sbjct: 81 L-VKIS--CHPTVNLKHLDLS-FNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 288 NITSLQLLDLSYNMLSHEIPAE---ITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLE 344
++ ++L + + E ++L ++ + + + + LE+
Sbjct: 137 HLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196
Query: 345 L------WNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASL---CNGGNLTKLILFN 395
+ S + L N L L L++ + + + + N
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256
Query: 396 NAFSGPI-----PVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGI 450
G + S ++ +L ++ ++ + + +
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVH 316
Query: 451 TDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNL--VGEIPDQFQDCPSL 508
+ + +D S N L ++ + L+T I+ N L + +I + SL
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSL 376
Query: 509 SVLDLSSNYFSGSIPSSI-ASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLT 567
LD+S N S + + L++LN+ +N LT I + + P + +LDL +N +
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK 434
Query: 568 GGIPENFGASPALEVLNVSYNRL 590
IP+ AL+ LNV+ N+L
Sbjct: 435 -SIPKQVVKLEALQELNVASNQL 456
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-26
Identities = 78/400 (19%), Positives = 129/400 (32%), Gaps = 48/400 (12%)
Query: 198 FLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGK 257
+ S N L +P++L + ++ N + +L+ L+ L +
Sbjct: 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILII-------- 52
Query: 258 IPAELGRLELLEIMFLYQNNFQGRLPAEI-GNITSLQLLDLSYNMLSHEIPAEITQLKNL 316
N Q L + L+ LDLS+N L I NL
Sbjct: 53 ----------------SHNRIQ-YLDISVFKFNQELEYLDLSHNKLVK-IS--CHPTVNL 92
Query: 317 QLLNLMCNQL-SGHVPAGLGGLTQLEVLELWNNSL-SGPLPVDLGKNSPLQWLDLSSNSF 374
+ L+L N + + G ++QL+ L L L + N L L
Sbjct: 93 KHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG 152
Query: 375 SGEIPASLCNGGNLTKLILF--NNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGR 432
E P L + + I+F N F + VS+ T +L ++
Sbjct: 153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSI 212
Query: 433 LEKLQRLELANN-SLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSN 491
L KLQ +N +L T + L + + S + + + F S
Sbjct: 213 LAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272
Query: 492 NNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAIS 551
+L +LS+ + S+ F + N + S
Sbjct: 273 TSL-----------KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPS 321
Query: 552 MMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
+ LD SNN LT + EN G LE L + N+L+
Sbjct: 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 8e-20
Identities = 53/350 (15%), Positives = 111/350 (31%), Gaps = 51/350 (14%)
Query: 26 VVAKTALNDELLALLSIKAGLVDPLNSLHDWKLPSAHCNWTGVWCNSNGAVEKLDLSHMN 85
++ + L L +IK L D S L N + + +E S +
Sbjct: 181 ILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN-PKLSNLTLNNIETTWNSFIR 239
Query: 86 LSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGA 145
+ V S++++ L F S +L +L V +
Sbjct: 240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIF 299
Query: 146 AGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNN 205
+ + N + + + + LD + ++ + +L +L+ L L N
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ 359
Query: 206 LTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRL 265
L ++ + + +L+ LD
Sbjct: 360 LK-ELSKIAEM---------------------TTQMKSLQQLD----------------- 380
Query: 266 ELLEIMFLYQNNFQGRLPAEI-GNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCN 324
+ QN+ SL L++S N+L+ I + +++L+L N
Sbjct: 381 -------ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSN 431
Query: 325 QLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSF 374
++ +P + L L+ L + +N L + + LQ + L +N +
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 2e-40
Identities = 70/322 (21%), Positives = 131/322 (40%), Gaps = 44/322 (13%)
Query: 268 LEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLS 327
++ + ++ LP + + L + N L+ +PA +L+ L++ NQL+
Sbjct: 42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTLEVSG---NQLT 94
Query: 328 GHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGN 387
+P GL +L + L LP S L L + N + +P
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTHLP-ALP------SGLCKLWIFGNQLT-SLPVLP---PG 142
Query: 388 LTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLT 447
L +L + +N + +P S L ++ NNQL+ ++P+ LQ L +++N L
Sbjct: 143 LQELSVSDNQLAS-LPALPS---ELCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQLA 194
Query: 448 GGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPS 507
+ + L N L +SLP+ L+ IVS N L +P
Sbjct: 195 S-LPTLPSELYKL---WAYNNRL-TSLPA---LPSGLKELIVSGNRL-TSLPV---LPSE 242
Query: 508 LSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLT 567
L L +S N + S+P + L++L++ NQLT +P+++ + + ++L N L+
Sbjct: 243 LKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
Query: 568 GGIPENFGASPALEVLNVSYNR 589
+ + + R
Sbjct: 298 ERTLQALREITSAPGYSGPIIR 319
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-39
Identities = 70/302 (23%), Positives = 115/302 (38%), Gaps = 44/302 (14%)
Query: 290 TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNS 349
+L++ + L+ +P + ++ L + N L+ +PA +L LE+ N
Sbjct: 40 NGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPP---ELRTLEVSGNQ 92
Query: 350 LSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTC 409
L+ LPV L L KL +F N + +PV
Sbjct: 93 LTS-LPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLTS-LPVLPPGL 143
Query: 410 HSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNH 469
L + +NQL+ ++P +L +L NN LT + + L + +S N
Sbjct: 144 QEL---SVSDNQLA-SLPALPS---ELCKLWAYNNQLTS-LPMLP---SGLQELSVSDNQ 192
Query: 470 LRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASC 529
L +SLP+ L NN L +P L L +S N + S+P +
Sbjct: 193 L-ASLPT---LPSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVLPSE- 242
Query: 530 EKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNR 589
L L + N+LT +P S L L + N LT +PE+ + +N+ N
Sbjct: 243 --LKELMVSGNRLT-SLPMLPS---GLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNP 295
Query: 590 LE 591
L
Sbjct: 296 LS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-38
Identities = 79/352 (22%), Positives = 123/352 (34%), Gaps = 71/352 (20%)
Query: 96 RLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASG 155
LN+ +GL ++LP+ L + + N L S PA L L SG
Sbjct: 38 LNNGNAVLNVGESGL-TTLPDCL--PAHITTLVIPDNNLT-SLPALPP---ELRTLEVSG 90
Query: 156 NNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELG 215
N + S+PV L +L +L +P L
Sbjct: 91 NQLT-------------------------SLPVLPPGLLELSIFSNPLTHLP-ALPSGLC 124
Query: 216 QLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQ 275
+L + N+ +PV L L D N +PA L L Y
Sbjct: 125 KLW------IFGNQL-TSLPVLPPGLQELSVSD----NQLASLPALPSELCKLW---AYN 170
Query: 276 NNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLG 335
N LP LQ L +S N L+ +P ++L L N N+L+ +PA
Sbjct: 171 NQLT-SLPMLPSG---LQELSVSDNQLA-SLPTLPSELYKLWAYN---NRLT-SLPALPS 221
Query: 336 GLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFN 395
L+ L + N L+ LPV + L+ L +S N + +P L L ++
Sbjct: 222 ---GLKELIVSGNRLTS-LPVLPSE---LKELMVSGNRLT-SLPMLP---SGLLSLSVYR 270
Query: 396 NAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLT 447
N + +P SL S V ++ N LS + R ++ + +
Sbjct: 271 NQLTR-LPESLIHLSSETTVNLEGNPLS-ERTLQALR--EITSAPGYSGPII 318
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-37
Identities = 77/396 (19%), Positives = 136/396 (34%), Gaps = 70/396 (17%)
Query: 170 TSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNE 229
L++ S ++P + L + NNLT +P +L ++E ++ N+
Sbjct: 40 NGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQ 92
Query: 230 FDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNI 289
+PV L L +PA L L ++ N LP
Sbjct: 93 LT-SLPVLPPGLLELSIFSNP----LTHLPALPSGLCKLW---IFGNQLT-SLPVLPPG- 142
Query: 290 TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNS 349
LQ L +S N L+ +PA ++L L N NQL+ +P GL +L + +N
Sbjct: 143 --LQELSVSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPSGLQELS---VSDNQ 192
Query: 350 LSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTC 409
L+ LP + L L +N + +PA L +LI+ N + +PV S
Sbjct: 193 LAS-LPTLPSE---LYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLTS-LPVLPS-- 241
Query: 410 HSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNH 469
L + + N+L+ ++P+ L L + N LT
Sbjct: 242 -ELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT---------------------- 274
Query: 470 LRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASC 529
LP +++ + + T + N L ++ S F + S+
Sbjct: 275 ---RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRET 331
Query: 530 EKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNS 565
L + L + + +N+
Sbjct: 332 RALHLAA--ADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-35
Identities = 66/345 (19%), Positives = 106/345 (30%), Gaps = 43/345 (12%)
Query: 76 VEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLN 135
+ L + NL+ + L +L + N L +SLP L L F L
Sbjct: 63 ITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQL-TSLPVLPPGLLELSIFSNPLTHLP 117
Query: 136 GSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQK 195
GL L GN + L L+ L + + S+P L K
Sbjct: 118 ALPS-------GLCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLA-SLPALPSELCK 165
Query: 196 LKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLG 255
L N LT +P L + + ++ N+ +P L L + N
Sbjct: 166 LW---AYNNQLT-SLPMLPSGL---QELSVSDNQL-ASLPTLPSELYKLWAYN----NRL 213
Query: 256 GKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKN 315
+PA L+ L + N LP L+ L +S N L+ +P + L +
Sbjct: 214 TSLPALPSGLKELIV----SGNRLTSLPVLPSE---LKELMVSGNRLT-SLPMLPSGLLS 265
Query: 316 LQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFS 375
L + NQL+ +P L L+ + L N LS + +
Sbjct: 266 LSVYR---NQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRF 320
Query: 376 GEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNN 420
AS L + + ++N
Sbjct: 321 DMAGASAPRETRALHLAAADW-LVPAREGEPAPADRWHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 69/367 (18%), Positives = 119/367 (32%), Gaps = 50/367 (13%)
Query: 74 GAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGL----------------FSSLPNS 117
+ L++S L+ + L L+ + L +SLP
Sbjct: 81 PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVL 139
Query: 118 LANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDL 177
L L VS N L S PA L L A N + L L+ L +
Sbjct: 140 PPGLQEL---SVSDNQLA-SLPALPSE---LCKLWAYNNQLT-SLPMLPSG---LQELSV 188
Query: 178 RGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVE 237
+ S+P L KL N LT +P L + +I++ N +PV
Sbjct: 189 SDNQLA-SLPTLPSELYKLW---AYNNRLT-SLPALPSGL---KELIVSGNRL-TSLPVL 239
Query: 238 FGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDL 297
L L + GN +P L L +Y+N RLP + +++S ++L
Sbjct: 240 PSELKEL-MVS---GNRLTSLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNL 291
Query: 298 SYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVD 357
N LS E + + + + AG E L + +P
Sbjct: 292 EGNPLS-ERTLQALR--EITSAPGYSGPIIRFDMAGASAPR--ETRALHLAAADWLVPAR 346
Query: 358 LGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRM 417
G+ +P + + + + + + T+ + + F I L+ +R
Sbjct: 347 EGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQISSWLAQLAEDEALRA 406
Query: 418 QNNQLSG 424
++
Sbjct: 407 NTFAMAT 413
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 3e-15
Identities = 29/138 (21%), Positives = 56/138 (40%), Gaps = 19/138 (13%)
Query: 454 IASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDL 513
+ + +++ + L ++LP + + ++ T ++ +NNL +P P L L++
Sbjct: 36 ACLNNGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLT-SLPALP---PELRTLEV 88
Query: 514 SSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPEN 573
S N + S+P +L + L L L + N LT +P
Sbjct: 89 SGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLT-SLPVL 139
Query: 574 FGASPALEVLNVSYNRLE 591
L+ L+VS N+L
Sbjct: 140 PP---GLQELSVSDNQLA 154
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-40
Identities = 77/307 (25%), Positives = 124/307 (40%), Gaps = 12/307 (3%)
Query: 290 TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLELWNN 348
T +LLDL N + E +L+ L L N +S V G L L L L +N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSN 90
Query: 349 SLSGPLPVDLGKNSP-LQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLS 407
L +P+ + L LD+S N + + NL L + +N + S
Sbjct: 91 RLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFS 149
Query: 408 TCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDI-ASSTSLSFIDI 465
+SL ++ ++ L+ +IP L L L L + ++ I D L ++I
Sbjct: 150 GLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEI 207
Query: 466 SRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQ-FQDCPSLSVLDLSSNYFSGSIPS 524
S ++ L NL + +++ NL +P + L L+LS N S S
Sbjct: 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGS 266
Query: 525 SIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPEN-FGASPALEVL 583
+ +L + L QL P A + L +L++S N LT + E+ F + LE L
Sbjct: 267 MLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETL 325
Query: 584 NVSYNRL 590
+ N L
Sbjct: 326 ILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-37
Identities = 80/333 (24%), Positives = 127/333 (38%), Gaps = 26/333 (7%)
Query: 62 HCNWTG--VWCNSNG----------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNG 109
C+ V C+ LDL + D F L L L N
Sbjct: 8 ECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI 67
Query: 110 LFSSLPNSLANLTSLKRFDVSQNFLNGSFPAG-LGGAAGLTFLNASGNNFSGFLLEDLGN 168
+ + P + NL +L+ + N L P G G + LT L+ S N L +
Sbjct: 68 VSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQD 126
Query: 169 ATSLETLDLRGSFFQGSIPV-SFKNLQKLKFLGLSGNNLTGKIPRE-LGQLSSMETMILA 226
+L++L++ + I +F L L+ L L NLT IP E L L + + L
Sbjct: 127 LYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLR 184
Query: 227 YNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAE- 285
+ + F L LK L+++ + L + + N +P
Sbjct: 185 HLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLA 243
Query: 286 IGNITSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVL 343
+ ++ L+ L+LSYN +S I + +L LQ + L+ QL+ V GL L VL
Sbjct: 244 VRHLVYLRFLNLSYNPIST-IEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVL 301
Query: 344 ELWNNSLSGPLPVDL-GKNSPLQWLDLSSNSFS 375
+ N L+ L + L+ L L SN +
Sbjct: 302 NVSGNQLTT-LEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-35
Identities = 74/330 (22%), Positives = 131/330 (39%), Gaps = 32/330 (9%)
Query: 170 TSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNE 229
T LDL + + F + L+ L L+ N ++ P L ++ T+ L N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 230 FDGEIPVE-FGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGN 288
IP+ F L+NL LD++ N +I+ L FQ
Sbjct: 92 LK-LIPLGVFTGLSNLTKLDIS-EN---------------KIVILLDYMFQD-------- 126
Query: 289 ITSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLELW 346
+ +L+ L++ N L I + L +L+ L L L+ +P L L L VL L
Sbjct: 127 LYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLR 184
Query: 347 NNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSL 406
+ +++ + L+ L++S + + + G NLT L + + + +++
Sbjct: 185 HLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAV 244
Query: 407 STCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDI 465
L + + N +S TI L +LQ ++L L L +++
Sbjct: 245 RHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNV 303
Query: 466 SRNHLRSSLPSTILSIPNLQTFIVSNNNLV 495
S N L + S S+ NL+T I+ +N L
Sbjct: 304 SGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-33
Identities = 67/346 (19%), Positives = 123/346 (35%), Gaps = 35/346 (10%)
Query: 201 LSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPA 260
+P + + + L N EF + +L+ L+L N
Sbjct: 18 CHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELN-EN------- 66
Query: 261 ELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEI-TQLKNLQLL 319
+ + F + +L+ L L N L IP + T L NL L
Sbjct: 67 --------IVSAVEPGAFNN--------LFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKL 109
Query: 320 NLMCNQLSGHVPAGL-GGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEI 378
++ N++ + + L L+ LE+ +N L + L+ L L + + I
Sbjct: 110 DISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SI 167
Query: 379 PA-SLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQ 437
P +L + L L L + + S + L + + + T+ L
Sbjct: 168 PTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227
Query: 438 RLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGE 497
L + + +LT + L F+++S N + + S + + LQ + L
Sbjct: 228 SLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVV 287
Query: 498 IPDQFQDCPSLSVLDLSSNYFSGSIPSSI-ASCEKLVNLNLRNNQL 542
P F+ L VL++S N + ++ S+ S L L L +N L
Sbjct: 288 EPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 6e-17
Identities = 40/177 (22%), Positives = 73/177 (41%), Gaps = 9/177 (5%)
Query: 418 QNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPST 477
+ +P G + + L+L N + D+ AS L ++++ N + + P
Sbjct: 19 HRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGA 75
Query: 478 ILSIPNLQTFIVSNNNLVGEIPDQ-FQDCPSLSVLDLSSNYFSGSIPSSI-ASCEKLVNL 535
++ NL+T + +N L IP F +L+ LD+S N + + L +L
Sbjct: 76 FNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSL 133
Query: 536 NLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPEN-FGASPALEVLNVSYNRLE 591
+ +N L +A S + +L L L +LT IP L VL + + +
Sbjct: 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNIN 189
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-40
Identities = 85/316 (26%), Positives = 131/316 (41%), Gaps = 66/316 (20%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG----EVNVLGKLRHRNI 768
+G G VY AE LN VA+K + + + + EV+ +L H+NI
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAI---FIPPREKE--ETLKRFEREVHNSSQLSHQNI 73
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
V ++ D +V EY+ +L E + G L VD + G+ + H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAIN--FTNQILDGIKHAHD 129
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET-VSMVAGSYGYIAPEYGYT 887
I+HRDIK NIL+DSN +I DFG+A+ + + T + V G+ Y +PE
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES-VDIVEWIRMKIRDNRNLEEALDPNVG 946
DE DIYS G+VL E+L G P + GE+ V I A+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFN---GETAVSI----------------AI----- 222
Query: 947 NCKHVQEEM----------------LLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990
KH+Q+ + ++LR T K +R + + M +
Sbjct: 223 --KHIQDSVPNVTTDVRKDIPQSLSNVILR----ATEKDKANRY--KTIQEMKDDLSSVL 274
Query: 991 KSSSNNDNRYENNKEK 1006
+ N++ YE +K K
Sbjct: 275 HENRANEDVYELDKMK 290
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-39
Identities = 80/468 (17%), Positives = 162/468 (34%), Gaps = 67/468 (14%)
Query: 100 LTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFS 159
S + ++ S L +L D + + G+ GLT L + NN +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 160 GFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSS 219
DL T+L L + ++ V+ L KL +L N LT K+ + Q
Sbjct: 78 TL---DLSQNTNLTYLACDSNKLT-NLDVT--PLTKLTYLNCDTNKLT-KLD--VSQNPL 128
Query: 220 METMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQ 279
+ + A N ++ + T L LD + +
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDC--------------------------HLNK 159
Query: 280 GRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQ 339
++ T L LD S+N ++ +++Q K L LN N ++ + L Q
Sbjct: 160 KITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQ 213
Query: 340 LEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFS 399
L L+ +N L+ +D+ + L + D S N + E+ S + LT L
Sbjct: 214 LTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT-ELDVSTLS--KLTTLHCIQTDLL 267
Query: 400 GPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTS 459
+ L+ L+ + + + + +L L+ +T D++ +
Sbjct: 268 E---IDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDLSQNPK 319
Query: 460 LSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFS 519
L ++ ++ L + L + L++ N ++ + P+L+ +
Sbjct: 320 LVYLYLNNTEL-TELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI 374
Query: 520 GSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLT 567
++P + L + + + L + D + N++T
Sbjct: 375 -TMPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTIT 420
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-39
Identities = 69/439 (15%), Positives = 143/439 (32%), Gaps = 46/439 (10%)
Query: 172 LETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFD 231
+ Q + +S + L L L +++T + + +L+ + +I N
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 232 GEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITS 291
++ TNL YL N + + L L + N ++
Sbjct: 78 T---LDLSQNTNLTYLACD-SNKLTNLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPL 128
Query: 292 LQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLS 351
L L+ + N L+ +++ L L+ N+ + TQL L+ N ++
Sbjct: 129 LTYLNCARNTLTE---IDVSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKIT 183
Query: 352 GPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHS 411
+D+ +N L L+ +N+ + ++ + LT L +N + + ++
Sbjct: 184 E---LDVSQNKLLNRLNCDTNNIT-KLDLNQNI--QLTFLDCSSNKLTE---IDVTPLTQ 234
Query: 412 LVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLR 471
L N L+ + L KL L L D+ +T L +
Sbjct: 235 LTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL---EIDLTHNTQLIYFQAEGCRKI 288
Query: 472 SSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEK 531
L + L + E+ P L L L++ + + ++ K
Sbjct: 289 KELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTK 340
Query: 532 LVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASP-----ALEVLNVS 586
L +L+ N + D ++ +P L + E + + ++L+
Sbjct: 341 LKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQF 398
Query: 587 YNRLEGPVPANGVLRTINR 605
N + GV
Sbjct: 399 GNPMNIEPGDGGVYDQATN 417
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-34
Identities = 77/420 (18%), Positives = 143/420 (34%), Gaps = 67/420 (15%)
Query: 75 AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFL 134
+ LD + +++ ++L LT L N + ++L L+ T+L N L
Sbjct: 43 TLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDSNKL 97
Query: 135 NGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQ 194
+ + LT+LN N + D+ L L+ + I VS +
Sbjct: 98 T-NLD--VTPLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTLT-EIDVS--HNT 148
Query: 195 KLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNL 254
+L L N K+ + + + T+ ++N+ ++ L L+ N+
Sbjct: 149 QLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNI 203
Query: 255 GGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLK 314
+L ++ L LD S N L+ EI +T L
Sbjct: 204 -----TKL----------------------DLNQNIQLTFLDCSSNKLT-EID--VTPLT 233
Query: 315 NLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSF 374
L + N L+ + + L++L L L +DL N+ L +
Sbjct: 234 QLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRK 287
Query: 375 SGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLE 434
E+ + L L + + LS LV + + N +L+ + V
Sbjct: 288 IKELDVTHNT--QLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELDV--SHNT 339
Query: 435 KLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNL 494
KL+ L N + + +L+ + ++P L+ N T VS + L
Sbjct: 340 KLKSLSCVNAHIQD--FSSVGKIPALNNNFEAEGQT-ITMPKETLT-NNSLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 57/295 (19%), Positives = 105/295 (35%), Gaps = 31/295 (10%)
Query: 300 NMLSHEIPAEITQL---KNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPV 356
N L N ++ L L L+ N+S++ +
Sbjct: 1 NTLKAGQTQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT- 58
Query: 357 DLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVR 416
+ K + L L +SN+ + + S NLT L +N + + ++ L +
Sbjct: 59 GIEKLTGLTKLICTSNNIT-TLDLSQNT--NLTYLACDSNKLTN---LDVTPLTKLTYLN 112
Query: 417 MQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPS 476
N+L+ + + L L A N+LT D++ +T L+ +D N + L
Sbjct: 113 CDTNKLT---KLDVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD- 165
Query: 477 TILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLN 536
+ L T S N + E+ L+ L+ +N + + + +L L+
Sbjct: 166 -VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLD 218
Query: 537 LRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
+N+LT +I ++ + L D S N LT L L+ L
Sbjct: 219 CSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTL---SKLTTLHCIQTDLL 267
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 68/299 (22%), Positives = 104/299 (34%), Gaps = 57/299 (19%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGD------FVGEVNVLGKLRH 765
++G G G VY+AE IVA+K + L S D E G+L+
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLM---SETL----SSDPVFRTRMQREARTAGRLQE 93
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAY 825
++V + F D + + +N L L ++ G L I + L
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVA--IVRQIGSALDA 149
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET-VSMVAGSYGYIAPEY 884
H HRD+K NIL+ ++ + DFG+A + T + G+ Y+APE
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD--------NRN 936
+ DIY+ VL E LTG P G+ + + + I
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPPYQ---GDQLSV---MGAHINQAIPRPSTVRPG 260
Query: 937 LEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPS-----MRDVITMLGEAKPRR 990
+ A D ++ R AK P+DR L A R
Sbjct: 261 IPVAFDA-------------VIAR----GMAKNPEDRYVTCGDLSAAAHAALATADQDR 302
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-39
Identities = 77/293 (26%), Positives = 114/293 (38%), Gaps = 53/293 (18%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH 765
+ IG G G V+ + NT+VAVK R L + F+ E +L + H
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC---RETLPPDLKAKFLQEARILKQYSH 171
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAY 825
NIVRL+G + IV E + G L + RL V + + A G+ Y
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR-TEGARLRVK--TLLQMVGDAAAGMEY 228
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI----- 880
L C IHRD+ + N L+ +I+DFG++R + V +G +
Sbjct: 229 LESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREE---ADGVYAASGGLRQVPVKWT 282
Query: 881 APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWI----RMKI 931
APE YG Y+ + D++SFG++L E + G P P + E++ R+
Sbjct: 283 APEALNYGRYSSES----DVWSFGILLWETFSLGASPY-PNL-SNQQTREFVEKGGRL-- 334
Query: 932 RDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
P C V M C A P RPS + L
Sbjct: 335 -----------PCPELCPDAVFRLME-------QCWAYEPGQRPSFSTIYQEL 369
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-39
Identities = 80/321 (24%), Positives = 125/321 (38%), Gaps = 78/321 (24%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGD------FVGEVNVLGKLRHR 766
+G G V+ A R + VAVK L RADL + D F E L H
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVL---RADL----ARDPSFYLRFRREAQNAAALNHP 72
Query: 767 NIVRLL--GFLHNDTNMM--IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQG 822
IV + G + IV EY++ +L + +H G + + Q
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIE--VIADACQA 128
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV---SMVAGSYGY 879
L + H + IIHRD+K NI++ + ++ DFG+AR + +V + V G+ Y
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 880 IAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES-VDIVEWIRMKIRDNRNLE 938
++PE VD + D+YS G VL E+LTG P G+S V +
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT---GDSPVSV--------------- 227
Query: 939 EALDPNVGNCKHVQEEML---------------LVLRIAFLCTAKLPKDRPS-----MRD 978
A +HV+E+ + +VL+ AK P++R D
Sbjct: 228 -AY-------QHVREDPIPPSARHEGLSADLDAVVLK----ALAKNPENRYQTAAEMRAD 275
Query: 979 VITMLGEAKPRRKSSSNNDNR 999
++ + P + R
Sbjct: 276 LVRVHNGEPPEAPKVLTDAER 296
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 57/224 (25%), Positives = 107/224 (47%), Gaps = 39/224 (17%)
Query: 707 IRESNVIGMGATGIVYKA----EMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
++ V+G GA G VYK E ++ VA+K+L R +++ + + E V+
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEILDEAYVMAS 73
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALG 818
+ + ++ RLLG T + ++ + M G L + + + + L++W +
Sbjct: 74 VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNW------CVQ 125
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG 878
+A+G+ YL +HRD+ + N+L+ + +I DFGLA+ ++ E G G
Sbjct: 126 IAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAK-LLGAEEKEYHAEG--G 179
Query: 879 YI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
+ A E + YT + D++S+GV + EL+T G +P
Sbjct: 180 KVPIKWMALESILHRIYTHQS----DVWSYGVTVWELMTFGSKP 219
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 68/326 (20%), Positives = 132/326 (40%), Gaps = 51/326 (15%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH--RNI 768
IG G + V++ + I A+K + + + + ++ + E+ L KL+ I
Sbjct: 15 KQIGSGGSSKVFQV-LNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH- 827
+RL + D + +V E N L L K+ + Y + + + +H
Sbjct: 72 IRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSY--WKNMLEAVHTIHQ 126
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA----GSYGYIAPE 883
H I+H D+K N L+ ++ DFG+A M + +T S+V G+ Y+ PE
Sbjct: 127 HG----IVHSDLKPANFLIVDG-MLKLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPE 179
Query: 884 -----------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIR 932
K+ K D++S G +L + G+ P F + ++ + + I
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIID 235
Query: 933 DNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT---MLGEAKPR 989
N +E P+ ++++ VL+ C + PK R S+ +++ + + P
Sbjct: 236 PNHEIE---FPD-----IPEKDLQDVLK---CCLKRDPKQRISIPELLAHPYVQIQTHPV 284
Query: 990 RKSSSNNDNRYENNKEKLVFSTSPVS 1015
+ + + +LV SP S
Sbjct: 285 NQMAKGTTEEMKYVLGQLVGLNSPNS 310
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-38
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKL-WRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
IG G+ G + +K++ + E E S EV VL ++H NIV+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES---RREVAVLANMKHPNIVQ 87
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
+ ++ IV +Y G L + ++ ++ D + + + + L ++H
Sbjct: 88 YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW--FVQICLALKHVHD-- 143
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----YGY 886
I+HRDIKS NI L + ++ DFG+AR++ E G+ Y++PE Y
Sbjct: 144 -RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 887 TLKVDEKIDIYSFGVVLLELLTGRRP 912
+ K DI++ G VL EL T +
Sbjct: 203 ----NNKSDIWALGCVLYELCTLKHA 224
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-37
Identities = 66/328 (20%), Positives = 129/328 (39%), Gaps = 55/328 (16%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH--RNI 768
IG G + V++ + I A+K + + + + ++ + E+ L KL+ I
Sbjct: 62 KQIGSGGSSKVFQV-LNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH- 827
+RL + D + +V E N L L K+ + Y + + + +H
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSY--WKNMLEAVHTIHQ 173
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA----GSYGYIAPE 883
H I+H D+K N L+ ++ DFG+A M + +T S+V G+ Y+ PE
Sbjct: 174 HG----IVHSDLKPANFLIVDG-MLKLIDFGIANQM--QPDTTSVVKDSQVGAVNYMPPE 226
Query: 884 -----------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIR 932
K+ K D++S G +L + G+ P F + ++ + + I
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIID 282
Query: 933 DNRNLE--EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT---MLGEAK 987
N +E + + + + V + L + PK R S+ +++ + +
Sbjct: 283 PNHEIEFPDIPEK---DLQDVLKCCL----------KRDPKQRISIPELLAHPYVQIQTH 329
Query: 988 PRRKSSSNNDNRYENNKEKLVFSTSPVS 1015
P + + + +LV SP S
Sbjct: 330 PVNQMAKGTTEEMKYVLGQLVGLNSPNS 357
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 62/287 (21%), Positives = 120/287 (41%), Gaps = 48/287 (16%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN--I 768
IG G + V++ + I A+K + + + + ++ + E+ L KL+ + I
Sbjct: 34 KQIGSGGSSKVFQV-LNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH- 827
+RL + D + +V E N L L K+ + Y + + + +H
Sbjct: 91 IRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSY--WKNMLEAVHTIHQ 145
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA----GSYGYIAPE 883
H I+H D+K N L+ ++ DFG+A M + +T S+V G+ Y+ PE
Sbjct: 146 HG----IVHSDLKPANFLIVDG-MLKLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPE 198
Query: 884 -----------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIR 932
K+ K D++S G +L + G+ P F + ++ + + I
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIID 254
Query: 933 DNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDV 979
N +E P+ ++++ VL+ C + PK R S+ ++
Sbjct: 255 PNHEIE---FPD-----IPEKDLQDVLK---CCLKRDPKQRISIPEL 290
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 68/307 (22%), Positives = 116/307 (37%), Gaps = 60/307 (19%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLN----TIVAVKKLWRSRADLETESSGDFVGEVNVLG 761
++ +G G G V VAVK L + + D E+ +L
Sbjct: 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL---KPESGGNHIADLKKEIEILR 78
Query: 762 KLRHRNIVRLLG--FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNI 815
L H NIV+ G + ++ E++ +GSL E L K ++ + +
Sbjct: 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKY------ 131
Query: 816 ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG 875
A+ + +G+ YL Y +HRD+ + N+L++S + +I DFGL + + E ++
Sbjct: 132 AVQICKGMDYLGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 188
Query: 876 SYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVE 925
APE + + D++SFGV L ELLT P I
Sbjct: 189 --RDSPVFWYAPECLMQSKFYIAS----DVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242
Query: 926 W--------IRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSM 976
+ +++ + L P NC V + M C P +R S
Sbjct: 243 THGQMTVTRLVNTLKEGKRLPC---PP--NCPDEVYQLMR-------KCWEFQPSNRTSF 290
Query: 977 RDVITML 983
+++I
Sbjct: 291 QNLIEGF 297
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 61/291 (20%), Positives = 112/291 (38%), Gaps = 62/291 (21%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+IG G G V+KA+ +K++ E + EV L KL H NIV
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKA---EREVKALAKLDHVNIVH 68
Query: 771 LLGF----------------LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN 814
G + I E+ + G+L + + ++ +L
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL- 127
Query: 815 IALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA 874
+ +G+ Y+H +I+RD+K +NI L + +I DFGL + +
Sbjct: 128 -FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK- 182
Query: 875 GSYGYIAPE----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMK 930
G+ Y++PE Y +++D+Y+ G++L ELL E+
Sbjct: 183 GTLRYMSPEQISSQDY----GKEVDLYALGLILAELLHVCDT----AFETSKFF----TD 230
Query: 931 IRDNRNLEEALDPNV-GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
+RD + K + +++L +K P+DRP+ +++
Sbjct: 231 LRDGI-----ISDIFDKKEKTLLQKLL----------SKKPEDRPNTSEIL 266
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 30/212 (14%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G G+ G V++ + + AVKK+ LE E+ L IV
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRVE----ELVACAGLSSPRIVP 114
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L G + + I E + GSLG+ + KQ G L D Y +GL YLH
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYY--LGQALEGLEYLHTRR 170
Query: 831 YPPIIHRDIKSNNILLDSN-LEPRIADFGLARMMIRKNETVSM-----VAGSYGYIAPE- 883
I+H D+K++N+LL S+ + DFG A + S+ + G+ ++APE
Sbjct: 171 ---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 884 ---YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
KV DI+S ++L +L G P
Sbjct: 228 VMGKPCDAKV----DIWSSCCMMLHMLNGCHP 255
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 74/296 (25%), Positives = 124/296 (41%), Gaps = 53/296 (17%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLN---TIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
+ + VIG G G VY + + AVK L + F+ E ++
Sbjct: 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKD 82
Query: 763 LRHRNIVRLLGF-LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ 821
H N++ LLG L ++ + ++V YM +G L + + + D + L VA+
Sbjct: 83 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAK 139
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI- 880
G+ YL + +HRD+ + N +LD ++ADFGLAR + E S+ + +
Sbjct: 140 GMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLP 195
Query: 881 ----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP---LDPEFGESVDIVEWIR 928
A E +T K D++SFGV+L EL+T G P ++ DI ++
Sbjct: 196 VKWMALESLQTQKFT----TKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLL 246
Query: 929 MKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
R L + P C + E ML C + RPS ++++ +
Sbjct: 247 QGRR----LLQ---PE--YCPDPLYEVML-------KCWHPKAEMRPSFSELVSRI 286
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 72/224 (32%), Positives = 107/224 (47%), Gaps = 36/224 (16%)
Query: 706 CIRESNVIGMGATGIVYKAEM---PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
I +IG G +G V + + + VA+K L +A DF+ E +++G+
Sbjct: 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL---KAGYTERQRRDFLSEASIMGQ 106
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALG 818
H NI+RL G + MIV EYM NGSL L G+ LV G
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGM------LRG 159
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG 878
V G+ YL Y +HRD+ + N+L+DSNL +++DFGL+R++ + G G
Sbjct: 160 VGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG--G 214
Query: 879 YI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
I APE + ++ D++SFGVV+ E+L G RP
Sbjct: 215 KIPIRWTAPEAIAFRTFSSAS----DVWSFGVVMWEVLAYGERP 254
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 81/333 (24%), Positives = 130/333 (39%), Gaps = 57/333 (17%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLN----TIVAVKKLWRSRADLETESSGDFVGEVNVLG 761
++ + +G G G V L +VAVK+L + + DF E+ +L
Sbjct: 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHS-GPDQQRDFQREIQILK 79
Query: 762 KLRHRNIVRLLG--FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNI 815
L IV+ G + ++ +V EY+ +G L + L + RL L+ +
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLY------ 132
Query: 816 ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG 875
+ + +G+ YL +HRD+ + NIL++S +IADFGLA+++ + +
Sbjct: 133 SSQICKGMEYLGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189
Query: 876 SYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVE 925
G APE ++ + D++SFGVVL EL T + P +
Sbjct: 190 --GQSPIFWYAPESLSDNIFSRQS----DVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC 243
Query: 926 WIRMKIRDNRNLEEALD-----PNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDV 979
+ L E L+ P C V E M LC A P+DRPS +
Sbjct: 244 --ERDVPALSRLLELLEEGQRLPAPPACPAEVHELMK-------LCWAPSPQDRPSFSAL 294
Query: 980 ITMLGE--AKPRRKSSSNNDNRYENNKEKLVFS 1010
L + R + E L FS
Sbjct: 295 GPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 327
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-37
Identities = 71/222 (31%), Positives = 107/222 (48%), Gaps = 32/222 (14%)
Query: 706 CIRESNVIGMGATGIVYKAEM---PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
I V+G G G V + + VA+K L + + DF+GE +++G+
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL---KVGYTEKQRRDFLGEASIMGQ 102
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALG 818
H NI+RL G + +MIV EYM NGSL L K + LV G
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGM------LRG 155
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG 878
+A G+ YL Y +HRD+ + NIL++SNL +++DFGL R++ E G
Sbjct: 156 IASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 879 YI---APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
I +PE Y +T D++S+G+VL E+++ G RP
Sbjct: 213 PIRWTSPEAIAYRKFTSAS----DVWSYGIVLWEVMSYGERP 250
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 31/222 (13%)
Query: 706 CIRESNVIGMGATGIVYKAE--MPRLNTI-VAVKKLWRSRADLETESSGDFVGEVNVLGK 762
+R +G G+ G+V + E P T+ VAVK L + + E+ DF+ EVN +
Sbjct: 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPEAMDDFIREVNAMHS 77
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALG 818
L HRN++RL G + M +V E GSL + L K G L + A+
Sbjct: 78 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRY------AVQ 129
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS-- 876
VA+G+ YL + IHRD+ + N+LL + +I DFGL R + + ++ M
Sbjct: 130 VAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 877 -YGYIAPE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
+ + APE ++ D + FGV L E+ T G+ P
Sbjct: 187 PFAWCAPESLKTRTFSHAS----DTWMFGVTLWEMFTYGQEP 224
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 14/209 (6%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
IG G+ G K I+ K+L + V EVN+L +L+H NIVR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 772 LG-FLHNDTNMM-IVYEYMNNGSLGEAL-HGKQAGRLL---VDWVSRYNIALGVAQGLAY 825
+ + IV EY G L + G + + L + + L
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL----RVMTQLTLALKE 126
Query: 826 LH--HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE 883
H D ++HRD+K N+ LD ++ DFGLAR++ G+ Y++PE
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE 186
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
+ +EK DI+S G +L EL P
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 7e-37
Identities = 28/299 (9%), Positives = 74/299 (24%), Gaps = 48/299 (16%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+ +G +V+ A+K A+ +L +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVF-TMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 772 LGFLH--------------------------NDTNMMIVYEYM--NNGSLGEALHGKQAG 803
N +++ + L L
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 804 RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863
R ++ + + + + A L ++H +N+ + + + D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW-- 242
Query: 864 IRKNETVSMVAGSYGYIAPEY--GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESV 921
+ + Y E+ T ++ + G+ + + P FG
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FGLVT 297
Query: 922 DIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEML-LVLRIAFLCTAKLPKDRPSMRDV 979
++ + ++L G+C + + + L+ R + R +
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAF--GSCTPLPDFVKTLIGR----FLNFDRRRRLLPLEA 350
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
V+G G GIVY +A+K++ + ++ S E+ + L+H+NIV+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEI----PERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
LG + + I E + GSL L K + + +GL YLH +
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHDNQ- 142
Query: 832 PPIIHRDIKSNNILLDS-NLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE------Y 884
I+HRDIK +N+L+++ + +I+DFG ++ + N G+ Y+APE
Sbjct: 143 --IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESV 921
GY DI+S G ++E+ TG+ P E GE
Sbjct: 201 GYGKAA----DIWSLGCTIIEMATGKPPF-YELGEPQ 232
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 62/297 (20%), Positives = 117/297 (39%), Gaps = 58/297 (19%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G G G+V++A+ + A+K++ +L E + EV L KL H IVR
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE---KVMREVKALAKLEHPGIVRY 68
Query: 772 LG-FLHNDTNMM-----------IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGV 819
+L +T I + +L + ++ + + +I L +
Sbjct: 69 FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCLHIFLQI 127
Query: 820 AQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA----- 874
A+ + +LH ++HRD+K +NI + ++ DFGL M + E +++
Sbjct: 128 AEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 875 -------GSYGYIAPE----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDI 923
G+ Y++PE Y K+DI+S G++L ELL P + +
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSY----SHKVDIFSLGLILFELLY------PFSTQMERV 234
Query: 924 VEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
+R+ + P + E ++V + P +RP ++I
Sbjct: 235 RTL--TDVRNLK-----FPPL--FTQKYPCEYVMVQD----MLSPSPMERPEAINII 278
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 78/296 (26%), Positives = 123/296 (41%), Gaps = 53/296 (17%)
Query: 706 CIRESNVIGMGATGIVYKAEM---PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
VIG G G+VY E + A+K L E + F+ E ++
Sbjct: 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL---SRITEMQQVEAFLREGLLMRG 78
Query: 763 LRHRNIVRLLGF-LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ 821
L H N++ L+G L + ++ YM +G L + + Q + D +S L VA+
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS---FGLQVAR 135
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI- 880
G+ YL + +HRD+ + N +LD + ++ADFGLAR I E S+ + +
Sbjct: 136 GMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLAR-DILDREYYSVQQHRHARLP 191
Query: 881 ----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP---LDPEFGESVDIVEWIR 928
A E +T K D++SFGV+L ELLT G P +DP D+
Sbjct: 192 VKWTALESLQTYRFT----TKSDVWSFGVLLWELLTRGAPPYRHIDPF-----DLTH--- 239
Query: 929 MKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
+ R L + P C + + M C P RP+ R ++ +
Sbjct: 240 -FLAQGRRLPQ---PE--YCPDSLYQVMQ-------QCWEADPAVRPTFRVLVGEV 282
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 713 IGMGATGIVYKAE--MPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G G G V + M + VA+K L + E + + + E ++ +L + IVR
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALGVAQGLAYL 826
L+G + +M+V E G L + L GK+ + + + V+ G+ YL
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAEL------LHQVSMGMKYL 126
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI-----A 881
+ +HRD+ + N+LL + +I+DFGL++ + + + + G A
Sbjct: 127 EEKNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA--GKWPLKWYA 181
Query: 882 PE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
PE + ++ + D++S+GV + E L+ G++P
Sbjct: 182 PECINFRKFSSRS----DVWSYGVTMWEALSYGQKP 213
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-36
Identities = 73/296 (24%), Positives = 123/296 (41%), Gaps = 53/296 (17%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLN---TIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
+ + VIG G G VY + + AVK L + F+ E ++
Sbjct: 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKD 146
Query: 763 LRHRNIVRLLGF-LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ 821
H N++ LLG L ++ + ++V YM +G L + + + D + L VA+
Sbjct: 147 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAK 203
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI- 880
G+ +L + +HRD+ + N +LD ++ADFGLAR + E S+ + +
Sbjct: 204 GMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEFDSVHNKTGAKLP 259
Query: 881 ----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP---LDPEFGESVDIVEWIR 928
A E +T K D++SFGV+L EL+T G P ++ DI
Sbjct: 260 VKWMALESLQTQKFT----TKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITV--- 307
Query: 929 MKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
+ R L + P C + E ML C + RPS ++++ +
Sbjct: 308 -YLLQGRRLLQ---PE--YCPDPLYEVML-------KCWHPKAEMRPSFSELVSRI 350
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 39/225 (17%)
Query: 706 CIRESNVIGMGATGIVYKA----EMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLG 761
+R+ V+G G G V+K E + V +K + +S + +G
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI---EDKSGRQSFQAVTDHMLAIG 70
Query: 762 KLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIAL 817
L H +IVRLLG + + +V +Y+ GSL + + + G L L++W +
Sbjct: 71 SLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNW------GV 122
Query: 818 GVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY 877
+A+G+ YL +HR++ + N+LL S + ++ADFG+A ++ ++ + S
Sbjct: 123 QIAKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ---LLYSE 176
Query: 878 GYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
A E +G YT + D++S+GV + EL+T G P
Sbjct: 177 AKTPIKWMALESIHFGKYTHQS----DVWSYGVTVWELMTFGAEP 217
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 67/297 (22%), Positives = 117/297 (39%), Gaps = 34/297 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
IG G VY+A VA+KK+ + D + E+++L +L H N+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA-DCIKEIDLLKQLNHPNVIKY 97
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEAL-HGKQAGRLL---VDWVSRYNIALGVAQGLAYLH 827
D + IV E + G L + H K+ RL+ W + + L ++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQLCSALEHMH 153
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE---- 883
++HRDIK N+ + + ++ D GL R K + G+ Y++PE
Sbjct: 154 SRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943
GY + K DI+S G +L E+ + P + + KI L
Sbjct: 211 NGY----NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC----KKIEQCDY--PPLPS 260
Query: 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNRY 1000
+ H EE+ ++ +C P+ RP + V + SS + + +
Sbjct: 261 D-----HYSEELRQLVN---MCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-36
Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 51/301 (16%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+ +G G G+V+K ++A K + +++ + E+ VL + IV
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLI---HLEIKPAIRNQIIRELQVLHECNSPYIVG 95
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
G ++D + I E+M+ GSL + L K+AGR+ + + +++ V +GL YL
Sbjct: 96 FYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGK--VSIAVIKGLTYLREKH 151
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM---VAGSYGYIAPE---- 883
I+HRD+K +NIL++S E ++ DFG++ +I SM G+ Y++PE
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQG 204
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943
Y + DI+S G+ L+E+ GR P+ P + ++++ +++ P
Sbjct: 205 THY----SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260
Query: 944 NVGNCKH-----------------VQEEMLLVLRIAF---------LCTAKLPKDRPSMR 977
K V E + F C K P +R ++
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 320
Query: 978 D 978
Sbjct: 321 Q 321
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-36
Identities = 77/225 (34%), Positives = 115/225 (51%), Gaps = 37/225 (16%)
Query: 706 CIRESNVIGMGATGIVYKA----EMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLG 761
C+ VIG G G VYK + VA+K L +A + DF+GE ++G
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL---KAGYTEKQRVDFLGEAGIMG 101
Query: 762 KLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIAL 817
+ H NI+RL G + MMI+ EYM NG+L + L ++ G LV
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGM------LR 154
Query: 818 GVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY 877
G+A G+ YL + Y +HRD+ + NIL++SNL +++DFGL+R++ E +G
Sbjct: 155 GIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG-- 209
Query: 878 GYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
G I APE Y +T D++SFG+V+ E++T G RP
Sbjct: 210 GKIPIRWTAPEAISYRKFTSAS----DVWSFGIVMWEVMTYGERP 250
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 22/221 (9%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
++G GAT V++ + + A+K + + E VL KL H+NIV+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV---QMREFEVLKKLNHKNIVKL 72
Query: 772 LGFLHNDTNMMI--VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
T + E+ GSL L L + + V G+ +L +
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLREN 131
Query: 830 CYPPIIHRDIKSNNILLDSNLEPR----IADFGLARMMIRKNETVSMVAGSYGYIAPE-- 883
I+HR+IK NI+ + + + DFG AR + +E + G+ Y+ P+
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLYGTEEYLHPDMY 187
Query: 884 ------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFG 918
+ K +D++S GV TG P P G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-36
Identities = 77/299 (25%), Positives = 122/299 (40%), Gaps = 48/299 (16%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLN----TIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
+++ +G G G V N +VAVK L +AD + + E+++L
Sbjct: 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL---KADAGPQHRSGWKQEIDILRT 89
Query: 763 LRHRNIVRLLG--FLHNDTNMMIVYEYMNNGSLGEALHGKQAG-RLLVDWVSRYNIALGV 819
L H +I++ G ++ +V EY+ GSL + L G L+ + A +
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQI 143
Query: 820 AQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGY 879
+G+AYLH Y IHRD+ + N+LLD++ +I DFGLA+ + +E +
Sbjct: 144 CEGMAYLHAQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200
Query: 880 I---APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDI-VEWIRMK 930
+ APE + D++SFGV L ELLT P I + +M
Sbjct: 201 VFWYAPECLKEYKFYYAS----DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256
Query: 931 IRDNRNLEEALD-----PNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
L E L+ P C V M C RP+ ++I +L
Sbjct: 257 ---VLRLTELLERGERLPRPDKCPAEVYHLMK-------NCWETEASFRPTFENLIPIL 305
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-35
Identities = 71/290 (24%), Positives = 122/290 (42%), Gaps = 49/290 (16%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH 765
I + +G G G VY+ + + VAVK L + D +F+ E V+ +++H
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVE--EFLKEAAVMKEIKH 275
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALGVAQ 821
N+V+LLG + I+ E+M G+L + L + L+ +A ++
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY------MATQISS 329
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGY-- 879
+ YL + IHR++ + N L+ N ++ADFGL+R ++ + + +
Sbjct: 330 AMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 385
Query: 880 IAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP----LDPEFGESVDIVEWIRMKIRDN 934
APE K K D+++FGV+L E+ T G P + E ++ + RM+
Sbjct: 386 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMER--- 440
Query: 935 RNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
P C + V E M C P DRPS ++
Sbjct: 441 --------PE--GCPEKVYELMR-------ACWQWNPSDRPSFAEIHQAF 473
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 31/220 (14%)
Query: 707 IRESNVIGMGATGIVYKA----EMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
++ V+G GA G VYK E ++ VA+K+L R +++ + + E V+
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEILDEAYVMAS 73
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALG 818
+ + ++ RLLG T + ++ + M G L + + + + L++W +
Sbjct: 74 VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNW------CVQ 125
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG 878
+A+G+ YL +HRD+ + N+L+ + +I DFGLA+ ++ E G G
Sbjct: 126 IAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAK-LLGAEEKEYHAEG--G 179
Query: 879 YI-----APEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP 912
+ A E + D++S+GV + EL+T G +P
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 56/292 (19%), Positives = 101/292 (34%), Gaps = 46/292 (15%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLW-RSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G G V E A+K++ + D E + E ++ H NI+R
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-----EAQREADMHRLFNHPNILR 90
Query: 771 LLGFLHNDTNMM----IVYEYMNNGSLGEAL-HGKQAGRLLVDWVSRYNIALGVAQGLAY 825
L+ + + ++ + G+L + K G L + + LG+ +GL
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLGICRGLEA 149
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA---------GS 876
+H HRD+K NILL +P + D G E +
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 877 YGYIAPE----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIR 932
Y APE + +DE+ D++S G VL ++ G P + + + + +
Sbjct: 207 ISYRAPELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGP----YDMVFQKGDSVALAV- 260
Query: 933 DNRNLEEALDPNVGN-CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
L P + + M+ P RP + +++ L
Sbjct: 261 -QNQLSIPQSPRHSSALWQLLNSMM----------TVDPHQRPHIPLLLSQL 301
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVR 770
++G G G VYK + + A+K + D+ + + E+N+L K HRNI
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVM-----DVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 771 LLG-FLH-----NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLA 824
G F+ D + +V E+ GS+ + + + L +W++ I + +GL+
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLS 143
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFG----LARMMIRKNETVSMVAGSYGYI 880
+LH +IHRDIK N+LL N E ++ DFG L R + R+N + + G+ ++
Sbjct: 144 HLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN---TFI-GTPYWM 196
Query: 881 APE---------YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
APE Y D K D++S G+ +E+ G PL
Sbjct: 197 APEVIACDENPDATY----DFKSDLWSLGITAIEMAEGAPPL 234
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-35
Identities = 53/221 (23%), Positives = 86/221 (38%), Gaps = 32/221 (14%)
Query: 711 NVIGMGAT--GIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDF---VGEVNVLGKLRH 765
VIG G V A V V+++ +LE S+ GE++V H
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRI-----NLEACSNEMVTFLQGELHVSKLFNH 85
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAY 825
NIV D + +V +M GS + + + ++ I GV + L Y
Sbjct: 86 PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIA--YILQGVLKALDY 143
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFG----LARMMIRKNETVSMVAGSYG--- 878
+HH Y +HR +K+++IL+ + + ++ + R+ S
Sbjct: 144 IHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 879 YIAPE------YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
+++PE GY D K DIYS G+ EL G P
Sbjct: 201 WLSPEVLQQNLQGY----DAKSDIYSVGITACELANGHVPF 237
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 46/226 (20%), Positives = 91/226 (40%), Gaps = 29/226 (12%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG-------------EVN 758
+ G + E + N A+KK +S + + + + E+
Sbjct: 38 TLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 759 VLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSL------GEALHGKQAGRLLVDWVSR 812
++ +++ + G + N + I+YEYM N S+ L + + +
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 813 YNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM 872
V +Y+H+ I HRD+K +NIL+D N +++DFG + M ++ +
Sbjct: 156 I--IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKG 209
Query: 873 VAGSYGYIAPE--YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPE 916
G+Y ++ PE + K+DI+S G+ L + P +
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 28/211 (13%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G G+ G VYKA IVA+K++ +E++ + + E++++ + ++V+
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV-----PVESDLQ-EIIKEISIMQQCDSPHVVK 88
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
G +T++ IV EY GS+ + + + L D ++ I +GL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIAT--ILQSTLKGLEYLHFM- 144
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFG----LARMMIRKNETVSMVAGSYGYIAPE--- 883
IHRDIK+ NILL++ ++ADFG L M ++N +++ + ++APE
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN---TVIGTPF-WMAPEVIQ 198
Query: 884 -YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
GY + DI+S G+ +E+ G+ P
Sbjct: 199 EIGY----NCVADIWSLGITAIEMAEGKPPY 225
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-35
Identities = 89/462 (19%), Positives = 155/462 (33%), Gaps = 29/462 (6%)
Query: 76 VEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSL-ANLTSLKRFDVSQNFL 134
+ L LS ++S L L L L N + SL + L+ DVS N L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRL 112
Query: 135 NGSFPAGLGGAAGLTFLNASGNNFSGF-LLEDLGNATSLETLDLRGSFFQGSIPVSFKNL 193
+ A L L+ S N+F + ++ GN T L L L + F+ + +L
Sbjct: 113 -QNISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL 169
Query: 194 Q-KLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNE-------FDGEIPVEFGNLTNLK 245
L L ++ G L ++ ++ + + L+N+K
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229
Query: 246 YLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRL-----PAEIGNITSLQLLDLSYN 300
D L + LL + + + L + +L+
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289
Query: 301 ML--SHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDL 358
E T LK+L + ++ A ++ + L + V
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349
Query: 359 GKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFS--GPIPVSLSTCHSLVRVR 416
S +L+ + N F+ + L LIL N + + SL +
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLD 409
Query: 417 MQNNQL-SGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLP 475
+ N L S E + L L++N LTG + + + +D+ N + S+P
Sbjct: 410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRI-MSIP 466
Query: 476 STILSIPNLQTFIVSNNNLVGEIPD-QFQDCPSLSVLDLSSN 516
+ + LQ V++N L +PD F SL + L N
Sbjct: 467 KDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-33
Identities = 98/475 (20%), Positives = 179/475 (37%), Gaps = 35/475 (7%)
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVS-FKNLQK 195
P L L+ S N+ S + D+ + L L L + + S+ F Q
Sbjct: 45 HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 196 LKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPV--EFGNLTNLKYLDLAVGN 253
L++L +S N L I ++S+ + L++N+FD +PV EFGNLT L +L L+
Sbjct: 102 LEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAK 157
Query: 254 LGGKIPAELGRLELLEIMFLYQNNFQGRLPAEI---GNITSLQLLDLSYNMLSHEIPAEI 310
+ L L I+ + E N T L L+ ++ S ++ +
Sbjct: 158 FRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217
Query: 311 TQLKNLQLLNLMCNQLSGH----VPAGLGGLTQLEVLELWNNSLSGPLPVDLGKN---SP 363
L +LQL N+ N + + L L + L + + V L + P
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277
Query: 364 LQWLDLSSNSFSGEIPASLCNGGNLTKLILF-----NNAFSGPIPVSLSTCHSLVRVRMQ 418
+++L++ + + + I L N F S + +
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337
Query: 419 NNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTI 478
+ V L N T + ++ L + + RN L +
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL-KNFFKVA 396
Query: 479 LSIPNLQTFIVSNNNLV----GEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVN 534
L N+ + + +L S+ VL+LSSN +GS+ + K+
Sbjct: 397 LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKV 454
Query: 535 LNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPEN-FGASPALEVLNVSYN 588
L+L NN++ IPK ++ + L L++++N L +P+ F +L+ + + N
Sbjct: 455 LDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 6e-31
Identities = 93/486 (19%), Positives = 172/486 (35%), Gaps = 51/486 (10%)
Query: 99 SLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGL-GGAAGLTFLNASGNN 157
+L+L N + ++ L+ L+ +S N + S + L +L+ S N
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNR 111
Query: 158 FSGFLLEDLGNATSLETLDLRGSFFQGSIPVS--FKNLQKLKFLGLSGNNLTGKIPRELG 215
SL LDL + F +PV F NL KL FLGLS ++ L
Sbjct: 112 LQNIS---CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-QLD--LL 164
Query: 216 QLSSMETMILAYNEFDGEIP-VEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLY 274
++ + + + I E +L +L ++F
Sbjct: 165 PVAHLHLSCILLDLVSYHIKGGETESLQIPN-------------------TTVLHLVFHP 205
Query: 275 QNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQ-------LKNLQLLNLMCNQLS 327
+ F ++ + + LQL ++ N + + L N+ L ++
Sbjct: 206 NSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKC 265
Query: 328 GHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNS-----PLQWLDLSSNSFSGEIPASL 382
+E L ++N +++ + + S L + + F A
Sbjct: 266 SVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALY 325
Query: 383 CNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELA 442
+ +L + V + S + N + ++ G L++LQ L L
Sbjct: 326 SVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQ 385
Query: 443 NNSLT--GGITDDIASSTSLSFIDISRNHLRSSLPSTILSIP-NLQTFIVSNNNLVGEIP 499
N L + + +SL +D+S N L S + ++ +S+N L G +
Sbjct: 386 RNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVF 445
Query: 500 DQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPK-AISMMPTLAI 558
P + VLDL +N SIP + + L LN+ +NQL +P + +L
Sbjct: 446 RCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQY 501
Query: 559 LDLSNN 564
+ L +N
Sbjct: 502 IWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-26
Identities = 76/419 (18%), Positives = 125/419 (29%), Gaps = 55/419 (13%)
Query: 72 SNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNS--LANLTSLKRFDV 129
N +E LD+SH L + + SL L+L N LP NLT L +
Sbjct: 98 FNQDLEYLDVSHNRLQ---NISCCPMASLRHLDLSFNDF-DVLPVCKEFGNLTKLTFLGL 153
Query: 130 SQNFL-NGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNAT------------------ 170
S L+ + G E L
Sbjct: 154 SAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQV 213
Query: 171 ----------SLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSM 220
L + L Q + + + L ++ ++ +
Sbjct: 214 NMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273
Query: 221 ETMILAYNEFD----------GEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEI 270
+ Y E L +L + A + I
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333
Query: 271 MFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHV 330
L ++ + +S L+ + N+ + + + LK LQ L L N L +
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NF 392
Query: 331 PAGLGGLTQLEVLELWNNSL----SGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGG 386
+ LE + SL S + L+LSSN +G + L
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PP 450
Query: 387 NLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANN 444
+ L L NN IP ++ +L + + +NQL ++P G F RL LQ + L +N
Sbjct: 451 KVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 2e-20
Identities = 63/338 (18%), Positives = 123/338 (36%), Gaps = 22/338 (6%)
Query: 79 LDLSHMNLSGCVSDHFQRLK-SLTSLNLCCNGLFSSLPN-SLANLTSLKRFDVSQNFLNG 136
LDL ++ G ++ Q ++ L N LFS N S+ L L+ ++ N N
Sbjct: 176 LDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENC 235
Query: 137 SFPAGLGGAAG-------LTFLNASGNNFSGFLLEDLGNATSLETL-----DLRGSFFQG 184
+T + L +E L + +
Sbjct: 236 QRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDRE 295
Query: 185 SIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNL 244
S L+ L + + M +L+ ++ V + ++
Sbjct: 296 EFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSF 355
Query: 245 KYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQ--GRLPAEIGNITSLQLLDLSYNML 302
+L+ + L+ L+ + L +N + ++ N++SL+ LD+S N L
Sbjct: 356 TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSL 415
Query: 303 SHEIPAEITQL-KNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKN 361
+ +++ +LNL N L+G V L +++VL+L NN + +P D+
Sbjct: 416 NSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMS-IPKDVTHL 472
Query: 362 SPLQWLDLSSNSFSGEIP-ASLCNGGNLTKLILFNNAF 398
LQ L+++SN +P +L + L +N +
Sbjct: 473 QALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 1e-13
Identities = 43/160 (26%), Positives = 71/160 (44%), Gaps = 10/160 (6%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPN---SLANLTSLKRFDVSQNF 133
L+ + + V LK L +L L NGL + N++SL+ DVS N
Sbjct: 356 TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLNS 414
Query: 134 L-NGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKN 192
L + ++ A + LN S N +G + L ++ LDL + SIP +
Sbjct: 415 LNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTH 471
Query: 193 LQKLKFLGLSGNNLTGKIPRE-LGQLSSMETMILAYNEFD 231
LQ L+ L ++ N L +P +L+S++ + L N +D
Sbjct: 472 LQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 40/205 (19%), Positives = 72/205 (35%), Gaps = 8/205 (3%)
Query: 79 LDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSF 138
+ + + + L + + +S + +QN S
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369
Query: 139 PAGLGGAAGLTFLNASGNNFS--GFLLEDLGNATSLETLDLRGSFFQ-GSIPVSFKNLQK 195
G L L N + N +SLETLD+ + + + +
Sbjct: 370 FQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429
Query: 196 LKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLG 255
+ L LS N LTG + R L ++ + L N IP + +L L+ L++A N
Sbjct: 430 ILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVA-SNQL 485
Query: 256 GKIPAE-LGRLELLEIMFLYQNNFQ 279
+P RL L+ ++L+ N +
Sbjct: 486 KSVPDGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 42/229 (18%), Positives = 88/229 (38%), Gaps = 34/229 (14%)
Query: 367 LDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTI 426
+D S+ + + +P L L L N+ S +S L +R+ +N++ ++
Sbjct: 36 VDYSNRNLT-HVPKDLPP--RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SL 91
Query: 427 PVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQ 485
F + L+ L++++N L I+ SL +D+S N LP
Sbjct: 92 DFHVFLFNQDLEYLDVSHNRLQN-ISCCPM--ASLRHLDLSFNDF-DVLP---------- 137
Query: 486 TFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCE-KLVNLNLRNNQLTG 544
+ +F + L+ L LS+ F +A + L+L + + G
Sbjct: 138 ------------VCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKG 185
Query: 545 DIPKAISMMPT--LAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
+++ + T L ++ N+ + + + A L++ N+ N
Sbjct: 186 GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN 234
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G ++ + A K + +S L+ E+++ L H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
GF ++ + +V E SL E K+ L Y + G YLH +
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYY--LRQIVLGCQYLHRNR-- 135
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----YGYTL 888
+IHRD+K N+ L+ +LE +I DFGLA + E ++ G+ YIAPE G+
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-- 192
Query: 889 KVDEKIDIYSFGVVLLELLTGRRPLD 914
++D++S G ++ LL G+ P +
Sbjct: 193 --SFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGD-FVGEVNVLGKLRHRNIVRL 771
+G G+ VY+AE VA+K + + + EV + +L+H +I+ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKA--MYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
+ + + +V E +NG + L K + + +R+ + + G+ YLH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMH-QIITGMLYLHSHG- 132
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----YGYT 887
I+HRD+ +N+LL N+ +IADFGLA + +E + G+ YI+PE +
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH- 189
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRPLD 914
+ D++S G + LL GR P D
Sbjct: 190 ---GLESDVWSLGCMFYTLLIGRPPFD 213
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 74/301 (24%), Positives = 120/301 (39%), Gaps = 48/301 (15%)
Query: 706 CIRESNVIGMGATGIVYKAE----MPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLG 761
++ +G G G V +VAVKKL + E DF E+ +L
Sbjct: 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLR-DFEREIEILK 66
Query: 762 KLRHRNIVRLLGFLHNDTN--MMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNI 815
L+H NIV+ G ++ + ++ EY+ GSL + L K R+ L+ +
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQY------ 119
Query: 816 ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG 875
+ +G+ YL Y IHRD+ + NIL+++ +I DFGL +++ + E +
Sbjct: 120 TSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 876 SYGYI---APE---YG-YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIR 928
I APE +++ D++SFGVVL EL T E + ++ +
Sbjct: 177 GESPIFWYAPESLTESKFSVAS----DVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 929 MKIRDNRNLEEALD-----PNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982
+L E L P C + M C RPS RD+
Sbjct: 233 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMT-------ECWNNNVNQRPSFRDLALR 285
Query: 983 L 983
+
Sbjct: 286 V 286
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 70/303 (23%), Positives = 119/303 (39%), Gaps = 67/303 (22%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
V+G GA G V KA + A+KK+ + L + EV +L L H+ +VR
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-----TILSEVMLLASLNHQYVVRY 67
Query: 772 LGFLHNDTNMM-------------IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALG 818
N + I EY NG+L + + + L + +
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQ 124
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA---- 874
+ + L+Y+H IIHRD+K NI +D + +I DFGLA+ + R + + + +
Sbjct: 125 ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 875 ----------GSYGYIAPE-------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEF 917
G+ Y+A E Y +EKID+YS G++ E++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHY------NEKIDMYSLGIIFFEMIYP-----FST 230
Query: 918 GESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMR 977
G + ++ R++ P+ + K E+ + I L P RP R
Sbjct: 231 GMERVNI------LKKLRSVSIEFPPDFDDNKMKVEKKI----IRLLIDHD-PNKRPGAR 279
Query: 978 DVI 980
++
Sbjct: 280 TLL 282
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-35
Identities = 69/288 (23%), Positives = 119/288 (41%), Gaps = 23/288 (7%)
Query: 290 TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLELWNN 348
LLDL N ++ + LKNL L L+ N++S + G L +LE L L N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKN 110
Query: 349 SLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNG-GNLTKLILFNNAF-SGPIPV-S 405
L LP + K LQ L + N + ++ S+ NG + + L N S I +
Sbjct: 111 QLKE-LPEKMPKT--LQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 166
Query: 406 LSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDI 465
L +R+ + ++ TIP G L L L N +T + +L+ + +
Sbjct: 167 FQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 223
Query: 466 SRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSS 525
S N + + ++ + P+L+ ++NN LV ++P D + V+ L +N S +I S+
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSN 281
Query: 526 -------IASCEKLVNLNLRNNQLTGDI--PKAISMMPTLAILDLSNN 564
++L +N + P + A + L N
Sbjct: 282 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 60/309 (19%), Positives = 113/309 (36%), Gaps = 31/309 (10%)
Query: 62 HCNWTGVWCNSNG----------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLF 111
C+ V C+ G LDL + ++ F+ LK+L +L L N +
Sbjct: 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 112 SSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATS 171
P + A L L+R +S+N L P + L L N +
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQ 146
Query: 172 LETLDLRG-SFFQGSIPV-SFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNE 229
+ ++L I +F+ ++KL ++ ++ N+T IP+ L S+ + L N+
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNK 203
Query: 230 FDGEIPVE-FGNLTNLKYLDLAVGNLGGKIPAE-LGRLELLEIMFLYQNNFQGRLPAEIG 287
++ L NL L L+ N + L L + L N ++P +
Sbjct: 204 IT-KVDAASLKGLNNLAKLGLS-FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260
Query: 288 NITSLQLLDLSYNMLSH------EIPAEITQLKNLQLLNLMCNQLSGH-VPAGL-GGLTQ 339
+ +Q++ L N +S P T+ + ++L N + + +
Sbjct: 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 320
Query: 340 LEVLELWNN 348
++L N
Sbjct: 321 RAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 56/306 (18%), Positives = 111/306 (36%), Gaps = 66/306 (21%)
Query: 291 SLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSL 350
L+++ S L ++P ++ + LL+L N+++ L L L L NN +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 351 SGPLPVDLGKNSP-LQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTC 409
S + L+ L LS N E+P
Sbjct: 89 SK-ISPGAFAPLVKLERLYLSKNQLK-ELPE---------------KMPK---------- 121
Query: 410 HSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLT-GGITDDI-ASSTSLSFIDIS 466
+L +R+ N+++ + F L ++ +EL N L GI + LS+I I+
Sbjct: 122 -TLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179
Query: 467 RNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQ-FQDCPSLSVLDLSSNYFSGSIPSS 525
++ +++P + P+L + N + ++ + +L+ L LS
Sbjct: 180 DTNI-TTIPQGLP--PSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLS----------- 224
Query: 526 IASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNV 585
N ++ +++ P L L L+NN L +P ++V+ +
Sbjct: 225 -------------FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270
Query: 586 SYNRLE 591
N +
Sbjct: 271 HNNNIS 276
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-35
Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 22/221 (9%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
++G GAT V++ + + A+K + + E VL KL H+NIV+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV---QMREFEVLKKLNHKNIVKL 72
Query: 772 LGFLHNDTNMMI--VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
T + E+ GSL L L + + V G+ +L +
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLREN 131
Query: 830 CYPPIIHRDIKSNNILLDSNLEPR----IADFGLARMMIRKNETVSMVAGSYGYIAPE-- 883
I+HR+IK NI+ + + + DFG AR + +E + G+ Y+ P+
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLYGTEEYLHPDMY 187
Query: 884 ------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFG 918
+ K +D++S GV TG P P G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 30/214 (14%)
Query: 712 VIGMGATGIVYKAE--MPRLNTIVAVKKLWRSRAD-LETESSGDFVGEVNVLGKLRHRNI 768
+G G G V K M ++ VAVK L + + + + + E NV+ +L + I
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKIL---KNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEAL--HGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
VR++G ++ M+V E G L + L + + +++ V+ G+ YL
Sbjct: 81 VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMKYL 133
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS---YGYIAPE 883
+ +HRD+ + N+LL + +I+DFGL++ + + APE
Sbjct: 134 EESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 884 ---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
Y ++ K D++SFGV++ E + G++P
Sbjct: 191 CINYYKFSSKS----DVWSFGVLMWEAFSYGQKP 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-35
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G G ++ + A K + +S L+ E+++ L H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYP 832
GF ++ + +V E SL E K+ L Y + G YLH +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYY--LRQIVLGCQYLHRNR-- 161
Query: 833 PIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY----GYTL 888
+IHRD+K N+ L+ +LE +I DFGLA + E ++ G+ YIAPE G+
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-- 218
Query: 889 KVDEKIDIYSFGVVLLELLTGRRPLD 914
++D++S G ++ LL G+ P +
Sbjct: 219 --SFEVDVWSIGCIMYTLLVGKPPFE 242
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 31/212 (14%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG--DFVGEVNVLGKLRHRNIV 769
IG G+ G V+K R +VA+K + DLE D E+ VL + +
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKII-----DLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
+ G DT + I+ EY+ GS + L + G L ++ I + +GL YLH +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIA--TILREILKGLDYLHSE 138
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFG----LARMMIRKNETVSMVAGSYGYIAPE-- 883
IHRDIK+ N+LL + E ++ADFG L I++N + V + ++APE
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN---TFVGTPF-WMAPEVI 191
Query: 884 --YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
Y D K DI+S G+ +EL G P
Sbjct: 192 KQSAY----DSKADIWSLGITAIELARGEPPH 219
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-35
Identities = 74/301 (24%), Positives = 120/301 (39%), Gaps = 48/301 (15%)
Query: 706 CIRESNVIGMGATGIVYKAE----MPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLG 761
++ +G G G V +VAVKKL + E DF E+ +L
Sbjct: 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLR-DFEREIEILK 97
Query: 762 KLRHRNIVRLLGFLHNDTN--MMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNI 815
L+H NIV+ G ++ + ++ EY+ GSL + L K R+ L+ +
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQY------ 150
Query: 816 ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG 875
+ +G+ YL Y IHRD+ + NIL+++ +I DFGL +++ + E +
Sbjct: 151 TSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP 207
Query: 876 SYGYI---APE---YG-YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIR 928
I APE +++ D++SFGVVL EL T E + ++ +
Sbjct: 208 GESPIFWYAPESLTESKFSVAS----DVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 263
Query: 929 MKIRDNRNLEEALD-----PNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982
+L E L P C + M C RPS RD+
Sbjct: 264 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMT-------ECWNNNVNQRPSFRDLALR 316
Query: 983 L 983
+
Sbjct: 317 V 317
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-34
Identities = 51/217 (23%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 706 CIRESNVIGMGATGIVYKAE--MPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL 763
+ +G G G V + M + VA+K L + E + + + E ++ +L
Sbjct: 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQL 393
Query: 764 RHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALGV 819
+ IVRL+G + +M+V E G L + L GK+ + + + V
Sbjct: 394 DNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAEL------LHQV 445
Query: 820 AQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGY 879
+ G+ YL + +HR++ + N+LL + +I+DFGL++ + + + +
Sbjct: 446 SMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502
Query: 880 I---APEYGYTLKVDEKIDIYSFGVVLLELLT-GRRP 912
+ APE K + D++S+GV + E L+ G++P
Sbjct: 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH 765
I + +G G G VY+ + + VAVK L + D T +F+ E V+ +++H
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KED--TMEVEEFLKEAAVMKEIKH 68
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALGVAQ 821
N+V+LLG + I+ E+M G+L + L + L+ +A ++
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY------MATQISS 122
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI- 880
+ YL + IHRD+ + N L+ N ++ADFGL+R+M + A +
Sbjct: 123 AMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFP 175
Query: 881 ----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
APE Y +++K D+++FGV+L E+ T G P
Sbjct: 176 IKWTAPESLAYNKFSIKS----DVWAFGVLLWEIATYGMSP 212
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 39/224 (17%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLN---TIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
+ + ++G G G VY+ VAVK + D ++ F+ E ++
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC---KKDCTLDNKEKFMSEAVIMKN 69
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALG 818
L H +IV+L+G + + I+ E G LG L + L LV + +L
Sbjct: 70 LDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLE-RNKNSLKVLTLVLY------SLQ 121
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG 878
+ + +AYL +HRDI NIL+ S ++ DFGL+R + ++ S
Sbjct: 122 ICKAMAYLESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY----KASVT 174
Query: 879 YI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
+ +PE + +T D++ F V + E+L+ G++P
Sbjct: 175 RLPIKWMSPESINFRRFTTAS----DVWMFAVCMWEILSFGKQP 214
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG--DFVGEVNVLGKLRHRNIV 769
VIG GAT +V A VA+K++ +LE + + + E+ + + H NIV
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRI-----NLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEAL-HGKQAGRLLVDWVSRYNIAL---GVAQGLAY 825
+ +V + ++ GS+ + + H G + IA V +GL Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM-----VAGSYGYI 880
LH + IHRD+K+ NILL + +IADFG++ + + G+ ++
Sbjct: 137 LHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 881 APE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
APE GY D K DI+SFG+ +EL TG P
Sbjct: 194 APEVMEQVRGY----DFKADIWSFGITAIELATGAAPY 227
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-34
Identities = 60/290 (20%), Positives = 100/290 (34%), Gaps = 53/290 (18%)
Query: 712 VIGMGATGIVYKAEMPRLNT-IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
I G G +Y A +N V +K L + E+ + E L ++ H +IV+
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGL---VHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 771 LLGF-----LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAY 825
+ F H D IV EY+ SL + +L V L + L+Y
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIA--YLLEILPALSY 197
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYG 885
LH +++ D+K NI+L + ++ D G + N + G+ G+ APE
Sbjct: 198 LHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI---NSF-GYLYGTPGFQAPEI- 248
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945
DIY+ G L L + G VD + ++ +
Sbjct: 249 VRTGPTVATDIYTVGRTLAALTLDLPTRN---GRYVDGLPEDDPVLKTYDSYGR------ 299
Query: 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPS----MR-DVITMLGEAKPRR 990
L+ R P+ R + M + +L E +
Sbjct: 300 -----------LLRR----AIDPDPRQRFTTAEEMSAQLTGVLREVVAQD 334
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 56/224 (25%), Positives = 91/224 (40%), Gaps = 39/224 (17%)
Query: 706 CIRESNVIGMGATGIVYKAEM---PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
I IG G G V++ VA+K + F+ E + +
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC---KNCTSDSVREKFLQEALTMRQ 72
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALG 818
H +IV+L+G + + + I+ E G L L + L L+ + A
Sbjct: 73 FDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ-VRKYSLDLASLILY------AYQ 124
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG 878
++ LAYL + +HRDI + N+L+ SN ++ DFGL+R M S G
Sbjct: 125 LSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKG 177
Query: 879 YI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
+ APE + +T D++ FGV + E+L G +P
Sbjct: 178 KLPIKWMAPESINFRRFTSAS----DVWMFGVCMWEILMHGVKP 217
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 75/308 (24%), Positives = 127/308 (41%), Gaps = 63/308 (20%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVL 760
+R +G G VYK + VA+K L + E +F E +
Sbjct: 10 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL---KDKAEGPLREEFRHEAMLR 66
Query: 761 GKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL--HGKQAGRLLVDWVSRY----- 813
+L+H N+V LLG + D + +++ Y ++G L E L + D
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 814 -----NIALGVAQGLAYL--HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866
++ +A G+ YL HH ++H+D+ + N+L+ L +I+D GL R +
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 867 NETVSMVAGSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRPLDPE 916
+ + APE YG +++ D I+S+GVVL E+ + G +P
Sbjct: 182 DYYK---LLGNSLLPIRWMAPEAIMYGKFSIDSD----IWSYGVVLWEVFSYGLQPY--- 231
Query: 917 FGESVDIVEWIRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPS 975
G S V + M IR+ + L P+ +C V M+ C + P RP
Sbjct: 232 CGYSNQDV--VEM-IRNRQVLPC---PD--DCPAWVYALMIE-------CWNEFPSRRPR 276
Query: 976 MRDVITML 983
+D+ + L
Sbjct: 277 FKDIHSRL 284
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH 765
+ IG G G+V+ VA+K + R +E DF+ E V+ KL H
Sbjct: 9 ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTI---REGAMSEE--DFIEEAEVMMKLSH 62
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAY 825
+V+L G + +V E+M +G L + L ++ + + L V +G+AY
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG---MCLDVCEGMAY 119
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI---AP 882
L C IHRD+ + N L+ N +++DFG+ R ++ T S G+ + +P
Sbjct: 120 LEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS--TGTKFPVKWASP 174
Query: 883 E---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
E + Y+ K D++SFGV++ E+ + G+ P
Sbjct: 175 EVFSFSRYSSKS----DVWSFGVLMWEVFSEGKIP 205
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 4e-34
Identities = 86/291 (29%), Positives = 131/291 (45%), Gaps = 53/291 (18%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH 765
+R +G G G V+ T VA+K L + T S F+ E V+ KLRH
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTL---KPG--TMSPEAFLQEAQVMKKLRH 238
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALGVAQ 821
+V+L + + + IV EYM+ GSL + L G+ L LVD A +A
Sbjct: 239 EKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM------AAQIAS 291
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS--YGY 879
G+AY+ Y +HRD+++ NIL+ NL ++ADFGLAR +I NE + +
Sbjct: 292 GMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKW 347
Query: 880 IAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938
APE + K D++SFG++L EL T GR P + M NR +
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-------------YPGM---VNREVL 391
Query: 939 EALD-----PNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
+ ++ P C + + + M C K P++RP+ + L
Sbjct: 392 DQVERGYRMPCPPECPESLHDLMC-------QCWRKEPEERPTFEYLQAFL 435
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-34
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 36/218 (16%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH 765
++ IG G G V + VAVK + + D + F+ E +V+ +LRH
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI---KNDATAQ---AFLAEASVMTQLRH 245
Query: 766 RNIVRLLGF-LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLA 824
N+V+LLG + + IV EYM GSL + L + GR ++ +L V + +
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI---- 880
YL + + +HRD+ + N+L+ + +++DFGL + G +
Sbjct: 304 YLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTKEASS--------TQDTGKLPVKW 352
Query: 881 -APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
APE ++ K D++SFG++L E+ + GR P
Sbjct: 353 TAPEALREKKFSTKS----DVWSFGILLWEIYSFGRVP 386
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 56/272 (20%), Positives = 90/272 (33%), Gaps = 37/272 (13%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVR 770
+G G+ G V+K + AVK+ + + EV K+ +H VR
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRS--MSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L + + E SL + + G L + LA+LH
Sbjct: 122 LEQAWEEGGILYLQTELCG-PSLQQHC--EAWGASLPEAQVW-GYLRDTLLALAHLHSQ- 176
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY---GYT 887
++H D+K NI L ++ DFGL + G Y+APE Y
Sbjct: 177 --GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAPELLQGSYG 233
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGN 947
D++S G+ +LE+ P GE ++R E
Sbjct: 234 TAA----DVFSLGLTILEVACNMEL--PHGGEGWQ-------QLRQGYLPPEFTA----- 275
Query: 948 CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDV 979
+ E+ VL + PK R + +
Sbjct: 276 --GLSSELRSVLV---MMLEPDPKLRATAEAL 302
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-34
Identities = 59/296 (19%), Positives = 111/296 (37%), Gaps = 24/296 (8%)
Query: 281 RLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAG-LGGLTQ 339
+P EI LLDL N +S + L++L L L+ N++S + L +
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRK 103
Query: 340 LEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNG-GNLTKLILFNNAF 398
L+ L + N L +P +L + L L + N ++P + +G N+ + + N
Sbjct: 104 LQKLYISKNHLVE-IPPNLPSS--LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPL 159
Query: 399 -SGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASS 457
+ L +R+ +L+ IP E L L L +N + +D+
Sbjct: 160 ENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRY 216
Query: 458 TSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNY 517
+ L + + N +R ++ +P L+ + NN L +P D L V+ L +N
Sbjct: 217 SKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNN 275
Query: 518 FSGSIPSSI-------ASCEKLVNLNLRNNQLTGDI--PKAISMMPTLAILDLSNN 564
+ + + ++L NN + P + + N
Sbjct: 276 IT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 68/311 (21%), Positives = 114/311 (36%), Gaps = 47/311 (15%)
Query: 291 SLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSL 350
L+++ S L +P EI+ + LL+L N +S GL L L L NN +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 351 SGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCH 410
S LQ L +S N EIP N S
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPP---------------NLPS----------- 123
Query: 411 SLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLT-GGITDDIASSTSLSFIDISRN 468
SLV +R+ +N++ +P G F L + +E+ N L G L+++ IS
Sbjct: 124 SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA 182
Query: 469 HLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQ-FQDCPSLSVLDLSSNYFSGSIPSSIA 527
L + +P + L + +N + I + L L L N S++
Sbjct: 183 KL-TGIPKDLPE--TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238
Query: 528 SCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPEN-------FGASPAL 580
L L+L NN+L+ +P + + L ++ L N++T + N
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296
Query: 581 EVLNVSYNRLE 591
+++ N +
Sbjct: 297 NGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 64/310 (20%), Positives = 115/310 (37%), Gaps = 34/310 (10%)
Query: 62 HCNWTGVWCNSNG----------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLF 111
HC+ V C+ G LDL + ++S D F+ L+ L +L L N +
Sbjct: 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 112 SSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATS 171
+ + L L++ +S+N L P L + L L N +
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRN 148
Query: 172 LETLDLRG-SFFQGSIPV-SFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNE 229
+ +++ G +F L KL +L +S LT IP++L ++ + L +N+
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNK 204
Query: 230 FDGEIPVE-FGNLTNLKYLDLAVGNLGGKIPAE-LGRLELLEIMFLYQNNFQGRLPAEIG 287
I +E + L L L N I L L L + L N R+PA +
Sbjct: 205 IQ-AIELEDLLRYSKLYRLGLG-HNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP 261
Query: 288 NITSLQLLDLSYNMLSHEIPAEI-------TQLKNLQLLNLMCNQLS-GHVPAGL-GGLT 338
++ LQ++ L N ++ ++ + ++L N + V +T
Sbjct: 262 DLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320
Query: 339 QLEVLELWNN 348
++ N
Sbjct: 321 DRLAIQFGNY 330
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG-DFVGEVNVLGKLRHRNIV 769
+G GA G VYKA+ + A K + + ++E D++ E+ +L H IV
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVI-----ETKSEEELEDYIVEIEILATCDHPYIV 79
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
+LLG ++D + I+ E+ G++ + L + + + + L +LH
Sbjct: 80 KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQV--VCRQMLEALNFLHSK 136
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFG----LARMMIRKNETVSMVAGSYGYIAPE-- 883
IIHRD+K+ N+L+ + R+ADFG + + +++ S + Y ++APE
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD---SFIGTPY-WMAPEVV 189
Query: 884 -------YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
Y D K DI+S G+ L+E+ P
Sbjct: 190 MCETMKDTPY----DYKADIWSLGITLIEMAQIEPPH 222
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-33
Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 17/214 (7%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G G G V + VA+K+ R +L ++ + E+ ++ KL H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQC---RQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 772 L------GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAY 825
L + ++ EY G L + L+ + L + R + ++ L Y
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRY 136
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPR---IADFGLARMMIRKNETVSMVAGSYGYIAP 882
LH + IIHRD+K NI+L + I D G A+ + + V G+ Y+AP
Sbjct: 137 LHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-GTLQYLAP 192
Query: 883 EYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPE 916
E K +D +SFG + E +TG RP P
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
IG G G V + VAVK + ++ F+ E +V+ +LRH N+V+
Sbjct: 27 QTIGKGEFGDVMLGDY--RGNKVAVKCI------KNDATAQAFLAEASVMTQLRHSNLVQ 78
Query: 771 LLGF-LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
LLG + + IV EYM GSL + L + GR ++ +L V + + YL +
Sbjct: 79 LLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG------YIAPE 883
+ +HRD+ + N+L+ + +++DFGL + + APE
Sbjct: 137 NF---VHRDLAARNVLVSEDNVAKVSDFGLTKEASST---------QDTGKLPVKWTAPE 184
Query: 884 ---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
++ K D++SFG++L E+ + GR P
Sbjct: 185 ALREKKFSTKS----DVWSFGILLWEIYSFGRVP 214
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 68/214 (31%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGD----FVGEVNVLGKLRHR 766
IG G+ G VY A R + +VA+KK+ + S + + EV L KLRH
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKM-----SYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
N ++ G + +V EY GS + L + L ++ + G QGLAYL
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAA--VTHGALQGLAYL 170
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE--- 883
H +IHRD+K+ NILL ++ DFG A +M N S V Y ++APE
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPY-WMAPEVIL 223
Query: 884 ----YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
Y D K+D++S G+ +EL + PL
Sbjct: 224 AMDEGQY----DGKVDVWSLGITCIELAERKPPL 253
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-33
Identities = 84/430 (19%), Positives = 156/430 (36%), Gaps = 65/430 (15%)
Query: 170 TSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNE 229
+ +DL + SF LQ L+FL + I
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNT--------------- 74
Query: 230 FDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAE-LGRLELLEIMFLYQNNFQG-RLPAEI- 286
F L++L L L N ++ L LE++ L Q N G L
Sbjct: 75 --------FRGLSSLIILKLD-YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFF 125
Query: 287 GNITSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAG-LGGLT--QLEV 342
+TSL++L L N + PA ++ +L+L N++ + L +
Sbjct: 126 KPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTL 184
Query: 343 LELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPI 402
L L + +L D++ E + ++T L L N F +
Sbjct: 185 LRLSSITL----------------QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESM 228
Query: 403 PVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSF 462
++ ++Q+ LS + +G + N + G ++ +
Sbjct: 229 AKRF--FDAIAGTKIQSLILSNSYNMGSS-FGHTNFKDPDNFTFKG------LEASGVKT 279
Query: 463 IDISRNHLRSSLPSTILS-IPNLQTFIVSNNNLVGEIPDQ-FQDCPSLSVLDLSSNYFSG 520
D+S++ + +L ++ S +L+ ++ N + +I D F L L+LS N+
Sbjct: 280 CDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG- 336
Query: 521 SIPSSI-ASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPEN-FGASP 578
SI S + + +KL L+L N + ++ +P L L L N L +P+ F
Sbjct: 337 SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLT 395
Query: 579 ALEVLNVSYN 588
+L+ + + N
Sbjct: 396 SLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 88/428 (20%), Positives = 147/428 (34%), Gaps = 74/428 (17%)
Query: 63 CNWTGVWCNSNG---------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSS 113
C + G V +DLS +++ F RL+ L L +
Sbjct: 10 VIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV 69
Query: 114 LP-NSLANLTSLKRFDVSQNFLNGSFPAG-LGGAAGLTFLNASGNNFSGFLLED--LGNA 169
+ N+ L+SL + N G G A L L + N G +L
Sbjct: 70 IRNNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL 128
Query: 170 TSLETLDLRGSFFQGSIPVS-FKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILA-- 226
TSLE L LR + + P S F N+++ L L+ N + +L +L
Sbjct: 129 TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS 188
Query: 227 --------YNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAE--LGRLELLEIMFLYQN 276
E T++ LDL+ GN + A+ + +I L +
Sbjct: 189 SITLQDMNEYWLGWEKCGNPFKNTSITTLDLS-GNGFKESMAKRFFDAIAGTKIQSLILS 247
Query: 277 NFQGRLPAEIGNI--------------TSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNL 321
N + + ++ DLS + + + + + +L+ L L
Sbjct: 248 NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTL 306
Query: 322 MCNQLSGHVPAG-LGGLTQLEVLELWNNSLSGPLPVDLGKNSP-LQWLDLSSNSFSGEIP 379
N+++ + GLT L L L N L + + +N L+ LDLS N +
Sbjct: 307 AQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIR-ALG 363
Query: 380 ASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQR 438
+ +F G +L + + NQL ++P G F RL LQ+
Sbjct: 364 ---------------DQSFLG--------LPNLKELALDTNQLK-SVPDGIFDRLTSLQK 399
Query: 439 LELANNSL 446
+ L N
Sbjct: 400 IWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 59/321 (18%), Positives = 109/321 (33%), Gaps = 57/321 (17%)
Query: 290 TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGL-GGLTQLEVLELWNN 348
+ +DLS N ++ ++L++LQ L + + GL+ L +L+L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 349 SLSGPLPVD-LGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLS 407
L + L+ L L+ NL +L N F
Sbjct: 90 QFLQ-LETGAFNGLANLEVLTLTQC--------------NLDGAVLSGNFFKP------- 127
Query: 408 TCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDIS 466
SL + +++N + P F + + L+L N + S ++
Sbjct: 128 -LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK--------SICEEDLLNFQ 178
Query: 467 RNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSI 526
H T+L + ++ ++ L E S++ LDLS N F S+
Sbjct: 179 GKHF------TLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF 232
Query: 527 ---ASCEKLVNLNLRNNQLTG---------DIPKAISM---MPTLAILDLSNNSLTGGIP 571
+ K+ +L L N+ G D + DLS + + +
Sbjct: 233 FDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALL 291
Query: 572 EN-FGASPALEVLNVSYNRLE 591
++ F LE L ++ N +
Sbjct: 292 KSVFSHFTDLEQLTLAQNEIN 312
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 35/174 (20%), Positives = 62/174 (35%), Gaps = 19/174 (10%)
Query: 49 PLNSLHDWKLPSAHCNWTGVWCN-------------SNGAVEKLDLSHMNLSGCVSDHFQ 95
+ L +++ + V+ DLS + + F
Sbjct: 237 AGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFS 296
Query: 96 RLKSLTSLNLCCNGLFSSLP-NSLANLTSLKRFDVSQNFLNGSFPAGL-GGAAGLTFLNA 153
L L L N + + + N+ LT L + ++SQNFL GS + + L L+
Sbjct: 297 HFTDLEQLTLAQNEI-NKIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDL 354
Query: 154 SGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVS-FKNLQKLKFLGLSGNNL 206
S N+ + +L+ L L + + S+P F L L+ + L N
Sbjct: 355 SYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 32/211 (15%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLET-ESSGDFVGEVNVLGKLRHRNIVRL 771
IG GA+G VY A VA++++ +L+ + E+ V+ + ++ NIV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-----NLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 772 LG-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L +L D + +V EY+ GSL + + + ++ + Q L +LH +
Sbjct: 83 LDSYLVGDE-LWVVMEYLAGGSLTDVVT---ETCMDEGQIAA--VCRECLQALEFLHSN- 135
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFG----LARMMIRKNETVSMVAGSYGYIAPE--- 883
+IHRDIKS+NILL + ++ DFG + +++ +MV Y ++APE
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---TMVGTPY-WMAPEVVT 189
Query: 884 -YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
Y K+DI+S G++ +E++ G P
Sbjct: 190 RKAY----GPKVDIWSLGIMAIEMIEGEPPY 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH 765
I +G G G+V + + VAVK + + + S +F E + KL H
Sbjct: 9 EITLLKELGSGQFGVVKLGKW-KGQYDVAVKMI---KEG--SMSEDEFFQEAQTMMKLSH 62
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAY 825
+V+ G + + IV EY++NG L L G + + V +G+A+
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLE---MCYDVCEGMAF 119
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI---AP 882
L + IHRD+ + N L+D +L +++DFG+ R ++ S G+ + AP
Sbjct: 120 LESHQF---IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS--VGTKFPVKWSAP 174
Query: 883 E---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
E Y Y+ K D+++FG+++ E+ + G+ P
Sbjct: 175 EVFHYFKYSSKS----DVWAFGILMWEVFSLGKMP 205
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH 765
+ +G G G+V + R VA+K + + + S +F+ E V+ L H
Sbjct: 25 DLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMI---KEG--SMSEDEFIEEAKVMMNLSH 78
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAY 825
+V+L G + I+ EYM NG L L + + + V + + Y
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE---MCKDVCEAMEY 135
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI---AP 882
L + +HRD+ + N L++ +++DFGL+R ++ T S GS + P
Sbjct: 136 LESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS--VGSKFPVRWSPP 190
Query: 883 E---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
E Y ++ K DI++FGV++ E+ + G+ P
Sbjct: 191 EVLMYSKFSSKS----DIWAFGVLMWEIYSLGKMP 221
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG-EVNVLGKLRHRNIV 769
+G G G VY A + I+A+K L +A LE + EV + LRH NI+
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRHPNIL 72
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-H 828
RL G+ H+ T + ++ EY G++ L ++ + + Y +A L+Y H
Sbjct: 73 RLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY--ITELANALSYCHSK 128
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----Y 884
+IHRDIK N+LL S E +IADFG + + + + G+ Y+ PE
Sbjct: 129 R----VIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTDLCGTLDYLPPEMIEGR 182
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRPLD 914
+ DEK+D++S GV+ E L G+ P +
Sbjct: 183 MH----DEKVDLWSLGVLCYEFLVGKPPFE 208
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-33
Identities = 86/291 (29%), Positives = 131/291 (45%), Gaps = 53/291 (18%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH 765
+R +G G G V+ T VA+K L + T S F+ E V+ KLRH
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTL---KPG--TMSPEAFLQEAQVMKKLRH 321
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALGVAQ 821
+V+L + + + IV EYM+ GSL + L G+ L LVD A +A
Sbjct: 322 EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM------AAQIAS 374
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS--YGY 879
G+AY+ Y +HRD+++ NIL+ NL ++ADFGLAR +I NE + +
Sbjct: 375 GMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKW 430
Query: 880 IAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938
APE + K D++SFG++L EL T GR P + M NR +
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-------------YPGM---VNREVL 474
Query: 939 EALD-----PNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
+ ++ P C + + + M C K P++RP+ + L
Sbjct: 475 DQVERGYRMPCPPECPESLHDLMC-------QCWRKEPEERPTFEYLQAFL 518
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-33
Identities = 60/293 (20%), Positives = 106/293 (36%), Gaps = 35/293 (11%)
Query: 282 LPAEIGNITSLQLLDLSYNMLSH---EIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLT 338
+ I N SL + YN +S + + + + L N+ + L +
Sbjct: 3 IMLPINNNFSLSQ-NSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--IN 59
Query: 339 QLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAF 398
Q L+L +LS LP +L + L+++ N+ +P +L L +N
Sbjct: 60 QFSELQLNRLNLSS-LPDNLPPQ--ITVLEITQNALI-SLPELP---ASLEYLDACDNRL 112
Query: 399 SGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASST 458
S +P ++ L + NNQL+ +P L+ + NN LT + + T
Sbjct: 113 ST-LPELPASLKHL---DVDNNQLT-MLPELPA---LLEYINADNNQLTM-LPELP---T 160
Query: 459 SLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLS----VLDLS 514
SL + + N L LP +L+ VS N L +P
Sbjct: 161 SLEVLSVRNNQLTF-LPE---LPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCR 215
Query: 515 SNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLT 567
N + IP +I S + + L +N L+ I +++S +
Sbjct: 216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 67/383 (17%), Positives = 124/383 (32%), Gaps = 44/383 (11%)
Query: 97 LKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGN 156
+ + L L L SSLP++L + +++QN L S P L +L+A N
Sbjct: 58 INQFSELQLNRLNL-SSLPDNL--PPQITVLEITQNAL-ISLPELPAS---LEYLDACDN 110
Query: 157 NFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQ 216
S L E + L+ LD+ + +P L+ + N LT +P
Sbjct: 111 RLS-TLPELPAS---LKHLDVDNNQLT-MLPELPALLEYI---NADNNQLT-MLPELPTS 161
Query: 217 LSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRL----ELLEIMF 272
L E + + N+ +P +L+ LD++ NL +PA R E
Sbjct: 162 L---EVLSVRNNQL-TFLP---ELPESLEALDVS-TNLLESLPAVPVRNHHSEETEIFFR 213
Query: 273 LYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPA 332
+N +P I ++ + L N LS I ++Q + +
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSD 270
Query: 333 GLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDL----SSNSFSGEIPASLCNGGNL 388
G + + D+ W +N+FS L + +
Sbjct: 271 GQQNTLHRPLADAVTAWFPENKQSDV----SQIWHAFEHEEHANTFS-AFLDRLSDTVSA 325
Query: 389 TKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTG 448
F + L + +R Q+ ++ L L L
Sbjct: 326 RNTSGFREQ----VAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVH 381
Query: 449 GITDDIASSTSLSFIDISRNHLR 471
++ + + + + + + R R
Sbjct: 382 QASEGLFDNDTGALLSLGREMFR 404
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 32/211 (15%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLET-ESSGDFVGEVNVLGKLRHRNIVRL 771
IG G+TGIV A VAVK + DL + EV ++ +H N+V +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMM-----DLRKQQRRELLFNEVVIMRDYQHFNVVEM 107
Query: 772 LG-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
+L + + ++ E++ G+L + + RL + ++ + V Q LAYLH
Sbjct: 108 YKSYLVGE-ELWVLMEFLQGGALTDIVS---QVRLNEEQIAT--VCEAVLQALAYLHAQ- 160
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFG----LARMMIRKNETVSMVAGSYGYIAPE--- 883
+IHRDIKS++ILL + +++DFG +++ + ++ S+V Y ++APE
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK---SLVGTPY-WMAPEVIS 214
Query: 884 -YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
Y ++DI+S G++++E++ G P
Sbjct: 215 RSLY----ATEVDIWSLGIMVIEMVDGEPPY 241
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 81/306 (26%), Positives = 132/306 (43%), Gaps = 60/306 (19%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVL 760
I +G GA G V+ AE L +VAVK L + DF E +L
Sbjct: 16 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARK-DFQREAELL 71
Query: 761 GKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRY------- 813
L+H +IV+ G + +++V+EYM +G L + L +++
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 814 -----NIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE 868
+IA +A G+ YL + +HRD+ + N L+ +NL +I DFG++R + +
Sbjct: 132 LSQMLHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 869 TVSMVAGSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFG 918
G + + PE Y +T + D ++SFGV+L E+ T G++P F
Sbjct: 189 YR---VGGHTMLPIRWMPPESIMYRKFTTESD----VWSFGVILWEIFTYGKQPW---FQ 238
Query: 919 ESVDIVEWIRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMR 977
S V I I R LE P C K V + ML C + P+ R +++
Sbjct: 239 LSNTEV--IEC-ITQGRVLER---PR--VCPKEVYDVMLG-------CWQREPQQRLNIK 283
Query: 978 DVITML 983
++ +L
Sbjct: 284 EIYKIL 289
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-33
Identities = 61/302 (20%), Positives = 114/302 (37%), Gaps = 57/302 (18%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLN---TIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
+ ++G G G V + + + + VAVK + + +F+ E +
Sbjct: 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE--EFLSEAACMKD 92
Query: 763 LRHRNIVRLLG-----FLHNDTNMMIVYEYMNNGSLGEAL--HGKQAGRLLVDWVSRYNI 815
H N++RLLG M++ +M G L L + G + +
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 816 ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG 875
+ +A G+ YL + + +HRD+ + N +L ++ +ADFGL++ + + G
Sbjct: 153 MVDIALGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY---RQG 206
Query: 876 SYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP---LDPEFGESVD 922
+ A E YT K D+++FGV + E+ T G P + +
Sbjct: 207 RIAKMPVKWIAIESLADRVYT----SKSDVWAFGVTMWEIATRGMTPYPGVQNH-----E 257
Query: 923 IVEWIRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981
+ + + L++ P +C + E M C P DRP+ +
Sbjct: 258 MYD----YLLHGHRLKQ---PE--DCLDELYEIMY-------SCWRTDPLDRPTFSVLRL 301
Query: 982 ML 983
L
Sbjct: 302 QL 303
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-33
Identities = 70/326 (21%), Positives = 127/326 (38%), Gaps = 65/326 (19%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLN---TIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
++G G G V +A++ + + VAVK L ++ ++ +F+ E + +
Sbjct: 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIE-EFLREAACMKE 81
Query: 763 LRHRNIVRLLGF------LHNDTNMMIVYEYMNNGSLGEAL----HGKQAGRL-LVDWVS 811
H ++ +L+G M++ +M +G L L G+ L L V
Sbjct: 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 812 RYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVS 871
+ +A G+ YL + IHRD+ + N +L ++ +ADFGL+R + +
Sbjct: 142 ---FMVDIACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-- 193
Query: 872 MVAGSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP---LDPEFG 918
G + A E YT D+++FGV + E++T G+ P ++
Sbjct: 194 -RQGCASKLPVKWLALESLADNLYT----VHSDVWAFGVTMWEIMTRGQTPYAGIENA-- 246
Query: 919 ESVDIVEWIRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMR 977
+I + L++ P C + V + M C + PK RPS
Sbjct: 247 ---EIYN----YLIGGNRLKQ---PP--ECMEEVYDLMY-------QCWSADPKQRPSFT 287
Query: 978 DVITMLGE-AKPRRKSSSNNDNRYEN 1002
+ L S++ D Y N
Sbjct: 288 CLRMELENILGHLSVLSTSQDPLYIN 313
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 70/221 (31%), Positives = 112/221 (50%), Gaps = 38/221 (17%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH 765
++ +G G G V+ +T VAVK L + + S F+ E N++ +L+H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSL---KQG--SMSPDAFLAEANLMKQLQH 67
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALGVAQ 821
+ +VRL + + + I+ EYM NGSL + L +L L+D +A +A+
Sbjct: 68 QRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAE 120
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI- 880
G+A++ Y IHRD+++ NIL+ L +IADFGLAR++ T
Sbjct: 121 GMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR----EGAKFP 173
Query: 881 ----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
APE YG +T+K D++SFG++L E++T GR P
Sbjct: 174 IKWTAPEAINYGTFTIKS----DVWSFGILLTEIVTHGRIP 210
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVR 770
+G G G V+K + ++AVK++ R E + + +++V+ K IV+
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQM---RRSGNKEENKRILMDLDVVLKSHDCPYIVQ 88
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
G +T++ I E M + L + G + + + + + + + L YL
Sbjct: 89 CFGTFITNTDVFIAMELMGTCAE--KLKKRMQGPIPERILGK--MTVAIVKALYYLKEKH 144
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR---KNETVSMVAGSYGYIAPE---- 883
+IHRD+K +NILLD + ++ DFG++ ++ K+ + G Y+APE
Sbjct: 145 G--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA----GCAAYMAPERIDP 198
Query: 884 -----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
Y D + D++S G+ L+EL TG+ P
Sbjct: 199 PDPTKPDY----DIRADVWSLGISLVELATGQFPYKN 231
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIV 769
+G GA G+V K I+AVK++ RA + ++ + ++++ + V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRI---RATVNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHG--KQAGRLLVDWVSRYNIALGVAQGLAYLH 827
G L + ++ I E M+ SL + + + D + + IA+ + + L +LH
Sbjct: 70 TFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLH 126
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM--VAGSYGYIAPE-- 883
+IHRD+K +N+L+++ + ++ DFG++ ++ V+ AG Y+APE
Sbjct: 127 SKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD---DVAKDIDAGCKPYMAPERI 181
Query: 884 ------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
GY K DI+S G+ ++EL R P D
Sbjct: 182 NPELNQKGY----SVKSDIWSLGITMIELAILRFPYDS 215
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVR 770
IG GA G V K I+AVK++ R+ ++ + + +++V+ + IV+
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRI---RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEAL---HGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
G L + + I E M+ S + + + + + + I L + L +L
Sbjct: 86 FYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKALNHLK 142
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR---KNETVSMVAGSYGYIAPE- 883
+ IIHRDIK +NILLD + ++ DFG++ ++ K G Y+APE
Sbjct: 143 ENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA----GCRPYMAPER 196
Query: 884 -------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
GY D + D++S G+ L EL TGR P
Sbjct: 197 IDPSASRQGY----DVRSDVWSLGITLYELATGRFPYPK 231
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 85/305 (27%), Positives = 126/305 (41%), Gaps = 59/305 (19%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVL 760
I +G GA G V+ AE L +VAVK L + ++ + DF E +L
Sbjct: 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQ---DFQREAELL 97
Query: 761 GKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL--HGKQAGRLLVDWVSR------ 812
L+H++IVR G +++V+EYM +G L L HG A L
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 813 ---YNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET 869
+A VA G+ YL + +HRD+ + N L+ L +I DFG++R + +
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214
Query: 870 VSMVAGSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGE 919
G + PE Y +T + D ++SFGVVL E+ T G++P +
Sbjct: 215 R---VGGRTMLPIRWMPPESILYRKFTTESD----VWSFGVVLWEIFTYGKQPW---YQL 264
Query: 920 SVDIVEWIRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRD 978
S I I R LE P C V M C + P+ R S++D
Sbjct: 265 SNTEA--IDC-ITQGRELER---PR--ACPPEVYAIMRG-------CWQREPQQRHSIKD 309
Query: 979 VITML 983
V L
Sbjct: 310 VHARL 314
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 79/303 (26%), Positives = 118/303 (38%), Gaps = 59/303 (19%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVGEVNVL 760
I +G GA G VY+ ++ + VAVK L + DF+ E ++
Sbjct: 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELDFLMEALII 87
Query: 761 GKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL-----HGKQAGRL-LVDWVSRYN 814
K H+NIVR +G I+ E M G L L Q L ++D +
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH--- 144
Query: 815 IALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPR---IADFGLARMMIRKNETVS 871
+A +A G YL + + IHRDI + N LL R I DFG+AR + R +
Sbjct: 145 VARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 872 MVAGSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESV 921
G + PE G +T K D +SFGV+L E+ + G P +S
Sbjct: 202 ---GGCAMLPVKWMPPEAFMEGIFTSKT----DTWSFGVLLWEIFSLGYMPY---PSKSN 251
Query: 922 DIVEWIRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
V + + ++ P NC V M C P+DRP+ ++
Sbjct: 252 QEV--LEF-VTSGGRMDP---PK--NCPGPVYRIMT-------QCWQHQPEDRPNFAIIL 296
Query: 981 TML 983
+
Sbjct: 297 ERI 299
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-32
Identities = 68/281 (24%), Positives = 110/281 (39%), Gaps = 43/281 (15%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVR 770
V+G GA G + M N VAVK++ EV +L + H N++R
Sbjct: 31 VLGHGAEGTIVYRGMFD-NRDVAVKRI--LPECFSFADR-----EVQLLRESDEHPNVIR 82
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-HD 829
+ I E +L E + K L ++ + GLA+LH +
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSLN 138
Query: 830 CYPPIIHRDIKSNNILL-----DSNLEPRIADFGLARMMIRKNETVSM---VAGSYGYIA 881
I+HRD+K +NIL+ ++ I+DFGL + + + S V G+ G+IA
Sbjct: 139 ----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 882 PEY---GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938
PE +DI+S G V +++ P FG+S+ I + L
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--P-FGKSLQRQANILLGACSLDCLH 251
Query: 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDV 979
+V + L+ + A P+ RPS + V
Sbjct: 252 PEKHEDV-IARE------LIEK----MIAMDPQKRPSAKHV 281
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 67/219 (30%), Positives = 115/219 (52%), Gaps = 34/219 (15%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH 765
++ +G G G V+ A +T VAVK + + + S F+ E NV+ L+H
Sbjct: 189 SLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTM---KPG--SMSVEAFLAEANVMKTLQH 242
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALGVAQ 821
+V+L + + + I+ E+M GSL + L + + L+D + +A+
Sbjct: 243 DKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLID------FSAQIAE 295
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI- 880
G+A++ Y IHRD+++ NIL+ ++L +IADFGLAR++ T G+ I
Sbjct: 296 GMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR--EGAKFPIK 350
Query: 881 --APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
APE +G +T+K D++SFG++L+E++T GR P
Sbjct: 351 WTAPEAINFGSFTIKS----DVWSFGILLMEIVTYGRIP 385
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-31
Identities = 67/297 (22%), Positives = 111/297 (37%), Gaps = 60/297 (20%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLN---TIVAVKKLWRSRADLETESSGDFVGEVNVLGK 762
I IG G G V++ VA+K + F+ E + +
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC---KNCTSDSVREKFLQEALTMRQ 447
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRL----LVDWVSRYNIALG 818
H +IV+L+G + + + I+ E G L L ++ L L+ + A
Sbjct: 448 FDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILY------AYQ 499
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG 878
++ LAYL + +HRDI + N+L+ SN ++ DFGL+R M S G
Sbjct: 500 LSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKG 552
Query: 879 YI-----APEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIR 932
+ APE + D++ FGV + E+L G +P + +K
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP-------------FQGVK-- 597
Query: 933 DNRNLEEALD-----PNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
N ++ ++ P NC + M C A P RP ++ L
Sbjct: 598 -NNDVIGRIENGERLPMPPNCPPTLYSLMT-------KCWAYDPSRRPRFTELKAQL 646
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G G G VY A + I+A+K L++S+ + E+ + LRH NI+R+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-EKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
+ H+ + ++ E+ G L + L ++ GR + S + +A L Y H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRF-DEQRSATFMEE-LADALHYCHERK- 134
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----YGYT 887
+IHRDIK N+L+ E +IADFG + + + G+ Y+ PE +
Sbjct: 135 --VIHRDIKPENLLMGYKGELKIADFGWSVHA--PSLRRRTMCGTLDYLPPEMIEGKTH- 189
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRPLD 914
DEK+D++ GV+ E L G P D
Sbjct: 190 ---DEKVDLWCAGVLCYEFLVGMPPFD 213
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 77/302 (25%), Positives = 117/302 (38%), Gaps = 57/302 (18%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVGEVNVL 760
I +G GA G VY+ ++ + VAVK L + DF+ E ++
Sbjct: 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELDFLMEALII 128
Query: 761 GKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL-----HGKQAGRL-LVDWVSRYN 814
K H+NIVR +G I+ E M G L L Q L ++D +
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH--- 185
Query: 815 IALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPR---IADFGLARMMIRKNETVS 871
+A +A G YL + + IHRDI + N LL R I DFG+AR + R
Sbjct: 186 VARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 872 MVAGSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESV 921
G + PE G +T K D +SFGV+L E+ + G P +S
Sbjct: 243 ---GGCAMLPVKWMPPEAFMEGIFTSKT----DTWSFGVLLWEIFSLGYMPY---PSKSN 292
Query: 922 DIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981
V + + ++ P NC ++ C P+DRP+ ++
Sbjct: 293 QEV--LEF-VTSGGRMDP---PK--NCPGPVYRIMT------QCWQHQPEDRPNFAIILE 338
Query: 982 ML 983
+
Sbjct: 339 RI 340
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 56/276 (20%), Positives = 92/276 (33%), Gaps = 22/276 (7%)
Query: 335 GGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPAS---LCNGGNLTKL 391
GG + +L+ + D+ K+ L+ L + + I + L +L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 392 ILFNNAFSGPIPVSLS--TCHSLVRVRMQNNQLSGTIP----VGFGRLEKLQRLELANNS 445
L N +G P L T L + ++N + + L+ L +A
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 446 LTGGITDDIASSTSLSFIDISRNHLRSSLPSTI----LSIPNLQTFIVSNNN---LVGEI 498
+ + +LS +D+S N L P LQ + N G
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 499 PDQFQDCPSLSVLDLSSNYFSGSIPSSIAS-CEKLVNLNLRNNQLTGDIPKAISMMPTLA 557
L LDLS N + + +L +LNL L +PK + L+
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP--AKLS 277
Query: 558 ILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGP 593
+LDLS N L P P + L++ N
Sbjct: 278 VLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 53/269 (19%), Positives = 92/269 (34%), Gaps = 19/269 (7%)
Query: 290 TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNS 349
L+ +D ++ + LK L + + G++ L+ L L N
Sbjct: 47 YLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLE 106
Query: 350 LSGPLPVDLGK--NSPLQWLDLSSNSFSGEIPA----SLCNGGNLTKLILFNNAFSGPIP 403
++G P L + L L+L + S++ L L +
Sbjct: 107 VTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSC 166
Query: 404 VSLSTCHSLVRVRMQNNQLSGTIPVG----FGRLEKLQRLELANN---SLTGGITDDIAS 456
+ +L + + +N G + + LQ L L N + +G + A+
Sbjct: 167 EQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA 226
Query: 457 STSLSFIDISRNHLRSSLPSTILSIP-NLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSS 515
L +D+S N LR + + P L + +S L LSVLDLS
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPA---KLSVLDLSY 283
Query: 516 NYFSGSIPSSIASCEKLVNLNLRNNQLTG 544
N PS ++ NL+L+ N
Sbjct: 284 NRLD-RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 6e-23
Identities = 54/276 (19%), Positives = 93/276 (33%), Gaps = 22/276 (7%)
Query: 263 GRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKN---LQLL 319
G L ++ +I SL+ L + + I ++ LQ L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 320 NLMCNQLSGHVPAGLGGLT--QLEVLELWNNSLSGPLPVDLG----KNSPLQWLDLSSNS 373
L +++G P L T L +L L N S + L+ L ++
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 374 FSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTC----HSLVRVRMQNNQ---LSGTI 426
+ L+ L L +N G + + C +L + ++N SG
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 427 PVGFGRLEKLQRLELANNSLTGGITDDIAS-STSLSFIDISRNHLRSSLPSTILSIPNLQ 485
+LQ L+L++NSL + L+ +++S L +P + L
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPKGLP--AKLS 277
Query: 486 TFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGS 521
+S N L P + P + L L N F S
Sbjct: 278 VLDLSYNRL-DRNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 8e-23
Identities = 56/307 (18%), Positives = 88/307 (28%), Gaps = 39/307 (12%)
Query: 156 NNFSGFLLEDLGNATSLETL----DLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIP 211
N +E G SLE L D Q + + +L++L +
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88
Query: 212 RELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIM 271
+ +S ++ + L E G P T L + N+
Sbjct: 89 LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV------------SWATR 136
Query: 272 FLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVP 331
+ Q L L++L ++ + ++ L L+L N G
Sbjct: 137 DAWLAELQQWLK------PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 332 ----AGLGGLTQLEVLELWNN---SLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCN 384
L+VL L N + SG LQ LDLS NS A C+
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
Query: 385 G-GNLTKLILFNNAFSGPIPVSLSTC--HSLVRVRMQNNQLSGTIPVGFGRLEKLQRLEL 441
L L L + L + + N+L P L ++ L L
Sbjct: 251 WPSQLNSLNLSFTGLK-----QVPKGLPAKLSVLDLSYNRLD-RNPS-PDELPQVGNLSL 303
Query: 442 ANNSLTG 448
N
Sbjct: 304 KGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 51/228 (22%), Positives = 85/228 (37%), Gaps = 18/228 (7%)
Query: 382 LCNGGNLTKLILFNNAFSGPIP-VSLSTCHSLVRVRMQNNQLSGTIPVGFGRLE---KLQ 437
G +L L+ + + + SL R+ ++ ++ I G R+ LQ
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 438 RLELANNSLTGGITDDIASST--SLSFIDISRNHLRSSLPST----ILSIPNLQTFIVSN 491
L L N +TG + +T L+ +++ + P L+ ++
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 492 NNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCE----KLVNLNLRNNQLT---G 544
+ + +Q + P+LS LDLS N G A C L L LRN + G
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218
Query: 545 DIPKAISMMPTLAILDLSNNSLTGGIPE-NFGASPALEVLNVSYNRLE 591
+ L LDLS+NSL + L LN+S+ L+
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 8e-21
Identities = 60/295 (20%), Positives = 90/295 (30%), Gaps = 28/295 (9%)
Query: 101 TSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSG 160
+S C L +L L + + + L L
Sbjct: 25 SSAFNCLGAADVELYGGGRSLEYL--LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPS 82
Query: 161 FLLED---LGNATSLETLDLRGSFFQGSIPVSFKNLQ--KLKFLGLSGNNLTGKIPRELG 215
+L + + L+ L L G+ P L L L + L
Sbjct: 83 RILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLA 141
Query: 216 QLS-----SMETMILAYNEFDGEIPVEFGNLTNLKYLDLA----VGNLGGKIPAELGRLE 266
+L ++ + +A + L LDL+ +G G +
Sbjct: 142 ELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP 201
Query: 267 LLEIMFLYQNNFQ---GRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQ-LKNLQLLNLM 322
L+++ L + G A LQ LDLS+N L A L LNL
Sbjct: 202 TLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS 261
Query: 323 CNQLSGHVPAGLGGLTQLEVLELWNNSLSG-PLPVDLGKNSPLQWLDLSSNSFSG 376
L VP GL +L VL+L N L P P +L + + L L N F
Sbjct: 262 FTGLK-QVPKGL--PAKLSVLDLSYNRLDRNPSPDELPQ---VGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 48/272 (17%), Positives = 83/272 (30%), Gaps = 43/272 (15%)
Query: 96 RLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAG--LTFLNA 153
LK LT + ++ L+ + + G+ P L A G L LN
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 154 SGNNFSGF--LLEDLGN--ATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGK 209
+++ L +L L+ L + + + L L LS N G+
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 210 IPRE----LGQLSSMETMILAYNEF---DGEIPVEFGNLTNLKYLDLAVGNLGGKIPAEL 262
+ +++ + L G L+ LDL+
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLS------------ 236
Query: 263 GRLELLEIMFLYQNNFQGRLPAEI-GNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNL 321
N+ + A + L L+LS+ L +P + L +L+L
Sbjct: 237 ------------HNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDL 281
Query: 322 MCNQLSGHVPAGLGGLTQLEVLELWNNSLSGP 353
N+L P+ L Q+ L L N
Sbjct: 282 SYNRLD-RNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 32/140 (22%), Positives = 44/140 (31%), Gaps = 13/140 (9%)
Query: 77 EKLDLSHMNLSGCV----SDHFQRLKSLTSLNLCCNGLFS---SLPNSLANLTSLKRFDV 129
LDLS G + + +L L L G+ + A L+ D+
Sbjct: 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDL 235
Query: 130 SQNFLNGSFPAGL-GGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPV 188
S N L + A + L LN S G L LDL + P
Sbjct: 236 SHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQV---PKGLPAKLSVLDLSYNRLD-RNP- 290
Query: 189 SFKNLQKLKFLGLSGNNLTG 208
S L ++ L L GN
Sbjct: 291 SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 32/200 (16%), Positives = 61/200 (30%), Gaps = 23/200 (11%)
Query: 52 SLHDWKLPSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLF 111
+L + + + ++ L ++ + + + +L++L+L N
Sbjct: 127 NLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPEL 186
Query: 112 SSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATS 171
++ P L NA SG
Sbjct: 187 GERG-----------------LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQ 229
Query: 172 LETLDLRGSFFQGSIPV-SFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEF 230
L+ LDL + + + S +L L LS L ++P+ L + + L+YN
Sbjct: 230 LQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRL 286
Query: 231 DGEIPVEFGNLTNLKYLDLA 250
D P L + L L
Sbjct: 287 D-RNP-SPDELPQVGNLSLK 304
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 72/303 (23%), Positives = 128/303 (42%), Gaps = 59/303 (19%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVL 760
I S +G G+ G+VY+ + T VA+K + +F+ E +V+
Sbjct: 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVM 82
Query: 761 GKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSR------YN 814
+ ++VRLLG + +++ E M G L L + ++
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 815 IALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA 874
+A +A G+AYL+ + + +HRD+ + N ++ + +I DFG+ R + ET
Sbjct: 143 MAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYRK 196
Query: 875 GSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP---LDPEFGESV 921
G G + +PE G +T D++SFGVVL E+ T +P L E
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYS----DVWSFGVVLWEIATLAEQPYQGLSNE----- 247
Query: 922 DIVEWIRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
++ + + L++ P+ NC + E M +C PK RPS ++I
Sbjct: 248 QVLR----FVMEGGLLDK---PD--NCPDMLFELMR-------MCWQYNPKMRPSFLEII 291
Query: 981 TML 983
+ +
Sbjct: 292 SSI 294
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 67/299 (22%), Positives = 112/299 (37%), Gaps = 56/299 (18%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIV 769
++G G++G V VAVK++ D+ E+ +L + H N++
Sbjct: 21 KILGYGSSGTVVFQGS-FQGRPVAVKRMLIDFCDIALM-------EIKLLTESDDHPNVI 72
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIA---LGVAQGLAYL 826
R D + I E N +L + + K + YN +A G+A+L
Sbjct: 73 RYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 827 HHDCYPPIIHRDIKSNNILLDS-------------NLEPRIADFGLARMMIRKNETVSM- 872
H IIHRD+K NIL+ + NL I+DFGL + + +
Sbjct: 132 HSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 873 ---VAGSYGYIAPE-------YGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESV 921
+G+ G+ APE ++ IDI+S G V +L+ G+ P FG+
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP----FGDKY 244
Query: 922 DIVEWIRMKIRDNRNLEEALDPNVGN-CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDV 979
I I ++ D ++ + +M+ P RP+ V
Sbjct: 245 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMI----------DHDPLKRPTAMKV 293
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-31
Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G GA G V + A+K + + + T S+ + EV VL L H NI++
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKII--RKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN------IALGVAQGLA 824
L F + N +V E G L + + + ++N I V G+
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRM----------KFNEVDAAVIIKQVLSGVT 150
Query: 825 YLHHDCYPPIIHRDIKSNNILLDS---NLEPRIADFGLARMMIRKNETVSMVAGSYGYIA 881
YLH I+HRD+K N+LL+S + +I DFGL+ + + + G+ YIA
Sbjct: 151 YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA-VFENQKKMKERLGTAYYIA 206
Query: 882 PEYGYTLK--VDEKIDIYSFGVVLLELLTGRRP 912
PE L+ DEK D++S GV+L LL G P
Sbjct: 207 PE---VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-31
Identities = 33/303 (10%), Positives = 79/303 (26%), Gaps = 59/303 (19%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKL-------WRSRADLETE---------------- 748
V+G +A V + ++ E
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 749 -SSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV----YEYMNNGSLGEALHGKQAG 803
F+ +++ + + ++R+ + + N + GE L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 804 RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863
+ +R + L V + LA LHH ++H ++ +I+LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 864 IRKNETVS-MVAGSYGYIAPE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEF 917
+ A + + D ++ G+ + + P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----N 317
Query: 918 GESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMR 977
+ + R +N+ + + L+ +DR
Sbjct: 318 TDD-AALGGSEWIFRSCKNIPQPVRA-------------LLEG----FLRYPKEDRLLPL 359
Query: 978 DVI 980
+
Sbjct: 360 QAM 362
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-31
Identities = 41/309 (13%), Positives = 92/309 (29%), Gaps = 70/309 (22%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVK------------------------KLWRSRADLET 747
V+G +A V L + +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 748 ESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYM----NNGSLGEALHGKQAG 803
+ F+ +++ + + ++R+ + + + Y N + GE L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 804 RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863
+ +R + L V + LA LHH ++H ++ +I+LD + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL--- 253
Query: 864 IRKNETVSMVAGSYGYIAPEY-----------GYTLKVDEKIDIYSFGVVLLELLTGRRP 912
++ + + S G+ PE + D ++ G+V+ + P
Sbjct: 254 -VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
Query: 913 LDPEFGESVDIVEWIRMKIRDNRNL-EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPK 971
+ + ++ EWI R +N+ + L+ +
Sbjct: 313 ITKD--AALGGSEWI---FRSCKNIPQPVRA--------------LLEG----FLRYPKE 349
Query: 972 DRPSMRDVI 980
DR +
Sbjct: 350 DRLLPLQAM 358
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 50/229 (21%), Positives = 87/229 (37%), Gaps = 44/229 (19%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVR 770
IG G G V+K I A+K+ + A E + + EV L +H ++VR
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ--NALREVYAHAVLGQHSHVVR 75
Query: 771 LLG-FLHNDTNMMIVYEYMNNGSLGEAL--HGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
+ +D +M+I EY N GSL +A+ + + + ++ L V +GL Y+H
Sbjct: 76 YFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELK--DLLLQVGRGLRYIH 132
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEP-------------------RIADFGLARMMIRKNE 868
++H DIK +NI + P +I D G + +
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SS 186
Query: 869 TVSMVAGSYGYIAPE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
G ++A E Y + K DI++ + ++
Sbjct: 187 PQVEE-GDSRFLANEVLQENYTHLPKA----DIFALALTVVCAAGAEPL 230
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 9e-31
Identities = 61/214 (28%), Positives = 91/214 (42%), Gaps = 31/214 (14%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G GA G V+ E +K + + R+ + E E+ VL L H NI+++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME---QIEAEIEVLKSLDHPNIIKI 85
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN------IALGVAQGLAY 825
+ NM IV E G L E + QA + + + LAY
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARG------KALSEGYVAELMKQMMNALAY 139
Query: 826 LH-HDCYPPIIHRDIKSNNILLDS---NLEPRIADFGLARMMIRKNETVSMVAGSYGYIA 881
H ++H+D+K NIL + +I DFGLA + + +E + AG+ Y+A
Sbjct: 140 FHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF-KSDEHSTNAAGTALYMA 194
Query: 882 PE---YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
PE K DI+S GVV+ LLTG P
Sbjct: 195 PEVFKRDV----TFKCDIWSAGVVMYFLLTGCLP 224
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 45/233 (19%), Positives = 83/233 (35%), Gaps = 49/233 (21%)
Query: 706 CIRESNVIGMGATGIVYKAEM-------PRLNTIVAVKKLWRSRADLETESSGDFVGEVN 758
+ + +G G ++K T V +K L S F +
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL----DKAHRNYSESFFEAAS 64
Query: 759 VLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALG 818
++ KL H+++V G ++V E++ GSL L K + + W +A
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWK--LEVAKQ 121
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPR--------IADFGLARMMIRKNETV 870
+A + +L + IH ++ + NILL + + ++D G++ ++ K
Sbjct: 122 LAAAMHFLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---- 174
Query: 871 SMVAGSYGYI-----APE---YG--YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
PE L D +SFG L E+ + G +P
Sbjct: 175 -----DILQERIPWVPPECIENPKNLNLAT----DKWSFGTTLWEICSGGDKP 218
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-30
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 36/216 (16%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
++G G+ G V K + AVK + ++A + + + + EV +L KL H NI++
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVI--NKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN------IALGVAQGLA 824
L L + ++ IV E G L + + ++ R++ I V G+
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRK----------RFSEHDAARIIKQVFSGIT 135
Query: 825 YLHHDCYPPIIHRDIKSNNILLDS---NLEPRIADFGLARMMIRKNETVSMVAGSYGYIA 881
Y+H I+HRD+K NILL+S + + +I DFGL+ ++N + G+ YIA
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKMKDRIGTAYYIA 191
Query: 882 PE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
PE Y EK D++S GV+L LL+G P
Sbjct: 192 PEVLRGTYD------EKCDVWSAGVILYILLSGTPP 221
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 45/234 (19%)
Query: 706 CIRESNVIGMGATGIVYKAEM--PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL 763
I+ +VIG G G V KA + L A+K++ + + DF GE+ VL KL
Sbjct: 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYASKDDHRDFAGELEVLCKL 82
Query: 764 -RHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN-------- 814
H NI+ LLG + + + EY +G+L + L + + +
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 815 ----IALGVAQGLAYL--HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE 868
A VA+G+ YL IHRD+ + NIL+ N +IADFGL+ R E
Sbjct: 143 QLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLS----RGQE 193
Query: 869 TVSMVAGSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP 912
V + G + A E Y YT D++S+GV+L E+++ G P
Sbjct: 194 VY--VKKTMGRLPVRWMAIESLNYSVYTTNS----DVWSYGVLLWEIVSLGGTP 241
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 74/309 (23%), Positives = 127/309 (41%), Gaps = 71/309 (22%)
Query: 711 NVIGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-R 764
+G GA G V +A L VAVK L +S A + + + E+ ++ L +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKE--ALMSELKIMSHLGQ 108
Query: 765 HRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN---------- 814
H NIV LLG + ++++ EY G L L K + N
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 815 IALGVAQGLAYL--HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM 872
+ VAQG+A+L + IHRD+ + N+LL + +I DFGLAR ++ +
Sbjct: 169 FSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN---Y 220
Query: 873 VAGSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP-----LDPEF 917
+ + APE YT++ D++S+G++L E+ + G P ++ +F
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQS----DVWSYGILLWEIFSLGLNPYPGILVNSKF 276
Query: 918 GESVDIVEWIRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSM 976
+ ++D + + P K++ M C A P RP+
Sbjct: 277 YK----------LVKDGYQMAQ---PA--FAPKNIYSIMQ-------ACWALEPTHRPTF 314
Query: 977 RDVITMLGE 985
+ + + L E
Sbjct: 315 QQICSFLQE 323
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 60/236 (25%), Positives = 96/236 (40%), Gaps = 42/236 (17%)
Query: 697 GFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSR-ADLETESSGDFVG 755
G T DI N IG G+ G V A A KK+ + D++ F
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-----RFKQ 55
Query: 756 EVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL--HG----KQAGRLLVDW 809
E+ ++ L H NI+RL ++T++ +V E G L E + A R++ D
Sbjct: 56 EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD- 114
Query: 810 VSRYNIALGVAQGLAYLH-HDCYPPIIHRDIKSNNILLDS---NLEPRIADFGLARMMIR 865
V +AY H + + HRD+K N L + + ++ DFGLA +
Sbjct: 115 ---------VLSAVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-K 160
Query: 866 KNETVSMVAGSYGYIAPE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPE 916
+ + G+ Y++P+ YG + D +S GV++ LL G P
Sbjct: 161 PGKMMRTKVGTPYYVSPQVLEGLYG------PECDEWSAGVMMYVLLCGYPPFSAP 210
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 36/215 (16%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
++G G+ G V K + AVK + ++A + + + + EV +L KL H NI++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVI--NKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEAL--HG----KQAGRLLVDWVSRYNIALGVAQGLAY 825
L + ++ IV E G L + + A R++ V G+ Y
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ----------VFSGITY 136
Query: 826 LHHDCYPPIIHRDIKSNNILLDS---NLEPRIADFGLARMMIRKNETVSMVAGSYGYIAP 882
+H I+HRD+K NILL+S + + +I DFGL+ ++N + G+ YIAP
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKMKDRIGTAYYIAP 192
Query: 883 E-----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
E Y EK D++S GV+L LL+G P
Sbjct: 193 EVLRGTYD------EKCDVWSAGVILYILLSGTPP 221
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-30
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 37/217 (17%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG-EVNVLGKLRHRNIV 769
V+G G+ G V + AVK + S+ ++ ++ + + EV +L +L H NI+
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVI--SKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN------IALGVAQGL 823
+L F + +V E G L + + ++ R++ I V G+
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRK----------RFSEVDAARIIRQVLSGI 139
Query: 824 AYLHHDCYPPIIHRDIKSNNILLDS---NLEPRIADFGLARMMIRKNETVSMVAGSYGYI 880
Y+H + I+HRD+K N+LL+S + RI DFGL+ ++ + G+ YI
Sbjct: 140 TYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKIGTAYYI 195
Query: 881 APE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
APE Y EK D++S GV+L LL+G P
Sbjct: 196 APEVLHGTYD------EKCDVWSTGVILYILLSGCPP 226
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 70/309 (22%), Positives = 121/309 (39%), Gaps = 60/309 (19%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVGEVNVLG 761
++ +G GA G V +A+ ++ VAVK L + A + E+ +L
Sbjct: 29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHR--ALMSELKILI 85
Query: 762 KL-RHRNIVRLLGF-LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN----- 814
+ H N+V LLG +M++ E+ G+L L K+ +
Sbjct: 86 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 815 -------IALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKN 867
+ VA+G+ +L IHRD+ + NILL +I DFGLAR + +
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 868 ETVSMVAGSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEF 917
+ V + APE YT++ D++SFGV+L E+ + G P P
Sbjct: 203 D---YVRKGDARLPLKWMAPETIFDRVYTIQS----DVWSFGVLLWEIFSLGASPY-PGV 254
Query: 918 GESVDIVEWIRMKIRDNRNLEEALDPNVGNCKH-VQEEMLLVLRIAFLCTAKLPKDRPSM 976
+ ++++ + P+ + + ML C P RP+
Sbjct: 255 KIDEEFCR----RLKEGTRMRA---PD--YTTPEMYQTML-------DCWHGEPSQRPTF 298
Query: 977 RDVITMLGE 985
+++ LG
Sbjct: 299 SELVEHLGN 307
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 37/222 (16%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG---------EVNVLG 761
+G GA G V + ++ A+K + +S+ D S + E+++L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 762 KLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN------I 815
L H NI++L + +V E+ G L E + + +++ I
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR----------HKFDECDAANI 151
Query: 816 ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS---NLEPRIADFGLARMMIRKNETVSM 872
+ G+ YLH I+HRDIK NILL++ L +I DFGL+ K+ +
Sbjct: 152 MKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSS-FFSKDYKLRD 207
Query: 873 VAGSYGYIAPEYGYTLK--VDEKIDIYSFGVVLLELLTGRRP 912
G+ YIAPE LK +EK D++S GV++ LL G P
Sbjct: 208 RLGTAYYIAPE---VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 88/319 (27%), Positives = 128/319 (40%), Gaps = 77/319 (24%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVGEVNVL 760
I IG GA G V++A P L T+VAVK L + + + DF E ++
Sbjct: 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALM 104
Query: 761 GKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL--HGKQAGRLLVDWVSRYN---- 814
+ + NIV+LLG M +++EYM G L E L L
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 815 --------------IALGVAQGLAYL--HHDCYPPIIHRDIKSNNILLDSNLEPRIADFG 858
IA VA G+AYL +HRD+ + N L+ N+ +IADFG
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFG 219
Query: 859 LARMMIRKNETVSMVAGSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT- 908
L+R + A I PE Y YT + D++++GVVL E+ +
Sbjct: 220 LSRNI---YSADYYKADGNDAIPIRWMPPESIFYNRYTTES----DVWAYGVVLWEIFSY 272
Query: 909 GRRP---LDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFL 964
G +P + E +++ +RD L P NC + M L
Sbjct: 273 GLQPYYGMAHE-----EVIY----YVRDGNILAC---PE--NCPLELYNLMR-------L 311
Query: 965 CTAKLPKDRPSMRDVITML 983
C +KLP DRPS + +L
Sbjct: 312 CWSKLPADRPSFCSIHRIL 330
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 61/259 (23%), Positives = 100/259 (38%), Gaps = 13/259 (5%)
Query: 291 SLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSL 350
S + + L+ +P I + L L N+L LTQL L L +N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 351 S-GPLPVDLGKNSP-LQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSL-S 407
S + L++LDLS N + ++ L L ++ S+
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123
Query: 408 TCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDI-ASSTSLSFIDI 465
+ +L+ + + + G F L L+ L++A NS DI +L+F+D+
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 466 SRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSS 525
S+ L P+ S+ +LQ +S+NN ++ SL VLD S N+ +
Sbjct: 183 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241
Query: 526 I--ASCEKLVNLNLRNNQL 542
L LNL N
Sbjct: 242 ELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 46/254 (18%), Positives = 96/254 (37%), Gaps = 16/254 (6%)
Query: 367 LDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTI 426
+ +S + +P + + T+L L +N L ++ + +N LS
Sbjct: 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-FK 67
Query: 427 PVG---FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILS-IP 482
L+ L+L+ N + ++ + L +D ++L+ ++ +
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 483 NLQTFIVSNNNLVGEIPDQ-FQDCPSLSVLDLSSNYFSGSIPSSI-ASCEKLVNLNLRNN 540
NL +S+ + + F SL VL ++ N F + I L L+L
Sbjct: 127 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185
Query: 541 QLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPAN--- 597
QL P A + + +L +L++S+N+ + +L+VL+ S N +
Sbjct: 186 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQ 244
Query: 598 GVLRTINRGDLAGN 611
++ +L N
Sbjct: 245 HFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 73/332 (21%), Positives = 115/332 (34%), Gaps = 94/332 (28%)
Query: 62 HCNWTGVWCNSNG----------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGL- 110
C+ T + CNS G + +L+L L F +L LT L+L NGL
Sbjct: 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 111 -FSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNA 169
S TSLK D+S N G+ +++ NF G
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFN--------------GVITMSS---NFLGL-------- 100
Query: 170 TSLETLDLRGSFFQGSIPVS-FKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYN 228
LE LD + S + S F +L+ L +L +S + +
Sbjct: 101 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI-------------- 145
Query: 229 EFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEI-G 287
F L++L+ L +A N+FQ +I
Sbjct: 146 ---------FNGLSSLEVLKMA------------------------GNSFQENFLPDIFT 172
Query: 288 NITSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLEL 345
+ +L LDLS L + L +LQ+LN+ N + L L+VL+
Sbjct: 173 ELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDY 230
Query: 346 WNNSLSGPLPVDLGKNSP--LQWLDLSSNSFS 375
N + ++ P L +L+L+ N F+
Sbjct: 231 SLNHIMT-SKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 55/240 (22%), Positives = 95/240 (39%), Gaps = 16/240 (6%)
Query: 170 TSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGK--IPRELGQLSSMETMILAY 227
+S L+L + Q F L +L L LS N L+ K + +S++ + L++
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 228 NEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAE--LGRLELLEIMFLYQNNFQGRLPAE 285
N + F L L++LD + ++ L L + + + +
Sbjct: 88 NGV-ITMSSNFLGLEQLEHLDFQ-HSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNG 144
Query: 286 I-GNITSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEV 342
I ++SL++L ++ N +I T+L+NL L+L QL + L+ L+V
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQV 203
Query: 343 LELWNNSLSGPLPVDLGKNSP-LQWLDLSSNSFSGEIPASLCNG--GNLTKLILFNNAFS 399
L + +N+ L K LQ LD S N +L L L N F+
Sbjct: 204 LNMSHNNFFS-LDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 51/227 (22%), Positives = 80/227 (35%), Gaps = 35/227 (15%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLW-RSRADLETESSGDFVGEVNVLGKLR-HRNIV 769
V+ G VY+A+ A+K+L EV + KL H NIV
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ-----EVCFMKKLSGHPNIV 89
Query: 770 RLLGFLHNDTN--------MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ 821
+ +++ E + + G L D V I +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV--LKIFYQTCR 147
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM---------IRKNETVSM 872
+ ++H PPIIHRD+K N+LL + ++ DFG A + ++ V
Sbjct: 148 AVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 873 VAGSYG---YIAPE----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y PE Y + EK DI++ G +L L + P
Sbjct: 207 EITRNTTPMYRTPEIIDLYSN-FPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 40/225 (17%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETE---SSGDFVGEVNVLGKLRHRN 767
IG G G V+KA+ + IVA+K++ R D + E SS + E+ +L +L+H+N
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSA--LREICLLKELKHKN 62
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
IVRL LH+D + +V+E+ + L + L + V + L +GL + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKSFLFQL--LKGLGFCH 118
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM---IRK--NETVSMVAGSYGYIAP 882
++HRD+K N+L++ N E ++A+FGLAR +R E V++ Y P
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL-----WYRPP 170
Query: 883 E-------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
+ Y ID++S G + EL RPL P G
Sbjct: 171 DVLFGAKLYS------TSIDMWSAGCIFAELANAGRPLFP--GND 207
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 58/246 (23%), Positives = 94/246 (38%), Gaps = 48/246 (19%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLET-ESSGDFVGEVNVLGKLRHRNIVR 770
IG G+ G+V A + I A+K + +++ + EV ++ KL H NI R
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 771 LLGFLHNDTNMMIVYEYMNNGSL-------GEALHGKQAGRLLVDWVSRYNIALG----- 818
L ++ + +V E + G L + GK A ++ +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 819 ------------------------VAQGLAYLHHDCYPPIIHRDIKSNNILLDS--NLEP 852
+ L YLH+ I HRDIK N L + + E
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209
Query: 853 RIADFGLARMMIRKNE----TVSMVAGSYGYIAPE--YGYTLKVDEKIDIYSFGVVLLEL 906
++ DFGL++ + N ++ AG+ ++APE K D +S GV+L L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 907 LTGRRP 912
L G P
Sbjct: 270 LMGAVP 275
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-29
Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 35/219 (15%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVK----KLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
VIG G +V + AVK + S L TE D E ++ L+H +
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE---DLKREASICHMLKHPH 87
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRY------NIALGVAQ 821
IV LL +D + +V+E+M+ L + + D Y + + +
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA------DAGFVYSEAVASHYMRQILE 141
Query: 822 GLAYLH-HDCYPPIIHRDIKSNNILLDSNLEP---RIADFGLARMMIRKNETVSMVAGSY 877
L Y H ++ IIHRD+K + +LL S ++ FG+A + G+
Sbjct: 142 ALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197
Query: 878 GYIAPE----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
++APE Y + +D++ GV+L LL+G P
Sbjct: 198 HFMAPEVVKREPY----GKPVDVWGCGVILFILLSGCLP 232
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 37/228 (16%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVK----KLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
+G GA G V A + VA+K + + + E + + + E+ +L KL H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEAL--HGK---QAGRLLVDWVSRYNIALGVAQG 822
I+++ F + + IV E M G L + + + + +L Y + L V
Sbjct: 77 IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-----YQMLLAV--- 127
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDSNLEP---RIADFGLARMMIRKNETVSMVAGSYGY 879
YLH + IIHRD+K N+LL S E +I DFG ++++ + + + G+ Y
Sbjct: 128 -QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTY 182
Query: 880 IAPE-------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
+APE GY V D +S GV+L L+G P +
Sbjct: 183 LAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPPFSEHRTQV 226
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-28
Identities = 83/322 (25%), Positives = 131/322 (40%), Gaps = 77/322 (23%)
Query: 711 NVIGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH 765
+G G G V KA L T VAVK L + A D + E NVL ++ H
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELR--DLLSEFNVLKQVNH 85
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL--HGKQAGRLLVDWVSRYN--------- 814
++++L G D ++++ EY GSL L K L SR +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 815 ---------IALGVAQGLAYL--HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863
A ++QG+ YL ++HRD+ + NIL+ + +I+DFGL+R +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 864 IRKNETVSMVAGSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP- 912
++ V S G I A E YT + D++SFGV+L E++T G P
Sbjct: 201 YEEDS---YVKRSQGRIPVKWMAIESLFDHIYTTQS----DVWSFGVLLWEIVTLGGNPY 253
Query: 913 --LDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKL 969
+ PE + ++ +E P+ NC + + ML C +
Sbjct: 254 PGIPPE--------RLFNL-LKTGHRMER---PD--NCSEEMYRLML-------QCWKQE 292
Query: 970 PKDRPSMRDVITMLGEAKPRRK 991
P RP D+ L + +R+
Sbjct: 293 PDKRPVFADISKDLEKMMVKRR 314
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-28
Identities = 75/306 (24%), Positives = 128/306 (41%), Gaps = 66/306 (21%)
Query: 711 NVIGMGATGIVYKAE-------MPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL 763
+G G G V AE P+ VAVK L + A + S D V E+ ++ +
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLS--DLVSEMEMMKMI 143
Query: 764 -RHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN-------- 814
+H+NI+ LLG D + ++ EY + G+L E L ++ + +
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 815 ----IALGVAQGLAYL--HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE 868
+A+G+ YL IHRD+ + N+L+ N +IADFGLAR + N
Sbjct: 204 DLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDI---NN 255
Query: 869 TVSMVAGSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFG 918
+ G + APE YT + D++SFGV++ E+ T G P
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQS----DVWSFGVLMWEIFTLGGSPY----- 306
Query: 919 ESVDIVEWIRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMR 977
+ + E ++ +++ +++ P NC + M C +P RP+ +
Sbjct: 307 PGIPVEELFKL-LKEGHRMDK---PA--NCTNELYMMMR-------DCWHAVPSQRPTFK 353
Query: 978 DVITML 983
++ L
Sbjct: 354 QLVEDL 359
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 35/215 (16%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G GA +V + A K + + L E + KL+H NIVRL
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKII--NTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQ------AGRLLVDWVSRYNIALGVAQGLAY 825
+ ++ +V++ + G L E + ++ A + + + +AY
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ----------ILESIAY 120
Query: 826 LH-HDCYPPIIHRDIKSNNILLDSNLEP---RIADFGLARMMIRKNETVSMVAGSYGYIA 881
H + I+HR++K N+LL S + ++ADFGLA + +E AG+ GY++
Sbjct: 121 CHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFAGTPGYLS 175
Query: 882 PE----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
PE Y + +DI++ GV+L LL G P
Sbjct: 176 PEVLKKDPY----SKPVDIWACGVILYILLVGYPP 206
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVK----KLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
+G GA G V A + VA++ + + + E + + + E+ +L KL H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEAL--HGK---QAGRLLVDWVSRYNIALGVAQG 822
I+++ F + + IV E M G L + + + + +L Y + L V
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-----YQMLLAV--- 252
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDSNLEP---RIADFGLARMMIRKNETVSMVAGSYGY 879
YLH + IIHRD+K N+LL S E +I DFG ++++ + + + G+ Y
Sbjct: 253 -QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTY 307
Query: 880 IAPE-------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGE 919
+APE GY V D +S GV+L L+G P +
Sbjct: 308 LAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPPFSEHRTQ 350
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 75/311 (24%), Positives = 129/311 (41%), Gaps = 66/311 (21%)
Query: 706 CIRESNVIGMGATGIVYKAEMPRL-------NTIVAVKKLWRSRADLETESSGDFVGEVN 758
+ +G GA G V AE + VAVK L + A + S D V E+
Sbjct: 36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLS--DLVSEME 92
Query: 759 VLGKL-RHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN--- 814
++ + +H+NI+ LLG D + ++ EY + G+L E L ++ + +
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 815 ---------IALGVAQGLAYL--HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863
+A+G+ YL IHRD+ + N+L+ N +IADFGLAR +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 864 IRKNETVSMVAGSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRPL 913
N + G + APE YT + D++SFGV++ E+ T G P
Sbjct: 208 ---NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS----DVWSFGVLMWEIFTLGGSPY 260
Query: 914 DPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKD 972
+ + E ++ +++ +++ P NC + M C +P
Sbjct: 261 -----PGIPVEELFKL-LKEGHRMDK---PA--NCTNELYMMMR-------DCWHAVPSQ 302
Query: 973 RPSMRDVITML 983
RP+ + ++ L
Sbjct: 303 RPTFKQLVEDL 313
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 52/293 (17%), Positives = 107/293 (36%), Gaps = 36/293 (12%)
Query: 701 ADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG-DFVGEVNV 759
LA + ++ + E + K + L + S ++
Sbjct: 55 VKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114
Query: 760 LGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGV 819
+ +N V L + I + +L + ++ ++ + +I + +
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMN-RRCSLEDREHGVCLHIFIQI 173
Query: 820 AQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA----- 874
A+ + +LH ++HRD+K +NI + ++ DFGL M + E +++
Sbjct: 174 AEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 875 -------GSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWI 927
G+ Y++PE + K+DI+S G++L ELL + E V I+ +
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQM-ERVRIITDV 286
Query: 928 RMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
R N + +E ++V + P +RP D+I
Sbjct: 287 R-----NLKFPLLFT------QKYPQEHMMVQD----MLSPSPTERPEATDII 324
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 76/308 (24%), Positives = 121/308 (39%), Gaps = 61/308 (19%)
Query: 707 IRESNVIGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVLG 761
+ +G GA G V +A L VAVK L + A L + E+ VL
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTERE--ALMSELKVLS 81
Query: 762 KL-RHRNIVRLLGFLHNDTNMMIVYEYMNNGSL--------GEALHGKQAGRLLVDWVSR 812
L H NIV LLG +++ EY G L + K + ++ D
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 813 ------YNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866
+ + VA+G+A+L IHRD+ + NILL +I DFGLAR +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 867 NETVSMVAGSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRPLDPE 916
+ V + APE YT + D++S+G+ L EL + G P
Sbjct: 199 SN---YVVKGNARLPVKWMAPESIFNCVYTFES----DVWSYGIFLWELFSLGSSPY--- 248
Query: 917 FGESVDIVEWIRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPS 975
G VD ++ +M I++ + P + + + M C P RP+
Sbjct: 249 PGMPVD-SKFYKM-IKEGFRMLS---PE--HAPAEMYDIMK-------TCWDADPLKRPT 294
Query: 976 MRDVITML 983
+ ++ ++
Sbjct: 295 FKQIVQLI 302
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVK-----KLWRSRADLETESSGDFVGEVNVLGKL-RH 765
++G G + +V + AVK A+ E + EV++L K+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL--HG----KQAGRLLVDWVSRYNIALGV 819
NI++L +T +V++ M G L + L K+ +++ +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA----------L 133
Query: 820 AQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGY 879
+ + LH I+HRD+K NILLD ++ ++ DFG + + E + V G+ Y
Sbjct: 134 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKLREVCGTPSY 189
Query: 880 IAPE------YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
+APE +++D++S GV++ LL G P
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 71/313 (22%), Positives = 124/313 (39%), Gaps = 70/313 (22%)
Query: 711 NVIGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-R 764
V+G GA G V A + + VAVK L + +AD + E+ ++ +L
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSERE--ALMSELKMMTQLGS 107
Query: 765 HRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL--HGKQAGRLLVDWVSRYN-------- 814
H NIV LLG + +++EY G L L ++ +++ ++
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 815 ---------IALGVAQGLAYL--HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863
A VA+G+ +L +HRD+ + N+L+ +I DFGLAR +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 864 IRKNETVSMVAGSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRPL 913
+ + V + APE G YT K D++S+G++L E+ + G P
Sbjct: 223 MSDSN---YVVRGNARLPVKWMAPESLFEGIYT----IKSDVWSYGILLWEIFSLGVNPY 275
Query: 914 DPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKH-VQEEMLLVLRIAFLCTAKLPKD 972
P + + I++ +++ P + M C A +
Sbjct: 276 -PGIPVDANFYK----LIQNGFKMDQ---PF--YATEEIYIIMQ-------SCWAFDSRK 318
Query: 973 RPSMRDVITMLGE 985
RPS ++ + LG
Sbjct: 319 RPSFPNLTSFLGC 331
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-28
Identities = 48/215 (22%), Positives = 89/215 (41%), Gaps = 34/215 (15%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G GA +V + A + + L E + L+H NIVRL
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMII--NTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEAL--HG----KQAGRLLVDWVSRYNIALGVAQGLAY 825
+ + + ++++ + G L E + A + + + + +
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ----------ILEAVLH 125
Query: 826 LH-HDCYPPIIHRDIKSNNILLDSNLEP---RIADFGLARMMIRKNETVSMVAGSYGYIA 881
H ++HR++K N+LL S L+ ++ADFGLA + + + AG+ GY++
Sbjct: 126 CHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181
Query: 882 PE----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
PE Y + +D+++ GV+L LL G P
Sbjct: 182 PEVLRKDPY----GKPVDLWACGVILYILLVGYPP 212
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-28
Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVK-----KLWRSRADLETESSGDFVGEVNVLGKLR-H 765
VIG G + +V + AVK S LE E E ++L ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLE-EVREATRRETHILRQVAGH 159
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL--HG----KQAGRLLVDWVSRYNIALGV 819
+I+ L+ + + M +V++ M G L + L K+ ++ +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS----------L 209
Query: 820 AQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGY 879
+ +++LH + I+HRD+K NILLD N++ R++DFG + + E + + G+ GY
Sbjct: 210 LEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKLRELCGTPGY 265
Query: 880 IAPE------YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
+APE +++D+++ GV+L LL G P
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 39/231 (16%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG----------------- 755
IG G+ G+V A NT A+K L + + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 756 -----EVNVLGKLRHRNIVRLLGFLH--NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVD 808
E+ +L KL H N+V+L+ L N+ ++ +V+E +N G + L D
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG---PVMEVPTLKPLSED 137
Query: 809 WVSRY--NIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866
Y ++ G+ YLH Y IIHRDIK +N+L+ + +IADFG++
Sbjct: 138 QARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 867 NETVSMVAGSYGYIAPE--YGYTLKVD-EKIDIYSFGVVLLELLTGRRPLD 914
+ +S G+ ++APE + +D+++ GV L + G+ P
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-28
Identities = 71/232 (30%), Positives = 110/232 (47%), Gaps = 54/232 (23%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
VIG G+ G+VY+A++ +VA+KK+ D ++ E+ ++ KL H NIVRL
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNR-----ELQIMRKLDHCNIVRL 112
Query: 772 LGFLH------NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALG------- 818
F + ++ + +V +Y+ E ++ + SR L
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYV-----PETVYR------VARHYSRAKQTLPVIYVKLY 161
Query: 819 ---VAQGLAYLH-HDCYPPIIHRDIKSNNILLDSNLEP-RIADFGLARMMIRKNETVSMV 873
+ + LAY+H I HRDIK N+LLD + ++ DFG A+ ++R VS +
Sbjct: 162 MYQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217
Query: 874 AGSYGYIAPE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
Y Y APE YT ID++S G VL ELL G +P+ P G+S
Sbjct: 218 CSRY-YRAPELIFGATDYT----SSIDVWSAGCVLAELLLG-QPIFP--GDS 261
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 42/227 (18%)
Query: 710 SNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNI 768
IG+G+ + + N AVK + +S+ D E + +L + +H NI
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--------IEILLRYGQHPNI 78
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGK------QAGRLLVDWVSRYNIALGVAQG 822
+ L + + +V E M G L + + + +A +L + +
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT----------ITKT 128
Query: 823 LAYLH-HDCYPPIIHRDIKSNNILLDSNLEP----RIADFGLARMMIRKNETVSMVAGSY 877
+ YLH ++HRD+K +NIL RI DFG A+ + +N + +
Sbjct: 129 VEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA 184
Query: 878 GYIAPE----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
++APE GY D DI+S GV+L +LTG P ++
Sbjct: 185 NFVAPEVLERQGY----DAACDIWSLGVLLYTMLTGYTPFANGPDDT 227
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 39/217 (17%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G GA +V + A K + + L E + KL+H NIVRL
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKII--NTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEAL--HG----KQAGRLLVDWVSRYNIALGVAQGLAY 825
+ ++ +V++ + G L E + A + + + +AY
Sbjct: 94 HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ----------ILESIAY 143
Query: 826 LH-HDCYPPIIHRDIKSNNILLDSNLEP---RIADFGLARMMIRKNETVSMVAGSYGYIA 881
H + I+HR++K N+LL S + ++ADFGLA + +E AG+ GY++
Sbjct: 144 CHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFAGTPGYLS 198
Query: 882 PE------YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
PE Y + +DI++ GV+L LL G P
Sbjct: 199 PEVLKKDPYS------KPVDIWACGVILYILLVGYPP 229
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 70/224 (31%), Positives = 109/224 (48%), Gaps = 36/224 (16%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDF----VGEVNVLGKLRHR 766
+ +G G VYKA N IVA+KK+ + +E+ + E+ +L +L H
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
NI+ LL + +N+ +V+++M L E + + L + Y + QGL YL
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFMET-DL-EVIIKDNSLVLTPSHIKAYMLMT--LQGLEYL 128
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM---IRK--NETVSMVAGSYGYIA 881
H I+HRD+K NN+LLD N ++ADFGLA+ R ++ V+ Y A
Sbjct: 129 HQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-----WYRA 180
Query: 882 PE--YG---YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
PE +G Y +D+++ G +L ELL R P P G+S
Sbjct: 181 PELLFGARMYG----VGVDMWAVGCILAELLL-RVPFLP--GDS 217
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 52/228 (22%), Positives = 92/228 (40%), Gaps = 40/228 (17%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+ G G G V + VA+KK+ + E + L L H NIV+L
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-----IMQDLAVLHHPNIVQL 84
Query: 772 LGFLH-------NDTNMMIVYEYMNNGSLGEALH------GKQAGRLLVDWVSRYNIALG 818
+ + D + +V EY+ + LH ++ + + L
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPILIKVFLFQL- 138
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLD-SNLEPRIADFGLARMMIRKNETVSMVAGSY 877
+ + LH + HRDIK +N+L++ ++ ++ DFG A+ + V+ + Y
Sbjct: 139 -IRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 878 GYIAPE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
Y APE YT +DI+S G + E++ G P+ G++
Sbjct: 197 -YRAPELIFGNQHYT----TAVDIWSVGCIFAEMMLG-EPIFR--GDN 236
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 40/216 (18%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRS-RADLETESSGDFVGEVNVLGKLR-HRNIV 769
+G G+ I K + N AVK + + A+ + E + L H NIV
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKE--------ITALKLCEGHPNIV 69
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGK------QAGRLLVDWVSRYNIALGVAQGL 823
+L H+ + +V E +N G L E + K +A ++ + +
Sbjct: 70 KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK----------LVSAV 119
Query: 824 AYLHHDCYPPIIHRDIKSNNILL---DSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI 880
+++H ++HRD+K N+L + NLE +I DFG AR+ N+ + + Y
Sbjct: 120 SHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYA 176
Query: 881 APE----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
APE GY DE D++S GV+L +L+G+ P
Sbjct: 177 APELLNQNGY----DESCDLWSLGVILYTMLSGQVP 208
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 82/309 (26%), Positives = 134/309 (43%), Gaps = 72/309 (23%)
Query: 711 NVIGMGATGIVYKAEMPRLN-------TIVAVKKLWRSRADLETESSGDFVGEVNVLGKL 763
+G GA G V AE L+ T VAVK L +S A + S D + E+ ++ +
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLS--DLISEMEMMKMI 131
Query: 764 -RHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN-------- 814
+H+NI+ LLG D + ++ EY + G+L E L ++ L + +N
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 815 ----IALGVAQGLAYL--HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE 868
A VA+G+ YL IHRD+ + N+L+ + +IADFGLAR + +
Sbjct: 192 DLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLARDI---HH 243
Query: 869 TVSMVAGSYGYI-----APE---YG-YTLKVDEKIDIYSFGVVLLELLT-GRRP---LDP 915
+ G + APE YT + D++SFGV+L E+ T G P +
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQS----DVWSFGVLLWEIFTLGGSPYPGVPV 299
Query: 916 EFGESVDIVEWIRMKIRDNRNLEEALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRP 974
E E ++ +R +++ P+ NC + M C +P RP
Sbjct: 300 E--------ELFKLLKEGHR-MDK---PS--NCTNELYMMMR-------DCWHAVPSQRP 338
Query: 975 SMRDVITML 983
+ + ++ L
Sbjct: 339 TFKQLVEDL 347
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 46/219 (21%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVK----KLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
V+G GA V+ + + A+K + LE E + VL K++H N
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENE--------IAVLKKIKHEN 67
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQ------AGRLLVDWVSRYNIALGVAQ 821
IV L + T+ +V + ++ G L + + + A ++ V
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ----------VLS 117
Query: 822 GLAYLH-HDCYPPIIHRDIKSNNILLDSNLEP---RIADFGLARMMIRKNETVSMVAGSY 877
+ YLH + I+HRD+K N+L + E I DFGL++M +N +S G+
Sbjct: 118 AVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTACGTP 171
Query: 878 GYIAPE----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
GY+APE Y + +D +S GV+ LL G P
Sbjct: 172 GYVAPEVLAQKPY----SKAVDCWSIGVITYILLCGYPP 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 70/223 (31%), Positives = 111/223 (49%), Gaps = 38/223 (17%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETE---SSGDFVGEVNVLGKLRHRN 767
IG G G+VYKA A+KK+ R + E E S+ + E+++L +L+H N
Sbjct: 8 EKIGEGTYGVVYKA-QNNYGETFALKKI---RLEKEDEGIPSTT--IREISILKELKHSN 61
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
IV+L +H +++V+E+++ L + L G L + + L G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSFLLQL--LNGIAYCH 117
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM---IRK--NETVSMVAGSYGYIAP 882
++HRD+K N+L++ E +IADFGLAR +RK +E V++ Y AP
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL-----WYRAP 169
Query: 883 E--YG---YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
+ G Y+ IDI+S G + E++ PL P G S
Sbjct: 170 DVLMGSKKYS----TTIDIWSVGCIFAEMVN-GTPLFP--GVS 205
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-27
Identities = 52/258 (20%), Positives = 93/258 (36%), Gaps = 9/258 (3%)
Query: 361 NSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNN 420
++ + + S E+P + N L L N + H L +++ N
Sbjct: 53 SNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 421 QLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTIL 479
+ I VG F L L LEL +N LT + + L + + N + S
Sbjct: 110 SIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFN 168
Query: 480 SIPNLQTFIVSNNNLVGEIPDQ-FQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLR 538
+P+L + + I + F+ +L L+L +P+ + L L +
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMS 226
Query: 539 NNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEG-PVPAN 597
N P + + +L L + N+ ++ F +L LN+++N L P
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLF 286
Query: 598 GVLRTINRGDLAGNAGLC 615
LR + L N C
Sbjct: 287 TPLRYLVELHLHHNPWNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 64/301 (21%), Positives = 109/301 (36%), Gaps = 58/301 (19%)
Query: 291 SLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSL 350
+ + LS +P I N + LNLM N + L LEVL+L NS+
Sbjct: 55 QFSKVVCTRRGLSE-VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 351 SGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCH 410
+ L L+L N + IP+ AF
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT-VIPS---------------GAFEYL--------S 147
Query: 411 SLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNH 469
L + ++NN + +IP F R+ L RL+L
Sbjct: 148 KLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGEL-----------------------KK 183
Query: 470 LRSSLPSTILS-IPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIAS 528
L + + NL+ + N+ ++P+ L L++S N+F P S
Sbjct: 184 L-EYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHG 240
Query: 529 CEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPEN-FGASPALEVLNVSY 587
L L + N+Q++ A + +L L+L++N+L+ +P + F L L++ +
Sbjct: 241 LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHH 299
Query: 588 N 588
N
Sbjct: 300 N 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 63/235 (26%), Positives = 92/235 (39%), Gaps = 13/235 (5%)
Query: 146 AGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPV-SFKNLQKLKFLGLSGN 204
+ +LN NN + + LE L L + + I V +F L L L L N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDN 133
Query: 205 NLTGKIPRE-LGQLSSMETMILAYNEFDGEIPVE-FGNLTNLKYLDLAVGNLGGKIPAE- 261
LT IP LS + + L N IP F + +L LDL I
Sbjct: 134 WLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGA 191
Query: 262 LGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNL 321
L L+ + L N + +P + + L+ L++S N P L +L+ L +
Sbjct: 192 FEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWV 249
Query: 322 MCNQLSGHVPAG-LGGLTQLEVLELWNNSLSGPLPVD-LGKNSPLQWLDLSSNSF 374
M +Q+S + GL L L L +N+LS LP D L L L N +
Sbjct: 250 MNSQVS-LIERNAFDGLASLVELNLAHNNLSS-LPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 19/83 (22%), Positives = 33/83 (39%), Gaps = 2/83 (2%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
E+L++S + F L SL L + + + N+ L SL +++ N L+
Sbjct: 221 EELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS- 279
Query: 137 SFPAG-LGGAAGLTFLNASGNNF 158
S P L L+ N +
Sbjct: 280 SLPHDLFTPLRYLVELHLHHNPW 302
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-27
Identities = 68/228 (29%), Positives = 109/228 (47%), Gaps = 47/228 (20%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
VIG G+ G+V++A++ + VA+KK+ D ++ E+ ++ ++H N+V L
Sbjct: 47 VIGNGSFGVVFQAKL-VESDEVAIKKV---LQDKRFKNR-----ELQIMRIVKHPNVVDL 97
Query: 772 LGFLH------NDTNMMIVYEYMNNGSLGEALH------GKQAGRLLVDWVSRYNIALGV 819
F + ++ + +V EY+ E ++ K + + + Y L
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPMLLIKLYMYQL-- 150
Query: 820 AQGLAYLH-HDCYPPIIHRDIKSNNILLDSNLEP-RIADFGLARMMIRKNETVSMVAGSY 877
+ LAY+H I HRDIK N+LLD ++ DFG A+++I VS + Y
Sbjct: 151 LRSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY 206
Query: 878 GYIAPE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
Y APE YT IDI+S G V+ EL+ G +PL P GES
Sbjct: 207 -YRAPELIFGATNYTT----NIDIWSTGCVMAELMQG-QPLFP--GES 246
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG----EVNVLGKLRHRNI 768
+G GA G V+ A N V VK + + + + +G E+ +L ++ H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGE-----ALHGKQAGRLLVDWVSRYNIALGVAQGL 823
+++L N +V E +G + H + L + ++ Y I + +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG--LDLFAFIDRHPR-----LDEPLASY-IFRQLVSAV 143
Query: 824 AYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE 883
YL IIHRDIK NI++ + ++ DFG A + + + G+ Y APE
Sbjct: 144 GYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTFCGTIEYCAPE 199
Query: 884 Y----GYTLKVDEKIDIYSFGVVLLELLTGRRPLD 914
Y +++++S GV L L+ P
Sbjct: 200 VLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFC 231
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 51/222 (22%), Positives = 99/222 (44%), Gaps = 41/222 (18%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVK----KLWRSRADLETESSGDFVGEVNVLGK 762
+ ++ ++G G G V+K E +A K + + + +++ E ++V+ +
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNE--------ISVMNQ 142
Query: 763 LRHRNIVRLLGFLHNDTNMMIVYEYMNNGSL-------GEALHGKQAGRLLVDWVSRYNI 815
L H N+++L + ++++V EY++ G L L +
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ------- 195
Query: 816 ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRI--ADFGLARMMIRKNETVSMV 873
+ +G+ ++H I+H D+K NIL + +I DFGLAR + E + +
Sbjct: 196 ---ICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLAR-RYKPREKLKVN 248
Query: 874 AGSYGYIAPE---YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
G+ ++APE Y + V D++S GV+ LL+G P
Sbjct: 249 FGTPEFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 69/225 (30%), Positives = 114/225 (50%), Gaps = 42/225 (18%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETE---SSGDFVGEVNVLGKLRHRN 767
+G G G+VYKA IVA+K++ R D E E S+ + E+++L +L H N
Sbjct: 27 EKVGEGTYGVVYKA-KDSQGRIVALKRI---RLDAEDEGIPSTA--IREISLLKELHHPN 80
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
IV L+ +H++ + +V+E+M L + L + G L + Y L +G+A+ H
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYLYQL--LRGVAHCH 136
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM---IRK--NETVSMVAGSYGYIAP 882
I+HRD+K N+L++S+ ++ADFGLAR +R +E V++ Y AP
Sbjct: 137 QHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL-----WYRAP 188
Query: 883 E-------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
+ Y +DI+S G + E++T +PL P G +
Sbjct: 189 DVLMGSKKYS------TSVDIWSIGCIFAEMIT-GKPLFP--GVT 224
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 40/225 (17%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG--EVNVLGKLRHRNI 768
+ +G G VYK + + +VA+K++ R LE E EV++L L+H NI
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEI---R--LEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
V L +H + ++ +V+EY++ L + L + + V + L +GLAY H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLD-DCGNIINMHNVKLFLFQL--LRGLAYCHR 118
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM---IRK--NETVSMVAGSYGYIAPE 883
++HRD+K N+L++ E ++ADFGLAR + NE V++ Y P+
Sbjct: 119 QK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTL-----WYRPPD 170
Query: 884 -------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESV 921
Y +ID++ G + E+ T RPL P G +V
Sbjct: 171 ILLGSTDYS------TQIDMWGVGCIFYEMAT-GRPLFP--GSTV 206
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 37/226 (16%), Positives = 71/226 (31%), Gaps = 36/226 (15%)
Query: 711 NVIGMGATGIVYKAEMPRLNT-----IVAVK-----KLWRSRADLETESSGDFVGEVNVL 760
+++G GA VY+A LN +K W + + L
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ---------LMERL 121
Query: 761 GKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEAL-HGKQAGRLLVDWVSRYNIALGV 819
++ ++V E + G+L A+ K ++ + A+ +
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 820 AQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP-----------RIADFGLARMM--IRK 866
+ +H IIH DIK +N +L + + D G + M K
Sbjct: 182 LYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 867 NETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
+ + G+ E + +ID + + +L G
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 30/209 (14%), Positives = 59/209 (28%), Gaps = 37/209 (17%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
G ++A L+ VA+ + + L + + + L ++ + R+
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFV-DPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
L +H ++V E++ GSL E R +A H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIR--AMQSLAAAADAAHRA-- 148
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVD 891
+ + + + + + +A + +
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPD-------AN 180
Query: 892 EKIDIYSFGVVLLELLTGRRPLDPEFGES 920
+ DI G L LL R PL S
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRS 209
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 47/284 (16%), Positives = 97/284 (34%), Gaps = 27/284 (9%)
Query: 290 TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGL-GGLTQLEVLELWNN 348
+++ LDLS N +++ +++ + NLQ L L N ++ + L LE L+L N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 349 SLSGPLPVDL-GKNSPLQWLDLSSNSFSGEIPASLCNG-GNLTKLILFNNAFSGPIPV-S 405
LS L S L +L+L N + SL + L L + N I
Sbjct: 111 YLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 406 LSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFID 464
+ L + + + L + ++ + L L + + ++S+ ++
Sbjct: 170 FAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLE 228
Query: 465 ISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPS 524
+ L + S + + + + + ++ +
Sbjct: 229 LRDTDLDTFHFSELSTGET----------------NSLIKKFTFRNVKITDESLF-QVMK 271
Query: 525 SIASCEKLVNLNLRNNQLTGDIPK-AISMMPTLAILDLSNNSLT 567
+ L+ L NQL +P + +L + L N
Sbjct: 272 LLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-26
Identities = 66/355 (18%), Positives = 118/355 (33%), Gaps = 66/355 (18%)
Query: 105 LCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLE 164
+ S + + S LN S P+GL + L+ S N +
Sbjct: 14 IISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNS 70
Query: 165 DLGNATSLETLDLRGSFFQGSIPV-SFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETM 223
DL +L+ L L + +I SF +L L+ L LS N L+ +
Sbjct: 71 DLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSW--------- 119
Query: 224 ILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLP 283
F L++L +L+L N ++
Sbjct: 120 --------------FKPLSSLTFLNL------------------------LGNPYKTLGE 141
Query: 284 AEI-GNITSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAGLGGLTQLE 341
+ ++T LQ+L + +I + L L+ L + + L + P L + +
Sbjct: 142 TSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVS 201
Query: 342 VLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSG----EIPA----SLCNGGNLTKLIL 393
L L L + + S ++ L+L E+ SL + +
Sbjct: 202 HLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 394 FNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLT 447
+ + + L+ L+ + NQL ++P G F RL LQ++ L N
Sbjct: 262 TDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 59/312 (18%), Positives = 111/312 (35%), Gaps = 65/312 (20%)
Query: 76 VEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLN 135
V+ LDLS+ ++ + QR +L +L L NG+ + +S ++L SL+ D+S N+L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL- 112
Query: 136 GSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQK 195
+ + FK L
Sbjct: 113 SNLSSSW-----------------------------------------------FKPLSS 125
Query: 196 LKFLGLSGNNLTGKIPREL-GQLSSMETMILAYNEFDGEIPVE-FGNLTNLKYLDLAVGN 253
L FL L GN L L+ ++ + + + +I + F LT L+ L++ +
Sbjct: 126 LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185
Query: 254 LGGKIPAE-LGRLELLEIMFLYQNNFQGRLPAEI-GNITSLQLLDLSYNMLSHEIPAEI- 310
L + L ++ + + L+ L +S++ L+L L +E+
Sbjct: 186 L-QSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243
Query: 311 -------TQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSP 363
+ + + + L V L ++ L LE N L +P +
Sbjct: 244 TGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLT 301
Query: 364 -LQWLDLSSNSF 374
LQ + L +N +
Sbjct: 302 SLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 48/256 (18%), Positives = 103/256 (40%), Gaps = 17/256 (6%)
Query: 368 DLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIP 427
SS S + IP+ L + L L NN + L C +L + + +N ++ TI
Sbjct: 37 KGSSGSLN-SIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIE 92
Query: 428 VG-FGRLEKLQRLELANNSLTGGITDDI-ASSTSLSFIDISRNHLRSSLPSTILS-IPNL 484
F L L+ L+L+ N L+ ++ +SL+F+++ N ++ +++ S + L
Sbjct: 93 EDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKL 151
Query: 485 QTFIVSNNNLVGEIPDQ-FQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLT 543
Q V N + +I + F L L++ ++ P S+ S + + +L L Q
Sbjct: 152 QILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211
Query: 544 GDIPKAISMMPTLAILDLSNN--------SLTGGIPENFGASPALEVLNVSYNRLEGPVP 595
+ + + ++ L+L + L+ G + + ++ L +
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMK 271
Query: 596 ANGVLRTINRGDLAGN 611
+ + + + N
Sbjct: 272 LLNQISGLLELEFSRN 287
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G V A VA+K + +++ L S EV ++ L H NIV+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQ--LNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRY--NIALGVAQGLAYLHHDC 830
+ + + ++ EY + G + + L GR+ I V Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQ----YCHQKR 134
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY----GY 886
I+HRD+K+ N+LLD+++ +IADFG + + G+ Y APE Y
Sbjct: 135 ---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 887 TLKVDEKIDIYSFGVVLLELLTGRRPLD 914
++D++S GV+L L++G P D
Sbjct: 191 DGP---EVDVWSLGVILYTLVSGSLPFD 215
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
++G G+ G V + AVK L + + + E+ +L +LRH+N+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 772 LGFLHNDTNMMI--VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ---GLAYL 826
+ L+N+ + V EY G + E L R V Y Q GL YL
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGY-----FCQLIDGLEYL 125
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM--IRKNETVSMVAGSYGYIAPE- 883
H I+H+DIK N+LL + +I+ G+A + ++T GS + PE
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 884 -YGYTLKVDEKIDIYSFGVVLLELLTGRRPLD 914
G K+DI+S GV L + TG P +
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 55/234 (23%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG-------EVNVLGKL 763
+G G G VYKA N VA+K++ R + E E G EV++L +L
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEE------GVPGTAIREVSLLKEL 90
Query: 764 RHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGL 823
+HRNI+ L +H++ + +++EY N L + + + + + + + L G+
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLYQL--INGV 145
Query: 824 AYLHHDCYPPIIHRDIKSNNILLDSNLEPR-----IADFGLARMM---IRK--NETVSMV 873
+ H +HRD+K N+LL + I DFGLAR IR+ +E +++
Sbjct: 146 NFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL- 201
Query: 874 AGSYGYIAPE-------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
Y PE Y +DI+S + E+L + PL P G+S
Sbjct: 202 ----WYRPPEILLGSRHYS------TSVDIWSIACIWAEMLM-KTPLFP--GDS 242
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 33/221 (14%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGD---FVGEVNVLGKLRHRN 767
IG G+ G+V+K IVA+KK + + E+ +L +L+H N
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF-----LESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
+V LL + +V+EY ++ ++ L + R + + + + +I Q + + H
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVK-SITWQTLQAVNFCH 119
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVS-MVAGSYGYIAPE--- 883
IHRD+K NIL+ + ++ DFG AR++ ++ VA + Y +PE
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW-YRSPELLV 175
Query: 884 ----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
YG +D+++ G V ELL+ PL P G+S
Sbjct: 176 GDTQYG------PPVDVWAIGCVFAELLS-GVPLWP--GKS 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 45/214 (21%), Positives = 87/214 (40%), Gaps = 36/214 (16%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G G GIV++ K + D E+++L RHRNI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-----LVKKEISILNIARHRNILHL 66
Query: 772 LGFLHNDTNMMIVYEYMNNGSL-------GEALHGKQAGRLLVDWVSRYNIALGVAQGLA 824
+ +++++E+++ + L+ ++ + V + L
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ----------VCEALQ 116
Query: 825 YLH-HDCYPPIIHRDIKSNNILLDSNLEP--RIADFGLARMMIRKNETVSMVAGSYGYIA 881
+LH H+ I H DI+ NI+ + +I +FG AR ++ + ++ + Y A
Sbjct: 117 FLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGDNFRLLFTAPEYYA 171
Query: 882 PEYGYTLK---VDEKIDIYSFGVVLLELLTGRRP 912
PE + V D++S G ++ LL+G P
Sbjct: 172 PE---VHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-26
Identities = 56/259 (21%), Positives = 96/259 (37%), Gaps = 11/259 (4%)
Query: 361 NSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNN 420
++ + + E+P + N L L N S L +++ N
Sbjct: 42 SNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 421 QLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTIL 479
+ TI +G F L L LEL +N LT + L + + N + S
Sbjct: 99 HIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFN 157
Query: 480 SIPNLQTFIVSNNNLVGEIPDQ-FQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLR 538
IP+L+ + + I + F+ +L L+L+ IP+ + KL L+L
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLS 215
Query: 539 NNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPEN-FGASPALEVLNVSYNRLEG-PVPA 596
N L+ P + + L L + + + I N F +L +N+++N L P
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAHNNLTLLPHDL 274
Query: 597 NGVLRTINRGDLAGNAGLC 615
L + R L N C
Sbjct: 275 FTPLHHLERIHLHHNPWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 67/301 (22%), Positives = 108/301 (35%), Gaps = 58/301 (19%)
Query: 291 SLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSL 350
+ L +P I N +LLNL NQ+ L LE+L+L N +
Sbjct: 44 QFSKVICVRKNLRE-VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 351 SGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCH 410
+ L L+L N + IP AF
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT-TIPN---------------GAFVYL--------S 136
Query: 411 SLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNH 469
L + ++NN + +IP F R+ L+RL+L
Sbjct: 137 KLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGEL-----------------------KR 172
Query: 470 LRSSLPSTILS-IPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIAS 528
L S + + NL+ ++ NL EIP+ L LDLS N+ S P S
Sbjct: 173 L-SYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQG 229
Query: 529 CEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPEN-FGASPALEVLNVSY 587
L L + +Q+ A + +L ++L++N+LT +P + F LE +++ +
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHH 288
Query: 588 N 588
N
Sbjct: 289 N 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-25
Identities = 61/244 (25%), Positives = 93/244 (38%), Gaps = 15/244 (6%)
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKL 196
P G+ + LN N + + LE L L + + +F L L
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 197 KFLGLSGNNLTGKIPRE-LGQLSSMETMILAYNEFDGEIPVE-FGNLTNLKYLDLAVGNL 254
L L N LT IP LS ++ + L N + IP F + +L+ LDL
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKR 172
Query: 255 GGKIPAE-LGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEI-TQ 312
I L L + L N + +P + + L LDLS N LS I
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSA-IRPGSFQG 229
Query: 313 LKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLELWNNSLSGPLPVD-LGKNSPLQWLDLS 370
L +LQ L ++ +Q+ + L L + L +N+L+ LP D L+ + L
Sbjct: 230 LMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTL-LPHDLFTPLHHLERIHLH 287
Query: 371 SNSF 374
N +
Sbjct: 288 HNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-23
Identities = 61/304 (20%), Positives = 102/304 (33%), Gaps = 67/304 (22%)
Query: 62 HCNWTG--VWCNSNG----------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNG 109
C+ V C L+L + + F+ L+ L L L N
Sbjct: 40 SCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 110 LFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNA 169
+ + + L +L ++ N L + P G F
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGA---------------FVYL-------- 135
Query: 170 TSLETLDLRGSFFQGSIPV-SFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYN 228
+ L+ L LR + + SIP +F + L+ L L +LS +
Sbjct: 136 SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK----------RLSYISEGA---- 180
Query: 229 EFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEI-G 287
F L+NL+YL+LA +IP L L L+ + L N+ +
Sbjct: 181 ---------FEGLSNLRYLNLA-MCNLREIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQ 228
Query: 288 NITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLELW 346
+ LQ L + + + L++L +NL N L+ +P L LE + L
Sbjct: 229 GLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLH 287
Query: 347 NNSL 350
+N
Sbjct: 288 HNPW 291
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-26
Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
IG G+ G V + + A+K + + +E + E+ ++ L H +V L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYM-NKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-HDC 830
++ +M +V + + G L H +Q + V + I + L YL
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEETV-KLFIC-ELVMALDYLQNQR- 135
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE------- 883
IIHRD+K +NILLD + I DF +A M+ R+ + +M AG+ Y+APE
Sbjct: 136 ---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM-AGTKPYMAPEMFSSRKG 191
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVD 922
GY+ V D +S GV ELL GRRP S
Sbjct: 192 AGYSFAV----DWWSLGVTAYELLRGRRPYHIRSSTSSK 226
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-26
Identities = 49/211 (23%), Positives = 88/211 (41%), Gaps = 24/211 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR-NIVR 770
+G G +V + A K L + R + + + E+ VL + ++
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRR--RGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ---GLAYLH 827
L N + ++++ EY G + + A + S ++ + Q G+ YLH
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV-----SENDVIRLIKQILEGVYYLH 148
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEP---RIADFGLARMMIRKNETVSMVAGSYGYIAPEY 884
+ I+H D+K NILL S +I DFG++R I + + G+ Y+APE
Sbjct: 149 QNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACELREIMGTPEYLAPE- 203
Query: 885 GYTLK---VDEKIDIYSFGVVLLELLTGRRP 912
L + D+++ G++ LLT P
Sbjct: 204 --ILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 40/220 (18%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVK-----KLWRSRADLETESSGDFVGEVNVLGKLRHR 766
+G G IV K A K +L SR + E + EVN+L ++RH
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSRE---EIEREVNILREIRHP 68
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSL------GEALHGKQAGRLLVDWVSRYNIALGVA 820
NI+ L N T+++++ E ++ G L E+L +A + L +
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ----------IL 118
Query: 821 QGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP----RIADFGLARMMIRKNETVSMVAGS 876
G+ YLH I H D+K NI+L P ++ DFG+A I + G+
Sbjct: 119 DGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEFKNIFGT 174
Query: 877 YGYIAPE----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
++APE L+ D++S GV+ LL+G P
Sbjct: 175 PEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASP 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-26
Identities = 67/253 (26%), Positives = 113/253 (44%), Gaps = 42/253 (16%)
Query: 677 EKLEMGKGEWPWRLM-AFQRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAV 735
+++G ++ M ++ LG ++G G+ G+V K IVA+
Sbjct: 10 SGVDLGTENLYFQSMEKYENLG--------------LVGEGSYGMVMKCRNKDTGRIVAI 55
Query: 736 KKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGE 795
KK S D + + E+ +L +LRH N+V LL +V+E++++ ++ +
Sbjct: 56 KKFLESDDDKMVKKIA--MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILD 112
Query: 796 ALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIA 855
L G L V +Y + G+ + H IIHRDIK NIL+ + ++
Sbjct: 113 DLELFPNG-LDYQVVQKYLFQI--INGIGFCHSHN---IIHRDIKPENILVSQSGVVKLC 166
Query: 856 DFGLARMMIRKNETVS-MVAGSYGYIAPE-------YGYTLKVDEKIDIYSFGVVLLELL 907
DFG AR + E VA + Y APE YG + +D+++ G ++ E+
Sbjct: 167 DFGFARTLAAPGEVYDDEVATRW-YRAPELLVGDVKYG------KAVDVWAIGCLVTEMF 219
Query: 908 TGRRPLDPEFGES 920
G PL P G+S
Sbjct: 220 MG-EPLFP--GDS 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 49/231 (21%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETE----SSGDFVGEVNVLGKLRHR 766
+G G VYK VA+K++ + L++E S+ + E++++ +L+H
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEV---K--LDSEEGTPSTA--IREISLMKELKHE 63
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNN--GSLGEALHGKQAGRLLVDWVSRYNIALGVAQ--- 821
NIVRL +H + + +V+E+M+N ++ R L + Q
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGL----ELNLVKYFQWQLLQ 119
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM---IRK--NETVSMVAGS 876
GLA+ H + I+HRD+K N+L++ + ++ DFGLAR + +E V++
Sbjct: 120 GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL---- 172
Query: 877 YGYIAPE-------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES 920
Y AP+ Y IDI+S G +L E++T +PL P G +
Sbjct: 173 -WYRAPDVLMGSRTYS------TSIDIWSCGCILAEMIT-GKPLFP--GTN 213
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-26
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 39/215 (18%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G GAT IVY+ + A+K L + D + E+ VL +L H NI++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL-KKTVDKK-----IVRTEIGVLLRLSHPNIIKL 113
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEAL--HG----KQAGRLLVDWVSRYNIALGVAQGLAY 825
T + +V E + G L + + G + A + + + +AY
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ----------ILEAVAY 163
Query: 826 LH-HDCYPPIIHRDIKSNNILLDSNLEP---RIADFGLARMMIRKNETVSMVAGSYGYIA 881
LH + I+HRD+K N+L + +IADFGL++ ++ + V G+ GY A
Sbjct: 164 LHENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMKTVCGTPGYCA 218
Query: 882 PE----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
PE Y +V D++S G++ LL G P
Sbjct: 219 PEILRGCAYGPEV----DMWSVGIITYILLCGFEP 249
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG-EVNVLGKLRHRNIVRL 771
+G+G G V E VAVK L R + + + + E+ L RH +I++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQK--IRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRY--NIALGVAQGLAYLHHD 829
+ T+ +V EY++ G L + + GR+ R I V Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVD----YCHRH 130
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----YG 885
++HRD+K N+LLD+++ +IADFGL+ MM E + GS Y APE
Sbjct: 131 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSCGSPNYAAPEVISGRL 186
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRPLD 914
Y ++DI+S GV+L LL G P D
Sbjct: 187 YA---GPEVDIWSCGVILYALLCGTLPFD 212
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVK--KLWRSRADLETESSGDFVGEVNVLGKLRHRNIV 769
+G G IV K A K K +SRA + EV++L ++ H NI+
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSL------GEALHGKQAGRLLVDWVSRYNIALGVAQGL 823
L N T+++++ E ++ G L E+L ++A + + G+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ----------ILDGV 128
Query: 824 AYLHHDCYPPIIHRDIKSNNILLDSNLEP----RIADFGLARMMIRKNETVSMVAGSYGY 879
YLH I H D+K NI+L P ++ DFGLA I + G+ +
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEF 184
Query: 880 IAPEYGYTLK---VDEKIDIYSFGVVLLELLTGRRP 912
+APE + + + D++S GV+ LL+G P
Sbjct: 185 VAPE---IVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 44/218 (20%), Positives = 87/218 (39%), Gaps = 43/218 (19%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVK----KLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
+G GA G+V++ + K + ++ E ++++ +L H
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNE--------ISIMNQLHHPK 109
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSL-------GEALHGKQAGRLLVDWVSRYNIALGVA 820
++ L + M+++ E+++ G L + + +
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ----------AC 159
Query: 821 QGLAYLH-HDCYPPIIHRDIKSNNILLDSNLEPR--IADFGLARMMIRKNETVSMVAGSY 877
+GL ++H H I+H DIK NI+ ++ I DFGLA + +E V + +
Sbjct: 160 EGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLAT-KLNPDEIVKVTTATA 214
Query: 878 GYIAPEYGYTLK---VDEKIDIYSFGVVLLELLTGRRP 912
+ APE + V D+++ GV+ LL+G P
Sbjct: 215 EFAAPE---IVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 32/216 (14%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVK--KLWRSRADLETESSGDFVGEVNVLGKLRHRNIV 769
+G G IV K A K K +SRA S + EV++L ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSL------GEALHGKQAGRLLVDWVSRYNIALGVAQGL 823
L N T+++++ E ++ G L E+L ++A + + G+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ----------ILDGV 128
Query: 824 AYLHHDCYPPIIHRDIKSNNILLDSNLEP----RIADFGLARMMIRKNETVSMVAGSYGY 879
YLH I H D+K NI+L P ++ DFGLA I + G+ +
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEF 184
Query: 880 IAPEYGYTLK---VDEKIDIYSFGVVLLELLTGRRP 912
+APE + + + D++S GV+ LL+G P
Sbjct: 185 VAPE---IVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 41/224 (18%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVR 770
V+G GA V + AVK + + S EV +L + + HRN++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKII--EKQPGHIRS--RVFREVEMLYQCQGHRNVLE 75
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGK------QAGRLLVDWVSRYNIALGVAQGLA 824
L+ F + +V+E M GS+ +H + +A ++ D VA L
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD----------VASALD 125
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSNLEP---RIADFGLARMMIRKNETVSMVA------- 874
+LH+ I HRD+K NIL + + +I DF L I+ N S ++
Sbjct: 126 FLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGS-GIKLNGDCSPISTPELLTP 181
Query: 875 -GSYGYIAPE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
GS Y+APE D++ D++S GV+L LL+G P
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-25
Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 40/220 (18%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVK-----KLWRSRADLETESSGDFVGEVNVLGKLRHR 766
+G G +V K A K + SR + E D EV++L +++H
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHP 74
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSL------GEALHGKQAGRLLVDWVSRYNIALGVA 820
N++ L N T+++++ E + G L E+L ++A L +
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----------IL 124
Query: 821 QGLAYLH-HDCYPPIIHRDIKSNNILLDSNLEP----RIADFGLARMMIRKNETVSMVAG 875
G+ YLH I H D+K NI+L P +I DFGLA I + G
Sbjct: 125 NGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFG 179
Query: 876 SYGYIAPEYGYTLK---VDEKIDIYSFGVVLLELLTGRRP 912
+ ++APE + + + D++S GV+ LL+G P
Sbjct: 180 TPEFVAPE---IVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-25
Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 27/210 (12%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLW-RSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G GA G+V++ A K + +D E E+ + LRH +V
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-----TVRKEIQTMSVLRHPTLVN 218
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN---IALGVAQ---GLA 824
L +D M+++YE+M+ G L E + D ++ + + Q GL
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEK---------VADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSNLEPRI--ADFGLARMMIRKNETVSMVAGSYGYIAP 882
++H + +H D+K NI+ + + DFGL + ++V + G+ + AP
Sbjct: 270 HMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSVKVTTGTAEFAAP 325
Query: 883 EYGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
E V D++S GV+ LL+G P
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 66/241 (27%), Positives = 95/241 (39%), Gaps = 63/241 (26%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDF----VGEVNVLGKLR-- 764
IG+GA G VYKA P VA+K + R G V EV +L +L
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 765 -HRNIVRLLGFLHND-----TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALG 818
H N+VRL+ + +V+E+++ L L L + +
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF- 129
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG 878
+GL +LH +C I+HRD+K NIL+ S ++ADFGLAR Y
Sbjct: 130 -LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--------------IYS 171
Query: 879 -------------YIAPE------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGE 919
Y APE Y +D++S G + E+ R+PL G
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYA------TPVDMWSVGCIFAEMFR-RKPLFC--GN 222
Query: 920 S 920
S
Sbjct: 223 S 223
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G GA G V A VAVK + RA + + E+ + L H N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 71
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRY--NIALGVAQGLAYLHHDC 830
G + EY + G L + + + + R+ + GV YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV----YLHGIG 125
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMM--IRKNETVSMVAGSYGYIAPE----Y 884
I HRDIK N+LLD +I+DFGLA + + ++ + G+ Y+APE
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRPLD 914
+ E +D++S G+VL +L G P D
Sbjct: 183 EFH---AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-24
Identities = 65/281 (23%), Positives = 106/281 (37%), Gaps = 28/281 (9%)
Query: 671 NGSCFEEKLEMGKGE--WPWRLMAFQRLGFTSADILACIRESNVIGMGATGIVYKAEMPR 728
+ + F + L+ W+ + Q + + V+G G G V ++
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYR------VLGKGGFGEVCACQVRA 207
Query: 729 LNTIVAVKKLWRSR--ADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYE 786
+ A KKL + R + + E +L K+ R +V L + +V
Sbjct: 208 TGKMYACKKLEKKRIKKRKGEAMA---LNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 264
Query: 787 YMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILL 846
MN G L ++ Y A + GL LH + I++RD+K NILL
Sbjct: 265 LMNGGDLKFHIYHMGQAGFPEARAVFY--AAEICCGLEDLHRER---IVYRDLKPENILL 319
Query: 847 DSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----YGYTLKVDEKIDIYSFGVV 902
D + RI+D GLA + V G+ GY+APE YT D ++ G +
Sbjct: 320 DDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFSP----DWWALGCL 374
Query: 903 LLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943
L E++ G+ P + + E R+ E P
Sbjct: 375 LYEMIAGQSPFQQR-KKKIKREEVERLVKEVPEEYSERFSP 414
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 37/213 (17%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRL 771
+G G V++A N V VK L + + E+ +L LR NI+ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-KI------KREIKILENLRGGPNIITL 96
Query: 772 LGFLHNDTNMMIVY--EYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-H 828
+ + + E++NN KQ + L D+ R+ + + + L Y H
Sbjct: 97 ADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKALDYCHSM 149
Query: 829 DCYPPIIHRDIKSNNILLDS-NLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE---- 883
I+HRD+K +N+++D + + R+ D+GLA E VA Y + PE
Sbjct: 150 G----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-FKGPELLVD 204
Query: 884 ---YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
Y Y+ +D++S G +L ++ + P
Sbjct: 205 YQMYDYS------LDMWSLGCMLASMIFRKEPF 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 52/239 (21%), Positives = 88/239 (36%), Gaps = 46/239 (19%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVR 770
V+G+G G V + R A+K L E V+ + +IV
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLL-YDSPKARQE--------VDHHWQASGGPHIVC 86
Query: 771 LLGF----LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN------IALGVA 820
+L H ++I+ E M G L + + + I +
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD--------QAFTEREAAEIMRDIG 138
Query: 821 QGLAYLHHDCYPPIIHRDIKSNNILL---DSNLEPRIADFGLARMMIRKNETVSMVAGSY 877
+ +LH I HRD+K N+L + + ++ DFG A+ + +
Sbjct: 139 TAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPCYTP 193
Query: 878 GYIAPE----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIR 932
Y+APE Y D+ D++S GV++ LL G P G+ I ++ +IR
Sbjct: 194 YYVAPEVLGPEKY----DKSCDMWSLGVIMYILLCGFPPFYSNTGQ--AISPGMKRRIR 246
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-24
Identities = 57/231 (24%), Positives = 96/231 (41%), Gaps = 53/231 (22%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDF----VGEVNVLGKLRHR 766
IG G G V+KA + VA+KK+ + E E F + E+ +L L+H
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEG---FPITALREIKILQLLKHE 76
Query: 767 NIVRLLGFLHND--------TNMMIVYEYMNN--GSLGEALHGKQAGRLLVDWVSRYNIA 816
N+V L+ ++ +V+++ + L + K + + R
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 132
Query: 817 LGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS 876
L GL Y+H + I+HRD+K+ N+L+ + ++ADFGLAR + +
Sbjct: 133 L--LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF---SLAKNSQPNR 184
Query: 877 YG-------YIAPE-------YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
Y Y PE YG ID++ G ++ E+ T R P+
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYG------PPIDLWGAGCIMAEMWT-RSPI 228
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-24
Identities = 64/254 (25%), Positives = 103/254 (40%), Gaps = 28/254 (11%)
Query: 669 NANGSCFEEKLEMGKGE--WPWRLMAFQRLGFTSADILACIRESNVIGMGATGIVYKAEM 726
+ + F+E L+ W+ + Q +G V+G G G V+ +M
Sbjct: 153 HLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFR------VLGRGGFGEVFACQM 206
Query: 727 PRLNTIVAVKKLWRSR--ADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784
+ A KKL + R + + + E +L K+ R IV L T++ +V
Sbjct: 207 KATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263
Query: 785 YEYMNNGSLGEALH--GKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSN 842
MN G + ++ + Y + GL +LH II+RD+K
Sbjct: 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY--TAQIVSGLEHLHQRN---IIYRDLKPE 318
Query: 843 NILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----YGYTLKVDEKIDIYS 898
N+LLD + RI+D GLA + AG+ G++APE Y V D ++
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV----DYFA 374
Query: 899 FGVVLLELLTGRRP 912
GV L E++ R P
Sbjct: 375 LGVTLYEMIAARGP 388
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 53/234 (22%), Positives = 89/234 (38%), Gaps = 14/234 (5%)
Query: 361 NSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNN 420
N P +P + ++ L N S S C +L + + +N
Sbjct: 10 NEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSN 66
Query: 421 QLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDI-ASSTSLSFIDISRNHLRSSLPSTI 478
L+ I F L L++L+L++N+ + L + + R L L +
Sbjct: 67 VLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGL 124
Query: 479 LS-IPNLQTFIVSNNNLVGEIPDQ-FQDCPSLSVLDLSSNYFSGSIPSSI-ASCEKLVNL 535
+ LQ + +N L +PD F+D +L+ L L N S S+P L L
Sbjct: 125 FRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRL 182
Query: 536 NLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPEN-FGASPALEVLNVSYN 588
L N++ P A + L L L N+L+ +P AL+ L ++ N
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 50/230 (21%), Positives = 78/230 (33%), Gaps = 29/230 (12%)
Query: 290 TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLELWNN 348
+ Q + L N +SH A +NL +L L N L+ + A GL LE L+L +N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDN 90
Query: 349 SLSGPLPVDLGKNSP-LQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLS 407
+ + L L L E+ F G
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGP---------------GLFRG------- 127
Query: 408 TCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDIS 466
+L + +Q+N L +P F L L L L N ++ SL + +
Sbjct: 128 -LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 467 RNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSN 516
+N + P + L T + NNL + +L L L+ N
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 53/275 (19%), Positives = 85/275 (30%), Gaps = 56/275 (20%)
Query: 295 LDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPL 354
L +P I Q + L N++S A L +L L +N L+
Sbjct: 16 TSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 355 PVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVR 414
+ L+ LDLS N+ + F G L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDP---------------ATFHG--------LGRLHT 109
Query: 415 VRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSS 473
+ + L + G F L LQ L L +N+L +
Sbjct: 110 LHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-------------------------A 143
Query: 474 LPSTILS-IPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSI-ASCEK 531
LP + NL + N + F+ SL L L N + + +
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGR 202
Query: 532 LVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSL 566
L+ L L N L+ +A++ + L L L++N
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 50/239 (20%), Positives = 82/239 (34%), Gaps = 23/239 (9%)
Query: 383 CNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLEL 441
C L +PV + + R+ + N++S +P F L L L
Sbjct: 18 CPQQGLQA-----------VPVGIPA--ASQRIFLHGNRIS-HVPAASFRACRNLTILWL 63
Query: 442 ANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILS-IPNLQTFIVSNNNLVGEIP- 499
+N L L +D+S N S+ + L T + L E+
Sbjct: 64 HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGP 122
Query: 500 DQFQDCPSLSVLDLSSNYFSGSIPSSI-ASCEKLVNLNLRNNQLTGDIPKAISMMPTLAI 558
F+ +L L L N ++P L +L L N+++ +A + +L
Sbjct: 123 GLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181
Query: 559 LDLSNNSLTGGIPEN-FGASPALEVLNVSYNRLEG-PVPANGVLRTINRGDLAGNAGLC 615
L L N + + + F L L + N L P A LR + L N +C
Sbjct: 182 LLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 63/321 (19%), Positives = 97/321 (30%), Gaps = 113/321 (35%)
Query: 68 VWCNSNG----------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNS 117
C G A +++ L +S + F+ ++LT L L N L +
Sbjct: 16 TSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 118 LANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDL 177
L L++ D+S N S
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPA------------------------------------ 99
Query: 178 RGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVE 237
+F L +L L L L ++ L
Sbjct: 100 -----------TFHGLGRLHTLHLDRCGLQ-ELGPGL----------------------- 124
Query: 238 FGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEI-GNITSLQLLD 296
F L L+YL L N Q LP + ++ +L L
Sbjct: 125 FRGLAALQYLY------------------------LQDNALQ-ALPDDTFRDLGNLTHLF 159
Query: 297 LSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLELWNNSLSGPL 354
L N +S +P L +L L L N+++ HV L +L L L+ N+LS L
Sbjct: 160 LHGNRISS-VPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSA-L 216
Query: 355 PVD-LGKNSPLQWLDLSSNSF 374
P + L LQ+L L+ N +
Sbjct: 217 PTEALAPLRALQYLRLNDNPW 237
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
IG GA GIV A L VA+KKL SR + E+ ++ + H+NI+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIIG 88
Query: 771 LLGFLHNDTNMM------IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLA 824
LL ++ IV E M+ +L + + + L Y + + G+
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME-----LDHERMSY-LLYQMLCGIK 141
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY 884
+LH IIHRD+K +NI++ S+ +I DFGLAR V Y Y APE
Sbjct: 142 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEV 197
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
+ E +DI+S G ++ E++ G L P
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKG-GVLFP 227
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 23/228 (10%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
+G GA G V A VAVK + RA + + E+ + L H N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 71
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRY--NIALGVAQGLAYLHHDC 830
G + EY + G L + + + + R+ + GV YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV----YLHGIG 125
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMM--IRKNETVSMVAGSYGYIAPE----Y 884
I HRDIK N+LLD +I+DFGLA + + ++ + G+ Y+APE
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIR 932
+ E +D++S G+VL +L G P D + +W K
Sbjct: 183 EFH---AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 227
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 65/210 (30%), Positives = 88/210 (41%), Gaps = 26/210 (12%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLL 772
IG G G+ +VAVK + R A E E+ LRH NIVR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-----EIINHRSLRHPNIVRFK 82
Query: 773 GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRY--NIALGVAQGLAYLHHDC 830
+ T++ I+ EY + G L E + AGR D + + GV+ Y H
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERI--CNAGRFSEDEARFFFQQLLSGVS----YCHSMQ 136
Query: 831 YPPIIHRDIKSNNILLDSNLEPR--IADFGLARMMIRKNETVSMVAGSYGYIAPE----Y 884
I HRD+K N LLD + PR I DFG ++ + G+ YIAPE
Sbjct: 137 ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLLRQ 192
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRPLD 914
Y K D++S GV L +L G P +
Sbjct: 193 EYDGK---IADVWSCGVTLYVMLVGAYPFE 219
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 64/241 (26%), Positives = 97/241 (40%), Gaps = 65/241 (26%)
Query: 711 NVIGMGATGIVYKAEMPRL-NTIVAVKKLWRSRADLETE---SSGDFVGEVNVLGKLR-- 764
IG GA G V+KA + VA+K++ R E S + EV VL L
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLST--IREVAVLRHLETF 71
Query: 765 -HRNIVRLLGFLH-----NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALG 818
H N+VRL +T + +V+E+++ L L + + + L
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL- 129
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG 878
+GL +LH ++HRD+K NIL+ S+ + ++ADFGLAR Y
Sbjct: 130 -LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--------------IYS 171
Query: 879 -------------YIAPE------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGE 919
Y APE Y +D++S G + E+ R+PL G
Sbjct: 172 FQMALTSVVVTLWYRAPEVLLQSSYA------TPVDLWSVGCIFAEMFR-RKPLFR--GS 222
Query: 920 S 920
S
Sbjct: 223 S 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG-EVNVLGKLRHRNIVRL 771
+G+G G V + VAVK L R + + + + E+ L RH +I++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQK--IRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRY--NIALGVAQGLAYLHHD 829
+ +++ +V EY++ G L + + GRL R I GV Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVD----YCHRH 135
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----YG 885
++HRD+K N+LLD+++ +IADFGL+ MM E + GS Y APE
Sbjct: 136 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSCGSPNYAAPEVISGRL 191
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRPLD 914
Y ++DI+S GV+L LL G P D
Sbjct: 192 YA---GPEVDIWSSGVILYALLCGTLPFD 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG----EVNVLGKLRHRNI 768
+G G+ G V A + VA+K + R D E++ L LRH +I
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLK-----KSDMHMRVEREISYLKLLRHPHI 71
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRY--NIALGVAQGLAYL 826
++L + T++++V EY G L + + K R+ D R+ I + Y
Sbjct: 72 IKLYDVITTPTDIVMVIEYAG-GELFDYIVEK--KRMTEDEGRRFFQQIICAIE----YC 124
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE--- 883
H I+HRD+K N+LLD NL +IADFGL+ +M + GS Y APE
Sbjct: 125 HRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVIN 180
Query: 884 -YGYTLKVDEKIDIYSFGVVLLELLTGRRPLD 914
Y ++D++S G+VL +L GR P D
Sbjct: 181 GKLYA---GPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 50/219 (22%), Positives = 84/219 (38%), Gaps = 32/219 (14%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRAD--LETESSGDFVGEVNVLGKLR----H 765
++G G G V+ VA+K + R+R S EV +L K+ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGE-----ALHGKQAGRLLVDWVSRYNIALGVA 820
++RLL + M+V E + G L + SR V
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGP-----LGEGPSR-CFFGQVV 149
Query: 821 QGLAYLHHDCYPPIIHRDIKSNNILLDS-NLEPRIADFGLARMMIRKNETVSMVAGSYGY 879
+ + H ++HRDIK NIL+D ++ DFG ++ + T G+ Y
Sbjct: 150 AAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--DGTRVY 204
Query: 880 IAPEY----GYTLKVDEKIDIYSFGVVLLELLTGRRPLD 914
PE+ Y ++S G++L +++ G P +
Sbjct: 205 SPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFE 240
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 47/223 (21%), Positives = 87/223 (39%), Gaps = 42/223 (18%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG----EVNVLGKLRHR- 766
++G G G VY N VA+K + + R + EV +L K+
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR--ISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 767 -NIVRLLGFLHNDTNMMIVYEYMNNGSLGE-----ALHGK----QAGRLLVDWVSRYNIA 816
++RLL + + +++ E + G A
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPV--QDLFDFITERGALQEELARSFFWQ-------- 157
Query: 817 LGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN-LEPRIADFGLARMMIRKNETVSMVAG 875
V + + + H+ ++HRDIK NIL+D N E ++ DFG ++ K+ + G
Sbjct: 158 --VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDG 210
Query: 876 SYGYIAPEY----GYTLKVDEKIDIYSFGVVLLELLTGRRPLD 914
+ Y PE+ Y + ++S G++L +++ G P +
Sbjct: 211 TRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIPFE 250
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 31/221 (14%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVG-------EVNVLGKLR 764
I G+ G V + VA+K+++ + +D T + E+ +L
Sbjct: 29 FISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 765 HRNIVRLLGFLH-----NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGV 819
H NI+ L + +V E M L + +H ++ ++ +Y +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI--VISPQHIQY-FMYHI 143
Query: 820 AQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGY 879
GL LH ++HRD+ NILL N + I DF LAR V + Y
Sbjct: 144 LLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW-Y 199
Query: 880 IAPE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
APE G+T + +D++S G V+ E+ R+ L
Sbjct: 200 RAPELVMQFKGFT----KLVDMWSAGCVMAEMF-NRKALFR 235
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 52/258 (20%), Positives = 92/258 (35%), Gaps = 74/258 (28%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWR-----SRADLETESSGDFVGEVNVLGKLRHR 766
+G G+ GIV + A+KK+ + +R E++++ L H
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR-------------ELDIMKVLDHV 60
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDW----------------- 809
NI++L+ + + + +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 810 ------VSRYNIALG--------------VAQGLAYLH-HDCYPPIIHRDIKSNNILLDS 848
V + I G + + + ++H I HRDIK N+L++S
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG----ICHRDIKPQNLLVNS 176
Query: 849 NL-EPRIADFGLARMMIRKNETVSMVAGSYGYIAPE-----YGYTLKVDEKIDIYSFGVV 902
++ DFG A+ +I +V+ + + Y APE YT ID++S G V
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRF-YRAPELMLGATEYT----PSIDLWSIGCV 231
Query: 903 LLELLTGRRPLDPEFGES 920
EL+ G +PL GE+
Sbjct: 232 FGELILG-KPLFS--GET 246
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-23
Identities = 50/221 (22%), Positives = 89/221 (40%), Gaps = 47/221 (21%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVR 770
V+G+G G V + R A+K L + E V + + + +IVR
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARRE--------VELHWRASQCPHIVR 119
Query: 771 LLGFLHN----DTNMMIVYEYMNNGSLGEALHGK--------QAGRLLVDWVSRYNIALG 818
++ N ++IV E ++ G L + + +A ++
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS---------- 169
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP---RIADFGLARMMIRKNETVSMVAG 875
+ + + YLH I HRD+K N+L S ++ DFG A+ + +++
Sbjct: 170 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCY 225
Query: 876 SYGYIAPE----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
+ Y+APE Y D+ D++S GV++ LL G P
Sbjct: 226 TPYYVAPEVLGPEKY----DKSCDMWSLGVIMYILLCGYPP 262
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 64/221 (28%), Positives = 94/221 (42%), Gaps = 40/221 (18%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRS--------RADLETESSGDFVGEVNVLGK 762
IG GA GIV A L+ VA+KKL R RA E+ ++
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA----------YRELVLMKC 117
Query: 763 LRHRNIVRLL------GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVS--RYN 814
+ H+NI+ LL L ++ +V E M L L + +S Y
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQ 172
Query: 815 IALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA 874
+ G + +LH IIHRD+K +NI++ S+ +I DFGLAR V
Sbjct: 173 MLCG----IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 225
Query: 875 GSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
Y Y APE + E +DI+S G ++ E++ + L P
Sbjct: 226 TRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KILFP 264
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 65/291 (22%), Positives = 115/291 (39%), Gaps = 22/291 (7%)
Query: 118 LANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDL 177
L + + ++ + G+T L+A G + +E + +L L+L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLEL 70
Query: 178 RGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVE 237
+ + + KNL K+ L LSGN L + + L S++T+ L + P
Sbjct: 71 KDNQIT-DLA-PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP-- 124
Query: 238 FGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDL 297
L+NL+ L L N I L L L+ + + L + N++ L L
Sbjct: 125 LAGLSNLQVLYLD-LNQITNISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKA 180
Query: 298 SYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVD 357
N +S +I + L NL ++L NQ+S P L + L ++ L N +++
Sbjct: 181 DDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ---P 233
Query: 358 LGKNSPLQWLDLSSNSFSGEI-PASLCNGGNLTKLILFNNAFSGPIPVSLS 407
+ N+ L ++ I PA++ + G L N S VS +
Sbjct: 234 VFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYT 284
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 48/306 (15%), Positives = 106/306 (34%), Gaps = 44/306 (14%)
Query: 288 NITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWN 347
+ + + + ++ + L + L+ ++ + G+ L L LEL +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 348 NSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLS 407
N ++ P L + + L+LS N + A + ++ L L + + P L+
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LA 126
Query: 408 TCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISR 467
+L + + NQ++ P L LQ L + N ++ L+ +
Sbjct: 127 GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-----------DLTPLA--- 170
Query: 468 NHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIA 527
++ L T +N + +I P+L + L +N S S +A
Sbjct: 171 ------------NLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDV--SPLA 214
Query: 528 SCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSY 587
+ L + L N +T + + ++ + + P + N+++
Sbjct: 215 NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--APATISDNGTYASPNLTW 272
Query: 588 NRLEGP 593
N
Sbjct: 273 NLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 48/256 (18%), Positives = 98/256 (38%), Gaps = 21/256 (8%)
Query: 333 GLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLI 392
L + ++++ + + L + I + NL L
Sbjct: 14 PDPALANAIKIAAGKSNVTDTVTQADLDG--ITTLSAFGTGVT-TIEG-VQYLNNLIGLE 69
Query: 393 LFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITD 452
L +N + P L + + + N L + L+ ++ L+L + +T
Sbjct: 70 LKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITD--VT 123
Query: 453 DIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLD 512
+A ++L + + N + + S + + NLQ + N + P + L+ L
Sbjct: 124 PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLK 179
Query: 513 LSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPE 572
N S I S +AS L+ ++L+NNQ++ D+ ++ L I+ L+N ++T +
Sbjct: 180 ADDNKIS-DI-SPLASLPNLIEVHLKNNQIS-DVS-PLANTSNLFIVTLTNQTITN---Q 232
Query: 573 NFGASPALEVLNVSYN 588
+ L V NV
Sbjct: 233 PVFYNNNLVVPNVVKG 248
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 62/278 (22%), Positives = 108/278 (38%), Gaps = 20/278 (7%)
Query: 191 KNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLA 250
L + +N+T + L + T+ I L NL L+L
Sbjct: 16 PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELK 71
Query: 251 VGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEI 310
N + L L + + L N + + I + S++ LDL+ ++ P +
Sbjct: 72 -DNQITDLA-PLKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP--L 125
Query: 311 TQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLS 370
L NLQ+L L NQ++ + L GLT L+ L + N +S P L S L L
Sbjct: 126 AGLSNLQVLYLDLNQIT--NISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKAD 181
Query: 371 SNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGF 430
N S +I L + NL ++ L NN S P L+ +L V + N ++
Sbjct: 182 DNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYN 237
Query: 431 GRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRN 468
L ++ + + T I+ + + + +++ N
Sbjct: 238 NNLVVPNVVKGPSGAPIAPAT--ISDNGTYASPNLTWN 273
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 49/245 (20%), Positives = 94/245 (38%), Gaps = 18/245 (7%)
Query: 76 VEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLN 135
K+ N++ V+ L +T+L+ G+ +++ + L +L ++ N +
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKDNQIT 76
Query: 136 GSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQK 195
P L +T L SGN + + S++TLDL + P L
Sbjct: 77 DLAP--LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP--LAGLSN 130
Query: 196 LKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLG 255
L+ L L N +T I L L++++ + + + P NL+ L L N
Sbjct: 131 LQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKAD-DNKI 185
Query: 256 GKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKN 315
I L L L + L N P + N ++L ++ L+ ++++ L
Sbjct: 186 SDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVV 242
Query: 316 LQLLN 320
++
Sbjct: 243 PNVVK 247
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 61/212 (28%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
VIG GA G V ++ + + A+K L L+ + F E +VL + I L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKIL-NKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-HDC 830
+D N+ +V +Y G L L K RL + Y + + +H
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLS-KFEDRLPEEMARFY--LAEMVIAIDSVHQLH- 195
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA-GSYGYIAPE------ 883
+HRDIK +NIL+D N R+ADFG ++ S VA G+ YI+PE
Sbjct: 196 ---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 884 ---YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y + D +S GV + E+L G P
Sbjct: 253 GGKGRYGPEC----DWWSLGVCMYEMLYGETP 280
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 3e-22
Identities = 57/235 (24%), Positives = 97/235 (41%), Gaps = 44/235 (18%)
Query: 713 IGMGATGIVYKAEMPRLNT--IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G G G VYKA+ A+K++ + S+ E+ +L +L+H N++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI---EGTGISMSA---CREIALLRELKHPNVIS 82
Query: 771 LLGFL--HNDTNMMIVYEYMNN------GSLGEALHGKQAGRLLVDWVSRYNIALGVAQG 822
L H D + ++++Y + + K+ +L V + G
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI--LDG 140
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDSNLEPR----IADFGLARMM---IRKNETVSMVAG 875
+ YLH + ++HRD+K NIL+ R IAD G AR+ ++ + V
Sbjct: 141 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 876 SYGYIAPE-------YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDI 923
++ Y APE Y + IDI++ G + ELLT P+ DI
Sbjct: 198 TFWYRAPELLLGARHYT------KAIDIWAIGCIFAELLT-SEPIFH--CRQEDI 243
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 87/497 (17%), Positives = 159/497 (31%), Gaps = 98/497 (19%)
Query: 122 TSLKRFDVSQNFLNGSFPAGLGGA-AGLTFLNASGNNFSGFLLEDLGNA----TSLETLD 176
++ D+ L+ + A L + + +D+ +A +L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 177 LRGSFFQGS----IPVSFKNLQ-KLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFD 231
LR + + + K++ L L LT G LSS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT---GAGCGVLSST----------- 108
Query: 232 GEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITS 291
L L+ L L+ LG L+LL L
Sbjct: 109 ------LRTLPTLQELHLSDNLLGDA------GLQLLCEGLLDPQ-------------CR 143
Query: 292 LQLLDLSYNMLSHE----IPAEITQLKNLQLLNLMCNQLSG----HVPAGLGGLT-QLEV 342
L+ L L Y LS + + + + + L + N ++ + GL QLE
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203
Query: 343 LELWNNSLS----GPLPVDLGKNSPLQWLDLSSNSFSGE-----IPASLCNGGNLTKLIL 393
L+L + ++ L + + L+ L L SN P L L L +
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263
Query: 394 FNNAFSGP----IPVSLSTCHSLVRVRMQNNQL--SGTIPVGFGRLE---KLQRLELANN 444
+ + + L SL + + N+L G + LE +L+ L + +
Sbjct: 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 323
Query: 445 SLTGGITDDIAS----STSLSFIDISRNHLRSS---LPSTILSIPN--LQTFIVSNNNL- 494
S T +S + L + IS N L + L P L+ +++ ++
Sbjct: 324 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383
Query: 495 ---VGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIA-----SCEKLVNLNLRNNQLTGDI 546
+ SL LDLS+N + + L L L + + ++
Sbjct: 384 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEM 443
Query: 547 PKAISMM----PTLAIL 559
+ + P+L ++
Sbjct: 444 EDRLQALEKDKPSLRVI 460
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-21
Identities = 75/406 (18%), Positives = 131/406 (32%), Gaps = 83/406 (20%)
Query: 242 TNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNM 301
+++ LD+ L + ELL ++ Q++ L
Sbjct: 3 LDIQSLDIQCEELS-----DARWAELLPLL------------------QQCQVVRLDDCG 39
Query: 302 LS----HEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGL--------TQLEVLELWNNS 349
L+ +I + + L LNL N+L G+ + +++ L L N
Sbjct: 40 LTEARCKDISSALRVNPALAELNLRSNELG---DVGVHCVLQGLQTPSCKIQKLSLQNCC 96
Query: 350 LS----GPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGG-----NLTKLILFNNAFS- 399
L+ G L L LQ L LS N LC G L KL L + S
Sbjct: 97 LTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSA 156
Query: 400 ---GPIPVSLSTCHSLVRVRMQNNQLSGT----IPVGFGRLE-KLQRLELANNSLT---- 447
P+ L + + NN ++ + G +L+ L+L + +T
Sbjct: 157 ASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC 216
Query: 448 GGITDDIASSTSLSFIDISRNHLRSS---LPSTILSIPN--LQTFIVSNNNL----VGEI 498
+ +AS SL + + N L L P+ L+T + + G++
Sbjct: 217 RDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDL 276
Query: 499 PDQFQDCPSLSVLDLSSNYFSGSIPSSIA-----SCEKLVNLNLRNNQLTGD----IPKA 549
+ SL L L+ N + +L +L +++ T
Sbjct: 277 CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV 336
Query: 550 ISMMPTLAILDLSNNSLTGGIPENFGAS-----PALEVLNVSYNRL 590
++ L L +SNN L L VL ++ +
Sbjct: 337 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-15
Identities = 49/275 (17%), Positives = 95/275 (34%), Gaps = 53/275 (19%)
Query: 361 NSPLQWLDLSSNSFSGEIPASLCNG-GNLTKLILFNNAFS----GPIPVSLSTCHSLVRV 415
+ +Q LD+ S A L + L + + I +L +L +
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 416 RMQNNQLSGTIPVGFGRL--------EKLQRLELANNSLT----GGITDDIASSTSLSFI 463
+++N+L VG + K+Q+L L N LT G ++ + + +L +
Sbjct: 62 NLRSNELG---DVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 464 DISRNHLRSS----LPSTILSI-PNLQTFIVSNNNL----VGEIPDQFQDCPSLSVLDLS 514
+S N L + L +L L+ + +L + + P L +S
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178
Query: 515 SNYFSGSIPSSIA-----SCEKLVNLNLRNNQLTGD----IPKAISMMPTLAILDLSNNS 565
+N + + + S +L L L + +T D + ++ +L L L +N
Sbjct: 179 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238
Query: 566 LTGGIPENFGA----------SPALEVLNVSYNRL 590
L + G S L L + +
Sbjct: 239 LG-----DVGMAELCPGLLHPSSRLRTLWIWECGI 268
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV-GEVNVLGKLRHRNIVR 770
++G G+ V A + A+K L + + E+ +V E +V+ +L H V+
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-HD 829
L +D + Y NG L + + ++ G +R+ A + L YLH
Sbjct: 95 LYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET-CTRFYTA-EIVSALEYLHGKG 150
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE---TVSMVAGSYGYIAPE--- 883
IIHRD+K NILL+ ++ +I DFG A+++ +++ S V G+ Y++PE
Sbjct: 151 ----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPELLT 205
Query: 884 -YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
D+++ G ++ +L+ G P
Sbjct: 206 EKSACKSS----DLWALGCIIYQLVAGLPP 231
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 58/234 (24%), Positives = 89/234 (38%), Gaps = 41/234 (17%)
Query: 288 NITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWN 347
+ S ++ L+ +P ++ K+ +L+L N L A L T+L L L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 348 NSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLS 407
L+ L VD G L LDLS N +P LT L +
Sbjct: 65 AELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV-------------- 107
Query: 408 TCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLT---GGITDDIASSTSLSFI 463
N+L+ ++P+G L +LQ L L N L G+ L +
Sbjct: 108 ----------SFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPT---PKLEKL 153
Query: 464 DISRNHLRSSLPSTIL-SIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSN 516
++ N+L LP+ +L + NL T ++ N+L IP F L L N
Sbjct: 154 SLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 50/206 (24%), Positives = 71/206 (34%), Gaps = 34/206 (16%)
Query: 170 TSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNE 229
L L + + +L L L LT
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT---------------------- 68
Query: 230 FDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEI-GN 288
++ V G L L LDL+ N +P L L ++ + N LP
Sbjct: 69 ---KLQV-DGTLPVLGTLDLS-HNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRG 122
Query: 289 ITSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAGL-GGLTQLEVLELW 346
+ LQ L L N L +P + T L+ L+L N L+ +PAGL GL L+ L L
Sbjct: 123 LGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQ 180
Query: 347 NNSLSGPLPVDLGKNSPLQWLDLSSN 372
NSL +P + L + L N
Sbjct: 181 ENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 51/213 (23%), Positives = 79/213 (37%), Gaps = 12/213 (5%)
Query: 379 PASLCNG-GNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQ 437
P + + ++ + +P L + + N L +L
Sbjct: 2 PICEVSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 438 RLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGE 497
+L L LT D + L +D+S N L+S LP ++P L VS N L
Sbjct: 59 QLNLDRAELTKLQVDG--TLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSL 115
Query: 498 IPDQFQDCPSLSVLDLSSNYFSGSIPSSI-ASCEKLVNLNLRNNQLTGDIPKAI-SMMPT 555
+ L L L N ++P + KL L+L NN LT ++P + + +
Sbjct: 116 PLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLEN 173
Query: 556 LAILDLSNNSLTGGIPENFGASPALEVLNVSYN 588
L L L NSL IP+ F S L + N
Sbjct: 174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 58/298 (19%), Positives = 77/298 (25%), Gaps = 114/298 (38%)
Query: 63 CNWTGVWCNSNG----------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFS 112
+ V C+ L LS L LT LNL
Sbjct: 10 ASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA---- 65
Query: 113 SLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSL 172
LT L+ L
Sbjct: 66 -------ELTKLQVDG---------------------------------------TLPVL 79
Query: 173 ETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDG 232
TLDL + Q S+P+ + L L L +S N LT +P
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGA------------------ 119
Query: 233 EIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEI-GNITS 291
L L+ L L N + LP +
Sbjct: 120 -----LRGLGELQELY------------------------LKGNELK-TLPPGLLTPTPK 149
Query: 292 LQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNN 348
L+ L L+ N L+ E+PA + L+NL L L N L +P G G L L N
Sbjct: 150 LEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 41/190 (21%), Positives = 66/190 (34%), Gaps = 33/190 (17%)
Query: 403 PVSLSTCH-SLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLS 461
P+ + S + V L+ +P + L L+ N L + T L+
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 462 FIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGS 521
+++ R L + L P L LDLS N S
Sbjct: 59 QLNLDRAEL-TKLQV-------------------------DGTLPVLGTLDLSHNQLQ-S 91
Query: 522 IPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPEN-FGASPAL 580
+P + L L++ N+LT A+ + L L L N L +P +P L
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKL 150
Query: 581 EVLNVSYNRL 590
E L+++ N L
Sbjct: 151 EKLSLANNNL 160
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 29/86 (33%), Positives = 42/86 (48%), Gaps = 3/86 (3%)
Query: 506 PSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNS 565
++L LS N +++ +L LNL +LT + +P L LDLS+N
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQ 88
Query: 566 LTGGIPENFGASPALEVLNVSYNRLE 591
L +P PAL VL+VS+NRL
Sbjct: 89 LQS-LPLLGQTLPALTVLDVSFNRLT 113
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 38/157 (24%), Positives = 54/157 (34%), Gaps = 30/157 (19%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSL-ANLTSLKRFDVSQNFLN 135
LDLSH L + Q L +LT L++ N L +SLP L L+ + N L
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL-TSLPLGALRGLGELQELYLKGNELK 137
Query: 136 GSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVS-FKNLQ 194
+ P GL + LE L L + +P L+
Sbjct: 138 -TLPPGL---------------LTPT--------PKLEKLSLANNNLT-ELPAGLLNGLE 172
Query: 195 KLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFD 231
L L L N+L IP+ + L N +
Sbjct: 173 NLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWL 208
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 8e-22
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G GA G V A R VA+KKL SR + E+ +L ++H N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQHENVIG 87
Query: 771 LL------GFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLA 824
LL L N + +V +M L + + K + +Y + + +GL
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK-----FSEEKIQY-LVYQMLKGLK 140
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE- 883
Y+H ++HRD+K N+ ++ + E +I DFGLAR E V + Y APE
Sbjct: 141 YIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVVTRW-YRAPEV 194
Query: 884 ----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
Y + +DI+S G ++ E+LTG + L
Sbjct: 195 ILSWMHYN----QTVDIWSVGCIMAEMLTG-KTLFK 225
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-22
Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSR--ADLETESSGDFVGEVNVLGKL---RHR 766
+IG G G VY + A+K L + R + + E +L +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNERIMLSLVSTGDCP 252
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
IV + H + + + MN G L H Q G + Y A + GL ++
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRFY--AAEIILGLEHM 308
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE--- 883
H+ +++RD+K NILLD + RI+D GLA K + + V G++GY+APE
Sbjct: 309 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV-GTHGYMAPEVLQ 363
Query: 884 --YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y D +S G +L +LL G P
Sbjct: 364 KGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-21
Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 57/234 (24%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKL--WRSRAD----LETESSGDFVGEVNVLGKLRH 765
++G GA G+V A IVA+KK+ + L E+ +L +H
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR---------EIKILKHFKH 68
Query: 766 RNIVRLL-----GFLHNDTNMMIVYEYMNNGSLGEA-LHGKQAGRLLVDWVSRYNIALGV 819
NI+ + N + I+ E M + LH + ++L D +Y I
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM------QTDLHRVISTQMLSDDHIQYFIY--- 119
Query: 820 AQ---GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS 876
Q + LH +IHRD+K +N+L++SN + ++ DFGLAR++ S G
Sbjct: 120 -QTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 877 YG----------YIAPE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
Y APE Y+ +D++S G +L EL RRP+ P
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYS----RAMDVWSCGCILAELFL-RRPIFP 224
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-21
Identities = 65/240 (27%), Positives = 102/240 (42%), Gaps = 37/240 (15%)
Query: 694 QRLGFTSADILACI-------RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLE 746
R GF ++ R+ +G GA G V A R VA+KKL R
Sbjct: 7 ARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQS 64
Query: 747 TESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM------IVYEYMNNGSLGEALHGK 800
+ E+ +L +RH N++ LL D + +V +M G L
Sbjct: 65 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKL 119
Query: 801 QAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860
L + ++ + + +GL Y+H IIHRD+K N+ ++ + E +I DFGLA
Sbjct: 120 MKHEKLGEDRIQF-LVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 175
Query: 861 RMMIRKNETVSMVAGSYGYIAPE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
R +E V + Y APE YT + +DI+S G ++ E++TG + L
Sbjct: 176 RQA--DSEMTGYVVTRW-YRAPEVILNWMRYT----QTVDIWSVGCIMAEMITG-KTLFK 227
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 19/207 (9%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSR--ADLETESSGDFVGEVNVLGKLRHRNIV 769
++G G G V + A+K L + A E + + E VL RH +
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSRHPFLT 211
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
L + V EY N G L H + D Y + L YLH +
Sbjct: 212 ALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFY--GAEIVSALDYLHSE 267
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----YG 885
+++RD+K N++LD + +I DFGL + I+ T+ G+ Y+APE
Sbjct: 268 K--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y V D + GVV+ E++ GR P
Sbjct: 326 YGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-21
Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
VIG GA G V + A+K L ++ S F E +++ +V+L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-HDC 830
+D + +V EYM G L ++ + W +R+ A V L +H
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKW-ARFYTA-EVVLALDAIHSMG- 188
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA-GSYGYIAPE----YG 885
IHRD+K +N+LLD + ++ADFG M ++ A G+ YI+PE G
Sbjct: 189 ---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRP 912
+ D +S GV L E+L G P
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 58/208 (27%), Positives = 83/208 (39%), Gaps = 22/208 (10%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSR--ADLETESSGDFVGEVNVLGKLRHRNIV 769
++G G G V A+K L + A E + V E VL RH +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTRHPFLT 68
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-H 828
L + V EY N G L H + + Y + L YLH
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY--GAEIVSALEYLHSR 124
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----Y 884
D +++RDIK N++LD + +I DFGL + I T+ G+ Y+APE
Sbjct: 125 D----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y V D + GVV+ E++ GR P
Sbjct: 181 DYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-21
Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 29/216 (13%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKL--WRSRADLETESSGDFVGEVNVLGKLRHRNIV 769
VIG GA V +M + + A+K + W E F E +VL R I
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC---FREERDVLVNGDRRWIT 124
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-H 828
+L ++ + +V EY G L + G + ++R+ +A + + +H
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDL--LTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRL 181
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVA-GSYGYIAPE---- 883
+HRDIK +NILLD R+ADFG + S+VA G+ Y++PE
Sbjct: 182 G----YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 884 -------YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y + D ++ GV E+ G+ P
Sbjct: 238 VGGGPGTGSYGPEC----DWWALGVFAYEMFYGQTP 269
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 8e-21
Identities = 65/224 (29%), Positives = 99/224 (44%), Gaps = 46/224 (20%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRS--------RADLETESSGDFVGEVNVLGK 762
+ +G GA G V A + VAVKKL R R E+ +L
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----------YRELRLLKH 84
Query: 763 LRHRNIVRLLGFLHNDTNMM------IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIA 816
++H N++ LL ++ +V M G L+ + L D ++ +
Sbjct: 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQF-LI 138
Query: 817 LGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS 876
+ +GL Y+H IIHRD+K +N+ ++ + E +I DFGLAR +E VA
Sbjct: 139 YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTGYVATR 193
Query: 877 YGYIAPE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
+ Y APE Y + +DI+S G ++ ELLTG R L P
Sbjct: 194 W-YRAPEIMLNWMHYN----QTVDIWSVGCIMAELLTG-RTLFP 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 8e-21
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 40/223 (17%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKL--WRSRADLE-TESSGDFVGEVNVLGKLRHRN 767
+ IG GA G+V A VA+KK+ + + + T + E+ +L + RH N
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT------LREIKILLRFRHEN 86
Query: 768 IVRLL-----GFLHNDTNMMIVYEYMNNGSLGEA-LHGKQAGRLLVDWVSRYNIALGVAQ 821
I+ + + ++ IV + M E L+ + L + Y + +
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLM------ETDLYKLLKTQHLSNDHICY-FLYQILR 139
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM----VAGSY 877
GL Y+H ++HRD+K +N+LL++ + +I DFGLAR+ ++ VA +
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 878 GYIAPE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
Y APE GYT + IDI+S G +L E+L+ RP+ P
Sbjct: 197 -YRAPEIMLNSKGYT----KSIDIWSVGCILAEMLSN-RPIFP 233
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 50/238 (21%), Positives = 84/238 (35%), Gaps = 28/238 (11%)
Query: 330 VPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNG-GNL 388
+P L + L+L N L LQ LDLS I +L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 389 TKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLT 447
+ LIL N + S SL ++ L+ ++ G L+ L+ L +A+N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
Query: 448 GGITDDI-ASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCP 506
+ ++ T+L +D+S N ++S + + + + +S
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS---------------- 181
Query: 507 SLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNN 564
LDLS N + I +L L L NQL + +L + L N
Sbjct: 182 ----LDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 16/213 (7%)
Query: 242 TNLKYLDLAVGNLGGKIPAE-LGRLELLEIMFLYQNNFQGRLPAEI-GNITSLQLLDLSY 299
+ K LDL+ N + + L+++ L + Q + +++ L L L+
Sbjct: 28 FSTKNLDLS-FNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTG 85
Query: 300 NMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSL-SGPLPVD 357
N + + + L +LQ L + L+ +G L L+ L + +N + S LP
Sbjct: 86 NPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 358 LGKNSPLQWLDLSSNSFSGEIPASLCNG-GNLT----KLILFNNAFSGPIPVSLSTCHSL 412
+ L+ LDLSSN I + + L L N + I L
Sbjct: 145 FSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRL 202
Query: 413 VRVRMQNNQLSGTIPVG-FGRLEKLQRLELANN 444
+ + NQL ++P G F RL LQ++ L N
Sbjct: 203 KELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 44/210 (20%), Positives = 79/210 (37%), Gaps = 12/210 (5%)
Query: 387 NLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNS 445
+ L L N S + L + + ++ TI G + L L L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 446 LTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIP-NLQTFIVSNNNL-VGEIPDQFQ 503
+ + +SL + +L +SL + + L+ V++N + ++P+ F
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNL-ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 504 DCPSLSVLDLSSNYFSGSIPSSI-ASCEKL----VNLNLRNNQLTGDIPKAISMMPTLAI 558
+ +L LDLSSN SI + ++ ++L+L N + I L
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKE 204
Query: 559 LDLSNNSLTGGIPENFGASPALEVLNVSYN 588
L L N L F +L+ + + N
Sbjct: 205 LALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 61/304 (20%), Positives = 94/304 (30%), Gaps = 94/304 (30%)
Query: 63 CNWTGVWCNSNG----------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFS 112
C + + LDLS L S F L L+L +
Sbjct: 7 VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-Q 65
Query: 113 SLPNSL-ANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATS 171
++ + +L+ L ++ N + S G FSG +S
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQ-SLALGA---------------FSGL--------SS 101
Query: 172 LETLDLRGSFFQGSIP-VSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEF 230
L+ L + S+ +L+ LK L ++ N +
Sbjct: 102 LQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFK------------------- 140
Query: 231 DGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEI-GNI 289
+P F NLTNL++LD L N Q + +
Sbjct: 141 ---LPEYFSNLTNLEHLD------------------------LSSNKIQ-SIYCTDLRVL 172
Query: 290 TSLQL----LDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLE 344
+ L LDLS N ++ I + L+ L L NQL VP G LT L+ +
Sbjct: 173 HQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIW 230
Query: 345 LWNN 348
L N
Sbjct: 231 LHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 41/166 (24%), Positives = 63/166 (37%), Gaps = 18/166 (10%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLA-NLTSLKRFDVSQNFL- 134
L L+ + F L SL L L +SL N +L +LK +V+ N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNL-ASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 135 ----NGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQ---GSIP 187
F + L L L+ S N DL + L+L I
Sbjct: 138 SFKLPEYF-SNL---TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQ 193
Query: 188 V-SFKNLQKLKFLGLSGNNLTGKIPRE-LGQLSSMETMILAYNEFD 231
+FK ++ LK L L N L +P +L+S++ + L N +D
Sbjct: 194 PGAFKEIR-LKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 20/89 (22%), Positives = 36/89 (40%), Gaps = 8/89 (8%)
Query: 504 DCPSLSVLDLSSNYFSGSIPSSI-ASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLS 562
P+++ F IP ++ S + NL+L N L + P L +LDLS
Sbjct: 6 VVPNITY-QCMELNFY-KIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 563 NNSLTGGIPEN-FGASPALEVLNVSYNRL 590
+ I + + + L L ++ N +
Sbjct: 61 RCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 56/234 (23%), Positives = 96/234 (41%), Gaps = 55/234 (23%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKL-WRSRAD----LETESSGDFVGEVNVLGKLRHR 766
+G G G+V+ A + VA+KK+ L E+ ++ +L H
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR---------EIKIIRRLDHD 68
Query: 767 NIVRLLGFLHNDTNMM--------------IVYEYMNNGSLGEA-LHGKQAGRLLVDWVS 811
NIV++ L + + IV EYM E L L++ +
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM------ETDLANVLEQGPLLEEHA 122
Query: 812 RYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS-NLEPRIADFGLARMMIRKNETV 870
R + +GL Y+H ++HRD+K N+ +++ +L +I DFGLAR+M
Sbjct: 123 RL-FMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 871 SM----VAGSYGYIAPE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
+ + Y +P YT + ID+++ G + E+LTG + L
Sbjct: 179 GHLSEGLVTKW-YRSPRLLLSPNNYT----KAIDMWAAGCIFAEMLTG-KTLFA 226
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 8e-20
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 712 VIGMGATGIVY---KAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNI 768
V+G G+ G V+ K + A+K L +A L+ E ++L ++ H I
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVL--KKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN--IALGVAQGLAYL 826
V+L + + ++ +++ G L + + V Y +AL L +L
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLF--TRLSKEVMFTEEDVKFYLAELALA----LDHL 142
Query: 827 H-HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE-- 883
H II+RD+K NILLD ++ DFGL++ I + G+ Y+APE
Sbjct: 143 HSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 884 --YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
G+T D +SFGV++ E+LTG P
Sbjct: 199 NRRGHTQSA----DWWSFGVLMFEMLTGTLP 225
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 9e-20
Identities = 61/259 (23%), Positives = 98/259 (37%), Gaps = 81/259 (31%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGD---FVGEVNVLGKLRHRNI 768
+IG G+ G V +A +VA+KK+ R E D + E+ +L +L H ++
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILR-----VFEDLIDCKRILREIAILNRLNHDHV 114
Query: 769 VRLLGFLH-----NDTNMMIVYEYMNNGSLGEA-LHGK--QAGRLLVDWVSR---YNIAL 817
V++L + + +V E ++ K + L + + YN+ L
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIA------DSDFK-KLFRTPVYLTELHIKTLLYNL-L 166
Query: 818 GVAQGLAYLH-HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS 876
G+ Y+H I+HRD+K N L++ + ++ DFGLAR + S + S
Sbjct: 167 ---VGVKYVHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 877 YG---------------------------YIAPE-----YGYTLKVDEKIDIYSFGVVLL 904
Y APE YT E ID++S G +
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT----EAIDVWSIGCIFA 275
Query: 905 ELLT----------GRRPL 913
ELL R PL
Sbjct: 276 ELLNMIKENVAYHADRGPL 294
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 67/243 (27%), Positives = 107/243 (44%), Gaps = 63/243 (25%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRS--------RADLETESSGDFVGEVNVLGK 762
+G GA GIV+K+ R +VAVKK++ + R E+ +L +
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT----------FREIMILTE 64
Query: 763 LR-HRNIVRLLGFLH--NDTNMMIVYEYMNNGSLGEA-LHGKQAGRLLVDWVSRYNIALG 818
L H NIV LL L ND ++ +V++YM E LH +L +Y +
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM------ETDLHAVIRANILEPVHKQY-VVYQ 117
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYG 878
+ + + YLH ++HRD+K +NILL++ ++ADFGL+R + + + S
Sbjct: 118 LIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 879 ---------------------YIAPE-----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y APE YT + ID++S G +L E+L +P
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT----KGIDMWSLGCILGEIL-CGKP 229
Query: 913 LDP 915
+ P
Sbjct: 230 IFP 232
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 2e-19
Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSR--ADLETESSGDFVGEVNVLGK-LRHRNI 768
V+G G+ G V +E + + AVK L + D + E + + E VL + +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT---MVEKRVLALPGKPPFL 404
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
+L + V EY+N G L H +Q GR Y A +A GL +L
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQS 460
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----Y 884
II+RD+K +N++LDS +IADFG+ + I T G+ YIAPE
Sbjct: 461 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y V D ++FGV+L E+L G+ P
Sbjct: 518 PYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-19
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSR--ADLETESSGDFVGEVNVLGK-LRHRNI 768
++G G+ G V+ AE + N A+K L + D + E + + E VL H +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT---MVEKRVLSLAWEHPFL 80
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH- 827
+ N+ V EY+N G L H + + + + Y A + GL +LH
Sbjct: 81 THMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFY--AAEIILGLQFLHS 136
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE---- 883
I++RD+K +NILLD + +IADFG+ + + + + G+ YIAPE
Sbjct: 137 KG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 192
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y V D +SFGV+L E+L G+ P
Sbjct: 193 QKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 92.1 bits (228), Expect = 3e-19
Identities = 49/287 (17%), Positives = 94/287 (32%), Gaps = 42/287 (14%)
Query: 288 NITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWN 347
+L ++ + +L ++ + + + V G+ L + L L
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 74
Query: 348 NSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLS 407
N L+ P L L WL L N + L SL
Sbjct: 75 NKLTDIKP--LTNLKNLGWLFLDEN--------------KIKDL------------SSLK 106
Query: 408 TCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISR 467
L + +++N +S I G L +L+ L L NN +T ++ T L + +
Sbjct: 107 DLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLED 162
Query: 468 NHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIA 527
N + S + + + LQ +S N++ +L VL+L S + +
Sbjct: 163 NQI-SDIVP-LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQS 218
Query: 528 SCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENF 574
+ + + L P+ IS ++ + +F
Sbjct: 219 NLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFTNEVSF 263
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 89.0 bits (220), Expect = 3e-18
Identities = 46/236 (19%), Positives = 88/236 (37%), Gaps = 16/236 (6%)
Query: 118 LANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDL 177
+ ++ + + + + A+ ++ ++ + ++ L L
Sbjct: 17 DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFL 72
Query: 178 RGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVE 237
G+ I NL+ L +L L N + + L L ++++ L +N +I
Sbjct: 73 NGNKLT-DIK-PLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DING- 126
Query: 238 FGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDL 297
+L L+ L L N I L RL L+ + L N + + +T LQ L L
Sbjct: 127 LVHLPQLESLYLG-NNKITDITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYL 182
Query: 298 SYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGP 353
S N +S ++ + LKNL +L L + L ++ + SL P
Sbjct: 183 SKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 236
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 87.1 bits (215), Expect = 1e-17
Identities = 38/251 (15%), Positives = 91/251 (36%), Gaps = 18/251 (7%)
Query: 316 LQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFS 375
+ + + P + L S++ + + + + + +++
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQNELNS--IDQIIANNSDIK 56
Query: 376 GEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEK 435
+ + N+TKL L N + P L+ +L + + N++ + L+K
Sbjct: 57 -SVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLS-SLKDLKK 110
Query: 436 LQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLV 495
L+ L L +N ++ + + L + + N + + + + L T + +N +
Sbjct: 111 LKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 166
Query: 496 GEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPT 555
+I L L LS N+ S + ++A + L L L + + S +
Sbjct: 167 -DIVP-LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVV 222
Query: 556 LAILDLSNNSL 566
+ ++ SL
Sbjct: 223 PNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 7e-09
Identities = 35/172 (20%), Positives = 55/172 (31%), Gaps = 11/172 (6%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
L L + S + LK L SL+L NG+ S + L +L L+ + N +
Sbjct: 90 GWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGI-SDING-LVHLPQLESLYLGNNKI-- 143
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKL 196
+ L L L+ N S + L T L+ L L + S + L+ L
Sbjct: 144 TDITVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKN--HISDLRALAGLKNL 199
Query: 197 KFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPV-EFGNLTNLKYL 247
L L K L T+ + + G+
Sbjct: 200 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVK 251
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-19
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSR--ADLETESSGDFVGEVNVLGK-LRHRNI 768
VIG G+ V + + + I A+K + + D + + E +V + H +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWV---QTEKHVFEQASNHPFL 72
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH- 827
V L ++ + V EY+N G L H ++ +L + Y + ++ L YLH
Sbjct: 73 VGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFY--SAEISLALNYLHE 128
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE---- 883
II+RD+K +N+LLDS ++ D+G+ + +R +T S G+ YIAPE
Sbjct: 129 RG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 184
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y V D ++ GV++ E++ GR P
Sbjct: 185 EDYGFSV----DWWALGVLMFEMMAGRSP 209
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 7e-19
Identities = 62/255 (24%), Positives = 94/255 (36%), Gaps = 78/255 (30%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRS--------RADLETESSGDFVGEVNVLGKL 763
+IG G+ G VY A VA+KK+ R R + E+ +L +L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI----------LREITILNRL 82
Query: 764 RHRNIVRLLGFL-----HNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSR---YNI 815
+ I+RL + + IV E ++ L + L + + YN+
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIF---LTEEHIKTILYNL 138
Query: 816 ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAG 875
L G ++H IIHRD+K N LL+ + ++ DFGLAR + + +T +
Sbjct: 139 -L---LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 876 SYG----------------------YIAPE-----YGYTLKVDEKIDIYSFGVVLLELLT 908
Y APE YT + IDI+S G + ELL
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT----KSIDIWSTGCIFAELLN 247
Query: 909 G----------RRPL 913
R PL
Sbjct: 248 MLQSHINDPTNRFPL 262
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 8e-19
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSR--ADLETESSGDFVGEVNVLGK-LRHRNI 768
V+G G+ G V A + + AVK L + D + E + + E +L H +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT---MTEKRILSLARNHPFL 86
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH- 827
+L + V E++N G L H +++ R Y A + L +LH
Sbjct: 87 TQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFY--AAEIISALMFLHD 142
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE---- 883
II+RD+K +N+LLD ++ADFG+ + I T + G+ YIAPE
Sbjct: 143 KG----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE 198
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y V D ++ GV+L E+L G P
Sbjct: 199 MLYGPAV----DWWAMGVLLYEMLCGHAP 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 712 VIGMGATGIVY---KAEMPRLNTIVAVKKLWRSRADL-----ETESSGDFVGEVNVLGKL 763
V+G G G V+ K I A+K L +A + +T + E N+L ++
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVL--KKAMIVRNAKDTAHT---KAERNILEEV 78
Query: 764 RHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN--IALGVAQ 821
+H IV L+ + ++ EY++ G L + ++ G + D Y I++
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMA--- 133
Query: 822 GLAYLH-HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYI 880
L +LH II+RD+K NI+L+ ++ DFGL + I G+ Y+
Sbjct: 134 -LGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYM 188
Query: 881 APE----YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
APE G+ V D +S G ++ ++LTG P
Sbjct: 189 APEILMRSGHNRAV----DWWSLGALMYDMLTGAPP 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSR--ADLETESSGDFVGEVNVLGK-LRHRNI 768
VIG G+ V + + + I A++ + + D + + E +V + H +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWV---QTEKHVFEQASNHPFL 115
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH- 827
V L ++ + V EY+N G L H ++ +L + Y + ++ L YLH
Sbjct: 116 VGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFY--SAEISLALNYLHE 171
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE---- 883
II+RD+K +N+LLDS ++ D+G+ + +R +T S G+ YIAPE
Sbjct: 172 RG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y V D ++ GV++ E++ GR P
Sbjct: 228 EDYGFSV----DWWALGVLMFEMMAGRSP 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-18
Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSR--ADLETESSGDFVGEVNVLGK-LRHRNI 768
V+G G+ G V +E + + AVK L + D + E + + E VL + +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT---MVEKRVLALPGKPPFL 83
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH- 827
+L + V EY+N G L H +Q GR Y A +A GL +L
Sbjct: 84 TQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQS 139
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE---- 883
II+RD+K +N++LDS +IADFG+ + I T G+ YIAPE
Sbjct: 140 KG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY 195
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y V D ++FGV+L E+L G+ P
Sbjct: 196 QPYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 23/209 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSR--ADLETESSGDFVGEVNVLGK-LRHRNI 768
VIG G+ G V A AVK L + E + + E NVL K ++H +
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHI---MSERNVLLKNVKHPFL 101
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH- 827
V L + V +Y+N G L H ++ L Y A +A L YLH
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFY--AAEIASALGYLHS 157
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE---- 883
+ I++RD+K NILLDS + DFGL + I N T S G+ Y+APE
Sbjct: 158 LN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK 213
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y V D + G VL E+L G P
Sbjct: 214 QPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 35/187 (18%), Positives = 66/187 (35%), Gaps = 10/187 (5%)
Query: 191 KNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLA 250
+ L G + T I Q++S+ + LA +E N+K L +
Sbjct: 20 STFKAYLNGLL-GQSSTANI--TEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTI- 73
Query: 251 VGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEI 310
+ L LE + + + + +TSL LLD+S++ I +I
Sbjct: 74 NNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 311 TQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLS 370
L + ++L N + L L +L+ L + + + + L L
Sbjct: 133 NTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAF 189
Query: 371 SNSFSGE 377
S + G+
Sbjct: 190 SQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 29/210 (13%), Positives = 66/210 (31%), Gaps = 34/210 (16%)
Query: 119 ANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLR 178
+ + + Q+ A + LT++ + N + L + A +++ L +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVTD--LTGIEYAHNIKDLTIN 74
Query: 179 GSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEF 238
P L L+ L + G ++T L L+S+ + ++++ D I +
Sbjct: 75 NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 239 GNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLS 298
L + +DL N + + L+ L++
Sbjct: 133 NTLPKVNSIDL-------------------------SYNGAITDIMPLKTLPELKSLNIQ 167
Query: 299 YNMLSHEIPAEITQLKNLQLLNLMCNQLSG 328
++ + I L L + G
Sbjct: 168 FDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 31/182 (17%), Positives = 71/182 (39%), Gaps = 14/182 (7%)
Query: 411 SLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITD--DIASSTSLSFIDISRN 468
+ + + + + + ++ L + LAN +TD I + ++ + I+
Sbjct: 24 AYLNGLLGQSSTA---NITEAQMNSLTYITLANI----NVTDLTGIEYAHNIKDLTINNI 76
Query: 469 HLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIAS 528
H + + I + NL+ + ++ + SL++LD+S + SI + I +
Sbjct: 77 HATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 529 CEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYN 588
K+ +++L N DI + +P L L++ + + P L L
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQ 191
Query: 589 RL 590
+
Sbjct: 192 TI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 31/153 (20%), Positives = 58/153 (37%), Gaps = 7/153 (4%)
Query: 97 LKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGN 156
+ SLT + L + + L + ++K ++ P + G + L L G
Sbjct: 43 MNSLTYITLANINV-TDLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGK 98
Query: 157 NFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQ 216
+ + + +L TSL LD+ S SI L K+ + LS N I L
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKT 157
Query: 217 LSSMETMILAYNEFDGEIPVEFGNLTNLKYLDL 249
L ++++ + ++ +E + L L
Sbjct: 158 LPELKSLNIQFDGVHDYRGIE--DFPKLNQLYA 188
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-17
Identities = 30/182 (16%), Positives = 70/182 (38%), Gaps = 7/182 (3%)
Query: 387 NLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSL 446
+ S ++ + +SL + + N ++ G ++ L + N
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLT--GIEYAHNIKDLTINNIHA 78
Query: 447 TGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCP 506
T + I+ ++L + I + S + + +L +S++ I + P
Sbjct: 79 TN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136
Query: 507 SLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSL 566
++ +DLS N I + + +L +LN++ + + D + I P L L + ++
Sbjct: 137 KVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQTI 193
Query: 567 TG 568
G
Sbjct: 194 GG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-16
Identities = 25/170 (14%), Positives = 69/170 (40%), Gaps = 15/170 (8%)
Query: 235 PVEFGNLTNLKYLDLA---VGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITS 291
+ + +L Y+ LA V +L G + ++ + + + I +++
Sbjct: 37 NITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNIHATN--YNPISGLSN 89
Query: 292 LQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLEL-WNNSL 350
L+ L + ++ + ++ L +L LL++ + + + L ++ ++L +N ++
Sbjct: 90 LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149
Query: 351 SGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSG 400
+ +P L L+ L++ + + + L +L F+ G
Sbjct: 150 TDIMP--LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 27/160 (16%), Positives = 62/160 (38%), Gaps = 12/160 (7%)
Query: 433 LEKLQRLELANNSLTGGITDDIASS--TSLSFIDISRNHLRSSLPSTILSIPNLQTFIVS 490
+ L +S T +I + SL++I ++ ++ + I N++ ++
Sbjct: 22 FKAYLNGLLGQSS-----TANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTIN 74
Query: 491 NNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAI 550
N + P +L L + + +++ L L++ ++ I I
Sbjct: 75 NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 551 SMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRL 590
+ +P + +DLS N I P L+ LN+ ++ +
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 32/193 (16%), Positives = 67/193 (34%), Gaps = 13/193 (6%)
Query: 284 AEIGNITSLQLLDLSYNMLSHEIPAEIT--QLKNLQLLNLMCNQLSGHVPAGLGGLTQLE 341
+ NI +L A IT Q+ +L + L ++ G+ ++
Sbjct: 12 QDNVNIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD--LTGIEYAHNIK 69
Query: 342 VLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGP 401
L + N + P + S L+ L + + + +L +LT L + ++A
Sbjct: 70 DLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 402 IPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITD--DIASSTS 459
I ++T + + + N I L +L+ L + + G+ D I
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFD----GVHDYRGIEDFPK 182
Query: 460 LSFIDISRNHLRS 472
L+ + +
Sbjct: 183 LNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 22/132 (16%), Positives = 51/132 (38%), Gaps = 5/132 (3%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136
+ L +++++ + + L +L L + + S +L+ LTSL D+S + +
Sbjct: 69 KDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKL 196
S + + ++ S N + L L++L+++ + + KL
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPELKSLNIQFDGVHDYRGIE--DFPKL 183
Query: 197 KFLGLSGNNLTG 208
L + G
Sbjct: 184 NQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 16/116 (13%), Positives = 41/116 (35%), Gaps = 4/116 (3%)
Query: 482 PNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQ 541
+ ++ SL+ + L++ + + + I + +L + N
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIH 77
Query: 542 LTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPAN 597
T + IS + L L + +T N +L +L++S++ + +
Sbjct: 78 AT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 4e-18
Identities = 47/266 (17%), Positives = 88/266 (33%), Gaps = 42/266 (15%)
Query: 258 IPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEI-TQLKNL 316
+P L + L+ +++S N + I A++ + L L
Sbjct: 28 LPRNAIELRF------VLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81
Query: 317 QLLNLM-CNQLSGHVPAG-LGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSF 374
+ + N L ++ L L+ L + N + V + LD+ N
Sbjct: 82 HEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 140
Query: 375 SGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGRL 433
I N+F G V + + N + I F
Sbjct: 141 IHTIE---------------RNSFVG-------LSFESVILWLNKNGIQ-EIHNSAFNGT 177
Query: 434 EKLQRLELANNSLTGGITDDI-ASSTSLSFIDISRNHLRSSLPSTIL-SIPNLQTFIVSN 491
+ + NN+L + +D+ ++ +DISR + SLPS L ++ L+ S
Sbjct: 178 QLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRI-HSLPSYGLENLKKLRAR--ST 233
Query: 492 NNLVGEIPDQFQDCPSLSVLDLSSNY 517
NL ++P + +L L+
Sbjct: 234 YNL-KKLPT-LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 7e-17
Identities = 46/280 (16%), Positives = 88/280 (31%), Gaps = 25/280 (8%)
Query: 62 HCNWTGVWCNSNG----------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLF 111
HC+ C + +L L F L + + N +
Sbjct: 8 HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 67
Query: 112 SSLP-NSLANLTSLKRFDVSQNFLNGSFPAG-LGGAAGLTFLNASGNNFSGFLLEDLGNA 169
+ + +NL L + + L +L S ++
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 127
Query: 170 TSLETLDLRGSFFQGSIPV-SFKNLQ-KLKFLGLSGNNLTGKIPRELGQLSSMETMILAY 227
LD++ + +I SF L + L L+ N + E +
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDN 187
Query: 228 NEFDGEIPVE-FGNLTNLKYLDLAVGNLGGKIPAE-LGRLELLEIMFLYQNNFQGRLPAE 285
N + E+P + F + LD++ + +P+ L L+ L Y +LP
Sbjct: 188 NNLE-ELPNDVFHGASGPVILDISRTRI-HSLPSYGLENLKKLRARSTYNLK---KLPT- 241
Query: 286 IGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQ 325
+ + +L L+Y SH A + + L+ +CN+
Sbjct: 242 LEKLVALMEASLTYP--SHCC-AFANWRRQISELHPICNK 278
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 5e-16
Identities = 41/303 (13%), Positives = 82/303 (27%), Gaps = 59/303 (19%)
Query: 291 SLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLELWNNS 349
S ++ + ++ EIP+++ +N L + +L + G G LE +E+ N
Sbjct: 10 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQND 65
Query: 350 LSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTC 409
+ + ++ FS N L ++ +
Sbjct: 66 VLEVIE---------------ADVFS--------NLPKLHEIRIEKA------------- 89
Query: 410 HSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRN 468
N L I F L LQ L ++N + S +DI N
Sbjct: 90 ----------NNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 138
Query: 469 HLRSSLPSTILS--IPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSI 526
++ ++ N + F + +N
Sbjct: 139 INIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVF 198
Query: 527 ASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVS 586
V L++ ++ + + L N E AL +++
Sbjct: 199 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKL-PTLEKL---VALMEASLT 254
Query: 587 YNR 589
Y
Sbjct: 255 YPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 36/184 (19%), Positives = 67/184 (36%), Gaps = 13/184 (7%)
Query: 415 VRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSL 474
Q ++++ IP L L + L I+IS+N + +
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 475 PSTILS-IPNLQTFIVSNNNLVGEIPDQ-FQDCPSLSVLDLSSNYFSGSIPSSI-ASCEK 531
+ + S +P L + N + I + FQ+ P+L L +S+ +P +
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQ 129
Query: 532 LVNLNL-RNNQLTGDIPKAI--SMMPTLAILDLSNNSLTGGIPEN-FGASPALEVLNVSY 587
V L++ N + I + + IL L+ N + I + F + E+
Sbjct: 130 KVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDN 187
Query: 588 NRLE 591
N LE
Sbjct: 188 NNLE 191
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 34/220 (15%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR------- 764
+G G V+ A+ NT VA+K + R TE++ D E+ +L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVY-TEAAED---EIKLLQRVNDADNTKE 80
Query: 765 ----HRNIVRLLG-FLHNDTNMM---IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIA 816
+I++LL F H N + +V+E + +L + + + + +V + I+
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQ--IS 137
Query: 817 LGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP------RIADFGLARMMIRKNETV 870
+ GL Y+H C IIH DIK N+L++ P +IAD G A +E
Sbjct: 138 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHY 192
Query: 871 SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGR 910
+ + Y +PE DI+S ++ EL+TG
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G G+ G V + A+K L + ++ + + E +L + +V+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKIL-DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-HDC 830
+++N+ +V EY+ G + H ++ GR +R+ A + YLH D
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEP-HARFYAA-QIVLTFEYLHSLD- 161
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----YGY 886
+I+RD+K N+L+D ++ DFG A+ + + T + G+ +APE GY
Sbjct: 162 ---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---LCGTPEALAPEIILSKGY 215
Query: 887 TLKVDEKIDIYSFGVVLLELLTGRRP 912
V D ++ GV++ E+ G P
Sbjct: 216 NKAV----DWWALGVLIYEMAAGYPP 237
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 60/345 (17%), Positives = 103/345 (29%), Gaps = 75/345 (21%)
Query: 289 ITSLQLLDLSYNMLSHE----IPAEITQLKNLQLLNLMCNQLSG----HVPAGLGGLTQL 340
S++ L + ++ E + A + + +++ + L N + + + L
Sbjct: 3 RFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 62
Query: 341 EVLELWNNSLSGPLPVD----------LGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTK 390
E+ E + L K L + LS N+F L +
Sbjct: 63 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF----- 117
Query: 391 LILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRL-EKLQRLELANNSLTGG 449
LS L + + NN L P ++ LQ L + +
Sbjct: 118 ---------------LSKHTPLEHLYLHNNGLG---PQAGAKIARALQELAVNKKA---- 155
Query: 450 ITDDIASSTSLSFIDISRNHLR----SSLPSTILSIPNLQTFIVSNNNL-----VGEIPD 500
++ L I RN L T S L T + N + + +
Sbjct: 156 -----KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLE 210
Query: 501 QFQDCPSLSVLDLSSNYFSG----SIPSSIASCEKLVNLNLRNNQLTGDIPKAISMM--- 553
C L VLDL N F+ ++ ++ S L L L + L+ A+
Sbjct: 211 GLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSK 270
Query: 554 ---PTLAILDLSNNSLTGGIPENFGAS-----PALEVLNVSYNRL 590
L L L N + P L L ++ NR
Sbjct: 271 LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 53/293 (18%), Positives = 104/293 (35%), Gaps = 55/293 (18%)
Query: 282 LPAEIGNITSLQLLDLSYNMLSH-------EIPAEITQLKNLQLLNLMCNQLSGHVPAGL 334
+ A + S++ + LS N + E A L+ + ++ ++ +P L
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 335 GGL-------TQLEVLELWNNSLSG----PLPVDLGKNSPLQWLDLSSNSFSGE------ 377
L +L + L +N+ PL L K++PL+ L L +N +
Sbjct: 84 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 143
Query: 378 -------IPASLCNGGNLTKLILFNNAFSGP----IPVSLSTCHSLVRVRMQNNQL---- 422
+ N L +I N + + L V+M N +
Sbjct: 144 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 203
Query: 423 -SGTIPVGFGRLEKLQRLELANNSLTG----GITDDIASSTSLSFIDISRNHLRS----S 473
+ G ++L+ L+L +N+ T + + S +L + ++ L + +
Sbjct: 204 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263
Query: 474 LPSTILSIPN--LQTFIVSNNNL----VGEIPDQFQD-CPSLSVLDLSSNYFS 519
+ + N LQT + N + V + + P L L+L+ N FS
Sbjct: 264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 61/358 (17%), Positives = 104/358 (29%), Gaps = 73/358 (20%)
Query: 72 SNGAVEKLDLSHMNLSG----CVSDHFQRLKSLTSLNLCCNGL----FSSLPNSLANLTS 123
+ ++E L ++ V S+ + L N + L ++A+
Sbjct: 2 ARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 61
Query: 124 LKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFF- 182
L+ + S F LL+ L L T+ L + F
Sbjct: 62 LEIAEFSDIFTGRVKDEIPEALR--------------LLLQALLKCPKLHTVRLSDNAFG 107
Query: 183 -QGSIPVS--FKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFG 239
P+ L+ L L N L +A + + +
Sbjct: 108 PTAQEPLIDFLSKHTPLEHLYLHNN-----------GLGPQAGAKIARALQELAVNKKAK 156
Query: 240 NLTNLKYLDLA---VGNLGGKIPAE-LGRLELLEIMFLYQNNF-----QGRLPAEIGNIT 290
N L+ + + N K A+ LL + + QN + L +
Sbjct: 157 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ 216
Query: 291 SLQLLDLSYNMLSHE----IPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELW 346
L++LDL N +H + + NL+ L L LS G + ++
Sbjct: 217 ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS---ARGAAAV--VDAFS-- 269
Query: 347 NNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLC-----NGGNLTKLILFNNAFS 399
+N LQ L L N + +L +L L L N FS
Sbjct: 270 -----------KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 52/311 (16%), Positives = 102/311 (32%), Gaps = 59/311 (18%)
Query: 196 LKFLGLSGNNLTGK----IPRELGQLSSMETMILAYNEFDGE----IPVEFGNLTNLKYL 247
++ L + +T + + L + S++ ++L+ N E + + +L+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 248 DLA---VGNLGGKIPAE-------LGRLELLEIMFLYQNNFQGR----LPAEIGNITSLQ 293
+ + G + +IP L + L + L N F L + T L+
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 294 LLDLSYNMLSHE-------------IPAEITQLKNLQLLNLMCNQLSG----HVPAGLGG 336
L L N L + + + L+ + N+L
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 337 LTQLEVLELWNNSL-----SGPLPVDLGKNSPLQWLDLSSNSFSGE----IPASLCNGGN 387
L +++ N + L L L+ LDL N+F+ + +L + N
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245
Query: 388 LTKLILFNNAFSGP----IPVSLSTCH--SLVRVRMQNNQLSGTIPVGFGR-----LEKL 436
L +L L + S + + S L +R+Q N++ + L
Sbjct: 246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 305
Query: 437 QRLELANNSLT 447
LEL N +
Sbjct: 306 LFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 7e-08
Identities = 25/171 (14%), Positives = 56/171 (32%), Gaps = 35/171 (20%)
Query: 456 SSTSLSFIDISRNHLRS----SLPSTILSIPNLQTFIVSNNNL----VGEIPDQFQDCPS 507
+ S+ + + + + S+ + +L +++ ++S N + + +
Sbjct: 2 ARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 61
Query: 508 LSVLDLSSNYFS----------GSIPSSIASCEKLVNLNLRNNQLTGD----IPKAISMM 553
L + + S + + ++ C KL + L +N + +S
Sbjct: 62 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 121
Query: 554 PTLAILDLSNNSLT-------------GGIPENFGASPALEVLNVSYNRLE 591
L L L NN L + + +P L + NRLE
Sbjct: 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 39/289 (13%), Positives = 81/289 (28%), Gaps = 55/289 (19%)
Query: 72 SNGAVEKLDLSHMNLS--GC--VSDHFQRLKSLTSLNLCCNGL----------FSSLPNS 117
+ +V+++ LS + +S++ K L L +
Sbjct: 30 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA 89
Query: 118 LANLTSLKRFDVSQNFLNGSFPAGLGGA----AGLTFLNASGNNFS-------------G 160
L L +S N + L L L N
Sbjct: 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149
Query: 161 FLLEDLGNATSLETLDLRGSFFQG----SIPVSFKNLQKLKFLGLSGNNLTGK-----IP 211
+ + NA L ++ + + +F++ + L + + N + + +
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209
Query: 212 RELGQLSSMETMILAYNEFDGE----IPVEFGNLTNLKYLDLA---VGNLGGKIPAE--- 261
L ++ + L N F + + + NL+ L L + G +
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 269
Query: 262 LGRLELLEIMFLYQNNFQGR-----LPAEIGNITSLQLLDLSYNMLSHE 305
L+ + L N + + L L+L+ N S E
Sbjct: 270 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 318
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 2e-17
Identities = 71/348 (20%), Positives = 122/348 (35%), Gaps = 96/348 (27%)
Query: 711 NVIGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-R 764
+G GA G V +A+ ++ VAVK L E + E+ +L +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR---ALMSELKILIHIGH 84
Query: 765 HRNIVRLLG-----------------------FLHNDTNMMIVY-----------EYMNN 790
H N+V LLG +L + N + Y +Y+
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144
Query: 791 ---------GSLGEALHGKQAGRLLVDWVSRYN--------------------IALGVAQ 821
S+ + +G + +S + VA+
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGS--YGY 879
G+ +L IHRD+ + NILL +I DFGLAR + + + V +
Sbjct: 205 GMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261
Query: 880 IAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938
+APE + + D++SFGV+L E+ + G P V I E ++++ +
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTRMR 316
Query: 939 EALDPNVGNC-KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985
P+ + + ML C P RP+ +++ LG
Sbjct: 317 A---PD--YTTPEMYQTML-------DCWHGEPSQRPTFSELVEHLGN 352
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 47/216 (21%), Positives = 79/216 (36%), Gaps = 58/216 (26%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVR 770
V+G+G G V + R A+K L + E V + + + +IVR
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARRE--------VELHWRASQCPHIVR 75
Query: 771 LLGF----LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRY------NIALGVA 820
++ ++IV E ++ G L R+ + I +
Sbjct: 76 IVDVYENLYAGRKCLLIVMECLDGGELFS--------RIQDRGDQAFTEREASEIMKSIG 127
Query: 821 QGLAYLH-HDCYPPIIHRDIKSNNILLDS---NLEPRIADFGLARMMIRKNETVSMVAGS 876
+ + YLH + I HRD+K N+L S N ++ DFG A+ +
Sbjct: 128 EAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK--------- 174
Query: 877 YGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y D+ D++S GV++ LL G P
Sbjct: 175 Y-------------DKSCDMWSLGVIMYILLCGYPP 197
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 67/218 (30%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 712 VIGMGATGIVY---KAEMPRLNTIVAVKKLWRS---RADLETESSGDFVGEVNVLGKLRH 765
V+G GA G V+ K + A+K L ++ + TE + E VL +R
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT---RTERQVLEHIRQ 117
Query: 766 RN-IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN--IALGVAQG 822
+V L +T + ++ +Y+N G L H Q R V Y I L
Sbjct: 118 SPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVLA---- 171
Query: 823 LAYLH-HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA-RMMIRKNETVSMVAGSYGYI 880
L +LH II+RDIK NILLDSN + DFGL+ + + E G+ Y+
Sbjct: 172 LEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 881 APE------YGYTLKVDEKIDIYSFGVVLLELLTGRRP 912
AP+ G+ V D +S GV++ ELLTG P
Sbjct: 228 APDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 43/259 (16%), Positives = 95/259 (36%), Gaps = 18/259 (6%)
Query: 333 GLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLI 392
+ L S++ + + + + + +++ + + N+TKL
Sbjct: 19 SDDAFAETIKDNLKKKSVTDAVTQNELNS--IDQIIANNSDIK-SVQG-IQYLPNVTKLF 74
Query: 393 LFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITD 452
L N + P L+ +L + + N++ + L+KL+ L L +N ++ +
Sbjct: 75 LNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS--DIN 128
Query: 453 DIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLD 512
+ L + + N + + + + L T + +N + +I L L
Sbjct: 129 GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLY 184
Query: 513 LSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPE 572
LS N+ S + ++A + L L L + + S + + ++ SL PE
Sbjct: 185 LSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PE 240
Query: 573 NFGASPALEVLNVSYNRLE 591
E NV ++ E
Sbjct: 241 IISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 44/236 (18%), Positives = 88/236 (37%), Gaps = 16/236 (6%)
Query: 118 LANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDL 177
+ ++ + + + + A+ ++ ++ + ++ L L
Sbjct: 20 DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFL 75
Query: 178 RGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVE 237
+ + + NL+ L +L L N + + L L ++++ L +N +I
Sbjct: 76 --NGNKLTDIKPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DING- 129
Query: 238 FGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDL 297
+L L+ L L N I L RL L+ + L N + + +T LQ L L
Sbjct: 130 LVHLPQLESLYLG-NNKITDITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYL 185
Query: 298 SYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGP 353
S N +S ++ + LKNL +L L + L ++ + SL P
Sbjct: 186 SKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 39/230 (16%), Positives = 85/230 (36%), Gaps = 16/230 (6%)
Query: 364 LQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLS 423
+L S + + + N ++ ++I N+ + + ++ ++ + N+L+
Sbjct: 26 TIKDNLKKKSVTDAVTQNELN--SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLT 81
Query: 424 GTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPN 483
P L+ L L L N + + L + + N + + ++ +P
Sbjct: 82 DIKP--LANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGISD--INGLVHLPQ 135
Query: 484 LQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLT 543
L++ + NN + L L L N S I +A KL NL L N ++
Sbjct: 136 LESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS 191
Query: 544 GDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGP 593
D+ +A++ + L +L+L + + + + L P
Sbjct: 192 -DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 57/301 (18%), Positives = 97/301 (32%), Gaps = 66/301 (21%)
Query: 96 RLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASG 155
NL + + + L S+ + + + + S G+ +T L +G
Sbjct: 22 AFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 77
Query: 156 NNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELG 215
N + ++ L N +L L L + + S K+L+KLK L L N ++
Sbjct: 78 NKLTD--IKPLANLKNLGWLFLDEN--KVKDLSSLKDLKKLKSLSLEHNGIS-------- 125
Query: 216 QLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQ 275
+I +L L+ L L N I
Sbjct: 126 -----------------DING-LVHLPQLESLYLG-NNKITDITV--------------- 151
Query: 276 NNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLG 335
+ +T L L L N +S +P + L LQ L L N +S L
Sbjct: 152 ----------LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS--DLRALA 197
Query: 336 GLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFN 395
GL L+VLEL++ + + S P + + G+ K +
Sbjct: 198 GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKW 255
Query: 396 N 396
+
Sbjct: 256 H 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 43/228 (18%), Positives = 87/228 (38%), Gaps = 16/228 (7%)
Query: 76 VEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLN 135
++++ ++ ++ Q L ++T L L N L + + LANL +L + +N +
Sbjct: 48 IDQIIANNSDIK--SVQGIQYLPNVTKLFLNGNKL-TDIKP-LANLKNLGWLFLDENKV- 102
Query: 136 GSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQK 195
+ L L L+ N S + L + LE+L L + + + L K
Sbjct: 103 -KDLSSLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNN--KITDITVLSRLTK 157
Query: 196 LKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLG 255
L L L N ++ I L L+ ++ + L+ N ++ L NL L+L
Sbjct: 158 LDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECL 213
Query: 256 GKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLS 303
K L + + + P I + + ++ +++
Sbjct: 214 NKPINHQSNLVVPNT--VKNTDGSLVTPEIISDDGDYEKPNVKWHLPE 259
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 5e-17
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSR--ADLETESSGDFVGEVNVLGKLRHRNIV 769
+G G+ G V+ A+K L + + E + E +L + H I+
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT---NDERLMLSIVTHPFII 69
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH-H 828
R+ G + + ++ +Y+ G L +++ R V+++ A V L YLH
Sbjct: 70 RMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNP-VAKFYAA-EVCLALEYLHSK 125
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE----Y 884
D II+RD+K NILLD N +I DFG A+ + T + G+ YIAPE
Sbjct: 126 D----IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT---LCGTPDYIAPEVVSTK 178
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRP 912
Y + D +SFG+++ E+L G P
Sbjct: 179 PYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 82.1 bits (202), Expect = 3e-16
Identities = 47/297 (15%), Positives = 95/297 (31%), Gaps = 38/297 (12%)
Query: 268 LEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLS 327
L L Q S + L + + + L L + +
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRP-ECWCRDSATDEQLFRCELSVEKST 362
Query: 328 GHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGN 387
+ + L +L+ LE N + + + PL + + FS +
Sbjct: 363 -VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLK---AVDPMR 418
Query: 388 LTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLT 447
L + F V + + + + L+ + +L + L+L++N L
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR 476
Query: 448 GGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPS 507
+LP + ++ L+ S+N L + + P
Sbjct: 477 -------------------------ALPPALAALRCLEVLQASDNALE-NVDG-VANLPR 509
Query: 508 LSVLDLSSNYFSG-SIPSSIASCEKLVNLNLRNNQLTGD---IPKAISMMPTLAILD 560
L L L +N + + SC +LV LNL+ N L + + M+P+++ +
Sbjct: 510 LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.4 bits (182), Expect = 8e-14
Identities = 44/215 (20%), Positives = 77/215 (35%), Gaps = 16/215 (7%)
Query: 162 LLEDLGNATSLETLDL---RGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLS 218
D L +L + + Q + S K LQ+L+ + R L L
Sbjct: 341 WCRDSATDEQLFRCELSVEKSTVLQSEL-ESCKELQELEPENKWCLLTIILLMRALDPLL 399
Query: 219 SMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNF 278
+ + ++ P+ L +L+ L + + ++ L +
Sbjct: 400 YEKETLQYFSTLKAVDPMRAAYLDDLRSKFL------LENSVLKMEYADVRVLHLAHKDL 453
Query: 279 QGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLT 338
L + + + LDLS+N L +P + L+ L++L N L +V G+ L
Sbjct: 454 T-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLP 508
Query: 339 QLEVLELWNNSLSG-PLPVDLGKNSPLQWLDLSSN 372
+L+ L L NN L L L L+L N
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 73.6 bits (180), Expect = 1e-13
Identities = 54/330 (16%), Positives = 92/330 (27%), Gaps = 56/330 (16%)
Query: 20 CFGSAKVVAKTALNDELLALLSIKAGLVDPLNSLHDWKLPSAHCNWTGVWCNSNGAVEKL 79
A + + + + + +VD +W+ P + VW
Sbjct: 251 SREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDL---PAA 307
Query: 80 DLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFP 139
L+ + S L + A L R ++S
Sbjct: 308 SLNDQLPQHTFRVIWTGSDSQKECVLLKDRPEC-WCRDSATDEQLFRCELSVEKST-VLQ 365
Query: 140 AGLGGAAGLTFLNASGN-------------NFSGFLLEDLGNATSLETLD--------LR 178
+ L L L + + E L ++L+ +D
Sbjct: 366 SELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDL 425
Query: 179 GSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEF 238
S F V ++ L L+ +LT + L QL + + L++N +P
Sbjct: 426 RSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPAL 482
Query: 239 GNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLS 298
L L+ L + N LE ++ + N+ LQ L L
Sbjct: 483 AALRCLEVLQAS-DN----------ALENVD---------------GVANLPRLQELLLC 516
Query: 299 YNMLS-HEIPAEITQLKNLQLLNLMCNQLS 327
N L + L LLNL N L
Sbjct: 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 73.6 bits (180), Expect = 2e-13
Identities = 40/205 (19%), Positives = 78/205 (38%), Gaps = 10/205 (4%)
Query: 387 NLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSL 446
L + L S + L +C L + +N TI + L L +L
Sbjct: 350 QLFRCELSVE-KSTVLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETL 405
Query: 447 TGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCP 506
T +++D R+ + +++ +++ +L + +
Sbjct: 406 QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLL 463
Query: 507 SLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSL 566
++ LDLS N ++P ++A+ L L +N L ++ ++ +P L L L NN L
Sbjct: 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRL 520
Query: 567 TG-GIPENFGASPALEVLNVSYNRL 590
+ + P L +LN+ N L
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.4 bits (169), Expect = 3e-12
Identities = 37/228 (16%), Positives = 80/228 (35%), Gaps = 10/228 (4%)
Query: 364 LQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLS 423
L L+ + + +L + S +T L R + + +
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDS-ATDEQLFRCELSVEKST 362
Query: 424 GTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPN 483
+ ++LQ LE N I + + L + + + S+L +
Sbjct: 363 -VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF-STL--KAVDPMR 418
Query: 484 LQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLT 543
+ + E + + VL L+ + + + + +L+L +N+L
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR 476
Query: 544 GDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
+P A++ + L +L S+N+L + P L+ L + NRL+
Sbjct: 477 -ALPPALAALRCLEVLQASDNALE--NVDGVANLPRLQELLLCNNRLQ 521
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-15
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 35/218 (16%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVK-----KLWRSRADLETESSGDFVGEVNVLGKLRHR 766
VIG G+ G V KA +++ VA+K K + +A E + +L LR +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----------IRILEHLRKQ 153
Query: 767 ------NIVRLLG-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGV 819
N++ +L F + ++ + +E ++ +L E + + + V ++ A +
Sbjct: 154 DKDNTMNVIHMLENFTFRN-HICMTFELLSM-NLYELIKKNKFQGFSLPLVRKF--AHSI 209
Query: 820 AQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP--RIADFGLARMMIRKNETVSMVAGSY 877
Q L LH IIH D+K NILL ++ DFG + +++ V S
Sbjct: 210 LQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYIQSR 263
Query: 878 GYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
Y APE + ID++S G +L ELLTG PL P
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLP 300
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 39/260 (15%), Positives = 78/260 (30%), Gaps = 43/260 (16%)
Query: 290 TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLEL-WN 347
+ ++ + IP + + Q L L+ L +P+ L + + + +
Sbjct: 11 HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSID 65
Query: 348 NSLSGPLPVDLGKNSP-LQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSL 406
+L L N + +++ + I +A
Sbjct: 66 VTLQQ-LESHSFYNLSKVTHIEIRNTRNLTYIDP---------------DALKE------ 103
Query: 407 STCHSLVRVRMQNNQLSGTIP--VGFGRLEKLQRLELANNSLTGGITDDIAS--STSLSF 462
L + + N L P + LE+ +N I +
Sbjct: 104 --LPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160
Query: 463 IDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQ-FQDCPS-LSVLDLSSNYFSG 520
+ + N +S+ + L ++ N + I F S S+LD+S +
Sbjct: 161 LKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT- 218
Query: 521 SIPSSIASCEKLVNLNLRNN 540
++PS E L L RN
Sbjct: 219 ALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 9e-15
Identities = 32/211 (15%), Positives = 63/211 (29%), Gaps = 12/211 (5%)
Query: 146 AGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPV-SFKNLQKLKFLGLSGN 204
L + N ++ + + + SF NL K+ + +
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 205 NLTGKIPRE-LGQLSSMETMILAYNEFDGEIP--VEFGNLTNLKYLDLAVGNLGGKIPAE 261
I + L +L ++ + + P + + L++ IP
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 262 L--GRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQ--LKNLQ 317
G + LY N F + N T L + L+ N I +
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 318 LLNLMCNQLSGHVPAG-LGGLTQLEVLELWN 347
LL++ ++ +P+ L L +L W
Sbjct: 209 LLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 44/233 (18%), Positives = 82/233 (35%), Gaps = 18/233 (7%)
Query: 362 SPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRM-QNN 420
+ ++ IP+ + L L + S ++ R+ + +
Sbjct: 11 HQEEDFRVTCKDIQ-RIPSLPPS---TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 421 QLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDI-ASSTSLSFIDISRNHLRSSLP--S 476
L + F L K+ +E+ N I D L F+ I L+ P +
Sbjct: 67 TLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLT 124
Query: 477 TILSIPNLQTFIVSNNNLVGEIPDQ-FQDCPSLSV-LDLSSNYFSGSIPSSIASCEKLVN 534
+ S +++N + IP FQ + ++ L L +N F+ S+ + KL
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDA 183
Query: 535 LNLRNNQLTGDIPKAI--SMMPTLAILDLSNNSLTGGIPEN-FGASPALEVLN 584
+ L N+ I K + ++LD+S S+T +P L N
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 48/283 (16%), Positives = 86/283 (30%), Gaps = 70/283 (24%)
Query: 59 PSAHC---NWTGVWCNSNG---------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLC 106
S C + + L L +L S F L +++ + +
Sbjct: 4 SSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVS 63
Query: 107 CNGLFSSLP-NSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLED 165
+ L +S NL+ + +
Sbjct: 64 IDVTLQQLESHSFYNLSKVTHI-------------------------------------E 86
Query: 166 LGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIP--RELGQLSSMETM 223
+ N +L +D P + K L LKFLG+ L P ++ +
Sbjct: 87 IRNTRNLTYID----------PDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFIL 135
Query: 224 ILAYNEFDGEIPVE-FGNLTN-LKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGR 281
+ N + IPV F L N L L N + L+ ++L +N +
Sbjct: 136 EITDNPYMTSIPVNAFQGLCNETLTLKLY-NNGFTSVQGYAFNGTKLDAVYLNKNKYLTV 194
Query: 282 LPAEI--GNITSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNL 321
+ + G + LLD+S ++ +P++ LK L N
Sbjct: 195 IDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 27/146 (18%), Positives = 57/146 (39%), Gaps = 13/146 (8%)
Query: 458 TSLSFIDISRNHLRS--SLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSS 515
++ ++ SLP P+ QT + +L F + P++S + +S
Sbjct: 11 HQEEDFRVTCKDIQRIPSLP------PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSI 64
Query: 516 NYFSGSIPSSI-ASCEKLVNLNLRNNQLTGDIPK-AISMMPTLAILDLSNNSLTGGIPEN 573
+ + S + K+ ++ +RN + I A+ +P L L + N L P+
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDL 123
Query: 574 --FGASPALEVLNVSYNRLEGPVPAN 597
++ +L ++ N +P N
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVN 149
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVK-----KLWRSRADLETESSGDFVGEVNVLGKLRH 765
++IG G+ G V KA VA+K K + ++A +E V +L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----------VRLLELMNK 109
Query: 766 R------NIVRLLG-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALG 818
IV L F+ + ++ +V+E ++ +L + L + ++ ++ A
Sbjct: 110 HDTEMKYYIVHLKRHFMFRN-HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKF--AQQ 165
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP--RIADFGLARMMIRKNETVSMVAGS 876
+ L +L IIH D+K NILL + +I DFG + + + + S
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYIQS 221
Query: 877 YGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDP 915
Y +PE + D ID++S G +L+E+ TG PL
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFS 259
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 51/163 (31%), Positives = 72/163 (44%), Gaps = 16/163 (9%)
Query: 290 TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGL-GGLTQLEVLELWNN 348
+ LDL L+ A L L LNL NQL + AG+ LT+L L L NN
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANN 93
Query: 349 SLSGPLPVDL-GKNSPLQWLDLSSNSFSGEIPASLCNG-GNLTKLILFNNAFSGPIPV-- 404
L+ LP+ + + L L L N +P+ + + L +L L N IP
Sbjct: 94 QLAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGA 150
Query: 405 --SLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANN 444
L+ +L + + NQL ++P G F RL KLQ + L N
Sbjct: 151 FDKLT---NLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 44/156 (28%), Positives = 62/156 (39%), Gaps = 8/156 (5%)
Query: 221 ETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAEL-GRLELLEIMFLYQNNFQ 279
E + L F LT L +L+L N + A + L L + L N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLD-YNQLQTLSAGVFDDLTELGTLGLANNQLA 96
Query: 280 GRLPAEI-GNITSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAGL-GG 336
LP + ++T L L L N L +P+ + +L L+ L L NQL +PAG
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDK 153
Query: 337 LTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSN 372
LT L+ L L N L + LQ + L N
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 48/193 (24%), Positives = 68/193 (35%), Gaps = 42/193 (21%)
Query: 378 IPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKL 436
IPA + KL L + + + L + + NQL T+ G F L +L
Sbjct: 33 IPA------DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85
Query: 437 QRLELANNSLT---GGITDDIASSTSLSFIDISRNHLRSSLPSTIL-SIPNLQTFIVSNN 492
L LANN L G+ D T L + + N L SLPS + + L+
Sbjct: 86 GTLGLANNQLASLPLGVFD---HLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKE------ 135
Query: 493 NLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSI-ASCEKLVNLNLRNNQLTGDIPKAIS 551
L L++N SIP+ L L+L NQL A
Sbjct: 136 ------------------LRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFD 176
Query: 552 MMPTLAILDLSNN 564
+ L + L N
Sbjct: 177 RLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 56/188 (29%), Positives = 74/188 (39%), Gaps = 28/188 (14%)
Query: 63 CNWTGVWCNSNG--AV--------EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFS 112
V C +V EKLDL L+ F+ L LT LNL N L
Sbjct: 14 EGKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-Q 72
Query: 113 SLP-NSLANLTSLKRFDVSQNFLNGSFPAGL-GGAAGLTFLNASGNNFSGFLLEDL---- 166
+L +LT L ++ N L S P G+ L L GN L+ L
Sbjct: 73 TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQ-----LKSLPSGV 126
Query: 167 -GNATSLETLDLRGSFFQGSIPVS-FKNLQKLKFLGLSGNNLTGKIPRE-LGQLSSMETM 223
T L+ L L + Q SIP F L L+ L LS N L +P +L ++T+
Sbjct: 127 FDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTI 184
Query: 224 ILAYNEFD 231
L N+FD
Sbjct: 185 TLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 48/159 (30%), Positives = 70/159 (44%), Gaps = 6/159 (3%)
Query: 170 TSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPREL-GQLSSMETMILAYN 228
E LDL+ + +F+ L KL +L L N L + + L+ + T+ LA N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93
Query: 229 EFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAEL-GRLELLEIMFLYQNNFQGRLPAEI- 286
+ F +LT L L L GN +P+ + RL L+ + L N Q +PA
Sbjct: 94 QLASLPLGVFDHLTQLDKLYLG-GNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151
Query: 287 GNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQ 325
+T+LQ L LS N L +L LQ + L NQ
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 47/217 (21%), Positives = 81/217 (37%), Gaps = 19/217 (8%)
Query: 191 KNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLA 250
L L ++T + +LS ++ + + TNLK L L+
Sbjct: 16 PGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLS 71
Query: 251 VGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQL--LDLSYNMLSHEIPA 308
N + L L LE + + +N + + I S L L L N L
Sbjct: 72 -HNQISDLSP-LKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELRDTDS- 123
Query: 309 EITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLD 368
+ LKNL++L++ N+L LG L++LEVL+L N ++ L + + W+D
Sbjct: 124 -LIHLKNLEILSIRNNKLK--SIVMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWID 178
Query: 369 LSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVS 405
L+ E + + + P +S
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYIS 215
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 32/181 (17%), Positives = 68/181 (37%), Gaps = 15/181 (8%)
Query: 387 NLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSL 446
N K L + + + + N+ + ++ G L+ L L++N +
Sbjct: 20 NAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQI 75
Query: 447 TGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCP 506
+ + T L + ++RN L++ + L + NN L D
Sbjct: 76 SD--LSPLKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFLDNNEL--RDTDSLIHLK 128
Query: 507 SLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSL 566
+L +L + +N SI + KL L+L N++T + ++ + + +DL+
Sbjct: 129 NLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKC 184
Query: 567 T 567
Sbjct: 185 V 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 35/162 (21%), Positives = 65/162 (40%), Gaps = 13/162 (8%)
Query: 286 IGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLEL 345
++ +Q + + + + NL+ L+L NQ+S + L LT+LE L +
Sbjct: 37 QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSHNQIS--DLSPLKDLTKLEELSV 92
Query: 346 WNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVS 405
N L ++ ++ L L L +N SL + NL L + NN +
Sbjct: 93 NRNRLKN---LNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVM-- 145
Query: 406 LSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLT 447
L L + + N+++ G RL+K+ ++L
Sbjct: 146 LGFLSKLEVLDLHGNEIT-NTG-GLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 34/185 (18%), Positives = 68/185 (36%), Gaps = 15/185 (8%)
Query: 406 LSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDI 465
+ V+ + + T V L +Q N+++ + T+L + +
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHL 70
Query: 466 SRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSS 525
S N + S + + L+ V+ N L + LS L L +N S
Sbjct: 71 SHNQISD--LSPLKDLTKLEELSVNRNRLK-NLN--GIPSACLSRLFLDNNELRD--TDS 123
Query: 526 IASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNV 585
+ + L L++RNN+L I + + L +LDL N +T + +++
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDL 179
Query: 586 SYNRL 590
+ +
Sbjct: 180 TGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 39/236 (16%), Positives = 75/236 (31%), Gaps = 19/236 (8%)
Query: 333 GLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLI 392
GL L S++ + +Q + +++ + + NL +L
Sbjct: 14 PDPGLANAVKQNLGKQSVTDLVSQKELSG--VQNFNGDNSNIQ-SLA-GMQFFTNLKELH 69
Query: 393 LFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITD 452
L +N S P L L + + N+L + L RL L NN L TD
Sbjct: 70 LSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIP---SACLSRLFLDNNELRD--TD 122
Query: 453 DIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLD 512
+ +L + I N L+S + + L+ + N + ++ +D
Sbjct: 123 SLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWID 178
Query: 513 LSSNYFSGSIPSSIASCEKLVNLN-LRNNQLTGDIPKAISMMPTLAILDLSNNSLT 567
L+ + +L N +++ P IS + +
Sbjct: 179 LTGQKCV---NEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 48/230 (20%), Positives = 86/230 (37%), Gaps = 19/230 (8%)
Query: 76 VEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLN 135
K +L +++ VS + L + + N + + SL + T+LK +S N +
Sbjct: 21 AVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI-QSLAG-MQFFTNLKELHLSHNQI- 75
Query: 136 GSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQK 195
S + L L L+ + N L + + L L L + + S +L+
Sbjct: 76 -SDLSPLKDLTKLEELSVNRNRLKN--LNGIPS-ACLSRLFLDNN--ELRDTDSLIHLKN 129
Query: 196 LKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLG 255
L+ L + N L I LG LS +E + L NE + L + ++DL G
Sbjct: 130 LEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDLT-GQKC 184
Query: 256 GKIPAELGRLELLEIM-FLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSH 304
P + L I + + + P I N S + + + +
Sbjct: 185 VNEP--VKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVY 232
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 39/204 (19%), Positives = 75/204 (36%), Gaps = 18/204 (8%)
Query: 118 LANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDL 177
L + + ++ + + +G+ N +N L + T+L+ L L
Sbjct: 15 DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHL 70
Query: 178 RGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVE 237
+ Q S K+L KL+ L ++ N L + + + + L NE +
Sbjct: 71 SHN--QISDLSPLKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNELRDTDSLI 125
Query: 238 FGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDL 297
+L NL+ L + N I LG L LE++ L+ N + + + +DL
Sbjct: 126 --HLKNLEILSIR-NNKLKSIVM-LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDL 179
Query: 298 SYNMLSHEIPAEITQLKNLQLLNL 321
+ +E + L + N
Sbjct: 180 TGQKCVNE---PVKYQPELYITNT 200
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 34/174 (19%), Positives = 62/174 (35%), Gaps = 37/174 (21%)
Query: 418 QNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPST 477
+ ++ P L + L S+T D+ +
Sbjct: 5 RPTPINQVFPDP--GLANAVKQNLGKQSVT----------------DLV----------S 36
Query: 478 ILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNL 537
+ +Q F N+N+ + Q +L L LS N S + S + KL L++
Sbjct: 37 QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSV 92
Query: 538 RNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
N+L ++ L+ L L NN L ++ LE+L++ N+L+
Sbjct: 93 NRNRLK-NLNG--IPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK 141
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 58/236 (24%), Positives = 88/236 (37%), Gaps = 43/236 (18%)
Query: 361 NSPLQWLDLSSNSFS---GEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRM 417
N+ +D SS + IPA + KL L +N S + L + +
Sbjct: 15 NNNKNSVDCSSKKLTAIPSNIPA------DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYL 68
Query: 418 QNNQLSGTIPVG-FGRLEKLQRLELANNSLT---GGITDDIASSTSLSFIDISRNHLRSS 473
+N+L T+P G F L+ L+ L + +N L G+ D + +L+ + + RN L S
Sbjct: 69 NDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQL---VNLAELRLDRNQL-KS 123
Query: 474 LPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSI-ASCEKL 532
LP + F L+ L L N S+P + L
Sbjct: 124 LPPRV-----------------------FDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSL 159
Query: 533 VNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYN 588
L L NNQL A + L L L NN L F + L++L + N
Sbjct: 160 KELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 21/227 (9%)
Query: 170 TSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPREL-GQLSSMETMILAYN 228
+ LDL+ + +F L KL+ L L+ N L +P + +L ++ET+ + N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 229 EFDGEIPVE-FGNLTNLKYLDLAVGNLGGKIPAEL-GRLELLEIMFLYQNNFQGRLPAEI 286
+ +P+ F L NL L L N +P + L L + L N Q LP +
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLD-RNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152
Query: 287 -GNITSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAGL-GGLTQLEVL 343
+TSL+ L L N L +P +L L+ L L NQL VP G L +L++L
Sbjct: 153 FDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEKLKML 210
Query: 344 ELWNNSLSGPLPVDLGKNSPL---QWLDLSSNSFSGEIPASLCNGGN 387
+L N P D N + +WL ++ G + + C G
Sbjct: 211 QLQEN------PWDCTCNGIIYMAKWLKKKADEGLGGVDTAGCEKGG 251
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 64/252 (25%), Positives = 94/252 (37%), Gaps = 66/252 (26%)
Query: 63 CNWTGVWCNSNG--AV--------EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFS 112
N V C+S A+ +KLDL LS S F RL L L L N L
Sbjct: 16 NNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-Q 74
Query: 113 SLPNSL-ANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATS 171
+LP + L +L+ V+ N L + P G+ F +
Sbjct: 75 TLPAGIFKELKNLETLWVTDNKLQ-ALPIGV---------------FDQL--------VN 110
Query: 172 LETLDLRGSFFQGSIPVS-FKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEF 230
L L L + + S+P F +L KL +L L N L +P+ F
Sbjct: 111 LAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPK---------------GVF 153
Query: 231 DGEIPVEFGNLTNLKYLDLAVGNLGGKIPAEL-GRLELLEIMFLYQNNFQGRLPAEI-GN 288
D LT+LK L L N ++P +L L+ + L N + R+P +
Sbjct: 154 DK--------LTSLKELRLY-NNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDS 203
Query: 289 ITSLQLLDLSYN 300
+ L++L L N
Sbjct: 204 LEKLKMLQLQEN 215
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 48/191 (25%), Positives = 70/191 (36%), Gaps = 38/191 (19%)
Query: 170 TSLETLDLRGSFFQGSIP--VSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAY 227
+ LDL + + + L L L LS N+L I E
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEA------------- 83
Query: 228 NEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAE-LGRLELLEIMFLYQNNFQGRLPAEI 286
F + NL+YLDL+ N + L+ LE++ LY N+ +
Sbjct: 84 ----------FVPVPNLRYLDLS-SNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNA 131
Query: 287 -GNITSLQLLDLSYNMLSHEIPAEI----TQLKNLQLLNLMCNQLSGHVPAGLGGLTQLE 341
++ LQ L LS N +S P E+ +L L LL+L N+L L L
Sbjct: 132 FEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV 190
Query: 342 VLELW--NNSL 350
L+ NN L
Sbjct: 191 KNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 45/212 (21%), Positives = 74/212 (34%), Gaps = 59/212 (27%)
Query: 290 TSLQLLDLSYNMLSHEIPAEIT--QLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLELW 346
+ LLDLS+N LS + AE T +L NL L L N L+ + + + L L+L
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96
Query: 347 NNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSL 406
+N L L FS L L
Sbjct: 97 SNHLH----------------TLDEFLFSD-----------LQAL--------------- 114
Query: 407 STCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLT---GGITDDIASSTSLSF 462
+ + NN + + F + +LQ+L L+ N ++ + D L
Sbjct: 115 ------EVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLML 167
Query: 463 IDISRNHLRSSLPSTILSIPNLQTFIVS-NNN 493
+D+S N L+ + + +P + +NN
Sbjct: 168 LDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 44/209 (21%), Positives = 77/209 (36%), Gaps = 44/209 (21%)
Query: 62 HCNWTGVWCNSNG----------AVEKLDLSHMNLSGCVSDH-FQRLKSLTSLNLCCNGL 110
C + C+ LDLSH NLS ++ RL +L SL L N L
Sbjct: 17 LCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL 76
Query: 111 FSSLP-NSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNA 169
+ + + + +L+ D+S N L+ + L DL
Sbjct: 77 -NFISSEAFVPVPNLRYLDLSSNHLH-TLDEF--------------------LFSDL--- 111
Query: 170 TSLETLDLRGSFFQGSIPV-SFKNLQKLKFLGLSGNNLTGKIPRE----LGQLSSMETMI 224
+LE L L + + +F+++ +L+ L LS N ++ + P E +L + +
Sbjct: 112 QALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLD 169
Query: 225 LAYNEFDGEIPVEFGNLTNLKYLDLAVGN 253
L+ N+ + L L + N
Sbjct: 170 LSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 13/162 (8%)
Query: 437 QRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILS-IPNLQTFIVSNNNLV 495
L + L + + + + +D+S N+L + + NL + ++S+N+L
Sbjct: 21 NILSCSKQQLPN-VPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL- 76
Query: 496 GEIPDQ-FQDCPSLSVLDLSSNYFSGSIPSSI-ASCEKLVNLNLRNNQLTGDIPKAISMM 553
I + F P+L LDLSSN+ ++ + + + L L L NN + A M
Sbjct: 77 NFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDM 135
Query: 554 PTLAILDLSNNSLTGGIPE----NFGASPALEVLNVSYNRLE 591
L L LS N ++ P + P L +L++S N+L+
Sbjct: 136 AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 14/160 (8%)
Query: 436 LQRLELANNSLTGGITDDIASS--TSLSFIDISRNHLRSSLPSTILS-IPNLQTFIVSNN 492
L+L++N+L+ + + + T+L + +S NHL + + S +PNL+ +S+N
Sbjct: 41 TALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSN 98
Query: 493 NLVGEIPDQ-FQDCPSLSVLDLSSNYFSGSIPSSI-ASCEKLVNLNLRNNQLTGDIP--- 547
+L + + F D +L VL L +N+ + + +L L L NQ++ P
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155
Query: 548 -KAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVS 586
K + +P L +LDLS+N L + PA +
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 34/138 (24%), Positives = 52/138 (37%), Gaps = 9/138 (6%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLP-NSLANLTSLKRFDVSQNFLN 135
L LSH +L+ S+ F + +L L+L N L +L ++L +L+ + N +
Sbjct: 67 HSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIV 125
Query: 136 GSFPAG-LGGAAGLTFLNASGNNFSGF---LLEDLGNATSLETLDLRGSFFQGSIPVSFK 191
A L L S N S F L++D L LDL + + +
Sbjct: 126 -VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQ 184
Query: 192 NLQKLK--FLGLSGNNLT 207
L L L N L
Sbjct: 185 KLPAWVKNGLYLHNNPLE 202
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 6e-13
Identities = 61/269 (22%), Positives = 96/269 (35%), Gaps = 74/269 (27%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-------- 764
+G G V+ + + VA+K + A+ TE++ D E+ +L +R
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVV--KSAEHYTETALD---EIRLLKSVRNSDPNDPN 99
Query: 765 HRNIVRLLG-FLH---NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVA 820
+V+LL F N T++ +V+E + + L + + L + V + I V
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK--IIQQVL 156
Query: 821 QGLAYLHHDCYPPIIHRDIKSNNILL---------------------------------- 846
QGL YLH C IIH DIK NILL
Sbjct: 157 QGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 847 ---------------DSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVD 891
L+ +IAD G A ++ + + Y + E +
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQTRQYRSLEVLIGSGYN 271
Query: 892 EKIDIYSFGVVLLELLTGRRPLDPEFGES 920
DI+S + EL TG +P GE
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEE 300
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 8e-13
Identities = 67/526 (12%), Positives = 145/526 (27%), Gaps = 98/526 (18%)
Query: 94 FQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNA 153
+R + S+ L F+ + + + L +
Sbjct: 62 IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYT---------WLEEIRL 112
Query: 154 SGNNFSGFLLEDLG-NATSLETLDLRG--SFFQGSIPVSFKNLQKLKFLGLSGNNLTGKI 210
+ LE + + + + L L F + + LK L L +++
Sbjct: 113 KRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVS 172
Query: 211 PRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEI 270
L T+L L+++ L ++
Sbjct: 173 GHWLSHFPD--------------------TYTSLVSLNIS--CLASEV------------ 198
Query: 271 MFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNL------MCN 324
+F L + +L+ L L+ + ++ + + L+ L +
Sbjct: 199 ------SFSA-LERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRP 251
Query: 325 QLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGE-IPASLC 383
+ + L G +L L + +++ LP S L L+LS + + LC
Sbjct: 252 DVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLC 311
Query: 384 NGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELAN 443
L +L + + + V STC L +R + E
Sbjct: 312 QCPKLQRLWVLDYIEDAGLEVLASTCKDLRELR-------------------VFPSEPFV 352
Query: 444 NSLTGGITDD-----IASSTSLSFIDISRNHLR-SSLPSTILSIPNLQTFIVSNNNLVGE 497
+T+ L + + ++L + + PN+ F +
Sbjct: 353 MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAP 412
Query: 498 --IPDQFQD---------CPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDI 546
+ + D C L L LS +K+ L++ +
Sbjct: 413 DYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLG 472
Query: 547 PKAISM-MPTLAILDLSN-NSLTGGIPENFGASPALEVLNVSYNRL 590
+ +L L++ + + N + L +S +
Sbjct: 473 MHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 9e-13
Identities = 64/449 (14%), Positives = 143/449 (31%), Gaps = 41/449 (9%)
Query: 40 LSIKAGLVDPLNSLHDWKLPSAHCNWTGVWCNSNGAVEKLDLSHMNLS-GCVSDHFQRLK 98
+ +K +L W +S +E++ L M ++ C+ + K
Sbjct: 71 VELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFK 130
Query: 99 SLTSLNLCCNGLFS--SLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAA----GLTFLN 152
+ L L FS L A +LK D+ ++ ++ L L LN
Sbjct: 131 NFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLN 190
Query: 153 ASG--NNFSGFLLEDLG-NATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSG------ 203
S + S LE L +L++L L + + + +L+ LG G
Sbjct: 191 ISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVR 250
Query: 204 NNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGK-IPAEL 262
++ + L + + ++ +P + + L L+L+ + + L
Sbjct: 251 PDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLL 310
Query: 263 GRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSY-NMLSHEIPAEITQ--------- 312
+ L+ +++ L L+ L + E +T+
Sbjct: 311 CQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMG 370
Query: 313 LKNLQLLNLMCNQLSGHVPAGLG-GLTQLEVLELWNNSLSGPLPVD----------LGKN 361
L+ + C Q++ + + L P + + ++
Sbjct: 371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEH 430
Query: 362 SP-LQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLST-CHSLVRVRMQN 419
L+ L LS + L + S + + C SL ++ +++
Sbjct: 431 CKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRD 490
Query: 420 NQLSG-TIPVGFGRLEKLQRLELANNSLT 447
+ +LE ++ L +++ S++
Sbjct: 491 CPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 5e-08
Identities = 38/277 (13%), Positives = 85/277 (30%), Gaps = 21/277 (7%)
Query: 342 VLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGG-NLTKLILFN-NAFS 399
V + W + + + L+ + L + + + N L+L + FS
Sbjct: 85 VPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFS 144
Query: 400 GP-IPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEK----LQRLELANNSLTGGITDD- 453
+ +TC +L + ++ + + L L ++ L ++
Sbjct: 145 TDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISC--LASEVSFSA 202
Query: 454 ----IASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVS------NNNLVGEIPDQFQ 503
+ +L + ++R L + + P L+ ++ +
Sbjct: 203 LERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS 262
Query: 504 DCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGD-IPKAISMMPTLAILDLS 562
C L L + +P+ + C +L LNL + + K + P L L +
Sbjct: 263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL 322
Query: 563 NNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGV 599
+ G+ L L V + P +
Sbjct: 323 DYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVAL 359
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 35/144 (24%), Positives = 59/144 (40%), Gaps = 12/144 (8%)
Query: 258 IPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEI-TQLKNL 316
+P + + L QN + P L+ +DLS N +S E+ + L++L
Sbjct: 30 LPETITEIRL------EQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82
Query: 317 QLLNLMCNQLSGHVPAGL-GGLTQLEVLELWNNSLSGPLPVDLGKNSP-LQWLDLSSNSF 374
L L N+++ +P L GL L++L L N ++ L VD ++ L L L N
Sbjct: 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKL 140
Query: 375 SGEIPASLCNGGNLTKLILFNNAF 398
+ + + L N F
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 36/157 (22%), Positives = 61/157 (38%), Gaps = 28/157 (17%)
Query: 290 TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGL-GGLTQLEVLELWNN 348
++ + L N + P + K L+ ++L NQ+S + GL L L L+ N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 349 SLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLST 408
++ LQ L L++N + + +AF L
Sbjct: 91 KITELPKSLFEGLFSLQLLLLNANKIN-CLRV---------------DAFQD-----L-- 127
Query: 409 CHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANN 444
H+L + + +N+L TI G F L +Q + LA N
Sbjct: 128 -HNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 29/140 (20%), Positives = 50/140 (35%), Gaps = 8/140 (5%)
Query: 378 IPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKL 436
+P +T++ L N P + S L R+ + NNQ+S + F L L
Sbjct: 30 LPE------TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82
Query: 437 QRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVG 496
L L N +T SL + ++ N + + NL + +N L
Sbjct: 83 NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT 142
Query: 497 EIPDQFQDCPSLSVLDLSSN 516
F ++ + L+ N
Sbjct: 143 IAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 39/181 (21%), Positives = 60/181 (33%), Gaps = 38/181 (20%)
Query: 63 CNWTGVWCNSNG----------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFS 112
C+ V C G + ++ L + F K L ++L N + S
Sbjct: 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-S 69
Query: 113 SLP-NSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATS 171
L ++ L SL + N + P L F G S
Sbjct: 70 ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSL---------------FEG--------LFS 105
Query: 172 LETLDLRGSFFQGSIPV-SFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEF 230
L+ L L + + V +F++L L L L N L L +++TM LA N F
Sbjct: 106 LQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
Query: 231 D 231
Sbjct: 165 I 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 33/144 (22%), Positives = 69/144 (47%), Gaps = 12/144 (8%)
Query: 402 IPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTG---GITDDIASS 457
IP +L ++ +R++ N + IP G F +KL+R++L+NN ++ +
Sbjct: 26 IPTNLPE--TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGL--- 79
Query: 458 TSLSFIDISRNHLRSSLPSTIL-SIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSN 516
SL+ + + N + + LP ++ + +LQ +++ N + D FQD +L++L L N
Sbjct: 80 RSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDN 138
Query: 517 YFSGSIPSSIASCEKLVNLNLRNN 540
+ + + ++L N
Sbjct: 139 KLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 37/157 (23%), Positives = 63/157 (40%), Gaps = 28/157 (17%)
Query: 170 TSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNE 229
++ + L + + P +F +KL+ + LS N Q+S LA +
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNN-----------QISE-----LAPDA 75
Query: 230 FDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAEL-GRLELLEIMFLYQNNFQGRLPAEI-G 287
F G L +L L L GN ++P L L L+++ L N L +
Sbjct: 76 FQG--------LRSLNSLVLY-GNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQ 125
Query: 288 NITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCN 324
++ +L LL L N L + L+ +Q ++L N
Sbjct: 126 DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 31/129 (24%), Positives = 54/129 (41%), Gaps = 6/129 (4%)
Query: 463 IDISRNHLRSSLPSTIL-SIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGS 521
I + +N + +P L+ +SNN + PD FQ SL+ L L N +
Sbjct: 37 IRLEQNTI-KVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 522 IPSSI-ASCEKLVNLNLRNNQLTGDIPK-AISMMPTLAILDLSNNSLTGGIPENFGASPA 579
+P S+ L L L N++ + A + L +L L +N L F A
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 580 LEVLNVSYN 588
++ ++++ N
Sbjct: 154 IQTMHLAQN 162
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 49/223 (21%), Positives = 83/223 (37%), Gaps = 52/223 (23%)
Query: 258 IPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQ 317
AE + L + + + S+ + + + + + I L N++
Sbjct: 17 AFAETIKANL-------KKKSVTDAVTQNE-LNSIDQIIANNSDIK-SVQG-IQYLPNVR 66
Query: 318 LLNLMCNQLSGHVPAGLG---GLTQLEVLELWNNSLSGPLPVDLGKN-SPLQWLDLSSNS 373
L L N+L + LT L L L N L LP + + L+ L L N
Sbjct: 67 YLALGGNKLHD-----ISALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQ 120
Query: 374 FSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGR 432
SL +G + L+ L + + +NQL ++P G F +
Sbjct: 121 L-----QSLPDG----------------VFDKLTN---LTYLNLAHNQLQ-SLPKGVFDK 155
Query: 433 LEKLQRLELANN---SLTGGITDDIASSTSLSFIDISRNHLRS 472
L L L+L+ N SL G+ D + T L + + +N L+S
Sbjct: 156 LTNLTELDLSYNQLQSLPEGVFDKL---TQLKDLRLYQNQLKS 195
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 43/195 (22%), Positives = 79/195 (40%), Gaps = 24/195 (12%)
Query: 378 IPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQ 437
A K L + + + + S+ ++ N+ + ++ G L ++
Sbjct: 17 AFAET------IKANLKKKSVTDAVTQNELN--SIDQIIANNSDIK-SVQ-GIQYLPNVR 66
Query: 438 RLELANNSLTG-GITDDIASSTSLSFIDISRNHLRSSLPSTILSIP-NLQTFIVSNNNLV 495
L L N L T+L+++ ++ N L SLP+ + NL+ ++ N L
Sbjct: 67 YLALGGNKLHDISALK---ELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQ 122
Query: 496 GEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVN---LNLRNNQLTGDIPKAI-S 551
F +L+ L+L+ N S+P + +KL N L+L NQL +P+ +
Sbjct: 123 SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGV--FDKLTNLTELDLSYNQLQS-LPEGVFD 178
Query: 552 MMPTLAILDLSNNSL 566
+ L L L N L
Sbjct: 179 KLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 55/233 (23%), Positives = 85/233 (36%), Gaps = 42/233 (18%)
Query: 99 SLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNF 158
NL + + + L S+ + + + + S G+ + +L GN
Sbjct: 20 ETIKANLKKKSV-TDAV-TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNK- 74
Query: 159 SGFLLEDLG---NATSLETLDLRGSFFQGSIPVS-FKNLQKLKFLGLSGNNLTGKIPREL 214
L D+ T+L L L G+ Q S+P F L LK L L N L
Sbjct: 75 ----LHDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVF 129
Query: 215 GQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLY 274
+L+++ + LA+N+ F LTNL LD L
Sbjct: 130 DKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD------------------------LS 165
Query: 275 QNNFQGRLPAEI-GNITSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQ 325
N Q LP + +T L+ L L N L +P + +L +LQ + L N
Sbjct: 166 YNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 48/147 (32%), Positives = 68/147 (46%), Gaps = 18/147 (12%)
Query: 94 FQRLKSLTSLNLCCNGLFSSLP-NSLANLTSLKRFDVSQNFLNGSFPAGL-GGAAGLTFL 151
+ L +LT L L N L SLP LT+LK + +N L S P G+ LT+L
Sbjct: 81 LKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYL 138
Query: 152 NASGNNFSGFLLEDLGNA-----TSLETLDLRGSFFQGSIPVS-FKNLQKLKFLGLSGNN 205
N + N L+ L T+L LDL + Q S+P F L +LK L L N
Sbjct: 139 NLAHNQ-----LQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQ 192
Query: 206 LTGKIPRE-LGQLSSMETMILAYNEFD 231
L +P +L+S++ + L N +D
Sbjct: 193 LKS-VPDGVFDRLTSLQYIWLHDNPWD 218
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.6 bits (164), Expect = 5e-12
Identities = 42/243 (17%), Positives = 71/243 (29%), Gaps = 63/243 (25%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADL----ETESSGDFVGEVNVLGKL----- 763
IG G G V++ +T VA+K + DL ++ + + E+ + +L
Sbjct: 28 IGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 764 ----RHRNIVRLLGF------------------------------LHNDTNMMIVYEYMN 789
R + L D + IV E+
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 790 NGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN 849
G E + K L + +I + LA HRD+ N+LL
Sbjct: 146 GGIDLEQMRTK-----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKT 198
Query: 850 LEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKID--IYSFGVVLLELL 907
++ + S S G YTL E+ ++ + +L
Sbjct: 199 SLKKLHYTLNGK---------SSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLF 249
Query: 908 TGR 910
TG
Sbjct: 250 TGD 252
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 53/328 (16%), Positives = 98/328 (29%), Gaps = 71/328 (21%)
Query: 288 NITSLQLLDLSYNMLSHEIPAEITQL-----KNLQLLNLMCNQLSGHVPAGLGGL----- 337
S+ L+LS N L + E+ Q+ N+ LNL N LS L
Sbjct: 49 TPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLS---YKSSDELVKTLA 105
Query: 338 ---TQLEVLELWNNSLSGPLPVDLGK-----NSPLQWLDLSSNSFSGEIPASLCNG---- 385
+ VL+L N S + + + + L+L N + L
Sbjct: 106 AIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAI 165
Query: 386 -GNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANN 444
N+ L L N + C L + + L+L+ N
Sbjct: 166 PANVNSLNLRGNNLAS------KNCAELAKFLASIPA-------------SVTSLDLSAN 206
Query: 445 SLTGGITDDIAS-----STSLSFIDISRNHLRSS----LPSTILSIPNLQTFIVSNNNLV 495
L ++A + +++ N L L S+ +LQT + + +
Sbjct: 207 LLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK 266
Query: 496 GEIPDQFQD-------CPSLSVLDLSSNYFSGSIPSSIAS-----CEKLVNLNLRNNQLT 543
+Q + + ++D + S I++ K +L N L
Sbjct: 267 NMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLI 326
Query: 544 -----GDIPKAISMMPTLAILDLSNNSL 566
+ +++ L + L
Sbjct: 327 FAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 47/279 (16%), Positives = 94/279 (33%), Gaps = 46/279 (16%)
Query: 358 LGKNSPLQWLDLSSNSFSGEIPASLC-----NGGNLTKLILFNNAFSGPIPVSL-----S 407
+ LDLS N+ L ++T L L N+ L +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 408 TCHSLVRVRMQNNQLSGTIPVGFGRL-----EKLQRLELANNSLTGGITDDIAS-----S 457
++ + + N LS + + L+L N + + +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 458 TSLSFIDISRNHLR----SSLPSTILSIP-NLQTFIVSNNNL----VGEIPDQFQDCP-S 507
S++ +++ N L L + +IP N+ + + NNL E+ P S
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197
Query: 508 LSVLDLSSNYFSGSIPSSIASC-----EKLVNLNLRNNQLTGDIPKAISMM----PTLAI 558
++ LDLS+N + +A +V+LNL N L G + + ++ L
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257
Query: 559 LDLSNNSLTGGIPENFGA-------SPALEVLNVSYNRL 590
+ L + + E A + +++ + +
Sbjct: 258 VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 69/341 (20%), Positives = 105/341 (30%), Gaps = 79/341 (23%)
Query: 98 KSLTSLNLCCNGL----FSSLPNSLA-NLTSLKRFDVSQNFLNGSFPAGLGGA-----AG 147
+TSL+L N L L + A S+ ++S N L L A
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 148 LTFLNASGNNFSGFLLEDLGNA-----TSLETLDLRGSFFQGS-----IPVSFKNLQKLK 197
+T LN SGN S ++L ++ LDL + F +
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 198 FLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGK 257
L L GN+L K EL Q ++ A N+ L+L NL K
Sbjct: 142 SLNLRGNDLGIKSSDELIQ------ILAAIP-------------ANVNSLNLRGNNLASK 182
Query: 258 IPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQL---- 313
AEL + L S+ LDLS N+L + AE+ +
Sbjct: 183 NCAELAKF-------LASIP------------ASVTSLDLSANLLGLKSYAELAYIFSSI 223
Query: 314 -KNLQLLNLMCNQLSG----HVPAGLGGLTQLEVLELWNNSLSGPLPVD-------LGKN 361
++ LNL N L G ++ L L+ + L + +
Sbjct: 224 PNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNI 283
Query: 362 SPLQWLDLSSNSFSGEIPASLCN-----GGNLTKLILFNNA 397
+ +D + + N G L N
Sbjct: 284 QKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQC 324
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 71/360 (19%), Positives = 119/360 (33%), Gaps = 84/360 (23%)
Query: 72 SNGAVEKLDLSHMNLS--GC--VSDHFQRLK-SLTSLNLCCNG--------LFSSLPNSL 118
V LDLS NL + F S+TSLNL N L L
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79
Query: 119 ANLTSLKRFDVSQNFLNGSFPAGLGGA-----AGLTFLNASGNNFSGFLLEDLGNA---- 169
AN+TSL ++S NFL+ L +T L+ N+FS + A
Sbjct: 80 ANVTSL---NLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 170 -TSLETLDLRGSFFQG----SIPVSFKNLQ-KLKFLGLSGNNLTGKIPRELGQL-----S 218
S+ +L+LRG+ + + + L L GNNL K EL + +
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196
Query: 219 SMETMILAYNEFDGEIPVEFG-----NLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFL 273
S+ ++ L+ N + E ++ L+L + L G L L
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLL-------- 248
Query: 274 YQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQL-------KNLQLLNLMCNQL 326
++ LQ + L Y+++ + + L + + L++ ++
Sbjct: 249 ------------KDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
Query: 327 SGHVPAGLGGLTQ--------LEVLELWNNSLS-----GPLPVDLGKNSPLQWLDLSSNS 373
P+ ++ +V L N L DL L+ +
Sbjct: 297 H---PSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKP 353
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 9e-04
Identities = 36/165 (21%), Positives = 60/165 (36%), Gaps = 32/165 (19%)
Query: 71 NSNGAVEKLDLSHMNLS--GCV--SDHFQRL-KSLTSLNLCCNG--------LFSSLPNS 117
N ++ L+L +L + ++ SLNL N L L +
Sbjct: 135 NLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASI 194
Query: 118 LANLTSLKRFDVSQNFLNGSFPAGLGGA-----AGLTFLNASGNNFSGFLLEDLGNA--- 169
A++TSL D+S N L A L + LN N G LE+L
Sbjct: 195 PASVTSL---DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDS 251
Query: 170 -TSLETLDLRGSFFQG-------SIPVSFKNLQKLKFLGLSGNNL 206
L+T+ L + ++ +F N+QK+ + +G +
Sbjct: 252 LKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 2e-11
Identities = 86/548 (15%), Positives = 169/548 (30%), Gaps = 79/548 (14%)
Query: 75 AVEKLDLSHMNLSGCVSDH----FQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVS 130
++ H+ ++ C + +R +L SL L + N V+
Sbjct: 46 KIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVT 105
Query: 131 QNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDL--GNATSLETLDLRG--SFFQGSI 186
+ ++ + L ++ S L+ L A LETL L F +
Sbjct: 106 E--ISNNLR-------QLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGL 156
Query: 187 PVSFKNLQKLKFLGLSGNNLTGKIPRELGQLS----SMETMILAYNEF----DGEIPVEF 238
+ +K+K L + ++ + K + L +L+ S+E + EF ++
Sbjct: 157 LSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIA 216
Query: 239 GNLTNLKYLDLAVGNL--GGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLD 296
N +L + + + LE L ++ + L L
Sbjct: 217 RNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLG 276
Query: 297 LSYNMLSHEIPAEITQLKNLQLLNL-MCNQLSGHVPAGLGGLTQLEVLELWN----NSLS 351
LS M +E+P ++ L+L + + LEVLE N L
Sbjct: 277 LS-YMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLE 335
Query: 352 GPLPVDLGKNSP-LQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCH 410
L + L+ L + + + G +++ L A C
Sbjct: 336 V-----LAQYCKQLKRLRIERGA---DEQGMEDEEGLVSQRGLIALA---------QGCQ 378
Query: 411 SLVRVRMQNNQLSGTIPVGFGR-LEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNH 469
L + + + ++ G L+ L L ITD
Sbjct: 379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLP--------------- 423
Query: 470 LRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQ-----FQDCPSLSVLDLSSNYFS-GSIP 523
L + + S ++ L+ F G + D Q P++ + L S +
Sbjct: 424 LDNGVRSLLIGCKKLRRFAFYLRQ--GGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLM 481
Query: 524 SSIASCEKLVNLNLRNNQLTGD-IPKAISMMPTLAILDLSNNSLTGGIPENFGAS---PA 579
C L L +R + I A++ +P+L L + + + +
Sbjct: 482 EFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWN 541
Query: 580 LEVLNVSY 587
+E++
Sbjct: 542 IELIPSRR 549
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 52/168 (30%), Positives = 68/168 (40%), Gaps = 39/168 (23%)
Query: 283 PAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGL-GGLTQLE 341
PA I T+ Q+L L N ++ P L NL+ L L NQL +P G+ LTQL
Sbjct: 35 PAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLT 91
Query: 342 VLELWNNSLSGPLPV----DLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNA 397
VL+L N L+ LP L L+ L + N + E+P + +LT L L
Sbjct: 92 VLDLGTNQLTV-LPSAVFDRLVH---LKELFMCCNKLT-ELPRGIERLTHLTHLAL---- 142
Query: 398 FSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANN 444
NQL +IP G F RL L L N
Sbjct: 143 --------------------DQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 43/181 (23%), Positives = 62/181 (34%), Gaps = 53/181 (29%)
Query: 170 TSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNE 229
T+ + L L + P F +L LK L L N QL ++ +
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN-----------QLGALPVGV----- 83
Query: 230 FDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEI-GN 288
F +LT L LD L N LP+ +
Sbjct: 84 --------FDSLTQLTVLD------------------------LGTNQLT-VLPSAVFDR 110
Query: 289 ITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLELWN 347
+ L+ L + N L E+P I +L +L L L NQL +P G L+ L L+
Sbjct: 111 LVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLSSLTHAYLFG 168
Query: 348 N 348
N
Sbjct: 169 N 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 40/180 (22%), Positives = 60/180 (33%), Gaps = 37/180 (20%)
Query: 63 CNWTGVWCNSNG--AV--------EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFS 112
C+ T V C S +V + L L ++ F L +L L L N L
Sbjct: 19 CSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-G 77
Query: 113 SLPNSL-ANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATS 171
+LP + +LT L D+ N L P+ + F
Sbjct: 78 ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAV---------------FD--------RLVH 113
Query: 172 LETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFD 231
L+ L + + +P + L L L L N L +LSS+ L N +D
Sbjct: 114 LKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 35/133 (26%), Positives = 57/133 (42%), Gaps = 11/133 (8%)
Query: 414 RVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLT---GGITDDIASSTSLSFIDISRNHL 470
+ + +NQ++ P F L L+ L L +N L G+ D + T L+ +D+ N L
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSL---TQLTVLDLGTNQL 100
Query: 471 RSSLPSTIL-SIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSI-AS 528
+ LPS + + +L+ + N L E+P + L+ L L N SIP
Sbjct: 101 -TVLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIPHGAFDR 157
Query: 529 CEKLVNLNLRNNQ 541
L + L N
Sbjct: 158 LSSLTHAYLFGNP 170
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 56/242 (23%), Positives = 91/242 (37%), Gaps = 65/242 (26%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVK-----KLWRSRADLETESSGDFVGEVNVLGKLRHR 766
+G G G V + AVK K + A +E ++L K+++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----------ADILKKIQND 91
Query: 767 -----NIVRLLG-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVA 820
NIV+ G F++ D +M +++E + SL E + ++ + + +
Sbjct: 92 DINNNNIVKYHGKFMYYD-HMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKL--YCIEIL 147
Query: 821 QGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP-------------------------RIA 855
+ L YL + H D+K NILLD ++
Sbjct: 148 KALNYLR-KM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 856 DFGLARMMIRKNETVSMVAGSYGYIAPE----YGYTLKVDEKIDIYSFGVVLLELLTGRR 911
DFG A K++ + + Y APE G+ D D++SFG VL EL TG
Sbjct: 205 DFGCA---TFKSDYHGSIINTRQYRAPEVILNLGW----DVSSDMWSFGCVLAELYTG-S 256
Query: 912 PL 913
L
Sbjct: 257 LL 258
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 61.9 bits (149), Expect = 4e-10
Identities = 26/161 (16%), Positives = 58/161 (36%), Gaps = 21/161 (13%)
Query: 448 GGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQ--DC 505
++ + + L+ + I ++L PNL++ + + L + + D
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 506 PSLSVLDL---SSNYFSGSIPSSIA------SCEKLVNLNLRNNQLTGDIPKAIS---MM 553
P+L L L +Y + L L + + + + + ++
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 554 PTLAILDLSNNSLTGG----IPENFGASPALEVLNVSYNRL 590
P L +D+S LT + ++ L+ +N+ YN L
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.4 bits (127), Expect = 2e-07
Identities = 24/151 (15%), Positives = 59/151 (39%), Gaps = 21/151 (13%)
Query: 241 LTNLKYLDLAVGNLGGKIPAELG-----RLELLEIMFLYQNNFQGRLPAEI-------GN 288
NLK L++ G L + ++ LE L +++ ++ +
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLV-LYVGVEDYGFDGDMNVFRPLFSKDR 250
Query: 289 ITSLQLLDLSYNMLSHEIP---AEITQLKNLQLLNLMCNQLSG----HVPAGLGGLTQLE 341
+L+ L + + + E L L+ +++ L+ + + + L+
Sbjct: 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLK 310
Query: 342 VLELWNNSLSGPLPVDLGKNSPLQWLDLSSN 372
+ + N LS + +L K+ P++ +D+S +
Sbjct: 311 FINMKYNYLSDEMKKELQKSLPMK-IDVSDS 340
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.9 bits (123), Expect = 6e-07
Identities = 29/215 (13%), Positives = 61/215 (28%), Gaps = 43/215 (20%)
Query: 337 LTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGG--NLTKLILF 394
L + +L + L + L+ L++ S + + NL KL+L+
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 395 NNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDI 454
++ L R L+ L + + + +
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSK---------------DRFPNLKWLGIVDAEEQNVVVEMF 272
Query: 455 ASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNL----VGEIPDQFQDCPSLSV 510
S L P L+T +S L + D L
Sbjct: 273 LESDIL---------------------PQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311
Query: 511 LDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGD 545
+++ NY S + + + +++ ++Q D
Sbjct: 312 INMKYNYLSDEMKKELQKSLP-MKIDVSDSQEYDD 345
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 1e-06
Identities = 24/156 (15%), Positives = 57/156 (36%), Gaps = 20/156 (12%)
Query: 416 RMQNNQLSGTIPVGFG--RLEKLQRLELANNSLTGGITDDIASS-----TSLSFIDISRN 468
+ N ++ GT + G L+ LE+ + L + +DI S L +
Sbjct: 173 LLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVED 232
Query: 469 HLRSSLPSTILSI------PNLQTFIVSNNNLVGEIPD---QFQDCPSLSVLDLSSNYFS 519
+ + + PNL+ + + + + + P L +D+S+ +
Sbjct: 233 YGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292
Query: 520 GS----IPSSIASCEKLVNLNLRNNQLTGDIPKAIS 551
+ + + L +N++ N L+ ++ K +
Sbjct: 293 DEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQ 328
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 3e-04
Identities = 30/206 (14%), Positives = 60/206 (29%), Gaps = 43/206 (20%)
Query: 112 SSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNA-- 169
L L + L + + G L L ++ED+ +
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 170 TSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNE 229
+LE L L + L S + +++ + + E
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPL----FSKDRFP-----------NLKWLGIVDAE 263
Query: 230 FDGEIP---VEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEI 286
+ +E L L+ +D++ G L + L +
Sbjct: 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLL--------------------LDHV 303
Query: 287 GNITSLQLLDLSYNMLSHEIPAEITQ 312
I L+ +++ YN LS E+ E+ +
Sbjct: 304 DKIKHLKFINMKYNYLSDEMKKELQK 329
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 52/238 (21%), Positives = 86/238 (36%), Gaps = 61/238 (25%)
Query: 712 VIGMGATGIVYKA-EMPRLNTIVAVK-----KLWRSRADLETESSGDFVGEVNVLGKLRH 765
+G G G V + + R + VA+K +R A LE +NVL K++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----------INVLKKIKE 75
Query: 766 R------NIVRLLG-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALG 818
+ V + F + +M I +E + + E L + V A
Sbjct: 76 KDKENKFLCVLMSDWFNFHG-HMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHM--AYQ 131
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP-------------------RIADFGL 859
+ L +LH + + H D+K NIL ++ R+ADFG
Sbjct: 132 LCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 860 ARMMIRKNETVSMVAGSYGYIAPE----YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
A +E + + + Y PE G+ + D++S G +L E G L
Sbjct: 189 A---TFDHEHHTTIVATRHYRPPEVILELGW----AQPCDVWSIGCILFEYYRG-FTL 238
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 47/173 (27%), Positives = 61/173 (35%), Gaps = 48/173 (27%)
Query: 283 PAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGL-GGLTQLE 341
P I LDL N L +L +L L L N+L +P G+ LT L
Sbjct: 23 PTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLT 79
Query: 342 VLELWNNSLSGPLPVD----LGKNSPLQWLDLSSNSFSGEIPASLCNG-----GNLTKLI 392
L L N L LP L + L+ L L++N SL +G L L
Sbjct: 80 YLNLSTNQLQS-LPNGVFDKLTQ---LKELALNTNQLQ-----SLPDGVFDKLTQLKDLR 130
Query: 393 LFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANN 444
L NQL ++P G F RL LQ + L +N
Sbjct: 131 L------------------------YQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 45/182 (24%), Positives = 63/182 (34%), Gaps = 54/182 (29%)
Query: 170 TSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNE 229
LDL + + F L L L L GN +L S+ +
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGN-----------KLQSLPNGV----- 71
Query: 230 FDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEI-GN 288
F LT+L YL+ L N Q LP +
Sbjct: 72 --------FNKLTSLTYLN------------------------LSTNQLQ-SLPNGVFDK 98
Query: 289 ITSLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLELW 346
+T L+ L L+ N L +P + +L L+ L L NQL VP G LT L+ + L
Sbjct: 99 LTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLH 156
Query: 347 NN 348
+N
Sbjct: 157 DN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 57/182 (31%), Positives = 77/182 (42%), Gaps = 40/182 (21%)
Query: 63 CNWTGVWCNSNG--AV--------EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFS 112
C+ T V C S G +V LDL +L + F L SLT L L N L
Sbjct: 7 CSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-Q 65
Query: 113 SLPNSLAN-LTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATS 171
SLPN + N LTSL ++S N L S P G + + L T
Sbjct: 66 SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNG--------------------VFDKL---TQ 101
Query: 172 LETLDLRGSFFQGSIPV-SFKNLQKLKFLGLSGNNLTGKIPRE-LGQLSSMETMILAYNE 229
L+ L L + Q S+P F L +LK L L N L +P +L+S++ + L N
Sbjct: 102 LKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDNP 159
Query: 230 FD 231
+D
Sbjct: 160 WD 161
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 29/96 (30%), Positives = 43/96 (44%), Gaps = 11/96 (11%)
Query: 258 IPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEI-TQLKNL 316
IP ++ L L N F +P E+ N L L+DLS N +S + + + + L
Sbjct: 29 IPRDVTELYL------DGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80
Query: 317 QLLNLMCNQLSGHVPAGL-GGLTQLEVLELWNNSLS 351
L L N+L +P GL L +L L N +S
Sbjct: 81 LTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 30/116 (25%), Positives = 47/116 (40%), Gaps = 19/116 (16%)
Query: 290 TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGL-GGLTQLEVLELWNN 348
+ L L N + +P E++ K+L L++L N++S + +TQL L L N
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88
Query: 349 SLSGPLPV----DLGKNSPLQWLDLSSNSFSGEIP----ASLCNGGNLTKLILFNN 396
L +P L L+ L L N S +P L L+ L + N
Sbjct: 89 RLRC-IPPRTFDGLKS---LRLLSLHGNDIS-VVPEGAFNDL---SALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 38/154 (24%), Positives = 53/154 (34%), Gaps = 39/154 (25%)
Query: 63 CNWTGVWCNSNG----------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFS 112
C T V C++ G V +L L N V K LT ++L N + S
Sbjct: 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYL-DGNQFTLVPKELSNYKHLTLIDLSNNRI-S 67
Query: 113 SLPNSL-ANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATS 171
+L N +N+T L +S N L P F G S
Sbjct: 68 TLSNQSFSNMTQLLTLILSYNRLR-CIPPRT---------------FDGL--------KS 103
Query: 172 LETLDLRGSFFQGSIPV-SFKNLQKLKFLGLSGN 204
L L L G+ +P +F +L L L + N
Sbjct: 104 LRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 22/81 (27%), Positives = 37/81 (45%), Gaps = 3/81 (3%)
Query: 170 TSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNE 229
+ L L G+ F +P N + L + LS N ++ + ++ + T+IL+YN
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 230 FDGEIPVE-FGNLTNLKYLDL 249
IP F L +L+ L L
Sbjct: 90 L-RCIPPRTFDGLKSLRLLSL 109
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 24/108 (22%), Positives = 50/108 (46%), Gaps = 11/108 (10%)
Query: 414 RVRMQNNQLSGTIPVGFGRLEKLQRLELANN---SLTGGITDDIASSTSLSFIDISRNHL 470
+ + NQ + +P + L ++L+NN +L+ ++ T L + +S N L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNM---TQLLTLILSYNRL 90
Query: 471 RSSLPSTIL-SIPNLQTFIVSNNNLVGEIPD-QFQDCPSLSVLDLSSN 516
R +P + +L+ + N++ +P+ F D +LS L + +N
Sbjct: 91 R-CIPPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGAN 136
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 34/182 (18%), Positives = 62/182 (34%), Gaps = 39/182 (21%)
Query: 63 CNWTGVWCNSNG----------AVEKLDLSHMNLSGCVSD-HFQRLKSLTSLNLCCNGLF 111
C T V C++ +L L++ + + F++L L +N N +
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 112 SSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATS 171
+ + + ++ N L + + F G S
Sbjct: 71 DIEEGAFEGASGVNEILLTSNRLE-NVQHKM---------------FKGL--------ES 106
Query: 172 LETLDLRGSFFQGSIPV-SFKNLQKLKFLGLSGNNLTGKIPRE-LGQLSSMETMILAYNE 229
L+TL LR + + SF L ++ L L N +T + L S+ T+ L N
Sbjct: 107 LKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANP 164
Query: 230 FD 231
F+
Sbjct: 165 FN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 37/176 (21%), Positives = 66/176 (37%), Gaps = 32/176 (18%)
Query: 202 SGNNLTGKIPRELGQLSSMETMILAYNEFDG-EIPVEFGNLTNLKYLDLAVGNLGGKIPA 260
S L KIP + + L NEF E F L L+ ++ + N I
Sbjct: 19 SNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFS-NNKITDIEE 74
Query: 261 ELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEI-TQLKNLQLL 319
F+G + + + L+ N L + ++ L++L+ L
Sbjct: 75 ---------------GAFEG--------ASGVNEILLTSNRLE-NVQHKMFKGLESLKTL 110
Query: 320 NLMCNQLSGHVPAGL-GGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSF 374
L N+++ V GL+ + +L L++N ++ P L L+L +N F
Sbjct: 111 MLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 30/130 (23%), Positives = 49/130 (37%), Gaps = 3/130 (2%)
Query: 437 QRLELANNSLTG-GITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLV 495
L L NN T T L I+ S N + + ++++N L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 496 GEIPDQFQDCPSLSVLDLSSNYFSGSIPSSI-ASCEKLVNLNLRNNQLTGDIPKAISMMP 554
F+ SL L L SN + + + + L+L +NQ+T P A +
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLH 153
Query: 555 TLAILDLSNN 564
+L+ L+L N
Sbjct: 154 SLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 31/168 (18%), Positives = 61/168 (36%), Gaps = 35/168 (20%)
Query: 330 VPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSP-LQWLDLSSNSFSGEIPASLCNGGNL 388
+P + L L NN + + K P L+ ++ S+N + +I
Sbjct: 26 IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEE-------- 74
Query: 389 TKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLT 447
AF G S + + + +N+L + F LE L+ L L +N +T
Sbjct: 75 -------GAFEG-----AS---GVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT 118
Query: 448 ---GGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNN 492
+ +S+ + + N + + P ++ +L T + N
Sbjct: 119 CVGNDSFIGL---SSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 506 PSLSVLDLSSNYFSGSIPSSI-ASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNN 564
+ L L++N F+ + I +L +N NN++T A + + L++N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 565 SLTGGIPEN-FGASPALEVLNVSYNRLE 591
L + F +L+ L + NR+
Sbjct: 92 RLE-NVQHKMFKGLESLKTLMLRSNRIT 118
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 49/238 (20%), Positives = 86/238 (36%), Gaps = 61/238 (25%)
Query: 712 VIGMGATGIVYKA-EMPRLNTIVAVK-----KLWRSRADLETESSGDFVGEVNVLGKLRH 765
+G GA G V + + VAVK + A E + VL L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE----------IQVLEHLNT 70
Query: 766 R------NIVRLLG-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALG 818
V++L F H+ ++ IV+E + S + + +D + + A
Sbjct: 71 TDPNSTFRCVQMLEWFEHHG-HICIVFELLGL-STYDFIKENGFLPFRLDHIRKM--AYQ 126
Query: 819 VAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP-------------------RIADFGL 859
+ + + +LH + + H D+K NIL + ++ DFG
Sbjct: 127 ICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 860 ARMMIRKNETVSMVAGSYGYIAPE----YGYTLKVDEKIDIYSFGVVLLELLTGRRPL 913
A +E S + + Y APE G+ + D++S G +L+E G +
Sbjct: 184 A---TYDDEHHSTLVSTRHYRAPEVILALGW----SQPCDVWSIGCILIEYYLG-FTV 233
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 57/347 (16%), Positives = 103/347 (29%), Gaps = 55/347 (15%)
Query: 260 AELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLL 319
+ L+ LE + + L L Y + AE+ L +L+ L
Sbjct: 20 CPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEV--LSSLRQL 77
Query: 320 NLMCNQLSGHVPAGLGGL--------TQLEVLELWNNSLSGPLPVDLGK-NSPLQWLDLS 370
NL +++ P + L+ + L + L L + L L
Sbjct: 78 NLAGVRMT---PVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQ 134
Query: 371 SNSFSGEIPASLC-----NGGNLTKLILFNNAFSGP----IPVSLSTCHSLVRVRMQNNQ 421
NS E L + +T L L NN + + L+ S+ + + +
Sbjct: 135 LNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTG 194
Query: 422 LSGTIPVGFGRL-------EKLQRLELANNSLTGG----ITDDIASSTSLSFIDISRNHL 470
L G L +LQ L +A N + SL + + N L
Sbjct: 195 LG---DEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251
Query: 471 RSS----LPSTILSIPNLQTFIVS--NNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPS 524
S L + +VS V E LS + + N + +
Sbjct: 252 SSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSE-----YWSVILSEVQRNLNSWD---RA 303
Query: 525 SIASCEKLVNLNLRNNQLTGDIPKAISMM----PTLAILDLSNNSLT 567
+ +L+ +L +++ P + + + L S
Sbjct: 304 RVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 42/307 (13%), Positives = 92/307 (29%), Gaps = 62/307 (20%)
Query: 294 LLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVL----ELWNNS 349
LL + ++ I L L+ + +L L L+ L E N
Sbjct: 6 LLSAHNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQR 65
Query: 350 LSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLC-----NGGNLTKLILFNNAFSGPIPV 404
S S L+ L+L+ + + L ++ L +
Sbjct: 66 FS------AEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDP---- 115
Query: 405 SLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIAS-----STS 459
+ +L+ V + ++L L NSL D+
Sbjct: 116 --AGLRTLLPV-----------------FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQ 156
Query: 460 LSFIDISRNHLRSS----LPSTILSIPNLQTFIVSNNNL----VGEIPDQFQDCPSLSVL 511
++ + +S N L ++ L + ++ + + L + + Q L L
Sbjct: 157 ITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQEL 216
Query: 512 DLSSNYFSGS----IPSSIASCEKLVNLNLRNNQLT-------GDIPKAISMMPTLAILD 560
+++ N + + + L L+L N+L+ D+ A + +
Sbjct: 217 NVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSL 276
Query: 561 LSNNSLT 567
+++
Sbjct: 277 TEGTAVS 283
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 53/360 (14%), Positives = 94/360 (26%), Gaps = 82/360 (22%)
Query: 70 CNSNGAVEKLDLSHMNL-SGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLA-----NLTS 123
E LD + + L SL LNL + +A +
Sbjct: 43 RQVLPPSELLDHLFFHYEFQNQRFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHA 102
Query: 124 LKRFDVSQNFLNGSFPAGLGGAAG----LTFLNASGNNFSGFLLEDLG-----NATSLET 174
L +++ L+ PAGL L N+ +DL + + T
Sbjct: 103 LDEVNLASCQLD---PAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITT 159
Query: 175 LDLRGSFFQGS----IPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEF 230
L L + + + + L L L L L++ L N
Sbjct: 160 LRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG---DEGLELLAAQ----LDRN-- 210
Query: 231 DGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNIT 290
L+ L++A G L R ++
Sbjct: 211 -----------RQLQELNVAYNGAGDTAALALAR-------AAREH-------------P 239
Query: 291 SLQLLDLSYNMLSH-------EIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVL 343
SL+LL L +N LS ++ + + + L +
Sbjct: 240 SLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAV------SEYWSVILSEV 293
Query: 344 ELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNG----GNLTKLILFNNAFS 399
+ NS + ++ L DL + + P G + L+ +
Sbjct: 294 QRNLNSW---DRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 2e-08
Identities = 22/100 (22%), Positives = 37/100 (37%), Gaps = 2/100 (2%)
Query: 300 NMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAG-LGGLTQLEVLELWNNSLSGPLPVDL 358
+ + + +NL L + Q H+ L GL +L L + + L P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 359 GKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAF 398
L L+LS N+ + G +L +L+L N
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 19/94 (20%), Positives = 31/94 (32%), Gaps = 4/94 (4%)
Query: 283 PAEIGNITSLQLLDLSYNMLSHEIPAE-ITQLKNLQLLNLMCNQLSGHVPAG-LGGLTQL 340
+ +L L + + + L L+ L ++ + L V +L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRL 82
Query: 341 EVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSF 374
L L N+L L + LQ L LS N
Sbjct: 83 SRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 20/101 (19%), Positives = 38/101 (37%), Gaps = 2/101 (1%)
Query: 491 NNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPS-SIASCEKLVNLNLRNNQLTGDIPKA 549
+ + +L+ L + + + + +L NL + + L P A
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 550 ISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRL 590
P L+ L+LS N+L + +L+ L +S N L
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 25/119 (21%), Positives = 46/119 (38%), Gaps = 6/119 (5%)
Query: 379 PASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQ 437
P + C G+ + A L +L + ++N Q + + L +L+
Sbjct: 2 PDACCPHGSSGLRCTRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELR 59
Query: 438 RLELANNSLTGGITDDIASS-TSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLV 495
L + + L + D LS +++S N L SL + +LQ ++S N L
Sbjct: 60 NLTIVKSGLRF-VAPDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 24/112 (21%), Positives = 33/112 (29%), Gaps = 3/112 (2%)
Query: 408 TCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITD-DIASSTSLSFIDIS 466
H +R + E L L + N + D+ L + I
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 467 RNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYF 518
++ LR P P L +S N L Q SL L LS N
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG-LSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 6e-07
Identities = 21/97 (21%), Positives = 36/97 (37%), Gaps = 4/97 (4%)
Query: 377 EIPASLCNGGNLTKLILFNNAFSGPIP-VSLSTCHSLVRVRMQNNQLSGTIPVG-FGRLE 434
+ L NLT+L + N + L L + + + L + F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 435 KLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLR 471
+L RL L+ N+L ++ SL + +S N L
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 6e-06
Identities = 24/97 (24%), Positives = 36/97 (37%), Gaps = 4/97 (4%)
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFL-LEDLGNATSLETLDLRGSFFQGSIPV-SFKNLQ 194
L GA LT L L L DL L L + S + + +F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 195 KLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFD 231
+L L LS N L + + Q S++ ++L+ N
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 6e-06
Identities = 12/97 (12%), Positives = 28/97 (28%), Gaps = 4/97 (4%)
Query: 185 SIPVSFKNLQKLKFLGLSGNNLTGKIPRE-LGQLSSMETMILAYNEFDGEIPVE-FGNLT 242
+ L L + + L L + + + + + + F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 243 NLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQ 279
L L+L+ N + + + L+ + L N
Sbjct: 81 RLSRLNLS-FNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 22/111 (19%), Positives = 39/111 (35%), Gaps = 15/111 (13%)
Query: 62 HCNW-TGVWCNSNGA------------VEKLDLSHMNLSGCV-SDHFQRLKSLTSLNLCC 107
+ +G+ C +GA + +L + + + + L L +L +
Sbjct: 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 108 NGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNF 158
+GL P++ L R ++S N L S L L SGN
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 26/98 (26%), Positives = 43/98 (43%), Gaps = 13/98 (13%)
Query: 258 IPAELGRLELLEIMFLYQNNFQGRLPAE--IGNITSLQLLDLSYNMLSHEIPAEI-TQLK 314
IP L L +N GR+ ++ G + L L+L N L+ I
Sbjct: 27 IPLHTTELLL-------NDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78
Query: 315 NLQLLNLMCNQLSGHVPAGL-GGLTQLEVLELWNNSLS 351
++Q L L N++ + + GL QL+ L L++N +S
Sbjct: 79 HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 23/120 (19%), Positives = 49/120 (40%), Gaps = 15/120 (12%)
Query: 378 IPASLCNGGNLTKLILFNNAFSGPIPVSL-STCHSLVRVRMQNNQLSGTIPVG-FGRLEK 435
IP T+L+L +N L LV++ ++ NQL+ I F
Sbjct: 27 IPLHT------TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASH 79
Query: 436 LQRLELANN---SLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNN 492
+Q L+L N ++ + + L +++ N + +P + + +L + +++N
Sbjct: 80 IQELQLGENKIKEISNKMFLGL---HQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 40/161 (24%), Positives = 64/161 (39%), Gaps = 22/161 (13%)
Query: 402 IPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLS 461
+ +LST + + + N + I +E L+ L L N + I + A + +L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKK-IENLDAVADTLE 96
Query: 462 FIDISRNHLRSSLPSTILSIPNLQTFIVSNNNL--VGEIPDQFQDCPSLSVLDLSSNYFS 519
+ IS N + S S I + NL+ +SNN + GEI D+ L L L+ N
Sbjct: 97 ELWISYNQIAS--LSGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN--- 150
Query: 520 GSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILD 560
L N NN + + + +P L LD
Sbjct: 151 -----------PLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 23/95 (24%), Positives = 38/95 (40%), Gaps = 5/95 (5%)
Query: 497 EIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTL 556
++ + L LS+N I SS++ E L L+L N + I ++ TL
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95
Query: 557 AILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
L +S N + L VL +S N++
Sbjct: 96 EELWISYNQIA--SLSGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 34/142 (23%), Positives = 62/142 (43%), Gaps = 16/142 (11%)
Query: 261 ELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLN 320
+ E ++ ++ A + + + + L LS N + +I + ++ ++NL++L+
Sbjct: 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILS 76
Query: 321 LMCNQLSGHVPAGLGGLTQ-LEVLELWNN---SLSGPLPVDLGKNSPLQWLDLSSNSFS- 375
L N + L + LE L + N SLSG + K L+ L +S+N +
Sbjct: 77 LGRNLIK--KIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITN 129
Query: 376 -GEIPASLCNGGNLTKLILFNN 396
GEI L L L+L N
Sbjct: 130 WGEI-DKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 27/130 (20%), Positives = 53/130 (40%), Gaps = 7/130 (5%)
Query: 295 LDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPL 354
L + ++ A ++ LK + L L N + + L G+ L +L L N +
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE--KISSLSGMENLRILSLGRNLIKKIE 86
Query: 355 PVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVS-LSTCHSLV 413
+D ++ L+ L +S N + + + + NL L + NN + + L+ L
Sbjct: 87 NLDAVADT-LEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143
Query: 414 RVRMQNNQLS 423
+ + N L
Sbjct: 144 DLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 34/168 (20%), Positives = 70/168 (41%), Gaps = 16/168 (9%)
Query: 408 TCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISR 467
T +R+ + + T EK++ L + + +++ + + +S
Sbjct: 6 TIKDAIRIFEERKSVVAT------EAEKVE-LHGMIPPIEK-MDATLSTLKACKHLALST 57
Query: 468 NHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIA 527
N++ S++ + NL+ + N + +I + +L L +S N + S+ S I
Sbjct: 58 NNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIE 112
Query: 528 SCEKLVNLNLRNNQLT--GDIPKAISMMPTLAILDLSNNSLTGGIPEN 573
L L + NN++T G+I ++ + L L L+ N L EN
Sbjct: 113 KLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 24/105 (22%), Positives = 43/105 (40%), Gaps = 6/105 (5%)
Query: 76 VEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLN 135
+ L LS N + +++L L+L N + + N A +L+ +S N +
Sbjct: 50 CKHLALST-NNIEKI-SSLSGMENLRILSLGRNLI-KKIENLDAVADTLEELWISYNQI- 105
Query: 136 GSFPAGLGGAAGLTFLNASGNNFSGFL-LEDLGNATSLETLDLRG 179
+ +G+ L L S N + + ++ L LE L L G
Sbjct: 106 -ASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAG 149
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 34/118 (28%), Positives = 48/118 (40%), Gaps = 10/118 (8%)
Query: 283 PAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGL-GGLTQLE 341
P I +S L+L N L +L L L+L NQ+ +P G+ LT+L
Sbjct: 23 PTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLT 79
Query: 342 VLELWNNSLSGPLPV---DLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNN 396
+L L N L LP D K + L+ L L +N +L K+ L N
Sbjct: 80 ILYLHENKLQS-LPNGVFD--KLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 40/154 (25%), Positives = 59/154 (38%), Gaps = 38/154 (24%)
Query: 63 CNWTGVWCNSNG--AV--------EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFS 112
C+ T + CNS G +V +L+L L F +L LT L+L N +
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-Q 65
Query: 113 SLPNSL-ANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATS 171
SLP+ + LT L + +N L S P G+ F T
Sbjct: 66 SLPDGVFDKLTKLTILYLHENKLQ-SLPNGV---------------FD--------KLTQ 101
Query: 172 LETLDLRGSFFQGSIPV-SFKNLQKLKFLGLSGN 204
L+ L L + + S+P F L L+ + L N
Sbjct: 102 LKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 31/110 (28%), Positives = 47/110 (42%), Gaps = 5/110 (4%)
Query: 288 NITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWN 347
++ L L + N ++ + + L+ L+ + L+ A L L +L+ LEL +
Sbjct: 18 DVKELVLDNSRSNEG--KLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELSD 73
Query: 348 NSLSGPLPVDLGKNSPLQWLDLSSNSFSG-EIPASLCNGGNLTKLILFNN 396
N +SG L V K L L+LS N L NL L LFN
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 7e-07
Identities = 23/89 (25%), Positives = 33/89 (37%), Gaps = 3/89 (3%)
Query: 480 SIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRN 539
L+ N L I L L+LS N SG + C L +LNL
Sbjct: 40 EFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSG 97
Query: 540 NQLTG-DIPKAISMMPTLAILDLSNNSLT 567
N++ + + + L LDL N +T
Sbjct: 98 NKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 23/90 (25%), Positives = 42/90 (46%), Gaps = 3/90 (3%)
Query: 503 QDCPSLSVLDLSSNYFS-GSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDL 561
+ + L L ++ + G + E+L L+ N LT I + + L L+L
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLEL 71
Query: 562 SNNSLTGGIPENFGASPALEVLNVSYNRLE 591
S+N ++GG+ P L LN+S N+++
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 31/132 (23%), Positives = 64/132 (48%), Gaps = 9/132 (6%)
Query: 387 NLTKLILFNNAFS-GPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNS 445
++ +L+L N+ + G + L + N L+ +I +L KL++LEL++N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNR 75
Query: 446 LTGGITDDIASSTSLSFIDISRNHLRS-SLPSTILSIPNLQTFIVSNNNLVGEIPD---- 500
++GG+ +L+ +++S N ++ S + + NL++ + N V + D
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCE-VTNLNDYREN 134
Query: 501 QFQDCPSLSVLD 512
F+ P L+ LD
Sbjct: 135 VFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 25/111 (22%), Positives = 47/111 (42%), Gaps = 4/111 (3%)
Query: 168 NATSLETLDLRGSFFQ-GSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILA 226
+ ++ L L S G + ++L+FL LT I L +L+ ++ + L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 227 YNEFDGEIPVEFGNLTNLKYLDLAVGNLGG-KIPAELGRLELLEIMFLYQN 276
N G + V NL +L+L+ + L +LE L+ + L+
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 28/114 (24%), Positives = 45/114 (39%), Gaps = 10/114 (8%)
Query: 240 NLTNLKYLDLA-VGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNI---TSLQLL 295
+++K L L + GK+ E LE + I N+ L+ L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKL 69
Query: 296 DLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSG-HVPAGLGGLTQLEVLELWNN 348
+LS N +S + + NL LNL N++ L L L+ L+L+N
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 30/107 (28%), Positives = 47/107 (43%), Gaps = 4/107 (3%)
Query: 75 AVEKLDLS-HMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNF 133
V++L L + G + + L L+ GL +S+ N L L LK+ ++S N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSIAN-LPKLNKLKKLELSDNR 75
Query: 134 LNGSFPAGLGGAAGLTFLNASGNNFSGFL-LEDLGNATSLETLDLRG 179
++G LT LN SGN +E L +L++LDL
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFN 122
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 23/88 (26%), Positives = 36/88 (40%), Gaps = 5/88 (5%)
Query: 482 PNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQ 541
NL+ + N L+ + P L L+LS N G + L +LNL N+
Sbjct: 49 VNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNK 106
Query: 542 LT--GDIPKAISMMPTLAILDLSNNSLT 567
L + + + + L LDL N +T
Sbjct: 107 LKDISTL-EPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 33/126 (26%), Positives = 51/126 (40%), Gaps = 10/126 (7%)
Query: 277 NFQGRLPAEIGNITSLQL----LDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPA 332
+ + R+ E+ N T + LD + +I + NL+ L+L+ L +
Sbjct: 9 DMKRRIHLELRNRTPAAVRELVLDNCKSNDG-KIEGLTAEFVNLEFLSLINVGLI--SVS 65
Query: 333 GLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFS--GEIPASLCNGGNLTK 390
L L +L+ LEL N + G L + K L L+LS N + L L
Sbjct: 66 NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKS 124
Query: 391 LILFNN 396
L LFN
Sbjct: 125 LDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 3/90 (3%)
Query: 503 QDCPSLSVLDLSSNYFS-GSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDL 561
+ ++ L L + + G I A L L+L N L + + +P L L+L
Sbjct: 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLEL 78
Query: 562 SNNSLTGGIPENFGASPALEVLNVSYNRLE 591
S N + GG+ P L LN+S N+L+
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 4/107 (3%)
Query: 75 AVEKLDLSHMNLS-GCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNF 133
AV +L L + + G + +L L+L GL S+ N L L LK+ ++S+N
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISVSN-LPKLPKLKKLELSENR 82
Query: 134 LNGSFPAGLGGAAGLTFLNASGNNFSGFL-LEDLGNATSLETLDLRG 179
+ G LT LN SGN LE L L++LDL
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFN 129
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 27/112 (24%), Positives = 45/112 (40%), Gaps = 6/112 (5%)
Query: 168 NATSLETLDLRGSFFQ-GSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILA 226
++ L L G I L+FL L L + L +L ++ + L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 227 YNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIP--AELGRLELLEIMFLYQN 276
N G + + L NL +L+L+ GN I L +LE L+ + L+
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLS-GNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 6e-05
Identities = 30/132 (22%), Positives = 60/132 (45%), Gaps = 9/132 (6%)
Query: 387 NLTKLILFNNAFS-GPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNS 445
+ +L+L N + G I + +L + + N L ++ +L KL++LEL+ N
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSENR 82
Query: 446 LTGGITDDIASSTSLSFIDISRNHLRSSLPSTILS-IPNLQTFIVSNNNLVGEIPD---- 500
+ GG+ +L+ +++S N L+ L + L++ + N + + D
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT-NLNDYRES 141
Query: 501 QFQDCPSLSVLD 512
F+ P L+ LD
Sbjct: 142 VFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 8e-05
Identities = 28/118 (23%), Positives = 46/118 (38%), Gaps = 12/118 (10%)
Query: 240 NLTNLKYLDL-AVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNI---TSLQLL 295
++ L L + GKI LE + L + N+ L+ L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKKL 76
Query: 296 DLSYNMLSHEIPAEITQLKNLQLLNLMCNQLS--GHVPAGLGGLTQLEVLELWNNSLS 351
+LS N + + +L NL LNL N+L + L L L+ L+L+N ++
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVT 133
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 39/219 (17%), Positives = 75/219 (34%), Gaps = 21/219 (9%)
Query: 380 ASLCNGGNLTKLILFNNAFS-GPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQR 438
A + + + L N+ + LS C L + ++ +LS I + L R
Sbjct: 87 AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVR 146
Query: 439 LELANNSLTGGITDD----IASS-TSLSFIDISRNHLRSSLPSTIL---SIPNLQTFIVS 490
L L+ S G ++ + SS + L +++S + + + +S
Sbjct: 147 LNLSGCS---GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203
Query: 491 NNNLVGEIPDQ-----FQDCPSLSVLDLSSNYF-SGSIPSSIASCEKLVNLNLRN-NQLT 543
+ + CP+L LDLS + L +L+L +
Sbjct: 204 G--YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII 261
Query: 544 GDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEV 582
+ + +PTL L + G + A P L++
Sbjct: 262 PETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 300
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 51/291 (17%), Positives = 94/291 (32%), Gaps = 37/291 (12%)
Query: 282 LPAEIGNITSLQLLDLSYNMLSHEIP-AEITQLKNLQLLNL-MCNQLSGHVPAGLGGLTQ 339
P G + S ++ + P AE +Q ++L + L ++
Sbjct: 60 HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSK 119
Query: 340 LEVLELWNNSLSGPLPVDLGKNSPLQWLDLSS-NSFSGEIPASLCNG-GNLTKLILFNNA 397
L+ L L LS P+ L KNS L L+LS + FS +L + L +L
Sbjct: 120 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL------ 173
Query: 398 FSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDD---- 453
+LS C +Q + E + +L L+ +
Sbjct: 174 -------NLSWCFDFTEKHVQVAVAHVS--------ETITQLNLSG--YRKNLQKSDLST 216
Query: 454 IASS-TSLSFIDISR-NHLRSSLPSTILSIPNLQTFIVSNNNLVGEI-PDQFQDCPSLSV 510
+ +L +D+S L++ + LQ +S + + + P+L
Sbjct: 217 LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 276
Query: 511 LDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDL 561
L + G++ + L +N + T I I +
Sbjct: 277 LQVFGIVPDGTLQLLKEALPHL-QINCSH--FTTIARPTIGNKKNQEIWGI 324
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 52/282 (18%), Positives = 90/282 (31%), Gaps = 35/282 (12%)
Query: 78 KLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSL-PNSLANLTSLKRFDVSQNFLNG 136
L L + V + RL S SL + +L P+ L S
Sbjct: 23 CLCLPELLKVSGVCKRWYRLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFM 82
Query: 137 SFP-AGLGGAAGLTFLNASGNNFSGFLLEDLGNA-TSLETLDLRGSFFQGSIPVSFKNLQ 194
P A + ++ S + L + + + L+ L L G I +
Sbjct: 83 DQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS 142
Query: 195 KLKFLGLSG-NNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLA--- 250
L L LSG + + + L + + L L+L+
Sbjct: 143 NLVRLNLSGCSGFSEFALQTLLS-----------------------SCSRLDELNLSWCF 179
Query: 251 -VGNLGGK--IPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSY-NMLSHEI 306
+ + + L + +N + L + +L LDLS ML ++
Sbjct: 180 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 239
Query: 307 PAEITQLKNLQLLNL-MCNQLSGHVPAGLGGLTQLEVLELWN 347
E QL LQ L+L C + LG + L+ L+++
Sbjct: 240 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 41/254 (16%), Positives = 77/254 (30%), Gaps = 15/254 (5%)
Query: 243 NLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNML 302
+ + + + + L + + LQ L L L
Sbjct: 71 GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 130
Query: 303 SHEIPAEITQLKNLQLLNL-MCNQLSGHVPAGLG-GLTQLEVLEL-WNNSLS-GPLPVDL 358
S I + + NL LNL C+ S L ++L+ L L W + + V +
Sbjct: 131 SDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 190
Query: 359 GKNSP-LQWLDLS--SNSFSGEIPASLCNG-GNLTKLIL-FNNAFSGPIPVSLSTCHSLV 413
S + L+LS + ++L NL L L + + L
Sbjct: 191 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 250
Query: 414 RVRMQN-NQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLS-----FIDISR 467
+ + + + G + L+ L++ G + + L F I+R
Sbjct: 251 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIAR 310
Query: 468 NHLRSSLPSTILSI 481
+ + I I
Sbjct: 311 PTIGNKKNQEIWGI 324
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 18/101 (17%), Positives = 39/101 (38%), Gaps = 4/101 (3%)
Query: 491 NNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAI 550
L+ + Q+ + LDL I + A+ ++ ++ +N++ +
Sbjct: 5 TAELIEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-F 60
Query: 551 SMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLE 591
++ L L ++NN + A P L L ++ N L
Sbjct: 61 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 23/117 (19%), Positives = 39/117 (33%), Gaps = 12/117 (10%)
Query: 237 EFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNI---TSLQ 293
++ N + LDL G I L+ + + N + ++ L+
Sbjct: 14 QYTNAVRDRELDLR-GYKIPVIENLGATLDQFDAIDFSDNEIR-----KLDGFPLLRRLK 67
Query: 294 LLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLS--GHVPAGLGGLTQLEVLELWNN 348
L ++ N + L +L L L N L G + L L L L + N
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 24/141 (17%), Positives = 44/141 (31%), Gaps = 30/141 (21%)
Query: 429 GFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFI 488
+ + + L+L + I + A+ ID S N +R +
Sbjct: 14 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK--------LDGFPL-- 62
Query: 489 VSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLT--GDI 546
L L +++N + L L L NN L GD+
Sbjct: 63 ----------------LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL 106
Query: 547 PKAISMMPTLAILDLSNNSLT 567
++ + +L L + N +T
Sbjct: 107 -DPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 25/115 (21%), Positives = 43/115 (37%), Gaps = 6/115 (5%)
Query: 284 AEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVL 343
A+ N + LDL + I L ++ N++ G L +L+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 69
Query: 344 ELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFS--GEIPASLCNGGNLTKLILFNN 396
+ NN + L L L++NS G++ L + +LT L + N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 24/118 (20%), Positives = 39/118 (33%), Gaps = 12/118 (10%)
Query: 260 AELGRLELLEIMFLYQNNFQGRLPAEIGNI----TSLQLLDLSYNMLSHEIPAEITQLKN 315
A+ + L I N+ +D S N + ++ L+
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRR 65
Query: 316 LQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVD-LGKNSPLQWLDLSSN 372
L+ L + N++ L L L L NNSL +D L L +L + N
Sbjct: 66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 25/121 (20%), Positives = 39/121 (32%), Gaps = 12/121 (9%)
Query: 332 AGLGGLTQLEVLELWNNSLSGPLPVDLGKNSP-LQWLDLSSNSFSGEIP--ASLCNGGNL 388
A + L+L + P+ +LG +D S N EI L
Sbjct: 13 AQYTNAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDN----EIRKLDGFPLLRRL 66
Query: 389 TKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLS--GTIPVGFGRLEKLQRLELANNSL 446
L++ NN L + + NN L G + L+ L L + N +
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRNPV 125
Query: 447 T 447
T
Sbjct: 126 T 126
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 3e-06
Identities = 102/763 (13%), Positives = 211/763 (27%), Gaps = 265/763 (34%)
Query: 266 ELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKN-----LQLLN 320
E E + Y++ A + N + D+ ++LS E I K+ L+L
Sbjct: 10 ETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFW 69
Query: 321 LMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPA 380
+ ++ V + + ++ L + P+ + P + + + +
Sbjct: 70 TLLSKQEEMVQKFVEEVLRINYKFLMS-------PIKTEQRQP----SMMTRMYIEQR-D 117
Query: 381 SLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPV----GFGR---- 432
L N N F+ VS + +R + + + + + G G+
Sbjct: 118 RLYND---------NQVFA-KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA 167
Query: 433 LEKLQ--RLELANNS----LTGG----ITDDIASSTSLSF-IDISRNHLRSSLPSTILSI 481
L+ +++ + L + L + ID + + L I
Sbjct: 168 LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227
Query: 482 PNLQTFIVSNNNLVGEIPDQFQDCPSLSVLD-LSS----NYFSGSIPSSIASCEKLVNLN 536
++Q + L+ +++C L VL + + N F+ S C+ L+
Sbjct: 228 HSIQAEL---RRLLKS--KPYENC--LLVLLNVQNAKAWNAFNLS-------CKILLTTR 273
Query: 537 LRN--NQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPAL--EVLNVSYNRLEG 592
+ + L+ IS LD + +LT P+ +L + L+ L
Sbjct: 274 FKQVTDFLSAATTTHIS-------LDHHSMTLT---PDE---VKSLLLKYLDCRPQDL-- 318
Query: 593 PVPANGVLRTINRGDLAGNAGLCGGVLHPCSRYSPIASSHRSLHAKHIIPGWMIAISSLF 652
P +P
Sbjct: 319 PREV------------------LTT--------NPRR----------------------- 329
Query: 653 AVGIAVFGA--RSLYKRWNANGSCFEEKLEMGKGEWPWRLMAFQRLGFTSADILACIRES 710
+++ R W+ W+ + +L L + +
Sbjct: 330 ---LSIIAESIRDGLATWD-----------------NWKHVNCDKLTTIIESSLNVLEPA 369
Query: 711 NVIGMGATGIVYK--AEMPR-LN-TIVAVKKLWRSRADLETESSGDFVGEVN---VLGKL 763
M + + P + + + +W D+ V +++ ++ K
Sbjct: 370 EYRKM------FDRLSVFPPSAHIPTILLSLIW---FDVIKSDVMVVVNKLHKYSLVEKQ 420
Query: 764 RHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGL 823
+ + + ++ + + + EY ALH R +VD YNI
Sbjct: 421 PKESTISIPS-IYLELKVKLENEY--------ALH-----RSIVD---HYNIPK------ 457
Query: 824 AYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE 883
+ D PP + D Y
Sbjct: 458 TFDSDDLIPP--YLD---------------------------------------QYFYSH 476
Query: 884 YGYTLKVDEKIDIYS-FGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942
G+ LK E + + F +V L+ ++ KIR D
Sbjct: 477 IGHHLKNIEHPERMTLFRMVFLDF------------------RFLEQKIR--------HD 510
Query: 943 PNVGNCKHVQEEMLLVLRI--AFLCTAKLPKDRPSMRDVITML 983
N L L+ ++C PK + ++ L
Sbjct: 511 STAWNASGSILNTLQQLKFYKPYICDND-PKYERLVNAILDFL 552
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 1e-04
Identities = 53/319 (16%), Positives = 93/319 (29%), Gaps = 96/319 (30%)
Query: 722 YKAEMPRL-NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN 780
Y + RL N K SR + L +LR V + G
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSRLQPYLKLR-------QALLELRPAKNVLIDG------- 157
Query: 781 MMIVYEYMNNGSLGEALHGKQ--AGRLLVD------------WVS--RYNIALGVAQGLA 824
++ GS GK A + + W++ N V + L
Sbjct: 158 -VL-------GS------GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ 203
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSN-LEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE 883
L + P R S+NI L + ++ L R++ K
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIHSIQAE-----LRRLLKSK----------------P 242
Query: 884 YGYTLKV-----DEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938
Y L V + K +F + LLT R F + D + +
Sbjct: 243 YENCLLVLLNVQNAKA-WNAFNLSCKILLTTR------FKQVTDFLSAATTTHISLDHHS 295
Query: 939 EALDPNVGNCKHVQEEML-LVLRIAFLCTAKLPKDRPSMRD----VITMLGEAKPRRKSS 993
L P +E+ L+L+ LP + ++++ E+ ++
Sbjct: 296 MTLTP---------DEVKSLLLKYLDCRPQDLP---REVLTTNPRRLSIIAESIRDGLAT 343
Query: 994 SNNDNRYENNKEKLVFSTS 1012
+N +K + +S
Sbjct: 344 WDNWKHVNCDKLTTIIESS 362
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 4e-04
Identities = 64/455 (14%), Positives = 120/455 (26%), Gaps = 164/455 (36%)
Query: 191 KNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNE----FDGEIP-VEFGN----- 240
L+ K + + G +GK + + + + D +I + N
Sbjct: 145 LELRPAKNVLIDGVLGSGK--------TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPE 196
Query: 241 -----LTNL------KYLDLAVGNLGGKIPAELGRLELLEIMFL--YQNNFQGRLPAEIG 287
L L + + + K+ + EL ++ Y+N
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN----------- 245
Query: 288 NITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMC------------NQLSG----HVP 331
L +L N+ + + NL C + LS H+
Sbjct: 246 ---CLLVLL---NVQNAKA---------WNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290
Query: 332 AG--LGGLTQLEVLEL---WNNSLSGPLPVDLGKNSPL-----------------QWLDL 369
LT EV L + + LP ++ +P W +
Sbjct: 291 LDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHV 350
Query: 370 SSNSFSGEIPASLCNGGNLT---------KLILFNNAFSGPIPVS--------------- 405
+ + + I +SL L +L +F S IP
Sbjct: 351 NCDKLTTIIESSL---NVLEPAEYRKMFDRLSVFPP--SAHIPTILLSLIWFDVIKSDVM 405
Query: 406 --LSTCHSLVRVRMQNNQLSGTIPVGFGRLEK------------LQRLELANNSLTGGIT 451
++ H V Q + + +IP + L+ + + + +
Sbjct: 406 VVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI 465
Query: 452 DDIASSTSLSFI-----DISRNHLRSSLPSTILSIPNLQTFI-------VSNNNLVGEIP 499
S I +I + L + + F+ + N G I
Sbjct: 466 PPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL---DFR-FLEQKIRHDSTAWNASGSIL 521
Query: 500 DQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVN 534
+ Q L Y + P E+LVN
Sbjct: 522 NTLQQ------LKFYKPYICDNDPKY----ERLVN 546
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 7e-04
Identities = 81/505 (16%), Positives = 148/505 (29%), Gaps = 141/505 (27%)
Query: 63 CNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNG------------- 109
C V C + + L+L + N V + Q+L N
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 110 ------LFSS--LPNSL------ANLTSLKRFDVSQNFL----NGSFPAGLGGAAGLTFL 151
L S N L N + F++S L L A T
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAA---TTT 287
Query: 152 NASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIP 211
+ S ++ S L D E L LK+L +L P
Sbjct: 288 HISLDHHSMTLTPD-------EVKSL---L--------------LKYLDCRPQDL----P 319
Query: 212 RELGQLSSME-TMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEI 270
RE+ + ++I I N K+++ L I + L LE E
Sbjct: 320 REVLTTNPRRLSIIAE------SIRDGLATWDNWKHVNCD--KLTTIIESSLNVLEPAE- 370
Query: 271 MFLYQNNFQ--GRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSG 328
Y+ F P +I ++ L + ++++ ++ + +L L+ + +
Sbjct: 371 ---YRKMFDRLSVFPPSA-HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426
Query: 329 HVPAGLGGLTQLEVLELWN---------NSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIP 379
+P + ++L N + + P D P +LD F I
Sbjct: 427 SIP----SIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPP-YLD---QYFYSHIG 478
Query: 380 ASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLE-KLQR 438
L N + ++ LF F + F LE K++
Sbjct: 479 HHLKNIEHPERMTLFRMVF-----------------------------LDFRFLEQKIRH 509
Query: 439 LELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVS-NNNLVGE 497
A N+ +G I + L + + ++ + P + + F+ NL+
Sbjct: 510 DSTAWNA-SGSILNT------LQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLI-- 560
Query: 498 IPDQFQDCPSLSVLDLSSNYFSGSI 522
+L ++ +I
Sbjct: 561 ------CSKYTDLLRIALMAEDEAI 579
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 9e-06
Identities = 30/174 (17%), Positives = 59/174 (33%), Gaps = 39/174 (22%)
Query: 713 IGMGATGIVYKAE--------MPRLNTIVAVK------KLWRSRADLETESSGDFVGEVN 758
GI+Y+A ++K +L+ + + + V +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 759 VLGKLRHRNIVRLLGF-LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSR----- 812
L I +GF +H D +V LG +L +D +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPS-----LGRSLQS------ALDVSPKHVLSE 158
Query: 813 ---YNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRI--ADFGLAR 861
+A + L +LH + Y +H ++ + NI +D + ++ A +G A
Sbjct: 159 RSVLQVACRLLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 39/167 (23%), Positives = 66/167 (39%), Gaps = 25/167 (14%)
Query: 713 IGMGATGIVYKAEMP-----RLNTIVAVKKLWRSRADLETES-------SGDFVGEVNVL 760
IG G G +Y A+M + VK L TE + + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 761 GKLRHRNIVRLLGF-LHNDTNMMIVYEYMNNGSLG---EALHGKQAGRLLVDWVSRYNIA 816
KL++ + + G LH+ Y +M G + ++ A R V ++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKS--YRFMIMDRFGSDLQKIYEANAKRFSRKTV--LQLS 158
Query: 817 LGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRI--ADFGLAR 861
L + L Y+H Y +H DIK++N+LL+ ++ D+GLA
Sbjct: 159 LRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 26/70 (37%), Positives = 36/70 (51%), Gaps = 4/70 (5%)
Query: 282 LPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGL-GGLTQL 340
+PA I T Q L L+ N ++ P L NLQ L N+L+ +P G+ LTQL
Sbjct: 27 VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQL 83
Query: 341 EVLELWNNSL 350
L+L +N L
Sbjct: 84 TQLDLNDNHL 93
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 36/168 (21%), Positives = 59/168 (35%), Gaps = 30/168 (17%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRAD---LETE-------SSGDFVGEVNVLGK 762
IG G G++Y A A + + L +E + D + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 763 LRHRNIVRLLGF-----LHNDTNMMIVYEYMNNGSLGEALHG--KQAGRLLVDWVSRYNI 815
L + I G M+ M LG L Q G V +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMV----ME--RLGIDLQKISGQNGTFKKSTV--LQL 156
Query: 816 ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRI--ADFGLAR 861
+ + L Y+H + Y +H DIK+ N+LL ++ AD+GL+
Sbjct: 157 GIRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 26/70 (37%), Positives = 37/70 (52%), Gaps = 4/70 (5%)
Query: 282 LPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGL-GGLTQL 340
+P I T+ Q+L L N ++ P +L L L+L NQL+ +PAG+ LTQL
Sbjct: 24 VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQL 80
Query: 341 EVLELWNNSL 350
L L +N L
Sbjct: 81 TQLSLNDNQL 90
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 26/109 (23%), Positives = 41/109 (37%), Gaps = 19/109 (17%)
Query: 466 SRNHLRSSLPSTILSIPNLQTFIVSNNNL--VGEIPDQFQDCPSLSVLDLSSNYFSGSIP 523
R+ + ++L +IP L + +SNN L + ++ Q P+L +L+LS N
Sbjct: 154 RRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNEL----- 208
Query: 524 SSIASCEKLVNLNLR-----NNQLTGDIP-------KAISMMPTLAILD 560
S +K+ L L N L P L LD
Sbjct: 209 KSERELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 40/159 (25%), Positives = 56/159 (35%), Gaps = 27/159 (16%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG--DFVGEVNVLGKLRH-RNIV 769
IG G G + + N VA+K LE S E +L I
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK--------LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 770 RLLGF-LHNDTNMMIVYEYMNNG-SLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
++ F N M V E + G SL E L + V IA+ + + Y+H
Sbjct: 69 QVYYFGPCGKYNAM-VLELL--GPSL-EDLFDLCDRTFSLKTVLM--IAIQLISRMEYVH 122
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPR-----IADFGLAR 861
I+RD+K N L+ I DF LA+
Sbjct: 123 SKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 35/157 (22%), Positives = 59/157 (37%), Gaps = 23/157 (14%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGD--FVGEVNVLGKLRH-RNIV 769
IG G+ G +Y VA+K E + E + ++ I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL--------ECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 770 RLLGFLHNDTNMMIVYEYMNNG-SLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
+ ++V E + G SL E L + + + V +A + + Y+H
Sbjct: 69 TIRWCGAEGDYNVMVMELL--GPSL-EDLFNFCSRKFSLKTVLL--LADQMISRIEYIHS 123
Query: 829 DCYPPIIHRDIKSNNILLDSNLEP---RIADFGLARM 862
+ IHRD+K +N L+ + I DFGLA+
Sbjct: 124 KNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 32/157 (20%), Positives = 59/157 (37%), Gaps = 21/157 (13%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH-RNIVRL 771
IG G+ G++++ N VA+K R +++ E L I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQ-LRDEYRTYKLLAGCTGIPNV 71
Query: 772 LGFLHNDTNMMIVYEYMNNG-SLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
F + ++V + + G SL E L + V V+ A + + +H
Sbjct: 72 YYFGQEGLHNVLVIDLL--GPSL-EDLLDLCGRKFSVKTVAM--AAKQMLARVQSIHEKS 126
Query: 831 YPPIIHRDIKSNNILLDSNLEPR-----IADFGLARM 862
++RDIK +N L+ + DFG+ +
Sbjct: 127 L---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 51/218 (23%), Positives = 84/218 (38%), Gaps = 38/218 (17%)
Query: 713 IGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGD--FVGEVNVLGKLR-HRNIV 769
IG G+ G +Y + N VA+K E + + E + L+ I
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 770 RLLGFLHNDTNMMIVYEYMNNG-SLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
+ F ++V + + G SL E L + +L + V +A + + ++H
Sbjct: 67 NVRWFGVEGDYNVLVMDLL--GPSL-EDLFNFCSRKLSLKTVLM--LADQMINRVEFVHS 121
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPR---IADFGLAR--------MMIRKNETVSMVAGSY 877
+ +HRDIK +N L+ I DFGLA+ I E ++ G+
Sbjct: 122 KSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT-GTA 177
Query: 878 GY--IAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRP 912
Y + G + D D+ S G VL+ L G P
Sbjct: 178 RYASVNTHLGIEQSRRD---DLESLGYVLMYFLRGSLP 212
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1018 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-26 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-24 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-24 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-24 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.001 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-12 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 7e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 7e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 8e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 2e-65
Identities = 79/278 (28%), Positives = 125/278 (44%), Gaps = 29/278 (10%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
IG G+ G VYK + + VAVK L + + F EV VL K RH NI+
Sbjct: 14 QRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQ--AFKNEVGVLRKTRHVNILL 68
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
+G+ + IV ++ SL LH + + + + +IA AQG+ YLH
Sbjct: 69 FMGY-STAPQLAIVTQWCEGSSLYHHLHIIE-TKF--EMIKLIDIARQTAQGMDYLHA-- 122
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM--VAGSYGYIAPEY---G 885
IIHRD+KSNNI L +L +I DFGLA + R + + ++GS ++APE
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945
+ D+Y+FG+VL EL+TG+ P +++ + I + +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYS-----NINNRDQIIFMVGRGYLSPDLSKVR- 235
Query: 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
+ + M R+ C K +RP ++ +
Sbjct: 236 ---SNCPKAM---KRLMAECLKKKRDERPLFPQILASI 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 6e-61
Identities = 63/298 (21%), Positives = 125/298 (41%), Gaps = 37/298 (12%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
+ + +G G G+V+K ++A K + +++ + E+ VL +
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLI---HLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
IV G ++D + I E+M+ GSL + L +AGR+ +++ V +GL YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRI--PEQILGKVSIAVIKGLTYLR 121
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYT 887
I+HRD+K +NIL++S E ++ DFG++ +I + + G+ Y++PE
Sbjct: 122 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQG 177
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGN 947
+ DI+S G+ L+E+ GR P+ P + ++++ +++ P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 948 CKHVQEEMLLVLRIAFL--------------------------CTAKLPKDRPSMRDV 979
+ + + L C K P +R ++ +
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 6e-60
Identities = 72/274 (26%), Positives = 127/274 (46%), Gaps = 29/274 (10%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G G G V+ +T VAVK L + + F+ E N++ +L+H+ +VR
Sbjct: 19 ERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 72
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L + + + I+ EYM NGSL + L +L ++A +A+G+A++
Sbjct: 73 LYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKL--TINKLLDMAAQIAEGMAFIEERN 129
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI-RKNETVSMVAGSYGYIAPEYGYTLK 889
IHRD+++ NIL+ L +IADFGLAR++ + + APE
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 890 VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949
K D++SFG++L E++T R P ++++ + R R
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGYRMVRP------------D 233
Query: 950 HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
+ EE+ ++ LC + P+DRP+ + ++L
Sbjct: 234 NCPEEL---YQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 8e-60
Identities = 73/297 (24%), Positives = 116/297 (39%), Gaps = 35/297 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
IG G G V++ + VAVK E S E+ LRH NI+
Sbjct: 10 SIGKGRFGEVWRGKWR--GEEVAVKIF-----SSREERSWFREAEIYQTVMLRHENILGF 62
Query: 772 LGFLHND----TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
+ + D T + +V +Y +GSL + L+ V +AL A GLA+LH
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLH 117
Query: 828 HDCY-----PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM----VAGSYG 878
+ P I HRD+KS NIL+ N IAD GLA +T+ + G+
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 879 YIAPEY------GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIR---- 928
Y+APE + ++ DIY+ G+V E+ + + +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 929 MKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985
++ E+ L PN+ N E + ++ +I C R + + L +
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 2e-58
Identities = 66/274 (24%), Positives = 105/274 (38%), Gaps = 23/274 (8%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
IG G+ G K I+ K+L + V EVN+L +L+H NIVR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 771 LLGFLHNDTN--MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH- 827
+ + TN + IV EY G L + R +D + + L H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 828 -HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGY 886
D ++HRD+K N+ LD ++ DFGLAR++ G+ Y++PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN 187
Query: 887 TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG 946
+ +EK DI+S G +L EL P ++ IR R + +
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKF--RRIPYRYSDELN 243
Query: 947 NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
++ R RPS+ +++
Sbjct: 244 E---------IITR----MLNLKDYHRPSVEEIL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (506), Expect = 9e-58
Identities = 67/296 (22%), Positives = 122/296 (41%), Gaps = 35/296 (11%)
Query: 697 GFTSADILACIRESNVIGMGATGIVYKAEMPRLN---TIVAVKKLWRSRADLETESSGDF 753
F ++C++ VIG G G V + VA+K L + + DF
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR---DF 74
Query: 754 VGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRY 813
+ E +++G+ H N++ L G + T +MI+ E+M NGSL L +
Sbjct: 75 LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF---TVIQLV 131
Query: 814 NIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMV 873
+ G+A G+ YL +HRD+ + NIL++SNL +++DFGL+R + +
Sbjct: 132 GMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 188
Query: 874 A-----GSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGES-VDIVEWI 927
+ + APE K D++S+G+V+ E+++ P + + D++ I
Sbjct: 189 SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PYWDMTNQDVINAI 246
Query: 928 RMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
R ++ + ++ C K RP ++ L
Sbjct: 247 EQDYRLPPPMDCPSA---------------LHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-57
Identities = 71/270 (26%), Positives = 117/270 (43%), Gaps = 28/270 (10%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G G G VY A + I+A+K L++++ + + EV + LRH NI+R
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILR 70
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L G+ H+ T + ++ EY G++ L + + D +A L+Y H
Sbjct: 71 LYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKF--DEQRTATYITELANALSYCHS-- 124
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
+IHRDIK N+LL S E +IADFG + + + + G+ Y+ PE
Sbjct: 125 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMIEGRMH 181
Query: 891 DEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKH 950
DEK+D++S GV+ E L G+ P + E + R + + +
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARD--- 233
Query: 951 VQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
L+ R P RP +R+V+
Sbjct: 234 ------LISR----LLKHNPSQRPMLREVL 253
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-57
Identities = 65/276 (23%), Positives = 116/276 (42%), Gaps = 29/276 (10%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
IG G G+V+ VA+K + E DF+ E V+ KL H +V+
Sbjct: 11 QEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSHPKLVQ 64
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L G + +V+E+M +G L + L ++ L + + L V +G + +
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEG---MAYLE 118
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM-VAGSYGYIAPEYGYTLK 889
+IHRD+ + N L+ N +++DFG+ R ++ T S + +PE +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 890 VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949
K D++SFGV++ E+ + + S ++VE I R P +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFRL-------YKP-----R 225
Query: 950 HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985
+ +I C + P+DRP+ ++ L E
Sbjct: 226 LASTHV---YQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (501), Expect = 3e-57
Identities = 70/278 (25%), Positives = 117/278 (42%), Gaps = 27/278 (9%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766
I + +G G G VY+ + + VAVK L ++E +F+ E V+ +++H
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-----EFLKEAAVMKEIKHP 73
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
N+V+LLG + I+ E+M G+L + L + V +A ++ + YL
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--SAVVLLYMATQISSAMEYL 131
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV-SMVAGSYGYIAPEYG 885
IHRD+ + N L+ N ++ADFGL+R+M T + + APE
Sbjct: 132 EK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945
K K D+++FGV+L E+ T P S + E + R R
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDYRMERP--------- 238
Query: 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
+ E++ + C P DRPS ++
Sbjct: 239 ---EGCPEKV---YELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (503), Expect = 3e-57
Identities = 82/325 (25%), Positives = 128/325 (39%), Gaps = 46/325 (14%)
Query: 698 FTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEV 757
F D + IG G+ G VY A R + +VA+KK+ E D + EV
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM-SYSGKQSNEKWQDIIKEV 66
Query: 758 NVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIAL 817
L KLRH N ++ G + +V EY + K+ + V +
Sbjct: 67 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTH 122
Query: 818 GVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSY 877
G QGLAYLH +IHRD+K+ NILL ++ DFG A +M N V G+
Sbjct: 123 GALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV----GTP 175
Query: 878 GYIAPEY---GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESV--DIVEWIRMKIR 932
++APE + D K+D++S G+ +EL + PL S I + ++
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ 235
Query: 933 DNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI-----------T 981
E + V C K+P+DRP+ ++ T
Sbjct: 236 SGHWSEYFRN--------------FVDS----CLQKIPQDRPTSEVLLKHRFVLRERPPT 277
Query: 982 MLGEAKPRRKSSSNNDNRYENNKEK 1006
++ + R K + + + K K
Sbjct: 278 VIMDLIQRTKDAVRELDNLQYRKMK 302
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 1e-56
Identities = 80/300 (26%), Positives = 128/300 (42%), Gaps = 49/300 (16%)
Query: 711 NVIGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH 765
IG GA G V++A P L T+VAVK L + + + DF E ++ + +
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDN 75
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQ--------------------AGRL 805
NIV+LLG M +++EYM G L E L G
Sbjct: 76 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135
Query: 806 LVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIR 865
+ + IA VA G+AYL +HRD+ + N L+ N+ +IADFGL+R +
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 866 KNETVSM--VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDI 923
+ + A ++ PE + + + D++++GVVL E+ + P +G +
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMA--- 247
Query: 924 VEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
E + +RD L + L + + LC +KLP DRPS + +L
Sbjct: 248 HEEVIYYVRDGNILAC-----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-56
Identities = 64/274 (23%), Positives = 112/274 (40%), Gaps = 33/274 (12%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
IG G G V + VAVK + ++ A + F+ E +V+ +LRH N+V+
Sbjct: 13 QTIGKGEFGDVMLGD--YRGNKVAVKCI-KNDATAQ-----AFLAEASVMTQLRHSNLVQ 64
Query: 771 LLG-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
LLG + + IV EYM GSL + L + GR ++ +L V + + YL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG- 121
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLK 889
+HRD+ + N+L+ + +++DFGL + + T + APE K
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKK 176
Query: 890 VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949
K D++SFG++L E+ + R P ++ + ++ ++
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRV--PYPRIP---LKDVVPRVEKGYKMDAP--------D 223
Query: 950 HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
+ + C RPS + L
Sbjct: 224 GCPPAV---YEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-56
Identities = 61/276 (22%), Positives = 112/276 (40%), Gaps = 29/276 (10%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G G G+V + R VA+K + + +F+ E V+ L H +V+
Sbjct: 10 KELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSED-----EFIEEAKVMMNLSHEKLVQ 63
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L G + I+ EYM NG L L + R + V + + YL
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRF--QTQQLLEMCKDVCEAMEYLES-- 118
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM-VAGSYGYIAPEYGYTLK 889
+HRD+ + N L++ +++DFGL+R ++ T S+ + PE K
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 890 VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949
K DI++FGV++ E+ + + F S + E I +R R
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETAEHIAQGLRLYRP------------H 224
Query: 950 HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985
E++ I + C + +RP+ + +++ + +
Sbjct: 225 LASEKV---YTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-56
Identities = 75/294 (25%), Positives = 125/294 (42%), Gaps = 33/294 (11%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766
+R +G G G V+ T VA+K L E F+ E V+ KLRH
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-----AFLQEAQVMKKLRHE 72
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
+V+L + + + IV EYM+ GSL + L G+ + ++A +A G+AY+
Sbjct: 73 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYV 129
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV-SMVAGSYGYIAPEYG 885
+HRD+++ NIL+ NL ++ADFGLAR++ T + APE
Sbjct: 130 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945
+ K D++SFG++L EL T R P ++++ + R P
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVE------RGYRMPCPPEC 239
Query: 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE----AKPRRKSSSN 995
+ + C K P++RP+ + L + +P+ + N
Sbjct: 240 PES---------LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-56
Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 30/279 (10%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766
++ IG G+ VYK VA +L + F E +L L+H
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ--RFKEEAEMLKGLQHP 68
Query: 767 NIVRLLGF----LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQG 822
NIVR + +++V E M +G+L L + + + + +G
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKG 124
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDS-NLEPRIADFGLARMMIRKNETVSMVAGSYGYIA 881
L +LH PPIIHRD+K +NI + +I D GLA + + V G+ ++A
Sbjct: 125 LQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMA 181
Query: 882 PEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941
PE Y K DE +D+Y+FG+ +LE+ T P + E + + R +
Sbjct: 182 PEM-YEEKYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYRRVTSGVKPASFD- 235
Query: 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
K E+ ++ C + +R S++D++
Sbjct: 236 -------KVAIPEVKEIIE---GCIRQNKDERYSIKDLL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 4e-56
Identities = 63/285 (22%), Positives = 113/285 (39%), Gaps = 33/285 (11%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLN---TIVAVKKLWRSRADLETESSGDFVGEVNVLGKL 763
+ + VIG G G VY + + AVK L R E F+ E ++
Sbjct: 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDF 85
Query: 764 RHRNIVRLLGF-LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQG 822
H N++ LLG L ++ + ++V YM +G L + V + + + +
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKG-- 142
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM----IRKNETVSMVAGSYG 878
+ +HRD+ + N +LD ++ADFGLAR M +
Sbjct: 143 ---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 879 YIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938
++A E T K K D++SFGV+L EL+T P V+ + ++ R L+
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGRRLLQ 255
Query: 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
++ + + + C + RPS ++++ +
Sbjct: 256 P---------EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-56
Identities = 76/285 (26%), Positives = 128/285 (44%), Gaps = 32/285 (11%)
Query: 706 CIRESNVIGMGATGIVYKAEMP----RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLG 761
C+ VIG G G VYK + + VA+K L + + DF+GE ++G
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV---DFLGEAGIMG 64
Query: 762 KLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ 821
+ H NI+RL G + MMI+ EYM NG+L + L K + + G+A
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAA 121
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE---TVSMVAGSYG 878
G+ YL + +HRD+ + NIL++SNL +++DFGL+R++ E T S
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 879 YIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938
+ APE K D++SFG+V+ E++T E ++++ I R ++
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGFRLPTPMD 237
Query: 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
+ ++ C + RP D++++L
Sbjct: 238 CPSA---------------IYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 4e-55
Identities = 61/276 (22%), Positives = 111/276 (40%), Gaps = 32/276 (11%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKL-WRSRADLETESSGDFVGEVNVLGKLRHRNIV 769
+G GA G VYKA+ + + A K + +S +LE D++ E+++L H NIV
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-----DYMVEIDILASCDHPNIV 72
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
+LL + + N+ I+ E+ G++ + + + + L YLH
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYLHD- 128
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY----- 884
IIHRD+K+ NIL + + ++ADFG++ R + G+ ++APE
Sbjct: 129 --NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 186
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944
D K D++S G+ L+E+ P + + + + P
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-----NPMRVLLKIAKSEP-------PT 234
Query: 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
+ L+ C K R + ++
Sbjct: 235 LAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLL 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 7e-55
Identities = 64/280 (22%), Positives = 110/280 (39%), Gaps = 31/280 (11%)
Query: 709 ESNVIGMGATGIVYKA--EMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR 766
E +G G G V K +M ++ VAVK L D + + + E NV+ +L +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 68
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
IVR++G + + M+V E G L + L + V + + V+ G+ YL
Sbjct: 69 YIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL 123
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM---IRKNETVSMVAGSYGYIAPE 883
+HRD+ + N+LL + +I+DFGL++ + + + + APE
Sbjct: 124 EE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943
K K D++SFGV++ E + + P G + + +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMK---GSEVTAMLEKGERMGCP--- 232
Query: 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
EM + LC ++RP V L
Sbjct: 233 -----AGCPREM---YDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 8e-55
Identities = 67/300 (22%), Positives = 121/300 (40%), Gaps = 48/300 (16%)
Query: 712 VIGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RH 765
V+G GA G V A ++ VAVK L E E + E+ ++ +L H
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE---ALMSELKMMTQLGSH 100
Query: 766 RNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQ-------------------AGRLL 806
NIV LLG + +++EY G L L K+ +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 807 VDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRK 866
+ + A VA+G+ +L +HRD+ + N+L+ +I DFGLAR ++
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 867 NETVSM--VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIV 924
+ V ++APE + K D++S+G++L E+ + P +
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277
Query: 925 EWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLG 984
+ I+ + ++ + EE+ ++++ C A + RPS ++ + LG
Sbjct: 278 KLIQNGFKMDQP------------FYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-54
Identities = 76/306 (24%), Positives = 128/306 (41%), Gaps = 38/306 (12%)
Query: 707 IRESNVIGMGATGIVYKAEMPRLNTI--VAVKKLWRSRADLETESSGDFVGEVNVLGKL- 763
I+ +VIG G G V KA + + A+K++ + + DF GE+ VL KL
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYASKDDHRDFAGELEVLCKLG 68
Query: 764 RHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQ------------AGRLLVDWVS 811
H NI+ LLG + + + EY +G+L + L + + +
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 812 RYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVS 871
+ A VA+G+ YL IHRD+ + NIL+ N +IADFGL+R + +
Sbjct: 129 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-T 184
Query: 872 MVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKI 931
M ++A E D++S+GV+L E+++ P G + + K+
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMT---CAELYEKL 239
Query: 932 RDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRK 991
LE+ L+ +E+ + C + P +RPS ++ L RK
Sbjct: 240 PQGYRLEKPLN--------CDDEV---YDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
Query: 992 SSSNND 997
+ N
Sbjct: 289 TYVNTT 294
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-54
Identities = 68/272 (25%), Positives = 104/272 (38%), Gaps = 28/272 (10%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G GA G V A VAVK + RA E + E+ + L H N+V+
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKMLNHENVVK 67
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
G + EY + G L + + + + G+ YLH
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM--VAGSYGYIAPEYGYTL 888
I HRDIK N+LLD +I+DFGLA + N + + G+ Y+APE
Sbjct: 124 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 889 KVD-EKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGN 947
+ E +D++S G+VL +L G P D + +W K N
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW----------- 229
Query: 948 CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDV 979
K + L +L + P R ++ D+
Sbjct: 230 -KKIDSAPLALLH---KILVENPSARITIPDI 257
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-54
Identities = 77/307 (25%), Positives = 116/307 (37%), Gaps = 46/307 (14%)
Query: 711 NVIGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-R 764
+G GA G V +A L VAVK L S E E + E+ VL L
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE---ALMSELKVLSYLGN 85
Query: 765 HRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGK--------------QAGRLLVDWV 810
H NIV LLG +++ EY G L L K + L +D
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 811 SRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV 870
+ + VA+G+A+L IHRD+ + NILL +I DFGLAR + + V
Sbjct: 146 DLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 871 --SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIR 928
++APE + + D++S+G+ L EL + P + I+
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262
Query: 929 MKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKP 988
R +H EM I C P RP+ + ++ ++ +
Sbjct: 263 EGFRMLSP------------EHAPAEM---YDIMKTCWDADPLKRPTFKQIVQLIEKQ-- 305
Query: 989 RRKSSSN 995
S+N
Sbjct: 306 -ISESTN 311
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-54
Identities = 61/276 (22%), Positives = 107/276 (38%), Gaps = 31/276 (11%)
Query: 713 IGMGATGIVYKAEMPRLNT--IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G G G V + VA+K L + +TE + + E ++ +L + IVR
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE---EMMREAQIMHQLDNPYIVR 73
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L+G +M+V E G L + L GK R + + + V+ G+ YL
Sbjct: 74 LIGVCQ-AEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEE-- 127
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV---SMVAGSYGYIAPEYGYT 887
+HRD+ + N+LL + +I+DFGL++ + + S + APE
Sbjct: 128 -KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGN 947
K + D++S+GV + E L+ + P + I + +E
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQK--PYKKMK---GPEVMAFIEQGKRMEC-------- 233
Query: 948 CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
E+ + C +DRP V +
Sbjct: 234 PPECPPEL---YALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 4e-54
Identities = 61/270 (22%), Positives = 114/270 (42%), Gaps = 27/270 (10%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
IG GA+G VY A VA++++ + + + E+ V+ + ++ NIV
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL----IINEILVMRENKNPNIVN 81
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L + +V EY+ GSL + + +D + Q L +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSNQ 136
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
+IHRDIKS+NILL + ++ DFG + + S + G+ ++APE
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 891 DEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKH 950
K+DI+S G++ +E++ G P E + + + + + P + N +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNE-----NPLRALYLIATNGT-------PELQNPEK 241
Query: 951 VQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
+ L C + R S ++++
Sbjct: 242 LSAIFRDFLN---RCLDMDVEKRGSAKELL 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-52
Identities = 76/283 (26%), Positives = 123/283 (43%), Gaps = 29/283 (10%)
Query: 711 NVIGMGATGIVYKAEMPRLN---TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
+G G+ G+V + E + VAVK L + E+ DF+ EVN + L HRN
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRN 72
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
++RL G + M +V E GSL + K G L+ +SRY A+ VA+G+ YL
Sbjct: 73 LIRLYGVVLTP-PMKMVTELAPLGSLLD-RLRKHQGHFLLGTLSRY--AVQVAEGMGYLE 128
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM---VAGSYGYIAPEY 884
IHRD+ + N+LL + +I DFGL R + + ++ M + + APE
Sbjct: 129 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944
T D + FGV L E+ T + + + + ++ L
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEGERLPRP---- 237
Query: 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987
+ +++ + C A P+DRP+ + L EA+
Sbjct: 238 ----EDCPQDI---YNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-51
Identities = 53/271 (19%), Positives = 105/271 (38%), Gaps = 28/271 (10%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
++G G+ V A + A+K L + E + E +V+ +L H V+
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVK 72
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L +D + Y NG L + + + G Y A+ ++ L +
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFY-----TAEIVSALEYLH 125
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM--VAGSYGYIAPEYGYTL 888
IIHRD+K NILL+ ++ +I DFG A+++ +++ G+ Y++PE
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 889 KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNC 948
+ D+++ G ++ +L+ G P + + I+ + E P
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAG-----NEYLIFQKIIKLEYDFPEKFFP---KA 237
Query: 949 KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDV 979
+ + E++L R ++
Sbjct: 238 RDLVEKLL----------VLDATKRLGCEEM 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 182 bits (463), Expect = 2e-51
Identities = 57/272 (20%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G GA G+V++ A K + + E+ + LRH +V L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET----VRKEIQTMSVLRHPTLVNL 88
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
+D M+++YE+M+ G L E + + ++ V +GL ++H +
Sbjct: 89 HDAFEDDNEMVMIYEFMSGGELFEKVA-DEHNKM--SEDEAVEYMRQVCKGLCHMHENN- 144
Query: 832 PPIIHRDIKSNNILLDS--NLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLK 889
+H D+K NI+ + + E ++ DFGL + K G+ + APE
Sbjct: 145 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEVAEGKP 201
Query: 890 VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG-NC 948
V D++S GV+ LL+G P E + E +R + N++++ + +
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGE-----NDDETLRNVKSCDWNMDDSAFSGISEDG 256
Query: 949 KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
K ++L P R ++ +
Sbjct: 257 KDFIRKLL----------LADPNTRMTIHQAL 278
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (451), Expect = 9e-50
Identities = 62/314 (19%), Positives = 121/314 (38%), Gaps = 34/314 (10%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G GA G+V++ + K + + E++++ +L H ++ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT----VKNEISIMNQLHHPKLINL 91
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
+ M+++ E+++ G L + + + + N +GL ++H
Sbjct: 92 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMHE--- 145
Query: 832 PPIIHRDIKSNNILLDSNLEPRI--ADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLK 889
I+H DIK NI+ ++ + DFGLA + +E V + + + APE
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLAT-KLNPDEIVKVTTATAEFAAPEIVDREP 204
Query: 890 VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG-NC 948
V D+++ GV+ LL+G P E D +E ++ R + +E +V
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGE-----DDLETLQNVKRCDWEFDEDAFSSVSPEA 259
Query: 949 KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDV-----ITMLGEAKPRRKSSSNNDNRYENN 1003
K + +L K P+ R ++ D + R SS + +
Sbjct: 260 KDFIKNLL----------QKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKI 309
Query: 1004 KEKLVFSTSPVSGL 1017
KEK +P +
Sbjct: 310 KEKYADWPAPQPAI 323
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-49
Identities = 66/302 (21%), Positives = 123/302 (40%), Gaps = 36/302 (11%)
Query: 707 IRESNVIGMGATGIVYKAEMPRL-----NTIVAVKKLWRSRADLETESSGDFVGEVNVLG 761
I S +G G+ G+VY+ + T VA+K + + + E +F+ E +V+
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVMK 78
Query: 762 KLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLV------DWVSRYNI 815
+ ++VRLLG + +++ E M G L L + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 816 ALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM--V 873
A +A G+AYL+ +HRD+ + N ++ + +I DFG+ R + +
Sbjct: 139 AGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 874 AGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD 933
+++PE D++SFGVVL E+ T P G S E + + +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLS---NEQVLRFVME 250
Query: 934 NRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML-GEAKPRRKS 992
L++ + + + + +C PK RPS ++I+ + E +P +
Sbjct: 251 GGLLDKP--------DNCPDML---FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
Query: 993 SS 994
S
Sbjct: 300 VS 301
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 7e-49
Identities = 62/300 (20%), Positives = 117/300 (39%), Gaps = 34/300 (11%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNT----IVAVKKLWRSRADLETESSGDFVGEVNVLGKL 763
++ V+G GA G VYK VA+K+L R +++ + + E V+ +
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEILDEAYVMASV 68
Query: 764 RHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGL 823
+ ++ RLLG + ++ + M G L L + + + N + +A+G+
Sbjct: 69 DNPHVCRLLGICLTS-TVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 824 AYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM--VAGSYGYIA 881
YL ++HRD+ + N+L+ + +I DFGLA+++ + + ++A
Sbjct: 125 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 882 PEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941
E + D++S+GV + EL+T P G I + L +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIP---ASEISSILEKGERLPQP- 235
Query: 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK--PRRKSSSNNDNR 999
++ I C RP R++I + P+R D R
Sbjct: 236 -------PICTIDV---YMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDER 285
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 3e-48
Identities = 64/285 (22%), Positives = 105/285 (36%), Gaps = 30/285 (10%)
Query: 712 VIGMGATGIVYKAEMPRLN---TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNI 768
IG G G V++ VA+K +D E F+ E + + H +I
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE---KFLQEALTMRQFDHPHI 70
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
V+L+G + + + I+ E G L + + L D S A ++ LAYL
Sbjct: 71 VKLIGVIT-ENPVWIIMELCTLGEL-RSFLQVRKYSL--DLASLILYAYQLSTALAYLES 126
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETV-SMVAGSYGYIAPEYGYT 887
+HRDI + N+L+ SN ++ DFGL+R M S ++APE
Sbjct: 127 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGN 947
+ D++ FGV + E+L P G + +I + L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVK--PFQGVK---NNDVIGRIENGERLPMP------- 231
Query: 948 CKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKS 992
+ + + C A P RP ++ L K+
Sbjct: 232 -PNCPPTL---YSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (432), Expect = 8e-48
Identities = 59/271 (21%), Positives = 108/271 (39%), Gaps = 24/271 (8%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+V+G GA V AE R +VA+K + + + + S E+ VL K++H NIV
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS---MENEIAVLHKIKHPNIVA 71
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L + ++ ++ + ++ G L + + K G SR + V + YLH
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASR--LIFQVLDAVKYLHDLG 127
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
+ LD + + I+DFGL++ M +S G+ GY+APE
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLAQKPY 186
Query: 891 DEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG-NCK 949
+ +D +S GV+ LL G P E + + ++ + ++ + K
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDE-----NDAKLFEQILKAEYEFDSPYWDDISDSAK 241
Query: 950 HVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
++ K P+ R + +
Sbjct: 242 DFIRHLM----------EKDPEKRFTCEQAL 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-47
Identities = 66/270 (24%), Positives = 115/270 (42%), Gaps = 25/270 (9%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
++G G+ G V+ AE + N A+K L + ++ + V + + H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
+ N+ V EY+N G L + + + + Y A + GL +LH
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFY--AAEIILGLQFLHSKG 123
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
I++RD+K +NILLD + +IADFG+ + + + + G+ YIAPE K
Sbjct: 124 ---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 891 DEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKH 950
+ +D +SFGV+L E+L G+ P + D E DN L+ +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQ-----DEEELFHSIRMDNPFYPRWLEKEAKD--- 232
Query: 951 VQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
L+++ + P+ R +R I
Sbjct: 233 ------LLVK----LFVREPEKRLGVRGDI 252
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 4e-47
Identities = 73/295 (24%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 711 NVIGMGATGIVYKAEMPRLN-------TIVAVKKLWRSRADLETESSGDFVGEVNVLGKL 763
+G GA G V AE L+ T VAVK L + + D + E+ ++ +
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMI 75
Query: 764 -RHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLL------------VDWV 810
+H+NI+ LLG D + ++ EY + G+L E L ++ L +
Sbjct: 76 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135
Query: 811 SRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM--IRKNE 868
+ A VA+G+ YL IHRD+ + N+L+ + +IADFGLAR + I +
Sbjct: 136 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 869 TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIR 928
+ ++APE + + D++SFGV+L E+ T P G VE +
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVP---VEELF 247
Query: 929 MKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITML 983
+++ +++ + E+ +++R C +P RP+ + ++ L
Sbjct: 248 KLLKEGHRMDK--------PSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 291
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 166 bits (420), Expect = 2e-46
Identities = 59/283 (20%), Positives = 109/283 (38%), Gaps = 36/283 (12%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGD-----FVGEVNVLGKLR- 764
++G G + +V + AVK + + + + EV++L K+
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 765 HRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLA 824
H NI++L +T +V++ M G L + L K + I + + +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVIC 124
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY 884
LH I+HRD+K NILLD ++ ++ DFG + + E + V G+ Y+APE
Sbjct: 125 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKLREVCGTPSYLAPEI 180
Query: 885 ------GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938
+++D++S GV++ LL G P + +RM + N
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-----KQMLMLRMIMSGNYQFG 235
Query: 939 EALDPNVG-NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
+ K + L P+ R + + +
Sbjct: 236 SPEWDDYSDTVKDLVSRFL----------VVQPQKRYTAEEAL 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-46
Identities = 56/270 (20%), Positives = 101/270 (37%), Gaps = 28/270 (10%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G G GIV++ K + D E+++L RHRNI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-----LVKKEISILNIARHRNILHL 66
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
+ +++++E+++ + E ++ A L + + V + L +LH
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERIN-TSAFEL--NEREIVSYVHQVCEALQFLHS--- 120
Query: 832 PPIIHRDIKSNNILLDSNLEPR--IADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLK 889
I H DI+ NI+ + I +FG AR + + + ++ + Y APE
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 890 VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949
V D++S G ++ LL+G P E + I + +E +
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAE-----TNQQIIENIMNAEYTFDEEAFKEIS--- 231
Query: 950 HVQEEMLLVLRIAFLCTAKLPKDRPSMRDV 979
E M V R K K R + +
Sbjct: 232 --IEAMDFVDR----LLVKERKSRMTASEA 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (419), Expect = 2e-46
Identities = 70/280 (25%), Positives = 114/280 (40%), Gaps = 30/280 (10%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
++G G V+ A RL+ VAVK L A + F E L H IV +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 772 LGFLHNDTN----MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
+T IV EY++ +L + +H G + +A L+
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEV-----IADACQALN 125
Query: 828 HDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM---VAGSYGYIAPEY 884
IIHRD+K NI++ + ++ DFG+AR + +V+ V G+ Y++PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 885 GYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944
VD + D+YS G VL E+LTG P + V +R++ A
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-----SPVSVAYQHVREDPIPPSARHEG 240
Query: 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRP-SMRDVITML 983
+ + +VL+ AK P++R + ++ L
Sbjct: 241 LS-----ADLDAVVLK----ALAKNPENRYQTAAEMRADL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 164 bits (416), Expect = 1e-45
Identities = 54/267 (20%), Positives = 97/267 (36%), Gaps = 29/267 (10%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+G G+ G V+ A+K L + + E +L + H I+R
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
+ G + + ++ +Y+ G L L Q A+ L +
Sbjct: 69 MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-------RFPNPVAKFYAAEVCLALEYLH 121
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
II+RD+K NILLD N +I DFG A+ + + + G+ YIAPE T
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVVSTKPY 178
Query: 891 DEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKH 950
++ ID +SFG+++ E+L G P + ++ + + + K
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDS-----NTMKTYEKILNAELRFPPFFNE---DVKD 230
Query: 951 VQEEMLLVLRIAFLCTAKLPKDRPSMR 977
+ ++ + R
Sbjct: 231 LLSRLI----------TRDLSQRLGNL 247
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-45
Identities = 61/292 (20%), Positives = 116/292 (39%), Gaps = 39/292 (13%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKL-WRSRADLETESSGDFVGEVNVLGKLRHRNIV 769
+ +G G VYKA N IVA+KK+ R++ + + + E+ +L +L H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
LL + +N+ +V+++M + + L + Y + L L +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAY-----MLMTLQGLEYL 116
Query: 830 CYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLK 889
I+HRD+K NN+LLD N ++ADFGLA+ N + + Y APE + +
Sbjct: 117 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 890 V-DEKIDIYSFGVVLLELLTGRRPL--------------------DPEFGESVDIVEWIR 928
+ +D+++ G +L ELL L + ++ + + +++
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 929 MKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
K L + + + + P R + +
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLF----------LFNPCARITATQAL 278
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 165 bits (418), Expect = 3e-45
Identities = 60/270 (22%), Positives = 104/270 (38%), Gaps = 27/270 (10%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLE--TESSGDFVGEVNVLGKLRHRNI 768
+IG G G VY + A+K L + R ++ + + ++++ I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 769 VRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH 828
V + H + + + MN G L L + A + GL ++H+
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN 125
Query: 829 DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYT- 887
+++RD+K NILLD + RI+D GLA + G++GY+APE
Sbjct: 126 ---RFVVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHASVGTHGYMAPEVLQKG 180
Query: 888 LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGN 947
+ D D +S G +L +LL G P ++ D E RM + L ++ P
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQH--KTKDKHEIDRMTLTMAVELPDSFSP---E 235
Query: 948 CKHVQEEMLLVLRIAFLCTAKLPKDRPSMR 977
+ + E +L + R
Sbjct: 236 LRSLLEGLL----------QRDVNRRLGCL 255
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 9e-45
Identities = 64/296 (21%), Positives = 111/296 (37%), Gaps = 42/296 (14%)
Query: 711 NVIGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH 765
+G GA G V +A+ ++ VAVK L E + E+ +L + H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR---ALMSELKILIHIGH 75
Query: 766 RNIVRLLG--FLHNDTNMMIVYEYMNNGSLGEALHGKQ------------AGRLLVDWVS 811
V L +M++ E+ G+L L K+ + +
Sbjct: 76 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 812 RYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVS 871
+ VA+G+ +L IHRD+ + NILL +I DFGLAR + + + V
Sbjct: 136 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 872 M--VAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRM 929
++APE + + D++SFGV+L E+ + P I E
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCR 248
Query: 930 KIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985
++++ + + EM + C P RP+ +++ LG
Sbjct: 249 RLKEGTRMRAP--------DYTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-44
Identities = 60/275 (21%), Positives = 109/275 (39%), Gaps = 28/275 (10%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG--DFVGEVNVLGKLRHRNIV 769
+G G +V K A K + + R D EV++L +++H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 770 RLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD 829
L N T+++++ E + G L + + L + + + + Q L +++
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFD--FLAEKESLTEEEATEF-----LKQILNGVYYL 129
Query: 830 CYPPIIHRDIKSNNILLDSNLEPR----IADFGLARMMIRKNETVSMVAGSYGYIAPEYG 885
I H D+K NI+L P+ I DFGLA + NE ++ G+ ++APE
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIV 188
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945
+ + D++S GV+ LL+G P + E + N E+ N
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGD-----TKQETLANVSAVNYEFEDEYFSNT 243
Query: 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
+ R K PK R +++D +
Sbjct: 244 S-----ALAKDFIRR----LLVKDPKKRMTIQDSL 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 5e-44
Identities = 64/287 (22%), Positives = 114/287 (39%), Gaps = 30/287 (10%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
IG G G+VYKA +VA+KK+ S + E+++L +L H NIV+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS--TAIREISLLKELNHPNIVK 65
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
LL +H + + +V+E+++ L + + + + + Y + Q L L
Sbjct: 66 LLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSY-----LFQLLQGLAFCH 119
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPE-YGYTLK 889
++HRD+K N+L+++ ++ADFGLAR T + + Y APE
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 890 VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949
+DI+S G + E++T R + ++ + R +E + P V +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 950 HVQEEMLLVLRIAFL----------------CTAKLPKDRPSMRDVI 980
+ R F P R S + +
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 5e-43
Identities = 73/292 (25%), Positives = 122/292 (41%), Gaps = 32/292 (10%)
Query: 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN 767
++ VIG G+ G+VY+A++ +VA+KK+ + + E + ++ KL H N
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE--------LQIMRKLDHCN 74
Query: 768 IVRLLGFLH------NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ 821
IVRL F + ++ + +V +Y+ A H +A + L + + +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-PVIYVKLYMYQLFR 133
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSN-LEPRIADFGLARMMIRKNETVSMVAGSYGYI 880
LAY+H I HRDIK N+LLD + ++ DFG A+ ++R VS + Y
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190
Query: 881 APEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940
ID++S G VL ELL G+ + G +VE I++ R
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIRE 249
Query: 941 LDPNVGNCKHVQEEMLLVLR----------IAFL--CTAKLPKDRPSMRDVI 980
++PN K Q + + IA P R + +
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-42
Identities = 66/286 (23%), Positives = 114/286 (39%), Gaps = 30/286 (10%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
IG G G V+KA+ + IVA+K++ D SS + E+ +L +L+H+NIVR
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS--ALREICLLKELKHKNIVR 65
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L LH+D + +V+E+ + + + + Q L L
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-------DLDPEIVKSFLFQLLKGLGFCH 118
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
++HRD+K N+L++ N E ++A+FGLAR S + Y P+ + K+
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 891 -DEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCK 949
ID++S G + EL RPL P D+ + ++ R E P++
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFP----GNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 950 HVQEEMLLVLRIAFL----------------CTAKLPKDRPSMRDV 979
+ + + + P R S +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-42
Identities = 60/267 (22%), Positives = 96/267 (35%), Gaps = 26/267 (9%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
++G G G V A+K L R + + V E VL RH +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKIL-RKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L + V EY N G L L ++ + A+ ++ L +
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRER-------VFTEERARFYGAEIVSALEYLH 122
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV 890
+++RDIK N++LD + +I DFGL + I T+ G+ Y+APE
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 891 DEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKH 950
+D + GVV+ E++ GR P + D + + + L P K
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF-----YNQDHERLFELILMEEIRFPRTLSP---EAKS 234
Query: 951 VQEEMLLVLRIAFLCTAKLPKDRPSMR 977
+ +L K PK R
Sbjct: 235 LLAGLL----------KKDPKQRLGGG 251
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-42
Identities = 62/305 (20%), Positives = 121/305 (39%), Gaps = 35/305 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVR 770
V+G+G G V + R A+K L + EV + + + +IVR
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML---------QDCPKARREVELHWRASQCPHIVR 69
Query: 771 LLGFLHN----DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
++ N ++IV E ++ G L + + S I + + + YL
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE--IMKSIGEAIQYL 127
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEP---RIADFGLARMMIRKNETVSMVAGSYGYIAPE 883
H I HRD+K N+L S ++ DFG A+ + +++ + Y+APE
Sbjct: 128 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPE 183
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943
K D+ D++S GV++ LL G P + I ++ +IR + +
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN--HGLAISPGMKTRIRMGQ-----YEF 236
Query: 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM--LGEAKPRRKSSSNNDNRYE 1001
V EE+ +++R P R ++ + + + ++ ++ + +
Sbjct: 237 PNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLK 293
Query: 1002 NNKEK 1006
+KE+
Sbjct: 294 EDKER 298
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (381), Expect = 3e-41
Identities = 64/285 (22%), Positives = 114/285 (40%), Gaps = 28/285 (9%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
IG G G+VYKA+ A+KK+ + D S + E+++L +L+H NIV+
Sbjct: 8 EKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPS--TTIREISILKELKHSNIVK 64
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
L +H +++V+E+++ + ++ V+ + L + G+AY H
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHD-- 118
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGY-TLK 889
++HRD+K N+L++ E +IADFGLAR + + Y AP+ + K
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 890 VDEKIDIYSFGVVLLELLTGRRPLDPE--------------FGESVDIVEWIRMKIRDNR 935
IDI+S G + E++ G S + + D
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 936 NLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
P K + E + +L P R + + +
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQAL 279
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 6e-40
Identities = 69/288 (23%), Positives = 120/288 (41%), Gaps = 27/288 (9%)
Query: 711 NVIGMGATGIVYKA-EMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL---RHR 766
IG GA G V+KA ++ VA+K++ + S + EV VL L H
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS--TIREVAVLRHLETFEHP 70
Query: 767 NIVRLLGFLH-----NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQ 821
N+VRL +T + +V+E+++ + G V + ++ + +
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDMMFQLLR 127
Query: 822 GLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIA 881
GL +LH ++HRD+K NIL+ S+ + ++ADFGLAR+ + S+V + Y A
Sbjct: 128 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-VTLWYRA 183
Query: 882 PEYGYTLKVDEKIDIYSFGVVLLELLTGRRPL--DPEFGESVDIVEWIRMKIRDNRNLEE 939
PE +D++S G + E+ + + + I++ I + ++ +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 940 ALDPNVGNCKHVQEEMLLVLRIAFL-------CTAKLPKDRPSMRDVI 980
AL + K Q V I L C P R S +
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (369), Expect = 2e-39
Identities = 46/301 (15%), Positives = 89/301 (29%), Gaps = 36/301 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
IG G+ G +Y VA+K + E + ++ +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ------LHIESKIYKMMQGGVGIPT 67
Query: 772 LG-FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
+ ++V E + L + + + +A + + Y+H
Sbjct: 68 IRWCGAEGDYNVMVMELLGPSLE--DLFNFCSRKF--SLKTVLLLADQMISRIEYIHSKN 123
Query: 831 YPPIIHRDIKSNNIL---LDSNLEPRIADFGLARMM-------IRKNETVSMVAGSYGYI 880
IHRD+K +N L I DFGLA+ + G+ Y
Sbjct: 124 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 881 APEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940
+ ++ + D+ S G VL+ G P + + + + +E
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNRY 1000
CK E L C + D+P + + + + D +
Sbjct: 241 -------CKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLF--RNLFHRQGFSYDYVF 288
Query: 1001 E 1001
+
Sbjct: 289 D 289
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (366), Expect = 4e-39
Identities = 43/303 (14%), Positives = 90/303 (29%), Gaps = 38/303 (12%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN-IVR 770
IG G+ G++++ N VA+K R + E L I
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ------LRDEYRTYKLLAGCTGIPN 65
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
+ F + ++V + + GR A + + +H
Sbjct: 66 VYYFGQEGLHNVLVIDLLGPSLED---LLDLCGRKFSVKTVAM-AAKQMLARVQSIHE-- 119
Query: 831 YPPIIHRDIKSNNILLDSNLEP-----RIADFGLARM-------MIRKNETVSMVAGSYG 878
+++RDIK +N L+ + DFG+ + ++G+
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 879 YIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938
Y++ + + D+ + G V + L G P + + + + L
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDN 998
E C EE + P + + +K + ++ D
Sbjct: 239 EL-------CAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLF--SKVLERLNTTEDE 286
Query: 999 RYE 1001
++
Sbjct: 287 NFD 289
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-39
Identities = 60/276 (21%), Positives = 107/276 (38%), Gaps = 40/276 (14%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRAD--LETESSGDFVGEVNVLGKLR--HRN 767
++G G G VY N VA+K + + R E + EV +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 768 IVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
++RLL + + +++ E + G L + + Q L +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF-----FWQVLEAVR 124
Query: 828 HDCYPPIIHRDIKSNNILLDSN-LEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEY-G 885
H ++HRDIK NIL+D N E ++ DFG ++ K+ + G+ Y PE+
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIR 182
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNL-EEALDPN 944
Y ++S G++L +++ G P + + E IR ++ + + E
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EEIIRGQVFFRQRVSSECQH-- 233
Query: 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVI 980
L+ C A P DRP+ ++
Sbjct: 234 ------------LIRW----CLALRPSDRPTFEEIQ 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 6e-39
Identities = 60/284 (21%), Positives = 112/284 (39%), Gaps = 16/284 (5%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+ IG GA G+V A VA+KK+ + + E+ +L + RH NI+
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ---RTLREIKILLRFRHENIIG 70
Query: 771 LLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC 830
+ + T + Y+ +G L+ + L + +GL Y+H
Sbjct: 71 INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHL-SNDHICYFLYQILRGLKYIHS-- 127
Query: 831 YPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSM---VAGSYGYIAPEYGYT 887
++HRD+K +N+LL++ + +I DFGLAR+ ++ + Y APE
Sbjct: 128 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 888 LKVD-EKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNVG 946
K + IDI+S G +L E+L+ R + ++ + + + + +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGK-----HYLDQLNHILGILGSPSQEDLNCII 241
Query: 947 NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990
N K + L + P D++ + P +
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 8e-39
Identities = 54/301 (17%), Positives = 109/301 (36%), Gaps = 46/301 (15%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
IG G G V+KA + VA+KK+ + + + E+ +L L+H N+V
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITALREIKILQLLKHENVVN 73
Query: 771 LLGFLH--------NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQG 822
L+ ++ +V+++ + G L + + + R +
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIKRV-----MQML 126
Query: 823 LAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNET----VSMVAGSYG 878
L L++ I+HRD+K+ N+L+ + ++ADFGLAR + + +
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 879 YIAPEYGYTLK-VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNL 937
Y PE + ID++ G ++ E+ T + + + + ++
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-----TEQHQLALISQLCGSI 241
Query: 938 EEALDPNVGNCKHVQEEMLLVLRIAFL-------------------CTAKLPKDRPSMRD 978
+ PNV N + ++ L+ + + P R D
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 979 V 979
Sbjct: 302 A 302
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-37
Identities = 71/274 (25%), Positives = 114/274 (41%), Gaps = 28/274 (10%)
Query: 711 NVIGMGATGIVYKAE---MPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHR- 766
V+G GA G V+ + A+K L ++ + +++ E VL +R
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 767 NIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYL 826
+V L +T + ++ +Y+N G L L ++ R V Y V + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIY-----VGEIVLAL 142
Query: 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI-RKNETVSMVAGSYGYIAPE-- 883
H II+RDIK NILLDSN + DFGL++ + + E G+ Y+AP+
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 884 YGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943
G D+ +D +S GV++ ELLTG P + GE E R ++ + +
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD-GEKNSQAEISRRILKSEPPYPQEMSA 261
Query: 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMR 977
+ L+ R K PK R
Sbjct: 262 LAKD---------LIQR----LLMKDPKKRLGCG 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 1e-36
Identities = 52/238 (21%), Positives = 102/238 (42%), Gaps = 14/238 (5%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G G+ G V + A+K L + + + + + E +L + +V+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 772 LGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY 831
+++N+ +V EY+ G + L + GR A + YLH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF--SEPHARFYAAQIVLTFEYLHSLD- 161
Query: 832 PPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVD 891
+I+RD+K N+L+D ++ DFG A+ + + T+ G+ +APE + +
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---GTPEALAPEIILSKGYN 216
Query: 892 EKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWI-RMKIRDNRNLEEALDPNVGNC 948
+ +D ++ GV++ E+ G P + + + I E I K+R + L + N
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL 272
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 4e-35
Identities = 60/302 (19%), Positives = 109/302 (36%), Gaps = 26/302 (8%)
Query: 694 QRLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDF 753
Q + T+ ++ A R+ +G GA G V A R VA+KKL+R +
Sbjct: 7 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRA 64
Query: 754 VGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRY 813
E+ +L +RH N++ LL D + ++ GK +
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 124
Query: 814 NIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMV 873
+ + +GL Y+H HRD+K N+ ++ + E +I DFGLAR +E V
Sbjct: 125 FLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGYV 179
Query: 874 AGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD 933
+ ++ + +DI+S G ++ E++TG+ G MK+
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF---KGSDHLDQLKEIMKVTG 236
Query: 934 NRNLEEALDPNVGNCKHVQEEMLLVLRIAFL----------------CTAKLPKDRPSMR 977
E K+ + + + + F + R +
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 978 DV 979
+
Sbjct: 297 EA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (329), Expect = 7e-34
Identities = 54/294 (18%), Positives = 105/294 (35%), Gaps = 43/294 (14%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIV 769
+G G V++A N V VK L + E+ +L LR NI+
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-------KIKREIKILENLRGGPNII 93
Query: 770 RLLGFLHNDTN--MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLH 827
L + + + +V+E++NN + + + + L Y H
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCH 146
Query: 828 HDCYPPIIHRDIKSNNILLDS-NLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGY 886
I+HRD+K +N+++D + + R+ D+GLA + ++ S + PE
Sbjct: 147 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLV 202
Query: 887 TLK-VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIR-------MKIRDNRNLE 938
+ D +D++S G +L ++ + P +V + D N+E
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 939 EALDPNVGNCKHVQEEMLLVLR-----------IAFL--CTAKLPKDRPSMRDV 979
N +H ++ + + FL + R + R+
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 7e-33
Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 19/228 (8%)
Query: 695 RLGFTSADILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV 754
+G ++ +L + IG GA GIV A L+ VA+KKL R +
Sbjct: 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK--RAY 64
Query: 755 GEVNVLGKLRHRNIVRLLGF------LHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVD 808
E+ ++ + H+NI+ LL L ++ +V E M+ Q ++ +D
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-------QVIQMELD 117
Query: 809 WVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE 868
+ + G+ +LH IHRD+K +NI++ S+ +I DFGLAR +
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSF 173
Query: 869 TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPE 916
++ + Y APE + E +DI+S G ++ E++ +
Sbjct: 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-32
Identities = 55/285 (19%), Positives = 106/285 (37%), Gaps = 22/285 (7%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVR 770
+ +G GA G V A + VAVKKL SR + E+ +L ++H N++
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 771 LLGFLH-----NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAY 825
LL + N + + ++ L + ++ + + + +GL Y
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-----LTDDHVQFLIYQILRGLKY 136
Query: 826 LHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYG 885
+H HRD+K +N+ ++ + E +I DFGLAR + +
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA--TRWYRAPEIML 191
Query: 886 YTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPNV 945
+ ++ +DI+S G ++ ELLTGR D ++ +++ +R L +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-----DHIDQLKLILRLVGTPGAELLKKI 246
Query: 946 GNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990
+ L P D++ + +
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (287), Expect = 3e-28
Identities = 50/238 (21%), Positives = 92/238 (38%), Gaps = 28/238 (11%)
Query: 712 VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRL 771
+G G V+ A+ NT VA+K + + E E+ +L ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-----AAEDEIKLLQRVNDADNTKE 74
Query: 772 LGFLH-NDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYN-----------IALGV 819
+ ++ + + + + + G L+ + +Y I+ +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 820 AQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP------RIADFGLARMMIRKNETVSMV 873
GL Y+H C IIH DIK N+L++ P +IAD G A +E +
Sbjct: 135 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---DEHYTNS 189
Query: 874 AGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKI 931
+ Y +PE DI+S ++ EL+TG +P+ G S + +I
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 108 bits (270), Expect = 2e-26
Identities = 56/269 (20%), Positives = 101/269 (37%), Gaps = 13/269 (4%)
Query: 281 RLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQL 340
++P ++ LLDL N ++ + LKNL L L+ N++S P L +L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 341 EVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSG 400
E L L N L L+ + + L + L SG
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSG 140
Query: 401 PIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSL 460
+ L +R+ + ++ TIP G L L L N +T + +L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 461 SFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSG 520
+ + +S N + + ++ + P+L+ ++NN LV ++P D + V+ L +N S
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
Query: 521 ------SIPSSIASCEKLVNLNLRNNQLT 543
P ++L +N +
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 103 bits (257), Expect = 1e-24
Identities = 58/302 (19%), Positives = 107/302 (35%), Gaps = 23/302 (7%)
Query: 62 HCNWTGVWCNSNG----------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLF 111
C+ V C+ G LDL + ++ F+ LK+L +L L N +
Sbjct: 9 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 112 SSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATS 171
P + A L L+R +S+N L L + L
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
Query: 172 LETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFD 231
+E L G +F+ ++KL ++ ++ N+T IP+ G S+ + L N+
Sbjct: 129 VE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT 184
Query: 232 GEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITS 291
L NL L L+ ++ L L + NN ++P + +
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH-LNNNKLVKVPGGLADHKY 243
Query: 292 LQLLDLSYNMLSH------EIPAEITQLKNLQLLNLMCNQLSGH--VPAGLGGLTQLEVL 343
+Q++ L N +S P T+ + ++L N + P+ + +
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 303
Query: 344 EL 345
+L
Sbjct: 304 QL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 102 bits (255), Expect = 2e-24
Identities = 62/293 (21%), Positives = 114/293 (38%), Gaps = 16/293 (5%)
Query: 202 SGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAE 261
S L K+P++L + L N+ +F NL NL L L + P
Sbjct: 18 SDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74
Query: 262 LGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNL 321
L LE ++L +N + + L++ + + + + Q+ ++L
Sbjct: 75 FAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT- 133
Query: 322 MCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPAS 381
+ SG G+ +L + + + +++ +P L + L L L N + AS
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPS--LTELHLDGNKITKVDAAS 190
Query: 382 LCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLEL 441
L NL KL L N+ S SL+ L + + NN+L +P G + +Q + L
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249
Query: 442 ANNSLTGGITDD------IASSTSLSFIDISRNHLRSS--LPSTILSIPNLQT 486
NN+++ ++D S S + + N ++ PST +
Sbjct: 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 302
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (250), Expect = 8e-24
Identities = 55/271 (20%), Positives = 104/271 (38%), Gaps = 17/271 (6%)
Query: 329 HVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNL 388
VP L +L+L NN ++ D L L L +N S P + L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 389 TKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELAN--NSL 446
+L L N T L R+ N+++ F L ++ +EL
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQEL---RVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 138
Query: 447 TGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCP 506
+G LS+I I+ ++ +++P + P+L + N + +
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNI-TTIPQGLP--PSLTELHLDGNKITKVDAASLKGLN 195
Query: 507 SLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSL 566
+L+ L LS N S S+A+ L L+L NN+L +P ++ + ++ L NN++
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 254
Query: 567 TGGIPENF------GASPALEVLNVSYNRLE 591
+ +F + +++ N ++
Sbjct: 255 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.5 bits (236), Expect = 5e-22
Identities = 62/268 (23%), Positives = 97/268 (36%), Gaps = 17/268 (6%)
Query: 137 SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKL 196
P L L+ N + D N +L TL L + P +F L KL
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 197 KFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLG- 255
+ L LS N L +P ++ + +++ + + NE F L + ++L L
Sbjct: 82 ERLYLSKNQLKE-LPEKMPK--TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 138
Query: 256 -GKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLK 314
G ++ L + + N G SL L L N ++ A + L
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLN 195
Query: 315 NLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSF 374
NL L L N +S L L L L NN L P L + +Q + L +N+
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNI 254
Query: 375 SGEIPASLCNGG------NLTKLILFNN 396
S C G + + + LF+N
Sbjct: 255 SAIGSNDFCPPGYNTKKASYSGVSLFSN 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 94.7 bits (234), Expect = 1e-21
Identities = 55/280 (19%), Positives = 98/280 (35%), Gaps = 14/280 (5%)
Query: 257 KIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNL 316
K+P +L ++ L N + N+ +L L L N +S P L L
Sbjct: 24 KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 317 QLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSG 376
+ L L NQL L +L V E + + L + + L + SG
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSG 140
Query: 377 EIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKL 436
+ L+ + + + + + SL + + N+++ L L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 437 QRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVG 496
+L L+ NS++ +A++ L + ++ N L P + +Q + NNN+
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISA 256
Query: 497 EIPDQFQD------CPSLSVLDLSSNYFS-GSIPSSIASC 529
+ F S S + L SN I S C
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.4 bits (215), Expect = 3e-19
Identities = 52/245 (21%), Positives = 93/245 (37%), Gaps = 7/245 (2%)
Query: 367 LDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTI 426
+ S ++P L + L L NN + +L + + NN++S
Sbjct: 15 VQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 427 PVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQT 486
P F L KL+RL L+ N L + L + +R S+ + L+ +
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFN-GLNQMIVVE 130
Query: 487 FIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDI 546
+ G FQ LS + ++ + +IP + L L+L N++T
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVD 187
Query: 547 PKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRG 606
++ + LA L LS NS++ + +P L L+++ N+L + I
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVV 247
Query: 607 DLAGN 611
L N
Sbjct: 248 YLHNN 252
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 63.1 bits (152), Expect = 4e-11
Identities = 27/153 (17%), Positives = 50/153 (32%), Gaps = 3/153 (1%)
Query: 459 SLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYF 518
L + S L +P + P+ + NN + F++ +L L L +N
Sbjct: 11 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 519 SGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASP 578
S P + A KL L L NQL K + L + + + +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 579 ALEVLNVSYNRLEGPVPANGVLRTINRGDLAGN 611
+E+ A ++ ++ +A
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 160
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.3 bits (129), Expect = 3e-08
Identities = 30/152 (19%), Positives = 50/152 (32%), Gaps = 8/152 (5%)
Query: 505 CPS-----LSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAIL 559
CP L V+ S +P + L+L+NN++T + L L
Sbjct: 4 CPFRCQCHLRVVQCSDLGLE-KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTL 60
Query: 560 DLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVL 619
L NN ++ P F LE L +S N+L+ R + V
Sbjct: 61 ILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVF 120
Query: 620 HPCSRYSPIASSHRSLHAKHIIPGWMIAISSL 651
+ ++ + L + I G + L
Sbjct: 121 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 152
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.5 bits (114), Expect = 2e-06
Identities = 27/184 (14%), Positives = 59/184 (32%), Gaps = 7/184 (3%)
Query: 30 TALNDELLALLSIKAGLVDPLNSLHDWKLPSAHCNWTGVWCNSNGAVEKLDLSHMNLSGC 89
L + ++ + + LN + +L + +G+ + ++KL + +
Sbjct: 103 QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 162
Query: 90 VSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLT 149
+ SLT L+L N + SL L +L + +S N ++ L L
Sbjct: 163 TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR 222
Query: 150 FLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFK------NLQKLKFLGLSG 203
L+ + N + ++ + L + F + L
Sbjct: 223 ELHLNNNKLVKVPGGL-ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 281
Query: 204 NNLT 207
N +
Sbjct: 282 NPVQ 285
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 108 bits (270), Expect = 2e-26
Identities = 69/301 (22%), Positives = 111/301 (36%), Gaps = 11/301 (3%)
Query: 34 DELLALLSIKAGLVDPLNSLHDWKLPSAHCN--WTGVWCNSNGA---VEKLDLSHMNLSG 88
+ ALL IK L +P +L W + CN W GV C+++ V LDLS +NL
Sbjct: 6 QDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 89 C--VSDHFQRLKSLTSLNL-CCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGA 145
+ L L L + N L +P ++A LT L ++ ++G+ P L
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 146 AGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNN 205
L L+ S N SG L + + +L + G+ G+IP S+ + KL N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 206 LTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRL 265
+ + N ++G
Sbjct: 185 RLTGKIPPTFA-NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243
Query: 266 ELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQ 325
+ L + L N G LP + + L L++S+N L EIP + L+ + N+
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
Query: 326 L 326
Sbjct: 303 C 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 97.9 bits (242), Expect = 1e-22
Identities = 65/260 (25%), Positives = 106/260 (40%), Gaps = 4/260 (1%)
Query: 367 LDLSSNSFSG--EIPASLCNGGNLTKLILFNNA-FSGPIPVSLSTCHSLVRVRMQNNQLS 423
LDLS + IP+SL N L L + GPIP +++ L + + + +S
Sbjct: 55 LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114
Query: 424 GTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPN 483
G IP +++ L L+ + N+L+G + I+S +L I N + ++P + S
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174
Query: 484 LQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLT 543
L T + + N + +L+ S S + +K
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANLNLAF-VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233
Query: 544 GDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTI 603
+ + L LDL NN + G +P+ L LNVS+N L G +P G L+
Sbjct: 234 AFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRF 293
Query: 604 NRGDLAGNAGLCGGVLHPCS 623
+ A N LCG L C+
Sbjct: 294 DVSAYANNKCLCGSPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 39.7 bits (91), Expect = 0.001
Identities = 34/129 (26%), Positives = 60/129 (46%), Gaps = 3/129 (2%)
Query: 431 GRLEKLQRLELANNSLTGGIT--DDIASSTSLSFIDISRNH-LRSSLPSTILSIPNLQTF 487
+ ++ L+L+ +L +A+ L+F+ I + L +P I + L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 488 IVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIP 547
+++ N+ G IPD +L LD S N SG++P SI+S LV + N+++G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 548 KAISMMPTL 556
+ L
Sbjct: 167 DSYGSFSKL 175
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 106 bits (264), Expect = 5e-25
Identities = 79/378 (20%), Positives = 142/378 (37%), Gaps = 31/378 (8%)
Query: 187 PVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKY 246
VS +L ++ L + I + L+++ + + N+ P NLT L
Sbjct: 37 TVSQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 92
Query: 247 LDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEI 306
+ + + P +F Q L LS
Sbjct: 93 ILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN---------RLELSSNT 143
Query: 307 PAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQW 366
++I+ L L L + L LT LE L++ +N L K + L+
Sbjct: 144 ISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK--VSDISVLAKLTNLES 201
Query: 367 LDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTI 426
L ++N S P + NL +L L N +L++ +L + + NNQ+S
Sbjct: 202 LIATNNQISDITPLGILT--NLDELSLNGNQLKDIG--TLASLTNLTDLDLANNQISNLA 257
Query: 427 PVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQT 486
P L KL L+L N ++ +A T+L+ ++++ N L P + L NL
Sbjct: 258 P--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDISPISNL--KNLTY 311
Query: 487 FIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDI 546
+ NN+ P L L ++N S SS+A+ + L+ +NQ++
Sbjct: 312 LTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367
Query: 547 PKAISMMPTLAILDLSNN 564
P ++ + + L L++
Sbjct: 368 P--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 98.2 bits (243), Expect = 2e-22
Identities = 79/390 (20%), Positives = 139/390 (35%), Gaps = 33/390 (8%)
Query: 151 LNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKI 210
N + + + + + TL + SI + L L + S N LT
Sbjct: 27 TVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDIT 82
Query: 211 PRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEI 270
P L L+ + +++ N+ P+ L + +
Sbjct: 83 P--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK---------NL 131
Query: 271 MFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHV 330
L + ++I ++ L L + L L+ L++ N++S
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191
Query: 331 PAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTK 390
LT LE L NN +S P+ + N L L L+ N +L + NLT
Sbjct: 192 VL--AKLTNLESLIATNNQISDITPLGILTN--LDELSLNGNQLKD--IGTLASLTNLTD 245
Query: 391 LILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGI 450
L L NN S P LS L +++ NQ+S P L L LEL N
Sbjct: 246 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN--QLED 299
Query: 451 TDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSV 510
I++ +L+++ + N++ P + S+ LQ +NN + + +++
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINW 355
Query: 511 LDLSSNYFSGSIPSSIASCEKLVNLNLRNN 540
L N S P +A+ ++ L L +
Sbjct: 356 LSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 94.3 bits (233), Expect = 5e-21
Identities = 84/382 (21%), Positives = 144/382 (37%), Gaps = 39/382 (10%)
Query: 78 KLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGS 137
K L N++ VS L +T+L G+ S+ + L +L + + S N L
Sbjct: 26 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI-KSIDG-VEYLNNLTQINFSNNQLTDI 81
Query: 138 FPAGLGGAAGLTFLNASGNNFSG---------FLLEDLGNATSLETLDLRGSFFQGSIPV 188
P L L + + N + L N + L+ + +
Sbjct: 82 TP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 139
Query: 189 SFKNLQKLKFLGLSGNNL------TGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLT 242
S + + L + + L L+++E + ++ N+ LT
Sbjct: 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS--DISVLAKLT 197
Query: 243 NLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNML 302
NL+ L + P + L+ + L N + + ++T+L LDL+ N +
Sbjct: 198 NLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 253
Query: 303 SHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNS 362
S+ P ++ L L L L NQ+S P L GLT L LEL N L P+
Sbjct: 254 SNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS--NLK 307
Query: 363 PLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQL 422
L +L L N+ S P + + L +L NN S SL+ ++ + +NQ+
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363
Query: 423 SGTIPVGFGRLEKLQRLELANN 444
S P L ++ +L L +
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 91.2 bits (225), Expect = 5e-20
Identities = 62/386 (16%), Positives = 121/386 (31%), Gaps = 59/386 (15%)
Query: 240 NLTNLKYLDLAVGNLGGKIP-AELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLS 298
L L N+ + +L ++ L+ L + G + + +L ++ S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 299 YNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQL----------------EV 342
N L+ P + L L + + NQ++ P
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 343 LELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPI 402
S + + LS + ++ I N +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 403 PVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSF 462
L+ SL+ NNQ+S P+G L L L N L +AS T+L+
Sbjct: 193 LAKLTNLESLI---ATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTD 245
Query: 463 IDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIP--------------------DQF 502
+D++ N + + P + + L + N + P
Sbjct: 246 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPI 303
Query: 503 QDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLS 562
+ +L+ L L N S P ++S KL L NN+++ +++ + + L
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 563 NNSLTGGIPENFGASPALEVLNVSYN 588
+N ++ P + L ++
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.9 bits (219), Expect = 2e-19
Identities = 68/374 (18%), Positives = 126/374 (33%), Gaps = 52/374 (13%)
Query: 273 LYQNNFQGRLP-AEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVP 331
L + N + ++ +T+LQ L + + L NL +N NQL+ P
Sbjct: 29 LGKTNVTDTVSQTDLDQVTTLQADRLGIKSID-----GVEYLNNLTQINFSNNQLTDITP 83
Query: 332 AGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKL 391
L LT+L + + NN ++ P+ N L + + +
Sbjct: 84 --LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS 141
Query: 392 ILFNNAFSGPIPVSLSTCH-------------SLVRVRMQNNQLSGTIPVGFGRLEKLQR 438
++ + SL R+ + + +L L+
Sbjct: 142 NTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLES 201
Query: 439 LELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEI 498
L NN ++ I T+L + ++ N L+ T+ S+ NL ++NN +
Sbjct: 202 LIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 257
Query: 499 PDQFQDCPSLSVLDLSSNYFSGSIP--------------------SSIASCEKLVNLNLR 538
P L+ L L +N S P S I++ + L L L
Sbjct: 258 P--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLY 315
Query: 539 NNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANG 598
N ++ P +S + L L +NN ++ + + L+ +N++ P
Sbjct: 316 FNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLAN 371
Query: 599 VLRTINRGDLAGNA 612
L I + L A
Sbjct: 372 -LTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 74.3 bits (181), Expect = 2e-14
Identities = 63/359 (17%), Positives = 115/359 (32%), Gaps = 52/359 (14%)
Query: 288 NITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWN 347
+ L ++ + T L + L + G+ L L + N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75
Query: 348 NSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIP---- 403
N L+ P L + L + +++N + P + L P+
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 404 -----------VSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITD 452
+S L ++ + T L L+RL++++N
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN--KVSDIS 191
Query: 453 DIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLD 512
+A T+L + + N + P I + NL ++ N L +L+ LD
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 513 LSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIP--------------------KAISM 552
L++N S P ++ KL L L NQ++ P IS
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305
Query: 553 MPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGN 611
+ L L L N+++ P + L+ L + N++ + L IN N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SSLANLTNINWLSAGHN 361
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 54.2 bits (129), Expect = 4e-08
Identities = 26/123 (21%), Positives = 45/123 (36%), Gaps = 7/123 (5%)
Query: 57 KLPSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPN 116
+L + + + + N LK+LT L L N + P
Sbjct: 267 ELKLGANQISNISPLAGLTALTNLELNEN-QLEDISPISNLKNLTYLTLYFNNISDISP- 324
Query: 117 SLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLD 176
+++LT L+R + N ++ + L + +L+A N S L L N T + L
Sbjct: 325 -VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLG 379
Query: 177 LRG 179
L
Sbjct: 380 LND 382
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 7e-04
Identities = 11/56 (19%), Positives = 24/56 (42%), Gaps = 4/56 (7%)
Query: 77 EKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQN 132
++L ++ +S L ++ L+ N + P LANLT + + ++
Sbjct: 332 QRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.2 bits (210), Expect = 2e-19
Identities = 27/157 (17%), Positives = 51/157 (32%), Gaps = 18/157 (11%)
Query: 711 NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSG------DFVGEVNVLGKLR 764
++G G V+ + VK + F +
Sbjct: 6 KLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 765 HRNIVRLLGFLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLA 824
R + +L G + VY + N L E + K+ R+ V+ + + + +A
Sbjct: 65 FRALQKLQGL-----AVPKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVA 117
Query: 825 YLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861
+H I+H D+ N+L+ I DF +
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (215), Expect = 2e-19
Identities = 54/261 (20%), Positives = 95/261 (36%), Gaps = 7/261 (2%)
Query: 354 LPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLV 413
+PV + Q + L N S AS NLT L L +N + + + L
Sbjct: 26 VPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 414 RVRMQNNQLSGTI-PVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRS 472
++ + +N ++ P F L +L L L L +L ++ + N L++
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 473 SLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKL 532
T + NL + N + F+ SL L L N + P + +L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 533 VNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEG 592
+ L L N L+ +A++ + L L L++N L+ S + +
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPC 262
Query: 593 PVPA---NGVLRTINRGDLAG 610
+P L+ + DL G
Sbjct: 263 SLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.2 bits (196), Expect = 6e-17
Identities = 61/289 (21%), Positives = 93/289 (32%), Gaps = 31/289 (10%)
Query: 233 EIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSL 292
+PV + + L + A L I++L+ N A + L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 293 QLLDLSYNM-LSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLS 351
+ LDLS N L PA L L L+L L P GL L+ L L +N+L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 352 GPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHS 411
L L L N S + +L +L+L N + P +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 412 LVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLR 471
L+ + + N LS L LQ L L +N D L
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC---------------DCRARPLW 247
Query: 472 SSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSG 520
+ LQ F S++ + +P + + L++N G
Sbjct: 248 A----------WLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.9 bits (190), Expect = 3e-16
Identities = 63/276 (22%), Positives = 96/276 (34%), Gaps = 15/276 (5%)
Query: 64 NWTGVWCNSNG----------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSS 113
C G A +++ L +S + F+ ++LT L L N L
Sbjct: 12 PKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 114 LPNSLANLTSLKRFDVSQNFLNGS-FPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSL 172
+ L L++ D+S N S PA G L L+ +L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 173 ETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDG 232
+ L L+ + Q +F++L L L L GN ++ R L S++ ++L N
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 233 EIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSL 292
P F +L L L L NL L L L+ + L N + A L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWL 250
Query: 293 QLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSG 328
Q S + + +P L L L N L G
Sbjct: 251 QKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (184), Expect = 2e-15
Identities = 58/272 (21%), Positives = 92/272 (33%), Gaps = 7/272 (2%)
Query: 106 CCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLED 165
C ++P + + +R + N ++ A LT L N +
Sbjct: 18 CPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 166 LGNATSLETLDLRGSFFQGSI-PVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMI 224
LE LDL + S+ P +F L +L L L L P L++++ +
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135
Query: 225 LAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPA 284
L N F +L NL +L L + L L+ + L+QN P
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195
Query: 285 EIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLE 344
++ L L L N LS + L+ LQ L L N A L+
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFR 254
Query: 345 LWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSG 376
++ + LP L L++N G
Sbjct: 255 GSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.5 bits (150), Expect = 5e-11
Identities = 40/184 (21%), Positives = 62/184 (33%), Gaps = 6/184 (3%)
Query: 49 PLNSLHDWKLPSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCN 108
L++LH + + ++ L L L D F+ L +LT L L N
Sbjct: 106 RLHTLHLDRCGLQELGPGLFRGLAA--LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163
Query: 109 GLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGN 168
+ S + L SL R + QN + P L L NN S E L
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223
Query: 169 ATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYN 228
+L+ L L + + L+ S + + +P+ L LA N
Sbjct: 224 LRALQYLRLNDNPWVCDCRARP-LWAWLQKFRGSSSEVPCSLPQRLAGRDLKR---LAAN 279
Query: 229 EFDG 232
+ G
Sbjct: 280 DLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.3 bits (126), Expect = 5e-08
Identities = 47/286 (16%), Positives = 75/286 (26%), Gaps = 47/286 (16%)
Query: 14 CYIGCTCFGSAKVVAK------TALNDELLALL-----------SIKAGLVDPLNSL--H 54
C C C+ KV A+ + A + A +L
Sbjct: 2 CPGACVCYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTIL 61
Query: 55 DWKLPSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSL 114
+ + + L F L L +L+L GL
Sbjct: 62 WLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG 121
Query: 115 PNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLET 174
P L +L+ + N L LT L GN S SL+
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181
Query: 175 LDLRGSFFQGSIPVSFKNLQ------------------------KLKFLGLSGNNLTGKI 210
L L + P +F++L L++L L+ N
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-D 240
Query: 211 PRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGG 256
R + ++ + +E +P L LA +L G
Sbjct: 241 CRARPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.7 bits (161), Expect = 2e-12
Identities = 46/289 (15%), Positives = 81/289 (28%), Gaps = 19/289 (6%)
Query: 317 QLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSG 376
Q L+L L V L + + + PL + +Q +DLS++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60
Query: 377 E-IPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEK 435
+ L L L L S PI +L+ +LVR+ + + L
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFAL-QTLLSS 119
Query: 436 LQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLV 495
RL+ N S T+ + S N
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK--------------NLQKS 165
Query: 496 GEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRN-NQLTGDIPKAISMMP 554
+ + + S L +L+L + + + +P
Sbjct: 166 DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP 225
Query: 555 TLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTI 603
TL L + G + A P L++ + + P N + I
Sbjct: 226 TLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 4e-08
Identities = 41/270 (15%), Positives = 84/270 (31%), Gaps = 18/270 (6%)
Query: 78 KLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPN-SLANLTSLKRFDVSQNFLNG 136
LDL+ NL D RL S + C F P + ++ D+S + +
Sbjct: 4 TLDLTGKNLHP---DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60
Query: 137 -SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQK 195
+ L + L L+ G S ++ L ++L L+L G +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 196 LKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDG---------EIPVEFGNLTNLKY 246
+ L+ + + + + + + G + +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 247 LDLAVGNLGGKIPAELGRLELLEIMFLYQ-NNFQGRLPAEIGNITSLQLLDLSYNMLSHE 305
L E +L L+ + L + + E+G I +L+ L + +
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 306 IPAEITQLKNLQLLNLMCNQLSGHVPAGLG 335
+ L +LQ+ C+ + +G
Sbjct: 241 LQLLKEALPHLQIN---CSHFTTIARPTIG 267
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.1 bits (157), Expect = 5e-12
Identities = 42/209 (20%), Positives = 72/209 (34%), Gaps = 7/209 (3%)
Query: 337 LTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNN 396
+ + +L+ LP DL K+ L LS N A+L LT+L L
Sbjct: 9 VASHLEVNCDKRNLTA-LPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 397 AFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIAS 456
+ ++ ++ ++P+ L L L+++ N LT +
Sbjct: 66 ELTKLQVD---GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122
Query: 457 STSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSN 516
L + + N L++ P + P L+ ++NNNL +L L L N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182
Query: 517 YFSGSIPSSIASCEKLVNLNLRNNQLTGD 545
+IP L L N +
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.3 bits (147), Expect = 9e-11
Identities = 40/212 (18%), Positives = 72/212 (33%), Gaps = 11/212 (5%)
Query: 309 EITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLD 368
E++++ + +N L+ +P L +L L N L L + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 369 LSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVR--MQNNQLSGTI 426
L + G L L + + + + L + N+L+
Sbjct: 62 LDRAELTKL-----QVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 427 PVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQT 486
L +LQ L L N L + + L + ++ N+L + + NL T
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 487 FIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYF 518
++ N+L IP F L L N +
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 5e-10
Identities = 46/207 (22%), Positives = 65/207 (31%), Gaps = 7/207 (3%)
Query: 120 NLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRG 179
+ S + + L + P L T L+ S N F L L T L L+L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL-- 62
Query: 180 SFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFG 239
+ + L L L LS N L L ++ + +++N
Sbjct: 63 DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALR 121
Query: 240 NLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSY 299
L L+ L L L P L LE + L NN + + +L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 300 NMLSHEIPAEITQLKNLQLLNLMCNQL 326
N L IP L L N
Sbjct: 182 NSLYT-IPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.2 bits (139), Expect = 1e-09
Identities = 50/187 (26%), Positives = 70/187 (37%), Gaps = 6/187 (3%)
Query: 282 LPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLE 341
LP ++ +L LS N+L A + L LNL +L+ G L L
Sbjct: 25 LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80
Query: 342 VLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGP 401
L+L +N L + L LD+S N + +L G L +L L N
Sbjct: 81 TLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139
Query: 402 IPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLS 461
P L+ L ++ + NN L+ LE L L L NSL I S L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198
Query: 462 FIDISRN 468
F + N
Sbjct: 199 FAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 9e-09
Identities = 46/211 (21%), Positives = 74/211 (35%), Gaps = 6/211 (2%)
Query: 405 SLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFID 464
+S S + V L+ +P + L L+ N L + T L+ ++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 465 ISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPS 524
+ R L L P L T +S+N L + D+S N +
Sbjct: 62 LDRAELTKLQVDGTL--PVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLG 118
Query: 525 SIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLN 584
++ +L L L+ N+L P ++ P L L L+NN+LT L+ L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 585 VSYNRLEGPVPANGVLRTINRGDLAGNAGLC 615
+ N L + L GN LC
Sbjct: 179 LQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 4e-07
Identities = 45/210 (21%), Positives = 72/210 (34%), Gaps = 7/210 (3%)
Query: 70 CNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDV 129
+ + +++ NL+ D K T L+L N L++ +L T L + ++
Sbjct: 6 VSKVASHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 130 SQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVS 189
+ L G + +N L +L LD+ + +
Sbjct: 63 DRAELTKLQV---DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 190 FKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDL 249
+ L +L+ L L GN L P L +E + LA N L NL L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 250 AVGNLGGKIPAELGRLELLEIMFLYQNNFQ 279
N IP LL FL+ N +
Sbjct: 180 Q-ENSLYTIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (114), Expect = 2e-06
Identities = 47/210 (22%), Positives = 66/210 (31%), Gaps = 21/210 (10%)
Query: 59 PSAHCNWTG----VWCNSNG----------AVEKLDLSHMNLSGCVSDHFQRLKSLTSLN 104
P + V C+ L LS L LT LN
Sbjct: 2 PICEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 105 L-CCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLL 163
L + +L L +L L T L+ S N + L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL----TVLDVSFNRLTSLPL 117
Query: 164 EDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETM 223
L L+ L L+G+ + P KL+ L L+ NNLT L L +++T+
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 224 ILAYNEFDGEIPVEFGNLTNLKYLDLAVGN 253
+L N IP F L + L GN
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLH-GN 205
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.9 bits (135), Expect = 7e-09
Identities = 23/92 (25%), Positives = 36/92 (39%), Gaps = 10/92 (10%)
Query: 315 NLQLLNLMCNQLS-GHVPAGLGGLTQLEVLELWNNSLSG----PLPVDLGKNSPLQWLDL 369
++Q L++ C +LS L L Q +V+ L + L+ + L N L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 370 SSNSFSGEIPASLCNG-----GNLTKLILFNN 396
SN + G + KL L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (134), Expect = 9e-09
Identities = 20/92 (21%), Positives = 35/92 (38%), Gaps = 10/92 (10%)
Query: 291 SLQLLDLSYNMLSHEIPAEI-TQLKNLQLLNLMCNQLSG----HVPAGLGGLTQLEVLEL 345
+Q LD+ LS AE+ L+ Q++ L L+ + + L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 346 WNNSLSGPLPVDLGK-----NSPLQWLDLSSN 372
+N L + + + +Q L L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 5e-08
Identities = 15/93 (16%), Positives = 33/93 (35%), Gaps = 5/93 (5%)
Query: 457 STSLSFIDISRNHLRSSLPSTILS-IPNLQTFIVSNNNL----VGEIPDQFQDCPSLSVL 511
S + +DI L + + +L + Q + + L +I + P+L+ L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 512 DLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTG 544
+L SN + + + ++ L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 2e-07
Identities = 20/98 (20%), Positives = 34/98 (34%), Gaps = 13/98 (13%)
Query: 499 PDQFQDCPSLSVLDLSSNYFSG----SIPSSIASCEKLVNLNLRNNQLTGDIPKAIS--- 551
Q L VL L+ S S+ +++ + L L+L NN L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 552 --MMPTLAILDLSNNSLTGGIPENFGA----SPALEVL 583
L L L + + + + A P+L V+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 2e-07
Identities = 16/92 (17%), Positives = 30/92 (32%), Gaps = 10/92 (10%)
Query: 483 NLQTFIVSNNNLVGE-IPDQFQDCPSLSVLDLSSNYFSG----SIPSSIASCEKLVNLNL 537
++Q+ + L + V+ L + I S++ L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 538 RNNQLTGDIPKAI-----SMMPTLAILDLSNN 564
R+N+L + + + L L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 2e-07
Identities = 17/92 (18%), Positives = 33/92 (35%), Gaps = 10/92 (10%)
Query: 507 SLSVLDLSSNYFSGS-IPSSIASCEKLVNLNLRNNQLTGD----IPKAISMMPTLAILDL 561
+ LD+ S + + ++ + L + LT I A+ + P LA L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 562 SNNSLTGGIPENFGA-----SPALEVLNVSYN 588
+N L S ++ L++
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 4e-07
Identities = 13/93 (13%), Positives = 32/93 (34%), Gaps = 13/93 (13%)
Query: 480 SIPNLQTFIVSNNNLVGE----IPDQFQDCPSLSVLDLSSNYFSGSIPSSIAS-----CE 530
L+ +++ ++ + SL LDLS+N + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 531 KLVNLNLRNNQLTGDIPKAISMM----PTLAIL 559
L L L + + ++ + + P+L ++
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 13/93 (13%), Positives = 29/93 (31%), Gaps = 10/93 (10%)
Query: 76 VEKLDLSHMNLS-GCVSDHFQRLKSLTSLNLCCNGL----FSSLPNSLANLTSLKRFDVS 130
++ LD+ LS ++ L+ + L GL + ++L +L ++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 131 QNFLNGSFPAGLGGAAG-----LTFLNASGNNF 158
N L + + L+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 21/89 (23%), Positives = 32/89 (35%), Gaps = 9/89 (10%)
Query: 329 HVPAGLGGLTQLEVLELWNNSLSG----PLPVDLGKNSPLQWLDLSSNSFSGEIPASLC- 383
+ L VL L + +S L L N L+ LDLS+N L
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
Query: 384 ----NGGNLTKLILFNNAFSGPIPVSLST 408
G L +L+L++ +S + L
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 2e-05
Identities = 18/97 (18%), Positives = 32/97 (32%), Gaps = 9/97 (9%)
Query: 271 MFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHE----IPAEITQLKNLQLLNLMCNQL 326
L + + L++L L+ +S + A + +L+ L+L N L
Sbjct: 350 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409
Query: 327 SGHVPAGLGG-----LTQLEVLELWNNSLSGPLPVDL 358
L LE L L++ S + L
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 24/151 (15%), Positives = 38/151 (25%), Gaps = 23/151 (15%)
Query: 51 NSLHDWKLPSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGL 110
S + L + Q L L L +
Sbjct: 322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 381
Query: 111 ----FSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDL 166
SSL +L SL+ D+S N L + L + +
Sbjct: 382 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES-----------------VRQ- 423
Query: 167 GNATSLETLDLRGSFFQGSIPVSFKNLQKLK 197
LE L L ++ + + L+K K
Sbjct: 424 -PGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 6e-05
Identities = 13/86 (15%), Positives = 28/86 (32%), Gaps = 9/86 (10%)
Query: 190 FKNLQKLKFLGLSGNNLTGK----IPRELGQLSSMETMILAYNEFDGEIPVEFG-----N 240
+ L+ L L+ +++ + L S+ + L+ N ++
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 241 LTNLKYLDLAVGNLGGKIPAELGRLE 266
L+ L L ++ L LE
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 6e-05
Identities = 13/66 (19%), Positives = 29/66 (43%), Gaps = 5/66 (7%)
Query: 532 LVNLNLRNNQLT-GDIPKAISMMPTLAILDLSNNSLTG----GIPENFGASPALEVLNVS 586
+ +L+++ +L+ + + ++ ++ L + LT I +PAL LN+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 587 YNRLEG 592
N L
Sbjct: 64 SNELGD 69
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 7e-05
Identities = 15/92 (16%), Positives = 30/92 (32%), Gaps = 5/92 (5%)
Query: 243 NLKYLDLAVGNLGGKIPAEL-GRLELLEIMFLYQNNFQGR----LPAEIGNITSLQLLDL 297
+++ LD+ L AEL L+ +++ L + + + +L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 298 SYNMLSHEIPAEITQLKNLQLLNLMCNQLSGH 329
N L + Q + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 2e-04
Identities = 22/90 (24%), Positives = 38/90 (42%), Gaps = 10/90 (11%)
Query: 458 TSLSFIDISRNHLR----SSLPSTILSIPNLQTFIVSNNNLVGEIPDQF-----QDCPSL 508
+ L + ++ + SSL +T+L+ +L+ +SNN L Q Q L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 509 SVLDLSSNYFSGSIPSSIASCEKLVNLNLR 538
L L Y+S + + + EK +LR
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKD-KPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 2e-04
Identities = 15/83 (18%), Positives = 26/83 (31%), Gaps = 9/83 (10%)
Query: 168 NATSLETLDLRGSFFQG----SIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQ-----LS 218
+ L L L S+ + L+ L LS N L +L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 219 SMETMILAYNEFDGEIPVEFGNL 241
+E ++L + E+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 18/81 (22%), Positives = 30/81 (37%), Gaps = 9/81 (11%)
Query: 268 LEIMFLYQNNFQGR----LPAEIGNITSLQLLDLSYNMLSHEIPAEITQ-----LKNLQL 318
L +++L + L A + SL+ LDLS N L ++ + L+
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 319 LNLMCNQLSGHVPAGLGGLTQ 339
L L S + L L +
Sbjct: 431 LVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 11/75 (14%), Positives = 19/75 (25%), Gaps = 5/75 (6%)
Query: 148 LTFLNASGNNFSGFLLEDLGNA-TSLETLDLRGSFFQG----SIPVSFKNLQKLKFLGLS 202
+ L+ S +L + + L I + + L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 203 GNNLTGKIPRELGQL 217
N L + Q
Sbjct: 64 SNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 12/96 (12%), Positives = 27/96 (28%), Gaps = 21/96 (21%)
Query: 171 SLETLDLRGSFFQGS-IPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNE 229
+++LD++ + LQ+ + + L LT +++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------ 50
Query: 230 FDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRL 265
L L+L LG + +
Sbjct: 51 --------LRVNPALAELNLRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 12/93 (12%), Positives = 28/93 (30%), Gaps = 10/93 (10%)
Query: 123 SLKRFDVSQNFLNGS-FPAGLGGAAGLTFLNASGNNFSGFLLEDLGNA----TSLETLDL 177
++ D+ L+ + + L + + +D+ +A +L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 178 RGSFFQGSIPVSF-----KNLQKLKFLGLSGNN 205
R + K++ L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 15/69 (21%), Positives = 29/69 (42%), Gaps = 5/69 (7%)
Query: 417 MQNNQLSGT-IPVGFGRLEKLQRLELANNSLTGGITDDIASS----TSLSFIDISRNHLR 471
+Q +LS L++ Q + L + LT DI+S+ +L+ +++ N L
Sbjct: 9 IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68
Query: 472 SSLPSTILS 480
+L
Sbjct: 69 DVGVHCVLQ 77
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.3 bits (129), Expect = 1e-08
Identities = 34/239 (14%), Positives = 68/239 (28%), Gaps = 24/239 (10%)
Query: 307 PAEITQ------LKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGK 360
P I L N + + ++ V L + L + ++ + +
Sbjct: 6 PTAINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQY 61
Query: 361 NSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNN 420
+ L L+L N + P +L I S + +
Sbjct: 62 LNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD 121
Query: 421 QLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILS 480
L IT+ + + +S + + S + + +
Sbjct: 122 VTPLAGLSNLQVLYLDLN----------QITNISPLAGLTNLQYLSIGNAQVSDLTPLAN 171
Query: 481 IPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRN 539
+ L T +N + P P+L + L +N S P +A+ L + L N
Sbjct: 172 LSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 3e-07
Identities = 33/227 (14%), Positives = 69/227 (30%), Gaps = 18/227 (7%)
Query: 288 NITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWN 347
+ + + + ++ + L + L+ ++ G+ L L LEL +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 348 NSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLS 407
N ++ + KN S + + A T + LS
Sbjct: 73 NQIT---DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 408 TCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISR 467
L Q I L+ + +A+ + L+ +
Sbjct: 130 NLQVLYLDLNQ-------ITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 468 NHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLS 514
N + P + S+PNL + NN + P + +L ++ L+
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 3e-07
Identities = 28/229 (12%), Positives = 66/229 (28%), Gaps = 20/229 (8%)
Query: 336 GLTQLEVLELWNNSLSGPLP-VDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILF 394
L + ++++ + DL + L + ++ L LI
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDG---ITTLSAFGTGVT-----TIEGVQYLNNLIGL 68
Query: 395 NNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDI 454
+ ++ + + + + G + +
Sbjct: 69 ELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 455 ASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLS 514
++ L + + + +S N + L+ L
Sbjct: 129 SNLQVL-------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD 181
Query: 515 SNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSN 563
N S P +AS L+ ++L+NNQ++ P ++ L I+ L+N
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 6e-06
Identities = 28/220 (12%), Positives = 86/220 (39%), Gaps = 18/220 (8%)
Query: 367 LDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTI 426
+ ++ + + + + +T L F + I + ++L+ + +++NQ++
Sbjct: 24 IAAGKSNVTDTVTQADLD--GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLA 79
Query: 427 PVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQT 486
P+ L + + + + ++++ + + +S T ++ +
Sbjct: 80 PLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 487 FIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDI 546
+ + +I + ++ LS S + +A+ KL L +N+++
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS 189
Query: 547 PKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVS 586
P ++ +P L + L NN ++ P + L ++ ++
Sbjct: 190 P--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 8e-06
Identities = 31/228 (13%), Positives = 67/228 (29%), Gaps = 20/228 (8%)
Query: 240 NLTNLKYLDLAVGNLGGKIP-AELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLS 298
L N + N+ + A+L + L +G + + +L L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELK 71
Query: 299 YNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDL 358
N ++ P + NL L ++ + L+ +
Sbjct: 72 DNQITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD 121
Query: 359 GKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQ 418
+I G L L+ L ++
Sbjct: 122 VTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD 181
Query: 419 NNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDIS 466
+N++S P L L + L NN ++ +A++++L + ++
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 37/198 (18%), Positives = 63/198 (31%), Gaps = 20/198 (10%)
Query: 187 PVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKY 246
V+ +L + L G +T I + L+++ + L N+ P++
Sbjct: 34 TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAPLKNLTKITELE 91
Query: 247 LDLAVGNLGGKIPAELGRLEL-------LEIMFLYQNNFQGRLPAEIGNITSLQLLDL-- 297
L I L ++ L + L ++ IT++ L
Sbjct: 92 LSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLT 151
Query: 298 -----SYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSG 352
S + L L L N++S P L L L + L NN +S
Sbjct: 152 NLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD 209
Query: 353 PLPVDLGKNSPLQWLDLS 370
P L S L + L+
Sbjct: 210 VSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 32/221 (14%), Positives = 63/221 (28%), Gaps = 23/221 (10%)
Query: 119 ANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLR 178
L + + ++ + + G+T L+A G + +E + +L L+L+
Sbjct: 16 PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELK 71
Query: 179 GSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEF 238
+ P+ L + I + T +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 239 GNLTNLKYLDLAVGNLGGKIPAE--------------LGRLELLEIMFLYQNNFQGRLPA 284
L + L G + L L L + N P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 285 EIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQ 325
+ ++ +L + L N +S P + NL ++ L NQ
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 35/219 (15%), Positives = 61/219 (27%), Gaps = 22/219 (10%)
Query: 191 KNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLA 250
L + +N+T + + L + T+ I L NL L+L
Sbjct: 16 PALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELK 71
Query: 251 VGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEI 310
+ P + + + T ++ + +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 311 TQLKNLQLLNLMCNQLSGHVPA--------------GLGGLTQLEVLELWNNSLSGPLPV 356
L + L+G L L++L L+ +N +S P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 357 DLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFN 395
L L + L +N S P L N NL + L N
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 31/221 (14%), Positives = 64/221 (28%), Gaps = 18/221 (8%)
Query: 78 KLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGS 137
K+ N++ V+ L +T+L+ G+ +++ + L +L ++ N +
Sbjct: 23 KIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKDNQITDL 78
Query: 138 FPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLK 197
P L+ + + T T + + + L
Sbjct: 79 APLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138
Query: 198 FLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGK 257
+I L+ NL+ L L +
Sbjct: 139 N----------QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188
Query: 258 IPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLS 298
P L L L + L N P + N ++L ++ L+
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.6 bits (123), Expect = 2e-08
Identities = 30/127 (23%), Positives = 59/127 (46%), Gaps = 9/127 (7%)
Query: 437 QRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVG 496
+ L LA+ LT + + ++ +D+S N LR+ P+ + ++ L+ ++
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNAL 55
Query: 497 EIPDQFQDCPSLSVLDLSSNYF-SGSIPSSIASCEKLVNLNLRNNQLTGD---IPKAISM 552
E D + P L L L +N + + SC +LV LNL+ N L + + M
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 553 MPTLAIL 559
+P+++ +
Sbjct: 116 LPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.1 bits (119), Expect = 6e-08
Identities = 24/104 (23%), Positives = 39/104 (37%), Gaps = 6/104 (5%)
Query: 490 SNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKA 549
++ +L + + ++ LDLS N P+ +A+ L L +N L A
Sbjct: 6 AHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVA 62
Query: 550 ISMMPTLAILDLSNNSLTGG-IPENFGASPALEVLNVSYNRLEG 592
L L NN L + + P L +LN+ N L
Sbjct: 63 NLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 3e-06
Identities = 33/142 (23%), Positives = 50/142 (35%), Gaps = 29/142 (20%)
Query: 79 LDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSF 138
L L+H +L+ V H ++L +T L+L N L +LP +LA L L+ S N L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQASDNALE--N 57
Query: 139 PAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKF 198
G+ L L N + + +L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQ-----------------------SAAIQPLVSCPRLVL 94
Query: 199 LGLSGNNLTGKIPRELGQLSSM 220
L L GN+L +L+ M
Sbjct: 95 LNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 5e-06
Identities = 30/136 (22%), Positives = 45/136 (33%), Gaps = 20/136 (14%)
Query: 342 VLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGP 401
VL L + L+ L + + LDLS N P +L L L +NA
Sbjct: 2 VLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 402 IPVSLSTCHSLVRVRMQNNQLSGTIPVG-FGRLEKLQRLELANNSLTGGITDDIASSTSL 460
V+ + + NN+L + + +L L L NSL
Sbjct: 59 DGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ------------ 104
Query: 461 SFIDISRNHLRSSLPS 476
+ + L LPS
Sbjct: 105 --EEGIQERLAEMLPS 118
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 7e-06
Identities = 22/107 (20%), Positives = 43/107 (40%), Gaps = 6/107 (5%)
Query: 463 IDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSI 522
+ ++ L ++ + + + +S+N L P L VL ++ +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQ--ASDNALEN 57
Query: 523 PSSIASCEKLVNLNLRNNQLTG-DIPKAISMMPTLAILDLSNNSLTG 568
+A+ +L L L NN+L + + P L +L+L NSL
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 7e-06
Identities = 30/125 (24%), Positives = 49/125 (39%), Gaps = 6/125 (4%)
Query: 317 QLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSG 376
++L+L L+ V L L + L+L +N L P L L+ L ++ +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNAL 55
Query: 377 EIPASLCNGGNLTKLILFNNAF-SGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEK 435
E + N L +L+L NN L +C LV + +Q N L + E
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 436 LQRLE 440
L +
Sbjct: 116 LPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 2e-05
Identities = 25/105 (23%), Positives = 36/105 (34%), Gaps = 6/105 (5%)
Query: 225 LAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPA 284
LA+ + + L + +LDL+ N +P L L LE++ N +
Sbjct: 5 LAHKDL--TVLCHLEQLLLVTHLDLS-HNRLRALPPALAALRCLEVLQASDNALENVDGV 61
Query: 285 EIGNITSLQLLDLSYNMLSH-EIPAEITQLKNLQLLNLMCNQLSG 328
Q L L N L + L LLNL N L
Sbjct: 62 ANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 1e-04
Identities = 29/109 (26%), Positives = 44/109 (40%), Gaps = 6/109 (5%)
Query: 245 KYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSH 304
+ L LA +L + L +L L+ + L N + P + + L++L S N
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--L 55
Query: 305 EIPAEITQLKNLQLLNLMCNQL-SGHVPAGLGGLTQLEVLELWNNSLSG 352
E + L LQ L L N+L L +L +L L NSL
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 51.8 bits (122), Expect = 2e-07
Identities = 36/312 (11%), Positives = 86/312 (27%), Gaps = 35/312 (11%)
Query: 291 SLQLLDLSYNMLSHE----IPAEITQLKNLQLLNLMCNQLSG----HVPAGLGGLTQLEV 342
S++ L + ++ E + A + + +++ + L N + + + LE+
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 343 LELWNNS---LSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFS 399
E + + +P L ++ A L +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 400 GPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIAS--- 456
+ + + ++ + L+ + N L G + A
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 457 ----------STSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCP 506
+ + + L L + + + P
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243
Query: 507 SLSVLDLSSNYFSGSIPSSIASC------EKLVNLNLRNNQLTGDIPKAI-----SMMPT 555
+L L L+ S +++ L L L+ N++ D + + MP
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 556 LAILDLSNNSLT 567
L L+L+ N +
Sbjct: 304 LLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 50.3 bits (118), Expect = 6e-07
Identities = 42/311 (13%), Positives = 86/311 (27%), Gaps = 32/311 (10%)
Query: 312 QLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGP----LPVDLGKNSPLQWL 367
+ K+L+L + V A L ++ + L N++ L ++ L+
Sbjct: 6 EGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 368 DLSSNS---FSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSG 424
+ S EIP +L + T + + +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 425 TIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNL 484
+ + L ++A + ++ L I RN L +
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 485 QTFIVSNNNLVGEIPDQFQDCPSLSVL-------------DLSSNYFSGSIPSSIASCEK 531
+ + + I + + L L + ++ S ++ ++ S
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 532 LVNLNLRNNQLTGDIPKAISMM------PTLAILDLSNNSLTGGIPENFGAS-----PAL 580
L L L + L+ A+ L L L N + P L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 581 EVLNVSYNRLE 591
L ++ NR
Sbjct: 305 LFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 37/295 (12%), Positives = 81/295 (27%), Gaps = 31/295 (10%)
Query: 282 LPAEIGNITSLQLLDLSYNMLSHEIPAEI-------TQLKNLQLLNLMCNQLSGHVPAGL 334
+ A + S++ + LS N + E + L+ + ++ ++ +P L
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 335 GGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILF 394
L Q + +++ LS ++ + G +
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 395 NNAFSGPIPVSLSTCHSLVRVRMQNNQLS-GTIPVGFGRLEKLQRLELANNSLTGGITDD 453
+ L + N+L G++ + + L G +
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202
Query: 454 IASSTSLSFIDISR------------NHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQ 501
I + S+L + S PNL+ +++ L
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262
Query: 502 FQDC------PSLSVLDLSSNYFSGSIPSSIAS-----CEKLVNLNLRNNQLTGD 545
D L L L N ++ + L+ L L N+ + +
Sbjct: 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.1 bits (102), Expect = 6e-05
Identities = 39/359 (10%), Positives = 89/359 (24%), Gaps = 43/359 (11%)
Query: 194 QKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGE----IPVEFGNLTNLKYLDL 249
+ LK ++ + + L + S++ ++L+ N E + + +L+ +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 250 A---VGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEI 306
+ G + +IP L L + + + A + LS + +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 307 PAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQW 366
L + V L + N L + +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL-ENGSMKEWAKTFQSH 185
Query: 367 LDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTI 426
L + L + + + + H + +
Sbjct: 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 245
Query: 427 PVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQT 486
L + L+ + + S L LQT
Sbjct: 246 RELG----------LNDCLLSARGAAAVVDAFSK------------------LENIGLQT 277
Query: 487 FIVSNNNLVGEIPDQFQD-----CPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNN 540
+ N + + + P L L+L+ N F + ++ + R
Sbjct: 278 LRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 49/308 (15%), Positives = 86/308 (27%), Gaps = 32/308 (10%)
Query: 123 SLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSG----FLLEDLGNATSLETLDLR 178
SLK ++ S A L + + SGN +L E++ + LE +
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 179 GSFFQ---GSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIP 235
F IP + + L + + + L+ + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 236 VEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLL 295
+ L +A + + L + +N + E L
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 296 DLSYNMLSHEIPAEITQLKNLQLLN-------------LMCNQLSGHVPAGLGGLTQLEV 342
+ M+ + I E + L+ L + S + L L
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 343 LELWNNSLSGPLPVDLG------KNSPLQWLDLSSNSFSGEIPASLCNG-----GNLTKL 391
L L + LS + +N LQ L L N + +L +L L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 392 ILFNNAFS 399
L N FS
Sbjct: 308 ELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.003
Identities = 44/327 (13%), Positives = 86/327 (26%), Gaps = 48/327 (14%)
Query: 185 SIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNL 244
S+ +K + LSGN + + R L + + +L
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSEN--------------------IASKKDL 61
Query: 245 KYLDLA---VGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNM 301
+ + + G + +IP L L + + + A + LS +
Sbjct: 62 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 121
Query: 302 LSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLS----GPLPVD 357
+ L + V L + N L
Sbjct: 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181
Query: 358 LGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLIL---------FNNAFSGPIPVSLST 408
+ L + + N E L G L F + S + ++L +
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241
Query: 409 CHSLVRVRMQNNQLSGTIPV------GFGRLEKLQRLELANNSLTGGITDDIASS----- 457
+L + + + LS LQ L L N + + +
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301
Query: 458 TSLSFIDISRNHLRSSLPSTILSIPNL 484
L F++++ N S + I +
Sbjct: 302 PDLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 3e-07
Identities = 21/95 (22%), Positives = 35/95 (36%), Gaps = 9/95 (9%)
Query: 490 SNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKA 549
N EI PSL L++S+N +P+ +L L N L ++P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVP-- 320
Query: 550 ISMMPTLAILDLSNNSLTGGIPENFGASPALEVLN 584
+ L L + N L P+ + L + +
Sbjct: 321 -ELPQNLKQLHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 23/101 (22%), Positives = 42/101 (41%), Gaps = 9/101 (8%)
Query: 220 METMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQ 279
+ + N EI +L+ L+++ N ++PA RLE L N+
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVS-NNKLIELPALPPRLERL---IASFNHLA 317
Query: 280 GRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLN 320
+P N L+ L + YN L E P +++L++ +
Sbjct: 318 -EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 4e-07
Identities = 23/91 (25%), Positives = 36/91 (39%), Gaps = 9/91 (9%)
Query: 466 SRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSS 525
N + + S P+L+ VSNN L+ E+P P L L S N+ + +P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPEL 322
Query: 526 IASCEKLVNLNLRNNQLTGDIPKAISMMPTL 556
+ L L++ N L P + L
Sbjct: 323 PQN---LKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 24/97 (24%), Positives = 40/97 (41%), Gaps = 12/97 (12%)
Query: 443 NNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQF 502
N+ + I SL +++S N L LP+ P L+ I S N+L E+P+
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKL-IELPA---LPPRLERLIASFNHL-AEVPELP 323
Query: 503 QDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRN 539
Q +L L + N P S + +L + +
Sbjct: 324 Q---NLKQLHVEYNPLR-EFPDIPES---VEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 4e-06
Identities = 23/92 (25%), Positives = 37/92 (40%), Gaps = 9/92 (9%)
Query: 297 LSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLPV 356
N S+EI + +L+ LN+ N+L +PA +LE L N L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLAE-VPE 321
Query: 357 DLGKNSPLQWLDLSSNSFSGEIPASLCNGGNL 388
L+ L + N E P + +L
Sbjct: 322 LPQN---LKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 7e-06
Identities = 20/93 (21%), Positives = 38/93 (40%), Gaps = 9/93 (9%)
Query: 345 LWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPV 404
+ N+ S + L+ L++S+N E+PA L +LI N + +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLAE-VPE 321
Query: 405 SLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQ 437
+L ++ ++ N L P +E L+
Sbjct: 322 LPQ---NLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 8e-06
Identities = 24/101 (23%), Positives = 39/101 (38%), Gaps = 12/101 (11%)
Query: 271 MFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHV 330
Y N + + SL+ L++S N L E+PA +L+ L N L+ V
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EV 319
Query: 331 PAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSS 371
P L+ L + N L P ++ L ++S
Sbjct: 320 P---ELPQNLKQLHVEYNPLRE-FPDIPES---VEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 8e-06
Identities = 20/117 (17%), Positives = 31/117 (26%), Gaps = 10/117 (8%)
Query: 54 HDWKLPSAHCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSS 113
+ + + + + S + SL LN+ N L
Sbjct: 240 PELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IE 298
Query: 114 LPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGF--LLEDLGN 168
LP L L S N L P L L+ N F + E + +
Sbjct: 299 LPALPPRLERL---IASFNHLA-EVPELPQ---NLKQLHVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 1e-05
Identities = 25/80 (31%), Positives = 34/80 (42%), Gaps = 8/80 (10%)
Query: 513 LSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPE 572
N S I S L LN+ NN+L ++P ++ P L L S N L +PE
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPE 321
Query: 573 NFGASPALEVLNVSYNRLEG 592
L+ L+V YN L
Sbjct: 322 LPQ---NLKQLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 22/93 (23%), Positives = 37/93 (39%), Gaps = 9/93 (9%)
Query: 393 LFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITD 452
+ NA S I SL + + NN+L +P RLE+L + N L + +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPE 321
Query: 453 DIASSTSLSFIDISRNHLRSSLPSTILSIPNLQ 485
+L + + N L P S+ +L+
Sbjct: 322 LP---QNLKQLHVEYNPL-REFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 3e-05
Identities = 51/322 (15%), Positives = 96/322 (29%), Gaps = 25/322 (7%)
Query: 290 TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNS 349
L+L+ LS +P +L+ L CN L+ +P L+ L + NN+
Sbjct: 38 RQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQ---SLKSLLVDNNN 89
Query: 350 LSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTC 409
L + L+ S + + K+I +N +P +
Sbjct: 90 LKALSDLP-------PLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSL 142
Query: 410 HSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNH 469
+ Q +L + F L + I + ++ +
Sbjct: 143 EFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQN 202
Query: 470 LRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASC 529
L + + + + D + S F + +
Sbjct: 203 LPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELP---QSLTFLDVSENIFSGL 259
Query: 530 EKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNR 589
+L N + +I + P+L L++SNN L +P P LE L S+N
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNH 315
Query: 590 LEGPVPANGVLRTINRGDLAGN 611
L L+ + + N
Sbjct: 316 LAEVPELPQNLKQL---HVEYN 334
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 9e-04
Identities = 18/90 (20%), Positives = 27/90 (30%), Gaps = 10/90 (11%)
Query: 130 SQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVS 189
N + + L LN S N LE L + +P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLIELP----ALPPRLERLIASFNHLA-EVPEL 322
Query: 190 FKNLQKLKFLGLSGNNLTG--KIPRELGQL 217
+NL++L + N L IP + L
Sbjct: 323 PQNLKQLH---VEYNPLREFPDIPESVEDL 349
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (113), Expect = 7e-07
Identities = 29/144 (20%), Positives = 51/144 (35%), Gaps = 12/144 (8%)
Query: 426 IPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQ 485
+ + + + L L +D + ++ + R+ + ++L +IP L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR---SDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELL 68
Query: 486 TFIVSNNNLVG--EIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLT 543
+ +SNN L ++ Q P+L +L+LS N KL L L N L+
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 544 GDIP-------KAISMMPTLAILD 560
P L LD
Sbjct: 129 DTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (103), Expect = 2e-05
Identities = 22/146 (15%), Positives = 45/146 (30%), Gaps = 6/146 (4%)
Query: 296 DLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLSGPLP 355
+L + + +++ + L L L VL ++ + L
Sbjct: 3 ELKPEQVEQ-LKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAAT-LR 58
Query: 356 VDLGKNSPLQWLDLSSNSFSG--EIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLV 413
+ L L+LS+N ++ + + NL L L N + L
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 414 RVRMQNNQLSGTIPVGFGRLEKLQRL 439
+ + N LS T + ++
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRER 144
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 3e-05
Identities = 24/116 (20%), Positives = 42/116 (36%), Gaps = 4/116 (3%)
Query: 464 DISRNHLRSSLPSTILSIPNLQTFIVSN--NNLVGEIPDQFQDCPSLSVLDLSSNYFSG- 520
D S+ L + + +V N +++ + ++ P L L+LS+N
Sbjct: 21 DGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRL 80
Query: 521 -SIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFG 575
+ S + L LNL N+L + L L L NSL+ +
Sbjct: 81 DDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQST 136
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 3e-05
Identities = 27/125 (21%), Positives = 50/125 (40%), Gaps = 5/125 (4%)
Query: 233 EIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSL 292
++ + + L + L + +L + ++ +++ L NI L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPEL 67
Query: 293 QLLDLSYNMLSH--EIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSL 350
L+LS N L ++ + + + NL++LNL N+L +LE L L NSL
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 351 SGPLP 355
S
Sbjct: 128 SDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 2e-04
Identities = 24/125 (19%), Positives = 40/125 (32%), Gaps = 5/125 (4%)
Query: 281 RLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQL 340
+L + L L ++ +LN + + + + +L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPEL 67
Query: 341 EVLELWNNSLSG--PLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAF 398
L L NN L + + K L+ L+LS N E G L +L L N+
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 399 SGPIP 403
S
Sbjct: 128 SDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 5e-04
Identities = 26/133 (19%), Positives = 45/133 (33%), Gaps = 5/133 (3%)
Query: 472 SSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEK 531
L + + + L VL+ S+ + ++ + +
Sbjct: 10 EQLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPE 66
Query: 532 LVNLNLRNNQLTG--DIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNR 589
L++LNL NN+L D+ + P L IL+LS N L + LE L + N
Sbjct: 67 LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 590 LEGPVPANGVLRT 602
L +
Sbjct: 127 LSDTFRDQSTYIS 139
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.5 bits (111), Expect = 2e-06
Identities = 35/186 (18%), Positives = 61/186 (32%), Gaps = 9/186 (4%)
Query: 407 STCH-SLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASS-TSLSFID 464
+ CH V L IP L L +N L +D + L ++
Sbjct: 4 AMCHCEGTTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLE 60
Query: 465 ISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPS 524
+ RN L P+ ++Q + N + F L L+L N S +P
Sbjct: 61 LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG 120
Query: 525 SIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLN 584
S L +LNL +N + L L+ + G P +++ +
Sbjct: 121 SFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSKVR---DVQIKD 176
Query: 585 VSYNRL 590
+ ++
Sbjct: 177 LPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.1 bits (97), Expect = 1e-04
Identities = 37/181 (20%), Positives = 64/181 (35%), Gaps = 15/181 (8%)
Query: 62 HCNWTGVWCNSNG----------AVEKLDLSHMNLSGCVSDHFQRLKS-LTSLNLCCNGL 110
HC T V C G +L L+ L SD L L L N L
Sbjct: 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL 66
Query: 111 FSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNAT 170
PN+ + ++ + +N + G L LN N S + +
Sbjct: 67 TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126
Query: 171 SLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEF 230
SL +L+L + F + +++ + L+ L+G P ++ + + L ++EF
Sbjct: 127 SLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSKVRDVQIKD---LPHSEF 182
Query: 231 D 231
Sbjct: 183 K 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.6 bits (93), Expect = 4e-04
Identities = 28/158 (17%), Positives = 50/158 (31%), Gaps = 5/158 (3%)
Query: 170 TSLETLDLRGSFFQGSIPVSFKNLQK-LKFLGLSGNNLTGKIPRELGQLSSMETMILAYN 228
L L + L L L N LTG P S ++ + L N
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 229 EFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGN 288
+ F L LK L+L + +P L L + +N
Sbjct: 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNPFNCNCHLAWF 147
Query: 289 ITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQL 326
L+ L+ P++ ++++Q+ +L ++
Sbjct: 148 AEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEF 182
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 9e-06
Identities = 31/216 (14%), Positives = 68/216 (31%), Gaps = 22/216 (10%)
Query: 282 LPAEIGNI------TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLG 335
+P I I +L ++ + +L ++ + + + G+
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGIQ 65
Query: 336 GLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFN 395
L + L L N L+ P+ + L+ L + S K +
Sbjct: 66 YLPNVTKLFLNGNKLTDIKPL-----ANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE 120
Query: 396 NAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIA 455
+ I + N T+ +L+ L + + + +A
Sbjct: 121 HNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-----PLA 175
Query: 456 SSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSN 491
T L + +S+NH+ S L + + + NL + +
Sbjct: 176 GLTKLQNLYLSKNHI-SDLRA-LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 32/221 (14%), Positives = 74/221 (33%), Gaps = 20/221 (9%)
Query: 347 NNSLSGPLPVDLGKNSP----LQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPI 402
+ +++ P P+ + +L S + + + N ++ ++I N+
Sbjct: 5 SETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELN--SIDQIIANNSDIKSVQ 62
Query: 403 PVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSF 462
+ ++ ++ + N+L+ L L+ L
Sbjct: 63 G--IQYLPNVTKLFLNGNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLK 115
Query: 463 IDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSI 522
++ S + + ++ +N L L L N S +
Sbjct: 116 SLSLEHNGISDINGLVHLPQLESLYLGNNKIT---DITVLSRLTKLDTLSLEDNQISDIV 172
Query: 523 PSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSN 563
P +A KL NL L N ++ D+ A++ + L +L+L +
Sbjct: 173 P--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 7e-05
Identities = 33/178 (18%), Positives = 61/178 (34%), Gaps = 14/178 (7%)
Query: 170 TSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNE 229
S++ + S + + L + L L+GN LT P L L ++ + L N+
Sbjct: 46 NSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENK 101
Query: 230 FDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNI 289
++ +L +++ L L + + +
Sbjct: 102 VKDLSSLKDLKKLK-------SLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSR 154
Query: 290 TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWN 347
+ + +I + L LQ L L N +S L GL L+VLEL++
Sbjct: 155 LTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 32/200 (16%), Positives = 69/200 (34%), Gaps = 16/200 (8%)
Query: 387 NLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSL 446
K L + + + + + +S+ ++ N+ + G L + +L L N L
Sbjct: 25 ETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKL 80
Query: 447 TGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCP 506
T + F+D ++ + +S + + P
Sbjct: 81 TDIKPLANLKNLGWLFLDENKVK------DLSSLKDLKKLKSLSLEHNGISDINGLVHLP 134
Query: 507 SLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSL 566
L L L +N + S + ++L +NQ++ +P ++ + L L LS N +
Sbjct: 135 QLESLYLGNNKITDITVLSRLTKLDTLSLE--DNQISDIVP--LAGLTKLQNLYLSKNHI 190
Query: 567 TGGIPENFGASPALEVLNVS 586
+ L+VL +
Sbjct: 191 SD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 29/204 (14%), Positives = 63/204 (30%), Gaps = 16/204 (7%)
Query: 336 GLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFN 395
+ L S++ + + + + + +++ + N+TKL L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQNELNS--IDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 396 NAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIA 455
N + P++ + + + ++ + SL DI
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKL---------KSLSLEHNGISDIN 128
Query: 456 SSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSS 515
L ++ T+LS + +N + +I L L LS
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSK 187
Query: 516 NYFSGSIPSSIASCEKLVNLNLRN 539
N+ S ++A + L L L +
Sbjct: 188 NHISD--LRALAGLKNLDVLELFS 209
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (102), Expect = 2e-05
Identities = 24/136 (17%), Positives = 45/136 (33%), Gaps = 7/136 (5%)
Query: 189 SFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLD 248
+ N + + L L G + I L + + + NE F L LK L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKTLL 69
Query: 249 LAVGNLGGKIPAELGRLELLEIMFLYQNNFQG----RLPAEIGNITSLQLLDLSYNMLSH 304
+ + L L + L N+ A + ++T L +L H
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 305 EIPAEITQLKNLQLLN 320
I ++ +++L+
Sbjct: 130 YRLYVIYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 2e-04
Identities = 29/137 (21%), Positives = 51/137 (37%), Gaps = 7/137 (5%)
Query: 430 FGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIV 489
+ + + L+L + I + A+ ID S N +R +L L+T +V
Sbjct: 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFPLL--RRLKTLLV 70
Query: 490 SNNNLVGEIPDQFQDCPSLSVLDLSSNYFSG-SIPSSIASCEKLVNLNLRN---NQLTGD 545
+NN + Q P L+ L L++N +AS + L L +
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY 130
Query: 546 IPKAISMMPTLAILDLS 562
I +P + +LD
Sbjct: 131 RLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.003
Identities = 23/162 (14%), Positives = 42/162 (25%), Gaps = 31/162 (19%)
Query: 91 SDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTF 150
+ + L+L + + N A L D S N +
Sbjct: 11 AAQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEI---------------- 53
Query: 151 LNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTG-K 209
L+ L+TL + + + L L L L+ N+L
Sbjct: 54 ----------RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELG 103
Query: 210 IPRELGQLSSMETMIL---AYNEFDGEIPVEFGNLTNLKYLD 248
L L S+ + + + ++ LD
Sbjct: 104 DLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 7e-05
Identities = 28/217 (12%), Positives = 61/217 (28%), Gaps = 6/217 (2%)
Query: 329 HVPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNL 388
+P+ L L L L+ +++S N I A + +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 389 TKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLS----GTIPVGFGRLEKLQRLELANN 444
I A + + + + + + + L ++ N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 445 SLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQD 504
T + S + +++N ++ + + NNNL D F
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 505 CPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQ 541
+LD+S + + +KL + N +
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 29/238 (12%), Positives = 64/238 (26%), Gaps = 10/238 (4%)
Query: 291 SLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSL 350
S ++ + ++ EIP+++ +N L + +L G LE +E+ N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 351 SGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCH 410
+ D+ N P + + L + + H
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 411 SL----VRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDIS 466
SL + ++ N + G + L L N + +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 467 RNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPS 524
N+L +S + ++ L + +P+
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 26/227 (11%), Positives = 47/227 (20%), Gaps = 7/227 (3%)
Query: 367 LDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTI 426
+ + EIP+ L N +L + S L ++ + N + I
Sbjct: 13 FLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 427 PVGFGRLEKLQRLEL----ANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIP 482
N + I + +
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 483 NLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQL 542
L + N E +L L+ N + + NN L
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 543 TGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNR 589
ILD+S + L + +
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 22/216 (10%), Positives = 48/216 (22%), Gaps = 6/216 (2%)
Query: 354 LPVDLGKNSPLQWLDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSL- 412
+P DL +N L + G+L K+ + N I + +
Sbjct: 23 IPSDLPRN--AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 413 ---VRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNH 469
+ N + + + + L I + N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 470 LRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASC 529
S + ++ N + F + +N
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 530 EKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNS 565
V L++ ++ + + L N
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.002
Identities = 12/79 (15%), Positives = 23/79 (29%)
Query: 271 MFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHV 330
++L +N Q +L N L +L++ ++
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 331 PAGLGGLTQLEVLELWNNS 349
GL L +L +N
Sbjct: 218 SYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 12/71 (16%), Positives = 18/71 (25%)
Query: 62 HCNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANL 121
N E + NL +D F L++ + S L NL
Sbjct: 165 IQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 224
Query: 122 TSLKRFDVSQN 132
L+
Sbjct: 225 KKLRARSTYNL 235
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (97), Expect = 8e-05
Identities = 21/148 (14%), Positives = 38/148 (25%), Gaps = 2/148 (1%)
Query: 408 TCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASS-TSLSFIDIS 466
H +R + E L L + N + L + I
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 467 RNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSI 526
++ LR P P L +S N L Q ++ + +
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124
Query: 527 ASCEKLVNLNLRNNQLTGDIPKAISMMP 554
E+ + +L ++ MP
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQGPLAHMP 152
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 5e-04
Identities = 20/112 (17%), Positives = 34/112 (30%), Gaps = 3/112 (2%)
Query: 456 SSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIP-DQFQDCPSLSVLDLS 514
S + +R+ + NL + N + + + L L +
Sbjct: 6 CPHGSSGLRCTRDGA-LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 515 SNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSL 566
+ P + +L LNL N L + +L L LS N L
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 0.001
Identities = 23/147 (15%), Positives = 43/147 (29%), Gaps = 4/147 (2%)
Query: 196 LKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVE-FGNLTNLKYLDLAVGNL 254
L + + L ++ + + + + + L L+ L + L
Sbjct: 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 255 GGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLS-HEIPAEITQL 313
P L + L N + L + SLQ L LS N L + +
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRW 127
Query: 314 KNLQLLNLMCNQLSGHVPAGLGGLTQL 340
+ L + +L H L +
Sbjct: 128 EEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.002
Identities = 27/122 (22%), Positives = 44/122 (36%), Gaps = 2/122 (1%)
Query: 505 CPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQ-LTGDIPKAISMMPTLAILDLSN 563
S L + + + E L L + N Q L + + + L L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 564 NSLTGGIPENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVLHPCS 623
+ L P+ F +P L LN+S+N LE ++ L+GN C L
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125
Query: 624 RY 625
R+
Sbjct: 126 RW 127
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (84), Expect = 0.003
Identities = 24/149 (16%), Positives = 41/149 (27%), Gaps = 17/149 (11%)
Query: 290 TSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGL-GGLTQLEVLELWNN 348
L + + + + +NL L + Q H+ GL +L L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 349 SLSGPLPVDLGKNSPLQWLDLSSNSFSGEIPASLCN---------------GGNLTKLIL 393
L P L L+LS N+ ++ L L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 394 FNNAFSGPIPVSLSTCHSLVRVRMQNNQL 422
+ G +P CH + N
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 29/201 (14%), Positives = 61/201 (30%), Gaps = 16/201 (7%)
Query: 119 ANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLR 178
L + + + + + +T L A ++ + +L ++
Sbjct: 15 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 70
Query: 179 GSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEF 238
+ P+ +I + L
Sbjct: 71 NNQLTDITPLKNLTKLVDIL------MNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 124
Query: 239 GNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLS 298
NLTNL L+L+ + + L ++ Q + N+T+L+ LD+S
Sbjct: 125 KNLTNLNRLELSSNTISDISALSGLT----SLQQLNFSSNQVTDLKPLANLTTLERLDIS 180
Query: 299 YNMLSHEIPAEITQLKNLQLL 319
N +S + + +L NL+ L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.7 bits (86), Expect = 0.003
Identities = 15/62 (24%), Positives = 27/62 (43%), Gaps = 3/62 (4%)
Query: 288 NITSLQLLDLSYNMLSHE-IPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELW 346
T + ++L + E + A ++ LK + L L N + + L G+ L +L L
Sbjct: 21 VATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE--KISSLSGMENLRILSLG 78
Query: 347 NN 348
N
Sbjct: 79 RN 80
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1018 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.95 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.93 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.92 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.92 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.91 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.91 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.89 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.77 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.77 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.72 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.66 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.64 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.6 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.59 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.58 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.14 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 99.04 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.92 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.78 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.73 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.32 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.17 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.0 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.78 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.6 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.18 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=210.3
Q ss_pred HHHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEE
Q ss_conf 86226534444107880299999189992999999522234321002666999999982367887012554686499139
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
..++|+..+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..|
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG----CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCC----CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
T ss_conf 5105388789812858299999998999899999984301----727999999999998679998805857798899989
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf 99971479997776303877753338999999999999999976219999919604799968775999809925413244
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~ 862 (1018)
+||||++||+|.+++.... +++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+|+.
T Consensus 94 ivmEy~~gg~L~~~~~~~~-----l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (293)
T ss_dssp EEEECCTTCBHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEECCCCCHHHHHHCCC-----CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf 9997037980898864159-----99999999999999999999987---972267768886887899686425156413
Q ss_pred ECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 11489505762357786686777989978544206699999999968999999988830099999998513563001149
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
+..........+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+... ............
T Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~~~------- 233 (293)
T d1yhwa1 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLIATNGT------- 233 (293)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHHCS-------
T ss_pred ECCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHCCC-------
T ss_conf 21366644444447773682664479988012031372999998048899899799-----999999985799-------
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 9988992039999999999987127999999998999999
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
+.... .......+.+++.+||++||++|||++|++++
T Consensus 234 ~~~~~---~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 234 PELQN---PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CCCSS---GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCC---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 98888---55379999999999866996689099999649
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.57 Aligned_cols=268 Identities=23% Similarity=0.358 Sum_probs=208.4
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEE
Q ss_conf 62265344441078802999991899929999995222343210026669999999823678870125546864991399
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|+..+.||+|+||+||+|.+..+++.||+|++.... ......++.+|+.++++++|||||++++++.+++..++
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf 568889789712778099999998999699999987540---97899999999999986799999949999998999999
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEE
Q ss_conf 99714799977763038777533389999999999999999762199999196047999687759998099254132441
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~ 863 (1018)
||||++||+|.+++..... +++..+..++.|++.||.|||+++ +|+||||||+||+++.++.+||+|||+|+.+
T Consensus 82 VmEy~~gg~L~~~l~~~~~----l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEECCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEECCCCCCHHHHHHHCCC----CCHHHHHHHHHHHHHHHHHHHHHC--CEECCCCCHHHEEECCCCCEEEEECCCCCCC
T ss_conf 9976799868998742499----999999999999999999999859--9971445779946878998999548776256
Q ss_pred CCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHC----------
Q ss_conf 1489505762357786686777989978544206699999999968999999988830099999998513----------
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD---------- 933 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 933 (1018)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+..................
T Consensus 156 ~~--~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 156 ID--SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HH--HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CC--CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 78--8621113771411946875899894888998999999999888998998878999999887517754577421233
Q ss_pred CCCC-CCCCCCCCCCC---------------CHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 5630-01149998899---------------2039999999999987127999999998999999
Q 001752 934 NRNL-EEALDPNVGNC---------------KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 934 ~~~~-~~~~~~~~~~~---------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
.... ....+...... .........+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 32211112223541347788766502687667644489999999999868994679089999609
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.81 Aligned_cols=254 Identities=25% Similarity=0.346 Sum_probs=206.7
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEE
Q ss_conf 62265344441078802999991899929999995222343210026669999999823678870125546864991399
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|++.+.||+|+||+||+|++..+++.||+|++..... ....+.+.+|+.++++++||||+++++++.+++..|+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEE
T ss_conf 7460899897217480999999999997999999845664---1279999999999985799888469654046743679
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEE
Q ss_conf 99714799977763038777533389999999999999999762199999196047999687759998099254132441
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~ 863 (1018)
||||+++|+|.+++..... +++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+|+..
T Consensus 81 vmEy~~gg~L~~~l~~~~~----l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 153 (271)
T ss_dssp EEECCTTEEGGGGSBTTTB----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHCCCC----CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEE
T ss_conf 8864589808999753799----99999999999999999999975---9835754689978878998798323142240
Q ss_pred CCCCC--CEEEECCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 14895--0576235778668677798997-85442066999999999689999999888300999999985135630011
Q 001752 864 IRKNE--TVSMVAGSYGYIAPEYGYTLKV-DEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 864 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
..... .....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.............. ......
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-----~~~~~~-- 226 (271)
T d1nvra_ 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKKTYL-- 226 (271)
T ss_dssp EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH-----TTCTTS--
T ss_pred CCCCCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH-----CCCCCC--
T ss_conf 4688653111325574742872861899999710161737999999829978888985999999986-----388878--
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 499988992039999999999987127999999998999999
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
+ ........+.+++.+||+.||++|||++|++++
T Consensus 227 --~------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 227 --N------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp --T------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --C------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --8------644699999999999767996689099999619
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.10 Aligned_cols=249 Identities=28% Similarity=0.409 Sum_probs=207.5
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 22653444410788029999918999299999952223432100266699999998236788701255468649913999
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 784 (1018)
+.|++.+.||+|+||.||+|++..+++.||+|++.+... ........+.+|+.++++++||||+++++++.+++..|+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf 376998898517785899999989994999999816885-6768999999999999856888888599999989998999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEEC
Q ss_conf 97147999777630387775333899999999999999997621999991960479996877599980992541324411
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~ 864 (1018)
|||+++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 85 mEy~~~g~L~~~l~~~~~----l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred EEECCCCCHHHHHHHCCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECC
T ss_conf 850479858988750489----99999999999999999999988---94652202344146689987115556335448
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 48950576235778668677798997854420669999999996899999998883009999999851356300114999
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..............+.+
T Consensus 158 --~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~~~~p~----- 225 (263)
T d2j4za1 158 --SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEFTFPD----- 225 (263)
T ss_dssp --CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTTCCCCCT-----
T ss_pred --CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHCCCCCCCC-----
T ss_conf --885235578876349999758998931440467599999832999988899-----99999999718999986-----
Q ss_pred CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 8899203999999999998712799999999899999
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVIT 981 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 981 (1018)
.....+.+++.+||++||++|||++|+++
T Consensus 226 --------~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 226 --------FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf --------68999999999976479768909999971
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=364.99 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=209.6
Q ss_pred HHHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEE
Q ss_conf 86226534444107880299999189992999999522234321002666999999982367887012554686499139
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
+.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..|
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC----CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 865758988984076819999998899989999998452----4316999999999998679979992999999899999
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECC--CCCEEECCCCCC
Q ss_conf 999714799977763038777533389999999999999999762199999196047999687759--998099254132
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS--NLEPRIADFGLA 860 (1018)
Q Consensus 783 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfg~a 860 (1018)
+||||++||+|.+++..... .+++..+..++.||+.||+|||++ ||+||||||+||+++. ++.+||+|||++
T Consensus 100 ivmE~~~gg~L~~~l~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a 173 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLT 173 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTS---CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEECCCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHH
T ss_conf 99985799889999976237---899999999999999999999756---976000154673641688986999545210
Q ss_pred EEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 44114895057623577866867779899785442066999999999689999999888300999999985135630011
Q 001752 861 RMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 861 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
+.+. .........||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.. ..+...............
T Consensus 174 ~~~~-~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~~~~~~~ 247 (350)
T d1koaa2 174 AHLD-PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----DDETLRNVKSCDWNMDDS 247 (350)
T ss_dssp EECC-TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCCCSCCG
T ss_pred EECC-CCCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHCCCCCCCC
T ss_conf 4425-6543200068624218899758998726765546599999985989989979-----999999998478898942
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 499988992039999999999987127999999998999999
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
........+.+++.+||+.||++|||++|++++
T Consensus 248 ---------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 ---------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---------235899999999999756896679089998629
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=362.06 Aligned_cols=258 Identities=21% Similarity=0.282 Sum_probs=210.6
Q ss_pred HHHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEE
Q ss_conf 86226534444107880299999189992999999522234321002666999999982367887012554686499139
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
+.+.|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++.+++..|
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC----HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 5403599899931778299999998999799999988726----467999999999998679979891999999899999
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEEC--CCCCEEECCCCCC
Q ss_conf 99971479997776303877753338999999999999999976219999919604799968775--9998099254132
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLD--SNLEPRIADFGLA 860 (1018)
Q Consensus 783 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfg~a 860 (1018)
+||||++||+|.+.+..... .+++..+..++.||+.||+|||++ ||+||||||+|||++ .++.+||+|||+|
T Consensus 103 ivmE~~~gg~L~~~~~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTC---CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEECCCCCHHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCC
T ss_conf 99982899808888986389---989999999999999999999977---926513144553113467884899525630
Q ss_pred EEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 44114895057623577866867779899785442066999999999689999999888300999999985135630011
Q 001752 861 RMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 861 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
+.+.. ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.. ..................
T Consensus 177 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~~ 250 (352)
T d1koba_ 177 TKLNP-DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----DLETLQNVKRCDWEFDED 250 (352)
T ss_dssp EECCT-TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHHCCCCCCSS
T ss_pred EECCC-CCCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHCCCCCCCC
T ss_conf 34378-872010047645348999747998976333898999999996889989979-----999999998478898930
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHC
Q ss_conf 499988992039999999999987127999999998999999--400
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM--LGE 985 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~ 985 (1018)
.. ......+.+++.+||+.||.+|||+.|++++ ++.
T Consensus 251 ~~---------~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 251 AF---------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp TT---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred CC---------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 02---------479999999999975699668918999960973488
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.18 Aligned_cols=254 Identities=23% Similarity=0.316 Sum_probs=206.3
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEE
Q ss_conf 62265344441078802999991899929999995222343210026669999999823678870125546864991399
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCC----CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
T ss_conf 03759847993077819999999999939999998728----99999999999999986799998849889800995899
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEE
Q ss_conf 99714799977763038777533389999999999999999762199999196047999687759998099254132441
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~ 863 (1018)
||||+++|+|.+++..... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 87 vmEy~~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp EEECCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCC
T ss_conf 9962799818899986289---999999999999999999999988---9887140700314878999899716123035
Q ss_pred CCCCCCEEEECCCCCCCCCCCCC-----CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 14895057623577866867779-----8997854420669999999996899999998883009999999851356300
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGY-----TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
...........||+.|+|||++. +..++.++||||+||++|||++|+.||.+... .+....+ .....
T Consensus 161 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--~~~~~~i---~~~~~--- 232 (288)
T d2jfla1 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MRVLLKI---AKSEP--- 232 (288)
T ss_dssp HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--GGHHHHH---HHSCC---
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH---HCCCC---
T ss_conf 778641001025626479999832025788888066578789999998208899999899--9999999---70799---
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 11499988992039999999999987127999999998999999
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
+.... .......+.+++.+||+.||++|||++|++++
T Consensus 233 ----~~~~~---~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 233 ----PTLAQ---PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ----CCCSS---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ----CCCCC---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ----87776---56699999999999766996689199999629
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.79 Aligned_cols=259 Identities=24% Similarity=0.317 Sum_probs=209.4
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEEC--CCCEE
Q ss_conf 2265344441078802999991899929999995222343210026669999999823678870125546864--99139
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN--DTNMM 782 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 782 (1018)
+.|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+.+|+.++++++||||+++++++.+ ....|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT--SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
T ss_conf 33799679830889199999999999799999987465--7979999999999999977899982489999917899899
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--CCCEEEECCCCCCEEECCCCCEEECCCCCC
Q ss_conf 999714799977763038777533389999999999999999762199--999196047999687759998099254132
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDC--YPPIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 783 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a 860 (1018)
+||||+++|+|.+++......+..+++..++.++.|++.||.|||++. ..+|+||||||+||+++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCE
T ss_conf 99956899938999985154578999999999999999999999971677887885867654257478885798001000
Q ss_pred EEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 44114895057623577866867779899785442066999999999689999999888300999999985135630011
Q 001752 861 RMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 861 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
+.+...........||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..++...+ .... .
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--~~~~~~~i----~~~~-~--- 231 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--QKELAGKI----REGK-F--- 231 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHH----HHTC-C---
T ss_pred EECCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCC--HHHHHHHH----HCCC-C---
T ss_conf 322457775566778823279999839999938988752789999801889989989--99999999----7189-9---
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 499988992039999999999987127999999998999999
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
.+.... ....+.+++.+||+.||.+|||++|++++
T Consensus 232 -~~~~~~------~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 -RRIPYR------YSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -CCCCTT------SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCCCC------CCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf -889743------59999999999767995579189999729
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=364.62 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=208.8
Q ss_pred HHHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEE
Q ss_conf 86226534444107880299999189992999999522234321002666999999982367887012554686499139
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
+.+.|++.+.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.++++++||||+++++++.+++..|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHH---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 766669988994065839999999999989999998157731---28999999999998679989991989999899888
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEEC---CCCCEEECCCCC
Q ss_conf 99971479997776303877753338999999999999999976219999919604799968775---999809925413
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLD---SNLEPRIADFGL 859 (1018)
Q Consensus 783 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfg~ 859 (1018)
+||||++||+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||++. .++.+|++|||+
T Consensus 84 lvmE~~~gg~L~~~l~~~~~----l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp EEECCCCSCBHHHHHHTCSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred EEEECCCCCCHHHHHHCCCC----CCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCE
T ss_conf 98852689848886530367----88789999999999998752413---055687046300110468882499831543
Q ss_pred CEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 24411489505762357786686777989978544206699999999968999999988830099999998513563001
Q 001752 860 ARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 860 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
|+.... .......+||+.|+|||++.+..+++++||||+||++|||++|+.||.+.. .................
T Consensus 157 a~~~~~-~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~~~~~~~ 230 (307)
T d1a06a_ 157 SKMEDP-GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN-----DAKLFEQILKAEYEFDS 230 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHTTCCCCCT
T ss_pred EEECCC-CCEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHCCCCCCCC
T ss_conf 587258-970440032842259188737999807873451599999985979999989-----99999998616877787
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1499988992039999999999987127999999998999999
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
+.. ......+.+++.+||++||++|||++|++++
T Consensus 231 ---~~~------~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 231 ---PYW------DDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---TTT------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---666------6789999999999760897579189998629
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.60 Aligned_cols=263 Identities=31% Similarity=0.429 Sum_probs=205.5
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEE
Q ss_conf 62265344441078802999991899929999995222343210026669999999823678870125546864991399
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.++|+..+.||+|+||+||+|+.. ..||||++... .......+.|.+|+.++++++||||+++++++.+ ...++
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVT--APTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCS--SCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECC--CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEE
T ss_conf 451899889830788589999999---98999999734--6998999999999999984799878645679715-58999
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEE
Q ss_conf 99714799977763038777533389999999999999999762199999196047999687759998099254132441
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~ 863 (1018)
||||+++|+|.+++..... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 81 v~Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEECCCCCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEEC
T ss_conf 9965899888999852357---899999999999999998887509---9951614789979818997887500221333
Q ss_pred CCCCC--CEEEECCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 14895--0576235778668677798---997854420669999999996899999998883009999999851356300
Q 001752 864 IRKNE--TVSMVAGSYGYIAPEYGYT---LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 864 ~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..... .+...+. ...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~~----~~~--- 226 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVG----RGY--- 226 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHH----HTS---
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHH----CCC---
T ss_conf 55677631256655743179999950568999953151635999999997889989989699-9999996----588---
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 1149998899203999999999998712799999999899999940059998
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~ 990 (1018)
..|..... .......+.+++.+||+.||++|||+++++++|+.++...
T Consensus 227 --~~p~~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 227 --LSPDLSKV--RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp --CCCCGGGS--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred --CCCCCHHC--CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf --89860003--6555499999999975889768929999999999999709
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=366.20 Aligned_cols=260 Identities=26% Similarity=0.343 Sum_probs=210.0
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEE
Q ss_conf 62265344441078802999991899929999995222343210026669999999823678870125546864991399
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.++|+..+.||+|+||+||+|.+..+++.||||++... ....++|.+|+.++++++|||||++++++.+++..++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-----CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-----CCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEE
T ss_conf 79939865982088808999999999969999997776-----1039999999999986799988267752745785478
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEE
Q ss_conf 99714799977763038777533389999999999999999762199999196047999687759998099254132441
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~ 863 (1018)
||||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 91 v~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEECCCCCCHHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 7631467606777530355--4157999999999999978889878---9305760457689989992898324454653
Q ss_pred CCCCCC-EEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 148950-5762357786686777989978544206699999999968999999988830099999998513563001149
Q 001752 864 IRKNET-VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 864 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
...... .....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ...+... +..... .
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~----i~~~~~-----~ 235 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYEL----LEKDYR-----M 235 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHH----HHTTCC-----C
T ss_pred CCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHH----HHCCCC-----C
T ss_conf 78872210355665466692787279998104302178999999867998877425-9999999----855888-----8
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 99889920399999999999871279999999989999994005999
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPR 989 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~ 989 (1018)
+.... ....+.+++.+||+.||++|||++++++.|+.+..+
T Consensus 236 ~~~~~------~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 236 ERPEG------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCC------CHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 88743------309999999997577976893999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=363.75 Aligned_cols=259 Identities=27% Similarity=0.456 Sum_probs=208.2
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCCCE---EEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCC
Q ss_conf 6226534444107880299999189992---9999995222343210026669999999823678870125546864991
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNT---IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN 780 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 780 (1018)
.++|+..+.||+|+||+||+|.+..+++ .||||++... ......+.|.+|+.++++++|||||+++|++..++.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 00427856980278829999999579978899999997844---598999999999999985799888618999962887
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCC
Q ss_conf 39999714799977763038777533389999999999999999762199999196047999687759998099254132
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 781 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a 860 (1018)
.++||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred EEEEEEECCCCCCEEEECCCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCC
T ss_conf 7999972279853002104567---999999999999999988988527---9835761504489889991998884431
Q ss_pred EEECCCCCCE-----EEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 4411489505-----76235778668677798997854420669999999996-89999999888300999999985135
Q 001752 861 RMMIRKNETV-----SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDN 934 (1018)
Q Consensus 861 ~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 934 (1018)
+......... ....||+.|+|||+..+..++.++|||||||++|||++ |+.||.... ..++...+. ..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--~~~~~~~i~----~~ 249 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--NQDVINAIE----QD 249 (299)
T ss_dssp --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHH----TT
T ss_pred EECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC--HHHHHHHHH----CC
T ss_conf 575677776536502566688300387888369978612144535789999867999999999--999999997----37
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 630011499988992039999999999987127999999998999999400599
Q 001752 935 RNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKP 988 (1018)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~ 988 (1018)
... +.... ....+.+++.+||+.||++|||++++++.|+++..
T Consensus 250 ~~~-----~~~~~------~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 250 YRL-----PPPMD------CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCC-----CCCTT------CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCC-----CCCCC------CHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 889-----99742------26999999999758797689299999999999841
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.25 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=211.1
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEE
Q ss_conf 62265344441078802999991899929999995222343210026669999999823678870125546864991399
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|++.+.||+|+||.||+|.+..+++.||+|++.+... .......++.+|+.++++++||||+++++++.+.+..|+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCC
T ss_conf 4742898898317684999999989998999999815654-497999999999999986799988778764035642111
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEE
Q ss_conf 99714799977763038777533389999999999999999762199999196047999687759998099254132441
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~ 863 (1018)
||||++||+|.+++..... +++..+..++.|++.||+|+|++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 83 v~ey~~gg~L~~~~~~~~~----~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred CEECCCCCCHHHHHHCCCC----CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCC
T ss_conf 0003579860555532567----75999999999996521134315---9622464777847658998888205652003
Q ss_pred CCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 14895057623577866867779899785442066999999999689999999888300999999985135630011499
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
..........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..............+..
T Consensus 156 ~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-----~~~~~~~i~~~~~~~p~---- 226 (337)
T d1o6la_ 156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFELILMEEIRFPR---- 226 (337)
T ss_dssp CCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCCT----
T ss_pred CCCCCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHCCCCCCCC----
T ss_conf 567862055100889966665048988833310223067889987899999969-----99999998528998986----
Q ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 98899203999999999998712799999999-----8999999
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPS-----MRDVITM 982 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 982 (1018)
. ....+.+++.+||++||.+||+ +.+++++
T Consensus 227 ------~---~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 227 ------T---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ------T---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ------C---CCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf ------6---8999999998666389344225652349999729
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=362.54 Aligned_cols=252 Identities=28% Similarity=0.381 Sum_probs=204.5
Q ss_pred HHHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEE
Q ss_conf 86226534444107880299999189992999999522234321002666999999982367887012554686499139
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
..+.|+..+.||+|+||.||+|.+..+++.||||++.... .......+.+.+|+.++++++|||||++++++.+++..|
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCS-SCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
T ss_conf 0785676279701888099999998999399999984444-358899999999999999778999823899999899889
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf 99971479997776303877753338999999999999999976219999919604799968775999809925413244
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~ 862 (1018)
+||||+++|+|..++..... +++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+|..
T Consensus 92 iv~E~~~~g~l~~~~~~~~~----l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEEEECCCCCHHHHHHHCCC----CCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCC
T ss_conf 99980699945789973799----99999999999999999999868---976667884217987999789844365334
Q ss_pred ECCCCCCEEEECCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 1148950576235778668677798---9978544206699999999968999999988830099999998513563001
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGYT---LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... .............
T Consensus 165 ~~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-----~~~~~~~i~~~~~---- 231 (309)
T d1u5ra_ 165 MAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNES---- 231 (309)
T ss_dssp SSS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCC----
T ss_pred CCC----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHCCC----
T ss_conf 677----873134766368899834678886721454558999999987889999979-----9999999982899----
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1499988992039999999999987127999999998999999
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
+.... . .....+.+++.+||+.||++|||++|++++
T Consensus 232 ---~~~~~-~---~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 232 ---PALQS-G---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ---CCCSC-T---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCCCC-C---CCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf ---98887-8---889999999999773796579189999719
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.87 Aligned_cols=259 Identities=23% Similarity=0.302 Sum_probs=210.9
Q ss_pred HHHHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCC--CCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC
Q ss_conf 88622653444410788029999918999299999952223432--1002666999999982367887012554686499
Q 001752 702 DILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADL--ETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 702 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
++.++|+..+.||+|+||.||+|.+..+++.||+|++.+..... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 85567798279811789599999999999899999987566321340689999999999998679989993889999799
Q ss_pred CEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCC----CEEEC
Q ss_conf 13999971479997776303877753338999999999999999976219999919604799968775999----80992
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL----EPRIA 855 (1018)
Q Consensus 780 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~ 855 (1018)
..|+||||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+|++
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~----l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEECCCCCCCCCHHCCCCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEEC
T ss_conf 89999986778643100103564----21557899999999998766625---422113330127982589866646964
Q ss_pred CCCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 54132441148950576235778668677798997854420669999999996899999998883009999999851356
Q 001752 856 DFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR 935 (1018)
Q Consensus 856 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 935 (1018)
|||+|..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+..........
T Consensus 160 DfG~a~~~~~-~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 160 DFGLAHKIDF-GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQETLANVSAVNY 233 (293)
T ss_dssp CCTTCEECTT-SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHTTCC
T ss_pred CHHHHHHCCC-CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHHCCC
T ss_conf 3344210577-763122477774309999818999976652214099999970889988999-----9999999981688
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 30011499988992039999999999987127999999998999999
Q 001752 936 NLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
...... .......+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~---------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 EFEDEY---------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CCCHHH---------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCHH---------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 887010---------47889999999999863896689199999619
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.48 Aligned_cols=252 Identities=19% Similarity=0.275 Sum_probs=207.6
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 22653444410788029999918999299999952223432100266699999998236788701255468649913999
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 784 (1018)
+.|++.+.||+|+||.||+|.+..+++.||||++.+... ........+.+|+.++++++||||+++++++.+++..|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf 877898898508790999999989997999999865775-5777899999999999876888861799999989988999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEEC
Q ss_conf 97147999777630387775333899999999999999997621999991960479996877599980992541324411
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~ 864 (1018)
|||++||+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+|+.+.
T Consensus 87 mEy~~gg~L~~~~~~~~~----l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp ECCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHCCCC----CCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECC
T ss_conf 970489877776531599----99999999999999999762165---08847677412366888538860321024225
Q ss_pred CCCC--CEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 4895--05762357786686777989978544206699999999968999999988830099999998513563001149
Q 001752 865 RKNE--TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 865 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
.... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..............+ .
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~~~~~----p 230 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EYLIFQKIIKLEYDF----P 230 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHTTCCCC----C
T ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHCCCCCC----C
T ss_conf 6776433355567755258440026898966623045699999803889989959-----999999997189999----8
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 9988992039999999999987127999999998999999
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
. .....+.+++.+||+.||++|||++|+++.
T Consensus 231 ~---------~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 231 E---------KFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp T---------TCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred C---------CCCHHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf 5---------479999999999855797689197897377
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.18 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=207.6
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCC-----EEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCC-CCCCCCEEEEEEECC
Q ss_conf 22653444410788029999918999-----299999952223432100266699999998236-788701255468649
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLN-----TIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHND 778 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 778 (1018)
++|++.+.||+|+||+||+|.+...+ ..||+|++.... .......+.+|+.++.++ +|||||++++++.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC---CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 9939701983078819999998578855420499999966335---8789999999999999715899686877888629
Q ss_pred CCEEEEEEECCCCCHHHHHHCCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECC
Q ss_conf 9139999714799977763038777-------------------533389999999999999999762199999196047
Q 001752 779 TNMMIVYEYMNNGSLGEALHGKQAG-------------------RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDI 839 (1018)
Q Consensus 779 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl 839 (1018)
+..++||||+++|+|.++++..... ...+++..++.++.|++.||+|||++ +|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCC
T ss_conf 9589999727999599999862577751022100001222001257789999999999999999999739---9050527
Q ss_pred CCCCEEECCCCCEEECCCCCCEEECCCCCCE--EEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCC
Q ss_conf 9996877599980992541324411489505--76235778668677798997854420669999999996-89999999
Q 001752 840 KSNNILLDSNLEPRIADFGLARMMIRKNETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPE 916 (1018)
Q Consensus 840 k~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~ 916 (1018)
||+||+++.++.+||+|||+|+......... ....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCC
T ss_conf 03214434598289851422220457786156234357876578388727999963303000399999983899999998
Q ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 888300999999985135630011499988992039999999999987127999999998999999400
Q 001752 917 FGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGE 985 (1018)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 985 (1018)
.... .+...+ ...... +.+..+ ...+.+++.+||+.||++|||++|++++|..
T Consensus 271 ~~~~-~~~~~~----~~~~~~-----~~p~~~------~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 271 PVDA-NFYKLI----QNGFKM-----DQPFYA------TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCSH-HHHHHH----HTTCCC-----CCCTTC------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHH-HHHHHH----HCCCCC-----CCCCCC------CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 9899-999998----569989-----988767------8999999999758896689399999999748
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.40 Aligned_cols=254 Identities=27% Similarity=0.437 Sum_probs=205.4
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 22653444410788029999918999299999952223432100266699999998236788701255468649913999
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 784 (1018)
+.|+..+.||+|+||+||+|.+. +++.||||++.. .....++|.+|+.++++++||||++++|++..++..++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~-----~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIRE-----GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCS-----SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECC-----CCCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEE
T ss_conf 99588889820888299999988-999999999878-----867689999999999966899756535243159933799
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEEC
Q ss_conf 97147999777630387775333899999999999999997621999991960479996877599980992541324411
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~ 864 (1018)
|||+++|+|.+++..... .+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 79 ~E~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp EECCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred EEECCCCCHHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECC
T ss_conf 983699918997520134---788999999999999987765316---43104431532666688776865532100236
Q ss_pred CCCCC-EEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 48950-5762357786686777989978544206699999999968-999999988830099999998513563001149
Q 001752 865 RKNET-VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTG-RRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 865 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
..... .....||+.|+|||++.+..++.++||||||+++|||+++ ++||... ....+...+.. ... ...
T Consensus 153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~---~~~----~~~ 223 (263)
T d1sm2a_ 153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDIST---GFR----LYK 223 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHHH---TCC----CCC
T ss_pred CCCCEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHH---CCC----CCC
T ss_conf 887335043001766678578607999840332105999999987898887789--99999999980---688----899
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 998899203999999999998712799999999899999940059
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~ 987 (1018)
|. .+ ...+.+++.+||+.||++|||+++++++|++++
T Consensus 224 p~--~~------~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 224 PR--LA------STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CT--TS------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC--CC------CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 54--36------799999999976579768919999999999998
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.83 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=198.1
Q ss_pred CCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEEC----CCCEE
Q ss_conf 65344441078802999991899929999995222343210026669999999823678870125546864----99139
Q 001752 707 IRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN----DTNMM 782 (1018)
Q Consensus 707 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~ 782 (1018)
|+..+.||+|+||+||+|.+..+++.||+|++.... ......+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEE
T ss_conf 885169700828499999999999599999985122--798999999999999985799985069999840334588899
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCC--EEEECCCCCCEEEC-CCCCEEECCCCC
Q ss_conf 999714799977763038777533389999999999999999762199999--19604799968775-999809925413
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPP--IIHRDIKSNNILLD-SNLEPRIADFGL 859 (1018)
Q Consensus 783 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~NIll~-~~~~~kl~Dfg~ 859 (1018)
+||||+++|+|.+++..... +++..+..++.||+.||+|||++ + |+||||||+||+++ .++.+||+|||+
T Consensus 89 ivmE~~~~g~L~~~l~~~~~----~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEECCCCCCHHHHHHCCCC----CCHHHHHHHHHHHHHHHHHHHHC---CCCEEECCCCHHHCEEECCCCCEEEEECCC
T ss_conf 99957898948999751355----46999999999999999999978---997996876743511667999889800576
Q ss_pred CEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 24411489505762357786686777989978544206699999999968999999988830099999998513563001
Q 001752 860 ARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEE 939 (1018)
Q Consensus 860 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1018)
|+.. .........||+.|+|||++.+ +++.++||||+||++|||++|+.||..... ....... +.......
T Consensus 162 a~~~--~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----~~~~~~~-i~~~~~~~- 232 (270)
T d1t4ha_ 162 ATLK--RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRR-VTSGVKPA- 232 (270)
T ss_dssp GGGC--CTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHH-HTTTCCCG-
T ss_pred CEEC--CCCCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCC----HHHHHHH-HHCCCCCC-
T ss_conf 5423--6876677553813008988478-999867110079999999878899987655----9999999-97389986-
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1499988992039999999999987127999999998999999
Q 001752 940 ALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
.++ ......+.+++.+||++||++|||+.|++++
T Consensus 233 ~~~---------~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 SFD---------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GGG---------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCC---------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 567---------5578999999999763797589299999677
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=350.05 Aligned_cols=250 Identities=25% Similarity=0.308 Sum_probs=207.0
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEE
Q ss_conf 62265344441078802999991899929999995222343210026669999999823678870125546864991399
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.+.|++.+.||+|+||+||+|++..+++.||+|++..... ......+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEE
T ss_conf 5470888897207680899999989997999999845775-488999999999999986369675330356852880056
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEE
Q ss_conf 99714799977763038777533389999999999999999762199999196047999687759998099254132441
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~ 863 (1018)
||||++||+|..++..... .++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 82 vmE~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp EECCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EEEECCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEE
T ss_conf 7650378632234322221----11007999999998765541247---6770556810503868998898317521671
Q ss_pred CCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 14895057623577866867779899785442066999999999689999999888300999999985135630011499
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
.. .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.. ............... .+
T Consensus 155 ~~---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i~~~~~~~----p~ 222 (316)
T d1fota_ 155 PD---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEKILNAELRF----PP 222 (316)
T ss_dssp SS---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHCCCCC----CT
T ss_pred CC---CCCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCC-----HHHHHHHHHCCCCCC----CC
T ss_conf 24---5643457634359999838999804304653336899975989999969-----999999997089889----97
Q ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 9889920399999999999871279999999-----98999999
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVITM 982 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 982 (1018)
. ....+.+++.+|+++||.+|+ |+++++++
T Consensus 223 ~---------~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 223 F---------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp T---------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C---------CCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf 7---------8999999999995449976664310219999819
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=347.52 Aligned_cols=250 Identities=18% Similarity=0.225 Sum_probs=206.8
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEE
Q ss_conf 62265344441078802999991899929999995222343210026669999999823678870125546864991399
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.++|++.+.||+|+||.||+|++..+++.||+|++.+.. .........+.+|+.+++.++||||+++++++.+....++
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHH-CCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCC
T ss_conf 237089889611768089999998999899999982677-4588999999999999997487727403444432222232
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEE
Q ss_conf 99714799977763038777533389999999999999999762199999196047999687759998099254132441
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~ 863 (1018)
||||+.+|+|.+++..... +++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 119 v~e~~~~g~l~~~l~~~~~----l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEECCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCCCCCCCHHHHHHHCCC----CCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEEC
T ss_conf 2223346622666751589----89999999999999989999859---9861767999936077897886101033322
Q ss_pred CCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 14895057623577866867779899785442066999999999689999999888300999999985135630011499
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ................
T Consensus 192 ~~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i~~~~~~~p----- 258 (350)
T d1rdqe_ 192 KG---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKIVSGKVRFP----- 258 (350)
T ss_dssp SS---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCC-----
T ss_pred CC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHCCCCCCC-----
T ss_conf 56---6643367635678899717998853311450078999975889989959-----9999999861798897-----
Q ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 9889920399999999999871279999999-----98999999
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVITM 982 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 982 (1018)
. .....+.+++.+||+.||.+|+ |+++++++
T Consensus 259 -----~---~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 259 -----S---HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -----T---TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----C---CCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf -----6---68999999999983409986065534549999719
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=351.15 Aligned_cols=253 Identities=23% Similarity=0.252 Sum_probs=200.3
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHH---HHHHHHHCCCCCCCCEEEEEEECCCCE
Q ss_conf 22653444410788029999918999299999952223432100266699---999998236788701255468649913
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFV---GEVNVLGKLRHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~---~E~~~l~~l~hpniv~~~~~~~~~~~~ 781 (1018)
+.|++.+.||+|+||.||+|++..+++.||+|++.+.... .......+. +++.+++.++||||+++++++.+.+..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC-HHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 7685101884288909999999999979999998458754-266799999999999998508998588999999989988
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCE
Q ss_conf 99997147999777630387775333899999999999999997621999991960479996877599980992541324
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~ 861 (1018)
|+||||++||+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEECCCCCHHHHHHHCCC----CCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEEE
T ss_conf 999991489838999873255----32789999999999999999977---96220444221678588967982201023
Q ss_pred EECCCCCCEEEECCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 4114895057623577866867779-899785442066999999999689999999888300999999985135630011
Q 001752 862 MMIRKNETVSMVAGSYGYIAPEYGY-TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 862 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
.... .......||+.|+|||++. +..++.++||||+||++|||++|+.||....... ...............
T Consensus 156 ~~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~--- 228 (364)
T d1omwa3 156 DFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAVEL--- 228 (364)
T ss_dssp ECSS--SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHHHHSSSCCCCC---
T ss_pred ECCC--CCCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHCCCCCCCC---
T ss_conf 3378--864331134554216876038999844104677899999985999888899899--999998604688878---
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 49998899203999999999998712799999999-----8999999
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPS-----MRDVITM 982 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 982 (1018)
. .. ....+.+++.+||++||++||| ++|++++
T Consensus 229 -~------~~---~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 229 -P------DS---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -C------SS---SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -C------CC---CCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf -8------77---8999999999985669888088743579999749
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.73 Aligned_cols=255 Identities=28% Similarity=0.433 Sum_probs=202.2
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEE
Q ss_conf 62265344441078802999991899929999995222343210026669999999823678870125546864991399
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 783 (1018)
.++|++.+.||+|+||.||+|.++ +++.||||++.. .....+.|.+|+.++++++|||||+++|++.+ +..++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECT-----TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECC-----CCCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEE
T ss_conf 899388679810798289999999-999999999864-----76888999999999986799988578731045-97699
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEE
Q ss_conf 99714799977763038777533389999999999999999762199999196047999687759998099254132441
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~ 863 (1018)
||||+++|+|.+++.... ...+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+|+..
T Consensus 85 v~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEECCCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEEC
T ss_conf 999578982888875147--89887889999999999999999748---9546756422515620244042341014773
Q ss_pred CCCCCC-EEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 148950-5762357786686777989978544206699999999968999999988830099999998513563001149
Q 001752 864 IRKNET-VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 864 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
...... .....|++.|+|||++.+..++.++|||||||++|||++|..|+..... ..++...+ ......
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~~i----~~~~~~----- 229 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNL----ERGYRM----- 229 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHH----HTTCCC-----
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC-HHHHHHHH----HHCCCC-----
T ss_conf 58864420356774444582898379998245645257999999968988888889-99999999----706888-----
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 99889920399999999999871279999999989999994005
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~ 986 (1018)
+....+ ...+.+++.+||+.||++|||++++++.|+++
T Consensus 230 ~~p~~~------~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 230 VRPDNC------PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCTTC------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCC------HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 896557------19999999997588976893999999986113
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.26 Aligned_cols=258 Identities=23% Similarity=0.358 Sum_probs=203.6
Q ss_pred HCCCCCC-EEECCCCEEEEEEECCC--CCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCE
Q ss_conf 2265344-44107880299999189--99299999952223432100266699999998236788701255468649913
Q 001752 705 ACIRESN-VIGMGATGIVYKAEMPR--LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 705 ~~~~~~~-~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 781 (1018)
+.+...+ .||+|+||.||+|.+.. ++..||||++... ......+.|.+|+.++++++|||||+++|++.. +..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHH---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEE
T ss_conf 4718878487306080999999960897689999998820---397899999999999986799888068656036-807
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCE
Q ss_conf 99997147999777630387775333899999999999999997621999991960479996877599980992541324
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~ 861 (1018)
|+||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEECCCCCHHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHH
T ss_conf 999980789968997521256---999999999999999987899868---81057676466045468854203313421
Q ss_pred EECCCCCCE---EEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 411489505---76235778668677798997854420669999999996-89999999888300999999985135630
Q 001752 862 MMIRKNETV---SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 862 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
.+....... ....||+.|+|||++.+..++.++|||||||++|||++ |+.||..... .++...+ ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i----~~~~~~ 231 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFI----EQGKRM 231 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHH----HTTCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCH--HHHHHHH----HCCCCC
T ss_conf 1554343211356211374335868872799995412322017899999389999999799--9999999----818999
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 0114999889920399999999999871279999999989999994005999
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPR 989 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~ 989 (1018)
+.+..+ ...+.+++.+||+.||++|||+.++.+.|+.....
T Consensus 232 -----~~p~~~------~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 232 -----ECPPEC------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -----CCCTTC------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCC------CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf -----999767------89999999997577976890999999999999998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.88 Aligned_cols=254 Identities=20% Similarity=0.262 Sum_probs=208.5
Q ss_pred HHHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEE
Q ss_conf 86226534444107880299999189992999999522234321002666999999982367887012554686499139
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMM 782 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 782 (1018)
+.++|++.+.||+|+||+||+|.+..+++.||+|++... ......+.+|+.+++.++||||+++++++.+++..|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC-----CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
T ss_conf 701058878983177839999999899969999997578-----665999999999998579979890989998899889
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCC--CCEEECCCCCC
Q ss_conf 9997147999777630387775333899999999999999997621999991960479996877599--98099254132
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN--LEPRIADFGLA 860 (1018)
Q Consensus 783 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfg~a 860 (1018)
+||||++||+|.+++.... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.+ ..++++|||.+
T Consensus 78 lvmE~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEECCCCCCHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHH
T ss_conf 9995389980889987538---9999999999999999999999876---997513554443443788518997644111
Q ss_pred EEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 44114895057623577866867779899785442066999999999689999999888300999999985135630011
Q 001752 861 RMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 861 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
+.... ........+++.|+|||...+..++.++||||+||++|+|++|+.||..... .............+...
T Consensus 152 ~~~~~-~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-----~~~~~~i~~~~~~~~~~ 225 (321)
T d1tkia_ 152 RQLKP-GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQIIENIMNAEYTFDEE 225 (321)
T ss_dssp EECCT-TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHTCCCCCHH
T ss_pred HCCCC-CCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHCCCCCCHH
T ss_conf 00346-7753212233222340210487778401130279999999828999999899-----99999998389998802
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 499988992039999999999987127999999998999999
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
.. ......+.+++.+|+++||.+|||++|++++
T Consensus 226 ~~---------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 AF---------KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HH---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HC---------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 23---------6789999999999866996689099999639
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.26 Aligned_cols=261 Identities=29% Similarity=0.462 Sum_probs=206.9
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCCC----EEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC
Q ss_conf 622653444410788029999918999----2999999522234321002666999999982367887012554686499
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLN----TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT 779 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 779 (1018)
..+|+..+.||+|+||.||+|.+..++ ..||||++... .......+|.+|+.++++++|||||+++|++.+..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf 899686159811779099999996899878799999998844---59689999999999998568987832367783388
Q ss_pred CEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCC
Q ss_conf 13999971479997776303877753338999999999999999976219999919604799968775999809925413
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGL 859 (1018)
Q Consensus 780 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 859 (1018)
..++||||+.+|++.+.+..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CEEEEEEECCCCCCHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCH
T ss_conf 03899972135740222102345---420899999999999854121212---342576564427888998499845510
Q ss_pred CEEECCCCCC---EEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 2441148950---5762357786686777989978544206699999999968999999988830099999998513563
Q 001752 860 ARMMIRKNET---VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRN 936 (1018)
Q Consensus 860 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 936 (1018)
++.+...... .....||+.|+|||++.+..++.++|||||||++|||++|..|+..... ...+...+ .....
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-~~~~~~~i----~~~~~ 231 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAI----NDGFR 231 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHH----HTTCC
T ss_pred HHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC-HHHHHHHH----HCCCC
T ss_conf 30035787652674267777343488887049999735563448989999967988655689-99999998----63578
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 00114999889920399999999999871279999999989999994005999
Q 001752 937 LEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPR 989 (1018)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~ 989 (1018)
.+.... ....+.+++.+||+.||++||||.++++.|+.+...
T Consensus 232 -----~~~~~~------~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 232 -----LPTPMD------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -----CCCCTT------CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCHH------HHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -----998504------579999999997767976893999999999998669
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.15 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=200.6
Q ss_pred CEEECCCCEEEEEEECC--CCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEEC
Q ss_conf 44410788029999918--9992999999522234321002666999999982367887012554686499139999714
Q 001752 711 NVIGMGATGIVYKAEMP--RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEYM 788 (1018)
Q Consensus 711 ~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 788 (1018)
+.||+|+||+||+|.+. .+++.||||++... .......++|.+|+.++++++|||||+++|++..+ ..++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHH--HCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC-CEEEEEECC
T ss_conf 783458782999999816973859999998801--08989999999999999867998985277775059-779999747
Q ss_pred CCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEECCCCC
Q ss_conf 79997776303877753338999999999999999976219999919604799968775999809925413244114895
Q 001752 789 NNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKNE 868 (1018)
Q Consensus 789 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~ 868 (1018)
++|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++.......
T Consensus 90 ~~g~L~~~l~~~~~----l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 90 ELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp TTEEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CCCCHHHHHHHCCC----CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCC
T ss_conf 88968999752257----89999999999999997668747---955677761131023567512341345331343234
Q ss_pred CE---EEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 05---76235778668677798997854420669999999996-899999998883009999999851356300114999
Q 001752 869 TV---SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDPN 944 (1018)
Q Consensus 869 ~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1018)
.. ....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.. ..++...+ ..+... +.
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--~~~~~~~i----~~~~~~-----~~ 231 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAML----EKGERM-----GC 231 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHH----HTTCCC-----CC
T ss_pred CCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCC--HHHHHHHH----HCCCCC-----CC
T ss_conf 43224456778420391665379998434430340313289658999999989--99999999----828999-----99
Q ss_pred CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 889920399999999999871279999999989999994005
Q 001752 945 VGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 945 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~ 986 (1018)
+..+ ...+.+++.+||+.||++|||++++.+.|+..
T Consensus 232 p~~~------~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 PAGC------PREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CTTC------CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCC------CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCH
T ss_conf 8656------79999999997588976890989999985288
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=349.21 Aligned_cols=263 Identities=25% Similarity=0.328 Sum_probs=212.2
Q ss_pred HHHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC---
Q ss_conf 86226534444107880299999189992999999522234321002666999999982367887012554686499---
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT--- 779 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 779 (1018)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+......+.+|+.+++.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHH-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCC
T ss_conf 0620698689960899299999999999899999985566-469899999999999998569998873114354326887
Q ss_pred -CEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCC
Q ss_conf -1399997147999777630387775333899999999999999997621999991960479996877599980992541
Q 001752 780 -NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFG 858 (1018)
Q Consensus 780 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 858 (1018)
..|+||||++|++|.+++..... +++..+..++.|++.||+|||+. ||+||||||+||+++.++..+++|||
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~----l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred CEEEEEEECCCCCEEHHHHCCCCC----CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHH
T ss_conf 669999977889871011203589----99999999999999999999857---95276346755665754320100344
Q ss_pred CCEEECCCCC---CEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 3244114895---0576235778668677798997854420669999999996899999998883009999999851356
Q 001752 859 LARMMIRKNE---TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR 935 (1018)
Q Consensus 859 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 935 (1018)
.+........ ......||+.|+|||++.+..+++++||||+||++|||++|+.||.... .............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~~~~~~~~ 231 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----PVSVAYQHVREDP 231 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHCCC
T ss_pred HHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHCCC
T ss_conf 43221235443333464257624369999839999966320265289999976979989969-----9999999984699
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHCCC
Q ss_conf 300114999889920399999999999871279999999-9899999940059
Q 001752 936 NLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRP-SMRDVITMLGEAK 987 (1018)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~eil~~L~~~~ 987 (1018)
.......+ .....+.+++.+|+++||++|| +++++...|..+.
T Consensus 232 ~~~~~~~~---------~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 232 IPPSARHE---------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCGGGTSS---------SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCHHCC---------CCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf 99710034---------789999999999866797677739999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.93 Aligned_cols=251 Identities=26% Similarity=0.372 Sum_probs=204.3
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCEEEEEEECCCCEEE
Q ss_conf 226534444107880299999189992999999522234321002666999999982-3678870125546864991399
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLG-KLRHRNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~l 783 (1018)
+.|++.+.||+|+||+||+|.+..+++.||||++.+.... .......+..|..++. .++||||+++++++.+++..|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~-~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEE
T ss_conf 9718865894087828999999999989999998055533-848999999999999984799968789889704983167
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEE
Q ss_conf 99714799977763038777533389999999999999999762199999196047999687759998099254132441
Q 001752 784 VYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMM 863 (1018)
Q Consensus 784 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~ 863 (1018)
||||+++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+||+++.++.+|++|||.++..
T Consensus 81 vmEy~~~g~L~~~i~~~~~----~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEECCCCCHHHHHHCCCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHC
T ss_conf 7750379808998640478----99999999999999999999868---9340347654044448996301555302323
Q ss_pred CCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 14895057623577866867779899785442066999999999689999999888300999999985135630011499
Q 001752 864 IRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 864 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
...........||+.|+|||++.+..++.++||||+||++|+|++|+.||.+... ..+...+ ....... |
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i---~~~~~~~-----p 223 (320)
T d1xjda_ 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSI---RMDNPFY-----P 223 (320)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH---HHCCCCC-----C
T ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH---HCCCCCC-----C
T ss_conf 5665334545787776899998279988323201122789898738899999899--9999999---7189989-----7
Q ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 9889920399999999999871279999999989-9999
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMR-DVIT 981 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-eil~ 981 (1018)
. .....+.+++.+||+.||++||++. ++++
T Consensus 224 ---~-----~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 ---R-----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---T-----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---C-----CCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf ---5-----679999999999654489878388999980
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.50 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=206.7
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 22653444410788029999918999299999952223432100266699999998236788701255468649913999
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 784 (1018)
+.|+..+.||+|+||+||+|+++ +++.||||++... .....+|.+|+.++++++||||++++|++.+++..++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~-----~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG-----SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESS-----SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCC-----CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEE
T ss_conf 99799689820788399999988-9989999998747-----57789999999999966898601588998507816999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEEC
Q ss_conf 97147999777630387775333899999999999999997621999991960479996877599980992541324411
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~ 864 (1018)
|||+++|+|.+++..... .+++..+.+++.|+++||+|||+. ||+||||||+||+++.++.+||+|||+++...
T Consensus 78 ~Ey~~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp EECCTTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred EECCCCCCHHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECC
T ss_conf 970489938886410246---776899999999999999987546---84346654135887699847988614420235
Q ss_pred CCCCC-EEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 48950-576235778668677798997854420669999999996-8999999988830099999998513563001149
Q 001752 865 RKNET-VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALD 942 (1018)
Q Consensus 865 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1018)
..... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .++.. .+..... ...
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--~~~~~----~i~~~~~---~~~ 222 (258)
T d1k2pa_ 152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAE----HIAQGLR---LYR 222 (258)
T ss_dssp SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHH----HHHTTCC---CCC
T ss_pred CCCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCH--HHHHH----HHHHCCC---CCC
T ss_conf 78722524657887757807863799885210336432467397559999889999--99999----9980797---899
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 99889920399999999999871279999999989999994005
Q 001752 943 PNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEA 986 (1018)
Q Consensus 943 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~ 986 (1018)
|. .+ ...+.+++.+||+.||++|||+++++++|.++
T Consensus 223 p~--~~------~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 223 PH--LA------SEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CT--TC------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CC--CC------CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf 65--46------59999999997668976893999999874188
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.41 Aligned_cols=255 Identities=24% Similarity=0.319 Sum_probs=200.8
Q ss_pred HHHCCCCC-CEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCC-CCCCCCEEEEEEEC---
Q ss_conf 86226534-44410788029999918999299999952223432100266699999998236-78870125546864---
Q 001752 703 ILACIRES-NVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHN--- 777 (1018)
Q Consensus 703 ~~~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--- 777 (1018)
+.+.|.+. +.||+|+||.||+|.+..+++.||+|++.. ...+.+|+.++.++ +||||+++++++.+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC---------CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
T ss_conf 014879810796545486999999889998999999897---------47799999999986699997829899950346
Q ss_pred -CCCEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECC---CCCEE
Q ss_conf -99139999714799977763038777533389999999999999999762199999196047999687759---99809
Q 001752 778 -DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS---NLEPR 853 (1018)
Q Consensus 778 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~k 853 (1018)
...+|+||||++||+|.+++..+.. ..+++..+..++.|++.||+|||+. ||+||||||+||+++. ++.+|
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~K 154 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILK 154 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEE
T ss_pred CCCEEEEEEECCCCCCHHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 89789999977899849999986278--7757999999999999999999976---986444100220113555566311
Q ss_pred ECCCCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf 92541324411489505762357786686777989978544206699999999968999999988830099999998513
Q 001752 854 IADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD 933 (1018)
Q Consensus 854 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 933 (1018)
++|||+|+.... ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.+..... ...........
T Consensus 155 l~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~~~~~i~~ 231 (335)
T d2ozaa1 155 LTDFGFAKETTS-HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKTRIRM 231 (335)
T ss_dssp ECCCTTCEECCC-CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCS
T ss_pred CCCCCEEEECCC-CCCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH--HHHHHHHHHHC
T ss_conf 354551233368-886432267756379277748988888888764516778865889988988778--89999999853
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 5630011499988992039999999999987127999999998999999
Q 001752 934 NRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
.. ... ...........+.+++.+|++.||++|||+.|++++
T Consensus 232 ~~-------~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 232 GQ-------YEF-PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CS-------SSC-CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC-------CCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 88-------888-985434699999999999756996579099999709
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.76 Aligned_cols=256 Identities=23% Similarity=0.358 Sum_probs=205.1
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCCE----EEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCC
Q ss_conf 226534444107880299999189992----9999995222343210026669999999823678870125546864991
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNT----IVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN 780 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 780 (1018)
..|+..+.||+|+||+||+|.+..+++ .||+|++... ......++|.+|+.++++++|||||+++|++.++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-C
T ss_conf 99978319820899299999995899889899999996513---4979999999999999867998881589999619-8
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCC
Q ss_conf 39999714799977763038777533389999999999999999762199999196047999687759998099254132
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 781 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a 860 (1018)
.++++|++.+|+|.+.+..... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla 158 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 158 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred EEEEEEECCCCCCCCCCCCCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCC
T ss_conf 3699984268740101113345---799999999999999999999876---9504762120311679987586025522
Q ss_pred EEECCCCCC--EEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 441148950--576235778668677798997854420669999999996-89999999888300999999985135630
Q 001752 861 RMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 861 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
+........ .....||+.|+|||++.+..++.++|||||||++|||+| |..||..... ..+...+....+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~~~~~~---- 232 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERL---- 232 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHHHTCCC----
T ss_pred EECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHCCCCC----
T ss_conf 2335444532236510586446708874699983565440799999999779999999998--9999999759989----
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 01149998899203999999999998712799999999899999940059
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~ 987 (1018)
+.... ....+.+++.+||+.||++|||+.+++++++.+.
T Consensus 233 -----~~p~~------~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 233 -----PQPPI------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp -----CCCTT------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCC------CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf -----99855------6899999999847899346919999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=347.78 Aligned_cols=263 Identities=30% Similarity=0.451 Sum_probs=210.3
Q ss_pred HHHCCCCCCEEECCCCEEEEEEECC-----CCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEEC
Q ss_conf 8622653444410788029999918-----99929999995222343210026669999999823678870125546864
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMP-----RLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN 777 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 777 (1018)
..++|++.+.||+|+||.||+|.+. .+++.||||++... ......++|.+|+.++++++|||++++++++..
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHH---CCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECC
T ss_conf 98893886798207883999999888765778829999998821---085799999999999996689976552466605
Q ss_pred CCCEEEEEEECCCCCHHHHHHCCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEE
Q ss_conf 9913999971479997776303877--------------------75333899999999999999997621999991960
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQA--------------------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHR 837 (1018)
Q Consensus 778 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 837 (1018)
....++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +++||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CEEEE
T ss_conf 980389998158992999998527554210000111001210346788989999999999999985541357---86854
Q ss_pred CCCCCCEEECCCCCEEECCCCCCEEECCCCCC--EEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCC
Q ss_conf 47999687759998099254132441148950--57623577866867779899785442066999999999689-9999
Q 001752 838 DIKSNNILLDSNLEPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGR-RPLD 914 (1018)
Q Consensus 838 dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~-~pf~ 914 (1018)
||||+||+++.++.+||+|||+|+.+...... .....+++.|+|||+..+..++.++|||||||++|||++|. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCC
T ss_conf 88401168989992898331442113677641115777767676798997268898056302523629999806899999
Q ss_pred CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 99888300999999985135630011499988992039999999999987127999999998999999400599
Q 001752 915 PEFGESVDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKP 988 (1018)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~ 988 (1018)
.. ...++... +..+.. .+....+ ...+.+++.+||+.+|++||||.||+++|+++..
T Consensus 245 ~~--~~~e~~~~----v~~~~~-----~~~p~~~------~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 245 GM--AHEEVIYY----VRDGNI-----LACPENC------PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TS--CHHHHHHH----HHTTCC-----CCCCTTC------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CC--CHHHHHHH----HHCCCC-----CCCCCCC------HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 98--99999999----973997-----8887325------2999999999748896579399999999998429
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.93 Aligned_cols=267 Identities=27% Similarity=0.349 Sum_probs=210.2
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCCEE--EEEEEEECCCCCCCCCHHHHHHHHHHHHHCC-CCCCCCEEEEEEECCCCE
Q ss_conf 2265344441078802999991899929--9999952223432100266699999998236-788701255468649913
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTI--VAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 781 (1018)
++|++.+.||+|+||.||+|.+..++.. ||||++... ......+.+.+|+.+++++ +||||+++++++.+++..
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEE
T ss_conf 996887798207882899999989996999999997823---38579999999999998622899883678888418736
Q ss_pred EEEEEECCCCCHHHHHHCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCC
Q ss_conf 99997147999777630387------------775333899999999999999997621999991960479996877599
Q 001752 782 MIVYEYMNNGSLGEALHGKQ------------AGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN 849 (1018)
Q Consensus 782 ~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~ 849 (1018)
++||||+++|+|.++++... .....+++..+..++.||+.|+.|+|+. +|+||||||+||+++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCC
T ss_conf 999980289869999864035555512310123457899999999999999998766308---95455505204898688
Q ss_pred CCEEECCCCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-CCCCCCCCCCCHHHHHH
Q ss_conf 98099254132441148950576235778668677798997854420669999999996899-99999888300999999
Q 001752 850 LEPRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRR-PLDPEFGESVDIVEWIR 928 (1018)
Q Consensus 850 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~-pf~~~~~~~~~~~~~~~ 928 (1018)
+.+||+|||+++..... .......||+.|+|||.+.+..++.++||||||+++|||++|.. ||... .......
T Consensus 164 ~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-----~~~~~~~ 237 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCAELYE 237 (309)
T ss_dssp GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHH
T ss_pred CCEEECCCCCCCCCCCC-CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCC-----CHHHHHH
T ss_conf 76387434432244422-34553013775555387526999962215313889999983689999999-----9999999
Q ss_pred HHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 9851356300114999889920399999999999871279999999989999994005999899999
Q 001752 929 MKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSN 995 (1018)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~~~~~~ 995 (1018)
. +..+. .+... .. ....+.+++.+||+.||++||||+++++.|+.+..+.+...+
T Consensus 238 ~-i~~~~------~~~~~--~~---~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~~ 292 (309)
T d1fvra_ 238 K-LPQGY------RLEKP--LN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 292 (309)
T ss_dssp H-GGGTC------CCCCC--TT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBC
T ss_pred H-HHHCC------CCCCC--CC---CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCCCCCC
T ss_conf 9-98268------88887--66---789999999997678966894999999999999861867789
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.21 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=205.2
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 22653444410788029999918999299999952223432100266699999998236788701255468649913999
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 784 (1018)
++|++.+.||+|+||.||+|.+.. ++.||||++... ....+.|.+|+.++++++|||||+++|++.+ +..++|
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPG-----TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTT-----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEECC-CCEEEEEEECCC-----CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEE
T ss_conf 997984699307980999999999-999999998804-----4888999999999986666788689999823-975999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEEC
Q ss_conf 97147999777630387775333899999999999999997621999991960479996877599980992541324411
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~ 864 (1018)
|||+++|+|.+++...... .++|..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~--~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEECCCCCHHHHHHHCCCC--CCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCC
T ss_conf 9944799435420000355--305999999999999999987541---14335312307999899929984425554256
Q ss_pred CCCC-CEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 4895-057623577866867779899785442066999999999689999999888300999999985135630011499
Q 001752 865 RKNE-TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEALDP 943 (1018)
Q Consensus 865 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1018)
.... ......||+.|+|||++.+..++.++||||||+++|||++|..|+..... ..+....+. .... .+
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-~~~~~~~i~----~~~~-----~~ 234 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVE----RGYR-----MP 234 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHH----TTCC-----CC
T ss_pred CCCCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCC-HHHHHHHHH----HCCC-----CC
T ss_conf 8873352454556654580898379989177413235899999868999998888-999999998----2689-----99
Q ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 98899203999999999998712799999999899999940059998
Q 001752 944 NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 944 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~ 990 (1018)
....+ ...+.+++.+||+.||++||++++|+++|+......
T Consensus 235 ~~~~~------~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 235 CPPEC------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCTTS------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCC------CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCC
T ss_conf 98323------799999999975669758919999999876662389
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.20 Aligned_cols=267 Identities=28% Similarity=0.308 Sum_probs=201.6
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC----C
Q ss_conf 226534444107880299999189992999999522234321002666999999982367887012554686499----1
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT----N 780 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~ 780 (1018)
+.|...+.||+|+||.||+|++. ++.||||++... ......+..|+..+.+++||||+++++++.+.+ .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CEEEEEEEEEECCCEEEEEEEEC--CEEEEEEEECCC-----CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEE
T ss_conf 68999889820788199999999--989999998720-----04679999999999627998683268899837986048
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-----CCCCEEEECCCCCCEEECCCCCEEEC
Q ss_conf 3999971479997776303877753338999999999999999976219-----99991960479996877599980992
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD-----CYPPIIHRDIKSNNILLDSNLEPRIA 855 (1018)
Q Consensus 781 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~dlk~~NIll~~~~~~kl~ 855 (1018)
+++||||+++|+|.++++... ++|..+++++.|++.|++|+|+. ..++|+||||||+||+++.++.+||+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~~-----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEECCCCCCHHHHHHCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEE
T ss_conf 999996466989899986589-----998999999999999999988766520468986615317313578688776887
Q ss_pred CCCCCEEECCCCCC----EEEECCCCCCCCCCCCCCC------CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC-----
Q ss_conf 54132441148950----5762357786686777989------97854420669999999996899999998883-----
Q 001752 856 DFGLARMMIRKNET----VSMVAGSYGYIAPEYGYTL------KVDEKIDIYSFGVVLLELLTGRRPLDPEFGES----- 920 (1018)
Q Consensus 856 Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~----- 920 (1018)
|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||++|..||.......
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred ECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHH
T ss_conf 63866234677762001355250354767822105654546777675012201599999996289988766311241012
Q ss_pred -----CCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf -----009999999851356300114999889920399999999999871279999999989999994005999
Q 001752 921 -----VDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPR 989 (1018)
Q Consensus 921 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~ 989 (1018)
..... ...... ....+|.........+....+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus 231 ~~~~~~~~~~-~~~~~~-----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 231 LVPSDPSVEE-MRKVVC-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TSCSSCCHHH-HHHHHT-----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHH-HHHHHH-----CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 2556430999-999875-----0246888776557768999999999997606985895999999999988886
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.41 Aligned_cols=265 Identities=25% Similarity=0.289 Sum_probs=201.5
Q ss_pred CCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCC-CCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 3444410788029999918999299999952223432-100266699999998236788701255468649913999971
Q 001752 709 ESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADL-ETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIVYEY 787 (1018)
Q Consensus 709 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 787 (1018)
..+.||+|+||+||+|.+..+++.||||++....... .....+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEECCCC
Q ss_conf 47999777630387775333899999999999999997621999991960479996877599980992541324411489
Q 001752 788 MNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMIRKN 867 (1018)
Q Consensus 788 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~ 867 (1018)
++++++......... +++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.|+......
T Consensus 82 ~~~~~~~~~~~~~~~----l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDNSLV----LTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTCCSS----CCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred HCCHHHHHHHHCCCC----CCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC
T ss_conf 345077655412667----78999999999999999886316---35503577625885377841146576100057875
Q ss_pred CCEEEECCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHC-CC-CCCCCCC--
Q ss_conf 50576235778668677798-9978544206699999999968999999988830099999998513-56-3001149--
Q 001752 868 ETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD-NR-NLEEALD-- 942 (1018)
Q Consensus 868 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~-- 942 (1018)
......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.. ..+....+...... .. .......
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCC--HHHHHHHHHHHCCCCCHHHCCCHHCCC
T ss_conf 543302047333639997267788805643630428999985969999999--999999999851899725452100021
Q ss_pred --CCCCCCCH--H----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf --99889920--3----9999999999987127999999998999999
Q 001752 943 --PNVGNCKH--V----QEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 943 --~~~~~~~~--~----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
........ . ......+.+++.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 344303478988678565689999999999763894569089999679
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.40 Aligned_cols=262 Identities=23% Similarity=0.349 Sum_probs=203.4
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCC-----CCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCC-CCCCCCEEEEEEEC
Q ss_conf 6226534444107880299999189-----99299999952223432100266699999998236-78870125546864
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPR-----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHN 777 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 777 (1018)
.++|+..+.||+|+||.||+|.+.. +++.||+|++... ......+.+.+|...+.++ +|+||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCC---CCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECC
T ss_conf 7997984498416783999999867775557839999998600---1717899999999998861499849974115404
Q ss_pred C-CCEEEEEEECCCCCHHHHHHCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCE
Q ss_conf 9-913999971479997776303877------------753338999999999999999976219999919604799968
Q 001752 778 D-TNMMIVYEYMNNGSLGEALHGKQA------------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNI 844 (1018)
Q Consensus 778 ~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NI 844 (1018)
. ...++||||+++|+|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred CCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCE
T ss_conf 79757999984589929999985366666532220233214689999999999999999988737---971786773106
Q ss_pred EECCCCCEEECCCCCCEEECCCCCC--EEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCCCCC
Q ss_conf 7759998099254132441148950--57623577866867779899785442066999999999689-99999988830
Q 001752 845 LLDSNLEPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGR-RPLDPEFGESV 921 (1018)
Q Consensus 845 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~-~pf~~~~~~~~ 921 (1018)
+++.++.+||+|||+|+........ .....||+.|+|||++.+..++.++||||+||++|||++|. .||...... .
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~ 244 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-E 244 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-H
T ss_pred EECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHH-H
T ss_conf 577998289845752001135665222475166721020368646889966322136789999986889999899989-9
Q ss_pred CHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 099999998513563001149998899203999999999998712799999999899999940059
Q 001752 922 DIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~ 987 (1018)
.+...+. .+... +.... ....+.+++.+||+.||++|||++|++++|+++.
T Consensus 245 ~~~~~~~----~~~~~-----~~~~~------~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 245 EFCRRLK----EGTRM-----RAPDY------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHHHH----HTCCC-----CCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHH----CCCCC-----CCCCC------CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 9999996----38988-----88865------7899999999976779667919999999997998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=338.51 Aligned_cols=257 Identities=23% Similarity=0.332 Sum_probs=206.5
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCC-----CCHHHHHHHHHHHHHCCC-CCCCCEEEEEEEC
Q ss_conf 6226534444107880299999189992999999522234321-----002666999999982367-8870125546864
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLE-----TESSGDFVGEVNVLGKLR-HRNIVRLLGFLHN 777 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 777 (1018)
.++|+..+.||+|+||+||+|++..+++.||||++........ ......+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCC
Q ss_conf 99139999714799977763038777533389999999999999999762199999196047999687759998099254
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADF 857 (1018)
Q Consensus 778 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 857 (1018)
++..|+||||+++|+|.+++..+.. +++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~----l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCCEEEEEECCCCCHHHHHHHHCCC----CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCC
T ss_conf 7605999976898668999986599----99999999999999999999875---9943234625489868998387124
Q ss_pred CCCEEECCCCCCEEEECCCCCCCCCCCCC------CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 13244114895057623577866867779------899785442066999999999689999999888300999999985
Q 001752 858 GLARMMIRKNETVSMVAGSYGYIAPEYGY------TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKI 931 (1018)
Q Consensus 858 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 931 (1018)
|.++.... ........||+.|+|||+.. ...++.++||||+||++|+|++|+.||.+... ........
T Consensus 155 G~a~~~~~-~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-----~~~~~~i~ 228 (277)
T d1phka_ 155 GFSCQLDP-GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----MLMLRMIM 228 (277)
T ss_dssp TTCEECCT-TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHH
T ss_pred HHEEECCC-CCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCH-----HHHHHHHH
T ss_conf 03167268-8721345246788898886053445678899233185656023103228889889999-----99999998
Q ss_pred HCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 135630011499988992039999999999987127999999998999999
Q 001752 932 RDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
...... ..+ ........+.+++.+||++||++|||++|++++
T Consensus 229 ~~~~~~---~~~------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 SGNYQF---GSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HTCCCC---CTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HCCCCC---CCC------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 189888---985------434689999999999765896689199999739
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.91 Aligned_cols=275 Identities=22% Similarity=0.297 Sum_probs=207.1
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 22653444410788029999918999299999952223432100266699999998236788701255468649913999
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 784 (1018)
+.|++.+.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.++++++||||+++++++.+++..|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
T ss_conf 99776517723768099999999999799999980222--5758999999999999867998388744533224320378
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEEC
Q ss_conf 97147999777630387775333899999999999999997621999991960479996877599980992541324411
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~ 864 (1018)
|||+.+ ++.+++...... .+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+|++|||.|+...
T Consensus 80 ~e~~~~-~~~~~~~~~~~~--~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALT--GIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp EECCSE-EHHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred EEECCC-CHHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECC
T ss_conf 862377-445554420256--888899999999999999986528---89921357114011346762103578613436
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCC-CCC----
Q ss_conf 4895057623577866867779899-7854420669999999996899999998883009999999851356-300----
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLK-VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR-NLE---- 938 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~---- 938 (1018)
..........||+.|+|||+..... ++.++||||+||++|+|++|+.||.+.... ..+............ ...
T Consensus 154 ~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCCCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHH-HHHHHHHHHCCCCCHHHCCCCCC
T ss_conf 88641001036521541122136657774221033331342796687998988999-99999998328983331444222
Q ss_pred --CCCCCCCCCCCH-H----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHCCCC
Q ss_conf --114999889920-3----9999999999987127999999998999999--400599
Q 001752 939 --EALDPNVGNCKH-V----QEEMLLVLRIAFLCTAKLPKDRPSMRDVITM--LGEAKP 988 (1018)
Q Consensus 939 --~~~~~~~~~~~~-~----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~~~~ 988 (1018)
............ . ......+.+++.+|++.||++|||++|++++ ++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 42124345432222044416678999999999976399557918999967870146999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.21 Aligned_cols=263 Identities=26% Similarity=0.343 Sum_probs=208.7
Q ss_pred HHCCCCCCEEECCCCEEEEEEEC-----CCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCC-CCCCCCEEEEEEEC
Q ss_conf 62265344441078802999991-----8999299999952223432100266699999998236-78870125546864
Q 001752 704 LACIRESNVIGMGATGIVYKAEM-----PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFLHN 777 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 777 (1018)
.++|+..+.||+|+||.||+|.+ ..+++.||||++.... .......+.+|+.+++++ +|||||++++++.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE
T ss_conf 89969854982068829999998066447788699999987424---877999999999998762699988789989831
Q ss_pred CCCEEEEEEECCCCCHHHHHHCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCC
Q ss_conf 9913999971479997776303877--------------75333899999999999999997621999991960479996
Q 001752 778 DTNMMIVYEYMNNGSLGEALHGKQA--------------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNN 843 (1018)
Q Consensus 778 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 843 (1018)
.+..++||||+++|+|.+++..... ....+++..+..++.||+.|++|||++ +++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCC
T ss_conf 997899997379987999998535665444445332223345889999999999999999988757---92666241021
Q ss_pred EEECCCCCEEECCCCCCEEECCCCCCE--EEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC-CCCCCCCC
Q ss_conf 877599980992541324411489505--762357786686777989978544206699999999968999-99998883
Q 001752 844 ILLDSNLEPRIADFGLARMMIRKNETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRP-LDPEFGES 920 (1018)
Q Consensus 844 Ill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~p-f~~~~~~~ 920 (1018)
|+++.++.++++|||.++......... ....||+.|+|||++.+..++.++||||||+++|||++++.| |... ...
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-~~~ 254 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVD 254 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CSS
T ss_pred CCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-CHH
T ss_conf 0000257521023401023367886158620135968767788617999974001025899999985899887789-989
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 00999999985135630011499988992039999999999987127999999998999999400599
Q 001752 921 VDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKP 988 (1018)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~ 988 (1018)
..+...+....+.. .. . .....+.+|+.+||+.||++||||.+++++|+++..
T Consensus 255 ~~~~~~i~~~~~~~----------~~--~---~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 255 SKFYKMIKEGFRML----------SP--E---HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHHHHHHHTCCCC----------CC--T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCC----------CC--C---CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 99999986689889----------85--4---365999999999757796579299999999987653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.53 Aligned_cols=259 Identities=29% Similarity=0.400 Sum_probs=206.0
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCC---CEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCE
Q ss_conf 2265344441078802999991899---9299999952223432100266699999998236788701255468649913
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRL---NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 781 (1018)
+.|++.+.||+|+||+||+|.+... ...||||++..... ......++|.+|+.++++++||||++++|++.+ ...
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCH
T ss_conf 891997898038883999999988999079999999983555-798999999999999986899998789877740-100
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCE
Q ss_conf 99997147999777630387775333899999999999999997621999991960479996877599980992541324
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLAR 861 (1018)
Q Consensus 782 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~ 861 (1018)
++||||+++|++.+.+..... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+|++|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred HEEEEEECCCCHHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHH
T ss_conf 114654238612544421268---999999999999999999875217---87520566888156556543325611555
Q ss_pred EECCCCCCE---EEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 411489505---76235778668677798997854420669999999996-89999999888300999999985135630
Q 001752 862 MMIRKNETV---SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNL 937 (1018)
Q Consensus 862 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1018)
......... ....|+..|+|||++.+..++.++||||||+++|||++ |+.||.+. ................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-----~~~~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGSQILHKIDKEGERL 234 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTSCCCC
T ss_pred HCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHHCCCCC
T ss_conf 30358875265476325731079999837999942156614899999996899999996-----9999999998479999
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 01149998899203999999999998712799999999899999940059
Q 001752 938 EEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~ 987 (1018)
+.... ....+.+++.+||++||++||||.++.+.|++++
T Consensus 235 -----~~~~~------~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 235 -----PRPED------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp -----CCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -----CCCCC------CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHCC
T ss_conf -----98544------5399999999976889667929999999999649
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.76 Aligned_cols=256 Identities=28% Similarity=0.431 Sum_probs=202.5
Q ss_pred CCCEEECCCCEEEEEEECCCCC---EEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEEC-CCCEEEE
Q ss_conf 3444410788029999918999---29999995222343210026669999999823678870125546864-9913999
Q 001752 709 ESNVIGMGATGIVYKAEMPRLN---TIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN-DTNMMIV 784 (1018)
Q Consensus 709 ~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv 784 (1018)
..++||+|+||+||+|.+..++ ..||||++.. .......++|.+|+.++++++||||++++|++.. +...++|
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred CCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 66698136880999999977998799999999884---369789999999999998678999867867898069943899
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEEC
Q ss_conf 97147999777630387775333899999999999999997621999991960479996877599980992541324411
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~ 864 (1018)
|||+++|+|.+++..... ..++..+++++.|++.||.|+|+. +|+||||||+||++++++.+||+|||+++...
T Consensus 108 ~E~~~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181 (311)
T ss_dssp EECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred EEEEECCCHHHHHCCCCC---CCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCC
T ss_conf 987406741442101345---404899999999988765200336---76257766875767799988991065232255
Q ss_pred CCCCC----EEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 48950----57623577866867779899785442066999999999689999999888300999999985135630011
Q 001752 865 RKNET----VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRNLEEA 940 (1018)
Q Consensus 865 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1018)
..... .....||+.|+|||+..+..++.++||||||+++|||++|+.||...... .++...+. .... .
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~---~g~~-~--- 253 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLL---QGRR-L--- 253 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHH---TTCC-C---
T ss_pred CCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHH---CCCC-C---
T ss_conf 66555310025655564556768874379997457466199999999789999888999-99999998---0898-8---
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 4999889920399999999999871279999999989999994005999
Q 001752 941 LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPR 989 (1018)
Q Consensus 941 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~ 989 (1018)
..| ..+ ...+.+++.+||+.||++||++.||+++|+++...
T Consensus 254 ~~p--~~~------~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 254 LQP--EYC------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCC--TTC------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCC--CCC------CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 996--447------59999999997688976893999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.15 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=203.9
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEEC-CCCEE
Q ss_conf 62265344441078802999991899929999995222343210026669999999823678870125546864-99139
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN-DTNMM 782 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~ 782 (1018)
.++|+..+.||+|+||.||+|.++ ++.||||+++.+ ...+.+.+|+.++++++||||++++|++.+ .+.++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred HHHEEEEEEEECCCCEEEEEEEEC--CEEEEEEEECCH------HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEE
T ss_conf 899488579820798089999999--909999998857------779999999999986789898549878872389289
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf 99971479997776303877753338999999999999999976219999919604799968775999809925413244
Q 001752 783 IVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 783 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~ 862 (1018)
+||||+++|+|.+++.... ...+++..+++++.||+.|++|||+. +|+||||||+||+++.++.+|++|||.++.
T Consensus 78 lv~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 152 (262)
T ss_dssp EEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred EEEECCCCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEE
T ss_conf 9996369998999987457--88889999999999998523211337---655366656760146899776324560034
Q ss_pred ECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 1148950576235778668677798997854420669999999996-899999998883009999999851356300114
Q 001752 863 MIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLEEAL 941 (1018)
Q Consensus 863 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1018)
.. .......++..|+|||++.+..+++++||||||+++|||++ |+.||... ...++...+.. ..
T Consensus 153 ~~---~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~----~~------ 217 (262)
T d1byga_ 153 AS---STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEK----GY------ 217 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTT----TC------
T ss_pred CC---CCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHC----CC------
T ss_conf 47---87765566646778178727988858877757999999997899999999--99999999980----89------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 9998899203999999999998712799999999899999940059
Q 001752 942 DPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 942 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~ 987 (1018)
.+.... .....+.+++.+||+.||.+|||+.+++++|+.++
T Consensus 218 ~~~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 218 KMDAPD-----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCC-----CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 999976-----57999999999975669768939999999999998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.58 Aligned_cols=258 Identities=26% Similarity=0.355 Sum_probs=206.5
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCC---CEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCC
Q ss_conf 62265344441078802999991899---929999995222343210026669999999823678870125546864991
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRL---NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTN 780 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 780 (1018)
.++|+..+.||+|+||.||+|.+..+ +..||+|++.. .........+.+|+.++++++||||+++++++. ++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT---TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCE
T ss_conf 8996987799307882999999936996449999999365---668799999999999998689999856988995-374
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCC
Q ss_conf 39999714799977763038777533389999999999999999762199999196047999687759998099254132
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLA 860 (1018)
Q Consensus 781 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a 860 (1018)
.++||||+++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+|++|||+|
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEEEEEECCCCCHHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHH
T ss_conf 7999984069807765422478---999999999999998775230226---7441410265532067896787650342
Q ss_pred EEECCCCC-CEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 44114895-0576235778668677798997854420669999999996-899999998883009999999851356300
Q 001752 861 RMMIRKNE-TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGESVDIVEWIRMKIRDNRNLE 938 (1018)
Q Consensus 861 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1018)
+....... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||..... .++...+. .....
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~~i~----~~~~~- 228 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIE----NGERL- 228 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHH----TTCCC-
T ss_pred EECCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH--HHHHHHHH----CCCCC-
T ss_conf 133677623305400583103266751699887452444247899998269999888999--99999998----18999-
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 11499988992039999999999987127999999998999999400599
Q 001752 939 EALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKP 988 (1018)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~ 988 (1018)
+....+ ...+.+++.+||+.||++|||+.++++.|+++..
T Consensus 229 ----~~~~~~------~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 229 ----PMPPNC------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp ----CCCTTC------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCC------CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ----898777------9999999999768797689299999999999977
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.63 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=208.3
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCCC-------EEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCC-CCCCCCEEEEEE
Q ss_conf 622653444410788029999918999-------299999952223432100266699999998236-788701255468
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLN-------TIVAVKKLWRSRADLETESSGDFVGEVNVLGKL-RHRNIVRLLGFL 775 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 775 (1018)
.++|+..+.||+|+||.||+|+....+ ..||||++... ........+.+|...+.++ +||||+++++++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCC---CCHHHHHHHHHHHHHHHHHCCCCEEEECCCCC
T ss_conf 899697009851678289999985787555667549999998811---28688999999999999813999697346522
Q ss_pred ECCCCEEEEEEECCCCCHHHHHHCCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCC
Q ss_conf 6499139999714799977763038777------------5333899999999999999997621999991960479996
Q 001752 776 HNDTNMMIVYEYMNNGSLGEALHGKQAG------------RLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNN 843 (1018)
Q Consensus 776 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 843 (1018)
.+++..++||||+++|+|.+++..+... ...+++..+..++.|++.||+|||+. +|+||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCC
T ss_conf 018868999973699909999986067764322233457434679999999999999999876637---97863022102
Q ss_pred EEECCCCCEEECCCCCCEEECCCCCC--EEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCC
Q ss_conf 87759998099254132441148950--576235778668677798997854420669999999996-899999998883
Q 001752 844 ILLDSNLEPRIADFGLARMMIRKNET--VSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT-GRRPLDPEFGES 920 (1018)
Q Consensus 844 Ill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~ 920 (1018)
|+++.++.+||+|||.++........ .....+++.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-- 243 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 243 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred EEECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH--
T ss_conf 245478976762211101135555543146678884663266751798882555477588888740179898999999--
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 0099999998513563001149998899203999999999998712799999999899999940059
Q 001752 921 VDIVEWIRMKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAK 987 (1018)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~ 987 (1018)
..+. ..+..+... +.... ....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 244 ~~~~----~~i~~~~~~-----~~p~~------~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 244 EELF----KLLKEGHRM-----DKPSN------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHH----HHHHTTCCC-----CCCSS------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH----HHHHCCCCC-----CCCCC------CHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 9999----999728888-----98743------5299999999976679767939999999998886
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.14 Aligned_cols=264 Identities=23% Similarity=0.358 Sum_probs=208.7
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCC-----CCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
Q ss_conf 6226534444107880299999189-----99299999952223432100266699999998236788701255468649
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPR-----LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND 778 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 778 (1018)
.++|+..+.||+|+||+||+|.+.. +++.||||++... ........|.+|+.++++++||||+++++++..+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~---~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf 8991883598207881899999878644778968999998701---2868999999999999976999884125478428
Q ss_pred CCEEEEEEECCCCCHHHHHHCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCE
Q ss_conf 913999971479997776303877------75333899999999999999997621999991960479996877599980
Q 001752 779 TNMMIVYEYMNNGSLGEALHGKQA------GRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEP 852 (1018)
Q Consensus 779 ~~~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 852 (1018)
...++||||+++|+|.+++..... ....+++..+.+++.|+++||.|||++ +|+||||||+||+++.++.+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCEE
T ss_conf 810677760489988999875033211344468879999999999999999987647---96543286775403599649
Q ss_pred EECCCCCCEEECCCCCCE--EEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCCCCCCHHHHHHH
Q ss_conf 992541324411489505--7623577866867779899785442066999999999689-9999998883009999999
Q 001752 853 RIADFGLARMMIRKNETV--SMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGR-RPLDPEFGESVDIVEWIRM 929 (1018)
Q Consensus 853 kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~-~pf~~~~~~~~~~~~~~~~ 929 (1018)
||+|||+++......... ....|++.|+|||.+.+..++.++||||||+++|||++|. .||... ...+....
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~~~~~~~~ 247 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVLRF 247 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHHHH
T ss_pred EEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
T ss_conf 9942454202357763031340231632378888736998833344437899999996899999998-----99999999
Q ss_pred HHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 8513563001149998899203999999999998712799999999899999940059998
Q 001752 930 KIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRR 990 (1018)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~ 990 (1018)
...... .+....+ ...+.+++.+||+.+|++|||+.+++++|++.....
T Consensus 248 i~~~~~------~~~p~~~------~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 248 VMEGGL------LDKPDNC------PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp HHTTCC------CCCCTTC------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred HHHCCC------CCCCCCC------HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCCC
T ss_conf 980888------8886335------399999999975779658939999999978761778
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.02 Aligned_cols=274 Identities=24% Similarity=0.294 Sum_probs=199.7
Q ss_pred HHHCCCCCCEEECCCCEEEEEEECCCC-CEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCC---CCCCCCEEEEEEEC-
Q ss_conf 862265344441078802999991899-9299999952223432100266699999998236---78870125546864-
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRL-NTIVAVKKLWRSRADLETESSGDFVGEVNVLGKL---RHRNIVRLLGFLHN- 777 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~- 777 (1018)
..++|++.+.||+|+||+||+|.+..+ ++.||+|++..... .......+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG--EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC--TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHC--CCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC
T ss_conf 758979888992155869999999888998999999802324--516799999999999987425898802366322146
Q ss_pred ----CCCEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEE
Q ss_conf ----9913999971479997776303877753338999999999999999976219999919604799968775999809
Q 001752 778 ----DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPR 853 (1018)
Q Consensus 778 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 853 (1018)
....+++|||++++.+......... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~k 156 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 156 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred CCCCCCEEEEEEEECCCCCHHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEE
T ss_conf 66667469999974058714444430378---999899999999999999999758---898357986278985899754
Q ss_pred ECCCCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf 92541324411489505762357786686777989978544206699999999968999999988830099999998513
Q 001752 854 IADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD 933 (1018)
Q Consensus 854 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 933 (1018)
++|||.++... .........||+.|+|||++.+..++.++||||+||++|||++|+.||.+... .+....+......
T Consensus 157 l~dfg~~~~~~-~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 157 LADFGLARIYS-FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGL 233 (305)
T ss_dssp ECSCCSCCCCC-GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCC
T ss_pred ECCHHHHHHHC-CCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHHCC
T ss_conf 21000101100-23457776548511483100179888111000328999999878799899898--9999999984079
Q ss_pred CCC--C-------CCCCCCCCCCC--CHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHCCC
Q ss_conf 563--0-------01149998899--2039999999999987127999999998999999--40059
Q 001752 934 NRN--L-------EEALDPNVGNC--KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM--LGEAK 987 (1018)
Q Consensus 934 ~~~--~-------~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~~~ 987 (1018)
... . ........... .........+.+++.+||+.||++|||++|++++ ++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCH
T ss_conf 9611053211110333022345645440445899999999998748966791899996696340752
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.23 Aligned_cols=270 Identities=27% Similarity=0.359 Sum_probs=195.1
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEEC------C
Q ss_conf 2265344441078802999991899929999995222343210026669999999823678870125546864------9
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN------D 778 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~ 778 (1018)
..|+..++||+|+||+||+|++..+++.||||++..... .+.+|+.++++++||||+++++++.. .
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH--------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
T ss_conf 776751698217683999999999997999999881606--------899999999866898987387899744765773
Q ss_pred CCEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCC-CEEECCC
Q ss_conf 913999971479997776303877753338999999999999999976219999919604799968775999-8099254
Q 001752 779 TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL-EPRIADF 857 (1018)
Q Consensus 779 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Df 857 (1018)
.+.++||||++++ +.+.+.........+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+||
T Consensus 92 ~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DF 167 (350)
T d1q5ka_ 92 VYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF 167 (350)
T ss_dssp CEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCC
T ss_pred EEEEEEEECCCCC-CHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECC
T ss_conf 1899998416886-0788886310368999999999999999999999866---87645788603787358971167336
Q ss_pred CCCEEECCCCCCEEEECCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH------
Q ss_conf 132441148950576235778668677798-9978544206699999999968999999988830099999998------
Q 001752 858 GLARMMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMK------ 930 (1018)
Q Consensus 858 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~------ 930 (1018)
|+++.... ........|++.|+|||...+ ..++.++||||+||++|||++|+.||...... ..+.......
T Consensus 168 G~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 168 GSAKQLVR-GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 245 (350)
T ss_dssp TTCEECCT-TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHH
T ss_pred CCHHHCCC-CCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHH-HHHHHHHHHHCCCHHH
T ss_conf 60544047-765320025555568277640468882100024652778550287998987999-9999999974898177
Q ss_pred -HHC-CCCCCCCCCCCCCCC----CHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHCCCC
Q ss_conf -513-563001149998899----2039999999999987127999999998999999--400599
Q 001752 931 -IRD-NRNLEEALDPNVGNC----KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM--LGEAKP 988 (1018)
Q Consensus 931 -~~~-~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~~~~ 988 (1018)
... ........-+..... .........+.+++.+||+.||++|||+.|++++ ++++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 654306210110355445674444315689999999999976589557929999966984524667
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.83 Aligned_cols=246 Identities=22% Similarity=0.323 Sum_probs=198.7
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCC--CCHHHHHHHHHHHHHCCC--CCCCCEEEEEEECCC
Q ss_conf 6226534444107880299999189992999999522234321--002666999999982367--887012554686499
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLE--TESSGDFVGEVNVLGKLR--HRNIVRLLGFLHNDT 779 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~ 779 (1018)
.++|++.+.||+|+||.||+|.+..+++.||||++........ .....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred CEEEEEEECCC-CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCC-CCEEECCC
Q ss_conf 13999971479-99777630387775333899999999999999997621999991960479996877599-98099254
Q 001752 780 NMMIVYEYMNN-GSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSN-LEPRIADF 857 (1018)
Q Consensus 780 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Df 857 (1018)
..++||||+.+ +++.+++..... +++..+..++.|++.||+|||++ +|+||||||+||+++.+ +.+|++||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~----l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEEECCCCCHHHHHHHCCCC----CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECCC
T ss_conf 689999833686228999861589----99999999999999999999877---97556676111477447884897754
Q ss_pred CCCEEECCCCCCEEEECCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 132441148950576235778668677798997-8544206699999999968999999988830099999998513563
Q 001752 858 GLARMMIRKNETVSMVAGSYGYIAPEYGYTLKV-DEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRN 936 (1018)
Q Consensus 858 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 936 (1018)
|+|+... ........||+.|+|||++.+..+ +.++||||+||++|||++|+.||... . . .......
T Consensus 156 G~a~~~~--~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~---~----i~~~~~~ 222 (273)
T d1xwsa_ 156 GSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----E---E----IIRGQVF 222 (273)
T ss_dssp TTCEECC--SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H---H----HHHCCCC
T ss_pred CCCEECC--CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCC----H---H----HHHCCCC
T ss_conf 6535324--445566565877479999848997886533255403453675688998873----6---7----7615447
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 0011499988992039999999999987127999999998999999
Q 001752 937 LEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
+.+. ....+.+++.+||+.||++|||++|++++
T Consensus 223 ----~~~~---------~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 223 ----FRQR---------VSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----CSSC---------CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CCCC---------CCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ----7877---------99999999999760897589399998539
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.13 Aligned_cols=269 Identities=20% Similarity=0.267 Sum_probs=201.4
Q ss_pred HHHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEEC-----
Q ss_conf 862265344441078802999991899929999995222343210026669999999823678870125546864-----
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN----- 777 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 777 (1018)
..++|++.+.||+|+||+||+|.+..+++.||||++.... .......++.+|+.++++++|||++++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC------CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH--CCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 6279889999722748299999998999799999984222--46378999999999999835999660676540246544
Q ss_pred ---CCCEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEE
Q ss_conf ---99139999714799977763038777533389999999999999999762199999196047999687759998099
Q 001752 778 ---DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRI 854 (1018)
Q Consensus 778 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 854 (1018)
....++||||++++.+......... ++...+..++.|++.|+.|||+. ||+||||||+||+++.++.+|+
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~----~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl 158 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL 158 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred CCCCCEEEEEEECCCCCCCCHHHHCCCC----CCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEE
T ss_conf 4457638999853578741012220344----33089999999999999885229---9885676722203668996876
Q ss_pred CCCCCCEEECCCCC----CEEEECCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 25413244114895----05762357786686777989-97854420669999999996899999998883009999999
Q 001752 855 ADFGLARMMIRKNE----TVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRM 929 (1018)
Q Consensus 855 ~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 929 (1018)
+|||++........ ......||+.|+|||++.+. .+++++||||+||++|||++|+.||.+... ......+..
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--~~~~~~i~~ 236 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQ 236 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHH
T ss_pred EECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCH--HHHHHHHHH
T ss_conf 313500223554443211356602497874289970799989178700678646617448799899899--999999998
Q ss_pred HHHCCC-CCC---------CCCCCCCCCCCHHHHH------HHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 851356-300---------1149998899203999------9999999987127999999998999999
Q 001752 930 KIRDNR-NLE---------EALDPNVGNCKHVQEE------MLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 930 ~~~~~~-~~~---------~~~~~~~~~~~~~~~~------~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
...... ... ..............+. ...+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 418998255344320344433201334455503340444599899999999873896589099999749
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=329.54 Aligned_cols=266 Identities=23% Similarity=0.306 Sum_probs=204.0
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 22653444410788029999918999299999952223432100266699999998236788701255468649913999
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 784 (1018)
++|+..+.||+|+||+||+|.++ +++.||||++.... .......++.+|+.++++++||||+++++++.+.+..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSS--GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEE
T ss_conf 99634318722778189999968-99999999981232--6858999999999999867998687660120467731589
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEEC
Q ss_conf 97147999777630387775333899999999999999997621999991960479996877599980992541324411
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~ 864 (1018)
+|++.++.+..+...... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+....
T Consensus 79 ~e~~~~~~~~~~~~~~~~----l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (286)
T ss_dssp EECCSEEHHHHHHTSTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred EEEEHHHHHHHHHHHCCC----CCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECC
T ss_conf 974004567899860477----51445689999999999986057---48826787750568689978732366430114
Q ss_pred CCCCCEEEECCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHH-HHHHHHCCCC----CC
Q ss_conf 48950576235778668677798-997854420669999999996899999998883009999-9998513563----00
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEW-IRMKIRDNRN----LE 938 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~----~~ 938 (1018)
..........+++.|+|||...+ ..++.++||||+||++|||++|+.||.+... .+.... .......... ..
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--ADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred CCCCCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCH--HHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 6765410102431101378871788888410021117589999779799898898--99999999863899711042123
Q ss_pred C------CCCCCCCCC--CHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1------149998899--2039999999999987127999999998999999
Q 001752 939 E------ALDPNVGNC--KHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 939 ~------~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
. ......... .........+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 3322143333356764666512589999999999866896689099998569
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.65 Aligned_cols=268 Identities=23% Similarity=0.337 Sum_probs=204.4
Q ss_pred HHHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC---
Q ss_conf 86226534444107880299999189992999999522234321002666999999982367887012554686499---
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT--- 779 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 779 (1018)
+.++|+..+.||+|+||+||+|.+..+++.||||++... .......+.+.+|+.+++.++|||+|++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST--TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH--HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCC
T ss_conf 477189988980177819999999999989999998522--259699999999999998668987547999863576555
Q ss_pred ---CEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECC
Q ss_conf ---13999971479997776303877753338999999999999999976219999919604799968775999809925
Q 001752 780 ---NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 780 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 856 (1018)
.+++||||+ +.+|.+..+... +++..+..++.|++.||+|||++ ||+||||||+||+++.++.+|++|
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~D 164 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 164 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred CCCEEEEEEECC-CCCHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCC
T ss_conf 541599998405-521899987402-----26999999999999999998737---876456685111121001221134
Q ss_pred CCCCEEECCCCCCEEEECCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 4132441148950576235778668677798-997854420669999999996899999998883009999999851356
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGYT-LKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR 935 (1018)
Q Consensus 857 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 935 (1018)
||.|+... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.... ..+............
T Consensus 165 fg~a~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 165 FGLARQAD---SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPA 240 (346)
T ss_dssp CTTCEECC---SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCH
T ss_pred CCCEECCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHH-HHHHHHHHCCCCCCH
T ss_conf 31022068---76310245533358899817878996501030038999999786998889768-999999850378848
Q ss_pred ----------------CCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHCCC
Q ss_conf ----------------30011499988992039999999999987127999999998999999--40059
Q 001752 936 ----------------NLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM--LGEAK 987 (1018)
Q Consensus 936 ----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~~~ 987 (1018)
...+........ ........+.+++.+||..||.+|||++|++++ ++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFAS--ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGG--TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHCCHHHHHHHCCCCCCCCCCHHH--HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 8886530003443311578666556677--5568999999999997729955792999996396237587
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.15 Aligned_cols=270 Identities=21% Similarity=0.275 Sum_probs=201.9
Q ss_pred HHHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC---
Q ss_conf 86226534444107880299999189992999999522234321002666999999982367887012554686499---
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDT--- 779 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 779 (1018)
+..+|+..+.||+|+||+||+|.+..+++.||||++.... .....+.+.+|+.++++++|||++++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCC
T ss_conf 3898599789940648099999999999499999980310---9589999999999999768989885888995056455
Q ss_pred -CEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCC
Q ss_conf -1399997147999777630387775333899999999999999997621999991960479996877599980992541
Q 001752 780 -NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFG 858 (1018)
Q Consensus 780 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 858 (1018)
..+++++++.+|+|.+++.... +++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~~-----l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG 154 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG 154 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEEECCCCHHHHHHCCC-----CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCC
T ss_conf 41499999625986566440589-----99999999999999999999978---98677787643788799977875457
Q ss_pred CCEEECCCCCC---EEEECCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 32441148950---57623577866867779-899785442066999999999689999999888300999999985135
Q 001752 859 LARMMIRKNET---VSMVAGSYGYIAPEYGY-TLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDN 934 (1018)
Q Consensus 859 ~a~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 934 (1018)
++......... .....|++.|+|||++. +..++.++||||+||++|+|++|+.||..... .+............
T Consensus 155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~--~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQLNHILGILGSP 232 (345)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSC
T ss_pred CEEECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCH--HHHHHHHHHHCCCC
T ss_conf 0565047776410101102652000387860478887410100467013377669799788888--99999876520699
Q ss_pred CCC----------CCC--CCCCCCCCCHHH----HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHCC
Q ss_conf 630----------011--499988992039----999999999987127999999998999999--4005
Q 001752 935 RNL----------EEA--LDPNVGNCKHVQ----EEMLLVLRIAFLCTAKLPKDRPSMRDVITM--LGEA 986 (1018)
Q Consensus 935 ~~~----------~~~--~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~~ 986 (1018)
... ... ..+.... .... .....+.+++.+|++.||.+|||+.|++++ +++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNK-VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCC-CCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred CHHHHHHHHHHHHHCCCCCCCCCCC-CCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 7566423433222202446775577-87778378999999999999764895679089998619865558
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=320.62 Aligned_cols=275 Identities=16% Similarity=0.171 Sum_probs=212.4
Q ss_pred HHHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCC-CCCCEEEEEEECCCCE
Q ss_conf 862265344441078802999991899929999995222343210026669999999823678-8701255468649913
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH-RNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~ 781 (1018)
+.++|++.+.||+|+||+||+|++..+++.||+|++... .....+.+|+..++.++| ++++.+++++..+...
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~------~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR------SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC------TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC------CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
T ss_conf 898069979984178829999999889979999997502------58299999999999964899987799996018811
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECC-----CCCEEECC
Q ss_conf 9999714799977763038777533389999999999999999762199999196047999687759-----99809925
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS-----NLEPRIAD 856 (1018)
Q Consensus 782 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~D 856 (1018)
++||||+ +++|.+++..... .+++..+..++.|++.||+|+|+. ||+||||||+||+++. ++.++++|
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred EEEEEEC-CCCHHHHHHHHCC---CHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECC
T ss_conf 7999964-8887999975203---110689999999999999999977---96626677131523475434479568723
Q ss_pred CCCCEEECCCCC-------CEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC-CHHHHHH
Q ss_conf 413244114895-------05762357786686777989978544206699999999968999999988830-0999999
Q 001752 857 FGLARMMIRKNE-------TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESV-DIVEWIR 928 (1018)
Q Consensus 857 fg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~-~~~~~~~ 928 (1018)
||+|+.+..... ......||+.|+|||.+.+..+++++||||+|+++|||++|+.||.+...... .....+.
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~ 229 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred CCEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
T ss_conf 66057714676654111024676277510267989648888869998983199999986987678853021999999997
Q ss_pred HHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHH
Q ss_conf 9851356300114999889920399999999999871279999999989999994005999899999985100
Q 001752 929 MKIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNRYE 1001 (1018)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~~~~~~~~~~~~ 1001 (1018)
... ......+.... . ...+.+++..|++.+|++||+++.+.+.|+++..+.....+...+|+
T Consensus 230 ~~~-~~~~~~~l~~~-------~---p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~ 291 (293)
T d1csna_ 230 EKK-QSTPLRELCAG-------F---PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 291 (293)
T ss_dssp HHH-HHSCHHHHTTT-------S---CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred HCC-CCCCHHHHCCC-------C---CHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 056-79995896579-------9---89999999998439930085999999999999997599999998989
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=322.93 Aligned_cols=275 Identities=17% Similarity=0.142 Sum_probs=205.7
Q ss_pred HHHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCC-EEEEEEECCCCE
Q ss_conf 8622653444410788029999918999299999952223432100266699999998236788701-255468649913
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIV-RLLGFLHNDTNM 781 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~ 781 (1018)
+.++|+..+.||+|+||.||+|.+..+++.||||++... ....++.+|+.+++.++|++++ .+.++..+.+..
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~------~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK------TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC------TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred ECCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHH------CCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEE
T ss_conf 888899968985078809999999889989999997210------05888999999999703899601799999519877
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECC---CCCEEECCCC
Q ss_conf 9999714799977763038777533389999999999999999762199999196047999687759---9980992541
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDS---NLEPRIADFG 858 (1018)
Q Consensus 782 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfg 858 (1018)
++||||+ ++++.+.+..... .+++..+..++.|++.||+|||++ ||+||||||+||+++. +..++++|||
T Consensus 79 ~ivme~~-~~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEEEECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEEEC-CCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCC
T ss_conf 8999873-8713332443068---876899999999999999999979---94426678766064335777615650467
Q ss_pred CCEEECCCCC-------CEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC--HHHHHHH
Q ss_conf 3244114895-------057623577866867779899785442066999999999689999999888300--9999999
Q 001752 859 LARMMIRKNE-------TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVD--IVEWIRM 929 (1018)
Q Consensus 859 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~ 929 (1018)
+|+.+..... ......||+.|+|||.+.+..+++++|||||||++|||++|+.||......... .......
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred CCEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCC
T ss_conf 51342554455410001357767873532999991899898321886177899998498766553057799999985235
Q ss_pred HHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHC
Q ss_conf 8513563001149998899203999999999998712799999999899999940059998999999851000
Q 001752 930 KIRDNRNLEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNNDNRYEN 1002 (1018)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~~~~~~~~~~~~~ 1002 (1018)
..... .....+ .....+.+++.+|++.+|++||++.++.+.|+.+..+.....+...+|+.
T Consensus 232 ~~~~~--~~~~~~----------~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~ 292 (299)
T d1ckia_ 232 KMSTP--IEVLCK----------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 292 (299)
T ss_dssp HHHSC--HHHHTT----------TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHH
T ss_pred CCCCC--HHHHCC----------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCCCCCCCCCCCHH
T ss_conf 67898--357534----------78899999999984399557919999999999999976999788938544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.89 Aligned_cols=268 Identities=24% Similarity=0.308 Sum_probs=208.5
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 22653444410788029999918999299999952223432100266699999998236788701255468649913999
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHNDTNMMIV 784 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 784 (1018)
++|++.+.||+|+||+||+|++..+++.||||++.... .......++.+|+.+++.++||||+++++++.+....++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
T ss_conf 99786269712868199999999999699999980321--7868999999999999856757888213544444311588
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEEEC
Q ss_conf 97147999777630387775333899999999999999997621999991960479996877599980992541324411
Q 001752 785 YEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARMMI 864 (1018)
Q Consensus 785 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~ 864 (1018)
++++.++++..++...+. +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.++...
T Consensus 80 ~~~~~~~~l~~~~~~~~~----~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGD----LDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EECCSEEHHHHHHHTTTC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEECCCCCCCCCCCCCCC----CCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCC
T ss_conf 630233222112123565----40367899999999998774339---98600146761211337826652046011046
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCC--C-----
Q ss_conf 4895057623577866867779899-7854420669999999996899999998883009999999851356--3-----
Q 001752 865 RKNETVSMVAGSYGYIAPEYGYTLK-VDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNR--N----- 936 (1018)
Q Consensus 865 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~----- 936 (1018)
..........+++.|+|||++.+.. ++.++||||+||++|||++|+.||....... +....+........ .
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHHHCCCCTTTCTTGG
T ss_pred CCCCCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHH-HHHHHHHHHCCCCCHHHHHHHH
T ss_conf 887510010344310146675069888804440265418899851899998899999-9999998611899735513443
Q ss_pred -CCCC-----CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -0011-----499988992039999999999987127999999998999999
Q 001752 937 -LEEA-----LDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 937 -~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
..+. .................+.+++.+|++.||.+|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2221133444544310433065689999999999864996689099999649
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=320.24 Aligned_cols=265 Identities=23% Similarity=0.286 Sum_probs=204.6
Q ss_pred HHHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEEC-----
Q ss_conf 862265344441078802999991899929999995222343210026669999999823678870125546864-----
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHN----- 777 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 777 (1018)
+.++|++.+.||+|+||+||+|.+..+++.||||++.... .......++.+|+.++++++||||+++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred ECCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCC
T ss_conf 3377599889621758599999999999899999988233--69799999999999998648987648998970256434
Q ss_pred -CCCEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECC
Q ss_conf -9913999971479997776303877753338999999999999999976219999919604799968775999809925
Q 001752 778 -DTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 778 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 856 (1018)
....|+||||+.+ ++.+.+... +++..+..++.|++.||+|||++ ||+||||||+||+++.++.++++|
T Consensus 93 ~~~~~~iv~Ey~~~-~l~~~~~~~------~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~d 162 (355)
T d2b1pa1 93 EFQDVYLVMELMDA-NLCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_dssp TCCEEEEEEECCSE-EHHHHHTSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred CCCEEEEEEECCCH-HHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEEC
T ss_conf 57626999841446-778765038------99999999999999999886522---112456776321136544313201
Q ss_pred CCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH-----
Q ss_conf 413244114895057623577866867779899785442066999999999689999999888300999999985-----
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKI----- 931 (1018)
Q Consensus 857 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~----- 931 (1018)
||.++.... ........+|+.|+|||++.+..+++++||||+||++|+|++|+.||.+... ......+....
T Consensus 163 f~~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~--~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 163 FGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGTPCP 239 (355)
T ss_dssp CCC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCH
T ss_pred HHHHHCCCC-CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCH--HHHHHHHHHHCCCCCH
T ss_conf 023211466-6553322146555581331477778774333566257898659899888977--8899999972058987
Q ss_pred --------------HCCC-----CCCCCCCC--CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf --------------1356-----30011499--988992039999999999987127999999998999999
Q 001752 932 --------------RDNR-----NLEEALDP--NVGNCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 932 --------------~~~~-----~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
.... .....+.. ..............+.+++.+|++.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 999876566777764175435666421264333543210133379999999999876994579089999669
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=320.55 Aligned_cols=295 Identities=31% Similarity=0.475 Sum_probs=198.9
Q ss_pred CCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCE--EEEEEECCC---CCEEEEECCCCCCCCC--CCCCCCCCCCCCE
Q ss_conf 03088999999987606799999689789999831--265873899---9889997599988764--3222356888888
Q 001752 30 TALNDELLALLSIKAGLVDPLNSLHDWKLPSAHCN--WTGVWCNSN---GAVEKLDLSHMNLSGC--VSDHFQRLKSLTS 102 (1018)
Q Consensus 30 ~~~~~~~~~ll~~k~~~~d~~~~~~~w~~~~~~c~--w~gv~c~~~---~~v~~l~l~~~~l~~~--~~~~~~~l~~L~~ 102 (1018)
-|.++|++||++||+++.||. .+++|..++|||. |.||+|+.. ++|+.|||+++++++. ++++++++++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHHCCCCC-CCCCCCCCCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf 989899999999999779998-6778899999988948896974899947988998989988888879847846753352
Q ss_pred EECCC-CCCCCCCCHHHHCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 87688-87678888211078998699864034589886445677888363168987776331123566665367124853
Q 001752 103 LNLCC-NGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSF 181 (1018)
Q Consensus 103 L~L~~-n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 181 (1018)
|+|++ |++.+.+|..|+++++|++|+|++|.+.+..+..+..+..|++++++.|.+....|..+++++.|+.+++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCC
T ss_conf 02026543330024311454200110203564344332222201110011112245555685122067400000023553
Q ss_pred CCCCCCCCCCCCCCC-CEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 476666123464644-5342016425898876246455301322001335788882434756643212324226744760
Q 001752 182 FQGSIPVSFKNLQKL-KFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPA 260 (1018)
Q Consensus 182 l~~~~p~~~~~l~~L-~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 260 (1018)
+.+.+|..+..+..+ +.+.+++|++++..|..+..+..+ .+++..+...+..+.
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-------------------------~l~l~~~~~~~~~~~ 215 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-------------------------FVDLSRNMLEGDASV 215 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-------------------------EEECCSSEEEECCGG
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-------------------------CCCCCCCCCCCCCCC
T ss_conf 3562031214431123231022464353324332222222-------------------------333333433222222
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 01497854468704896786688211188877766553787764469742256677356433573535358998888744
Q 001752 261 ELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLDLSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQL 340 (1018)
Q Consensus 261 ~l~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 340 (1018)
.+..+++++.+++..|.+.+.+ ..+..+++|+.|++++|++++.+|..+..+++|++|+|++|++++.+|. +..+++|
T Consensus 216 ~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L 293 (313)
T d1ogqa_ 216 LFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRF 293 (313)
T ss_dssp GCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGS
T ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-CCCCCCC
T ss_conf 2222222111222222222222-2222455444444765706660876884799999897958835166898-6667998
Q ss_pred CEEEECCCC-CCC
Q ss_conf 547731572-446
Q 001752 341 EVLELWNNS-LSG 352 (1018)
Q Consensus 341 ~~L~L~~n~-l~~ 352 (1018)
+.+++++|+ +++
T Consensus 294 ~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 294 DVSAYANNKCLCG 306 (313)
T ss_dssp CGGGTCSSSEEES
T ss_pred CHHHHCCCCCCCC
T ss_conf 9788688950019
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=318.12 Aligned_cols=261 Identities=19% Similarity=0.233 Sum_probs=197.8
Q ss_pred HHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCC-CCCCCEEEEEEEC--CCC
Q ss_conf 6226534444107880299999189992999999522234321002666999999982367-8870125546864--991
Q 001752 704 LACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHN--DTN 780 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~ 780 (1018)
.++|++.+.||+|+||+||+|++..+++.||+|++.. ...+++.+|+.+++.++ ||||+++++++.. ...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~-------~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-------SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECH-------HHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCC
T ss_conf 8671897898317481999999889997999999888-------999999999999985157998767999998168771
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCC-CEEECCCCC
Q ss_conf 3999971479997776303877753338999999999999999976219999919604799968775999-809925413
Q 001752 781 MMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNL-EPRIADFGL 859 (1018)
Q Consensus 781 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~ 859 (1018)
.++||||+++++|.+... .+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .++++|||.
T Consensus 107 ~~~v~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp EEEEEECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred EEEEEEECCCCCHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCC
T ss_conf 268886317985899746-------899999999999999999887643---3443456441237748998366415654
Q ss_pred CEEECCCCCCEEEECCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH----------
Q ss_conf 24411489505762357786686777989-9785442066999999999689999999888300999999----------
Q 001752 860 ARMMIRKNETVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIR---------- 928 (1018)
Q Consensus 860 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---------- 928 (1018)
|+.... ........+|+.|+|||...+. .++.++||||+||++|+|++|+.||...............
T Consensus 177 a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 177 AEFYHP-GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp CEECCT-TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred CEECCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHH
T ss_conf 266468-8744432248642476102688888845232335455587604889998876018999999998788415555
Q ss_pred --HHH-HCCCCCCCCCCCCCC-------CCCHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf --985-135630011499988-------992039999999999987127999999998999999
Q 001752 929 --MKI-RDNRNLEEALDPNVG-------NCKHVQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM 982 (1018)
Q Consensus 929 --~~~-~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 982 (1018)
... ............... ...........+.+++.+|++.||++|||++|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 5422544474300000333433112115521124489999999999866995689089999649
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.93 Aligned_cols=258 Identities=26% Similarity=0.318 Sum_probs=205.0
Q ss_pred HHCCCCCCEEECCCCEEEEEEEC---CCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCC-CCCCEEEEEEECCC
Q ss_conf 62265344441078802999991---899929999995222343210026669999999823678-87012554686499
Q 001752 704 LACIRESNVIGMGATGIVYKAEM---PRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRH-RNIVRLLGFLHNDT 779 (1018)
Q Consensus 704 ~~~~~~~~~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~ 779 (1018)
.++|++.+.||+|+||+||+|.+ ..+++.||+|++.+.....+....+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred HHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf 10259998983287839999998765887948999998367721016899999999999986467983999620002487
Q ss_pred CEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECCCCC
Q ss_conf 13999971479997776303877753338999999999999999976219999919604799968775999809925413
Q 001752 780 NMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIADFGL 859 (1018)
Q Consensus 780 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 859 (1018)
..+++|||+.+|+|.+++..... .++.....++.|++.|+.|+|+. +|+||||||+||+++.++.++|+|||+
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred CEEEEEECCCCCHHHHHHHHCCC----CCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCC
T ss_conf 30012312341179999873045----43788888899999999885149---989654773201246999888741320
Q ss_pred CEEECCC-CCCEEEECCCCCCCCCCCCCCC--CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 2441148-9505762357786686777989--978544206699999999968999999988830099999998513563
Q 001752 860 ARMMIRK-NETVSMVAGSYGYIAPEYGYTL--KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRDNRN 936 (1018)
Q Consensus 860 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 936 (1018)
++.+... ........|++.|+|||...+. .++.++||||+||++|+|++|+.||........ ..............
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~~~~~~ 254 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSEPP 254 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCCCC
T ss_pred HHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHCCCCCCC
T ss_conf 22203444432212223333310687605776887132517777999999768999888877779-99999833568998
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 00114999889920399999999999871279999999-----98999999
Q 001752 937 LEEALDPNVGNCKHVQEEMLLVLRIAFLCTAKLPKDRP-----SMRDVITM 982 (1018)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 982 (1018)
. . ......+.+++.+|+++||++|| |++|++++
T Consensus 255 ~-------~------~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 255 Y-------P------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp C-------C------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred C-------C------CCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf 8-------6------547999999999974458988199974509999749
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.83 Aligned_cols=271 Identities=22% Similarity=0.293 Sum_probs=202.4
Q ss_pred HHHHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECC---
Q ss_conf 88622653444410788029999918999299999952223432100266699999998236788701255468649---
Q 001752 702 DILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNIVRLLGFLHND--- 778 (1018)
Q Consensus 702 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 778 (1018)
++.++|+..+.||+|+||+||+|.+..+++.||||++... .......+++.+|+.++++++|||++++++++...
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT--TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCH--HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCC
T ss_conf 5898718888983178839999999999979999998820--02868999999999999866898742599999634645
Q ss_pred --CCEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEECC
Q ss_conf --913999971479997776303877753338999999999999999976219999919604799968775999809925
Q 001752 779 --TNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPRIAD 856 (1018)
Q Consensus 779 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 856 (1018)
...+++++++.+|+|.+++..++ +++..+..++.|++.||+|||++ ||+||||||+||+++.++.++++|
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~~~-----l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~d 164 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKCQK-----LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 164 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTTCC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCCEEEEEEEECCCCHHHHCCCCC-----CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 6686499999625886232002245-----30999999999999999999738---876516677633455432200132
Q ss_pred CCCCEEECCCCCCEEEECCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHC-C
Q ss_conf 41324411489505762357786686777989-978544206699999999968999999988830099999998513-5
Q 001752 857 FGLARMMIRKNETVSMVAGSYGYIAPEYGYTL-KVDEKIDIYSFGVVLLELLTGRRPLDPEFGESVDIVEWIRMKIRD-N 934 (1018)
Q Consensus 857 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~ 934 (1018)
||.+... ........|++.|+|||...+. .++.++||||+||++|+|++|+.||.+... ......+...... .
T Consensus 165 fg~a~~~---~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~--~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 165 FGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTPG 239 (348)
T ss_dssp C----CC---TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCC
T ss_pred CCHHCCC---CCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHCCCCC
T ss_conf 1000125---75444434543555835533775678551243205899999768899788988--999999997307997
Q ss_pred CCCC---------CCCC--CCCCCCCH---HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHCCC
Q ss_conf 6300---------1149--99889920---39999999999987127999999998999999--40059
Q 001752 935 RNLE---------EALD--PNVGNCKH---VQEEMLLVLRIAFLCTAKLPKDRPSMRDVITM--LGEAK 987 (1018)
Q Consensus 935 ~~~~---------~~~~--~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~~~ 987 (1018)
.... .... +....... .......+.+++.+|++.||.+|||++|++++ +++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 577320010244544430355787555662678999999999997758834593899985599548799
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=282.72 Aligned_cols=269 Identities=21% Similarity=0.240 Sum_probs=193.0
Q ss_pred HCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCC-----------CCCCCEEEE
Q ss_conf 226534444107880299999189992999999522234321002666999999982367-----------887012554
Q 001752 705 ACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-----------HRNIVRLLG 773 (1018)
Q Consensus 705 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~ 773 (1018)
++|++.+.||+|+||+||+|++..+++.||||++... ......+.+|+.+++.++ |+||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC-----CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEE
T ss_conf 8579989975077818999999999979999998343-----13368999999999984014555554227676478998
Q ss_pred EEEC--CCCEEEEEEECCCCCHHH-HHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCCEEEECCCCCCEEECCC
Q ss_conf 6864--991399997147999777-630387775333899999999999999997621-999991960479996877599
Q 001752 774 FLHN--DTNMMIVYEYMNNGSLGE-ALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHH-DCYPPIIHRDIKSNNILLDSN 849 (1018)
Q Consensus 774 ~~~~--~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~dlk~~NIll~~~ 849 (1018)
++.. ....+++++++..+.... ...... ...+++..+..++.|++.|++|||+ . ||+||||||+||+++.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIV 162 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEE
T ss_pred EEEECCCCCEEEEEEECCCCCCCCCCCCCCC--CCCCCHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECC
T ss_conf 7631256520234320003542000001223--467868999999999999988876405---86465677057056305
Q ss_pred CC------EEECCCCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC-CCC
Q ss_conf 98------09925413244114895057623577866867779899785442066999999999689999999888-300
Q 001752 850 LE------PRIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLTGRRPLDPEFGE-SVD 922 (1018)
Q Consensus 850 ~~------~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~-~~~ 922 (1018)
+. ++++|||.+.... .......|++.|+|||+..+..++.++||||+||++++|++|+.||.+.... ...
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYD---EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETT---BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CCCCCCCEEEEEECCCCCCCC---CCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf 765644305675314421234---45422366521057132146677764320123789999987889989875543210
Q ss_pred ----HHHHHHHH-------HHCCCCCCCCCC---------CCC---------CCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf ----99999998-------513563001149---------998---------8992039999999999987127999999
Q 001752 923 ----IVEWIRMK-------IRDNRNLEEALD---------PNV---------GNCKHVQEEMLLVLRIAFLCTAKLPKDR 973 (1018)
Q Consensus 923 ----~~~~~~~~-------~~~~~~~~~~~~---------~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~R 973 (1018)
+...+... ..........++ ... ............+.+++.+|++.||.+|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHC
T ss_conf 26899999998379987886245322000132012202432357764442100015674358999999999877994579
Q ss_pred CCHHHHHHH--HHCC
Q ss_conf 998999999--4005
Q 001752 974 PSMRDVITM--LGEA 986 (1018)
Q Consensus 974 Pt~~eil~~--L~~~ 986 (1018)
||++|++++ +++.
T Consensus 320 pta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 320 ADAGGLVNHPWLKDT 334 (362)
T ss_dssp BCHHHHHTCGGGTTC
T ss_pred CCHHHHHCCCCCCCC
T ss_conf 089999669340789
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.1e-42 Score=246.44 Aligned_cols=188 Identities=30% Similarity=0.494 Sum_probs=110.1
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 434625442455657775366898752367614772357897000289876-3023457733478975457888655320
Q 001752 434 EKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNL-QTFIVSNNNLVGEIPDQFQDCPSLSVLD 512 (1018)
Q Consensus 434 ~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 512 (1018)
..|+.+++++|.+....+..+..++.++.+++++|.+.+.+|..+..+..+ +.+.+++|++++..+..+..+.. ..++
T Consensus 125 ~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~ 203 (313)
T d1ogqa_ 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVD 203 (313)
T ss_dssp TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEE
T ss_pred HHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCC
T ss_conf 110011112245555685122067400000023553356203121443112323102246435332433222222-2333
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf 23620368889721000234516324620138731000258845144055652368879788898999549930880557
Q 001752 513 LSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEG 592 (1018)
Q Consensus 513 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~l~~ 592 (1018)
++.|...+.+|..+..++.++.+++++|.+.+.++ .+..+++|+.|+|++|++++.+|..+..+++|++|++++|+|+|
T Consensus 204 l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g 282 (313)
T d1ogqa_ 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCC
T ss_conf 33343322222222222221112222222222222-22245544444476570666087688479999989795883516
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 7899743344477788888678888888988
Q 001752 593 PVPANGVLRTINRGDLAGNAGLCGGVLHPCS 623 (1018)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~N~~~C~~~l~~~~ 623 (1018)
.+|..+.+..++.+++.||+.+||.|++.|.
T Consensus 283 ~iP~~~~L~~L~~l~l~~N~~l~g~plp~c~ 313 (313)
T d1ogqa_ 283 EIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313 (313)
T ss_dssp ECCCSTTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCC
T ss_conf 6898666799897886889500198988989
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=5.6e-38 Score=222.13 Aligned_cols=82 Identities=23% Similarity=0.244 Sum_probs=36.1
Q ss_pred CCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 68888888768887678888211078998699864034589886445677888363168987776331123566665367
Q 001752 96 RLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETL 175 (1018)
Q Consensus 96 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 175 (1018)
.+.+|++|++++++|.+. +.+..+++|++|++++|++++. | .++.+++|++|++++|.+.+.. .++++++|+.|
T Consensus 42 ~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L 115 (384)
T d2omza2 42 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGL 115 (384)
T ss_dssp HHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEE
T ss_pred HHCCCCEEECCCCCCCCC--CCCCCCCCCCEEECCCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCC
T ss_conf 957878998999898776--2424589999896818817988-6-3347711010301343332222--11123343334
Q ss_pred ECCCCCCC
Q ss_conf 12485347
Q 001752 176 DLRGSFFQ 183 (1018)
Q Consensus 176 ~L~~n~l~ 183 (1018)
+++++.+.
T Consensus 116 ~~~~~~~~ 123 (384)
T d2omza2 116 TLFNNQIT 123 (384)
T ss_dssp ECCSSCCC
T ss_pred CCCCCCCC
T ss_conf 43322222
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=2.5e-38 Score=224.01 Aligned_cols=96 Identities=20% Similarity=0.223 Sum_probs=48.5
Q ss_pred ECCCCCCCCCCCHHHHCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 76888767888821107899869986403458988644567788836316898777633112356666536712485347
Q 001752 104 NLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQ 183 (1018)
Q Consensus 104 ~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 183 (1018)
.+..+++.+.+. ...+.+|++|+++++.++. + ..+..+++|++|++++|+++++. .++++++|++|++++|.+.
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred HHCCCCCCCCCC--HHHHCCCCEEECCCCCCCC-C-CCCCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCC
T ss_conf 867777788639--8895787899899989877-6-24245899998968188179886--3347711010301343332
Q ss_pred CCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 666612346464453420164258
Q 001752 184 GSIPVSFKNLQKLKFLGLSGNNLT 207 (1018)
Q Consensus 184 ~~~p~~~~~l~~L~~L~L~~n~l~ 207 (1018)
+.. .+.++++|+.|+++++.++
T Consensus 102 ~i~--~l~~l~~L~~L~~~~~~~~ 123 (384)
T d2omza2 102 DIT--PLANLTNLTGLTLFNNQIT 123 (384)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCC
T ss_pred CCC--CCCCCCCCCCCCCCCCCCC
T ss_conf 222--1112334333443322222
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-35 Score=207.89 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=121.6
Q ss_pred CCCCC-CEEEEEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEEEECCCCC
Q ss_conf 99998-31265873899988999759998876432223568888888768887678888211078998699864034589
Q 001752 58 LPSAH-CNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNG 136 (1018)
Q Consensus 58 ~~~~~-c~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~ 136 (1018)
+|..| |.|++|.|+. .+++.++ ..+ .+.+++|+|++|+|+.+.+.+|.++++|++|++++|.+..
T Consensus 4 ~p~~c~c~~~~~~C~~-----------~~L~~lP-~~l--~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~ 69 (305)
T d1xkua_ 4 CPFRCQCHLRVVQCSD-----------LGLEKVP-KDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69 (305)
T ss_dssp CCTTCEEETTEEECTT-----------SCCCSCC-CSC--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCCEECCCEEEECC-----------CCCCCCC-CCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC
T ss_conf 9998895599998559-----------9988519-888--9997989784991898696576046565231123443445
Q ss_pred CCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 88644567788836316898777633112356666536712485347666612346464453420164258988762464
Q 001752 137 SFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQ 216 (1018)
Q Consensus 137 ~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~ 216 (1018)
..|..|..++.|++|++++|+++.+... ....+..|++..|.+....+..+.....+..+....|.....
T Consensus 70 i~~~~f~~l~~L~~L~l~~n~l~~l~~~---~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~------- 139 (305)
T d1xkua_ 70 ISPGAFAPLVKLERLYLSKNQLKELPEK---MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS------- 139 (305)
T ss_dssp BCTTTTTTCTTCCEEECCSSCCSBCCSS---CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG-------
T ss_pred CCHHHHHCCCCCCEECCCCCCCCCCCCC---HHHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCC-------
T ss_conf 2356652798557831568756767640---011132321024610234444540133110000123333346-------
Q ss_pred CCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEE
Q ss_conf 55301322001335788882434756643212324226744760014978544687048967866882111888777665
Q 001752 217 LSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQNNFQGRLPAEIGNITSLQLLD 296 (1018)
Q Consensus 217 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~ 296 (1018)
...+..+..+++|+.+++++|.+.. ++.. ..++++.|++.+|......+..+..++.++.|+
T Consensus 140 ---------------~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~ 201 (305)
T d1xkua_ 140 ---------------GIENGAFQGMKKLSYIRIADTNITT-IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201 (305)
T ss_dssp ---------------GBCTTGGGGCTTCCEEECCSSCCCS-CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEE
T ss_pred ---------------CCCCCCCCCCCCCCCCCCCCCCCCC-CCCC--CCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCC
T ss_conf ---------------7776422345656712034677451-6710--177667898978867788826764134133015
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 5378776446974225667735643357353535899888874454773157244
Q 001752 297 LSYNMLSHEIPAEITQLKNLQLLNLMCNQLSGHVPAGLGGLTQLEVLELWNNSLS 351 (1018)
Q Consensus 297 Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 351 (1018)
+++|.+.+..+..+..+++|++|+|++|.++ .+|..+..+++|++|++++|+|+
T Consensus 202 ~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp CCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCC
T ss_conf 4455332223454334433224302554002-46311033467898989898657
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-34 Score=202.34 Aligned_cols=109 Identities=21% Similarity=0.297 Sum_probs=50.5
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 87630234577334789754578886553202362036888972100023451632462013873100025884514405
Q 001752 482 PNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDL 561 (1018)
Q Consensus 482 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 561 (1018)
++|+.|++++|.+....+..|..++.++.|++++|.+.+..+..+.++++|++|+|++|+|+ .+|.+|..+++|+.|+|
T Consensus 171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~L 249 (305)
T d1xkua_ 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249 (305)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEEC
T ss_conf 76678989788677888267641341330154455332223454334433224302554002-46311033467898989
Q ss_pred CCCCCCCCCCCCC------CCCCCCCEEEECCCCCC
Q ss_conf 5652368879788------89899954993088055
Q 001752 562 SNNSLTGGIPENF------GASPALEVLNVSYNRLE 591 (1018)
Q Consensus 562 s~N~l~~~~~~~~------~~~~~L~~l~l~~N~l~ 591 (1018)
++|+|+......| ...++|+.+++++|+++
T Consensus 250 s~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CCCCCCCCCHHHCCCCCHHCCCCCCCEEECCCCCCC
T ss_conf 898657638100267210021588897889899576
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-34 Score=203.94 Aligned_cols=154 Identities=21% Similarity=0.174 Sum_probs=55.6
Q ss_pred CCCEEECCCCCCCCCCCHHHHCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEECCC-CCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 88888768887678888211078998699864034589886445677888363168-98777633112356666536712
Q 001752 99 SLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNAS-GNNFSGFLLEDLGNATSLETLDL 177 (1018)
Q Consensus 99 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~-~n~l~~~~~~~l~~l~~L~~L~L 177 (1018)
.+++|+|++|+|+.+.+.+|.++++|++|++++|.+....+..+..+..+..+... .+.+..+.+..|+++++|++|++
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEEC
T ss_conf 98889774881798797786414213000013445433211121222222222222102235446201010102778756
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 485347666612346464453420164258988762464553013220013357888824347566432123242
Q 001752 178 RGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVG 252 (1018)
Q Consensus 178 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 252 (1018)
++|.+....+..+....+|+.+++++|.+++..+..|..+++|+.|++++|++....+..|.++++|+.+++++|
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N 187 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHC
T ss_conf 885443201353320001211020014314458057404340502231417656625666546563413142114
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-33 Score=195.03 Aligned_cols=203 Identities=25% Similarity=0.247 Sum_probs=108.0
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 44188624775468876567875434625442455657775366898752367614772357897000289876302345
Q 001752 411 SLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVS 490 (1018)
Q Consensus 411 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 490 (1018)
.+.+++.+++.++. +|..+. +.+++|+|++|.|++..+..|..+++|+.|+|++|+|+.. + .+..+++|+.|+++
T Consensus 11 ~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECC
T ss_pred CCEEEECCCCCCCE-ECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCC
T ss_conf 98699806999886-196757--6889898849928985977863456552213566544443-1-11112232111112
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 77334789754578886553202362036888972100023451632462013873100025884514405565236887
Q 001752 491 NNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGI 570 (1018)
Q Consensus 491 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 570 (1018)
+|+++ ..+..+..+++|+.|++++|.+....+..+..+.+++.|++++|.+....+..+..++.++.+++++|+|++..
T Consensus 86 ~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~ 164 (266)
T d1p9ag_ 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP 164 (266)
T ss_dssp SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred CCCCC-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCC
T ss_conf 22221-11112122222222222223110110011222211112212434210221233322111000000015652237
Q ss_pred CCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 9788898999549930880557789974334447778888867888888
Q 001752 571 PENFGASPALEVLNVSYNRLEGPVPANGVLRTINRGDLAGNAGLCGGVL 619 (1018)
Q Consensus 571 ~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~N~~~C~~~l 619 (1018)
+..|..+++|++|++++|+|+..++....+..++.+++.||||.|+|.+
T Consensus 165 ~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 165 AGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred CCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCCCEEEECCCCCCCCCCH
T ss_conf 2001342124234301397855686677788899998369998788643
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.8e-30 Score=179.05 Aligned_cols=114 Identities=27% Similarity=0.216 Sum_probs=43.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 02898763023457733478975457888655320236203688897210002345163246201387310002588451
Q 001752 478 ILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLA 557 (1018)
Q Consensus 478 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 557 (1018)
+..+++|+.|++++|.+....+..+..+.++..|++++|.++...+..+..++.|+.|++++|++++..+..|..+++|+
T Consensus 96 ~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~ 175 (266)
T d1p9ag_ 96 GQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175 (266)
T ss_dssp TTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCC
T ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 12222222222222311011001122221111221243421022123332211100000001565223720013421242
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf 44055652368879788898999549930880557
Q 001752 558 ILDLSNNSLTGGIPENFGASPALEVLNVSYNRLEG 592 (1018)
Q Consensus 558 ~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~l~~ 592 (1018)
.|+|++|+|+ .+|..+..+++|+.|++++|+|.+
T Consensus 176 ~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp EEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred EEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCCC
T ss_conf 3430139785-568667778889999836999878
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.95 E-value=1.2e-24 Score=148.77 Aligned_cols=95 Identities=28% Similarity=0.355 Sum_probs=40.5
Q ss_pred CCCEEECCCCCCCCCCCHHHHCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 88888768887678888211078998699864034589886445677888363168987776331123566665367124
Q 001752 99 SLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLR 178 (1018)
Q Consensus 99 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 178 (1018)
++++|+|++++++. +|+ .+++|++|++++|+++ .+|..+ .+|+.|++++|.++.+. .+ .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~~-lp~---~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l~--~l--p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPE---LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKALS--DL--PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCS---CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCCC--SC--CTTCCEEECC
T ss_pred CCCEEEECCCCCCC-CCC---CCCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCCHHH--HH--CCCCCCCCCC
T ss_conf 99899937999887-889---8789888989999796-336203---32033266551432032--10--2211111334
Q ss_pred CCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 85347666612346464453420164258
Q 001752 179 GSFFQGSIPVSFKNLQKLKFLGLSGNNLT 207 (1018)
Q Consensus 179 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 207 (1018)
+|.+. .+| .+..+++|+.|++++|.+.
T Consensus 107 ~n~l~-~lp-~~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 107 NNQLE-KLP-ELQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp SSCCS-SCC-CCTTCTTCCEEECCSSCCS
T ss_pred CCCCC-CCC-CHHHHCCCEEECCCCCCCC
T ss_conf 55432-221-0011013123113565100
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.95 E-value=5e-25 Score=150.91 Aligned_cols=34 Identities=24% Similarity=0.240 Sum_probs=15.2
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCEECCCCCCCCC
Q ss_conf 98699864034589886445677888363168987776
Q 001752 123 SLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSG 160 (1018)
Q Consensus 123 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 160 (1018)
++++|||+++.++ .+|.. +++|++|++++|+++.
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~ 72 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTE 72 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSS
T ss_pred CCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCCC
T ss_conf 9989993799988-78898---7898889899997963
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=3.5e-27 Score=162.76 Aligned_cols=174 Identities=14% Similarity=0.102 Sum_probs=119.7
Q ss_pred CCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCC--------------CCCHHHHHHHHHHHHHCCCCCCCCEEEE
Q ss_conf 53444410788029999918999299999952223432--------------1002666999999982367887012554
Q 001752 708 RESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADL--------------ETESSGDFVGEVNVLGKLRHRNIVRLLG 773 (1018)
Q Consensus 708 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~~~~~E~~~l~~l~hpniv~~~~ 773 (1018)
.+.+.||+|+||+||+|.+. +++.||||+++...... .......+..|...+.++.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred HHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 22778024856599999979-99999999986044346665565630008889999997789999999816999144998
Q ss_pred EEECCCCEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEE
Q ss_conf 68649913999971479997776303877753338999999999999999976219999919604799968775999809
Q 001752 774 FLHNDTNMMIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCYPPIIHRDIKSNNILLDSNLEPR 853 (1018)
Q Consensus 774 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 853 (1018)
+.. .+++|||+++..+.+. +......++.|++.+++|||+. ||+||||||+||+++++ .++
T Consensus 82 ~~~----~~lvme~~~~~~~~~l-----------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EET----TEEEEECCCCEEGGGC-----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred ECC----CEEEEEEECCCCCCCH-----------HHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEE
T ss_conf 628----8899995045654200-----------1578999999999999998268---88983689036114289-899
Q ss_pred ECCCCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 925413244114895057623577866867779899785442066999999
Q 001752 854 IADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLL 904 (1018)
Q Consensus 854 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ 904 (1018)
++|||.|.....+.... ....... ...+ ...+.++.++|+||..--+.
T Consensus 143 liDFG~a~~~~~~~~~~-~l~rd~~-~~~~-~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 143 IIDFPQSVEVGEEGWRE-ILERDVR-NIIT-YFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp ECCCTTCEETTSTTHHH-HHHHHHH-HHHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred EEECCCCCCCCCCCCHH-HHHHHHH-HHHH-HHCCCCCCCCCHHHHHHHHH
T ss_conf 98778843089987099-9987799-9999-97578998446899999874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=6.2e-31 Score=183.39 Aligned_cols=108 Identities=21% Similarity=0.305 Sum_probs=46.6
Q ss_pred CCEEECCCCCCCCC-CCHHHHCCCCCCEEEEEECCCCCC----CCCCCCCCCCCCEECCCCCCCCCCCCC----CCC-CC
Q ss_conf 88887688876788-882110789986998640345898----864456778883631689877763311----235-66
Q 001752 100 LTSLNLCCNGLFSS-LPNSLANLTSLKRFDVSQNFLNGS----FPAGLGGAAGLTFLNASGNNFSGFLLE----DLG-NA 169 (1018)
Q Consensus 100 L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~~~----~l~-~l 169 (1018)
|+.|++++|+++.. ....+..+++++.|+|++|.++.. +...+...++|++|+|++|.++..... .+. ..
T Consensus 4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~ 83 (460)
T d1z7xw1 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS 83 (460)
T ss_dssp EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTT
T ss_pred CCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCCC
T ss_conf 77798208958868999999767799999828999988999999999853999888979598597289999999984378
Q ss_pred CCCCEEECCCCCCCCC----CCCCCCCCCCCCEEEECCCCCC
Q ss_conf 6653671248534766----6612346464453420164258
Q 001752 170 TSLETLDLRGSFFQGS----IPVSFKNLQKLKFLGLSGNNLT 207 (1018)
Q Consensus 170 ~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~n~l~ 207 (1018)
.+|++|+|++|.++.. ++.++..+++|++|+|++|.+.
T Consensus 84 ~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 84 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf 877887788877543221012110000343200244433202
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.7e-30 Score=181.00 Aligned_cols=110 Identities=19% Similarity=0.251 Sum_probs=68.4
Q ss_pred CEEEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCC----CCHHHHCCCCCCEEEEEECCCCCCC----CCCCCC-
Q ss_conf 8899975999887643-22235688888887688876788----8821107899869986403458988----644567-
Q 001752 75 AVEKLDLSHMNLSGCV-SDHFQRLKSLTSLNLCCNGLFSS----LPNSLANLTSLKRFDVSQNFLNGSF----PAGLGG- 144 (1018)
Q Consensus 75 ~v~~l~l~~~~l~~~~-~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~Ls~n~l~~~~----p~~l~~- 144 (1018)
+++.||+++++++... ..-+..++++++|+|++|+|+.. +...+..+++|++|||++|.++... ...+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCCEECCCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 78883631689877763----31123566665367124853476
Q 001752 145 AAGLTFLNASGNNFSGF----LLEDLGNATSLETLDLRGSFFQG 184 (1018)
Q Consensus 145 l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~ 184 (1018)
..+|++|+|++|.++.. ++..+..+++|++|++++|.+..
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHH
T ss_conf 88778877888775432210121100003432002444332023
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.92 E-value=2.8e-24 Score=146.80 Aligned_cols=180 Identities=21% Similarity=0.211 Sum_probs=127.9
Q ss_pred CCCCC-CEEEEEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CCCHHHHCCCCCCEEEEEECCCC
Q ss_conf 99998-31265873899988999759998876432223568888888768887678-88821107899869986403458
Q 001752 58 LPSAH-CNWTGVWCNSNGAVEKLDLSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFS-SLPNSLANLTSLKRFDVSQNFLN 135 (1018)
Q Consensus 58 ~~~~~-c~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~l~ 135 (1018)
+|..| |.|+.|.| ++++++.++. .+ .+++++|+|++|.|+. ..+..|.++++|+.|+|++|.+.
T Consensus 2 CP~~C~C~~~~v~C-----------s~~~L~~iP~-~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~ 67 (192)
T d1w8aa_ 2 CPAMCHCEGTTVDC-----------TGRGLKEIPR-DI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67 (192)
T ss_dssp CCTTSEEETTEEEC-----------TTSCCSSCCS-CC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC
T ss_pred CCCCCEECCCEEEE-----------ECCCCCCCCC-CC--CCCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCC
T ss_conf 39998976999997-----------0899670298-98--9787889848987755302002578762721301363221
Q ss_pred CCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 98864456778883631689877763311235666653671248534766661234646445342016425898876246
Q 001752 136 GSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELG 215 (1018)
Q Consensus 136 ~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~ 215 (1018)
...+..+..+++|++|+|++|+++.+.+..|.++++|++|+|++|.++...+.+|.++++|++|+|++|.+...... ..
T Consensus 68 ~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~ 146 (192)
T d1w8aa_ 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AW 146 (192)
T ss_dssp CBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HH
T ss_pred CCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCH-HH
T ss_conf 21212221122221010035534434979980797465524577453535977856875334200036443435302-77
Q ss_pred CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 4553013220013357888824347566432123242267
Q 001752 216 QLSSMETMILAYNEFDGEIPVEFGNLTNLKYLDLAVGNLG 255 (1018)
Q Consensus 216 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 255 (1018)
-...++.+.+..+.+....|.. +..++.++++.+.+.
T Consensus 147 ~~~~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 147 FAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK 183 (192)
T ss_dssp HHHHHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCC
T ss_pred HHHHHHHHCCCCCCEEECCCHH---HCCCEEEECCHHHCC
T ss_conf 7642354035689827689843---369886144875575
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=6.3e-24 Score=144.88 Aligned_cols=37 Identities=16% Similarity=0.213 Sum_probs=18.3
Q ss_pred CCCEEECCCCCCCCCCCHHHHCCCCCCEEEEEECCCC
Q ss_conf 8888876888767888821107899869986403458
Q 001752 99 SLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLN 135 (1018)
Q Consensus 99 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~ 135 (1018)
++++|++++|.|..+.+.+|.++++|++|++++|.+.
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~ 66 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 66 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTC
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCC
T ss_conf 8899987699189649668614643232110221124
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.6e-23 Score=140.72 Aligned_cols=84 Identities=17% Similarity=0.197 Sum_probs=29.5
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCEECCCCCCCCCC-CCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEE
Q ss_conf 986998640345898864456778883631689877763-311235666653671248-534766661234646445342
Q 001752 123 SLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGF-LLEDLGNATSLETLDLRG-SFFQGSIPVSFKNLQKLKFLG 200 (1018)
Q Consensus 123 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~ 200 (1018)
++++|++++|.++...+..|.++++|++|++++|.+... .+..|.+++.++++.+.. |.+....+..|.++++|+.++
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 88999876991896496686146432321102211242010011222222222111112343222222122222222223
Q ss_pred ECCCCC
Q ss_conf 016425
Q 001752 201 LSGNNL 206 (1018)
Q Consensus 201 L~~n~l 206 (1018)
+++|.+
T Consensus 110 l~~~~l 115 (242)
T d1xwdc1 110 ISNTGI 115 (242)
T ss_dssp EESCCC
T ss_pred CCHHHH
T ss_conf 421111
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=4.1e-23 Score=140.42 Aligned_cols=203 Identities=20% Similarity=0.372 Sum_probs=0.0
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 66446402464520124899885220434457788754334566441886247754688765678754346254424556
Q 001752 367 LDLSSNSFSGEIPASLCNGGNLTKLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSL 446 (1018)
Q Consensus 367 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 446 (1018)
++++.+.+.+.. .+..+.+|+.|++.+|.++.. ..+..+++|+.|++++|++++..+ +..+++++++++++|.+
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HHHCCCCCCCCC--CHHHCCCCCEEECCCCCCCCC--HHHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCCCCCCC
T ss_conf 984888767757--987848868997779999766--457448888376357853202543--11233432012111222
Q ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 57775366898752367614772357897000289876302345773347897545788865532023620368889721
Q 001752 447 TGGITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSI 526 (1018)
Q Consensus 447 ~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 526 (1018)
+. ...+..++.|+.++++++.. .....+...+.+..+.++++.+....+ +..+++|+.|++++|.+.+..+ +
T Consensus 98 ~~--i~~l~~l~~L~~l~l~~~~~--~~~~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~n~~~~~~~--l 169 (227)
T d1h6ua2 98 KN--VSAIAGLQSIKTLDLTSTQI--TDVTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--L 169 (227)
T ss_dssp SC--CGGGTTCTTCCEEECTTSCC--CCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--G
T ss_pred CC--CCCCCCCCCCCCCCCCCCCC--CCCCHHCCCCCHHHHHCHHHHHCHHHH--HCCCCCCCCCCCCCCCCCCCHH--H
T ss_conf 22--22222222221221222443--311000002301222000000000000--0102111002333333331001--0
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECC
Q ss_conf 0002345163246201387310002588451440556523688797888989995499308
Q 001752 527 ASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPALEVLNVSY 587 (1018)
Q Consensus 527 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~ 587 (1018)
.++++|+.|++++|++++..+ +..+++|+.|+|++|+++...| +..+++|+.|++++
T Consensus 170 ~~l~~L~~L~Ls~n~l~~l~~--l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 170 ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp TTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred CCCCCCEECCCCCCCCCCCHH--HCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEEEEC
T ss_conf 564633564458884177853--4479999989795996899802--03699989897129
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.89 E-value=2.7e-23 Score=141.45 Aligned_cols=109 Identities=22% Similarity=0.290 Sum_probs=46.8
Q ss_pred CCCEEECCCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 34625442455657-77536689875236761477235789700028987630234577334789754578886553202
Q 001752 435 KLQRLELANNSLTG-GITDDIASSTSLSFIDISRNHLRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDL 513 (1018)
Q Consensus 435 ~L~~L~L~~N~l~~-~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 513 (1018)
.+++|+|++|.|++ .....|..+++|+.|++++|.+....+..|..+++|+.|++++|+++...+..|.++++|+.|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCC
T ss_conf 87889848987755302002578762721301363221212122211222210100355344349799807974655245
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 362036888972100023451632462013
Q 001752 514 SSNYFSGSIPSSIASCEKLVNLNLRNNQLT 543 (1018)
Q Consensus 514 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 543 (1018)
++|+|+++.+..|..+++|+.|+|++|.+.
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
T ss_conf 774535359778568753342000364434
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=2.9e-21 Score=130.27 Aligned_cols=179 Identities=21% Similarity=0.299 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEECCCCCCCCC
Q ss_conf 59998876432223568888888768887678888211078998699864034589886445677888363168987776
Q 001752 81 LSHMNLSGCVSDHFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSG 160 (1018)
Q Consensus 81 l~~~~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 160 (1018)
+..+.+++.++. ..+..|++|++++|.+....+ +..+++|++|++++|.+++..+ ++.+++|++|++++|++++
T Consensus 31 l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~ 104 (210)
T d1h6ta2 31 LKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD 104 (210)
T ss_dssp TTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred HCCCCCCCCCCH--HHHCCCCEEECCCCCCCCCHH--HHHCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC
T ss_conf 575765775188--795484589782798887444--7648998987698960258601--1358621201433333212
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 33112356666536712485347666612346464453420164258988762464553013220013357888824347
Q 001752 161 FLLEDLGNATSLETLDLRGSFFQGSIPVSFKNLQKLKFLGLSGNNLTGKIPRELGQLSSMETMILAYNEFDGEIPVEFGN 240 (1018)
Q Consensus 161 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~ 240 (1018)
+. .+.++++|+.|++++|.+... ..+..+++++.++++.|.++ .+..+..+++|+.+++++|++++..+ +.+
T Consensus 105 l~--~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~--~~~~~~~l~~L~~l~l~~n~l~~i~~--l~~ 176 (210)
T d1h6ta2 105 LS--SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP--LAG 176 (210)
T ss_dssp GG--GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GTT
T ss_pred CC--CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCC--CCC
T ss_conf 22--121222111223456532211--22011111222112223334--54310001332100134643025645--367
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 56643212324226744760014978544687048
Q 001752 241 LTNLKYLDLAVGNLGGKIPAELGRLELLEIMFLYQ 275 (1018)
Q Consensus 241 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~ 275 (1018)
+++|+.|++++|.+... ..+..+++|+.|+++.
T Consensus 177 l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 177 LTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209 (210)
T ss_dssp CTTCCEEECCSSCCCBC--GGGTTCTTCSEEEEEE
T ss_pred CCCCCEEECCCCCCCCC--HHHCCCCCCCEEECCC
T ss_conf 89899998979989987--2116999989997118
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=7.2e-21 Score=128.06 Aligned_cols=178 Identities=24% Similarity=0.325 Sum_probs=0.0
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 22043445778875433456644188624775468876567875434625442455657775366898752367614772
Q 001752 390 KLILFNNAFSGPIPVSLSTCHSLVRVRMQNNQLSGTIPVGFGRLEKLQRLELANNSLTGGITDDIASSTSLSFIDISRNH 469 (1018)
Q Consensus 390 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~ 469 (1018)
...++.+.+++.... ..+.+++.|++.+|.+... ..+..+++|++|++++|++++..+ +..+++|+.|++++|.
T Consensus 22 ~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEECH--HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHHCCCCCCCCCCH--HHHCCCCEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCC
T ss_conf 999677877885598--7946878998999999775--202137886757545655667640--1677522311112222
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf 35789700028987630234577334789754578886553202362036888972100023451632462013873100
Q 001752 470 LRSSLPSTILSIPNLQTFIVSNNNLVGEIPDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKA 549 (1018)
Q Consensus 470 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 549 (1018)
+....+ +..+++|+.|++++|.+... ..+..+++|+.|++++|++. ....+..+++|+.|++++|++++..+
T Consensus 96 ~~~~~~--l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~--~~~~l~~~~~L~~L~l~~n~l~~l~~-- 167 (199)
T d2omxa2 96 IADITP--LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS--DISALSGLTSLQQLNFSSNQVTDLKP-- 167 (199)
T ss_dssp CCCCGG--GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC--CCGGGTTCTTCSEEECCSSCCCCCGG--
T ss_pred CCCCCC--CCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHC--CCCCCCCCCCCCCCCCCCCCCCCCCC--
T ss_conf 222211--11122322211122222232--10001223677643111100--23433321111112234555567701--
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 0258845144055652368879788898999549
Q 001752 550 ISMMPTLAILDLSNNSLTGGIPENFGASPALEVL 583 (1018)
Q Consensus 550 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 583 (1018)
+..+++|+.|++++|+++...+ +..+++|++|
T Consensus 168 l~~l~~L~~L~ls~N~i~~i~~--l~~L~~L~~L 199 (199)
T d2omxa2 168 LANLTTLERLDISSNKVSDISV--LAKLTNLESL 199 (199)
T ss_dssp GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEE
T ss_pred CCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCC
T ss_conf 1679989999787997998810--1278998949
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.3e-20 Score=126.68 Aligned_cols=258 Identities=16% Similarity=0.139 Sum_probs=0.0
Q ss_pred CEEECCCCCCCCCCCHHHHCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEECCCCCCCC-CCCCCCCCCCCCCCEEECCC
Q ss_conf 88876888767888821107899869986403458988644567788836316898777-63311235666653671248
Q 001752 101 TSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFS-GFLLEDLGNATSLETLDLRG 179 (1018)
Q Consensus 101 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~L~~ 179 (1018)
+++||+++.+.......+... .+..+.+++..+. ..........+|++|+++++.+. ......+..+++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~~-~~~~lrl~~~~~~-~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMD-QPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHHT-TCSEEECTTCEEC-SCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCCHHHHHHHHC-CCEEEECCCCCCC-CCHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 779789997881479998745-5427465233345-52244256787887889898457779999997487765145234
Q ss_pred CCCCCCCCCCCCCCCCCCEEEECC-CCCCCCCCCCCC-CCCCHHHHHCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 534766661234646445342016-425898876246-455301322001335---788882434756643212324226
Q 001752 180 SFFQGSIPVSFKNLQKLKFLGLSG-NNLTGKIPRELG-QLSSMETMILAYNEF---DGEIPVEFGNLTNLKYLDLAVGNL 254 (1018)
Q Consensus 180 n~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~l~-~l~~L~~L~L~~n~l---~~~~~~~~~~l~~L~~L~L~~n~l 254 (1018)
|.+.+..+..+..+++|+.|++++ +.+++..-..+. .+++|++|+++++.. .+.........++|+.|+++.+..
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred CCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCC
T ss_conf 67986789998518997571510013412355403657887435652245332333220001000111110122135542
Q ss_pred C---CCCCCCCCCCCCCCEEECCCCC-CCCCCCHHHCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 7---4476001497854468704896-7866882111888777665537-877644697422566773564335735353
Q 001752 255 G---GKIPAELGRLELLEIMFLYQNN-FQGRLPAEIGNITSLQLLDLSY-NMLSHEIPAEITQLKNLQLLNLMCNQLSGH 329 (1018)
Q Consensus 255 ~---~~~~~~l~~l~~L~~L~l~~n~-~~~~~p~~l~~l~~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 329 (1018)
. ..+......+++|+.|++++|. +++.....+..+++|++|++++ +.+++.....++.+++|+.|++.++--.+.
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~ 240 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECCCCHHH
T ss_conf 44444343423232221235532234778303333213576877989999978737899972699989896448889899
Q ss_pred CCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCC
Q ss_conf 5899888874454773157244689967788998
Q 001752 330 VPAGLGGLTQLEVLELWNNSLSGPLPVDLGKNSP 363 (1018)
Q Consensus 330 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~~~~ 363 (1018)
.......+++|+. ..+.++...+..++....
T Consensus 241 l~~l~~~lp~L~i---~~~~ls~~~~~~~~~~~~ 271 (284)
T d2astb2 241 LQLLKEALPHLQI---NCSHFTTIARPTIGNKKN 271 (284)
T ss_dssp HHHHHHHSTTSEE---SCCCSCCTTCSSCSSTTC
T ss_pred HHHHHHHCCCCCC---CCCCCCCCCCCCCCCCCC
T ss_conf 9999976843661---686587777885476664
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.77 E-value=3.6e-21 Score=129.76 Aligned_cols=239 Identities=19% Similarity=0.158 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEEECCCCCCCC----------CCCCCCCCCCHHHHHCCC
Q ss_conf 31123566665367124853476----6661234646445342016425898----------876246455301322001
Q 001752 162 LLEDLGNATSLETLDLRGSFFQG----SIPVSFKNLQKLKFLGLSGNNLTGK----------IPRELGQLSSMETMILAY 227 (1018)
Q Consensus 162 ~~~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~----------~p~~l~~l~~L~~L~L~~ 227 (1018)
+...+.....|++|+|++|.+.. .+...+...++|+.|+++++..... +...+...++|+.|++++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
T ss_conf 99999638997889784983778999999999985899888888777543345421067879998875477756330000
Q ss_pred CCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-------------CCCCCCCEEECCCCCCC----CCCCHHH
Q ss_conf 335788----88243475664321232422674476001-------------49785446870489678----6688211
Q 001752 228 NEFDGE----IPVEFGNLTNLKYLDLAVGNLGGKIPAEL-------------GRLELLEIMFLYQNNFQ----GRLPAEI 286 (1018)
Q Consensus 228 n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~l-------------~~l~~L~~L~l~~n~~~----~~~p~~l 286 (1018)
|.++.. +...+...++|++|++++|.+.......+ ...+.|+.+.++.|.+. ..+...+
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l 182 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCHH
T ss_conf 13455433310111002343210000024666654311112122221100014676421110136501355433221111
Q ss_pred CCCCCCCEEECCCCCCCCC-----CCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEEECCCCCCCCCCCC
Q ss_conf 1888777665537877644-----697422566773564335735353----5899888874454773157244689967
Q 001752 287 GNITSLQLLDLSYNMLSHE-----IPAEITQLKNLQLLNLMCNQLSGH----VPAGLGGLTQLEVLELWNNSLSGPLPVD 357 (1018)
Q Consensus 287 ~~l~~L~~L~Ls~n~l~~~-----~p~~l~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 357 (1018)
...+.|+.|++++|.+... +...+...++|+.|++++|.++.. +...+...++|++|++++|.+.+.....
T Consensus 183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~ 262 (344)
T d2ca6a1 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262 (344)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred HHHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHH
T ss_conf 23332133543332222222320024332110121122233332222222234443323221111030047567156678
Q ss_pred C------CCCCCCCEEECCCCCCCCCCCCCCC-----CCCCCCEECCCCCCCCC
Q ss_conf 7------8899885666446402464520124-----89988522043445778
Q 001752 358 L------GKNSPLQWLDLSSNSFSGEIPASLC-----NGGNLTKLILFNNAFSG 400 (1018)
Q Consensus 358 l------~~~~~L~~L~Ls~n~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~ 400 (1018)
+ .....|+.|++++|.++......+. +.+.|+.|++++|++..
T Consensus 263 l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCC
T ss_conf 887763156888898989898698089999999997038999989787980898
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=4.7e-18 Score=112.61 Aligned_cols=85 Identities=18% Similarity=0.045 Sum_probs=28.3
Q ss_pred CCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 56888888876888767888821107899869986403458988644567788836316898777633112356666536
Q 001752 95 QRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSLET 174 (1018)
Q Consensus 95 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 174 (1018)
.+...+++|+|++|+|+.+ ++.+..+++|+.|+|++|.++. + ..+..+++|++|++++|.++.+.+..+..+++|+.
T Consensus 15 ~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp ECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred CCCCCCCEEECCCCCCCCC-CCCCCCCCCCCEEECCCCCCCC-C-CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 6857484897889978865-7620041459989897997876-4-77445761306431021345777632233453443
Q ss_pred EECCCCCC
Q ss_conf 71248534
Q 001752 175 LDLRGSFF 182 (1018)
Q Consensus 175 L~L~~n~l 182 (1018)
|++++|.+
T Consensus 92 L~L~~N~i 99 (162)
T d1a9na_ 92 LILTNNSL 99 (162)
T ss_dssp EECCSCCC
T ss_pred CEECCCCC
T ss_conf 42030001
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=1.5e-16 Score=104.39 Aligned_cols=20 Identities=20% Similarity=0.340 Sum_probs=6.4
Q ss_pred HHHHCCCCCCEEEEEECCCC
Q ss_conf 21107899869986403458
Q 001752 116 NSLANLTSLKRFDVSQNFLN 135 (1018)
Q Consensus 116 ~~~~~l~~L~~L~Ls~n~l~ 135 (1018)
++|.++++|+.|+|++|.|+
T Consensus 50 ~~f~~l~~L~~L~Ls~N~l~ 69 (156)
T d2ifga3 50 RDLRGLGELRNLTIVKSGLR 69 (156)
T ss_dssp GGSCSCCCCSEEECCSSCCC
T ss_pred HHHCCCCCCCCCEEECCCCC
T ss_conf 12256666672162021247
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.64 E-value=2.1e-16 Score=103.49 Aligned_cols=12 Identities=42% Similarity=0.742 Sum_probs=3.8
Q ss_pred CCCCEEEECCCC
Q ss_conf 644534201642
Q 001752 194 QKLKFLGLSGNN 205 (1018)
Q Consensus 194 ~~L~~L~L~~n~ 205 (1018)
++|+.|++++|.
T Consensus 90 ~~L~~L~l~~N~ 101 (124)
T d1dcea3 90 PRLVLLNLQGNS 101 (124)
T ss_dssp TTCCEEECTTSG
T ss_pred CCCCEEECCCCC
T ss_conf 999999897996
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=2.1e-15 Score=98.01 Aligned_cols=89 Identities=22% Similarity=0.208 Sum_probs=33.2
Q ss_pred CCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 578886553202362-0368889721000234516324620138731000258845144055652368879788898999
Q 001752 502 FQDCPSLSVLDLSSN-YFSGSIPSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTGGIPENFGASPAL 580 (1018)
Q Consensus 502 ~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L 580 (1018)
+..+++|+.|++++| .|+.+.+..|.++++|+.|++++|+|+...+.+|..+++|+.|+|++|+|+...+..|... .|
T Consensus 27 l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~-~l 105 (156)
T d2ifga3 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SL 105 (156)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC-CC
T ss_pred CCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCCC-CC
T ss_conf 25765657431689866443692122566666721620212477420111245543333226787851574563353-21
Q ss_pred CEEEECCCCCC
Q ss_conf 54993088055
Q 001752 581 EVLNVSYNRLE 591 (1018)
Q Consensus 581 ~~l~l~~N~l~ 591 (1018)
+.|++++|+|.
T Consensus 106 ~~L~L~~Np~~ 116 (156)
T d2ifga3 106 QELVLSGNPLH 116 (156)
T ss_dssp CEEECCSSCCC
T ss_pred CCCCCCCCCCC
T ss_conf 24335798633
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.59 E-value=8.1e-18 Score=111.30 Aligned_cols=109 Identities=22% Similarity=0.226 Sum_probs=40.3
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 23568888888768887678888211078998699864034589886445677888363168987776331123566665
Q 001752 93 HFQRLKSLTSLNLCCNGLFSSLPNSLANLTSLKRFDVSQNFLNGSFPAGLGGAAGLTFLNASGNNFSGFLLEDLGNATSL 172 (1018)
Q Consensus 93 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 172 (1018)
++..+++|++|+|++|+|..+ + .+..+++|++|+|++|.++ .+|.....+.+|++|++++|.++.+ +.+..+++|
T Consensus 43 sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L 117 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNL 117 (198)
T ss_dssp HHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHS
T ss_pred HHHCCCCCCEEECCCCCCCCC-C-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCC
T ss_conf 776260461519944689986-4-4247825357341353432-1000033221233333333222222--222222234
Q ss_pred CEEECCCCCCCCCCC-CCCCCCCCCCEEEECCCCC
Q ss_conf 367124853476666-1234646445342016425
Q 001752 173 ETLDLRGSFFQGSIP-VSFKNLQKLKFLGLSGNNL 206 (1018)
Q Consensus 173 ~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~n~l 206 (1018)
+.|++++|.++.... ..+..+++|+.|+|++|.+
T Consensus 118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l 152 (198)
T d1m9la_ 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHH
T ss_pred CCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCC
T ss_conf 11123410212554221236777630234279843
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.58 E-value=6.9e-18 Score=111.66 Aligned_cols=20 Identities=25% Similarity=0.408 Sum_probs=7.5
Q ss_pred HHHHCCCCCCEEEEEECCCC
Q ss_conf 21107899869986403458
Q 001752 116 NSLANLTSLKRFDVSQNFLN 135 (1018)
Q Consensus 116 ~~~~~l~~L~~L~Ls~n~l~ 135 (1018)
.++..+++|++|+|++|.++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~ 61 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIE 61 (198)
T ss_dssp HHHHHTTTCCEEECSEEEES
T ss_pred HHHHCCCCCCEEECCCCCCC
T ss_conf 67762604615199446899
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.14 E-value=4.6e-10 Score=68.64 Aligned_cols=145 Identities=16% Similarity=0.079 Sum_probs=95.4
Q ss_pred HHHCCCCCCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCC-CCCCCEEEEEEECCCCE
Q ss_conf 86226534444107880299999189992999999522234321002666999999982367-88701255468649913
Q 001752 703 ILACIRESNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 703 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 781 (1018)
....|+..+..+.++.+.||+... .++.+.+|+.... .......+.+|...+..+. +--+++++.+..+++..
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~----~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSR----YKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGG----GTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHCEEEEECCCCCCCCCEEEEEE--CCCEEEEEECCCC----CCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf 513527997678998771899990--8986999984887----6532556999999999876069987289997508964
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCC------------------------------
Q ss_conf 99997147999777630387775333899999999999999997621999------------------------------
Q 001752 782 MIVYEYMNNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCY------------------------------ 831 (1018)
Q Consensus 782 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~------------------------------ 831 (1018)
++||++++|.++.+...... . ...++.+++..++.||+...
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~------~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ------S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS------C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEECCCCCCCCCCCCCC------C---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_conf 99998604334354334402------6---99999989999999855684214357644656555778998776555543
Q ss_pred --------------------------CCEEEECCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf --------------------------9919604799968775999809925413244
Q 001752 832 --------------------------PPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 832 --------------------------~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~ 862 (1018)
..++|+|+.+.||++++++...++||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 033232005799999999844986781789860047642364996599960231441
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.04 E-value=9.3e-12 Score=77.99 Aligned_cols=65 Identities=29% Similarity=0.245 Sum_probs=27.6
Q ss_pred CCCCCCEEECCCCCCCCCC--CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 8886553202362036888--9721000234516324620138731000258845144055652368
Q 001752 504 DCPSLSVLDLSSNYFSGSI--PSSIASCEKLVNLNLRNNQLTGDIPKAISMMPTLAILDLSNNSLTG 568 (1018)
Q Consensus 504 ~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 568 (1018)
.++.|++|+|++|+|+... +..+..+++|+.|+|++|.|+...+..+.....|+.|++++|+++.
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred HCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCC
T ss_conf 4878788637776666773158898658856100043572134234422203310426648997676
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.92 E-value=4.8e-11 Score=74.05 Aligned_cols=66 Identities=30% Similarity=0.326 Sum_probs=27.1
Q ss_pred CCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 28987630234577334789--7545788865532023620368889721000234516324620138
Q 001752 479 LSIPNLQTFIVSNNNLVGEI--PDQFQDCPSLSVLDLSSNYFSGSIPSSIASCEKLVNLNLRNNQLTG 544 (1018)
Q Consensus 479 ~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 544 (1018)
..+++|++|++++|+++... +..+..+++|+.|++++|.|+...+-.+....+|+.|++++|++..
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred HHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCC
T ss_conf 74878788637776666773158898658856100043572134234422203310426648997676
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.78 E-value=1.2e-08 Score=60.91 Aligned_cols=131 Identities=14% Similarity=0.076 Sum_probs=82.0
Q ss_pred EEECCC-CEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCC--CCCCCEEEEEEECCCCEEEEEEEC
Q ss_conf 441078-80299999189992999999522234321002666999999982367--887012554686499139999714
Q 001752 712 VIGMGA-TGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR--HRNIVRLLGFLHNDTNMMIVYEYM 788 (1018)
Q Consensus 712 ~lG~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~ 788 (1018)
.+..|. .+.||+.... .+..+++|..... ....+..|...++.+. .-.+++++.+..+++..++||+++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~-------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred ECCCCCCCCEEEEEEEC-CCCEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEE
T ss_conf 76786547758999938-9878999958966-------776899999999999865999886132224566159998744
Q ss_pred CCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---------------------------------------
Q ss_conf 79997776303877753338999999999999999976219---------------------------------------
Q 001752 789 NNGSLGEALHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHD--------------------------------------- 829 (1018)
Q Consensus 789 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~--------------------------------------- 829 (1018)
+|.++.+... .. ...+.+++..++.||+.
T Consensus 89 ~G~~~~~~~~---------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (255)
T d1nd4a_ 89 PGQDLLSSHL---------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 156 (255)
T ss_dssp SSEETTTSCC---------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred ECCCCCCCCC---------CH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHH
T ss_conf 1355432212---------68---99999999999987368854488755412468899999987541101134011213
Q ss_pred ----------------CCCCEEEECCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf ----------------999919604799968775999809925413244
Q 001752 830 ----------------CYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 830 ----------------~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~ 862 (1018)
....++|+|+.+.||+++.+..+.++||+.+..
T Consensus 157 ~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 157 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 7999999998718765795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.73 E-value=1.1e-07 Score=55.51 Aligned_cols=82 Identities=13% Similarity=0.075 Sum_probs=52.6
Q ss_pred CCEEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCC---CCHHHHHHHHHHHHHCCC-C--CCCCEEEEEEECCCCEEE
Q ss_conf 4444107880299999189992999999522234321---002666999999982367-8--870125546864991399
Q 001752 710 SNVIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLE---TESSGDFVGEVNVLGKLR-H--RNIVRLLGFLHNDTNMMI 783 (1018)
Q Consensus 710 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~E~~~l~~l~-h--pniv~~~~~~~~~~~~~l 783 (1018)
.+.||.|....||++.....++.+++|.-........ .....+...|...++.+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEECCCCCH
Q ss_conf 9971479997
Q 001752 784 VYEYMNNGSL 793 (1018)
Q Consensus 784 v~e~~~~gsL 793 (1018)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.32 E-value=3.9e-06 Score=47.04 Aligned_cols=74 Identities=16% Similarity=0.260 Sum_probs=50.1
Q ss_pred CCEEECCCCEEEEEEECCC-------CCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCC-CCCCCEEEEEEECCCCE
Q ss_conf 4444107880299999189-------992999999522234321002666999999982367-88701255468649913
Q 001752 710 SNVIGMGATGIVYKAEMPR-------LNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLR-HRNIVRLLGFLHNDTNM 781 (1018)
Q Consensus 710 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 781 (1018)
.+.++.|-.-.+|++.... ..+.|.+++.- .........+|..+++.+. +.-.+++++++.+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g------~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF------NPETESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC------SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC------CCCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----
T ss_conf 9991785334348999688775445789817999659------961165899999999999757999808998189----
Q ss_pred EEEEEECCCCCH
Q ss_conf 999971479997
Q 001752 782 MIVYEYMNNGSL 793 (1018)
Q Consensus 782 ~lv~e~~~~gsL 793 (1018)
.+|+||++|.++
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEECCCCC
T ss_conf 569997345548
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.17 E-value=1.2e-07 Score=55.33 Aligned_cols=110 Identities=18% Similarity=0.277 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCC-CCCCCC----CCCCCCCCCCCCCCCCCCCCCC----CCCCCCCCCCCCCCEEECCCCCCCCC----
Q ss_conf 8987523676147-723578----9700028987630234577334----78975457888655320236203688----
Q 001752 455 ASSTSLSFIDISR-NHLRSS----LPSTILSIPNLQTFIVSNNNLV----GEIPDQFQDCPSLSVLDLSSNYFSGS---- 521 (1018)
Q Consensus 455 ~~~~~L~~L~Ls~-N~l~~~----~~~~~~~l~~L~~L~l~~N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~~---- 521 (1018)
.+.+.|+.|+|++ +.++.. +...+...+.|++|++++|.+. ..+...+...+.|+.|+|++|.++..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf 28999819782799998989999999997637764540120156215679887531000234330033010214599999
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCC-------CCCCCCCCCCCCEEECCCC
Q ss_conf 897210002345163246201387-------3100025884514405565
Q 001752 522 IPSSIASCEKLVNLNLRNNQLTGD-------IPKAISMMPTLAILDLSNN 564 (1018)
Q Consensus 522 ~~~~~~~l~~L~~L~Ls~N~l~~~-------~~~~~~~l~~L~~L~Ls~N 564 (1018)
+...+...+.|+.|++++|++... +...+...++|+.|+++.+
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCC
T ss_conf 99999848938987788776888657999999999972998538648688
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.00 E-value=3.6e-05 Score=41.75 Aligned_cols=139 Identities=14% Similarity=0.117 Sum_probs=76.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCCC--CEEE-----EEEECCCCEEEEEEEC
Q ss_conf 78802999991899929999995222343210026669999999823678870--1255-----4686499139999714
Q 001752 716 GATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRNI--VRLL-----GFLHNDTNMMIVYEYM 788 (1018)
Q Consensus 716 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni--v~~~-----~~~~~~~~~~lv~e~~ 788 (1018)
+.-..||++... +|+.+++|+.+.. .....++..|...+..+....+ +..+ ......+..+.++++.
T Consensus 33 s~EN~vy~v~~~-dg~~~VlK~~rp~-----~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~ 106 (325)
T d1zyla1 33 SYENRVYQFQDE-DRRRFVVKFYRPE-----RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 106 (325)
T ss_dssp CSSSEEEEECCT-TCCCEEEEEECTT-----TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred CCCCEEEEEECC-CCCEEEEEEECCC-----CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEEC
T ss_conf 612026999838-9997999984787-----7889999999999999985599878752068980566534799998652
Q ss_pred CCCCHHH-----------HH-------HCCC-CCCCCCC----------------------HHHHHHHHHHHHHHHHHH-
Q ss_conf 7999777-----------63-------0387-7753338----------------------999999999999999976-
Q 001752 789 NNGSLGE-----------AL-------HGKQ-AGRLLVD----------------------WVSRYNIALGVAQGLAYL- 826 (1018)
Q Consensus 789 ~~gsL~~-----------~l-------~~~~-~~~~~~~----------------------~~~~~~i~~~i~~~L~~L- 826 (1018)
+|..+.. .+ .... ..+...+ ......++..+...+...
T Consensus 107 ~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~ 186 (325)
T d1zyla1 107 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 186 (325)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 77688999999999989999998863035786556778978876656899987476998898999999999999999845
Q ss_pred HCCCCCCEEEECCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf 219999919604799968775999809925413244
Q 001752 827 HHDCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 827 H~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~ 862 (1018)
.+....+++|+|+.+.||+++++ ..++||+-++.
T Consensus 187 ~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 187 REDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCCCCCEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 45687120247888042878389--35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.78 E-value=0.00013 Score=38.62 Aligned_cols=152 Identities=13% Similarity=0.038 Sum_probs=76.9
Q ss_pred HHHCCCCCC-----EEECCCCEEEEEEECCCCCEEEEEEEEECCCCCCCCCHHHHHHHHHHHHHCCCCCC--CCEEEEE-
Q ss_conf 862265344-----44107880299999189992999999522234321002666999999982367887--0125546-
Q 001752 703 ILACIRESN-----VIGMGATGIVYKAEMPRLNTIVAVKKLWRSRADLETESSGDFVGEVNVLGKLRHRN--IVRLLGF- 774 (1018)
Q Consensus 703 ~~~~~~~~~-----~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~- 774 (1018)
+...|..++ .|..|.--+.|+.... +..+++|++... ....+...|...+..+...+ ++..+..
T Consensus 11 ~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~------~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~ 82 (316)
T d2ppqa1 11 FLTQYDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR------VEKNDLPFFLGLMQHLAAKGLSCPLPLPRK 82 (316)
T ss_dssp HHTTBCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred HHHHCCCCCCEEEECCCCCCCCCEEEEEEC--CCCEEEEECCCC------CCHHHHHHHHHHHHHHHHCCCCCCCCCEEC
T ss_conf 998679998568523788852673899978--972899980789------998899999999875430255545564104
Q ss_pred -----EECCCCEEEEEEECCCCCHHHH--------------HH----CCC----CC---------------CCCCCHHHH
Q ss_conf -----8649913999971479997776--------------30----387----77---------------533389999
Q 001752 775 -----LHNDTNMMIVYEYMNNGSLGEA--------------LH----GKQ----AG---------------RLLVDWVSR 812 (1018)
Q Consensus 775 -----~~~~~~~~lv~e~~~~gsL~~~--------------l~----~~~----~~---------------~~~~~~~~~ 812 (1018)
.........++.+..+...... ++ ... .. .........
T Consensus 83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (316)
T d2ppqa1 83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 162 (316)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHH
T ss_conf 89762134125502453114655333204678888899876454443202453101110120024567777653114127
Q ss_pred HHHHHHHHHHHHHHHC-CCCCCEEEECCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf 9999999999997621-9999919604799968775999809925413244
Q 001752 813 YNIALGVAQGLAYLHH-DCYPPIIHRDIKSNNILLDSNLEPRIADFGLARM 862 (1018)
Q Consensus 813 ~~i~~~i~~~L~~LH~-~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~ 862 (1018)
...+......+..... ..+.|++|+|+.+.||+++++...-+.||+.+..
T Consensus 163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 999999987642048554545033378636564020454126742221236
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.60 E-value=1.7e-06 Score=49.05 Aligned_cols=111 Identities=14% Similarity=0.265 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCC-CCCC----CCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCC----
Q ss_conf 8987523676147-7235----78970002898763023457733478----975457888655320236203688----
Q 001752 455 ASSTSLSFIDISR-NHLR----SSLPSTILSIPNLQTFIVSNNNLVGE----IPDQFQDCPSLSVLDLSSNYFSGS---- 521 (1018)
Q Consensus 455 ~~~~~L~~L~Ls~-N~l~----~~~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~---- 521 (1018)
.+.+.|+.|++++ +.++ ..+...+...+.|++|++++|.+... +...+...+.++.+++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred HCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHH
T ss_conf 55999868876899998989999999888419825743015896117789999987752122101210254322014788
Q ss_pred CCCCCCCCCCCCE--EECCCCCCCC----CCCCCCCCCCCCCEEECCCCC
Q ss_conf 8972100023451--6324620138----731000258845144055652
Q 001752 522 IPSSIASCEKLVN--LNLRNNQLTG----DIPKAISMMPTLAILDLSNNS 565 (1018)
Q Consensus 522 ~~~~~~~l~~L~~--L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~ 565 (1018)
+...+...++|+. |++++|.+.. .+...+...++|+.|+++.+.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 99999848652477321677867679999999999849984788581898
|